Methods for predicting drug responsiveness

Abstract
The present invention provides drug response predictors and biomarkers useful for assessing the responsiveness of a subject to treatment with one or more target drugs of interest, such as 5-fluorouracil (5-FU), irinotecan, and/or oxaliplatin. In particular, the invention provides methods useful in determining whether a subject is sensitive or resistant to a target drug by, e.g., measuring the expression level of one or more biomarkers of sensitivity and/or resistance to the drug in a biological sample obtained from the subject. The invention further features devices and kits for assessing target drug responsiveness in a subject, for example, by determining the expression level of such biomarkers.
Description
FIELD OF THE INVENTION

The invention features methods, devices, and kits for assessing cancer patient responsiveness to chemotherapy drugs.


BACKGROUND

Gene expression analysis can reveal the presence of a disease, such as cancer, in a patient, its type, stage, and origin, and whether genetic mutations are involved. Gene expression analysis can also be used to predict the efficacy of a therapy. For example, the National Cancer Institute (NCI) has tested compounds, including chemotherapy agents, for their effect in limiting the growth of 60 human cancer cell lines. NCI has also measured gene expression in those 60 cancer cell lines using DNA microarrays. Various studies have explored the relationship between gene expression and compound effect using the NCI datasets.


The antimetabolite 5-flourouracil (5-FU) is the standard of care in systemic treatment of primary and metastatic colorectal cancer, with further activity in a wide range of solid tumors, including other gastrointestinal malignancies, breast cancer, head and neck cancers, and ovarian carcinomas. It is manufactured not only as 5-FU, but also as an oral agent, capecitabine, and as a prodrug, tegafur (DeVita et al., DeVita, Hellmann, and Rosenberg's Cancer: Principles and Practice of Oncology, 8th ed., Philadelphia, Lippincott Williams and Wilkins, 2005). 5-FU treatment results in a survival benefit in the adjuvant setting of colorectal cancer (Rougier et al., Ann Oncol. 1993; 4 Suppl 2:21-8). Response rates for 5-FU monotherapy in metastatic colorectal cancer are low (10-15%) (Longley et al., Nat. Rev. Cancer 3: 330-338, 2003), therefore it is currently combined with either topoisomerase-1 inhibitor irinotecan as FOLFIRI regimen or platinum-based oxaliplatin as a FOLFOX regimen and targeted EGFR-inhibitor cetuximab according to KRAS-status. Many rivaling factors at the level of both tumor cell characteristics and patient variability may impact the efficacy of 5-FU (Longley et al., supra). After three decades of examining potential predictive biomarkers, the results are mostly far from any clinical realization.


Adjuvant treatment of stage II to III colorectal cancer patients has stagnated, even with many attempts at introducing new drugs in the past decade (Venook et al., Am. Soc. Clin. Oncol. 83-89, 2014). Biomarkers to assist physicians with respect to prognosis, prediction of treatment efficacy, and expected severe toxicities to antineoplastic treatment of colon cancer are and have long been eagerly awaited. Although research on prognostic biomarkers in colon cancer began as early as 1981, few prognostic biomarkers have been implemented clinically except for carcinoembryonic antigen (CEA) (Ichiki et al., Oncology 38: 27-30, 1981) and microsatellite instability (MSI) (Reimers et al., supra), even though many have been examined (Roth et al., Natl. Cancer Inst. 104: 1635-1646, 2012; Bezulier et al., J. Clin. Pharm. Ther. 28: 403-408, 2003; Watanabe et al., N. Engl. J. Med. 344: 1196-1206, 2001; Allegra et al., J. Clin. Oncol. 20: 1735-1743, 2002).


Furthermore, during chemotherapy for cancers, critical time is often lost due to a trial and error approach to finding an effective therapy. In addition, cancer cells often develop resistance to a previously effective therapy. In such situations, patient outcome would be greatly improved by early detection of such resistance. Thus, there is a need in the art for proven methods, kits, and devices that can be used to predict the sensitivity or resistance of cancer patients to treatment with chemotherapeutic drugs.


SUMMARY OF THE INVENTION

The invention enables the assessment of responsiveness of a subject to treatment with a target drug of interest, e.g., by determining the expression level of one or more biomarkers of sensitivity or resistance to the drug, such as the biomarkers disclosed herein. Exemplary target drugs for which a subject's responsiveness can be assessed by the methods of the present invention include 5-fluorouracil (5-FU), capecitabine, tegafur, irinotecan, oxaliplatin, and derivatives, analogs, and prodrugs thereof.


In a first aspect, the invention features a method of assessing the responsiveness of a subject to treatment with 5-fluorouracil (5-FU) by:


(a) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 2 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 1 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of resistance or the biomarker of sensitivity indicates whether the subject is responsive to the treatment.


In some embodiments, the method further includes, prior to the determining of (a) or (b), providing the one or more biological samples obtained from the subject.


In certain embodiments, the method includes:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 1 in one or more biological samples obtained from the subject; and


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 2 in one or more biological samples obtained from the subject.


In particular embodiments, the difference between the levels of expression of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates whether the subject is responsive to the treatment.


In some embodiments, the method further includes: (c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to 5-FU, administering an effective amount of the 5-FU to the subject.


In a second aspect, the invention features a method of treating a subject by:


(a) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 2 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 1 in one or more biological samples obtained from the subject; and


(c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to 5-FU (e.g., according to the methods of the invention), administering an effective amount of 5-FU to the subject.


In some embodiments, the method includes:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 1 in one or more biological samples obtained from the subject; and


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 2 in one or more biological samples obtained from the subject.


In a third aspect, the invention features a method of treating a subject, the subject having previously been determined to be responsive to treatment with 5-FU by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 1 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 2 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicates whether the subject is responsive to the treatment;


the method including administering an effective amount of 5-FU to the subject.


In some embodiments of any of the above aspects, the method further includes administering one or more additional therapies to the subject.


In some embodiments, the one or more additional therapies is administered concurrently with the administration of 5-FU. In other embodiments, the one or more additional therapies is administered separately from the administration of 5-FU. In certain embodiments, the one or more additional therapies is administered prior to the administration of 5-FU. In alternate embodiments, the one or more additional therapies is administered after the administration of 5-FU. In particular embodiments, the one or more additional therapies is administered within 1 week of the administration of 5-FU (e.g., within about 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours, 24 hours, 36 hours, 2 days, 3 days, 4 days, 5 days, 6 days, or 1 week of the administration of 5-FU).


In some embodiments, the one or more additional therapies includes one or more additional therapeutic agents, surgery, or radiation therapy. In certain embodiments, the one or more additional therapies includes one or more additional therapeutic agents. In particular embodiments, the 5-FU is administered alone or in admixture with the one or more additional therapeutic agents.


In some embodiments, the one or more additional therapeutic agents is selected from the group consisting of: irinotecan, oxaliplatin, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, estramustine, other chemotherapeutic agents known in the art, and combinations thereof. In certain embodiments, the one or more additional therapeutic agents includes everolimus, temsirolimus, bleomycin, or lomustine. In particular embodiments, the one or more therapeutic agents includes leucovorin and at least one of irinotecan or oxaliplatin.


In some embodiments, the one or more additional therapeutic agents is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In various embodiments, the one or more additional therapeutic agents is administered in dosage form.


In some embodiments, the 5-FU is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In certain embodiments, the 5-FU is administered to the subject intravenously.


In some embodiments, the method further includes one or more additional administrations of an effective amount of 5-FU to the subject. In certain embodiments, the 5-FU is administered to the subject once daily. In particular embodiments, the 5-FU is administered to the subject once daily for up to four days. In specific embodiments, the administration of 5-FU is repeated 30 days after the completion of the previous administration. In certain embodiments, the administration of 5-FU is repeated for at least 12 to 60 months (e.g., at least 12 months, 13 months, 14 months, 15 months, 16 months, 17 months, 18 months, 19 months, 20 months, 24 months, 25 months, 30 months, 36 months, 40 months, 48 months, 50 months, or 60 months).


In various embodiments, the 5-FU is administered in dosage form. In certain embodiments, the 5-FU is administered in daily doses of up to 800 mg (e.g., about 50 mg, 100 mg, 150 mg, 200 mg, 250 mg, 300 mg, 400 mg, 500 mg, 600 mg, 700 mg, or 800 mg).


In some embodiments, the determining step (a) or (b) occurs prior to the administration. In alternate embodiments, the determining step (a) or (b) occurs concurrent with the administration. In certain embodiments, the determining step (a) or (b) occurs after the administration. In various embodiments, the determining step (a) or (b) occurs multiple times.


In some embodiments, the administration occurs multiple times. In certain embodiments, each of the determining step (a) or (b) occurs prior to each of the administrations. In other embodiments, each of the determining step (a) or (b) occurs concurrent with each of the administrations. In specific embodiments, each of the determining step (a) or (b) occurs after each of the administrations.


In some embodiments of any of the above aspects, the biomarker of resistance is NT5E. In certain embodiments, the expression level of the NT5E indicates the resistance of the subject to the treatment.


In some embodiments of any of the above aspects, one or more of the biomarkers of resistance is selected from the group consisting of: NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158; and/or one or more of the biomarkers of sensitivity is selected from the group consisting of: APRT, GSR, TUFM, MRPS2, MTHFD2, WDR59, ANP32B, PMM2, STOML2, and NDUFAB1.


In some embodiments of any of the above aspects, one or more of the biomarkers of resistance is selected from the group consisting of: NT5E, CNN3, ACTN1, FLNA, and ATP2B4; and/or one or more of the biomarkers of sensitivity is selected from the group consisting of: APRT, GSR, TUFM, MRPS2, and MTHFD2.


In certain embodiments, the difference between the expression levels of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates the sensitivity of the subject to the treatment. In various embodiments, the expression levels of the one or more biomarkers of sensitivity in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of sensitivity in a control indicates the sensitivity of the subject to the treatment. In particular embodiments, the expression levels of the one or more biomarkers of resistance in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of resistance in a control indicates the resistance of the subject to the treatment. In specific embodiments, the expression level in the subject is significantly higher than in the control. In alternate embodiments, the expression level in the subject is significantly lower than in the control.


In a fourth aspect, the invention features a method of assessing the responsiveness of a subject to treatment with irinotecan by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 3 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 4 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicates whether the subject is responsive to the treatment.


In some embodiments, the method includes, prior to the determining step (a) or (b), providing the one or more biological samples obtained from the subject.


In certain embodiments, the method includes:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 3 in one or more biological samples obtained from the subject; and


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 4 in one or more biological samples obtained from the subject.


In particular embodiments, the difference between the levels of expression of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates whether the subject is responsive to the treatment.


In specific embodiments, the method further includes: (c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to irinotecan, administering an effective amount of the irinotecan to the subject.


In a fifth aspect, the invention features a method of treating a subject by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 3 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 4 in one or more biological samples obtained from the subject; and


(c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to irinotecan, administering an effective amount of irinotecan to the subject.


In some embodiments, the method includes:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 3 in one or more biological samples obtained from the subject; and


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 4 in one or more biological samples obtained from the subject.


In a sixth aspect, the invention features a method of treating a subject, the subject having previously been determined to be responsive to treatment with irinotecan by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 3 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 4 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicates whether the subject is responsive to the treatment;


the method including administering an effective amount of irinotecan to the subject.


In some embodiments of any of the above aspects, the method further includes administering one or more additional therapies to the subject.


In some embodiments, the one or more additional therapies is administered concurrently with the administration of irinotecan. In other embodiments, the one or more additional therapies is administered separately from the administration of irinotecan. In certain embodiments, the one or more additional therapies is administered prior to the administration of irinotecan. In alternate embodiments, the one or more additional therapies is administered after the administration of irinotecan. In particular embodiments, the one or more additional therapies is administered within 1 week of the administration of irinotecan (e.g., within about 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours, 24 hours, 36 hours, 2 days, 3 days, 4 days, 5 days, 6 days, or 1 week of the administration of irinotecan).


In some embodiments, the one or more additional therapies includes one or more additional therapeutic agents, surgery, or radiation therapy. In certain embodiments, the one or more additional therapies includes one or more additional therapeutic agents. In particular embodiments, the irinotecan is administered alone or in admixture with the one or more additional therapeutic agents.


In some embodiments, the one or more additional therapeutic agents is selected from the group consisting of: 5-FU, oxaliplatin, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, estramustine, other chemotherapeutic agents known in the art, and combinations thereof. In certain embodiments, the one or more additional therapeutic agents includes everolimus, temsirolimus, bleomycin, or lomustine. In particular embodiments, the one or more therapeutic agents includes 5-FU and leucovorin.


In some embodiments, the one or more additional therapeutic agents is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In various embodiments, the one or more additional therapeutic agents is administered in dosage form.


In some embodiments, the irinotecan is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In certain embodiments, the irinotecan is administered to the subject intravenously.


In some embodiments, the method further includes one or more additional administrations of an effective amount of irinotecan to the subject. In certain embodiments, the irinotecan is administered to the subject once weekly, once every other week, or once every three weeks. In particular embodiments, the irinotecan is administered to the subject in six week cycles (e.g., every six weeks). In various embodiments, the administration of irinotecan is repeated for at least 12 to 60 months (e.g., at least 12 months, 13 months, 14 months, 15 months, 16 months, 17 months, 18 months, 19 months, 20 months, 24 months, 25 months, 30 months, 36 months, 40 months, 48 months, 50 months, or 60 months).


In some embodiments, the irinotecan is administered in dosage form. In certain embodiments, the irinotecan is administered in doses of up to 125 mg/m2, 180 mg/m2, or 350 mg/m2. (e.g., about 10 mg/m2, 20 mg/m2, 30 mg/m2, 40 mg/m2, 50 mg/m2, 100 mg/m2, 125 mg/m2, 150 mg/m2, 175 mg/m2, 180 mg/m2, 200 mg/m2, 250 mg/m2, 300 mg/m2, or 350 mg/m2).


In some embodiments, the determining step (a) or the determining step (b) occurs prior to the administration. In other embodiments, the determining step (a) or the determining step (b) occurs concurrent with the administration. In various embodiments, the determining step (a) or the determining step (b) occurs after the administration. In certain embodiments, the determining step (a) or the determining step (b) occurs multiple times.


In some embodiments, the administration occurs multiple times. In certain embodiments, each of the determining step (a) or the determining step (b) occurs prior to each of the administrations. In alternate embodiments, each of the determining step (a) or the determining step (b) occurs concurrent with each of the administrations. In further embodiments, each of the determining step (a) or the determining step (b) occurs after each of the administrations.


In some embodiments, the biomarker of sensitivity is PRF1. In certain embodiments, the expression level of the PRF1 indicates the sensitivity of the subject to the treatment.


In some embodiments, one or more of the biomarkers of sensitivity is selected from the group consisting of: PRF1, GZMB, PTPRC, PTPRC, PTPRCAP, PDE4DIP, ACAP1, PTPRC, S1PR1, and DOCK2; and/or one or more of the biomarkers of resistance is selected from the group consisting of: CCND1, LGALS3, INPP4B, TMEM97, TCF7L2, SFN, LAPTM4B, LSR, SFN, and TMEM97.


In some embodiments, one or more of the biomarkers of sensitivity is selected from the group consisting of: PRF1, GZMB, PTPRC, PTPRC, and PTPRCAP; and/or one or more of the biomarkers of resistance is selected from the group consisting of: CCND1, LGALS3, INPP4B, TMEM97, and TCF7L2.


In various embodiments, the difference between the expression levels of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates the sensitivity of the subject to the treatment. In certain embodiments, the expression levels of the one or more biomarkers of sensitivity in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of sensitivity in a control indicates the sensitivity of the subject to the treatment. In particular embodiments, the expression levels of the one or more biomarkers of resistance in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of resistance in a control indicates the resistance of the subject to the treatment. In specific embodiments, the expression level in the subject is significantly higher than in the control. In alternate embodiments, the expression level in the subject is significantly lower than in the control.


In a seventh aspect, the invention features a method of assessing the responsiveness of a subject to treatment with oxaliplatin by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 5 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 6 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicates whether the subject is responsive to the treatment.


In some embodiments, the method includes, prior to the determining of (a) or (b), providing the one or more biological samples obtained from the subject.


In some embodiments, the method includes:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 5 in one or more biological samples obtained from the subject; and


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 6 in one or more biological samples obtained from the subject.


In certain embodiments, the difference between the levels of expression of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates whether the subject is responsive to the treatment.


In some embodiments, the method further includes: (c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to oxaliplatin, administering an effective amount of the oxaliplatin to the subject.


In an eighth aspect, the invention features a method of treating a subject by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 5 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 6 in one or more biological samples obtained from the subject;


(c) if the levels of expression of the one or more biomarkers of sensitivity or the one or more biomarkers of resistance indicate that the subject is responsive to oxaliplatin, administering an effective amount of oxaliplatin to the subject.


In some embodiments, the method includes the determining of (a) and the determining of (b).


In a ninth aspect, the invention features a method of treating a subject, the subject having previously been determined to be responsive to treatment with oxaliplatin by:


(a) determining a level of expression of one or more biomarkers of sensitivity selected from, e.g., the biomarkers of Table 5 in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance selected from, e.g., the biomarkers of Table 6 in one or more biological samples obtained from the subject;


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicates whether the subject is responsive to the treatment;


the method including administering an effective amount of oxaliplatin to the subject.


In some embodiments, the method further includes administering one or more additional therapies to the subject. In certain embodiments, the one or more additional therapies is administered concurrently with the administration of oxaliplatin. In alternate embodiments, the one or more additional therapies is administered separately from the administration of oxaliplatin. In particular embodiments, the one or more additional therapies is administered prior to the administration of oxaliplatin. In other embodiments, the one or more additional therapies is administered after the administration of oxaliplatin. In certain embodiments, the one or more additional therapies is administered within 1 week of the administration of oxaliplatin.


In some embodiments, the one or more additional therapies includes one or more additional therapeutic agents, surgery, or radiation therapy. In certain embodiments, the one or more additional therapies includes one or more additional therapeutic agents. In particular embodiments, the oxaliplatin is administered alone or in admixture with the one or more additional therapeutic agents. In various embodiments, the one or more additional therapeutic agents is selected from the group consisting of: 5-FU, irinotecan, capecitabine, tegafur, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, and estramustine. In certain embodiments, the one or more additional therapeutic agents includes everolimus, temsirolimus, bleomycin, or lomustine. In particular embodiments, the one or more additional therapeutic agents includes 5-FU and leucovorin.


In some embodiments, the one or more additional therapeutic agents is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In some embodiments, the one or more additional therapeutic agents is administered in dosage form.


In various embodiments, the oxaliplatin is administered to the subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin. In specific embodiments, the oxaliplatin is administered to the subject intravenously.


In some embodiments, the method further includes one or more additional administrations of an effective amount of oxaliplatin to the subject. In certain embodiments, the oxaliplatin is administered to the subject once every two weeks. In particular embodiments, the oxaliplatin is administered to the subject once every two weeks for up to six months. In various embodiments, the administration of oxaliplatin is repeated for at least 12 to 60 months (e.g., at least 12 months, 13 months, 14 months, 15 months, 16 months, 17 months, 18 months, 19 months, 20 months, 24 months, 25 months, 30 months, 36 months, 40 months, 48 months, 50 months, or 60 months).


In some embodiments, the oxaliplatin is administered in dosage form. In certain embodiments, the oxaliplatin is administered in doses of up to 85 mg/m2. (e.g., about 10 mg/m2, 20 mg/m2, 30 mg/m2, 40 mg/m2, 50 mg/m2, 60 mg/m2, 70 mg/m2, 80 mg/m2, or 86 mg/m2).


In some embodiments, the determining of (a) or the determining of (b) occurs prior to the administration. In alternate embodiments, the determining step (a) or the determining step (b) occurs concurrent with the administration. In various embodiments, the determining step (a) or the determining step (b) occurs after the administration. In certain embodiments, the determining step (a) or the determining step (b) occurs multiple times.


In some embodiments, the administration occurs multiple times. In certain embodiments, each of the determining step (a) or the determining step (b) occurs prior to each of the administrations. In alternative embodiments, each of the determining step (a) or the determining step (b) occurs concurrent with each of the administrations. In various embodiments, each of the determining step (a) or the determining step (b) occurs after each of the administrations.


In some embodiments of any of the above aspects, the biomarker of sensitivity is selected from MRPL16 and at least a second biomarker of sensitivity selected from the biomarkers of Table 5. In certain embodiments, the second biomarker of sensitivity is selected from the group consisting of: ANP32A, SRSF2, PDSS1, PRIM1, HNRNPA1, NDUFAB1, GLTSCR2, RNPS1, and ICAM2. In particular embodiments, the second biomarker of sensitivity is selected from the group consisting of: ANP32A, SRSF2, PDSS1, and PRIM1. In specific embodiments, the second biomarkers of sensitivity is ANP32A.


In some embodiments, the biomarker of sensitivity is selected from MRPL16 and the biomarker of resistance is selected from one or more of the biomarkers of Table 6. In certain embodiments, the biomarker of resistance is selected from the group consisting of: LPP, RHOC, CAPN2, FLNA, WDR1, FLNA, ACTN1, CNN3, FLNA, and ACTN1. In particular embodiments, the biomarker of resistance is selected from the group consisting of: LPP, RHOC, CAPN2, FLNA, and WDR1. In specific embodiments, the biomarker of resistance is LPP.


In some embodiments, one or more of the biomarkers of sensitivity is selected from the group consisting of: MRPL16, ANP32A, SRSF2, PDSS1, PRIM1, HNRNPA1, NDUFAB1, GLTSCR2, RNPS1, and ICAM2; and/or one or more of the biomarkers of resistance is selected from the group consisting of: LPP, RHOC, CAPN2, FLNA, WDR1, FLNA, ACTN1, CNN3, FLNA, and ACTN1.


In some embodiments, one or more of the biomarkers of sensitivity is selected from the group consisting of: MRPL16, ANP32A, SRSF2, PDSS1, and PRIM1; and/or one or more of the biomarkers of resistance is selected from the group consisting of: LPP, RHOC, CAPN2, FLNA, and WDR1.


In some embodiments, the difference between the expression levels of the one or more biomarkers of sensitivity and the one or more biomarkers of resistance indicates the sensitivity of the subject to the treatment.


In some embodiments, the method further involves predicting sensitivity of the subject to combination treatment with oxaliplatin and 5-FU, and the method further includes: (c) determining a level of expression of one or more biomarkers of resistance to 5-FU selected from the biomarkers of Table 2 in one or more biological samples obtained from the subject; in which the biomarker of sensitivity is MRPL16. In certain embodiments, the one or more biomarkers of resistance to 5-FU is selected from the group consisting of: NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158. In particular embodiments, the one or more biomarkers of resistance to 5-FU is selected from the group consisting of: NT5E, CNN3, ACTN1, FLNA, and ATP2B4. In a specific embodiment, the biomarker of resistance to 5-FU is NT5E.


In particular embodiments, the expression level of NT5E is determined using a probe capable of detecting a nucleic acid having the sequence of, e.g., SEQ ID NO. 94, 1015, 1016, 1683, 2064, 2207, 2316, 2446, 2714, or 2778. In specific embodiments, the probe includes a sequence having at least 5 continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence complementary to, e.g., SEQ ID NO. 94, 1015, 1016, 1683, 2064, 2207, 2316, 2446, 2714, or 2778.


In certain embodiments, the difference between the expression levels of the MRPL16 and the one or more biomarkers of resistance to 5-FU indicate the sensitivity of the subject to the combination treatment with oxaliplatin and 5-FU.


In various embodiments, the expression levels of the one or more biomarkers of sensitivity in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of sensitivity in a control indicates the sensitivity of the subject to the treatment. In some embodiments, the expression levels of the one or more biomarkers of resistance in the subject having a statistically significant difference from the expression levels of the one or more biomarkers of resistance in a control indicates the resistance of the subject to the treatment. In certain embodiments, the expression level in the subject is significantly higher than in the control. In alternate embodiments, the expression level in the subject is significantly lower than in the control.


In some embodiments of any of the aspects of the invention, the method further includes determining the expression level of one or more additional biomarkers (e.g., biomarkers of cancer, e.g., colon cancer or breast cancer). In some embodiments, the one or more additional biomarkers is selected from the group consisting of: carcinoembryonic antigen (CEA), BRAF, KRAS, Fas-ligand, p53, Ki-67, thymidylate-synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, microsatellite instability (MIS), and 18q allelic loss of heterozygosity (LOH18q). In certain embodiments, an elevated level of the one or more additional biomarkers indicates that the subject is responsive to the treatment.


In some embodiments of any of the aspects of the invention, the method further includes, prior to the determining of (a) or (b), amplification of the biomarkers from the one or more biological samples. In some embodiments, the method further includes, prior to the determining of (a) or (b), reverse transcription of the biomarkers from the one or more biological samples. In certain embodiments, the product of the amplification or the reverse transcription is cDNA.


In some embodiments of any of the aspects of the invention, the one or more biological samples includes cDNA.


In some embodiments of any of the aspects of the invention, the levels of expression are determined using a microarray or sequencing. In some embodiments, the microarray includes a plurality of nucleic acid probes. In certain embodiments, one or more of the nucleic acid probes (e.g., each of the nucleic acid probes) are configured to hybridize to a target RNA molecule or a target cDNA molecule (e.g., an RNA or DNA (e.g., cDNA) molecule corresponding to one or more of the biomarkers of sensitivity and/or resistance of any one or more of Tables 1-12). In particular embodiments, the one or more of the nucleic acid probes (e.g., each of the nucleic acid probes) includes a sequence having at least, e.g., 75%, 85%, 90%, 95%, 98%, 99%, or 100% sequence identity to a continuous sequence (e.g., a sequence of at least 5, 10, 15, 20, or more nucleic acids in length; such as, e.g., 15 nucleic acids in length) within the target nucleic acid molecule (e.g., a target RNA or DNA (e.g., cDNA) molecule, such as a molecule having the sequence of one or more of the biomarkers of sensitivity and/or resistance of of any one or more of Tables 1-12). In other embodiments, the one or more of the nucleic acid probes (e.g., each of the nucleic acid probes) includes a sequence having at least, e.g., 75%, 85%, 90%, 95%, 98%, 99%, or 100% sequence identity to the complement of a continuous sequence (e.g., a sequence of at least 5, 10, 15, 20, or more nucleic acids in length; such as, e.g., 15 nucleic acids in length) within the target nucleic acid molecule (e.g a target RNA or DNA (e.g., cDNA) molecule, such as a molecule having the sequence of one or more of the biomarkers of sensitivity and/or resistance of any one or more of Tables 1-12). In specific embodiments, each of the target RNA molecules includes at least one of the biomarkers (e.g., an RNA molecule encoding a biomarker protein or transcribed from a biomarker gene). In alternate embodiments, each of the target cDNA molecules is derived from at least one of the biomarkers (e.g., a cDNA reverse-transcribed from a biomarker RNA molecule or having a substantially identical nucleotide sequence to the coding sequence of a biomarker gene).


In some embodiments, each of the nucleic acid probes has a length of, e.g., about 5 nucleotides (nt), 10 nt, 15 nt, 20 nt, 25 nt, 30 nt, 50 nt, 75 nt, 100 nt, 150 nt, or 200 nt (e.g., at least 15 nt). In various embodiments, the nucleic acid probes are single-stranded. In certain embodiments, the nucleic acid probes include DNA, cDNA, RNA, a nucleic acid analog, or a combination thereof.


In some embodiments, the nucleic acid probes are labeled. In certain embodiments, each of the nucleic acid probes is labeled with at least one of a dye molecule, fluorescent molecule, small molecule, nucleic acid barcode, or polypeptide. In particular embodiments, the label is a non-naturally occurring label.


In some embodiments, the microarray is an Almac array. In alternate embodiments, the microarray is an Affymetrix array.


In some embodiments, the sequencing is performed by RNA-Seq. In certain embodiments, the sequencing is performed by 454 pyrosequencing, Illumina sequencing by synthesis, SOLiD sequencing, Ion Torrent sequencing, or PacBio RS sequencing. In particular embodiments, the sequencing includes labeling the one or more biological samples with a plurality of non-naturally occurring labels. In specific embodiments, each of the non-naturally occurring labels are selected from the group consisting of a dye molecule, fluorescent molecule, small molecule, nucleic acid barcode, and polypeptide.


In some embodiments of any of the aspects of the invention, the levels of expression of the one or more biomarkers of sensitivity and/or the levels of expression of the one or more biomarkers of resistance are determined using a NanoString nCounter system.


In some embodiments of any of the aspects of the invention, the determining step (a) and the determining step (b) are performed using the same biological sample. In some embodiments, the determining step (a) and the determining step (b) are performed using different biological samples. In various embodiments, one or more of the biological samples is formalin-fixed paraffin embedded (FFPE) tissue. In some embodiments, one or more of the biological samples is fresh frozen tissue. In certain embodiments, the one or more of the biological samples is obtained from a tumor. In particular embodiments, the one or more of the biological samples includes a tumor biopsy.


In some embodiments of any of the aspects of the invention, the level of expression of the biomarkers of sensitivity and/or the biomarkers of resistance is determined using a device or a kit (e.g., a device or a kit as described herein).


In some embodiments of any of the aspects of the invention, the subject is suffering from cancer or has a predisposition to cancer. In certain embodiments, a cancer has been resected from the subject.


In some embodiments, the cancer is selected from the group consisting of: colorectal cancer, leukemia (e.g., acute myeloid leukemia, acute lymphoid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, acute myeloblastic leukemia, acute promyelocytic leukemia, acute myelomonocytic leukemia, acute monocytic leukemia, acute erythroleukemia, or chronic leukemia), myeloma (e.g., multiple myeloma), myelodysplastic syndrome, lymphoma (e.g., diffuse large B-cell lymphoma, cutaneous T-cell lymphoma, peripheral T-cell lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia, or lymphocytic lymphoma), cervical cancer, prostate cancer, esophageal cancer, melanoma, glioma (e.g., oligodendroglioma), pancreatic cancer (e.g., adenosquamous carcinoma, signet ring cell carcinoma, hepatoid carcinoma, colloid carcinoma, islet cell carcinoma, or pancreatic neuroendocrine carcinoma), ovarian cancer (e.g., ovarian adenocarcinoma or embryonal carcinoma), gastrointestinal stromal tumor, sarcoma (e.g., fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, angiosarcoma, endotheliosarcoma, lymphangiosarcoma, lymphangioendotheliosarcoma, leiomyosarcoma, Ewing's sarcoma, or rhabdomyosarcoma), breast cancer, ER-positive cancer, bladder cancer, head and neck cancer (e.g., squamous cell carcinoma of the head and neck), lung cancer (e.g., non-small cell lung carcinoma, large cell carcinoma, bronchogenic carcinoma, or papillary adenocarcinoma), metastatic cancer, oral cavity cancer, uterine cancer, testicular cancer (e.g., seminoma or embryonal carcinoma), skin cancer (e.g., squamous cell carcinoma or basal cell carcinoma), thyroid cancer (e.g., papillary carcinoma or medullary carcinoma), brain cancer (e.g., astrocytoma or craniopharyngioma), stomach cancer, intra-epithelial cancer, bone cancer, biliary tract cancer, eye cancer, liver cancer (e.g., hepatocellular carcinoma or hepatoma), larynx cancer, kidney cancer (e.g., renal cell carcinoma or Wilms tumor), gastric cancer, blastoma (e.g., nephroblastoma, medulloblastoma, hemangioblastoma, neuroblastoma, or retinoblastoma), polycythemia vera, chordoma, synovioma, mesothelioma, adenocarcinoma, sweat gland carcinoma, sebaceous gland carcinoma, cystadenocarcinoma, bile duct carcinoma, choriocarcinoma, epithelial carcinoma, ependymoma, pinealoma, acoustic neuroma, schwannoma, meningioma, pituitary adenoma, nerve sheath tumor, cancer of the small intestine, cancer of the endocrine system, cancer of the penis, cancer of the urethra, cutaneous or intraocular melanoma, a gynecologic tumor, solid tumors of childhood, and neoplasms of the central nervous system.


In certain embodiments, the cancer is colorectal cancer. In particular embodiments, the colorectal cancer is colon cancer or rectal cancer. In specific embodiments, the colon cancer is selected from the group consisting of: adenocarcinoma, gastrointestinal carcinoid tumor, primary colorectal lymphoma, leiomyosarcoma, colorectal melanoma, and squamous cell carcinoma. In one embodiment, the colon cancer is adenocarcinoma. In particular embodiments, the colon cancer is Stage 0, Stage I, Stage II, Stage III, or Stage IV colon cancer. In one embodiment, the colon cancer is Stage II colon cancer. In another embodiment, the colon cancer is Stage III colon cancer.


In certain embodiments, the cancer is breast cancer. In particular embodiments, the breast cancer is medullary carcinoma. In specific embodiments, the breast cancer is Stage 0, Stage I, Stage II, Stage III, or Stage IV breast cancer.


In a tenth aspect, the invention features a method of assessing the responsiveness of a subject to treatment with 5-FU, irinotecan, or oxaliplatin by:


(a) determining a level of expression of one or more biomarkers of sensitivity in one or more biological samples obtained from the subject; or


(b) determining a level of expression of one or more biomarkers of resistance in one or more biological samples obtained from the subject; in which the one or more biomarkers of sensitivity includes a gene determined to have at least a 0.25 Pearson correlation between the mRNA expression level of the gene and growth inhibition of a cultured cell exposed to the drug, and/or the one or more biomarkers of resistance includes a gene determined to have at least a −0.25 Pearson correlation between the mRNA expression level of the gene and growth inhibition of a cultured cell exposed to the drug; and


in which the levels of expression of the biomarker of sensitivity or the biomarker of resistance indicate whether the subject is responsive to the treatment.


In some embodiments of any of the aspects of the invention, responsiveness (e.g., sensitivity or resistance) to treatment with 5-FU also indicates responsiveness to treatment with a 5-FU analog (e.g., a prodrug, derivative, metabolite, or enantiomer of 5-FU). In certain embodiments, if a subject is determined to be sensitive to 5-FU, then the subject is also determined to be sensitive to a 5-FU analog. In other embodiments, if a subject is determined to be resistant to 5-FU, then the subject is also determined to be resistant to a 5-FU analog. In particular embodiments, the 5-FU analog is a 5-FU prodrug (e.g., capecitabine or tegafur).


In some embodiments of any of the aspects of the invention, responsiveness (e.g., sensitivity or resistance) to treatment with irinotecan also indicates responsiveness to treatment with an irinotecan analog (e.g., a prodrug, derivative, metabolite, or enantiomer of irinotecan). In certain embodiments, if a subject is determined to be sensitive to irinotecan, then the subject is also determined to be sensitive to an irinotecan analog. In other embodiments, if a subject is determined to be resistant to irinotecan, then the subject is also determined to be resistant to an irinotecan analog.


In some embodiments of any of the aspects of the invention, responsiveness (e.g., sensitivity or resistance) to treatment with oxaliplatin also indicates responsiveness to treatment with an oxaliplatin analog (e.g., a prodrug, derivative, metabolite, or enantiomer of oxaliplatin). In certain embodiments, if a subject is determined to be sensitive to oxaliplatin, then the subject is also determined to be sensitive to an oxaliplatin analog. In other embodiments, if a subject is determined to be resistant to oxaliplatin, then the subject is also determined to be resistant to an oxaliplatin analog.


In an eleventh aspect, the invention features a device for detecting the level of expression of one or more biomarkers (e.g., biomarkers of sensitivity and/or resistance to a target drug, e.g., 5-FU, irinotecan, or oxaliplatin, or derivatives, analogs, or prodrugs thereof), which includes:


at least one single-stranded nucleic acid having at least 75% sequence identity (e.g., 75%, 85%, 90%, 95%, 98%, 99%, or 100% sequence identity) to a nucleic acid sequence complementary or identical to at least 5 consecutive nucleotides of one or more biomarkers selected from the biomarkers of Table 1 or 2;


in which at least one single-stranded nucleic acid is sufficient for the detection of the level of expression of the one or more biomarkers, and the device allows for specific hybridization between the single-stranded nucleic acid and the one or more biomarkers or complementary nucleic acids thereof.


In a twelfth aspect, the invention features a device configured to perform a method (e.g., a method of assessing the responsiveness of a subject to treatment with, e.g., 5-FU, irinotecan, or oxaliplatin; or a method of treating a subject) described herein.


In a thirteenth aspect, the invention features a kit including:


(i) reagents for collecting nucleic acids from a biological sample, for example, a biological sample obtained from a subject (e.g., a subject suffering from or susceptible to cancer, e.g., colon cancer or breast cancer);


(ii) reagents for amplifying the nucleic acids to produce an amplified sample; and/or


(iii) at least one device of the present invention.


In a fourteenth aspect, the invention features a method for identifying biomarkers of sensitivity or resistance to a target drug by:


(i) contacting a first cell with an effective amount of the target drug;


(ii) incubating the first cell and a second cell not contacted with an effective amount of the target drug under identical conditions in parallel;


(iii) measuring the growth inhibition values (G150) for the first cell and the second cell;


(iv) obtaining the gene expression profiles (e.g., using a microarray, sequencing, and/or a NanoString nCounter system) for the first cell and the second cell; and


(v) determining a correlation (e.g., a Pearson correlation) comparing the gene expression profiles for the first cell and the second cell with respect to their G150 values;


in which the correlation between the expression level of a gene from the gene expression profiles of the first cell and the second cell and the G150 values for the first cell and the second cell being, e.g., at least 0.25 indicates that the gene is a biomarker of sensitivity, and the correlation between the expression level of a gene from the gene expression profiles of the first cell and the second cell and the G150 values for the first cell and the second cell being, e.g., −0.25 or less indicates that the gene is a biomarker of resistance.


In all aspects of the invention, the level of expression of the biomarkers of sensitivity to 5-FU can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 1-93 and the sequences listed in Table 7. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 1-93 and the sequences listed in Table 7.


In all aspects of the invention, the level of expression of the biomarkers of resistance to 5-FU can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 94-208 and the sequences listed in Table 8. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 94-208 and the sequences listed in Table 8.


In all aspects of the invention, the level of expression of the biomarkers of sensitivity to irinotecan can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 209-353 and the sequences listed in Table 9. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 209-353 and the sequences listed in Table 9.


In all aspects of the invention, the level of expression of the biomarkers of resistance to irinotecan can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 354-398 and the sequences listed in Table 10. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 354-398 and the sequences listed in Table 10.


In all aspects of the invention, the level of expression of the biomarkers of sensitivity to oxaliplatin can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 399-578 and the sequences listed in Table 11. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 399-578 and the sequences listed in Table 11.


In all aspects of the invention, the level of expression of the biomarkers of resistance to oxaliplatin can be determined using a probe capable of detecting a nucleic acid having the sequence of at least one of SEQ ID NOs. 579-826 and the sequences listed in Table 12. In some embodiments, the probe includes a sequence including at least 5 (e.g., at least 15) continuous nucleotides and at least 75% identity (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) to a sequence identical to or complementary to at least one of SEQ ID NOs. 579-826 and the sequences listed in Table 12.


In all aspects of the invention, the expression level of NT5E can be determined using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 94, 1015, 1016, 1683, 2064, 2207, 2316, 2446, 2714, and 2778, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to, or complementary to, e.g., SEQ ID NO. 94, 1015, 1016, 1683, 2064, 2207, 2316, 2446, 2714, or 2778.


In all aspects of the invention, the expression level of CNN3 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 95, 1157, 1476, or 1847, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to, or complementary to, e.g., SEQ ID NO. 95, 1157, 1476, or 1847.


In all aspects of the invention, the expression level of ACTN1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 96, 934, 2203, 2469, 2737, 2816, or 2817, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to, or complementary to, e.g., SEQ ID NO. 96, 934, 2203, 2469, 2737, 2816, or 2817.


In all aspects of the invention, the expression level of FLNA can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 97, 1387, 1490, 1542, 1621, 1773, 1867, 1902, 1960, 2048, 2051, 2347, or 2348, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 97, 1387, 1490, 1542, 1621, 1773, 1867, 1902, 1960, 2048, 2051, 2347, or 2348.


In all aspects of the invention, the expression level of ATP2B4 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 98, 1498, 1845, 2056, 2284, 2285, 2523, or 2627, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 98, 1498, 1845, 2056, 2284, 2285, 2523, or 2627.


In all aspects of the invention, the expression level of APRT can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 1 or 1201, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 1 or 1201.


In all aspects of the invention, the expression level of GSR can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 2, 907, 1148, 1722, or 2750, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 2, 907, 1148, 1722, or 2750.


In all aspects of the invention, the expression level of TUFM can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 3 or 1146, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 3 or 1146.


In all aspects of the invention, the expression level of MRPS2 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 4 or 839, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 4 or 839.


In all aspects of the invention, the expression level of MTHFD2 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 5 or 1189, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 5 or 1189.


In all aspects of the invention, the expression level of PRF1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 209, 2314, 2315, or 2881, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 209, 2314, 2315, or 2881.


In all aspects of the invention, the expression level of GZMB can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 210, 1681, or 1682, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 210, 1681, or 1682.


In all aspects of the invention, the expression level of PTPRC can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 211, 212, 1020, 1632, 1675, 1998, 1999, 2535, 2636, or 2797, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 211, 212, 1020, 1632, 1675, 1998, 1999, 2535, 2636, or 2797.


In all aspects of the invention, the expression level of PTPRCAP can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 213, 1645, or 1646, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 213, 1645, or 1646.


In all aspects of the invention, the expression level of CCND1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 354, 1592, 1593, 1679, 1727, 1752, 1817, 2013, or 2640, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 354, 1592, 1593, 1679, 1727, 1752, 1817, 2013, or 2640.


In all aspects of the invention, the expression level of LGALS3 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 355, 1299, 1334, 1335, or 2069, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 355, 1299, 1334, 1335, or 2069.


In all aspects of the invention, the expression level of INPP4B can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 356, 919, 1453, 1616, 1617, 2199, 2386, 2625, or 2626, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 356, 919, 1453, 1616, 1617, 2199, 2386, 2625, or 2626.


In all aspects of the invention, the expression level of TMEM97 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 357, 966, 2532, or 2566, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 357, 966, 2532, or 2566.


In all aspects of the invention, the expression level of TCF7L2 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 358, 955, 1536, 1852, 2081, 2099, 2171, 2192, 2219, 2539, 2575, 2665, or 2880, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 358, 955, 1536, 1852, 2081, 2099, 2171, 2192, 2219, 2539, 2575, 2665, or 2880.


In all aspects of the invention, the expression level of MRPL16 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 399 or 1144, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 399 or 1144.


In all aspects of the invention, the expression level of ANP32A can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 400, 1921, 2357, 2358, 2736, 2799, or 2800, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 400, 1921, 2357, 2358, 2736, 2799, or 2800.


In all aspects of the invention, the expression level of SRSF2 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of, e.g., SEQ ID NO. 401, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 401.


In all aspects of the invention, the expression level of PDSS1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 402, 862, or 2058, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 402, 862, or 2058.


In all aspects of the invention, the expression level of PRIM1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 403, 2266, or 2267, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 403, 2266, or 2267.


In all aspects of the invention, the expression level of LPP can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 579, 984, 1031, 1437, 1693, 1731, 1828, 1831, 1872, 2040, 2063, 2104, 2109, 2119, 2123, 2160, 2197, 2400, 2401, 2618, 2784, 2852, or 2853, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 579, 984, 1031, 1437, 1693, 1731, 1828, 1831, 1872, 2040, 2063, 2104, 2109, 2119, 2123, 2160, 2197, 2400, 2401, 2618, 2784, 2852, or 2853.


In all aspects of the invention, the expression level of RHOC can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of, e.g., SEQ ID NO. 580, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 580.


In all aspects of the invention, the expression level of CAPN2 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 581, 1521, 1552, 1900, 1965, 2154, 2233, 2234, or 2826, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 581, 1521, 1552, 1900, 1965, 2154, 2233, 2234, or 2826.


In all aspects of the invention, the expression level of FLNA can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 582, 584, 587, 1387, 1490, 1542, 1621, 1773, 1867, 1902, 1960, 2048, 2051, 2347, or 2348, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 582, 584, 587, 1387, 1490, 1542, 1621, 1773, 1867, 1902, 1960, 2048, 2051, 2347, or 2348.


In all aspects of the invention, the expression level of WDR1 can be determined, e.g., using a probe capable of detecting a nucleic acid having the sequence of any one or more of, e.g., SEQ ID NO. 583, 894, 1135, 1136, 1390, 2194, 2335, 2506, 2839, or 2862, or a complement thereof. In some embodiments, the probe includes a sequence having at least 5 (e.g., at least 15) continuous nucleotides and at least 75% (e.g., 75%, 80%, 85%, 90%, 95%, 99%, or 100%) identity to a sequence identical to or complementary to, e.g., SEQ ID NO. 583, 894, 1135, 1136, 1390, 2194, 2335, 2506, 2839, or 2862.


Definitions


As used herein, “5-fluorouracil,” “fluorouracil,” and “5-FU” refer to a compound having the structure of Formula (I), or to formulations containing such a compound.




embedded image


A “5-FU analog” means any therapeutic agent having a structure similar to the compound of Formula (I) and/or biological activity the same or similar to that of the compound of Formula (I), for example, prodrugs (e.g., capecitabine and tegafur), derivatives, metabolites, and enantiomers of Formula (I). If a specific formulation of 5-FU or a 5-FU analog is meant, that formulation is referenced by its specific name.


The term “irinotecan,” as used herein, refers to a compound having the structure of Formula (II), or to formulations containing such a compound.




embedded image


An “irinotecan analog” means any therapeutic agent having a structure similar to the compound of Formula (II) and/or biological activity the same or similar to that of the compound of Formula (II), for example, prodrugs, derivatives, metabolites, and enantiomers of Formula (II). If a specific formulation of irinotecan or an irinotecan analog is meant, that formulation is referenced by its specific name.


By “oxaliplatin” is meant a compound having the structure of Formula (III), or to formulations containing such a compound.




embedded image


An “oxaliplatin analog” means any therapeutic agent having a structure similar to the compound of Formula (III) and/or biological activity the same or similar to that of the compound of Formula (III), for example, prodrugs, derivatives, metabolites, and enantiomers of Formula (III). If a specific formulation of oxaliplatin or an oxaliplatin analog is meant, that formulation is referenced by its specific name.


The terms “capecitabine” and “Xeloda,” as used herein, mean a compound having the structure of Formula (IV), or to formulations containing such a compound.




embedded image



Capecitabine compounds can be, e.g., metabolized into 5-FU in the body and can thus be used as a prodrug for 5-FU, such as for the treatment of cancers, e.g., colon cancer or breast cancer.


The term “tegafur,” as used herein, means a compound having the structure of Formula (V), or to formulations containing such a compound.




embedded image



Tegafur compounds can be, e.g., metabolized into 5-FU in the body and can thus be used as a prodrug for 5-FU. Tegafur can be used according the methods of the invention, for example, as a component of the combination drug tegafur/uracil for the treatment of, e.g., cancers (e.g., colon cancer or breast cancer).


The terms “responsive” and “responsiveness,” as used herein with respect to a subject's responsiveness to a treatment, e.g., treatment with a compound, such as an anti-cancer agent (e.g., 5-FU, irinotecan, or oxaliplatin), or treatment with radiation, refer to the likelihood that the treatment has (e.g., induces) a desired effect, or alternatively refers to the strength of a desired effect caused or induced by the treatment in a cell, a tumor, or subject (e.g., a mammal, such as a human). For example, the desired effect can include inhibition of the growth of a cell, e.g., a cancer cell, in vitro or in a tumor, person, or living organism by more than 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 100% relative to the growth of a cell not exposed to the treatment. The desired effect can also include reduction in tumor mass by, e.g., about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 100%. Responsiveness to treatment may be determined by a cell-based assay that measures the growth of treated cells as a function of the cells' absorbance of an incident light beam as used to perform the NCI60 assays described herein. In this example, lesser absorbance indicates lesser cell growth, and thus, sensitivity to the treatment. A greater reduction in growth indicates more sensitivity to the treatment. According to the present invention, “responsiveness” is a measure of the sensitivity or resistance of a subject to a treatment, e.g., for cancer, for example, by treatment with a target drug (e.g., 5-FU, irinotecan, and oxaliplatin). A “sensitive” or “responsive” subject is one in which the treatment will produce the desired effect (e.g., as defined above), for example, as compared to a control subject (e.g., the population median). A “resistant” subject is one in which the treatment will have no effect, will produce an effect less than that observed in a control subject (e.g., the population median), or will produce an effect only if the treatment is administered in an amount greater than would be applied to a control subject (e.g., the population median).


A “sensitivity biomarker” and “biomarker of sensitivity” to a target drug, as used herein, mean a gene or gene product for which the expression level (e.g., mRNA expression level or protein expression level) has been correlated to higher subject sensitivity to treatment with the target drug (e.g., 5-FU, irinotecan, oxaliplatin, or combinations thereof). In certain embodiments, an increased level of expression of the sensitivity biomarker in a biological sample obtained from a subject, relative to a control subject (e.g. the population median), indicates that the subject is sensitive to the treatment. For example, biomarkers of sensitivity to 5-FU include those listed in Table 1, biomarkers of sensitivity to irinotecan include those listed in Table 3, and biomarkers of sensitivity to oxaliplatin include those listed in Table 5.


A “resistance biomarker” and “biomarker of resistance” to a target drug, as used herein, mean a gene or gene product for which the expression level (e.g., mRNA expression level or protein expression level) has been correlated to reduced subject sensitivity to treatment with the target drug (e.g., 5-FU, irinotecan, oxaliplatin, or combinations thereof). In certain embodiments, an increased level expression of the resistance biomarker in a biological sample obtained from a subject, relative to a control subject (e.g. the population median), indicates that the subject is resistant to the treatment. For example, biomarkers of resistance to 5-FU include those listed in Table 2, biomarkers of resistance to irinotecan include those listed in Table 4, and biomarkers of resistance to oxaliplatin include those listed in Table 6. By “gene” is meant, e.g., a coding or noncoding gene whose activity can be determined by measuring the produced RNA. Examples include protein coding genes, microRNAs, small nuclear RNAs and other RNAs with catalytic, regulatory or coding properties.


“Compound” as used herein means a chemical or biological substance, e.g., a drug, a protein, an antibody, or an oligonucleotide, which may be used to treat a disease or which has biological activity in vivo or in vitro. Compounds may or may not be approved by the U.S. Food and Drug Administration (FDA). Compounds of the invention include, e.g., anti-cancer agents (e.g., chemotherapy agents) that may inhibit cancer growth. Anti-cancer agents (chemotherapy agents) include 5-FU, capecitabine, tegafur, irinotecan, oxaliplatin, fulvestrant (also known under the name FASLODEX®), gefitinib (IRESSA®), ERLOTINIB (TARCEVA®), tamoxifen, trastuzumab (HERCEPTIN®), cisplatin, belinostat, and vincristine.


By “target drug” is meant a drug or combination of drugs that can be used to treat a subject, e.g., a patient suffering from or susceptible to a disease, disorder, or condition of interest (e.g., a cancer, such as colon cancer). Different subjects may have varying responsiveness (e.g., sensitivity and/or resistance) to a target drug, which can be assessed according to the methods and/or using the devices of the invention. Exemplary target drugs include 5-FU, irinotecan, and oxaliplatin, as well as prodrugs, derivatives, metabolites, enantiomers, analogs, and combinations thereof.


By “biomarker” and “biomarker gene” is meant a gene (e.g., a protein-coding DNA, mRNA, microRNA, or noncoding RNA) in a cell, the expression of which correlates to responsiveness (e.g., sensitivity or resistance) of the cell (and thus the patient containing the cell or from which the cell was obtained) to a treatment (e.g., exposure to a compound of the invention).


The terms “expression level” and “level of expression,” as used herein, refer to the amount of a gene product in a cell, tissue, biological sample, organism, or subject, e.g., amounts of DNA, RNA, or proteins, amounts of modifications of DNA, RNA, or protein, such as splicing, phosphorylation, acetylation, or methylation, or amounts of activity of DNA, RNA, or proteins associated with a given gene.


“Microarray” as used herein means a device employed by any method that quantifies one or more subject oligonucleotides, e.g., DNA or RNA, or analogs thereof, at a time. One exemplary class of microarrays consists of DNA probes attached to a glass or quartz surface. For example, many microarrays, including those made by Affymetrix, use several probes for determining the expression of a single gene. The DNA microarray may contain oligonucleotide probes that may be, e.g., full-length cDNAs complementary to an RNA or cDNA fragments that hybridize to part of an RNA. Exemplary RNAs include mRNA, miRNA, and miRNA precursors. Exemplary microarrays also include a “nucleic acid microarray” having a substrate-bound plurality of nucleic acids, hybridization to each of the plurality of bound nucleic acids being separately detectable. The substrate may be solid or porous, planar or non-planar, unitary or distributed. Exemplary nucleic acid microarrays include all of the devices so called in Schena (ed.), DNA Microarrays: A Practical Approach (Practical Approach Series), Oxford University Press (1999); Nature Genet. 21(1)(suppl.):1-60 (1999); Schena (ed.), Microarray Biochip: Tools and Technology, Eaton Publishing Company/BioTechniques Books Division (2000). Additionally, exemplary nucleic acid microarrays include substrate-bound plurality of nucleic acids in which the plurality of nucleic acids are disposed on a plurality of beads, rather than on a unitary planar substrate, as is described, inter alia, in Brenner et al., Proc. Natl. Acad. Sci. USA 97(4):1665-1670 (2000). Examples of nucleic acid microarrays may be found in U.S. Pat. Nos. 6,391,623, 6,383,754, 6,383,749, 6,380,377, 6,379,897, 6,376,191, 6,372,431, 6,351,712 6,344,316, 6,316,193, 6,312,906, 6,309,828, 6,309,824, 6,306,643, 6,300,063, 6,287,850, 6,284,497, 6,284,465, 6,280,954, 6,262,216, 6,251,601, 6,245,518, 6,263,287, 6,251,601, 6,238,866, 6,228,575, 6,214,587, 6,203,989, 6,171,797, 6,103,474, 6,083,726, 6,054,274, 6,040,138, 6,083,726, 6,004,755, 6,001,309, 5,958,342, 5,952,180, 5,936,731, 5,843,655, 5,814,454, 5,837,196, 5,436,327, 5,412,087, 5,405,783, the disclosures of which are incorporated herein by reference in their entireties. Exemplary microarrays may also include “peptide microarrays” or “protein microarrays” having a substrate-bound plurality of polypeptides, the binding of a oligonucleotide, a peptide, or a protein to each of the plurality of bound polypeptides being separately detectable. Alternatively, the peptide microarray, may have a plurality of binders, including but not limited to monoclonal antibodies, polyclonal antibodies, phage display binders, yeast 2 hybrid binders, aptamers, which can specifically detect the binding of specific oligonucleotides, peptides, or proteins. Examples of peptide arrays may be found in WO 02/31463, WO 02/25288, WO 01/94946, WO 01/88162, WO 01/68671, WO 01/57259, WO 00/61806, WO 00/54046, WO 00/47774, WO 99/40434, WO 99/39210, WO 97/42507 and U.S. Pat. Nos. 6,268,210, 5,766,960, 5,143,854, the disclosures of which are incorporated herein by reference in their entireties.


“Complement” of a nucleic acid sequence or a “complementary” nucleic acid sequence as used herein refers to an oligonucleotide which is in “antiparallel association” when it is aligned with the nucleic acid sequence such that the 5′ end of one sequence is paired with the 3′ end of the other. Nucleic acids are referred to as being “complementary” if they contain nucleotides or nucleotide homologues that can form hydrogen bonds according to Watson-Crick base-pairing rules (e.g., G with C, A with T or A with U) or other hydrogen bonding motifs such as for example diaminopurine with T, 5-methyl C with G, 2-thiothymidine with A, inosine with C, pseudoisocytosine with G, etc. Anti-sense RNA may be complementary to other oligonucleotides, e.g., mRNA. A complementary nucleic acid sequence may include non-naturally-occurring bases, e.g., inosine and 7-deazaguanine. When complementary nucleic acid sequences form a stable duplex, they are said to be “hybridized.” “Complementarity” may not be perfect; stable duplexes of complementary nucleic acids may contain mismatched base pairs or unmatched bases. Those skilled in the art of nucleic acid technology can determine duplex stability empirically considering a number of variables including, for example, the length of the oligonucleotide, percent concentration of cytosine and guanine bases in the oligonucleotide, ionic strength, and incidence of mismatched base pairs.


To “inhibit growth” and “inhibition of growth,” as used herein, mean causing a reduction in cell growth in vivo or in vitro by about, e.g., 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 99% or more, as evident by a reduction in the size or number of cells exposed to a treatment (e.g., exposure to a compound), relative to the size or number of cells in the absence of the treatment. Growth inhibition may be the result of a treatment that induces apoptosis in a cell, induces necrosis in a cell, inhibits cell proliferation and/or cell cycle progression, disrupts cellular metabolism, induces cell lysis, or induces some other mechanism that reduces the size or number of cells.


By “NCI60” is meant a panel of 60 cancer cell lines from lung, colon, breast, ovarian, leukemia, renal, melanoma, prostate and brain cancers including the following cancer cell lines: NSCLC_NCIH23, NSCLC_NCIH522, NSCLC_A549ATCC, NSCLC_EKVX, NSCLC_NCIH226, NSCLC_NCIH332M, NSCLC_H460, NSCLC_HOP62, NSCLC_HOP92, COLON_HT29, COLON_HCC-2998, COLON_HCT116, COLON_SW620, COLON_COL0205, COLON_HCT15, COLON_KM12, BREAST_MCF7, BREAST_MCF7ADRr, BREAST_MDAMB231, BREAST_HS578T, BREAST_MDAMB435, BREAST_MDN, BREAST_BT549, BREAST_T47D, OVAR_OVCAR3, OVAR_OVCAR4, OVAR_OVCAR5, OVAR_OVCAR8, OVAR_IGROV1, OVAR_SKOV3, LEUK_CCRFCEM, LEUK_K562, LEUK_MOLT4, LEUK_HL60, LEUK_RPMI8266, LEUK_SR, RENAL_UO31, RENAL_SN12C, RENAL_A498, RENAL_CAKI1, RENAL_RXF393, RENAL_7860, RENAL_ACHN, RENAL_TK10, MELAN_LOXIMVI, MELAN_MALME3M, MELAN_SKMEL2, MELAN_SKMEL5, MELAN_SKMEL28, MELAN_M14, MELAN_UACC62, MELAN_UACC257, PROSTATE_PC3, PROSTATE_DU145, CNS_SNB19, CNS_SNB75, CNS_U251, CNS_SF268, CNS_SF295, and CNS_SF539.


The terms “biological sample” and “sample,” as used herein, refer to any specimen (e.g., cells, tissue (e.g., a tissue sample obtained by biopsy, such as a tumor biopsy), blood, serum, plasma, urine, sputum, cerebrospinal fluid, lymph tissue or fluid, or pancreatic fluid) taken from a subject. In certain embodiments, the biological sample is taken from a portion of the body affected by a cancer (e.g., a biopsy). Biopsy (e.g., colorectal cancer biopsy, breast cancer biopsy, gastrointestinal malignancy biopsy, head and neck cancer biopsy, or ovarian cancer biopsy) may involve fine needle aspiration biopsy, core needle biopsy (e.g., stereotactic core needle biopsy, vacuum-assisted core biopsy, or magnetic resonance imaging (MRI) guided biopsy), or surgical biopsy (e.g., incisional biopsy or excisional biopsy). In certain embodiments, the biological sample is obtained from a tumor (e.g., a tumor biopsy). The sample may undergo additional purification and processing, for example, to remove cell debris and other unwanted molecules. Additional processing may further involve amplification, e.g., using PCR (RT-PCR). The standard methods of sample purification, such as removal of unwanted molecules, are known in the art.


The terms “effective amount,” “amount effective to,” and “therapeutically effective amount,” as used interchangeably herein, refer to an amount of an anti-cancer agent (e.g., 5-FU, irinotecan, or oxaliplatin) sufficient to produce a desired result, such as complete response (CR) of the patient having a cancer, partial response (PR) of the patient having a cancer, or stable disease (SD) in the patient having a cancer. The desirable response criteria (CR, PR, or SD) are well-known in the art, see, e.g., Response Evaluation Criteria in Solid Tumors (RECIST).


The terms “patient” and “subject,” as used interchangeably herein, refer to any animal (e.g., a mammal, e.g., a human). A subject to be treated or tested for responsiveness to an anti-cancer agent according to the methods described herein may be one who has been diagnosed with a cancer (e.g., colorectal cancer, breast cancer, gastrointestinal malignancy, head and neck cancer, or ovarian cancer). Diagnosis may be performed by any method or technique known in the art, such as self-exam, x-ray (e.g., mammogram), MRI, or biopsy. Non-limiting example of a subject include a human having colon cancer or rectal cancer, or a female (e.g., a postmenopausal female) having a breast cancer (e.g., a hormone receptor positive breast cancer). A subject may have been identified using techniques and methods known in the art. To minimize exposure of a subject to drugs that may not be useful, the subject may be determined as either responsive or non-responsive to a specific anti-cancer agent (e.g., 5-FU, irinotecan, or oxaliplatin) according to the methods of the invention. A “control” or “control subject” refers, for example, to a subject not suffering from or not susceptible to a disease, disorder, or condition treatable or diagnosable with the methods, devices, and/or kits described herein, or to a population median (e.g., a median level measured in a set of subjects not suffering from or not susceptible to a disease, disorder, or condition treatable or diagnosable with the methods, devices, and/or kits described herein).


“Treatment,” “medical treatment,” to “treat,” and “therapy” mean administering or exposing a subject, a cell, or a tumor to, e.g., a compound, such as an anti-cancer agent (e.g., a drug, a protein, an antibody, a nucleic acid, a chemotherapeutic agent, or a radioactive agent), or to some other form of medical intervention used to treat or prevent a disease, disorder, or condition (e.g., surgery, cryotherapy, radiation therapy, or combinations thereof). In certain embodiments, the disease to be treated is cancer or symptoms of cancer. Radiation therapy includes the administration of a radioactive agent to a subject, or exposure of a subject to radiation. The radiation may be generated from sources such as particle accelerators and related medical devices or agents that emit, e.g., X-radiation, gamma radiation, or electron (Beta radiation) beams. A treatment may further include surgery, e.g., to remove a tumor from a subject or living organism.


The terms “cancer” and “cancerous” refer to or describe the physiological condition in mammals that is typically characterized by unregulated cell growth. Included in this definition are benign and malignant cancers. A cancer may include a solid or liquid tumor. By “early stage cancer” or “early stage tumor” is meant a cancer that is not invasive or metastatic or is classified as a Stage 0, I, or II cancer. Exemplary cancers include colorectal cancer (e.g., colon cancer and rectal cancer), leukemia (e.g., acute myeloid leukemia, acute lymphoid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, acute myeloblastic leukemia, acute promyelocytic leukemia, acute myelomonocytic leukemia, acute monocytic leukemia, acute erythroleukemia, and chronic leukemia), myeloma (e.g., multiple myeloma), myelodysplastic syndrome, lymphoma (e.g., diffuse large B-cell lymphoma, cutaneous T-cell lymphoma, peripheral T-cell lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia, and lymphocytic lymphoma), cervical cancer, prostate cancer, esophageal cancer, melanoma, glioma (e.g., oligodendroglioma), pancreatic cancer (e.g., adenosquamous carcinoma, signet ring cell carcinoma, hepatoid carcinoma, colloid carcinoma, islet cell carcinoma, and pancreatic neuroendocrine carcinoma), ovarian cancer (e.g., ovarian adenocarcinoma or embryonal carcinoma), gastrointestinal stromal tumor, sarcoma (e.g., fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, angiosarcoma, endotheliosarcoma, lymphangiosarcoma, lymphangioendotheliosarcoma, leiomyosarcoma, Ewing's sarcoma, and rhabdomyosarcoma), breast cancer (e.g., medullary carcinoma), ER-positive cancer, bladder cancer, head and neck cancer (e.g., squamous cell carcinoma of the head and neck), lung cancer (e.g., non-small cell lung carcinoma, large cell carcinoma, bronchogenic carcinoma, and papillary adenocarcinoma), metastatic cancer, oral cavity cancer, uterine cancer, testicular cancer (e.g., seminoma and embryonal carcinoma), skin cancer (e.g., squamous cell carcinoma, and basal cell carcinoma), thyroid cancer (e.g., papillary carcinoma and medullary carcinoma), brain cancer (e.g., astrocytoma and craniopharyngioma), stomach cancer, intra-epithelial cancer, bone cancer, biliary tract cancer, eye cancer, liver cancer (e.g., hepatocellular carcinoma or hepatoma), larynx cancer, kidney cancer (e.g., renal cell carcinoma and Wilms tumor), gastric cancer, blastoma (e.g., nephroblastoma, medulloblastoma, hemangioblastoma, neuroblastoma, and retinoblastoma), polycythemia vera, chordoma, synovioma, mesothelioma, adenocarcinoma, sweat gland carcinoma, sebaceous gland carcinoma, cystadenocarcinoma, bile duct carcinoma, choriocarcinoma, epithelial carcinoma, ependymoma, pinealoma, acoustic neuroma, schwannoma, meningioma, pituitary adenoma, nerve sheath tumor, cancer of the small intestine, cancer of the endocrine system, cancer of the penis, cancer of the urethra, cutaneous or intraocular melanoma, a gynecologic tumor, solid tumors of childhood, and neoplasms of the central nervous system.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a graph grouping predicted sensitivity to 5-FU by indication. Each gray circle represents the predicted 5-FU sensitivity of one patient. Patients are grouped according to indication, and the relative mean predicted sensitivity (black cross) for an indication is related to the relative response rate for that indication. The predictions can only be used for relative comparisons: comparing indications to each other. It cannot be used for absolute predictions of response rate for a given indication. The predictions are normalized to a scale of 0-100 for all 3522 patients in this plot.



FIG. 2 is a graph showing predicted sensitivity to 5-FU in 226 Japanese non-small cell lung cancer (NSCLC) adenocarcinomas according to mutation status. Boxes represent first and third quartiles, and whiskers indicate minimum and maximum values. The dark line indicates the median value.



FIG. 3 is a graph showing predicted sensitivity to 5-FU in 243 breast cancer patients according to receptor status. Boxes represent first and third quartiles, and whiskers indicate minimum and maximum values. The dark line indicates the median value.



FIG. 4 is a graph comparing predicted sensitivity to 5-FU and Afinitor (everolimus) in 243 breast cancer patients.



FIG. 5 is a graph showing disease-free survival of patients predicted sensitive to 5-FU (gray) and patients predicted resistant to 5-FU (black). HR=hazard ratio.



FIG. 6 is a graph showing the predicted sensitivity of colorectal cancer patients to FOLFIRI. CR=complete responders, PR=partial responders, SD=stable disease, PD=progressive disease, CC=correlation coefficient. Boxes represent first and third quartiles, and whiskers indicate minimum and maximum values. The dark line indicates the median value.



FIG. 7 is a graph showing the predicted sensitivity of colorectal cancer patients (responders and non-responders) to FOLFOX. Boxes represent first and third quartiles, and whiskers indicate minimum and maximum values. The dark line indicates the median value.





DETAILED DESCRIPTION OF THE INVENTION

Drug response predictors are assays that, based on a biological sample from a subject, can predict whether the subject will respond to a specific drug or drug combination. The present invention provides drug response predictors and biomarkers useful for assessing the responsiveness of subjects to treatment with one or more specified target drugs of interest, e.g., 5-fluorouracil (5-FU), irinotecan, and/or oxaliplatin, as well as analogs thereof, such as prodrugs (e.g., capecitabine or tegafur), derivatives, metabolites, enantiomers, and combinations thereof. In particular, the invention provides methods useful in determining whether a subject is, e.g., sensitive or resistant to a target drug by, e.g., measuring the expression level (e.g., mRNA or protein expression level) of one or more biomarkers of sensitivity and/or resistance to the drug in a biological sample obtained from the subject. The expression levels of sensitivity biomarkers can then be compared to the expression of, for example, (i) other sensitivity biomarkers, (ii) resistance biomarkers, or (iii) biomarker expression levels in control subjects, to assess the subject's responsiveness to treatment with the target drug. Conversely, the expression levels of resistance biomarkers can be compared to the expression of, for example, (i) other resistance biomarkers, (ii) sensitivity biomarkers, or (iii) biomarker expression levels in control subjects, to assess the subject's responsiveness to treatment with the drug. In certain embodiments, the target drug includes 5-FU (or a prodrug thereof, e.g., capecitabine or tegafur), irinotecan, and/or oxaliplatin. Pre-clinical and clinical validation of drug response predictors have been developed by the present inventors for a number of other drugs (see, e.g., U.S. Pat. No. 8,445,198; PCT Publication No. WO2011/135459; PCT Publication No. WO2012163541; Chen et al., Mol. Cancer Ther. 11(1): 34-44, 2012; Bullinger et al., 2013, presented at ESMO conference 2012; Wang et al., J. National Cancer Inst. 105(17): 1284-91, 2013; Knudsen et al., PLOS ONE, 9(2): e87415, 2014; each of which is incorporated herein in its entirety).


The invention further features devices and kits for determining the expression level of such biomarkers, e.g., arrays of oligonucleotide probes suitable for hybridization to and detection of the biomarkers (e.g., biomarkers of sensitivity or resistance to, for example, 5-FU, irinotecan, and oxaliplatin). Also featured are methods of identifying biomarkers of sensitivity or resistance to a drug based on the correlation of biomarker expression to treatment efficacy, e.g., the growth inhibition of cancer cells. As such, the methods, devices, and kits described herein provide novel and effective means to, e.g., diagnose and/or monitor patient responsiveness to particular drug regimens of interest. Moreover, the methods, devices, and kits of the invention can be used to identify subject subpopulations that are responsive to a drug previously thought to be ineffective for treating disease (e.g., cancer, such as colorectal cancer) in the general population.


Methods of Diagnosis and Monitoring


The invention features diagnostic methods useful for assessing a subject's likely responsiveness to treatment with one or more target drugs (e.g., 5-FU, irinotecan, or oxaliplatin). Such methods can also be used to monitor a subject's responsiveness to such target drugs during or after treatment. In some embodiments, the subject is suffering from or at risk of developing a disease or condition (in particular, cancer, e.g., colorectal cancer), such as a disease or condition treatable with one or more target drugs, such as those described herein.


Indications


The methods, devices, and kits of the invention can be used for diagnosing, prognosing, monitoring, treating, and/or preventing cancer in a subject suffering from, diagnosed with, or susceptible to cancer. Non-limiting examples of cancers that can be diagnosed, prognosed, monitored, treated, or prevented using the present invention include colorectal cancer (e.g., colon cancer and rectal cancer), leukemia (e.g., acute myeloid leukemia, acute lymphoid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, acute myeloblastic leukemia, acute promyelocytic leukemia, acute myelomonocytic leukemia, acute monocytic leukemia, acute erythroleukemia, and chronic leukemia), myeloma (e.g., multiple myeloma), myelodysplastic syndrome, lymphoma (e.g., diffuse large B-cell lymphoma, cutaneous T-cell lymphoma, peripheral T-cell lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia, and lymphocytic lymphoma), cervical cancer, prostate cancer, esophageal cancer, melanoma, glioma (e.g., oligodendroglioma), pancreatic cancer (e.g., adenosquamous carcinoma, signet ring cell carcinoma, hepatoid carcinoma, colloid carcinoma, islet cell carcinoma, and pancreatic neuroendocrine carcinoma), ovarian cancer (e.g., ovarian adenocarcinoma or embryonal carcinoma), gastrointestinal stromal tumor, sarcoma (e.g., fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, angiosarcoma, endotheliosarcoma, lymphangiosarcoma, lymphangioendotheliosarcoma, leiomyosarcoma, Ewing's sarcoma, and rhabdomyosarcoma), breast cancer (e.g., medullary carcinoma), ER-positive cancer, bladder cancer, head and neck cancer (e.g., squamous cell carcinoma of the head and neck), lung cancer (e.g., non-small cell lung carcinoma, large cell carcinoma, bronchogenic carcinoma, and papillary adenocarcinoma), metastatic cancer, oral cavity cancer, uterine cancer, testicular cancer (e.g., seminoma and embryonal carcinoma), skin cancer (e.g., squamous cell carcinoma, and basal cell carcinoma), thyroid cancer (e.g., papillary carcinoma and medullary carcinoma), brain cancer (e.g., astrocytoma and craniopharyngioma), stomach cancer, intra-epithelial cancer, bone cancer, biliary tract cancer, eye cancer, liver cancer (e.g., hepatocellular carcinoma or hepatoma), larynx cancer, kidney cancer (e.g., renal cell carcinoma and Wilms tumor), gastric cancer, blastoma (e.g., nephroblastoma, medulloblastoma, hemangioblastoma, neuroblastoma, and retinoblastoma), polycythemia vera, chordoma, synovioma, mesothelioma, adenocarcinoma, sweat gland carcinoma, sebaceous gland carcinoma, cystadenocarcinoma, bile duct carcinoma, choriocarcinoma, epithelial carcinoma, ependymoma, pinealoma, acoustic neuroma, schwannoma, meningioma, pituitary adenoma, nerve sheath tumor, cancer of the small intestine, cancer of the endocrine system, cancer of the penis, cancer of the urethra, cutaneous or intraocular melanoma, a gynecologic tumor, solid tumors of childhood, and neoplasms of the central nervous system.


In certain embodiments, the cancer is a colon cancer, such as colorectal cancer (e.g., adenocarcinoma, gastrointestinal carcinoid tumor, primary colorectal lymphoma, leiomyosarcoma, colorectal melanoma, and squamous cell carcinoma). The colon cancer can be, for example, a Stage 0, Stage I, Stage II, Stage III, or Stage IV colon cancer. In certain embodiments, the colon cancer is Stage II or Stage III colon cancer. In alternate embodiments, the cancer is a breast cancer, such as medullary carcinoma. The breast cancer can be, for example, a Stage 0, Stage I, Stage II, Stage III, or Stage IV breast cancer.


Target Drugs


The present invention features drug response predictors for drugs of interest (“target drugs”), in which the expression level of one or more of a panel of biomarkers is used to determine a subject's responsiveness (e.g., sensitivity or resistance) to a target drug. A target drug can be useful for treating or preventing a condition, disease, or disorder such as those described herein (e.g., colon cancer). In certain embodiments, the target drug is one previously thought to be ineffective for treating or preventing a condition, disease, or disorder, such as those described herein, in a patient or subpopulation of patients, but which may be effective in certain subject subpopulations (e.g., a subpopulation identifiable by the methods, devices, or kits of the invention). Exemplary target drugs include, but are not limited to, 5-fluorouracil (5-FU), irinotecan, and/or oxaliplatin, as well as analogs thereof, such as prodrugs, derivatives, metabolites, enantiomers, and combinations thereof.


Biomarkers of Drug Responsiveness


Particular subsets of a patient population may be sensitive or resistant to a particular target drug. The present invention provides a set of biomarker genes, the expression levels of which (e.g., as detected in biological samples obtained from a subject, such as a patient in need of treatment) are indicative of sensitivity or resistance to certain target drugs (e.g., 5-FU, irinotecan, or oxaliplatin). Such biomarkers can be identified using methods such as those the inventors have previously described in, e.g., Chen et al. (Mol. Cancer Ther. 11:34-33, 2012), Wang et al. (J. Nat. Cancer Inst. 105: 1284-1291, 2013), and Knudsen et al. (PLoS One, 9: e87415, 2014), each of which are incorporated by reference herein in their entirety. In certain embodiments, an algorithm based on growth inhibition values (GI50) of a cell line (e.g., NCI60 cells) is subjected to treatment with a target drug and gene expression is determined (e.g., by microarray analysis, next generation sequencing, or NanoString). After normalization, genes with, e.g., a Pearson correlation greater than 0.25 or below −0.25 can be classified as biomarkers of sensitivity or resistance, respectively.


Biomarkers of responsiveness identified as described above can be used to predict drug responsiveness in subjects, e.g., patients suffering from or susceptible to a disease, disorder, or condition (e.g., colon cancer) treatable with the drug, by measuring their expression level in a biological sample obtained from the subject. For example, the expression level of one or more biomarkers of 5-FU resistance, such as those shown in Table 2 (e.g., NT5E), or biomarkers of 5-FU sensitivity, such as those shown in Table 1, can be measured in a biological sample obtained from the subject, and the resultant measurement can be used to assess the subject's responsiveness to 5-FU treatment. The expression level of a biomarker can be measured in a biological sample, e.g., using a device or method of the present invention. For example, a microarray containing probes directed to one or more such biomarkers can be used to measure the mRNA expression level of the biomarkers. Each probe can have, e.g., at least 5, 10, 15, 20, or 25 or more contiguous nucleic acid residues (e.g., at least 10) that are complementary to a nucleic acid sequence of a selected biomarker; the probe sequence can be at least 85% (e.g., 90%, 95%, 99%, or 100%) identical to the sequence of the biomarker. In some embodiments, subjects showing elevated expression of a biomarker, e.g., relative to the population median, are predicted to be resistant to treatment with the drug, while subjects showing reduced expression of a biomarker, e.g., relative to the population median, are predicted to be sensitive to treatment with the drug. In one embodiment, subjects with an elevated level of NT5E expression relative to the population median are predicted to be resistant to treatment with 5-FU, while subjects with an NT5E expression level below the population median are predicted to be sensitive to 5-FU treatment. In some embodiments, subjects showing elevated expression of a biomarker, e.g., relative to the population median, are predicted to be sensitive to treatment with the drug, while subjects showing reduced expression of a biomarker, e.g., relative to the population median, are predicted to be resistant to treatment with the drug.


The expression level of multiple biomarkers (e.g., biomarkers of sensitivity and/or resistance to a target drug) in a biological sample (e.g., a biological sample obtained from a subject) can be compared to: (i) each other, (ii) a predetermined cutoff level (for example, the expression level in a control, a median expression level observed in a population of controls, or the median expression level in the overall population), or (iii) an expression level in patients that are sensitive and/or resistant to a target drug (e.g., 5-FU, irinotecan, and oxaliplatin). Such comparisons can be used to determine a subject's responsiveness to a target drug, such as 5-FU, irinotecan, and oxaliplatin. For example, the difference in expression level between a biomarker of sensitivity and a biomarker of resistance can be used to predict responsiveness (e.g., sensitivity or resistance) to the target drug.


In some embodiments, a minimum difference in expression level between a biomarker of sensitivity and a biomarker of resistance in the subject is required to classify a subject as responsive (e.g., sensitive and/or resistant) to a target drug. In alternate embodiments, a minimum difference in expression level of a biomarker of sensitivity and/or a biomarker of resistance between a subject and a control (e.g., a population median) is required to classify the subject as responsive (e.g., sensitive and/or resistant) to a target drug. In certain embodiments, the minimum difference is a statistically significant difference (e.g., as determined according to statistical methods well known in the art, such as a t-test). In various embodiments, the minimum difference is at least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 50%, 60%, 70%, 80%, 90%, or 100%.


In other embodiments, a maximum difference in expression level of a biomarker of sensitivity and/or a biomarker of resistance between a subject and the median expression level of the biomarker in a population that is sensitive or resistant, respectively, to the target drug, is required to classify the subject as sensitive or resistant, respectively, to the target drug. In certain embodiments, the maximum difference is a statistically significant difference (e.g., as determined according to statistical methods well known in the art, such as a t-test). In various embodiments, the maximum difference is at least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 50%, 60%, 70%, 80%, 90%, or 100%.


The following tables list biomarkers of responsiveness (sensitivity or resistance) to 5-FU, irinotecan, and oxaliplatin. Each AffyID probeset can match several genes or isoforms, and one gene can be matched by several probesets. Sequences for Almac probes to one or more of the biomarkers of sensitivity or resistance to 5-FU, irinotecan, or oxaliplatin, can also be found in the sequences listed in Tables 7-12, which list probesets, including Almac IDs and probe sequences, which can be used to detect the listed biomarkers.


5-FU


Biomarkers identified as indicative of sensitivity or resistance to 5-FU are shown in Tables 1 and 2, respectively, below.









TABLE 1







Genes predicting sensitivity to 5-FU ranked in order of


correlation coefficient (CC). Affymetrix IDs listed are


publically available online at the Affymetrix


NetAffx ™ Analysis Center. The probe


sequence shows the sequence of one (median) of 11 probes


listed by Affymetrix for that Affymetrix ID.











Gene
Affymetrix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














APRT
203219_s_at
0.442
CTCTCCTGCAGTATGAGTGACCACA
SEQ ID NO. 1





GSR
205770_at
0.408
GCAATAGCTGCTGGCCGAAAACTTG
SEQ ID NO. 2





TUFM
201113_at
0.407
GAACATGGCCTGTCGGATTATCCTG
SEQ ID NO. 3





MRPS2
218001_at
0.402
GTTACTTACTCAGCTGATGTCACAG
SEQ ID NO. 4





MTHFD2
201761_at
0.386
GCTGTCCTTTTGAGGCTTAGTCAGT
SEQ ID NO. 5





WDR59
218505_at
0.378
AAGTGCCGGTGACAAGCTGTCTGTC
SEQ ID NO. 6





ANP32B
201305_x_at
0.374
GACTGCTCATGGATTTTGTAGCTGT
SEQ ID NO. 7





PMM2
203201_at
0.366
AGGAAACGGTTCATGTGTCACTTTT
SEQ ID NO. 8





STOML2
215416_s_at
0.366
GGACCCGAGAGTCGGCCATCAATGT
SEQ ID NO. 9





NDUFAB1
202077_at
0.364
GAATAAAGTATCAGACCCTTTGGCT
SEQ ID NO. 10





ANP32A
201051_at
0.361
TTTGGAGTTCTCTTACGTTTCCTGG
SEQ ID NO. 11





IL27RA
222062_at
0.361
GAATGACTGCATGGATAGAACCACT
SEQ ID NO. 12





MIR3658
209825_s_at
0.359
GTCAGGAGGCACTGCTCATCTGTAC
SEQ ID NO. 13


UCK2





USH1C
211184_s_at
0.358
ACACACACCAGATGGCATCCTTGGG
SEQ ID NO. 14





APRT
213892_s_at
0.351
TGCGTGCTCATCCGAAAGCGGGGGA
SEQ ID NO. 15





SERPINB1
212268_at
0.347
ACAGCAGGCATCGCAACTTTCTGCA
SEQ ID NO. 16





RUVBL1
201614_s_at
0.345
GGACCATGCTGTATACTCCACAGGA
SEQ ID NO. 17





HSPD1
200806_s_at
0.341
GAAGCTCTAAGTACACTCGTCTTGA
SEQ ID NO. 18





RBM47
218035_s_at
0.338
CTACTGAGGCCTTTAAGCACCGCTA
SEQ ID NO. 19





KBTBD11
204301_at
0.336
GTGAGATCAAAGCTCCTCCAAAGCC
SEQ ID NO. 20





GCLC
202923_s_at
0.335
TACTCTGGAGCAACCTACTGTCTAA
SEQ ID NO. 21





S100A14
218677_at
0.335
CATGTGGGGAGAGGACCAGCTGGGT
SEQ ID NO. 22





HMGB1
200679_x_at
0.333
CAAAGGAGAACATCCTGGCCTGTCC
SEQ ID NO. 23





MYC
202431_s_at
0.326
GCTAAAACGGAGCTTTTTTGCCCTG
SEQ ID NO. 24





HSD17B7
220081_x_at
0.325
TCAGGCCAGGCTCAGTGGCTCATGC
SEQ ID NO. 25





FABP5
202345_s_at
0.324
AATGAGCAAATCTCCATACTGTTTC
SEQ ID NO. 26





PRIM1
205053_at
0.323
GACAAATATGGACCCTGGCTGGAGT
SEQ ID NO. 27





HSPE1
205133_s_at
0.323
GTCGCTGTTGGATCGGGTTCTAAAG
SEQ ID NO. 28





MRPS35
217942_at
0.323
TTTCCCCACAAGCTGGCATTTCAGT
SEQ ID NO. 29





SLC19A1
211576_s_at
0.32
GCTGGGGAAGTACGTCCCAGCGGCC
SEQ ID NO. 30





PGD
201118_at
0.319
TAAGGCAGGCAGCCACCGAGTTTGG
SEQ ID NO. 31





LGALS4
204272_at
0.319
CGCTGTGGCTTGGATCGCTTCAAGG
SEQ ID NO. 32





PRR13
217794_at
0.319
CCCAGCAGGCCTTTTGTTGGTTGCA
SEQ ID NO. 33





EEF1B2
200705_s_at
0.316
GTCTGGGGCTCATCTAAACTAGTTC
SEQ ID NO. 34


SNORA41





GTF2E1
205930_at
0.314
GAACTTTCACACAAGGGTCTGTAAC
SEQ ID NO. 35





INSIG1
201625_s_at
0.313
GATGACTTACCCTGAAGTCTTCCCT
SEQ ID NO. 36





ZFP36
201531_at
0.311
ATATATTGGGTCGTCTGCTTCCCTT
SEQ ID NO. 37





SLC9A3R1
201349_at
0.31
GGAAGGTGAATGTGTTCCCGTCCTC
SEQ ID NO. 38





PTGES2
218083_at
0.309
GCGCCTGGCGATACTGGTTGGGGGC
SEQ ID NO. 39





RNPS1
200060_s_at
0.308
GGTGGTCTTTCAGGTTATCTTGGCA
SEQ ID NO. 40





GCNT3
219508_at
0.307
AACCATCACCTGTTGGCCAACAAGT
SEQ ID NO. 41





CALML4
221879_at
0.307
CGACCTGCGGTCAAAACTCACGAGT
SEQ ID NO. 42





DDC
205311_at
0.306
AATAAATATCATCCTGCCTTCATGG
SEQ ID NO. 43





INSIG1
201627_s_at
0.305
AACCAATCTGAGCCTTGTATCTCTT
SEQ ID NO. 44





USH1C
205137_x_at
0.305
TGACGATGAGCTGACCTTCTTGCTG
SEQ ID NO. 45





GPX2
202831_at
0.304
CAAGACTTGGGTAAGCTCTGGGCCT
SEQ ID NO. 46





GCN1L1
216232_s_at
0.304
TAAGAACACCGTGGTCAGGGCCTAC
SEQ ID NO. 47





AGMAT
221648_s_at
0.304
GTACCCTCTATGACTGTAATTCCTG
SEQ ID NO. 48





TSPAN8
203824_at
0.303
GGTTTGGTGTTTTCTATGGTCCTGT
SEQ ID NO. 49





GCSH
213129_s_at
0.303
AATGCCCTTTAACTTTCTAATGATT
SEQ ID NO. 50





RPL3
215963_x_at
0.302
GATTGGCCAGGGCTACCTTATCAAG
SEQ ID NO. 51





CYBA
203028_s_at
0.3
ACTTTGGTGCCTACTCCATTGTGGC
SEQ ID NO. 52





PPRC1
203737_s_at
0.297
GTTCTGCAAGAGGAGCTATTCTGAT
SEQ ID NO. 53





HRSP12
203790_s_at
0.297
AAAGCTGCAGGCTGTGACTTCACTA
SEQ ID NO. 54





FASN
212218_s_at
0.296
ACACCAGAGCTGCCGACTTGGAGAC
SEQ ID NO. 55





CALML4
64408_s_at
0.294
CACCCTTCCTGGACGGGACTATTGA
SEQ ID NO. 56





CLDN3
203954_x_at
0.293
AGAAGAAGTACACGGCCACCAAGGT
SEQ ID NO. 57





RPL13A
200715_x_at
0.29
TCCTCCATTGTTGCCCTGGAATGTA
SEQ ID NO. 58


SNORD32A


SNORD33


SNORD34


SNORD35A





SEL1L3
212314_at
0.29
GTAGTCTTCTCCATGAATTACACGT
SEQ ID NO. 59





MRPL16
217980_s_at
0.289
CTGTGAGCCGCGGGACTCTAGAGAA
SEQ ID NO. 60





MUC13
218687_s_at
0.289
GGAGTAAGAGCCTTAGGTCAGTTTG
SEQ ID NO. 61





RPL13
212933_x_at
0.288
AAGCACTGTTGGTTGTTTGGTTAGT
SEQ ID NO. 62


SNORD68





TPT1
216520_s_at
0.288
GACTCGCTCATTGGTGGAAATGCCT
SEQ ID NO. 63





TXN
208864_s_at
0.287
CAGATCGAGAGCAAGACTGCTTTTC
SEQ ID NO. 64





TPK1
221218_s_at
0.286
TGGCCCGCGTGATTGTGGCATTTAA
SEQ ID NO. 65





TMPO
203432_at
0.285
AGTAATTTTATTTGTTGTCTTCTGA
SEQ ID NO. 66





HSP90AB1
214359_s_at
0.284
ATCTCTGTCAGAGTATGTTTCTCGC
SEQ ID NO. 67





SHMT2
214437_s_at
0.284
CCTTAACTTCTCGACAGTTCCGTGA
SEQ ID NO. 68





SEL1L3
212311_at
0.283
GGAAGGTACGATAATCCCACACCAT
SEQ ID NO. 69





ANK3
206385_s_at
0.281
TTACTGTATTGTGTACTGGCTATAA
SEQ ID NO. 70





ALG5
218203_at
0.281
GACCTACTTTTTATACGACTTCGAT
SEQ ID NO. 71





HMGB1
200680_x_at
0.28
CCTGTCCATTGGTGATGTTGCGAAG
SEQ ID NO. 72





CCT3
200910_at
0.28
GGTGAGACGGGTACTTTGGTGGACA
SEQ ID NO. 73





TSR3
213105_s_at
0.279
AAAATCTAGAGACATGAGGGACATA
SEQ ID NO. 74





ANP32B
201306_s_at
0.275
GTAGCGTGGATAGCTGTGATTGGTG
SEQ ID NO. 75





ETS2
201329_s_at
0.273
GGTTCTGGCTGTTTGAGATTCTCAA
SEQ ID NO. 76





ATIC
208758_at
0.273
TCAGTCTAACTCTGTGTGCTACGCC
SEQ ID NO. 77





RPL13
212191_x_at
0.273
GACCATCGGCATTTCTGTGGATCCG
SEQ ID NO. 78


SNORD68





FBXL14
213145_at
0.271
AAAAGGTCACACAGTGCGGCTTCCT
SEQ ID NO. 79





LPCAT4
40472_at
0.268
TGGCCAATGGGACTGTGCAAGCACC
SEQ ID NO. 80





NUP37
218622_at
0.267
AAGTGTTTTCTGTACCTTAGATTCA
SEQ ID NO. 81





WBSCR22
207628_s_at
0.266
GTGTTCACCAATGAGAGGTTCCCAT
SEQ ID NO. 82





PDSS1
220865_s_at
0.266
GGTGTGCAACAAACAACCTACCTCG
SEQ ID NO. 83





SLX1A-
209607_x_at
0.265
TGAGCGCTTCGATGCGGACTATGCG
SEQ ID NO. 84


SULT1A3


SLX1B-


SULT1A4


SULT1A3


SULT1A4





GTF3A
215091_s_at
0.265
TATGTCGCTGTCCAAGAGAAGGCTG
SEQ ID NO. 85





ATHL1
219359_at
0.265
CAGGTGTGCATGGGTCCAAGGCCCT
SEQ ID NO. 86





MIR4680
212593_s_at
0.264
TTTTGTAAGTGCCATGTTTATTATC
SEQ ID NO. 87


PDCD4





CNOT1
200860_s_at
0.263
TGCTGTACCTTTTTGCAGAGGCCAA
SEQ ID NO. 88





DUSP2
204794_at
0.263
CTCAGCTGACATTTAACACTTCCTC
SEQ ID NO. 89





EPCAM
201839_s_at
0.262
ACTTGGACTCCATCGTTAAAATTAT
SEQ ID NO. 90





CASP7
207181_s_at
0.261
GAAATGGATGTAAGCCTGGCCCATA
SEQ ID NO. 91





RPL13
208929_x_at
0.26
AGCTGACCGGACCGGTCATGCCCGT
SEQ ID NO. 92


SNORD68





RPL13
214351_x_at
0.258
TGAAGGAGTACCGCTCCAAACTCAT
SEQ ID NO. 93


SNORD68
















TABLE 2







Genes predicting resistance to 5-FU ranked in order


of correlation coefficient (CC). Affymetrix IDs listed are


publically available online at the Affymetrix NetAffx ™


Analysis Center. The probe sequence shows the sequence


of one (median) of 11 probes listed by Affymetrix


for that Affymetrix ID.











Gene
Affymetrix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














NT5E
203939_at
−0.478
GTCACTGTAAATCATTCTTAAGCCC
SEQ ID NO. 94





CNN3
201445_at
−0.474
GAGCTCAGTATTTAGTCCTTTGTTT
SEQ ID NO. 95





ACTN1
208637_x_at
−0.44
CTTCCTTCAAGATCCTGGCTGGGGA
SEQ ID NO. 96





FLNA
200859_x_at
−0.422
GAGGGAGCCATTTGGTGGCGCTGCT
SEQ ID NO. 97





ATP2B4
212135_s_at
−0.42
CACCTTTCATATCTAGGGACCACCC
SEQ ID NO. 98





CYR61
210764_s_at
−0.417
TTGTGAGGTGCGGCCTTGTGGACAG
SEQ ID NO. 99





ACTN1
208636_at
−0.414
AAATCCCCTCAGAGGTGTGACTAGT
SEQ ID NO.






100





LGALS1
201105_at
−0.411
ATCATGGCTTGTGGTCTGGTCGCCA
SEQ ID NO.






101





RHOC
200885_at
−0.41
GGCCCCTGGAGTTGTTTCTGCAGGG
SEQ ID NO.






102





RAB32
204214_s_at
−0.41
GGCTTTGCCGGATGGTTTGAAACCT
SEQ ID NO.






103





TMEM158
213338_at
−0.409
CACCGATATATTGTTACCGCTGAAA
SEQ ID NO.






104





CYR61
201289_at
−0.404
GCTTTTATTCGTCCTTTGACAAAAG
SEQ ID NO.






105





FLNA
214752_x_at
−0.4
AATGGGGGGACGAGCACATCCCAGG
SEQ ID NO.






106





SNAPC1
205443_at
−0.398
GGTCAAGGGCAAGTCAAAGCAACTA
SEQ ID NO.






107





CCND1
208712_at
−0.396
CCCGGTCATCTAGCAAGCTGCCGAA
SEQ ID NO.






108





FLNA
213746_s_at
−0.396
AAAGCAGGCAACAACATGCTGCTGG
SEQ ID NO.






109





FYN
210105_s_at
−0.384
CCTATGTGATTTTAACTCTGTCTTC
SEQ ID NO.






110





TRAM2
202369_s_at
−0.376
GCACTCTAGAGCTACTTGTTCACGT
SEQ ID NO.






111





DNAJB6
209015_s_at
−0.37
GTTGAACTCATGTTTCAGTTCGCGA
SEQ ID NO.






112





CD44
212063_at
−0.37
TACTTTGACTTTTCAGAGCACACCC
SEQ ID NO.






113





PEA15
200787_s_at
−0.369
CACCCACCTGTACTCTGGAGAGACT
SEQ ID NO.






114





F3
204363_at
−0.369
AAAGCTTCTATGGTTGACATTGTAT
SEQ ID NO.






115





GRB10
209409_at
−0.366
TTCTCTTTTCTGCACTTAATACCTG
SEQ ID NO.






116





CD59
200985_s_at
−0.363
GGTAGGATATCTTGGCTTTGCCACA
SEQ ID NO.






117





PRNP
201300_s_at
−0.363
AGGTCTTTGAAATATGCATGTACTT
SEQ ID NO.






118





LOC100506032
201103_x_at
−0.361
GAGGACAGGTCAGCTGTCTGGCTCA
SEQ ID NO.


NBPF10



119


NBPF11


NBPF12


NBPF15


NBPF16


NBPF24


NBPF7 NBPF8


NBPF9





VIM
201426_s_at
−0.359
GCAGTCCCTCACCTGTGAAGTGGAT
SEQ ID NO.






120





CD44
204489_s_at
−0.357
TTGAATGGGTCCATTTTGCCCTTCC
SEQ ID NO.






121





DKK1
204602_at
−0.356
GAGTCTAGAACGCAAGGATCTCTTG
SEQ ID NO.






122





MARCKS
201670_s_at
−0.353
TGCATACTTTGCATCTTTATTCAAA
SEQ ID NO.






123





PPAP2B
212226_s_at
−0.352
GCACCATCCCAGTGATGTTCTGGCA
SEQ ID NO.






124





IL6ST
212195_at
−0.351
GATGGGTCGTGTGATGAGATGCATT
SEQ ID NO.






125





CAV1
212097_at
−0.35
CAGAAAGCTGCCTGGTATATCCAAA
SEQ ID NO.






126





PURA
204020_at
−0.346
AGGATTTCCATGTAGCTGTGGTGCT
SEQ ID NO.






127





STK17A
202693_s_at
−0.345
GTTACTTCATATACTCTAGGACAAT
SEQ ID NO.






128





LOX
204298_s_at
−0.344
GTTGTGCGCTGTGACATTCGCTACA
SEQ ID NO.






129





NR3C1
201865_x_at
−0.337
GAACTACGCTTGCTCATTTTTTCTT
SEQ ID NO.






130





PPAP2B
212230_at
−0.336
GATTATAAACTGTGTCTCGACCTGT
SEQ ID NO.






131





MARCKS
201669_s_at
−0.333
CGATCATAGTCTTAGGAGTTCATTT
SEQ ID NO.






132





LOC100506032
213612_x_at
−0.332
TTTACTGTGCCTTTGTTTTTACTAG
SEQ ID NO.


NBPF10



133


NBPF11


NBPF12


NBPF15


NBPF16


NBPF24


NBPF7 NBPF8


NBPF9





FAM50A
203262_s_at
−0.329
GCGCTCGAGATCCTTCGGAAAGACT
SEQ ID NO.






134





CAV1
203065_s_at
−0.326
ATCTGGGGCATTTACTTCGCCATTC
SEQ ID NO.






135





QKI
212636_at
−0.322
GTATTTGCAGAGTATTAGCTTTGAA
SEQ ID NO.






136





IL6ST
212196_at
−0.321
GTACACCTGCCCTAAGGAGAAAATA
SEQ ID NO.






137





LEPRE1
220750_s_at
−0.321
GAGTCTCTCTCAGGCAGTGAATCGA
SEQ ID NO.






138





EMP3
203729_at
−0.317
GAGGGGGCAGCTTCGGATACTGCTT
SEQ ID NO.






139





GRB10
210999_s_at
−0.316
AACGACGATTTGCTGCTGTGAACCC
SEQ ID NO.






140





ZNHIT6
218932_at
−0.315
TATGTAACTTACCCTTGTGAGACAA
SEQ ID NO.






141





CALU
200757_s_at
−0.31
GGTATAATGTAACTTCACCCCAGCC
SEQ ID NO.






142





PTPRK
203038_at
−0.31
ATGCTCCACGTAGCTGTAACTTCAC
SEQ ID NO.






143





PSMD2
200830_at
−0.309
GGCCACTGAGGAGTTTCTTCCTGTT
SEQ ID NO.






144





PCMT1
205202_at
−0.309
AACATGCTGTGTAAGCTGTGTCCTA
SEQ ID NO.






145





CD59
200983_x_at
−0.306
AAAACAGTTCTTCTGCTGGTGACTC
SEQ ID NO.






146





THY1
208850_s_at
−0.305
CCTCGGCAGGCATGGCTGGTGCCTG
SEQ ID NO.






147





CD44
210916_s_at
−0.303
GAGTCGTCAGAAACTCCAGACCAGT
SEQ ID NO.






148





TRIB2
202478_at
−0.302
GTTCGGATTTGACTGCCTGTATATG
SEQ ID NO.






149





NR3C1
211671_s_at
−0.301
GGACGTAATCTCCACAGTCAAAGAA
SEQ ID NO.






150





FTSJ1
205324_s_at
−0.3
TGAGTTGTTCACCTTAACCCATTAC
SEQ ID NO.






151





CALU
200755_s_at
−0.298
GAACCTGCCATTACCTGGGCAAGGA
SEQ ID NO.






152





KIF2C
209408_at
−0.296
AGGAGCTCTTAGTTACCCTTTTGTG
SEQ ID NO.






153





LEPROT
202378_s_at
−0.295
GATAACGCTGAAGCAGGCCTCTCAT
SEQ ID NO.






154





AAK1
205434_s_at
−0.295
CCGCTGCGCGATTGACACGCATATT
SEQ ID NO.






155





MAP7D1
217943_s_at
−0.295
CCTTGGATCCGGGCACAGTTGTGAG
SEQ ID NO.






156





C19orf10
221739_at
−0.294
ATCGCAGATCCGGGGCACAAAGAGG
SEQ ID NO.






157





CENPF
207828_s_at
−0.292
TACCCCTGGGAGGTGCCAGTCATTG
SEQ ID NO.






158





CAPN2
208683_at
−0.29
AATCGTTCTCCTTACAATCAAGTTC
SEQ ID NO.






159





CD44
209835_x_at
−0.288
AGCAAACACAACCTCTGGTCCTATA
SEQ ID NO.






160





ATM
210858_x_at
−0.287
TGCTCATACAGCAGGCCATAGACCC
SEQ ID NO.






161





MXRA7
212509_s_at
−0.286
GAGCTATCTAGGTTTGTCTGGAAAG
SEQ ID NO.






162





THY1
213869_x_at
−0.286
CCCTAACGAGACACATTTGCCCAAA
SEQ ID NO.






163





FHL2
202949_s_at
−0.285
CTCACCCAGGCAATCTTGCCTTCTG
SEQ ID NO.






164





RND3
212724_at
−0.285
GCAGCCAAGGTCTGTGTTCAGCACT
SEQ ID NO.






165





AXL
202686_s_at
−0.283
GTTGGACACCTTTAGGTTCTTTGCT
SEQ ID NO.






166





LOXL2
202998_s_at
−0.281
GACAGGTTGTCATCAGCTTGTCCCA
SEQ ID NO.






167





CTNNAL1
202468_s_at
−0.28
GATCCATGATGGCTCTCTTAGTCCA
SEQ ID NO.






168





CD44
204490_s_at
−0.28
GGACACCCCAAATTCCAGAATGGCT
SEQ ID NO.






169





TFE3
212457_at
−0.28
GCCAGGCCCCATGGAGGGTATACTG
SEQ ID NO.






170





SPTAN1
215235_at
−0.28
ATCATCATGTCACTGTGGGGACCCA
SEQ ID NO.






171





LIMA1
217892_s_at
−0.28
AGAACTGTCTTACACCACTTGAGCT
SEQ ID NO.






172





MSN
200600_at
−0.279
TTATTATTACTGTTTGTCTTCTCCC
SEQ ID NO.






173





NR2F2
209121_x_at
−0.279
GTTTGTTTGCTTAATTTCCTTCTGT
SEQ ID NO.






174





PTPLA
219654_at
−0.279
AGAGAGTGTGGTGCTTTTTCTGGTC
SEQ ID NO.






175





FHL1
201540_at
−0.278
GGATCACCTACTTACTGTATTCTAC
SEQ ID NO.






176





C20orf3
206656_s_at
−0.278
ATAACGTGCGGTCATACCTTTCTTC
SEQ ID NO.






177





OXSR1
202696_at
−0.276
GAGATTCCTCCTTATGATGTATGCT
SEQ ID NO.






178





TIMP2
203167_at
−0.276
GAACCACAGGTACCAGATGGGCTGC
SEQ ID NO.






179





OSBPL3
209626_s_at
−0.276
ATAACATTAGTGTATTTCTCCTGTG
SEQ ID NO.






180





ZNF331
219228_at
−0.276
TTCATTTATGGATCGAGCCTCGTGA
SEQ ID NO.






181





SEPT7
213151_s_at
−0.275
GAAATGGGAATCATGGCCTCTTGAA
SEQ ID NO.






182





JUN
201466_s_at
−0.274
ATCTATATGGAATTGCTTACCAAAG
SEQ ID NO.






183





IFRD1
202146_at
−0.274
GCTGTATGAGACTTTGTGCATTTTA
SEQ ID NO.






184





CDH11
207173_x_at
−0.273
TTTCGCCTTAAACTCTGGACACTCT
SEQ ID NO.






185





USP33
214843_s_at
−0.273
TGAAGACCTGGTTTTGATGCTGCCT
SEQ ID NO.






186





LPP
202822_at
−0.272
ACTGATGTAACCTCAAAGCCTCTCA
SEQ ID NO.






187





LHFPL2
212658_at
−0.27
TTTAAGGGCTAATCTCACACCTCCT
SEQ ID NO.






188





PURA
204021_s_at
−0.269
GGCGTGTTTATGCGAGTGAGCGAGG
SEQ ID NO.






189





FKBP9
212169_at
−0.269
TCAACAGAGTATTTCCCTTGGCCGA
SEQ ID NO.






190





SOGA2
213358_at
−0.269
AATTTGCACTGTTACATTTTGGTTC
SEQ ID NO.






191





TUBB
211714_x_at
−0.268
CAAGCGCATCTCGGAGCAGTTCACT
SEQ ID NO.






192





PTRF
208789_at
−0.267
TGATTCTGTTCGGACTGGGTTCTCA
SEQ ID NO.






193





PMP22
210139_s_at
−0.267
AACTGCTTTTGTACCTAGCTAGGCT
SEQ ID NO.






194





RAB31
217762_s_at
−0.267
AGGACATTAGGATTGGTGCTCAGAA
SEQ ID NO.






195





RAB31
217763_s_at
−0.267
GAGTGAGCACACTGGCTTTGCATCC
SEQ ID NO.






196





MAP4K4
206571_s_at
−0.266
GGAATTCCTTGTAACTGGAGCTCGG
SEQ ID NO.






197





CRIM1
202552_s_at
−0.264
GGTAATTAATCCATTCCTGGCATAA
SEQ ID NO.






198





SVIL
202565_s_at
−0.264
GCATTAGGTATGACTTGTTCTGAGT
SEQ ID NO.






199





ROBO1
213194_at
−0.261
GTTGTGGCCAATGTCGAAACCTACA
SEQ ID NO.






200





EMC3
217882_at
−0.261
AGACCTCCACTTCGAAGGCATGTTC
SEQ ID NO.






201





ULK2
204062_s_at
−0.26
GTGGAGTTCCTACATGCAGTGAGTG
SEQ ID NO.






202





SCRN1
201462_at
−0.259
TCATGTGCACATGCCGTTGCAGCAC
SEQ ID NO.






203





RAB31
217764_s_at
−0.258
TAAAGAGCTTCCATCTGGGCTGGAC
SEQ ID NO.






204





FOXN3
218031_s_at
−0.258
ACCGATGTGTCTATGGTGCTGCACC
SEQ ID NO.






205





RPF1
218462_at
−0.258
AACGGGATTACATATTCTTCAGATT
SEQ ID NO.






206





EBNA1BP2
201323_at
−0.254
GCCTCAAGAGGCCTGGCAAGAAAGG
SEQ ID NO.






207





ATM
212672_at
−0.254
AGAATCTGGGGTTTGCCAGTCAGTT
SEQ ID NO.






208









In some aspects of the invention, one or more biomarkers of sensitivity and/or resistance to 5-FU are measured in a biological sample obtained from a subject (e.g., a subject suffering from or susceptible to a disease, disorder, or condition treatable with 5-FU, such as cancer, e.g., colon cancer) using, e.g., a microarray, sequencing, NanoString, a protein array, or PCR-based methods, such as those described herein. In certain embodiments, the microarray includes probes capable of recognizing the one or more biomarkers of sensitivity and/or resistance to 5-FU, such as probes at least about 15 nt in length that have, e.g., a sequence with at least 5 (e.g., at least 10) contiguous nucleotides that are complementary to or identical to the sequence(s) of the biomarker(s). In some embodiments of any of the above aspects, any one of the biomarkers from Tables 1 and 2 can be used to assess a subject's sensitivity and/or resistance to treatment with 5-FU. Alternatively, a combination of any of the biomarkers of Tables 1 and 2 may be used. For example, combinations that include the top 5, 10, 15, or 20 biomarkers from Tables 1 and/or 2 may be used. In some embodiments, one or more biomarkers of resistance to 5-FU is selected from the group consisting of NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158, and/or one or more biomarkers of sensitivity to 5-FU is selected from the group consisting of APRT, GSR, TUFM, MRPS2, MTHFD2, WDR59, ANP32B, PMM2, STOML2, and NDUFAB1. In certain embodiments, the one or more biomarkers of resistance to 5-FU include NT5E, CNN3, ACTN1, FLNA, and/or ATP2B4, and/or the biomarkers of sensitivity to 5-FU include GSR, TUFM, MRPS2, and/or MTHFD2. In particular embodiments, one or more biomarkers of resistance includes NT5E.


Furthermore, a combination of any of the biomarkers of Tables 1-4 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of 5-FU and irinotecan, and a combination of any of the biomarkers of Tables 1, 2, 5, and 6 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of 5-FU and oxaliplatin.


Irinotecan


Biomarkers identified as indicative of sensitivity or resistance to irinotecan are shown in Tables 3 and 4, below.









TABLE 3







Genes predicting sensitivity to irinotecan ranked in order


of correlation coefficient (CC). Affymetrix IDs listed are


publically available online at the Affymetrix NetAffx ™


Analysis Center. The probe sequence shows the sequence


of one (median) of 11 probes listed by


Affymetrix for that Affymetrix ID.











Gene
Affymetrix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














PRF1
214617_at
0.552
GAGGTGGCTGGGTTTACACGCTAAT
SEQ ID NO.






209





GZMB
210164_at
0.527
TGCGAATCTGACTTACGCCATTATT
SEQ ID NO.






210





PTPRC
207238_s_at
0.479
GAAGGTTCTGAACCCACGAGTGGCA
SEQ ID NO.






211





PTPRC
212587_s_at
0.464
TGGCTGAATTTCAGAGCATCCCGCG
SEQ ID NO.






212





PTPRCAP
204960_at
0.462
AGCAATGTGGAGAGGCGTCCAGCCC
SEQ ID NO.






213





LOC728802
213388_at
0.46
CCTCTTTCTCAATCTATAACCTTTG
SEQ ID NO.


PDE4DIP



214





ACAP1
205213_at
0.459
CCCTGCTACGACTGGCAAAGATGAG
SEQ ID NO.






215





PTPRC
212588_at
0.459
ATTGCATATGCATAGTTCCCATGTT
SEQ ID NO.






216





S1PR1
204642_at
0.456
ACTTTTAAGTCCAGCTATTCATTAG
SEQ ID NO.






217





DOCK2
213160_at
0.42
GATTCCTGAACTCAAGGTACCAGCA
SEQ ID NO.






218





ARHGEF6
209539_at
0.416
TAACCATGCTTACACACTAAACTAT
SEQ ID NO.






219





CD3D
213539_at
0.415
GGAATGACCAGGTCTATCAGCCCCT
SEQ ID NO.






220





CYTIP
209606_at
0.414
GTTGTGTTATAGTTTATGCTTCTTA
SEQ ID NO.






221





ATF3
202672_s_at
0.412
CTCTCCACTCAATGTCTTAGGTCAG
SEQ ID NO.






222





SERPINA1
202833_s_at
0.412
GCATGTTTAACATCCAGCACTGTAA
SEQ ID NO.






223





FAM129A
217967_s_at
0.408
GGTAATCTTCTATGTCAGAGCTAGT
SEQ ID NO.






224





HSD17B7
220081_x_at
0.408
TGCATACCTTCTGTACATTCTGGGG
SEQ ID NO.






225





HCLS1
202957_at
0.405
GAACATTTCTCTTGTGTTCCTGACT
SEQ ID NO.






226





CD247
210031_at
0.4
TGATTCACTTCACGCTTTCAGCGAA
SEQ ID NO.






227





KBTBD11
204301_at
0.396
AGTGGCCACATCATTTCCACGTTTT
SEQ ID NO.






228





LOC728802
214129_at
0.395
GAAAGATCCTTGTCTGATTTTGGCA
SEQ ID NO.


PDE4DIP



229





FAM129A
217966_s_at
0.393
TACTCATCCTGCTATCAATTTCTTA
SEQ ID NO.






230





PHF11
221816_s_at
0.393
ATCACTCTTTGCACACTCTTGTGTT
SEQ ID NO.






231





PNMA2
209598_at
0.389
GGATTTTCACGATGTTCCTGTCTGC
SEQ ID NO.






232





DDX23
201440_at
0.387
CCAAGGGGTGCTGTATGCTCTAGGC
SEQ ID NO.






233





TRIM14
203148_s_at
0.387
AGGGTTACTGATCACTTACCTTCTT
SEQ ID NO.






234





CD53
203416_at
0.385
TCTAAATAATGCCCAGTCTTCTCCC
SEQ ID NO.






235





ITGA4
213416_at
0.382
GTACTATGGTTGTCCAACACAGGCC
SEQ ID NO.






236





NFIL3
203574_at
0.378
GATAGTCCATGCGAAGGCTGTATAT
SEQ ID NO.






237





ZAP70
214032_at
0.377
ATCACCAGAATAAACCCAGCTTCCC
SEQ ID NO.






238





IL6R
205945_at
0.376
AATATCCAATATTCGCTGTGTCAGC
SEQ ID NO.






239





IFI16
208965_s_at
0.373
GGTTAAGTCCTTACTGAGCAACGAT
SEQ ID NO.






240





PTPRE
221840_at
0.371
GACACCTGTGTTTCAGCATTTGGAG
SEQ ID NO.






241





RAC2
213603_s_at
0.369
GCCAGTCAGGACTTTTGCTATTGCA
SEQ ID NO.






242





PSMB9
204279_at
0.368
GTGGACCATCGAGTCATCTTGGGCA
SEQ ID NO.






243





PSMD11
208776_at
0.368
GCTGTCCAATATGTAGCCGCTAGCC
SEQ ID NO.






244





CCDC109B
218802_at
0.367
AGGATTATACTTACTCAGCTGTTAA
SEQ ID NO.






245





GOS2
213524_s_at
0.366
GCCTGACTCCGCTGGGAGAGTGCAG
SEQ ID NO.






246





RFTN1
212646_at
0.365
GCTGATTGTCTTGACCAAACCCACA
SEQ ID NO.






247





PTPN7
204852_s_at
0.362
GACAGCTGCCTTGATACCAGCTCTC
SEQ ID NO.






248





SERPINA1
211429_s_at
0.362
ACCTATGATCTGAAGAGCGTCCTGG
SEQ ID NO.






249





ADD2
205268_s_at
0.358
TAAATGCCAACACTGTCTTCTCATG
SEQ ID NO.






250





KIAA0226L
44790_s_at
0.357
TTCACTGATGCTGAGCCAGTTTGTA
SEQ ID NO.






251





PSMB8
209040_s_at
0.356
GTCATGGACAGTGGCTATCGGCCTA
SEQ ID NO.






252





CD93
202878_s_at
0.355
TCAGCAGATTTTGCCCACTATTCCT
SEQ ID NO.






253





N4BP2L1
213375_s_at
0.353
ACATGTGTAATTAGTCGGCAGCTCA
SEQ ID NO.






254





TPK1
221218_s_at
0.353
TCTGTGTGCCCTGAAAATGTTACCA
SEQ ID NO.






255





SELPLG
209879_at
0.348
TCCATCTAGTGACAAGTGACCCCCA
SEQ ID NO.






256





WDR59
218505_at
0.348
GCTGATGGACAGTGGCCTTCTAAAA
SEQ ID NO.






257





NARF
219862_s_at
0.348
CGGAGAGGTGGTGTTACGCTTTGCT
SEQ ID NO.






258





PPRC1
203737_s_at
0.347
GACACATTGTTGAAACAGGCCCAGA
SEQ ID NO.






259





HNRNPA1
222040_at
0.346
ATTCCCAGTAGTGACAGTGGATATA
SEQ ID NO.






260





SEC31B
209889_at
0.345
GCCTCTGACTTGGTATTTCCAGGTC
SEQ ID NO.






261





IKZF1
205038_at
0.344
CCCATATCCCTTCTGTAATTTGTAC
SEQ ID NO.






262





IL27RA
222062_at
0.341
CATATGCCAACACGGGGTCTGGGTG
SEQ ID NO.






263





STAT3
208991_at
0.339
ACATACTCCTGGCATTGCACTTTTT
SEQ ID NO.






264





BATF
205965_at
0.337
ATGCTCAAGTCCCATGGCACAGAGC
SEQ ID NO.






265





ARHGAP15
218870_at
0.337
GCCTTTCAAGCGACAGATGCCTCAT
SEQ ID NO.






266





SLA
203761_at
0.336
TAAGCATTCCGTCCATCTAAGCTCA
SEQ ID NO.






267





LAT
211005_at
0.33
GTGCGAGTCTGAGTCAGAGATTTGG
SEQ ID NO.






268





MIR3658 UCK2
209825_s_at
0.328
TGATGTGATCATCCCTAGAGGTGCA
SEQ ID NO.






269





NAP1L1
208752_x_at
0.327
GATGAACCTATTCTGAAGCACTTGA
SEQ ID NO.






270





CBFB
202370_s_at
0.326
AGAGCTCCTTGGTTTTTTACTTCTG
SEQ ID NO.






271





TM6SF1
219892_at
0.325
AAATATTACTTCATGTTCCTCCTTT
SEQ ID NO.






272





FMNL1
204789_at
0.324
TCAAGGAAGGTGGTCCTCAGCTCGG
SEQ ID NO.






273





INSIG1
201626_at
0.321
GAACAAAATTTGCACTCTACCAGAT
SEQ ID NO.






274





IFI16
208966_x_at
0.32
GAAACTTCACCAGACTTTTTCTTCT
SEQ ID NO.






275





PRKCQ
210038_at
0.315
CCATTCTCAGCAGACTCCAGTATTG
SEQ ID NO.






276





FSCN1
210933_s_at
0.315
GACTCCACAGGCAAATACTGGACGG
SEQ ID NO.


LOC100653350



277





TRIM22
213293_s_at
0.315
GACTATATCTAATTCCTCTGATCAC
SEQ ID NO.






278





TACC3
218308_at
0.315
GACCAACTTACCACAGATCTGAACT
SEQ ID NO.






279





SLC35G2
219569_s_at
0.314
CCTTGGACAAATTCCATCCAGCTTT
SEQ ID NO.






280





TAF1A
206613_s_at
0.313
GTGAGAAAGCTTTTGTGGCTGGTTT
SEQ ID NO.






281





RHOH
204951_at
0.312
CACAACACTTATGTATGCACCCCAA
SEQ ID NO.






282





NAP1L1
212967_x_at
0.311
GGGTTGTACAGGGTGCCAGATAGAT
SEQ ID NO.






283





JUNB
201473_at
0.308
CTGCTGGAAACAGACTCGATTCATA
SEQ ID NO.






284





PTPN2
213137_s_at
0.308
GTGCTCTACGGAAACGTATTCGAGA
SEQ ID NO.






285





MCL1
200797_s_at
0.307
GCTGTACTTTTGATAGCTGTGCCAG
SEQ ID NO.






286





GNA15
205349_at
0.307
CAGACCGCTGGAAAACACTGTCACT
SEQ ID NO.






287





EIF4A1
214805_at
0.307
CTTTTTCCTGGGTCATGCTGCAACA
SEQ ID NO.






288





CXorf57
219355_at
0.306
TATTCTTGCTGTACTCATTGGTAGT
SEQ ID NO.






289





SAMSN1
220330_s_at
0.305
TGGACACATTTTATCCTGATCCACA
SEQ ID NO.






290





INSIG1
201627_s_at
0.302
AGACCATACCAGACCTAATTTGCAA
SEQ ID NO.






291





HNRNPR
208765_s_at
0.302
ACCCTCCAGATTACTACGGCTATGA
SEQ ID NO.






292





FAM216A
204521_at
0.301
TGGAGAGAGAGGACTCGGGGTCTTC
SEQ ID NO.






293





SRSF7
213649_at
0.298
AGATCTACTAGACCATGGGCCAAAG
SEQ ID NO.






294





MFNG
204153_s_at
0.295
GCCTTTCTTGCTGTTAGGGGCTACC
SEQ ID NO.






295





GPR183
205419_at
0.295
GCAGGACTTCCCTTATAAAGCAAAA
SEQ ID NO.






296





BCAT1
214452_at
0.295
GATTTCTTTGGCTACCTGTGCATAA
SEQ ID NO.






297





PLAGL1
209318_x_at
0.293
AATAACTTTATGTGGCACTGCCTAG
SEQ ID NO.






298





BIRC3
210538_s_at
0.293
CAGGGACACATTTCTCTGTCTTTTT
SEQ ID NO.






299





CUTC
218970_s_at
0.293
ACAGAATTCCACTGTTCTGCTCGGT
SEQ ID NO.






300





UBE2L6
201649_at
0.292
GTTTGCAGTTACAGGCCAGTTCTCC
SEQ ID NO.






301





SLA
203760_s_at
0.292
GTCTGGGTTTGCAGATGGGTGCCCT
SEQ ID NO.






302





CYTH4
219183_s_at
0.292
TCTGTCACCTCATTGGTCCATGAAG
SEQ ID NO.






303





FAN1
203678_at
0.291
GAGCCAACATCACGTTTTGTTAGCT
SEQ ID NO.






304





ANP32B
201305_x_at
0.29
GACTGCTCATGGATTTTGTAGCTGT
SEQ ID NO.






305





GMFG
204220_at
0.288
AGCTGAGGAAATTCCGCTTCCGAAA
SEQ ID NO.






306





LOC100288366
213646_x_at
0.288
AAATGTGACCCTCGCCATGGTAAAT
SEQ ID NO.


TUBA1B



307






222315_at
0.288
CTGCACCATTCAAACTAGCCAACCC
SEQ ID NO.






308





SLC19A1
211576_s_at
0.287
GGCCTCAGGGTCTAAGGAGCGCTAG
SEQ ID NO.






309





PMAIP1
204286_s_at
0.285
AGGCAGCTATTTTACCATCTGGTAT
SEQ ID NO.






310





EIF1
212225_at
0.285
TAGGCCTAATTCGTTTTCCTTTGTG
SEQ ID NO.






311





TRBC1
211796_s_at
0.284
CCGAGGCCTGGGGTAGAGCAGACTG
SEQ ID NO.






312





LARS2
34764_at
0.284
CCCCTGCAGTTCAGCAGTTAACAGA
SEQ ID NO.






313





SRRT
222047_s_at
0.282
GTATGGTGCTGGTCGAGGGAACTAT
SEQ ID NO.






314





CTCF
202521_at
0.281
GATTCTTGCACATGAACTGTCACAT
SEQ ID NO.






315





ITK
211339_s_at
0.281
CATGTGACGTTTTGACTGGCTTGAG
SEQ ID NO.






316





AKAP2
202759_s_at
0.28
GCCGTATATAGATCAATGTCCACAT
SEQ ID NO.


PALM2-AKAP2



317





TAP1
202307_s_at
0.279
TGGTGGAGCAGGCTGACCACATCCT
SEQ ID NO.






318





TIAM1
213135_at
0.279
CTCCAGTGCAACACATCCATCTGAA
SEQ ID NO.






319





CD99
201028_s_at
0.278
TGGAGAAAATGACGACCCACGACCA
SEQ ID NO.






320





CSDA
201161_s_at
0.277
ACTGATAGGCAGTTCTCTGGGGCCC
SEQ ID NO.






321





IL4R
203233_at
0.277
CCACCAGATCATGGCCCACGTGGAG
SEQ ID NO.






322





C1orf114
206721_at
0.277
AAACAGAGATCCACAACAAGCTTTT
SEQ ID NO.






323





SLC16A3
202855_s_at
0.276
TGTTCGTGGTGAGCTACGCCAAGGA
SEQ ID NO.






324





USP7
201498_at
0.275
GAGGGCATGCTCACTAGTGGTTAGT
SEQ ID NO.






325





PAPD7
202466_at
0.275
GTAGGCCTGTACTAATCTCTACGCA
SEQ ID NO.






326





RFX5
202963_at
0.275
TGGCAGCATCTTGTCATACGTGTCA
SEQ ID NO.






327





MAP4K1
214219_x_at
0.274
CCAGCAACCTCTACATCCAGGAATG
SEQ ID NO.






328





WHSC1
209053_s_at
0.272
GATTCCTCGAAACTGCCATTGTGAT
SEQ ID NO.






329





CYFIP2
215785_s_at
0.271
ATGGCCGACCGGATCAGGAAGTATC
SEQ ID NO.






330





FHOD1
218530_at
0.271
GGTGTGAAGGTGCTGTATCCCGGAA
SEQ ID NO.






331





TGFB1
203085_s_at
0.269
TGGATCCACGAGCCCAAGGGCTACC
SEQ ID NO.






332





LARP4B
208954_s_at
0.267
AGTGAGTGTCTTGACATTTTCACCC
SEQ ID NO.






333





SP110
209762_x_at
0.267
GAGGCTCACCTTAGAGCTTCTGAGT
SEQ ID NO.






334





DPY19L1
212792_at
0.266
GGTAGCAGGTTCCATAGGCGTACAA
SEQ ID NO.






335





CSDA
201160_s_at
0.265
GATGCTGGTGCTAAACCTCCAAGTG
SEQ ID NO.






336





ANP32E
221505_at
0.265
TAATGCTCTTTGTATGGCAGTATGT
SEQ ID NO.






337





FLI1
204236_at
0.264
TGACCTCGGTCACAAAAGCAGTTTT
SEQ ID NO.






338





ARHGAP19
212738_at
0.263
GCTAATGCCGAGATCTTCTACCAGC
SEQ ID NO.






339





POM121
213360_s_at
0.263
CCTTATGTAAGGTAGACCCTCCTAG
SEQ ID NO.


POM121C



340





LOC100506390
200833_s_at
0.262
GATTGTGTGTCTATCCAACAGGGAG
SEQ ID NO.


RAP1B



341





PSMB10
202659_at
0.262
CCACGTGGGTGCATCGCTGATCGTG
SEQ ID NO.






342





RHOG
203175_at
0.262
TCCAGCTTTCCACACAGTTGTTGCT
SEQ ID NO.






343





FNBP1
212288_at
0.262
GAGTTGCCTGTTTGTCTCTGGAGAT
SEQ ID NO.






344





KIAA0226L
219471_at
0.262
CCCGGTGTGCGAGGATCACAGCGAG
SEQ ID NO.






345





DNAJC2
213097_s_at
0.261
ATAGCAGAAGCGGTGCCTGGCAGGA
SEQ ID NO.






346





ANP32B
201306_s_at
0.259
CTTCCATGTAGTCCCTCTTGGTAAT
SEQ ID NO.






347





TRIP13
204033_at
0.259
ATAGGTCAGTTACTGGTCTCTTTCT
SEQ ID NO.






348





SP140
207777_s_at
0.259
GGGAAGGATGTTGGCAGCGACACCA
SEQ ID NO.






349





PRPF3
202251_at
0.258
GACCTTGCGCTGAGTGAATCTGTGT
SEQ ID NO.






350





ICOS
210439_at
0.257
CAGGTGTTCCCTGAGTTGTTTGCAG
SEQ ID NO.






351





CORO1A
209083_at
0.256
TATCTCTCCATGTTCAGTTCCAAGG
SEQ ID NO.






352





TRBC1
210915_x_at
0.255
AAAGGCCACACTGGTGTGCCTGGCC
SEQ ID NO.






353
















TABLE 4







Genes predicting resistance to irinotecan ranked in order


of correlation coefficient (CC). Affymetrix IDs listed are


publically available online at the Affymetrix NetAffx ™


Analysis Center. The probe sequence shows the sequence


of one (median) of 11 probes listed by


Affymetrix for that Affymetrix ID.











Gene
Affymetrix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














CCND1
208712_at
−0.406
ATCTCAATGAAGCCAGCTCACAGTG
SEQ ID NO.






354





LGALS3
208949_s_at
−0.404
TGATTGTGCCTTATAACCTGCCTTT
SEQ ID NO.






355





INPP4B
205376_at
−0.38
GAATGGTATTCGTTTCACCTGTTGT
SEQ ID NO.






356





TMEM97
212281_s_at
−0.344
TACAGCCAGGCATAACATATCCACT
SEQ ID NO.






357





TCF7L2
212761_at
−0.332
GTTTTATGCTCTTATTCCAAGTTCA
SEQ ID NO.






358





SFN
33323_r_at
−0.33
GCATGTCTGCTGGGTGTGACCATGT
SEQ ID NO.






359





LAPTM4B
214039_s_at
−0.327
CCAAGTATGTCTAGTCACCTTTTAA
SEQ ID NO.






360





LSR
208190_s_at
−0.323
GTCGTCTGATCTGACGTTTTCTACG
SEQ ID NO.






361





SFN
209260_at
−0.323
CCTGCTGCCTCTGATCGTAGGAATT
SEQ ID NO.






362





TMEM97
212282_at
−0.317
GTCTAGCATCTCAAGGCTGATCTGG
SEQ ID NO.






363





SFN
33322_i_at
−0.313
ATGTCTGCTGGGTGTGACCATGTTT
SEQ ID NO.






364





C19orf21
212925_at
−0.303
TGAAATGGGACCCCTGCTGATTCTT
SEQ ID NO.






365





SERPINB6
211474_s_at
−0.302
AGGCAGACTTCTCTGGAATGTCCCA
SEQ ID NO.






366





NR2F2
209120_at
−0.3
AGACACATGCTGAGGTTTTGAATAA
SEQ ID NO.






367





CTBP2
210835_s_at
−0.299
ATTGAAGACAGTACAGGCTGCTGTA
SEQ ID NO.






368





LAPTM4B
208767_s_at
−0.298
TCTGTTCCCTCTCTTTTGAAAATGT
SEQ ID NO.






369





SQLE
209218_at
−0.297
TCTCCTAACCCTCTAGTTTTAATTG
SEQ ID NO.






370





SORL1
203509_at
−0.292
GAATATCACAGCTTACCTTGGGAAT
SEQ ID NO.






371





GPX4
201106_at
−0.29
ATCTGCGTGAACGGGGACGACGCCC
SEQ ID NO.






372





JUP
201015_s_at
−0.286
TCTCTGGGTCTGATTTTCTCACTGA
SEQ ID NO.






373





LAPTM4B
208029_s_at
−0.286
AAGACCATTAGAAAGCACCAGGCCG
SEQ ID NO.






374





ACTN1
208636_at
−0.279
ATATTCCATCCTTTTTACTGATTTT
SEQ ID NO.






375





CPNE3
202119_s_at
−0.277
AAATTACCCATATTGACTTTCACAC
SEQ ID NO.






376





TJP1
202011_at
−0.274
ATGCGTGCATACCACTTTTGTTCTT
SEQ ID NO.






377





KRT18
201596_x_at
−0.272
GAGCTGCTGAGACGACGCTCACAGA
SEQ ID NO.






378





KDELR3
204017_at
−0.271
GATACCTGCCTTGTACTTAGTACCT
SEQ ID NO.






379





DSG2
217901_at
−0.27
AAGTTGGTCTTAAGCTTCCACCTTG
SEQ ID NO.






380





LRP5
209468_at
−0.268
GAAAGTCCATGATGAGCTCCGTGAG
SEQ ID NO.






381





SUV420H1
218242_s_at
−0.268
TCCCTTCACTTATCAGCATACTATT
SEQ ID NO.






382





CTBP2
201220_x_at
−0.267
ATAGAGCTTTTTCCTTTATCAGTCC
SEQ ID NO.






383





RRBP1
201204_s_at
−0.266
AGAGCCCCAGTTTGTAAATGAACCT
SEQ ID NO.






384





EPCAM
201839_s_at
−0.266
ACTTGGACTCCATCGTTAAAATTAT
SEQ ID NO.






385





LAD1
203287_at
−0.266
GCTGTGGATCTGTTTGGCCAGGGTC
SEQ ID NO.






386





PPAP2B
212226_s_at
−0.266
GAAATCCTTTCACCTGTGGACATTA
SEQ ID NO.






387





SORL1
212560_at
−0.266
ATCGTCACAGCCAAGTAATAACCCA
SEQ ID NO.






388





LITAF
200704_at
−0.265
GACCTTCAAGGGTCCTCGTTTTGAT
SEQ ID NO.






389





ACTN1
208637_x_at
−0.265
CCCTGCCCGCGAAGTGACAGTTTAC
SEQ ID NO.






390





APOBEC3B
206632_s_at
−0.263
AGCAATGTGCTCCTGATCAAGTAGA
SEQ ID NO.






391





LITAF
200706_s_at
−0.262
TTCTCTGTGCCAGATCTTCAGTGCC
SEQ ID NO.






392





ASAH1
213702_x_at
−0.262
CAAGACCGTTTGTCCACTTCATTTT
SEQ ID NO.






393





MLPH
218211_s_at
−0.262
TTCACTCTTGGCTTTCTTATGTTGC
SEQ ID NO.






394





LAMB1
201505_at
−0.261
ATAGCACATGCTTGTAACAGAGGAG
SEQ ID NO.






395





TGFBR3
204731_at
−0.26
GAATAGTGTCACCAATTCCACCAAG
SEQ ID NO.






396





TMEM97
212279_at
−0.259
ATACTCTCCACATTTCTGTTTGAGG
SEQ ID NO.






397





SLC25A1
210010_s_at
−0.256
TCATGTTCTGTGTCACGTGACCCTG
SEQ ID NO.






398









In some aspects of the invention, one or more biomarkers of sensitivity and/or resistance to irinotecan are measured in a biological sample obtained from a subject (e.g., a subject suffering from or susceptible to a disease, disorder, or condition treatable with irinotecan, such as cancer, e.g., colon cancer) using, e.g., a microarray, sequencing, NanoString, a protein array, or PCR-based methods, such as those described herein. In certain embodiments, the microarray includes probes capable of recognizing the one or more biomarkers of sensitivity and/or resistance to irinotecan, such as probes at least about 15 nt in length that have, e.g., a sequence with at least 5 (e.g., at least 10) contiguous nucleotides that are complementary to or identical to the sequence(s) of the biomarker(s). In embodiments of any of the above aspects, any one of the biomarkers from Tables 3 and 4 can be used to assess a subject's sensitivity and/or resistance to treatment with irinotecan. Alternatively, a combination of any of the biomarkers of Tables 3 and 4 may be used. For example, combinations that include the top 5, 10, 15, or 20 biomarkers from Tables 3 and/or 4 may be used. In some embodiments, one or more biomarkers of sensitivity to irinotecan is selected from the group consisting of PRF1, GZMB, PTPRC, PTPRC, PTPRCAP, PDE4DIP, ACAP1, PTPRC, S1PR1, and DOCK2, and/or one or more biomarkers of resistance to irinotecan are selected from the group consisting of CCND1, LGALS3, INPP4B, TMEM97, TCF7L2, SFN, LAPTM4B, LSR, SFN, and TMEM97. In certain embodiments, the one or more biomarkers of sensitivity include PRF1, GZMB, PTPRC, PTPRC, and/or PTPRCAP, and the one or more biomarkers of resistance include CCND1, LGALS3, INPP4B, TMEM97, and/or TCF7L2. In particular embodiments, one or more biomarkers of sensitivity include PRF1.


Furthermore, a combination of any of the biomarkers of Tables 1-4 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of 5-FU and irinotecan, and a combination of any of the biomarkers of Tables 3-6 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of irinotecan and oxaliplatin.


Oxaliplatin


Biomarkers identified as indicative of sensitivity and resistance to oxaliplatin are shown in Tables 5 and 6, below.









TABLE 5







Genes predicting sensitivity to oxaliplatin ranked in order


of correlation coefficient (CC). Affymetrix IDs listed are


publically available online at the Affymetrix NetAffx ™


Analysis Center. The probe sequence shows the


sequence of one (median) of 11 probes listed by


Affymetrix for that Affymetrix ID.











Gene
Affymetrix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














MRPL16
217980_s_at
0.444
ACGTGACACCTGTGAAGGCTGGCCG
SEQ ID NO.






399





ANP32A
201051_at
0.432
TCACATGATGATACCTGCTTTTCTC
SEQ ID NO.






400





SRSF2
214882_s_at
0.428
AGAGTCCTTGGAACAAGCAACTGGC
SEQ ID NO.






401





PDSS1
220865_s_at
0.413
CTGTTCTTTCTGGCAGCTATCTTAC
SEQ ID NO.






402





PRIM1
205053_at
0.411
CGCATCTCTGTGCCTATTGATTTGC
SEQ ID NO.






403





HNRNPA1
222040_at
0.409
TAGTCATTCACCTCTGCTTATATGA
SEQ ID NO.






404





NDUFAB1
202077_at
0.407
GAGGACACATTTTGGCATTCTTGCT
SEQ ID NO.






405





GLTSCR2
217807_s_at
0.393
GTTGTAGCTGCCATCAGATGCCGGA
SEQ ID NO.






406





RNPS1
200060_s_at
0.389
CCCCGATGACCTGGGATGGTGGCCA
SEQ ID NO.






407





ICAM2
213620_s_at
0.388
GTGTCGGACAGCCAGATGGTCATCA
SEQ ID NO.






408





DENND2D
221081_s_at
0.388
TTCTCACTTTTCATCCAGGAAGCCG
SEQ ID NO.






409





LCP1
208885_at
0.383
GGAGTCCCAAATGTCATCAGGTTTT
SEQ ID NO.






410





SEPT6
213666_at
0.383
GAACCAGCACTGTTTAGCCTGATAC
SEQ ID NO.






411





NUP210
213947_s_at
0.383
TAAATAGGAGCCTTTCTACTGGTTT
SEQ ID NO.






412





CORO1A
209083_at
0.379
GCTCCAGAAGCGCTTGGACAGGCTG
SEQ ID NO.






413





SHMT2
214437_s_at
0.379
TGAAGAGCAAGACTGCCAAGCTCCA
SEQ ID NO.






414





USP7
201498_at
0.378
GCCTTGGCAGACTTACGATCTCAAC
SEQ ID NO.






415





GLYR1 SEPT6
212414_s_at
0.376
AATCATTTGGCATTCACATGTGGCT
SEQ ID NO.






416





TUFM
201113_at
0.375
TAGAGAAAGGCCAGCGTTTCACCCT
SEQ ID NO.






417





RPL13A
200715_x_at
0.374
TCCTCCATTGTTGCCCTGGAATGTA
SEQ ID NO.


SNORD32A



418


SNORD33


SNORD34


SNORD35A





MYB
204798_at
0.374
GCTGCTATGGTCTTAGCCTGTAGAC
SEQ ID NO.






419





ICAM2
204683_at
0.37
TGAGACTCTGCACTATGAGACCTTC
SEQ ID NO.






420





CYFIP2
215785_s_at
0.365
CAGCCTGCCATAGGATCCAACTGGA
SEQ ID NO.






421





BCL11A
210347_s_at
0.362
GTGGAAATGCGCATGAGTCCCCAAC
SEQ ID NO.






422





EZH2
203358_s_at
0.358
TTTTGCCAAGAGAGCCATCCAGACT
SEQ ID NO.






423





SEPT6
212415_at
0.358
AGAAAATAGCAGACGTTTCCCCTCT
SEQ ID NO.






424





MRPS2
218001_at
0.356
GTGAGCGACATGTGCAGAACGGCCC
SEQ ID NO.






425





HCLS1
202957_at
0.355
GGTTTGCCTCATTGTGCTATTTGCC
SEQ ID NO.






426





HNRNPA1
214280_x_at
0.355
TGTTCTGCAGCTCAAATTCCATTTT
SEQ ID NO.






427





CYFIP2
220999_s_at
0.353
GAGTTGATAAACATTTCCATCTTCA
SEQ ID NO.






428





MYC
202431_s_at
0.351
GCAACCTCACAACCTTGGCTGAGTC
SEQ ID NO.






429





NCKAP1L
209734_at
0.35
TGCCTATCGGGAGGTGTCTCGGGCC
SEQ ID NO.






430





REPIN1
219041_s_at
0.349
GATGGAGGGCCAGCTGAGGGGAAGT
SEQ ID NO.






431





MTHFD2
201761_at
0.348
GTATGTTACCCTTCAGTAAGTTCTC
SEQ ID NO.






432





EWSR1
209214_s_at
0.345
CAGTGTCCCAATCCGGGTTGTGGAA
SEQ ID NO.






433





GCH1
204224_s_at
0.344
TTCATATCCATGATCTTGAGTCCAT
SEQ ID NO.






434





SRSF7
213649_at
0.343
CCTAGCTTCACCTTATTCTTTAAAG
SEQ ID NO.






435





HNRNPA2B1
205292_s_at
0.341
GAGGATGAGAGCCCAGAGGTAACAG
SEQ ID NO.






436





MZB1
221286_s_at
0.341
AAGACCAGATCTATGAAGCCCACCA
SEQ ID NO.






437





ALDH5A1
203608_at
0.339
GAGCTGATCTGCATCTGTTTATCCA
SEQ ID NO.






438





PPRC1
203737_s_at
0.339
TGAAACAGAGGTTCTCCGTTTTTGG
SEQ ID NO.






439





PCCB
212694_s_at
0.339
AGCTTCTCTACGCATTTGCTGAGGC
SEQ ID NO.






440





PSMB10
202659_at
0.338
CTCACCCACAGAGCCCGTGAAGAGG
SEQ ID NO.






441





ATHL1
219359_at
0.338
GCCTCTGCTACAGCGTGGAGTGGGA
SEQ ID NO.






442





SLC9A3R1
201349_at
0.336
GGAAGGTGAATGTGTTCCCGTCCTC
SEQ ID NO.






443





RHOH
204951_at
0.335
TGTTTTCTCTGGGTACACCCCAAGC
SEQ ID NO.






444





SKAP1
205790_at
0.335
GGGCCTATGGGATTGCCATGGTGAC
SEQ ID NO.






445





GTF3A
215091_s_at
0.334
TACAACTGTGTTTAATCTCCAAAGC
SEQ ID NO.






446





MIR1292
200875_s_at
0.333
TCCAAAGAGGAGCCGGTCAGCAGTG
SEQ ID NO.


NOP56



447


SNORD110


SNORD57


SNORD86





MFNG
204153_s_at
0.331
ATCTTCCTGCTATAAATGTGGGTGT
SEQ ID NO.






448





SHMT2
214096_s_at
0.331
GTGCCCTTCAGAGCCAGTAGCAGGC
SEQ ID NO.






449





PRKX PRKY
204060_s_at
0.33
CTTAGTTTGATCTTCCATGGTGGAC
SEQ ID NO.






450





CNBP
206158_s_at
0.33
GTCTGACCTCAGTAGCTATTAAATA
SEQ ID NO.






451





CD8B
207979_s_at
0.33
GAGTAAGAAATGCTGCCCATGCCAC
SEQ ID NO.






452





RPS3A
200099_s_at
0.328
GACCCGAGAGGTGCAGACAAATGAC
SEQ ID NO.


SNORD73A



453





PAICS
201014_s_at
0.328
GAACACTGCATATCCAGTTATCAGC
SEQ ID NO.






454





CXCR4
209201_x_at
0.327
GTTGGCTGCCTTACTACATTGGGAT
SEQ ID NO.






455





AKAP1
201675_at
0.324
GTAACCATTTTCTATTTGTGCAAAC
SEQ ID NO.






456





LOC100506248
211921_x_at
0.324
GAGGATGACGATGTCGATACCAAGA
SEQ ID NO.


LOC728026



457


MIR1244-1


MIR1244-2


MIR1244-3


PTMA





FABP5
202345_s_at
0.321
GCATTGGTTCAGCATCAGGAGTGGG
SEQ ID NO.






458





RNF44
203286_at
0.319
CTAGGCATGACAGTGGGCACCTTCC
SEQ ID NO.






459





RNU86 RPL3
211666_x_at
0.318
GCCTGCGCAAGGTGGCCTGTATTGG
SEQ ID NO.


SNORD83B



460





CXCR4
217028_at
0.318
GTTTTTCCTGTTCTTAAGACGTGAT
SEQ ID NO.






461





GTF3A
201338_x_at
0.317
TTGGCCTCTCATCTCAGTGGATATA
SEQ ID NO.






462





GMFG
204220_at
0.317
AAGACCGGCAGATGGTGGTGCTGGA
SEQ ID NO.






463





WDR59
218505_at
0.317
GGGCCAGTGTTACAGTGTTACCCTG
SEQ ID NO.






464





NASP
201970_s_at
0.316
GAGAGTCCCCGGAAAGATGATGCAA
SEQ ID NO.






465





TRIM14
203148_s_at
0.313
CATGCCAGGATTTATCAGCATTCCC
SEQ ID NO.






466





CALML4
221879_at
0.311
AGAAATTCTTCTAGCCATGTTGATG
SEQ ID NO.






467





HNRNPM
200072_s_at
0.309
GCCGAGAGAGCCTGCCGGATGATGA
SEQ ID NO.






468





HMGB1
200679_x_at
0.309
GAGAGGTGGAAGACCATGTCTGCTA
SEQ ID NO.






469





TTF1
204771_s_at
0.309
ATTACAGAACTACCAGCATCTGCTC
SEQ ID NO.






470





TSR3
213105_s_at
0.309
ACATAAATGGGCCTGGCAGCCTCGG
SEQ ID NO.






471





ADA
204639_at
0.307
TGGTTGAATCTGAAACCCTCCTTCT
SEQ ID NO.






472





GCN1L1
216232_s_at
0.307
AACCTCCTCAAGATGCGGCAGGGTG
SEQ ID NO.






473





PTMA
208549_x_at
0.306
ACGCCCCTGCTGACGAGGAAAATGG
SEQ ID NO.






474





DAZAP1
218443_s_at
0.306
GAGCCTTTTGTTTTACGGTATATTG
SEQ ID NO.






475





THUMPD1
206555_s_at
0.305
GTTCAGAAATCACCTTTAGTCAAAA
SEQ ID NO.






476





MDN1
212693_at
0.305
GTGCTCTGTTCTACTTAATGTTCTG
SEQ ID NO.






477





CD53
203416_at
0.301
GCATCTTCCCATTGTCGAATTAGTC
SEQ ID NO.






478





RPL13
212933_x_at
0.301
AATTTCAAAGCCTTCGCTAGTCTCC
SEQ ID NO.


SNORD68



479





ADA
216705_s_at
0.301
ATCAATGCGGCCAAATCTAGTTTCC
SEQ ID NO.






480





CD247
210031_at
0.3
AAATTTGGCTTCTGTTGTCACCTTC
SEQ ID NO.






481





FBXL14
213145_at
0.3
GTAGGATGTATATTTTCGTTGGATT
SEQ ID NO.






482





TMEM177
218897_at
0.3
CGAATCAAACATTTACCCTACACCA
SEQ ID NO.






483





PCBP2
204031_s_at
0.298
GATGCATCTGCTCAGACTACTTCTC
SEQ ID NO.






484





UTP3
209486_at
0.297
GATCAACAAGCTGTCCGTTGTGGAT
SEQ ID NO.






485





RUVBL1
201614_s_at
0.296
GTAACTGTTCCTGTGGTTGCTTTGA
SEQ ID NO.






486





LGALS9
203236_s_at
0.296
ATGTGCAGACATAGGCGGCTTCCTG
SEQ ID NO.






487





CXCR4
211919_s_at
0.296
GTGGTCTATGTTGGCGTCTGGATCC
SEQ ID NO.






488





CD3D
213539_at
0.296
GAAGCAGCCATTACCAACTGTACCT
SEQ ID NO.






489





AQP3
39248_at
0.296
CTGTCATAATGCAGGCATGAAGGGT
SEQ ID NO.






490





CBFA2T3
208056_s_at
0.294
GAAATTCATGCTTGCACCGAGTACA
SEQ ID NO.






491





SH2D1A
211210_x_at
0.294
GCTTGCCACTGGGCTGGATGGCAGC
SEQ ID NO.






492





HSPD1
200807_s_at
0.292
GAAGTTAAGCAGCCTTTCTGTGGAG
SEQ ID NO.






493





NAP1L1
212967_x_at
0.292
ATCCTTGCTGCAGACTTCGAAATTG
SEQ ID NO.






494





PTPN2
213137_s_at
0.292
GTGCTCTACGGAAACGTATTCGAGA
SEQ ID NO.






495





CDK5RAP3
218740_s_at
0.292
GCAACACCTGTTTATGATCCTGGCC
SEQ ID NO.






496





CHD7
218829_s_at
0.292
GCATTACCTCAGCTCTAAACTAGCC
SEQ ID NO.






497





EEF1B2
200705_s_at
0.291
GTCTGGGGCTCATCTAAACTAGTTC
SEQ ID NO.


SNORA41



498





ITGB7
205718_at
0.291
GACAGTCCCACTCTCTGAAGGAGGG
SEQ ID NO.






499





BIN2
219191_s_at
0.291
TCTTTGACTTACGACCCATTTTGCA
SEQ ID NO.






500





BLM
205733_at
0.29
GAGGAAATACCCGTATCTTCCCACT
SEQ ID NO.






501





SHMT2
214095_at
0.29
CAAACAGTGATTTGTCTCCCTCAAT
SEQ ID NO.






502





RPS6
209134_s_at
0.289
TCCTGGACTGACTGATACTACAGTG
SEQ ID NO.






503





TRBC1
210915_x_at
0.288
TGACTCCAGATACTGCCTGAGCAGC
SEQ ID NO.






504





LOC100506248
200772_x_at
0.286
CACCATGTCAGACGCAGCCGTAGAC
SEQ ID NO.


LOC728026



505


MIR1244-1


MIR1244-2


MIR1244-3


PTMA





ATP5G2
208764_s_at
0.284
CTCTTTTGTCTGATGGTAGCCTTTC
SEQ ID NO.






506





TOP1
208901_s_at
0.284
GCATTCGCTGTACCCTTTAAGATAT
SEQ ID NO.






507





MX2
204994_at
0.283
TACTCCCTCAGCATCAGAGCATGCA
SEQ ID NO.






508





MAP4K1
206296_x_at
0.283
TACAGGAGCTGAGAGACCCTACCCT
SEQ ID NO.






509





SH2D1A
211211_x_at
0.283
AGAGAAGATCCTGATGTCTGCCTGA
SEQ ID NO.






510





HSPD1
200806_s_at
0.282
TAGTATCCAGTCCATTGTACCTGCT
SEQ ID NO.






511





ITM2A
202747_s_at
0.282
GAGCTCTTTGGCAAACTGGCGAGTG
SEQ ID NO.






512





ATIC
208758_at
0.282
TGTGATTGAGGCCTGCGACGAACTG
SEQ ID NO.






513





RPL10A
200036_s_at
0.281
GACCAGCAGCACTGTGACGAGGCTA
SEQ ID NO.






514





UBE2L6
201649_at
0.28
GTTTGCAGTTACAGGCCAGTTCTCC
SEQ ID NO.






515





RAD51C
209849_s_at
0.28
GCTGCTACAATACGGCTAATCTTTC
SEQ ID NO.






516





ABCA7
219577_s_at
0.28
GGAAGGACGAGGACACCGAAGAGCA
SEQ ID NO.






517





TMEM176B
220532_s_at
0.28
GGGTACAGATGGATGCGGCGAAGTC
SEQ ID NO.






518





MSH2
209421_at
0.279
AGCCCTGGAACTTGAGGAGTTTCAG
SEQ ID NO.






519





ATP2A3
213036_x_at
0.279
AATGGGCTCCATGTTCTGTAGCCCC
SEQ ID NO.






520





IFITM1
214022_s_at
0.278
TTCTTGAACTGGTGCTGTCTGGGCT
SEQ ID NO.






521





SNRNP70
201221_s_at
0.277
CCATCTGCTGTGTTTGGACGCGTTC
SEQ ID NO.






522





IMPDH2
201892_s_at
0.277
TCATATTGCGAAAGCCTTGGCCCTT
SEQ ID NO.






523





SNRPG
205644_s_at
0.277
GATGGCGACTAGTGGACAACAGAAC
SEQ ID NO.






524





MAP4K1
214219_x_at
0.277
TCCCCCAGGCCTGTAGTGGTGGAGA
SEQ ID NO.






525





TRA2B
200892_s_at
0.276
TACTCACCTCGTCGCTATTAAAGCA
SEQ ID NO.






526





RPL3
215963_x_at
0.276
TGGTGCAGATGAAACGGCAGGCTCT
SEQ ID NO.






527





TRIAP1
218403_at
0.276
GTGAACACCATTTCAGAGCTCTCAG
SEQ ID NO.






528





ARHGAP15
218870_at
0.275
ACGTTCACATCTGTCTTGATGCCTA
SEQ ID NO.






529





PTPN2
213136_at
0.274
GATTACTTTGTATTGTACTGCCATT
SEQ ID NO.






530






216380_x_at
0.274
CAGCCACGTGCAGCCTATCAAGCTG
SEQ ID NO.






531





TPT1
216520_s_at
0.274
GATATTGTCATGAACCATCACCTGC
SEQ ID NO.






532





PVRIG
219812_at
0.274
AGGACCCTTAGGAGTTCGATGAGAG
SEQ ID NO.






533





SRSF5
203380_x_at
0.273
TAAACTGTAAATAACTTGCCCTGGG
SEQ ID NO.






534





IQGAP2
203474_at
0.273
ACTGTGATATAGGTACTCTGATTTA
SEQ ID NO.






535





PIM2
204269_at
0.273
TATCCCAAGTGCTCTTATTCTGGTG
SEQ ID NO.






536





CALML4
64408_s_at
0.273
CTTCTAGCCATGTTGATGGTGGACA
SEQ ID NO.






537





IL2RG
204116_at
0.272
GGTGTGTCTAAGGGACTGGCTGAGA
SEQ ID NO.






538





PTPN7
204852_s_at
0.272
ACCTCAGGTCTACCTCAGGACTGAA
SEQ ID NO.






539





ATP2A3
207522_s_at
0.272
AGGAAGATGGCCTCTGATGGACAGA
SEQ ID NO.






540





NFATC3
210555_s_at
0.272
GAGCCTAACTTTGCAACCATTGGTC
SEQ ID NO.






541





CD3G
206804_at
0.269
TGGAGTTCGCCAGTCGAGAGCTTCA
SEQ ID NO.






542





CD1C
205987_at
0.268
AATATAGTGATGCCATCCCGTCGAC
SEQ ID NO.






543





SLC19A1
211576_s_at
0.268
GTGGGCGCTGGGGAAGTACGTCCCA
SEQ ID NO.






544





IRF7
208436_s_at
0.267
CAACAGCCTCTATGACGACATCGAG
SEQ ID NO.






545





FYB
211795_s_at
0.267
ATGTCCTTCGGAGTTACCTAGCGGA
SEQ ID NO.






546





ITM2A
202746_at
0.266
CATCCTGACAATAAATTCCATCCGT
SEQ ID NO.






547





TRBC1
211796_s_at
0.266
TCGGAGAATGACGAGTGGACCCAGG
SEQ ID NO.






548





BCL11B
219528_s_at
0.266
TAAGGAAATCAGCCTTTCATCCCGG
SEQ ID NO.






549





HMGB1
200680_x_at
0.265
GTCTATAAAGCATTTAACCCCCCTG
SEQ ID NO.






550





RPL27A
203034_s_at
0.265
TACCACTTAAAGAGGAACCAGAGCT
SEQ ID NO.


SNORA3



551





PFDN5
210908_s_at
0.265
GCGCAGTCTATTAACATCACGGAGC
SEQ ID NO.






552





IKZF1
205038_at
0.264
CCCATATCCCTTCTGTAATTTGTAC
SEQ ID NO.






553





CD28
206545_at
0.264
AACAATGTCATTTGCTGCTATTATT
SEQ ID NO.






554





RNU86 RPL3
212039_x_at
0.264
GATCAAGAACAATGCCTCCACTGAC
SEQ ID NO.


SNORD83B



555





SRSF3
208672_s_at
0.263
GAAACACAGGCCATCAGGGAAAACG
SEQ ID NO.






556





ANP32B
201305_x_at
0.262
AAGACCCCAGATGACCTGCAGAAAC
SEQ ID NO.






557





P2RX5
210448_s_at
0.262
GGGAATAGCATTGTGCGTGTCCGGA
SEQ ID NO.






558





TMPO
203432_at
0.261
ATCTCTTCATTGACTGGTAGCAACC
SEQ ID NO.






559





LCP2
205269_at
0.261
AAAAGATTATTTAATGCCCATTTCA
SEQ ID NO.






560





HNRPDL
209067_s_at
0.261
CAATAGTGCCTATGGTGGTGATCAA
SEQ ID NO.






561





TFB1M
219169_s_at
0.261
TCACTCCCTTGATACAGCCCAAGAT
SEQ ID NO.






562





RNU86 RPL3
211073_x_at
0.26
TACCATCACCGCACTGAGATCAACA
SEQ ID NO.


SNORD83B



563





TRAF3IP3
213888_s_at
0.26
GAGGCAGCGGGATGGACTACATGAC
SEQ ID NO.






564





LRMP
204674_at
0.259
TCCAGAAGTCTGTGGATGCCGCTCC
SEQ ID NO.






565





SRSF5
212266_s_at
0.259
GCAAGTCCCGTTCTGTTAGTAGGTC
SEQ ID NO.






566





TAPBPL
218747_s_at
0.259
CAGAGACGGCAAGCACCTACAGGAC
SEQ ID NO.






567





LBR
201795_at
0.258
AAAGTGGTGGCGTTTTCTGTACTGG
SEQ ID NO.






568





SP110
208392_x_at
0.258
ATGACCCTAGGAGAGCTGCTGAAGC
SEQ ID NO.






569





RGPD3
210676_x_at
0.258
AGGAGCCTCCATTATGGCATGCTGA
SEQ ID NO.


RGPD4



570


RGPD5


RGPD6


RGPD8





CBWD1
220175_s_at
0.257
GATTGTCCAGGGTGTCCATGAGCTC
SEQ ID NO.


CBWD2



571


CBWD3


CBWD5


CBWD6


CBWD7


LOC100653334





ATP5D
203926_x_at
0.255
GATCCAGATCCGAATCGAGGCCAAC
SEQ ID NO.






572





IGJ
212592_at
0.255
AAACATGTTCTAGAACTAGTTACAA
SEQ ID NO.






573





RPLP0
214167_s_at
0.255
CCAGCCCAGAACACTGGTCTCGGGC
SEQ ID NO.






574





USH1C
211184_s_at
0.254
ACACACACCAGATGGCATCCTTGGG
SEQ ID NO.






575





PTPRCAP
204960_at
0.253
CCTCCATGTCACCGCACTGTAGAGG
SEQ ID NO.






576





AARSD1
222064_s_at
0.252
ACCTGAATCTGCTCAGAGACCTGGC
SEQ ID NO.


PTGES3L-



577


AARSD1





SH2D1A
210116_at
0.251
ATGGGTGGTTTACCATTTCTTGAGG
SEQ ID NO.






578
















TABLE 6







Genes predicting resistance to oxaliplatin ranked in order of


correlation coefficient (CC). Affymetrix IDs listed are publically


available online at the Affymetrix NetAffx ™ Analysis Center.


The probe sequence shows the sequence of one (median) of 11 probes


listed by Affymetrix for that Affymetrix ID.











Gene
Affymerix ID
CC
Affymetrix Probe sequence
SEQ ID NO.














LPP
202822_at
−0.51
CATTTCTTGGGATCGCTCGTTTGGT
SEQ ID NO.






579





RHOC
200885_at
−0.495
AGAACAAGCGTCGGAGGGGCTGTCC
SEQ ID NO.






580





CAPN2
208683_at
−0.483
AATCAAGTTCTTGACCCTATTCGGC
SEQ ID NO.






581





FLNA
200859_x_at
−0.469
TCTCGGCTTTCACTTGGGCAGAGGG
SEQ ID NO.






582





WDR1
200609_s_at
−0.467
AGTGTGTGACTCACACCTTGTGGCT
SEQ ID NO.






583





FLNA
214752_x_at
−0.465
CCCCCTGCGAGGAGATCCTGGTGAA
SEQ ID NO.






584





ACTN1
208637_x_at
−0.458
GGCGCTGTACGGCGAGAGTGACCTC
SEQ ID NO.






585





CNN3
201445_at
−0.457
TCTTCCCTCAATAGTTGCCTTTTAG
SEQ ID NO.






586





FLNA
213746_s_at
−0.456
GAGCAGCTTCACAGTAGACTGCAGC
SEQ ID NO.






587





ACTN1
208636_at
−0.455
AAATCCCCTCAGAGGTGTGACTAGT
SEQ ID NO.






588





ALCAM
201952_at
−0.44
TTCGGCTCTCCAATTTAACTCTTTG
SEQ ID NO.






589





CD44
212063_at
−0.438
TGTCTCCTGAAGACTTCCCTTAAAA
SEQ ID NO.






590





CAV2
203323_at
−0.437
GATGAGCAGACTTCTCGGAATTCAT
SEQ ID NO.






591





PRSS23
202458_at
−0.435
AACGTGGCTGTCAGAATCACTCCTC
SEQ ID NO.






592





F3
204363_at
−0.427
GACATTGGTATTCTGGGCAGCTTCC
SEQ ID NO.






593





RAB31
217763_s_at
−0.425
GTGCCATCGTGGTTGAGACAAGTGC
SEQ ID NO.






594





ACTN4
200601_at
−0.423
GAGGAGCTGAGTTGGCAGACCGGGC
SEQ ID NO.






595





CAV2
203324_s_at
−0.423
GAGAATATACAATGATCCTGGAAAT
SEQ ID NO.






596





CYR61
210764_s_at
−0.423
GCCAATGAAGCAGCGTTTCCCTTCT
SEQ ID NO.






597





LMNA
212086_x_at
−0.422
CAGTGACTGTGGTTGAGGACGACGA
SEQ ID NO.






598





PSMD2
200830_at
−0.419
CAGTGTTGTTGGCCCACGGGGAACG
SEQ ID NO.






599





FKBP9
212169_at
−0.415
AATAACCACATGGCTACCTTCTATC
SEQ ID NO.






600





CYR61
201289_at
−0.414
GCATTCCATCCCTTCCTGAAGGGGG
SEQ ID NO.






601





WDR1
200611_s_at
−0.413
AGGAGTGGACAATCACCTACTGAGG
SEQ ID NO.






602





CAV1
203065_s_at
−0.413
GGTGCCAATTTCAAGTTCCAAGTTG
SEQ ID NO.






603





CAV1
212097_at
−0.41
AATTTTTTATCATGCATGTCCTGTA
SEQ ID NO.






604





CYP1B1
202436_s_at
−0.409
GTGCTTGGAGTTTACCTGGCTTATT
SEQ ID NO.






605





CD44
204489_s_at
−0.408
GTGTGCTATGGATGGCTTCTAACAA
SEQ ID NO.






606





COTL1
221059_s_at
−0.408
GCACATTTGATATAGCTCTTTTTCT
SEQ ID NO.






607





EPAS1
200878_at
−0.407
CCAAGCTTCATATTAACCCTACCTG
SEQ ID NO.


LOC100652809



608





RAB31
217762_s_at
−0.406
AACTGTTAGCAAGCGGCATTTGGAT
SEQ ID NO.






609





RAB31
217764_s_at
−0.406
AGACCCTGTAGTCCAGTGGTGCTGC
SEQ ID NO.






610





RRBP1
201206_s_at
−0.405
GACCCCGTTCAGCTGAAGACGCAGC
SEQ ID NO.






611





CKAP4
200999_s_at
−0.404
GGGAATGCAGGCCAAGTCCTTTTAT
SEQ ID NO.






612





RND3
212724_at
−0.404
ATAGCTGGCGAGTGCTTTCTGTATT
SEQ ID NO.






613





CD44
209835_x_at
−0.403
GGACACCCCAAATTCCAGAATGGCT
SEQ ID NO.






614





LOXL2
202998_s_at
−0.402
GTGTAAGTGACTCATCTTCCTGTTG
SEQ ID NO.






615





LEPROT
202378_s_at
−0.401
ACATGTGCACATGCGGCATTTTACT
SEQ ID NO.






616





ATP2B4
212135_s_at
−0.4
GTGGAAAAGCCTCTAAATGCATCCC
SEQ ID NO.






617





TMEM158
213338_at
−0.399
AAAGCAAGGTTTGTGCTGCGCTTCC
SEQ ID NO.






618





ANXA2
210427_x_at
−0.398
ACCAGCTTGCGAATAACAGTCCCCG
SEQ ID NO.






619





S100A11
200660_at
−0.397
AATACAGAACTAGCTGCCTTCACAA
SEQ ID NO.






620





SDC4
202071_at
−0.397
CAGCGAGAGCATGTCCATCTGTTGG
SEQ ID NO.






621





PEA15
200787_s_at
−0.396
CACCCACCTGTACTCTGGAGAGACT
SEQ ID NO.






622





CD44
212014_x_at
−0.395
GAGTCGTCAGAAACTCCAGACCAGT
SEQ ID NO.






623





FNDC3B
218618_s_at
−0.395
CAACACAGACTACAGGTTCCGCGTA
SEQ ID NO.






624





LOX
204298_s_at
−0.394
TCATGCGTATGCCTCAGGCTGCACA
SEQ ID NO.






625





ANXA2
213503_x_at
−0.394
CAGAAAGCGCTGCTGTACCTGTGTG
SEQ ID NO.






626





COL4A1
211980_at
−0.393
CATTAGTATTCCTCATTCTGCATCC
SEQ ID NO.






627





YPEL5
217783_s_at
−0.389
AACTGTACTTTGTACCCTCACATAC
SEQ ID NO.






628





TNFRSF12A
218368_s_at
−0.384
AACACTAGGGGCTGGCCCACTAGGA
SEQ ID NO.






629





PDLIM7
203370_s_at
−0.382
CAAGACGCCCATCCGGAACAGGGCC
SEQ ID NO.






630





CD44
204490_s_at
−0.382
GGGAGCTGGGACACTTAACAGATGC
SEQ ID NO.






631





ANXA2
201590_x_at
−0.381
GCTGATCGGCTGTATGACTCCATGA
SEQ ID NO.






632





MAP1B
212233_at
−0.381
GTGGCAGTTCAGAGACACGCTTTTC
SEQ ID NO.






633





EXT1
201995_at
−0.38
ATACCGAGACATTGAGCGACTTTGA
SEQ ID NO.






634





IL6ST
212195_at
−0.379
TTTCTTGAACACAGGCTTTGTCTGA
SEQ ID NO.






635





CAST
212586_at
−0.379
AAGCAGCCCTTTTTACAGTCTAGTT
SEQ ID NO.






636





SGCE
204688_at
−0.378
CTTGCTTATATCATGTGCTGCCGAC
SEQ ID NO.






637





LEPRE1
220750_s_at
−0.378
GATGAGCTATGACAGCGTCCAGGTC
SEQ ID NO.






638





CYP1B1
202437_s_at
−0.376
CTCATTACTTATACTGGGACACCAT
SEQ ID NO.






639





CALU
200757_s_at
−0.375
GGTATAATGTAACTTCACCCCAGCC
SEQ ID NO.






640





BHLHE40
201170_s_at
−0.375
GGCATATGGAGTGTCCTTATTGCTA
SEQ ID NO.






641





MAP1LC3B
208786_s_at
−0.372
GTACTTGCATGGGGTTCACTATTTA
SEQ ID NO.






642





MYOF
201798_s_at
−0.37
GGCTTCATTTCAAGAGTCATCCAGC
SEQ ID NO.






643





PTRF
208790_s_at
−0.368
CCCCGCTTGGACACAGTCCGAGTGG
SEQ ID NO.






644





TRAM2
202369_s_at
−0.367
GTCACTCTGCCTAAAAGCACTCTAG
SEQ ID NO.






645





C20orf3
206656_s_at
−0.365
GCTCCTTGCACTTGGAACAGGGCTC
SEQ ID NO.






646





TPM4
209344_at
−0.364
GTCATAACCCACAGATAGATCAACC
SEQ ID NO.






647





S100A10
200872_at
−0.362
TCAAAAAGACCCTCTGGCTGTGGAC
SEQ ID NO.






648





FAM50A
203262_s_at
−0.362
GCGCTCGAGATCCTTCGGAAAGACT
SEQ ID NO.






649





PTRF
208789_at
−0.362
CCAGGTTCTCAAGACACGAGTCCCC
SEQ ID NO.






650





ACTB ACTB
AFFX-
−0.362
GAAGGATTCCTATGTGGGCGACGAG
SEQ ID NO.


LOC100505829
HSAC07/X00351_5_at


651





LRP12
219631_at
−0.361
TGGACCCTAGGGATTTGCACTAAAA
SEQ ID NO.






652





PPIC
204517_at
−0.357
GAACTTAAATATATCCCCTTCCTCA
SEQ ID NO.






653





MYOF
211864_s_at
−0.357
TACCAAATCGACCAGAAACCTCCTT
SEQ ID NO.






654





LGALS1
201105_at
−0.355
GCTTCGTGCTGAACCTGGGCAAAGA
SEQ ID NO.






655





LAMB1
201505_at
−0.355
AAGAGTCAGCTGATGCCAGAAGGAA
SEQ ID NO.






656





FAM171A1
212771_at
−0.355
GTGTAACGTGGGTTCTGTTTAGCGA
SEQ ID NO.






657





PTPRK
203038_at
−0.354
CCTGTGGCCCAGCACTGGTCAAGAA
SEQ ID NO.






658





GRB10
209409_at
−0.353
AACCTTTATTCCATGTGCTTTGCTT
SEQ ID NO.






659





GALNT2
217788_s_at
−0.352
GACTTACTGCGGTTGCGTTAGTTTC
SEQ ID NO.






660





CDH11
207173_x_at
−0.351
AGTTCTGAGCTGTAATTTCGCCTTA
SEQ ID NO.






661





LOXL2
202997_s_at
−0.35
TCTCAGGGCTGCAACCACGAGGAGG
SEQ ID NO.






662





MAPK1
212271_at
−0.348
GTGGAGTTGACTCGGTGTTCTGTCC
SEQ ID NO.






663





LDLR
202068_s_at
−0.347
TTGTTCAGTGACTATTCTCGGGGCC
SEQ ID NO.






664





CD44
210916_s_at
−0.347
AAAATGGTCGCTACAGCATCTCTCG
SEQ ID NO.






665





MXRA7
212509_s_at
−0.347
GATCAGTCTCAAATGGGTTTCTTGG
SEQ ID NO.






666





PLOD2
202620_s_at
−0.346
TTATCAAGTGTCAAGATCAGCAAGT
SEQ ID NO.






667





C19orf10
221739_at
−0.345
CATCCTTCATGAGCCTGCAGAACTG
SEQ ID NO.






668





CD59
200983_x_at
−0.344
GTCTTCTGCCATTCAGGTCATAGCC
SEQ ID NO.






669





EGFR
201983_s_at
−0.344
GTGTCAACAGCACATTCGACAGCCC
SEQ ID NO.






670





PLAU
205479_s_at
−0.342
AGCAGCTGAGGTCTCTTGAGGGAGC
SEQ ID NO.






671





TUBB6
209191_at
−0.342
GATCACACCATGGAGACTTTCTACT
SEQ ID NO.






672





MPRIP
214771_x_at
−0.34
GACTTCCTGTTGTCTTCATCAAAGC
SEQ ID NO.






673





RAB32
204214_s_at
−0.339
GGAGAAGTATCCCTGCTAGTGGCTC
SEQ ID NO.






674





MDFIC
211675_s_at
−0.339
GTTACAGGCGGTGTCCTTTTAAATG
SEQ ID NO.






675





PLAU
211668_s_at
−0.336
GGAATTGTGAGCTGGGGCCGTGGAT
SEQ ID NO.






676





CORO1C
221676_s_at
−0.336
CCACCGCTCTCATTTCATGGAGTCT
SEQ ID NO.






677





JAK1
201648_at
−0.335
CTTTGGGGCAAGCTATTCCAGCACT
SEQ ID NO.






678





TMBIM1
217730_at
−0.335
CCTACTGTGGTACTGAAGACTTCTG
SEQ ID NO.






679





VCAN
221731_x_at
−0.335
GAAATGGTTTCACTTGCTCTTTGAC
SEQ ID NO.






680





EPHA2
203499_at
−0.334
AGGGACCGGTGCTGCAGGAGTGTCC
SEQ ID NO.






681





EHD2
221870_at
−0.334
TATTTAAGTGGAGCCCCTACGTAGA
SEQ ID NO.






682





CRIM1
202552_s_at
−0.333
GGTAATTAATCCATTCCTGGCATAA
SEQ ID NO.






683





ULK2
204062_s_at
−0.333
GTGGAGTTCCTACATGCAGTGAGTG
SEQ ID NO.






684





KDELR3
204017_at
−0.332
AGTAATCAGTCAATCCAATATCCCC
SEQ ID NO.






685





RRAS
212647_at
−0.332
GACGAGGCTTTTGAGCAGCTGGTGC
SEQ ID NO.






686





CD59
200985_s_at
−0.331
GGTAGGATATCTTGGCTTTGCCACA
SEQ ID NO.






687





EHD2
45297_at
−0.331
CTGAACGGAACAGTGTCCCCACAGA
SEQ ID NO.






688





MYL9
201058_s_at
−0.33
GCGTGCCGAGCTGAGGCAGATGTTC
SEQ ID NO.






689





P4HA1
207543_s_at
−0.33
GGGTGGTAATATTGGCATTCTGATT
SEQ ID NO.






690





LAMB3
209270_at
−0.33
AATGCTTTCCATCTCCAGGAGACTT
SEQ ID NO.






691





PTPLA
219654_at
−0.328
GACAGAGATCACTCGCTATTCCTTC
SEQ ID NO.






692





NT5E
203939_at
−0.327
ATAGGAAGTATGTTTGTTTCTTAGT
SEQ ID NO.






693





OPTN
202074_s_at
−0.326
GGAATATTCCGATTCATTCCTGCCC
SEQ ID NO.






694





COL4A2
211966_at
−0.326
TGTGGATCGGATATTCCTTCCTCAT
SEQ ID NO.






695





CALU
200755_s_at
−0.325
GGCAAGGAAAGATCCCTTTGCTCTA
SEQ ID NO.






696






208540_x_at
−0.325
GACTGAGCGGTGCATTGAGTCCCTG
SEQ ID NO.






697





NR3C1
211671_s_at
−0.325
ACCAGTGCCCAAAGTCTGTGTGATG
SEQ ID NO.






698





NR3C1
201865_x_at
−0.324
GAACTACGCTTGCTCATTTTTTCTT
SEQ ID NO.






699





KDELR2
200699_at
−0.323
TAACCTTGGCTATGTTACCACCGTT
SEQ ID NO.






700





SEPT7
213151_s_at
−0.323
TAATGACCAACCTGTTTCTACCTAT
SEQ ID NO.






701





NFIB
209289_at
−0.322
TGCACGAAGATATAATGTCCACATT
SEQ ID NO.






702





AHNAK
211986_at
−0.321
CAGACGGAGGTCAGGTCTTCCTCTT
SEQ ID NO.






703





IL6ST
212196_at
−0.321
GACAAAACTAGTTCACTCACTGCTT
SEQ ID NO.






704





VCAN
204620_s_at
−0.32
GGCTGGAAATGGTTTCACTTGCTCT
SEQ ID NO.






705





SCRN1
201462_at
−0.319
AGCACAAGCTTATGCTTCCCGTAGC
SEQ ID NO.






706





MARCKS
201670_s_at
−0.319
CTTTGTCAATCTATGGACATGCCCA
SEQ ID NO.






707





TPM4
212481_s_at
−0.319
TGCCATCTTCGCTTTGCTGGAAATG
SEQ ID NO.






708





ANXA2P2
208816_x_at
−0.317
CAGAAAGCGCTGCTGTACCTGTGTG
SEQ ID NO.






709





MECOM
221884_at
−0.317
AGTCCAAATCGCAGGCATATGCTAT
SEQ ID NO.






710





MVP
202180_s_at
−0.316
AGACAACCACGTGGTGCCTGTACTG
SEQ ID NO.






711





NFIB
209290_s_at
−0.316
GAATCACTATTCCTGGTTATCTCAC
SEQ ID NO.






712





FAM190B
209379_s_at
−0.316
GTGGGCACCAATCTACAACTATGTC
SEQ ID NO.






713





FOSL1
204420_at
−0.315
AGGGCAGCTGCTATTTATTTTCCTA
SEQ ID NO.






714





PLAUR
210845_s_at
−0.314
TCTCCTCTGGACCTAAACCTGAAAT
SEQ ID NO.






715





GRB10
210999_s_at
−0.314
GAACTCTTGCCCTGGAATAATCTTG
SEQ ID NO.






716





TAGLN2
200916_at
−0.312
AGCTGTGGCTGCAGGAACTTAATTT
SEQ ID NO.






717





COL6A1
212091_s_at
−0.312
TCACAGCGGGCAGGACGGACCCCGC
SEQ ID NO.






718





RRBP1
201204_s_at
−0.309
GCCCCAGTTTGTAAATGAACCTGTG
SEQ ID NO.






719





TXNRD1
201266_at
−0.309
TGGCATTTAGGCAGCAGAGCCCCTG
SEQ ID NO.






720





AURKA
204092_s_at
−0.309
TTTTTTCTCTGGTGGCATTCCTTTA
SEQ ID NO.






721





RRAS2
212589_at
−0.309
TCAAGTGTGTACAACAGTCCCATGA
SEQ ID NO.






722





LRP12
220253_s_at
−0.308
CCTGATACTGTAGTTCACTGTAGAA
SEQ ID NO.






723





NPC1
202679_at
−0.306
TCTTCACAGTGTTCCCCTAGAAAGG
SEQ ID NO.






724





AXL
202686_s_at
−0.306
AGATTCTAACGGTCTGTTCTGTTTC
SEQ ID NO.






725





GATA6
210002_at
−0.306
GCGTTGCAGCAATCAGTGTTAAATC
SEQ ID NO.






726





CAMSAP2
212765_at
−0.305
GAGCATTGCTTACAGGTTTTTTGTT
SEQ ID NO.






727





ZDHHC7
218606_at
−0.305
GTCTGAGGGTCTTCCTTTATGCTTG
SEQ ID NO.






728





HK1
200697_at
−0.304
AATCGTGTGTCCGTGGAACCAGTCC
SEQ ID NO.






729





MARCKS
201668_x_at
−0.303
TGCTTTTTGATCTCTTCGACTAAAA
SEQ ID NO.






730





NFIB
213032_at
−0.303
GAAGTATGGCTTTTTATGCATCCTT
SEQ ID NO.






731





ATP1B1
201242_s_at
−0.302
ATATGCTTTACACTAGCTTTCTGCA
SEQ ID NO.






732





BASP1
202391_at
−0.302
AGTGACAAACATTCTCTCATCCTAC
SEQ ID NO.






733





BCL6
203140_at
−0.301
AAACTGCGTTAAAGGCTCGATTTTG
SEQ ID NO.






734





ID3
207826_s_at
−0.301
GTGGCCTGAAGAGCCAGAGCTAGCT
SEQ ID NO.






735





RRAS2
212590_at
−0.301
AATGATCACCATGTTAGCCTTAGAC
SEQ ID NO.






736





SPATS2L
222154_s_at
−0.301
TTTTCACTCAGTTTTGGTTCCCTGC
SEQ ID NO.






737





PMP22
210139_s_at
−0.3
GACCGTGAGTTCCTAGAGCTTGGCT
SEQ ID NO.






738





CDC14B
221556_at
−0.3
ATCCGATGATAGTACTGCAGTTTTC
SEQ ID NO.






739





FHL2
202949_s_at
−0.299
CTCACCCAGGCAATCTTGCCTTCTG
SEQ ID NO.






740





PRNP
201300_s_at
−0.298
AGCAGTTAACATCTGAAGTGTCTAA
SEQ ID NO.






741





MARCKS
201669_s_at
−0.298
AAATCTTGATATCCAGAAGCACATG
SEQ ID NO.






742





ADAMTS1
222162_s_at
−0.298
GACACAATGAGCTTAGTACCTCCAA
SEQ ID NO.






743





KCMF1
217938_s_at
−0.296
CTCTCCTAATACTCCACATTCAAAC
SEQ ID NO.






744





CTSA
200661_at
−0.295
TCCCGCAGCAGTTCCTGAATGGGGT
SEQ ID NO.






745





TPBG
203476_at
−0.295
AGGGGATTTGCTTCCTTGTTATGTA
SEQ ID NO.






746





CCND1
208712_at
−0.295
CGCAAGTCTGAGGGTCTGGGCGGCG
SEQ ID NO.






747





CASK
211208_s_at
−0.294
AATGTGATACTGTCTCTTTGAAGCA
SEQ ID NO.






748





ZYX
200808_s_at
−0.293
CTGACCCAGGACCCAACATGGTCTA
SEQ ID NO.






749





VEGFA
210512_s_at
−0.293
TCTACATACTAAATCTCTCTCCTTT
SEQ ID NO.






750





HBXIP
202300_at
−0.292
TTGATGCTCATATCTGTTCTTCAGC
SEQ ID NO.






751





ZCCHC14
212655_at
−0.292
ATTGCTCCACTGTTCACCAAGGAAG
SEQ ID NO.






752





CDC42BPA
214464_at
−0.292
TCCCACCTCACTGGATCTTGATGTT
SEQ ID NO.






753





CD63
200663_at
−0.29
CCCGACTCCTGCTGCATTAATGTTA
SEQ ID NO.






754





ADAM9
202381_at
−0.29
AAATATGTTGATTCATGGCTATAAT
SEQ ID NO.






755





LIF
205266_at
−0.29
GATGGTACAGATGTTCCTGCCTTAG
SEQ ID NO.






756





SPTBN1
200671_s_at
−0.289
ATGACAGTTTCACAACCTGCATTGA
SEQ ID NO.






757





RBPMS
209488_s_at
−0.289
AAGCTCACATCTAAACAGCCTGTAG
SEQ ID NO.






758





DKK1
204602_at
−0.288
TTACCCCATTTAATTCTAGAGTCTA
SEQ ID NO.






759





TGFBR2
208944_at
−0.288
TAGAGGCGCCTAGAAATTCCACTTG
SEQ ID NO.






760





POFUT2
209578_s_at
−0.288
AGGGCAACGCTAGACACAGAATCCG
SEQ ID NO.






761





ARID5B
212614_at
−0.288
GTGAGACCCATACCATTGCAATGAT
SEQ ID NO.






762





PYGL
202990_at
−0.287
GGAACGTGGAACCTTCAGATCTAAA
SEQ ID NO.






763





LDOC1
204454_at
−0.287
CACTTCTTTTTTCCTATGCACTGGT
SEQ ID NO.






764





PPAP2B
212226_s_at
−0.287
GCACCATCCCAGTGATGTTCTGGCA
SEQ ID NO.






765





FTH1
214211_at
−0.287
GCCGTTGTTCAGTTCTAATCACACT
SEQ ID NO.






766





SVIL
202565_s_at
−0.286
AGCTCTGCCACCAATATGTATCTTC
SEQ ID NO.






767





PLEC
201373_at
−0.285
CAGGTGGAGGTGTCAGGCTGCTGGC
SEQ ID NO.






768





PHACTR2
204048_s_at
−0.285
GTCAAAGCAACCATACTTCACCTAG
SEQ ID NO.






769





FLNB
208613_s_at
−0.285
GCCAGCGTCTAGTTAGCCCTGGCTC
SEQ ID NO.






770





ZYX
215706_x_at
−0.283
ACTGCTAGAGCCCAGACCTGAGTGA
SEQ ID NO.






771





GJA1
201667_at
−0.282
CTACGGTCATGTTCAGCTTCATTGC
SEQ ID NO.






772





KCTD12
212192_at
−0.282
CAGGCATCTGAAAACCTTATCTGCT
SEQ ID NO.






773





RABAC1
203136_at
−0.281
GGAGTCCAAGCTTGTGCTCTTTGGC
SEQ ID NO.






774





SLC39A7
202667_s_at
−0.28
ACATCAATCGTGTGTCCTGATTTGG
SEQ ID NO.






775





ELF4
31845_at
−0.28
AGTGCCTGAGGACCTTTGCTGTGTC
SEQ ID NO.






776





SERPINH1
207714_s_at
−0.278
TGGGGGGGAGGTGAGGTACCAGCCT
SEQ ID NO.






777





MALT1
210017_at
−0.277
TCGGCACTACTTCTATTCAGCATTG
SEQ ID NO.






778





PPAP2B
212230_at
−0.277
CCTTCTACTGAACCTTTGAGGAAAG
SEQ ID NO.






779





NPC2
200701_at
−0.276
GCATCTGGCCAATGAGTCTGCTGAG
SEQ ID NO.






780





CD55
201925_s_at
−0.276
GATCTGTAATGTTATTTCCACTTAT
SEQ ID NO.






781





SYNJ2
212828_at
−0.276
TGGTAGGATTCCCAGGTCAGCAGCA
SEQ ID NO.






782





MICALL1
55081_at
−0.276
TGCCCAGCAGCTCTTGGTCAAAGCA
SEQ ID NO.






783





ITGA5
201389_at
−0.275
GAAGCCAGGAATTTCCCAGGACCTG
SEQ ID NO.






784





TFE3
212457_at
−0.275
ATAAAAGCTAGGCGTGTTTGATGCG
SEQ ID NO.






785





CREB3L1
213059_at
−0.275
GCCGCTGGGCCTTTTTAATTGCCAA
SEQ ID NO.






786





SOGA2
213358_at
−0.275
ATGTGACTCAGTCTGTTCCACTGTA
SEQ ID NO.






787





COL5A2
221729_at
−0.275
GGTGCTATGCTTCTGTTATTATTCC
SEQ ID NO.






788





TIMP1
201666_at
−0.274
GACCACCTTATACCAGCGTTATGAG
SEQ ID NO.






789





COL6A2
209156_s_at
−0.274
TCACGGGCAACGACAGTCTGCACGA
SEQ ID NO.






790





RYBP
201846_s_at
−0.273
GAATTTCGCACCCTGACGATTACTC
SEQ ID NO.






791





WNT5A
205990_s_at
−0.273
ACATCCCCTCAGTTGCAGTGAATTG
SEQ ID NO.






792





SEC61A1
217716_s_at
−0.273
GGACTGTCACTGTGGACGCCAAAAT
SEQ ID NO.






793





SNAPC1
205443_at
−0.272
GGTCAAGGGCAAGTCAAAGCAACTA
SEQ ID NO.






794





LAPTM4B
214039_s_at
−0.272
TTTTTACCTTGACTACCTGAATTGC
SEQ ID NO.






795





FOXN3
218031_s_at
−0.272
CGTGAGATGCTCACGAGTACCCTTC
SEQ ID NO.






796





PPP4R1
201594_s_at
−0.271
CCAGCCCTGTGTGTGAATCGTTTGT
SEQ ID NO.






797





YES1
202932_at
−0.271
GACACTCTCTACCAAGAGGGTCTTC
SEQ ID NO.






798





HABP4
209818_s_at
−0.271
AGAGGCTCGAGAGCAGGCCATTTCC
SEQ ID NO.






799





HSBP1
200941_at
−0.27
GTGACTTAGGCAGGAGTCGACCTCC
SEQ ID NO.






800





RCN1
201063_at
−0.27
TATCAGATTCTTTCTTTTCGACTTT
SEQ ID NO.






801





YWHAZ
200640_at
−0.269
CAAGATTACCTTCCTGTTTTAGCCT
SEQ ID NO.






802





VIM
201426_s_at
−0.268
TGTGGATGTTTCCAAGCCTGACCTC
SEQ ID NO.






803





ID1
208937_s_at
−0.268
GTGCGCTGTCTGTCTGAGCAGAGCG
SEQ ID NO.






804





ZNF264
205917_at
−0.267
TTATTGACCTTCCATGGTCCTCACT
SEQ ID NO.






805





CD55
201926_s_at
−0.266
GTTGACAGGTTTGCTTGGGACGCTA
SEQ ID NO.






806





CTNNAL1
202468_s_at
−0.266
ACGGATGGGTCTCAGTTACAAATAA
SEQ ID NO.






807





JUN
201466_s_at
−0.265
AGGTGCTTATTCTCAAAGCAGGAAT
SEQ ID NO.






808





VOPP1
208091_s_at
−0.265
GACAACTGCGTGGGTCCAAACACTC
SEQ ID NO.






809





IL8
202859_x_at
−0.264
GCTGTGTTGGTAGTGCTGTGTTGAA
SEQ ID NO.






810





AMOTL2
203002_at
−0.264
TATCGTTTTTAGGTTTGGTATGTGT
SEQ ID NO.






811





CETN2
209194_at
−0.264
GCATTTCCACATATCCACAAACACA
SEQ ID NO.






812





KRT14
209351_at
−0.264
AAGGTCATGGATGTGCACGATGGCA
SEQ ID NO.






813





IGFBP3
210095_s_at
−0.264
GAGTCATTCTCATGCTTTTCTTTAT
SEQ ID NO.






814





ZFP36L1
211962_s_at
−0.264
GGACTGCAAATTGAGTTTCTTTCTC
SEQ ID NO.






815





MAP7D1
217943_s_at
−0.264
CTCAGTGCATTCGTGTGCTCGCACG
SEQ ID NO.






816





DNAJB1
200664_s_at
−0.263
GGACCTTTCTACCAGTTGTGGACCA
SEQ ID NO.






817





RNH1
206050_s_at
−0.263
CTGGTCCTGTACGACATTTACTGGT
SEQ ID NO.






818





AMIG02
222108_at
−0.263
GAGTAACTTCTTAAATCCCTGTTCT
SEQ ID NO.






819





SPTBN1
212071_s_at
−0.261
GTGCTCAGTCGTACGACCTGTACCT
SEQ ID NO.






820





FHL1
201540_at
−0.26
CAGGGCTGTCATCAACATGGATATG
SEQ ID NO.






821





TUBB3
213476_x_at
−0.26
GTGAAGGTGGCCGTGTGTGACATCC
SEQ ID NO.






822





MGAT1
201126_s_at
−0.258
TGAAGGGGGCAAGCAAGACCTCTCC
SEQ ID NO.






823





KIF2C
209408_at
−0.257
AGTGACATGGGACACTCCTTTTCTG
SEQ ID NO.






824





SLC20A1
201920_at
−0.256
AGAGCATGCTCTGCGTTGTTGGTTT
SEQ ID NO.






825





TSPAN4
209263_x_at
−0.256
ATATTTACGTATTCTCCAAAGCAGT
SEQ ID NO.






826









In some aspects of the invention, one or more biomarkers of sensitivity and/or resistance to oxaliplatin are measured in a biological sample obtained from a subject (e.g., a subject suffering from or susceptible to a disease, disorder, or condition treatable with oxaliplatin, such as cancer, e.g., colon cancer) using, e.g., a microarray, sequencing, NanoString, a protein array, or PCR-based methods, such as those described herein. In certain embodiments, the microarray includes probes capable of recognizing the one or more biomarkers of sensitivity and/or resistance to oxaliplatin, such as probes at least about 15 nt in length that have, e.g., a sequence with at least 5 (e.g., at least 10) contiguous nucleotides that are complementary to or identical to the sequence(s) of the biomarker(s). In embodiments of any of the above aspects, any one of the biomarkers from Tables 5 and 6 can be used to assess a subject's sensitivity and/or resistance to treatment with oxaliplatin. Alternatively, a combination of any of the biomarkers of Tables 5 and 6 may be used. For example, combinations that include the top 5, 10, 15, or 20 biomarkers from Tables 5 and/or 6 may be used. In some embodiments, one or more biomarkers of sensitivity to oxaliplatin is selected from the group consisting of MRPL16, ANP32A, SRSF2, PDSS1, PRIM1, HNRNPA1, NDUFAB1, GLTSCR2, RNPS1, and ICAM2. In certain embodiments, the biomarkers include MRPL16 and one or more of the biomarkers selected from the group consisting of ANP32A, SRSF2, PDSS1, PRIM1, HNRNPA1, NDUFAB1, GLTSCR2, RNPS1, and ICAM2 (preferably ANP32A, SRSF2, PDSS1, and/or PRIM1). In some embodiments, one or more biomarkers of resistance to oxaliplatin is selected from the group consisting of LPP, RHOC, CAPN2, FLNA, WDR1, FLNA, ACTN1, CNN3, FLNA, and ACTN1 (preferably LPP, RHOC, CAPN2, FLNA, and/or WDR1). In particular embodiments, one or more biomarkers of resistance includes LPP.


Furthermore, a combination of any of the biomarkers of Tables 1, 2, 5, and 6 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of 5-FU and oxaliplatin, and a combination of any of the biomarkers of Tables 3-6 can be used to assess a subject's sensitivity and/or resistance to treatment with the combination of irinotecan and oxaliplatin. In some embodiments, a subject's sensitivity to combination treatment with oxaliplatin and 5-FU is assessed by determining an expression level (e.g., mRNA or protein expression) of one or more biomarkers of sensitivity and/or resistance to 5-FU (e.g., the biomarkers shown in Tables 1 and 2, respectively), and one or more biomarkers of sensitivity and/or resistance to oxaliplatin. In certain embodiments, the one or more biomarkers of resistance to 5-FU are selected from the group consisting of NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158, and the biomarker of sensitivity to oxaliplatin is MRPL16. In particular embodiments, the biomarkers of resistance to 5-FU include NT5E, CNN3, ACTN1, FLNA, and/or ATP2B4. In one embodiment, the biomarker of resistance to 5-FU is NT5E.


Biomarker Expression Analysis Methods, Devices, and Kits


The methods, devices, and kits of the invention can be used to predict the responsiveness (e.g., sensitivity or resistance) of a subject to a target drug of interest based on the expression levels (e.g., mRNA expression level or protein expression level) of one or more biomarkers of sensitivity and/or resistance in a biological sample obtained from the subject. The biological sample can include, for example, cells, tissue (e.g., a tissue sample obtained by biopsy), blood, serum, plasma, urine, sputum, cerebrospinal fluid, lymph tissue or fluid, or pancreatic fluid. In certain embodiments, the biological sample is fresh frozen or formalin-fixed paraffin embedded (FFPE) tissue obtained from the subject, such as a tumor sample (e.g., a biopsy). Numerous methods of determining biomarker expression levels, or expression profiling, are known in the art, including, but not limited to, polymerase chain reaction (PCR), reverse transcriptase PCR (RT-PCR), quantitative real-time PCR (qPCR), Northern blots, Western blots, Southern blots, microarrays, NanoString nCounter technologies (e.g., those described in U.S. Patent Application Nos. US 2011/0201515, US 2011/0229888, and US 2013/0017971, each of which is incorporated by reference in its entirety), next generation sequencing (e.g., RNA-Seq techniques), and proteomic techniques (e.g., mass spectrometry or protein arrays).


PCR-Based Techniques


Tissue or cell samples from mammals can be conveniently assayed for mRNA levels using Northern, dot blot or PCR analysis. For example, qPCR assays are well known in the art. In some embodiments, an mRNA corresponding to a biomarker of sensitivity or resistance can be detected in a biological sample by (a) producing cDNA from the sample by reverse transcription using at least one primer; (b) amplifying the cDNA so produced using a target polynucleotide as sense and antisense primers to amplify target cDNAs therein; and (c) detecting the presence of the amplified target cDNA using polynucleotide probes. In certain embodiments, primers and probes comprising the sequences described herein are used to detect expression of one or more genes, as described herein. In addition, such methods can include one or more steps that allow one to determine the levels of target mRNA in a biological sample (e.g., by simultaneously examining the levels a comparative control mRNA sequence of a “housekeeping” gene such as an actin family member or GAPDH). Optionally, the sequence of the amplified target cDNA can be determined. The primers for these assays may be labeled for detection according to methods known in the art.


Microarrays


Expression levels of biomarkers of sensitivity or resistance may be determined using high-throughput expression profiling platforms, such as microarrays. Microarray technology offers high resolution quantification of mRNA expression levels at a genomic or transcriptomic scale. In certain embodiments, a microarray for use in the methods of the invention for assessing the responsiveness of a subject to treatment with a target drug (e.g., 5-FU, oxaliplatin, and/or irinotecan, as well as analogs thereof, such as prodrugs, derivatives, metabolites, enantiomers, and combinations thereof) contains or is produced by generating oligonucleotide probes (e.g., DNA, cDNA, or RNA probes) capable of hybridizing to one or more biomarkers of sensitivity or resistance to a target drug of interest (e.g., one or more of the biomarkers of Tables 1-6) or their complement sequences (preferably the probe sequence is complementary to all or a portion of the biomarker sequence). For example, such biomarkers can include one or more (e.g., at least 5, 10, 15, or 20 or more (e.g., all)) 5-FU markers of Tables 1 and/or 2, one or more (e.g., at least 5, 10, 15, or 20 or more (e.g., all)) irinotecan markers of Tables 3 and/or 4, or one or more (e.g., at least 5, 10, 15, or 20 or more (e.g., all)) oxaliplatin markers of Tables 5 and/or 6. An oligonucleotide probe can be complementary or identical to a portion (e.g., at least 5, 10, 15, or 20 or more nucleic acid residues; preferably at least 15 contiguous nucleic acid residues) or the entirety of a biomarker sequence, or may have, e.g., about 75%, 80%, 85%, 90%, 95%, 99%, or 100% sequence identity to a sequence complementary or identical to a portion (e.g., at least 5, 10, 15, or 20 or more nucleic acid residues; preferably at least 15 contiguous nucleic acid residues) or the entirety of a biomarker sequence. A probe can have a length of, for example, about 5 nucleotides (nt), 10 nt, 15 nt, 20 nt, 25 nt, 30 nt, 50 nt, 75 nt, 100 nt, 150 nt, or 200 nt (preferably at least 15 nt). In certain embodiments, a probe is between 20-24 nt in length and/or has at least 85% sequence identity to a sequence complementary to a biomarker sequence. In other embodiments, a probe is between 20-24 nt in length and/or has at least 85% sequence identity to a sequence identical to a biomarker sequence.


In some embodiments, a microarray for use in the methods of assessing responsiveness to 5-FU includes probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of resistance to 5-FU: NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158; and/or probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of sensitivity to 5-FU: APRT, GSR, TUFM, MRPS2, MTHFD2, WDR59, ANP32B, PMM2, STOML2, and NDUFAB1. In certain embodiments, the biomarkers of resistance include NT5E, CNN3, ACTN1, FLNA, and ATP2B4; and/or the biomarkers of sensitivity include APRT, GSR, TUFM, MRPS2, and MTHFD2. In particular embodiments, the biomarker of resistance is NT5E.


In some embodiments, a microarray for use in the methods of assessing responsiveness to irinotecan includes probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of resistance to irinotecan: CCND1, LGALS3, INPP4B, TMEM97, TCF7L2, SFN, LAPTM4B, LSR, SFN, and TMEM97; and/or probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of sensitivity to irinotecan: PRF1, GZMB, PTPRC, PTPRC, PTPRCAP, PDE4DIP, ACAP1, PTPRC, S1PR1, and DOCK2. In certain embodiments, the biomarkers of resistance include: CCND1, LGALS3, INPP4B, TMEM97, and TCF7L2; and/or the biomarkers of sensitivity include: PRF1, GZMB, PTPRC, PTPRC, and PTPRCAP. In particular embodiments, the biomarker of sensitivity is PRF1.


In some embodiments, a microarray for use in the methods of assessing responsiveness to oxaliplatin includes probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of resistance to oxaliplatin: LPP, RHOC, CAPN2, FLNA, WDR1, FLNA, ACTN1, CNN3, FLNA, and ACTN1; and/or probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of the following biomarkers of sensitivity to oxaliplatin: MRPL16, ANP32A, SRSF2, PDSS1, PRIM1, HNRNPA1, NDUFAB1, GLTSCR2, RNPS1, and ICAM2. In certain embodiments, the biomarkers of resistance include: LPP, RHOC, CAPN2, FLNA, and WDR1. MRPL16, ANP32A, SRSF2, PDSS1, and PRIM1. In particular embodiments, the biomarker of sensitivity is MRPL16. In some embodiments, a microarray for predicting responsiveness (e.g., sensitivity) of a subject to combination treatment with oxaliplatin and 5-FU includes probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of one or more biomarkers of resistance to 5-FU selected from the biomarkers of Table 2, and one or more probes about 15 nt in length, which are complementary to at least 5 contiguous nucleotides of MRPL16. In certain embodiments, the biomarkers of resistance to 5-FU are NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158. In particular embodiments, the biomarkers of resistance to 5-FU are NT5E, CNN3, ACTN1, FLNA, and ATP2B4. In one embodiment, the biomarker of resistance to 5-FU is NT5E.


In certain embodiments, a probe is single-stranded or double-stranded. In some embodiments, a probe is labeled (e.g., detectably labeled with a fluorescent molecule, dye molecule, small molecule, epitope tag, barcode sequence, polypeptide, or any other detectable molecule). Probes can be detectably labeled and immobilized on a solid support to form a microarray. Probes can be either prefabricated and spotted to the surface or directly synthesized on to the surface (in situ). The microarray can be configured such that the sequence and position of each member of the array is known. For example, a selection of genes whose expression correlate with the presence of a disease (e.g., colon cancer), an increased likelihood of developing the disease, or increased severity of the disease can be arrayed on a solid support. Hybridization of a labeled probe with a particular target nucleic acid (e.g., an mRNA corresponding to a biomarker of responsiveness (e.g., sensitivity and/or resistance) to a target drug) indicates that the sample from which the mRNA was derived expresses that gene (e.g., the biomarker of responsiveness to the target drug).


Differential gene expression analysis of disease tissue can provide valuable information. Microarray technology utilizes nucleic acid hybridization techniques and computing technology to evaluate the mRNA expression profile of thousands of genes within a single experiment (see, e.g., PCT Publication WO 01/75166; U.S. Pat. Nos. 5,700,637; 5,445,934; 5,807,522; Lockart, Nat. Biotechnol. 14: 1675-1680, 1996; and Cheung et al., Nat. Genet. 21(Suppl): 15-19, 1999). Thousands of genes are typically represented in a single array. In some embodiments, a microarray assay for determining the expression level of one or more biomarkers of drug responsiveness involves the following steps: 1) preparation of fluorescently labeled target from RNA isolated from a sample, 2) hybridization of the labeled target to the microarray, 3) washing and scanning of the array, 4) analysis of the scanned image and 5) generation of gene expression profiles. Commercially available microarray systems can be used, such as an Affymetric array (e.g., an Affymetrix GeneChip® system) or an Almac array. Details of various microarray methods can be found in the literature. See, for example, U.S. Pat. No. 6,232,068 and Pollack et al., Nat. Genet. 23: 41-46, 1999. In alternate embodiments, a protein array can be used to measure the protein expression level of one or more biomarkers of responsiveness (e.g., sensitivity and/or resistance) to a target drug (e.g., 5-FU, irinotecan, and oxaliplatin), such as one or more of the biomarkers listed in Tables 1-6.


Exemplary probe sequences suitable for use in the methods of the invention are provided in Tables 7-12 below.









TABLE 7







Genes and corresponding Almac probesets predicting sensitivity to 5-FU. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





ALG5
ADXCRIH.469.C1_at
TTCTAAATGAGCTCGAGATCCACATGCTATAGCCATTTGATTAGGCCAAGGCTGTAGATCATT
SEQ ID




TAGCCCCTTTTCTAATTTCTCAACATCTGGAAACTTTGTGGCTCCATCAGCATCTGCCATAAG
NO:




GATCTTTTCTCCTCGAGAACTGAATATACCCATTCTAATCGCTCCACCTTTTTCACGATTCTT
1166




CACCAGGGTTATCACACGTACTTTGTCACTTTCATATTTCTGGCAATTTTTAAAAGCTACCTT




TGAGGTCTGATCT





ALG5
ADXCRIHRC.469.C1_s_at
GTTCTAAATTAGTTCCATTCTGGAGCTGGCTACAAATGGGTAAAGACCTACTTTTTATACGAC
SEQ ID




TTCGATATTTGACTGGTGCCTGGAGGCTTGAGCAAACTCGGAAAATGAATTAGGTTGTTTGCA
NO:





1313





ALG5
ADXCRSS.Hs#S11048289_at
GAATTTTAACATAACGCATGCCCCTTATATTTAGCTCTATTTAAGCAAAATTTAGTGTCCTCT
SEQ ID




TAGTATGATTAGGCTTCTCAAAGTTGTACATATTCTGAACTTTTCAATAAACCTTTAAAAGAT
NO:




TTTTAATGTCAACTTTTTTAAAATCAGTTTCTAAAAATGAGATATTCTCATTGAAAATAAATA
2082




TTTTTATTAGTGATATTTAAATATTGAAAAACTATCTCTGCTTTTTCCCTCAGAATCAAATGG




CTATA





ANK3
ADXCRAG_NM_001149_s_at
GGCAGCACGCTGTAAAATTATTACTGTATTGTGTACTGGCTATAAGATGTAGACACCTTTCAG
SEQ ID




TAAGCCAATCATTTGTAACCATTCTAGCAGTGTCATATTAGGTTAATAAGGCTGCTGTGTTTT
NO:




AAAGGGCATTTTTATTTGGGTTTTGGTGAAATTCTTTAATTTGTTGATTATATTCACATAAAA
1008




TCAGCATTCATTGACACATAGCTCTAATGACATATGTATGAAAAACCATACACTGGATGACCT




AGTCGATTATTTAAGCA





ANK3
ADXCRSS.Hs#S1861798_at
AAAATGAATCTACTGCCTCCTCCGAAGCTAGTCCTTCAGATACTAGAAGACAATTATGCCCTC
SEQ ID




TTTATCAAAGGCCCTACTTAAACCAGTTCAGTGATAATCTATCTTCTATACCCGTTTTTCATA
NO:




AATAGAACCATGTGTTGTTTCTTGCATAATTATAGAAGTGTTCAAGAGAAACGAAGAGAGTGA
2097




GTGGCAGGACCATGGTGTGATGCAGGAGGAAGAGCTCTTGGCTAGAATCTGCTCCCAACTCTC




CAACTAACTGTGAATCATTGAATTGTTACTTAATGCCTCTATAA





ANK3
ADXCRPD.11257.C1_at
ATTTCCTCAATCTAAGCCTCTGGTTTTAAGACACCTTTGACACTGGTTGTTGTTTCTGCACGT
SEQ ID




GTTTTCAGAGCGGGCTAACACCACTGCATGTAGCTGCACATTACGATAATCAGAAAGTGGCCC
NO:




TTCTGCTTTTGGACCAAGGAGCCTCACCTCACGCAGCCGCAAAGGTACCTATAATTCCACAGC
2298




CTAAGGAGACTGATGGGTAAGGTCTATCAGTCTCTATCTGCACATCTACTTCTGCTTCAGCAG




GAGCACCCTCCTAGTTTAGCCACGACATGCCGG





ANK3
ADXCRAD_BX092880_at
TGTGAATGAGCAAAGATTCTGTCTTGGTGACACAGTAGTTCATATCAAATGAAATGTTTAATT
SEQ ID




GAAACCTTAGAAACTGTAACAAGGTATGAGGCACGATAAAGAAGAAAGAGAATGAAAGAATTA
NO:




AAAGGCTTCCTTCTCAGTCTCAAATTCCTACTGCCTTAAGAATTTTTAAATTAAAACCAGTTC
2582




TTCATAAGCAATCAGTGGCTGAGAATTTGAGGTTATAACCTGGCATGGATATATGTGACACA





ANP32A
ADXCRPAGD.232.C2_s_at
CTTCATTTTTGTTACCTGATAGAATAGCTTTTCTTATGAGATATATATAATGTGATACTATGT
SEQ ID




TTGGATATTTTTGGTCTTAAAGCAAGACTCAGTGGTGTATCTTCATTAAAAGCTTCCTTTAAA
NO:




AAAGTTACAGAGTTACTAAAAAAACAAGTACCCAAACAATCAAGTTGGGCCAACCTTGGAACC
1921




TTGTTTTGAATATCTTTCATTGTTTTGTTTGTCGTATTGTAAAAAGAATGTATGGTTGAAAAC




TCAGGAA





ANP32A
ADXCRAAD_AL547157_s_at
AAGAAGGTTATAACGATGGAGAGGTAGATGACGAGGAAGATGAAGAAGAGCTTGGTGAAGAAG
SEQ ID




AA
NO:





2357





ANP32A
ADXCRAD_AL547157_x_at
GGAGGATGAAGAAGGTTATAACGATGGAGAGGTAGATGACGAGGAAGATGAAGAAGAGCTTGG
SEQ ID




TGAAGAAGAAAGGGGTCAGAAGCGAAAACGAGAACCTGAAGATGAGGGAGAAGATGATGACTA
NO:




AGTGGATAACCTATTTTGAA
2358





ANP32A
ADXCRAD_CN349881_s_at
TTGTAAATAGCAACCTAAAGGCGTATTTTGGCACTGGTCTGGGGACATTCCCCATCTCTCATC
SEQ ID




CCTTTTCCCCCTTCACAGATGGTGGTGGGCTTCGCTCTACAAAGAGGACTCTGATGTTACTCT
NO:




TGAGCTTATGAGCCAGAGAGCTGAAAACCGCAGGCTTGTTGTGTTAAGTTACAAGGAAAATGG
2736




ATTTGGTAATTAAAATTAGAAGAAACACACCTTCAAACTTCAACTTCTTTAAAAGAAAAAAAA




AACTGTCCTATCTTGTTCTGTAAAATATTAGAACGCTTTGT





ANP32A
ADXCRAD_T67821_at
TTTAATGAAGATACACCACTGAGTCTTGCTTTAAGACCAAAAATATCCAAACATAGTATCACA
SEQ ID




TTATATATATCTCATANGAAAAGCTATTCTATCAGGNAACAAAAATGAAGCTTCCCCCTCACC
NO:




TAGCAGTTCATCTGGGAATGCATCTTGGAAAAGATCCAATGGCCTGTTGGACTCAAAGAAGCC
2799




ATCCCCAAAAAAATTGTATAAAAGGGTTTATTGAAATTTATCCAATGACCAACCGG





ANP32A
ADXCRAAD_T67821_x_at
TTTAATGAAGATACACCACTGAGTCTTGCTTTAAGACCAAAAATATCCAAACATAGTATCACA
SEQ ID




TTATATATATCTCATANGAAAAGCTATTCTATCAGGNAACAAAAATGAAGCTTCCCCCTCACC
NO:




TAGCAGTTCATCTGGGAATGCATCTTGGAAAAGATCCAATGGCCTGTTGGACTCAAAGAAGCC
2800




ATCCCCAAAAAAATTGTATAAAAGGGTTTATTGAAATTTATCCAATGACCAACCGG





ANP32B
ADXCRIH.2787.C1_s_at
ACATTCCGCCTTCCTTCCATGTAGTCCCTCTTGGTAATCTACCACCAAGCTTGTGGACTTCAC
SEQ ID




TCCAACAAAATTGTAAGCGTTGTTAGGTTTTTGTGTAAGATTCTTGCTGTAGCGTGGATAGCT
NO:




GTGATTGGTGAGTCAACCGTCTGTGGCTACCAGTTACACTGAGATTGTAACAGCATTTTTACT
1143




TTCT





APRT
ADXCRIH.1533.C1_s_at
GTGGAGCTGACCTCGCTTAAGGGCAGGGAGAAGCTGGCACCTGTACCCTTCTTCTCTCTCCTG
SEQ ID




CAGTATGAGTGACCACA
NO:





1201





ATHL1
ADXCRIH.1963.C1_s_at
GATGTTCGCAGGAAAAATCTGGAGATTTACGAGGCTGTGACGTCCCCCCAGGGCCCCGCCATG
SEQ ID




ACCTGGAGCATGTTTGCTGTGGGCTGGATGGAGCTGAAGGACGCAGTGCGGGCCCGGGGCCTC
NO:




CTGGACAGGAGCTTTGCCAACATGGCTGAACCCTTCAAGGTGTGGACGGAGAATGCAGACGGG
1222




TCAGCGCTGTGAACTTCCTGACAGGCATGGGGGGCTTCCTGCAGGCGGTGGTCTTCGGGTGCA




CGGGGGTTCAGGGTCACCCGAGCGGGTGTGACCTTTGAC





ATHL1
ADXCRAD_AJ708476_s_at
AGTGGGATGGCTCTCTTCCCTCAGCCACGCCGCTTGTGAGGACAGAGGTGGGGGAGTGGGAAG
SEQ ID




TGGGAAGTCACCAGAGAACAGGAGAGGGATTTGAGGGCGCGACCCCAGCGCTCTCCACGGACC
NO:




AGCCAGAGGGACTGGAGCCAGGTGTGCATGGGTTCAAGGCCCTGGCCCTGCCCAGCCTCTGTC
1756




TTGGGAGCTCAGCCCCAGGGTTCGGTCGTCAGCAGTTTCCCAAGAACAAGATGTGATGGCATC




TGCTGCTGAAACCCTGATGAGGACCAGGCCCC





ATIC
ADXCRAD_BU189824_at
TCTTCCCTTTCCGAGATAACGTAGACAGAGCTAAAAGGAGTGGTGTGGCGTACATTGCGGCTC
SEQ ID




CCTCCGGTTCTGCTGCTGACAAAGTTGTGATTGAGGCCTGCGACGAACTGGGAATCATCCTCG
NO:




CTCATACGAACCTTCGGCTCTTCCACCACTGATTTTACCACACACTGTTTTTTGGCTTGCTTA
2723




TGTGTAGGTGAACAGTCACGCCTGAAACTTTGAGGATAACTTT





CALML4
ADXCRAG_NM_033429_s_at
TACAAACTGACATTGTCTACTATACATTTTTAAAAGCCATTTTACTGGTTTGGCATGCGGTAT
SEQ ID




GGAAATTCTAAGAGAGAAAGTTTTAAGGCAATGAATCACAGATTTAAGTTCATGGAATTTATG
NO:




GTAACTTTATCTGTTTATGTACATTTTCCCCTTTGTTAAACAATTAACAGCAGCACACTCTGG
1048




GACCACCAGCTATTTTCCCTCTCTTTCTGAAATCTAAGCTTTGT





CALML4
RDCR490_C03_at
GGGAGCAGCACGAACTCCTGAAGACTTGGGAGCGTCAGCAGCTTCTGCGGAAGGGGTGGGGCT
SEQ ID




GAGGGTGGAGAGAGGAAGGGAAGGAAGAAAAGGGGAGCCTTCCTGGCCAGGGTAACCGGCACT
NO:




AAGAGGCCTCACTCCAAGCCCCCGAGGAGCCTGTGGTGGGGCTGGAGACCCGGGCTCAGCCCC
1373




TCCACCACCCTTAAAGTCCTCAGAAGGTGGGAACTGAACTGGGCACAGGCTGGGAAACCGGCT




GTGCGCTGGGCACTTGGAT





CALML
RDCR490_C03_x_at
GAGCAGCACGAACTCCTGAAGACTTGGGAGCGTCAGCAGCTTCTGCGGAAGGGGTGGGGCTGA
SEQ ID




GGGTGGAGAGAGGAAGGGAAGGAAGAAAAGGGGAGCCTTCCTGGCCAGGGTAACCGGCACTAA
NO:




GAGGCCTCACTCCAAGCCCCCGAGGAGCCTGTGGTGGGGCTGGAGACCCGGGCTCAGCCCCTC
1374




CACCACCCTTAAAGTCCTCAGAAGGTGGGAACTGAACTGGGCACAGGCTGGGAAACCGGCTGT




GCGCTGGGCACTTGGATTTTGCCAGCTGC





CALML4
ADXCRAD_BX431388_s_at
GAAGCAGATATCGAACCCAATGGCAAAGTGAAGTATGATGAATTTATCCACAAGATCACCCTT
SEQ ID




CCTGGACGGGACTATTGAAGGAGGAGAATGGGAGAGCCTCCCCTGGGCCTGAAAACTTGGAGC
NO:




AATTAATTTTTTTTAAAAAGTGTTCTTTTCACTTGGGAGAGATGGCAAACACAGTGGCAAGAC
1753




AACATTACCCAACTATAGAAGAGAGGCTAACTAGCAACAATAATAGATGATTTCAGCCATGGT




ATGAGTAGATCTTTAA





CALML4A
ADXCRSS.Hs#S2988186_at
ACGTCTTTCCCGCTCACTGTAGCTGCCACCCATTCTTTTTAATCCCCAGAGAGCATACAGATG
SEQ ID




AGCCCCAGTGGGCCATCTCAGCCACATAGGGGACAGGCCGGGGAGAGGATCTAGAGCTGGCCC
NO:




AGGAAAGGAGGCCCTTTTCATTTTGAGGGAGGCCTCCCATCAGAGAAGGGTCCAGTCCTGCCC
2163




CGACCCTGTCCTTCCCATGATACCCACAATCCCAGGGTGACCTGTCTCCAGGGCAGAAGTGAC




AGACGAGGGCTAGGAGACTGGCTGAGGCCTAAGTCCTCTGCAAT





CALML4
ADXCRAD_BQ928122_at
CTGGCCTGCAGGAAAGGAGCGCCCAGCTGCGCGCCTGGGCCGCCCGTCGCTCCCAGTGCTGCC
SEQ ID




GCCCTCGCGTTGCCTCCATGGCTGCCCCGCAGGCCCCTCGGCCCTGCCTTTTCCGAGGAAAAA
NO:




CGGTTCAGCTCGGTG
2341





CALML4
ADXCRAD_BQ928122_x_at
AGGTCGAGGTGGAAGGGAGCCGTGCGGGCAGCCTCATCAGCGCTCACAGAGCCATGCCTGGCC
SEQ ID




TGCAGGAAAGGAGCGCCCAGCTGCGCGCCTGGGCCGCCCGTCGCTCCCAGTGCTGCCGCCCTC
NO:




GCGTTGCCTCCATGGCTGCCCCGCAGGCCCCTCGGCCCTGCCTTTTCCGAGGAAAAACGGTTC
2342




AGCTCGGTG





CALML4
ADXCRAD_AI348378_at
AGATCTTGAAAGTTTTATGTGTTTAAAATTGAAATTGTCTAAAAAAATGCTCTTTCCACATTA
SEQ ID




ATTTAGTTAGGATATATTTTCACTCCATTTCAGACACTTGACTCA
NO:





2835





CALML4
ADXCRAD_AW025529_at
ACCGCAGGTCGGACGCCATGACGTAACCTTTCTTCTCCTTGTCCACCATCAACATGGCTAGAA
SEQ ID




GAATTTCTTTCTTTGGGTCTTCTTGTTTTATTTGCATGTGCATAATGGTCAGAAAAGTGGAGA
NO:




AATCCAGCTCTCCATTTCCGTCTATCCCGTGGGTCTGCAGGTGCCGCTGCACCTCCCCTGGCG
2902




TTGGGCTGGCCCCCAGGCACCTCATGGCCACCATGAGGTCGGGGGCTTTATCTTCCCCCTCTG




CTGCTGTCATACAAGGAGAAGCATTTCTTGTCTCATTAATTT





CASP7
ADXCRPD.1914.C1_at
GATAGTCTATGTATGTGTAAAACAATCTGTTTTGGCTTTATGTGCAAAATCTGTTATAGCTTT
SEQ ID




AAAATATATCTGGAACTTTTTAGATTATTCCAAGCCTTATTTTGAGTAAATATTTGTTACTTT
NO:




TAGTTCTATAAGTGAGGAAGAGTTTATGGCAAAGATTTTTGGCACTTTGTTTTCAAGATGGTG
1529




TTATCTTTTGAATTCTTGATAAATGACTGTTTTTTTCTGCCTAATAGTAACTGGTTAAAA





CASP7
ADXCRPD.1914.C1_x_at
GATAGTCTATGTATGTGTAAAACAATCTGTTTTGGCTTTATGTGCAAAATCTGTTATAGCTTT
SEQ ID




AAAATATATCTGGAACTTTTTAGATTATTCCAAGCCTTATTTTGAGTAAATATTTGTTACTTT
NO:




TAGTTCTATAAGTGAGGAAGAGTTTATGGCAAAGATTTTTGGCACTTTGTTTTCAAGATGGTG
1530




TTATCTTTTGAATTCTTGATAAATGACTGTTTTTTTCTGCCTAATAGTAACTGGTTA





CASP7
ADXCRSS.Hs#S3017613_at
GTGAATATGCTTACATCCCAGAGACTACATATATGGCAACAAAGAAAACAAAGTCCTGGCCCT
SEQ ID




CAGGGAGCTTCTAATCCAGTAACCACAATTTGGTGGTATGTTCACGGCATACAAGAAACAGTG
NO:




GAAGGTCTGTCAAGGTTTACAACAATGAAAATTTCCCCCTAAATTCCTAGCAGGTCGCAAAGT
2181




GCTCATACGCAATTCAAAAGCAGCGACAACCTGGGGTATTAGGCTCTCTTTCTATGTCAGCAG




GGATGCCCACATGGCAGATGCCCAA





CCT3
ADXCRIH.1715.C1_at
AGCTCTGTGAGGACATTATCCAACTGAAGCCCGATGTGGTCATCACTGAAAAGGGCATCTCAG
SEQ ID




ATTTAGCTCAGCACTACCTTATGCGGGCCAATATCACAGCCCATCCGCAGAGTCCGGAAGACA
NO:




GACAATAATCGCATTGCTAGAGCCTGTGGGGCCCCGGATAGTCGCCGACCAGAGGAACTGA
1125





CCT3
ADXCRIH.2536.C1_at
AGGAATGACCTCTAGGGCCTGGGCAACAGCCCTGTATGGCCATTGTTCCACACCAGTCATGGC
SEQ ID




CTTGGATTTTTCTGTCAAGGCATGGGCCACAGCCATCTCGGAGGCCCCACCCCCTGGCACCAG
NO:




CTGAGGGTCCAGGAAACATTGCGACACACTTGCATGGCATCCTGAAGGTTGCGTTCTACTTCC
1209




GAGAAAATCTCTTTGCTA





CCT3
ADXCRIRC.2536.C1_at
HAGAAAGGCGATGACCAGAGCCGGCAAGGCGGGGCTCCTGATGCTGGCCAGGAGTGAGTGCTA
SEQ ID




GGCAAGGCTACTTCAATGCACAGAACCAGCAGAGTTTCCCCTTTTCCTGAGCCAGAGTGCCAG
NO:




GAACACTGTGGACGTCTTTGTTCAGAAGGGATCAGGTTGGGGGGCAGCCCCCAGTCCCTTTCT
1321




GTCCCAGCTCAGTTTTCCAAAAGACACTGACATGTAATTTTTCTC





CLDN3
ADXCRIH.1252.C1_at
TGCAGCCTTGCCTCGGAGGCCAGCCCACCCCCAGAAGCCAGGAAGCCCCCGCGCTGGACTGGG
SEQ ID




GCAGCTTCCCCAGCAGCCACGGCTTTGCGGGCCGGGCAGTCGACTTCGGGGCCCAGGGACCAA
NO:




CCTGCATGGACTGTGAAACCTCACCCTTCTGGAGCACGGGGCCTGGGTGACCGCCAATACTTG
2231




ACCACCCCGTCGAGCCCCATCGGGCCGCTGCCCCCATGCTCGCGCTGGGCAGGGACCGG





CNOT1
ADXCRIH.3349.C1_at
TTCCAGACAAAGGTTTTCTCTTTCATGTATTTACACAAGTTCAAAATGATATTCACAGCATCT
SEQ ID




TCTAAATTTTGGCCAAGAGTCAAAAAAATGCATTTAAACTTTGGAACGTGCCCACATAAGACA
NO:




GGAGGCTGATCCCAACAGTAGTTGGGGCAGATACCCACAAACCAAAGGGCTGGGAAAGTCAGG
1129




AAGAGTTGAAAGGATTCTTCAGTCAGTTTATGAACTCGGTGCAGTGAGACCTCTAGACTGACA




CGTACAACAGAGATGCAGTTTCGTCTAACTGGCACCTGTCCCTTCGGA





CNOT1
ADXCRIH.2766.C1_at
TTTGTTGACAGATGCACCACCAGGGAATACTGACACCGATGATCTCATACCAAGGT
SEQ ID





NO:





1137





CNOT1
ADXCRIH.2766.C1_s_at
GATTGCCCCAGCTGATGGAAGTAGTGCGATCCAACTATGAAGCAATGATTGATCGTGCTCATG
SEQ ID




GAGGCCCAAACTTTATGATGCAT
NO:





1138





CNOT1
ADXCRIH.2766.C1_x_at
GATTGCCCCAGCTGATGGAAGTAGTGCGATCCAACTATGAAGCAATGATTGATCGTGCTCATG
SEQ ID




GAGGCCCAAACTTTATGATGCATTCTGGGATCTCTCAAGCCTCAGAGTATGATGACCCTCCCA
NO:




GGCCTGAGGGAGAAGGCAGAGTATCTTCTGAGGGAATGGGTGAATCTCTACCATTTCAGCAGC
1139




AGCTGGCCGCGACAGTACCAAAGCTTTCTCTGCATTTGTTGACAGATGCACCACCAGGGAATA




CTGACACCGATGATCTCATACCAAGGT





CNOT1
ADXCRIHRC.3349.C1_s_at
TAGGAAAGGGAACCAAATCTCATTAATTAATTGTTCTCCCCCATTACCCCACTGAATGAATGG
SEQ ID




CCATACAGGCTAAGCTGAATAATGACAAAGTTGAAAGGACCAATACAGCCCCTTTTATAAGGA
NO:




TTTTGAATGTTTTGCAAATGTATTGGTCCCTGTGTTGTATTTTGTAGCCTTTTCCTGGGCTTC
1309




AGCTCCCCTACTTCTTGTATGTGTATGCATACTGTAGCTAACCATTAAAGTCATG





CNOT1
ADXCRPD.235.C1_at
CCGGGACCACTGCAAACTGTCCGTATCCCTTTCCCTCCCCACAGAAAAACCCCGCGCCCAAAA
SEQ ID




ATCGGCCCTGTGCTGTCCC
NO:





1502





CNOT1
ADXCRPD.6310.C1_s_at
AGCTCCTGGCTTTGTATATGCCTGGCTTGAACTGATTTCCCATCGGATATTTATTGCAAGAAT
SEQ ID




GCTGGCACATACGCCACAGCAGAAGGGGTGGCCTATGTATGCACAGCTACTGATTGATCTTAT
NO:




TCAAATATTTAGCGCCTTTCCTTAGAAATGTGGAACTCACCAAACCTATGCAAATCCTCTACA
1741




AGGGCACTTCAAGAGTGCTGCTGGTTCTTTTGCATGAT





CNOT1
ADXCRPD.12126.C1_at
GGCCTGTCTGCAAGCATTAATGCAGGAGTGTTTTTCACGGAGCTAACAGAAAACATCTTCCAC
SEQ ID




TGTGTAAGTC
NO:





2302





CNOT1
ADXCRPD.12126.C1_s_at
ACTCCATTTGCCTTTGTTATTGACCTTGCTGCACTTGCTTCACGTCGTGAATACCTCAAACTT
SEQ ID




GATAAGTGGCTCACAGATAAAATTCGAGAGCATGGGGAGCCTTTTATCCAGGCGTGTATGACT
NO:




TTTTTAAAGAGACGGTGTCCTTCTATTTTGGGCGGACCTGCCCCAGAAAAAGACCAGCCCAAA
2303




AGTGCTCAACTTCCTCCAGAAACTTTGGCGACAATGTTGGCCTGT





CNOT1
ADXCRPD.12126.C2_at
CATGTTTCTTCCTTTCTCGTTAGGAAGAGCTTGGATTTGATTGAATCTCTGCTGAGGCTTGCA
SEQ ID




GAGGTTGGGCAGTATGAGCAAGTCAAACAGCTCTTCAGCTTCCCTATCAAACACTGTCCAGAC
NO:




ATGCTGGTATTGGCCTTACTACAAATTAACACCTCTCTGGCATACCTTGCGCCATGAACTTAT
2304




CTCCACTCTGATGCCAATTTTCCTTGGAACCATCCTAACTCAGCTATTATTTTGCACTATGCA




TGGCATGGGCACGTAAGATGTGACACGTGGCATCTCTCAATACGG





CNOT1
ADXCRPD.12126.C2_s_at
GCTTGGATTTGATTGAATCTCTGCTGAGGCTTGCAGAGGTTGGGCAGTATGAGCAAGTCAAAC
SEQ ID




AGCTCTTCAGCTTCCCTATCAAACACTGTCCAGACATGCTGGTATTGGCCTTACTACAAATTA
NO:




ACACCTCTCTGGCATACCTTGCGCCATGAACTTATCTCCACTCTGATGCCAATTTTCCTTGGA
2305




ACCATCCTAACTCAGCTATTATTTTGCACTATGCATGGC





CNOT1
ADXCRAD_NM_206999_at
GGCTATTTCCTTGGTATAGGTACAAAACGTATTACTGCTTGTCTGTAATAATTTTTTTCTTTG
SEQ ID




TCTATATATGGCACTGGGCGTTACCACTTATTCTTAATAATCACCATATTTGTTTGATGTCTT
NO:




CCATCATTTTAGATTGTAATTCTGTGAGGCAAAGCATCATGTCTGTGTGTTTTTTTTTTTTTC
2757




TGTTATATTCTCAACACGATGTTTGACAGATAGTAGATACCCAA





CYBA
ADXCRIH.1394.C1_s_at
ATTGCGAGCGGCATCTACCTACTGGCGGCTGTGCGTGGCGAGCAGTGGACGCCCATCGAGCCC
SEQ ID




AAGCCCCGGGAGCGGCCGCAGATCGGAGGCACCATCAAGCAGCCGCCCAGCAACCCCCCGCCG
NO:




CGGCCCCCGGCCGAGGCCCGCAAGAAGCCCAGCGAGGAGGAGGCTGCGGTGGCGGCGGGGGGA
1119




CCCCCGGGAGGTCCCCAGGTCAACCCCATCCCGGTGACCGACGAGGTCGTGTGACCTCGCCCC




GGA





DDC
ADXCRAG_AY526322_at
GATTATTCAGACTAATCTGTGGTCAATACAGAGCATCTTTATTTAAATACATATTCAAGTTAG
SEQ ID




TGTCAAAAAGAGTGCACAAAGTGCTGCTGGCACTGGAATTAGATGTTTCCTTACTGACCTCTG
NO:




GTATCTCCTGATAACAGGCCCCTCCTGCTTAGTGTTGGGAAAGTCCCAGATTGATCTAGACAC
910




AACTAACAGCTGATATGAAAGATTTGTCCTGGAATCACATGTCTCC





DDC
ADXCRAD_CD013938_s_at
GAGGGTTGTGATTTTGTCTGCTTAGTATCTCATCAACAAAGAAATATTATTTGCTAATTAAAA
SEQ ID




AGTTAATCTTCATGGCCATAGCTTTTATTCATTAGCTGTGATTTTTGTTGATTAAAACATTAT
NO:




AGATTTTCATGTTCTTGCAGTCATCAGAAGTGGTAGGAAAGCCTCACTGATATATTTTCCAGG
1005




GCAATCAATGTTCACGCAACTTGAAATTATATCTGTGGTCTTCAAATTGTCTTTTGTCATGTG




GCTAAATGCC





DUSP2
ADXCRPD.6684.C1_s_at
AGCTGTGACAACCAGGAGCCCTGTCTGTGGGTTCGTCTGCCCAGGGCCTGGAGCCCAAGCCCT
SEQ ID




GTGTTCCTGGGGAAGCTGGGGACTTGGGAAGTGATGGGTGTGTCATGTTGCGTGTGTCTGTCT
NO:




GTGAGCCTTTCACACCTGTGCTGGCGCTGGAAAATTATTTGTGCTCAGCTGACATTTAACACT
1779




CCCTCCCCCGCTTCCTCCTAGCCCTGTGGGCAGGGGTTGGAAACTTAGCACTTTATATTTATA





EEF1B2
ADXCRIH.572.C1_s_at
TAGATGTGAAACCTTGGGATGATGAGACAGATATGGCGAAATTAGAGGAGTGCGTCAGAAGCA
SEQ ID




TTCAAGCAGACGGCTTAGTCTGGGGCTCATCTAAACTAGTTCCAGTGGGATACGGAATTAAGA
NO:




AACTTCAAATACAGTGTGTAGTTGAAGATGATAAAGTTGGAACAGATATGCTGGAGGAGCAGA
2228




TCACTGCTTTTGAGGACTATGTGCAGTCCATGGATGTGGCTGCTTTCAACAAGATCTAAAATC




CATCCTGG





EEF1B2
ADXCRIH.572.C3_at
GCTCTCGAAGTTTATCAGGATGTTCACATGACAAAACTGGACCCAGGCTACTTTAGTTTTGTT
SEQ ID




GGGATATTGTAAGCTAAATTTTTCTGTAACCTTAGAAGGCCAAGAGACTGAAGCCCTCCATTT
NO:




TTTCACAGAACAGGTAGAACATGGACAGCAGCAATTCAACTTTTCCCCACACTGCCCTGCCAA
2229




TGTGCCTCGACCTTGACCTGGGGGGCCCACCTCTGGGGTGAGAGGGTGGCTCATTCATTCAGT




CCTTGGCCATTCTTCTGAAACTGCCAACAAGGGTG





ETS2
ADXCRAG_AL832032_at
CCCCCTTCAGTCGGCTCTCATTCTCCTTCCTGCTGCCCTGTGAAGAAGAACATATTTGCTTCC
SEQ ID




CCTTCTGCCATGAATGTAAGTTTCTTGAGGCGTCCCCAGCCATGCCAAACTGTG
NO:





893





ETS2
ADXCRIH.651.C1_s_at
GTATTTATCACTTGGACATCTGTTTATAATATAAACAGACATGTGACTGGGAACATCTTGCTG
SEQ ID




CCAAAAGAATCCTAGGCAGTGGCTCATTGTATGTGAGGTTGAACCACGTGAAATTGCCAATAT
NO:




TAGGCTGGCTTTTATCTACAAAGAAGGAGTTTCATGGGGTTCAGCCTAACAGTTATGGAAACT
1111




ACAGTCCTTATAAACCATTGGCATG





ETS2
ADXCRPD.8805.C1_at
ATTTGTCTGGCAAAATTAAGTTCTTTTTTCTTTAAAATGAACTTTTTTTCTTATTTCGAAGTG
SEQ ID




ATGTGTATGTAAAGAGGCAGTGTAGACTGGTGGTTAGGAGCACTCTGGAGTCAGAAGCCTGCT
NO:




TCAGAATCTTGGCTACCTCACTTACCAAGGATAGAGCTGTGGGGAGTTTACTTGTTCTCACTC
1449




TCTCTTCTTTTTTCCATCTGTAAAATGGCAAAAATAAACCACCTAAGTAAAATGGCCTCTGCG




AGAGACCCATAAATTA





ETS2
ADXCRPD.3556.C1_at
GGTAAGATATGGCTACAAACAGATCAAAACTTCCACTTCAAGATGCTAGAAAGAAGC
SEQ ID





NO:





1597





ETS2
ADXCRPD.3844.C1_x_at
CAACTTTATTTTGACTACTTTGATAACTTAAATAATTCTTTGTTACAGTGTTACTTCGTATTA
SEQ ID




GAGAGAATGTTTTTATTCTCAGGCGATAGATGCAAAAATATTTAAAGTGCAGCTCACTTTCAA
NO:




ACGGTTCAGCCAAATGTCGATGATTTTTGAATCTAAGTGGTGAGTATACAAATGTTCCTCGTA
1655




TTCATCTTTTATCTTTTTTGTATATTTGAAAATTTTTGGAATACAAAGTTGGAAAAAATAAAT




CATGCCCAAAAGATTGCCAGTAG





ETS2
ADXCRSS.Hs#S1228156_at
ATTCTGCACATTTGGTTCTATGTCATTTGCCATAGTCTTAAGGACGTAGGTTCCATAATCATC
SEQ ID




CCTTATTCTGTAGAGGAGGCCCAAGGTTAGTGAGCAGAGGAAGGTTCCACTGTCGGGAACCGG
NO:




TGGTCTTCAAACTCCTGTGCTCCTCTTTTGATATCTTTCTGCTCATATATGTTGGAAACAGCC
2067




CAGCATGAGCAAAGCACCACCTCCTAGCCCCCAGCCTGTGCCAGCCCTGCAAAGAGGAAATAT




GGCTCCACTCAGGGAGCCCATCAGCGACTCAGGGA





ETS2
ADXCRSS.Hs#S2874408_at
TTCCTCCTCAGCAACGGGCACAGGTCGTTCCAGTTTTGGCCAGGCGGTGGCGCTCGAGGCAAA
SEQ ID




CGGTGTCATGAAACGGTCACTGGATGCACTGACCCTGAAGATGCTCTCAAAGCACGAGTCCGT
NO:




TCATCAGAGAGTGGACTTGACACCCATCAGAAACATTCCCGGAGTGCGTTGGTGTGAAGGTGC
2072




GAGGAGAGTCGGGGAAGCATCCCGAAGCCCTGCTAGGCGAATGGGTACTGCTGAGATTACAGG




GTCAGCACAAAGCA





ETS2
ADXCRSS.Hs#S3746017_at
CTCTTCTTATTTGAATACCCTTGACTTCCTCTCTTCCTATTTGAATACTCTTTCTTTCTCTTG
SEQ ID




CCTGATTGCTCTGGCCAGAACTTCCAGTACTGTGTTGAATAGGGGTGGTGAGAGAGAGCATCC
NO:




TTGTCCTTGTGCCGGTTTTCAAAGGGAATGCTTTCTGCTTTTACTCATTCGGTATGATACTGT
2200




CTATGGAT





ETS2
ADXCRSS.Hs#S3746017_x_at
ACAATTTGACCTTCTCTCTTCTTATTTGAATACCCTTGACTTCCTCTCTTCCTATTTGAATAC
SEQ ID




TCTTTCTTTCTCTTGCCTGATTGCTCTGGCCAGAACTTCCAGTACTGTGTTGAATAGGGGTGG
NO:




TGAGAGAGAGCATCCTTGTCCTTGTGCCGGTTTTCAAAGGGAATGCTTTCTGCTTTTACTCAT
2201




TCGGTATGATACTGTCTATGGAT





ETS2
ADXCRSS.Hs#S3736200_at
GGTTAATATCCATGCTATAAAGTTTTATTTTTTCATCAACAAAACTAATTGCATTGGCACTTT
SEQ ID




CAAAATGTTGTTTGCACATAAATGATTTATACTTAAGTATGAGTGTAACAATCTTGCCATCAG
NO:




GACCTGGTCTGTTGGGAGATATCAGTGAATGGAGCCTGGCTCTTCCAATGGGCAACCGTTGTT
2210




TGTTGGTGAAGCTGCCACCCTTGAGACCTGCCTGGTCTCCTTCCCACCTGTAGCTGGCTAAGT




AGTGTCTCCCCACAATTCAC





ETS2
ADXCRSS.Hs#S3738574_at
CTTGCTCTAAGAATTGCCTGGACTAGCACTAACAGTGCTGACCTATGGAAGATCGTGTGAGCC
SEQ ID




ACTTAAGCAACTGCGAAAGTTCTAGTGGCCATATTAAAAAAGCAAAAAGAAACAGGTGAAGTT
NO:




AATTTTCTTATTTTACTTGGCCTCATATAGCAATTATCATTTCAATATGTAATCAATACATTA
2217




AAAATTATCAGGGAGACATTTTATATTCTCTGTTTCATACTAAGACTTCCAAATCTGGTGTGC




ATGACTATACTCTGCTTGTCCTG





ETS2
ADXCRIH.2576.C1_s_at
GCAGGATTGAAAATGTCCAGGAAAGTGGCCAAGAAGCAGTGGCCTTATTGCATCCCAAACCAC
SEQ ID




GCCTCTTGACCGGCTGCCTCTCTTGTGGCAGCAACGGCACAGCTAATTCTACTCACAGTGCTT
NO:




TTAAGTGAAAATGGTCGAGAAAGAGGCACCAGGAAGCCGTCCTGGCGCCTGGCAGTCCGTGGG
2259




ACGGGATGGGTTCTGGCTGTTTGAGATTCTCAAAGGAGCGAGCATGTCGTGGACACACACAGA




CTATTTTTAGAT





ETS2
ADXCRIH.2576.C2_at
ACAACCATGTCATTTCAGAAGTTAGTTTGTATATATTATAATAATCTTATAATTGTTCTCAGA
SEQ ID




ATCCCTTAACAGTTGTATTTAACAGAAATTGTATATTGTAATTTAAAATAATTATATAACTGT
NO:




ATTTGAAATAAGAATTCAGACATCTGAGGTTTTATTTCATTTTTCAATAGCACATATGGAATT
2260




TTGCAAAGATTTAATCTGCCAAGGGGCCGACTAAGAGACGTTGTAAAGTATGTATTATTCACA




TTTAATAGACTTACAGGGATAACGCCTGTTGG





ETS2
ADXCRAD_AI632259_x_at
CTCCTGCTTCAGCCTGGGAGGCAGAGCTTGCAGTGAGCCGAGATTGCGCCACTGCACTCCAGC
SEQ ID




CTGGGAGACAGAGCGAGACTCCGTCTCAAAAAAACAAAACAAAACAAACAAACAAACAAAAAA
NO:




CAACAAAGCAATCAATACCAGANACATGAAAGAAAAATGCCAGTTCTCAGAGCTGTT
2831





ETS2
ADXCRAD_AV646177_at
TGTAACCATTCTCAGCTGTTACATTTCTGCTCTTTATCCTTTTTTTTTTTTTTTTTGGTTTAA
SEQ ID




AAGCAGCGATCCATCAGCAACACCAAACTTGAAATTGATTTATGTGGAAAAACTTGGCTTGTC
NO:




TGCCATCTAACAAGCCCTGTTGAGTAAAATAAGCAAGCTTAAATTTGATTAGTTGTGTGTCTG
2847




CCTGAAACCATTTAGTAGAGCACTTTAATTCTGCATGGTTTTTA





ETS2
ADXCRAD_AK023838_x_at
GAGGTATCAGGGAACCGAGATCGCACCGCTGTACTCCAGCCTGGGCGACAGAACAAGACTTCG
SEQ ID




TCTCAAAAATATATCTATACAAGCACAAGGTT
NO:





2869





FABP5
ADXCRPD.277.C1_x_at
GTGTGTTGGATTAATTAGGATCATCCCTTTGGTTAATAAATAAATGTGTTTGTGCTAANNNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCNNNNNNNNNNNNNNNNNNNNNNNNNNN
NO:




NNAATATGTTCGGGCCGCCTCGGGCCCTTCAAAAAACTTTTTCAAGAACCATTTCGTTTTGGC
1504




CCCCGCGGGCCCCAATAGGGTAAAGTGAAAACTTGGCCCATACCTTGTTTTCCCATAGGAAAA




TCCCCTGGGCCATTGAACAAAGG





FASN
ADXCRAG_NM_004104_s_at
TACTGTAACTGTCAGTGTACACGTCTGGACCCCGTTTCATTTTTACACCAATTTGGTAAAAAT
SEQ ID




GCTGCTCTCAGCCT
NO:





1025





FASN
ADXCRAD_BQ188744_s_at
ATTTCCCCGATGTCCCCTGCGGGCGCGGGCAGCCACCCAAGCCTGCTGGCTGCGGCCCCCTCT
SEQ ID




CGGCCAGGCATTGGCTCAGCCCGCTGAGTGGGGGGTCGTGGGCCAGTCCCCGAGGAGCTGGGC
NO:




CCCTGCACAGGCACACAGGGCCCGGCCACACCCAGCGGCCCCCCGCACAGCCACCCGTGGGGT
2528




GCTGCCCTTATGCCCGGCGCCGGGCACCAACTCCATGTTTGGTGTTTG





FBXL14
ADXCRPD.4724.C1_s_at
GGAGGAATAGATGACTTTCTTTCTTTTGGTGGGGGTTGGGACTTGTGGCTTTAAAGAAATCAC
SEQ ID




TTCTGAGTAGGATGTATATTTTCGTTGGATTTTTGTTGTTATTTCTTTAGAACCCTCCACAGC
NO:




AACATGCAAGACCATGGAGTTAAAGAAACCCAGAGACCTTTATCAATTAATTGTACTGTTTGT
1696




GAAT





FBXL14
ADXCRPD.10538.C2_at
AATCTCATTGGATTACTCCTCCTTACATTACTGCGTTTGGATTTGTAGTCTTAACAAGGCAAT
SEQ ID




AAATGGAAGGGGAAAGAAGGAATCAATTCATGGTAACTAGAATGTAATGAGCACTTGCATTAA
NO:




GTCACAATTTAATTTGTATACTTTCGGAAATTCTTTCCTGGTTGTAAGCCTAAAGGGGCCTGC
2297




CTAG





GCLC
ADXCRAG_BC022487_s_at
AGCCTGACTGCTCTCAGTGCAAAGACCCAGAACCCAGCCTTCCTTCACCTGAAACAGCTGCAG
SEQ ID




CGTGCACACACACTTCTTGTGCATATATCTCTGGTCTATTTATTTTCAAAACTAAGTATAATC
NO:




CAAATTGAATGCTGGAATCAGATTTTTCCATTCTGAATGTGTTTAAATAACATGGCCAAGGAT
948




AATTTCTTTCTGTTTTCTTGACATTTATAGGTAGTATAAGATATGTGACTTCCAAATAAAC





GCLC
ADXCRAD_CR738919_s_at
AAAAATGGCGTTCTTCTCTTGTGGCCTGTTATTCTGATTGCTGCTGTATACAGTTTTGTCACT
SEQ ID




CTTTAGTTTTTAGTTAAGCATACTGATAGACTTTCCTCTAAAAGCCATTCACTCCAGATTTTA
NO:




CCTGGGGAATATTCTACATACTGCTTACTTTCTCTATAAAACTCATCAATAAATCATGAAAGG
1010




CACTGAGTTTTGTAAATCAGGACCCTAAATGTTTAATTGTAAATAAGTTTCAGATAATTATTA




TAGCTTTGCGTTGAAGTTTGTTGT





GCLC
ADXCRPD.5046.C1_s_at
ATAACTCTGTATTGTAGATTATGCAGATCTTTACAGGCATAAATATTTAAACTGTAATATGCT
SEQ ID




AACTTGAAGAGATTGCAATAAAGCTGCTTCAGCTAACCCTGTTTATGTTTAAATACTAGGGTT
NO:




TGTTCTATATTTTATACATGCATTTTGGATGATTAAAGAATGCCTGGTTTTCGTTTGCAATTT
1638




GCTTGTGTAAATCAGGTTGTAAAAAGGCAGATAAATTGAAATGTTTGTGGTATGAGGAA





GCLC
ADXCRPD.8360.C1_s_at
GTAATTGTACAATACTTGCATTCCAGAGTTAAAATGTTTACTGTAAATTTTTGTTCTTTTAAA
SEQ ID




GACTACCTGGGACCTGATTTATTGAAATTTTTCTCTTTAAAAACATTTTCTCTCGTTAATTTT
NO:




CCTTTGTCATTTCCTTTGTTGTCTACATTAAATCAAATGAATCCATTGAAAGTGCTTCAAGGG
1851




TAATCTTGGGTTTCTAGCCCCTTATCTATGATGTTTCTTTTGCAA





GCN1L1
ADXCRAG_U88837_s_at
TGATACTGCCCACCATACAGAAGTCCTTACTGAGGAGTCCAGAGAATGTTATTGAAACTATTT
SEQ ID




CTAGTCTGCTGGCATCAGTGACGCTTGACCTCAGCCAGTATGCCATGGACATCGTGAAAGGAC
NO:




TGGCTGGTCACCTGAAATCCAACAGTCCCCGCCTGATGGATGAAGCTGTGCTGGCACTGCGGA
1077




ACCTGGCACGCCAGTGCAGTGACTCTTCGGCCATGGAGTCCCTGACCAAGCACCTATTTGCTA




TCCTCGGAGGCTCGGAAGGAAAACTAACTGTTGTAGCCCAGAA





GCN1L
ADXCRAG_XM_0457920_at
TAAAGGCTTTGATTTAATCTTGATATAAACAGATTTTTAAAAATCTCCACCCATTAAACATGA
SEQ ID




AGCTTCCTGCATCAGGAA
NO:





1085





GCN1L1
ADXCRAD_BU599568_s_at
TCTTCTCCTGTGCTTGAGCTCTGGTTTGAGAGCTGGCGCTACCAACCTTTTTCCTATATCCCG
SEQ ID




AGTGGGGCACAGACGGTGGATCTCTGCCCAGTGTGGTGTGTCTGGCTTGGCTTTTCAATATTG
NO:




TGAGGTCTGAATGGATCTGATCCCTGTCAGATGAAAATGATTCACAGCTCTGGCAGTTCCCAA
1086




GTCTGGGGAGGGGTATAGGTTTGAAAGGCTGTTTGAA





GCN1L1
ADXCRPD.13574.C1_at
AAGCCTTAGGTTGGTAATCCGGCTGAACTCGGCTTGACGGCCTGAGGCCC
SEQ ID





NO:





1664





GCN1L1
ADXCRPD.13574.C1_s_at
GATGCCCTAAATGCCATCACTAAGAAGCTGGATGCTGGCAACCAGTTGGCACTCATTGAAGAG
SEQ ID




CTGCACAAGGAAATCCGGCTCATAGGGAACGAGAGCAAAGGCGAGCATGTGCCAGGATTCTGC
NO:




CTCCCGAAGAAGGGAGTGACCTCCATCCTTCCAGTGTTGCGGGAAGGAGTCCTGACTGGCAGC
1665




CCTGAGCAGAAGGAGGAGGCAGCCAAAGCCTTA





GCN1L
ADXCRAD_BQ890025_at
TCCAGTTTAGCCATGGCTAGGGTCCTGGAACTATAATAAGCAAGGGTCCAGACTGGTGGGGTT
SEQ ID




TCCTCCTTTCTCCTGTGGCTTGGAACCTCTTGGGTTTGAAAAGCTGGGCGCCTACCNAAACCC
NO:




TTTTTTTCCCTATAATCCCCGGAATTGGGGGGCAACAGAACGGTTGGGGAATCTCCTG
2576





GCNT3
ADXCRIH.1160.C1_s_at
GATCTTTTGCCTTGCAAATTGCTGCCTGGGTGAATGCTGCTTGTTCTCTCACCCCTAACCCTA
SEQ ID




GTAGTTCCTCCACTAACTTTCTCACTAAGTGAGAATGAGAACTGCTGTGATAGGGAGAGTGAA
NO:




GGAGGGATATGTGGTAGAGCACTTGATTTCAGTTGAATGCCTGCTGGTAGCTTTTCCATTCTG
1183




TGGAGCTGCCGTTCCTAATAATTCCAGGTTTGGTAGCGTGGA





GCNT3
ADXCRPD.15673.C1_at
GAAGGTCAGGACTTTGTGAACATATAAAACTGCAGATGGCTATTAGATATCCAAGTAGAGATG
SEQ ID




CTGAAGAGATGAATGTATATAGAAGTCTGAATTTGGGAGAGAGATCTGGATAGGAGATACTTA
NO:




CCTGGTGTTTAACAGCTTACAGATTGTGTAAAGTCATGAAACGGATAAGAACCTTAAAAGAGA
1778




GAAAAGGGAATAGAGGTTACCAAATGAATTGCAGTTTCCAAATTGCAGAG





GCNT3
ADXCRSS.Hs#S1924358_at
GGTGTGAACCGCTGTATCCAGCCTCTTTTTCAACTAACATCTTATCTGAGGTATAATATCCGT
SEQ ID




ATGCAAAAATACAAAAATTCCAAATATCTAACTCAAGAATTTTACAAAGTGAGCACACCTGTG
NO:




TAACTAGAACACTGGTCAAGAAAGAGAACATTCCCAGCAACCCAGAGTATCTCTTGTGTTCCT
2112




TTCCGATGGCTTTCCAAAAATAACCATTGTTCTCACTTCTAACATCACAGATTATTTTGCCTG




TT





GCNT3
ADXCRSS.Hs#S2978009_at
TACTCCTCATGGATCATACCTCGCTCTCCTCAGATGTTTTAATATATCCTTGAGATGGGGTCT
SEQ ID




TGCTGTGTCACCCAGGCTGAAGTATACTGAGTGGTACAATCATTGCTCACTGCTGGCCTTGAA
NO:




CTCCTGAGATAGGAGGCGATCCCCCCATCTCAGCCTCCTAAAGTGCCGGGATTACAGACGTGA
2136




GCCATCGCATCCAGCCTGGAAGTATTTTGAAGGTTCAGTGTGAGGATTTGCTGACAGATTGAG




CTGGAG





GPX2
ADXCRIH.789.C1_s_at
AGGAGCCTTAGGATGCAGCATGCCTTCAGGAGACACTGCTGGACCTCAGCATTCCCTTGATAT
SEQ ID




CAGTCCCCTTCACTGCAGAGCCTTGCCTTTCCCCTCTGCCTGTTTCCTTTTCCTCTCCCAACC
NO:




CTCTGGTTGGTGATTCAACTTGGGCTCCAAGACTTGGGTAAGCTCTGGGCCTTCACAGAATGA
1147




TGGCACCTTCCTAAACCCTCATGGGTGGTGTCTGAGAGGCGTGAAGGGCCTGGAGCCACTCTG




CTAGAAGA





GPX2
ADXCRPD.10475.C1_at
AGGCTATACTCAACACACGTGCAATTGAAAGCAGGCGAGGCAAAACCAGGGCAGAGGAAAGGA
SEQ ID




AAGGGGTGTGTGTGTAGGTATGGATTTATGGGTAGGTAGGTCGGTAGGTTAGTTGAAGAGGAG
NO:




GTTCTAAGCAGTATAACCTAAGCCTCTTTTCTCTTTCTTCTGCTTCAAACACCTTAAGAACTG
1419




CTCAGGGTAGACTGGAGACAAAAGCAACAGCTCAGAAGTGCTAAATCTTGAAGAGCAGCCAAA




GCATGGGCAACA





GSR
ADXCRAG_AY338490_at
TCACTTGAGCTTGGGTGAGGTGAGGCTGCAGTGAGTCCTGATCATGCTGCTGCACTCAATCTT
SEQ ID




GGACAACA
NO:





907





GSR
ADXCRIH.3783.C1_s_at
GACATCACTGATGATACGGCATGATAAGGTACTTAGAAGTTTTGATTCAATGATCAGCACCAA
SEQ ID




CTGCACGGAGGAGCTGGAGAACGCTGGCGTGGAGGTGCTGAAGTTCTCCCAGGTCAAGGAGGT
NO:




TAAAAAGACTTTGTCGGGCTTGGAAGTCAGCATGGTTACTGCAGTTCCCGGTAGGCTACCAGT
1148




CATGACCATGATTCCAGATGTTG





GSR
ADXCRPD.5551.C1_at
AGACCGGCAATTTATGAGGAGTAGTAGGCGCACGGTACGCATCGCTCGTACCCATGTGACGCA
SEQ ID




AGGTCGACGCGGCCTNACTTACTAGGTGACTGACAGCGGGATGGGTGTGTCGTCACCCGGTCC
NO:




GCGCCCCACCACGCCCATGGTGATATGACGTTTCACTATAGTCCTAGACAGACGTACTCGTAT
1722




TTGCCCACGGGTCTCTGATGCTANACACCCACGCTGTTGCTCCANCGTTATTACCCATACCAC




AAGAATGACGAGNCNCCCCTCTATTTTATTACACAGCGACGCCACG





GSR
ADXCRAD_BM978758_at
AGCCTCACCTCACCCAAGCTCAAGTGATCCTCTCACCTCAGCCTCCCAAGTAGCTGAGATTAC
SEQ ID




AGATGCACATCACCACACTCGGGTAATTTTTTTTACTCTCTGTAGAGATGCAGTCTTGCTATG
NO:




CTGTGCATGCTGGCCTCAAACTTGTAGGCTCAAGTAA
2750





GTF2E1
ADXCRAG_BC005917_at
AGACTGCTGCAGACGGGAAAACCACTCGCCATAACTACTACTTCATCAATTATCGTACTCTTG
SEQ ID




TTAATGTGGTAAAATATAAACTGGACCACATGAGCAGAAGAATTGAGACCGATGAGAGAGATT
NO:




CGACCAACCGGGCTTCCTTCAAATGTCCTGTCTGTAGTAGTACTTTCACAGACTTAGAAGCTA
920




ATCAGCTCTTTGATCCTATGACAGGTGAGGTTTATCCAGTTTGT





GTF2E1
ADXCRAD_BG571275_at
TGAGCCTTGTATGGAGTGATGTTTCATTTACCTGGGTTGTGTTAATGACTGAATGTTGACCAT
SEQ ID




AAATCTGTTTTATACTGACTGAAGTTTGTCATTTTTAAGTTCCTTGTAACCATCTTGCGCGCA
NO:




TATTCACCATTGAACTATTCTTTCCCAATATAAAAATACACGAACACACACACTTTTTCTGGC
2449




CCTCTGGCCCCTCTAAAAAATTTTTTTGACACCAATCGTTGGGCGGCGGCCCCGTGTGTTTGG




AACAAGTGTGAACAAGGTTCCAAA





HMGB1
ADXCRAG_AL110194_s_at
AAATCTATAATTAATTGGGCCAACTTTTAAAATGAAGATGCTTTTTAAAACTAATGAACTAAG
SEQ ID




ATGTATAAATCTTAGTTTTTTTGTATTTTAAAGATAGGCATATGGCATATTGATTAACGAGTC
NO:




AAATTTCCTAACTTTGCTGTGCAAAGGTTGAGAGCTATTGCTGATTAGTTACCACAGTTCTGA
888




TGATCGTCCCATCACAGTGTTGTTAATGTTTGCTG





HMGB1
ADXCRAG_U51677_x_at
ATGATGAATAAGTTGGTTCTAGCGCAGTTTTTTTTTTCTTGTCTATAAAGCATTTAACCCCCC
SEQ ID




TGTACACAACTCACTCCTTTTAAAGAAAAAAATTGAAATGTAAGGCTGTGTAAGATTTGTTTT
NO:




TAAACTGTACAGTGTCTTTTTTTGTATAGTTAACACACTACCGAATGTGTCTTTAGATAGCCC
1068




TGTCCTGGTGGTATTTTCAATAGCCACTAACCTTGCCTG





HMGB1
ADXCRIH.157.C4_s_at
TTTAGTAGGTACGTCATGACAACTACCATTTTTTTAAGATGTTGAGAATGGGAACAGTTTTTT
SEQ ID




TAGGGTTTATTCTTGACCACAGATCTTAAGAAAAT
NO:





1289





HMGB1
ADXCRAD_CN401906_s_at
AACTCATTCATTAGTCATGTTTATCTGCTTAGGAGTTTAGGGAACAATTTGGCAATTTTGTGG
SEQ ID




TTTTCGAGATTATCGTTTTCTTAAAGTGCCAGTATTTTAAAATAGCGTTCTTGTAATTTTACA
NO:




CGCTTTTGTGATGGAGTGCTGTTTTGTTATATAATTTAGACTTGGATTCTTTCCATTTGCATT
2402




TGTTTATGTAATTTCAGGAGGAATACTGAACATCTGAGTCCTGGATGATACTAATAAA





HMGB1
ADXCRAD_BX429991_at
GTATGGTCTAACCTTTACCATAGGACTTTATTCTTTAAACTCCATTACATGTAAGGGCCGTTA
SEQ ID




TATTTTGCAGCCTCCACATTAAGAATACTTGGTATGCTTTCTCCAAAGCGGTGAGCTTATATA
NO:




CAAGACTGGCATATTAAAATTTTCCGCTACACTTACTCCAAGAAAGCTTTGGAATAGCAGTCT
2572




TAT





HMGB1
ADXCRAD_DN601918_x_at
GATGCTTCAGTCAACTTCTCAGAGTTTTCTAAGAAGTGCTCAGAGAGGTGGAAGACCATGTCT
SEQ ID




GCTAAAGAGAAAGGAAAATTTGAAGATATGGCAAAAGCGGACAAGGCCCGTTATGAAAGAGAA
NO:




ATGAAAACCTATATCCCTCCCAAAGGGGAGACAAAAAAGAAGTTCAAGGATCCCAATGCACCC
2603




AAGAGGCCTCCTTCGGCCTTCTTCCTCTTCTGCTCTGAGTATCGCCCAAAAATCAAAGGAGAA




CATCCTGGCCTGTCCATTGGTGATGTTGC





HMGB1
ADXCRAD_CX757597_at
GAAAAGCGCCCATGTAACACAAACTGCCATTCAACAGGTATTTCCCTTACTACCTAAGGAATT
SEQ ID




GTACCATTGCTCAGAATTGTAGGATTTACTATGTTGAAACTACAGGAGAGCCGGGCGCATGGT
NO:




CACCCTGTATCCAGCCTTTGGAGGCANGCGGCAATCACAGTCAGAATGAACATCTGCTACTGT
2620




GAACCGCTCATAAATCAAAATACACTGTGCTGCCTGATCATATCGAGTAGCGAATGTGACGAG




GATCAGACATGCTGCCACGGA





HRSP12
ADXCRIH.2614.C1_s_at
TACACCTGTGTGCACCTGTATTACTGAATATAGGAAAGAGATACCCATTACATAGTTACTCAG
SEQ ID




TAAACAAAAAGAGAAATACCAGGTAGGAAAGAAGAGTTACTATTCCTGAGAAATAATCAAGAA
NO:




CATATTTAATTTAAACTAATGATGTGAACTATTTAGTTTTGATGTCCGTTATGTGATTCTGCT
1098




TTTACTTGAGTAAAAT





HSP90AB1
200064_at
AATAGACTTGTGTCTTCACCTTGCTGCATTGTGACCAGCACCTACGGCTGGACAGCCAATATG
SEQ ID




GAGCGGATCATGAAAGCCCAGGCACTTCGGGACAACTCCACCATGGGCTATATGATGGCCAAA
NO:




AAGCACCTGGAGATCAACCCTGACCACCCCATTGTGGAGACGCTGCGGCAGAAGGCTGAGGCC
833




GACAAGAATGATAAGGCAGTTAAGGACCTGGTGGTGCTGCTGTTTGAAACCGCCCTGCTATCT




TCTGGCTTTTCCCTTGAGGATCCCCAGACCCACTCCAACCGCATCTATCGCATGATCAAGCTA




GGTCTAGGTATTGATGAAGATGAAGTGGCAGCAGAGGAACCCAATGCTGCAGTTCCTGATGAG




ATCCCCCCTCTCGAGGGCGATGAGGATGCGTCTCGCATGGAAGAAGTCGATTAGGTTAGGAGT




TCATAGTTGGAAAACTTGTGCCCTTGTATAGTGTCCC





HSP90AB1
ADXCRIH.3279.C1_x_at
CTTGTATAGTGTCCCCATGGGCTCCCACTGCAGCCTCGAGTGCCCCTGTCCCACCTGGCTCCC
SEQ ID




CCTGCTGGTGTCTAGTGTTTTTTTCCCTCTCCTGTCCTTGTGTTGAAGGCAGTAAACTAAGGG
NO:




TGTCAAGCCCCATTCCCTCTCTACTCTTGACAGCAGGATTGGATGTTGTGTATTGTGGTTTAT
1100




TTTATTTTCTTCATTTTGTTCTGAAATTAAAGTATGCAAAAATAAAGAATATGCCGTTT





HSP90AB1
ADXCRAD_DN602116_s_at
GAAAGTGGTTGTGATCACAAAGCACAACGATGATGAACAGTATGCTTGGGAGTCTTCTGCTGG
SEQ ID




AGGTTCCTTCACTGTGCGTGCTGACCATGGTGAGCCCATTGGCAGGGGTACCAAAGTGATCCT
NO:




CCATCTTAAAGAAGATCAGACAGAGTACCTAGAAGAGAGGCGGGTCAAAGAAGTAGT
2329





HSPD1
ADXCRAG_AJ250915_at
TTTGTACATTCCTGATACTGGGTACAAGAGCCATGTACCAGTGTACTGCTTTCAACTTAAATC
SEQ ID




ACTGAGGCATTTTTACTACTATTCTGTTAAAATCAGGATTTTAGTGCTTGCCACCACCAGATG
NO:




AGAAGTTAAGCAGCCTTTCTGTGGAGAGTGAGAATAATTGTGTACAAAGTAGAGAAGTATCCA
881




ATTATGTGACAACCTTTGTGTAA





HSPD1
ADXCRAD_BM313583_s_at
AACAGCATGATTGGGTTAGGAATTTGCATAGGATGAGTTCAGTGGTGAGACTTTTGAAACTAC
SEQ ID




ACACATCTACCTTGTTTTAGTCCTATTTTCAAAATTTTGGCATTGTGAGATTTTATTTACTGT
NO:




GTGAACCTAAAGTTACTGTTTAAGTACATGCCACGCAACTCTGTGTTATTAAGAAGCACTGTC
2588




TCAGAAGCTGTGTGTAAATTTAATATTAAGGCACTAAAGACCAAGCATAGGTACATGCCTGTA





HSPD1
ADXCRAD_AW674195_at
TTTTTATTACACAAAGGTTGTCACATAATTGGATACTTCTCTACTTTGTACACAATTATTCTC
SEQ ID




ACTCTCCACAGAAAGGCTGCTTAACTTCTCATCTGGTGGTGGCAAGCACTAAAATCCTGATTT
NO:




TAACAGAATAGTAGT
2850





HSPD1
ADXCRAD_AW674195_x_at
AATGTTTTACACACATGCCAGCCTGCCCTTCAACTGGCTTTCAATTTTCAGTATCTTCTAATC
SEQ ID




ATGGAAATGCTAACACAATTATTAACTTTAAACAAATTTTTATTACACAAAGGTTGTCACATA
NO:




ATTGGATACTTCTCTACTTTGTACACAATTATTCTCACTCTCCACAGAAAGGCTGCTTAACTT
2851




CTCATCTGGTGGTGGCAAGCACTAAAATCCTGATTTTAACAGAATAGTAGT





HSPE1
ADXCRIHRC.2093.C1_s_at
GGACTGCAGCTAAGTGTCCACTCCCCAAAGTCTTCCTATTCCTAACTCCATGACAGCTCCTCA
SEQ ID




GTAGAGCTTTCCTCCTCAGAAGCAACTAGAACAATGCAGTTAACATTATTTGGCCCCAACGGC
NO:




GTTTACTGTGTATTTTGGCTGAGATCTTTAGAAGCCCGAGGCCTAAACAATTAACTGAGGAAC
1380




ATCTAA





HSPE1
ADXCRIH.2093.C1_at
TTCTAGATGACAAGGTGTGTAAACTTAATAATTCTAAAAAGAAGTCAGATATTTGCAATTAGT
SEQ ID




TGTCTTAACTAATGGTTTTTTTCACTTGCAGGATTATTTCCTATTTAGAGATGGTGACATTCT
NO:




TGGAAAGTACGTAGACTGAAATAAGTCACTATTGAAATGGCATCAACATGATGCTGCCCATTC
2247




CACTGAAGTTCTGAAATCTTTCGTCATGTAAATAATTTCCATATTTCTCTTTTATAATAAACT




AATGATAAGTAATCCTCGTGC





HSPE1
ADXCRIH.2093.C1_s_at
GAATATGGAGGCACCAAAGTAGTTCTAGATGACAAGGTGTGTAAACTTAATAATTCTAAAAAG
SEQ ID




AAGTCAGATATTTGCAATTAGTTGTCTTAACTAATGGTTTTTTTCACTTGCAGGATTATTTCC
NO:




TATTTAGAGATGGTGACATTCTTGGAAAGTACGTAGACTGAAATAAGTCACTATTGAAATGGC
2248




ATCAACATGATGCTGCCCATTCCACTGAAGTTCTGAAATCTTTCGTCATGTAAATAATTTCC





HSPE1
ADXCRIH.2093.C2_at
TTCTAGATGACAAGGATTATTTCCTATTTAGAGATGGTGACATTCTTGGAAAGTACGTAGACT
SEQ ID




GAAATAAGTCACTATTGAAATGGCATCAACATGATGCTGCCCATTCCACTGAAGTTCTGAAAT
NO:




CTTTCGTCATGTAAATAATTTCCATATTTCTCTTTTATAATAAACTAATGATAACTAATGACA
2249




TCCAGTGTCTCCAAAATTGTTTCCTTGTACTGATATAAACACTTCCAAATAAA





HSPE1
ADXCRI H.2093.C2_x_at
TTCTAGATGACAAGGATTATTTCCTATTTAGAGATGGTGACATTCTTGGAAAGTACGTAGACT
SEQ ID




GAAATAAGTCACTATTGAAATGGCATCAACATGATGCTGCCCATTCCACTGAAGTTCTGAAAT
NO:




CTTTCGTCATGTAAATAATTTCCATATTTCTCTTTTATAATAAACTAATGATAACTAATGACA
2250




TCCAGTGTCTCCAAAATTGTTTCCTTGTACTGATATAAACACTTCCAAATA





IL27RA
ADXCRAD_BG756941_at
GCAAGACCCTCAGTACAAAATAAACGTCAGAAACAAAAACAATTAGCTTGGGGCATTATGGCA
SEQ ID




CACACCTGTTATCCGAGCCACTTGGAAGCTGAGGGGGAGATCGGTTGAGCCAGGAGTTCGAAG
NO:




TGAGGACTCTGATTGCACATGGATCCAGGTGCGTACCAATGGACTTTTTCAAATA
2631





IL27RA
ADXCRAD_NM_004843_at
AACACTGCATTTGGGCACCATCTCAGCTCCCTTGCATCCAGGTGCAGCATGGACTGAGTTCTT
SEQ ID




GACAACAGAATGTGGTCAGAAGTGACATATGCCAACACGGGGTCTGGGTGGGGGCTCCCCCAC
NO:




ATCCTTTCCTTGCCTATGAGCTGGAACATAACACATGCCTATGATCCAGCTTTGGTCATACCC
2770




AAGGGGAAGGTGGAGCAAGAAATGAAAAGGAACCTGAATCCCTGAATGACTGCATGGATAGAA




CCACT





INSIG1
ADXCRIH.1510.C1_s_at
GAATGACCCCCTTATATATTTTCTGAAAATGAAAACAGTTACATGAAAAAAATTTCCAATGAA
SEQ ID




GATGTCAGCATTTTATGAAAAACCAGAAGTTATTAGATGAAAGCAGCGAGTGAATCTTTAAAC
NO:




AGACTTGATCACGCACACACAATAAGTCTTTCTCTCC
1196





INSIG1
ADXCRAD_BU191559_at
AATCTATTTAGATCGGGCTGACTGTACAAATGACTCCTGGAAAAAACTCTTCACCTAGTCTAG
SEQ ID




AATAGGGAGGTGGAGAATGATGACTTACCCTGAAGTCTTCCCTTGACTGCCCGCACTGGCGCC
NO:




TGTCTGTGCCCTGGAGCATTCTGCCCAGGCTACGTGGGTTCAGGCAGGTGGCAGCTTCCCAAG
2371




TATTCGATTTCATTCATGTGATTA





INSIG1
ADXCRAD_BU570382_at
GATTTTTTTGCCAATAGTTTATAGAAAATATATGAACCAAAGTGATTTGAGTTTGTAAAAATG
SEQ ID




TAAAATAGTATGAACAAAATTTGCACTCTACCAGATTTGAACATCTAGTGAGGTTCACATTCA
NO:




TACTAAGTTTTCAACATTGTGT
2372





INSIG1
ADXCRAD_BU570382_x_at
GATTTTTTTGCCAATAGTTTATAGAAAATATATGAACCAAAGTGATTTGAGTTTGTAAAAATG
SEQ ID




TAAAATAGTATGAACAAAATTTGCACTCTACCAGATTTGAACATCTAGTGAGGTTCACATTCA
NO:




TACTAAGTTTTCAACATTGTGTTCTTTTTGCATTCATTTTTTA
2373





INSIG1
ADXCRAD_AL541939_s_at
TTTTAAATTCTGTGAAAGTGGCTTGATTAAAAG
SEQ ID





NO:





2611





KBTBD11
ADXCRPD.18308.C1_at
AGGCAGTCTCAGCAATGCCTCTGCCCTCCCTGCAGCAGTCCCAAAATGAACAGCCACACCTTG
SEQ ID




GAGGGTGTGGCTTTTCTGTTTCATGCGGTGCAAACCCTAGCGGCTCCACACCCCAGGGACTGG
NO:




CCCCCAAAAAGCAAAAACACTGCTCATGGCTTGGCAGGTCCTCTAGTATGTATTTTTATGTGA
1420




TATCACTATTCAGAACTGTGGTGTATACTATTCTATAAATTTCCACTATAGGTTGGCCGGACA




TCCTTTAATGCTGGGTATTAATTCCTCTTATTCT





KBTBD11
ADXCRPDRC.18308.C1_at
GGTTCATGTGAGATGCAGAGGCAATGAGCTTGAGCCTTCCTACCTTTACTTCCGGCTGGATAC
SEQ ID




TTGCTCTGGGGAACAATCCCATCAATACCGCAGACGGCTTTGCCGGCCGCCTTCGCCAAAGCC
NO:




TGGGATTCGGAAACATACGGGGAAACGGGGCGCGGAATCCGAGGAGGGCCACGACAGCGACCA
1927




GGGAGAAAAACGGCAGGTGCGGGAAGAACCTGGGCCACACAACAAAAACACGGAAGTGAGAAC




ACCTGGCCACACGAAGGAAGACATGAA





KBTBD11
ADXCRAD_NM_014867_at
CTTCAGACACGCCAAGTGGATGGATTTGGATTGAACGCATATGAAACAGGAGACGGGTTCTCA
SEQ ID




TGTGAGATCAAAGCTCCTCCAAAGCCTGTTCAAGCTCTAAGCGATTCTCAAATGTTACCATTT
NO:




ATTAAAGGTAAACTACACCTGTTGAAGGCCAAGTTCAGGGCAGCTGTTGTGATCTGTGTAGTT
2772




AATGTATTTATTAATGCTTGACTTTTAAAATCCTGGGCATAAATAGTGCAGAGCCTCGTATGT




TTGTCAGTTCATGCCGAGATG





LGALS4
ADXCRIH.255.C1_at
AGAAGAAGATCACCCACAACCCATTTGGTCCCGGACAGTTCTTTGATCTGTCCATTCGCTGTG
SEQ ID




GCTTGGATCGCTTCAAGGTTTACGCCAATGGCCAGCACCTCTTTGACTTTGCCCATCGCCTCT
NO:




CGGCCTTCCAGAGGGTGGACACATTGGAAATCCAGGGTGATGTCACCTTGTCCTATGTCCAGA
1258




TCTAATCTATTCCTGGGGCCATAACTCATGGGAAAACAGAATTATCCCCTAGGACTCCTTT





MRPL16
ADXCRIH.2001.C1_s_at
ACATGCTGGGCATACGGAAAGTACTGAGCCCATATGACTTGACCCACAAGGGGAAATACTGGG
SEQ ID




GCAAGTTCTACATGCCCAAACGTGTGTAGTGAGTGTAGGAGATAACTGTATATAGGCTACTGA
NO:




AAGAAGGATTCTGCATTTCTATTCCCCTCAGCCTACCCACTGAAGTCTTTGGGTAGCTCTTAA
1144




GCCATAACTAAGGAGCAGCATTTGAGTAGATTTCTGAAA





MRPS2
ADXCRAD_AL583494_s_at
TTGGCTGCAGTTAGGACCTCAGTGGCTGGTATGGCCGAGCTGCTAGAAGATGCTGCTGTCCCT
SEQ ID




GTGATCCCAGCAGCCCTCCCTTCACCGTGACCCCTGACCTTTGTCAGGAAGGTGCAGTTTTTC
NO:




TTCTCAATCTAAATGCCTTTCAGGTGGGCCGCTTCCTTGGCTACCTGGTTCCAGGGGGCTGTT
839




TTGTAATGAGATGCTGCTGGCAGGCCACTCAGAGGCTCCCAGCTGGGTTGGTGGGACAGCCAG




GCCAGATGACCTGATTCCAGCAAAAATAA





MRPS35
ADXCRIH.1462.C1_at
AAACTTGTAGGAGAGCGATACTGCAAGACCACAGATGTGCTTACCATCAAAACAGATAGGTGC
SEQ ID




CCTTTAAGGAGGCAGAATTACGATTATGCAGTGTATCTACTAACAGTGTTATACCATGAGTCT
NO:




TGGAATACTGAAGAATGGGAAAAAAGTAAGACTGAAGCAGACATGGAAGAGTATATATGGGAA
1155




AATAGCTCATCAGAAAGAAATATCCTGGAAACGCTCTCCAGATGAAAGCTG





MRPS35
ADXCRIH.2579.C1_at
AATGGGTTCTGGGCCTGCCTTCCCAGGTAACCAAAACCATTATTCAAAAGCAACTACTGAAAT
SEQ ID




GCCAGCTTGTGGGGAAAGAAATGGGAAAGGTGATAAAATCACAATTAAATGCATGTATATACA
NO:




TGAATACCAAAGCTATTATGTAGAAATAAAATCAAAACACTTTAGACCAAGAAGAAATCAGAG
1213




ACCTCCTAGTCTATTGCCCCCAGTGTAAAAATTAAAAAACTCTGGAGTAATCATTGCCATTAA




GCATTAGTATG





MRPS35
ADXCRIH.2579.C1_x_at
AAGGAAATGGGTTCTGGGCCTGCCTTCCCAGGTAACCAAAACCATTATTCAAAAGCAACTACT
SEQ ID




GAAATGCCAGCTTGTGGGGAAAGAAATGGGAAAGGTGATAAAATCACAATTAAATGCATGTAT
NO:




ATACATGAATACCAAAGCTATTATGTAGAAATAAAATCAAAACACTTTAGACCAAGAAGAAAT
1214




CAGAGACCTCCTAGTCTATTGCCCCCAGTGTAAAAATTAAAAAACTCTGGAGTAATCATTGCC




ATTAAGGATTAGTATG





MRPS35
ADXCRIHRC.2579.C1_at
GGCTCATTTTGCCAGGGCCAAGCTACCAGAAAAGTAGAAGTGGAGATTACCTGGTATGTATCT
SEQ ID




CTCTGGGTGCCCCAGTTAGAGCTGCCACAGCTCAGGAAAAAGATGAGGCATAACGACCTTGAA
NO:




TGTAATTGGAGTAAGTGACAAAATAAGAACTACCCTGGGAAACCCTGCATTCAATGTAGCTGT
1324




CAATTCAGTATTTTTAAGTACACCTGTCAGCTGTTTCTTACCACTTCGATGGTTGTGATTA





MTHFD2
ADXCRI H.873.C1_s_at
GCTGCAAAAAAGGTGCTGAGGCTTGAAGAGCGAGAAGTGCTGAAGTCTAAAGAGCTTGGGGGT
SEQ ID




AGCCACTAATTAACTACTGTGTCTTCTGTGTCACAAACAGCACTCCAGGCCAGCTCAAGAAGC
NO:




AAAGCAGGCCAATAGAAATGCAATATTTTTAATTTATTCTACTGAAATGGTTTAAATGATGCC
1189




TTGTATTTATTGAAAGCTTAAATGGGTGGGTGTTTCTGCACATACCTTCTGCAGTACCTCACC




AGGGAGCAT





MUC13
ADXCRIH.333.C1_s_at
GGGTGTAGGTTTCTGAGGTGTGCCATTGGGGCCTCAGCCTTCTCTGGTGACAGAGGCTCAGCT
SEQ ID




GTGGCCACCANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAATGGGGGCAACCACATCCA
NO:




GTACAAGCTTTTACAAATGTTATTAGTGTCCTTTTTTATTTCTAATGCCTTGTCCTCTTAAAA
1126




GTTATTTTATTTGTTATTATTATTTGTTCTTGACTGTTAATTGTGAATGGTAATGCAATAAAG




TGCC





MUC13
ADXCRIH.2577.C1_s_at
AAGATCTGAAATGCGTGCTGATGACAAGTTTGTTAATGTAACAATAGTAACAATTTTGGCAGA
SEQ ID




AACCACAAGTGACAATGAGAAGACTGTGACTGAGAAAATTAATAAAGCAATTAGAAGTAGCTC
NO:




AAGCAACTTTCTAAACTATGATTTGACCCTTCGGTGTGATTATTATGGCTGTAACCAGACTGC
1212




GGATGACTGCCTCAATGGTTTAGCATGCGATTGCAAATCTGACCTGCAAAGGCCTAACCCACA




GAGCCCTTTCTGCGTTGCTTCC





MYC
ADXCRIH.2640.C1_s_at
TGATCAAATGCAACCTCACAACCTTGGCTGAGTCTTGAGACTGAAAGATTTAGCCATAATGTA
SEQ ID




AACTGCCTCAAATTGGACTTTGG
NO:





1105





MYC
ADXCRPD.8111.C1_at
CAGTGTCCGTCTCCGGCTGTCAGAAATGCGGTGAGCCGAAATTTAAATGCCCTCCCGGAGACG
SEQ ID




GGGACAAGTCAGCGGCTGCGGAGCGATCTGGCTCACACAGGCGATATGCGGTCCCTACTCCAA
NO:




GGAGCTCAGGATGCAAGGGGCTTTCTGCCCACCGCAAAGCAACCCCCAGCCCCCCAAAACCCA
1806




GAGAGCAATTAACACAATAAAGCAGGAATGTCCGACCGGCCGGGAGTCAGCGTGAATATATTC




ATAAGGCAGAAATCTCGAAAGGGTAGTCTT





MYC
ADXCRSS.Hs#S854806_at
GGGAGGAGACTCAGCCGGGCAGCCGAGCACTCTAGCTCTAGGATGTAAACAGAGTAAGAGAGC
SEQ ID




CGCATGAATTAACTACGCGCGCCTACCATTTTCTTTTGCTCCCTCTCAAACCCTCTCCCTTTC
NO:




TCTGCTGCTCCTCCGTAGCAGTACTGTTTGACAAACCGCATCCTTGTCCTGTGAGTATAAATC
2226




ATCGCAGGCGGAACAGCTG





MYC
ADXCRAD_CA454569_at
TAAATATTGGGCCATTAAATGGTAAATAAACTTTTAATAAAACCGTTTTATTAGCAAGTTACA
SEQ ID




CCAGAAATTTCAATCCCCTAGGTATATATAGTACCCTCAAGTATTTATTA
NO:





2390





NDUFAB1
ADXCRIH.1103.C1_s_at
TTGGGTTTGAAATTCCTGATATAGATGCTGAAAAGTTAATGTGTCCACAAGAAATTGTAGATT
SEQ ID




ACATTGCAGATAAGAAGGATGTATATGAATAAAGTATCAGACCCTTTGGCTTTGCTGAGAGAG
NO:




GACTCAGATGATAGTGACGAATGTCTGGCAGTGAGGACACATTTTGGCATTCTTGCTGACTCT
1172




GACAGAGTGATTCTGATGGACTTGTATTTAA





NUP37
ADXCRIH.1894.C1_s_at
AAATTCATCATTTAGGACACCCTCAGCCCATCCTCATGGGTTCTGTAGCCGTTGGATCTGGAC
SEQ ID




TGTCCTGGCATCGAACTCTCCCTCTGTGTGTAATTGGAGGAGACCACAAGCTGTTGTTTTGG
NO:




GTGACTGAAGTATAAAGTGTTTTCTGTACCTTAGATTCACAAACTTTGTATTTTTAGTACATA
1171




TTTTGAAGAATTTCTATAGTACATATTTTGAAGAATTTTTATATCAAATATACCGTATACTTT




AGAAAATGTCTCAGTTGCTTTTATTA





NUP37
ADXCRSS.Hs#S1923985_at
AAGCAACAAGTAAACACACCTATGAAAGCAACTTGTTTGAGCTGTCTCAACTTCTCTGCAGCT
SEQ ID




GTTCTGGCTGTATCTGTATTCTAGTACTTCTTTGAACTCTAGAGAAAAGTTTGTTCATCAAAA
NO:




CCTCATGAAGTTTAAAGGTAGTCTATTGCCTTTTGTCCTTTTTCAAAAATCTTATTTCTTTAT
2111




TTAAATTGACAGGTAAAAATTGTATTTTTATGATGTACAACATGATGTTTTGATATATGAATA




CATTGTGGAATGGCCAAACCAAGCAACC





PDCD4
ADXCRAG_NM_014456_s_at
CATTACTGGTGGGATCTGGTCACACAAGATAGCATTAAACGTGACATGGCACATAAAATTGGT
SEQ ID




TAAAAAATTTTGTTTTTTAATTACGTAATGTAAAAGCCCAACAAACACTTTATGCAAGATTGG
NO:





1042




AATGTATCTTCAA





PDCD4
ADXCRPD.13022.C1_s_at
GAAATTCCGGACATTAATCTGGATGTCCCACATTCATACTCTGTGCTGGAGCGGTTTGTAGAA
SEQ ID





NO:




GAATGTTTTCAGGCTGGATAATTTCCTTACAACTCAGAGATCTTTGTCCTTCAAG
1567





PDCD4
ADXCRPD.5572.C1_s_at
TTCCAGGGAACATACTGATTGGTCTTAAAAGACTAGACAGTTAAGTAAAAGGTGGCTGGAACA
SEQ ID




TCTATTTTTCTACAAAACTGGAAAAATGAACCTGGTTCTAGAAGAATGTACACCAAAATAAAA
NO:




CATGTGAAGCAGTATTGATTCTTTATTGGGAGTACATTTTTTAGGTCTCTTAAACTTTAATTT
1724




CACACA





PDCD4
ADXCRSS.Hs#S1435288_at
TGTTCCCACGGAGGTTTCTGCTTGTTCCCAGTAAGTTGTGATTCTCTGTATCCACGTGTCTTT
SEQ ID




CTCCAATTTGGGGGGCTTCAGTTTGCTCTGTGACCTCCATTCTCTGATGGATCTAAGAAGAGT
NO:




TGTTGATTTTCAGTTTGTTTAGCTATTTGTTAGGACAGAGTGACAACTTTCAAGCTCCTTACA
2076




TGCTGCATCAGAAACCAGAA





PDCD4
ADXCRAD_BE544684_at
ATTTACTATGTATGTTTCACTTACAATTTGTAGGGAAAAAAAGTCTTCAAGGGAACACTAAGA
SEQ ID




TTAAATGACCTAGCGTTCAAATATGCTTCCTTATGAGATTCACAATTTACCTGTGTGAAATTA
NO:




ACGTTCTAAGAGACCTAAAAATGTTCTCCCCAATAAGAACTCATACT
1567





PDCD4
ADXCRAD_BE544684_x_at
AAGTGATACCTGCATTTTTTCCCCAGGTAATCTTAATTTACTATGTATGTTTCACTTACAATT
SEQ ID




TGTAGGGAAAAAAAGTCTTCAAGGGAACACTAAGATTAAATGACCTAGCGTTCAAATATGCTT
NO:




CCTTATGAGATTCACAATTTACCTGTGTGAAATTAACGTTCTAAGAGACCTAAAAATGTTCTC
2548




CCCAATAAGAACTCATACT





PDCD4
ADXCRAD_BM550622_at
TCTGACCTAGAGCTTTATTTAAGTTTTAGAAATATGTAATACCTTTCATCATTCCATCATCC
SEQ ID




CTAAATTCTGNTACCCAAATAATGGCTAATGTTACAAAAAGTTATACTCCCAGAGACCCAA
NO:




AGCTTGACATTTACCTATTGTATTGAGAAATTATTCCCAATACCAATAAAGGAATGGTCCTA
2663




TTTTTTAACCCCTCTTTTAACTAGCCTAATACCTCCCGCAAGGCCCTCAACGTCCT




GGGGCTA





PDCD4
ADXCRAD_BM550622_x_at
AATGCAGGTATCACTTTTACTCCATTGTTATCTGACCTAGAGCTTTATTTAAGTTTTAGAAAT
SEQ ID




ATGTAATACCTTTCATCATTCCATCATCCCTAAATTCTGNTACCCAAATAATGGCTAATGTTA
NO:




CAAAAAGTTATACTCCCAGAGACCCAAAGCTTGACATTTACCTATTGTATTGAGAAATTATTC
2664




CCAATACCAATAAAGGAATGGTCCTATTTTTTAACCCCTCTTTTAACTAGCCTAATACCTCCC




GCAAGG





PDCD4
ADXCRAD_BC043171_at
CATTGGTAGGGAACTATCCAGTATTTATATTCCTATGTATGTATATCAGATTAATTTTGAGGC
SEQ ID




TTGGTATTCCTAAAAGATTTGGATGTGTGTATTTCTTTAACTTGACGTAAACATGTATCACAA
NO:




ACATATCTTTTAATTCCAATTAAAGGGGTGCTTTGGCACATGCTG
2781





PDCD4
ADXCRAD_BC043171_x_at
CATTGGTAGGGAACTATCCAGTATTTATATTCCTATGTATGTATATCAGATTAATTTTGAGGC
SEQ ID




TTGGTATTCCTAAAAGATTTGGATGTGTGTATTTCTTTAACTTGACGTAAACATGTATCACAA
NO:




ACATATCTTTTAATTCCAATTAAAGGGGTGCTTTGGCACATGCTGAAATCTGGGATTTT
2782





PDSS1
ADXCRAD_BM824056_s_at
AACTTCGACCATCCCCAGAAAGAGATGCCCTCATTCAGCTTTCAGAAATTGTACTCACAAGAG
SEQ ID




ATAAATGACAACTCTTTCTGTTCTTTCTGGCAGCTATCTTACCAGACTGTGCCTAAAGAATTT
NO:




TGTGGAATACACTTTGTTTGCTTCATGTGCAGATAACCAAAAATCATTTTAAAAGATATCAAA
862




CTTATTGATGGGCAAT





PDSS1
ADXCRPDRC.11127.C1_at
GCACACCATCACTCTGTAGTACATACTGTCGAGCTCTGTCTACATCTCCAGGCAAACTGAACC
SEQ ID




GTCGCATGATCATAGCATTCATTTCTGGGAACTGCTGACAGGCAAACAGGACAGGACCAGTGG
NO:




CTAACCCGAGCTTCAGATCAGCTGATGTTGGTTTGCCCATCTGGTCAGAACACGAGGTGAAGT
2058




CCAATACATCATCTATTAGCTGAAAAGCTATTCCTACATTTTTTCCGTACTGATAGGCGATCC




CA





PGD
ADXCRAD_CX873763_s_at
ACAGACCAGGACATTCCATGTGCCTCATGGCACTGCCACCTGGCCCCTTGCCCTATTTTCTGT
SEQ ID




TCAGTTTTTTAAAAGTGTTGTAAGAGACTCCTGAGGAAGACACACAGTTTATTTGTAAAGTAG
NO:




CTCTGTGAGAGCCACCATGCCCTCTGCCCTTGCCTCTTGGGACTGACCAGGAGCTGCTCATGT
912




GCGTGAGAGTGGGAACCATCTCCTTGCGGCAGTGGCTTCCGCGTGCCCCGTGTGCTGGTGCGG




TTCCC





PMM2
ADXCRPD.16616.C1_at

SEQ ID




CTGGCCAAGTGGGAGCAGACCCTAGGGAGTTTGCACCTCGGCTGGGCCGGATTCGGACCGGCT
NO:




CTGTGTTCACTACACTCAGAATAGCCTGGCTGCTTCTCTGTCTCCGAGACCGGAGGTAGTGGG
1826




AACCAACAGCTGGGCTGGAGAGTTGGTGCTGGCAAAACAGTCCTTGCCCTGGGGCCGGTTCTT




ACCCAGGTCCAGAGAAACCAACGCGGGATGTCAGACTTCACCAAAAGGACTTTCTGGTTGCCC




CTG





PMM2
ADXCRAD_BE390153_at

SEQ ID




TGGGCACTTGCCGACCTGAGTCTGGGGCCAGGGAGCCCAGGCTGCCCTGCACTCCTGCCTCCC
NO:




AGCCCACAGCCAGGTGCTTTCATCACAGCTAAACCTGGTTCCCTCCAAACCTCCCAGCCACTC
2408




GGGCTTGTAACTGTCTGAGCCCCGGATCCGGTGGGGTGAAAGCAGCCAGCTCATCCCAGTGAC




TCACAGGACACAGCCATCCAGCGGCATCTTTCCTTGTCGAATGATACTGTAATGACCTTCCAA




AGTGAAGAGTAGCAC





PPRC1
ADXCRPD.9220.C1_at
CAGGTATTGAAACAAGTTAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCCA
SEQ ID





NO:




GTGTTTGGAACATAAGTCACTATGCAGACTAATAAACATCAACTAGAG
1398





PPRC1
ADXCRPD.9220.C1_x_at
TCCCTGCTATCCTTTTTCTCCTTTGGAGGTGCNCCAACCTCCTCCACCCCCTTCCCCTACTCT
SEQ ID




AGGGGAGAGAGCTGCTAGTGAGATGACTGTTTTATAAAGAAATGGAAAAAAGTGAAATAAAAA
NO:




ATATGTTGAATCAGATTTTTTAAAAGGGGTATTTGTTTTTTTATAACAGGTATTGAAACAAGT
1399




TAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCCAGTGTTTGGAACATAAGT




CACTATGCAGACTAATAAACATCAACTAGAG





PPRC1
ADXCRPD.16668.C1_at
AGGGCTTCACTGCAGAGCTGTCTTCTTGGCTGGGGCTGGTGGGATGACAAGACAAGGGATGTC
SEQ ID




TGCCAGCCCTGTGGGAGTCTCTGGAAGGCTAGGCCACTTCCCAGTTGGGGGCTGTGGACTTCT
NO:




CTCTTCTGTTTCTGCTTGGCGTTGCTGCCTTCGTCGCCGGTACTCAGATAAGCTGAGAGGCCG
1832




AGGTCTGGCTTCATGGGTTGTAGCACTGGTACCACTTTCAATTTTCA





PPRC1
ADXCRPDRC.16668.C1_at

SEQ ID




GAAGAGAGAAGTCCACAGCCCCCAACTGGGAAGTGGCCTAGCCTTCCAGAGACTCCCACAGGG
NO:




CTGGCAGACATCCCTTGTCTTGTCATCCCACCAGCCCCAGCCAAGAAGACAGCTCTGCAGTGA
2033




AGCCCTGAAACACCCCTTGAGATTTGCCTTGTGCCTATAGGTCCCAGCCCTGCTTCTCCTAGT




CCTGAGCCACCTGTAAGCAAACCTGTGCCTCATCTCCCACTGAGCAGGTGCCATCCCAGAAGA




TGCCACTGTTGGCGAGACCTT





PRIM1
ADXCRPD.724.C1_at
CCGTGAATTGGATGCCATTTCCACTAATGAAGAGGAAAAAGAGGAGAATGAAGCTGAATCTGA
SEQ ID




TGTCAAACATAGAACCAGAGATTATAAGAAGACCAGTCTAGCACCTTATGTGAAAGTTTTTGA
NO:




ACATTTTCTTGAAAATCTGGATAAATCCCGAAAAGGAGAACTTCTTAAGAAGAGTGATTTACA
2266




AAAAGATTTCTGAAGACAGAGCTCCTCAAACCATTGTGGATATCTTCTGCCTTCAACCACAGA




TCAAATACTTCAAGAGCCATTTAATAAA





PRIM1
ADXCRPD.724.C2_at
GCCATTGCAACTGGCCGTATTAAGTCCTTTGTATCCTCACTGTTCCATACTAGCTCAGCCTAT
SEQ ID




GATGTGGACTTCAGCAAATGTGTAAGCAAATCTTTGTGCATGATGTGTGTTAAATAGAAGCAT
NO:




TAGGCAAAAAAGAATGTAAAAGTAAATGGGCTTTGTTTTGTTTCCTTTGCTGTTCTTCCATAT
2267




ATTATC





PRR13
ADXCRIH.1445.C1_at
TCCACTTATAATACTTGTGATTGGGGAGGTTTGTGGAAATTCAATTATGATGAAAAACCTATC
SEQ ID




TTTTTTGTAATGTTGGCATACTTGGGGAATTTAGTGGCAAATACATTCCCCAGCAGGCCTTTT
NO:




GTTGGTTGCACTAACTGCAAGGTTGCTGGGAAGTAGAGTCCATTTGGTTGATGAGCTTTGACT
1285




GCGGTTTTGGAACCTTACCTCTCCTCCTTAGCCCAATATGCTGTCTTGGGTCCT





PTGES2
ADXCRIH.498.C1_s_at
ACAGGACAGCAGGACGGTTTGTTTTCAGTGGA
SEQ ID





NO:





1170





RNPS1
200060_s_at
CAGGGAAAAGTGAGGCTCTTGGGGGTGGTTTGACCCTGCTTACCTGGGAGCACACTTTTCCCT
SEQ ID




TCCCCGATGACCTGGGATGGTGGCCAGGCCGTGCCCTTGCTGTTGCTGGGCAGTGTCCTTTTG
NO:




GAAAGGGAGCTGCCCCAGGCTTTAGTGCAGCTGCCAACCCTGTTAGGCCTGGCCTCTCGAGGC
832




CTCTTCTGATCTCAAGGGTCACACCCCCTCAAAGATCCTCTCACCCATGGTAGTTGCTGCTCG




TGGTTCTGTCTGTCCGTGCACCGATGCACACACCGCACCCCACCACTGTACTCTGAAATTGGC




GAGTGAGTGGAGAGCCAGCTCTGCGGAGTCATCACGCAGCCATGGTTGTGCCTGCCGTTCATG




GTGGTCTTTCAGGTTATCTTGGCAACATGTACATTGCTTTTATTTTTTTTCTTTTTTGCTTTC




ATTGTACAGTCAGTACTATAAAATTTCTCTTTTGAGTTTTATACCTTTGTAGCATTTTAGATG




ACATTGTGTTTGTACTTTGTTG





RNPS1
ADXCRPD.500.C1_at
ATGCATAGATATACACACCACGCCCCCACCGCGATGTTAACGACACCGCGAGATAATACTATT
SEQ ID




CCCCCCACACTGCGTCTCTGTTCTGTTTCTNAGCACACCTCTCACCTCTCCTCTTATCTCTGT
NO:




GGCGGTCGAGAACATTGCACTCACCCCACTATTTATCTCTATTCTTTCTCTATTACTGACCAA
1561




CATATCCTCTGTGCGCACCCTCGCGCGGAAACAACAACATCGTGTACACACCACAAGAAGTAA




GCACATGATTGCTAGCCTGGGACACCGCGCCCTCATAATATATA





RNPS1
ADXCRAD_CX785467_at
GATCGGAATGCAAATCTAGTTCTGGGTTCACTGCCTTCTCACTT
SEQ ID





NO:





2688





RNPS1
ADXCRAD_CX785467_x_at
GATCGGAATGCAAATCTAGTTCTGGGTTCACTGCCTTCTCACTTGTCCCCTCGCCCCTAGTAA
SEQ ID





NO:




CTTTCTGTTCCTCACCA
2689





RNPS1
ADXCRAD_NM_006711_at
AATAAACCCAAGATCATCTGAGATGAATATTAATTTTATTCTCATTTTATAGATGAGGAAATG
SEQ ID




GGAGTTTTAAAGACATTCAATAACTTTGGCCAAGGTCATTCAGCTATTAAATTTTAAGACCAT
NO:




AAACCAATTGGATTCCTGGAGGAATTC
2859





RPL13
ADXCRIH.350.C2_s_at
GAATCAGTCGGCAGTCATGCTGGGTCTCCACGTGGTG
SEQ ID





NO:





1273





RPL13
ADXCRAD_BM907731_at
TTTACACCACCCTCGTGGAATTGGCGAAAAAAACTGCCCGAGCTTGTGGGAAACTTTTTGTGG
SEQ ID




GAGAGGAACCCCTTACTTTTCGGGGGGGGGGCGCACAAATTTGGTGACCAACCTCCGCCCCCC
NO:




ACAGAATTTCGAGGCCCCCCGAGGGGACCAAAATAAACACTCTTCTCAGCCGACACATTGCGG
2637




CTAAAACAAACGCACCGACAAAATACCTTTCGCGCGCGGTTGAGAACCATTTTC





RPL13
ADXCRAD_AI554467_at
AGACAGGTTGTTAAACCCACATGCACCAAAGGGCAAGGGAACAACCAAGCGTCAGGAGAACCC
SEQ ID




GGAGGACCTCCCGGGGATTGGGGGTCAGGTTCGCTGCCATAAGTACTGCTGAAAAGCAACCCT
NO:




GAGTCAATCACCTTCCCTG
2882





RPL13
ADXCRAD_AI554467_x_at
GCTTTCTCCTTCTTATAGACCTAGAAGAGAAAGACAGGTTGTTAAACCCACATGCACCAAAGG
SEQ ID




GCAAGGGAACAACCAAGCGTCAGGAGAACCCGGAGGACCTCCCGGGGATTGGGGGTCAGGTTC
NO:




GCTGCCATAAGTACTGCTGAAAAGCAACCCTGAGTCAATCACCTTCCCTGGGATTTA
2883





RPL13A
ADXCRIH.613.C1_at

SEQ ID




AGCGGCCTGGCCTCGCTTGGTTTTGTGGGGCAGCATACCTCGCACGGTCCGCCAGAAGATGCG
NO:




GCTGGGGGCCCGGAAGTGGTAGGGGCCTCGGGAAGGGTTGGTGTTCATCCGCTTGCGGAGGAA
1280




AGCCAGGTACTTCAACTTGTTTCTGTAGAAATTGCCAGAAATGTTGATGCCTTCACAGCGTAC




GACCACCACCTTCCGGCCCAGCAGTACCTGTTTAGCCACGATGGCCGCCAGGCGGCCCAGGAG




ATGGCCTCGACCATCAAGCA





RPL13A
ADXCRIHRC.613.C1_x_at
GCTGCCCTCAAGGTCGTGCGTCTGAAGCCTACAAGAAAGTTTGCCTATCTGGGGCGCCTGGCT
SEQ ID




CACGAGGTTGGCTGGAAGTACCAGGCAGTGACAGCCACCCTGGAGGAGAAGAGGAAAGAGAAA
NO:




GCCAAGATCCACTACCGGAAGAAGAAACAGCTCATGAGGCTACGGAAACAGGCCGAGAAGAAC
1331




GTGGAGAAGAAAATTGACAAATACACAGAGGTCCTCAAGACCCACGGACTCCTGGTCTGAGCC




CAATAAAGACTGTTAATTCCTCGTGCCGAA





RPL3
ADXCRIH.445.CB1_s_at
CCTTGCTGGTGCAGACGAAGCGGCGGGCTCTGGAGAAGATTGACCTTAAGTTCATTGACACCA
SEQ ID




CCTCCAAGTTTGGCCATGGCCGCTTCCAGACCATGGAGGAGAAGAAAGCATTCATGGGACCAC
NO:




TGAAGAAAGACCGAATTGCAAAGGAAGAAGGAGCTTAATGCCAGGAACAGATTTTGCAGTTGG
1162




TGGGGTCTCAATAA





RUVBL1
ADXCRAD_CN389613_s_at
AAGAGCATGTCGAAGAGATCAGTGAACTTTTCTATGATGCCAAGTCCTCCGCCAAAATCCTGG
SEQ ID




CTGACCAGCAGGATAAGTACATGAAGTGAGATGGCTGAGGTTTTCAGCAGCAAGAGACTCCCC
NO:




AGGTGTGCCTGGCCTGGGTCCAGCCTGTGGGCGCTTGCCCCTGGGCTTGGGGCTGCCGTCCCC
918




ACTCAGGCGTGGGCTGCAGCGCTGTCAGTTCAGTGTGGAAAGCATTTCTTTTTAAGTTATCGT




AACTGTTCCTGTGGTTGCTTTGAAAGAACCCTTC





S100A14
ADXCRIH.2777.C1_s_at
TGATTTGAATAATGGAGCTGGGAATATGGCTGGATATCTGGTACTAAAAAAGGGTCTTTAAGA
SEQ ID




ACCTACTTCCTAATCTCTTCCCCAATCCAAACCATAGCTGTCTGTCCAGTGCTCTCTTCCTGC
NO:




CTCCAGCTCTGCCCCAGGCTCCTCCTAGACTCTGTCCCTGGGCTAGGGCAGGGGAGGAGGGAG
1140




AGCAGGGTTGGGGGAGAGGCTGAGGAGAGTGTGACATGTGGGGAGAGGACCAGCTGGGTGCTT




GGGCATTGACAGAATGATGGTTGTTTTGTATCATTTGATT





SERPINB1
ADXCRIH.2353.C1_at
TTTGGAAGCCACAAAATAGACAGACACCCTGACTGTTGAAGGGAGGTTTAAAAACAGATATTC
SEQ ID




AATTGAAATGTAAGAGAGCACCTCAATTGAGAGCCCAGGTTACGAAGACAAGCTTGCCTCGCC
NO:




TGACTTTTCTGTCCCTTGTTCTGCAGGATTAGTATTCTGTTACAGACTTCTAGTTTTAGACTC
1122




TTCATTAAAGGGCCAATGGTTATAACCTGC





SERPINB1
ADXCRIH.2353.C1_s_at
ATCTATAAAATTGCTATATCCTCCTGATAGCCATGGGAAAACATGATAAGATGGTCATTTATT
SEQ ID




TTGCAGTTAGAATTTTGGAAGCCACAAAATAGACAGACACCCTGACTGTTGAAGGGAGGTTTA
NO:




AAAACAGATATTCAATTGAAATGTAAGAGAGCACCTCAATTGAGAGCCCAGGTTACGAAGACA
1123




AGCTTGCCTCGCCTGACTTTTCTGTCCCTTGTTCTGCAGGATTAGTATTCTGTTACA





SERPINB1
ADXCRAD_D11859_s_at
GGGCTCTTGGACTGATATAAAACTTTGTNAAATGTAGTTCTTTGAATGGAGCTTGAAACGCCG
SEQ ID




CATATNCTTGCTCCCACAAGGATAGTGGGCATCATGAATTAATAAAACGTCCTAGGATTCTGC
NO:




A
2457





SERPINB1
ADXCRAD_W52010_s_at
AAGGTGCAGCCTGGGATTCAAGTTCAAGGGGCTGCGAAACTTCTATTACTCATCACTTTAGAT
SEQ ID




ATGAAAGCATTTTAAATGTTTTTTTTAAATCCATTAAAAAAAAAAAACCTCTGTTACTAATTG
NO:




TTAGTTGCTTCTTGCAGGGTTATATCAGTTCCTAGCTTGAGGTTTTCCACGGGACTTTAAAAC
2834




CTCAGCA





SHMT2
ADXCRAD_BP384660_s_at
AACAAGACTTAGAAGGAGGGCCCAGGCACTTTCTGTTTGAACCCCTGTCATGATCACAGTGTC
SEQ ID




AGAGACGCGTCCTCTTTCTTGGGGAAGTTGAGGAGTGCCCTTCAGAGCCAGTAGCAGGCAGGG
NO:




GTGGGTAGGCACCCTCCTTCCTGTTTTTATCTAATAAAATGCTAACCTGCCCTGAGTTTCCAT
2559




TACTGTGGGT





SHMT2
ADXCRAD_CX788770_at
ACTGCCAAGCTCCAGGATTTCAAATCCTTCCTGCTTAAGGACTCAGAAACAAGTCAGCGTCTG
SEQ ID




GCC
NO:





2669





SHMT2
ADXCRAD_CX788770_s_at
TCAGCGTCTGGCCAACCTCAGGCAACGGGTGGAGCAGTTTGCCAGGGCCTTCCCCATGCCTGG
SEQ ID




TTTTGATGAGCATTGAAGGCACCTGGGAAATGAGGCCCACAGACTCAAAGTTACTCTCCTTCC
NO:




CCCTACCTGGGCCAGTGAAATAGAAAGCCTTTCTATTTTTTGGTGCGGGAGGGAAGACCTCTC
2670




ACTTAGGGCAAGAGCCA





SLC19A1
ADXCRAG_U17566_s_at

SEQ ID




GAAGTACGTCCCAGCGGCCTCAGGGTCTAAGGAGCGCTAGTGCCTTGCCCACAGGTGCGGGAC
NO:




CATCTGATGTGATGTGAATACTCTTCCCACATACATTAAACACACTTA
1064





SLC19A1
ADXCRPD.7962.C1_s_at

SEQ ID




GCCGCGGGCTTCGTGAAGATCCGCTGGGCGCGCTGGTCCAAGCTGCTCATCGCGGGCGTCACG
NO:




GCCACGCAGGCGGGGNCTGGTCTTCCTTCTGGCGCACACGCGCCACCCGAGCAGCATCTGGCT
1389




GTGCTATGCGGCCTTCGTGCTGTTCCGCGGCTCCTACCAGTTCCTCGTGCCCATCGCCACCTT




TCAGATTGCATCTTCTCTGTCTAAAGAGCTCTGTGCCCTGGTCTTCGGGGTCAACACGTTCTT




TGCCACCATCGTCAAGACCATCATCACTTTCATTGTCTCGGACGTGC





SLC9A3R1
ADXCRIH.2825.C1_s_at
TTTTGTTAAGAGTGCAGTATTGCAGAGTCTAGAGGAATTTTTGTTTCCTTGATTAACATGATT
SEQ ID




TTCCTGGTTGTTACATCCAGGGCATGGCAGTGGCCTCAGCCTTAAACTTTTGTTCCTACTCCC
NO:




ACCCTCAGCGAACTGGGCAGCACGGGGAGGGTTTGGCTACCCCTGCCCATCCCTGAGCCAGGT
1169




ACCACCATTGTAAGGAAACACTTTCAG





STOML2
ADXCRIH.3851.C1_at
CTGCCTCCGTTATGAGATCAAGGATATCCATGTGCCACCCCGGGTGAAAGAGTCTATGCAGAT
SEQ ID




GCAGGTGGAGGCAGAGCGGCGGAAACGGGCCACAGTTCTAGAGTCTGAGGGGACCCGAGAGTC
NO:




GGCCATCAATGTGGCAGAAGGAAGAAACAGGCCCAGATCCTGGCCTCCGAAGCAGAAAAGGCT
1187




GAACAGATAAATCAGCAGCTGAGAGGCCAGTGCAGTTCTGGCGAAAGCCAAAGCTAAAGCTGA




AGCTATTCGAATCCTGGCTGCAGCTCTGACACAACATAATGG





TMPO
ADXCRAD_CN272683_s_at
CTAGCTATAAGGCTATAATTGGAAATTTGTATTTTTTATTTACAGCAAAACATTTATTCAGTC
SEQ ID




ATCCAGTTTGCTACCAAAATATGTTTTAGATAAGTGTGTGTATGTTTGTTTAGAAGTTAGAAA
NO:




TTGTAAACACTGGTCTTATGTTTCATTTGGATTCATTATTGCATTGTCTTGTTACCAGAAACA
1061




AATTTTGCCGAGCTTTTTTTGCCCTATATTTCCCAGCATAATTTGATTAGAAAGT





TMPO
ADXCRIH.3127.C1_at
GAAATTGTGAGAAGCTTCATTTAGTGTTTAAAAATGTGGGGAGATAAATCAGACTTAACATGT
SEQ ID




ATGTAAGATCAATTCACTTAAAAGTATGGTCCAAATAGCAAAAATAGGACCAGGTGAAACATG
NO:




TAGTCATTTTTTAAAAACATGTACTTGGTCTTTTGTGTGTGTCTGTTTTATTCCATTAGAATA
1197




AATGTGTCCTTGATGTAATGCAAAGCATTTCTTCCTGATTAAATTGTAGATGTAGACTTTAC





TMPO
ADXCRIH.3127.C1_x_at
TCCCATACTGTTTTCAGCCTTTTGTTTATAATTAGAAATTGTGAGAAGCTTCATTTAGTGTTT
SEQ ID




AAAAATGTGGGGAGATAAATCAGACTTAACATGTATGTAAGATCAATTCACTTAAAAGTATGG
NO:




TCCAAATAGCAAAAATAGGACCAGGTGAAACATGTAGTCATTTTTTAAAAACATGTACTTGGT
1198




CTTTTGTGTGTGTCTGTTTTATTCCATTAGAATAAATGTGTCCTTGATGTAATGCAAAGCATT




TCTTCCTGATTAA





TMPO
ADXCRIH.994.C1_s_at
ATATCCTGGGATAGTGCATGTTCACCATCTATTTTGTCAGATAATGGGGCCTTTTAAAAAATA
SEQ ID




ATACTTTGCTTTCATGATATATTGTATTTTTGTGGAAAGTTAAGTTTAGCAATATATACTCTA
NO:




AAAGCAAATTTAATTTTTTTTAAGCCATAAAGAAATTATACTATATCCCAGTATCTGTATGTC
1247




TGTATAAAGCAGTGTATTATC





TMPO
ADXCRIHRC.3127.C1_at
TGAAATCAAAATTGTGTGCTGGTCTAAATATACATCTTCGGCTTCTTCCTTTTTAGTAAGTAT
SEQ ID




TTTTATTTCAGATGTATTTAAAAATAACTTACATTTTTAGTGTGCTTTATGGTCAATGACTGT
NO:




AAAGTTGAAACTCAAATGAGTCAGTTTAAAATTTTTGTCTCATTTGATTCTATTGAAATTTTA
1320




ATCACCTACTACTTTAATCAAGTTATTCATGAGGTAAGTTTCAGCT





TMPO
ADXCRPD.3658.C1_at
TTGTTCACAGTGTTGGCACATGGTAAGGGCTAAGACACTTGATTAGCATAATATTCAAAATTA
SEQ ID




GAAATTGTACACTATTGTACTCTCTTTCAAAAGGCAAACAGCCTAAAACTGTTTGGAAAAAAC
NO:




AGCTTGTACAGTATATTGTACACTTCCTGTGATAGACTAGTGGACTGATACACCCACTAATGC
1615




ACAGCAGTAATAGTCCACCTCTTTACACANTTATGCATGTTAAGTGACAAAAAAACTCACTTT




AAAAGGCCAAATGATAAAAACATCAGCCTTGAGGCTCTTCGATATAGA





TMPO
ADXCRPD.12957.C1_at
TAAACATGCAAACTCACTACCAAATTGGCTTATAGTAATATTAGGCCTTAGCAATTCCATTAA
SEQ ID




ATTAAGAGCAACTCATTATTGGAGAACACTTTCTAAGTTGAACTGTAATCATACAAACCGCAC
NO:




AGCCAAGCAAGTAACTTAAAGACATTGTTGTTAAAATAGTCCATTTTGGATTACCTATCTAAA
1676





TMPO
ADXCRAD_BX482009_s_at
AAAAGGGACGCTCCATTCCCGTATGGATAAAAATTTTGCTGTTTGTTGTTGTGGCAGTTTTTT
SEQ ID




TGTTTTTGGTCTATCAAGCTATGGAAACCAACCAAGTAAATCCCTTCTCTAATTTTCTTCATG
NO:




TTGACCCTAGAAAATCCAACTGAATGGTATCTCTTTGGCACGTTCAACTTGGTCTCCTATTTT
2649




CAATAACTGTTGAAAAACATTTGTGTACACTTGTTGACTCCAAGAACTAAAAATAATGTGATT




TCGCCTCAATAA





TPK1
ADXCRAD_CD511474_at
TAAAATGGAAGCGGTTGGACTGATGGTGTCTGAGGTTCTTTCCCACACTGAAATTCTAAATAT
SEQ ID




TGACACTTAGCAGTCATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCTGG
NO:




TGCATCGAAATGTAATCACCCTTTCTTTTGTAAAAGAGACCCATCTTCTATCTTCCTTTCCCA
2381




CCTTTTCTCTGTTTTTATGAAAACCCAACTGTTGGACATTCCAAACCATTGGATTTGA





TPK1
ADXCRAD_CD511474_s_at
ATTGACACTTAGCAGTCATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCT
SEQ ID





NO:




GGTGCATCGAAATGTA
2382





TPK1
ADXCRAD_CD511474_x_at
CATCCCAGTCTGATATTCACCTAAGTTTCCGGACCCTTTTCCTTAGCTGTAAAATGGAAGCGG
SEQ ID




TTGGACTGATGGTGTCTGAGGTTCTTTCCCACACTGAAATTCTAAATATTGACACTTAGCAGT
NO:




CATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCTGGTGCATCGAAATGTA
2383




ATCACCCTTTCTTTTGTAAAAGAGACCCATCTTCTATCTTCCTTTCCCACCTTTTCTCTGTTT




TTATGAAAACCCAACTGTTGGACATTCCAAACCATTGGATTTG





TPK1
ADXCRAD_CR745173_s_at
TGGCCCGCGTGATTGTGGCATTTAAGGAGCAGTGGCCCATGTGACTGTGGCATTTTCGGCACT
SEQ ID




TTTCATTACTTTCTGCTTGACCGGAAGTTGAGGCTTAGCTATGTTTCCATCTTCAGTTTCTGA
NO:




AGACTAGTTATATATTCCTTACTAGAAATATATTCATAATATATAAAAGAAATATATCTGTGA
2592




TTTTAAAATTTTGCTACCAAAGAATGCATGTTCTGTGTGCCCTGAAAATGTTAC





TPT1
ADXCRAD_NM_017627_s_at
GGGACTGATGTCATCTTGAGCTCTTCATTTATTTTGACTGTGATTTATTTGGAGTGGAGGCAT
SEQ ID




TGTTTTTA
NO:





1167





TPT1
ADXCRIH.18.CB1_x_at
ACTCATCAATTAACTTCTACAGTGGAGACTACTTCTGGGACTGGAATATAAAAAAGAATCAAA
SEQ ID




GGTTCTGATTTTGAGTTGCAATAAAGGGAAAGACCATGCTCATAGCAGTGCCAACATCTGAAG
NO:




TGTGGAGCCTTACCCATTTCATCACCTACAACGGAAGTAGTTAACTGGAAGAGATTACCAAGA
1168




GAATAAAAAGAGACTCATTCAGTGGAACCAACCTCGTGCAGCCCGGG





TPT1
ADXCRPD.14624.C1_at
CCAGCTGGAGTTTTTGGGACGCTTTTGTGGGGGCACCGCTGAGTCCGGATAGTGGGACCCAAG
SEQ ID




TCGTCCTGCTCGGCCCCTGGGGAATAATCGTGTGGGGCGCAAGGTCTGTGGGAAGGGACTTGG
NO:




AGAGGAGGGAAGATGTCGCGGGAGTCTGCACAGGGTTTCCATGTGTTCCAATTCTTCGTCCCA
1733




TAATTCAAAGCTCGTGGCATTCTGTGGCCGACCGCTACCGAGCTAGCTCTTCCCTTTACTATT




TCGCACTTGGTCTTGGAAAAGAT





TPT1
ADXCRPDRC.14624.C1_at
TTATGGGACGAAGAATTGGAACACATGGAAACCCTGTGCAGACTCCCGCGACATCTTCCCTCC
SEQ ID




TCTCCAAGTCCCTTCCCACAGACCTTGCGCCCCACACGATTATTCCCCAGGGGCCGAGCAGGA
NO:




CGACTTGGGTCCCACTATCCGGACTCAGCGGTGCCCCCACAAAAGCGTCCCAAAAACTCCAGC
2009




TGGGGCAGCCCTGGGGCCGATGCTGAAAAGTTGTCAGAGGCCCTCGGGCAGTCCCGAGATCTA




CCCCAGGCCAGAGGGCCTGACCCTCCCTAAATGCGACGTTCT





TPT1
ADXCRSS.Hs#S2979085_at
GGGTGCAGCACAAGTTCCTTCATAGGACTTTAAGACTCTTTGGGATCTAGTCCCTGCGTATCT
SEQ ID




CTCCAGTTCTCCTTACCATTCTCCTGTATCTGCCTCTGGCTGCAGCTGTGCCACAGCCAGACT
NO:




CTGGAAGGAGCCTCTTGCTGTCAATTATCCAACAAGTGTTTACTGGGTACCCACTTCTGCCAG
2143




GCACTGGGTTAGAGGTTGGAGACATAGCAGTAAAGACTTGCTCTAGTGGAAGACAA





TPT1
ADXCRSS.Hs#S3017795_at
ACTACTCCAGATTTTTCACCTGCAAGTGGTAAGTCAGGCCAACTTCCGTTGGTGACCCGTTAT
SEQ ID




CTCTGCTTGAAAAAAGATAAGGAGATTCTCCACTTTGGCCTCAGCTCTTAGCTAGGTTCTTTA
NO:




GTCCAGCTAGGAGTTACTGAGCCTCCACCAAGAAGGTGAATCATTTGACCTCATTTAGCTCCT
2175




CCTCCTTATTTATCTTTATTAGAGCTTGCAGTGATGGAGAGTAAGTGATTGGGACCTCAAACT




TCTAACACATAATTCTCTCAGGCGGGTTTGGAATGGTACTCTA





TSPAN8
ADXCRIH.257.C1_at
CTATGGTCCTGTATTGCCAGATCGGGAACAAATGAATCTGTGGATGCATCAACCTATCGTCAG
SEQ ID




TCAAACCCCTTTAAAATGTTGCTTTGGCTTTGTAAATTTAAATATGTAAGTGCTATATAAGTC
NO:




AGGAGCAGCTGTCTTTTTAAAATGTCTCGGCTAGCTAGACCACAGATATCTTCTAGACATATT
1298




GAACACATTTAAGATTTGAGGGATATA





TSPAN8
RDCR023_G12_at
AGTTGAGAGGCAGATACATTAAAAACCACTATAAATCACAATGAATTAATATTAATATCTATA
SEQ ID




ATACCCGAAGATTCTTTTCAATCTAGAAATGTTTTGGTTTAGTAACTGCTACTGAAAATAATT
NO:




TATAAAAGGAAATAGAAAGTATCTCAGGGGAAACTACCCTTTCCTTGACTACTGATCTTTTTC
1342




ACTGATCTTATCAAAATTAAAGAGGCTCTGCCCTGAAGGGGAATTGCTGTCATTAATACTTAA




AGTATGTCGCTAAGATTTAAAGTAACTCAA





TSPAN8
RDCR023_G12_x_at
GAGGCAGATACATTAAAAACCACTATAAATCACAATGAATTAATATTAATATCTATAATACCC
SEQ ID




GAAGATTCTTTTCAATCTAGAAATGTTTTGGTTTAGTAACTGCTACTGAAAATAATTTATAAA
NO:




AGGAAATAGAAAGTATCTCAGGGGAAACTACCCTTTCCTTGACTACTGATCTTTTTCACTGAT
1343




CTTATCAAAATTAAAGAGGCTCTGCCCTGAAGGGGAATTGCTGTCATTAATACTTAAAGTATG




TCGCTAAGATTTAAAGTAACTCAA





TSPAN8
1_RDCR049_C08_at
TTTTTATTCCTCTTGGAAATGCCTAAAACTACAGCAAGAGAAATTCTAGACTTCTGGATTTTT
SEQ ID




ATGCAGATGATTTAAACCAGATGATCATAACCTTTTTATGGAAGCAGTACGTATATTTAGCCC
NO:




CCAGGGACCTGAGATCCCCAGTGCTCCAGAGGAGACGCTCTGCAGAAGAATGTGTGTGTTCCA
1355




GAAAAGGGAGTAGGTCCTCTGGTGGCAGCTGCTACTGTGCAGTTTATATGGGGCCAGTTAGAT




AGAGGCTGATTGGCC





TUFM
ADXCRIH.1094.C1_s_at
TAGAGAAAGGCCAGCGTTTCACCCTGCGAGATGGCAACCGGACTATTGGCACCGGTCTAGTCA
SEQ ID




CCAACACGCTGGCCATGACTGAGGAGGAGAAGAATATCAAATGGGGTTGAGTGTGCAGATCTC
NO:




TGCTCAGCTTCCCTTGCGTTTAAGGCCTGCCCTAGCCAGGGCTCCCTCCTGCTTCCAGTACCC
1146




TCTCATGGCATAGGCTGCAACCCAGCAGAGGGCAGCTAGATGGACATTTCCCCTGCTCGGAAG




GG





TXN
ADXCRIH.324.C1_s_at
AGTCAAATGCATGCCAACATTCCAGTTTTTTAAGAAGGGACAAAAGGTGGGTGAATTTTCTGG
SEQ ID




AGCCAATAAGGAAAAGCTTGAAGCCACCATTAATGAATTAGTCTA
NO:





1124





TXN
ADXCRPD.10055.C1_at
TTTTTCCTGTCTTACCTGGATCTTGCAATAAAGGATGCCTGGTTTAATTTTCTTGAAAATCAC
SEQ ID




ATTAGGGAAGGCTTTGAATGAAATTGATCTGGAACAATAAGTGATGATTTGGAAAAACAATTG
NO:




CTATACTTCTATGTAACCTGCTGCAGCTCTCCCCATGTCTCCACCTCTAGAGGTGGGGTTCAG
1842




GGATTTGCATAACTAAAAAATTTATGAAAGTGTTGTCCTACCTTTCTCAGGAACACCATTTGT




GAATTATTTTCCCAAATATCGAGGGAGGTGATCTTCT





UCK2
ADXCRPD.10643.C1_at
AAGATTAGATTCCTGCCTCGGGCCAGGTGAAAGGAAGGCAGGAAAGAGATTCTGTTTCCTGAC
SEQ ID




CCAACATTATCACAAAAGACTGTAACAAGGGCTGTGGGAGTTATGGACCAGGAACCTGGTTGA
NO:




AAACCATTATAAATCATAACACCACAAGGACCTATATTTTGCTTTTTAGGACATTGTAGTAGG
1461




TGGGTAGTTTTCATCCTCTTGCTTTTTAAAATCTATCTTGCCCAGAAGTTTATTGGGCATTTC




TATGGAAACACAACACCTCTCTTAAAT





UCK2
ADXCRPD.9879.C1_s_at

SEQ ID




GCAGGCCGCATTGACCCGTCTCCATCGGACCCCAGCCCCTATCTCCAAGAGACAGAGGAGGGG
NO:




TCAGGAGGCACTGCTCATCTGTACATACTGTTTCCTATGACATTACTGTATTTAAGAAAACAC
1541




CATGGAGATGAAATGCCTTTGANNNNNNNNNNNNNNNNGTACTTTGGAACGACAAAATGAAAC




A





UCK2
ADXCRPD.5097.C1_s_at
ACTGGCATTCCAGGTCAGCTTGGCTGTGGTCTTAGAGGCAGGGAGTGCCTACCCAGTCCTGCC
SEQ ID




TCAGGAGCAGGGTGAGTAGCTAAATACAGACTTAGGCTTTTTTTCCCCCCTTTTAAGATGCTT
NO:




GCTCCTCTCCCTTTTCTTTTTACCACCCTACCTTTATTGTTAGTGGTTACAAAGTGACCACAT
1651




ATTATGTACTTTGCTGTAA





UCK2
ADXCRPD.14415.C1_s_at
TAGCGGCAAGTCTTCCGTGTGTGCTAAGATCGTGCAGCTCCTGGGGCAGAATGAGGTGGACTA
SEQ ID




TCGCCAGAAGCAGGTGGTCATCCTGAGCCAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCA
NO:




GAAGGCCAAAGCCCGGAAGGGCCAGTTCAACTTTGACCACCCGGATGCCTTTGACAATGAACT
1702




CATTCTCAAAACAC





UCK2
ADXCRPD.15116.C1_at
CCCCTCTGCCAGACAGTGGGTTGAACACACATGTACACCTGAGGAGGAGGGTCTGACGAGGGC
SEQ ID




TGCCTCAGAGTCAGAGGCAGCAGGACTAGCTCTGTATGTTCGACCTCATGTCTGGCCCATCTT
NO:




GAGTCCCAGGCTCATACAAAATCACCTGTGTTCAGATACAGATTCAACTCAGTATTTAATGAG
1715




CCAAGCACTACTTGAAGCATCTTGACAGTCCTTCTCTTCACATAAGCCCCGACAATCACATCT




GCAAGGTACGTATCAAGTCCCTACGTTCCGAGACA





UCK2
ADXCRPD.14599.C1_at
TTAAACTCCACCAAGACCCAGCAAGAAGAGCCTCATGGCAGGCTAGGACTGAGTTCTTCCCAG
SEQ ID




AAGACAGGTCTAAAACACAAGCTTTTCCACCTTAACAATGGATGTCTCCTGACCCCTTCCTCC
NO:




AGAAATCAAATGGCCAATCTGATGCCCACTTCAGCTTCTGTCATCCCTCTGTAGTCAGACAAG
1728




GAGGGCTCGCTCAGCTTGCATTTCCTTCCTGAAGAGTATTCACTACCTCTCTTGTTCAAACAC




TATGTATCACTCAAT





UCK2
ADXCRPDRC.5097.C1_at
GCAAAGTACATAATATGTGGTCACTTTGTAACCACTAACAATAAAGGTAGGGTGGTAAAAAGA
SEQ ID




AAAGGGAGAGGAGCAAGCATCTTAAAAGGGGGGAAAAAAAGCCTAAGTCTGTATTTAGCTACT
NO:




CACCCTGCTCCTGAGGCAGGACTGGGTAGGCACTCCCTGCCTCTAAGACCACAGCCAAGCTGA
1983




CCTGGAATGCCAGTCCCCGGTATGAGGAAGGCAGC





UCK2
ADXCRPDRC.5097.C1_x_at
GCCTTTTTGTCTGTCTTTATTTACAGCAAAGTACATAATATGTGGTCACTTTGTAACCACTAA
SEQ ID




CAATAAAGGTAGGGTGGTAAAAAGAAAAGGGAGAGGAGCAAGCATCTTAAAAGGGGGGAAAAA
NO:




AAGCCTAAGTCTGTATTTAGCTACTCACCCTGCTCCTGAGGCAGGACTGGGTAGGCACTCCCT
1984




GCCTCTAAGACCACAGCCAAGCTGACCTGGAATGCCAGTCCCCGGTATGAGGAAGGCAGCAGA




ACGCCCAGAGACA





USH1C
ADXCRIH.2211.C1_s_at

SEQ ID




ACCAGGGCCAGATAAGGAACAGCTCGGGCCACTCTTCTGAAGGCCAACGTGGAGGAAAGGGAG
NO:




CAGCCAGCCATTTGGGAGAAGATCTCAAGGATCCAGACTCTCATTCCTTTCCTCTGGCCCAGT
1242




GAATTTGGTCTCTCCCAGCTCTGGGGGACTCCTTCCTTGAACCCTAATAAGACCCCACTGGAG




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAATTGCTGCCAGGATTGTCACTCCA





USH1C
ADXCRPD.18376.C1_s_at
GTCCATCAAAGTGAGACACATCGGCCTGATCCCCGTGAAAAGCTCTCCTGATGAGCCCCTCAC
SEQ ID




TTGGCAGTATGTGGATCAGTTCGTGTCGGAATCTGGGGGCGTGCGAGGCAGCCTGGGCTCCCC
NO:




TGGAACATCGGGAAACCAAGGAGAAGAAGGTCTTCATCAGCCTGGTAGGCTCCCGAGGCCTTG
1421





USH1C
ADXCRAD_NM_025034_at
ACATGCACACATAGGATTTTACTTGAAAAAAATAATAAAGGAGACAGATATGTCAAATCTTTT
SEQ ID




TCAGGCACTAATAACATGTAAATGTAAAAGAACTAGAATCTTCTCCACATACCACCTCCCATC
NO:




AGAAATCATGTCCTTGAAAGTGCTGTTGATAAAGAAATAGGGTTGCCTTTCCCCTATTCCTTA
2848




ATCTAATTATTCCAGAAACAGCTGTCATTTTGGTTTTCATT





WDR59
ADXCRPD.15558.C1_s_at
CAGTGTTACCCTGTAAGGTGTTAGCCTTAAACCACCGAGCAGCGTTCTCTTGATGCCAGTGCA
SEQ ID




GAGACCAGAGTCAGATGCCCGAGGACAGTGGGTAGGAATTTCATCAACAAATGGACCTATGGC
NO:




ATCATGGCTTTAGAAGCTGGTACATTTACTGAGCTGATGGACAGTGGCCTTCTAAAATATGAC
1764




ACTTAAATTGTAAATATGCACTGTACTTAAGGATTCTTAAGATGTATTTTTTTGTTATTTCTC




CTCCAGCTGCTATCCCTTGGCTAATAAA





WDR59
ADXCRAD_AA393120_at
CCCCTAGAAATCTCCTGGAAGAGAGGAAATCAGATCAACTGGGGCTGCCTCAGACCTTGCAGC
SEQ ID




AGGAATTCTCCCTGATCAATGTGCAAATCCGGAATGTCAATGTGGAGATGGATGCGGCAGACA
NO:




GGAGCTGCACAGTGTCTGTGCACTGCAGCAACCATCGTGTCAAGATGCTGGTGAAGTTCCCTG
2596




CACAGT





ZFP36
ADXCRIH.2153.C1_s_at
GGGAATCCTGGTGCTCAAATTACCCTCCAAAAGCAAGTAGCCAAAGCCGTTGCCAAACCCCAC
SEQ ID




CCATAAATCAATGGGCCCTTTATTTATGACGACTTTATTTATTCTAATATGATTTTATAGTAT
NO:




TTATATATATTGGGTCGTCTGCTTCCCTTGTA
1194
















TABLE 8







Genes and corresponding Almac probesets predicting resistance to 5-FU. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





ACTN1
ADXCRAD_BM714793_at
AAGAGAATTTATGTGGCTTCTCATTTTTAAATCCCCTCAGAGGTGTGACTAGTCTCTTTATC
SEQ ID




AGCACACACTTAAAAAATTTTTAATATTGTCTATTAAAAATAGGACAAACTTGGAGAGTATG
NO:




GACAACTTTGATATTGCTTGGCACAGATGGTATTAAAAAA
2737





ACTN1
ADXCRAD_CX871590_s_at
TCTCCTGCCTGGGTTCGGTTTCAGCTCCCAGCCTCCACCCGGGTGAGCTGGGGCCCACGTGG
SEQ ID




CATCGATCCTCCCTGCCCGCGAAGTGACAGTTTACAAAATT
NO:





2469





ACTN1
ADXCRAD_M95178_at
GACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAAATTGCGCTGAATCG
SEQ ID




TATGCTTTTTCC
NO:





2816





ACTN1
ADXCRAD_M95178_x_at
GTGCGCCGTGCCCACAGATGTGAAATGAATGTAATCTAATAGAAGCCTAATCAGCCCACCAT
SEQ ID




GTTCTCCACTGAAAAATCCTCTTTCTTTGGGGTTTTTCTTTCTTTCTTTTTTGATTTTGCAC
NO:




TGGACGGTGACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAAATTGCG
2817




CTGAATCGTATGCTTTTTCCTTTTGA





ACTN1
ADXCRAG_BC011987_s_at
GGAAAGATTAACTATTTGCACCGAAATGTCTTGTTTTGTTGCGACATAGGAAAATAACCAAG
SEQ ID




CACAAAGTTATATTCCATCCTTTTTACTGATTTTTTTTTCTTCTATCTGTTCCATCTGCTGT
NO:




ATTCATTTCTCCAATCTCATGTCCATTTTGGTGTGGGAGTCGGGGTAGGGGGTACTCTTGTC
934




AAAAGGCACATTGGTGCATGTGTGTTTGCTAGCTCACTTGTCCATGAAAATATTT





ACTN1
ADXCRSS.Hs#S3748482_at
GGCACAGAGGAAACCCGCTGAGCCTGCTTCCTTAGTTCTGGCAGATGGGTCAGCCCCCACAG
SEQ ID




GACTCAGGATTCAATTTAGCCCGGGGTTCTGGCTCCATCTCCCACAGTGCCGGTGCCAGTGT
NO:




GCTCCTAAGTACTGTTTGTGCAAACCTGGCTCTGACTGAGACAAGGAGCCTTAGGAGTAGTA
2203




GGGACAGGAGACACAGCAAACTAGGGCTCAGA





ATM
ADXCRAD_BU501514_s_at
ATACAGCAGGCCATAGACCCCAAAAATCTCAGCCGACTTTTCCCAGGATGGAAAGCTTGGGT
SEQ ID




GTGATCTTCAGTATATGAA
NO:





2467





ATM
ADXCRAD_N29457_at
GCCAGTTCTCCGCAGTGAAATGCTAGGAAAATGTCTTTAGAAGACAGAATTCTTTCTGAATG
SEQ ID




CAAGTCTAAAATGCTTAAAAGAGATTAAAGGTTTTAAAGACCCAAATCAGAAATATCCATTA
NO:




GATACATCTCATTTGAATCCTAAGAGTTTAAACATAATAAACGCTGTATTTATTTATTTTAT
2812




TTCTTTTTTATTTTTTTGAGGCAGAGTCTCACTTTGTTGCCCAGGCTGGAGTGCAGTGGTGC




AGTCTTGGCTCACTGCAGCCTGTCTTCTGGGTTAAAACGATTCTC





ATM
ADXCRAG_U67093_s_at
TTGGTCATTATAGTATATGCCTAAAATGTATGCACTTAGGAATGCTAAAAATTTAAATATGG
SEQ ID




TCTAAAGCAAATAAAAGCAAAGAGGAAAAACTTTGGACATCGTAAAGACTAGAATAGTCTTT
NO:




TAAAAAGAAAGCCAGTATATTGGTTTGAAATATAGAGATGTGTCCCAATTTCAAGTATTTTA
1071




ATTGCACCTTAATGAAATTATCTATTTTCTATAGATTTTAGTACTATTGAATGTATTACTTT




ACTGTTACCTGAATTTATTAT





ATM
ADXCRPD.14974.C1_at
ATTTGTTAATCCTCCGCAGCTGGGATGAACATTTTCCTAAGGATGGAGAAGAGATAATACTC
SEQ ID




ACTAATACACGAGTCAGTAGTTTTACTTTCAGGTGGCTTTTAATCTGATGTTTATCTAATAT
NO:




GATGACAGCTGGGGGACAGAGAAATGTTCCACTTCTACCTATGTATCAAACTAGATACCTAA
1768




GCCCTTCC





ATM
ADXCRPD.3071.C1_s_at
ATTTGGGACTCTGCCATATTCTTTCCGTCTATTTAAAAGGATTGGATTATGAAAATAAAGAC
SEQ ID




TGGTGTCCTGAACTAGAAGAACTTCATTACCAAGCAGCATGGAGGAATATGCAGTGGGACCA
NO:




TTGCACTTCCGTCAGCAAAGAAGTAGAAGGAACCAGTTACCATGAATCATTGTACAATGCTC
1493




TACAAT





ATM
ADXCRPDRC.14974.C1_s_at
AACTACTGACTCGTGTATTAGTGAGTATTATCTCTTCTCCATCCTTAGGAAAATGTTCATCC
SEQ ID




CAGCTGCGGAGGATTAACAAATGGGTGATTGAGCTTTCTCCTCGTATTTGGACCTTGAAGGT
NO:




TATATAAATTTTTTTCTTATGAAGAGTTGGCATTTCTTTTTATTGCCAATGGCAGGCACTCA
2017




TTCATATATGATCTCCTCACCTTCCCCTCCCCTAAAACCAATCTCCAGAACTTTTTGGACTA




TAAAT





ATM
ADXCRSS.Hs#S11049845_at
CCTTGTTTGCCTTGGTATCATTCAGCGGAGGCTGCAGAACAGCAAAGATTGCTATCTGTTCC
SEQ ID




TTCCTCTGGAAGCTTCGTCCCAGAGGGGAATGCGCCAGATGCCTGCTGGAGCTCTCCTGTAT
NO:




GTGGTGTCTGTCGACCCCTGCTGGGAGGTGTCTCCCAGTCAGGAGGCACGGGGGTCAGGGAT
2084




CCACTTGAGGAGGCAGTCTGTCCCTTAGTAGAGCTTGAGCGCTGTGTTGGGAGATCCAA





ATM
ADXCRSS.Hs#S11049845_x_at
CCTTGTTTGCCTTGGTATCATTCAGCGGAGGCTGCAGAACAGCAAAGATTGCTATCTGTTCC
SEQ ID




TTCCTCTGGAAGCTTCGTCCCAGAGGGGAATGCGCCAGATGCCTGCTGGAGCTCTCCTGTAT
NO:




GTGGTGTCTGTCGACCCCTGCTGGGAGGTGTCTCCCAGTCAGGAGGCACGGGGGTCAGGGAT
2085




CCACTTGAGGAGGCAGTCTGTCCCTTAGTAGAGCTTGAGCGCTGTGTTGGGAGATCCAAGGA




GCTGGCAGGCAGGAACGTTTAAGTCTGTTGAGGCTGCACCC





ATP2B4
ADXCRAD_BQ223439_s_at
CCCCATTCAGGTCATGGTAGAATCTACTCCTTGGTAGTCACTTGTCATTTTTANAGAAATGA
SEQ ID




TGACAATCCTCTTGGCATCACCCCACCCCACATTCTCCCCGATGGTCCTCTCCTGAATTCTG
NO:




GATTTTGTCCTACAAGTCTGTGCCATTTATAA
2627





ATP2B4
ADXCRAD_CN299966_at
ACAAATGGTGATATCAAAGCAACGTATACCCCAGTCCAGTGTGTGTTGCCATAATTTGCAAT
SEQ ID




TCAGCTTAACAGTGCACCCAATCTATATTTGCATTTTG
NO:





2523





ATP2B4
ADXCRPD.10094.C1_at
AGCCATCTTTATACTTAGGGAAGAAAAATTGTTGGGTTCTAGACTTTTTTAATATAAATTTT
SEQ ID




GTTGATATGGAATTAGGTAAGTTTAAGTGTCTATGTGCATATGTTTTTATATAAGTTTTTTC
NO:




TATTCAGTTTCACTGATCCAACTGGCAGTGGGTAAATATGGCATAAGTTAATAACACTTTTC
1845




CCCAAAATGGTGCTTTGGATTTGAAAAGGGTCTGATGGGGAGAAGGAGAACGTATCATCCTA




GCTTCCTCTCTTATAAACCTAGAAAAACGGGTAGTAAACTGTGGATAGTCA





ATP2B4
ADXCRPD.11491.C1_at
TTCATTTTTCTTCCCCTCTGCTAGTTTGGAAGTTATATTATACCAAGTTTTTTAGTATTAGC
SEQ ID




CTAGAAATCTTAACATAAAGACTTCTAATAAGCAATATCTTTAATTTTTTTTNCCTACCCAA
NO:




TACTAGATCATGAGCATTTTCCCACATCATAAAGAATTGGTCACAAGTCAGCCCCAAACATA
1498




GTCCAGTGGAATCCAATGATA





ATP2B4
ADXCRPD.5728.C2_at
ATGGGAGCTCATCTCCTTCCATCTCTCCTAATCAAGAGCAAAGGGAACAGCAGGCCTAACAG
SEQ ID




CAGGGTTGGGAAGGCAAA
NO:





2284





ATP2B4
ADXCRPD.5728.C2_x_at
CAATAGTCAATCTTTGGTTTTTCTTTTTGGTACAAAAATACCAGTGCTTGTTATACTAGTTA
SEQ ID




CTAAAAGAAGAAGAAACTCAAAATTCCTATCTGCGTGCTAATTTGAAAAGAACAACGTAGAT
NO:




AGATTTGTTGGCACATATATATGGCATATTCACATATGGCATATATACATATGGGGAGAAAA
2285




CATGAACCAAAGGCCAATTCAGTTATGGGAGCTCATCTCCTTCCATCTCTCCTAATCAAGAG




CAAAGGGAACAGCAGGCCTAACAGCAGGGTTGGGAAGGCAAA





ATP2B4
ADXCRPDRC.5728.C1_s_at
TGGAAGGAGATGAGCTCCCATAACTGAATTGGCCTTTGGTTCATGTTTTCTCCCCATATGTA
SEQ ID




TATATGCCATATGTGAATATGCCATATATATGTGCCCACAAATCTATCTACGTTGTTCTTTT
NO:




CAAATTAGCACGCAGATAGGAATTTTGAGTTTCTTCTTCTTTTAGTAACTAGTATAACAAGC
2056




ACTGGTATTTT





AXL
ADXCRAD_NM_021913_s_at
GTTCTAACCCTATACTGTAGTATTCTTTGGGGTGCCCCTCTCCTTCTTAGCTATCATTGCTT
SEQ ID




CCTCCTCCCCAACTGTGGGGGTGTGCCCCCTTCAAGCCTGTGCAATGCATTAGGGATGCCTC
NO:




CTTTCCCGCAGGGGATGGACGATCTCCCACCTTTCGGGCCATGTTGCCCCCGTGAGCCAATC
1586




CCTCACCTTCTGAGTACAGAGTGTGGACTCTGGTGCCTCCAGAGGGGCTCAGGTCACATAAA




ACTT





C19orf10
ADXCRIH.3832.C1_s_at
AGAGAACAGAGGGTCCAGGGCCCTCCTGGCTCCCAACAGCTTCTCAGTTCCCACTTCCTGCT
SEQ ID




GAGCTCTTCTGGACTCATGATCGCAGATCCGGGGCACAAAGAGGGTGGGGAACATGGGGGCT
NO:




ATGCTGGGGAAAGCAGCCATGCTCCCCCGACCTCCAGCCGAGCATCCTTCATGAGCCTGCAG
1178




AACTGCTTTCCTATGTTTACCCAGGG





CALU
ADXCRAD_BP380290_s_at
GAATGCTGATGGTTTCATTGATCTAGAAGAGTATATTGGTGACATGTACAGCCATGATGGGA
SEQ ID




ATACTGATGAGCCAGAATGGGTAAAGACAGAGCGAGAGCAGTTTGTTGAGTTTCGGGATAAG
NO:




AACCGTGATGGGAAGATGGACAAGGAAGAGACCAAAGACTGGATCCTTCCCTCAGACTATGA
2344




TCATGCAGAGGCAGAAGCCAGGCACCTGGTCTATGAATCAGACCAAAACAAGGATGGCAAGC




TTACCAAGGAGGAGATCGTTGACAAGTATGACTTAT





CALU
ADXCRAD_CN403921_s_at
GATAATTTAATAATGCCACCAACTCTGGCTTAGTTAAGTGAGAGTGTGAACTGTGTGGCAAG
SEQ ID




AGAGCCTCACACCTCACTAGGTGCAGAGAGCCCAGGCCTTATGTTAAAATCATGCACTTGAA
NO:




AAGCAAACCTTAATCTGCAAAGACAGCAGCAAGCATTATACGGTCATCTTGAATGATCCCTT
1564




TGAAATTTTTTTTTTGTTTGTTTGTTTAAATCAAGCCTGAGGCTGGTGAACAGTAGCTACAC




ACCCATATTGTGTGTTCTGTGAATGCTAGCTCTCTTGAATTTGGATATT





CALU
ADXCRAD_CX788634_s_at
ATGTCATTGAAAGTGCCTTTAACGAAAGAAATGGTCACTGAATGGGAATTCTCTTAAGAAAC
SEQ ID




CCTGAGATTAAAAAAAGACTATTTGGATAACTTATAGGAAAGCCTAGAACCTCCCAGTAGAG
NO:




TGGGGATTTTTTTCTTCTTCCCTTTCTCTTTTGGACAATAGTTAAATTAGCAGTATTAGTTA
1218




TGAGTTTGGTTGCAGTGTTCTTATCTTGTGGGCTGATTTCCAAAACCACATGCTGCTGAATT




TACCAGGGATCCTCATACCTCACAATGCAAACCACTTACTACCAG





CALU
ADXCRPD.558.C1_at
GTAAACCAAGTTTTATATTCTGCAATGCGAACAGGTACCTATCTGTTTCTAAATA
SEQ ID





NO:





1563





CAPN2
ADXCRAD_AK023851_s_at
AGAATGGCAGTTGTCAGTCCTGTCCGTGTAACAGAGGAGTGAAGTGGTGAGGAGGGCAGGTC
SEQ ID




TAAGGCACTGGCAGCTCTTTTCCATGGATTTTGAACTCTGGAGGAAGGCAGCAACTAAATAA
NO:




CTGTCTCATTCTGCTATTATGCATTGTATTAGCAAAGTGAAAATATAGTCTATCTGGTTACA
2826




AATAACACTAACTTGCTTAAAACTTTACATATCCTAGGAAATATCTCTACCCCTAGATTGCA




ATGTAGAGTCAACCCCATCT





CAPN2
ADXCRIH.1382.C1_at
GTATCTGGACCTCAAAATTATGGGAACATTTACTTAAACGGATGATCATAGCTGAAAATAAT
SEQ ID




GATACTGTCAATTTGAGATAGCAGACGTTTCACACATCAAGTAAAAGATTTGCATATCATTA
NO:




TACTAAATGCAAATGAGTCGCTTAACCCTTGACCAGGTCAAAGAAAAGCTTT
2233





CAPN2
ADXCRIH.1382.C2_s_at
TGGCTCTGTTTCTCAGTACTTTGAAGTTATAACTAATCTGCCTGAAGACTTCTCATGATGGA
SEQ ID




AAATCAGCCAAGGACTAAGCTTCCATAGAAATACACTTTGT
NO:





2234





CAPN2
ADXCRPD.2526.C1_at
GGCACGAGAATGTACTCTCCTGGCGGCAGCTTGAAGCGGTTGAGCACCTCCCGGAGGTTGAT
SEQ ID




GAAGGTGTCTGAGCGCTCCCTGGCGCGATTCGTCAGGAAGAAGTTTTTGCTGAGGTGGATGT
NO:




TGGTCTGCCCACTTAACTCCTCTGGAACCTCATAGATGCCAAAGCCGATGGTGTGCATGTCC
1521




TCGCCCATCTTCCTCTGCCGCCGTCGGTGCTTCTGAATGAG





CAPN2
ADXCRPD.6630.C1_s_at
TGCGCTTGATCAACTGAACCAGTATGCCAAAACCAGGCATCCAATTTGTAAACCAATTATGA
SEQ ID




TAAAGGACAAAATAAGCTGTTTGCCACCTCAAAACTTTATGAACTTCACCACCACTAGTGTC
NO:




TGTCCATGGAGTTAGAGGGGACATCACTTAGAAGTTCTTATAGAAAGGACACAAGTTTGTTT
1900




CCTGGCTTTACCTTGGGAAAATGCTAGCAACATTATAGAAATTTTGCCTTGTTGCCTTATCT




TCTTCCAAATGTACTGTTAA





CAPN2
ADXCRPD.9976.C1_at
TCGGCTCCGGTGACCGAGTACGCGTGCCCCTTCACCAGCTTCTGAAACGTGAATGGCCTCCG
SEQ ID




AGTCCCCGGCGCTGGTGATGTCGATGGAGCAGCCAAGGAGAGAGCCTTTTTGCAGAGCTTTC
NO:




TGGATGATCTTGAACAGGTTGGGAGGGGGCTTCTTCAACTCATACCACTCAGCAATGCTCCG
1552




GTGAAGTCTTCGAAGCCCTCAGTGGTGGCACCCCCTGATAGTGCTTCATAGCATCCGTTGAT




CTTGCGTATGCCTTC





CAPN2
ADXCRPDRC.9976.C1_at
ACGCGTACTCGGTCACCGGAGCCGAGGAGGTTGAAAGTAACGGAAGCCTACAGAAACTGATC
SEQ ID




CGCATCCGAAATCCCTGGGGAGAAGTGGAGTGGACAGGGCGGTGGAATGACAACTGCCCAAG
NO:




CTGGAACACTATAGACCCAGAGGAGAGGGAAAGGCTGACCAGACGGCATGAAGATGGAGAAT
1965




TCTGGATGTCTTTCAGTGACTTCCTGAGGCACTATTCCCGCCTGGAGATCTGTAACCTGCCG




AAGACCCAGCTTGAG





CAPN2
ADXCRSS.Hs#S2984172_at
GAGCCACCACGGGTAGCAAAGTGAACTTCCCCCGAATCACGGTTAAGCCCCCTGGGCCACAT
SEQ ID




GGAGCTGTCATCTGCAGTTTTTCCCACCTCGGAGGCCTGACCCTGTGCTCTCCATAATCAAT
NO:




GAGTAGATGTGGCCCTTTATGTTCCCTGAGGCTTCCCTGACTGCTCATTAAAAGGATCTGCT
2154




CAGTCCTAGTGAATTGATTTACTTTGCCACAGTCCTTGAAGGATGCTACAGATCAAAAGGTG




TCCAGGAAAGTGATCTTAAAGATGCTGACACTACTCCCAGTT





CAV1
ADXCRIH.1095.C2_at
TTTATTCCTCCTGCTCATATTGTGATTCTGCCTTTGGGGACTTTTCTTAAACCTTCAGTTAT
SEQ ID




GANNNNNNNNNCATACACTTATTGGAACTCTGCTTGATTTTTGCCTCTTCCAGTCTTCCTGA
NO:




CACTTTAATTACCAACCTGTTACCTACTTTGACTTTTTGCATTTAAAACAGACACTGGCATG
1272




GATATAGTTTTACTTTTAAACTGTGTACATAACTGAAAATGTGCTATACTGCATACTTTTTA




A





CAV1
ADXCRPD.1261.C1_s_at
TCAAGTTCCAAGTTGCTAATACAGCAACAATTTATGAATTGAATTATCTTGGTTGAAAATAA
SEQ ID




AAAGATCACTTTCTCAGTTTTCATAAGTATTATGTCTCTTCTGAGCTATTTCATCTANNNNN
NO:




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTTTGCATGTGGA
1881




TCAACCATCGCTTTATT





CCND1
ADXCRAD_BM551840_x_at
TGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACAAGTCCTGGATGTTGTGTGTATCG
SEQ ID




AGAGGCCAAAGGCTGGTGGCAAGTGCACGGNGCACAGCGGAGTCTGTCCTGTGACGCGCAAG
NO:




TCTGAGGGTCTGGGCGGCGGGCGGCTGGGTCTGTGCATTTCTGGTTGCACCGCGGCGCTTCC
1593




CAGCACCAACATGTAACCGGCATG





CCND1
ADXCRAD_BQ436873_at
AAAAATAGTATTTGCATAACCCTGAACGGTGGGGGAAGAGGGGTGTGCTACANATGATAGAG
SEQ ID




GGATTTTATACCCCAATTATCAACTCCGTTTTTATATTAATG
NO:





2640





CCND1
ADXCRPD.13939.C1_at
TTCACATTGTTTGCTGCTATGTGGAGGATCAGTGTTTTGTGTTACAATGTCATATACTGCCA
SEQ ID




TGTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCNNNNNNNNNNNNNNNNN
NO:




NNNNNNNATGTGATCAATTTTGACTTAATGTGATTACTGCTCTATTCCAAAAAGGTTGCTGT
1727




TTCACAATACCTCATGCTTC





CCND1
ADXCRPD.15960.C1_at
TGCCCGACAAACCTCCACTGGATGGTTTGTCACTGGATGGTTTGTTGGGGTGGTGGTCACAG
SEQ ID




GCGCAAAGGACATGCACACGGCCACGCTACGCTACTGTAACCAAG
NO:





1817





CCND1
ADXCRPD.16054.C1_at
ACCAAGTAGCTGTGGGTTGAACCTGGACGTGAGCTGGTTGCAGGGCCGTTGGGTAGAAAACC
SEQ ID




AGCATCTCATAAACAGGTCACTACAAAAATAGGAAGAGTATAAAAATAGAATATATTATGTC
NO:




ACTATTTCGTCTTCTCTTTATAGTAGCGTATCGTAGGAGTGGGACAAGGTGGCCTTTCCCGA
1752




CACTGCTACGCTGGTCTGTGCCCGACAAACCTCACCTGATGTTGTACCTGAGTACGTTACTA




AATCCTCAAGACCTTACACACAGC





CCND1
ADXCRPD.3501.C1_s_at
TCTGTCTGAACCACGCGGGGGCCTTGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCAC
SEQ ID




AAGTCCTGGATGTTGTGTGTATCGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGGGCACAGC
NO:




GGAGTCTGTCCTGTGACGCGCAAGTCTGAGGGTCTGGGCGGCG
1592





CCND1
ADXCRPD.3980.C1_s_at
GGAGGTGGACCTGGCTTGCACACCCACCGACGTGCGGGACGTGGACATCTGAGGGCGCCAGG
SEQ ID




CAGGCGGGCGCCACCGCCACCCGCAGCGAGGGCGGAGCCGGCCCCAGGTGCTCCCCTGACAG
NO:




TCCCTCCTCTCCGGAGCATTTTGATACCAGAAGGGAAAGCTTCATTCTCCTTGTTGTTGGTT
1679




GTTTTTTCCTTTGCTCTTTCCCCCTTCCATCTCTGACTTAAGCAAAAGA





CCND1
ADXCRPDRC.16054.C1_at
GTAGTGACCTGTTTATGAGATGCTGGTTTTCTACCCAACGGCCCTGCAACCAGCTCACGTCC
SEQ ID




AGGTTCAACCCACAGCTACTTGGTTTGTGTTCTTCTTCATATTCTAAAACCATTCCATTTCC
NO:




AAGCACTTTCAGTCCAATAGGTGTAGGAAATAGCGCTGTTTTTGTTGTGTGTGCAGGGAGGG
2013




CAGTTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCAAGCAGGACTTTGAGG




CAAGTG





CD44
ADXCRAD_BM840380_s_at
GAGATCACTTCCAGCCTAATGTGCATTTGGCTGGAATATGGTTGTCTCAGAATAACATCATG
SEQ ID




CACTCGGGCTTTTATACTTCTGCCTTTAGGGGACTGTGGCAGCATGGCATGGGTCAAGAAGT
NO:




ACTTCTCCTTCATCTTCCTTTGATGTCGGTAACTCATCCTTTCTGCACTGCGGGAGTTGTTA
2459




ATGCTTTTGTGTCCTCCAGTTCACATGCTGATTGCTAAGAAGAAAATGAGCATGAGTGAACC




CAAAGCTGCTGAAACATTCTGCGTTTATGCAACTTCCTTG





CD44
ADXCRAD_BP233968_at
TGAATGGGTCCATTTTGCCCTTCCATAGCCTAATCCCTGGGCATTGCTTTCCACTGAGGTTG
SEQ ID




GGGGTTGGGGTGTACTAGTTACACATCTTCAACAGACCCCCTCTAGAAATTTTTCAGATGCT
NO:




TCTGGGAGACACCCAAAGGGTGAAGCTATTTATCTGTAGTAAACTATTTATCTGTGTTTTTG
2428




AAATATTAAACCCTGGATCAGTCCTTTGATCAGTATAAT





CD44
ADXCRAD_CN347079_s_at
TCAACAGTCGAAGAAGGTGTGGGCAGAAGAAAAAGCTAGTGATCAACAGTGGCAATGGAGCT
SEQ ID




GTGGAGGACAGAAAGCCAAGTGGACTCAACGGAGAGGCCAGCAAGTCTCAGGAAATGGTGCA
NO:




TTTGGTGAACAAGGAGTCGTCAGAAACTCCAGACCAGTTTATGACAGCTGATGAGACAAGGA
1104




ACCTGCAGA





CD44
ADXCRAD_CV026388_at
AATGCCTTTGATGGACCAATTACCATAACTATTGTTAACCGTGATGGCACCCGCTATGTCCA
SEQ ID




GAAAGGAGAATACAGAACGAATCCTGAAGACATCT
NO:





2327





CD44
ADXCRAD_CV026388_x_at
GTATGACACATATTGCTTCAATGCTTCAGCTCCACCTGAAGAAGATTGTACATCAGTCACAG
SEQ ID




ACCTGCCCAATGCCTTTGATGGACCAATTACCATAACTATTGTTAACCGTGATGGCACCCGC
NO:




TATGTCCAGAAAGGAGAATACAGAACGAATCCTGAAGACATCTACCCCAGC
2328





CD44
ADXCRIH.1441.C1_at
CATCAAGAACAGACAAGGGTGTGTAGCGGTTTACAAATACAGCCATAAAAAAGTCAAACAGG
SEQ ID




ATCTACATGGCATCATCATTCCCCTTGGCCAATCCT
NO:





2235





CD44
ADXCRIH.1441.C1_s_at
AATCGGACACCCTGACTGATGAATAAATGCCACAAAGGACTTGCCAAGTGGGAGAAAATATG
SEQ ID




AGGTTAGAGGATAAAGCCAGTACTCTCTTGTTTGGTCATAAACTTGCCTATCTGGTGATAAG
NO:




ATTCCAATGATGGGAATCCCTTTAACCTTTTGAGGGACTCCCCAGGCACTTAACTCATCCTA
2236




AATAGCAACTGCATCAAGAACAGACAAGGGTGTGTAGCGGTTTACAAATACAGCCATAAAAA




AGTCAAACAGGATCTACATGGCATCA





CD44
ADXCRIH.1441.C2_s_at
ATGGTCCATTCACCTTTATGTTATAGATATGTCTTTGTGTAAATCATTTGTTTTGAGTTTTC
SEQ ID




AAAGAATAGCCCATTGTTCATTCTTGTGCTGTACAATGACCACTGTTATTGTTACTTTGACT
NO:




TTTCAGAGCACACCCTTCCTCTGGTTTTTGTATATTTATTGATGGATCAATAATAATGAGGA
2237




AAGCATGATATGTATATTGCTGAGTTGAAA





CD44
ADXCRIHRC.1441.C1_s_at
GAAGAAGAAAAGCTCCTGACTAAATCAGGGCTGGGCTTAGACAGAGTTGATCTGTAGAATAT
SEQ ID




CTTTAAAGGAGAGATGTCAACTTTCTGCACTATTCCCAG
NO:





1379





CD44
ADXCRPD.11577.C1_s_at
AAACAGCATTGCTTTCTGAAATTAGGGCCCAATTAATAATCAGCAAGAATTTGATCGTTCCA
SEQ ID




GTTCCCACTTGGAGGCCTTTCATCCCTCGGGTGTGCTATGGATGGCTTCTAACAAAAACTAC
NO:




ACATATGTATTCCTGATCGCCAACCTTT
1527





CD44
ADXCRSS.Hs#S1228681_at
TGCATTCCATTCCTTGTGTCTTAAAAGCAGACTGCAGTGTAGCTGAAGCAACCTTCTATTCA
SEQ ID




TGCCAAAGTGCTTTATTCTGTGACTATACCTTGTATTGAGCTCTAAAACCTCAGAGAGCTTT
NO:




AAACTGGTTTTGCCTTTATAGAAAGGTTAAGTCCATTTGTGCATTACAGCTTTTATTCTGTG
2068




TGTGTGTGCATACTTAAATTAAAATGGAAATTTATTTGTTAGGTTAGTTTCTCCCAGAATTG




CTCCTGGCAAAGAG





CD44
ADXCRSS.Hs#S3898008_at
GTGAAACCAAAAGAACGCAGGCAAGAAACAGAACAGGAGGGGGAGGGCGACTAAAACATACA
SEQ ID




CTACCAGGGGAAGAAGAAAAAGTGGCCGCAGCCCCAGGAGGAAAATAAAGAAAAGGAACCCA
NO:




CCACCTAGAAGACAGACATAATAAAAAAGAACACGCCGAGCATGCACGCGTCAAAAACAAAA
2222




GAAGAAGGAGAAAACAAGCACCGCACGAGGTGAAGTCATTTGTGAAGGAAACGCACAACACA




ATATGTGCGGGGAGGAAAAATAAGAGCGATACCACCCTCACG





CD59
ADXCRAD_BP343697_s_at
TGCTAACTCCTAGCTGACTCAGCATAGATTGTATAAAATACCTTTGTAACGGCTCTTAGCAC
SEQ ID




ACTCACAGATGTTTGAGGCTTTCAGAAGCTCTTCTAAAAAATGATACACACCTTTCACAAGG
NO:




GCAAACTTTTTCCTTTTCCCTGTGTATTCTAGTGAATGAATCTCAAGATTCAGTAGACCTAA
2355




TGACATTTGTATTTTATGATCTTGGCTGTATTTAATGGCATAGGCTGACTTTTGCAGATGGA




GGAATTTCTTGATTAA





CD59
ADXCRD_BP396775_s_at
CCTCGTGGGTTTATTATTACCTCATAGGGACTTTGCCTCCTGACAGCAGTTTATGGGTGTTC
SEQ ID




ATTGTGGCACTTGAGTTTTCTTGCATGCTTGTTAGAGAAACCAAGTTTGTCATCAACTTCTT
NO:




ATTTAACCCCCTGGCTATAACTTCATGGATTATGTTATAATTAAGCCATCCAGAGTAAAATC
1004




TGTTTAGATTATCTTGGAGTAAGGGGGAAAAAATCTGTAATTTTTTCTCCTCAACTAG





CD59
ADXCRAD_CN431378_s_at
GATAGCAGGGCATGAAAACTTAGAGAGGTACAAGTGGCTGAAAATCGAGTTTTTCCTCTGTC
SEQ ID




TTTAAATTTTATATGGGCTTTGTTATCTTCCACTGGAAAAGTGTAATAGCATACATC
NO:





2354





CD59
ADXCRAD_CX784253_s_at
GAGCTAACGTACTACTGCTGCAAGAAGGACCTGTGTAACTTTAACGAACAGCTTGAAAATGG
SEQ ID




TGGGACATCCTTATCAGAGAAAACAGTTCTTCTGCTGGTGACTCCATTTCTGGCAGCAGCCT
NO:




GGAGCCTTCATCCCTAAGTCAACACCAGGAGAGCTTCTCCCAAACTCCCCGTTCCTGCGTAG
2353




TCCGCTTTCTCTTGCTGCCACATTCTAAAGGCTT





CD59
ADXCRPD.15392.C1_at
GGGCTATTGAGAGTCAGCACCAGCACTGATCATATATAGGATCAGCCTACTGGGGTTGGCCA
SEQ ID




CGTTGTATGTAGCTGCGAATAGCAAGGAGGGGAACAGCAACATCCCTAGGGAAACCGATCAC
NO:




AGAAAGGCAGCTCACTACCCCACAGTAAAAAGAACCTTGAGTTTCCCAGTTCAGTCCCCTGC
1745




TGGGTGCATGCTACCCCCCTCCTCTCCCAGAGGCTCTGGACCTACACAGCTGCTGAAAAAGA




GAAAATGTCCTTACCTACAATGAACCATCACAGGCACCCA





CD59
ADXCRPD.18131.C1_s_at
GGCAAGCTCTTCACTATGACAGTAAAGGCTCTCTGCCTGCTGCCAAAGCCTGTGACTTTCTA
SEQ ID




ACCTGGCCTCACGCTGGGTAAGCTTAAGGTAGAGGTGCAGGATTAGCAAGCCCACCTGGCTA
NO:




CCAGGCCGACAGCTACATCCTCCAACTGAACCTGATCAACGAAGAGGGATTCATGTGTCTGT
1883




CTCAGTTGGTTCCAAATGAAACCAGGGAGCAGG





CD59
ADXCRPD.5301.C1_s_at
AACCCACTGGTGCAAGTCCTAGATTCCAAAGGCTGAAGAACCTGGAGTCTGATGTCCAAGAG
SEQ ID




CAGGAAGAGTGGAAGAAAGCCAGAAGACTCAGCAAACAAGGTAGACAGTGTCTACCACCACA
NO:




GTGGCCATACCAAAGAGGCTACCGATTCCTTCCTGCTACCTGGATCCCTGAAGTTGCCCTGG
1692




TCTCTGCACCTTCTAAACCTAGTTCTTAAGAGCTTTCCATTACATGAGCTGTCTCAAAGCCC




TCCAATAAA





CD59
ADXCRPDRC.15392.C1_at
ATCTTTCCCCTTGCGGTACTAATCTATTGGCGCACAAGGAGGGCGTCACAGTGCT
SEQ ID





NO:





2011





CD59
ADXCRPDRC.15392.C1_s_at
GTAGTGAGCTGCCTTTCTGTGATCGGTTTCCCTAGGGATGTTGCTGTTCCCCTCCTTGCTAT
SEQ ID




TCGCAGCTACATACAACGTGGCCAACCCCAGTAGGCTGATCCTATATATGATCAGTGCTGGT
NO:




GCTGACTCTCAATAGCCCCAC
2012





CDH11
ADXCRAD_BG435621_at
ACAAACTAGTGGTGGGGGCACAGCAGAGCCCACGAAAAGAAGTTTTGT
SEQ ID





NO:





2458





CDH11
ADXCRAD_CX866982_s_at
GGGTCCCTGAGCTCCCTAGAGTCGGCCACCACAGATTCAGACTTGGACTATGATTATCTACA
SEQ ID




GAACTGGGGACCTCGTTTTAAGAAACTAGCAGATTTGTATGGTTCCAAAGACACTTTTGATG
NO:




ACGATTCTAACAATAACGATACAAATTTGGCCTTAAGAACTGTGTCTGGCGTTCTCAAGAAT
2709




CTAGAA





CDH11
ADXCRAG_D21254_s_at
TTGTTACTGCTGATTCTTGTAAATCTTTTTGCTTCTACTTTCATCTTAAACTAATACGTGCC
SEQ ID




AGATATAACTGTCTTGTTTCAGTGAGAGACGCCCTATTTCTATGTC
NO:





986





CENPF
ADXCRAD_AU132621_at
TCTTTCTCTTACAATCTGTTTTAGACATCTTTGCTTATGAAACCTGTACATATGTGTGTGTG
SEQ ID




GGTATGTGTTTATTTCCAGTGAGGGCTGCAGGCTTCCTAGAGGTGTGCTATACCATGCGTCT
NO:




GTCGTTGTGCTTTTTTCTGTTTTTAGACCAATTTTTTACAGTTCTTTGGTAAGCATTGTCGT
2490




ATCTGGTGATGGATTAACATATAGCCTTTGTTTTCTAATAAAATAGTCGCCTTCGTTTTCTG




TAAGA





CENPF
ADXCRAG_AF118076_at
TATGCCATATATAATATCCCAGAGGGATCTGCTATAATATTGCATAATCGAATTCATATTTC
SEQ ID




TGCAGCAAAATGTGTGGATACTCTCACAAGGCAGGATAAATAGAGACTATATATACTGGGCC
NO:




AGGTG
859





CENPF
ADXCRAG_AF118076_x_at
TGATGCCATATCAGATGGTTTTAGAATTCTGCACTTTAATAATGTAATGCATATGCCATATA
SEQ ID




TAATATCCCAGAGGGATCTGCTATAATATTGCATAATCGAATTCATATTTCTGCAGCAAAAT
NO:




GTGTGGATACTCTCACAAGGCAGGATAAATAGAGACTATATATACTGGGCCAGGTG
860





CENPF
ADXCRPD.1656.C1_s_at
GAAGGCACTTTGTGTGTCAGTACCCCTGGGAGGTGCCAGTCATTGAATAGATAAGGCTGTGC
SEQ ID




CTACAGGACTTCTCTTTAGTCAGGGCATGCTTTATTAGTGAGGAGAAAACAATTCCTTAGAA
NO:




GTCTTAAATATATTGTACTCTTTAGATCTCCCATGTGTAGGTATTGAAA
1464





CENPF
ADXCRPD.17056.C1_at
TCATCCTCTTGTGTGCCTGACAGCTCTAGTCTTAGCAGTTTGGGAGACTCCTCCTTTTACAG
SEQ ID




AGCTCTTTTAGAACAGACAGGAGATATGTCTCTTTTGAGTAATTTAGAAGGGGCTGTTTCAG
NO:




CAAACCAGTGCAGTGTAGATGAAGTATTTTGCAGCAGTCTGCAGGAGGAGAATCTGACCAGG
1788




AAAGAAATCCCTTCGGCCCCAGCGAAGGGTGTTGAAGAGCTTGAGTCCCTCTGTGAGGTGTA




CCGGCAGTCCCTCGAGAAGCTAGAAGA





CNN3
ADXCRIH.2427.C1_s_at
GCATTTGTGATTATATGTGTACTCATTCTCTTACCTAGCGAACAAGATCTTTTCAAAGTGGT
SEQ ID




GTTTCTAAAAGAGCATGTACAAAAGTGGCCTGTGGACATTTAGGCCTGGGTGATGCATTTGC
NO:




TCTTCCTGTTTGTGCCAATGTATCAATGTAAAGTTGCTCTGTTTTCTTCAACTGTATTTATT
1157




GCTGCATTTCTCAGCATAAACTTATCCCATTGT





CNN3
ADXCRPD.1098.C1_s_at
AAGAGCAAATGCATCACCCAGGCCTAAATGTCCACAGGCCACTTTTGTACATGCTCTTTTAG
SEQ ID




AAACACCACTCTGAAAAGATCTTGTTCGCTAGGTAAGAGAATGAGTACACATATAATCACAA
NO:




ATGCACACTGATCATGACTTTATTTAAAAATTAGCAAACAATACTGTAGAAACATTGATATG
1847




TAAATTTCTAAAATGCTGCATCTTAAATTTAGTTGGCAAAGACCACATTTAGCAATAAGCAT




GAGTTTAGTCTTCCATGTAGAAACCAGATA





CNN3
ADXCRPD.2332.C1_at
CATATCAAATGGTTTCTAACAGGTATTGGTTTGCCTAATTTTCAAAACAAACCTCCTTGATC
SEQ ID




CACGGGGGCCCTTTTGATGAATTACAATGGGGGAACCTCCATTTCCCCTTTACCCGACGGCG
NO:




GAACACCACAATTCTTTTTTCCCCAAGCGGGGTTGCTCTCTCTTTACCAAGCAATCCTTTGG
1476




TTACCCAATCACCGTGTGCGCCTTGTGTGGTAACACTTTTTCAACGCGCCCTCATGCGGAGA




CGAAATCGCACTCTCTTTGCG





CRIM1
ADXCRAD_AI651806_s_at
ACATTTTCTTTTCACGTTAAGCATACTGGGTATCTGTGTCTTTCACAACAAGCATTTTTAAA
SEQ ID




AGAAAACTCAATGCACAAATGGGTTAATTAGTATAAAAGTGCTAAGGGCTGTTTGAAAAGTT
NO:




ACCACTATAGTATACAGTCAGTTATATTTGAGGCATACTACAACAAACTTCCAGCTTATTGT
2454




GGACAATATTCCAGTAGTTGTTTCAAACCATTGTTTGAAAAAAAAAAAAAAAAAATCCAGGA




GCTGATTAGTGATGCAG





CRIM1
ADXCRAD_BC016339_s_at
AAGAATCTTCACTTGGGTGCAGCCTGTTATCTCTGTAATCTACCTGGAGGTGACCCATATCT
SEQ ID




AGGAGAAAAAAAATTATAAGCATTTATTACCTAAACCAGAATTGTTAAGGATTATTTTAATG
NO:




ACATTGCAAATAGAGATCAGCAACTTGGTTTTATTGCTTCCCAGTTTTTTGAGGCTAAAAAT
2786




GTGATTAAAATCTAATGTTGATCCAAAGAGCTCTTAGTAGAGAGCAGAGCGCTTA





CRIM1
ADXCRAD_BG621095_s_at
AAAAAATTGTAGATGCTTGCTTTTTGTTTTTTCAATCATGGCCATATTATGAAAATACTAAC
SEQ ID




AGGATATAGGACAAGGTGTAAATTTTTTTATTATTATTTTAACAGATATGATTTATCCTGAG
NO:




TGCTGTATCTATTACTCTTTTACTTTGGTTCCTGTTGTGCTCTTGTAAAAAGAAAAATATAA
1128




ATTTCCTGAAGAATAAAATAGATATATGGCACTTGGAGTGCATCATAGTTCTACAGTTTGTT




T





CRIM1
ADXCRAD_C16716_s_at
CTTCTAGCCGTCAAACTCTGATCGACTTACACTTAAGACTGTGTCTTTGGTAGCCTACCCTA
SEQ ID




TTCCACTTTTATTACAAAGGCAGCTCTTAAGACATAAATCCATCTCTTCAGGCTCGAACTGC
NO:




AAAACACACGTCGAGAGGTGACAATGTTGGGACTGTCAAAAAGAACTTAAAGAGTGGGATAA
2751




CCAGCCGGGC





CRIM1
ADXCRAD_CD101810_at
AAATAGAATTGACCTCCAGCCCGGATTAGGCATAAATTTTG
SEQ ID





NO:





2396





CRIM1
ADXCRAD_CD101810_x_at
GGTGTTCTACCTGTTTGCATCAAAGGAAAAAAAGATTTTTTTTCCAAGGGCCAATTTTTTTA
SEQ ID




TCTTTTCCCAAAAAAAATTTGTTAATGGAACATTTACAAAAATAGAATTGACCTCCAGCCCG
NO:




GATTAGGCATAAATTTTGGTTGGGA
2397





CRIM1
ADXCRAD_AA642418_s_at
GACTTATACTCATGAGGTCTACCTACAGTCCATTCCCATTTAGGGGAAGAGAAAGGAGAGGA
SEQ ID




AATGGCCAAGAAGTCCATAAGAAGTGGACAGTGCTTTAACTTTTTCAAGTTTTGCTAACATA
NO:




TTTTATGTAAGTTATTCAATACCCCCATATTAAAGAGCAGCAGCTATTAAACACCAACATTT
2873




ATTAGCTGCTGGAAAGTAATAAATAACTTCAGCTAGTCCCCTTCAGTTTCCATAAAATTATA




AAACCAACCATTTGACGTGAAAAAGCAGTTT





CRIM1
ADXCRAG_AC007401_at
GGGCAGAAAAGCCATGTCGCCATTTACTTGACACCTTTCAGTGCCACACACACCCTTCTGCC
SEQ ID




CCTCCCCTGCCTAGTCCAGGGCTTCACACTGAGCCTTCCTATGACAATAGGGGCCGAACTGC
NO:




CACTGGTTTCTGAGGCCTCAGTGTAAAGGGCAAATGCGACACCAATTCCAACAAACCTGTAA
842




ATGTCAATGGCTAAGTAGTAAAAGTTTCTGCAGAGGCCCCAGAGCTGGGATTGATTCAGTTC




CACCTCAGGTTTTTTCCTGAGTGAGAGGGAGAGACGTAACTTTGGAAT





CRIM1
ADXCRAG_AF168681_x_at
ACTAATGATAATCCATCTCCCTTCGCTGACTCTCTTTTCGGACTCAGCCCGCCTGCATCCAG
SEQ ID




GTGAAATAAACAGCCGTGTTGCTCACACAAAGCCTGTTTGGTGGTCTCTTCACACGGACGCA
NO:




CATGAAATTTGGTGCCGTGACTCGGATCGGGGGACCTCCCTTGGGAGATCAATCCCCCTGTC
869




CTCCTGCTCTTTGCTCCATGAGAAAGATCCACCTACGACCTCAGGTCCTCAGACCGACCAGC




CCAAAAAACAT





CRIM1
ADXCRPD.11873.C1_at
GTCCCTACTGCATAGAAGACACAATTCCAAAGAAGGTGGTGTGCCACTTCAGTGGGAAGGCC
SEQ ID




TATGCCGACGAGGAGCGGTGGGACCCTTGACAGCTGCACCCACTGCTACTGCCTGCAGGGCC
NO:




AGACCCTCTGCTCGACCGTCAGCTGCCCCCCTCTGCCTGTGTTAGCCCATCAACGTGGAAGG
1583




AAGTTGCTGCCCATGCGTCCATGTAAGG





CRIM1
ADXCRPD.11873.C1_s_at
TGCATTGATAGCGTAATTAGCTGTTTCTCTGAGTCCTGCCCTTCTGCATCCTGTGAAAGACC
SEQ ID




TGTCTTGAGAAAAGGCCAGTGATGTCCCTACTGCATAGAAGACACAATTCCAAAGAAGGTGG
NO:




TGTGCCACTTCAGTGGGAAGGCCTATGCCGACGAGGAGCGGTGGGACCCTTGACAGCTGCAC
1584




CCACTGCTACTGCCTGCAGGGCCAGACCCTCTGCTCGACCGTCAGCTGCCCCCCTCTGCCTG




TGTTAGCCCATCAACGTGGAAGGAAGTTGCTGCCCA





CRIM1
ADXCRPD.15616.C1_at
ACAGATGTCACAGCCGTGCTTATTCTTCAGCAATCCAAGTGGACAATACTTGTCACAGATTA
SEQ ID




TGGGTCTGCACTTCTTGGGCCTTGGGCGGCACTCACAGATCTCACAGTTTTGGGCATCAGTA
NO:




AGGAAACCGAAGGGACAGTTCAAGGTGCAGCCTTGTTTACGTTCTGAACATAGTTCCTCGGT
1774




GTTTATGCACTCACAGGTCCGACAACCATTGTGATCGCGTTTGAAACCATTAATGCAGTCCT




TCCCTGTCAGAGGCAGTTTGATACGGTCCCGAC





CRIM1
ADXCRPDRC.15616.C1_s_at
AGTGCAGACCCATAATCTGTGACAAGTATTGTCCACTTGGATTGCTGAAGAATAAGCACGGC
SEQ ID




TGTGACATCTGTCGCTGTAAGAAATGTCCAGAGCTCTCATGCAGTAAGATCTGCCCCTTGGG
NO:




TTTCCAGCAGGACAGTCACGGCTGTCTTATCTGCAAGTGCAGAGAGGCCTCTGCTTCAGCTG
2018




NGCCACCCATCCTGTCGGACACTTGTCTCACCGTGGATGGTCATCATCATAAAAATGAGGAG




AGCTGGCACGATGNGTGCCGNGAATGCTACTGTCTCAATGGACGGG





CRIM1
ADXCRSS.Hs#S1805720_s_at
GAAGATGTTTGTCTGAGCATCCCATGAGGTAAGCAGCCCCATGGAAGGACCAGCTGCATCCA
SEQ ID




GCAAAGGGCTCCAGGTCCCTGACGTAGTTGACGGTGATGGCAGAAGTAAATCTTTGTATTCT
NO:




TGCAGAGACTTTGTTTTTCTGTCATTCCACAGCAGCTCAGCATACTCTAATAAACGTCCTCC
2065




TCTTCCCCTTCGTAGCATTCTGGGACTAATCAGGGTTTCATCTGCTCACATATTGTAGCGAT




GGGTTC





CTNNAL1
ADXCRPD.129.C1_at
GACAGACACACTGGGAGTCGTGCTGCGCACCCCCCCTATTATTTTCGCGCACCCAATTTAAA
SEQ ID




GAGGTGGGCCGGCCGCGCCCACCCGTCCATCACCTCGATATGCACACTACCTCCGCCGTCGG
NO:




GGCCCTCGCGGCCCGCCATGCTGTTCGCAAACACTCACCGCCCGGCCGCGGGTCCGCGATGC
1484




TGCGCGTGTGTGAGAAGTATGGTGAGCGCGATATGGCGGCAACACCACTGTCGACTTGTCTC




G





CYR61
ADXCRIH.1579_C1_at
TACCTAATATCTGAGTGTATGCCATTCGGTATTTTTAGAGGTGCTCCAAAGTCATTAGGAAC
SEQ ID




AACCTAGCTCACGTACTCAATTATTCAAACAGGACTTATTGGGATACAGCAGTGAATTAAGC
NO:




TATTAAAATAAGATAATGATTGCTTTTATACCTTCAGTAGAGAAAAGTCTTTGCATATAAAG
1207




TAATGTTTAAAAAACATGTATTGAACACGACATTGTATGAAGCACAA





CYR61
ADXCRPD.10589.C1_at
GGAACCGCATCTTCACAGTCCTGGTCAGCTGGGGCGTGCAGCATCGGCCGTCCACGCAGGAA
SEQ ID




CCGCAGTACTTGGGCCGGTATTTCTTCACACTCAAACATCCAGCGTAAGTAAACCTGACTGG
NO:




GTTCGGGGGATATCTTGGTACTTGCTGCATTTCTTGCCCTTCTGTAAGAGAAAGGCGAGAAG
1443




GCAAGTTAGGGGTGATATTTCTCTTTCTTCAAAAAGATGTTCACATCCCAACCACCTGCCAG




GCAACAGTCTACACGTCCCTTAAGGAACTTACTTTCAGGCTGCTGT





DKK1
ADXCRAG_AF177394_s_at
GTTATCTTGACTGACAAATATTCTATATTGAACTGAAGTAAATCATTTCAGCTTATAGTTCT
SEQ ID




TAAAAGCATAACCCTTTACCCCATTTAATTCTAGAGTCTAGAACGCAAGGATCTCTTGGAAT
NO:




GACAAATGATAGGTACCTAAAATGTAACATGAAAATACTAGCTTATTTTCTGAAATGTACTA
870




TCTTAATGCTTAAATTATATTTCCCTTTAGGCTGTGATAGTTTTTG





DNAJB6
ADXCRAD_BQ222360_at
GGAAAAGGAGTGGTATTTGAATGCTTTCTGTGGGACAATGTACCCCCTAAACACATCATGTA
SEQ ID




TTTTTAAATTGCCACCCTACCTAAAATAAAACCATAAGCCATATTTGAAA
NO:





2717





DNAJB6
ADXCRAD_BQ222360_s_at
AAAATGCCAGCAATTTTAATCTAGCAGTGTTGAAGCTGGGAATTTTTTGGCGCAATCCATGT
SEQ ID




AGCAGTGACCCAGGCTTGGGAGCCAGAAACAAGTGTGACCT
NO:





2718





DNAJB6
ADXCRIH.476.C2_at
TTGTGTCTGAAATGTGAGCCACGTAGTGTCGGCCTGCTGTGAAGTTAACATTGCCAGGACGA
SEQ ID




TTCTTCTACAGAAATAATTTCAATTTTTTTCAGTATTTAGTAGTGAAAGATATTAATACATT
NO:




AATGGTAATACATTTCTGGTTTAATATAAATTAAGGATGTTTTCTAGTTGTGCATGAATGCT
1281




GGCAACTTAGTAAGTTTTGACAATTGTTTAAATATGTAATGTTAAGCTTAGGTTTAAAAAAG




TAAAGCTGGTAAACTGGGTCTTTGTCATTTG





DNAJB6
ADXCRPD.14111.C1_at
GAGTGTGGCCTCGAGACAGTCCTGACCGACGCTGCTACCTAGCGCGTGTGCACGACCGCATG
SEQ ID




CCGAGCACGGTGGAGCGCCAGCGTCTGGGGGTGCACCGCGTGCCTCAAGTCCGGTCTAGTGA
NO:




TTGCCTTTGGTCGANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
1657




NNNNNNTTTCAATCCTGCTGCGGACGCGAGG





DNAJB6
ADXCRPDRC.14111.C1_at
TGAGTAACATTCATGCAATGAGCACTCAGTGG
SEQ ID





NO:





1986





DNAJB6
ADXCRPDRC.14111.C1_s_at
AGGACTGTCTCGAGGCCACACTCGCTCGGCAGGATTATTCGATCACGGATCAGTCAGAGCAG
SEQ ID




GGTCAGGAGACGGGGCTGACGGCACGGGTGGCGGGGACAGACGTTTGGGACTTGGCCGCGAC
NO:




TCTCTGCTTCTCTCCAGCTCTCAATCTGCTGCATTTTCCTCTAGTGCTTCCGGATCCTCTTC
1987




ATTCTTTTCGGCATACTCAACCACTCCGCATGCTGCTGGAATATTTCTGGCTTTAGAAGTAC




AGGAGGCGCAGATGGCTAACTGAGTAACATTCATG





DNAJB6
ADXCRSS.Hs#S1921365_at
GAAACAGTCTCGTACATCACGGTTCATTTTTAACCTTTTTTCTTAAATTTTAGAGATGGCAT
SEQ ID




CTCATTATTTTTCCCCAAGCTGGACTCGAACTCCTGGGCTCAAGGAATCTCCTACCTCAGCC
NO:




TCCCCAGTAGCTGGCATTACAGGGGTACACCACCATGCCTGGCTTAGTATGTGATGTTTTTA
2100




TGTGTATTTAAAAAAGACTCCTTAACTTCTTCTAAGTGACCTGTGTGTAGGTGTGCCTGTGT




ATGAACTCTGTCCAA





DNAJB6
RDCR166_G12_at
TCTGGGGTGTTTTGCGCGTGTGTAAATACCGGCCCGTTTTTCTCCAGCATGGCCCCTAATCC
SEQ ID




ATGGGACACTAGGGAGGGGTGCCCTGAGCAAAAATTTTTTGGCTAAAATAATTAGCTAAATC
NO:




CCATGTAAAAATTAT
1360





DNAJB6
RDCR166_G12_s_at
TGGGCGCATCTAGTTAGAATGAAGTGACTTTCGTAAGGAGTCAATGTTCGCGAACTGAAACA
SEQ ID




TGAGTTCAACCTCCTTGTGCCGGCCTCTGGGGTGTTTTGCGCGTGTGTAAATACCGGCCCGT
NO:




TTTTCTCCAGCATGGCCCCTAATCCATGGGACACTAGGGAGGGGTGCCCTGAGCAAAAATTT
1361




TTTGGCTAAAATAATTAGCTAAATCCCATGTAAAAATTATGGAATCTAGCAAAACCTACACC




ATATTT





EMP3
ADXCRPD.3976.C1_s_at
TTGCACCAGCGTGGCGGTGTTTACTGGCGCCTTGATCTATGCCATTCACGCCGAGGAGATCC
SEQ ID




TGGAGAAGCACCCGCGAGGGGGCAGCTTCGGATACTGCTTCGCCCTGGCCTGGGTGGCCTTC
NO:




CCCCTCGCCCTGGTCAGCGGCATCATCTACATCCACCTACGGAAGCGGGAGTGAGC
1915





F3
ADXCRAD_BU941055_at
GGAATTGTTACTGGTGTACTTATTCTATCTTCCATTTTATTATTTATGTACAATTTTGGTGT
SEQ ID




TTGTATTA
NO:





2425





F3
ADXCRAD_BU941055_x_at
GGAATTGTTACTGGTGTACTTATTCTATCTTCCATTTTATTATTTATGTACAATTTTGGTGT
SEQ ID




TTGTATTAGCTC
NO:





2426





FAM50A
ADXCRPD.13832.C1_s_at
AATCCAACATTGACAAGAAGTTCTCTGCGCACTACGACGCGGTGGAGGCAGAGCTCAAGTCC
SEQ ID




AGCACCGTGGGTCTCGTGACCCTGAATGA
NO:





1708





FAM50A
ADXCRPD.6370.C1_at
TGGGACAAGTACACGATCCGCTGAGCATCCAGGAGGCTGCGCGGCCCCGGCTCCTCAGCTCC
SEQ ID




CTCAGTGTGCCCCGTGGTGTCACCGGGACTCCAGGCACCCGCTCCCCTGCGACCATGCCAGG
NO:




CACGCTGGGAGGAGGACGGCAGCTGCTCGTGTCCTGCCCCTGCCACATCAGTGACTGCTTTA
1743




TTCTTTTCCAATAAAGAAGTGCACGTGTCAGAGCTGGAGCGCCTGCATTGTGAGAAACCAA





FAM50A
ADXCRPD.6370.C1_x_at
GACAAGTACACGATCCGCTGAGCATCCAGGAGGCTGCGCGGCCCCGGCTCCTCAGCTCCCTC
SEQ ID




AGTGTGCCCCGTGGTGTCACCGGGACTCCAGGCACCCGCTCCCCTGCGACCATGCCAGGCAC
NO:




GCTGGGAGGAGGACGGCAGCTGCTCGTGTCCTGCCCCTGCCACATCAGTGACTGCTTTATTC
1744




TTTTCCAATAAAGAAGTGCACGTGTCAGAGCTGGAGCGCCTGCATTGTGAGAAACCAA





FAM50A
ADXCRPDRC.6370.C1_at
ACTGCTGCATGGTGTTGCCCTTTCTCATCTTGACTGTCCGCCGGTGCCCAGAGCCATCCCAG
SEQ ID




TAGCTGAAGGTGATCTCGATCTCCTCACTCTTGATCTTCTCCTGCTTGGCTTCCCACTCCTG
NO:




CCGCAGCTCTTCCCGAAGCCGATTCTCCTCCTCCTCACGGTCTCGATCAGGCAAGAAGCTTG
2010




TGTCAACGTCTGGGT





FHL1
ADXCRAD_BP325154_s_at
GTGATTCCTAGGACTTTTCCTCAAGAGGAAATCTGGATTTCCACCTACCGCTTACCTGAAAT
SEQ ID




GCAGGATCACCTACTTACTGTATTCTACATTATTATATGACATAGTATAATGAGACAATATC
NO:




AAAAGTAAACATGTAATGACAATACATACTAACATTCTTGTAGGAGTGGTTAGAGAAGCTGA
1850




TGCCTCATTTCTACATTCTGTCATTAGCTATTATCATCTAACGTTTCAGTGTATCCTTACAG




AAATAAAGCAGCA





FHL1
ADXCRAD_BP361024_at
GACTGTGTCAAGAGTGAGCCACCCAGTCTCTAAAGCTAGGAAGCCCCCAGTGTGCCACGGGA
SEQ ID




AACGCTTGCCTCTCACCCTGTTTCCCAGCGCCAACCTCCGGGGCAGGCATCCGGGTGGAGAG
NO:




AGGACTTGTCCCTCGTGGGTGGTGGTTCTTTATAGAA
2502





FHL1
ADXCRAD_CX872156_s_at
CACTTACCAGGATCAGCCCTGGCATGCCGATTGCTTTGTGTGTGTTACCTGCTCTAAGAAGC
SEQ ID




TGGCTGGGCAGCGTTTCACCGCTGTGGAGGACCAGTATTACTGCGTGGATTGCTACAAGAAC
NO:




TTTGTGGCCAAGAAGTGTGCTGGATGCAAGAACCCCATCACTGGG
2369





FHL1
ADXCRPD.10038.C1_at
TGCAGAAGAGTCAATCTACCTAAGTTTTCATTTTTAAATTGCAGCCGGACAGAAATTCACTT
SEQ ID




TGCTGCAGGGTTGCTTTTTGCTAAATGCTAATATGATCACTGTGTGCCCTTATTTGAGTAAT
NO:




ACTGTAAAATGGGAGAAAAGACGGAAGGAGAACTTTAAAGAAGGGAAGGACCACTCTTCCCC
1838




TATTGATGGTATAGGGCAGAAAGTAAGGACACAAAGAACGAGATTCAAATGCCATTTTACAG




GACAGGAGCCCCTGTCAGTTTACAGCTTGAGACACGCGACGGGTACCGAG





FHL1
ADXCRPD.11024.C1_s_at
TGTGCTTTCAAATAACTAACACGAACTTCCAGAAAATTAACATTTGAACTTAGCTGTAATTC
SEQ ID




TAAACTGACCTTTCCCCGTACTAACGTTTGGTTTCCCCGTGTGGCATGTTTTCTGAGCGTTC
NO:




CTACTTTAAAGCATGGAACATGCAGGTGATTTGGGAAGTGTAGAAAGACCTGAGAAAACGAG
1409




CCTGTTTCAGAGGAACATCGTCACAACGAATACTTCTGGAAG





FHL1
ADXCRPD.16965.C1_at
GGGCCCTATGAACAGACCATTCCTGGGGACCGAATACCTTGCTTTCCACCTGCAAAAAAAGT
SEQ ID




CTCCCTGGGAAATCCTGGCCCAACAAAAGAGCTTTGTTNTTTCCCCCCAGCGAACAAAGGGT
NO:




ATTTGTCCCTGAATGTGTGCCAAAAAACACGTGTAAACACTAACAAGGAGGCTCTCTTGGAC
1388




CTTCGAAAAAAGGGCAATTGGAAATCTCCGGCCCCTTTTGAGGCCCTTGACTTTCATGGCCC




TCATCCCCAGTCGATAAGGG





FHL1
ADXCRPDRC.10038.C1_at
AGTATTACTCAAATAAGGGCACACAGTGATCATATTAGCATTTAGCAAAAAGCAACCCTGCA
SEQ ID




GCAAAGTGAATTTCTGTCCGGCTGCAATTTAAAAATGAAAACTTAGGTAGATTGACTCTTCT
NO:




GCATGTTTCTCATAGAGCAGAAAAGTGCTAATCATTTAGCCACTTAGTGATGTAAGCAAGAA
2035




GCATAGGAGATAAAACCCCCACTGAGATGCCTCTCATGCCTCAGCTGGGACCCAGCTTGAGA




CCCGCGA





FHL1
ADXCRSS.Hs#S3747393_at
TGCAGCTCCCTTTGCCAAGGCATTTCCTATAGAATCCTGCCACCCAAAAGGTACCAAATATG
SEQ ID




AGTTTCTATTAGCTTTCAACTTCTTTAAACATATGCTAATTTGTTCCTCTCCCCCGAAAAAG
NO:




AGATTTGCACGGGTAAATAGATAGCAATTATTTCATTTGTGCAGGAAATACAAGAATTGAGA
2193




CTACTTTCTAAAACTATCCACAAACATGGTTATTGTGCTAGCAAACTTCCAGCGTAATTTAG




AGAGAAAGAATGAGAGAAAATAAATGAGCAGTTGCCTGGTACTCAC





FHL2
ADXCRIH.1926.C1_at
TTGTGATAGTTCAGTCCCAGGGAAAGAGAAAACTCGCCCTAGGCCCTAGGTGGGAAGATGGT
SEQ ID




TTGAAATTTTTGTAATCGAGTAAGGCACACCCAAATGTAAAAATCCTTTTGAATGATGCCTT
NO:




TATAAATCTTTCTCTCACTGTCTATTTAAGTGCAATTAACATATGTCACGAACTTGAAAGTT
2240




TTCTAAACTCAATAAGGTAATGACCAGTTGTTATTTACAGCTCTGTAACCTCCCGTTGCGTC




AAGTCTAAACCAAGATTATGTGAC





FHL2
ADXCRIH.1926.C1_s_at
CGCCCTAGGCCCTAGGTGGGAAGATGGTTTGAAATTTTTGTAATCGAGTAAGGCACACCCAA
SEQ ID




ATGTAAAAATCCTTTTGAATGATGCCTTTATAAATCTTTCTCTCACTGTCTATTTAAGTGCA
NO:




ATTAACATATGTCACGAACTTGAAAGTTTTCTAAACTCAATAAGGTAATGACCAGTTGTTAT
2241




TTACAGCTCTGTAACCTCCCGTTGCGTCAAGTCTAAACCAAGATTATGTGACTTGCAATAAA




GTTATTCAGA





FHL2
ADXCRIH.1926.C2_at
CGCTTCACAGCTCGCGATGACTTTGCCTACTGCCTGAACTGCTTCTGTGACTTGTATGCCAA
SEQ ID




GAAGTGTGCTGGGTGCACCAACCCCATCAGCGGACTTGGTGGCACAAAATACATCTCCTTTG
NO:




AGGAACGGCAGTGGGCATAACGACTGCTTTAACTGTAAGAAGTGCTCCCTCTCACTGGTGGG
2242




GCGTGGCTTCCTCACAGAGAGGGACGACATCCTTGTGCCCCGACTGTGGGAAAGACATCTGA




ATCAACACAGAGAAGTTGCTGCTTGTGATCTCCCACACGAATTTTTATGTT





FHL2
ADXCRIH.1926.C2_s_at
TCAGCGGACTTGGTGGCACAAAATACATCTCCTTTGAGGAACGGCAGTGGGCATAACGACTG
SEQ ID




CTTTAACTGTAAGAAGTGCTCCCTCTCACTGGTGGGGCGTGGCTTCCTCACAGAGAGGGACG
NO:




ACATCCTTGTGCCCCGACTGTGGGAAAGACATCTGAA
2243





FKBP9
ADXCRAD_CD251162_s_at
GCAGAGGCCAGCTGCCGCAAGACAGCAATGACAGTCCACCTGCCGACCTGATTCCTGCATCA
SEQ ID




TGGAATAACCACATGGCTACCTTCTATCCTCTGTTCCCAAATGGTGGTGGCACTTATCCTGA
NO:




AGTCGTCAATGATTTCCCTTTGAAACTACTTTATTTTACTAATTTAAACTATTTTGTACTGA
923




TGTAGCCCTGAGGTAGTTCATGAAAATGCTGTGCACTCATTCCATGGAATAAATGTTGGAAA




GCTGATCTTTTCTGATATAA





FKBP9
ADXCRPD.16135.C1_at
GGGCCATCATCAGAATTTGCACAGGCTGCTGGGAAGAGCCATGGCTGTCTGCTGGGAACTCT
SEQ ID




GCTGGGGCAAGCAAGCCCTTTGACTCTCCTGCCCATCTCAAGAATATTT
NO:





1762





FKBP9
ADXCRPD.16135.C1_x_at
GGGCCATCATCAGAATTTGCACAGGCTGCTGGGAAGAGCCATGGCTGTCTGCTGGGAACTCT
SEQ ID




GCTGGGGCAAGCAAGCCCTTTGACTCTCCTGCCCATCTCAAGAATATTTCTAA
NO:





1763





FKBP9
ADXCRPD.3075.C1_s_at
AGAAGTTTGGGCTGATCGCCAGTGATAGTAAACAAAATCTGTGCAGAGGGCCTTAGCATGGG
SEQ ID




ATGTGTCCAGTATTGAAAAGGCTGCACTGCCAACCATGATTTGTGAGCCTTCTGGGAAATTT
NO:




TGTTATTAAAGGAATATATAGTGTCAGACGGAAGTTATAATCATCTTGGAGGAACCATAAGA
1918




AAAGGTGTCCAGGGTATCTATATAAA





FLNA
ADXCRAD_CN332899_at
TGACCTCTCGGCTTTCACTTGGGCAGAGGGAGCCATTTGGTGGCGCTGCTTGTCTTCTTTGG
SEQ ID




TTCTGGGAGGGGTGAAGGATGGGGGTCCTGTACACAACCACCCA
NO:





2347





FLNA
ADXCRAD_CN332899_x_at
TGACCTCTCGGCTTTCACTTGGGCAGAGGGAGCCATTTGGTGGCGCTGCTTGTCTTCTTTGG
SEQ ID




TTCTGGGAGGGGTGAAGGATGGGGGTCCTGTACACAACCAC
NO:





2348





FLNA
ADXCRPD.10169.C1_at
TCAGGCAACCTGACGGAGACCTACGTTCAGGACCGTGGCGATGGCATGTACAAAGTGGAGTA
SEQ ID




CACGCCTTACGAGGAGGGACTGCACTCCGTGGACGTGACCTATGACGGCAGTCCCGTGCCCA
NO:




GCAGCCCCTTCCAGGTGCCCGTGACCGAGGGCTGCGACCCCTCCCGGGTGCGTGTCCACGGG
1867




CCAGGCATCCAAAGTGGCACCACCAAC





FLNA
ADXCRPD.13338.C1_at
GGTAGGCGTCAATGTCACTTACTGGAGGGGATCCCAGCCCTAAGAGCCCTTTCTCAGTGGCA
SEQ ID




GTATCTCCAAGCCTGGACCTCAGCAAGATCAAGGTGTCTGGCCTGGGAGAGAAGGTGGACGT
NO:




TGGCAAAGACCAGGAGTTCACAGTCACAATCAAAGGGTGCTGGTGGTACAAGGCAAAGTGGC
1621




ATCCAAGTATTGTGGGCCCCTCGGGTGCAGCGGTGCCCTGCAAGGTGGAGCCAGGCCTGGGG




GCTGACAACAGTGTGGTGCGCTTCCTGCCCCGTGAGGAAGGGCCCTATGA





FLNA
ADXCRPD.15612.C1_at
GCTACACCATTATGGTCCTCTTTGCTGACCAGGCCACGCCCACCAGCCCCATCCGAGTCAAG
SEQ ID




GTGGAGCCCTCTCATGACGCCAGTAAGGTGAAGGCCGAGGGCCACTGGCACTCAGTCGCACT
NO:




GGTGTCGAGCTTGGCAAGCCCACCCACTTCACAGTAAATGCCAAAGCTGCTGGCAAAGGCAA
1773




GCTGGACGTCCAGTTCTCAGGACTCACCAAGGGGGATGCAGTGCGAGATGTGGACATCATCG




ACCACCATGACAACACCTACACAGTCAAGTACACGCCTGTCCAGT





FLNA
ADXCRPD.16964.C1_at
TGGGCTGTCACTTTTGCTGGCGTCACCCTGTGACTTATCCACGTACACCTCGAAGGGGCTCT
SEQ ID




TGGCGATGTGCTGGCCAGCAAAGAGCACAGTAACCTTATGAGTCCCCGTCAACTCGGGGACG
NO:




TACCAGACGGAGAAGGTGCGGTTCTTGTCGTTATTGGCGGTCACTTTTGCCTCCTCCTGGTG
1387




TCCGGCCGGGTCCTCCACGTACACCAGCACCTCTCCCTGGCCAGCACCTCTGGTCTCCACAG




TGAACTCTACCCGCTTCTTCACAATGCACGTGATCAAATCCTGTAGAGTC





FLNA
ADXCRPD.3034.C1_at
AGTACAATGAACAGCACGTCCCAGGCAGCCCCTTCACTGCTCGGGTCACAGGTGACGACTCC
SEQ ID




ATGCGTATGTCCCACCTAAAGGTCGGCTCTGCTGCCGACATCCCCATCAACATCTCAGAGAC
NO:




GGATCTCAGCCTGCTCGTACGGCCACTGTGGTCCCGCCCTCGGGCCGCGAGGAGCCCTGTCT
1490




GCTGAAGCGGCTGCGCAATGGCCACGTGCGCATTGCATTCGTGCCCAAGGAG





FLNA
ADXCRPD.3150.C3_at
CTCATGGGTCTTGCCCGATGGGCTGGTCACCTGGGCTGTCATATCCTGGATGCTAATTTCAG
SEQ ID




GGATTTTCAGGCTGAGGTCACAATGACTACCAACGTTGGCCACTGAAGGAGCCCGACGCCTG
NO:




CGGGTGATGCTCTCTTTCACCCGGCCCTCGCCTGTCACCTTCACAGAGAAGGGGCTGCCAGG
1902




CACGTGCTGGTCGGCAAACTTGATGTTGATGATGTAGTTGCCTGGCTCTGTGGGGCAGTAGG




TGACCCTGCACGTCC





FLNA
ADXCRPD.3227.C1_at
TTCACCCTGTCTGGGTGGAAGTCCTGGGGCGCGTCACGGATGTCAGCCATGAAGGGGCTGAG
SEQ ID




GCGGATGTCTTCGCTGTTGCACAGCACGTGAACGGCATACTCGCCAGCCTCCTGCGGCCAGT
NO:




AGCGCACATCACAGGAGCCGTCGCCCTTGTCGTCACATTCGATCTTAGCCTGCGATGGCCCT
1542




TCCACCGAGAAGCCCAGCGTGCCCACGTCGTCCCCGATAGCCTCCACCACAAAGTCTGCTGA




CTTGCCAACGACG





FLNA
ADXCRPDRC.16964.C1_at
AAAAGTGACCGCCAATAACGACAAGAACCGCACCTTCTCCGTCTGGTACGTCCCCGAGTTGA
SEQ ID




CGGGGACTCATAAGGTTACTGTGCTCTTTGCTGGCCAGCACATCGCCAAGAGCCCCTTCGAG
NO:




GTGTACGTGGATAAGTCACAGGGTGACGCCAGCAAAAGTGACAGCCCAAGGTCCCGGCCTGG
2051




AGCCCAGTGGCAACATCGCCAACAAGACCACCTACTTTGAGATCTCCACGGCAGGAGCTGGC




AC





FLNA
ADXCRPDRC.3150.C3_s_at
GTCTCGTCAGCAACCACAGCCTCCACGAGACATCATCAGTGTTTGTAGACTCTCTGACCAAG
SEQ ID




GCCACCTGTGCCCCACAGCATGGGGCCCCGGGTCCTGGGCCTGCTGACGCCAGCAAGGTGGT
NO:




GGCCAAGGGCCTGGGGCTGAGCAAGGCCTACGTAGGCCAGAAGAGCAGCTTCACAGTAGACT
2048




GCAGCAAAGC





FLNA
ADXCRPDRC.3227.C1_at
AGAAGACAGGTGTGGCCGTCAACAAGCCAGCAGAGTTCACAGTGGATGCCAAGCACGGTGGC
SEQ ID




AAGGCCCCACTTCGGGTCCAAGTCCAGGACAATGAAGGCTGCCCTGTGGAGGCGTTGGTCAA
NO:




GGACAACGGCAATGGCACTTACAGCTGCTCCTACGTGCCCAGGAAGCCGGTGAAGCACACAG
1960




CCATGGTGTCCTGGGGAGGCGTCAGCATCCCCAACAGCCCCTTCAGGGTGAATGTGGGAGCT




GGCAGACACCCCAACAAGGTCAAAGTAT





FOXN3
ADXCRAD_BM995629_s_at
CCGTGTAGGTCTATTGGCCAGCCAAGGTCAGACGACCCTAAGCATCAATAGTAAACCTCTTG
SEQ ID




GTCTTCTGATTGCTTTATCACTTTTTTTTTTTTTCTGTAAAACAAAACAAAACTCAGAAATG
NO:




TTACAGAATCAGAGTATTAAAAAATGTACAAGTGTATATGCTTCCCAGACACACATGGATAC
2480




ATTTTTCCTCCACATTTTCACCATGGCAGTATTAAGTAGTGAGTGTGAATGACACAGCATGA




AACTGGTTACTGAATCAGCTATGAGCTCAGATGGCCTCAAC





FOXN3
ADXCRAD_BP254636_s_at
CATCTTGTGGCTCCCCAGTGGTCAGCGGAGACCCCAAGGAGGATCACAACTACAGCAGTGCC
SEQ ID




AAGTCCTCCAACGCCCGGAGCACCTCGCCCACCAGCGACTCCATCTCCTCCTCCTCCTCCTC
NO:




AGCCGACGACCACTATGAGTTTGCCACCAAGGGGAGCCAGGAGGGCAGCGAGGGCAGCGAGG
2438




GGAGCTTTCGGAGCCACGAGAGCCCCAGCGACACGGAAGAGGACGACA





FOXN3
ADXCRAD_CR735795_s_at
TGGACGTTGGACTGTTCATGCGCATCGGGTGTCAGTGACTCATGGAGAAGAAATGGGGTAAA
SEQ ID




TTTTTAGTGATGTTGCTAATCATTGAATTCTGTTCTCTATTAAATTAAGAAAATGTTCCAAA
NO:




AGCCATAAGCCTGAAGATTGGCCCTGTGCACGCACGCACACACACACACACACACACACACA
1073




CACACACACACACGAAGGAGAGAGAGAGAAAACTGATGGGGAAAACAAGCTGTGTCTTCTTA




ACTGCCCAAGTGAAAAGCAACCAAGTCCAGGAAATTACAATAGCTGTT





FOXN3
ADXCRAG_AF138861_s_at
GGTTCATTTTAGTTTCAGATAGATGGCTTCACCAAAGAACTCTTGAAAGAATACTGATTAGG
SEQ ID




GAGGGGCAGGGAAGTAGGAGCTTATGGTATATTATAAGGCTGGGAAAAATCTATGATGCAAA
NO:




CCCTTTCCACATAGTACT
865





FOXN3
ADXCRAG_U68723_at
TTTTTCTGTCTATCAAAACTATTTGATCCAAGTGAAAAAAAAAAAAAAACTAGAAAGCTACGG
SEQ ID




AACCTGCAATGCGGCCG
NO:





1072





FOXN3
ADXCRPD.10462.C1_s_at
GTTCTGTTATGTTCATGTAAACCTAAAGAAACAGTGTGGAGGCAGGCGCGATCAGCCGAACT
SEQ ID




CTAGGGACTTGGTGTTGCTTGGAAGGCATCCATACCTGCATTTTGCATTCTTCGTATGTAAT
NO:




CATATTGCCAAAGACAAACTATTTCATCATTTATTGTAAATAACACTTTTCCCCAGACCTAC
1418




CATAAAGTTTCTGTGATGTATTGTCTTCCAGTTGCAAT





FOXN3
ADXCRPD.12156.C1_at
CCGAGCTGACGAGTCATAGATGCATAATTGCAAGATATAACCAGTAGGAGAGAGAGAATACAC
SEQ ID




AAGGAGTATAACCACCATCGGCGGTGCTCTCTCAAAAGGA
NO:





1511





FOXN3
ADXCRPD.12156.C1_s_at
AAGGTGCAGCACCATAGACACATCGGTTTCGGCTGTTAAAAGATGGATCGTTTTAAAAACTG
SEQ ID




TGTTTTCCTTCCTTAATTTTTGGTCAGTGAAGCTAGCACTTGTTTGCTGAACTGTGGAAGAA
NO:




CTGCAAGGTCACACACATTATTCATGATAAAGCAACCGAGCTGACGAGTC
1512





FOXN3
ADXCRPD.8652.C1_at
TAATCGGATGTCAGGCAGAGAAAACGTCGAGGTCACTCGTCTTCCTGAAGGGCCTTGGAGAA
SEQ ID




ACCGCTGCCCCCGTAACACTGACTCAGTCCACTGGAGACACTAATTCCTGAGCTTTCTGGCT
NO:




TCTTACTGGGAGGCATGACTGGACCCATTTACGTGAAGGCTCCTGGCCGGAGCGGGGCACGG
1405




GGGTGCGGGGGCGCCGCTGCCCTTCAGCAGGAGCCGACAAACTTTCGCGGGCG





FOXN3
ADXCRPD.8765.C1_at
TCTTGAAGAAGGTACTGCCCGGCCAGATGGGTGGACCTGATGTGCTTTGATATGCCTGAGGA
SEQ ID




CAGGTGGGAGGTGTATTGAACACGTGTGGGTGTGGGTGATAAGGTGTCTTTTTCAAAGCCTG
NO:




AATTAGATTTTGTCTATACTCTGGGTCTATGCACCACAACGACCCTTTCCCAATACTCTGAC
1423




TCCTCTCTTTGTCCACTTTCTTAAAACACTTATTCAATGATAAATTGTGTCTCACTGAGTTT




TTCCACCCAGTAGGTGCATTTGCAAAAT





FOXN3
ADXCRPDRC.12156.C1_at
GTGAACGATCATTTCTGACTTAACCGTGAGATGCTCACGAGTACCCTTCCTGTTGTTTTGTT
SEQ ID




AGCATTGAAATCGAGACTATTTATTTGGAATATATACAACAGTGTTTTTCCACTGTATTTCA
NO:




TTTGCAAAAGTTGAGAACTGCTTTCTCTACCCTTTGCCAAATTAATGAATATCCAATATGGG
1953




ATTTTCAAAGACTCCGATATGGTGAACCTATTAAACCTAGAAATTGTATTCATCCTTTCATG




ACTGTGGCCTGAGTTCCCCAG





FOXN3
ADXCRPDRC.8652.C1_s_at
GAGCCTTCACGTAAATGGGTCCAGTCATGCCTCCCAGTAAGAAGCCAGAAAGCTCAGGAATT
SEQ ID




AGTGTCTCCAGTGGACTGAGTCAGTGTTACGGGGGCAGCGGTTTCTCCAAGGCCCTTCAGGA
NO:




AGACGAGTGACCTCGACGTTTTCTCTGCCTGACATCCGATTATAAGAAGGGGGCCATGGAAG
1924




ATGAAGAGCTGACCAACCTGAACTGGCTGCACGAGAGCAAGAACTTGCTGAAGAGCTTTG





FOXN3
ADXCRPDRC.8765.C1_s_at
AAAGGGTCGTTGTGGTGCATAGACCCAGAGTATAGACAAAATCTAATTCAGGCTTTGAAAAA
SEQ ID




GACACCTTATCACCCACACCCACACGTGTTCAATACACCTCCCACCTGTCCTCAGGCATATC
NO:




AAAGCACATCAGGTCCACCCATCTGG
1928





FTSJ1
ADXCRAG_BC023584_s_at
GGGTAACCATGAACTTGATGGAAGAAAATGTTACATCTTTATTTTCAGCAATGAAACTGAAA
SEQ ID




TTTAGCCTTACTCCCAAGTTATAAATGCTGGCAACAAATCACAGTAGTAAAAGCAGTACCTG
NO:




GGATTTTCCCACCAATACAAACCAGTTACAGCAACTGTAATGTAACATAAAAAGGGCATCTT
949




GAAGTATTGTTCATATTTGTCACCTCTTGGAATGATAGCAGATCCTGTAAGTTGATGTATTA




ATTAAAAAGCCCATATATTACTGCATCTCAA





FTSJ1
ADXCRPD.6080.C1_at
ATCCACACAGAAGTGCGGACACCGTTTTTNNNNNNNNNNNNNNNNNNNNNNNNNNNTCCGAG
SEQ ID




TGGCCCACGCCCTTTGGTGGGGCCCCCTGGAGAATGGGGCAAACACCCCCGGATATATGTAC
NO:




CGCGTGTCCCCCCTCACCCCCACCTACGGTGTGGGCCAATTTGGCACCCCATTCTCCAAAAA
1704




CGGGCTCCAACGCGCACCGCAAAAAACCCGCCAATCTGTGATGATAGAACTTTCGGTCTCTA




AAAGAATCCCACCAATTATACCGAGGGACCTTG





FYN
ADXCRAD_CB268908_s_at
AAGAGTGCCATACCCAGGCATGAACAACCGGGAGGTGCTGGAGCAGGTGGAGCGAGGCTACA
SEQ ID




GGATGCCCTGCCCGCAGGACTGCCCCATCTCTCTGCATGAGCTCATGATCCACTGCTGGAAA
NO:




AAGGACCCTGAA
2574





FYN
ADXCRPD.4372.C1_s_at
CCCAAATCCGAACCTCCTCTGTGAAGCATTCGAGACAGAACCTTGTTATTTCTCAGACTTTG
SEQ ID




GAAAATGCATTGTATCGATGTTATGTAAAAGGCCAAACCTCTGTTCAGTGTAAATAGTTACT
NO:




CCAGTGCCAACAATCCTAGTGCTTTCCTTTTTTAAAAATGCAAATCCTATGTGATTTTAACT
1630




CTGTCTTCACCTGATTCAACTNNNNNNNNNNNNGTATTATTTTCCAAAAGTGGCCTCTTTGT




CTA





FYN
ADXCRPD.8770.C1_at
GCGCGTCGTTGCAGTTGCGCCATCTGTCAGGAGCGGAGCCGGCGAGGAGGGGGCTGCCGCGG
SEQ ID




GCGAGCAGCAGGGGTCGCCGCGAGCCGAAGGCCTTCGAGACCCGCCCGCCGGCCGGCGGCGA
NO:




GAGTAGAGGCGAGGTTGTTGTGCGAGCGGCGCGTCCTCTC
1426





GRB10
ADXCRAD_BG258819_at
AAGATCAGCGGAAACGTTGAAAATAACTGGAATGATCATCTGGGGTGGGCCGCTACGAACAG
SEQ ID




AACCGCAAACAGGATGGCATGAATCTTGCCCTGGATATCTGACATTACACGGACTGTCACTA
NO:




ACGATGACACC
2496





GRB10
ADXCRAD_BI833263_at
GGGCGCGGCGCCAAAAAGCAGACCCCGAAGAGAGAGCCGCATAGGCACAAGAGGCCACAGCC
SEQ ID




AGATACCAACGGACAACAAGCTGGGCAAACAAATGGCGACACGACCGACGGAAAAAACCACG
NO:




AGGAGACACAGCCAACCCAGACGACAAACCCGAGACACGCCGCCCACAAGACAGGGAACCAC
2507




AAGCACCCCGACCGGGAGGCACACTCAAAGGACGCCGCACCCACCCACACAGGCAGGAGAGC




GCCGACCGCGGCAACAAGAGCACCCAGA





GRB10
ADXCRAG_NM_001001549_s_at
AAGCTGGCGGTAGATTTGTGATGTCACAGTGCAAACTGCAGTGACTGTAAATTGGCCTGGCG
SEQ ID




TGTATAAACGTTTTCAGGGAATGCAGAAGGTATTAATGAAGAGACAAAACCTTTATTCCATG
NO:




TGCTTTGCTTCATTCTGTACATAGCTCTTTGGCTCGTGAACCTAATTGTAAACTTTCAGGTA
1007




TTTTTGTACAAATAAGGGACTGATGTTCTGTTTCTTGTAATT





GRB10
ADXCRPD.15300.C1_at
CAGAGGTGTGAAGGCTCGCCATAGAGGAGGGCTTGTTGAGTGTCACTCCTGGAGCCTACGGA
SEQ ID




GTCGCAGGGAGGCCTGGCATGGTCAGGTAGACTTGGTAAGGCCTGACTGCTGGGGAATGTAT
NO:




CCTGCCAATAGATTCCTGGGCCTGGAACAGCTCTTCTTTGGACACATGCCATCCATCTTTGG
1740




AATAAGACAATCTGGCATTTATGTACCTGGTGGGTTACC





IFRD1
ADXCRAD_BI823993_s_at
TGTCGAGATAAGAGAGCAGATGTTGGAGAATTCTTCTAGATTTTCAGAACTTGAAGACTATT
SEQ ID




TTCTAATTTCTATTTTTTTTTCTATTTCAATGTATTTAAACTCTAGACACAGTTTTTATCCT
NO:




GGATTAACTTAGATAACTTTTGTAGCAGTGGTTATATTGCTT
2616





IFRD1
ADXCRPD.4641.C1_s_at
CCTGTCACTGGCATCAACAAAAGGAATTATACCATGAGACCTTATAGCTGTACTTAAAAGCC
SEQ ID




ATTCAGTTCAGCTATTGGGAGTTCATGATGAATTAGCATATGCCAGAAAGGTTGCTAACCTT
NO:




AACATCTGAGAGCAGTAACAC
1690





IFRD1
RDCR181_H11_at
CTGTCCGTGTTTATTGCAGTTCTCTGGTTTGTCTGGAGTGTTTGCAAGTCAGTCATCATAGT
SEQ ID




GGCAGCTTCCGCCTGCTACAGGATATTTATATATGGAAGCATACCATGGCAGGAGTGCTGGA
NO:




AAGGTGGTGTCAGCTAACAGTTGCTTCAGCCAGATAAGGACGGTAACTTCAGTCCAATAAAA
1352




AACCTCATCAGTTACCAACTAAATCAAGGCAT





IFRD1
RDCR181_H11_x_at
TGTCCGTGTTTATTGCAGTTCTCTGGTTTGTCTGGAGTGTTTGCAAGTCAGTCATCATAGTG
SEQ ID




GCAGCTTCCGCCTGCTACAGGATATTTATATATGGAAGCATACCATGGCAGGAGTGCTGGAA
NO:




AGGTGGTGTCAGCTAACAGTTGCTTCAGCCAGATAAGGACGGTAACTTCAGTCCAATAAAAA
1353




ACCTCATCAGTTACCAACTAAATCAAGGCAT





IL6ST
ADXCRAD_AU280467_s_at
GATAACAGTTACTCCAGTATATGCTGATGGACCAGGAAGCCCTGAATCCATAAAGGCATACC
SEQ ID




TTAAACAAGCTCCACCTTCCAAAGGACCTACTGTTCGGACAAAAAAAGTAGGGAAAAACGAA
NO:




GCTGTCTTAGAGTGGGACCAACTTCCTGTTGATGTTCAGAATGGATTTATCAGAAATTATAC
2508




TATATTTTATAGAACCATCATTGGAAATGAAACTGCTGTGAATGTGGATTCTTCCCACACAG




AATATACATTGTCCTCTTTGACTAGTG





IL6ST
ADXCRAD_AV662263_s_at
CTGATGTAAGTGTTGTGGAAATAGAAGCAAATGACAAAAAGCCTTTTCCAGAAGATCTGAAA
SEQ ID




TCATTGGACCTGTTCAAAAAGGAAAAAATTAATACTGAAGGACACAGCAGTGGTATTGGGGG
NO:




GTCTTCATGCATGTCATCTTCTAGGCCAAGCATTTCTAGCAGTG
2434





IL6ST
ADXCRAD_BQ887381_at
AGGGATTTTTACCACATGAAAGTCATTCCAGTGGACCCTAACCTCCTTATTGGTGGAAGG
SEQ ID




TTAGTG
NO:





2658





IL6ST
ADXCRAD_BQ887381_s_at
TTTTACTATGGATCAGTCGGCACTCGGGAACAGCAGCAAGGAAAAAAAGCAAATTTCATTC
SEQ ID




ACATGTTC
NO:





2659





IL6ST
ADXCRAD_BQ887381_x_at
TTTTACTATGGATCAGTCGGCACTCGGGAACAGCAGCAAGGAAAAAAAGCAAATTTCATTCA
SEQ ID




CATGTTCTGGGTTCATACCTCTTCTCTACCTAATTGGTCATTTTAAATTTCCAGCCTTATTC
NO:




CCTGGATAAGGGATTTTTACCACATGAAAGTCATTCCAGTGGACCCTAACCTCCTTATTGGT
2660




GGAAGGTTAGTG





IL6ST
ADXCRAD_CN265168_s_at
AACAGTTGGCATGGAGGCTGCGACTGATGAAGGCATGCCTAAAAGTTACTTACCACAGACTG
SEQ ID




TACGGCAAGGCGGCTACATGCCTCAGTGAAGGACTAGTAGTTCCTGCTACAACTTCAGCAGT
NO:




ACCTATAAAGTAAAGCTAAAATGATTTTATCTGTGAATTCAGATTTTAAAAAGTCTTCACTC
1054




TCTGAAGATGATCATTTGCCCTTAAGGACAAAAATGAACTGAAGTTTCACATGAGCTATTTC




CATTCCAGAATATCTGGGATTCTACTTTAAGCACTA





IL6ST
ADXCRPD.11859.C1_at
AAATGCTTGGCCTAGAAGATGACATGCATGAAGACCCCCCAATACCACTGCTGTGTCCTTCA
SEQ ID




GTATTAATTTTTTCCTTTTTGAACAGGTCCAATGATTTCAGATCTTCTGGAAAAGGCTTATT
NO:




GTCATTTGCTTCTATTTCCACAACACTTACATCAGTGAAATTGCCATCTGAATACATTTGAT
1581




CTTCCGAATTAAAATTGTGCCTTGGAGGAGTGTGAGGTGACCACTGGGCAATATGACTCTTT




GAAGGATCTGGAACATTAGGCCAGATGTGTAAACAATTAGGTCTCGCTTAT





IL6ST
ADXCRPD.13648.C1_at
GATAGACCATCTAAAGCACCAAGTTTCTGGTATAAAATAGATCCATCCCATACTCAAGGCTA
SEQ ID




CAGAACTGTACAACTCGTGTGGGAGACATTGCCTCCTTT
NO:




1687





IL6ST
ADXCRPD.13648.C1_x_at
ATATGTGTATAGGATTCGCTGTATGAAGGAAGATGGTAAGGGATACTGGAGTGACTGGAGTG
SEQ ID




AAGAAGCAAGTGGGATCACCTATGAAGATAGACCATCTAAAGCACCAAGTTTCTGGTATAAA
NO:




ATAGATCCATCCCATACTCAAGGCTACAGAACTGTACAACTCGTGTGGGAGACATTGCCTCC
1688




TTTTGAAGCCAAT





IL6ST
ADXCRPD.14481.C1_s_at
TGTTTACTAACATATATTGACCAAGTACATCAAGCAGGAGAGATCTTCCTTCATTCTGTTAT
SEQ ID




AGTCCACATCATTCTAATTTTGCTCAGTTGTTATTAAGAGCATATTCCTAAACCATACACTT
NO:




TTGTTTCAATAAAGTTTTATTTTGTTGAGATGAATAAAATAACAAAGTTATAAGCTGCATAA
1707




GACAAAAGTTCAATT





IL6ST
ADXCRPDRC.11859.C1_s_at
ACACTTCGAGCACTGTCCAGTATTCTACCGTGGTACACAGTGGCTACAGACACCAAGTTCCG
SEQ ID




TCAGTCCAAGTCTTCTCAAGATCCGAGTCTACCCAGCCCTTGTTAGATTCAGAGGAGTGGCC
NO:




AGAAGATCTACAATTAGTAGATCATGTAGATGGCGGTGATGGTATTTTTCCCAGGCAACAGT
1971




ACTTCAAACAGTACTGCAGTCAGCATGAATCCAGTCCAGATATTTCACATTTTGAAAGGTCA




AAGCAAGTTTCATCAGTCAATGAGG





JUN
ADXCRAD_AJ712294_s_at
AGGAAGCGCATGAGGAACCGCATCGCTGCCTCCAAGTGCCGAAAAAGGAAGCTGGAGAGAAT
SEQ ID




CGCCCGGCTGGAGGAAAAAGTGAAAACCTTGAAAGCTCAGAACTCGGAGCTGGCGTCCACGG
NO:




CCAACATGCTCAGGGAACAGGTGGCACAGCTTAAACAGAAAGTCATGAACCACGTTAACAGT
2719




GGGTGCCAACTCATGCTAACGCAGCAGTTGCAAACATTTTGA





JUN
ADXCRAD_NM_002228_s_at
CAGCCCACTGAGAAGTCAAACATTTCAAAGTTTGGATTGTATCAAGTGGCATGTGCTGTGAC
SEQ ID




CATTTATAATGTTAGTAGAAATTTTACAATAGGTGCTTATTCTCAAAGCAGGAATTGGTGGC
NO:




AGATTTTACAAAAGATGTATCCTTCCAATTTGGAATCTTCTCTTTGACAATTCCTAGATAAA
2694




AAGATGGCCTTTGCTTATGAATATTTATAACAGCATTCTTGTCACAATAAATGT





JUN
ADXCRIH.716.C2_at
GATGAAAAGCTGATTACTGTTCAATAAACAGCTTCCTGCCTTT
SEQ ID





NO:





1287





JUN
ADXCRIH.716.C2_s_at
CAAACTGCAATAGAGACTGTAGATTGCTTCTGTAGTACTCCTTAAGAACACAAAGCGGGGGG
SEQ ID




AGGGTTGGGGAGGGGCGGCAGGAGGGAGGTTTGTGAGAGCGAGGCTGAGCCTACAGATGAAC
NO:




TCTTTCTGGCCTGCCTTCGTTAACTGTGTATGT
1288





JUN
ADXCRPDRC.3805.C1_s_at
AACTTGTGCGCGCAGCCCAAACTAACCTCACGTGAAGTGACGGACTGTTCTATGACTGCAAA
SEQ ID




GATGGAAACGACCTTCTATGACGATGCCCTCAACGCCTCGTTCCTCCCGTCCGAGAGCGGAC
NO:




CTTATGGCTACAGTAACCCCAAGATCCTGAAA
2045





KIF2C
ADXCRAD_CV804054_at
GCAGCCTGAAAAGCAGGCTAGCAGACAAATAAACAGCAAGAAAACGGCCCCATTGACGACTG
SEQ ID




GCAATAAAAAT
NO:





2651





KIF2C
ADXCRAD_CV804054_s_at
CTGGAGACCTTTGTGAACAAAGCGGAATCTGCTCTGGCCCAGCAAGCCAAGCATTTCTCAGC
SEQ ID




CCTGCGAGATGTCATCAAGGC
NO:





2652





KIF2C
ADXCRPD.737.C1_s_at
AGCATCCTGCCTGCGTGGACTGGCTGCTAATGGAGAGCTCCCTGGGGTTGTCCTGGCTCTGG
SEQ ID




GGAGAGAGACGGAGCCTTTAGTACAGCTATCTGCTGGCTCTAAACCTTCTACGCCTTTGGGC
NO:




CGAGCACTGAATGTCTTGTACTTTAA
1607





LEPRE1
ADXCRAD_CN309928_s_at
AGACGGATGGGTGACTAGACCCATGGAGAGGAACTCTTCTGCACTCTGAGCTGGCCAGCCCC
SEQ ID




TCGGGGCTGCAGAGCAGTGAGCCTACATCTGCCACTCAGCCGAGGGGACCCTGCTCACAGCC
NO:




TTCTACATGGTGCTACTGCTCTTGGAGTGGACATGACCAGACACCGCACCCCCTGGATCTGG
1914




CTGAGGGCTCAGGACACAGGCCCAGCCACCCCCAGGGGCCTCCACAGGCCGCTGCATAACAG




CGATACAGTACTTAAGTGTCTGTGTAGACAACCAAAGAATAA





LEPROT
ADXCRPD.1565.C1_at
TTGCCTGCCAACACAAGGCCGCAGTCCCCATTTGATCACAGCCACACGAGCAAGAATAACAG
SEQ ID




GAAATCCAAAGGCAGAAACAACAATTCCAGTAGTGAAGAAATATGCCAGTTCCCGACAGGCA
NO:




CTACTGGTTGCATCTGAGTCATAGGTGACTCTTTTGGCAATGAAATGGGGGATGGGGGAGAT
1442




GGCGTGGAAAATCAGGACGAATAAGGGCCAGTAAACGCCATAATCCTCTAAGGCACATCCCA




GCATAAGAAAAGTCAGTCCAATAGCCCCACTGAAGGATAATGGCCCGA





LEPROT
ADXCRPDRC.1565.C1_s_at
CTGAAGCCCCACTCTGGACCCAGGACATTTTGATGAGATCCAAAGGAGTTGTATGCACATGA
SEQ ID




AAGTTTGAGAAGCATCATCATAGAGAAGTAAACATCACACCCAACTTCCTTATCTTTCCAGT
NO:




GGCTAAACCACTTAACCTCTCTGGGTGTTACCTGCTCATTTGTTT
1933





LGALS1
ADXCRIH.2899.C1_at
GAAAGACAGCCTCCCGCTGCTCGGTCCCCCAGGCCCCGCCGTCCTTGCTGTTGCACACGATG
SEQ ID




GTGTTGGCGTCGCCGTGGGCGTTGAAGCGAGGGTTGAAGTGCAGGCACAGGTTGTTGCTGTC
NO:




TTTGCCCAGGTTCAGCACGAAGCTCTTAGCGTCAGGAGCCACCTCGCCTCGCACTCGAAGGC
1181




ACTCTCCAGGTTTGAGATTCAGGTTGCTGGCGACCAGACCACAAGCCATGATT





LGALS1
ADXCRIHRC.2899.C1_at
AACACCATCGTGTGCAACAGCAAGGACGGCGGGGCCTGGGGGACCGAGCAGCGGGAGGCTGT
SEQ ID




CTTTCCCTTCCAGCCTGGAAGTGTTGCAGAGGTGTGCATCACCTTCGACCAGGCCAACCTGA
NO:




CCGTCAAGCTGCCAGATGGATACGAATTCAAGTTCCCCAACCGCCTCAACCTGGAGGCCATC




AACTACATGGCAGCTGACGGTGACTTCAAGATCAAATGTGTGGCCTTTGACTGAAATCAGCC




AGCCCATGGC





LHFPL2
ADXCRAG_AY309920_s_at
CTGGGATTTCTTCTGAGACTGTGGTGAAACTCCTTCCAAGGCTGAGGGGGTCAGTAGGTGCT
SEQ ID




CTGGAGGGACTCGGCACCACTTGATATTCAACAGCCACTTGAGCCAAATATAAAATTGTATT
NO:




TACAGCTGATGGACTCAATTTGAGCCTTCAAACTTGTAGTTATCCTATTATATTGTAAACTA
905




ATACATTGTCTAGCATTGATTTGGTTCCTGTGCATATGTATTTTCACTATGTGCTCCCCTCC




CCAGATCTTAATTAAACCAG





LHFPL2
ADXCRPD.5554.C1_at
AGAAGAAATCCCAGTCGTGCCTTTAACTCTTTTGGCCCTTGGGAGTCATTGCAACCCCAATA
SEQ ID




CAAATGCCGGCCCAGGGATTTCCAGTGGCCACAAGTTATTGCACAGAGAGGTCTGTTCTAAG
NO:




CCAGACTCTTACAGCTAAGGAGGTGTGAGATTAGCCCTTAAATACTGGTCTAGCATTAGCAT
1723




GGTCTATAAAAGCATGTTAAGAAATAGCTCCTCAGTGATTATGTACCAGCTACTAGTTATCC




TACTAAGAGAAAAGGCAACATGGCAGCTTCACATTTC





LHFPL2
ADXCRPDRC.5554.C1_at
AAATATCTTGCGTTAGCGTGAAAGTATGTTGANTTAACACGGGGAGCCCGCCCCGAACTACC
SEQ ID




ATGCAAGAACCCCCGCCGAAAAACGAGACTTTTGTGTATCGCCGTGATGTCGGGGCGGTGGG
NO:




GAACACTCGCCGGCGGGTGGCANAGCGCGGGGGTGGCACAAAGATTGATTACCCCGCAATAA
2008




GACCGGCCCGATCGTGCAACACGGCGCGTCTTCATTCTCGCGCCACAACCCCTATATTATTG




TTCTCATCAGCGACGGTTCTTTGTACGACAATGCACACGG





LHFPL2
ADXCRSS.Hs#S1449485_at
TACTTCCATGCATCAGATTTATGACAAAAGCAATTATATAAGCAGCAAAGGCAAAACCCCCA
SEQ ID




CGTGTCTGTCTCTGCTTTTCCTTTTATTGCTTTTTTTCATGTGGGCCTCTTTCACCCTCAAT
NO:




CATTGCTCACTTCCAAGAAGGCTGAGCCTGCATACACCAGGCCCTTCACCACCACTGCCAGC
2070




GCCATTCCCACGACCACACACCCTTCACCCCAGCCCTGCAGAGGCAGGGTTCAGCCCCAGGG




CAATCTATCTGGTCAGACTGGTGG





LIMA1
ADXCRAD_BP321052_s_at
GACCATCCTCCTGCTGAAGTGACAAGCCACGCTGCTTCTGGAGCCAAAGCTGACCAAGAAGA
SEQ ID




ACAAATCCACCCCAGATCTAGACTCAGGTCACCTCCTGAAGCCCTCGTTCAGGGTCGATATC
NO:




CCCACATCAAGGACGGTGAGGATCTT
2752





LIMA1
ADXCRAD_BX365807_s_at
TTTTATCACAGTATTCTCAGGGTGAAATTAAACCAACTATAGGCCTTTTTCTTGGGATGATT
SEQ ID




TTCTAGTCTTAAGGTTTGGGGACATTATAAACTTGAGTACATTTGTTGTACACAGTTGATAT
NO:




TCCAAATTGTATGGATGGGAGGGAGAGGTGTCTTAAGCTGTAGGCTTTTCTTTGTACTGCAT
1229




TTATAGAGATTTAGCTTTAATATTTTTTAGAGATGTAAAACATTCTGCTTTCTTAGTCTTAC




CTAGTCTGAAACATT





LIMA1
ADXCRAD_CD653165_at
AACACAAAAACCTTCTAATCTAGAGATACTTACTAATCTCATTACATGAGAATGCTATGCTG
SEQ ID




TAGTGTACTGGGATATCACTGAATACCAATCATGATCCAAGATATAGA
NO:





2337





LIMA1
ADXCRSS.Hs#S1914330_at
CCTCGCTAACACTTGTCAAACTATATTTTAACTATACCCCACAATAAGAAATATTTTACATT
SEQ ID




CCTACTCAGTTTATACACATACAAATAACTGAAACAAAAACTTTAGAAAAAACCTACCTATA
NO:




CTATGTCTGATGCACTTTGACATTTTCGATTGCATTCTGTTCTTTTTCATCAAAACAAACAT
2087




GTTGCTTCTGATCGCTCAAGTTGCTTTTACA





LIMA1
ADXCRSS.Hs#S3738155_at
TTCTCTATGTTGCCTCACTTTATTTCTGAGAAAATAGTTGTTACATATCATTTCTTCCAAGT
SEQ ID




AACTCAAAGTGCAAATATAAATGTGACAAATCGGGGAAACATTCCAAATTAACTCATTTTAA
NO:




TCATAGAGTCTTACAGAAGGAAGTAACCAAGATGTCACTTTCTCCAGCTTTCCTTTCTGAGC
2105




AATCCTTCCTAAAATACTCTTGAAAGATGTTTTGGCATCTGTGTGACATTTCTAGCTATTAG




ATAGCTCTAGCTAGACAGCTTCTCC





LIMA1
ADXCRSS.Hs#S3738155_x_at
TAGCCCCTGGAGAGCATGTCTTTTTCTCTATGTTGCCTCACTTTATTTCTGAGAAAATAGTT
SEQ ID




GTTACATATCATTTCTTCCAAGTAACTCAAAGTGCAAATATAAATGTGACAAATCGGGGAAA
NO:




CATTCCAAATTAACTCATTTTAATCATAGAGTCTTACAGAAGGAAGTAACCAAGATGTCACT
2106




TTCTCCAGCTTTCCTTTCTGAGCAATCCTTCCTAAAATACTCTTGAAAGATGTTTTGGCATC




TGTGTGACATTTCTAGCTATTAGATAGCTCTAGCTAGACAGCTTCTCC





LOX
ADXCRAD_CV574618_s_at
TAGAAGGCAAAGCAAAACTCCCAATGGATAAATCAGTGCCTGGTGTTCTGAAGTGGGAAAAA
SEQ ID




ATAGACTAACTTCAGTAGGATTTATGTATTTTGAAAAAGAGAACAGAAAACAACAAAAGAAT
NO:




TTTTGTTTGGACTGTTTTCAATAACAAAGCACATAACTGGATTTTGAACGCTTAAGTCATCA
1013




TTACTTGGGAAATTTTTAATGTTTATTATTTACATCACTTTGTGAATTAACACAGTGTTTCA




ATTCTGTAATTACATATTTGACTCTT





LOXL2
ADXCRAD_BI825165_at
GGAATAACAAGAAAGATCTATGAACAGAACACAAACAAACACAGCAAGCTAACAAAA
SEQ ID





NO:





2695





LOXL2
ADXCRAD_CF619371_at
CCATGGTGGGTCTGCCCGCCAGCTGGGCCTTGGGAATTCGCCCACCAAACGCCTTTCAAGAA
SEQ ID




AACCTTGGTTATTGGGCCCCGGAAGATGTTCAACAGCCCAACAA
NO:





2405





LOXL2
ADXCRAG_AF117949_s_at
GAAACTTGTCAGAAGGCATAGGAGTTGTGCGAGGGCTGGATGGGAAGTCTAGATTTAAACAG
SEQ ID




CCACCAGGCAGCTTATCAAAGCAAGAGGGCATCCGTTCACAGGACAGGGGCTCCCAGCAATT
NO:




CCCAGTGGCAGTGGGGGGTGGCTGGCCCAAGCCCCAAGTCACCCAGACACAGGGGACTTCCC
858




CTTGTGTCAACAGCATGCTAGGGCCCAGCAAACTAGAGGGTAGGTAGGACCACCTTGGCACC




AA





LOXL2
ADXCRAG_NM_002318_s_at
CACCCCTTGTTTTTCAAGATACTATTATTATATTTTCACAGACTTTTGAAGCACAAATTTAT
SEQ ID




TGGCATTTAATATTGGACATCTGGGCCCTTGGAAGTACAAATCTAAGGAAAAACCAACCCAC
NO:




TGTGTAAGTGACTCATCTTCCTGTTGTTCCAATTCTGTGGGTTTTTGATTCAACGGTGCTAT
1014




AACCAGGGTCCTGG





LOXL2
ADXCRPD.4590.C1_at
GGGTTGCTCTGGCTTGTACGCTTTCCGGAATCTCGAGGGTCCGTCAGGGCTGAAGACCTGCC
SEQ ID




CAGGCACACAACTCACCACGGCCGGTAGCCCATTCTCGCAGGTGACATTCTTCATGGGGTCC
NO:




AGTGACACCTGGGGGCCCAGCTTGCAGCTGGAGATGTGGGCCTCTGTGCCGGTGCAGTCCAT
1674




GGAGAATGGCCAGTAGCGCTGCTTCCTCCGTGAAGCACACATTTTGTACACTTT





LOXL2
ADXCRPDRC.4590.C1_s_at
ACCGTCTGCGACGACAAGTGGGACCTGGTGTCGGCCAGTGTGGTCTGCAGAGAGCTGGGCTT
SEQ ID




TGGGAGTGCCAAAGAGGCAGTCACTGGCTCCCGACTGGGGCAAGGGATCGGACCCATCCACC
NO:




TCAACGAGATCCAGTGCACAGGCAATGAGAAGTCCATTATAGACTGCAAGTTCAATGCCGAG
1997




TCTCAGGGCTGCAACCACGAGGAGGATGCTGGTGTGAGATGCAACACCCCTGCCAT





LPP
ADXCRAD_AI079544_at
GACCTAAAACTGTCTCCAGGACACAAGGCTATTCCAAGCAACATTAAGAGAGAGCTCTGTAG
SEQ ID




GAAAAGAGGGTCTTGTCAACACAATTCTCAGAATAA
NO:





2852





LPP
ADXCRAD_AI079544_s_at
GGACTCACAAGTCATACCCTACTAAACACCCATCAGATGGACTTGTCTACTTTATTGAGAAA
SEQ ID




CAACAGAAGATAGACCTGCAAGTCCAGCTGTTCATCTACCTCCACCCCACAGCCCAAGCCAC
NO:




ATTCCCACCCTTTGTGGATGAAGCTCAGGGATGCAGATCCCATTCCAAGATCC
2853





LPP
ADXCRAD_AL833171_at
TTGGCCTATTCTGGACTGCAAATAGCATTGCCAAGCACTTCCCTTAAATAACTTCTCTTTTT
SEQ ID




TGCAGGACTATCCTCTCAGCCCTGCCAAAACCCCATCACCTACTCTTTCTTTACTACTTTGC
NO:




CTATTTAATGCTGGAATTTTTATTTAAACTGTAGCTGATTTACTGAAGGTAATTAAGTGCTT
2784




TCATGCTGTAGATCTCCTGCTAGACTACAGGCTGTACTTGGGAGTGAGAGTGAACCAAATGT




AA





LPP
ADXCRAD_BM456598_at
TTGTCTTGGAAGTATCTCATAGGTCTTTAAATGAGTAAAACATTTTTATGCCAGAAGGTGAT
SEQ ID




ATAATGGATGTTAGTGTTTTTTATTGGATTTTACAGGAGTTTTAGTCAGATAATGAGGACAG
NO:




AGACCTCCACTTGAATTCTTTACCACCATTTCAGCAATATTTTTTTAATGGCCTTTCACTTG
2400




GATTTTGGCTTAAATAAGGGCCCCGAACAAGATCCAAAACTTTGTGTCCTCAGGGAAGGGCC




ATTAATA





LPP
ADXCRAD_BM456598_x_at
TTGTCTTGGAAGTATCTCATAGGTCTTTAAATGAGTAAAACATTTTTATGCCAGAAGGTGAT
SEQ ID




ATAATGGATGTTAGTGTTTTTTATTGGATTTTACAGGAGTTTTAGTCAGATAATGAGGACAG
NO:




AGACCTCCACTTGAATTCTTTACCACCATTTCAGCAATATTTTTTTAATGGCCTTTCACTTG
2401




GATTTTGGCTTAAATAAGGGCCCCGAACAAGATCCAAAACTTTGTGTCCTCAGGGAAGGGCC




ATTAATA





LPP
ADXCRAD_CX867590_at
TCTTGATGGGCCTTTTGTCCCAGGACTTCCACATTT
SEQ ID





NO:





2618





LPP
ADXCRAG_BX648297_s_at
GTAGGGTATGACTTGTGAGTCCACAAGGCCAGCAGTATATATGCTGAATGGACTGCTTAGCA
SEQ ID




GTAACACACTGGAAAAATCCAAAAAGAATGGATTTCAAGTTGGCAAAAAATGCATTAGAAGT
NO:




CAGCAGTGTGATGTGGTCAGGAGAACAACCAGAGTGACTGTGGGATGAGGTCTTGGATAGCT
984




TTGTT





LPP
ADXCRAG_NM_005578_at
AAATAAGTCATGTGTCCCAGCATAAGGCATCAGGTTGTTAGATGCTGGCATCTCTGCAGCTC
SEQ ID




AAAGATGTGGGTTCTTTTTCTTGTCATTAACACATTGTTATTTCTGTAGGACCAACTTCTCT
NO:




GATCAAAATTACTTTTCTGGGTATGTGCTGATTAAGGGGGTGGACTTATCAACACTATAATT
1031




GTTCCCTATGAAAGATTCCACAGAGATGTTTATGGTGA





LPP
ADXCRPD.11183.C1_at
GAATGACCAACAATTTGGCTTTCCTAGAAAGAGAAGAGAATATCTGAATTCCCTGTAAACTG
SEQ ID




GTAAATCCTCTACCATCAGTCCTGAATTCTGAGGGGGCCTGATATTTAAGCAACAAAACTTA
NO:




GAAGGTTCCACCTGTTATTCCTAGCTCTGTCACTAAAAATCGTGTCCAAACAGAGGTAATAC
1437




GAATGTGTTACCCGTTCCCGAAATTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCC




AGAGCACAGAATGGATCCAGTGTAGTAGTGCAGGTGACCA





LPP
ADXCRPD.14604.C1_at
AATACCGAACTAATGGTCCTTGTCTCAATGACCTGCCTATCCTTTGTCCCTTCATGGGAATC
SEQ ID




TTCTCACAGATCAAGTTACTATGATCTACAAGGCCAGTTCCCATAGCCTCGTTCCACTTACA
NO:




CACGATCTTAACCATTTCTGTCCAGTGGGAGTCACCCACTCACCTCCTAAAACCTCTATGCA
1731




TGCCCCATACCCCTAGTCATAATACTCTTATACAAATGTTTAACACTTTGCAGTTGAAGACC




CAAT





LPP
ADXCRPD.16626.C1_s_at
CTAGATGATTCCAGTGCCCTTCCATCTATCTCTGGAAACTTTCCTCCTCCACCACCTCTTGA
SEQ ID




TGAAGAGGCTTTCAAAGTACAGGGGAATCCCGGAGGCAAGACACTTGAGGAGAGGCGCTCCA
NO:




GCCTGGACGCTGAGATTGACTCCTTGA
1828





LPP
ADXCRPD.16635.C1_at
TTAGTTAAGAACATGACCCGAAGAGTGAAAGGTATTTCCTGTTCCAAATAGGAGCCCAGTCT
SEQ ID




GCATTTTCTACTACATGATTTAGTAGAAAGACACATTGCATTTGAACCATATTTCTTCTGCT
NO:




AGCCAATTCCATCTTATCTACAACTTTTTGATAATTATTTTGAGAAATAGATCTAGATCACA
1831




GCCTTCCAATTCCTAGGCCAGGATACTT





LPP
ADXCRPD.5328.C1_s_at
GAGCTATAGTACATGTGTGTTATGAATGAAATATGACAGCATGTTCCATACCCCTGCTTTAG
SEQ ID




CCATCTGTGGGAAACCAGCAAACTGAAAAAGACACCTCTGCAAAATGTGCCTCAAGTCCATT
NO:




TCTTGGGATCGCTCGTTTGGTGCACTCTCGTGGGAGACAATCAGAGAACAACATATACTTGT
1693




GCCTTATTTTCA





LPP
ADXCRPD.9098.C1_at
GCATCCACAGTGAATGGGATCCCATCCAGGCTGCGGTGGCACATCACCGCAGGGTGAAACAG
SEQ ID




GTGAGGATGATTAGGCCTTCCCGGTGGCTCGGAGAATCCGCTCCATGATGGGCTTGGAACAC
NO:




ACATTGCACTGCTCCAGAGTATTAATGTAGCAGGGCTCGCAGTATGCTTTCTTTTCCACAGC
1872




ATAAAATGGCTGCCCTCGGAGCTTGTTGTTGAGATGATGCANGTNAAACAATCCACGTGGAA




GACCTGATCCATGGCAGTGCATTCTGTACCTTTCCCAACTA





LPP
ADXCRPDRC.9098.C1_s_at
AGGAGACTGTCCGTATTGTGGCTTTGGATCGAGATTTCCATGTTCACTGCTACCGATGCGAG
SEQ ID




GATTGCGGTGGTCTCCTGTCTGAAGGAGATAACCAAGGCTGCTACCCCTTGGATGGGCACAT
NO:




CCTCTGCAAGACCTGCAACTCTGCCCGCATCAGGGTGTTGACCGCCAAGGCGAGCACTGACC
2040




TTTAGATTCAGTCACCTGTTCAGCCG





LPP
ADXCRSS.Hs#S1294625_at
TGAAGGTCTTCAGCAAAAATTTGGACTGTAAACACAGCTTGGCATTATCAGCATTCTGTTAA
SEQ ID




GTTCAAAGAAGAGATAGTTACAACAAATACAGCTTGCTTTATTTCTGAAACAAAACTGTGCA
NO:




CATATTTGTGGCCATACTACTAATTAACCTGTAGATTGTTCCTTTCATCTATTCAGCGTGTT
2063




TTTCTGCCCCCTGTTACAACAGTGTTGGGTTACTTTTCCCATATGGACTATATTTAAACAGT




TCCCTTATAGGCATTAGAG





LPP
ADXCRSS.Hs#S1908923_at
TGCCCTTTTTTGTGCCTGGGCTTCATCCTTGGAATGTTTTACCTCATGGGCCATGAGACGGC




TGCCTGCTGAAACCCAAACTATAGATATCCCTGTTCCCATTTAGGGGAAAGAGCCTGGTTTG
SEQ ID




CTATATTCTCATAGGCTTGGCTGACTGTATATTTCTGAACCAGTCATTGAAGCCAAGAGAAT
NO:




GGGATTATGGTAATATGAACCACTATTCTCCTGAAACTGAATTTGGACATAGTCCCATCCAA
2119




ACCTCATGGTACTTACACAGTGG





LPP
ADXCRSS.Hs#S1910599_at
GAAGACAACAACAGGTAAACGAGAAAATCCTTGGAAAAGAACACCGTTAATTTACAATAGTA
SEQ ID




TATGTCTCTCTCTGGCCAACGTACTTTGTTTCATGACACTACTGGCATCATCCATCCCAAAT
NO:




ACTTTCGGTCGCTGTGTGTTTCAGACTCTGAAAAACCTTCAAATAACACAATAAAACCTGCT
2123




CCTCTTTTCCTTTAATCTTACATAAAGGCAGTTCTCTTAAGTCTATAGTCAAAGC





LPP
ADXCRSS.Hs#S1921588_at
GATTCAGTGGGCAACTGTGGCAATAGTTCTTGGCTAACCTGGTCACTATGGAAGTTCTTTCC
SEQ ID




GTGGAAAAAGATTCTCCATCCTTCAATTTGAGATAAGATTTACTAATTGAGACCTCATTTGT
NO:




ATCTGATTTTAATCTTTGCATCATTTTAGTTTTAATAAACTAACTTTCCAACTTACCAGATT
2104




TTCGGGTTGACAAAGACCATTATTTAGAGAAACACAGGCAAAGGAAAGTCTAAAAGCTTTGG




CTGGAATTTCAACTGCTTCTGGTCCAGAAT





LPP
ADXCRSS.Hs#S2732094_at
CAAAAATTCCTGCATATACCCACTCAGGAAATATTTTCCCAAATCTTCTCCATCTCAACTCT
SEQ ID




GTGAGGCATTGGAAGAGGTGCTTTTAGGCATAGACTGATGCACTCTATATATGATGTCTCGC
NO:




CCTCCAGGGCAGCACACAGTTTAGTGAGGTAAATGTCTCATGAATATTCCACAAGATCCACC
2109




TTGATAATGCTCTAACGTTACTCATAGAGGGCTGAATGTGGAAAGATGCTTTCGTCTGGTGG




CAAA





LPP
ADXCRSS.Hs#S2984275_at
GTAGCAGAAGCAGGACTGGAACCCAGAACCCAAGTTGGACCACTAGACTGGTGCCTCTCCCT
SEQ ID




AAGCCCACTCTGCCTCTTCCATGTCTGTGAATGAGCTTACCACTCCTAGCTATGCAAAACTG
NO:




CATAGAACCATTTCAGCAAGAGGCTCAGGTAGCATTAAAGAAGTTCCCACCTCAACGATGTC
2160




AATTTTTTGTTACTGTTGTCTTGAGGAAGCATGTTTGCTTTTAAACGCTCCCAAATTAAAAG




CCATTCTCAGCCTTCCTACAATTGTATG





LPP
ADXCRSS.Hs#S3748577_at
ATGGCAGTGAGCATTTATTCCGGGCTGAGTTTTACACTACCCATACTGTCTCTAACTCTCCC
SEQ ID




AACACTCCCACAAGGCAGGTGCTATTATCCCCATTTTACTTTTGAGAAAATTAAGGCCTAAA
NO:




GAAGTGAGAAAGCTTGTCCAAACCGCTATAGCTCTTGGGCAAAGGCATTAGTGACCAATGTG
2197




TATTTGACTCCAAAGCCCAGGATGTTAGCCACAGTGCAGGGCTACTATCCTTTTATACAATC




TGTCAGGCTTCTTCCATCCGTGGCATGTATTCATCTA





MAP4K4
ADXCRAD_BG110060_at
GAAAGCGCGAAAACAACACAGAGAACACAACAAGAGGAGATGAGTGGGCGCGTCAGAATGAA
SEQ ID




AGCGGGGGCCACCACCACGCAACCACCATGAAAGAAGACGACGCAACAGAAAACAAAAAAAG
NO:




GAGGCCGACACCATAACGGAGGAGAACAGAAGAGAGGAGAAGACATCGATCGGGGAGAAAAG
2682




AGACCACAGCAACAGACGGAACAAGGATGACGCACAACGGAGCAGAAGAA





MAP4K4
ADXCRAD_BP228866_s_at
ATATCGAAGTCCTGGCTTTTCTCGTTTTCTCACTTGCTCTCTTGTTCTCTGTTTTTTTAAAC
SEQ ID




CAATTTTACTTTATGAATATATTCATGACATTTGTAA
NO:





2343





MAP4K4
ADXCRAD_BQ647365_at
GTAGAAGCAGTGTGATCCAGGGATTACTGGCCTCCAGAGTCTTCAAGATCCTGAGAACTTGG
SEQ ID




AATTCCTTGTAACTGGAGCTCGGAGCTGCACCGAGGGCAACCAGGACAGCTGTGTGTGCAGA
NO:




CCTCATGTGTTGGGTTCTCTCCCCTCCTTCCTGTTCCTCTTATATACCAGTTTATCCCCATT
2704




CTTTTTTTTTTTCTTACTCCAAAATAAATCAAGGCTGCAATGCAGCTGGTGCTGTTCAGATT




CT





MAP4K4
ADXCRAG_BC065036_s_at
TAGGTTTTCGTCTTAGTTGTAGCACACTTACCCTAATTTTGCCAATTATTAATTTGCTAAAT
SEQ ID




AGTAATACAAATGACAAACTGCATTAAATTTACTAATTATAAAAGCTGCAAAGCAGACTGGT
NO:




GGCAAGTACACAGCCCTTTTT
975





MAP4K4
ADXCRPD.1395.C1_at
TTTCTTCTGCAAGTGCAGACTGTGGTAAAACTTTTGTTGCACGTCTAGGTTTAAACAAAAAT
SEQ ID




TAAACCTTTAACTGAGGCAGTGCTAATACTGTCACACGACAAAGTTCTGGCCATTATACAAA
NO:




ATGCACACGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNA
1397




GAACCATCTGCACATGATTTAGGCAACCTGGTACACAGAAAAATGACTGAGTTCTTGGCCAG





MAP4K4
ADXCRPD.17623.C1_s_at
AAGTTCCATTGTGAACGTGCCTGGTGAGTCTACTCTTCGCCGAGATTTCCTGAGACTGCAGC
SEQ ID




AGGAGAACAAGGAACGTTCCGAGGCTCTTCGGAGACAACAGTTACTACAGGAGCAACAGCTC
NO:




CGGGAGCAGGAAGAATATAAAAGGCAACTGCTGGCAGAGAGACAGAAGCGGATTGAGCAGCA
1402




GAAAGAACAGAGGCGACGGCTAGAAGA





MAP4K4
ADXCRPD.2985.C1_at
AGTAGGCGGCTTTGGCCTTCAGCACTGCTCCAAACTCATACAAATGAAACATCCATTTCCAT
SEQ ID




CTTCTTTTACTTCCCCAAAAAGTAAGCTTCTCAGCTTGTCTTTACAGGTATACACAAAACCA
NO:




CCAGCTGCTGTGTCTGCATTCATGAGTGGATGTACTTGTCTTACCAGATGTTTGTAGCTCAA
1603




AGGAGGGCCTTTTTCAAAAAGATGGAACCAGGAACAGGAAACTGACAAGAGGTCAGAGTGGG




TGCCAAGTGGGATGGGAAGCAAACAGGTACAAATGGCCGGACGCGT





MAP4K4
ADXCRPDRC.1395.C1_s_at
AATGCAATGCACTAAAACTATTTTAAGAATGTAGTTAATTCTGCTTATTCATAAAGTGGGCA
SEQ ID




TCT
NO:





1923





MAP4K4
ADXCRPDRC.2985.C1_s_at
ATTTGTATGAGTTTGGAGCAGTGCTGAAGGCCAAAGCCGCCTACTGGTTTGTAGTTAACCTA
SEQ ID




GAGAAGGTTGAAAAATTAATCCTACCTTTAAAGGGATTTGAGGTAGGCTGGATTCCATCGCC
NO:




ACAGGACTTTAGTTAGAATTAAATTCCTGCTTGTAATTTATATCCATGTTTAGGCTTTTCAT
1973




AAGATGAAACATGCCACAGTGAACACACTCGTGTA





MAP4K4
ADXCRSS.Hs#S1921392_at
GACAAAAGCCTCTGAAGTAGGCATTATTCCATTTTACAGATGAGGAAACTGAGCTTTATCAT
SEQ ID




GCTTAAAAGTATGTATTGCTGTCTTGGGGAAAAAGGCAGGATATGACTACTAAATAATGAGG
NO:




TTAACTGCCTAGGAGGCTCATACACTATAAATTCACCTTGAAAATTATTTATGGGCCTCAAA
2101




TTTATGTTCCTGGGAAAGAGGAGCAAAAGATTAAATCATTTTTATTAGTTCAGTGACAATTC




TAAAAATGAAACCCAGAAATGTACTCACTCCTAACCACTC





MAP4K4
ADXCRSS.Hs#S1921392_x_at
GACAAAAGCCTCTGAAGTAGGCATTATTCCATTTTACAGATGAGGAAACTGAGCTTTATCAT
SEQ ID




GCTTAAAAGTATGTATTGCTGTCTTGGGGAAAAAGGCAGGATATGACTACTAAATAATGAGG
NO:




TTAACTGCCTAGGAGGCTCATACACTATAAATTCACCTTGAAAATTATTTATGGGCCTCAAA
2102




TTTATGTTCCTGGGAAAGAGGAGCAAAAGATTAAATCATTTTTATTAGTTCAGTGACAATTC




TAAAAATGAAACCCAGAAATGTACTCACTCCTAACCACTC





MAP4K4
ADXCRSS.Hs#S2732925_at
TACCATGATCTCTTTGTGCTTCCTCATCTTTCATTGGCAAATCTCTGGAATGGGCCATATAA
SEQ ID




ATGCAGCCCTCAAATCCTTAACAGCTTATGATTCGGCTTCCATCACTCACATTTAAGCTTTT
NO:




CTTAAAGATCACTTTCCACCATCATCAAGAAACAACTGTAGTCAGTTCTCTTGTCCTTCCAT
2135




TTCTTAGGACTATCAAAATATTGTGATTTGATATTTGACTCACCCTACTTCTCTAACCTTGT




ACCGTCACAGT





MAP4K4
ADXCRSS.Hs#S2984613_at
TTGTTATGGAGCAGGTTCAGTAATAAGAGTTGGTGAGTATTATTCAGAAGAGAAGCTGCCTC
SEQ ID




TTGGGTTGAGTAATTAATAAAGTGATTCATTGGGAGGTAGTTTTTTGTCTGTAAGAATCTCT
NO:




AAGGAATGATCACAATGATAAGTTTTAGGACATCCCGTTTTAAAAACTGGACTCTTACAAAC
2157




TTTGTTATCTAGATAGCATTAGGTATAACTAAATTGGGGAGACAAAAGTGAAAAACGATTAA




CCATATAAGGGTGGTTTCA





MAP4K4
ADXCRSS.Hs#S2984613_x_at
TTGTTATGGAGCAGGTTCAGTAATAAGAGTTGGTGAGTATTATTCAGAAGAGAAGCTGCCTC
SEQ ID




TTGGGTTGAGTAATTAATAAAGTGATTCATTGGGAGGTAGTTTTTTGTCTGTAAGAATCTCT
NO:




AAGGAATGATCACAATGATAAGTTTTAGGACATCCCGTTTTAAAAACTGGACTCTTACAAAC
2158




TTTGTTATCTAGATAGCATTAGGTATAACTAAATTGGGGAGACAAAAGTGAAAAACGATTAA




CCATATAAGGGTGGTTTCACAATGGCACGTG





MAP7D1
ADXCRAD_BU178034_x_at
GTAAATAGCTTGTGCTCAGACTCCTCTGCGTGGAGAAGGTGGGTGCANGAGGCAGACCCTCC
SEQ ID




CCCCAAAGCCCCCTGGGGAGATCTTCCTCTCTCTATTTAACTGTAACTGAGGGGGGATCCCC
NO:




AGGTCTGGGGGATGGGGGACAACCTTGGGGCCACAGGATACTGGGTTTGCTTCAGGGGGTAC
2681




CCATGGCCCCCCTGCCCTCGGCCTGGGAATCAGTGGNTACTGGCATCTGAATTAAAATGTTC




TTCCCCGA





MAP7D1
ADXCRPD.6828.C1_s_at
TTGCCTTGATTTGGTGGGGTACAGTGGATGTGAATACTGTAAATAGCTTGTGCTCAGACTCC
SEQ ID




TCTGCGTGGAGAGGGTGGGTGCAGGAGGCAGACCCTCCCCCCAAAGCCCCCTGGGGAGATCT
NO:




TCCTCTCTCTATTTAACTGTAACTGAGGG
871





MAP7D1
ADXCRSS.Hs#S1907164_at
GGCTTAATGTGATTTGCTCCATAACACTGTGCCAATGACATTTCATCAGGGTTGGCAAAATT
SEQ ID




GTGAAGAAAATATTTGTATTCAGGGTCAATAGTGTGCCGGGTCACAAGAGGAGTTCCAAACT
NO:




TCTTGTTTGCCTCTTGAGAAGTTTTTCTTGTTGAGCTGCTGGAGTAAACACTCATTATTATT
2126




TTTATTAACTTCTACCTGTGTGGCTTAGTCCAGGAAGCTGCCCAAACACTATTGAGATGGAG




TTGTTTTGCTTCTCTTCAAATGTTTATCTTTT





MARCKS
ADXCRAD_AV732105_at
GAATGTACTTTGCTTTACAAAATGCTATAACTCTGCTTAGGNGTCTATTTTCTTGAGCCACT
SEQ ID




AAAGCGAAAATAATGT
NO:





2375





MARCKS
ADXCRAD_AV732105_s_at
ATTTTAAACTCAACCAAGCTGTGATAAGTGGAATGGTTACTGTTTATACTGTGGTATGTTTT
SEQ ID




TGATTACAGCAGATAATGCTTTCTTTTCCAGTCGTCTTTGAGAATAAAGGAAAAAAAATCTT
NO:




CAGATGCAATGGTTNTGTGTAGCATCTTGGCTATCATGTTTTGGAAATACTGGAGAAGCTTT
2376




GACCAATT





MARCKS
ADXCRAD_BM557039_at
AAAATAGCTTTTGAGGATTAACGCAAAAATAAAATAACTCCTTGTACCAGGTCCAGAAATTG
SEQ ID




GCCTATTAAAACCTGAATTTGGGCAGTATTTTATAATGGGCCATTTGGCTTGTGGGTTACA
NO:




AAA
2623





MARCKS
ADXCRAD_CD103045_at
TGAGGGAGGTTTACAGCACTACAGGTCTTGAGTTAAGAAGGAAAGAGGAAAAAGAAAAAACC
SEQ ID




CCCATACCCCGATTTAAAAAAAAAAAAAACCGATCCTTAGTCTTTAGAAGTTCCATTTAAAC
NO:




CCATAGGGAACCTTTTCCCCTTAATCCTCATGGTTAAGCCTGTACCCAGTTCCAG
2612





MARCKS
ADXCRAD_CD110028_at
CAACGGCAGCGTCCCGGCCCGCCGAACAAAGAGGAAGCCCGCGGGCCGCCGGGAAGCGGGGG
SEQ ID




GCGGCCTTCACCCCTCCCTCGGGCCCGAAAAAAGGGTGAAGTCGGGTCCCGCCGAACCGCCA
NO:




TGCCCTCCCTAAAGG
2374





MARCKS
ADXCRIH.653.C1_s_at
AGTGAATAGTCAAAAATCCTGTTAGCAAACTGTTATATATTGCTAAGTTTGTTCTTTTAACA
SEQ ID




GCTGGAATTTATTAAGATGCATTATTTTGATTTTATTCACTGCCTAAAACACTTTGGGTGGT
NO:




ATTGATGGAGTTGGTGGATTTTCCTCCAAGTGATTAAATGA
1112





MARCKS
ADXCRIHRC.653.C1_at
TTTTTGATCCATTATTCCAATTAAGAATGCGTGTCAAAACCTAATTTGTTATTTTTCTAATG
SEQ ID




AGTTTAAGATTTGGCATTCAGTTGTTACACATGTGGTTCAATGATTTATCATGAACCCTAAA
NO:




CTGCACACTGCTCAAAAACAGCAAAACAGATGTGCATTAAATGAAATAATGTTTTTGATACA
1305




TATCTTAAATTTCAATCAGTTTAGGGTCCTTTGAAGGAAAAGATATCCAGTTATCGGGTGGC




AAAGAGCAGAGGAGGTAAACTCCTCGTGCCG





MARCKS
ADXCRPD.2741.C1_at
GGGTCTCCTCTCTCGGGCGGCTACTACTCCACACCGAGAGGGAGTGTCTTACAAGGCGGCCG
SEQ ID




GCGTGCAAACAAAAAAATAATATAACCGNNNNNNNNNNNTCGGTCGCACCTATATTCGAGCA
NO:




AAGAAAAGCGTGGGTGGTAAAGTATATTCTATAAACACAATTTCCTCGCGCCCACCACGGTG
1908




GAATACCCACTCCCCATAAAACGGCCGGTGGGAGAAGACTCTCGAACACCGCCCG





MARCKS
ADXCRPD.3926.C1_at
AATCCTCCCGTCTCTCCAAAACCATCTCCCCGTCCCCTGACATTGCGGCGCTCTGANNNNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NO:




NNNNNNNGAGAGAGCTTTTTGGCGCGCGCCTTTCCCCTGGCGCTTTTCTCCCCGGGAGGATT
1672




GTTCTCCACTTTTCGCCCGTCATAGCCTAAATCCG





MARCKS
ADXCRPD.4423.C1_at
TTCAACAAAGAAACTCAACAGATCCAAGAGGGGAAACAAAGAGCCTCGGGTTGGTGTAACGA
SEQ ID




CGGGGCGAGCAGCAGCAGCAGCGGCGGCCAACAGCGGCAGCCTACAGCACACCGGAGGAAGG
NO:




GGGGTGGGGGTGGTGGAGAGGACAGAACAGAACCGATTAAATACACTCCGGATAAAAAAATT
1648




TTAGTCGAAGAGATCAAAAAGCAGCAGCACAGGAGGGAGGGAAAAAGGGTGGAAAAGTCGAG




CACCAAAAAAGGAGCCCCAGT





MARCKS
ADXCRPD.4423.C1_x_at
CCCATGCTGGCTTCTTCAACAAAGAAACTCAACAGATCCAAGAGGGGAAACAAAGAGCCTCG
SEQ ID




GGTTGGTGTAACGACGGGGCGAGCAGCAGCAGCAGCGGCGGCCAACAGCGGCAGCCTACAGC
NO:




ACACCGGAGGAAGGGGGGTGGGGGTGGTGGAGAGGACAGAACAGAACCGATTAAATACACTC
1649




CGGATAAAAAAATTTTAGTCGAAGAGATCAAAAAGCAGCAGCACAGGAGGGAGGGAAAAAGG




GTGGAAAAGTCGAGCACCAAAAAAGGAGCCCCAGT





MARCKS
ADXCRPD.8271.C1_at
CCGTCCTCGGCCTTGGGCGAAGAAGTCGAGGAGGCGGCCGACGCGGCCTCTCCCTCCGCGGC
SEQ ID




CGTGGGCGAGCCGGGCTCGGCAGCCTCGCCTTCCGCGGGGGCCTCCTTCTCTACCGGGCTGG
NO:




CCCCGGCCTCGGGGGCAGCGGCGGCTGCCGGCTCACCTTTCGCGGCCGCG
1829





MARCKS
ADXCRPD.8271.C1_x_at
CCGCTCAGCTTGAAAGACTTCTTGAAGGAAAAGCGCTTCNNNNNNNNNNNCGGGGTCTCGTT
SEQ ID




GCTGGGCGAGGGCGTGGCCCCGTCCTCGGCCTTGGGCGAAGAAGTCGAGGAGGCGGCCGACG
NO:




CGGCCTCTCCCTCCGCGGCCGTGGGCGAGCCGGGCTCGGCAGCCTCGCCTTCCGCGGGGGCC
1830




TCCTTCTCTACCGGGCTGGCCCCGGCCTCGGGGGCAGCGGCGGCTGCCGGCTCACCTTTCGC




GGCCGCGAAAGGCGACGCCGCCCCGCTCCCGGCGGACGAGGGCTCCTCCTTG





MARCKS
ADXCRPDRC.4423.C1_s_at
CGTTACACCAACCCGAGGCTCTTTGTTTCCCCTCTTGGATCTGTTGAGTTTCTTTGTTGAAG
SEQ ID




AAGCCAGCATGGGTGCCCAGTTCTCCAAGACCGCAGCGAAGGGAGAAGCCGCCGCGGAGAGG
NO:




CCTGGGGAGGCGGCTGTGGCCTCGTCGCCTTCCAAAGCGAACGGACAGGAGAATGGCCACGT
1981




GAAGGTAAACGGCGAC





MARCKS
ADXCRPDRC.8271.C1_s_at
GAAGGCGAGGCTGCCGAGCCCGGCTCGCCCACGGCCGCGGAGGGAGAGGCCGCGTCGGCCGC
SEQ ID




CTCCTCGACTTCTTCGCCCAAGGCCGAGGACGGGGCCACGCCCTCGCCCAGCAACGAGACCC
NO:




CGNNNNNNNNNNNGAAGCGCTTTTCCTTCAAGAAGTCTTTCAAGCTGAGCGGCTTCTCCTTC
2032




AAGAAGAACAAGAAGGAGGCTGGAGAAGGCGGTGAGGCTGAGGCGCCC





MARCKS
RDCR156_A02_at
GAAGTGAAATAATCATGCCTGCCCTGGCTGCTTCTGTGAGTGGAAGATCATAATTGGAGTGC
SEQ ID




ATGAAAGACTTTGTAAACTGTTAAGTGCTCTATAAACGTTAGCATTTTACTCAATAAATTTT
NO:




TATCACACATTCGATGGAATAAGGAAAGAGAATTGAAATAATACAGTTTTTCTTCATTGCCT
1347




TAGATTATAATTCAGATATAATACAGTTCATTACATTTCATAGTTGTGGCTATTTCAGTAAA




T





MARCKS
RDCR156_A02_x_at
AGTGAAATAATCATGCCTGCCCTGGCTGCTTCTGTGAGTGGAAGATCATAATTGGAGTGCAT
SEQ ID




GAAAGACTTTGTAAACTGTTAAGTGCTCTATAAACGTTAGCATTTTACTCAATAAATTTTTA
NO:




TCACACATTCGATGGAATAAGGAAAGAGAATTGAAATAATACAGTTTTTCTTCATTGCCTTA
1348




GATTATAATTCAGATATAATACAGTTCATTACATTTCATAGTTGTGGCTATTTCAGTAAAT





MSN
ADXCRAG_BC011827_s_at
AGAATGACAGACTAACTCCCAAGATAGGCTTCCCCTGGAGTGAAATCAGGAACATCTCTTTC
SEQ ID




AATGATAAGAAATTTGTCATCAAGCCCATTGACAAAAAAGCCCCGGACTTCGTCTTCTATGC
NO:




TCCCCGGCTGCGGATTAACAAGCGGATCTTGGCCTTGTGCATGGGGAACCATGAACTATACA
933




TGCGCCGTCGCAAGCCTGATACCATTGAGGTGCAGCAGATGAAGGCACAGGCCCGGGAGGAG




AAGCACCAGAAGCAGATGGAGCGTGCTA





MSN
ADXCRAG_M69066_s_at
CTGACCTTGAGGAGTCTTGTGTGCATTGCTGTGAATTAGCTCACTTGGTGATATGTCCTATA
SEQ ID




TTGGCTAAATTGAAACCTGGAATTGTGGGGCAATCTATTAATAGCTGCCTTAAAGTCAGTAA
NO:




CTTACCCTTAGGGAGGCTGGGGGAAAAGGTTAGATTTTGTATTCAGGGGTTTTTTGTGTACT
998




TTTTGGGTTTTTAAAAAATTGTTTTTGGAGGGGTTTATGCTCAATCCATGT





MSN
ADXCRPD.2854.C1_x_at
GTACTTTTCCACTTTGGATTTTGCAAATGCCCCCTAACCCTTTACTGGTTGTCCCTATGGGG
SEQ ID




AATCCAAGTGG
NO:





1582





MXRA7
ADXCRAD_BX099460_at
TGATCACCCCACTGGCAGGACAATTCACAGTTCTTGAGCAAACTGAGTTAGGGAGGGTATGC
SEQ ID




TAACGACAGAACCTATGCAAGTTCTTAGAAATATTTTTTGTTTGCTGAAATAAAGCTCAATC
NO:




AACACACTACCTTAAAAAAAAGTGGGAGCAGTGGCATTTCCATGCCTCATGCTCACCATCAT
2442




GAGGTTAACTTCCCGCCGTCGCCTCTTGCCTGCCAGGGGTTTTTCGGGAGCCCCTCTCTGTT




CCACTCTGATTCCTTTTGNTTCTTTGCTGACCATTCACTCTCTG





MXRA7
ADXCRIH.2503.C1_at
ATGGCAACAGCCACACAGTCATTGCCTTCAACACAGAGCCACGTGTCCCCAAACAGCAATAG
SEQ ID




TCATGCCCTTGTCCAGGCTGGGATCTAATTGATACAATAGGTCGTTGACTCCCTCCTAGTAG
NO:




AGCTATCTAGGTTTGTCTGGAAAGTTTCCGACCCTGGCTTATAGGCACCACACCTCATGTAC
1205




TCCTCATGGCTTGGATCTCTGTATTCAGCCTTTGTTCAGTCC





MXRA7
ADXCRPD.17734.C1_at
AAAGGCCTCTAACCTGCTGGAAGATAGGGACCAAGTTGAGTATTTTATTTCTTCTGTCTACA
SEQ ID




GCATCCAGCATAGTTCTAATTAAATACAATTAGGCAAGTACTCAAATAAGTCTTGCCTAATT
NO:




ATATTTAAAGTAAGTATCCTGCTTAAGTGAGAGAAATTCTTGGCAGATCTTACCTCTAGTAC
1422




TATTGTTTAGTGCCAGGATGGAAGGTGAGTCTCTGAATTAGACTTTTTGCTGAAAGAACGCT




CCCAGCTGGGCATGCT





NR2F2
ADXCRAD_CB217549_s_at
ATTATAATTGTTGATATTTTCCCTTTTTAAAAAATACCATTGAAATCAGCATGACAAAAATA
SEQ ID




ACACTGTTGGCACTTATAGGTAACGTGATTGATTCAGTATCTTAGAGTTTACAGTTTGTGTT
NO:




TTAAAAAAACTGAAGGTTTTTTTTTAAGTGCAACATTTCTGTATACTGTAAAAGTTATAATA
979




ACTGAACTGTTTGGTCGAGTCTTTGTGTGTTA





NR2F2
ADXCRAD_CB956496_at
GCGAGCGAGATCTTTGGAGAGATTTTTTTTTTTGCCTCCTACTTCTGTCTTGAAGCCAGACA
SEQ ID




ATCGACTTCAGCTCTCCCTCCCCTCCCTCTTTCTCCACGTTCTGCTCCCACTCGCTCTCCTG
NO:




TCCCCTTCCCCTCCCCTCCCGGCGGAAAGCCCCCCGAAACCAACAAAGCTGAGCCGAGAGAA
2487




ACAAACAAAACAAACACACCGGGCCAGACAAGCCATCGACAAAACTTTGCAAAGTCAACC





NR2F2
ADXCRAD_CB956496_x_at
GCGAGCGAGATCTTTGGAGAGATTTTTTTTTTTGCCTCCTACTTCTGTCTTGAAGCCAGACA
SEQ ID




ATCGACTTCAGCTCTCCCTCCCCTCCCTCTTTCTCCACGTTCTGCTCCCACTCGCTCTCCTG
NO:




TCCCCTTCCCCTCCCCTCCCGGCGGAAAGCCCCCCGAAACCAACAAAGCTGAGCCGAGAGAA
2488




ACAAACAAAACAAACACACCGGGCCAGACAAGCCATCGACAAAACTTTGCAAAGTC





NR2F2
ADXCRPD.4673.C1_at
GAATTGCCATATACGGCCAGTTAAAACTGCTGCCGGACAGTAACATATCCCGGATGAGGGTT
SEQ ID




TCGATGGGGGTTTTACCTACCAAACGGACGAAAAACAATTGCTCTATGACTGAGGAGGAGAC
NO:




GGTGCGGAGGGAAGGGAGGCGAAGCAAAAGCTTTCCGAATCTCGTCGGCTGGTTGGGGTACT
1691




GGCTCCTAACGTATTCTTCCAAAGCACACTGAGACTTTTCCTGCAAGCTTTCCACATGGGCT




ACATCAGAGAGACCACAGGCATCTGGAAGA





NR2F2
ADXCRPDRC.4673.C1_s_at
ATCCGGGATATGTTACTGTCCGGCAGCAGTTTTAACTGGCCGTATATGGCAATTCAATAA
SEQ ID





NO:





2001





NR3C1
ADXCRAD_AI934556_at
GATGAATGTGCGCTTTGGAAATGTTTAAATAGATATGAAATGATTAAATAAAATCACAGTCT
SEQ ID




TGTGCAACATCCATAGCTTACAGTTATTTGGCAACTATGAAACCACAGTTACTAATGGAATT
NO:




AAGACTTTNTAAAAAATTGCAAATGTACTTATTTGTATATGAAAGAGGTATTCAGCTATTAA
2815




CTCAGTATTTAATAAACATTGATATGTAATTTTTACTTGAAATGGCCTAAGGTTTATAATAC




CAACTAGTTCATAGAGCTTTTTT





NR3C1
ADXCRAD_BQ433598_at
GGTTACTTTCACATACAGCCCTCCCCCAGCAGTTGAATGACAACAGAAGCTTCAGAAGTTTG
SEQ ID




GCAATAGTTTGCATAGAGGTACCAGCAATATGTAAATAGTGCAGAATCTCATAGGTTGCCAA
NO:




TAATACACTAATTCCTTTCTATCCTACAACAAGAGTTTATTTCCAAATAAAATGAGGACATG
2380




TTTTTGTTTTCTTTGAATGGGCTTTTGAATGTTATTTGTTATTTTCAGAATTTTGGAGAAAT




TATTTAATAAAAAAACAATCATTTGGCTTTTTGAATGCTC





NR3C1
ADXCRAD_CA392568_at
GTGCCTTTTATAGCTATTACTGTCTGGTTTTAACAATTTCCTTTATATTTAGTGAACTACGC
SEQ ID




TTGCTCATTTTTTCTTACATAATTTTTTATTCAAGTTATTGTACAGCTGTTTAAGATGGGCA
NO:




GCTAGTTCGTAGCTTTCCCAAATAAACTCTAAACATTAATCAATCATCTGTGTGAAAATGGG
2379




TTGGTGCTTCTAACCTGATGGCACTTAGCTATCAGAAGACCACAAAAATTGACTCAAATCTC




CAGTATTCTTG





NR3C1
ADXCRAG_X03348_s_at
AAAGTGTCTTTTTACCTACGCAGTGAAATGTCAGACTGTAAAACCTTGTGTGGAAATGTTTA
SEQ ID




ACTTTTATTTTTTCATTTAAATTTGCTGTTCTGGTATTACCAAACCACACATTTGTACCGAA
NO:




TTGGCAGTAAATGTTAGCCATTTACAGCAATGCCAAATATGGAG
1078





NR3C1
ADXCRSS.Hs#S1907985_at
GGGACTAATGTAGCCTTGCTTCTGAGATGTGGCCCCTAGGTCTCTACTGAATGCCCGGCATA
SEQ ID




TTTAATTAGATCTTTCTTTCCTCTATGGCCTCAAGGGATTTCACCCTAAGTATGCACAAATT
NO:




TTTATTCAGCCGAAGACTGTACAGATTTCTGGAGGCCTTTCTTTGTGTACCTCCTTCGTTTC
2121




CAGTAGTCTGACCCATAAATTGTACAGATTTCTG





NR3C1
ADXCRSS.Hs#S821188_at
AATGAGCAAGCGTAGTTCACTAAATATAAAGGAGTTTGTTAAAACCAGACAGTAATAGCTAT
SEQ ID




AAAAGGCACAACTTCCCTTTTCTGATATACACTTGTAAACTTTTTTTCAGGTTTCCATGCAT
NO:




AAATCAAAAATGCTATCCTAACTATACAGGGGGGGGATACACCAACAGAAAGTCTAGAAAAT
2224




TTCATCCAGCCAACTGTGTAAAAAAGTATGAAGAGAAAGTTCCTCACACAGACTTTGGGCAC




TGGTGGTTTAGGTGGCATCCATCTTTGACTGT





NT5E
ADXCRAD_BC015940_at
TTCTTTACACAGGTAATTGTTTCAAAAGGATTGCATGGGCCAGGATGTCCAGATAAGCACTG
SEQ ID




TGTCTCTTTTGCCTTTGTAACTGTTATTACTCTTTTTACTGCTATTTAATATGTAATGTATA
NO:




TTATATGATCTATAATATATATGTAATATACATTAAATGGGAACATGTGCAAATCTTACAAA
2778




A





NT5E
ADXCRAD_BG611920_at
TAAAAATTGGACAGATTAGCCCAAAAAAAGACACAATCACAACAAACAAAACAAAAACTATT
SEQ ID




GTTGGCGGCACTGTGCGCCCCAAAGAAACTCTGTAAAACACCTAGCGGTTAGGCACAGCGGC
NO:




CCCATAGGAAAGCGAACATGTGCAAACATGTCCCCAGAAAAACCCGGAACAAAAAAACGGCG
2714




CGGAAACGCACCCAAAAAACACGCCCGGGGAACCGCGGTTTTGGACAAACCAGAGACATCAC




AACAAAA





NT5E
ADXCRAD_BM704188_at
GGAGAAAGCTCCCTCCGTTCTGATGCTTTTGAGCTTATCAGGGACACCCTGCAGCAGAAATT
SEQ ID




CCAGCTGATCCTTCAGCCTTCAGAGTTGATGAGGTGGGGCTCACACACATCTGGATTTGAAG
NO:




AAGAATCGTGGGTTTCAAGAACTCTGTGGTCTCTTAAGCATTGGTATTCCACAGCTACACTT
2446




CCCTGATACTTTGCACTCAGTAATGACAA





NT5E
ADXCRAD_BX404438_s_at
TTGTGGGAATCGTTGGATACACTTCCAAAGAAACCCCTTTTCTCTCAAATCCAGGGACAAAT
SEQ ID




TTAKTGTTTGAAGATGAAATCACTGCATTACAACCTGAAGTAGATAAGTTAAAAACTCTAAA
NO:




TGTGAACAAAATTATTGCACTGGGACATTCGGGTTTTGAAATGGATAAACTCATCGCTCAGA
2316




AAGTGAGGGGTGTGGACGTCGTGGTGGGAGGACACTCCAACACATTTCTTT





NT5E
ADXCRAG_NM_002526_at
CTTTGAACCACTTTGCAATTGTAGATTCCCAACAATAAAATTGAAGA
SEQ ID





NO:





1015





NT5E
ADXCRAG_NM_002526_s_at
GCAGCAAAATAATAGCCTCGGTTCTATGCATATATGGATTGCTATAAAAAATGTCAATAAGA
SEQ ID




TTGTACAAGGAAAATTAGAGAAAGTCACATTTAGGGTTTATTTTTTACACTTGGCCAGTAAA
NO:




ATAGGGTAAATCCTATTAGAAATTTTTTAAAGAACTTTTTTTAAGTTTCCTAAATCTGTGTG
1016




TGTATTGTGAAGTGGTATAAGAAATGACTTTGAACCACT





NT5E
ADXCRPD.5241.C1_at
CACAGAGTTCTTGAAACCCACGATTCTTCTTCAAATCCAGATGTGTGTGAGCCCCACCTCAT
SEQ ID




CAACTCTGAAGGCTGAAGGATCAGCTGGAATTTCTGCTGCAGGGTGTCCCTGATAAGCTCAA
NO:




AAGCATCAGAACGGAGGGAGCTTTCTCCCCTTCTCTCATCTCATTAAAATGAGCTTTCTTGT
1683




TGTGGGGGGTTGGGGAGGGACCTTTAAAACCAAACAATGGTGCCCTCTTATCATCTTTTNCT




GTCCTCCTTTCTCCAAGTTTCCAGAGGG





NT5E
ADXCRSS.Hs#S1299958_at
ATTGAACAGAGAATCTACCCCAAAGCTGTGAGCTTAATTACTCTCAAGCTCCGGGGTCAAAG
SEQ ID




AGATCTGGTGTCCATTCTTATCACGTCTCCCTTTTTGCGGGGATGGTGCCTGTTAATTTATT
NO:




CAGCTTCTTCGACGCGGTTTCCCTTTCAATAAGATTGAGATAAAGCATTTTTCGAAAGATCT
2064




AGATTGAGATAAAGCATTCTTTGAAAGATCTAGCAGTAAA





NT5E
ADXCRSS.Hs#S3735513_at
TTCCCTCTGGCAAGGAAAGACTCAGATAAAATTCCCCATGACTTCTAAAGGTGCTCCTGGGC
SEQ ID




ATTACTTTTCATTGTTTTTCCTGGGGATGCTGTTTCCTCAGAATGTCGTTGTATTATAGTAC
NO:




ATTCCTTAAGGGATATGGTTTTCATTTTCCTGAATGTTGCTCCTTTCTCTCATTTTACCAGC
2207




AACTTGTTACTCCCTTTCACTTTCAGACTCTTTTCTCTCTTTCCCTTCTCCTTCAGCAACTT




CTCTCCCCATTGAAGTTAGAAGT





OSBPL3
ADXCRAD_CN419328_s_at
GGAAATCCGACGATGACTCTTGGGTGAGCAACGGCACCTATTTGGAACTTAGAAAAGATCTT
SEQ ID




GGTTTTTCCAAACTGGACCATCCTGTCTTATGGTGAAAAAGTAAAGAAGAAAGATAACATTA
NO:




GTGTATTTCTCCTGTGCTTGCCTTCTGAAGTGGCACAAACCTGTGTTTATATATTTAAAAGA
2741




TACTCTAGGATGATCACTTGTGCTTAGCTTAACATTGTAACTCTTTAAGTCTATATTTTCCT




CAGTGCGTTTCTTTACAATTTCAAATGTTACCCTGA





OSBPL3
ADXCRAG_AF392444_s_at
TCTGTGTTGGAAACCTGCGTCATGTAAATATCTGCAAATCATGACAGTCTAAAGTGCAAACC
SEQ ID




ATTTTCAGAGACTTTGGGGAATGCAGTGATCAGAAGTGGCTAATTTATTTTATTTCTGATTA
NO:




TTTTATCCAGAGGGTACTTTTTTAATGGATATTTGTAAATCTTCCACTTAACCACTGAAAAT
877




TATTTTGTTTTAATCCCACCCTTCCATCCATACCTCTGCCTCCCCAAAAAGCTCCTATTAAT




TTGCTTATCCCCCTCATGTAGCTAGTTGAATGTG













OSBPL3
ADXCRPD.12932.C1_at
GATTCCATTAATACAAAGTCCTAGAACAGGTAAAACCAGATGGTAGTGATAGAAATCAGAGG
SEQ ID




CATCAGGGTTAGAGTTGACTGCAAAAGGGCATGAGGGAGCTCTTTGGGTGAGGGAATGTTCT
NO:




TTGAGGTGATGATTGAAGCGATGGTTACATAGGCATATACATGTGCTCCAAACTCATCAGTC
1670




TGTACAT





OSBPL3
ADXCRPD.2801.C1_at
TGCTTCCTTTTCAAGAAGGTGCCGTATACGTCTTATATAAAAATATACATTCCATTAATCTT
SEQ ID




ATATCCACTCCCTAACCACTAAAATGCAAATGAAAATATTCTTCAGACTCCAGCACCAGCAG
NO:




AATTGTTCTGTATGAGCAATTCAAGAGCTGTCTGAGGCAAAAAGATATTTCAGCTACCAAAT
1579




TAAACTTGGGTAGCTTACGCATGGGTGAGTAACCCTGGGAATTCT





OSBPL3
ADXCRPD.2979.C1_at
ATAGTATTGCTCGTAGCCTTTCGGCATAGGATTTGCTCTCCATACACAGGCAGAAGAGGAGC
SEQ ID




CGCCGCCACAGTAGATGCTTTCATGCCATTTCCCAAACAGCCGATGAACCGCTTTTCCACTC
NO:




CTGTCAAACACTGTGCCTTCAATCTCATGGGCATTAGTGCTCCAGTATTTTGCCTTTATAAA
1602




ATTCACTTTCA





OSBPL3
ADXCRPDRC.2801.C1_at
TTGAGATACTTTAAAGAATTCCAGAGCATATC
SEQ ID





NO:





1968





OSBPL3
ADXCRPDRC.2801.C1_s_at
ATATGTGTAGTAGTTGAATTGTGTTATCAAAGCATGTCCAACTTCTGTCCAGATGACATTAA
SEQ ID




AACCAAAGCCTAATTGTTAAGCCTCTTATTCTAAAGTCCATAGCAATGCTATGGAATATCAA
NO:




GTATAATGATGTAGTAAAAAGATTTCTCCAGA
1969





OSBPL3
ADXCRPDRC.2979.C1_s_at
GAAAAGCGGTTCATCGGCTGTTTGGGAAATGGCATGAAAGCATCTACTGTGGCGGCGGCTCC
SEQ ID




TCTTCTGCCTGTGTATGGAGAGCAAATCCTATGCCGAAAGGCTACGAGCAATACTATAGCTT
NO:




CACACAGTTTGCGCTGGAATTAAATGAAATGGATCCATCATCAAAGTCTTTATTGCCACCTA
1972




CTGACACTCGATTTAGGCCAGACCAG





OXSR1
ADXCRAG_BC008726_s_at
GTAATATGTGCCAATGCTATTTGTGAAATGTTTGGTCTTTCTAAACGACTAAAGGATTTGTT
SEQ ID




GGGTTTTTGCTTAAGTTTTGAACCAAATCCTAGAGCCAGCTGATAATATTTAATAATCTAGA
NO:




GGAGAGAATAATGATGTACCAATAAGTGGAGATTCCTCCTTATGATGTATGCTAGGTTATGG
925




AAGATGTAAAATATTCAACTTTTTCCTCCTTTTTTTGGACTTTGTATTTTACTGCATGTTT





OXSR1
ADXCRPD.10116.C1_s_at
TGAGATGATCAGACACCGGAGTTCAACGTCCCAGCAGTCTTGGTAAAAGGAGGGAGCCTACT
SEQ ID




GAGCCAGGAGGGAGAAAAGAAGATTGACCAGCTTGCTAGAAAAATACTTAGCNNNNNNNNNN
NO:




NNNNNNNNGTGGAGGGGGGACGGAGAGGAACAAGGATGGGGAGGTAGGAATGAGGTATAGAA
1859




AAGAGATAGCATCTTCTTTGGCACAAGACTAGTGGCT





PCMT1
ADXCRIH.1058.C2_s_at
GTTGTAGATACAATCAGCTGCTTTGTTACCTTAAAACTAGGCATTTGTAAATATTAAACCAT
SEQ ID




AAGATGGCAGGTGATGTCCTGTAAACACTCAGCTGTTCAGATTGGACATAACTGACTTAGTT
NO:




CTTCCCTTCTCTCTCTCTCAAAATTATAGGAGACTTGTAGTTTAGTGTGGTTTTCTGTTTCT
1291




AATTTGCTGCTGATAATGTATATGAACTTAACATGCTGTGTAAGCTGTGTCCTAGTTCTTGA




ACAGTTTATGCAGTGCTGCTTTGCCAAATAAAGTT





PEA15
ADXCRAD_CN347927_at
TGAACTGTCCTTCCATTTGGGATATGTTACATTAGAGTGAGAGAGAGAATAAGGAGCCTTTC
SEQ ID




TTATGGAAGAAATGGGAGAAGAGAGACAGGGTTCTTTTCAGCAGAGTCTAGTAGTTTCTCTG
NO:




TAAGGCAAAATAATCTAAAAAGACTAACCTGCCCACCCACTCCTTATATTGCTGTGAGATTG
2608




CCCCTATCTTGTGCTCTTCTGTCTGCAGTGTGCACGGCCTTGTTCTAACCC





PEA15
ADXCRAD_CX867144_s_at
GTGTTTTCCTTTGCACCGATCCCCACCCCAATTCAATCCCGGAAGGGACTTACTTAGGAAAC
SEQ ID




CCTTCTTTACTAGATATCCTGGCCCCCTGGGCTTGTGAACACCTCCTAGCCACATCACTACA
NO:




GTACAGTGAGTGACCCCAGCCTCCTGCCTACCCCAAGATGCCCCTCCCCACCCTGACCGTGC
1154




TAACTGTGTGTACATATATATTCTACATATATGTATATTAAAACTGCACTGCCATGTCTGCC




CTTT





PEA15
ADXCRPD.14289.C1_at
AAATCAGCACATTCCTCCTACTTCCCTTTCCTCCACTCCCCCCATATCTTTAAAGTGTGGAA
SEQ ID




GCAGAAAGGACCTGCATTTTCCTACATTGAGGAGCTGACATAGGGGTAAGGTATGGGAGAGG
NO:




TAGGTGGATCCAGGGAAAA
1684





PEA15
ADXCRPD.14289.C1_s_at
AAAAGCCAGAGTTCCATGTTTGTACTCCTTGTGCTGGACTGTTTCCTGAGTACCAGCAGGTC
SEQ ID




CCTTTTTGTCTC
NO:





1685





PEA15
ADXCRPD.14289.C1_x_at
AAATCAGCACATTCCTCCTACTTCCCTTTCCTCCACTCCCCCCATATCTTTAAAGTGTGGAA
SEQ ID




GCAGAAAGGACCTGCATTTTCCTACATTGAGGAGCTGACATAGGGGTAAGGTATGGGAGAGG
NO:




TAGGTGGATCCAGGGAAAAGCAGTGGGGACGGAAGGCAAGAGACCACTCAACCCCCACCTGG
1686




AAGGGGCAAAGAAAAGCCAGAGTTCCATGTTTGTACTCCTTGTGCTGGACTGTTTCCTGAGT




ACCAGCAGGTCCCTTTTTGT





PMP22
ADXCRPD.5015.C1_s_at
AAATCATAAAGCCTTCATCACTCCCACATTTTTCTTACGGTCGGAGCATCAGAACAAGCGTC
SEQ ID




TAGACTCCTTGGGACCGTGAGTTCCTAGAGCTTGGCTGGGTCTAGGCTGTTCTGTGCCTCCA
NO:




AGGACTGTCTGGCAATGACTTGTATTGGCCACCAACTGTAGATGTATATATGGTGCCCTTCT
1634




GATGCTAAGACTCCAGACCTTTTGT





PPAP2B
ADXCRAD_CD678016_s_at
TAAACTGTGTCTCGACCTGTGTTATTTACATTAGCTGCTTAAAAAAGCATTGAGTTAATTTT
SEQ ID




TTTAAATATCAACTAAAATATCATAGTTCTGTGGTAGACATTGTTTTATAATGAAATAACTG
NO:




CAACTAGAGAAAACTGTATAAAAACATTAAATTGTCAGTATTTTTGTAAGGTTCCATTTTGT
1024




AAAGAGAATAATATTCAAAGACTTTTGTAGCATACAAAGTGAAAACTTGTATCTGCGAAACT




ATACTTGTATTAAATGTGCTTTT





PPAP2B
ADXCRAG_AF480883_at
GCTCGTAACACAACTCTCATCTCAGGCTCTTCTAAAGAGCTTTTGTATTCTAAAGAGGATTT
SEQ ID




TTCCATCAGAGAGGTAGGAGCTGTAGGAACCCCGAGGGCAGATAAGCAGCCCTCACTCTAGA
NO:




TAAGGTATGCTGGGGGAGCTTACTGAGGGAATCCTGTACACAGCCCACATCAAAGGAAGGCT
878




GAGAATGGCCTGTGGCTCC





PPAP2B
ADXCRPD.13412.C1_s_at
ATGTTCTGGCAGGATTTGCTCAAGGAGCCCTGGTGGCCTGCTGCATAGTTTTCTTCGTGTCT
SEQ ID




GACCTCTTCAAGACTAAGACGACGCTCTCCCTGCCTGCCCCTGCTATCCGGAAGGAAATCCT
NO:




TTCACCTGTGGACATTATTGACAGGAACAATCACCACAACATGATGTAGGTGCCACCCACCT
1641




CCTGAGCTGTTTTTGTAAAATGACTGCTGACAGCAAGTTCTTGCTGCTCTCCAATCTCATCA




GACAGTA





PPAP2B
ADXCRSS.Hs#S524340_at
TGACTGATAGCTGCCGCTTATGGTTACTTAGTAAAAACTCCTGTTGCTAAATGGCTCAAATG
SEQ ID




GATGTCTGTGTGTTTATTTTGCCATCTAATACAAAGCATAAATTTTTCTTACTCCAGTAGCT
NO:




CATCAAACCCTTGAATCTTTCATCATAAGCACATTGAGGCAGGAACTATGCCTGTGCCATCC
2129




TCACACCTTTGCAAGTGGCACTCAATAAATGTTTCTCAAGTATTGTTCAGACTCAGTGAGGG




TCACATCCCCAGGAGGAA





PRNP
ADXCRAD_CX762421_at
ATAACATTGGTTATCTGGACTATTTTGGACTAGTGCACAGGTGAGCTAAACAATCTAGACAT
SEQ ID




CTGAATACTTGCTGGATCTCTGCTCTCACACTAAGTCATACTATGCTACTATAAATCAACTA
NO:




TAAGAATCATTAGAACGAACTCGCAG
2673





PRNP
ADXCRAD_CX762421_s_at
CTCTTTGTCCCGGATAGGCTAATCAATACCCTTGGCACTGATGGGCACTGGAAAACATAGAG
SEQ ID




TAGACCTGAGATGCTGGTCAAGCCCCCTTTGATTGAGTTCATCATGAGCCGTTGCTAATGCC
NO:




AGGCCAGTAAAAGTATAACA
2674





PRNP
ADXCRIH.1264.C1_s_at
CATAGGACAGACTTAGGAGTTTTGTTTAGAGCAGTTAACATCTGAAGTGTCTAATGCATTAA
SEQ ID




CTTTTGTAAGGTACTGAATACTTAATATGTGGGAAACCCTTTTGCGTGGTCCTTAGGCTTAC
NO:




AATGTGCACTGAATCGTTTCATGTAAGAATCCAAAGTGGACACCATTAACAGGTCTTTGAAA
1241




TATGCATGTACTTTATATTTTCTATATTTGTAACTTTGCATGTTCTTGTTTTG





PSMD2
ADXCRAD_CF130280_s_at
ACAGGGTTCCAGACGCATACAACCCCAGTGTTGTTGGCCCACGGGGAACGGGCAGAATTGGC
SEQ ID




CACTGAGGAGTTTCTTCCTGTTACCCCCATTCTGGAAGGTTTTGTTATCCTTCGGAAGAACC
NO:




CCAATTATGATCTCTAAGTGACCACCAGGGGCTCTGAACTGTAGCTGATGTTATCAGCAGGC
1018




CATGCATCCTGCTGCCAAGGGTGGACACGGCTGCAGACTTCTGGGGGAATTGTCGCCTCCTG




CTCTTTTGTTACTGAGTGAGA





PTPLA
ADXCRAD_CD299090_at
ATCTCTGCAAAACAAGTGCTTTTTCCAGAATAACCAAGATTTACTGAGTCCAAGTTTTTAAT
SEQ ID




AACAAGAAATAAACAACCTTTGTGAAAATAATCATGGGATTGGTATGGGTTTT
NO:





2585





PTPLA
ADXCRAD_CD299090_s_at
ATTATTTTCTTCTTATAACCATGGCATCATATATACCTTTGTTTCCACAACTCTATTTTCAT
SEQ ID




ATGTTACGTCAAAGAAGAAAG
NO:





2586





PTPRK
ADXCRAD_AU145587_at
TGCTGGGCTGTTCTCTACCGAATACCATAAAACTGAATATTGTTCACCACTATGGTCGATCT
SEQ ID




TTCTAACTTTAAAGAGTACACAACTGAACTCAATTACTCCAAAGATATGTGAAAACACAGAA
NO:




AAATGACCCCTGTTAAAAGAGTAAACCTAGCTTTTGNTTTACTTTCCTTTTATATAAAAAAA
2864




GATGTACAGGGTTCTCTTCT





PTPRK
ADXCRAG_Z70660_at
TATTGAGCCAGCAGCTGTTGTACCTGTTACACTTGTGCAGAAAGATTTTAATGTGGGGGGTG
SEQ ID




GGAGACTTTTACATTTGAGAGGTAAAAGTATTTTTTTTATGAAGTTGTGTATCTTAATAAAA
NO:




AGAACTGAATTAGTTTTTATTACTATATTAAAGCATCAACATTTCATGCCACATAAAATTAT
1097




ATTTAATAAGAACCAGATTGAAATGAGAACGTATTGGTGTTTGTACAGTGAACATGCCACCT




TTTTCCATGGTTTCAGGTAGTGCAGCTACCACATGTT





PTPRK
ADXCRIH.91.C1_at
TATAATGTGCTTTCTCCATATAGACATATTTACACTTGAGTCTTTGGCTTATGTTATTTTCT
SEQ ID




AAAAAGAACTTTAAATGATCCAGCCATCATTGCACATTAAAAGAAAATAAGCCAGTTATATA
NO:




TATTTATATATTCCCATAGAGATCTGCTACACTGGAAACATATAAAAAACGAACTTTACTAT
1182




GAATTTGCACAGCTTTTCTTTTCTTCTTCCTTTTAAGATTCATCAGCTTTCATTTTAGAAAG




GGAGCCTCGTGC





PTPRK
ADXCRIHRC.91.C1_s_at
CAATGCCAGATTCCTGTTTTGCGCATTGTCATGGGATTCTTAAGTGAACCTTTCTAAATGTG
SEQ ID




GTCTTGTTCACATGCTCCACGTAGCTGTAACTTCACATCATCAGCTTGCAGTTTGTAATTGA
NO:




CTAAAGCATTCCAGTGTCCTCTTTCTAGATTGCCAGCTCATGACATGGTGCTTATAAAGA
1318





PTPRK
ADXCRPD.10919.C1_at
CATAATAGTTCCAAGCTAAAAACAACCCAAATGTCTGTCAGCAGTGCAATGTATAAATAAAT
SEQ ID




GGTGGCATATTCATAAAGTGAAATATTGTACTGCAAATAAATGAAAGAACCATTGCTTTATA
NO:




CAATAACATGAATGAATTTCGCAAACACAATCTTAAGGGAGAGAAACCAGATGCAAGAGAGT
1525




ATGTATATATACATTTATATAAATTATGTAAGTTTCAGAAACAGGCAAAACTAATCAATGAT




ATTAGAAATCAGCATATTATTTACTTGAAGAGGATTTGGGCAACTT





PTPRK
ADXCRPD.11104.C1_at
GGCAGTGGATAATCGTCCGGCCTTCCCCTTCCTCGCATTCCTCCTGCCACTTTTCCACCTGA
SEQ ID




AGTATCAGTTTCAAGAATGACCTTTTGGAACCAGGCACTTCTCGATGAGAAGCCCATCCTAG
NO:




GTACTGAAACTGTTGCACCATCAGATAACCTTCCTGTGGTCTTGTTAGATTGCATATCCTAA
1425




AAATCCGGTTGATCACATCACAGTCCATTGAACAAGACATACATTCCACTTGGATGGGGCCA




TATCGTAGCATCCCTTCCTCTGGCCAGTACTGAGGGCAGCCCTG





PTPRK
ADXCRPD.13194.C1_at
ATCACATGAATATATCTGCCTGACAAAAATTTGGGAAGTCCAGCATCTCTGATTTAAAAAGA
SEQ ID




AGAAACTATTTGTAATTTTAGTCTCTTGTTCTTAATGCAGGATCTGACCATTGGTTAGTAAT
NO:




GCAACAGCTGCGATTAGCAATGAAGGAAAACTATTTTCAGAGTCTTCTCATGACCTAGCCAC
1595




ATTAGCAATCTAAAAATACAAACAGGAAAAGTTTTTAAAAGCTTAACCTTTTATAAAGTGAC




TAAACTGCATAAGCCATCAGCCACAGA





PTPRK
ADXCRPD.13198.C1_at
CACCGGAGGTAGTTGATAGATCGAGAATACACAAGGACACTCACAGTCACACATAGAACCTA
SEQ ID




GAAACAACACTCCCCAAAACAGATGTAGATTCAACAAAATACTATAAAAAGCCATAAAGCAT
NO:




ATTCAGTATATAATGTTTAAATTGTTCTGACATATATGTTGTTTGTATACCCGCACAAATGT
1596




TACTGTCATTAAACTAATGATCCTATTTTCTTCTTCTCAAAAAAAGTCCTAGAAATCTGTTT




GTGATGGCTTGATGAAGTTTAGTCACTTTATAAAAGCCACCTTGG





PTPRK
ADXCRPD.14082.C1_at
ACTAATATGTTCAAAGTGCCAGGATTCAGTCCTTTCTGGCTATATAATAGGTAACTGAAATC
SEQ ID




AATGCAGTGAGTGTCGTTCTCCTTCATTGTAGGCAGCTGAAGTCTGGCTTTTTCTCCAGGGT
NO:




CGTGATCTGAAGAGTCCACTATCATATAGGAACCTTGGGGCATCTCGGGTGGTAGATAATGA
1647




GGCTCTTGAGCACTAACATGCACCCATTCAAAGTCATCATACAGATCCTGGTGGTAATCACA




GGCCCCTGGAC





PTPRK
ADXCRPD.6814.C1_s_at
TATAGCATATGATCACTCCAGAGTGATTTTGCAACCCGTAGAGGATGATCCTTCCTCAGATT
SEQ ID




ATATTAATGCCAACTATATTGATGGCTACCAGAGACCAAGTCATTACATTGCAACCCAAGGT
NO:




CCCGTTCATGAAACAGTGTATGATTTCTGGAGGATGATTTGGCAAGAACAATCTGCTTGCAT
1797




TGTGATGGTTACAAATTTAGTTGAGGTTGGCCGGGTTAAATGCTATAAATATTGGCCTGATG




ATACTGAAGTTTA





PTPRK
ADXCRPDRC.14082.C1_s_at
GGATTCACGGGTAGAGATTGGCTTCGGGCTGAGCTAGCAGTGAGCACCTTTTGGCCCAATGA
SEQ ID




ATATCAGGTAATATTTGAAGCTGAAGTCTCAGGAGGGAGAAGTGGTTATATTGCCATTGATG
NO:




ACATCCAAGTACTGAGTTATCCTTGTGATAAATCTCCTCATTTCCTCCCGTCTAGGGGATGT
1980




AGAGGTGAATGCAGGGCAAAACGCTACATTTCAGTGCATTGCCACAGGGAGAGATG





PTPRK
ADXCRSS.Hs#S2979568_at
TGCTGTGTTAGCAACTGACGTACAATAAAGTTGAATTCACCCGAATATCTAAGTCTTAAAAG
SEQ ID




ATAAATGCAAGTAGCTGGTAGCTGATTTAGGCACCAGTAACAGAAGTGAACACCTAAAAAGT
NO:




AAATGCTATCACAGGTAGGAACATGTGAGTGACCCTGATTACTTGTCAGTAGGAAAAGATGT
2148




GGAGTGCAGGCATATTCTCTTTCTACTTTGGATCAGCAATCAGATTCACTCACAGATCATCG




ATTC





PTPRK
ADXCRSS.Hs#S794492_at
GACCTTATTATTTCTCAGTTTACATACCAATACTCTCCTATACATACACAATATACTAAGAG
SEQ ID




GAATACTGTTGTCTTCGTACCCAAATTACACATAAACAGATAAAAACTGACTTTTGCCATCC
NO:




CTTTGCAAATGTTGTAGCAAATTCTAATGTTCTCAGGCCACGCTGGTTCATGATCCGAGAAT
2190




CTGAGACAGTTATAGTCGAAATGTCATAGGAGGCAGGCGTGGTGGCTTGCCCTGTAATTCAG




CACTTGGGAGGTCCCTTGGACGA





PTPRK
RDCR460_E08_at
AGAAATATGCCTTGCCTTCAGAGAATTTATAGAAAGTCTATCTGTCAGTGCTAGGGTGCTAG
SEQ ID




GGGCTGGGAGGAGCTGAGAGCAGCTCTAAAGCCAGGAAGCTGGACCTAAAACAGATGGCTAT
NO:




TGAGCGAAGTATTTGAAGCTAGATGATGTGTAAGTAATAATATTCTCTGAGCACCTCTATTA
1370




TTATTTTTTAGGTTCTCTGCATCAGAATGAGGAAAGAGATTTAATAAGTTGTGAATTTTAAA




TTCATGAGAATGCCAATAGAGACC





PTRF
ADXCRAD_AI282511_s_at
CTTACTTGGGCAGAAATGTATTACTTATTGTGCCTATTTTCTTT
SEQ ID





NO:





2833





PTRF
ADXCRAD_AL545542_at
GCTCCTTCCCTAGGAGCATGGGTGGCACGTGCC
SEQ ID





NO:





2330





PTRF
ADXCRAD_AL545542_x_at
AGGGTGCCGGCCCTGCCACCAAGTTGAGAGCTGGAGGGGAGGTGGGGAGAGAACATCACAGA
SEQ ID




GCAGCCAGCCCTGGTTCACTCCTGGSAGTTTCTTCTCAAGCTCCTTCCCTAGGAGCATGGGT
NO:




GGCACGTGCCTGTTGGTCTCAGC
2331





PTRF
ADXCRAD_BI869786_at
GGTGTATCCCGGTATTTGGTGTACAAACAGTTGGTCCCATTATTGAAGTCGCACTTTTATAT
SEQ ID




ACACACATAGTACGATGTCAACCGTTGTTTTACACACCGCTGGAGATCGGGCAAAACACGCG
NO:




AACAGACACGGGGCGAAACCTCGGGCAGAAGCGCACCCCAACATCACAGAGGGGGCTGAACA
2642




CCAAGGCGCAAAACTCAACCATAAAGCGAGATTAAAGACAGACGAGGGCACAAAGTAAAACC




TGTACACGCGCCAACACGGGACACAA





PTRF
ADXCRAD_BU186765_at
TTCCATTGAACCCAAAGGTCCGCAACACCTGCCTCCCAGGCCTGGGGCGGAAAAAATTGAAA
SEQ ID




CACCTCCTCTCCACCTTGAATGGGAGCCTTCAAGGG
NO:





2474





PTRF
ADXCRAD_BU186765_x_at
TCTACTAAGCCGAAACCCATCTCTACTAAAATTACCAAAATTTNCCTGGGCATGATTGCGCA
SEQ ID




TGCCTGTAAATCCAGCTACTTTTGGAGGCTTGAGGGGGGCAGCAATTGCTTGAACCTGGGGA
NO:




AGGGGGCAGGTTTCCATTGAACCCAAAGGTCCGCAACACCTGCCTCCCAGGCCTGGGGCGGA
2475




AAAAATTGAAACACCTCCTCTCCACCTTGAATGGGAGCCTTCAAG





PTRF
ADXCRPD.10702.C1_s_at
GACAGAGCAGAATGAGCCCTCACCCTGGCTGGGGGTCCAGCACAGGCTGTATCTGCAGAGGG
SEQ ID




TCCCAGAGGAACGCTGGAGCCAAGAGAAGCCCTGGGAAGGAGGGGTGGGGAACGACATGCAT
NO:




GTGAGGGATGGCACACTGATGTGTTTATGCACCTGCACACAGGAGCGCATGGCCATGGCTT
1478





PTRF
ADXCRPD.2246.C1_x_at
TCTCCCCAGTCACAGCCTGAAGGGAGGCCCCGAGAGCTTCCTCCTTCCCCCCACCTGCTCCT
SEQ ID




TACCTTCTCTGCCCTGCTTTTTAGAACTGCAGTTCATTGTTTTAAGGGATTGGGGGAGGGAG
NO:




CCTGGGGACACAAACCTTTTATACAATACAAAGCTTTGCNNNNNNNNNNNNNNNNCTTCCCT
1917




TTTCCCNTTTCTCGGTTCTCTTTTCTCTCCTCTGGAATGGGCTGAAGACCCCTCTGCC





PURA
ADXCRAD_CD677455_at
ACTGCTGCATGACTATCATCTTTGAGTGAAGAGAAA
SEQ ID





NO:





2621





PURA
ADXCRAG_BC036087_s_at
ATGCTAAGTGTATTTGTGTTCCCCAAGTGTACAAGCCTTCTATCAAAAGTATGTTCTATAAC
SEQ ID




TCATATATTCAAGGTGTAGGGTATGAAAATGCAAAGTTTAGGAGAGCACTTTACCAAGCTGG
NO:




TGTCCTCCAAACTGAAATTGTTTGTAACGATAGTCTTTTACAG
957





PURA
ADXCRIH.2305.C1_at
CGGAACTCGATGAGCCCCTGCGCGGGCAGCGCAATGGTCTGGCCCTGCGTGGAGCCCAGGCC
SEQ ID




AGGCCCCCGGTTGACCGTCTGGCGGATGCGCAGGAAGCGGCCGCGCTGGTTCTCCTTGAGAT
NO:




CCATGTAGTACTTGCGGTTCTCGCGCACCAGGAACTCGCTTTTGAGCGCCCGGCGCGGCTCG
1117




TCCTGCGCCTGGGCCAGGTCCGGCGGCTGGCTGGGGCCCAGCTGCGCGTAGTGCTCGATGAA




GTCGCCCAGGTAGTCGCGGAACTCCACGGCCACTGACATGGAAAGA





PURA
ADXCRIH.2305.C1_x_at
CGGAACTCGATGAGCCCCTGCGCGGGCAGCGCAATGGTCTGGCCCTGCGTGGAGCCCAGGCC
SEQ ID




AGGCCCCCGGTTGACCGTCTGGCGGATGCGCAGGAAGCGGCCGCGCTGGTTCTCCTTGAGAT
NO:




CCATGTAGTACTTGCGGTTCTCGCGCACCAGGAACTCGCTTTTGAGCGCCCGGCGCGGCTCG
1118




TCCTGCGCCTGGGCCAGGTCCGGCGGCTGGCTGGGGCCCAGCTGCGCGTAGTGCTCGATGAA




GTCGCCCAGGTAGTCGCGGAACTCCACGGCCACTGACATGGAAAG





PURA
ADXCRIHRC.2305.C1_s_at
ATGTGGGCTCCAACAAGTACGGCGTGTTTATGCGAGTGAGCGAGGTGAAGCCCACCTATCGC
SEQ ID




AACTCCATCACCGTGCCCTACAAGGTGTGGGCCAAGTTCGGACACACCTTCTGCAAGTACTC
NO:




GGAGGAGATGAAGAAGATTCAAGAGAAGCAGAGGGAGAAGCGGGCTGCCTGTGAGCAGCTTC
1308




ACCAGCAGCAACAGCAGCAGCAGGAGGAGACCGCCGCTGCCACCCTGCTACTGCAGGGTGAG





QKI
ADXCRAD_BM931336_s_at
ATGTACTTAGAGCTTTTTGAGTGTAGAATTTTAAATGGCAGGATTTTACAGTGTTTACATGC
SEQ ID




AAGTGCATTTTATAAGTGTTCTATATGTGTAAAATAGTATTTTCAACTGGAAAGTGTTGGCT
NO:




AGTGCAAAAGGCCTGGCCATTTTCTGGTTCCCATGATGTTGCCTACACTGCTAGACTACAGT
1057




TTAGTATCGCTTTGTATCATGAGGCCAAGAAATTCCATGTTGTTT





QKI
ADXCRAD_BQ720286_at
ACACTTTCAATTTTATTTGAGGCTTTCCACACTATTTAAAAGGAAAATGTAAGAAATTTGAC
SEQ ID




ATTCCTGGAGTTATTATAACCATTAGGAAAATGAGCCATAACATTCACCTCCTGATTTTTAC
NO:




CCATTTAAGGGGGAGAATTAAGTAAAACAGAACTGGCTTACAGGG
2634





QKI
ADXCRAD_BQ720286_x_at
TCTCAAGCCAACTGCAGCTGGAAAGTGCTGCTTATCCTCCACCCCCAGAAAATGCATGTATC
SEQ ID




AATATGAGAATAAAGAACGCACACTTTCAATTTTATTTGAGGCTTTCCACACTATTTAAAAG
NO:




GAAAATGTAAGAAATTTGACATTCCTGGAGTTATTATAACCATTAGGAAAATGAGCCATAAC
2635




ATTCACCTCCTGATTTTTACCCATTTAAGGGGGAGAATTAAGTAAAACAGAACTGGCTTACA




GGG





QKI
ADXCRAD_BU508110_at
CCATCTACCCCAACAAAAGACAAAGAAATTGTTGTCCTCCACTCAGCTTTTTTTTTTTTTTT
SEQ ID




CCTGTTTGGGGGAAGGTGGTCTAGAAACTGCACGTGATAGTAAGTAAAGCAATTAGGGCCCA
NO:




ATTCTCCCCACAGCCTGGATCATCTTTTAAATACCCACCCCAAGCCAACGGGAAAAAAGGCC
2319




TCCCTTTAAAAAGGGGAAAACAAAGGCCCTTACTTACCCCAAGGACAGAGGCCGTTATCGGT




GAGAAACTT





QKI
ADXCRAD_BU508110_x_at
AGCGAGCTGAGGCACTTGTCCGTTCGTCTTACCATCTACCCCAACAAAAGACAAAGAAATTG
SEQ ID




TTGTCCTCCACTCAGCTTTTTTTTTTTTTTTCCTGTTTGGGGGAAGGTGGTCTAGAAACTGC
NO:




ACGTGATAGTAAGTAAAGCAATTAGGGCCCAATTCTCCCCACAGCCTGGATCATCTTTTAAA
2320




TACCCACCCCAAGCCAACGGGAAAAAAGGCCTCCCTTTAAAAAGGGGAAAACAAAGGCCCTT




ACTTACCCCAAGGACAGAGGCCGTTATCGGTGAGAAACTT





QKI
ADXCRAD_CK002286_s_at
TTATACCTGGACATTTTAGATGTTTATCAAAGGTCTTTTATGGGGAAGAAAGTAAATGTATG
SEQ ID




AAATAATAAATGTGTGACATTTATAGGGAATGTTGGCTCTGAACAAACTTTTGAAAACTTGG
NO:




TTGACAAAATTTTGGATCAACTGAAAAAAGCATGACTTTTGAAATCTCTGAATGCCTTGGTT
2530




CTCAGTATTATCATT





QKI
ADXCRAD_CN295279_at
ACAAGGTACATGCATTATGTGTCACATTACTGGGCAAACTGTTCAAGTATTTTTTTTTAAAC
SEQ ID




CTCCCTGTATAGAAAAAAATCATTAAGGATGTAAAAGCCATGCTTGCCTATTTGCTGTATAC
NO:




ATGTAATGAAATTGTAGATAAAGTGTAGTGCATTGAAACAAATGAACAAAAAGTAGATACTT
2728




TTACTATACAAGGGTGCTGGTGCAGAAAA





QKI
ADXCRAD_R41907_at
CTGGACAACTTTTTAATGCTGTTTTACCNCAGNGAGAAAGCAATGAACAAAAGCATATTAAC
SEQ ID




ATATTATCATTTAATTAAAATGTATTCAAACCAACTTTCAACTTGTACTACCAGTATGTCTT
NO:




AATTTTATA
2868





QKI
ADXCRAD_AA935633_at
AAGTTTTCTGCCTCCACAATCTTTCAAATGCCAACACAAATAGGAAAAGCAGAACCCCTTAA
SEQ ID




AGGGACAGCTCAGGTTTTCTCTGGAGCAACTTGAAATTAACAGATTTGCTATTCCAACAGCG
NO:




GAAAATGCCCATTTCAACGTTGGTGAGTGCTGTATGTTTAACATACGGAAGCAAAACGACGA
2845




GAAAGCCGTAACACCTAACCATTTTCTACTTTTAAGTTGTTTCTATGACTTTCAAGACAACA




GAACTCCTGGGATTTTT





QKI
ADXCRAG_AF142421_s_at
AGCTGGCCCTACCATAATGCCTTTGATCAGACAAATACAGACCGCTGTCATGCCAAACGGAA
SEQ ID




CTCCTCACCCAACTGCTGCAATAGTTCCTCCAGGGCCCGAAGCTGGTTTAATCTATACACCC
NO:




TATGAGTACCCCTACACATTGGCACCAGCTACATCAATCCTTGAGTATCCTATTGAACCT
866





QKI
ADXCRPD.17514.C1_at
GAAAGTGTTGCCATGAGGGAAGAACTTAAGGGAGTTTAGAAAAGTAATGCGATGACGCAACT
SEQ ID




GTAACACTATGTTTAAAAGGATAGTGTCCTGGGTGAAATTACTGTTGCTTCTTTTACGCCAG
NO:




AA
1888





QKI
ADXCRPD.17514.C1_x_at
GCATCATGCATGAACCTTCGGGCAGGGATATCATTGGTGAAGTGATTTCAAAAAGTATTCAA
SEQ ID




AATTTGAGATGCTGTTTAGTCACTACAGTGCCCTCAAAGGGCAGAAGTTGCAGCCTTTTTTA
NO:




TATTGCCTGCCAAAATATGAAGTATTAGAAGAAAGTGTTGCCATGAGGGAAGAACTTAAGGG
1889




AGTTTAGAAAAGTAATGCGATGACGCAACTGTAACACTATGTTTAAAAGGATAGTGTCCTGG




GTGAAATTACTGTTGCTTCTTTTACGCCAGAA





QKI
ADXCRPD.1932.C1_s_at
GATACAAAATGCAAAATCCACAATTTTGATAAACTGAAAATTGCCAATTTGTTTTGCAGTAC
SEQ ID




TTTATTATATTGGGGTGGCCTTGTCCTTTTTGGGCTTTTAGTTAGCTAATGAATGAATACAT
NO:




TAGACACTTTTGGGTTTTAGTTGGGATTTTACATAGCTTGCATTTTAATTCTTTGGTTCTTT
1534




GCTGTTTCTATTAACCCACAGCATTAT





RAB31
ADXCRAD_AL552789_s_at
GACCGACTGGGTATCTAGCTTACTGTTTTAACATCATTGTTGAAACCAGACCCTGTAGTCCA
SEQ ID




GTGGTGCTGCCCTGTTGTGCAAACTGCTCCTTTTTCTCGTGTTTTTGTAAAGAGCTTCCATC
NO:




TGGGCTGGACCCAGTTCTTGCACATACAAGACACCGCTGCAGTCAGCTAGGACCTTTCCGCC
2580




ATGTATTCTATTCTGTAGTAAAGCATTTCCATCAACAATGCCTAATTGTATCTGTTATTTTT




GGTTTAACACACACTGATTCATACT





RAB31
ADXCRPD.1938.C1_s_at
AGCCGCCGGTGCTGTTGACCCAAGGGCCGTGGTCCACGGTACTTGAAGAAGCCAGAGCCCAC
SEQ ID




ATCCTGTGCACTGCTGAAGGACCCTACGCTCGGTGGCCTGGCACCTCACTTTGAGAAGAGTG
NO:




AGCACACTGGCTTTGCATCCTGGAAGACCTGCAGGGGGCGGGGCAGGAAATGTACCTGAAAA
1535




GGATTTTAGAAAACCCTGGGAAAACCCACCACACCACCACAAAATGGCCTTTAGTGTATGAA




ATGCACATGGA





RAB31
ADXCRPD.2065.C1_at
AATGCGCCGGCCTAACAATAGTTATAAAAAATTGGGGGGAGGACAACCTCCCCTTCCCCCTC
SEQ ID




CCGGATCCCCCGCCCGCCTTTTTTTTCCGCACTATTATCCGCCTCTGCCCCGCCGCCTCAGA
NO:




ATACCTCTATCCCGCCGCGGAGAAATTNATTCGCGCCCCGTATTTTCTGCCCGCCGCGAACA
1412




CGCCCGCCAACCAGTATTCTCGGGAAAATAATATAATGGGACTCAAAAACACCGCTCCCCGC




CCAAATACGAACGTCGCGGTGGTTATTACTTCTCGCCC





RAB31
ADXCRPD.2471.C1_at
GGTTGTAAAGCCTCATTGTAGACAAGGCCTGAGCATCCACAGAGAAGATACAATGTTTATAT
SEQ ID




GAATCCTGGTGTGCCCAAGTGTGATCTACTCTCTTCACTGACTACTCTGAGTGCTGATGAGA
NO:




ATATATATATTATCCTCTGACTGGCTTGAATAGCTAAGACAATACAGAAAGGTAACAGAGTG
1496




GTTTCACACCCTCATGTGCTTCTGAAATAAAACCATGGGCTCATTAGTGGGTAGCTCACTAT




CTGTGGCAA





RAB31
ADXCRPD.8667.C1_s_at
GATTGGATTAAAGACCTGGCACTTCAGTAACTCAGCACGCTTCCACTTCACTCAACTTAAGA
SEQ ID




GAGTTCATTGACAGTGTTAGGATGTGAAGGCTGGGAAACACTTATTTTGCTTCAAGAGTTCC
NO:




ACTTGGCTCTCCCAAATAGGTACCTCAAAAACTGTTAGCAAGCGGCATTTGGATGTCTTGAC
1406




AGGGGCTTTGCAGGGATTTTTAGGGTTTTTTCCACATTGTCCACATTAATGGTTGGCATGAT




TGTGCTTGCAGGCCAAGAAATGATCATACCCCTTGCCAA





RAB32
ADXCRPD.4345.C1_at
TTTGTCATTGTTGCCATCATATGGAAGATAATGTTTACATCCTTTTAAACATTTTTATATGA
SEQ ID




CAATTCCTCAGGATTTGGTAAGGCTTCCAAGTTGTAGCTT
NO:





1906





RAB32
ADXCRPD.4345.C1_s_at
ATGTCATGTTAGCTGGGAGTCTTCCCACATGTGGCACTTCAAAAGGCAGCACCACTGGGCGC
SEQ ID




CTGCACTTATTTGAAAATGGAACTTTGGGAGAAGTATCCCTGCTAGTGGCTCTGTAACTTAA
NO:




CAGATGACAATTAGGCTTTT
1907





RND3
ADXCRPD.11316.C1_at
TTCCACAAACTATGTCATCAGGCTCATTTTTCAAAACCAATGTGCACAACACCTGGTCAAAC
SEQ ID




TTCTGCGTCAACTACATTCCGTGTCAATAAAATGTTTGCTTTGCCAAGGGAGACTCTGAGAA
NO:




AGTGACCAATATGTAGCAACTGAGAAGTCATTTAAAGGACATCAGA
1472





RND3
ADXCRPD.1153.C1_s_at
CACTCAGTTCTATGTCTTACAAGCACTTTGTCTTGTCTCTGCAAGAAAATTCGATTCCAGTC
SEQ ID




ATTTCCCATAAAATACAGACATTTTACCAACATAATATGCTTTGATTGATGCAGCATTATGC
NO:




TTTGGGCAGTATTACAAAATAGCTGGCGAGTGCTTTCTGTATTT
1868





ROBO1
ADXCRAG_NM_133631_s_at
AGATAAGTATCAGGTCTGACCCCAGTGGAAAACAAAGCCAAACAAAACTGAACCACAAAAAA
SEQ ID




AAAGGCTGGTGTTCACCAAAACCAAACTTGTTCATTTAGATAATTTGAAAAAGTTCCATAGA
NO:




AAAGGCGTGCAGTACTAAGGGAACAATCCATGTGATTAATGTTTTCATTATGTTCATGTAAG
1051




AAGCCCCTTATTTTTAGCCATAATTTTGCATACTGAA





41889
ADXCRAD_AI831470_at
ATTAAGTTTATCCTTTTCTCCATCTTTTCTTTCTTGCCACCTAATGAAGGAAATGTCTCCAA
SEQ ID




GGTCTTTTTGACTAATAGAAACTAAATGTATAACTCGACATCTAGAAGGGTTTCAAGATAGT
NO:




AGATATGTCTGCTGGGATGTTTTGTCATTACCCTGCCCAATGTTGCGACGCTAGGAGTTTCC
2805




TTGACACTACATTATAAATAAGGCCCAACCTGTTAGCAAAAATATCACATTCCCTAATTTTC




TCTCCTTTAACTGTGTGTAATTTATCCAGGCATGTCTTTAGTTCAG





41889
ADXCRAD_BF855173_at
AAGGTACTTAGAGCTCTTACTTTCTAAGTACAGAACACCCTAGACAATTCAAGGCATCTTAA
SEQ ID




TCTCCATCAAGAACAAAAAAAAAAATAATTTTGGTCATGCGGTTAAATCCATCATTAGGGAT
NO:




AAAACGGGTGCAAATGGGTCAAAGGGATCCAACAAACACGGATGTCCAAGCGGGCATATGGG
2333




CAACTATTACGTTAACGGGGGGTCAATAGAGAGTTAAAAAGATCTTCCCTTTCTTCTGGTTC




TTTTCCAGGGTTCTGGAAGAGTTCTGGT





41889
ADXCRAD_N39126_at
CAACAGAAAGATGGACTAAATATAAAGGGGGGAATTCCTGGACCTCCTTTGGGTGGCTAGAC
SEQ ID




TGGTANGTCATAGGCTAAGCCGGAAGGGTGG
NO:





2855





41889
ADXCRAD_N39126_s_at
AAACAAGTACAATATCCTGGCATAAAACTATCTTTCAGACAAAATCCACCTGCTGTGTATTA
SEQ ID




AAAAATGTAATACTTGAAAACTTCCTGCCTTGGGAGAGACTAAACCCGATTCATAATACAAA
NO:





2856





41889
ADXCRIH.335.C3_s_at
TTACACTTTATGGTAAGTAGCAGGGGGGGAAATGCATTTATAGATCATTTCTAGGCAAAATT
SEQ ID




GTGAAGCTAATGACCAACCTGTTTCTACCTATATGCAGTCTCTTTATTTTACTAGAAATGGG
NO:




AATCATGGCCTCTTGAAGAGAAAAAAGTCACCATTCTGCATTTAGCTGTAT
1260





41889
ADXCRPD.177.C1_s_at
ATAAAGGACCGTTTACCTCTTGCTGTGGTAGGTAGTAATACTATCATTGAAGTTAATGGCAA
SEQ ID




AAGGGTCAGAGGAAGGCAGTATCCTTGGGGTGTTGCTGAAGTTGAAAATGGTGAACATTGTG
NO:




ATTTTACAATCCTAAGAAATATGTTGATAAGAACACACATGCAGGACTTGAAAGATGTTACT
1905




AATAATGTCCACTATGAGAACT





41889
ADXCRSS.Hs#S1914581_at
GGGCCCAGAGTTTGCTCCCAGGGAATCTAATGAACCACCTGGAATCAAACATTTGGAGAGAA
SEQ ID




GGCCAGTCACTTTTATCGGAACGTCAGATGGTCATGGACCCTCAAGAATGATTGAAGAAATT
NO:




TGTAAGCCCAGTTAAAACATCCACAGTCTTCTTTCCTCAGTGCAAAAGTTGCCCTTTTTGAT
2088




ATCTCATATTTAGAGTAAAAAAATTTCGTTAATAAGAGATCCTCT





SCRN1
ADXCRAD_CK001870_at
AGATGGAAATGCTATTGGCGGGAATATATAAAAAAAAAGAATCTTCTGTTCTGCATGG
SEQ ID





NO:





2046





SCRN1
ADXCRAD_CK001870_s_at
GAGCAGCAGGTCATGTGCACATGCCGTTGCAGCACAAGCTTATGCTTCCCGTAGCCGTGGCT
SEQ ID




TTTCATTCTGCACAGTCCCAGGTCCCAGCTCCCCTCTTATGGTTTCTGTCATAATGTGCTTT
NO:




ATCTGATTGACTCCAAACATCCCGAAATGTCACCTGCAGATTTCTCGTGGGAACCAATATGT
2047




ACATGTT





SCRN1
ADXCRIH.243.C1_at
ATAATCGAAATTATGGAGGTTCCTTAGTGCTCAATAATATAAGACCTGTTGTTATTAGAACG
SEQ ID




AGTCTTTCTTATAAACTAACAGAGCAGGTATATGCCTGTTAGATCTTAGCTGTGGGGTTCCT
NO:




TTACTATTGGGTGAATCATTAGGTATAAAAAATAATCATCAACCAGGCCAAATACTTTGCTT
1256




CCTAGCTGATGTCATCCCACATTGGTACAGTGTTATTCATTACTGGGTGGTTCAACAGGGAA




GCCAGTGGGA





SCRN1
ADXCRIH.243.C1_s_at
GGTTCCTTTACTATTGGGTGAATCATTAGGTATAAAAAATAATCATCAACCAGGCCAAATAC
SEQ ID




TTTGCTTCCTAGCTGATGTCATCCCACATTGGTACAGTGTTATTCATTACTGGGTGGTTCAA
NO:




CAGGGAAGCCAGTGGGACCAGTGTGTCTGTCATGAAAC
1257





SCRN1
ADXCRPD.2301.C1_at
CACGTGCTTCCTTACTAAGGCTGAGAGCTCAACTGAAGACCTTCCCCAATAAATGACAGATG
SEQ ID




GCTCTTCAGTCAGGAATGCAGTTAGTGGTTTCATGACAGACACACTGGTCCCACCTGGCTTC
NO:




CCTGCTGAACCACCCAGTACTGAATAACACCTGTACCAATGTGGGATGACATCAGCTAGGAA
1899




GCAAAGTAATTTGCCTGGTTGATGATTATTTTTTATACCTAATGATTCACCCAATAGTAAAG




GAACCCCACAGCTAAGATC





SNAPC1
ADXCRPD.2725.C1_at
GAAAGAATCCATCCTTAAAGTCAAAAACTAATGATGGAGAAGAAAAAATGGAAGGAAATACA
SEQ ID




CAAGAAACGGAGAGATGTGAAAGGGCAGAATCATTAGCGAAAATAAAATCAAAGGCCTTTTC
NO:




AGTTGTCATACAGGCATCCAAATCAAGAAGGCATCATCAAGTCAAACTCGACTCTTCGGACT
1555




CTGATTCTGCATCTGGTCAAGGCAAGTCAAAGCAACTAGGAAAAAAGAGAAGAAAGAAAGAG




TGAAACCAGCAGGAAGGAAGATGTCTCTCTAGAATAATAC





SPTAN1
ADXCRAD_CA435088_s_at
AATTGATTTCTATTTGCCATTCTCCAAAAGACAAAAAAAGTTGGTTTTTTTTTTTTTCGGTC
SEQ ID




TTTTGTTTGTTTGTTTGTTTTTTAAAAAATAGGGTCTTGCTTTGTTGCCCAAACTGGAGGTC
NO:




AGTGGCTTTTCACAGCTGCAGTTATAGCCTACTGCA
2571





SPTAN1
ADXCRPD.3100.C1_s_at
TCCGGTCCAGTCACAATCATCATGTCACTGTGGGGACCCAGATCTGTGTCTTGAAGCAGCTG
SEQ ID




CCCTCATTCCGACTTCAGAAAATCGAAGCAGCTGGCTCCTCC
NO:





2277





SPTAN1
ADXCRPD.9848.C1_at
TCAGTTCAACTGAGCGACGTGTATACTCCTGGGCGTGAAACAG
SEQ ID





NO:





2293





SPTAN1
ADXCRPD.9848.C1_s_at
AAGATTATGGCGACACTCTTGCCGCCATCCAGGGCTTACTGAAGAAACATGAAGCTTTTGAG
SEQ ID




ACAGACTTCACCGTCCACAAGGATCGCGTGAATGATGTCTGCACCAATGGACAAGACCTCAT
NO:




TAAGAAGAACAATCACCATGAGGAGAACATCTCTTCAAAGATGAAGGGCCTGAACGGGAAAG
2294




TGTCAGACCTGGAGAAAGCTGCAGCCCAGAGAAAGGCGAAGCTGGATGAGAACTCGGCCTTC




CTTCAGTTCAA





SPTAN1
ADXCRPD.9848.C2_at
GAGGAGAACGACAAACTGCGCCAGGAGTTTGCCCAGCACGCCAACGCCTTCCACCAGTGGAT
SEQ ID




CCAAGAGACCAGGACATACCTCCTCGATGGGTCCTGTATGGTGGAAGAGTCGGGGACCCTCG
NO:




AATCCCAGCTTGAAGCTACCAACGCAAGCACCAGGAAATCCGAGCCATGAGAAGTCAGCTCA
2295




AAAAGATCGAGGACCTGGGCCGCCATGGAGGAGCCCTCATCCTGGACA





STK17A
ADXCRAD_AW183478_at
GAAATTCAACAATGAGCATCTGTCCTTCCTCTATACCACTACTAGAGAAAGGGATTAATTAC
SEQ ID




CTCCTAGTTTTCATTTGAAAACAACAAAACACAAGATCAATCAAATATCATTTCCCAGTTGA
NO:




TTAAAACTTATACATTTTATACATTTCATAAACAACGTTTCACCACACCAAAATATTGTTGA
2801




ATTATAGTTAAAACTGGATTTATAAACCGAGTAAACTCAATAGTACTGGTTAGTCCTTTATA




AATTTGGGGATAGAAAAAAAGGAACATTAACAGCTTTAGATAAG





STK17A
ADXCRAD_BQ227453_s_at
AACTTTGTCAAATTTGTGGAGTTAGGTGGAAGCCAGATTTTAAAAGTTGCCAACCAGGATAT
SEQ ID




TTAACAGGTACAGTTACCCGTTTCAATGTTATTTTTAAGAAGGGAGATGTTGGCACCTTTGA
NO:




ATTCTACATCCTGTTTCTC
2617





STK17A
ADXCRAD_AA234664_at
AAGTGAGTAAAATCCCCTAGAGCAGAGAGAGAGAGAGAGAGAGAGAGTGTCTTCATGCCAAC
SEQ ID




CACAGCCTGTTTCTGCTGAGTTTCTTATCAGCCCTCAAGCTATGCTAGGAAAAGTTATAAAA
NO:




TGCCAAAATATTTATAAACATTTACTTTGTCCATAAAATATTTACATTGGATACTCTGTAAG
2398




TAGGAGGTACTTTGTCCCAAAAAGATGTATAAGAATGTACTAATAGTTTTATTTGATTAGGA




TTGAACAGTTCAGTTGTATCTATGCCCCACAGTGACCAGTAAAGT





STK17A
ADXCRPD.362.C1_at
GCCGACCGGCGCACATGTGATAAGAAGATACTGTGGGGTGGCCCCCCCTTGCGGCCCCCCAG
SEQ ID




AAAGAAATCTTTTTAAAACCCCCTTTTTCTTTTTTGGGCGGCCGCGGGGGCGCCCCCCCGAT
NO:




AGGGGACAAGGCCGGGATACGGGGGGCTCGAAACCGTTGTGGCCCCTTCCACAGAGGAAAGA
1909




TACCCGGTGGCCACCCGGATAAATAACCGCGGCCTGTGTGTTT





STK17A
ADXCRPD.7382.C1_at
AACGACTTATGCGACCAGATTTTAGAAGGTGTACACTATTTTACAACACTCGTGACTGTAGT
SEQ ID




TCATCTGGCATTTGAAGCCTCAGGAATATTCTGGTGAACCAGTGAATCTCCATTGGGTGACA
NO:




TTACCGATCGCAGATTTGGGCTACCCAAGACTATTGAAGACCAGTGAAGAGCTCGAGGAACA
1784




TCATGGGTAACCCTGAATATGTGGGTCCGGACATCCTAAGTTATGATCCTCATAGCCATGCC




ACA





SVIL
ADXCRAD_CA396083_s_at
GAAGCTTGAGATCTATCTCACCGACGAAGACTTCGAGTTTGCACTAGACATGACGAGGGATG
SEQ ID




AATACAACGCCCTGCCCGCCTGGAAGCAGGTGAACCTGAAGAAAGCAAAAGGCCTGTTCTGA
NO:




GTGGGGAGACGCCAGAGGAGCCTCACGGTCACGTCCAACAACACCACTGCACCAGGGAAATG
846




GATAT





SVIL
ADXCRAD_CN402078_s_at
GTATCTTCATACACGTTTGGAAATGTTTCCTGCAGCATTAGGTATGACTTGTTCTGAGTACT
SEQ ID




GCTTCCGGTGCTAAAATGAACAAAGAATTTGTACTTAATGGCATGGACTCTGGAGAATCTAT
NO:




GCGAATCAACCTTTCTACCTTAATATCTCCCCAAAAATGTATAGTGCCTTGTTTTTATGTAC
1315




AGTTTATATACAGAAAAGTTTGCTCTGCATTTTTGATGATGGTTTGGAACATTATCTACAAT





SVIL
ADXCRIH.3823.C1_at
GGCATTGCCTAGCTGGAACAAGAAGGCAGTGCTATCTATAGCAGCTGCGGCTTAAGTGCACA
SEQ ID




TAACAGATACTTTTATTAATTCTGATAACCTCCTGAATGGTGGAAAGAAGTTTCCAAACAGT
NO:




TCCCTTGAACATTTACAAAATACACAACTCCGGGACAGCAGTATCTTTAACAATGTCATGTT
1176




CTGAAAACTCTGAT





SVIL
ADXCRIHRC.3823.C1_at
ACCGGTTGTAAAAACAGTACACATGTCATTTTGTGATATAGGACTCCCAAATAAAAGTATCA
SEQ ID




GAATAAACACCTCGTGC
NO:





1314





SVIL
ADXCRPD.12020.C1_s_at
GCTTCTGGGTGGCCAAACCAGTTACCCAATCTGCTGGAGACCCAAAAGAAGATGAACTCTAT
SEQ ID




GAAGCAGCCATAATAGAAACTAACTGCATTTACCGTCTCATGGATGACAAACTTGTTCCTGA
NO:




TGACGACTACTGGGGGAAAATTCCGAAGTGCTCCCTTCTGCAACCCAAAGAGGTACTGGTGT
1489




ATGATTTTGGTAGTGAAGTTTACGTATGGCATGGGAAAGAAGTCACATTAGCACAACGAAA





SVIL
ADXCRPD.9920.C1_at
GTGAGTCAAGAAGGCCCTCCCCTGTCGGCGTTTGATCTCTCCAGCAGCAAACATCGCACATG
SEQ ID




GATTCTTGCAGAGCTTCTCCTGCGGCTGTTCCGAAGAATCCTGGGGCTTCCAGGACACGGGG
NO:




GCTGTGGTTTAAGCAATAGTTTTCCCAGCAGCTGTCCCCGTCTGCTCGGAAGTGGGCTCCCC
1551




GAACTCTGCCGCTCTTAGTGAAAACTTCCTTTTCATAACATTCTCCACCTCCACCTTCTCTT




CAAAGGGCAGCCTGTCCTCAAGTC





SVIL
ADXCRPDRC.9920.C1_at
CATGTCTATAAAGAAAGATGGCACTGTTGAAGAAAAGCGGGGAGGAAGATTGGAGAAACAGA
SEQ ID




CTCAGCAGGAGGCAGGAGGGCGGCAGCGCCGCCACAGCCGCACACCCAGAAGCAGGCGTCCC
NO:




TCATCAGAAGCGT
1963





SVIL
ADXCRPDRC.9920.C1_s_at
TGGAAGCCCCAGGATTCTTCGGAACAGCCGCAGGAGAAGCTCTGCAAGAATCCATGTGCGAT
SEQ ID




GTTTGCTGCTGGAGAGATCAAACGCCGACAGGGGAGGGCCTTCTTGACTCACCCAGCAA
NO:





1964





TFE3
ADXCRPD.14170.C1_at
CCTTTTGAAGGCACGGCAGAACGAAAGACATCAACAACCTTAATTTGAGCGTCGCAAGGCGA
SEQ ID




TTCCAACATTTACCGACAGGAATCAGGGAACTGGGGCCTCCTCATCCTAGTCCAGTGACCGG
NO:




AGA
1660





TFE3
ADXCRPD.2523.C1_s_at
TTATTGCTCCGCATACTGAGAATCTAGGCCACCCCAACCTCTGTTCCCCACCCAGTTCTTCA
SEQ ID




TTTGGAGGAATCACCCCA
NO:





1520





THY1
ADXCRAD_BM704951_at
CTGGAATCTGTCCTCGTGTCCACCTGGCCTTCGCTCCTCCAGCAGTGCCTGCCTGCCCCCGC
SEQ ID




TTCGCTGGGGTCTCCACGGGTGAGGCTGGGGAACGCCACCTCTTCCTCTTCCCTGACTTCTC
NO:




CCCAACCACTTAGTANCAACGCTACCCCAGGGGCTAATGACTGCACACTGGGC
2556





THY1
ADXCRAD_BM704951_x_at
GTTCTTCCTGTTCTGTGACTGTGTATAGTGCCACCACAGCTTATGGCATCTCATTGAGGACA
SEQ ID




AAGAAAACTGCACAATAAAACCAAGCCTCTGGAATCTGTCCTCGTGTCCACCTGGCCTTCGC
NO:




TCCTCCAGCAGTGCCTGCCTGCCCCCGCTTCGCTGGGGTCTCCACGGGTGAGGCTGGGGAAC
2557




GCCACCTCTTCCTCTTCCCTGACTTCTCCCCAACCACTTAGTANCAACGCTACCCCAGGGGC




TAATGACTGCACACTGGGCTTCTTTTCAGAATGACCCTAACAAGACACAT





THY1
ADXCRPD.3397.C1_at
AAAGAGCACGTGCTTCTTTGTCTCACGGGTCAGGCTGAACTCGTACTGGATGGGTGAACTGC
SEQ ID




TGGTATTCTCATGGCGGCAGTCCAGACGAAGGCTCTGGTCCACTAGGCAGGCCGTTAGGCTG
NO:




GTCACCTTCTGCCCTCGGGAGACCTGCAAGACTGTTAGCAGGAGAGCGATGCTGATGGCCAG
1904




GCTCATGGTTCTGGGATCTCAGTCCTGGATCTGGACTGGGTCTTCCGCTG





THY1
ADXCRPDRC.3397.C1_s_at
CATCCTTGCCCATCGGGACCAGAAACCTGGGAGAGACTTGGATGAGGAGTGGTTGGGCTGTG
SEQ ID




CCTGGGCCTAGCACGGACATGGTCTGTCCTGACAGCACTCCTCGGCAGGCATGGCTGGTGCC
NO:




TGAAGACCCCAGATGTGAGGGCACCACCAAGAATTTGTGGCCTACCTTGTGAGGGAGAGAAC
2049




TGAGCATCTCCAGCATTCT





TIMP2
ADXCRPD.1038.C1_s_at
ACTTGCTGCCGTAATTTAAAGCTCTGTTGATTTTGTTTCCGTTTGGATTTTTGGGGGAGGGG
SEQ ID




AGCACTGTGTTTATGCTGGAATATGAAGTCTGAGACCTTCCGGTGCTGGGAACACACAAGAG
NO:




TTGTTGAAAGTTGACAAGCAGACTGCGCATGTCTCTGATGCTTTGTATCATTCTTGAGCAAT
1841




CGCTCGGTCCGTGGACAATAA





TMEM158
ADXCRPD.7689.C1_at
AACAAATACACAGGATTTGGTCATTTTCTGCCATGAATCTAGGGCACGTGGGTGCCGGGAAG
SEQ ID




GAGTCGGGCAGGGGGATGCAATAGAGGGGAAAGGGCCCCATTTCCCTCCTCTCCGTCTTCGG
NO:




AGCTGCGATCCCACCCTCAGTCCAAGGGCTTAAACATCTGCTTTTCGGAACTGGAAGCGCAG
1836




CACAAACCTTG





TMEM158
ADXCRPD.7689.C1_x_at
AACAAATACACAGGATTTGGTCATTTTCTGCCATGAATCTAGGGCACGTGGGTGCCGGGAAG
SEQ ID




GAGTCGGGCAGGGGGATGCAATAGAGGGGAAAGGGCCCCATTTCCCTCCTCTCCGTCTTCGG
NO:




AGCTGCGATCCCACCCTCAGTCCAAGGGCTTAAACATCTGCTTTTCGGAACTGGAAGCGCAG
1837




CACAAACCTTGCTTTTCAAAGGCGCTGGG





TMEM158
ADXCRPDRC.7689.C1_s_at
GATTAAATTGCTATTGCTGTAGTAAGAGAAGCTCTTTGTATCTGAACATAGTTGTATTTGAA
SEQ ID




ATTTGTGGTTTTTTAATTTATTTAAAATTGGGGGGAGGGCATGGGAAGGATTTAACACCGAT
NO:




ATATTGTTACCGCTGAAAATGAACTTTATGAACCTTTTCCAAGTTGATCTATCCAGTGACGT
2034




GGCCTGGTGGGCGTTTCTTCTTGTACT





TRAM2
ADXCRAD_BM700086_s_at
AGGCTGTGTCATTGGCAGGGCTTCACATGCAGGAGGCCTCTCTCAGGTGAGTCCAGGTTAAA
SEQ ID




CTGTTGAGTTGTGGCTTCAACAGATATGTATGGCATGCTGGGATGTGCCAGGTGCCTGCGTT
NO:




GTGCCAGTTGCTGGAGAGGTAGTGTGAGCAGAGCAGCTGAAATCTTGCCATCAAGCAACCCT
2739




CATTCTCATGCCTGTAGGTTTCCATTGCTCTGTCCCAGGACACTTGCGTGCCAGAGACGCCA




CAACTTCATGTCCCTGTCTCTTGCAA





TRAM2
ADXCRAD_BM789115_s_at
TGGTGCCCTGAGCAACTGATAATGCAAATGTGGACAAAGTGTCTGTTTTCTACTCTAGCCTG
SEQ ID




TTCATATGGACCAAATTTCAACAAGGAACTCAAGGAAAATTTGTACCTGCCGTATTTATGCT
NO:




TTCATGTAAAAAAGGGTTGGGGGGAGGGGTGTCTTTTTGCTTTTGGTGAACTTTTTTTCAAA
988




ATCATTTTTCCACTGTTTCTGTCTGGTTTTAAAACAAATTACAGTTTTGTATGGATTTT





TRIB2
ADXCRAD_CX783483_at
ATCCTGGTCAGGAAATGACATGTTAATGCTTTGCTC
SEQ ID





NO:





2393





TRIB2
ADXCRAD_CX783483_s_at
ACACATCCTGGCATCGCACTGTTAGCATTTAATTTCTTGTTAGGATTCAGGGAAGGAACAGT
SEQ ID




TGGCCAAGAATTTTTTTTCTTTTAAACAAGCCAACCACCTAGCTGGTAATTAATGAGGTTCA
NO:




CTTAAAAAAAAAATTCGGTGCACACAGACTGACATGAAACCTGGGTGCTACAGTAAAAGAAA
2394




ACAAAAGTCCAGTTTGTGTCTCTTAATCGCTCACTTCAACTCATTTCTTCTAAA





TRIB2
ADXCRPD.1189.C1_s_at
GGCTTCACCCTTCGTAACCAGGAGACAAGGCGGCCATGGATTTGCCCTTGATTCTATTTTGC
SEQ ID




TAATGGAAGATAGAAAGGAGAGAAGGNNNNNNNNNNNNNNAACATTCTGAAGATGGTGCTGT
NO:




GTCAAGAAGGACCTTTTTTTTCCCCTCTCCCCTATTTTTTAAGTACCTTGGAGGAGGAGAGG
1870




TTGGTGACATGCATGGTGGGGATCTATGGCCTC





TUBB
ADXCRAD_CX872111_at
AACATGAACGACCTCGTCTCTGAGTATCAGCAG
SEQ ID





NO:





2481





TUBB
ADXCRAD_CX872111_s_at
GTATCAGCAGTACCAGGATGCCACCGCAGAAGAGGAGGAGGATTTCGGTGAGGAGGCCGAAG
SEQ ID




AGGAGGCCTAAGGCAGAGCCCCCATCACCTCAGGCTTCTCAGTTCCCTTAGCCGTCTTACTC
NO:




AACTGCCCCTTTCCTCTCCCTCAGAATTTGTGTTTGCTG
2482





TUBB
ADXCRIH.194.C3_at
TCCAGAAACGTCTTCTTAATCCCCACCTTTTCTTACTCCCAAAAAAGAATGAACACCCCTGA
SEQ ID




CTCTGGAATGGTGTATACTGCCACATCAGTGTTTGAGTCAGTCCCCAGAAGAGAGGGGAACC
NO:




CTCCTCCATCTTTTTTGCAACATCTCATTTCTTCCTTTTGCTGTTGCTTCCCCCCTCACACA
1261




CTTGGTTTTGTTCTATCCTACATTTGAGATTTC





TUBB
ADXCRIH.194.C3_x_at
TCCAGAAACGTCTTCTTAATCCCCACCTTTTCTTACTCCCAAAAAAGAATGAACACCCCTGA
SEQ ID




CTCTGGAATGGTGTATACTGCCACATCAGTGTTTGAGTCAGTCCCCAGAAGAGAGGGGAACC
NO:




CTCCTCCATCTTTTTTGCAACATCTCATTTCTTCCTTTTGCTGTTGCTTCCCCCCTCACACA
1262




CTTGGTTTTGTTCTATCCTACATTTGAGATTTCTATTTTGTGTTGAACTTGCTGCTTTTTTT




CATATTGAAAAGATGACATCGCCCCAAGAGCCAAAAA





ULK2
ADXCRAD_BP319713_at
GAGCTTTTCCATTTGGTGCTCCAATGTCTCCTGCTGGACCCATCTGCCTAGTGGAAGGCAGC
SEQ ID




AAAATTTCAAGAAACAGGTGAGGTTGAGCAGCTTGGTGCAACCCCATGGG
NO:





2317





ULK2
ADXCRAD_BP319713_x_at
AGAGAAGACTGTCGGCGCTCTGCCATAGCACCGCAACCGTGTGAGCAGCAGGCTCATCCCGT
SEQ ID




GGACCGGTGGTGGGAACGTGAGGAAGAGGGGAAGGAAGGAAGAGCTTTTCCATTTGGTGCTC
NO:




CAATGTCTCCTGCTGGACCCATCTGCCTAGTGGAAGGCAGCAAAATTTCAAGAAACAGGTGA
2318




GGTTGAGCAGCTTGGTGCAACCCCATGGGGCCCTGGAGTTGGAGCTCAACAGCAATGGATTT




CAGA





ULK2
ADXCRAD_CK818454_s_at
AGTTGGTGACCTAAAGGCTTGTTAGTGATGTGGAGTTCCTACATGCAGTGAGTGGAAAATGA
SEQ ID




AGTTCGTTTTCTCTTAGGAAAATGGGCAGCTGTCTTCTGCCTAATGTGTATTTTTCATGTTA
NO:




ATTCTGACAGTTCACCAAATAGCTAGTCATGGAGAATGCAGGCAGTTAACTTAATATCCCTC
2421




CAGGAATGGTTCCTACGTTGTGTATTATTTGGTTTCTTTTACTTACCTGCTTGAATACT





ULK2
ADXCRAD_NM_014683_at
AAGTGATTGGCCTAAAGTCAGGAACTAGGCAAGTGGTCAAGCCATGCTTTGTGACTTTCAAG
SEQ ID




TTAATTCTTCTTGTTCTTGTATATTAAAGGTCTTGGGGTAGATGGTGTGTGTGAAACAGTGA
NO:




AGTCTCAACAGCAGAAAAGAACAAAATGTAAATTCATGAATAATGGTTCTGGTTATACTTCC
2771




ATTATCAAGGCTAATTAAGAGATTTTGCCTTGAGTATAGCAATAATAAACAAATGCTTTATG




TTTCCCT





USP33
ADXCRAD_BP275873_s_at
GAAGACCTGGTTTTGATGCTGCCTCAGAACATTTGGGATAACCTATATAGCAGGTATGGTGG
SEQ ID




AGGACCAGCTGTCAACCATCTGTACATTTGTCATACTTGCCAAATTGAGGCGGAGAAAATTG
NO:




AAAAAAGAAGAAAAACTGAATTGGAAATTTTTATTCGGCTTAACAGAGCGTTCCAAAAAGAG
2569




GACTCTCCAGCTACTTTTTATTGCATCAGTATGCAGTGGTTTAGAGAATGGGAAGTTTTGTG




AAGGGTAAAGATGGAGATCCTCCAGGTCCTATTGA





USP33
ADXCRAG_AF383172_s_at
CATGAAGTGTGGAATGTGTCACTACGATTGTTGATAAAGCTGAGGCCACTTGCAACTTGATT
SEQ ID




TTTTAAATGAAATAGATAAAGTCTTTTTGAATAATATAGTATGCACTGCTATTTGCTTGATT
NO:




ATGTAATGTCAAAAGTTTAACTATATTCCAAGTACAAAAACATACTGGATTACATTGAGGAT
876




GTTGAATAGCATTCATGATGGCTTTGTTTTGGTTTGGGGCAGCTGTCACCAGCTAAAGCAA




TG





VIM
ADXCRAD_AL046837_s_at
TTTTAAACTTGGCTGTATTGTGTACAACTATTATACCATCTTTTATAAACACAGTTTTTTAA
SEQ ID




GAAATTTCTTTTTGTAAGTTACAACATTCCACTGGATCCTTATATTGCCTGTAGTGGAAGAG
NO:




GGTCTTGTGTGTCTGCCCCTTCTAGTTTTCACTCATGCAGAAGCAACATAACCTTCTGATTT
953




GCACAATAAATNACATATATTTAGCAGGATTTTTATTTGCCGTGATATATAGGATAATTTAG




TCTTTGGCATGTGGC





VIM
ADXCRAD_CX873552_s_at
AAGCAGGAGTCCACTGAGTACCGGAGACAGGTGCAGTCCCTCACCTGTGAAGTGGATGCCCT
SEQ ID




TAAAGGAACCAATGAGTCCCTGGAACGCCAGATGCGTGAAATGGAAGAGAACTTTGCCGTTG
NO:




AAGCTGCTAACTACCAAGACACTATTGGCCGCCTGCAGGATGAGATTCAGAATATGAAGGAG
1312




GAAATGGCTCGTCACCTTCGTGAATACCAAGACCTGCTCAATGTTAAGATGGCCCTTGACAT




TGAGATTGC





VIM
ADXCRIH.436.C1_at
TATTCTGAATCTCATCCTGCAGGCGGCCAATAGTGTCTTGGTAGTTAGCAGCTTCAACGGCA
SEQ ID




AAGTTCTCTTCCATTTCACGCATCTGGCGTTCCAGGGACTCATTGGTTCCTTTAAGGGCATC
NO:




CACTTCACAGGTGAGGGACTGCACCTGTCTCCGGTACTCAGTGGACTCCTGCTTTGCCTGGC
1159




GCAGGGCGTCATTGTTCCGGTTGGCAGCCTCAGAGAGTCAGCAAACTTGGATTTCCTCTTCG




TGGAGTTTCTTCAAAAGGCAATCTCTTCTTGCAAAGAT





ZNF331
ADXCRAD_AW959541_s_at
TCATGCCACCCACTCTACCAGTTGTCCCCACCATCCCCCGCCCTCCTTCCTGTGAGACACTG
SEQ ID




GGCCAAAGGCTCACTACCCCTGTGCGTTGTCCAGCACACAGACACTATGTGCATTATTTGTA
NO:




CATAAGGATAATCACATCTACCTGAGACTGCTATCATG
2447





ZNF331
ADXCRAD_BU176917_at
TAAGTCTCGAATGGTGTGGCCCTTCTGAGTAGCGTGATGAAATCTCTCGCTGTCCGGGTCCA
SEQ ID




CCCGGCCGGGGATGTGAGTCATCCCCTTGGTCCAGCACATCCACGCTGTATACACCACCCAC
NO:




CCTGGTAGTGACTTAGTAACCGGCCTTGGTGATCAGGGATCAACTATGCCAACATCCGCAGT
2683




GCCCTGTGGCCCAAAGCAGGGCCTCACGTTTGGCTTTAACGGGGGGGCCCCAGGGGAGGCCA




GGAATAGGGGGATTGCCTGGGTGGATTCCAGAATA





AAK1
ADXCRAD_BP360257_at
GGCAACACCTCGGCCCTGGGCAGGGGCTACATTGGAAAAATCTTCGGCATGGGGCGAAAGAA
SEQ ID




GGTCACAGTGAACAAGGGGTTGGCGAAA
NO:





2628





AAK1
ADXCRAD_BP360257_x_at
TCCTCTCCGAGGTGAAATCTGAGAAGAAATCCTTGGATCTCTTTTCTTAAAAAAAAAAAAAA
SEQ ID




AAAAAAAACTTCTGAAACCCAGGGGGTTTTGGCTTGGCGGCCCCCTATCCCCAAAAAAAAAA
NO:




AGTTTTTCAACTCCCGGGAAAACCAGGGGGGTTTTGGCCTGGGCTCCGGCTCCAGGGGGGGA
2629




GGGGGCAACACCTCGGCCCTGGGCAGGGGCTACATTGGAAAAATCTTCGGCATGGGGCGAAA




GAAGGTCACAGTGAACAAGGGGTTGGCGAAAGGGGGATTGGCTATTGAATT





AAK1
ADXCRAG_AB028971_s_at
TGCTGAGCGGCTTATGTTCTGAATTTGTTTATGAGAACTGATCATTAGTGAGACTGGCCACA
SEQ ID




GTATTTAACCTTGCACATGCATGCTCAGTGAAGCCTAGACATTCAGAGCAGCAGAAATAAAG
NO:




TAACTTATTTTTCTTTCCACCTTGCCTGAGACTGGCATTTTAGAGACCTGTTAA
836





AAK1
ADXCRAG_NM_014911_s_at
GAAGCCAAGGCTATTTAATCTCACTTGTATCACTCCAAATGAAGTGTTTTCCTTGCTTTTCG
SEQ ID




GGGGTACAACGTCTATTTTTTGCCTTTCTTGATATCTGGAGATTTCTAGAGTGGATCTCTTA
NO:




TGAATGAGGAGGAATGTGGAAAGTTTCACATTTAGTTAGAAGAACTTTAAAAAATTGGTTTC
1044




TAACTAGACTACCTTTACTGAACTTAATGAAATTTAGCAGATTCTTCTT





AAK1
ADXCRAG_XM_371497_x_at
CACTCTGGGAGGCTGTGTTGGGCCGATCGCTTGAGCTCATGAGTTCAAGACCAACCTGGGCA
SEQ ID




ACATGGCAAAACCTTGTCTCTACAAAAAATACAAAAATTAGCCAGGCATGGTGGTGCACACC
NO:




TGTAGTCCCAGCTACTTGGGAGGCTTAGGTGGGAGGATGGCTTGAGCACGGGAGGCAGAGGT
1090




TGCACTAAGCCAAGATCGTGTCACTGCACTCCAGCCCAGGCAATAGAGCCAGACCCTGT





AAK1
ADXCRPD.17316.C1_at
TCTTCTGCAGCTTTATGGACTGGAGCAGAGATTGCTGTGGGGGCAAACTCTTCCAGAAGGTC
SEQ ID




AGTAGTAGGGTTAGAGAGCAGAGAGCAATCAAGCAGGGAATCTTCCCCGGTGAGAGAATCTG
NO:




TGCGATTCGAGGTCACAGATTCCGTCTGAGATGGGAGGCGCTGGGGAACTGGGGGCTCCAGT
1848




CCTGGTATGAGACTCTCAACAGCAACATCAGCTTTTTCTTTCGTAACAGAGCATT





AAK1
ADXCRPDRC.17316.C1_at
AGGTGGGCACTCTAGAAACAGCAGTGGGAGCTCTGAGTCCAGTCTTCCCAACCTAGCCAGGT
SEQ ID




CTTTACTGCTGGTGGATCAGCTCATAGACCTGTAGCCGTGACCCAGTAGCAGATGCAGTTCT
NO:




GTAACCTTCATACCGTAAAATACATTTTCATTACGGAGTTATG
2036





AAK1
RDCR092_B07_s_at
AACTCCCTCTGCTGACTATTTGGAATGGACTGAATGAGGAGGTCTCTCCAGCCAGAAGGAGT
SEQ ID




ATTGAGGTCATCAGGCCTCAGAAAACAATGTACACATAATCTCGGGCTGTGAACAAGAGAAA
NO:




GGAGGGGGGGAAACATGAAAGTCAATCTTAACAATTTTTGCAATACCTCTTATTTGCAGACC
1363




ATTGGATTTATGTTATTGCACTCTCGGTGTGATTTATCGTATGTATCTGAT
















TABLE 9







Genes and corresponding Almac probesets predicting sensitivity to irinotecan. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





ANP32B
ADXCRIH.2787.C1_s_at
ACATTCCGCCTTCCTTCCATGTAGTCCCTCTTGGTAATCTACCACCAAGCTTGTGGACTTCAC
SEQ ID




TCCAACAAAATTGTAAGCGTTGTTAGGTTTTTGTGTAAGATTCTTGCTGTAGCGTGGATAGCT
NO:




GTGATTGGTGAGTCAACCGTCTGTGGCTACCAGTTACACTGAGATTGTAACAGCATTTTTACT
1143




TTCT





ANP32E
ADXCRAG_AL832674_s_at
CTGTGCAATCAAAATTAGAGTACTTTGGTTTGAAAACAACACTTAGAGCCTCCAGATAACTTT
SEQ ID




TAAGACTTATTTAGCTTTGTGGGTGGTATTTTCATGCAAATAAGTAAGGGTGGGTTTTATATT
NO:




TTGTAGAAGTTTTCGGTCCTATTTTAATGCTCTTTGTATGGCAGTATGTATATATTGTGTTAA
896




GTTCCTCAAGAATCTCCTTAAAAACTTTGAAGTTAATACTTTTGTGCAACTGTGTTTTGAATA




AAGCCATGACAGTGTTAAAA





ANP32E
ADXCRAG_AY057381_s_at
TAATGTTTCTGGGTGTGCAATAGAGTGATCACATCTTTGTTTCTTCATGTACGATAGCTATCC
SEQ ID




CTACAGAAGATAATGTGTAACTTTTTATAGGAAAAGTGTGGTTTTACTATTTTTGCCTTATCA
NO:




TTCCAAATAAGAACTAGTCTGTTAATGATCATATTGTATGTAGAGAAAAATTTTCATTGACTC
902




CCATTGTGGAATTCCCTAGCAATTTATTTAGACTTAATTTTTTAAATTCAAGCTTACTGTATT




AGT





ANP32E
ADXCRPD.6256.C1_at
AATGTTTTAAGACGGCTCCCTCCAGTTACCCGGTAGGAAGACTTTCTGGCCGAAAATTCTTTG
SEQ ID




AAAAAATACTTGGAAAAAGGTCCCTCTCGCCCCCCGCTTTTAAACTGGTGGGAGGAGTCCCCC
NO:




AAACCCCCTGGTGAAACGATCCTCTAGCCATTAAAACGTTCATTTCTTCTGAAAACTTCACCT
1732




GGCCGGCCCATTATTTGCCAATAACCTCTTAAGAGTGGTGAATCTTTTGGGCACCCAGGGAGC




GGGGAATAAATTGTGAAGGACCGCCTCGCGG





ANP32E
ADXCRAD_CN391960_at
AAAATTTGCAGTACTCCTGATTATTCTTTTATTGTTTTTGACTGTTCCCTGTTTTTTTCTGTG
SEQ ID




ACTGCTGTAACTTAAAGTTTTTG
NO:





2691





ANP32E
ADXCRAD_AI697657_s_at
GCAATTCCTTTATGATCACCTTCCCTTCTTGTTTCACTCCCTCCCGCTCTCTCAAAAGGAACT
SEQ ID




TGGGAAACTTGTGAAACCCAGGAAAACCTTTAGTCTTATACCTCAACTACCTTTCAGTCCTGT
NO:




CTGGGTTTTAAATAAGTGAAGTAGAAGAAATTGAGTATTTTCTGACATAAGAATATATTATCA
2807




ATACAGTTTTATGCAGTAAGCTCTCCTTACCATANATGTTTCTTGGTTGACAACATCTAAGAC




AATATT





ARHGAP15
ADXCRPD.9769.C1_at
AAAAACATCTTCAGTGCTCCGGTGACAACGTGGATGTCCTCCCACTGGCTGTCGTCCAAATTC
SEQ ID




AGCTTCTCTTCAGTTTAATGAAGTGACAAATTATTGGCTTGCTCTGGAGGTCAAATGACCACT
NO:




GTGAAAAATCTGCAGCTTACTAGGGGTGTCCACAGGTCTCCATCCAGTTCTGATAGAAGGGCT
1508




GGTATTCCAGAAACGACTTGGTTGACAATAAATCTTAACTTCTGTATTGTTGCCAGATTGCCA




CTAACTCGATATATTCCATCAACATCTAGACCTC





ARHGAP15
ADXCRPDRC.9769.C1_s_at
TACCCTTCTGCGAGCTGAAAATGAAACAGGAAACATGGCGATCCACATGGTCTACCAGAACCA
SEQ ID




GATAGCTGAGCTCATGCTGAGTGAGTACAGTAAGATCTTCGGCTCAGAGGAAGACTGACAGAC
NO:




AAGACAAGCTACTGAATACGTTCACATCTGTCTTGATGCCTAATATTTTTACATTTCTGTAAA
1952




CATATTTCTGAAATATTTTTTGCCTTTCAAGCGACAGATGCCTCATTTTGTGAA





ARHGAP15
ADXCRAD_AI510829_at
GATAAATCTCACACACATACTTCCACTCATACCCACCACATGTATTATATTAGCAATATCATA
SEQ ID




CTCTAGGTCTTCTGGTTTGAGTCAGTATAACATGATAGGCACATTTCTATGGAATTTCATGCA
NO:




TTATTTTCTTTTAATGCTTATGAGGGTAAGTACCAAAATATCCATTTTTCATTCACAGAGTAG
2854




AATTATTTTTTGACTTTTTTTGTGATCTTTTGACCAACTCTCACATCCAGAAAATGTGCCATT





ARHGAP19
ADXCRAD_BE278749_s_at
GCCACAGCCTGTGCTAAAGAGCCATGGAGCCCTCCCCTGGCCATGTCTGGGGACAGATAGAAC
SEQ ID




CTGTTGGGGGAAATATTCCCTCACCCCAGGGTTCTTTCTGCAGAGCAAGGGTTGCCTTTGTCC
NO:




TATCCCTGAGCTTGCTCAACAAGAGAAACAAGGTTTCTTAAGTGTTTTGGTTAAAGTTTTCAT
2729




TCTTATTTGACTATGTATATGTAATTGTAAAGAAACGATCCTATGCATTGTCTTTCT





ARHGEF6
ADXCRAD_BM694731_s_at
GATGAGTACATATGCATGTTTCGGGGACTTGGCCCTTCTGATGAGGGGCCCTCGGTACTCTGG
SEQ ID




ATAACGAAGCTTGTGCAGAGTGGTAACCATGCTTACACACTAAACTATAATATAAAGGAAATG
NO:




AAGCCATGTTAATCTGAGAGCAGTGTCGCCATAGTTGTGTTGTTTACAATACTCTATAAATGG
956




GTTCCTGTTGCCCTGTAATTAAACTGCTGCCCGTAGAGGCCTTTCAGTTCCTTTTCTGTCCTT




CCCCTTCTTAACACAAGCTCAAA





ATF3
ADXCRAG_AB066567_s_at
AGCCGGCCCGCCTGAGAGACACTAGGGGAAATAGCTTTTGTGGGCAAGCAGGGTGGCCGGTGG
SEQ ID




TGCTCAGCAGTCTTTCCAGTGGCTGTGTCCCTCCTCCAAATGTGGACAGGCCATGACAGAGTC
NO:




TTAGCCCAAGTCCCACAGATCCCCAAAAGTTCTGTTGATTGCTTCAGGGGATCAGTGAAAATT
841




AGGGAATTTTGTGTGTTGCTATATACATTTTTTCTGGGGAGATGAGCTTCTCATTGAGATCTG




TGACTCAGAATCGACTAAGCCACCATAAGTCTGGATT





ATF3
ADXCRAG_AY426987_at
CGTGAACAGCGTTTCCAATTAGAATCTGCCTGAAAGGAGGTCCCATTTGCCCACTGAGCATCC
SEQ ID




TGTGTTCTCATGGTGGCTCTAACTCCAGAAGATTTTAACACAGTCTCATCAAACACTGCTTTC
NO:




AGGGAGGAATTTACACTGAGGTTAAAAGGACTGTTGAGGACTAATGCTAACAGAAGCTAACAT
909




TTATTGCGTAGGACAATACACTAAACACTTCACATGTATTATCCCA





ATF3
ADXCRPD.13867.C1_at
TTAGCAAAACCCTCAAACACCAGTGACCCAGGAGGGGACAGGCAGGGGACGATGGCAGAAGCA
SEQ ID




CTCACTTCCGAGGCAGAGACCTGGCCTGGGTGTTGAAGCATCATTTTGCTCCAGGCTCCGCTC
NO:




GGGGCGGCCAGGGTCGGGACGGGGTCGGGCGGGCTGTTTGTCTGGCCGGCGGGCGAGCACACG
1712




AGGACTCACGGCCGGCGCGCGGGCTGAAGGGTGCGCTCGGGCGGCGGCGAGAGAAGAGAGCTG




TGCAGTGCGCGCCTGGCTGCGATCCCGGGAATT





ATF3
ADXCRPD.1294.C1_s_at
GTGGTACCCAGGCTTTAGCATTATTGGATGTCAATAGCATTGTTTTTGTCATGTAGCTGTTTT
SEQ ID




AAGAAATCTGGCCCAGGGTGTTTGCAGCTGTGAGAAGTCACTCACACTGGCCACAAGGACGCT
NO:




GGCTACTGTCTATTAAAATTCTGATGTTTCTGTGAAATTCTCAGAGTGTTTAATTGTACTCAA
1882




TGGTATCATTACAATTTTCTGTAAGAGAAAATATTACTTATTTATCCTAGTATTCCTAACCTG




TCAG





ATF3
ADXCRPDRC.13867.C1_s_at
TGTACCTCTAGAATCCCAGCAGCAGAGAACCATCAAGGCGGGAGGGCCTGCAGTGATTCAGCA
SEQ ID




GGCCCTTCCCATTCTGCCCCAGAGTGGGTCTTGGACCAGGGCAAGTGCATCTTTGCCTCAACT
NO:




CCAGGATTTAGGCCTTAACACACTGGCCATTCTTATGTTCCAGATGGCCCCAGCTGGTGTCCT
2007




GCCCGCCTTTCATCTGGATTCTACAAAAACCAGGATGCCCACCGTTAGGATTCAGGCAGCAGT




GTCTGTACC





ATF3
ADXCRAD_AB078026_s_at
GAATGCTGAACTGAAGGCTCAGATTGAGGAGCTCAAGAACGAGAAGCAGCATTTGATATACAT
SEQ ID




GCTCAACCTTCATCGGCCCACGTGTATTGTCCGGGCTCAGAATGGGAGGACTCCAGAAGATGA
NO:




GAGAAACCTCTTTATCCAACAGATAAAAGAAGGAACATTGCAGAGCTAA
2779





BATF
ADXCRPD.6100.C1_at
CACACAGACTGTGGCAGAACTGCGCCCCATCCCGCAGAGGCCCCCTGTCCACCTGGAGACCCG
SEQ ID




GAGACAGAGGCCTGGACAAGGAGTGAACACGGGAACTGTCACCACTGGAAAGGCGTGAAGCCT
NO:




CCCAACAGTGCCGCAGCGTTTCGAGGGGCGTGTGCTGGACCCCACCACTGTGGGTTGCAGGCC
1716




CAATGCAGAAGAGTATTAAGAAAGATGCTCAAGTCCCATGGCACAGAGCAAGGCG





BCAT1
ADXCRAG_AL390172_s_at
AATTTTCTTTGTGGCAGTCATTTATTAAGGATTCAACTCGTGATACACCAAAAGAAGAGTTGA
SEQ ID




CTTCAGAGATGTGTTCCATGCTCTCTAGCACAGGAATGAATAAATTTATAACACCTGCTTTAG
NO:




CCTTTGTTTTCAAAAGCACAAAGGAAAAGTGAAAGGGAAAGAGAAACAAGTGACCGAGAAGTC
890




TTGTTAAGGAATCAGGTT





BCAT1
ADXCRPD.1208.C1_at
TAAAAACAGTGGGTTGAGCCCCAGCTCCATGTATTAGGTAGCTAGGTATATTGTGGGATTATT
SEQ ID




CCTTGTTAAGTCACCCCAGGAAACATTTGCAGAATTTAGAAATGCATCCAGATTTGTGAGTTT
NO:




ATTTTTAAGACCTGACTAAAAATCTGCACTCTTCAAAAACTTATTGATGAAGTACAAATTGAG
1878




GCAGAAATTTACATTCCTTTGCTTAATCCCTGAGAATGAGTATAATGATCATAGAACTAGTTC




GAGAGACTGCAATGTGTCCAGACTACTGTCAGACC





BCAT1
ADXCRAD_BU953528_at
TATTTGCAGATTCCTCATCAAATCTGTAATTATGCACAGTTTTCTGTTATCAATAAAACAAAA
SEQ ID




GAATCCCAAANNNNNANNNNNNNANAAAAAAAANNAACATGTCCGGCCGCCCTCGGCCCTCGA
NO:




AGAAACTTTCTAGGAACCTTCGTTTTGGGCGCGCGGGCCCCAGTTAAGGTAGGTGAACATGG
2413





BCAT1
ADXCRAD_BU953528_x_at
TATTTGCAGATTCCTCATCAAATCTGTAATTATGCACAGTTTTCTGTTATCAATAAAACAAAA
SEQ ID




GAATCCCAAANNNNNANNNNNNNANAAAAAAAANNAACATGTCCGGCCGCCCTCGGCCCTCGA
NO:




AGAAACTTTCTAGGAACCTTCGTTTTGGGCGCGCGGGCCCCAGTTAAGGTAGGTGAACATGGG
2414




GCCATAGCTGGTTTCCCTAGGGAGAACCCTGGGCCATGAACTA





BCAT1
ADXCRAD_BG393815_at
CTCAAAAGATTGTCGTAAGAACAACAATGTCAAGACCAAAAAA
SEQ ID





NO:





2431





BCAT1
ADXCRAD_BM472661_at
TTCCTCCATGATTTTAGTGGCCTCCTTTTGTACTTCACTCAGATACTAAATAGTAGGTTATTC
SEQ ID




CTTTATATAAGGTACATTTCTGCTCC
NO:





2671





BCAT1
ADXCRAD_BM472661_x_at
GAGTGATTGTTTCTTCATGCCAGAGAANATGAATTGCAATCATCAAATGGTGTTTCATAACTT
SEQ ID




GGTAGTAGTAACTTACCTTACCTTACCTAGAAAAATATTAATGTAAGCCATATAACATGGGAT
NO:




TTTCCTCCATGATTTTAGTGGCCTCCTTTTGTACTTCACTCAGATACTAAATAGTAGGTTATT
2672




CCTTTATATAAGGTACATTTCTGCTCCTCAAACAAAT





BIRC3
ADXCRPD.2751.C1_at
GTGTTATATGAGCATGATTTGGTAACTTCAGG
SEQ ID





NO:





1557





BIRC3
ADXCRPD.2751.C1_s_at
TTAATCCGGAAGAATAGAATGGCACTTTTTCAACATTTGACTTGTGTAATTCCAATCCTGGAT
SEQ ID




AGTCTACTAACTGCCGGAATTATTAATGAACAAGAACATGATGTTATTAAACAGAAGACACAG
NO:




ACGTCTTTACAAGCAAGAGAACTGATTGATACGATTTTAGTAAAAGGAAATATTGCAGCCACT
1558




GTATTCAGAAACTCTCTGCAAGAAGCTGAAGCTGTGTTATATGAGCA





BIRC3
ADXCRPD.793.C1_at
TGACACATTAAAATACTTCTACAGTGACAAAGAAAAATCAAGAACAAAGCTTTTTGATATGTG
SEQ ID




CAACAAATTTAGAGGAAGTAAAAAGATAAATGTGATGATTGGTCAAGAAATTATCCAGTTATT
NO:




TACAAGGCCACTGATATT
1608





BIRC3
ADXCRPD.793.C1_x_at
TGACACATTAAAATACTTCTACAGTGACAAAGAAAAATCAAGAACAAAGCTTTTTGATATGTG
SEQ ID




CAACAAATTTAGAGGAAGTAAAAAGATAAATGTGATGATTGGTCAAGAAATTATCCAGTTATT
NO:




TACAAGGCCACTGATATTTTAAACGTCCCA
1609





BIRC3
ADXCRPD.1900.C1_at
ATGAACATTTAGGGACTGTGGTTTTTATAAAGAATTCGGGGAGAAAAATTTATAAGGCCACGA
SEQ ID




CCCGGGNTTAACAGAAAAGGNAAAAAACTGGTTGGCGCCTTCGGGCCTCAAGAGGTT
NO:





2273





BIRC3
ADXCRPD.1900.C1_x_at
GGGACCATTTCTCTGTCTTTTTTGATCAGGGCCTATACATCGAAGGTGTGCATATATGNTGAA
SEQ ID




TGAACATTTAGGGACTGTGGTTTTTATAAAGAATTCGGGGAGAAAAATTTATAAGGCCACGAC
NO:




CCGGGNTTAACAGAAAAGGNAAAAAACTGGTTGGCGCCTTCGGGCCTCAAGAGGTT
2274





BIRC3
ADXCRPD.1900.C2_s_at
TCCTTCCCATAAGATGCTTCTTCATTGCCACTTGTAGAACACGGGGGTCAACCCATCATAAAA
SEQ ID




TCTATTATGGAATGCCTGAGACAAGAATCAAACAGTCCCTTTAGTAAGTTTGTTTATTCACTT
NO:




CTCTATTGATTCATTCAAGAAGTCTCATGCCAGCCCCACCTATTGGAAGAAGGTCTGAGTTTT
2275




ATTCTTATCTCTTTGGTATTAATTCTGAAACTTAGAAAGTACACTGGTTAGCAATGCTTGGGA




CCAACAG





BIRC3
ADXCRAD_U37546_x_at
TATTTTGGCATTGTACTAATACCTGGTTTTTTTTTTGTTTTGTTTTTTTGTACAGACAGGGCA
SEQ ID




GCATACTGAGACCCTGCCTTTAAAAACAAACAGAACAAAAACAAAACACCAGGGACACATTTC
NO:




TCTGTCTTTTTTGATCAGTGTCCTATACATCGAAGGTGTGCATATATGTTGAATGACATTTTA
2814




GGGACATGGTGTTTT





BIRC3
ADXCRAD_AA805622_at
GTGCCTACTATTTAAATACCCTATACCTGAGTTACAAATCACCTAAGCACAATTACAAATAAT
SEQ ID




TCAGCCTAGCACCCATGCAGGACACTGGCTAGTACATGGGTAGCCAGCAGAGCCTCTTAGCAG
NO:




AGGCAAAATCAATTGCATTTCAAGGAAATAAGTCTCCCAGCATCAGAATGCAGAGATGGATTC
2860




TTTCCTCCCCTCACTTGGTCCCTAATTGTTCTCTT





C1orf114
ADXCRAG_BC026073_s_at
GTAGAGTAAGTAAAACTTCTCTGAAAAATAAGTTCATACAGATATGAAAGCTGAACTTATTTA
SEQ ID




TAGAAGGGAGTCTGGATATCAGACTAACAGCCTATGGAAGAAGTAGAAAAGTTGTTCAAGAAC
NO:




TACCCTTGCAAAAGATGCAACATGCAGATAACTACAATTAGGTTCTAAGAGGTCTTGTGAAAA
951




TAAAATGATTCCTATTTTGTTCAGACTTTGATGGAACAG





CBFB
ADXCRIH.116.C1_at
TTTGTAAGGAGGTGCCAAATGACTTAGCACTGTTTTCCACTCTGTATCTNNNNNNNNNGTTGC
SEQ ID




AATTTGACAGTAAGCCTATTTAAAAAATATTCTTACATTAATTCATCTCAAAAGGTTCTATTA
NO:




ATAGTCCTTTTGCAAAATACCATATATATAACTGTGAACGTTTTTTCCAGAATTAATGGAAGA
1283




AAATGCATCCTCTGCACAGATGAACATTTTCTCT





CBFB
ADXCRIH.116.C1_x_at
GAGGTGCCAAATGACTTAGCACTGTTTTCCACTCTGTATCTNNNNNNNNNGTTGCAATTTGAC
SEQ ID




AGTAAGCCTATTTAAAAAATATTCTTACATTAATTCATCTCAAAAGGTTCTATTAATAGTCCT
NO:




TTTGCAAAATACCATATATATAACTGTGAACGTTTTTTCCAGAATTAATGGAAGAAAATGCAT
1284




CCTCTGCACAGATGAACATTTTCTCTCTAAAACCCTCGTG





CBFB
ADXCRAD_AL557216_s_at
ATTTTTCTGTCATTTAGCACCATGCTGCTTCTGTCTGTCTTAATGCTGGCATTAAGATCATGA
SEQ ID




GCCCTTTTTCTCCAGTAGTACAGGCTTTGAAAACTACTTCTATTAAGTTATTGATGCAATTTG
NO:




ATATTTTTTCATAATCTATATTTAAACAAAATTACATCATTGCATCATCTTTTCTAAATTCAT
1332




CTCCATTAAAACTTGCCTTAAGCTACCAGATTGCTTTTGCCACCATTGGCCATACTGTGTGTT




T





CBFB
ADXCRAD_AL561208_at
TCTCAACCTTAGGCAGTAATAGACATCACAAACTGCCATGGTTTTGCACTATGATTATAATAC
SEQ ID




CTGCATTTCTAATTTTTTAAGCATGTAGCCAGTAATAATTTGAAGTTTTTTTTCTATGCAAGC
NO:




TTACCTTGTTGGCATTATTTTTAGGGAGTTGAA
2455





CBFB
ADXCRAD_AL561208_x_at
CTCAACCTTAGGCAGTAATAGACATCACAAACTGCCATGGTTTTGCACTATGATTATAATACC
SEQ ID




TGCATTTCTAATTTTTTAAGCATGTAGCCAGTAATAATTTGAAGTTTTTTTTCTATGCAAGCT
NO:




TACCTTGTTGGCATTATTTTTAGGGAGTTGAA
2456





CCDC109B
ADXCRAD_BM830891_at
GAGTAGGCAATTTCTTCAGTTCTTCCACAAGAAATCAAAGCAACAGCACTTTGATGTGCAGCA
SEQ ID




ATACAACAAGTTAAAAGAAGACCTTGCTAAGGCTAAAGAATCCCTGAAACAGGCGCGTCATTC
NO:




TCTCTGTTTGCAAATGCAAGTAGAAGAACTCAATGAAAAGAATTAATCTTACAGTTTTAAATG
2712




TCGTCAGATTTTCCATTATGTATTGATTTTGCAACTTAGGATGTTTTTGAGTCCCATGGTTCA




TTTTGATTGT





CD247
ADXCRAD_NM_198053_at
AGAGGAGGCCGTTGATTCACTTCACGCTTTCAGCGAATGACAAAATCATCTTTGTGAAGGCCT
SEQ ID




CGCAGGAAGACCCAACACATGGGACCTATAACTGCCCAGCGGACAGTGGCAGGACAGGAAAAA
NO:




CCCGTCAATGTACTAGGATACTGCTGCGTCATTACAGGGCACAGGCCATGGATGGAAAACGCT
2773




CTCTGCTCTGCTTTTTTTCTACTGTTTTAATTTATACTGGCATGCTAAAGCCTTCCTATTTTG




CATAA





CD3D
ADXCRAG_BC039035_at
AAAAATAGATGTTGGGTCTCGTCAAGTGCTTACCCTGCATCCATTGAGATGATAATATGGTTT
SEQ ID




TACTTTTTTAGTCTGTTAATATGGTACATTACATTGATGGCACGATATGTTAAACCAACCT
NO:





959





CD3D
ADXCRAG_BC039035_x_at
AGTTCTTTTCTTTCTAGTTTGCTGAGAATTTTTATCAAAAATAGATGTTGGGTCTCGTCAAGT
SEQ ID




GCTTACCCTGCATCCATTGAGATGATAATATGGTTTTACTTTTTTAGTCTGTTAATATGGTAC
NO:




ATTACATTGATGGCACGATATGTTAAACCAACCTTTCATTCCTGAAAAAAACTCTAGTCATTT
960




GGTATTATTCT





CD3D
ADXCRAD_BX457462_s_at
CGTGGCTGGCATCATTGTCACTGATGTCATTGCCACTCTGCTCCTTGCTTTGGGAGTCTTCTG
SEQ ID




CTTTGCTGGACATGAGACTGGAAGGCTGTCTGGGGCTGCCGACACACAAGCTCTGTTGAGGAA
NO:




TGACCAGGTCTATCAGCCCCTCCGAGATCGAGATGATGCTCAGTACAGCCACCTTGGAGGAAA
2553




CTGGGCTCGGAACAAGTGAACCTGAGACTGGTGGCTTCTAGAAGCAGCCATTACCAACTGTAC




CTTCCCTTCTTGCTCAGCCAATAAAT





CD53
ADXCRPD.1819.C1_at
GGTTGCTATGCGAAAGCAAGACTGTGGGTTCATTCCATTTTCCTNATATCGNGATCATCACCA
SEQ ID




TCTGTGTATGTGTGAATGAAGGTTTTGGGGATGTCCTTTTGCCCTGACCCTGAACTGNCAGAT
NO:




TGACAAACCCAGCAGACCCATAGGGTATTGATCTGCAGNAANTCCTTGGGGTGGAAAGAAACT
1497




GGTTTCATCTTCGGGAATGCCAAACCATTTTATAGCATGGAGCCCCTACCTGT





CD53
ADXCRPD.3701.C1_at
TGGACCATTGTCACAACCCTCTGTTTCTCTTTGACTAAGTGCCCTGGCTACAGGAATTACACA
SEQ ID




GTTCTCTTTCTCCAAAGGGCAAGATCTCATTTCAATTTCTTTATTAGAGGGCCTTATTGATGT
NO:




GTTCTAAGTCTTTCCAGAAAAAAACTATCCAGTGATTTATATCCTGATTTCAACCAGTCACTT
1629




AGCTGATAATCACAGTAA





CD53
ADXCRAD_AW293276_at
TTGAACACTCAGTGCTGACCAGAGATTAACATAGGGCATGCAATACTAAAATTGGTTTGCATT
SEQ ID




TCACTTTCTGCTTCAACGTTCAGTAAATCCATCATAGCCCTACCAAGTGCCAGGGCAGTTGCT
NO:




GGTCAGTGGTTGTCCTAGTCTTTCTCCACAAACCTGAAAAACCCTGGAGATTTCCAAACCCCT
2849




TCAGGAGCAGATAACATGAGGAGACAAGACCTCAGGGATTCAGTCTAGTTGGAAGATAGTTGT




GGCTTCTTCTCAGAGCCTATTCTGGAGGTCCAAAT





CD93
ADXCRAG_NM_012072_at
TATGTGCCTATCCTAATAAACTCTTAAACACATT
SEQ ID





NO:





1039





CD93
ADXCRAG_NM_012072_s_at
CAAATTTGTTTGACTAATTCTGGAATTACAAGATTTCTATGCAGGATTTACCTTCATCCTGTG
SEQ ID




CATGTTTCCCAAACTGTGAGGAGGGAAGGCTCAGAGATCGAGCTTCTCCTCTGAGTTCTAACA
NO:




AAATGGTGCTTTGAGGGTCAGCCTTTAGGAAGGTGCAGCTTTGTTGTCCTTTGAGCTTT
1040





CD93
ADXCRPD.8173.C1_s_at
GCAGGTATTTTCTACGGGTGTTTGATGTTCCTGAAGTGGAAGCTGTGTGTTGGCGTGCCACGG
SEQ ID




TGGGGATTTCGTGACTCTATAATGATTGTTACTCCCCCTCCCTTTTCAAATTCCAATGTGACC
NO:




AATTCCGGATCAGGGTGTGAGGAGGCTGGGGCTAAGGGGCTCCCCTGAATATCTTCTCTGCTC
1812




ACTTCCACCATCTAAGAGGAAAAGGTGAGTTGCTCATGCTGATTAGGATTGAA





CD93
ADXCRAD_BU150433_at
ATTTCCATCACCTTTGAAACATAGCTTTTAGCTTGGGAAATCTGA
SEQ ID





NO:





2743





CD93
ADXCRAD_BU150433_x_at
GATCATTAGGTACTTTTGTTTCAACCTTTATTCCTGTAAATATTTCTGTGAAAACTAGGAGAA
SEQ ID




CAGAGATGAGATTTGACAAAAAAAAATTGAATTAAAAATAACACAGTCTTTTTAAAACTAACA
NO:




TAGGAAAAGCCTTTCCTATTATTNTCTCTTCTTAAGCTTCTCCATTGTCTAAATCAGGAAAAA
2744




CAGGAAAACACAGCTTTTCTAGCAGCTGCAAAAATGGTTTAATGCCCCCCTACATATTTCCAT




CACCTTTGAAACATAGCTTTTAGCTTGGGAAATCTGA





CD99
ADXCRIH.3577.C1_at
GTTGGCATTCCGGTGGCTCTCCATGTCCACCTCCCCTTGTTCTGCATTTTCTTTGAAGCATAG
SEQ ID




CTTCTTTTTCTGGTAAGCAATGAAGCTAGAGATGGCTCCAGCCACGGCGACCACGACAGCCCC
NO:




CACAATCCCGGGGATCACGCCTGGGGCGTCGGCCTCTTCCCCTTCTTTCCTGTGGCTGCCTCC
1223




ACCATCACTGCCTCCTTTTCCTTCTCCACCTGAAACGCCATCCGCAAGGTCAGCATCTGAAAA




GCTACCGGAGGAACTAG





CD99
ADXCRIH.3577.C1_x_at
TTGGCATTCCGGTGGCTCTCCATGTCCACCTCCCCTTGTTCTGCATTTTCTTTGAAGCATAGC
SEQ ID




TTCTTTTTCTGGTAAGCAATGAAGCTAGAGATGGCTCCAGCCACGGCGACCACGACAGCCCCC
NO:




ACAATCCCGGGGATCACGCCTGGGGCGTCGGCCTCTTCCCCTTCTTTCCTGTGGCTGCCTCCA
1224




CCATCACTGCCTCCTTTTCCTTCTCCACCTGAAACGCCATCCGCAAGGTCAGCATCTGAAAAG




CTACCGGAGGAAC





CSDA
ADXCRIH.625.C1_s_at
GTTCATTTTGGATGCTGGTGCTAAACCTCCAAGTGTCATGATTTNNNNNNNNNNNNNNTTTAT
SEQ ID




GTCCTTCTTATTTATTTCTAGGATGAGGGGAGGAAAACATTTTTGCTTTCTTATGTGACTCTC
NO:




TTTGAAAATGTGC
1107





CSDA
ADXCRSS.Hs#S1919678_at
TGCTGCACCGCCTACAAAATCAAATAAAGTTGATTATCCAACAGACAAAGGGAAGGCACACAC
SEQ ID




AACTCCTTTAGTTTATACTACTGTTTCTGATTACTAAACAGGTTCTGAAACTGTTTCTGATTA
NO:




CTAAAACCAGGCTTAGTTAGGGACTTTTAGCATCAGTATTCCTAAGTGGTCACTAGTAGTTAA
2096




AACACTGCCTGTCTAGAAAAAAGAAGTTGAGTATCATCCACTCTGTCTGAATGCTTATACCCT




CAACAAAGCTTATCAAAATGAGGTCAATCCCAGAAATA





CTCF
ADXCRAG_BC014267_s_at
AATCATGTAGCAGAATGGCACCCAGACCACTGCCCACCAGTGACGGACATGCACGTGGCAGAT
SEQ ID




CATGATTTCCAGCCCACGGAGCCAGCATTTGAACCTTGTATAATTAACTTTCAGTTATGATTT
NO:




CCCATCGACATTTTCTTTGCCCTGTTTGTAGCTGATTGTTGTGTTTTATAAATCTTCTGTTAA
939




GGCAGAAGGGTGATTATGAGTGGTTCACAGCAGCCCTTATAAGCTGGGCCAGAAAATTTCACT




AGGTCAG





CTCF
ADXCRPD.12254.C1_at
GAGGGCATAGCGCTCATGAAACACAGCATCACAGTAACGGCATTTCTTGCCTTGCCCAATATA
SEQ ID




GGAATGCTGCTTTCGCAAGTGGACACCCAAATCACTTTTTCGGGCTATGACTGTGTCACAGTG
NO:




GGGACAGTGAAGTTTGGCCGCATTTTCTGTGTGCTTCTGTAAAATGTGCATCTTCATGGTACC
1545




ACTTTGGGTAAACCGAGCATGACAAATATAACATTCATAAGGCTTTTCCCCTGAATGGGTTCT




CATGTGCCTTTTCAGCTTGTATGTGTCCCCGCTGGACTACAGCA





CTCF
ADXCRPDRC.12254.C1_s_at
GTCACACAAGAATGAGAAGCGCTTTAAGTGTGACCAGTGTGATTACGCTTGTAGACAGGAGAG
SEQ ID




GCACATGATCATGCACAAGCGCACCCACACCGGGGAGAAGCCTTACGCCTGCAGCCACTGCGA
NO:




TAAGACCTTCCGCCAGAAGCAGCTTCTCGACATGCACTTCAAGCGCTATCACGACCCCAACTT
1961




CGTCCCTGCGGCTTTTGTCTGTTCTAAGTGTG





CTCF
ADXCRAD_CB164277_at
TAAAAAGTGATTCTTGCACATGAACTGTCACATGTTTAAAAATGTGTTTTTTAGAGAGCCTCA
SEQ ID




GTCTTACTGATTTCAAACACTTTTTTCTTCTGTGTATTGCTTTTAAGAGAGCCATCAGTTAGC
NO:




TATCAGACTCTAGGTTGATGCATTTTGTACTTAGCTGTACTGTGTGATATTTTTCATTATTTT
2395




AGGACGCCAACATGAGACCTGTAATAAAATATGTAATGGGGTTGAAAGCTGGGGAGGAGGATC




TACTGCTGTACAGCTAATAAATCATAACGGAT





CUTC
ADXCRPD.14073.C1_at
TTCTACTGGCTTCACATTAACAATAATTTTNGTTGAATTTGAATTCTTAAAAATCTACTGACA
SEQ ID




ACATTTAAGTC
NO:





1642





CUTC
ADXCRPD.14073.C1_s_at
TCCTGAAGTACATGCCATGTACTCCCCCTTTATTTCTACCTTGGATCAATGGCCTCTGCGGAG
SEQ ID




TGTAGTGAAAGACATCTTTTTATTATGATCTACACTTTAAAAAACCAAAGGCTGCCTGTATTA
NO:




CA
1643





CUTC
ADXCRPD.14073.C1_x_at
CTCAATCCAAAATTACCCTTAAGTGGAAGTCCTGAAGTACATGCCATGTACTCCCCCTTTATT
SEQ ID




TCTACCTTGGATCAATGGCCTCTGCGGAGTGTAGTGAAAGACATCTTTTTATTATGATCTACA
NO:




CTTTAAAAAACCAAAGGCTGCCTGTATTACATTTGCTTTGGGGAGTTGTTAAGACTCTGTTTT
1644




TTCTACTGGCTTCACATTAACAATAATTTTNGTTGAATTTGAATTCTTAAAAATCTACTGACA




ACATTTAAGTCAGTGTGAGGAA





CUTC
ADXCRPDRC.2453.C1_at
ACAGATGTGACCAAAGTAAGGACTTTGAATGCTATCGCAAAGAACATCCTGGTGTAGCCAGAC
SEQ ID




CTCTCTGAGAGACATGGATATCACAGGGATGAAGGTAGAACTATAATCTGCAATTCTCTATGA
NO:




CACAGCTTTAACCTTCTTCTCTGGCCAGGACAGTCGCAATCCTTTGNTTTTAATTTTCACATG
1945




GGCCATGGGAGAATGTGGCCCAAAGAAAGAAAAAGAAATTTGGAAACAGGAGATACAGGTCAC




TTTCCTTTTTGCTTAGTCCTTAACCAGTG





CUTC
ADXCRPDRC.2453.C1_s_at
TGCTATCGCAAAGAACATCCTGGTGTAGCCAGACCTCTCTGAGAGACATGGATATCACAGGGA
SEQ ID




TGAAGGTAGAACTATAATCTGCAATTCTCTATGACACAGCTTTAACCTTCTTCTCTG
NO:





1946





CXorf57
ADXCRAD_NM_018015_s_at
ATCTGATTCCAGTTAAGCTATAAACTTGTGGGATTTTCTTGTAGCCCTATAGTTCTGTGACTT
SEQ ID




CATTTGCTATACGCTTTAAATGTGTTGAGCAGCCTATGAACCTAAAGACATACTGCAGTTTGT
NO:




TCATAAATGTATTCAGTCTTTTATTCTTTATAATTGTGTGTAAATGTTAACTAAACAGTGGAT
2774




TCCTCTCGTGTTACAGTTTTGAGTGAA





CYFIP2
ADXCRAG_AF132197_s_at
TGGGAATTTTTGTACAATGAATTTACATTTATTTATGGTGACATATTTACGCTTGTGATCAAA
SEQ ID




TAATGATGTTAAATTCTTAAATCATATTTGCTATGCAGCTGAAGATGATATTTTGA
NO:





863





CYFIP2
ADXCRAG_AF132197_x_at
TTTCAGAAACTGTCAAATGTACCATATTTGTATTAAGAGTTGTTGGGAATTTTTGTACAATGA
SEQ ID




ATTTACATTTATTTATGGTGACATATTTACGCTTGTGATCAAATAATGATGTTAAATTCTTAA
NO:




ATCATATTTGCTATGCAGCTGAAGATGATATTTTGATTTGTATTTTGGGGGTACCTGTGTTGA
864




GTTGATAAACATTTCCATCTTCATTAAAACTGCTTCCAAACTAAA





CYFIP2
ADXCRAG_BC011762_s_at
AGACAGACAGTTCCACTGTGGAGCATGTGCGCTGCTTCCAGCCACCCATCCACCAGTCCTTGG
SEQ ID




CCACCACTTGCTAAGCAGAAGATCCTGCAGACCCTTATCTGGAGGAGGAAGAGAAGCAGGAGA
NO:




GAGAAAGCCACAGCCAGCCTGCCATAGGATCCAACTGGACAACGTGTGGGATGGACCTGGAAA
932




CAAGCACCTCCCCAAACACATCACCACTCCCTAGGGCGGGGCCTGTGCATGCTCTCCCATGAC




ATCTCCATGCTGGTTTCTCCATAGCATAAATG





CYFIP2
ADXCRPD.9810.C1_s_at
CCATGCCGAGCGCAGGAAGGACTTTGTCTCTGAGGCCTACCTCCTGACCCTTGGCAAGTTCAT
SEQ ID




CAACATGTTTGCTGTCCTGGATGAGCTAAAGAACATGAAGTGCAGCGTCAAGAATGACCACTC
NO:




TGCCTACAAGAGGGCAGCACAGTT
1540





CYFIP2
ADXCRSS.Hs#S2524484_at
GGCTCAGTGCGCACAACTAGCTAGAGGCACTGACTTTGTAAGCAACAACACTATCTTCTTGAG
SEQ ID




GTCTAATAATTGCCTTGGCAAAGGGCAGCCAATGCCAACGAGGAACCCTGTGTACACAAGTTT
NO:




CTCATCCCGAAAGTGGACACTGGGTGCTCAAAAAATGCCTTCTGGTGACAGTAACACCTGACC
2071




AGTCAAACAAACATGCACGCA





CYFIP2
ADXCRSS.Hs#S3733207_at
GCCTATGTTGTAGAATCCCTCGTACCCAGAGTGGGAGAAGATTACACCCGGGGCACTGCAGGG
SEQ ID




AGGGAACCAGGAGAGATGAAGTAGTAAGCTGAGGCATGCCCTTCTGGCCAGGCTGGCGTCTCT
NO:




GGGCATGGCCACATCTGTTCACAGTCTGAGACTTGAGTCCTGGGGTCACACAAGGGCACTGGG
2161




TAGGAGATGTCTATCTTGGGAGGAGGTCTTGGGAAGCAACCACAGATAG





CYFIP2
ADXCRAD_AV725374_at
GATATTTTGAATTGTATCTTGCGGGTCCCTGTGTTGAAGTGATAAACATTTGCATCTTATTAA
SEQ ID




AACTGCTTTCACACTTGTAGACCCCACAACTTACAACAATTAATTGGCCGTTGTTTTACAACG
NO:




GCTGACTGGGAAACCCTTGCCGTCCCCAACTTTATTGCTTGT
2591





DDX23
ADXCRIH.3762.C1_at
TGAGGAAGGTGATGGCCACCCCACTCTTGCCTGCTCGTCCCGTGCGGCCAATGCGGTGGATGT
SEQ ID




AATCTTCAATATTTTTGGCCATATCATAGTTGACAACCATAGACACATCTTGGATGTCAATAC
NO:




CACGACCAGCCACATCTGTAGCCACCAAAATATCCTTGGCCCCAGCCTTGAGGTTGGACAACG
1145




CAAACTCTCGCTGCTCCTGGCCTTTTCCACCGTGCAGTGTGCAAGCATTGTACCCCATCTTCT




CCAGGGATTTGGCCAACACGTCGCAGC





DDX23
ADXCRPD.1564.C1_s_at
TGGCACCATGAGGATTACAGACAGTGGAATCTTACTGTCATCTGGACAGCTGTTTTCCTGTTT
SEQ ID




GGATGGTAAAGGAAGTTGAGAGTCTTTAGACCTGTGCACAGCCCCACACCAAGGGGTGCTGTA
NO:




TGCTCTAGGCATCCCCTCCCCCAGGGGATTTTCTAAGTAGATGGGGGGACACGGTGAACTGGC
1441




TGTGTCCATCTTTGTCACTGAGTGAAATCTCTGTTTTCTATTCTCTGAGAAGATAAGTTTGTA




TGTTCTGAGAATA





DDX23
ADXCRPD.15034.C1_s_at
GAAGGACCGAGATCGAGACAAGGATGGGCACAGACGGGACAAGGACCGTAAACGATCCAGCTT
SEQ ID




ATCTCCTGGTCGAGGAAAAGACTTTAAATCTCGGAAGGACAGAGACTCTAAGAAGGATGAAGA
NO:




GGATGAACATGGTGATAAGAAGCCTAAGGCCCAGCCATTATCCCTGGAGGAGCTTCTGGCCAA
1698




GAAAAAGGCTGAGGAAGAAGCTGAGGCTAAGCCCAAGTTCCTCTCTAAAGCAGAACGAGAGGC




TGAAGCTCTAAAGCGACGGCAGCAG





DOCK2
ADXCRAD_NM_004946_at
GTAGATTCCTGAACTCAAGGTACCAGCAAGAATGCCTTCTCCCAGTGTGCTCTCCCCAACATC
SEQ ID




CTAGGCACAGCTTTCATAACCCAGTTTCTTAGGTGTAAGAAACTGCTTTTATCTCATTTATTA
NO:




AGTCTCAGAACTTAACAGAAAAGGAAGCCTTTTAAATATTCTTTTTAATTTTATTTTAGATTA
2777




ACAGTTTTGTACTTTACATTTTTTTATACAACCAACCAGTTTCTTTTCTAGCCAATCATCTCT




GAAGAGTTGCTGTTTCTTACTGACAAT





DPY19L 1
RDCR162_A06_s_at
AGATGTAGTTCTCCGTAGGCAGCAGGTCATGTAGCAGTCATTCTTTTACAACTTCTAGGACTT
SEQ ID




TGTAAACACTGTTCTGGAATACAGTGGTGAAGTGAGGTTTGGAATTCTTCACTAAGAGGTTAC
NO:




ATAAGGGAGTTTTCCCAGCATTGGCAGGATCTTCTACATCTCAAATTTCAGCATACTGCAACC
1358




AGGCTTGGATCTTCTTACACACCATGACTCTTCTAGAATGTAATAGTTCACTTTTAACTTTAT




CAGTTCTCGCTTCACTTCTTCGGCTGCTTTCCGACTATACATTGA





DPY19L1
ADXCRPD.17046.C1_at
AAAAATGACTTACACCTTTATCAATTGGTTACTATTTCAATGCACCCTTTAA
SEQ ID





NO:





1786





DPY19L1
ADXCRPD.17046.C1_s_at
TGGTGAAGGATTCCAAACCTCACTTCACCACTGTATTCCAGAACAGTGTTTACAAAGTCCTAG
SEQ ID




AAGTTGTAAAAGAATGACTGCTACATGACCTGCTGCCTACGGAGAACTACATCTGTAATGGTT
NO:




TTAATGTTTTGCTAAGTCATGTGTTGTTCATATCCCAAAAACTTTTATAGGTAACTGTTTTCA
1787




AATAGA





DPY19L1
ADXCRPD.10268.C1_s_at
TTTTTGCTTTAGTATGAGGAAAGTAAGGATGGGCAAAGAAGCGATCAAAATAGCTATTGCTAC
SEQ ID




AACATTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCTAAAAATGCTT
NO:




GGCAAAAAAAATATAGTGTTAAAATAGGCCAGTGATATTAATGAGAAAATGAAAGTATGTATC
1880




AGGAATAAAGTGATATTGCATAGGAGTATTGTATTTTTATGAAT





DPY19L1
ADXCRAD_BU607292_at
TATTGCTACAACATTTTCGAAAACAAAGTTGGGGCTGTATTTCTTTAAAAAGATAAGCCTCTA
SEQ ID




AAAATGCTTGGCAAAAAAAATATAGTGTTAAAATAGGCCAGTGATATTAATGAGAAAATGAAA
NO:




GTATGTATCAGGAATAAAGTGATATTGCATAGGAGTATTGTATTTTTATGAATTTTATGCCAG
2540




TTGTTTACATGTACCCTCGTTCCGAA





DPY19L1
ADXCRAD_BU607292_x_at
GTTTTGCATATTGTTAGCATTTACAAATATTTTTGCTTTAGTATGAGGAAAGTAAGGATGGGC
SEQ ID




AAAGAAGTGATCAAAATAGCTATTGCTACAACATTTTCGAAAACAAAGTTGGGGCTGTATTTC
NO:




TTTAAAAAGATAAGCCTCTAAAAATGCTTGGCAAAAAAAATATAGTGTTAAAATAGGCCAGTG
2541




ATATTAATGAGAAAATGAAAGTATGTATCAGGAATAAAGTGATATTGCATAGGAGTATTGTAT




TTTTATGAATTTTATGCCAGTTGTTTACATGTACCCTCGTTCCGAA





DPY19L1
ADXCRAD_BF447983_at
GAATAAGGCCTCTGCTAGAGTCCCAAATAAAGGATTAATTATCCTAAAGAAAAAGCCCCAAAA
SEQ ID




TAATAATCTTTGGGATCAAAAGGATTCTACCATCAGCCTCATATAAGTGGAACACAATGTAGG
NO:




AAGCTCTTTTCTCAACCTGCTTTCACTACTCCCAGATTCAAGTAAAGCCACAACCAATTTACA
2870




AGGCCCAGTACA





EIF1
ADXCRAD_BP342358_s_at
GGAGCTTTTGGTGGTAGATCCCCTGGTGTCTCCAACCTGACTAGGTGGACAGAGCTCAAAGAG
SEQ ID




GCCCTCTTACCGCTAGCGAGGTGATAGGACATCTGGCTTGCCACAAAGGTCTGTTCGACCAGA
NO:




CATAT
1279





EIF1
ADXCRAD_CX761856_s_at
GTTTGCCTGCAATGGTACTGTAATTGAGCATCCGGAATATGGAGAAGTAATTCAGCTACAGGG
SEQ ID




TGACCAACGCAAGAACATATGCCAGTTCCTCGTAGAGATTGGACTGGCTAAGGACGATCAGCT
NO:




GAAGGTTCATGGGTTTTAAGTGCTTGTGGCTCACTGAAGCTTAAGTGAGGATTTCCTTGCAAT
2529




GAGTAGAATTTCCCTTCTCT





EIF4A1
ADXCRIH.1587.C1_s_at
GAGGACTCTTCGAGACATTGAGACCTTCTACAACACCTCCATTGAGGAAATGCCCCTCAATGT
SEQ ID




TGCTGACCTCATCTGA
NO:





1208





EIF4A1
ADXCRPD.16013.C1_s_at
CTTGGCTCTCAGTTTTCTCAGAGTGAACATGCCTCGTAGCTTGGGTCCTATGGCAGGAGTGCA
SEQ ID




ATAGGACATGGATATGCATCACCTGTTCTATAAAACTGGTTGCTGGCTG
NO:





1748





FAM129A
ADXCRAG_AB050477_s_at
GTGCAAAGGGCTTAGCTAAGTTATCGAGCTTAAAACCCGTCAATTAAACAAACATTATTTGAA
SEQ ID




CAGTTACTGCATGCCACGCACTGTGTTGGGCTTAGTAATAAAAAAAAGAAAAGATAAGTGCTT
NO:




GTTCTAGCATAAATTAAAAGGTCCAAGGGAATTTAATCTGGAAGAGAACATATGCCAATTTTT
838




AAACTATGACAGCTTTTTTTTTTCTCTTTCCATTCAAATAGTCCTGGTTCATTCCCAGAAGGG




CACAAA





FAM129A
ADXCRAG_AL137572_s_at
TAATAATAGTATCAGTCGGTGCAACAGTTGGCAACATGTGCCTTCACACTTTACCATAAAGAG
SEQ ID




ACGGGTTTGAGGGTTTGCCTTCTAAAGTCTGCAACTTCAAGAAAAAAAAATCGACACTGTGGA
NO:




TTGACTTTCCCGGTCACTATATAAAGCAAATAAACTTAAAACACTTTGTAACCATGTATTTAC
889




TCTGCCAGGTGCCTATATTCCAATAAA





FAM129A
ADXCRPD.3083.C1_s_at
TGAAGATAACATGGCCTTGCCCAGTGAAAGTGTGTCCAGCTTAACAGATCTAAAGCCCCCCAC
SEQ ID




AGGGTCAAACCAGGCCAGCCCTGCCAGGAGAGCTTCTGCCATTCTGCCAGGAGTTCTGGGTAG
NO:




TGAGACCCTCAGTAACGAAGTATTCCAGGAGTCAGAGGAAGAGAAGCAGCCTGAGGTCCCTAG
1495




CTCGTTGGCCAAAGGAGAAAGCCTTTCTCTCCCTGG





FAM129A
ADXCRPD.13585.C1_at
ACACCTGGCCTTGGAGTCGCTTTTAAATCTCTTTTACACATCCTGTATTCCAGTCCGTAAATA
SEQ ID




AACAAATATTTTTTGCTTTCTCCATAGTATATCCAGATTCATTCAGGCCACAACAATCTTTCA
NO:




TTTGATGTACTCAAGTAAGTTCCCAACTGGTTTTTCTACTTCCCATGCTTACTC
1668





FAM129A
ADXCRPD.14825.C1_at
GATACCTCAGCCATTAGCAAGCTCTGTCAGTTTTTTTCTTTTCTTATGCCTGTCTTATTCTTT
SEQ ID




CTCTCTTGGTTTATGCTTCAGAGCACTTGAAAAACCAGTATCACTAAAATCTAATTTTTGTCA
NO:




AATTATCTTCAAAAATTGTATGGCTCTTTTTATTGTATTGAGTGTCCCTTAACTCTCAGCATT
1759




TTTTGTAGTTTGGCAGTAGACTTTCTGACATTCTCTCTTATTTCCATATCCCAGTGAAATCAT




TGTTCCATTTCAGCTAGA





FHOD1
ADXCRAG_AB041046_s_at
ATGACCTGGTGCAGGCACTGGGACTAAGCAAGGGTCCTGGCCTGGAGGTGTGAAGGTGCTGTA
SEQ ID




TCCCGGAAATCTATCTGGACCCTGGACTGCAGTGCAGGAGATGACAGAGTGAGGAGGGCCCAG
NO:




AGCAGAATTCTGGCCCCAGAACTCTGTGCCCAGGAGCCATGCCTTGAGCAGTATTAGCCGTGT
837




GTGTATGCATGTGAGTGTGTGTGTATGTGTGTGTGTGCATGCATATGCATGTGCATGTGTGTG




AGCTCCTTGAACGCACGGAGCA





FHOD1
ADXCRAD_BU522109_at
TGCGCGCCTCTTTCTTGTATCCTCACCCCGATTTGTTACGCCGCTACGCCGCCGCTTCTATAT
SEQ ID




TCCTTTTCATGCACCGCCTGGCGTCGCCTTTTGCGCGCCGACG
NO:





2584





FSCN1
ADXCRPD.10135.C1_at
CTGGGCACATGTCCCAAGCCTGTCAGTGGCCCTCCCTGGTGCACTGTCCCCGAAACCCCTGCT
SEQ ID




TGGGAAGGGAAGCTGTCGGGTGGGCTAGGACTGACCCTTGTGGTGTTTTTTTGGGTGGTGGCT
NO:




GGAAACAGCCCCTCTCCCACGTGGCAGAGGCTCAGCC
1863





FSCN1
ADXCRPD.10135.C1_x_at
GGGCACATGTCCCAAGCCTGTCAGTGGCCCTCCCTGGTGCACTGTCCCCGAAACCCCTGCTTG
SEQ ID




GGAAGGGAAGCTGTCGGGTGGGCTAGGACTGACCCTTGTGGTGTTTTTTTGGGTGGTGGCTGG
NO:




AAACAGCCCCTCTCCCACGTGGCAGAGGCTCAGCCTGGCTCCCTTCCCTGGAGCGGCAGGGCG
1864




TGACGGCCACAGGGTCTGCCCGCTGCACGTTCTGCCAAGGTGGTG





FSCN1
ADXCRSS.Hs#S2731818_at
TTCCAGGCATGATTGCGGGCTTACTTGCTGTCATTCTATTTTTCAGCAAAACTCTGGGTAGGA
SEQ ID




ATGTCGGAAATTATACCTTTTGAAATCCCTCCTTGAAAACATGGAGATTTGTAGGTATGCAGA
NO:




GGCAATTGTAACAATATAAAGTATTGTATCTCTTCCACTAGAGTAGGAGGGCCTGACTGTCGG
2092




CCCCTGGGTCTGTCTTCCATTACTTGTCTTGACTTCCGCTGTAAAAGCATTAAGTGGGAAGGT




AGCAGTTCTGCTGAACAAGCAGACATTGCCTTCTGTAAG





FSCN1
ADXCRAD_AJ708655_s_at
CTGTAGTAGCGAGTGATCTGGCGGGGGGCGTCTCAGCACCCTCCCCAGGGGGTGCATCTCAGC
SEQ ID




CCCCTCTTTCCGTCCTTCCCGTCCAGCCCCAGCCCTGGGCCTGGGCTGCCGACACCTGGGCCA
NO:




GAGCCCCTGCTGTGATTGGTGCTCCCTGGGCCTC
2701





FSCN1
ADXCRAD_BC004908_at
AAACCGTGGACCCCGCCTCGCTCTGGGAGTACTAGGGCCGGCCCG
SEQ ID





NO:





2875





FSCN1
ADXCRAD_BC004908_s_at
GTAAGTGTCATTTGTATAACTCTAAACGCCCATGATAGTAGCTTCAAACTGGAAATAGCGAAA
SEQ ID




TAAAATAACTCAGTCTGCA
NO:





2876





G0S2
ADXCRPD.11190.C1_at
GATACAGTTTGTGCCATCAGGGAACACACACACTGTTTGGCAATATAAACTGTATACACCTGC
SEQ ID




AGAAGAGGGATGAAAGCACCTTTTCCGTATGTATATGATTGCCTTTACCATGTCGTAATGAGG
NO:




TTTGTGATTTAATTTTCTATTTCTCCCAACATCGAGAACTCCTCCATGGCGAGGATTATTTCT
1438




CACATCCTCTAGCCCTAGCACACTGACTGGAAAATAACTGATGCTCAGGGAGTGTTTGTGAAT





GMFG
ADXCRPD.1437.C1_at
TGATCTCTGGGCTGGGGACTGAATTCCTGATGTCTGAGTCCTCAAGGTGACTGGGGACTTGGA
SEQ ID




ACCCCTAGGACCTGAACAACCAAGACTTTAAATAAATTTTAAAATGGCGCCAGGCCCCCCCAC
NO:




GTAAAAGAAAANAACTTGTTCGGCCGCCCTCGGCCCCTCAAAAAACTTTTCTAAACCCTTTCG
1417




TTTGGGCCCCCGGGGCCCACTTAGGTAAGGGAAAAATGGGGCCTAAACCTGTTTCCCTAGGAA




AATCCCTTGGCCATGAACTAA





GNA15
ADXCRPD.9260.C1_s_at
CGGACGGGACCCAGTGATACTTGTATATTACACAGTCCTGATTTCAGACAAT
SEQ ID





NO:





1400





GNA15
ADXCRPD.9260.C1_x_at
TGAGGAGCGGCTCAGTGTCACCTCCCACAGCCACCGGCCCTGACCCTTAATCCAGACACCGAT
SEQ ID




GGAAGTCGACTTTTCATATCTTTCTCCTGAAATGAACTCTGTTTTAAATTGGAATA
NO:





1401





GNA15
ADXCRPD.8623.C1_s_at
GCACTCTAGTGGACAGGAGAAGGAACGCCTTCCAGGAACCTGTGGACTAGGGGTGCAGGGACT
SEQ ID




TCCCTTTGCAAGGGGTAACAGACCGCTGGAAAACACTGTCACTTTCAGAGCTCGGTGGCTCAC
NO:




AGCGTGTCCTGCCCCGGTTTGCGGACGAGAGAAATCGCGGCCCACAAGCATCCCCCCATCCCT
1404




TGCAGGCTGGGGGCTGGGCATGCTGCATCTTAACCTTTTGTATTTATTCCCTCACCTTCTG





GNA15
ADXCRSS.Hs#S1223446_at
AGGGACCCTACATCTGGCATCTGGATGTCACCCTGAGCACAGAAGCCTTTCCCCTCACTGGGC
SEQ ID




CAGGGACACAGATGTTCACCAAGCGTCACTCGCAGGAGTAAACACTGATGCCACAGTTGCTCC
NO:




CTGCAGGGACCCTCCAGTGACGGCTGCAGAGGGCAGAGTTGCCGGTATCCTCCTGGGGCAGAA
2061




GAGCAGGCGCAGCGCCCTGCCCCGCGTGGTGAGCAGCTCAACCTCACACTCTCAGGCCACGCA




CAGGCGGGAGAA





GZMB
ADXCRPD.5219.C1_at
CTATACAAATGTCCCATGGCTACCCCCTACCACTATTAAGTAAATCCCAGCCTCGCCCTCCGG
SEQ ID




TACTAATACACCACCTAAAACCACTCTTGGTGGCACTGCGCTTCAGANNNNNNNNNNNNNNNN
NO:




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAATTTTCCACAGTCCTCTGACGCCCG
1681




ACCCCTGGCTCCTGGTGCAACCCGTCCACCTGGTGAACGTTCATTCTTTCGC





GZMB
ADXCRPD.5219.C1_x_at
TTCCTTTCCCTATACAAATGTCCCATGGCTACCCCCTACCACTATTAAGTAAATCCCAGCCTC
SEQ ID




GCCCTCCGGTACTAATACACCACCTAAAACCACTCTTGGTGGCACTGCGCTTCAGANNNNNNN
NO:




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAATTTTCCACAGTCCTC
1682




TGACGCCCGACCCCTGGCTCCTGGTGCAACCCGTCCACCTGGTGAACGTTCATTCTTTCGC





HCLS1
ADXCRPD.1749.C1_at
ATAAAAACCTCCTTGTTCGCTGCAGCCCCGGGGGGTGTAAGGGGGAAATTGGCGGCCCTGGGC
SEQ ID




CATACGGAAAACAAGGCGCCGTGACACTCCAACAGAAGATCGGCACCGTCCCATCCACACGGC
NO:




TGCAAACTTGCGCCAAAATGCATCTAAACCACGAGAACGCCCGGGGGGGATCCACCCCGCGTG
1483




GGCACGCCGCGGGGAGAGAGGGCGAACGCCGAAACCCAGGTGTGGCGAGCAAAGCTACCCCAT




AAAACCT





HCLS1
ADXCRPD.6475.C1_s_at
GTCCTCTCTATCCTGGATGAGCTCATGAACATTTCTCTTGTGTTCCTGACTCCTTCCCAATGA
SEQ ID




ACACCTCTCTGCCACCCCAAGCTCTGCTCTCCTCCTCTGTGAGCTCTGGGCTTCCCAGTTTGT
NO:




TTACCCGGGAAAGTACGTCTAGATTGTGTGGTTTGCCTCATTGTGCTATTTGCCCACTTTCCT
1760




TCCCTGAAGAAATATCTGTGAACCTTCTTTCTG





HNRNPA1
200016_x_at
AACTCGAGGACTGTATTTGTGACTAATTGTATAACAGGTTATTTTAGTTTCTGTTCTGTGGAA
SEQ ID




AGTGTAAAGCATTCCAACAAAGGGTTTTAATGTAGATTTTTTTTTTTGCACCCCATGCTGTTG
NO:




ATTGCTAAATGTAACAGTCTGATCGTGACGCTGAATAAATGTCTTTTTTTTAATGTGCTGTGT
830




AAAGTTAGTCTACTCTTAAGCCATCTTGGTAAATTTCCCCAACAGTGTGAAGTTAGAATTCCT




TCAGGGTGATGCCAGGTTCTATTTGGAATTTATATACAACCTGCTTGGGTGGAGAAGCCATTG




TCTTCGGAAACCTTGGTGTAGTTGAACTGATAGTTACTGTTGTGACCTGAAGTTCACCATTAA




AAGGGATTACCCAAGCAAAATCATGGAATGGTTATAAAAGTGATTGTTGGCACATCCTATGCA




ATATATCTAAATTGAATAATGGTACCAGATAAAATTATAGATGGGAATGAAGCTTGTGTATCC




ATTATCATGT





HNRNPA1
ADXCRAD_CN296684_s_at
GAACTGATAGTTACTGTTGTGACCTGAAGTTCACCATTAAAAGGGATTACCCAAGCAAAATCA
SEQ ID




TGGAATGGTTATAAAAGTGATTGTTGGCACATCCTATGCAATATATCTAAATTGAATAATGGT
NO:




ACCAGATAAAATTATAGATGGGAATGAAGCTTGTGTATCCATTATCATGT
2549





HNRNPR
ADXCRIH.1214.C1_s_at
CAAGCTAGTGCTTTGTCTTAGTAGTTTTAAGAAATTAAAGCAAACAAATTTAAGTTTTCTTGT
SEQ ID




ATTGAAAATAACCTATGATTGTATGTTTTGCATTCCTAGAAGTAGGTTAACTGTGTTTTTAAA
NO:




TTGTTATAACTTCACACCTTTTTGAAATCTGCCCTACAAAATTTGTTTGGCTTAAACGTCAAA
1302




AGCCGTGACAATTTGTTCTTTGATGTGATTGTATTTCCAATTTCTTGTTCATGTAAG





HNRNPR
ADXCRPD.2849.C2_at
ATCAGGTCCCTTTGTGGACTCTTGCACCTTGCTCCCCTGTTTCTCTCTCTGCCTGTAGGTCTT
SEQ ID




CATAACTCCACATAAAAATGCACTTTTGTTCTGAACATGTGATAAGTCACTTTCCTTGAACTG
NO:




CTGTAGTACAGACAGAGCTCCTTCTTCATTAAATTCCCTGAGAGCATCAATTGCTCTTTCATC
1894




AAGATCGACATAAGCTACCAATCCAGGGCAGAGCGGGGGCCGGCAGCCGGGCCCGTGAGAATC




AGCGCGAGGCGCTTTGAAAACGACTAGAAATGGCGCGCGCG





HNRNPR
ADXCRPDRC.2849.C2_at
GCATTTCTGTGGCAAACAACAGACTTTTTGTTGGATCCATTCCGAAGAATAAGACTAAAAGAA
SEQ ID




AACATTTTGGAAGAATTCAGTAAAGTCACAGAGGGTTTGGTGGACGTTATTCTCTATCATCAA
NO:




CCCGATGACAAAAAGAAGAATCGGGGGTTCTGCTTCCTTGAATATGAGGATCACCAGTCAGCA
2044




AGCACAAGCCAGACGCCGGCTGATGAGTGGAAAAGTAAAAGTGTGGGGAAATGTAGTTACAGT




TGAATGGGCTGACCCTGTGGAAGAACCA





HNRNPR
ADXCRAD_CX788441_at
CTTTGGGACCACCAAGAGGCTCTAGGGGTGGCAGAGGGGGTCCTGCTCAACAGCAGAGAGGCC
SEQ ID




GTGGTTCCCGTGGATCTCGGGGCAATCGTGGGGGCAATGTAGGAGGCAAGAGAAAGGCAGATG
NO:




GGTACAACCAGCCTGATTCCAAGCGTCGTCAGACCAACAACCAACAGAA
2472





HNRNPR
ADXCRAD_CX788441_x_at
CTTTGGGACCACCAAGAGGCTCTAGGGGTGGCAGAGGGGGTCCTGCTCAACAGCAGAGAGGCC
SEQ ID




GTGGTTCCCGTGGATCTCGGGGCAATCGTGGGGGCAATGTAGGAGGCAAGAGAAAGGCAGATG
NO:




GGTACAACCAGCCTGATTCCAAGCGTCGTCAGACCAACAACCAACAGAACTGGGGTTCCCAAC
2473




CCATCGCTCAGCAGCCGCTTCAGCAAGGTGGTGACTATTCTGGTAAC





IFI16
ADXCRIH.3101.C1_s_at
ATGTTTCATGCCACAGTGGCAACTGAGAATGAAGTCTTCCGAGTGAAGGTTTTTAATATTGAC
SEQ ID




CTAAAGGAGAAGTTCACCCCAAAGAAGATCATTGCCATAGCAAATTATGTTTGCCGCAATGGG
NO:




TTCCTGGAGGTATATCCTTTCACACTTGTGGCTGATGTGAATGCTGACCGAAACATGGAGATC
1195




CCAAAAGGATTGATTAGAAGTGCCAGCGTAACTCCTAAAATCAATCAGCTTTGCTCACAAACT




AAAGGAAG





IFI16
ADXCRAD_BM806453_s_at
TTCTTCTAAAATCTGGATGTCATTGACGATAATGTTTATGGAGATAAGGTCTAAGTGCCTAAA
SEQ ID




AAAATGTACATATACCTGGTTGAAATACAACACTATACATACACACCACCATATATACTAGCT
NO:




GTTAATCCTATGGAATGGG
1433





IFI16
ADXCRPD.1023.C1_at
GTTCTCCAAAAACGCCCAGTGATAGTGAAGGTACTGAGTACAACAAAGCCATTTGAATATGAG
SEQ ID




ACCCCAGAAATGGAGAAAAAAATAATGTTTCATGCTACAGTGGCTACACAGACACAGTTCTTC
NO:




CATGTGAAGGTTTTAAACACCAGCTTGAAGGAGAAATTCAATGGAAAGAAAATCATCATCATA
2268




TCAGATTATTTGGAATATGATAGTCTCCTAGAGGTCAATGAAGAATCTACTGCATCTGAAGCT




GGTCCTAACCAAAAATTTGAGGATGGTCCGGCACAGCG





IFI16
ADXCRAD_CD252021_x_at
GAGCAGAGGCAACTCCTGGAGCTCAGAAAAGAAAAAAATCAACCAAAGAAAAGGCTGGACCCA
SEQ ID




AAAGGGAGTAAGGTGTCCGAAGAACAGACTCAGCCTCCCTCTCCTGCAGGAGCCGGCATGTCC
NO:




ACAGCCATGGGCCGTTCCCCCATCTCCCAAGACCTCATTGTCAGCTCCACCCCAAACTTTCTC
2479




AACTGAGAAACCCGAAAACAGTGGCCCAATGTCCAGGTAAACTCCCAGAAA





IKZF1
ADXCRAG_BC018349_s_at
GGGTTCTTAGTCTCAGCACTATGACATTTTGGGCTGACTACTTATTTGTTAGGCAGGAGCTCT
SEQ ID




CCTGTGCATTGTAGGATAATTAGCAGTATCCCTGGTGGCTACCCAATAGACGCCAGTAGCACC
NO:




CCGAATTGACAACCCAAACTCTCCAGACATCACCAACTGTCCCCTGCGAGGAGAAATCACTCC
945




TGGGGGAGAACCACTGACCCAAATGAATT





IKZF1
ADXCRAD_BG685498_at
GTTAGTATAGAATTCTCGAAACTTGGGAATTCACAAATCAGGACTGGGGACTGCGAGACCACA
SEQ ID




AATTTCTGATCGCATTTCTGATGGATGTGTCACACCTTTTCTGTCAAAACTAACATGTCTTGG
NO:




AGGTTAATCGACGTCCCTTGGGTGGACACACACA
2443





IKZF1
ADXCRAD_BG685498_x_at
GTTAGTATAGAATTCTCGAAACTTGGGAATTCACAAATCAGGACTGGGGACTGCGAGACCACA
SEQ ID




AATTTCTGATCGCATTTCTGATGGATGTGTCACACCTTTTCTGTCAAAACTAACATGTCTTGG
NO:




AGGTTAATCGACGTCCCTTGGGTGGACACACACA
2444





IKZF1
ADXCRAD_BM456472_s_at
GTGTGGTGATTGTTCAGGTCGAATCTGTTGTATCCAGTACAGCTTTAGGTCTTCAGCTGCCCT
SEQ ID




TCTGGCGAGTACATGCACAGGATTGTAAATGAGAAATGCAGTCATATTTCCAGTCTGCCTCTA
NO:




TGATGATGTTAAATTATTGCTGTTTAGCTGTGAACAAGGGATGTACCACTGGAGGAATAGAGT
2749




ATCCTTTTGTACACATTTT





IL27RA
ADXCRAD_BG756941_at
GCAAGACCCTCAGTACAAAATAAACGTCAGAAACAAAAACAATTAGCTTGGGGCATTATGGCA
SEQ ID




CACACCTGTTATCCGAGCCACTTGGAAGCTGAGGGGGAGATCGGTTGAGCCAGGAGTTCGAAG
NO:




TGAGGACTCTGATTGCACATGGATCCAGGTGCGTACCAATGGACTTTTTCAAATA
2631





IL27RA
ADXCRAD_NM_004843_at
ACACTGCATTTGGGCACCATCTCAGCTCCCTTGCATCCAGGTGCAGCATGGACTGAGTTCTTG
SEQ ID




ACAACAGAATGTGGTCAGAAGTGACATATGCCAACACGGGGTCTGGGTGGGGGCTCCCCCACA
NO:




TCCTTTCCTTGCCTATGAGCTGGAACATAACACATGCCTATGATCCAGCTTTGGTCATACCCA
2770




AGGGGAAGGTGGAGCAAGAAATGAAAAGGAACCTGAATCCCTGAATGACTGCATGGATAGAAC




CACT





IL4R
ADXCRAG_NM_000418_s_at
GGGACAATTTGCTGCCAAACACCCATGCCCAGCTGTATGGCTGGGGGCTCCTCGTATGCATGG
SEQ ID




AACCCCCAGAATAAATATGCTCAGCCACCCTGTGGGCCGGGCAATCCAGACAGCAGGCATAAG
NO:




GCACCAGTTACCCTGCATGTTGGCCCAGACCTCAGGTGCTAGGGAAGGCGGGAACCTTGGGTT
1003




GAGTAATGCTCGTCTGTGTGTTTTAGTTTCATCACCTGT





IL4R
ADXCRPD.13542.C1_at
TCAGCTGACAACAACTTGCATAAGGGCTTACCATGTTAAGGAGCTGTCTTAGATAGCAAATAA
SEQ ID




ATATTCCAAGCTTATCTCATGTCCAAAACTAACTCCTGATTCCCGCCCCTCCCCAAAGTACCT
NO:




TCTCTTCTGGCATCCTTCTACATTTCAGAAATGACAACCGCGTCCTTCCCAGTAGTTTAGGTC
1662




AGAAATCTTGGAGTCATCCTGGCCACTTCTCTTTCTCTGTCTTTCACCTCAATTCCAATCTGT




CCTCAAATCTACCTCCCAGAGAG





IL4R
ADXCRSS.Hs#S523708_at
CCAGTGGACACAGAATGGAAGGACTGTTCCCAGTTCGGTTTTCAATCAGCAGCAGGCATGCCT
SEQ ID




TCCAGCAAGCACACCTCATCTCAATACGCCTTCCTGGGCACTTAAGTTCAGGGGTGGAAACAG
NO:




CTGGGCTGAAGGGGGCTTGGTGGTCTACTGCGACCAGCTCCGTTTCAAAGGTGGGAGGACTGA
2128




GGCCCAGGCAGGGGCAGGAATCCCATCAGATTTGGGAAAATACAGGGCGGCTTCCTC





IL4R
ADXCRSS.Hs#S3742921_at
GATCTGAGCTTGTATTTGGTGCCCAGGACATGTGCTGGGTTCCCGAAATCCCAAAGACACAGA
SEQ ID




CCCTACCCTCAGGGATTTCTCATTCTAGCAACATAGACTGATCAATTACTGATTATAACGTTA
NO:




GAAGGCATGTCTGAAGTAGACAGCCATCAGGACATGGTGATTTCAGGCTGGGCTTTGAAGAAT
2185




GACTAGGAGTTTTTCAAGTGTCGAAACTGAACCCTGACCAACCTTTGCTTTTGCAGAC





IL4R
ADXCRAD_AA767714_at
GCCAATGGCAGATGAGAATCAATTCAAAACTTTCCCAAGCACCTGGTTCTGTGCTGGGTTCTG
SEQ ID




GAGATACAGCCATGGAGACCCTGCCTATGGAGCTCACAGCCCAGGGCAGGAGACACGTGGCTC
NO:




AACTGATATCCACAGTGCAGGATGAGCAATGCTGAGAGGGCTGTGCGGTGGCAGGGTCAGGGT
2896




ACTGCCAGCTGCCACTGCACCTACCACGTTGAAGAATCTTCTTTCATTGAGTTTTCACGACAG




CCCTTACTCCT





IL6R
ADXCRAG_NM_181359_at
ACCACCATCACCAGACAGGTGCGAAAGGATGAAAGTGACCATGTTTTGTTTACGGTTTTCCAG
SEQ ID




GTTTAAGCTGTTACTGTCTTCAGTAAGCCGTGATTTTCATTGCTGGGCTTGTCTGTAGATTTT
NO:




AGACCCTATTGCTGCTTGAGGCAACTCATCTTAGGTTGGCAA
1055





IL6R
ADXCRAD_BP313907_s_at
AAGCACCATAACTTTGTTTAGCCCAAAACCAAGTCAAGTGAAAAAGGAGGAAGAGAAAAAATA
SEQ ID




TTTTCCTGCCAGGCATGGTGGCCCACGCACTTCGGGAGGTCGAGGCAGGAGGATCACTTGAGT
NO:




CCAGAAGTTTGAGATCAGCCTGGGCAATGTGATAAAACCCCATCTCTACAAAAAGCATAAAAA
2450




TTAGCCAAGTGTGGTAGAGTGTGCCTGAAGTCCCA





INSIG1
ADXCRIH.1510.C1_s_at
GAATGACCCCCTTATATATTTTCTGAAAATGAAAACAGTTACATGAAAAAAATTTCCAATGAA
SEQ ID




GATGTCAGCATTTTATGAAAAACCAGAAGTTATTAGATGAAAGCAGCGAGTGAATCTTTAAAC
NO:




AGACTTGATCACGCACACACAATAAGTCTTTCTCTCC
1196





INSIG1
ADXCRAD_BU191559_at
AATCTATTTAGATCGGGCTGACTGTACAAATGACTCCTGGAAAAAACTCTTCACCTAGTCTAG
SEQ ID




AATAGGGAGGTGGAGAATGATGACTTACCCTGAAGTCTTCCCTTGACTGCCCGCACTGGCGCC
NO:




TGTCTGTGCCCTGGAGCATTCTGCCCAGGCTACGTGGGTTCAGGCAGGTGGCAGCTTCCCAAG
2371




TATTCGATTTCATTCATGTGATTA





INSIG1
ADXCRAD_BU570382_at
GATTTTTTTGCCAATAGTTTATAGAAAATATATGAACCAAAGTGATTTGAGTTTGTAAAAATG
SEQ ID




TAAAATAGTATGAACAAAATTTGCACTCTACCAGATTTGAACATCTAGTGAGGTTCACATTCA
NO:




TACTAAGTTTTCAACATTGTGT
2372





INSIG1
ADXCRAD_BU570382_x_at
GATTTTTTTGCCAATAGTTTATAGAAAATATATGAACCAAAGTGATTTGAGTTTGTAAAAATG
SEQ ID




TAAAATAGTATGAACAAAATTTGCACTCTACCAGATTTGAACATCTAGTGAGGTTCACATTCA
NO:




TACTAAGTTTTCAACATTGTGTTCTTTTTGCATTCATTTTTTA
2373





INSIG1
ADXCRAD_AL541939_s_at
TTTTAAATTCTGTGAAAGTGGCTTGATTAAAAG
SEQ ID





NO:





2611





ITK
ADXCRAD_NM_005546_at
TGGTATTACCTTTTTCAAGCTCAGATTCATCTAATCCTCAACTGTACATGTGTACATTCTTCA
SEQ ID




CCTCCTGGTGCCCTATCCCGCAAAATGGGCTTCCTGCCTGGTTTTTCTCTTCTCACATTTTTT
NO:




AAATGGTCCCCTGTGTTTGTAGAGAACTCCCTTATACAGAGTTTTGGTTCTAGTTTTATTTCG
2767




TAGATTTTGCATTTTGTACCTTTTGAGACTATGTATTTATATTTGGATCAGATGCATATTTAT




TAATGTACAGTCACTGCTAGTGTTCAA





JUNB
ADXCRIH.455.C1_s_at
GAAACAGACTCGATTCATATTGAATATAATATATTTGTGTATTTAACAGGGAGGGGAAGAGGG
SEQ ID




GGCGATCGCGGCGGAGCTGGCCCCGCCGCCTGGTACTCAAGCCCGCGGGGACATTGGGAAGGG
NO:




GACCCCCGCCCCCTGCCCTCCCCTCTCTGCACCGTACTGTGGAAAAGAAACACGCACTTAGTC
1165




TCTAAAGAGTTTATTTTAAGACGTGTTTGTGTTTGTG





KBTBD11
ADXCRPD.18308.C1_at
AGGCAGTCTCAGCAATGCCTCTGCCCTCCCTGCAGCAGTCCCAAAATGAACAGCCACACCTTG
SEQ ID




GAGGGTGTGGCTTTTCTGTTTCATGCGGTGCAAACCCTAGCGGCTCCACACCCCAGGGACTGG
NO:




CCCCCAAAAAGCAAAAACACTGCTCATGGCTTGGCAGGTCCTCTAGTATGTATTTTTATGTGA
1420




TATCACTATTCAGAACTGTGGTGTATACTATTCTATAAATTTCCACTATAGGTTGGCCGGACA




TCCTTTAATGCTGGGTATTAATTCCTCTTATTCT





KBTBD11
ADXCRPDRC.18308.C1_at
GGTTCATGTGAGATGCAGAGGCAATGAGCTTGAGCCTTCCTACCTTTACTTCCGGCTGGATAC
SEQ ID




TTGCTCTGGGGAACAATCCCATCAATACCGCAGACGGCTTTGCCGGCCGCCTTCGCCAAAGCC
NO:




TGGGATTCGGAAACATACGGGGAAACGGGGCGCGGAATCCGAGGAGGGCCACGACAGCGACCA
1927




GGGAGAAAAACGGCAGGTGCGGGAAGAACCTGGGCCACACAACAAAAACACGGAAGTGAGAAC




ACCTGGCCACACGAAGGAAGACATGAA





KBTBD11
ADXCRAD_NM_014867_at
CTTCAGACACGCCAAGTGGATGGATTTGGATTGAACGCATATGAAACAGGAGACGGGTTCTCA
SEQ ID




TGTGAGATCAAAGCTCCTCCAAAGCCTGTTCAAGCTCTAAGCGATTCTCAAATGTTACCATTT
NO:




ATTAAAGGTAAACTACACCTGTTGAAGGCCAAGTTCAGGGCAGCTGTTGTGATCTGTGTAGTT
2772




AATGTATTTATTAATGCTTGACTTTTAAAATCCTGGGCATAAATAGTGCAGAGCCTCGTATGT




TTGTCAGTTCATGCCGAGATG





LARS2
ADXCRAG_BC025989_s_at
GATGGCCAGGAATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTCA
SEQ ID




GCAATTAAGTGTTCCCACTAGAACTGACCTAAGCCACTGATTAATATTTAATGAGGGAAGGTA
NO:




GGGGAGAATCTAGCCATTTTATAATGCCAGAAATCTATATATGTTATCTGATGCCATTTTTCT
950




GAAGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTTTTTAGT





LARS2
ADXCRSS.Hs#S2986318_at
GATGCCACAGCAGATGTGTCAAACCATTTTTCCTGCTCATGGCATGTAGTTTGAGAGAGCTTG
SEQ ID




ATAGTGAAGCTGCCAGCTCAGCTGTGACTGGCCACTCATTTGCAGACTAGAATGCCTTACTGG
NO:




CCTGGGCTTGCTTAAGGTAATTGCTTCTAGACTCCTCACTCCTGCTGGGCCACAGTTGCTTGA
2164




ACAGTCAAATAAGGGGTTGGGGGGTAGAGGATATATCTCAAAACCTTCTTTGTGCTTGAAGAT




TTGTGATTCCTTGTTCTTTGGAGAA





LARS2
ADXCRAD_AK025190_x_at
TGTAATCACAGAACATGGGGAAGCTGAGGCAGGCAGATTGCTTGAGGCCAGGAGTTAGAGACC
SEQ ID




AGCCTGGCCAACATAGTCAAACTCTGTCTCTACTAAAAATACAAAAATTAGCCAGGTGTAGGG
NO:




GCTCATGCCTGTAATCCTCCCAAGAAGCTGGGCTGAGGCACGAGAATTGCTTGAACCCAAGGG
2820




GCATAGGTTGCAGTGAGCCAAGATCATGCTGCTGCCCTCCAGCTTGGGCAATAAAGCA





MAP4K1
ADXCRAD_BG397984_s_at
TTCTGGAAGCATGGAGTGCAGGTGTGGGCTCTAGGCTCGGATCAGCTGCTACAGGAGCTGAGA
SEQ ID




GACCCTACCCTCACTTTCCGTCTGCTTGGCTCCCCCAGGCCTGTAGTGGTGGAGACACGCCCA
NO:




GTGGATGATCCTACTGCTCCCAGCAACCTCTACATCCAGGAATGAGTCCCTAGGGGGGTGTCA
1070




GGAACTAGTCCTTGCACCCCCTCCCCCATAGACACACTAGTGGTCATGGCATGTCCTCATCTC




CCAATAAACATGACTTTAGCCTCTGCAAAA





MCL1
ADXCRAG_AF118124_s_at
AGTTTTCAATAATTAGGTCTAAGTGGAGTTTTAAGGTTACTGATGACTTACAAATAATGGGCT
SEQ ID




CTGATTGGGCAATACTCATTTGAGTTCCTTCCATTTGACCTAATTTAACTGGTGAAATTTAAA
NO:




GTGAATTCATGGGCTCATCTTTAAAGCTTTTACTAAAAGATTTTCAGCTGAATGGAACTCATT
861




AGCTGTGTGCATATAAAAAGATCACATCAGGTGGATGGAGAGACATTTGATCCCTTGTTTGCT




TAATAAAT





MCL1
ADXCRIH.2623.C1_s_at
AGAAGGATGGCGCTCCCAGTGACTACTTTTTGACTTCTGTTTGTCTTACGCTTCTCTCAGGGA
SEQ ID




AAAACATGCAGTCCTCTAGTGTTTCATGTACATTCTGTGGGGGGTGAACACCTTGGTTCTGGT
NO:




TAAACAGCTGTACTTTTGATAGCTGTGCCAGGAAGGGTTAGGACCAACTACAAATTAATGTTG
1101




GTTGTCAAATGTAGTGTGTTTCCCTAACTTTCTG





MCL1
ADXCRIH.2463.C2_at
CATAAGCCGCTTATTTATATCATGTATCTCTAAGGACCTAAAAGCACTTTA
SEQ ID





NO:





1267





MCL1
ADXCRIH.2463.C2_s_at
TCTTAAGATCTGGTTACGGTAACTAAAAAAGCCTGTCTGCCAAATCCAGTGGAAACAAGTGCA
SEQ ID




TAGATGTGAATTGGTTTTTAGGGGCCCCACTTCCCAATTCATTAGGTATGACTGTGGAAATAC
NO:




AGACAAGGATCTTAGTTGATATTTTGGGCTTGGGGCAGTGAGGGCTTAGGACACCCCAAGTGG
1268





MCL1
ADXCRPD.7685.C1_s_at
GCAACCACGAGACGGCCTTCCAAGGCATGCTTCGGAAACTGGACATCAAAAACGAAGACGATG
SEQ ID




TGAAATCGTTGTCTCGAGTGATGATCCATGTTTTCAGCGACGGCGTAACAAACTGGGGCAGGA
NO:




TTGTGACTCTCATTTCTTTTGGTGCCTTTGTGGCTAAACACTTGAAGACCATAAACCAAGAAA
1835




GCTGCATCGAACCATTAGCAGAAAGTATCACAGACGTTCTCGTAA





MCL1
ADXCRAD_BP365482_s_at
AGGAGATGGAAGCCCCGGCCGCTGACGCCATCATGTCGCCCGAAGAGGAGCTGGACGGGTACG
SEQ ID




AGCCGGAGCCTCTCGGGAAGCGGCCGGCTGTCCTGCCGCTGCTGGAGTTGGTCGGGGAATCTG
NO:




GTAATAACACCAGTACGGACGGGTCACTACCCTCG
2345





MCL1
ADXCRAD_BQ962674_at
ACCATGGTGCTATTATTAGGCTTGCTTGTTACACACACAGGTCTAAGCCTAGTATGTCAATAA
SEQ ID




AGCAAATACTTACTGTTTTGTTTCTATTAATGATTCCCAAACCTTGTTGCAAGTTTTTGCATT
NO:




GGCATCTTTTGGATTTCAGTCTTGGATGTTTGTTCTATCAGACTTAACCTTTTATTTCCTGTC
2346




CTTCCTTGAAAATTGCTGATTTGGTTCTGCTCCCTCTACAGATAATTTATATCAATTTCCCTA




CAGCCTTTC





MCL1
ADXCRAD_CX866513_at
TTGGCAGACAGGCTTTTTTAGTTACCGTAACCAGATCTTAAGATTAATTAAAAACTACATAAA
SEQ ID




GTGCTTTTAGGTCCTTAGAGATACATGATATAAATAAGCGGCTTATGATCAAGAACGATAAAT
NO:




ACATAGGTAAAAATAGCTCTAGCAAAGATGACCTTATGGCTCTGAGATGGGCAGGCAGGGCAA
2558




TTCTTCCCCATTACATTCTTAGTCATCTTATTCATACCTATTTTTAAATGGAGTCCACAGACT




AAAGGTCATGTTCCGAGACTGAAGCTTTCAAATGACCCTAGTTCCAAT





MCL1
ADXCRAD_BF981280_at
AACCATAGGCGACAGCGGACACCAACAAACGAGCAGAAACTCCACCAGCTGAAACGCAGCCAT
SEQ ID




GCAGAGCAAACACAGAGCAACCACGCATCATCATACAAAAAGCCAGAGCCACCACGGAACCCA
NO:




TACACGAAACAGTAACAACAAGCAGCACAACAACACCGCCGTCCGACACACACGTCGATCAAA
2667




TACAGACACCGATAGCAAAACATAGCAACAACGAGAGCGAATCGAAAGCCTCAACGCCTCAAC




CCCCTAGTCAGTCCCACGCCACATATACG





MCL1
ADXCRAD_BF724558_at
GCCCGACCCGGAGAGCTGTTTCTTAATCTGCCTGGAGGAAAATCCCAGCCCCCAAATTTCCAC
SEQ ID




ATACTTCACATAGATAACACTGTAACAACTTTGAAACTAAGAGGGAGAGA
NO:





2841





MCL1
ADXCRAD_BF724558_x_at
CCCAGGCCCCGGAGTGCAATGGCATGATCTCAGCTCACTGCAACCTCCGCCTCCCGGGTTCGA
SEQ ID




GCGATTCTCCTGCCTCAGCCTCCCAAAGTGCTGGGATTACAGGCCTGAGCCACAGCGCCCGAC
NO:




CCGGAGAGCTGTTTCTTAATCTGCCTGGAGGAAAATCCCAGCCCCCAAATTTCCACATACTTC
2842




ACATAGATAACACTGTAACAACTTTGAAACTAAGAGGGAGAG





MFNG
ADXCRPD.17460.C1_x_at
TGGCAATTGGCACTGAAGGCACCCAAGCCCCTGGAGCCTTTCTTGCGGTTAGGGCTAACATGG
SEQ ID




ACCAGCTTTGGCAGAGGAACTAAGCAATCCAATAAGATGTTCTTGGAAAGTTTTGAGCCACTC
NO:




CCATCTTCTGGCAAAATGTGGGTTGAAGGCGGATCT
1873





MFNG
ADXCRPDRC.7895.C1_s_at
AACCCAAGGGCGCTGCTGCAGCTTCTGAGAGCCTTCCCGCTGGCCCGCGACGTCTATGTGGGA
SEQ ID




AGGCCCAGCCTGAACCGGCCCATCCATGCCTCAGAGCCACAGCCCCACAACCGCACGAGGCTG
NO:




GTACAGTTCTGGTTTGCCACTGGGGGTGCTGGCTTCTGCATCAATCGCAAACTGGCTTTGAAG
2043




ATGGCTCCGTGGGCCAGTGGCTCCCGTTTCATGGACACATCTGCTCTCAT





MFNG
ADXCRAD_NM_002405_at
ACGGGTCCCAGCCAATTGTGATGATCCTTTTTGCTCATTTCCCAGCCTTTCTTGCTGTTAGGG
SEQ ID




GCTACCATGGGACCAGCTCTGGCCAGAGGGAACTAAGCAAATCCAATAGAGATGTTTCTGGGG
NO:




AAGGTTTTGCAGCCCACTCCCCATCTTCCTGCTATAAATGTGGGTGTGATGGCTGGATCTGGG
2775




GCAGCCACCTTGCTACCATGAAGGAAAGGCCAAGACAATCATCCACAGCTATTCCCTCCAGCA




TCTGGTTCTGTACAAAAATTA





NAP1L1
ADXCRIH.187.C2_s_at
TGAAAACTTCCTTTCTGAGAAGTTAGTGTTAAGGTCTTGGAATGTGAACACATTGTTTGTAGT
SEQ ID




GCTATCCATTCCTCTCCTGAGATTTTAACTTACTACTGGAAATCCTTAACCAATTATAATAGC
NO:




TTTTTTTCTTTATTTTCAAATGATTTCCTTTGCTTTGATTAGACACTATGT
1301





NAP1L1
ADXCRPD.3079.C1_s_at
TCAAAGATAGAATCCCATTTTTAATGAACTGAAGTAGCAAAATCATCTTTTTCATTCTTTAGG
SEQ ID




AAATAGCTATTGCCAAAGTGAAGGTGTAGATAATACCTAGTCTTGTTACATAAAGGGGATGTG
NO:




GTTTGCAGAAGAATTTTCTTTATAAAATTGAAGTTTTAAGGGACGTCAGTG
1494





NAP1L1
ADXCRPD.367.C1_s_at
AGTGAAGTTCTCAGATGCTGGCCAGCCTATGAGTTTTGTCTTAGAATTTCACTTTGAACCCAA
SEQ ID




TGAATATTTTACAAATGAAGTGCTGACAAAGACATACAGGATGAGGTCAGAACCAGATGATTC
NO:




TGATCCCTTTTCTTTTGATGGACCAGAAATTATGGGTTGTAC
1910





NAP1L1
ADXCRAD_BP220549_at
AGTTACTGGTACCACAGTGAGGTGAATAAAACGGGATTTTCAGAAGTTAGCCTGAATTTAACT
SEQ ID




GTATTTTTAAATTTAACCTCCATTAACTAAGCATCTTTTCTTTGTGGTAGGGTCTACCTTCTG
NO:




CTTCCCTGGAAAGGATGAATTTACATCATTCGACAAGCCTATTTTCAAGTTATTTGNTGGTTG
2470




TTTGCTTGTTTTTGTTTTTGCAGCTAAAATAAAAATTTCAAATACAATTTTAGTTCTTACAAG




ATAATGTCTTAATTTTGTACCAATTCAGGTAGAAG





NAP1L1
ADXCRAD_BP220549_x_at
AGTTACTGGTACCACAGTGAGGTGAATAAAACGGGATTTTCAGAAGTTAGCCTGAATTTAACT
SEQ ID




GTATTTTTAAATTTAACCTCCATTAACTAAGCATCTTTTCTTTGTGGTAGGGTCTACCTTCTG
NO:




CTTCCCTGGAAAGGATGAATTTACATCATTCGACAAGCCTATTTTCAAGTTATTTGNTGGTTG
2471




TTTGCTTGTTTTTGTTTTTGCAGCTAAAATAAAAATTTCAAATACAATTTTAGTTCTTACAAG




ATAATGTCTTAATTTTGTACCAATTCAGGTAGAAG





NAP1L1
ADXCRAD_CX870261_s_at
CAAGGGACGTGGGACAGTTCGTACTGTGACTAAAACAGTTTCCAATGACTCTTTCTTTAACTT
SEQ ID




TTTTGCCCCTCCTGAAGTTCCTGAGAGTGGAGATCTGGATGATGATGCTGAAGCTATCCTTGC
NO:




TGCAGACTTCGAAATTGGTCACTTTTTACGTGAGCGTATAATCCCAAGATCAGTGTTATATTT
2555




TACTGGAGAAGCTATTGAA





NAP1L1
ADXCRAD_BQ884238_at
GACTATGACCCAAAGAAGGATCAAAACCCAGCAGAGTGCAAGCAGCAGTGAAGCAGGATGTAT
SEQ ID




GTGGCCTTGAGGATAACCTGCACTGGTCTACCTTCTGCT
NO:





2641





NARF
ADXCRAD_CN367752_s_at
GGAGGTCCTCGCCTGTGCTGGAGGATGCTTAAATGGCAGAGGCCAAGCCCAGACTCCAGACGG
SEQ ID




ACATGCGGATAAGGCCCTGCTGCGGCAGATGGAAGGCATTTACGCTGACATCCCTGTGCGGCG
NO:




TCCGGAGTCCAGTGCACACGTGCAGGAGCTGTACCAGGAGTGGCTGGAGGGGATCAACTCCCC
940




CAAGGCCCGAGAGGTGCTGCATACCACGTACCAGAGCCAGGAGCGTGGCACACACAGCCTGGA




CATCAAGTGGTGAAGTCAGGCCAGGGCCTT





NARF
ADXCRSS.Hs#S2978401_at
GAAACAGTACTTGGATCCACATCTTAGTCAAATTATTAAAATACAGCAGACAAGGACAGGATC
SEQ ID




ATAGTCCTCATCTTTCTCTCTTCCCCCACATTAATACATTATTATTTCAATGAAATGAGCCAA
NO:




ATTTTAAACCTAAACTACTTATGTACTCTTGCAAATTTTCTGATAATTTTTAATATAAATTCA
2147




AAACATAAATTCATTTTGAAGTTGGAATTTGAATAAACTCATTGTGGTTCAAATAAGAGACCA




ACGAC





NFIL3
ADXCRAD_BG925633_s_at
GAGACTTATAGCCACACAACCAATCTCTGCTTCAGACTCTGGGTAAATTACTACTGAGTAAGA
SEQ ID




GCTGGGCATTTAGAAAGATGTCATTTGCAATAGAGCAGTCCATTTTGTATTATGCTGAATTTT
NO:




CACTGGACCTGTGATGTCATTTCACTGTGATGTGCACATGTTGTCTGTTTGGTGTCTTTTTGT
1805




GCACAGATTATGATGAAGATTAGAATGTGTTATCACTCTGCCTGTGTATAGTCAGATA





NFIL3
ADXCRSS.Hs#s5972058_at
GGGCCGAAGTGATGATGTATCTAATATTATATCCTAGAACATTCACAGAGTAGCTGCAGAATG
SEQ ID




TCTTGAGCTGGAACATCCCCAAGAGGCCATATATATATCCCAGGGATTTTACAGTGGACCTCA
NO:




CTAGGCCGGAGTAACTGTAAAGTCAGATGGATAATGAGAATTCAGGACGTTAGCCACACGTGG
2062




ACTGTGGCAAAAAGAAAGTGACCCACTGAAGAAGACTGTTTTTCAGCTCTCTCATCAATTGCT




GTTTCCAGGAGCCCACAGCTCCAATTACTCAAAAGA





NFIL3
ADXCRAD_AK095268_x_at
GGAGATCAAAACCATCTTGGCCAACATGGTGAAATCCCATCTCTACTAGAAAATACAAAAATT
SEQ ID




AGCTGGGTGTGGTGGCATGTGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGCCAGGAGAATTA
NO:




CTTGAACCGGGGAGGTGGAGGTTGCAGTGAGCCAAGATCACTCCACTGCACTCTAGCCTGGTG
2795




ACAGAGCGAGACTTTGTCCCAAA





PDE4DIP
ADXCRAG_BX647660_s_at
GCCAGACCAACTCTGTTGAAATTCTTGCATAGAGCAAACCTGTGCTCATTTTTAAGTGGCATG
SEQ ID




GGAGAGGCCCCAAGCCTAGTAAAGCCTAGTCTGTGTCTTCACAGTGCTGGTAGAATGTGTTCG
NO:




TGTGTATAAATATATGATATAGATTTATATATGTTGCTAACGCCATATATTGAAGGCCAACAT
983




AACTGGTGGACAGGGT





PDE4DIP
ADXCRPD.5634.C1_at
CACGGGTTCTTATATGAAGATACACTTATAATCTGGTATGTTACCTGGTCAAGAGGAAATTCA
SEQ ID




ATATACAAGACAGGCATGAACCTTGGAGCACTTCTTCCTGACAGTATAAGTGAACTTAAAAGG
NO:




ACGTCAAGTGCCAATAGGAACTTACATACAAGCAGCCAGAGTACAGTCCCATATGGGAGATAA
1739




CACGAAATCACTAATCCTTCTTCTTTTCTTTGCTTTTGCTATCATAGTCTCGAA





PDE4DIP
ADXCRAD_CK002790_at
TCTTCATTTTAGAATGTTATCTTGGTATGTTTAAAAGGAAAAACTTAAGATGTGTTGCAATTG
SEQ ID




CAGTATGAGTTTCAGGTATGTACATGTTATGTGTGTGTGTGAGAGACACACACAAACACATTT
NO:




CAAACATGTTTTATGTTTAAGCTCAATATTCAAACACAGAAATATAACATCTATTCTTAATAT
2498




GTTTTATGTAAGTACAGCAGCAGCATTATTAAATACTGTATTTCTATGGTGATTGAAAATTAG




TANGCAGAGAATTTTGTATGGGTCTTAATATTTTTGTATA





PDE4DIP
ADXCRAD_CK002790_x_at
TCTTCATTTTAGAATGTTATCTTGGTATGTTTAAAAGGAAAAACTTAAGATGTGTTGCAATTG
SEQ ID




CAGTATGAGTTTCAGGTATGTACATGTTATGTGTGTGTGTGAGAGACACACACAAACACATTT
NO:




CAAACATGTTTTATGTTTAAGCTCAATATTCAAACACAGAAATATAACATCTATTCTTAATAT
2499




GTTTTATGTAAGTACAGCAGCAGCATTATTAAATACTGTATTTCTATGGTGATTGAAAATTAG




TANGCAGAGAATTTTGTATGGGTCTTAATATTTTTGTATA





PDE4DIP
ADXCRAD_BG192476_s_at
AATGCTGGGAAGTCCTAACCACATCAAGAATGCCTCAGATCAGTGACC
SEQ ID





NO:





2630





PDE4DIP
ADXCRAD_H24473_at
AACTCATACTGCAATTGCAACACATCTTAGTT
SEQ ID





NO:





2888





PDE4DIP
ADXCRAD_H24473_s_at
GCCTACTAATTTTCAATCACCATAGAAAATACAGTATTTAATAATGCTGCTGCTGTACTTACA
SEQ ID




TAAAACATATTAAGGAATAGATGTTATATTTCTGTGTTTGAATATTGAGCTTAAACATAAAAC
NO:




ATGTTTGAAATGTGTTTGTGTGTGTCTCTCACACACACACATAACATGTACATACCTGAAACT
2889




CATACTGCAAT





PHF11
ADXCRIH.2487.C1_s_at
TTCCTAAGCCAAGAGTCATGTCAAATTGCAATCAGGCTCAAAACCAGAGACCAGGCTGTGAAA
SEQ ID




TCCACACATCTTTAGAACTAGTCGTCTCCTCTTGGCCTCAGCAGCTCTTCCCTGTTCTTACTG
NO:




GTTGACATTTTGATCACTCTTTGCACACTCTTGTGTTTTTTGCTCACTGTCACACTCCCAGCA
1161




CCTAGTATGCTCAGTAAATGTTTGTGGAATAAGTGCATAAAATGTTCTTAACCTTTGATTCTA




CTTACAGCCCATGATAGCCTCTTAGATA





PHF11
ADXCRAD_BE621153_at
AAAACAATCGGAACACAAGTCAGTAATTAGTAGACACAGCAGATCGTACCAACGGCCGGCTAA
SEQ ID




AGGGCCCGACACTAAAATACCATCGACCACACCACGAGCCAAACACACACAACGGGCA
NO:





2595





PLAGL1
ADXCRPD.569.C1_s_at
TTTTCTTTGCTCTGTCTAGCTTAAACTACTACTCAAGCTGCTTAAGTTCTTAAGTATTGTTTG
SEQ ID




TAATCACCAATAAATAAGTGCATTTGTAATTCATCAGTCATTATTAGCTTTTATTAAAAGAAG
NO:




ATTACGTTTTACAATGTAACTATAATCTCTTGAATTTGGTATCTTATTAATGAGTTTTAAAGA
1565




TGTAAAACCTAACCTTTTTTAAAGCTCCATTGTCTTATGTTT





PLAGL1
ADXCRAD_CA942280_s_at
ATGATATACTATGACTAGGCTGTGTATTTCTTTTCAGGGATTTTTCTACCTTCAGGGTTGGAT
SEQ ID




GTAGTTTAGTTACTATTACCATAGCCAACCTGTAGTTTTACATATACATTTTCTTGTGGAGCA
NO:




ATAGAGTTCTCCATTTTACAGAAGCATTTTAAATGTAGTTTGAATATTTTCCACAAGATGCTG
2495




CAATGTGAGTTATCACTTCATTTATCTTA





PMAIP1
ADXCRAG_BC013120_at
GGAACAGTTAGTTCTCATCTAGAATGAAAGTTCCATATATGCATTGGTGAATATATATGTATA
SEQ ID




CACATACTTACATACTTATATGGGTATCTGTATAGATAATTTGTATTAGAGTATTATATAGCT
NO:




TCTTAGTAGGGTCTCAAGTAAGTTTCATTTTTTTTATCTGGGCTATATACAGTCCTCAAATAA
936




ATAATGTCTTGATTTTATTTCAGCAGGAATAA





PMAIP1
ADXCRPD.936.C1_at
GATTCAGAAGTTTCTGCCGGAAGTTCAGTTTGTCTCCAAATCTCCTGAGTTGAGTAGCACACT
SEQ ID




CGACTTCCAGCTCTGCTGGAGCCCGCGCGGGGCTCGGTTGAGCGTTCTTGCGCGCCTTCTTCC
NO:




CAGGCATCTCCGCCGGTGCCGCCGCCCACTCAGCTACAGAGCCCGGGAACCTCAGCCTCCAAC
1633




TGGAGCACCTCGGACAGCTGCAGGACGCGAGCTGAACACGAACAGTCCTGCAGGCAGGGATGG




GGAATCGGGTGTCCGGACGCGCGAT





PMAIP1
ADXCRPDRC.936.C1_s_at
CTTGGGGCCAGTAAATCAGTAGACTGAACATTCAATATAATAAAAGAACATGGGGATTTTGTA
SEQ ID




TAACCAGGGATAATAAAAAGAAAACAGAAGTTGATTTTTAATTGATGTTTTTGAAACTTAGTA
NO:




GAACAAATATTCAGAAGTAACTTGATAAGAAATGAATGTTTCTAAAGAAGTTTCTAAAGATTC
1977




GGAAAATGCTCCTTGTCACATTAGTGTGCATCCTACAAAAAGTGATCTCTTA





PNMA2
ADXCRAG_XM_376764_s_at
TATTTTTTCTGATTGTGGTTCAGTTTAACTGAAGAATATCCTGAGATTGTAAGAAAAGCATTT
SEQ ID




TTTAAAAGGTATCACTTGTGATCATTTATCTTTCTAAATTCTATTTTTAATACTGTTCCACCA
NO:




AAGTGATGCAGTGGTTACCATGACACCCTAATTTCATGTGTTTTTGTATTTATGAAAATAGTT
1092




TCATTGTCATTTATTGGCGGTAT





PNMA2
ADXCRAD_BU073065_s_at
CCTGGGGGCAGGACCCACAGCCAGTGGGCTAAGACCTTTAAAAAATTTTTTTCTTTAATGTAT
SEQ ID




GGGACTGAAATCAAACCATGAAAGCCAATTATTGACCTTCCTTCCTTCCTTCCTTCCCTCCCT
NO:




TCCTCCTTCTCTCCTTCTCTCCTCCTCTCTCCTCTCCTCTCCTCTCTTTCCTTCCTTCCTTCC
2647




TTTTTTTCTTTTTCTCTTTCTTCTTTATTTCTTGGGTCTCACTCTCATCACCC





PPRC1
ADXCRPD.9220.C1_at
CAGGTATTGAAACAAGTTAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCCA
SEQ ID




GTGTTTGGAACATAAGTCACTATGCAGACTAATAAACATCAACTAGAG
NO:





1398





PPRC1
ADXCRPD.9220.C1_x_at
TCCCTGCTATCCTTTTTCTCCTTTGGAGGTGCNCCAACCTCCTCCACCCCCTTCCCCTACTCT
SEQ ID




AGGGGAGAGAGCTGCTAGTGAGATGACTGTTTTATAAAGAAATGGAAAAAAGTGAAATAAAAA
NO:




ATATGTTGAATCAGATTTTTTAAAAGGGGTATTTGTTTTTTTATAACAGGTATTGAAACAAGT
1399




TAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCCAGTGTTTGGAACATAAGT




CACTATGCAGACTAATAAACATCAACTAGAG





PPRC1
ADXCRPD.16668.C1_at
AGGGCTTCACTGCAGAGCTGTCTTCTTGGCTGGGGCTGGTGGGATGACAAGACAAGGGATGTC
SEQ ID




TGCCAGCCCTGTGGGAGTCTCTGGAAGGCTAGGCCACTTCCCAGTTGGGGGCTGTGGACTTCT
NO:




CTCTTCTGTTTCTGCTTGGCGTTGCTGCCTTCGTCGCCGGTACTCAGATAAGCTGAGAGGCCG
1832




AGGTCTGGCTTCATGGGTTGTAGCACTGGTACCACTTTCAATTTTCA





PPRC1
ADXCRPDRC.16668.C1_at
GAAGAGAGAAGTCCACAGCCCCCAACTGGGAAGTGGCCTAGCCTTCCAGAGACTCCCACAGGG
SEQ ID




CTGGCAGACATCCCTTGTCTTGTCATCCCACCAGCCCCAGCCAAGAAGACAGCTCTGCAGTGA
NO:




AGCCCTGAAACACCCCTTGAGATTTGCCTTGTGCCTATAGGTCCCAGCCCTGCTTCTCCTAGT
2033




CCTGAGCCACCTGTAAGCAAACCTGTGCCTCATCTCCCACTGAGCAGGTGCCATCCCAGAAGA




TGCCACTGTTGGCGAGACCTT





PRF1
ADXCRAD_BQ654088_at
TTCTTTGGCCTTAATGGGAGCCCATCAACTTCAACTGCTCGTGGCTTCTTTGCCCACATGCTT
SEQ ID




TTCCCCTGAAAAAAAATGGAGGGCCGGCCCTGACCTGGCCTCACAATGAAACTAAA
NO:





2314





PRF1
ADXCRAD_BQ654088_x_at
TGCAGTCACAGCTACACAGATCACAGCTTCAGCCAGGAGCTGGGCAGAAAGCCAAGAGGCTGT
SEQ ID




TCCCACCAGGCTGCTCAGGGCTGGTCTTTTAGGACCCTTTCCTTGGACCCCCTATGGTGGGGG
NO:




CAAAACTTTCTTTGGCCTTAATGGGAGCCCATCAACTTCAACTGCTCGTGGCTTCTTTGCCCA
2315




CATGCTTTTCCCCTGAAAAAAAATGGAGGGCCGGCCCTGACCTGGCCTCACAATGAAACTAAA





PRF1
ADXCRAD_A1445650_at
TTATGGGCCCTTTATAAAGCTATGTACATGGGGAAACAGGTCAGGACAGGCCTCCTTTTGTTT
SEQ ID




AAGGGGCAAAGCATTGGGGGCAAAAAAAACAAACCAGTTGGAGCTGATGGGGCTCCAGTTAAG
NO:




GCAATGAAGGCTTTGCCACACCATAAAGGGCTCAGGGGAAGGGTCCTAAAAAACCACCCCTGA
2881




GCAGCCTGGGGGGAACAGCCTTTTGGCCTTCTGCCCAGCTCCTGGCTGAAGCTGTGATCTGTG




TACCTGTGACTGCAGGGCTTGAAAATGGCGGAGGGCTTAGGCAGT





PRKCQ
ADXCRAG_NM_006257_at
CTGTTTGCAGCAGTCAATTGAGTTGAATTAGAATTCCAACCATACATTTTAAAGGTATTTGTG
SEQ ID




CTGTGTGTATATTTTGATAAAATGTTGTGACTTCATGGCAAACAGGTGGATGTGTAAAAATGG
NO:




AATA
1032





PRKCQ
ADXCRAD_AA234512_s_at
AAGGTTTGCTAGACACCTTCGCTTGTTATCTTGTCAAGATAGAAAAGATAGTATCATTTCACC
SEQ ID




CTTGCCAGTAAAAACCTTTCCATCCACCCATTCTCAGCAGACTCCAGTATTGGCACAGTCACT
NO:




CACTGCCATTCTCACACTATAACAAGAAAAGAAATGAAGTGCATAAGTCTCCTGGGAAAAGAA
1033




CCTTAACCCCTTCTCGTGCCATGACTGGTGATTTCATGACTCATAAGCCCCTCCGTAGGCATC




ATTCAAGATCAATGGCCCATGCATGCTGTTTG





PRPF3
ADXCRAG_AF016370_s_at
GCATGGGGCTGAACACTACTGGGACCTTGCGCTGAGTGAATCTGTGTTAGAGTCCACTGATTG
SEQ ID




AGACTACTGCAAGCCCTTGCCTCTCCTCCCTTGCCTTTGTCTCTTCAGTCCTCTCACTTATTC
NO:




TATTTCCCAACCCCCTCCCACTTGTTTGTGTGATCTCAGAACTGTGCCAAGCAGACACTGGGA
844




CAAAGGGAGAATATCTTGCTCCCCTCCTGAGTCAGCCTGGTGTTGCCCTTTATTCCCCTTATG




TGCATA





PRPF3
ADXCRAD_BG680099_at
ACCTAGCGGACGTCTCTCTATAAAAGCGAGAGTGACGCGCCCGGTGTAAAAACCAACGCACGG
SEQ ID




GGACAGCAGAGACAAACTATGTCTCCTAGTGGTGCATCACCTTTGAGAAGGAACACACATCAT
NO:




ACGGCGTGGCGGAGACACACATATAGGAAACCACCCCTCAACGCAGGTAATAAGTGGCCAGGA
2389




GGGAACATATACAGCTCGTGAGAGGCATATTAGGGGAGCAGCCGACCCCGCTACCCTCTGCCC




GGCGTCAAAAATTATCCATGGCGGATTCTGTGAACTCA





PSMB10
ADXCRIH.3674.C1_at
TCGCGGCCCGTAGATAACGCGTGTAGCTCCATCTTGGACGCCACCATCCGTGTGGTCATCTCG
SEQ ID




GCGTCCGCGGCTACTCCAGCCCCACAGCAGTAGATTTTGGGGGCGATGAAGTGGATCTTCTCG
NO:




CAGCTCTTGTCCGCCACGACCGAATCGTTAGTGGCTCGCGTATCGGCGCCCAGAATGACCCCC
1114




GTCTTGGAACACCAAGCCCGCGATGGTGGTCCCGGTCTTGCGTGCGTGAAGGGACCTTGAGCC




CCGGGAGGACGCGTTCCAATGATGCATTTT





PSMB10
ADXCRIHRC.3674.C1_s_at
TCACCGCCGGGATCTTGGGTGACCTGGGCTCCGGGGGCAATGTGGACGCATGTGTGATCACAA
SEQ ID




AGACTGGCGCCAAGCTGCTGCGGACACTGAGCTCACCCACAGAGCCCGTGAAGAGGTCTGGCC
NO:




GCTACCACTTTGTGCCTG
1307





PSMB8
ADXCRAG_557528_s_at
CTGGGCGGTCATGGCGCTACTAGATGTATGCGGAGCCCCCCGAGGGCAGCGGCCGGAATCGGC
SEQ ID




TCTCCCGGTTGCGGGAAGCGGGCGTCGCTCGGACCCAGGACACTACAGTTTCTCTATGCGATC
NO:




TCCAGAGCTCGCTTTA
1082





PSMB8
ADXCRIH.1957.C1_at
TCAATCTGAACGTTCCTTTCTCCGTCCCCACCCAGGGACTGGAAGAATTCTGTGGGCTCCAGG
SEQ ID




CCCGGGCATCCGCTGGAAACAGGGGTGGGTAGGGTCGTGTCATCTAAAGGCGCAGCTTCAACC
NO:




AGAAGACTAGAAGTCAGCCAGGAGCTGGGAGTAGTGTCACGCGGGGTGGGGGTTCCTATGAGC
2244




ATCACTTTACAAAACCAGGAGGGACGGAAGTGCGAGGGGGCAGAGTCTTGGAAACAGGTCCTG




GGCCAACTGCAACAGAATATACCCGCCGCGTGTA





PSMB8
ADXCRIH.1957.C2_at
GAGGCGTTGTCAATATGTACCACATGAAGGAAGATGGTTGGGTGAAAGTAAAAGTACAGATGT
SEQ ID




CAGTGACCTGCTGCACCCGTACCGGGAACCAATCAA
NO:





2245





PSMB8
ADXCRIH.1957.C2_s_at
TCTCCACGGGTAGTGGGAACACTTATGCCTACGGGGTCATGGACAGTGGCTATCGGCCTAATC
SEQ ID




TTAGCCCTGAAGAGGCCTATGACCTTGGCCGCAGGGCTATTGCTTATGCCACTCACAGAGACA
NO:




GCTATTCTGGAGGCGTTGTCAATA
2246





PSMB9
ADXCRPD.891.C1_at
CCGGCAGCACCTTTATCTATGGTTATGTGGATGCAGCATATAAGCCAGGCATGTCTCCCGAGG
SEQ ID




AGTGCAGGCGCTTCACCACAGACGCTATTGCTCTGGCCATGAGCCGGGATGGCTCAAGCGGGG
NO:




GTGTCATCTACCTGGTCACTATTACAGCTGCCGGTGTGGACCATCGAGTCATCTTGGGCAATG
1618




AACTGCCAAAATTCTATGATGAGTGAACCTTCCCCAGACTTCTCTTTCTTATTTTGTAATAAA




CTCTCTAGGGCCAAAA





PSMD11
ADXCRIH.2540.C1_at
CCACGTCGGCCTTGGAGAGTTTGATGAGACTAGATATGTGTTCAATCTGTACTCTGGAAAAAG
SEQ ID




GCTCAATGACTCGGATCAGATTCTGTTCTAGTAAGTTATCATACAACTTGGCCAAGTGTGTGC
NO:




TGATGATTGGGTCATCCCGGAGCTCTGCCCGGTAATCTGTCAGAGCCTTTTCAAAATCTGCCA
1210




GTGATCTGTTCTTGCTAGCCCTGAGCTCACGCATTTTAATGCTTTCTGTCTGCCTCCCTGCAT




ACCGAATGCAAG





PSMD11
ADXCRIHRC.2540.C1_at
AGCTCTGTCTTTTGCGTGTCGAGACTGAAAACCTCCTCCTGGTGTCCTCATGGCTTCCTGATT
SEQ ID




GACACTGCTCTGT
NO:





1322





PSMD11
ADXCRIHRC.2540.C1_x_at
AGCTCTGTCTTTTGCGTGTCGAGACTGAAAACCTCCTCCTGGTGTCCTCATGGCTTCCTGATT
SEQ ID




GACACTGCTCTGTCTTCTCTTGCAGAGTTGGATCTGTAGCGGTCCTTTGGAGAGTGTGTGTGG
NO:




CGGGAGAGTGAAACCTTGGGGGAAAATGCTAGGAGATTCTTTTTTCTTTTTGTTCTACTTTTC
1323




GCTCGGAAAGTTTTTAAATCCTCATTTGGTGCATCTGTATTCCAGCCAATAGGTGTGCCAGTT




TTCATGTAATCTTTACTGGCCCAACTTG





PSMD11
ADXCRPD.139.C1_at
GGACCGGGGCAGAATTAACGTGCAAAGAAATGGGTTGGTGAAGTTTTCTTTACAGGCCCTTTC
SEQ ID




CGGGGCGGCCCGCTGGAAGACCCCTTCCGCCAACACGGGCTCTTCAACGGAAGCCCGGGAAAT
NO:




CGCCCGCGGGCGCATTACCACACGCCCGCCGCCGCGCGCATCCGCATATATAAATACTCTGGC
1903




CCCCAGAGGG





PTPN2
ADXCRIH.138.C1_at
GCAAAGCAAGACCTGAAGCCCACTCCGGAAACTAAAGTGAGGCTCGCTAACCCTCTAGATTGC
SEQ ID




CTCACAGTTGTTTGTTTACAAAGTAAACTTTACATCCAGGGGATGAAGAGCACCCACCAGCAG
NO:




AAGACTTTGCAGAACCTTTAATTGGATGTGTTAAGTGTTTTTAATGAGTGTATGAAATGTAGA
1199




AAGATGTACAAGAAATAAATTAGGAGAGATTACTTTGTATTGTACTGCCATTCCTACTGTAT





PTPN2
ADXCRPD.12103.C1_s_at
CGGCCCTTGCGCCTTTCTAGCATAAAGTGGTGTGTCAGAGCCACTGTCTCCACAGAAAGCACC
SEQ ID




ACGTTTGTTTCATTTGACTTATTTGAACCCGTTTCTCCTGCCTTTGCCTTTTTAAATAAAAAT
NO:




AGCAAAAATTGATTCAAGTGAATCTATTAGAATTTTCTAAAATGGAGCCCATTTGTCTTTTCA
1509




GTCTTGCAAGTAAAGTCTTTAAAACAATTAAGCCTCCCAATGATTTAACCGTATT





PTPN2
ADXCRPD.2533.C1_at
CAGTATTACACAGTGGGAGGTCCAAATTGGATTAGACTTTGGCATTGAATTCCAAAGTATTGG
SEQ ID




TAAGTCTAGCACATACTATAAAGGCTTTGCTAAATTCTGGTGGGTACATTATTTTTAAAACCT
NO:




GTCTGTCTGTCGGTATCACACAGAGGTCACTTCTTGAGTAAAATAAGATGACCTTAAGAATTC
1523




ACATAATTCTTGAAGAAGAATATAAGTCACGATGCTTCCACATGAGGCCGCGTCACACCACCA




TCGTTTGGAAATCCAGCACCTCAGCCGT





PTPN7
ADXCRAG_NM_002832_s_at
GGAGGAGCTGCTCCTTCCTTACAGCCTTGGGGATGGACTTGCCCACACCTCCACCTCCCCTGA
SEQ ID




GCCCTGTGAGAGGCACGACTGTCTATGCCAATGAGGCTCGGTGGGGGGCTCTCAAGTGCCTGA
NO:




TCCTGCCCTGGGCTCAGAGCCAGCCCAGAGGGAAGCAACTGCACAGCCCCACAGGCCCTCCCT
1019




GGCACTGTCCCCCCAACCCCATCTCAGAGCTCAGAGGGTACAAGCTCCAGAACAGTAA





PTPN7
ADXCRAD_BG388017_x_at
TGAGCCCTGTGAGAGGCACGACTGTCTATGCCAATGAGGCTCGGTGGGGGGCTCTCAAGTGCC
SEQ ID




TGATCCTGCCCTGGGCTCAGAGCCAGCCCAGAGGGAAGCAACTGCACAGCCCCACAGGCCCTC
NO:




CTTGGGCACTGTCCCCCCAGACCCATCTCAGAGCTCAGAGGGTACAAGCTCCAGAACAGTAAG
2705




CAAGTGGGAAAATAAAGACTTCTTGGATGACTGAAGACAAAAAA





PTPRC
ADXCRAD_BM795677_s_at
GTTTTCAATTTTGCATGCTCGATTATTCCCTGTACAATATTTAAAATTTATTGCTTGATACTT
SEQ ID




TTGACAACAAATTAGGTTTTGTACAATTGAACTTAAATAAATGTCATTAAAATAAATAAATGC
NO:




AATATGTATTAATATTCATTGTATAAAAATAGAAGAATACAAACATATTTGTTAAATATTTAC
1020




ATATGAAATTTAATATAGCTATTTTTATGGAATTTTTCATTGATATGAAAAATATGATATTGC




ATATGCATAGTTCCCATGTTAAATC





PTPRC
ADXCRPD.12778.C1_at
TAAGCCTGTATGTACTTTGTTGTCAGCAACTTCTAGGTCTTTCTATCTTTGCCACTTCTAGTT
SEQ ID




CTTCCTCTCTTACATATGTTACATATGCACATATGCATGTGCACAATCACTGGTATGAATGCA
NO:




AAGTCAAAAGAGAAAATATAAAAACAGCTTATTTTCCAAACTGCTTTACTAAGCCCTCTGCAA
1632




AGTTTTAGTTCTTTCTGCTCAGATTTATGAAATAAAAACTTCCTGTGTTAAATGTCAAAAAAG




TCCAGCAAGATAGCCTTGATT





PTPRC
ADXCRPD.12952.C1_at
TTCATCTGAATCATGCTCACTCTCTTTACTCATTTCCAGCTCATGTTTAAGTGGCACTCTGTT
SEQ ID




ATAGTCATATGGGATGACATTAGAATTCCTGTTTTTACTTTTATTTTCTTCTTGATTTCCAAT
NO:




GTGCTGTGTCCTCCAGCTCCTATATGAAGGAAGTCTCTGGAATTCAGCCTCTAGTGGAGACGG
1675




CTCACTGGGTGGATCCCTTTTCTTCATGTTATGTAGATATGGATGTAATTCAGACAAATTCAC




TTCTGTTTCTCCAAACTGATTGTATTCCACCAAAGCCTGAGT





PTPRC
ADXCRPDRC.12952.C1_at
TGCTGCTCAGGACCACTGATGGACGAAGACTTC
SEQ ID





NO:





1998





PTPRC
ADXCRPDRC.12952.C1_s_at
GAGACTTCCTTCATATAGGAGCTGGAGGACACAGCACATTGGAAATCAAGAAGAAAATAAAAG
SEQ ID




TAAAAACAGGAATTCTAATGTCATCCCATATGACTATAACAGAGTGCCACTTAAACATGAGCT
NO:




GGAAATGAGTAAAGAGAGTGAGCATGATTCAGATGAATCCTCTGATGATGACAGTGATTCAGA
1999




GGAACCAAGCAAATACATCAATGCATCTTTTATAATGAGCTACTGGAAACCTGAAGTGATGAT




TGCTGCTCAG





PTPRC
ADXCRAD_BX436427_s_at
AGGGTCAAACTACATAAATGCCAGCKATATTGATGGTTTCAAAGAACMMAGGAAATACATTGC
SEQ ID




TGCACAAGGTCCCAGGGATGARACTGTTGATGATTTCTGGAGGTGATTTTGGKGAWCWKAAAG
NO:




CCTTWGTTATTKTCATGGTCACTCGATGTKAAGAAGGAAACAGGAACAAGTGTGCAGAATACT
2535




GGCCGTCAATGGAAGAGGGCACTCGGGCTTTTG





PTPRC
ADXCRAD_BG546180_s_at
GAAAATAGGTATACAGTGGATTAATTAAATGCAGCGAACCAATATTTGTAGAAGGGTTATATT
SEQ ID




TTACTACTGTGGAAAAATATTTAAGATAGTTTTGCCAGAACAGTTTGTACAGACGTATGCTTA
NO:




TTTTAAAATTTTATCTCTTATTCAGTAAAAAACAACTTCTTTGTAATCGTTATGTGTGTATAT
2636





PTPRC
ADXCRAD_BC031525_at
ATTACTGTACTTAGTTGGCTATGCTGGCATGTCATTATGGGTAAAAGTTTGATGGATTTATTT
SEQ ID




GTGAGTTATTTGGTTATGAAAATCTAGAGATTGAAGTTTTTCATTAGAAAATAACACACATAA
NO:




CAAGTCTATGATCATTTTGCATTTCTGTAATCACAGAATAGTTCTGCAATATTTCATGTATAT
2797




TGGAATTGAAGTTCAATTGAATTTTATCTGTATTTAGTAAAAATTAACTTTAGCTTTGATACT




AATGAATAAAGCTGGGTTT





PTPRCAP
ADXCRPD.5068.C1at
CCCAACCACAGGCATCAGGCAACCATTTGAAATAAAAC
SEQ ID





NO:





1645





PTPRCAP
ADXCRPD.5068.C1_x_at
ACCACAGGCATCAGGCAACCATTTGAAATAAAACTCCTTCAGCCTG
SEQ ID





NO:





1646





PTPRE
ADXCRAG_BC050062_s_at
ACAGTAGAATAACCACGGGCAATTAAACTTTAAATTTTCTGAGCAGCATTTTGGTATTTAAAC
SEQ ID




ATTTCTTGTAAAAAGCTGAGACAGTTTGTAAGAAAAGAATCCTTAAAATCTAGATTTATACCA
NO:




TTTTTTAAAGTCCCACCTTTCAATGTTTAATAAAACAAAAAGAAATCCTTAATCTAAAAGCTA
970




AATTATTTTTGAATGGAAATACTACTGAGACCATTGACACTGGATAACAGTAATGATCCCATT




ACCA





PTPRE
ADXCRAG_NM_006504_at
AACCTTTACTTTGACTACCAGCCTGTGTTTTT
SEQ ID





NO:





1035





PTPRE
ADXCRAD_BM725213_s_at
TTTAAATGAGCCTGACACCTGTGTTTCAGCATTTGGAGACATCCCCATGTTATTCTTTTAAGT
SEQ ID




GTATAATTACTGATACTTTTTTGTTTGTTTGTTTAACTAAGTTGTGTTTAACTTATGTGCAGT
NO:




CTTTATAATGTATGTATGTTATTACAGTTTCAACTATCATATTTTCTTTGATTACATTTATAA
1036




TTTGATCTTGCTCTGATTATAATGCCAGTGAATGTTGCTGAACTCTTTGTATATGCAAATTGC




AAGATTTAAACCATTCTGATGCAAGGATAAACCT





RAC2
ADXCRAG_BC001485_s_at
AATTTTCTACGCCTCTGGGGATATCTGCTCAGCCAATGGAAAATCTGGGTTCAACCAGCCCCT
SEQ ID




GCCATTTCTTAAGACTTTCTGCTCCACTCACAGGATCCTGAGCTGCACTTACCTGTGAGAGTC
NO:




TTCAAACTTTTAAACCTTGCCAGTCAGGACTTTTGCTATTGCAA
914





RAC2
ADXCRAD_CV027630_s_at
AAACCGTGTTCGACGAGGCCATCCGGGCCGTGCTGTGCCCTCAGCCCACGCGGCAGCAGAAGC
SEQ ID




GCGCCTGCAGCCTCC
NO:





2461





RAP1B
ADXCRIH.1784.C1_s_at
ACCTGAGAGAACAGATTCTTCGAGTTAAAGACACTGATGATGTTCCAATGATTCTTGTTGGTA
SEQ ID




ATAAGTGTGACTTGGAAGATGAAAGAGTTGTAGGGAAGGAACAAGGTCAAAATCTAGCAAGAC
NO:




AATGGAACAACTGTGCATTCTTAGAATCTTCTGCAAAATCAAAAATAAATGTTAATGAGATCT
1133




TTTATGACCTAGTGCGGCAAATTAACAGAAAAACTCCAGTGCCCGGGAAGGCTCGCAAAAGTC




ATCATGTCAGCTGCTTAATATACTAAATGCATTGTAGCTCTGA





RAP1B
ADXCRIH.1078.C2_at
GCTCTTTGGACTTTCTTTTATTATGCTAAAATAGTGGTGCTTTTAGGATTTACATTATTGTAC
SEQ ID




TCTCCAATACAAAGTATGGGGCATGTTAAAGTATACAGTACACCATTTTCATACATGTACAAC
NO:




ATTGGTGGATGAAGAATGTCTCTTAGCAGTAATACTGGAGGTAGCCCTCGTGCCGA
1303





RAP1B
ADXCRIH.1078.C2_x_at
AGCGAAGTTATCTGGAGTAGTCTATATAGGAGCTCTTTGGACTTTCTTTTATTATGCTAAAAT
SEQ ID




AGTGGTGCTTTTAGGATTTACATTATTGTACTCTCCAATACAAAGTATGGGGCATGTTAAAGT
NO:




ATACAGTACACCATTTTCATACATGTACAACATTGGTGGATGAAGAATGTCTCTTAGCAGTAA
1304




TACTGGAGGTAGCCCTCGTGCCGA





RAP1B
ADXCRIHRC.1078.C2_s_at
ATATGTAATTGGTCACAAGGCCTAATTTGCAGTAACTATTGCTGTTTTATTTAACAATGCCTT
SEQ ID




GTTGCTTTGTATGCATTAATGTTTGGATGTAAAGATTGTGTGTCTATCCAACAGGGAGCCACA
NO:




GTATTTAAATTGACCAACCTAATGTTACAACTACTTTGAGGTGGCCAAATGTAAACTAAAAGC
1336




CTTAATTAAAGTGGTGCAATTTTGTATAACTTAGCATCAGTAGTTCAATAAATTTGGATTGCC




ATGCAAGGGCTTG





RFTN1
ADXCRAG_BC032349_s_at
ATCGGGACTGGCTGGCGCCCTTGTTATGTGCTATTTTAATCAGTGTAACATTGGTCAAGTTGT
SEQ ID




TACCCATGTATGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGA
NO:




TGCAACTGGCGAACCTTGGAGAGGGAATGCTGATTGTCTTGACCAAACCCACAGC
954





RFTN1
RDCR221_B10_at
GCAAGTATGCCGTTCTGGTGAAGATCATGGGGCAAAGTGAATTTTGATTCTTGAGTTTCTGTG
SEQ ID




GGCCAGAAATCCAGGTGGGCTGAACTGGGTCGTCTGCTGCTTAGGGTCTCAAAACACTGAAAT
NO:




GGGATGTCAGCAGAGCTGTGTGCCTTATTAGAGGTTTTGGTGGGGAAGAATCCACTTCCAAGC
1346




TCACTTAGGTTGTTGGCCTTGTGGTTGCAGGTCTGAGGTCCTTGTTTTCTTGCAGGCAGTTAT




CCAGGAGCTGGTCCTTGCTCCT





RFTN1
ADXCRPD.13500.C1_at
GAAAACTGAGTCTTACACAATGAAGTGCTACATCTTGGACATTAGACTGCTTGTTCCTCCATT
SEQ ID




AGAGCAGCCGACTGACCAGTAAATCAATCCAAGAGTTCAATAAGGAAAGATACAAGTGAGGCT
NO:




AGCAAACGCCCAAGAGACTGAAAATACAGTGGGGTGGTAATACCTCAAGAAACCAAACCTCAT
1659




GTGAACTAGGGAAGCAAGCAGTGCTCCAGGTGGTCTACTGACAACAAGACCGGAGGATGCACA




AAGAAGATAAAACGCACGTGGCGACTCACCAG





RFX5
ADXCRAG_AL050135_s_at
AAGCAGTAAACCAACTAATATTTATTGAAGACCTACTTTGTCCTCTACATAGGGTAGCTTCTG
SEQ ID




TCAGGGAATCTTGGTTCTTCCCAAGAAACACTGATTTTCTTTCAGGGAGACTTCATGTGTTCA
NO:




TTTATTTCCACCACAGCAGATTTTAAGAAATTATAATATGTAATATTTGATATCTATAAAGAG
886




TATATCTAACGTGAATAAATTATGAAGCATACTAATGAGTACCTATGACCCATAACACATATA




CATT





RFX5
ADXCRPD.5339.C1_s_at
AGGACCATTTAAGTCTGGGCCACTTAATGGCTGCCAGCATTCCTAAGATTACACTTTTCCCCA
SEQ ID




TTTATGTCCAATCAGAAAAAGAAGGCATCTTTGTACCAGAAATCTCAGCAAAAGCCCTAATAT
NO:




TCACACTGATTAGGCCTGGGTCACATGTCCACCCTGACCAATCACTGTGGCCAGGAGGATGAT
1694




ACATGCTA





RFX5
ADXCRAD_BI256444_at
CAAGGGATTCTCATGGTTCATGTGACTTAGAAAGTCCATAGGTAAGTGCTGGCTCCAGGTGAA
SEQ ID




GCACTTGAACCAGTAGTTCAGTATGTCTCTAAATACCGGACTGACTTTTTTCTCACTGTTGCA
NO:




TCTTCTGTAGGACCACTTAAGTCTGGCCACTTAATGGTTGCACATTCCTAGATTACCTTTTCC
2403




CA





RFX5
ADXCRAD_BI256444_x_at
TTAAAACTACCAAGGGATTCTCATGGTTCATGTGACTTAGAAAGTCCATAGGTAAGTGCTGGC
SEQ ID




TCCAGGTGAAGCACTTGAACCAGTAGTTCAGTATGTCTCTAAATACCGGACTGACTTTTTTCT
NO:




CACTGTTGCATCTTCTGTAGGACCACTTAAGTCTGGCCACTTAATGGTTGCACATTCCTAGAT
2404




TACCTTTTCCCA





RHOG
ADXCRIH.1986.C1_s_at
ATCACACCGCAGCAGGGCCAGGCACTGGCCAAGCAGATCCACGCTGTGCGCTACCTCGAATGC
SEQ ID




TCAGCCCTGCAACAGGATGGTGTCAAGGAAGTGTTCGCCGAGGCTGTCCGGGCTGTGCTCAAC
NO:




CCCACGCCGATCAAGCGTGGGCGGTCCTGCATCCTTCTTGTGACCCTGGCACTTGGCTTGGAG
1225




GCTGCC





RHOH
ADXCRAD_BM919440_at
ATCCCTTGGGGGAACTGGTGATGAATAATTCCATCTTTGGATTAAAAAAGTGAAAATAGTCTC
SEQ ID




CCATAATTTTTGGGACCAATGAAGTTGAGT
NO:





2435





RHOH
ADXCRAD_BM919440_s_at
GGATACAGTTATTGATGAGGCTTGGCCACTGGATGTTTTCACTAACTACACTCTACAAGTGAA
SEQ ID




CTCCTTGCCCAGGCCAGTTAGAAAATCCCT
NO:





2436





SAMSN1
ADXCRAD_CD522843_s_at
GAGGATTCGCTGTTGAAACAAGTTGTCCAAGCAATGTTATATTCATTTTTATACTTATTGGGA
SEQ ID




AAGTGTGAGTTAATATTGGACACATTTTATCCTGATCCACAGTGGAGTTTTAGTAATTATATT
NO:




TTGTTGATTTCTTCATTTTGTTTTCTGGTATAAAAGTAGAGATAATGTGTAGTCACTTCTGAT
872




TTAGTGAAACCAATTGTAATAATTGTGGAAATGTTTTGTCTTTAAGTGTAAATATTTTAAAAT




TTGACATACCCTAATGTTAAT





SAMSN1
RDCR115_B08_at
ATTGCTAAAATATGTGTCTATTAAATCAATGTACTCAATGTACATCTCTGTGGAAATCTTCTC
SEQ ID




TCTGTACCTAACCTCTGATATGTTTTCTGAAGGATGAGG
NO:





1344





SAMSN1
RDCR115_B08_s_at
GATGGAGAGAATGCCCACCCATATAGAAACAGTGACCCTGTGATTGGGGACCCACACAGAGAA
SEQ ID




AGTGTCCCTCAAAGCCAGTGACTCCATGGATAGTCTCTACAGTGGACAGAGCTCATCAAGTGG
NO:




CATAACAAGCTGTTCAGATGGTACCAGTAACCGGGACAGCTTTCGACTGGATGACGATGGCCC
1345




CTATTC





SAMSN1
ADXCRPD.2125.C1_at
CCCAAACCGCCTCCATTATTTGAAGTTTTACTTTGTTCTCCACTTCCATTTGTGGGATCTCCT
SEQ ID




TCATGTGCCTCAGTTGAATCATCTGGTTTTGATAAAGAATTATTCCGAAAACGATCGAAATTC
NO:




CCAAAACTGCTGCTTCGCTTTGGTTTTTGATGTTTCTCCTTCTCTGAAACATTGGATGGCTTT
1429




CTCTTGAGCATTTTGAATTCTGACTACTCCTAGTGAGTGCACTTTCTGCTGT





SAMSN1
ADXCRAD_BU198472_s_at
TTATCACAGAGCCAAGTGACTGAACACGCATTCCCAACTATATATCTACAGATGCATTCCATT
SEQ ID




TTAACTCTTCTTGAGCTAAAACGTCAAATAGGAGAG
NO:





2323





SAMSN1
ADXCRAD_BQ082118_x_at
AGTTATTTTACTCATGCTGTGTTTTTTAATATAAGCTTTACAAAAAAAGATGCATTCCCTTCC
SEQ ID




TGTTCACACTCTTACCATGTTTTTGTTCTTCCTTAAGAATGATTGTGTGTGTGTGTGTGTGTG
NO:




TGTGTGTGTGTAAGTGTAACATCATGGGTTTTCTTTCTTCACTTGTAAAGTTTTATCTAGAAA
2448




TACTTTTACAGGTTATGTTGAGGTACACAAAGATAATGTTCTAAGATTGTGTATTGGATT





SEC31B
ADXCRAG_NM_015490_s_at
TGCCCTTGACTCCACCTATGTTGGAGCCTTAGCCCAAGGCCATTCCTTCTGTGATGATAAAGC
SEQ ID




CCAGTTCTGGAATTGGAGCCATATTAAGGAATGATTCTCTTCCAGCGCTGCTCCTCAAGGGTT
NO:




GGGGGTCCTTCTCCCTCGCAGCCACCACATGTCTCAGGGCTACCTTCTCCGATTGGATTTGCA
1045




TTTGTGGCACTGTCTTTGATGCAGTGATGTACTTAA





SEC31B
ADXCRPD.17780.C1_at
AAAGCAGGCACTCAGCTGGTTTTGGAGCCAAGCCTACAGCATCACATACCTGGCAGCAAGGAA
SEQ ID




AAGAGTCGGGAAAAAGAAACAGAATCTGTTGCAGAAGTCCCCCTCTTCTGCAGGGAGGAGTTA
NO:




TGTAACAGCAGAAGTGGCCTCCTAGCAAGAGAGGCTGCCTGGTTTAGACCAGCAGCTTATGAG
1424




CGATGATGAGGACAGCCTTCAGGATAGGCATGAAGCTGGACACCTCGCTGAAGCTGATACA





SEC31B
ADXCRPDRC.17780.C1_at
CTGCTGTGACCATCATGTGGTCTTTGTTCTCCTTCTGTCGTCTTCTCGGATCCTCTAGATC
SEQ ID





NO:





1929





SEC31B
ADXCRPDRC.17780.C1_s_at
AAACCAGCTGAGTGCCTGCTTTTTACTCCTTTTATGTCTGGCCTTCTAGGATCTGGTCCAAGA
SEQ ID




CACTCTCAGGGCCTGGGAGGCAGGGCATAGAAATCAGTTCTTCACTCTCCCTAATACTACACT
NO:




CTGTAAGGACCTGGGGCAGGATATCTTCTCCCCCCAGGGGATCTTCTATTTAAGTGGCTTTTG
1930




AGAGGGTGAACAGGATTGTTACTTTTAAGCCTACCTCTG





SELPLG
ADXCRAG_AY331789_at
GTCTCTCATTAACAGCCAGTAGCTTATTGGTGATCCTAGATGCAGCCTGCAACCTTTTGTACA
SEQ ID




ACTCACAGAAGCACTGATTTGCTGTCAAATGGTGGAAAAGTTCAAGCTGCCAAACTTTTTCTT
NO:




AAAGGACCAAACAGTGAATACTGTAGGCCTTAACTGTTGCAACACCATAGCCTCTGTTGCAAC
906




AACTCAACTCTGTCCTTGTAGTACA





SELPLG
ADXCRAG_U02297_s_at
GGGCAAGTGGAGCCACCTCTTTCCTCCCTCCGCGGATGAAGCCCAGCCACATTTCAGCCGAGG
SEQ ID




TCCAAGGCAGGAGGCCATTTACTTGAGACAGATTCTCTCCTTTTTCCTGTCCCCCATCTTCTC
NO:




TGGGTCCCTCTAACATCTCCCATGGCTCTCCCCGCTTCTCCTGGTCACTGGAGTCTCCTCCCC
1059




ATGTA





SELPLG
ADXCRSS.Hs#S2980215_s_at
GCACACTCAGTGACTATAAGCTTCCTGAGAGCAGGGCTGTTCTGAAGAGATTTGAGTTTTCTC
SEQ ID




CTGGCCATGGAGAGTGTAATTAAGTAGCCCTGGGCCCTTGAAGACTTATAGTGCAGGTTGACT
NO:




GAAAGAACTAAATCAGCCAGTCTTTGCGGAGAGGTTGTCATGCAAACGAAGTGCTAAGGGTCT
2144




TGCATGCATCCCTTCATTTTATCCTCACAATAGACTGTGAAGTAGGCACCGCCATCCCTGTTG




TGCATTGTGCAGGC





SELPLG
ADXCRAD_BI818193_s_at
GGGCAGCTTGGGTCTTCTTGGGCACCTCTCTGGGAAAACCCAGGGTGAGGTTCAGCCTGTGAG
SEQ ID




GGCTGGGATGGGTTTCGTGGGCCCAAGGGCAGACCTTTCTTTGGGACTGTGTGGACCAAGGAG
NO:




CTTCCATCTAGTGACAAGTGACCCCCAGCTATCGCCTCTAGCCTTCCCCTGTTGGCCACTTTC
2500




CAGGGTGGACTCTGTCTTGTTCACTGCAGTATCCCAACTGCAG





SERPINA1
ADXCRIH.3253.C1_s_at
TACTGGAACCTATGATCTGAAGAGCGTCCTGGGTCAACTGGGCATCACTAAGGTCTTCAGCAA
SEQ ID




TGGGGCTGACCTCTCTCGGGGTCACAGAGGAGGCACCTCTGAAGCTCTCCAAGGCTGTGCATA
NO:




AGGCTGTGCTGACCATCGA
1259





SLA
ADXCRPD.8133.C1_at
AGGCTAAGAAGTCCTTTGGGCTAATGTTTAGGGTCACGAAGTTCCTTTAAAAAGAGAGGAAAG
SEQ ID




CATACCAAAAGTCCCTATGGATTAGTTAAAGTAGTTCCATTCAGGGCACCCATCTGCAAACCC
NO:




AGACCTTCTGCCAGGACACAGCTTTTGTTTCCTCTCCCTCTCAGGCTTGCCATACAGAAGTTC
1807




TCTCCAATGACCTTGGAGTGTAACTGTCTGGACAGGTCCAGTTCCTTGGAGAGCAGTCCTGGT




GCCCCTTCCTGTGAGAGTGGGCTTGTCCC





SLA
ADXCRAD_AL548133_s_at
AAAGGAACCAGCCAACGTATGAGAAATGAATGTAACACTGTGGACATTGACTTCCCGCATAAG
SEQ ID




GCAGGGTGACCCCCTGAACTCCAGATGTCTGCACAGTATCTTATGTGTTGTTTTCCGTTGTGA
NO:




CGAATGTGATTGGAAC
1866





SLA
ADXCRPDRC.8133.C1_at
CATTAAGTCCTCTGTAAGGTGTCAGGCAAGCCNNNNNNNNNNNNNNNNTGGGTAAGTCCTAAC
SEQ ID




CCCCCACAAAGGTGTTCCCAGTGACTACCT
NO:





2026





SLA
ADXCRAD_BX436824_s_at
ACCAAAGCCATATGGGTGGAAGTCAGTTGGCCTCCCTGGTTCTGCAGAGGGCCAGAAGAATGA
SEQ ID




GAGAGAGGAAGACTGCTGGCAGGGAAATCGAGGAGGCGAGACTAGAACTGCACCAGCTTCCCT
NO:




GATGTCTGCAGCCATGGCTTTGCAGCGCAGACAGAGCTTCTCTGGGATGCTGGGATTCTTGCC
2027




TGTATGAATGCATCAAGTATTCATTTATTGCCCGAATAGGCATTGCATTAAGTC





SLC16A3
ADXCRPD.4071.C1_at
GGACCTGTCCCGTAGAGCATGTGCCAGCAGGATGGAGGAGATCCAGGCTGTGTCGCTGTAGCC
SEQ ID




GATCCCAAACTCCTGTATGAGCTCCTTGAAGAAGACACTGACGGCCTTGGGGAAGGCGTAGGA
NO:




GAAGCCAGTGATGACGAAACAGCCGAAGAGCACTGGACCAGC
1575





SLC16A3
ADXCRPDRC.4071.C1_at
ATATTCGCGCCCCATGGTAGCCAAACACCGAGCACAACCACTCCCCCTCTTGTCGCGGCTCGT
SEQ ID




ACCACATACCCGTCTCTTACGCGCGCCACAAGCATGAGGNGCTCACGCCCATCTTTTTTGTCC
NO:




ACCTCCGTGATGAAACCCCGCGCCCACTGACTTTATTAGCGCCCTACGCACTACACATAATTG
1967




CCGCCAGCCTGATACCCACACCGCGTCCTNATAGATCACTCGTCGCCCTGTAGCG





SLC19A1
ADXCRAG_U17566_s_at
GAAGTACGTCCCAGCGGCCTCAGGGTCTAAGGAGCGCTAGTGCCTTGCCCACAGGTGCGGGAC
SEQ ID




CATCTGATGTGATGTGAATACTCTTCCCACATACATTAAACACACTTA
NO:





1064





SLC19A1
ADXCRPD.7962.C1_s_at
GCCGCGGGCTTCGTGAAGATCCGCTGGGCGCGCTGGTCCAAGCTGCTCATCGCGGGCGTCACG
SEQ ID




GCCACGCAGGCGGGGNCTGGTCTTCCTTCTGGCGCACACGCGCCACCCGAGCAGCATCTGGCT
NO:




GTGCTATGCGGCCTTCGTGCTGTTCCGCGGCTCCTACCAGTTCCTCGTGCCCATCGCCACCTT
1389




TCAGATTGCATCTTCTCTGTCTAAAGAGCTCTGTGCCCTGGTCTTCGGGGTCAACACGTTCTT




TGCCACCATCGTCAAGACCATCATCACTTTCATTGTCTCGGACGTGC





SP110
ADXCRIH.149.C1_s_at
ATCCTCAGTGAAGTGCATTCGGAATGAGGATGGAACTTGGTTAACACCAAATGAATTTGAAGT
SEQ ID




CGAAGGAA
NO:





1202





SP110
ADXCRIH.149.C1_x_at
ATATACGTTGTGAAAGGACGACCCTAGGAGAGCTGCTGAAGAGTGGACCTTTGCTCTGTCCTC
SEQ ID




CAAGAATAAATCTCCAGAGAGAGTTTAAATAGCAAGTGAATTTCTACTACC
NO:





1203





SP110
ADXCRPD.2201.C1_s_at
AAGCACTTCAGTGACCAATGACAAGTTAACATCCAAAATGAATGCGGAAGAAGACTCAGAAGA
SEQ ID




GATGCCCAGCCTCCTCACTAGCACTGTGCAAGTGGCCAGTGACAACCTGATCCCCCAAATAAG
NO:




AGATAAAGAAGACCCTCAAGAGATGCCCCACTCTCCCTTGGGCTCTATGCCAGAGATAAGAGA
1456




T





SP110
ADXCRAD_NM_080424_s_at
GACTTTGGCCAGGTAGGACTTGACTTAGAGGCAGAATTTGAAAAAGATCTCAAAGACGTGCTC
SEQ ID




GGTTTTCATGAAGCCAATGACGGCGGTTTCTGGACTCTTCCTTGACCCTGTTCTGTAAAGACT
NO:




GAAGCATCCCCACCTCAGGATTCAGCTGATGGGACCCTGGCTTGGACTGTTGATTGCCAGTGA
2760




GTCTGGGATGTAATTGGCTGCCCTCAGGACCCAAACCCAGACACTTCATAGGATTATCACACC




CTCCATCTTTATT





SP140
ADXCRAG_U36500_s_at
TCCCATACAGGCTCTTACCTCTTCTCCTGAGGGCTGCTCCAGACAACATTTATTACCCAGAAG
SEQ ID




ACCTTTTGTCTGAAAACCAGCCAAGCTTTATTCAGGACACACTTCTTGCCTTCACTTTCCCAC
NO:




TTCCGTGGCCACCTCCATGCAGAAGCCCTAAGCCCACATTCTTTCGATAGCTCACGGTGGTGC
1066




ATGAGTGTCCATCATCTGACTCTT





SP140
ADXCRPD.734.C1_at
AGCACATACTGGTACCCCTGAGAGGAGCTGCCTGTGAAAGCTATAAAGACAGAAAANNNNNNN
SEQ ID




NNNNNNNNNNNCCTTTTCCCGACCCATGGGGTTTAAATTTCCAAACTTGTGGGGAAGGCAAGG
NO:




CTGATGAAGAACTTGACCTTTTGGAACAAAAGAAAATTGAAAGCGGCATTTCTTGGCAAAGGG
1605




TTT





SP140
ADXCRPD.734.C1_x_at
TATCATCCAGTGCAGTCCTGGGTCAACTTGTTTCTCCAACAAAGACTGGAGAAGTCACGAAGA
SEQ ID




GAGCCTAGCACATACTGGTACCCCTGAGAGGAGCTGCCTGTGAAAGCTATAAAGACAGAAAAN
NO:




NNNNNNNNNNNNNNNNNCCTTTTCCCGACCCATGGGGTTTAAATTTCCAAACTTGTGGGGAAG
1606




GCAAGGCTGATGAAGAACTTGACCTTTTGGAACAAAAGAAAATTGAAAGCGGCATTTCTTGGC




AAAGGGTTT





SP140
ADXCRAD_BG757090_at
TGCGCGGACAACGAGGTACAGGACAGGGCCCAGAGCCAAAGCTGGTACCCTGACCCAAGATTC
SEQ ID




CCGGCCCACAACGGGGATAAACCGGCACGGACCCCATAAAAGAGGAACCAGATAACATCACCA
NO:




GAAAAGCCAGGGTAAACCGTGACTACAGAAACGCCGAAGAACAAACAGCACGCACAAGCGCGG
2707




CAACA





SP140
ADXCRAD_BG757090_x_at
TGCGCGGACAACGAGGTACAGGACAGGGCCCAGAGCCAAAGCTGGTACCCTGACCCAAGATTC
SEQ ID




CCGGCCCACAACGGGGATAAACCGGCACGGACCCCATAAAAGAGGAACCAGATAACATCACCA
NO:




GAAAAGCCAGGGTAAACCGTGACTACAGAAACGCCGAAGAACAAACAGCACGCACAAGCGCGG
2708




CAACA





STAT3
ADXCRAG_AY572796_at
GAGAGGAGGTGGTTGCCTTAATCCCCCCCGCCAACCCCCTTATGTTAGCCACCAGCCCGGAGG
SEQ ID




TAAGGGGTGCCTGGAGGAGCAGGAGGTCAATAGTCCAACGGCAGAAAGGTGTCAGAGTGGAGG
NO:




CCTCCCTCCCCGGCCCCCTCCTACCCCCCAGAGCGGCCTCGTCCTGTCTGGGGTCAGATAAGC
911




CACCTAAGCGGGGTGGGGGGTAGATACTCCCACCGCACCAAGGCCTCCCCTTCCACAGTTGGC




TCCTTTATCACTTTCCCTTCAGTT





STAT3
ADXCRIH.2963.C1_s_at
GTTCAGGGCTTCTCTGGAGCAGATATTGTCAAGTTCATGGCCTTAGGTAGCATGTATCTGGTC
SEQ ID




TTAACTCTGATTGTAGCAAAAGTTCTGAGAGGAGCTGAGCCCTGTTGTGGCCCATTAAAGAAC
NO:




AGGGTCCTCAGCCCTGCCCGCTTCCTGTCCACTGCCCCTCCCCATCCCCAGCCCAGCCGAGGG
1233




AATCCCGTGGGTTGCTTACCTACCTATAAGTGGTTTATAAGCTGCTGTCCTGGCCACTGCATT




CAATTCCAATGTGTACTTCATAGTGT





STAT3
ADXCRPD.13006.C1_s_at
TAATGGTGAAGGTGCTGAACCCTCAGCAGGAGGGCAGTTTGAGTCCCTCACCTTTGACATGGA
SEQ ID




GTTGACCTCGGAGTGCGCTACCTCCCCCATGTGAGGAGCTGAGAACGGAAGCTGCAGAAAGAT
NO:




ACGACTGAGGCGCCTACCTGCATTCTGCCACCCCTCACACAGCCAAACCCCAGATCATCTGAA
1566




ACTACTAACTTTGT





STAT3
ADXCRPD.15731.C1_s_at
GGATAACGTCATTAGCAGAATCTCAACTTCAGACCCGTCAACAAATTAAGAAACTGGAGGAGT
SEQ ID




TGCAGCAAAAAGTTTCCTACAAAGGGGACCCCATTGTACAGCACCGGCCGATGCTGGAGGAGA
NO:




GAATCGTGGAGCTGTTTAGAAACTTAATGAAAAGGTAATTTAGCATCCTTGTCCCTTTCCCTC
1783




ATCTAAAAAATACCTAAAAGACTCACGTGGTAGAGTGAGAGGCGGGCTGACTTCTGGTCA





STAT3
ADXCRPD.7602.C1_s_at
GGTGTGGTTGCACTGAAGTTAACAAGATTCAAACCGTCGCCCAAGTTGGTATTTCCATGTTTG
SEQ ID




GTACACATCACTCTGTGCCATATCAGGTCGTTGTTAAGTGTGGTGACAAAATCAGTGGTTAGT
NO:




CATTTTTTTAATTAAAAATGTGTATAGTGTGTACCTGCTGGTCTTACTGTATGTGCAACTAAA
1827




GGTTTACATAGTCTGTGTATGGGTTGTAAATTTTTGGCTGGCTGTGCTGATAAAGCATTGGGC




TT





STAT3
ADXCRSS.Hs#S1751591_s_at
TCAGGATGGTACGTGGTTGCCAGCAGAGAGCTGCTCCTCAAGTGAAGGAGGTAGAATCAAAGC
SEQ ID




CAATAGGAAAGAGCCTCAGATGCTTATATATGTACCGTGGGGATTCAGAGTGAAAGCAGTCAT
NO:




TGGACTAGGGGTGGGGTTAGGGAGAGCCTGTCTGACAGACACAAGAAAGGGATGGATACGCCA
2108




CCCAGAGAAAAAAGCATTTTAGGCAAGAACAAAT





STAT3
ADXCRAD_BX409785_x_at
AGAAACTCAGTTACAGCCTCCTTGGTGCTTTAGCATTCAGCTCCCTTCAGCTGGNATTTATAT
SEQ ID




AATCCTGAAACGGCTTTAGTCCA
NO:





2644





STAT3
ADXCRAD_AI682905_x_at
AAGAGATGAGGGTTCACTTTGTTGCCCAGGCTGGTCTTGAACTCCTGGGCTCAAGCAACCCTC
SEQ ID




TTGCCTCCATCTCCCAAAGTGCTGGGATTATAGGCATCGGCCACTGCACCCAGCTACACACAC
NO:




TTTTTCACCACCACTCCAGCAAAGTTCTGAACAGAAAATTACCTTTAAAGAGTTTCTCTGTGT
2872




CATAAAAATACTTGGCAAAAGGTATTAATAAAATCTGACATACAAGGGATGTAATGACCCTTC




AAAATCACTATTCTTATTGCTCGGAAGCGATCAATACATTG





TACC3
ADXCRAD_BX107802_s_at
CAGGCGGAAGCGTTGGCCCTCCAGGCCAGCCTGAGGAAGGAGCAGATGCGCATCCAGTCGCTG
SEQ ID




GAGAAGACAGTGGAGCAGAAGACTAAAGAGAACGAGGAGCTGACCAGGATCTGCGACGACCTC
NO:




ATCTCCAAGATGGAGAAGATCTGACCTCCACGGAGCCGCTGTCCCCGCCCCCCTGCTCCCGTC
1785




TGTCTGTCCTGTCTGATTCTCTTAGGTGTCATGTTCTTT





TAF1A
ADXCRPD.7472.C1_s_at
CTACATTAAAACATTCTTAGGCCATTGCTTTCTAACTTTTATAGCATCTACAGAAAATTTCAA
SEQ ID




TAATGTACAGTACACTGAGATAAACAGAGAAAGTTGGCTCCAGCTGCCATCTCCATGTATGTA
NO:




TCATCCACGCTATCCCCTGCTGCCCGGATGAGACTGAGGAGAGAGGATCAGAAGTCTTGTGCA
1798




ACCCTGGTTGGAATACTCTGCACTGATATTTTTTGAAAATCAACTTTATTGAAATTTAGTTTT




CAGAGAGTAAACACACTTAT





TAF1A
ADXCRAD_CN293583_at
AACCACCTTGCGTGGGTTCAAGAAGAGTGGAACTCCAGGAAAAACTGGTGGCCAGGCTTTCAT
SEQ ID




TTCAGCTACTTTTGGGCAAAAAGTGATTGGAAGGAAGATACAGCTTTGGCCTGTGAGAAAGCT
NO:




TTTGTGGCTGGTTTACTGTTAGGAAAAGGTTGTAGATATTTCCGGTATATTTTAAAGCAAGAT
2453




CACCAAATCTTAGGGAAGAAAATTAAGCGGATGAAGAGATCTGTGAAAAAATACAGTATTGTA




AATCCAAGACTCTGATACTGAATTTTAG





TAP1
ADXCRPD.4854.C2_s_at
CAGCTGCCTCCAGGATGAGTTACTTGAAATTTGCCTTGAGTGTGTTACCTCCTTTCCAAGCTC
SEQ ID




CTCGTGATAATGCAGACTTCCTGGAGTACAAACACAGGATTTGTAATTCCTTACTGTAACGGA
NO:




GTTTAGAGCCAGGGCTGATGCTTTGGTGTGGCCAGCACTCTGAAACTGAGAAATGTTCAGAAT
2282




GTACGGAAAGATGATCAGCTATTTTCAACATAACTGAAGGCATATGCTGGCCCATAA





TGFB1
ADXCRPD.3499.C1_at

SEQ ID




GGAAAGGCCGGTTCATGCCATGAATGGTGGCCAGGTCACCTCGGCGGCCGGTAGTGAACCCGT
NO:




TGATGTCCACTTGCAGTGTGTTATCCCTGCTGTCACAGGAGCAGTGGGCGCTAAGGCGAAAGC
1580




CCTCAATTTCCCCTCCACGGCTCAACCACTGCCGCACAACTCCGGTGACATCAAAAGATAACC




ACTCTGGCGAGTCGCTGGGTGCCAGCAGCCGGTTGCTGAGGTATCGCCAGGAATTGTTGCTGT




ATTTCTGGTACAGCTCCACGTGCTGCTCCACTTTTAACTTGA





TGFB1
ADXCRAD_BU782064_s_at
TCCACGGAGAAGAACTGCTGCGTGCGGCAGCTGTACATTGACTTCCGCAAGGACCTCGGCTGG
SEQ ID




AAGTGGATCCACGAGCCCAAGGGCTACCATGCCAACTTCTGCCTCGGGCCCTGCCCCTACATT
NO:




TGGAGCCTGGACACGCAGTACAGCAAGGTCCTGGCCCTGTACAACCAGCATAACCCGGGCGCC
1970




TCGGCGGCGCCGTGCTGCGTGCCGCAGGCGCTGGAGCCGCTGCCCATCGTGTACTACGTGGGC




CGCAAGCCCAAGGTGGAGCAGCTGTCCAACATGATCGTG





TGFB1
ADXCRAD_NM_000660_at
TTAAGGGAGGAGTTCCTGCCCACCAGGAACCTGCTTTAGTGGGGGATAGTGAAGAAGACAATA
SEQ ID




AAAGATAGTAGTTCAGGCCAGGCGGGGTGCTCACGCCTGTAATCCTAGCACTTTTGGGAGGCA
NO:




GAGATGGGAGGATACTTGAATCCAGGCATTTGAGAC
2802





TGFB1
ADXCRAD_NM_000660_x_at
TTAAGGGAGGAGTTCCTGCCCACCAGGAACCTGCTTTAGTGGGGGATAGTGAAGAAGACAATA
SEQ ID




AAAGATAGTAGTTCAGGCCAGGCGGGGTGCTCACGCCTGTAATCCTAGCACTTTTGGGAGGCA
NO:




GAGATGGGAGGATACTTGAATCCAGGCATTTGAGACCAGCCTGGGTAACATAGTGAGACCCTA
2803




TCTCTACAAAACACTTTTAAAAAATGTACACCTGTGGTCCCA





TIAM1
ADXCRAG_U16296_at
TCCAGGAAACTGAACACTGAGATCTGACTGCGTCACCTGCCCCGTAGAGAATGTGTGTAGATA
SEQ ID




CTTCCTGCCCTAACTCTGCCCACCCTCCTGTACCGTCGACAAGAATGTCCCCTTAGGTCGCGC
NO:




TCTTGCACACACGGTTTTGGCAGCTGACTTGGTTCTGAAGCCATGTAGCCACCCAACTTTGTC
1062




ATTTTCAACAACATCAGAAAGAATTGATCAGAATCCCAAATAAAACCCAAAAGTGTCTAATGT




ATTCA





TIAM1
ADXCRAD_BM808025_at
ATATCATCTCCGGTTCGATCGCGTCCAGATGGAAAACGGAAGCAGAGGCTTCTAATCGTCGCA
SEQ ID




TTTACTGGCTCCAGTGCAACACATCCATCTGAAAACACTCGGAAGTCTGGTGCTTGGAGAGGG
NO:




TGCCATTGTCTCTTGTACATAAGGTCATGACGTGTCTATGTCAAAAGTTCTTATATATTTCTT
2666




TTATAAGCTGAAAGAAGGTCTATTTTTATGTTTTTAGGTCTATGAATGGAACGTTGTAAATGC




TTGTC





TM6SF1
ADXCRAD_BG570659_at
AATATTACTTCATGTTCCTCCTTTCTAAATTACTAACTTTTGTTATACTGGTACTGATATTTT
SEQ ID




GTCCCATTTCACTCTCTTCTCATACGTGAGTACTTAAGAATATGTACATTCTTGCTCTGCACT
NO:




GTATGTGTGAGCTATATGGTATTGTGTAAATTTTTTTTGGAAGGACAATGGAAATTCTTGAGA
2587




AACAGTTTGTTTAAACGAAATATATTTCAAACTCATTTGTGAATAAATTGATCATCCATCTCA




ATATGTTTGA





TM6SF1
ADXCRAD_BG285017_at
GAATTTTTTAATATGCACAGGCCATATTCTCTTTTGAATAGTTTCATTTCATGCTCACTACTG
SEQ ID




TTGGCACTAAATGTAATTTTTTACACTTATAATTATTTTATATGTCAAACAATATTGAGATGG
NO:




ATGATCAAGTTTATTCACCAAATGATTTGAATATATTTCTTTAAACAAACTGTTTCTCAAGAA
2745




TTCCATTTTCCTTCAAAAAAATTTACACAATATCATATAGCTCACACATACAGGCAGAGCCAG




AATGTCTATTCTAAGTACCACGTTGTGGA





TPK1
ADXCRAD_CD511474_at
TAAAATGGAAGCGGTTGGACTGATGGTGTCTGAGGTTCTTTCCCACACTGAAATTCTAAATAT
SEQ ID




TGACACTTAGCAGTCATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCTGG
NO:




TGCATCGAAATGTAATCACCCTTTCTTTTGTAAAAGAGACCCATCTTCTATCTTCCTTTCCCA
2381




CCTTTTCTCTGTTTTTATGAAAACCCAACTGTTGGACATTCCAAACCATTGGATTTGA





TPK1
ADXCRAD_CD511474_s_at
ATTGACACTTAGCAGTCATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCT
SEQ ID




GGTGCATCGAAATGTA
NO:





2382








TPK1
ADXCRAD_CD511474_x_at
CATCCCAGTCTGATATTCACCTAAGTTTCCGGACCCTTTTCCTTAGCTGTAAAATGGAAGCGG
SEQ ID




TTGGACTGATGGTGTCTGAGGTTCTTTCCCACACTGAAATTCTAAATATTGACACTTAGCAGT
NO:




CATAGGGCTGATAATACACACAGTTACTGACTTAGCCTAAACAACCTGGTGCATCGAAATGTA
2383




ATCACCCTTTCTTTTGTAAAAGAGACCCATCTTCTATCTTCCTTTCCCACCTTTTCTCTGTTT




TTATGAAAACCCAACTGTTGGACATTCCAAACCATTGGATTTG





TPK1
ADXCRAD_CR745173_s_at
TGGCCCGCGTGATTGTGGCATTTAAGGAGCAGTGGCCCATGTGACTGTGGCATTTTCGGCACT
SEQ ID




TTTCATTACTTTCTGCTTGACCGGAAGTTGAGGCTTAGCTATGTTTCCATCTTCAGTTTCTGA
NO:




AGACTAGTTATATATTCCTTACTAGAAATATATTCATAATATATAAAAGAAATATATCTGTGA
2592




TTTTAAAATTTTGCTACCAAAGAATGCATGTTCTGTGTGCCCTGAAAATGTTAC





TRIM14
ADXCRAG_NM_033219_s_at

SEQ ID




TGGACTACGAGGCCGGCGTCCTCGCCTTCTACGACGTGACGGGCGGCATGAGCCACCTGCATA
NO:




CCTTCCGCGCCACGTTCCAGGAGCCGCTCTACCCGGCCCTGCGGCTCTGGGAGGGGGCCATCA
922




GCATCCCCCGGCTGCCCTAGGGGCCAGGACCGGCGTGACAGCCTCCAGA





TRIM14
ADXCRPDRC.2569.C2_at
GCAGCAGCAGACTTGTTTAGGGCCTGTTTGAAACTAGCCTAGGAGAGGAAACCTTCAAAGCAC
SEQ ID




GGTAGGCGTGATGGGTCGGGGAAAGCTGGGGCAGGGAGAGGGCCCTAAGAAGCAGGCAGTAAG
NO:




GGGACCAGCCACGCTGATCTAGGTAGATTAGGCGAGACTGGGCAGCTGCGGCGACCTGGAGGC
2053




TGTCACGCCGGTCCT





TRIM14
ADXCRPD.2569.C1_s_at
CATTCCCAAGGGAGCTTGCACGGTACTGACCGAGTGCTGAGACTACTGGTATTCCCAGCTGCC
SEQ ID




ATGTGGCAGCAGCAGGAGCTACTAGAATATTCTCAGCACAGGAATGAGGCTTCCTTGGTTTCC
NO:




ATGTCTGTAAGGGTTACTGATCACTTACCTTCTTCTCTT
2276





TRIM14
ADXCRAD_BX389413_at
TGGTCTCACTGGGAGTTCATGGTGCTTCAGTCCCTAGCACCCAGTGATACCCCCACAGGTAGC
SEQ ID




CCTAAGCATCCTGAAACATCATCCGC
NO:





2407





TRIM14
ADXCRAD_BI222503_at
CACTTAACCCCTCAGCTATGAAAAGGCTTCCAGGAGTTTCCATGACATAACAAAACAACAATA
SEQ ID




CAAGCGCCTCACCTTAGCATTCAAGGCTTGTCTAGTCTGCCCAACAATTACTTATCCTCACCT
NO:




AGCTCCTACCAGTCTTCTTAGAGACTCTCCAGTCAGAACATGTGTCGCATAGTTCCACTCCAC
2740




ACCTCTCTGCTGACAGCACATTCATGCAGACAAGTCTTTCCACTGTCTCAGACTTCCGCAGGC




TTACCTGCGCAGGCAAGTCTAACCAA





TRIM22
ADXCRPD.1317.C1_at
GACACCCCATATTCATCACAAAATTAAAGCAAGAAGTCCATAGTAATTTATTTGCTAATAGTG
SEQ ID




GATTTTTAATGCTCAGAGTTTCTGAGGTCAAATTTTATCTTTTCACTTACAAGCTCTATGATC
NO:




TTAAATAATTTACTTAATGTATTTTGGTGTATTTTCCTCAAATTAATATTGGTGTTCAAGACT
1393




ATATCTAATTCCTCTGATCACTTTGAGAAACAAACTTTTATTAAATGTAAGGCACTTTTCTAT




GAATTT





TRIM22
ADXCRPD.1317.C1_x_at
GACACCCCATATTCATCACAAAATTAAAGCAAGAAGTCCATAGTAATTTATTTGCTAATAGTG
SEQ ID




GATTTTTAATGCTCAGAGTTTCTGAGGTCAAATTTTATCTTTTCACTTACAAGCTCTATGATC
NO:




TTAAATAATTTACTTAATGTATTTTGGTGTATTTTCCTCAAATTAATATTGGTGTTCAAGACT
1394




ATATCTAATTCCTCTGATCACTTTGAGAAACAAACTTTTATTAAATGTAAGGCACTTTTCTAT




GAAT





TRIM22
ADXCRPD.2309.C1_at
ACAAGTTTCTCTGGGATGTCGCTTTTCTCGACCTGCTTATCCGTATTTCAATCCTTGGAACTG
SEQ ID




CCTAGTCCCCATGACTGTGTGCCCACCGAGCTCCTGAGTGTTCTCATTCCTTTACCCACTTCT
NO:




GCATAGTAGCCCTTGTGCTGAGACTCAGATTCTGCACCTGAGTTCATCTCTACTGAGACCATC
1474




TCTTCCTTTCTTTTCCCTTCTTTTACTTAGAATGCCTTTGAATTCATTTGCCTAGGGCTTCCA




TAGCCAAGCATCATA





TUBA1B
ADXCRIH.69.C1_at
GATCATGTCTTTTCCATGTGTACCTGTAATATTTTTCCATCATATCTCAAAGTAAAGTCATTA
SEQ ID




ACATCCTCGTGC
NO:





1293





TUBA1B
ADXCRIH.69.C1_x_at
TTTTGGCCCTGCAGCATGTCATGCTCCCAGAATTTCAGCTTCAGCTTAACTGACAGACGTTAA
SEQ ID




AGCTTTCTGGTTAGATTGTTTTCACTTGGTGATCATGTCTTTTCCATGTGTACCTGTAATATT
NO:




TTTCCATCATATCTCAAAGTAAAGTCATTAACATCCTCGTGC
1294





UBE2L6
ADXCRPD.250.C1_at
TGCCCTTAACCCGATTTGGCCATTCCCCTCTCTCCCCCGTACTATACACCCCCGCCCCGCCTT
SEQ ID




CCTTCCCGCCTTTGTGCGCCTGTCCGATCATANTTTCCGCCCATGGTCCACGTTCTCCGCCGC
NO:




GTAACCTATATCCTGGATTCTCTTCCCGCCCCGCGTGTGCTACCCCCTTATTGCCATTTTCCC
1893




GTTACGCGGAGTTCGCCCGAGGCCCGGGGCTTTGTCGCCGCGTACTTTAGGCCCCGCCCCGCC




TAAGTTCCGCCTTCATTATACCGCGCTGTG





UCK2
ADXCRPD.10643.C1_at
AAGATTAGATTCCTGCCTCGGGCCAGGTGAAAGGAAGGCAGGAAAGAGATTCTGTTTCCTGAC
SEQ ID




CCAACATTATCACAAAAGACTGTAACAAGGGCTGTGGGAGTTATGGACCAGGAACCTGGTTGA
NO:




AAACCATTATAAATCATAACACCACAAGGACCTATATTTTGCTTTTTAGGACATTGTAGTAGG
1461




TGGGTAGTTTTCATCCTCTTGCTTTTTAAAATCTATCTTGCCCAGAAGTTTATTGGGCATTTC




TATGGAAACACAACACCTCTCTTAAAT





UCK2
ADXCRPD.9879.C1_s_at
GCAGGCCGCATTGACCCGTCTCCATCGGACCCCAGCCCCTATCTCCAAGAGACAGAGGAGGGG
SEQ ID




TCAGGAGGCACTGCTCATCTGTACATACTGTTTCCTATGACATTACTGTATTTAAGAAAACAC
NO:




CATGGAGATGAAATGCCTTTGANNNNNNNNNNNNNNNNGTACTTTGGAACGACAAAATGAAAC
1541




A





UCK2
ADXCRPD.5097.C1_s_at
ACTGGCATTCCAGGTCAGCTTGGCTGTGGTCTTAGAGGCAGGGAGTGCCTACCCAGTCCTGCC
SEQ ID




TCAGGAGCAGGGTGAGTAGCTAAATACAGACTTAGGCTTTTTTTCCCCCCTTTTAAGATGCTT
NO:




GCTCCTCTCCCTTTTCTTTTTACCACCCTACCTTTATTGTTAGTGGTTACAAAGTGACCACAT
1651




ATTATGTACTTTGCTGTAA





UCK2
ADXCRPD.14415.C1_s_at
TAGCGGCAAGTCTTCCGTGTGTGCTAAGATCGTGCAGCTCCTGGGGCAGAATGAGGTGGACTA
SEQ ID




TCGCCAGAAGCAGGTGGTCATCCTGAGCCAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCA
NO:




GAAGGCCAAAGCCCGGAAGGGCCAGTTCAACTTTGACCACCCGGATGCCTTTGACAATGAACT
1702




CATTCTCAAAACAC





UCK2
ADXCRPD.15116.C1_at
CCCCTCTGCCAGACAGTGGGTTGAACACACATGTACACCTGAGGAGGAGGGTCTGACGAGGGC
SEQ ID




TGCCTCAGAGTCAGAGGCAGCAGGACTAGCTCTGTATGTTCGACCTCATGTCTGGCCCATCTT
NO:




GAGTCCCAGGCTCATACAAAATCACCTGTGTTCAGATACAGATTCAACTCAGTATTTAATGAG
1715




CCAAGCACTACTTGAAGCATCTTGACAGTCCTTCTCTTCACATAAGCCCCGACAATCACATCT




GCAAGGTACGTATCAAGTCCCTACGTTCCGAGACA





UCK2
ADXCRPD.14599.C1_at
TTAAACTCCACCAAGACCCAGCAAGAAGAGCCTCATGGCAGGCTAGGACTGAGTTCTTCCCAG
SEQ ID




AAGACAGGTCTAAAACACAAGCTTTTCCACCTTAACAATGGATGTCTCCTGACCCCTTCCTCC
NO:




AGAAATCAAATGGCCAATCTGATGCCCACTTCAGCTTCTGTCATCCCTCTGTAGTCAGACAAG
1728




GAGGGCTCGCTCAGCTTGCATTTCCTTCCTGAAGAGTATTCACTACCTCTCTTGTTCAAACAC




TATGTATCACTCAAT





UCK2
ADXCRPDRC.5097.C1_at
GCAAAGTACATAATATGTGGTCACTTTGTAACCACTAACAATAAAGGTAGGGTGGTAAAAAGA
SEQ ID




AAAGGGAGAGGAGCAAGCATCTTAAAAGGGGGGAAAAAAAGCCTAAGTCTGTATTTAGCTACT
NO:




CACCCTGCTCCTGAGGCAGGACTGGGTAGGCACTCCCTGCCTCTAAGACCACAGCCAAGCTGA
1983




CCTGGAATGCCAGTCCCCGGTATGAGGAAGGCAGC





UCK2
ADXCRPDRC.5097.C1_x_at
GCCTTTTTGTCTGTCTTTATTTACAGCAAAGTACATAATATGTGGTCACTTTGTAACCACTAA
SEQ ID




CAATAAAGGTAGGGTGGTAAAAAGAAAAGGGAGAGGAGCAAGCATCTTAAAAGGGGGGAAAAA
NO:




AAGCCTAAGTCTGTATTTAGCTACTCACCCTGCTCCTGAGGCAGGACTGGGTAGGCACTCCCT
1984




GCCTCTAAGACCACAGCCAAGCTGACCTGGAATGCCAGTCCCCGGTATGAGGAAGGCAGCAGA




ACGCCCAGAGACA





USP7
ADXCRAG_AY376241_s_at
CCCCAAAGAGGAGTCGCTACACTTACCTTGAAAAGGCCATTAAAATCCATAACTGATTTCCAA
SEQ ID




GCTGGTGTGTTCAAGGCGAGGACGGTGTGTGGGTGGCCCCTTAACAGCCTAGAACTTTGGTGC
NO:




ACGTGCCCTCTAGCCGAAGTCTTCAGCAAGAGGATTCGCTGCTGGTGTTAATTTTATTTTATT
908




GAGGCTGTTCAGTTTGGCTTCTCTGTATCTATTGACTGCCCTTTTTGAG





USP7
ADXCRPD.11382.C1_at
GAAATACTTGCCTAAGTTTCCCTGATGCTTTCTCCCCAAGCTCCACGGCCTTTTTACATTCTT
SEQ ID




CTAACAGGTCCCGGACACACCCATGCTTGTCTGGATATAGTGTTATTTCCTAAGTAATGAAAA
NO:




GATAAAATAAGTGCTTTCAAGAAAGCATAAAAGGTCTGCTACCACAAAGGAAGAGAGGAGAAA
1480




GTTGCATCATTGTTCTCAACTGTCCCCAGCTGGCCCCCATGTTCTTGCTCTCATTCCNCACCC




CAACTCCCTCATCTGTGAATTCACTC





USP7
ADXCRPD.16454.C1_at
GTCTGTCTGGATAAAAGCGTGGCATCACCATAATCTTCCATGGCAGATTTCGCACAAAACACG
SEQ ID




GAGGGCTAAGGACCGACTCACTCAGTCTGCTGAAGCGCTCCACAGTGAACTGAAAGGCTGCCT
NO:




CGGAGCGCCAACTGGTGTCATCCTCCATGTCCTCCTCCGCGGTGTTGTGTCCATCACTCAGGG
1794




CCACATTCCCATTGATCACAGGGTTCTGAGTAATTCTTGGTGGCTCATCATGTATCTCCCG





USP7
ADXCRPD.949.C1_s_at
CTGCAAGTGAATTTCACTGATGTTGATATTCATTGTGTGTAGTTTTATTTCGGTCCCAGCCCC
SEQ ID




GTTTCCTTTTATTTTGGAGCTAATGCCAGCTGCGTGTCTAGTTTTGAGTGCAGTAAAATAGAA
NO:




TCAGCAAATCACTCTTATTTTTCATCCTTTTCCGGTATTTTTTGGGTTGTTTCTGTGGGAGCA
1919




GTGTACACCAACTCTTCCTGTATATTGCCTT





USP7
ADXCRPDRC.11382.C1_at
AAGTATTTCTTGAGCCCAATTGTGGACGTTCAGTTAGGGGTGGCAGTTAACGCTGACCTCTGC
SEQ ID




AGTTGCGTTGGTGGAAATCACCCAGCTGGGATCCATGCGCGTCATTCCCAGACTCAGTGGGGT
NO:




GTGCCTCCATTGCAAAGACAGTTGCACAGAAGCTCAACACAGACCCATTGTTGCTCCAGTTTT
1940




TCAAGTCTCAGGGGTAACCCTCAAGCCGCTGTGGTGCAGAGGGTTATGCGTGTTTCACAATTA




AGCCGCGACA





USP7
ADXCRPDRC.16454.C1_at
GGGATTTCCAATATTATGGGCATGGAGTAAATGGC
SEQ ID





NO:





2022





USP7
ADXCRPDRC.16454.C1_s_at
GACTGAGTGAGTCGGTCCTTAGCCCTCCGTGTTTTGTGCGAAATCTGCCATGGAAGATTATGG
SEQ ID




TGATGCCACGCTTTTATCCAGACAGACCACACCAAAAAAGCGTAGGGATTCTTTCTCCAGTGC
NO:




AATGCTGAATCTGATTCCACGTCATGGTCTTGCGAATGCACAAGCAGTGCTGAAGATAATAAC
2023




TTACAGAGATGATGAAAAGTCGTTCAGTCGTCGTATTAGTCATTTGTTCTTCCA





USP7
ADXCRSS.Hs#S2990382_at
GATAAATCTTCGTGAAGTGGCAGAAAATATGAAAGCCAGCCAATTGGAATCTTGCTTATTCTG
SEQ ID




ATCTGTTATCTCAGGGGTTAGATTCGCGTGCTGAAGTGGTCTACGTAACTTCCATAGCGATTG
NO:




GGAGGTGTTCTCTGGTGGGGTAGCAGTTCTGTGTTATGACATCACACATGGAATTCACGGGGA
2141




GGAAAGCTGGGTATAGGCATTAAGTGCCCAGTAGAGCAGGT





USP7
ADXCRAD_BU956106_at
CGCTCTTTCCCTTCATTGTGGGGCATTGTTCGGGCCCTTC
SEQ ID





NO:





2368





USP7
ADXCRAD_CA439064_at
GAAGGGCCTCGTGACACATCAGGTCACATCTCCAGTCACCTTATTTGTACACAGTTCTCTCCT
SEQ ID




GGAAAACCTTTCATTTCTTAAGAGTAAATGTGACTAGTTAGAGGCTAAAAAAAAAAAAAAAAA
NO:




GAAACAAGAGACCCTGCCCCCGCAAAACGGAATTAGAAGGAAAAGTACATCTCAGTGAAACCT
2489




TGTTACAAATGCCAAGGTTTCCCAGGCCTGTTTCCAGGGAGAGTAGAATCTTCCTCCACTTCC




ACGTAACTCACTGAATTATA





USP7
ADXCRAD_CA437914_at
TGTGTACCTTGGAGTGACTTCCTTTCTCAACTTCCACTGCAGTGTGTGTGCCTTCTGCTCTGA
SEQ ID




GAGCTGCCTTGTGACCCGTGTGATAGAAAGCAGGGAGTGAGGGTCCCCGCGGACCTGGCCCTT
NO:




CCCTCCTTCCTCCCCCAGAAAGAGGAGTTAGAGCAGGGGTGCGAGAGCCGTTCGCTGTGGGTT
2597




TGTCTTTGAACAAACATTAAGGTGTCTTGTTTTTGTTCTGGGCTGGGGGTTGGCTGTAGTCTT




AGGTAACTGAAAGTTCCTACTCTCCCTTAAG





USP7
ADXCRAD_AI972599_at
TTGGGAACCAAATGGCTCCAAAAGCCATTTGTCCTCCAAGCGACTACAGGGCAAAGTAGTGAG
SEQ ID




AATCATGCCCATCTCTCTGAAATAAACAATCAATTCAGGGGCTTCTTTCTACAGCCCAAATGT
NO:




TGGCTAGATGGAACAGAAGTGACTCAATCTGTCAAATACAAAATCAGGAGTCACCCCTTCCAG
2811




TTTCAGTTCATCGTTCAAATGGAATCATATCCTTCCTCTGTTTGGCTTTTCTATGGGAACTGC




GC





WDR59
ADXCRPD.15558.C1_s_at
CAGTGTTACCCTGTAAGGTGTTAGCCTTAAACCACCGAGCAGCGTTCTCTTGATGCCAGTGCA
SEQ ID




GAGACCAGAGTCAGATGCCCGAGGACAGTGGGTAGGAATTTCATCAACAAATGGACCTATGGC
NO:




ATCATGGCTTTAGAAGCTGGTACATTTACTGAGCTGATGGACAGTGGCCTTCTAAAATATGAC
1764




ACTTAAATTGTAAATATGCACTGTACTTAAGGATTCTTAAGATGTATTTTTTTGTTATTTCTC




CTCCAGCTGCTATCCCTTGGCTAATAAA





WDR59
ADXCRAD_AA393120_at
CCCCTAGAAATCTCCTGGAAGAGAGGAAATCAGATCAACTGGGGCTGCCTCAGACCTTGCAGC
SEQ ID




AGGAATTCTCCCTGATCAATGTGCAAATCCGGAATGTCAATGTGGAGATGGATGCGGCAGACA
NO:




GGAGCTGCACAGTGTCTGTGCACTGCAGCAACCATCGTGTCAAGATGCTGGTGAAGTTCCCTG
2596




CACAGT





WHSC1
ADXCRAG_AF071593_s_at
CCTGTTGAGGTGTGAAATGCCCCGTCAGAAATTAAATACAAACTTAAATGTGCCTATTGGTGT
SEQ ID




CTAAACTTCATACAATGTAAGGTCAGATTCCTTTTAGGAATACTGGGTGCTGTCACCAGGTTT
NO:




GATAGTTAGACT
851





WHSC1
ADXCRAG_AF071594_s_at
ACTGTGGCTAGTTGTCTGTCCGGTGGCTGGGAGGGGGTGTGGTGGGAAAAAGTCGGAATCTCT
SEQ ID




GCAATCTGTGTCATGGACTGTACTATTGTAAGGTCTATATTCTGTATGTGGGTCCCAGACCCT
NO:




GATCAGGAAATGAGCCTCATGTGTGTCGTTAACATTTATATATTTCCATTCAAAATATGTATT
852




CAGTGTTTATTTCCTCAAAACAGACTTTGTTAATGTAGGAAATCTCTCCAAGTGGAAACGTGC




TAACTTTTTCTGTA





WHSC1
ADXCRAG_AF083391_at
TTTATTCCTTTAGTAGAGCAAATTCTTATTTTTTTCGCCTTCACTGGTAACAGCTTTTGTGGG
SEQ ID




AGC
NO:





854





WHSC1
ADXCRAG_AF083391_s_at
ACCAGTCAAGTTGGATTTGAACCCAGCTGCTCTGTACTGCACTTAGAATGATGTAATATTCCA
SEQ ID




GGATGCTGCTGCAGGTGGCGTATCATCGTACACACTCAGTGACATTTCTATCACAATCATTTT
NO:




ATGGAAGATGTGTGATAATCTGTTTTTACTGGTA
855





WHSC1
ADXCRPD.10380.C1_at
CCATATGCCAATTAACTTTAACCTAAAAAAATAGAGTGGGAGGGAACCTTGACATTCGGAGAA
SEQ ID




ATTCNAGTGTGCCGGTAACGCTGAGGAGTGAGGCTGTTTGTCCAGGAACGCTGAGCTGGGCTC
NO:




AGACGGTCATCAGTGCAGACGCAGCGGACGCTGCTGAGGATGGCTCAGTGGTGGGGAGGCGCT
1396




CCCTCCCGAGGAGGCCTGTACGTCTGTGTCCTGGCGGCTCGAGCTGGGTCCTCCGGGCCAGTT




CATGCTCG





WHSC1
ADXCRPD.1426.C1_at
GCGTCTCGTCAGATATCTCTACTGAAATGTGGTGCGTGTCGCGGGGNCGAGNAGACACTCTTC
SEQ ID




TTTCGACTNACTCTACCTGTGACTATATATGTGTGNNCTCGTTCCGCCTNACTACGCATTTAG
NO:




CACACTATCCCTCGTTAGTCTCTCGTCTCCCCATAATACGAGTACCACGCGCTCGTCTGTCAT
1416




ATCAGATAGGATACATAGTCTGGGGCCTCTCGTATGATTCATTTCGCTCGCCCGCCACGAGTA




ACAATCTTGCGTTCCCACCCTCCTTCGTCCCTCTGTCGTTGGAAGGCC





WHSC1
ADXCRPDRC.10380.C1_s_at
TCCCAAGGGTCGCTAGAAACTCGTCTTCGCGTTGCCCCCTTTCTGGCTCTCAGCGCCGTCGCC
SEQ ID




ACTCGGGAGAGGCTGGGTGAGGCCCGTGTGAGGACTGACCCTGGATTCCTCGAAACTGCCATT
NO:




GTGATCATTACTCTGCTCTTTGGAAATGGCTG
1922





WHSC1
ADXCRAD_BM712589_s_at
GTCAGAAGTTGATAGGTTGTTAAATACATTTATATAATACATTAAATATGTGAAATTAATACA
SEQ ID




CCTTCCTACATTTTGAAGGTGATGCATAGATCCCATAGTGTGCATCATGTTCCTTATATGAAA
NO:




ACGTTTAAATTACTGGGTCTTTTCCATTAAACTACTTTTGTATGGCTTAGATAAATCTTCCAT
2351




TAGTGTTCATTTTTATAGAATTATGCTGTTAAAACTACTTTAGGTGAACAAATAAACTTGTCT




ATTATATATTAACGCGACTGAACTACAG





WHSC1
ADXCRAD_BM755805_s_at
CAGGTGTCCGCATTTTTGCATGGTAAGGAAAAGGCTTACTTGCCCTTCAGCTCATAAAAGCAG
SEQ ID




AAGGTGTGCTATTCACAGTACCATGCGAGTAGCCCACAGTTAATTCCCGGCAGATTCTTTGGC
NO:




TGTGTTTTATCTTTAATGAACGTTTCTGACTAATATTTTGTTGTAAACCATTAAGTAATGTAA
2352




CGCATGTAAGATGCTTAGGGTGCCTGGCCAGGACTCCGTGGTTTCCTGTTGTGACAGTAATAA




T





WHSC1
ADXCRAD_CN390223_s_at
TGGTGCTGTGTGACCGCAAGTTCTGCACCAAGGCCTACCACCTGTCCTGCCTGGGCCTTGGCA
SEQ ID




AGCGGCCCTTCGGGAAGTGGGAATGTCCTTGGCATCATTGTGACGTGTGTGGCAAACCTTCGA
NO:




CTTCATTTTGCCACCTCTGCCCCAATTCGTTCTGTAAGGAGCACCAGGACGGGACAGCCTTCA
2483




GCTGCACCCCGGACGGGCGGTCCTACTGCTGTGAGCATGACTTAGGGGCGGCATCGGTCAGAA




GCACCAA





WHSC1
ADXCRAD_CN390208_s_at
CCCGTAGTTTTTTCTCCTCATGGATTTGAATGAAATGCCAATAACACGTCCACTTTCAACGTG
SEQ ID




TAGTTTACGCGGAGCACTTTCGAGGCCTGGCCGGGTTGGGCCTACTTCTCACCTGGGCCTATC
NO:




TTCTGAACTCGCTAGGTTCTTATCAACATT
2484





WHSC1
ADXCRAD_BF970701_at
GTGTTGGACACTGTGTATGAGTATTTTGTTTCAAAACTTTAACGCCTTTTCTTACGTTAAAAA
SEQ ID




CAAAAAGGGGGGCGCTAAAGTTCTCCCGAGCGCCCAGTAGCGGTACCCGCTTTCCGTCCACAG
NO:




GGGCCCCATGAGAGCCGGAAATAAGCAAAGACAGGCGAGTTTAACAGCGGCGCGGGAACCCGC
2485




GCCGTCGGGACCTGGGAGGAACCACTCCGGGGGACATGGACACCCAGAAGAAGCCGGAAAAAA




AGGGAGCTAAACGCACTCGCGAGTGCTGTAAAACACACAAG





ZAP70
ADXCRAG_BC053878_at

SEQ ID




ACACCGGCCTTGCATTGCCTGCCTGGCCCCCTGTCCTCTCTGGCTGGGGAGCAGGGAGGTCCG
NO:




GGAGGGTGCGGCTGTGCAGCCTGTCCTGGGCTGGTGGCTCCCGGAGGGCCCTGAGCTGAGGGC
973




ATTGCTTACACGGATGCCTTCCCCTGGGCCCTGACATTGGAGCCTGGGCATCCTCAGGTGGTC




AGGCGTAGATCACCAGAATAAACCCAGCTTCC





ZAP70
ADXCRAG_BC053878_x_at
GAGGGTGCGGCTGTGCAGCCTGTCCTGGGCTGGTGGCTCCCGGAGGGCCCTGAGCTGAGGGCA
SEQ ID




TTGCTTACACGGATGCCTTCCCCTGGGCCCTGACATTGGAGCCTGGGCATCCTCAGGTGGTCA
NO:




GGCGTAGATCACCAGAATAAACCCAGCTTCC
974





ZAP70
ADXCRAD_AW950959_at
TGAGCCCTGCTTGGGTTGTTCCACACACAGTTGGCCTGT
SEQ ID





NO:





2321





ZAP70
ADXCRAD_AW950959_s_at
GCACTCATGAGTGACTGCTGGATCTACAAGTGGGAGGATCGCCCCGACTTCCTGACCGTGGAG
SEQ ID




CAGCGCATGCGAGCCTGTTACTACAGCCTGGCCAGCA
NO:





2322
















TABLE 10







Genes and corresponding Almac probesets predicting resistance to irinotecan. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





ACTN1
ADXCRAG_BC011987_s_at
GGAAAGATTAACTATTTGCACCGAAATGTCTTGTTTTGTTGCGACATAGGAAAATAACCAAGC
SEQ ID




ACAAAGTTATATTCCATCCTTTTTACTGATTTTTTTTTCTTCTATCTGTTCCATCTGCTGTAT
NO:




TCATTTCTCCAATCTCATGTCCATTTTGGTGTGGGAGTCGGGGTAGGGGGTACTCTTGTCAAA
934




AGGCACATTGGTGCATGTGTGTTTGCTAGCTCACTTGTCCATGAAAATATTT





ACTN1
ADXCRSS.Hs#S3748482_at
GGCACAGAGGAAACCCGCTGAGCCTGCTTCCTTAGTTCTGGCAGATGGGTCAGCCCCCACAGG
SEQ ID




ACTCAGGATTCAATTTAGCCCGGGGTTCTGGCTCCATCTCCCACAGTGCCGGTGCCAGTGTGC
NO:




TCCTAAGTACTGTTTGTGCAAACCTGGCTCTGACTGAGACAAGGAGCCTTAGGAGTAGTAGGG
2203




ACAGGAGACACAGCAAACTAGGGCTCAGA





ACTN1
ADXCRAD_CX871590_s_at
TCTCCTGCCTGGGTTCGGTTTCAGCTCCCAGCCTCCACCCGGGTGAGCTGGGGCCCACGTGGC
SEQ ID




ATCGATCCTCCCTGCCCGCGAAGTGACAGTTTACAAAATT
NO:





2469





ACTN1
ADXCRAD_BM714793_at
AAGAGAATTTATGTGGCTTCTCATTTTTAAATCCCCTCAGAGGTGTGACTAGTCTCTTTATCA
SEQ ID




GCACACACTTAAAAAATTTTTAATATTGTCTATTAAAAATAGGACAAACTTGGAGAGTATGGA
NO:




CAACTTTGATATTGCTTGGCACAGATGGTATTAAAAAA
2737





ACTN1
ADXCRAD_M95178_at
GACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAAATTGCGCTGAATCGT
SEQ ID




ATGCTTTTTCC
NO:





2816





ACTN1
ADXCRAD_M95178_x_at
GTGCGCCGTGCCCACAGATGTGAAATGAATGTAATCTAATAGAAGCCTAATCAGCCCACCATG
SEQ ID




TTCTCCACTGAAAAATCCTCTTTCTTTGGGGTTTTTCTTTCTTTCTTTTTTGATTTTGCACTG
NO:




GACGGTGACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAAATTGCGCTG
2817




AATCGTATGCTTTTTCCTTTTGA





ASAH1
ADXCRAG_U70063_at
TAAACAGTCACTGGAAAGAGTGCCAGTCAGCAGTCATGCACGCTGATAAAAAA
SEQ ID





NO:





1074





ASAH1
ADXCRAG_U70063_s_at
TCTTCAGATTGATAGGGAGTTTTAAAGAAATTTTAGTAGTTACTAAAATTATGTTACTGTATT
SEQ ID




TTTCAGAAATCAAACTGCTTATGAAAAGTACTAATAGAACTTGTTAACCTTTCTAACCTTCAC
NO:




GATTAACTGTGAAATGTACGTCATTTGTGCAAGACCGTTTGTCCACTTCATTTTGTATAATCA
1075




CAGTTGTGTTCCTGACACTCAATAAACAGT





ASAH1
ADXCRSS.Hs#S1748600_at
TTTTCCTTATTTTCAGACTACTGTACTGCCTATTAAAGTTGATTTCAGACATGCAAAAAAACC
SEQ ID




TGGAAGAAATGTTGCAGGGCTAGAAACATTCTTCTCTTCCTCATAGTTTACTTCTACCCATCT
NO:




ACATGATTTGATAGAAGTGCTCGCAGGAGGTGCTTCCTTAACTTCGGTGTATGTCATGACATC
2086




TGTCCTTTTCTTGAGGGCCAGAACAC





ASAH1
ADXCRAD_BQ186493_s_at
GATCAAGATACGGAAGAGCCCAGCACTCCACGATGCTCCATCATGCCCCTTTGCAGAAAATAC
SEQ ID




TGCCTCCTCCAGTAAACACTATTCTGATGTCACTATAGATAAGTTTTGCCTCTTCGTGAACTT
NO:




TGTATAAATAGAACTGAACAATATGAACTGTCCTGTGTGATTTCTTGTATTTCATTATGGGTG
2730




GTGTGCTATTGTATCAACAGGGTAT





C19orf21
ADXCRIH.3146.C1_at
AGGGTGGCACAGATCGCAGCACCTTGAGGGGCTGCGGGTCTGAGGGAGGAGACACTCAGCTCC
SEQ ID




TCCCTCTGAGAAGTCTCAAGCTGAGAGGAGAGACCTGCCCCTTTCCAACCCTGGGAAACCATC
NO:




CAGTCTGAGGGAGGAGGCCAAACTCCCAGTGCTGGGGGTCCCTGTGCAGCCCTCAAACCCTTC
1204




ACCTTGGTGCACCCAGCCACACCTGGTGGACACAAAGCTCTCACATCGATAGGATCCCATGAG




GATGGTCCCCTTCCCTGCGAGAAA





CCND1
ADXCRPD.3501.C1_s_at
TCTGTCTGAACCACGCGGGGGCCTTGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACA
SEQ ID




AGTCCTGGATGTTGTGTGTATCGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGGGCACAGCGG
NO:




AGTCTGTCCTGTGACGCGCAAGTCTGAGGGTCTGGGCGGCG
1592





CCND1
ADXCRAD_BM551840_x_at
TGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACAAGTCCTGGATGTTGTGTGTATCGA
SEQ ID




GAGGCCAAAGGCTGGTGGCAAGTGCACGGNGCACAGCGGAGTCTGTCCTGTGACGCGCAAGTC
NO:




TGAGGGTCTGGGCGGCGGGCGGCTGGGTCTGTGCATTTCTGGTTGCACCGCGGCGCTTCCCAG
1593




CACCAACATGTAACCGGCATG





CCND1
ADXCRPD.3980.C1_s_at
GGAGGTGGACCTGGCTTGCACACCCACCGACGTGCGGGACGTGGACATCTGAGGGCGCCAGGC
SEQ ID




AGGCGGGCGCCACCGCCACCCGCAGCGAGGGCGGAGCCGGCCCCAGGTGCTCCCCTGACAGTC
NO:




CCTCCTCTCCGGAGCATTTTGATACCAGAAGGGAAAGCTTCATTCTCCTTGTTGTTGGTTGTT
1679




TTTTCCTTTGCTCTTTCCCCCTTCCATCTCTGACTTAAGCAAAAGA





CCND1
ADXCRPD.13939.C1_at
TTCACATTGTTTGCTGCTATGTGGAGGATCAGTGTTTTGTGTTACAATGTCATATACTGCCAT
SEQ ID




GTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCNNNNNNNNNNNNNNNNNNN
NO:




NNNNNATGTGATCAATTTTGACTTAATGTGATTACTGCTCTATTCCAAAAAGGTTGCTGTTTC
1727




ACAATACCTCATGCTTC





CCND1
ADXCRPD.16054.C1_at
ACCAAGTAGCTGTGGGTTGAACCTGGACGTGAGCTGGTTGCAGGGCCGTTGGGTAGAAAACCA
SEQ ID




GCATCTCATAAACAGGTCACTACAAAAATAGGAAGAGTATAAAAATAGAATATATTATGTCAC
NO:




TATTTCGTCTTCTCTTTATAGTAGCGTATCGTAGGAGTGGGACAAGGTGGCCTTTCCCGACAC
1752




TGCTACGCTGGTCTGTGCCCGACAAACCTCACCTGATGTTGTACCTGAGTACGTTACTAAATC




CTCAAGACCTTACACACAGC





CCND1
ADXCRPD.15960.C1_at
TGCCCGACAAACCTCCACTGGATGGTTTGTCACTGGATGGTTTGTTGGGGTGGTGGTCACAGG
SEQ ID




CGCAAAGGACATGCACACGGCCACGCTACGCTACTGTAACCAAG
NO:





1817





CCND1
ADXCRPDRC.16054.C1_at
GTAGTGACCTGTTTATGAGATGCTGGTTTTCTACCCAACGGCCCTGCAACCAGCTCACGTCCA
SEQ ID




GGTTCAACCCACAGCTACTTGGTTTGTGTTCTTCTTCATATTCTAAAACCATTCCATTTCCAA
NO:




GCACTTTCAGTCCAATAGGTGTAGGAAATAGCGCTGTTTTTGTTGTGTGTGCAGGGAGGGCAG
2013




TTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCAAGCAGGACTTTGAGGCAAG




TG





CCND1
ADXCRAD_BQ436873_at
AAAAATAGTATTTGCATAACCCTGAACGGTGGGGGAAGAGGGGTGTGCTACANATGATAGAGG
SEQ ID




GATTTTATACCCCAATTATCAACTCCGTTTTTATATTAATG
NO:





2640





CPNE3
ADXCRAG_AF077226_at
CAAGCTATAGTTAATGCCTCCAGGCTGCCTATGTCCATCATAATTGTTGGAGTTGGAGGTGCT
SEQ ID




GACTTCAGCGCCATGGAGTTTCTGGATGGTGATGGTGGAAGTCTCCGCTCCCCATTGGGCGAA
NO:




GTGGCCATCAGAGATATTGTCCAGTTTGTGCCTTTCAGACAGTTCCAGAATGCTCCAAAAGAA
853




GCACTTGCTCAGTGTGTCTTGGCAGAGATTCCCCAGCAGGTGGTGGGCTACTTCAATACATAC




AAACTCCTTCCTCCCAAGAACCCAGCCACGAAACAACAGAAG





CPNE3
ADXCRIH.2935.C1_s_at
AGAAAAATTTGAAGTCTGATCAGAGATTTACAACTGTTCATTATAGTGGTGCCTTAGGCAATC
SEQ ID




TTTCCAAAGTAAATTCAGGGCCCCATTGCTACTTATGCCATATTTGGACATACNNNNNNNNNN
NO:




NCTTCAATTTTGTAAACTTCCTGGAAAGCTG
1227





CPNE3
ADXCRAD_BP222406_at
TGAAATTCAGAATTCCGTTTCCTTCTAACTAATGAAAAACTGCTTACTAAAAAAAAATTTTAT
SEQ ID




ACTTTCCTTGCTAAGGTCCCATATATTGATTTGTACAGATCCACTTAGTCATTTTCTCCTTTT
NO:





2387





CPNE3
ADXCRAD_BP222406_x_at
TGAAATTCAGAATTCCGTTTCCTTCTAACTAATGAAAAACTGCTTACTAAAAAAAAATTTTAT
SEQ ID




ACTTTCCTTGCTAAGGTCCCATATATTGATTTGTACAGATCCACTTAGTCATTTTCTCCTTTT
NO:




TTTAAGAACCATTTTCATCTGATTTTTAAACTCACGATACCAGTTATCTGTTAATCAAAATTG
2388




CATTTTACAATTTAATAATGTGATATTTCCTATGTCTACAGCAT





CPNE3
ADXCRAD_CB153171_s_at
AAGCTGTCTTCACTAAGTATCCCCTAGTCTCTATATATGTGGTTAGTAGTCATGGAAATGACA
SEQ ID




CATAAAGTACGCCAGAAGTTTGATGGAACGTGTTAGAAACTGTTTTGTGCTTTTATGGATGTC
NO:




ATACTTGACAATACATGTGTAAGTTACTAATATATGAATTGATGCTAAATATATCTTACATTT
2615




GA





CTBP2
ADXCRAG_AL833398_s_at
GTTACATGTTCTATTCATAGTCTTTTGTGAATCATTGCCTTTTTGTTTAAAAAGATGGCCTAT
SEQ ID




TTTGAGCCTTTGTATAGGTACATTCCTGTTTTTGTGACAAAAGAAAAACTTTAAAATTGTCCC
NO:




AAACAGAAAAATAATGGCTATCAGAAGTATGTTTTGTTTTAGTGTGAGTTACCGTTACTGTAT
899




TTGTTTATTGTAAAGGTGGACATTTAGCGTTCAGTGCAGTTTTCAATAA





CTBP2
ADXCRIH.1931.C1_at
GTGACTTGAGTTCCCTTAAGTCCTCTGGGGCTGGTGACCTC
SEQ ID





NO:





1216





CTBP2
ADXCRIH.1931.C1_s_at
ACGGAAGCGCTGAAAGACTAGGATGTGATTTATTAACGACCAACTTCTGTTATTGTGTGTTAA
SEQ ID




GTTTTTCATCTGTGCATCAAATCACAAAAAGAATAAATAGAGCTTTTTCTTTATCAGTCCCTT
NO:




GGGCACAGAAGGTCCTGAACACCCTGCTCTACAATGTTGCATCAGAGTTCAAACAACAAATAA
1217




AAAATATTAAGAGGGAAATCCCCATCCTGTGACTTGAGTTCCCTTAAGTCCTCTGGGGCTGGT




GACCTCTTTTTGCTAATAG





CTBP2
ADXCRSS.Hs#S3008063_at
TCACCCAAGGGACCACACTGGGAAACCCAGTAGTTGTCTCGGCCATGGCACTAAGACCTTTGC
SEQ ID




ACCCTGGCCATCTTGTTCCGGGACAGCCAGCATCTGTGGTGTGGTATAGAGACAAAGCTGCCA
NO:




CCTCCAGGACACTTGCTCCTTCCTGGCCTTCCTGCTGCCCTGAAACCTGTGGCCTGTGTGTTA
2168




GTGGAAACATTCTCAGTTTCATTGCTCAGTAAACCTTAGGTTATCCAAACTGCAAATAAAATG




TTCTCTACTTTCTAGATTTTTATAACTTGCTATTTTGAG





CTBP2
ADXCRAD_BG614034_at
TTCTGACTTTAATCTACCCCAAAGCAAAATGACCTGGACCTGGTTCAAGGGAGGGAAGTGAAC
SEQ ID




CTTGAAACTGTTTTGGCCAATAACCTTAACAAACAAAATGATATTTACCAAAAGAAGTGTTGC
NO:




AAATAGTCTCATGAGTTAAGAGCTTGATTTAATGGATCTTCTTTTT
2365





CTBP2
ADXCRAD_BG614034_x_at
TTCTGACTTTAATCTACCCCAAAGCAAAATGACCTGGACCTGGTTCAAGGGAGGGAAGTGAAC
SEQ ID




CTTGAAACTGTTTTGGCCAATAACCTTAACAAACAAAATGATATTTACCAAAAGAAGTGTTGC
NO:




AAATAGTCTCATGAGTTAAGAGCTTGATTTAATGGATCTTCTTTTT
2366





CTBP2
ADXCRAD_CX866865_s_at
GACTTGAGTCCCTTAAGTCTACAGGGGCTGGTGACCTCTTTTTGCTAATAGGAAAATCACATT
SEQ ID




ACTACAAAATGGGGAGAAAACTGTTTGCCTGTGGTAGACACCTGCACGCATAGGATTGAAGAC
NO:




AGTACAGGCTGCTGTACAGAGAAGCGCCTCTCACATCTGAACTGCATACTGAGCGGGCAAGTC
2503




GGTTGTAAGTTCAGTAAA





CTBP2
ADXCRAD_AK024129_x_at
ACTTAAGAAGTAATGTCCCTTGGCTGGGCGCGGTGGCTCATGCTTGTAATCCCAGCACTTTGG
SEQ ID




GAGCTGGAGGTGGGCGAATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGGGCAACATGGCGA
NO:




AACCCCGTCTCTACTAAAAATACAAAAATTAACCGGGCATGGTGGCAGGCTATAATCCCAGGT
2829




ACTCGGGAGGCTGAGGCGGGAGACTCGCTTGAACCCAGGAGTTGGAAGTTGCAGGGAGCTG





DSG2
ADXCRIH.2137.C1_at
AGAGTACCTAGTTCATCAGCCGTCCAGTAAAGCAACCCAAGGAAACTGACTGGGTCTCTTTGC
SEQ ID




CTACCGTATTAACATTAAACATTGATGTTTCTGTATTCTGTACTTTACTGCACCCCAGCAGAC
NO:




TTTCAACAACTCATT
1191





DSG2
ADXCRPD.13409.C1_at
TTTCATCGTGGCTTCCTTGGCCATACCTCCTACTCCATTTCGTCCTACTAGACTGCCCCCTTG
SEQ ID




ATCCACTGGCAGAAATGATGGCACCACCTTGTCTTCAGGTGGTGCTCCTTCATTATTCCAAGG
NO:




ATGCAGCATCTCTATGGTGCCAGGTATGGGGGTAAAGCCTTTGGCGCCCTTTCCGCAATGGCA
1640




CATCAGCAGTAAAAGTGGTACCAATAGCAGGAGCAGAAAGGCCAAAATCATGAGCGCAATTGC




TGCGGGTCCCAGGCCCACATAGGAGTCATG





DSG2
ADXCRPD.13497.C1_at
AGTCAATGTAGAAGTTACGCGCATAAAAGTGTTCGATGCAGATGAAATAGGTTCTGATAATGG
SEQ ID




GCTGGCAAATTTTACATTTGCATCAGGAAATGAAGGAGGTTATTTCCACATAGAAACAGATGC
NO:




TCAAACTAACGAAGGAATTGTGACCCTTATTAAGGAAGTAGATTATGAAGAAATGAAGAATCT
1653




TGACTTCAGTGTTATAGTCGCTAATAAAGCAGCTTTTCACAAGTCGATTAGGAGTAATACCAG




CTACACCCATTCCATCATGTCAAGTGAACATGTGACGAGGCTCATTTA





DSG2
ADXCRAD_BQ887548_s_at
TTTCATGTTTCCAATGTACCTGATTTTTCATGAGCCTTACAGACACACAGAGACACATACACA
SEQ ID




TTGATCTTAAAATTTTTCTCAGTCACTGATATGCAAAGGACCACACTGTCTCTGCTTCCAGGA
NO:




GTATTTTTAGAAATGTTCCACAATTTACTGAAGACATANAGATGATGCTGCTGCTTANGTGCC
2313




TTTTAGCAAGCTATGCAAACAATCCTGATAAAANCAGATACTTAGAGAGTCAATCTGGCTTCT




GAGAA





DSG2
ADXCRAD_BE171045_s_at
GAGGAGTAGGTATTCTCTGAATTAACCATAGATTTGCTCACAGAGCTGAATGTGAAGCTGTGT
SEQ ID




TCATACTTGTTTCTGTGGCAGGTTTTTGTCTCTGCTCAATTTCCTTATTTATATCTATTTTTT
NO:




GACCCAGGCAAACTTCAGCTAG
2324





GPX4
ADXCRIH.2240.C1_at
ACCAAGTTCCTCATCGACAAGAACGGCTGCGTGGTGAAGCGCTACGGACCCATGGAGGAGCCC
SEQ ID




CTGGTGATAGAGAAGGACCTGCCCCACTATTTCTAGCTCCACAAGTGTGTGGCCCCGCCCGAG
NO:




CCCCTGCCCACGCCCTTGGAGCCTTCCACCGGCACTCATGACGGCCTGCCTGCAAACCTGCTG
1246




GTGGGGCAGACCCGAAAATCCAGCGTGCACCCCGCCGGAGGAAGGTCCCATGGCCTGCTGGGC




TTGGCTCGGCGCCCCCACCCCTGGCTACCTTGTGGGAATAAACAGA





INPP4B
ADXCRAG_BC005274_at
CTTACTCACTGTGATCAAATGGTGAATATGTACCAAGACATTCTGACAGAACTTAGCAAGGAA
SEQ ID




ACAGGGTCCTCTTTCAAATCAAGCAGCAGCAAAGGAGAGAAAACATTAGAATTTGTTCCAATA
NO:




AATCTACATCTGCAAAGAATGCAGGTACACAGCCCTCACTTGAAAGATGCTCTCTACGATGTC
919




ATCACTGTGGGAGCCCCAGCTGCCCATTTTCAGGGATTTAAGAATGGTGGTCTTCGGAAGCTA




CTCCATAGATTTGAAAC





INPP4B
ADXCRPD.8849.C1_at
GATGATCACAGATGTTTCCCAAAATCTAGGAACTACTTCAATTCATCATCAGCATATGGCTCT
SEQ ID




GAAAGAAATCCATTTTAAAAAATCTTACATGATTCAGTACTGTCATTTCTAGTTCTAAGCTTC
NO:




TATGTGTTGAGCCTAGCTGATTGAGATGGGTTCACAAAGGGTAAATTTCATTCATGAGTATTT
1453




AAATGTTTCTGAGGAAACATGGATCATTTCAATAGGACTAG





INPP4B
ADXCRPD.12698.C1_at
CTCAGACCCTGCCAAATACCATTCTAATTCTGTTCTGTTTCTATGAGTTTGACTTTTTTAGAT
SEQ ID




TCCGCATGTGAGAACATAAAGTATTTGTCTTTCTCTGTCTGACTTAGCATAATGCCCTCAAGG
NO:




TTCATCCATTTTGTTGCAAATGACAGAATTTCTTACTTTTCT
1616





INPP4B
ADXCRPD.12698.C1_x_at
TAAAGTCTGTACCTTTGATCATCATCTTCCCATTTCCTCCTCCCCTCAGACCCTGCCAAATAC
SEQ ID




CATTCTAATTCTGTTCTGTTTCTATGAGTTTGACTTTTTTAGATTCCGCATGTGAGAACATAA
NO:




AGTATTTGTCTTTCTCTGTCTGACTTAGCATAATGCCCTCAAGGTTCATCCATTTTGTTGCAA
1617




ATGACAGAATTTCTTACTTTTCTTTGCCTGAAATAAT





INPP4B
ADXCRSS.Hs#S3748650_at
AATTCTAAGCAATGATATGTGGACTAATTCGATGATCTACATGGAGGTTTACTGCCTTTGAAA
SEQ ID




GAAGCAGTGATGACTCGAAGCCTATGTGGCCTCATTAGTGAAAATAATTTCAGAGGAACTTTA
NO:




TCTTTGACAGGATTTACAGCTGGATAGATTAGGAAAAATAATTCAATGGCATAGGATATTTGG
2199




CCTTTTACAGGGCATTTCATGACATACTTGTGAAAGATGGAGAAATATAGGCCATGCAATGAT




ATG





INPP4B
ADXCRAD_CB852249_at
GGTGCCATATTGCTTTGTATAAGTTATTTTCCATCAAGGATTTGTGTCTGCTTTGTGTGCTGC
SEQ ID




TATATAATAATTATGTCTTGCTGAAGTTCTTCTGCTTATTGAATTCCTCTACTGAAGTTCCTT
NO:




ACTTATTCAAATAAGTAAGGTAGGAGGTACTTAGTCAATTGAGCAGCTAATTGGCTAAAAGTG
2386




TCTTGAGCACAAGATAAGCATGTACTGAAAAACTGAGTATCTCTTGTCCATTGTTA





INPP4B
ADXCRAD_BG199926_s_at
CACTTGAACAATGCTCAATCTTGAGAGATGAGCACCAGTTACACAAGGACTTCTTTATCCGAG
SEQ ID




CGCTGGATTGCATGAGAAGAGAAGGATGCCGCATAGAGAATGTACTGAAGAATATCAAATGCA
NO:




GAAAGTATGCTTTCAACATGCTACAGCTGATGGCTTTCCCCAAGTACTACAGACCTCCAGAGG
2625




GGACTTATGGAAAAGCTGACACCTAAGTTTACCAACATGTTA





INPP4B
ADXCRAD_BG199926_x_at
ACATCGATGTCAGTGACACTTGAACAATGCTCAATCTTGAGAGATGAGCACCAGTTACACAAG
SEQ ID




GACTTCTTTATCCGAGCGCTGGATTGCATGAGAAGAGAAGGATGCCGCATAGAGAATGTACTG
NO:




AAGAATATCAAATGCAGAAAGTATGCTTTCAACATGCTACAGCTGATGGCTTTCCCCAAGTAC
2626




TACAGACCTCCAGAGGG





JUP
ADXCRAG_AF233882_x_at
ACAGAGCAAGAACCCGTGTCTTAAAAGAAAAGAAAAACAGGAGGCTGGGTGCAGTGGCTCACA
SEQ ID




TCTGTAGTTCCAGCACTTTGGGAGGTGCAGGCAGAGGCGGAAGCGGAAGGATCACTTGAGGCC
NO:




AGGAGTTTGAGACCATCATGGGTAACATAGTGAGACACCCATCTCTTACAAAAAATT
873





JUP
ADXCRIH.2082.C1_s_at
AGCTGCCCTAGCTGACCCCGAGAAGTGCTCTTGGCTGACCCCTCTGGTGTGTGGTGAGGGGCT
SEQ ID




TTCTCTTCCCCTTCCTGTTTCAGACCCCCCCATTTCCCGCACATGGTGTGGGGGGCTGGGGGA
NO:




GGTCCAAGCAGAGTGTTTTATTATTATCGCTTTATGT
1152





KDELR3
ADXCRIH.3560.C1_at
GTATGTGACCAAAGTCCTTAAGGGAAAGAAGTTAAGTCTTCCAATGCCAATCTGAGGACCTTC
SEQ ID




AGAGACAGTCTACGCCTTAACAAGCACATGAAGGAAACTATTTTGAATGTTCTCTTTGGCAAC
NO:




TTATCCATAATTTGGGATCAAATGTTAAAACCAGAAAAGTGTTTAGTGTGGATTTCAGCA
1221




AACCTG





KDELR3
ADXCRPD.11126.C1_at
AGAGGAGGGACATTGTTCCAGATTGGGGTTGACTTGCCCATCATGAGTCTTGCCCTCAGGCCT
SEQ ID




TGGAGAACAATCATTTATGTTTTTTATTTCGTCGGTAAGACACCTTAAGGTTTCTTGTTGCAG
NO:




TGAGGCACCATCTTTGTGCAGTTGGCCGAGGTTTTTTATGACCTTACAATGGGTCTTTAAGGG
1428




CGATCTATTGATGA





KDELR3
ADXCRPD.3569.C1_at
TACTTAGGCGAGTACCATTTGCACAATCACTGTTTTACTTATGAGCAGATACAGATATATCCA
SEQ ID




AACCCTTACCTACTAGGTATCCTGCTAGGGTTTTCAATTCCAATTCTTGTATTAAGTTTTTTC
NO:




CTTTCAGTTTTAGGTGCGAAAGTAATCAGTCAATCCAATATCCCCCATCTTTGTCTTGAAACA
1599




AAAACTGTTTTAAGACGTCTACGTTGAATTATTCAGAGAATTAAGCAATAAAAGCTCACACCT




TAT





KDELR3
ADXCRPDRC.11126.C1_at
GACCTTTTCATCAATAGATCGCCCTTAAAGACCCATTGTAAGGTCATAAAAAACCTCGGCCAA
SEQ ID




CTGCACAAAGATGGTGCCTCACTGCAACAAGAAACCTTAAGGTGTCTTACCGACGAAATAAAA
NO:




AACATAAATGATTGTTCTCCAAGGCCTGAGGGCAAGACTCATGATGGGCAAGTCAACCCCAAT
1932




CTGGAACAATGTCCCTCCTCTTAG





KDELR3
ADXCRSS.Hs#S3732256_at
GGCTTAACCAGCTAGACATTCCTCTAAATACATACGTAACAAAAATTGATGGCAGGAGATTTT
SEQ ID




ATTGGGATCACTGGATACCTACACTCAACAGGCAGAACTTGGCTAATTCCATTTATACCACTA
NO:




CTGAGACAGTGAAGACAAATTAAGAATCAGAACAGGAAGCACATAGCATAGGGATACCCGTGT
2149




CAGCGACATATTTAATATGCCCCTCAGCTTAAGACTCAATACTGAACAGACCAAAAGGCCACC




TCAATTGCCGCTCCCGCCACACTTGCTATTGAAACT





KRT18
ADXCRIH.1401.C1_s_at
CACCAAAGTTCTGAGGCATTAAGCCAGCAGAA
SEQ ID





NO:





1151





LAD1
ADXCRAG_NM_005558_at
TCTTCTCACATTAAGGTGGTGGCTTGCCACTCAGCAGTCCTAGCTTGGTGACTGGGAACTGCC
SEQ ID




ACATACAGGGCCAGGCCTACCCTCCTTCCCCACAAGCCCCCTCCAACCCCCACCCCCATGCTC
NO:




TGGACCTCATGGCTCCTATGAGCTTGGAGCATGGTGAACCATCAGAGAATCTAGAACCAACCA
1029




AGCTAGGAACATCAGCCTGGTGCCCTGTTAA





LAD1
ADXCRIH.3628.C1_s_at
AAGTGCCTCTTTGTCTATGATGTCCCCCTTCTCTGAGGCCTGGACCCACCCATCTTTGTCCCT
SEQ ID




GGGGCCTGCTCCCAGCCACTGAGGCCCGCTCTGCCAGGGGAGAAGGAGCTGCCGTGCGTCTTC
NO:




CCTGTGCCCCGTCTCCCTGCTTGGTTCTCCCCTCCCTTCCCTGGCCGGCTGCCATGGCCAGGA
1108




GCTAAGTGCCTTTTTGTGTGCAACCACTTACCCTTTCTCTGAAAAACCTGTTCTCAGGAAGGA




TCTGATAAACTCATTTA





LAPTM4B
ADXCRIH.1454.C1_s_at
TATATTTGATATACTTCTGCCTAACAACATGGAAAAGGGTTTTCTTTTCCCTGCAAGCTACAT
SEQ ID




CCTACTGCTTTGAACTTCCAAGTATGTCTAGTCACCTTTTAAAATGTAAACATTTTCAGAAAA
NO:




ATGAGGATTGCCTTCCTTGT
1153





LGALS3
ADXCRIH.184.C1_at
AATCACAAACATCAGAATGCCCAGACTGTACCGCACTTCCCGCTACTCAGAGGATTTCTCAGC
SEQ ID




TCCTGCCGGCAGAGTCCACTCCCTTCCGCCCTGGGCCTTTTGGTGAAAGGGTTACTGTGAGTG
NO:




AGTCCCAGGCCTCGCTCTGCCTGGCTTTCTTCCCAAATCTGCTGCTGGAAAAACAAGGCTCCA
1299




GCTTGCAAGCCCTCATTGGACAAATGAGTCCA





LGALS3
ADXCRIHRC.184.C1_at
GAATCTAAACCTTACATGTGTAAAGGTTTCATGTTCACTGTGAGTGAAAATTTTTACATTCAT
SEQ ID




CAATATCCCTCTTGTAA
NO:





1334





LGALS3
ADXCRIHRC.184.C1_s_at
AATACAAGTACTGGTTGAACCTGACCACTTCAAGGTTGCAGTGAATGATGCTCACTTGTTGCA
SEQ ID




GTACAATCATCGGGTTAAAAAA
NO:





1335





LGALS3
ADXCRSS.Hs#S1444631_at
TTTCTCCTGTTCCTTCCCATGTCAAGGCTCCAAAAGCACAAGATGCTTCACAGCTGTTGTAGG
SEQ ID




TGCTCCAGCAGTGAGGGGAGGAGGGCAGCTGGGCCCCTGAGGCATGGGTGGAGTTTTCTTAAG
NO:




CTTAGGATCACCTGTGCCATGGCCTGAATTACCTGAACCTTGAAACAACCAGAATATCCTTCT
2069




CTTTGATTTGCCCACCTGTGATATTTACTCAATCACTTTTAGAAATGGCATCG





LITAF
ADXCRIH.2736.C1_s_at
TCTAGGTTGGCTGCTGTGTCATCTTTGAAGTCAAGACAAAGCTGGGCTCGACCTTCAAGGGTC
SEQ ID




CTCGTTTTGATAATACTTCAGAATAGGGAACTCATGTGAATACTACTATGTAGAAATAAAACC
NO:




TAGACCTTGAGCGAACATCTGTATATTGGTTGAAAACGATAGTGGTAACCATTGATCCCCCTT
1134




CATTTGATGTTTGGAAAATTCCAGTAATTATCATTTTTGCAACGAATATGGATACCACA





LITAF
RDCR260_H04_s_at
GTAACTGCAGACTTCATTAGCACACAGATTCACTTTAATTTCTTAANNNNNNNNNNAAATACA
SEQ ID




AGGAGGGGGCTATTAACACCCAGTACAGACATATCCACAAGGTCGTAAATGCATGCTAGAAAA
NO:




ATAGGGCTGGATCTTATCACTGCCCTGTCTCCCCTTGTTTCTCTGTGCCAGATCTTCAGTGCT
1341




CCTTTCCATACAGGGATTTTTTTCTCATAGAGTAATTATATGAACAGTTTTTATGACCTCCTT




TTGGTCTGAA





LITAF
ADXCRPD.553.C1_at
GTTCACCCGGTGAACTATTTATGAGTTCTTCTGGTGTGAAGAAAGGGCTCATGTTGCATTTCC
SEQ ID




AGCCATTGCTACAAAGAACCTTTATTTGTTCAGTAAGCGGTAGAAAATCCTTCCGCGATTAAA
NO:




AACTTCAGACTTGCTGAATATCCTGCAATGTCAAGATGACCGATGTTGAGTTGGGTGGATTTG
1562




CTAACGAGTCAGATTTGAACATGAGGCTATTGGAACACAATAGGCGTCATTGATGGCGGCAAG




CCATAGCTTTCAAGTT





LITAF
ADXCRAD_BX410303_at
AAGCACATTTTTGAGCCATGTCTGGGTACCATGGTGGCGGAATGCTTGGGGACC
SEQ ID





NO:





2339





LITAF
ADXCRAD_BX410303_x_at
GGGCCTGAACATAATTTCAAGAGGAGGATTTATAAAACCATTTTCTGTAATCAAATGATTGGT
SEQ ID




GTCATTTTCCCATTTGCCAATGTAGTCTCACTTAAAAAAAAAAAAAAGAAAAGAAATGGATAA
NO:




TTTCATCTACTGCCTTTACTTGGGGGTTAATGTGATTCTTAAACACCTTCATCATGGAACTCT
2340




CAGAGTGGGGGTCCGTTTTTGTTTTCCTGGTGGGGGGGTTTTTGAAAGAATAAGGAAAAGCAC




ATTTTTGAGCCATGTCTGGGTACCATGGTGGCGGAATGCTTG





LRP5
ADXCRPD.3405.C1_at
TGGACCCCGCTCACGGGTACATGTACTGGACAGACTGGGGTGAGACGCCCCGGATTGAGCGGG
SEQ ID




CAGGGATGGATGGCAGCACCCGGAAGATCATTGTGGACTCGGACATTTACTGGCCCAATGGAC
NO:




TGACCATCGACCTGGAGGAGCAGAAGCTCTACTGGGCTGACGCCAAGCTCAGCTTCATCCACC
1572




GTGCCAACCTGGACGGCTCGTTCCGGCAGAAGGTGGTGA





LRP5
ADXCRSS.Hs#S1910362_at
ACCTCTTGAGCGCTTTTCTATGAAGCATCCTGTTTAAGCCTCGCACTTCTGTGATGTGGAGGT
SEQ ID




GCAGTAATTATCCCCATTTCACAGACAGGATGTTGAGGTCAGAGGGGTTGAGTGATTGTCATG
NO:




GGCCAGGTCTCAGCCAGGCTTGCTAACCCTGGAGTCTGGCGTCTGCTCTGAAGTGGTCCTCTC
2120




AGCTGGAGACTGACCTGGCCTTTTGCTTGTGATGTCGGCCTTAAAAATTTTGGGGGATGCTCT




CGGACTTTTGGATGGGTTCA





LRP5
ADXCRSS.Hs#S2985193_at
GGTGCTATTGAGTTCCATCATGTCCTTACTGATTTTCTAACTGCTGGATTTCACCATTTCTGA
SEQ ID




TGGAGGGGTGTTGAAGTTTCCAACTATAATAGTAGATTCATCTATTCTCCCTTGCAGTTCTAT
NO:




CAGTTTTTGCCTCATGTATTTTGACACTGTTATTAGGCAAATACACATTAAGGATTGTTATGT
2150




CCTCTTGGAATATTTCTTCCTTTATCATTATGTAATACCTCTCTTTAGCCTTGATAACTTTTC




TTGTTATGAAGCCTGCTCTATCTGCAAGGAAC





LRP5
ADXCRSS.Hs#S3011054_at
TGGAACCACTGTTTTACACCACAGGTTTAGGGACTGTTTGTGAGTTAAGGGTTCCTTTCGGTG
SEQ ID




ATCTGTGAACTTGGTCTTTGCAGTACCTAGATCCTGCCTTGGAGATTATTTAGTAGTGGGGAT
NO:




TATTTAGATGGTATACTTAACCATTTTTCAGATGCCTGAAGACTGAACTTTAGAAGCATTTGT
2177




TAATTGATTTTATAAAATATCTTAGGACTTTTTTTTCTTAACCTCATGAAAATACATTACCAT




ACTGTGCTGAAACTAA





LRP5
ADXCRAD_BM790129_at
ACAGGCCCTACATCATTCGAGGAATGGCGCCCCCGACGACGCCCTGCAGCACCGACGTGTGTG
SEQ ID




ACAGCGACTACAGCGCCAGCCGCTGGAAGGCCAGCAAGTACTACCTGGATTTGAACTCGGACT
NO:




CAGACCCCTATCCACCCCCACCCACGCCCCACAGCCAGTACCTGTCGGCGGAGGACAGCTGCC
2497




CGCCCTCGCCCGCCACCGAGAGGAGCTACTTCCATC





LSR
ADXCRAD_BI837070_at
TTAATTGGAAGGAACACGTGAGTTGAAGCCCTGGCCGATTACCCCTTCCCGGAGTCTAATAAA
SEQ ID




AGGGTATTAATCACAAGAAAAAGAAAAGAGCGAAAAGAGACGGAGAACATGCGAGAAAGGACG
NO:




ACAG
1046





LSR
ADXCRAD_BI837070_s_at
TACTCGGAGACCGACTCGCAGGCGTCCCGAGAGCGCAGGCTCAAGAAGAACTTGGCCCTGAGT
SEQ ID




CGGGAAAGTTTAGTCGTCTGATCTGACGTTTTCTACGTAGCTTTTGTA
NO:





1047





MLPH
ADXCRPD.10614.C1_at
CTTCGAGGGAGTACTTTAAGATGACTCCACTCAGCCTCAAGGTCACTCCCTGCACATGTCCTC
SEQ ID




AGTTCCCTGAGGCTAGGGACAGCCCACTAGTCCCTCACAGATGAGTCCTGCTCAGAGTAGGCA
NO:




GCCCCTCACAAGGCTGAGGGCCTGGAGGAGGCTGAATACTGGGGCCTCTGGGTGCCACTCCAA
1460




TCCGGAAGAGCAGCCGACCAGCATCTCACCTTCCAGACACGGCGTCCTGGCTGAGCTCTGCCC




GCCTGGAGGCTCCCACAGGATGGCCATGGATTTTTAGCTGCCATCTC





MLPH
ADXCRPD.13135.C1_at
AGGATCCGAGTGGTAGTGTTTCTGAGAGTCAGGGTCTAGGTGCTGGAGTGCGCACGGAGGCCG
SEQ ID




ATGTAGAGGAGGAGGCCCTGAGGAGGAAGCTGGAGGAGCTGACCAGCAACGTCAGTGACCAGG
NO:




AGACCTCGTCCGAGGAGGAGGAGGCCAAGGACGAAAAGGCAGAGCCCAACAGGGACAAATCAG
1588




TTGGGCCTCTAGCGT





MLPH
ADXCRPD.15019.C1_at
AATAGACAACTTGATTCTCCTCTTCATCCTGTTGTCTTCAGGCTAGGAGACTAGGAGATGCTC
SEQ ID




AGCCAGCCAAGGATGTCCCATGGGTCTCTACCTGGCCACCCTGAGAGGTCTCTATGCTGGCCT
NO:




CACCCAAGAGGTCTCTATCCTGGCCACACTGGGGAGGTCTCTATCCTGGACACCCTAGTCCTC
1697




CACTGTACCCTGCATCCACAGGTCCCTGGATGGACTTGGATGAGTTGGCTCTTCCCCTTTTCT




CAGAATAACTGTAGGCCTGTGGTTAC





MLPH
ADXCRPD.1115.C1_s_at
GAAGGAGCACCCTCCACATGGACTCCCACCTGCAAGTGGACAGCGACATTCAGTCCTGCACTG
SEQ ID




CTCACCTGGGTTTACTGATGACTCCTGGCTGCCCCACCATCCTCTCTGATCTGTGAGAAACAG
NO:




CTAAGCTGCTGTGACTTCCCTTTAGGACAATGTTGTGTAAATCTTTGAAGGACACACCGAAGA
1895




CCTTTATACTGTGATCTTTTACCCCTTTCACTCTTGGCTTTCTTATGTTGCTT





MLPH
ADXCRSS.Hs#S1921395_at
GTATCCAGGCAGAACGGTACCCTGAGGGCCAGCACAGCAGGAAGAAAGACAAGGACATGTGTA
SEQ ID




CTGCCCTGCATTCCAGGCTGGAGGAGTCCTCTTAAATAAGAGCCCAGAAGTGTCCTGGGGCAG
NO:




CAGCTGGAGGCTGATATATTTCAGAGGCTGAAATTAGGGGAAAGGAGAACTGTACTGTGCTTT
2103




AGATTCTTTAAAACATAACTTCCCTTCTTCATAGCCAAGAGACAGGAACGGA





NR2F2
ADXCRAD_CB217549_s_at
ATTATAATTGTTGATATTTTCCCTTTTTAAAAAATACCATTGAAATCAGCATGACAAAAATAA
SEQ ID




CACTGTTGGCACTTATAGGTAACGTGATTGATTCAGTATCTTAGAGTTTACAGTTTGTGTTTT
NO:




AAAAAAACTGAAGGTTTTTTTTTAAGTGCAACATTTCTGTATACTGTAAAAGTTATAATAACT
979




GAACTGTTTGGTCGAGTCTTTGTGTGTTA





NR2F2
ADXCRPD.4673.C1_at
GAATTGCCATATACGGCCAGTTAAAACTGCTGCCGGACAGTAACATATCCCGGATGAGGGTTT
SEQ ID




CGATGGGGGTTTTACCTACCAAACGGACGAAAAACAATTGCTCTATGACTGAGGAGGAGACGG
NO:




TGCGGAGGGAAGGGAGGCGAAGCAAAAGCTTTCCGAATCTCGTCGGCTGGTTGGGGTACTGGC
1691




TCCTAACGTATTCTTCCAAAGCACACTGAGACTTTTCCTGCAAGCTTTCCACATGGGCTACAT




CAGAGAGACCACAGGCATCTGGAAGA





NR2F2
ADXCRPDRC.4673.C1_s_at
ATCCGGGATATGTTACTGTCCGGCAGCAGTTTTAACTGGCCGTATATGGCAATTCAATAA
SEQ ID





NO:





2001





NR2F2
ADXCRAD_CB956496_at
GCGAGCGAGATCTTTGGAGAGATTTTTTTTTTTGCCTCCTACTTCTGTCTTGAAGCCAGACAA
SEQ ID




TCGACTTCAGCTCTCCCTCCCCTCCCTCTTTCTCCACGTTCTGCTCCCACTCGCTCTCCTGTC
NO:




CCCTTCCCCTCCCCTCCCGGCGGAAAGCCCCCCGAAACCAACAAAGCTGAGCCGAGAGAAACA
2487




AACAAAACAAACACACCGGGCCAGACAAGCCATCGACAAAACTTTGCAAAGTCAACC





NR2F2
ADXCRAD_CB956496_x_at
GCGAGCGAGATCTTTGGAGAGATTTTTTTTTTTGCCTCCTACTTCTGTCTTGAAGCCAGACAA
SEQ ID




TCGACTTCAGCTCTCCCTCCCCTCCCTCTTTCTCCACGTTCTGCTCCCACTCGCTCTCCTGTC
NO:




CCCTTCCCCTCCCCTCCCGGCGGAAAGCCCCCCGAAACCAACAAAGCTGAGCCGAGAGAAACA
2488




AACAAAACAAACACACCGGGCCAGACAAGCCATCGACAAAACTTTGCAAAGTC





PPAP2B
ADXCRAG_AF480883_at
GCTCGTAACACAACTCTCATCTCAGGCTCTTCTAAAGAGCTTTTGTATTCTAAAGAGGATTTT
SEQ ID




TCCATCAGAGAGGTAGGAGCTGTAGGAACCCCGAGGGCAGATAAGCAGCCCTCACTCTAGATA
NO:




AGGTATGCTGGGGGAGCTTACTGAGGGAATCCTGTACACAGCCCACATCAAAGGAAGGCTGAG
788




AATGGCCTGTGGCTCC





PPAP2B
ADXCRAD_CD678016_s_at
TAAACTGTGTCTCGACCTGTGTTATTTACATTAGCTGCTTAAAAAAGCATTGAGTTAATTTTT
SEQ ID




TTAAATATCAACTAAAATATCATAGTTCTGTGGTAGACATTGTTTTATAATGAAATAACTGCA
NO:




ACTAGAGAAAACTGTATAAAAACATTAAATTGTCAGTATTTTTGTAAGGTTCCATTTTGTAAA
1024




GAGAATAATATTCAAAGACTTTTGTAGCATACAAAGTGAAAACTTGTATCTGCGAAACTATAC




TTGTATTAAATGTGCTTTT





PPAP2B
ADXCRPD.13412.C1_s_at
ATGTTCTGGCAGGATTTGCTCAAGGAGCCCTGGTGGCCTGCTGCATAGTTTTCTTCGTGTCTG
SEQ ID




ACCTCTTCAAGACTAAGACGACGCTCTCCCTGCCTGCCCCTGCTATCCGGAAGGAAATCCTTT
NO:




CACCTGTGGACATTATTGACAGGAACAATCACCACAACATGATGTAGGTGCCACCCACCTCCT
1641




GAGCTGTTTTTGTAAAATGACTGCTGACAGCAAGTTCTTGCTGCTCTCCAATCTCATCAGACA




GTA





PPAP2B
ADXCRSS.Hs#S524340_at
TGACTGATAGCTGCCGCTTATGGTTACTTAGTAAAAACTCCTGTTGCTAAATGGCTCAAATGG
SEQ ID




ATGTCTGTGTGTTTATTTTGCCATCTAATACAAAGCATAAATTTTTCTTACTCCAGTAGCTCA
NO:




TCAAACCCTTGAATCTTTCATCATAAGCACATTGAGGCAGGAACTATGCCTGTGCCATCCTCA
2129




CACCTTTGCAAGTGGCACTCAATAAATGTTTCTCAAGTATTGTTCAGACTCAGTGAGGGTCAC




ATCCCCAGGAGGAA





RRBP1
ADXCRAG_AF006751_s_at
AGAAGAAGTTAACAAGTGACCTGGGGCGCGCCGCCACGAGACTGCAGGAGCTTCTGAAGACGA
SEQ ID




CCCAGGAGCAGCTGGCAAGGGAGAAGGACACGGTGAAGAAGCTGCAGGAACAGCTGGAAAAGG
NO:




CAGAGGACGGCAGCAGCTCAAAGGAGGGCACCTCTGT
843





RRBP1
ADXCRAG_BC009700_x_at
ACTCAGAATCAAAGCAAAAAGGCTGAAGGAGCCCCAAACCAGGGCAGAAAGGCAGAGGGAACC
SEQ ID




CCAAACCAGGGCAAAAAGACAGAGGGAACCCCAAACCAAGGGAAAAAGGCAGAGGGAACCCCA
NO:




AACCAAGGCAAAAAGGCAGAAGGAACCCCAAACCAAGGCAAAAAGGCGGAGGGGGCCCAGAAC
928




CAGGGTAAAAAGGTAGATACAACCCCAAACCAGGGGAAAAAGGTGGAGGGGGCCCCAACCCAG




GGCAGAAAGGCCGAGGGGGCTCAGAACCAGGCCAAAA





RRBP1
ADXCRPD.7803.C1_s_at
GAGGCGTTTGACGTTCTAGGTTATCCCTCCGCAAGGGGATTCTCTGCCTGGCTTGCTGATGTC
SEQ ID




ATATCTGGTGGGGAGTGGATTTAGATCTGACACTTTTTCTGCTCTTCAGAAGCAGAAGCACAA
NO:




GCCCAGTATCCCAATTCTGGTTTAATCTCAAA
1876





RRBP1
ADXCRAD_CB159041_at
TAAACACTATCCTGGGCGCAGCCCCGGGCCACCGCCGAGTGACGCCAAAGCCCTGGTTGACTC
SEQ ID




TGACAGCCCCGTGGGTGTGTGGGAGGCCGGGCGCTCTGGGGTCTGTCTGTCAGT
NO:





2360





RRBP1
ADXCRAD_CB159041_s_at
AAAGCCCTGGTTGACTCTGACAGCCCCGTGGGTGTGTGGGAGGCCGGGCGCTCTGGGGTCTGT
SEQ ID




CTGTCAGTGCAATCGTTTAGTGTTTTTTCAGTGGGGCGGGGCGGGAAGCGGGTGGGACCGGGC
NO:




AGCCAGTTCTCAAAGGCTGTGGGGCCGACTGGAGGCCACAGCCCCTCACCCCTAGACGTTGCC
2361




AACCAGAACTGACGTG





RRBP1
ADXCRAD_BQ778389_at
TGGTGGTGAGTTTTCGCCATCTCCTTGCGCTGGTTGGCTAGGGCTTCTTCATATGACGTTTCC
SEQ ID




TTCATGGAGAAAGTCGACACCAGGAAGATGCCAATGGCAGAAACAACCATGAATCCTCCAAAG
NO:




ACCACAACCCCCAAGGTTTGAGTGTCGTAAATATCCATCCTGGCTTGCTTTC
2362





RRBP1
ADXCRAD_BQ931525_at
CCATGAGAGAACAAGTCTCCTTAGAGCCACAAGAAGTAGACCCTTCCCAGAGCCCCCAGTTTT
SEQ ID




GTAAAATGAAACCCTGTGCTCCCCATTTT
NO:





2363





RRBP1
ADXCRAD_BQ931525_x_at
CCATGAGAGAACAAGTCTCCTTAGAGCCACAAGAAGTAGACCCTTCCCAGAGCCCCCAGTTTT
SEQ ID




GTAAAATGAAACCCTGTGCTCCCCATTTTGGATAAACCACTAATCCCG
NO:





2364





RRBP1
ADXCRAD_CN262594_s_at
CACAGTGAAGCATCTCGAAGAGATTGTAGAGAAGCTAAAAGGAGAACTTGAAAGTTCGGACCA
SEQ ID




GGTGAGGGAGCACACGTTGCATTTGGAGGCAGAGCTGGAAAAGCACATGGCGGCCGC
NO:





2610





RRBP1
ADXCRAD_BE646396_at
GAGCAGAGCACATACCTGGTCCGAACTTACAAGTCTCCTTATAGCTTCTCTACAATCTC
SEQ ID





NO:





2822





RRBP1
ADXCRAD_BE646396_s_at
GCAGGTCTGCACAGGGCCCGTGGCTGGGTCTCAGGGTCCTCTGAGGTAGTCAATGTCTCTCAT
SEQ ID




TAAGGAAAAACAGGATGGACAAGATCCCTTGGCTTGAGAGAGAATGCCTCTCTTAAGGCACAC
NO:




GGTCCATGAGGAAGAAATCAGTGAAGTGTCCTCTGCATTAACGTCACTTTCAAAGAAGCTCCC
2823




NGGACATGAGAAAGAGTTCTCTGAGCAGAGCACATA





SERPINB6
ADXCRIH.878.C1_s_at
AGCTGCCATCATGATGATGCGGTGTGCCAGATTCGTCCCCCGCTTCTGCGCCGACCACCCCTT
SEQ ID




CCTTTTCTTCATCCAGCACAGCAAGACCAACGGGATTCTCTTCTGCGGCCGCTTTTCCTCTCC
NO:




GTGAGGACAGGGCAGTCTTGGTGTGCAGCCCCTCTCCTCTCTGTCCCCTGACACTCCACAGTG
1190




TGCCTGCAACCCAAGTGGCCTTATCCGTGCAGTGGTGGCAGTTCAGAAATAAAGGGCCCATTT





SERPINB6
ADXCRPD.16952.C1_at
CCATGTACTGGTCTGACTCATGATACAGTAGTAGAATCAGTAGAAGTGATGCTGTACAGAGCT
SEQ ID




AGGCCCTTTTTAAAAGGCCTGACAGCTGCCATGTTCACTCTCTTGTACACTGGCACCATGACA
NO:




GAAGGAAGTCCAGGCTATCCTGCCGAAGCA
1386





SERPINB6
ADXCRPD.11180.C1_at
ATCCTGCTGCAACAAGCCAAGCCTTCCTGCGCCTGAACTCACAGCACACTCAGGACACCACCT
SEQ ID




TGCCTCATGGGCTGTGGGTGCATGCCCATCTACACCTTCACAGACAGGCTCACGGGTAGGGTC
NO:




AGGCTGCACATCTCTCTAGCCCTGCCGTGCAGTGGGTGTGGCAGCCCCAGCAGGGTCCAGAGC
1436




AGGAATGCAGCTGGATAGTCGGGAGGGGGGAGCTGGGGTATCTTCAGGCAAGTCGGAATCACA




GAATCACATGTTAAAGTCCACCAAGCCCTTAGAGAGACCTACCATCA





SERPINB6
ADXCRSS.Hs#S2986702_at
TGCCCTGAGGCCATCTCTTTTAGAATCTTTTGCCAGCTGGAAAGGCTGGGAAGAAGAAACATT
SEQ ID




TTTATTCTCCACCCAGTACATCCTGGATTGGAAATAGTTCCTTTAAATTCTGCTTGAAAATGG
NO:




AACAGTTCCTTCATCTTTCTCTTCCCATGTGTTACCCTAGGCAGCAAAAAGAAGCCAGCTTCC
2167




TCCTGGACCCCTTAGCCAGATGCAGGAGTTCCCGGGGGAGGCACTCCATCCTCCCTGTCACTG




AGGGTGACCTTCTTTCCACTT





SFN
ADXCRIH.2281.C1_at
CAGAGCTGAGTGTTGCCCGCCACCGCCCCGCCCTGCCCCCTCCAGTCCCCCACCCTGCCGAGA
SEQ ID




GGACTAGTATGGGGTGGGAGGCCCCACCCTTCTCCCCTAGGCGCTGTTCTTGCTCCAAAGGGC
NO:




TCCGTGGAGAGGGACTGGCAG
1253





SFN
ADXCRIH.2281.C1_x_at
CAGAGCTGAGTGTTGCCCGCCACCGCCCCGCCCTGCCCCCTCCAGTCCCCCACCCTGCCGAGA
SEQ ID




GGACTAGTATGGGGTGGGAGGCCCCACCCTTCTCCCCTAGGCGCTGTTCTTGCTCCAAAGGGC
NO:




TCCGTGGAGAGGGACTGGCAGAGCTGAGGCCACCTGGGGCTGGGGATCCCACTCTTCTTGCAG
1254




CTGTTGAGCGCACCTAACCACTGGTCATG





SFN
ADXCRPD.9737.C1_at
TGCTTTTCTGCTCAATACTGGACAGCACCCTCCAGGCAGCCCTCTGGCCGCCCACCACGTTCT
SEQ ID




TATAGGCTACTGAGAGCAGGTTTCGCTCTTCGCAGGAGAGCTCCTCGCCCTTCTCCACGGCGC
NO:




CTTTCATGAAGGCTGCCATGTCCTCATAGCGTTCGGCCTGCTCTGCCAGCTTGGCCTTCTGGA
1506




TCAGACTGGCTCTCTCCATGGCTCTGGGGACACACAGCGGGCGGCGGGCTAACTGCTGCCTG




GCCTCGTG





SFN
ADXCRPDRC.9737.C1_at
CCCAGAGCTGAGTGGTGCCCGCAAACCGCCGGCTGCCCAATCAAGTACCACAACG
SEQ ID





NO:





1949





SFN
ADXCRPDRC.9737.C1_s_at
TCTTCCACTACGAGATCGCCAACAGCCCCGAGGAGGCCATCTCTCTGGCCAAGACCACTTTCG
SEQ ID




ACGAGGCCATGGCTGATCTGCACACCCTCAGCGAGGACTCCTACAAAGACAGCACCCTCATCA
NO:




TGCAGCTGCTGCGAGACAACCTGACACTGTGGACGGCCG
1950





SFN
ADXCRPDRC.9737.C1_x_at
TCTTCCACTACGAGATCGCCAACAGCCCCGAGGAGGCCATCTCTCTGGCCAAGACCACTTTCG
SEQ ID




ACGAGGCCATGGCTGATCTGCACACCCTCAGCGAGGACTCCTACAAAGACAGCACCCTCATCA
NO:




TGCAGCTGCTGCGAGACAACCTGACACTGTGGACGGCCGACAACGCCGGGGAAGAGGGGGGCG
1951




AGGCTCCCCAGGAGCCCCAGAGCTGAGTGGTGCCCGCAAACCGCCGGCTGCCCAATCAAGTA




CCACAACG





SFN
ADXCRAD_CN335041_at
CCCTGCTGCCTCTGATCGTAGGAATTGAGGAGTGTCCCGCCTTGTGG
SEQ ID





NO:





2754





SFN
ADXCRAD_CN335041_s_at
CGCCTTGTGGCTGAGAACTGGACAGTGGCAGGGGCTGGAGATGGGTGTGTGTGTGTGTGTGTG
SEQ ID




TGTGTGTGTGTGTGTGCGCGCGCGCCAGTGCAAGACCGAGATTGAGGGAAAGCATGTCTGCTG
NO:




GGTGTGACCATGTTTCCTCTCAATAAAGTTCCCCTGTGACA
2755





SFN
ADXCRAD_CN335041_x_at
CCCTGCTGCCTCTGATCGTAGGAATTGAGGAGTGTCCCGCCTTGTGGCTGAGAACTGGACAGT
SEQ ID




GGCAGGGGCTGGAGATGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGCGCGCGCGCC
NO:




AGTGCAAGACCGAGATTGAGGGAAAGCATGTCTGCTGGGTGTGACCATGTTTCCTCTCAATAA
2756




AGTTCCCCTGTGA





SLC25A1
ADXCRAD_CN295781_s_at
ACTGTGTCCCAGTGTCTGGCCCAGCCATGGCTGGATGTGCATCTGGCCTATGACCCTGTGCCT
SEQ ID




GTGTTTCATGTTCTGTGTCACGTGACCCTGTGCCCCGCCTCCCGGGGTGCCCGTGTGGCCTGG
NO:




GTCCTCGGCCCTGTAGCCCTGGCCCGGTCCCAGTCCGGTGCCTTCCACCCTGCCCTGGCCTAC
2501




CACAGCTGCCTCCGGGCCTCGGCCTGGCTTCACCGCATTCCAGGGGCTGCAGCCCCCTGCTTC




TCCCGCCATTGGCCTTAACTGGCCCTCGGGC





SORL1
ADXCRAG_U60975_s_at
TGAAGATGCCCCTATGATAACTGGATTTTCAGATGACGTCCCCATGGTGATAGCCTGAAAGAG
SEQ ID




CTTTCCTCACTAGAAACCA
NO:





1069





SORL1
ADXCRPD.18092.C1_at
CTGGGTTGCCAAAGGTAAAATATATAAAAGAGAAGCCTCTGACTTGGTTCCTGCTTCTGGTCT
SEQ ID




CTCTCCATCAAACGCATTCTGCCCACTACTTATCCTTCCCAAAGATGAACTTTCATCACATGA
NO:




CATCAGTGGTTCCCAACTGCTTCTCCGATAAAGTCCACAAAGCCTTTCTGTCCTGGCGCTGCC
1871




CACTCATCTAACTTCACCTTGCACCCTGTGCCCATGCCCATTCTCCATAACTCAAACCAGTTT




CCTGCCAT





SORL1
ADXCRAD_BX089897_s_at
TTTCTTCCCCGACTGAAAGATGGCTTTGTCCGTTGAGTTGAAAACTATTAAGTCCTGCCTTCC
SEQ ID




TCACTTTTCATCACGTGGCTTCTGTTTTTGAATTCCTTTTTGTTTTCAGTGATCCCACCACTA
NO:




GATATCCACATTGACAGCTATGGTGAAAATTATCTAAGCTTCACCCTGACCATGGAGAGTGAT
2476




ATCAAGGTAATGTGGGAATTTCAAGCCAGCAGCTGGATGGGGCTTTATTTTGTATGGGAACTG




AAAGGACATAGCACAGTAAGACTGG





SQLE
ADXCRAG_AF098865_at
GATTGTTACCATAAATTAGTGCTAATGCTGAGGAG
SEQ ID





NO:





856





SQLE
ADXCRAD_CB106889_s_at
TGGATTACAAAACCTCGAGCCCTTCTCAGTAGTGGTGCTGTATTGTACAAAGCGTGTTCTGTA
SEQ ID




ATATTTCCTCTAATTTACTCAGAAATGAAGTATATGGTTCATTAAGCTTAAAGGGGAACCATT
NO:




TGTGAATGAATATTTGGAACTTACCAAGTCCTAAGAGACTTTTGGAAGAGGATATATATAGCA
857




TAGTACCATACCACTTATAAAGTGGAAACTCTTGGACCAAGAT





SQLE
ADXCRPD.8241.C1_at
CAGAGGCTTCTTTTTCCGCGGACGGAGACACTGTACAGCCCAACCTCGGGAAAACGCCAACGC
SEQ ID




AGACGGATTCTCCAACAAAAGATGGGCTCGGACTCAAGAGTGCGGCTCCAGGGCAATGCAGCC
NO:




CAACCTAAAGATTTAGAAGGCTTCCCGTTTTCGTGGGCGCCAGAGCCGCCCACGGCGACTGCA
1825




GTTTCCCACCGATTAAAGGTGGGTTTCACGGTAACTCCCTCAGATTGCGGCGGCGATTCCCGA




CGGGTTCTCAACAGCAT





SQLE
ADXCRPDRC.8241.C1_s_at
TTTCCCGAGGTTGGGCTGTACAGTGTCTCCGTCCGCGGAAAAAGAAGCCTCTGAACCCGGGCC
SEQ ID




GGCCCGCAGCCCCCGTCGTTTCCGGCCGCTGCTCGCCGTCGCCCAGAGGCTAGGCCACGTTTT
NO:




CCCCCAGTGCCGAGGTGTTTCTGTGACCCCTCCCTCCACTCCCATTCCCTTCTGAAAGGGCAC
2031




CTGCTCTTGGTGAGAAAAGAAATTATAGCACGAAGAGCCAGTATCAGAAGAGTATCCATCACC




CGCAGCAACCGCTCAGGGAACACCAT





SQLE
ADXCRAD_BU754109_at
GTATAAGTCCCTGTACTTCAATGAAACTAATTCTTAAATTAAAATTTCTCAATTATTCCTGGC
SEQ ID




TCCCACAGACCAGAACATATGGATAAATCCATAGGCAAAAAACAAGCTTCTATTTTAATCAAG
NO:




GGTTATAGCTTCCTCTACCACCACCTTTAACTGCTGTTCCCTAGAAAGAAAACAGTACTAAAT
2783




ATTGCGTTTCTTCATTTCTTTGGGCCACCTTCTCATTGGGATACTAACAGATAATAAAATATC




AAAATGTGTAAGGAAGAAAGATTTGCAGTAATTCCCTCGTGCC





SQLE
ADXCRAD_BF979497_at
GCCCTTGGGACCTCACTTGTGGGAACCTTAACCCATCGAGACAGAAATCCGGTGACGGCGCCA
SEQ ID




AGAAGCTGGACCAGGGGCTTCGGCGTCGACCACACCTGTTAGAGCCGGACCATGGCCCGAGCC
NO:




GCGGCGGGGCCCCGGAGGCCACAGGCCAAGGCGGGCGAGGCAGCGCTCGAAAACACGGTGACC
2867




CCAAGAGGGAGAAGCCACTAGCGCAGAAGGGAA





SUV420H1
ADXCRAG_BC002522_s_at
GGGTGCTCTCTTCCACTACAGAGAATCCTGAAGAAAAGGGAAGGTGTTTCCCATGATGGTGAA
SEQ ID




TGTCACTGCCATGAATTCCTGAATCTACCTGCTGCTGGGAGTCAGAGTCCAAGCATAACCCGT
NO:




GTAGCATAAAAGCAGCGCTGTAGCCCTATTCCAGTCTTTTTCGTTAATGTCCAGAGTGAACAA
915




CAAGAGTTAGTCAATCATTAACTGTTGACTGTTGATTCTCATAA





SUV420H1
RDCR087_E11_s_at
CTTTATGTTCAATACCAGGTTCTTTTCATTTCTCTGGATTATTTTGCAAATCATTGGACAGAG
SEQ ID




AATTTGGGAATATAAATCTGTAACAGGTGTTTGACACCAGTAAGTCTCTTTATTTCTGGGAAA
NO:




TGTGTACCTGTACTTTCTGATATACAGTGTTCCTAAGTAAAAATCAATTCACGGGATTTGTAT
1362




AGTGTCTATAGGAAAGTAGCC





SUV420H1
ADXCRPD.8158.C1_s_at
GATGACAACAAGCAACATTTATCTAATGAACTACAGCTATCTTAATTTGGTTCTTCAAGTTTT
SEQ ID




CTGTTGCACTTGTAAAATGCTACAAGGAATATTAAAAAAATCTATTCCCTTTAACTTATAATA
NO:




GTTTATGAAATAAAAACATGAGTCCCAGCTTTTGTTCTGTGGTAACCTATAAAAAAAGTTTGT
1811




CTTTGAGATTCAATGTAAA





SUV420H1
ADXCRSS.Hs#S2577958_at
GTTCTTTATTACCAGCTTGAATGGGCAATGCCGCTAAAGATTTTAAGGCAGATTTAAGTAGTT
SEQ ID




TTCAATTTGAGTAATTTTTCTTGCTTTGGCTTTTCACAGGTAATGGTAACTCGGGATTTGAAG
NO:




GACAGAGTCGCTATGTACCATCCTCTGGAATGTCCGCCAAGGAACTCTGTGAAAATGATGACC
2132




TAGCAACCAGTTGGGTTCTTGATCCCTATTAGGTTTTCAAACACACAAAATGAATACTAGGTA




ATTTTCAGTCTTTATCCTGAATGGAACAGA





SUV420H1
ADXCRSS.Hs#S2577958_s_at
ATGGTAACTCGGGATTTGAAGGACAGAGTCGCTATGTACCATCCTCTGGAATGTCCGCCAAGG
SEQ ID




AACTCTGTGAAAATGATGACCTAGCAACCAGTT
NO:





2133





SUV420H1
ADXCRAD_BQ722638_at
TGCAGCATAACGACCACACAAACCACCACANATATTGTCCCCCCCTTGCGCCCCCCCCCCTTC
SEQ ID




CTCCCCTTTCATCCCCGGTCCTTATCCACAACCCCCCCCGGGGGAACATGCTCTTCCAATAAT
NO:




CCCCTCCCCTCCTTACCCACGGGGGCCTAACAAGGTAAGGTGGCAAAATAACCTCCCCCGCCG
2350




CCCCCCTTTTATTTAAACACCCCTGTCCCGGCCGAAAACTCTGCCATGCGTGCCACCC





SUV420H1
ADXCRAD_NM_017635_at
AAAAGTCCAGTGGAGAAAATCTCAATGCTTACTGTTACTACTAATTGATTCCTACTAGTTTCC
SEQ ID




AGGTTTG
NO:





2768





SUV420H1
ADXCRAD_NM_017635_x_at
GGTGTTTGACACCAGTAGGTCTCTTTATTTCTGGGAAATGTGTACCTGTACTTTCTGATATAC
SEQ ID




AGTGTTCCTAAGTAAAAATCAATTCAGGGGATTTGTATAGTGTCTATAGGAAAGTAGCCCATG
NO:




TCTTGAAATATGAAAAGGAATCTGAAGGTCATGAAAAGTCCAGTGGAGAAAATCTCAATGCTT
2769




ACTGTTACTACTAATTGATTCCTACTAGTTTCCAGGTTTG





TCF7L2
ADXCRAG_BC032656_s_at
GTGCCATGTGGCTACATTAGTTGATGTTTATCGAGTTCATTGGTCAATATTTGACCCATTCTT
SEQ ID




ATTTCAATTTCTCCTTTTAAATATGTAGATGAGAGAAGAACCTCATGATTCTACCAAAATTTT
NO:




TATCAACAGCTGTTTAAAGTCTTTGTAGCGTTTAAAAAATATATATATATACATAACTGTTAT
955




GTAGTTCGGATAGCTTAGTTTTAA





TCF7L2
ADXCRPD.1966.C1_at
TTAAAGAGCCCTCCATCTTGCCTCTTGGCCGCTTCTTCCAAACTTTCCCGGGATTTGTCTCGG
SEQ ID




AAACTTTCGGAGCGAGGCGGAGGCCGTCTTTCCGCCTCGGAATCGGAGGAGCTGTTTTGATTC
NO:




GTTTCTGATTCATTGACTAGAGACGATTTGACATCAGCTAAATCCCTCTCTGCCGAGGAGTTT
1536




TCGGAGCTCTTCTCCTCCTGTTCGCCCTCGTCTTTGAAGGAAATCAGTTCGTCGTTGGCGC




CTAGGTCA





TCF7L2
ADXCRPD.16751.C1_at
CGGTACTATACTTCTGTGCAGGCAGGTTCTGGTGTTGGGGACAAGGGTGTGAGTGAGAGGACT
SEQ ID




GAGTTGTTGCCTTTAGGAAGTGTACCGTCTAGCCAGGAGTAACGGCTTGAGTCGAAGTCGGCT
NO:




CCCATTGGGCCTCTTAGGGAGTCCCAGTTTGCTCTGAGGCCTGCTCCTCTCTGGGAAGAAATC
1852




ACCTTGAGAGCTTCTGGGATTTGGAACTCCCTGCATGGTTGGATCCCTTCCATCTTCATGTGA




ATAGTCTTGGTAATGAGGCTGCCC





TCF7L2
ADXCRSS.Hs#S11047314_at
TTGCTCCTTGGGACAACTGAAGAATCCTTAGATAATTAATAGTATGAAATACTGCCCTTTTAG
SEQ ID




TTGAAAAATGTCACAATAATGTAATAAGATAAATAAGGAGGTGTCGCTTTAACCTGTATCGTG
NO:




TAGTCTCCTCTACTTACTAACACTTACTTGTATTACTAGAAGCATTATTTTTTAAATCATGGA
2081




AAATTGGTGGCAAGCTGAGCATACAGTTGTTTATTTCTGTTTGACTGATTATTACAACTTCAT




TATTTGATGAAGGTTCTGTACGTTTTCCTTTAAGACACATA





TCF7L2
ADXCRSS.Hs#S1920919_at
TTTCAAGCAAACCACATCATTACCCACAGAGGCCATTGGTGAGATATTTGTAAGTCTCCTGAC
SEQ ID




AGTGGCTGGAGTTCGTTGCTTGGTAGTAGTTTCTCTGTCTCAGCCCTGGAGATGGGAGTGACC
NO:




ACCTGCTCTCTCTGGACAGAGGCTGTCCACGTTCATGCAATTCCTTGGACACCGGTGGCGCAG
2099




CGGGAGGCGTAACTGGGAGTGGGAGACCCTGAACTGTGCCGGTTCTTGCAGAGTATCAC





TCF7L2
ADXCRSS.Hs#S3013361_at
CGTCCTTTATGTGGCACACCCTTAAGGGAGACATCTTCCTGTCTGTGTATTGCACCCTCTTAA
SEQ ID




AACTACATTCCTTTCCCTTCAGCATTGGCATCTCTGTCCTTGTGTATTACCTGGGATGACTAT
NO:




TCAGTTAACAAATGCTTTCTTCCTAGGCTGTGAGCCCCAGTTTGTTGGATGATTGGATGGAGG
2171




CTATCAGCGC





TCF7L2
ADXCRSS.Hs#S3742718_at
TGTGAGTTGTACACCATGACTGGAATCGCTTGGACATACTCTTCAGCAGACATCGTGTGACTG
SEQ ID




TGGAAGAAATGAGTTTCATGAAGATGACTGATAGAAGGAAGCCACTGAACCAGTCCTCTATCT
NO:




CCTCTTCCAAGGCTAAAGTTTGGAGCCACTTGCAGAAGGCTCTCCTCAAACCCCTGTGTTCTT
2192




TGCCTACCCCTGCTGTTGCCACATCATCTTGGAGAGCTGGCTGC





TCF7L2
ADXCRSS.Hs#S3891559_at
GAGGGCGAGCACAATTTTACACAATTTACTGGCCAACTGTGGGCGAACAGTGCGGGGGCATAA
SEQ ID




GCGGGGTGGGATTTTTTGTGGGCGAATCTTGGGATGCGCCAGAGATGGGGGGACAATTTGAGT
NO:




GTCGGGGAAAATCTGTTTCCTTTTATTAATTTCATAGAGTATTGCCTTGGTCATTTGTCTATG
2219




AGAGATTTTCAATAATAGAGTGCTTGGCGAACACACATAATCTGGGGGGATGGCGATAAAGGA




AAATTTAAAACATACTTCATTGCGGGCCGAGACT





TCF7L2
ADXCRAD_AU118429_s_at
AGAAGCCCCACATAAAGAAACCTCTTAATGCATTCATGTTGTATATGAAGGAAATGAGAGCAA
SEQ ID




AGGTCGTAGCTGAGTGCACGTTGAAAGAAAGCGCGGGCATCAACCAGATCCTTGGGCGGAGGT
NO:




GGCATGCACTGTCCAGAGAAGAGCAAGCGAAATACTACGAGCTGGCC
2539





TCF7L2
ADXCRAD_BU173366_s_at
AATTCTGTATATTAGATTACTCTTAAACGAAAAACCAGCTGCCGCTTTTATGTACACATATTA
SEQ ID




CATACGAGTANGCAGCAGACTTTAAAAATAAAAAAACCTAGGCATGTTGATGTTGCAAAATGC
NO:




TGTATAAAGCTGAAACTGGTCATTCAGTGCCATTGTAGTTGACATGAAGCGATTGTAAAACTG
2575




TCTCCGATTTTTCTCTGGTT





TCF7L2
ADXCRAD_AV758440_at
GTATAAAGCTGAAACCTGTTCATTCAGTGCCATTGTAGTTGACATGAAGCGATTGTAAAACTG
SEQ ID




TCTCCGATTTTTCTCTGGTTTATTAAAATGCTAACTATAACATTTTTTGTGAATACTTTGAAT
NO:




GTTTCCTAACAGTTGTGATGTTACTGTTCCGTTTTATGCTCTTATTCCAAGTTCATTTTTAAT
2665




GGTTTGGAAGCCATTTTTGTAATGAATAAATGTTCATGCTGTACAGTATCTGTAGCATGCCGT




TCTGGATTAATAA





TCF7L2
ADXCRAD_AA664011_at
AAATCGGAGACAGTTTTACAATCGCTTCATGTCAACTACAATGGCACTGAATGAACAGGTTTC
SEQ ID




AGCTTTATACAGCATTTTGCAACATCAACATGCCTAGGTTTTTTTTATTTTTAAAGTCTGCTG
NO:




CCTACTCGTATGTAATATGTGTACATAAAAGCGGCACGTGGTTTTTCGTTTAAGAGTAATCTA
2880




ATATACAGAATTTTGGCACGTAAAGTTTTGTACACGGTCAGTCCGGGTCCTAAGGGCGCAGGG




TAGGGCATCCCACTGGGAGTTCAA





TGFBR3
ADXCRAG_NM_003243_s_at
AACTGTAGCAAGATGCAAATGCATGGCAAATCTGTCGGTCTCCAGTTGGTTATCTGAATAGTG
SEQ ID




TCACCAATTCCACCAAGACAGTGCTGAGATTGGAAAGGGCACTCATTTGGATTGCCTTACTTC
NO:




TCTTGCCTTAAATATATCCCATATATTTAATATGTCAAAAAGGGCTTGAGGTGAATTTCATTA
1021




AATGGAATAATATGATGCCACTTTGCAGCTAAAATAAGCTCAGTGATACCTCCTTGTT





TGFBR3
ADXCRIH.3170.C1_at
ATAAGGTATTTTCTCCCTAGCTTCTCATTTACAGTATTTCTAATTGCTTCACACTTTACAGTT
SEQ ID




TTAATACAAAGTACAAGCTCTACTTTTATAACGTGTACTACAAGTTTCTTTAAAAGAATGTTG
NO:




TATTTTCAGCTGACCTCTTGTATCTTGCATTCTTTGTTATTTTCTGCAGGCTACCCC
1206





TGFBR3
ADXCRSS.Hs#S624533_s_at
AAGATTGATGTCTTAGAAGGACAGGGTTAAAACCTTCTGTAATATATTTAAATATATATTTTT
SEQ ID




AAGAGAGATGCTACATTGCCAATGATTTTATAAATAATTTAAAATTAATTTACAAATTTATAG
NO:




ATGCAAACCAAAAGATCTTTTTAAAAGAGAGAGAGAGGAAAAAAATCACCTTTTATTTGTTTG
2187




GGTCTCATTGTCAGAATTATTATTCAGATCAAGAAACCTGTGTCGATAAAACCTAATCTCATA




TTGGAGAGTGAATGTCGTTAAGTATTTCTGAA





TGFBR3
ADXCRAD_BF664880_at
CCGGTAAGCACGACGCAACGAGCGACAGACACAGAGCCGACAGCAGACAGAAAGCGCAAAAGA
SEQ ID




GACAAGCGAAGACGGCAAACAACGCGGAGGAGAGACGGCACCAGCCCGAAGGCGAGAGCAAGC
NO:




GCACCAGCGACAGAAGAAGGAAAGCAAGAAACCACAAACAGACGAGCCAACAAAACAAAAAAG
2432




AAGAGACAACAACAGAGGAACGACACAGACAGAACCAGCACAGAAGAAACACAACAGAGAAAC




AACGGGACCAA





TGFBR3
ADXCRAD_BF677896_at
ACAGTGGTGTGAAGAACCCCAGTAAGGTATTTACTTTCCACTGTACTCATATGTTTGGTTGAA
SEQ ID




CTCTTAACTCTATCCTTATTGGTTATTACTTGTTAATTCTGAGTTTCCCTTTATAAACTTTCC
NO:




TAAAAAAAAAAAAAAAAAAAATTGGGGGCGCGCGCAGAAAATTTAACACCATTG
2632





TGFBR3
ADXCRAD_BF677896_x_at
TATGACTGTGAGACTTTTCCAAGGGATTTTTTTAAAAAACACATTAGGCTTTGTGCAGAAGTA
SEQ ID




AAGAAACAGTGGTGTGAAGAACCCCAGTAAGGTATTTACTTTCCACTGTACTCATATGTTTGG
NO:




TTGAACTCTTAACTCTATCCTTATTGGTTATTACTTGTTAATTCTGAGTTTCCCTTTATAAAC
2633




TTTCCTAAAAAAAAAAAAAAAAAAAATTGGGGGCGCGCGCAGAAAATTTAACACCATTG





TGFBR3
ADXCRAD_AW268884_at
GAAGTTGGATTCAGTCGTCCTGGCTCTGCCATTAGCCCATCCCTGGAGTTTAAAAAAGCAAGT
SEQ ID




CTTTTTAACTTCTTGGAGTTCAGTTTCCTCACCTGTGAAATGAAGAAGCTGAATAAGCTCATC
NO:




TTAGGGTTATTTGCTGCTCCAACAGTCTAATATTCTCTGAGGAACAATATGCTTGGGTTCATG
2838




GGAGAGTCACTTCCCACAGGAACCACGCTGACCAGAGCACCTGATTGCTAGCCTCTCTTCTCT




GGA





TGFBR3
ADXCRAD_BF439431_x_at
GGTCTTATTCTGTCACTCAGACTGGAGTACAGTGGCATGATCATAGCTCACTGTGGCCTTGAA
SEQ ID




CTCTGGGGCTCAAGCAATCCTCTTGGTGGTTTTAAAAATTTTTGTAGAGACAGGAGTCTTGCT
NO:




ATATTCCCCAGGCTGGTCTTGAATTCCTGCCTCAAGCAATCTTCCTGCCTTGGCCTCCAAAAG
2895




CATCAGGATTACAGAAGTGAGCTATCATACCTGACTCAAATATTA





TJP1
ADXCRAG_L14837_at
TCTGTTAATCATTAGGTGTGACTGAATTTCTTTTGCCGTTATTAAAAATCTCAAATTTCTAAA
SEQ ID




TCTCCAAAATA
NO:





993





TJP1
ADXCRAD_BM352913_s_at
TTGAGCCTTGAACTTTGACCTCTGCAGCAATAAAGCAGCGTTTCTATGACACATGCAAGGTCA
SEQ ID




TTTTTTTTAAGAAAAAGGATGCACAGAGTTGTTACATTTTTAAGTGCTGCATTTAAAAGATAC
NO:




AGTTACTCAGAATTCTCTAGTTTGATTAAATTCTTGCAAAGTATCCCTACTGTAATTTGTGAT
994




ACAATGCTGTGCCCTAAAGTGTATTTTTTTACTAATAGACAATTTATTATGGCACATCAGCAC




GATTTCTGTTTAGATAATACACCACTACATTCTGTTAAT





TJP1
ADXCRIH.3943.C1_s_at
AAGGTGAAACACTGCTGAGTCCTTTGGTGATGTGTGGTCCCCATGGCCTCAAGTTCCTGAAGC
SEQ ID




CTGTGGAGCTGCGCTTACCACACTGTGCGTCCATGACTCCTGACGGTGATCCTAAAACCTGGC
NO:




AAAACAAGTGTCTTCCCGGAGATCCAAATTATCTCGTTGGAGCAAACTGTGTTTCTGTCCTTA
1240




TTGACCACTTTTAACTCTTGAAATATAGGA





TJP1
ADXCRPD.11593.C1_at
TGGGCTTCCGGTCTGAGTCTACCATGTGTGTCATACCCAGGAGCTGGCTGCTCTTCGTGCCGC
SEQ ID




AGGGCGGATGCTCTAGGTGCCTGTTCGTAACGTGGTCTGCTGTCGTAAGACAGAGGGGCTGGC
NO:




TCTTCAAAACGTGGAAAGTACCCTCGTTCTGAGGACTCTTCGGGATGCTGTCTGGAGTCAAGG
1531




TCTTGAGAGTGCTGATTATCAAAAGGTGGCCGAGATGGGTAGGGCTGTTTGTCATCATAATAT




GACCACTGTTCTTCATACATGGG





TJP1
ADXCRPD.14975.C1_s_at
TTAAATGCACCTGGAATATATAACCAGTGTTGTGGATTTAACAGAAATGTACAGCAAGGAGAT
SEQ ID




TTACAACTGGGGGAGGGTGAAGTGAAGACAATGACTTACTGTACATGAAAACACATTTTTCTT
NO:




AGGGAAGGATACAAAAGCATGTGAGACTGGTTCCATGGCCTCTTCAGATCTCTAACTTCACCA
1769




TATTACCACAGACATACTAACCAGCAGAAATGCCTTACCCTCATGTTCTTAATTCTTAGCTCA




TTCTCCTTGTGTTACTAAGTTTTTATGGCTTTTGTGCATTATCTAGAT





TJP1
ADXCRPDRC.11593.C1_s_at
AGATCTGCATCCTTAGAGACCAAGAAGGATGTAAATGACACTGGCAGTTTTAAGCCTCCAGAA
SEQ ID




GTAGCATCTAAACCTTCAGGTGCTCCCATCATTGGTCCCAAACCCACTTCTCAGAATCAATTC
NO:




AGTGAACATGACAAAACTCTGTACAGGATCCCAGAACCTCAAAAACCTCAACTGAAGCC
1959




ACCTGA





TJP1
ADXCRSS.Hs#S2984021_at
TAGTTCAAAGCAACCCATCGTTCTTGCTTACATCTGCATTTCAAACCAGCTTTAAAAACTTAA
SEQ ID




GTGGATTGATTAGTTCTAAGTTATTCTTGCCCAGACTTTCATATATTTCCTTGACTGGCTACT
NO:




GGATTATAGTATTCCGAACCCTGGCCAGCTTAAGATTAGAGTAGATAGCAAGAAGACTTTTCT
2152




TCTGCAACAGCTGTTACCGAGTTTAGAAGCCCTTTAGACTTGTTCCGAGGGATTGTGCTCTTA




CAGGATAGATCCCTGGATTCCCACTC





TJP1
ADXCRAD_BM674772_at
TCTGCCTCTACTAAATGGCTCCAAACAGCTGCAATTTCACAACCAAAGTTTTTTACTTGAAAC
SEQ ID




AGCATGTTACTCCTTGCTAATCTAATTGAGTGTGTATTAATCGGCTACACTGGTCACACATTT
NO:




GATTGGGTAAGACCTAAAGTAGGCTCTGCTTAACAGTGAGTCCGTTCATGTGACCTATAAAAT
2599




CTCTCTCAGAGACTCCTTTCCAGTCCATCTTTGTCAGCTGTCTTGTCTAGAGCTTTCAACTAG




CTCATAGCCTCCAGATAACAAGGTCCTCGTGCCGAA





TJP1
ADXCRAD_BM674772_s_at
ATTGAGTGTGTATTAATCGGCTACACTGGTCACACATTTGATTGGGTAAGACCTAAAGTAGGC
SEQ ID




TCTGCTTAACAGTGAGTCCGTTCATGTGACCTATAAAATCTCTCTCAGAGACTCCTTTCCAGT
NO:




CCATCTTTGTCAGCTGTCTTGTCTAGAGCTTTCAACT
2600





TJP1
ADXCRAD_CN372474_at
TGACTCCTGACGGTTGGTCTTTTGCTCTAAAATCATCCGACTCCTCGTCGGGTGATCCTAA
SEQ ID




AA
NO:





2668





TJP1
ADXCRAD_AL109707_at
ATTACCGATGGTTGATGGACATGCCAAGGTATTGACCTCTTAAGCCAGTAGTGGCTGGTTAGA
SEQ ID




GCTTGGCAAAGGAGCAGCCCCCTCAGTTTATCTCAGTGTGCCATACAAATAATATTTTCTCTG
NO:




GATGTTACAGTGTGAAAAAGGGTGGGAAGTAGTGCCCTGTTGAGCCATATTAGAGCCCCAGGC
2830




AAAAGAAA





TJP1
ADXCRAD_AW173166_at
GGGTAAACAACTATCTGATGTACATATTCAACTGTCACTGAGGACCAGTAGAGAGATCAGAAT
SEQ ID




CCATGAGGAGGCAAATTCTGCCTGTTTTTTTCTGATATAATTCCAGGGCCCACAAGAGTACAA
NO:




CAGTGCTTGGCATACAGTAGAACACTAAAAAATTACTTAGTCTTTAAGAATGAATAGGGTTTC
2897




AATGGTTTCTAGAAATATAAGATGAAGAAAATATCTTCTGGAAATACAAATGAAAGAATGAAG




CATATATTATTCTAGACAGTAAA





TMEM97
ADXCRAG_BC045655_s_at
CTACAGCCAGGCATAACATATCCACTGTGTGCATAGAGGGTCTCTTCACGTTGATGCTTGGCA
SEQ ID




TTCCATCAGCTTTCTCTAAGTCTTTGCTCAAGTTCAACCTTAAAATGATGTTAG
NO:





966





TMEM97
ADXCRAD_CX867137_s_at
TTAATTTTCATGTTGCGGAGCCCCTACTACAAGTATGAAGAGAAAAGAAAAAAAAAATGAAGG
SEQ ID




AAACAACCACTGGCCCAGGGTAGAGATGCCTACAGGGTGGTTGCTTGTTGGATACAATACAAG
NO:




GAACACTGCTCAGAACCCACGTCTTCAGCAGCATTTGAAACACTGGCAGCAATGCACAAGAGC
2532




AAGATGGTGTCAGGAACCATGTCAAACCCTC





TMEM97
ADXCRAD_BU857068_at
TCTTCCTGCCAAGAAAGAATGGGGGATTCCATTCCTTGAGGGATTATGCCAAATTAACAAGAA
SEQ ID




TCTCGGGGGAAACACAGGATAAAT
NO:





2566
















TABLE 11







Genes and corresponding Almac probesets predicting sensitivity to oxaliplatin. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





HNRNPA1
200016_x_at
AACTCGAGGACTGTATTTGTGACTAATTGTATAACAGGTTATTTTAGTTTCTGTTCTGTGGA
SEQ ID




AAGTGTAAAGCATTCCAACAAAGGGTTTTAATGTAGATTTTTTTTTTTGCACCCCATGCTGT
NO:




TGATTGCTAAATGTAACAGTCTGATCGTGACGCTGAATAAATGTCTTTTTTTTAATGTGCTG
830




TGTAAAGTTAGTCTACTCTTAAGCCATCTTGGTAAATTTCCCCAACAGTGTGAAGTTAGAAT




TCCTTCAGGGTGATGCCAGGTTCTATTTGGAATTTATATACAACCTGCTTGGGTGGAGAAGC




CATTGTCTTCGGAAACCTTGGTGTAGTTGAACTGATAGTTACTGTTGTGACCTGAAGTTCAC




CATTAAAAGGGATTACCCAAGCAAAATCATGGAATGGTTATAAAAGTGATTGTTGGCACATC




CTATGCAATATATCTAAATTGAATAATGGTACCAGATAAAATTATAGATGGGAATGAAGCTT




GTGTATCCATTATCATGT





RPL10A
200036_s_at
CAGCTTGAAGAACTATGATCCCCAGAAGGACAAGCGCTTCTCGGGCACCGTCAGGCTTAAGT
SEQ ID




CCACTCCCCGCCCTAAGTTCTCTGTGTGTGTCCTGGGGGACCAGCAGCACTGTGACGAGGCT
NO:




AAGGCCGTGGATATCCCCCACATGGACATCGAGGCGCTGAAAAAACTCAACAAGAATAAAAA
831




ACTGGTCAAGAAGCTGGTCAAGAAGTATGATGCGTTTTTGGCCTCAGAGTCTCTGATCAAGC




AGATTCCACGAATCCTCGGCCCAGGTTTAAATAAGGCAGGAAAGTTCCCTTCCCTGCTCACA




CACAACGAAAACAT





RNPS1
200060_s_at
CAGGGAAAAGTGAGGCTCTTGGGGGTGGTTTGACCCTGCTTACCTGGGAGCACACTTTTCCC
SEQ ID




TTCCCCGATGACCTGGGATGGTGGCCAGGCCGTGCCCTTGCTGTTGCTGGGCAGTGTCCTTT
NO:




TGGAAAGGGAGCTGCCCCAGGCTTTAGTGCAGCTGCCAACCCTGTTAGGCCTGGCCTCTCGA
832




GGCCTCTTCTGATCTCAAGGGTCACACCCCCTCAAAGATCCTCTCACCCATGGTAGTTGCTG




CTCGTGGTTCTGTCTGTCCGTGCACCGATGCACACACCGCACCCCACCACTGTACTCTGAAA




TTGGCGAGTGAGTGGAGAGCCAGCTCTGCGGAGTCATCACGCAGCCATGGTTGTGCCTGCCG




TTCATGGTGGTCTTTCAGGTTATCTTGGCAACATGTACATTGCTTTTATTTTTTTTCTTTTT




TGCTTTCATTGTACAGTCAGTACTATAAAATTTCTCTTTTGAGTTTTATACCTTTGTAGCAT




TTTAGATGACATTGTGTTTGTACTTTGTTG





RPS6
200081_s_at
ACTTCGTACTTTCTATGAGAAGCGTATGGCCACAGAAGTTGCTGCTGACGCTCTGGGTGAAG
SEQ ID




AATGGAAGGGTTATGTGGTCCGAATCAGTGGTGGGAACGACAAACAAGGTTTCCCCATGAAG
NO:




CAGGGTGTCTTGACCCATGGCCGTGTCCGCCTGCTACTGAGTAAGGGGCATTCCTGTTACAG
834




ACCAAGGAGAACTGGAGAAAGAAAGAGAAAATCAGTTCGTGGTTGCATTGTGGATGCAAATC




TGAGCGTTCTCAACTTGGTTATTGTAAAAAAAGGAGAGAAGGATATTCCTGGACTGACTGAT




ACTACAGTGCCTCGCCGCCTGGGCCCCAAAAGAGCTAGCAGAATCCGCAAACTTTTCAATCT




CTCTAAAGAAGATGATGTCCGCCAGTATGTTGTAAGAAAGCCCTTAAATAAAGAAGGTAAGA




AACCTAGGACCAAAGCACCCAAGATTCAGCGTCTTGTT





MDN1
ADXCRAG_AB002299_at
CTGTTGTTGATGTAATTTGTGACTCTTCTTAATGGAAGATGACAGGATTGTAAAAGGTATGC
SEQ ID




TAGGGGACTGATCTTCTCTGCTGGATCAGTCAGTCAGCTGTTACTAGTTGATGCTGTGCTAA
NO:




CATGATCCCCTCCTACTTCCATGTTGCTCTTACTACAAAGGTTATCATTTGCATTTATGTCC
835




ATGGTAGGCTGAGCTATAATATGCTGGCTTTGCAGCAGAATGAAAAGGATGAGTTGGTGTAG




CCTTATAAG





MRPS2
ADXCRAD_AL583494_s_at
TTGGCTGCAGTTAGGACCTCAGTGGCTGGTATGGCCGAGCTGCTAGAAGATGCTGCTGTCCC
SEQ ID




TGTGATCCCAGCAGCCCTCCCTTCACCGTGACCCCTGACCTTTGTCAGGAAGGTGCAGTTTT
NO:




TCTTCTCAATCTAAATGCCTTTCAGGTGGGCCGCTTCCTTGGCTACCTGGTTCCAGGGGGCT
839




GTTTTGTAATGAGATGCTGCTGGCAGGCCACTCAGAGGCTCCCAGCTGGGTTGGTGGGACAG




CCAGGCCAGATGACCTGATTCCAGCAAAAATAA





ABCA7
ADXCRAG_AB055390_s_at
CCCTGGCGCGCGTCTTTGGAGAGCTGGCGGTGCACGGCGCAGAGCACGGCGTGGAGGACTTT
SEQ ID




TCCGTGAGCCAGACGATGCTGGAGGAGGTATTCTTGTACTTCTCCAAGGACCAGGGGAAGGA
NO:




CGAGGACACCGAAGAGCAGAAGGAGGCAGGAGTGGGAGTGGACCCCGCGCCAGGCCTGCAGC
840




ACCCCAAACGCGTCAGCCAGTTCCTCGATGACCCTAGCACTGCCGAGACTGTGCTCTGA





ATP2A3
ADXCRAG_AF068220_at
TGTCCCGGAACCACATGCACGAAATGAGCCAGAAGTGAGCGCTGGGAACAGAGTGGAGTCTC
SEQ ID




CGGTGTGTACCTCAGACTGATGGTGCCCATGTG
NO:





849





ATP2A3
ADXCRAD_BX437326_s_at
GACTGTGAGGTGTTCGAGTCACGCTTCCCCACCACCATGGCCTTGTCCGTGCTCGTGACCAT
SEQ ID




TGAAATGTGCAATGCCCTCAACAGCGTCTCGGAGAACCAGTCGCTGCTGCGGATGCCGCCCT
NO:




GGATGAACCCCTGGCTGCTGGTGGCTGTGGCCATGTCCATGGCCCTGCACTTCCTCATCCTG
850




CTCGTGCCGCCCCTGCCTCTCATTTTCCAGGTGACCCCACTGAGCGGGCGCCAGTGGGTGGT




GGTGCTCCAGATATCTCTGCCTGT





PDSS1
ADXCRAD_BM824056_s_at
AACTTCGACCATCCCCAGAAAGAGATGCCCTCATTCAGCTTTCAGAAATTGTACTCACAAGA
SEQ ID




GATAAATGACAACTCTTTCTGTTCTTTCTGGCAGCTATCTTACCAGACTGTGCCTAAAGAAT
NO:




TTTGTGGAATACACTTTGTTTGCTTCATGTGCAGATAACCAAAAATCATTTTAAAAGATATC
862




AAACTTATTGATGGGCAAT





CYFIP2
ADXCRAG_AF132197_s_at
TGGGAATTTTTGTACAATGAATTTACATTTATTTATGGTGACATATTTACGCTTGTGATCAA
SEQ ID




ATAATGATGTTAAATTCTTAAATCATATTTGCTATGCAGCTGAAGATGATATTTTGA
NO:





863





CYFIP2
ADXCRAG_AF132197_x_at
TTTCAGAAACTGTCAAATGTACCATATTTGTATTAAGAGTTGTTGGGAATTTTTGTACAATG
SEQ ID




AATTTACATTTATTTATGGTGACATATTTACGCTTGTGATCAAATAATGATGTTAAATTCTT
NO:




AAATCATATTTGCTATGCAGCTGAAGATGATATTTTGATTTGTATTTTGGGGGTACCTGTGT
864




TGAGTTGATAAACATTTCCATCTTCATTAAAACTGCTTCCAAACTAAA





BIN2
ADXCRAG_AF146531_s_at
CTCAGGGAATATTTAATTCTGGTTTTAGCATTATTAGAATAAGACTTTATACATTAACTAAA
SEQ ID




GTGGAGCTTTAATCACTATAAAAAGCAAAAGTATNTATAGACACAGACACTTGCCTATACAG
NO:




AGACATAACCACACACACTCAGAGGATAGTGAACAAATCTGTCTTTGACTTACGACCCATTT
867




TGCAAGAC





MDN1
ADXCRAG_AF503925_s_at
AGCAGGTGCCTGAACTCGTAACTAGAGAAGAGTTATCCTTCTTCCCTGCCTTGGAAGCCCTG
SEQ ID




GCCTGGGAGGAGGTCATACCCCACCGTTGGAGCCCAGCTGCCTGTTTTCTTTTGCAGGGGAT
NO:




CTGGGCACCTGTGCCTTGAGGAGATGCTGCCAGGAGCATGGGACTCTGACAGTCCTTTGTAT
879




AAAGGACTAAAGGGAGCTGCCCTTTTGACCCTGTTCTAAGCTCTGCCTTGCCAAGCCCATAG




TGTGTGCCCAAAAGCTGTCAAGTGGCCAAGACAGCTCGTTTCTGGAG





HSPD1
ADXCRAG_AJ250915_at
TTTGTACATTCCTGATACTGGGTACAAGAGCCATGTACCAGTGTACTGCTTTCAACTTAAAT
SEQ ID




CACTGAGGCATTTTTACTACTATTCTGTTAAAATCAGGATTTTAGTGCTTGCCACCACCAGA
NO:




TGAGAAGTTAAGCAGCCTTTCTGTGGAGAGTGAGAATAATTGTGTACAAAGTAGAGAAGTAT
881




CCAATTATGTGACAACCTTTGTGTAA





BCL11A
ADXCRAG_AJ404611_s_at
AAGCTGTTTGTCGTAACTTGAAATTTTATCTTTTACTATGGGAGTCACTATTTATTATTGCT
SEQ ID




TATGTGCCCTGTTCAAAACAGAGGCACTTAATTTGATCTTTTATTTTTCTTTGTTTTTATTT
NO:




TTTTTTTTATTTAGATGACCAAAGGTCATTACAACCTGGCTTTTTATTGTATTTGTTTCTGG
882




TCTTTGTTAAGTTCTATTGGAAAAACCACTGTCTGTGTTTTTTTGGCAGTTGTCTGCATTAA




CCTGTTCAT





BCL11A
ADXCRAG_AJ404613_s_at
CTTTCTGGCCCAGTTAATTTGCACAGAACTTTTCTCAGTTTGGTATTTTTTACTGCTTGGAG
SEQ ID




ATCCAGAAGAGAATTAGAAACAACATAGCAAATTAAAATAGGTTTGTCAATAATAGAGCTCA
NO:




GACACCTGTGTGCTGTAGATTCACATACAGGCCGTGAACCTAAGTGGGGAAAATCCTACCTA
883




TCCACCTTCTGGCTAGATTACCTAGCTTAGTGAAAAG





BCL11B
ADXCRAG_AJ404614_s_at
TTATTATTGCTTGGTATTTGTGCTCTGTTTAAGAAACAGGCACTTTTTTTTATTATGGATAA
SEQ ID




AATGTTGAGATGACAGGAGGTCATTTCAATATGGCTTAGTAAAATATTTATTGTTCCTTTAT
NO:




TCTCTGTACAAGATTTTGGGCCTCTTTTTTTCCTTAATGTCACAATGTTGAGTTCAGCATGT
884




GTCTGCCATTTCATTTGTACGCTTGTTCAAAACCAAGTTTGTTCTGGTTTCAAGTTATAAAA




ATAAATTGGACATTTAACTTGATCTCC





NUP210
ADXCRAG_AK074101_s_at
ACGTGTGATCCCTTTCACTCCATCAGGACACCAGGACTGTCCTTAGGAAAATGTCCTTGAGA
SEQ ID




TGGCAGCAGGAGTCATATTTTCTGTGTGTGTGTTTCGGAAAGCCGCTGTGTCCTGCCTCAGC
NO:




ACAAAGACCCAGTGTCATTTGCTCCTCCTGTTCCTGTGCCACTCCAGAACCTCAGCAGATCT
885




GAGCCACCGCCTGCCAGTGTGAGAGGCGGCCACTTTCATGGCAGCT





HMGB1
ADXCRAG_AL110194_s_at
AAATCTATAATTAATTGGGCCAACTTTTAAAATGAAGATGCTTTTTAAAACTAATGAACTAA
SEQ ID




GATGTATAAATCTTAGTTTTTTTGTATTTTAAAGATAGGCATATGGCATATTGATTAACGAG
NO:




TCAAATTTCCTAACTTTGCTGTGCAAAGGTTGAGAGCTATTGCTGATTAGTTACCACAGTTC
888




TGATGATCGTCCCATCACAGTGTTGTTAATGTTTGCTG





PAICS
ADXCRAG_AL833068_x_at
AATTAGCTGGGCGTGATGACAGGCACCTGTAATCTCAGCTACTCGGGAGGCTGAGACAGGAG
SEQ ID




AATTGCCTGAACCCGGGGGGTGGAGGTTGCAGTGAGCCAAGATCATGCCACTGCACTCCAGC
NO:




CTGGGCAACAGAACGGAACTCTGTCTCAAATAAA
897





CHD7
ADXCRAG_AL833190_at
CAGTTCAGCAAGCTAACATAATAATAAAAACAAGTTTTGCTGTCATTAAGTTTTATCATTGA
SEQ ID




GCTGTTAGGAGGGAAGAACTACTTAGGTATTTCCATTTGGAATGGCAGGTTCACCACAGAGG
NO:




CTCACATTGAGATCAAGTTGTCTTCGACAGCCTTTATAGCCACTGTTTGCCTC
898





41888
ADXCRAG_AY034177_s_at
ACACGTACACACATCCCTCACTTCTCTTAAGCCAAGAAGTTTGCTTTCCCTAGCTGCAGTGT
SEQ ID




AGATGGCTCTTGTTTTTGTTTTTTTGTTTTAATCATTTGGCATTCACATGTGGCTGTTAATA
NO:




TGTGCTTGTTTTT
901





USP7
ADXCRAG_AY376241_s_at
CCCCAAAGAGGAGTCGCTACACTTACCTTGAAAAGGCCATTAAAATCCATAACTGATTTCCA
SEQ ID




AGCTGGTGTGTTCAAGGCGAGGACGGTGTGTGGGTGGCCCCTTAACAGCCTAGAACTTTGGT
NO:




GCACGTGCCCTCTAGCCGAAGTCTTCAGCAAGAGGATTCGCTGCTGGTGTTAATTTTATTTT
908




ATTGAGGCTGTTCAGTTTGGCTTCTCTGTATCTATTGACTGCCCTTTTTGAG





TRIAP1
ADXCRAD_BU539578_s_at
TTCAGAGCTCTCAGTGTGCAGTTCAGGAATTAAGATACTTGGAATAGCTGTGGAGGAAGAAC
SEQ ID




CTAAATTGCAAAGATCTGCTATTGCCAGCTCTCAACCCAAGTCAGTGAATTGTCAACCTGCA
NO:




TATCCTAAAAATGTCAAAATGCTGCATCTGGTTAAATGTCGGGGTAGGGGGGAAGCTGAAGG
916




TGCTCGCTTCATTTGCCTTGTTTACTCATCCTGCCCTGTAATGTCTGTAATCCTGAA





RUVBL1
ADXCRAD_CN389613_s_at
AAGAGCATGTCGAAGAGATCAGTGAACTTTTCTATGATGCCAAGTCCTCCGCCAAAATCCTG
SEQ ID




GCTGACCAGCAGGATAAGTACATGAAGTGAGATGGCTGAGGTTTTCAGCAGCAAGAGACTCC
NO:




CCAGGTGTGCCTGGCCTGGGTCCAGCCTGTGGGCGCTTGCCCCTGGGCTTGGGGCTGCCGTC
918




CCCACTCAGGCGTGGGCTGCAGCGCTGTCAGTTCAGTGTGGAAAGCATTTCTTTTTAAGTTA




TCGTAACTGTTCCTGTGGTTGCTTTGAAAGAACCCTTC





IMPDH2
ADXCRAG_BC006124_at
AGTGTCTGGTGCTGTGCAGGACAAAGGGTCAATCCACAAATTTGTCCCTTACCTGATTGCTG
SEQ ID




GCATCCAACACTCATGCCAGGACATTGGTGCCAAGAGCTTGACCCAAGTCCGAGCCATGATG
NO:




TACTCTGGGGAGCTTAAGTTTGAGAAGAGAACGTCCTCAGCCCAGGTGGAAGGTGGCGTCCA
921




TAGCCTCCATTCGTATGAGAAGCGGCTTTTCTGAAAAGGGATCCAGCACACCTCCT





TRIM14
ADXCRAG_NM_033219_s_at
TGGACTACGAGGCCGGCGTCCTCGCCTTCTACGACGTGACGGGCGGCATGAGCCACCTGCAT
SEQ ID




ACCTTCCGCGCCACGTTCCAGGAGCCGCTCTACCCGGCCCTGCGGCTCTGGGAGGGGGCCAT
NO:




CAGCATCCCCCGGCTGCCCTAGGGGCCAGGACCGGCGTGACAGCCTCCAGA
922





LCP1
ADXCRAG_BC007673_s_at
TGTAATGGAACTTAGCCATTTTTCAAAGCAATTGAAATGCATTGCTCTGGATCTGTTCCTTG
SEQ ID




GCAGTGGACTCAGAAAGCCAACATGTGGCTCCTCCCAGCCCATAACCAGTATTTTTGCTGCT
NO:




TCTGAATACAAATTGGTTGGTTTTGACTTCAGATTGAACTTACTGTAGCCTCAGATGATTTC
924




CCCCCTCCGCCTCCAGGAAGAAAGAATGTTACTGCCTTAATAAA





EZH2
ADXCRAG_BC010858_s_at
AAATGGAAATCCCTTGACATCTGCTACCTCCTCCCCCCTCCTCTGAAACAGCTGCCTTAGCT
SEQ ID




TCAGGAACCTCGAGTACTGTGGGCAATTTAGAAAAAGAACATGCAGTTTGAAATTCTGAATT
NO:




TGCAAAGTACTGTAAGAATAATTTATAGTAATGAGTTTAAAAATCAACTTTTTATTGCCTTC
929




TCACCAGCTGCAAAGTGTTTTGTACCAGTGAATTTTTGCAATAATG





CYFIP2
ADXCRAG_BC011762_s_at
AGACAGACAGTTCCACTGTGGAGCATGTGCGCTGCTTCCAGCCACCCATCCACCAGTCCTTG
SEQ ID




GCCACCACTTGCTAAGCAGAAGATCCTGCAGACCCTTATCTGGAGGAGGAAGAGAAGCAGGA
NO:




GAGAGAAAGCCACAGCCAGCCTGCCATAGGATCCAACTGGACAACGTGTGGGATGGACCTGG
932




AAACAAGCACCTCCCCAAACACATCACCACTCCCTAGGGCGGGGCCTGTGCATGCTCTCCCA




TGACATCTCCATGCTGGTTTCTCCATAGCATAAATG





PCCB
ADXCRAG_BC017735_at
GTACAATTTGAAACTGATGCTTCACCTTTCCTTTAA
SEQ ID





NO:





941





PCCB
ADXCRAD_CB163512_s_at
TTTCTCCCAGAATTGTGGGCTTCACTGGAAGTGAAGGTGCAGGAATGACTGGACTGTCCACC
SEQ ID




CCAGCCCTGCCTGCCTGTGGTTTTGGCCAGGGAGCAAGCCATGAGGTGCCCTGGCACATGCA
NO:




CAAATTGATCCTTTGCGTGACAGTCTTGTATGGAAAACAGATGCTGACAGAATTGTAGACTA
942




CCATGCCACACAAAAAGGCTAAATATCTACTCCAATGGGTTTCCAGTTCAGTTTGAAGTCAA




TCAAATTTTTGTATTTTTCGGTGTCTCCTTGATTGGTTTTGCTA





PCCB
ADXCRAG_BC018013_at
CTCGAGTTAGTTTTTTTATCCATAGGTGAGATATATAGTAAGTTTTTAAGGCAAAGTATTTC
SEQ ID




TTAGGCTTAAGTTTCCTTATTTTAAAAATAGGGTAATATGCCCTATCTATCTCCTAATTCCT
NO:




CCATGAATTGAGGATTAAATGTGATGTTTGCAATTGTGGTATATGTGTTTAGCAGTACAGAT
944




GCTCAATAAGGCATAGCACCCTATGTTGACTCAGGTTATTTCCAGAA





IKZF1
ADXCRAG_BC018349_s_at
GGGTTCTTAGTCTCAGCACTATGACATTTTGGGCTGACTACTTATTTGTTAGGCAGGAGCTC
SEQ ID




TCCTGTGCATTGTAGGATAATTAGCAGTATCCCTGGTGGCTACCCAATAGACGCCAGTAGCA
NO:




CCCCGAATTGACAACCCAAACTCTCCAGACATCACCAACTGTCCCCTGCGAGGAGAAATCAC
945




TCCTGGGGGAGAACCACTGACCCAAATGAATT





BCL11A
ADXCRPDRC.960.C1_s_at
CATTCGGCGTAGTACCCAGAGAGCTCAAGATGTGTGGCAGTTTTCGGATGGAAGCTCGAGAG
SEQ ID




CCCTTAAGTTCTGAGAAAATTTGAAGCCCCCAGGGGTGGGGTGGACGGTGCCGCCCAGTCGA
NO:




CGTCAGCGTGGTCTGTCATCCTGCTAGTTTGTGATGTTTTCTGACAGTAGCCTCCAAGAAGC
947




CGTTGTGCGAAGACAGAGTCCTGCAGAGTCCTTCCAGCCTAGGCCTGCAGCGCCATTTTA





CD3D
ADXCRAG_BC039035_at
AAAAATAGATGTTGGGTCTCGTCAAGTGCTTACCCTGCATCCATTGAGATGATAATATGGTT
SEQ ID




TTACTTTTTTAGTCTGTTAATATGGTACATTACATTGATGGCACGATATGTTAAACCAACCT
NO:





959





CD3D
ADXCRAG_BC039035_x_at
AGTTCTTTTCTTTCTAGTTTGCTGAGAATTTTTATCAAAAATAGATGTTGGGTCTCGTCAAG
SEQ ID




TGCTTACCCTGCATCCATTGAGATGATAATATGGTTTTACTTTTTTAGTCTGTTAATATGGT
NO:




ACATTACATTGATGGCACGATATGTTAAACCAACCTTTCATTCCTGAAAAAAACTCTAGTCA
960




TTTGGTATTATTCT





RNF44
ADXCRAG_BC039833_at
AATATTGTTGCTGATTTCAGAGGGATATTCACTAATAAATGTAT
SEQ ID





NO:





962





RNF44
ADXCRAG_BC039833_s_at
TTTCCATTCCATGGGATTCACATTGGTTTGTAGCATTTAACATAACTAGTATGTTGTATTAT
SEQ ID




ATATATGTGTATACTGATTGAAATTTTTAACAGATTTGTACTTTTTTTAAAATGAAAGTTGC
NO:




TAGTTCTGCTTGACCAAGTAGTG
963





SKAP1
ADXCRAD_CR741870_s_at
CCAAGTCTCTTGACACCTCAGAGTGACTGTAAGCTACCAGTAAGACAAGTGGGAAGAGGCAC
SEQ ID




GTTCATCAAACCTGTTACTAAACCAGCCTAGTCATAGCTCATCCCCATCTCTAAATGTGTCC
NO:




ACACAACCACATCTGCCTTTTCCACAAGCTTTTCACAAAGAAGGTGAGAGAGAAGGAAACCT
969




TGGGAGGAGGACATTACTGGTTGTTCTGGCTGGTTTGAA





NASP
ADXCRAD_CX783596_s_at
GATATTTCCCACCTTGTCAGAAAGAAGAGGAAACCAGAGGAAGAGAGTCCCCGGAAAGATGA
SEQ ID




TGCAAAGAAAGCCAAACAAGAGCCGGAGGTGAACGGAGGCAGTGGGGATGCTGTCCCCAGTG
NO:




GAAATGAAGTTTCGGAAAACATGGAGGAGGAGGCTGAGAATCAGGCTGAAAGCCGGGCAGCA
972




GTGGAGGGGACAGTGGAGGCTGGAGCTACAGTTGAAAGCACTGCATGTTAA





NUP210
ADXCRAG_BC067089_s_at
GTGTCGCCATGGTAAGCTTGGGCCATCGGTCCCCACTGTTGGTTTTCATTCCTTATCTGGGC
SEQ ID




TGTTGTGTGGTTAATTGATTGATCATTTTGAAAGCTAGCACTTGACTCACACTCGGAATCCC
NO:




AGAA
976





HNRNPA2B1
ADXCRAG_BX537494_s_at
GAATGTGATACTCAGGGCTTACTCTATACACCAATGAGTCTTCTTTGATCCTAAGACCACCA
SEQ ID




CTGAAGTTGTTTAGGTTCTTTTGGACAAACATGATAAACTTCTTCAGA
NO:





978





PAICS
ADXCRAG_BX538303_at
TAGGCACAAAATTTAATTCTCAGAGCCTATAAAAACAGTAAAGGAAATAGGCATGAACACAC
SEQ ID




AAGGCCAGATAACAGCAGTAACATTTTGGCAACTGAAAGGCAAACACAGTGGTAGCTAAGTT
NO:




AGCAGACCAAGAAAACTTAATC
980





PAICS
ADXCRAG_BX538303_x_at
TAGGCACAAAATTTAATTCTCAGAGCCTATAAAAACAGTAAAGGAAATAGGCATGAACACAC
SEQ ID




AAGGCCAGATAACAGCAGTAACATTTTGGCAACTGAAAGGCAAACACAGTGGTAGCTAAGTT
NO:




AGCAGACCAAGAAAACTTAATCAAAATTAGCTGGCATGG
981





THUMPD1
ADXCRAG_BX640898_at
TGCAGTCTTATGGTTTAGAAAACTTGTTTAGCTCCATAGAGGAAAGAATGTTAAACTTTGTA
SEQ ID




TTTTAAAACATGATTCTCTGAGGTTAAACTTGGTTTTCAAATGTTATTTTTACTTGTATTTT
NO:




GCTTTTGGTACGGCCAGAAATCGAGCTTGTTTTTTCATAGTTCCTGATATTTTCAGAA
982





TRAF3IP3
ADXCRAD_NM_025228_s_at
CCTCCCAGAAGGCAATGTGGGCGATGGCTCCCAGTGCTGATGGTGGTGATTGCTGCAGCACT
SEQ ID




GGCAGTGTTCCTGGCCAATAAAGACAACCTGATGATCTGAATAATTTGTGACAACTGCCTTG
NO:




GGTGAAAATCAGAAGCAAGCAACTCAGCGAAAAACTCAGAAGGTTTGGGTACATTACAGCTT
985




GGGTTTTCCAACTGACTTAGGATTTCTGACTTTTTATTAATTTCTTAACCTACTGTAAATAA




ACTTCACCTGACCAGATTGTTCCT





HNRNPA2B1
ADXCRAG_D28877_s_at
TCTTTGTAAGAGTGTAGAAGCATTCCTTCTTTGATAATGTTAAATTTGTAAGTTTCAGGTGA
SEQ ID




CATGTGAAACCTTTTTTAAGATTTTTCTCAAAGTTTTGAAAAGCTATTAGCCAGGATCATGG
NO:




TGTAATAAGACATAACGTTTTTCCTTTAAAAAAATTTAAGTGCGTGTGTAGAGTTAAGAAGC
987




TGTTGTACATT





MX2
ADXCRAD_AJ711736_s_at
AAATTCTTCTTTTGTATGTCCAGTCTCCTGCACAGCACCTGCAGCATTGTAACTGCTTAATA
SEQ ID




AATGACATCTCACTGAACGAATGAGTGCTGTGTAAGTGATGGAGATACCTGAGGCTATTGCT
NO:




CAAGCCCAGTCCTTGGACATTTAGTGACTGTTAGCCGGTCCCTTTCAGATCCAGTGGCCATG
995




CCCCCTGCTTCCCATGGTTCACTGTCATTGTGTTTCCCAGCCTCTCCACTCCCCCGCCAGAA




AGGAGCCTGAGTGATTCTCTTTTCTTCTTGTTTCCCTGATTATGATGA





ITGB7
ADXCRAG_M68892_s_at
CTTCTCCTTGGAGGACAGTGGGAACTGGAGGGTGAGAGGAAGGGTGGGTCTGTAAGACCTTG
SEQ ID




GTAGGGGACTAATTCACTGGCGAGGTGCGGCCACCACCCTACTTCATTTTCAGAGTGACACC
NO:




CAAGAGGGCTGCTTCCCATGCCTGCAACCTTGCATCCATCTGGGCTACCCCACCCAAGTATA
997




CAATAAAGTCTTACCTCAG





ADA
ADXCRAD_CB158570_s_at
GGGCAGAACCTCTGAAGACGCCACTCCTCCAAGCCTTCACCCTGTGGAGTCACCCCAACTCT
SEQ ID




GTGGGGCTGAGCAACATTTTTACATTTATTCCTTCCAAGAAGACCATGATCTCAATAGTCAG
NO:




TTACTGATGCTCCTGAACCCTATGTGTCCATTTCTGCACACACGTATACCTCGGCATGGCCG
1001




CGTCACTTCTCTGATTATGTGCCCTGGCCAGGGACCAGCGCCCTTGCACATGGGCATGGTTG




AATCTGAAACCCTCCTTCTGTGGCAACTTGTACTGAA





CD1C
ADXCRAG_NM_001765_s_at
ATTGCCTTGGTAGTGATAGTGCCCTTGGTGATTCTAATAGTCCTTGTGTTATGGTTTAAGAA
SEQ ID




GCACTGCTCATATCAGGACATCCTGTGAGACTCTTCCCCCTGACTCCCCCATTGTGTTAAGA
NO:




ACCCAGCAACCCAGGAGCCTAGTACAATATAGTGATGCCATCCCGTCGACTCTCCATTTAAA
1012




TTGTTTCTCTTTCTGCATAATAAA





PTPN7
ADXCRAG_NM_002832_s_at
GGAGGAGCTGCTCCTTCCTTACAGCCTTGGGGATGGACTTGCCCACACCTCCACCTCCCCTG
SEQ ID




AGCCCTGTGAGAGGCACGACTGTCTATGCCAATGAGGCTCGGTGGGGGGCTCTCAAGTGCCT
NO:




GATCCTGCCCTGGGCTCAGAGCCAGCCCAGAGGGAAGCAACTGCACAGCCCCACAGGCCCTC
1019




CCTGGCACTGTCCCCCCAACCCCATCTCAGAGCTCAGAGGGTACAAGCTCCAGAACAGTAA





LCP2
ADXCRAD_BP306313_s_at
CAGATATTATTGACTACTTCAGGAAAATGCCACTTCTGCTCATTGATGGGAAAAACCGAGGT
SEQ ID




TCCAGATACCAGTGCACATTAACGCATGCTGCAGGGTACCCATAGCAAGTTATAGCCGAGCA
NO:




AATGAACCGTCCTCCTGCCTCTGTTGCCAACACGAGATCAATCAGCCTTGGTCAATGGACAA
1030




ACACTTAGGACTGAACTGAACCCCTC





IQGAP2
ADXCRAG_NM_006633_s_at
CAACACAATAACACTTTCTGTATAAAAGTATATATTTTATGTGATTTATTCCTACTAAATGA
SEQ ID




AAGTGCACTACTGCCTCATGTAAAGACTCTTGCACGCAGAGCCTTTAAGTGACTAAGGAACA
NO:




ACATAGATAGTGAGCATAGTCCCCACCTCCACCCCTCACAATTTATTTGAATACTTCAATTG
1037




TGCCTCTCAATTTTTT





TTF1
ADXCRAG_NM_007344_at
ATCGCACCACCGCATGAGAGAGAGAGATTACTATTTCTTGTCCCTTTTTCTCAGTTTGATTA
SEQ ID




TATTTATATACATATGTCAGTAAATCTGTTTTCAGTATTGATGTTTAATAAAGAATGTACAA
NO:




TGGCCAGAGTTCTACTCTTTCCTCTGGAGCATTAAAATATATTGCCATTCCTATTAAAACGT
1038




ATTTG





CALML4
ADXCRAG_NM_033429_s_at
TACAAACTGACATTGTCTACTATACATTTTTAAAAGCCATTTTACTGGTTTGGCATGCGGTA
SEQ ID




TGGAAATTCTAAGAGAGAAAGTTTTAAGGCAATGAATCACAGATTTAAGTTCATGGAATTTA
NO:




TGGTAACTTTATCTGTTTATGTACATTTTCCCCTTTGTTAAACAATTAACAGCAGCACACTC
1048




TGGGACCACCAGCTATTTTCCCTCTCTTTCTGAAATCTAAGCTTTGT





NFATC3
ADXCRAG_NM_173164_x_at
CAGGTACCACGGCTCACGCCTGTATCCCAGCACTTTGGAAGGCTGAGGCGGGTGGATCACAA
SEQ ID




GGTCAGGAGTTCAAGACCAGCCTGGCCAACATGGTGTAACGCTGTCTCTACTAAAAATACAA
NO:




AAAATTAGCCAGGCATGGTGGTGTGTGACTATAATCCCAGCTACTCGGGAGGCTGAGACAGG
1052




AGAATCACTTGAACCCGGGAGGTGGCAGTTGCAGGGAGCTAAGATCGCGCC





TMPO
ADXCRAD_CN272683_s_at
CTAGCTATAAGGCTATAATTGGAAATTTGTATTTTTTATTTACAGCAAAACATTTATTCAGT
SEQ ID




CATCCAGTTTGCTACCAAAATATGTTTTAGATAAGTGTGTGTATGTTTGTTTAGAAGTTAGA
NO:




AATTGTAAACACTGGTCTTATGTTTCATTTGGATTCATTATTGCATTGTCTTGTTACCAGAA
1061




ACAAATTTTGCCGAGCTTTTTTTGCCCTATATTTCCCAGCATAATTTGATTAGAAAGT





SLC19A1
ADXCRAG_U17566_s_at
GAAGTACGTCCCAGCGGCCTCAGGGTCTAAGGAGCGCTAGTGCCTTGCCCACAGGTGCGGGA
SEQ ID




CCATCTGATGTGATGTGAATACTCTTCCCACATACATTAAACACACTTA
NO:





1064





MYB
ADXCRAG_U22376_x_at
GGGAATTCGTTCACAAATGTACTGATACCACAGATGTGGGCAGGGGCTAGGAGAGCAACAGG
SEQ ID




GTGCAGCCTGAAGGCACCTGGAAGGCCGCCTGGAGGGGGACAGTCAGGAAAGCAGGAGCCCT
NO:




TGAGAGGAGCACTAGCCTTTGATGAGACCACTGCCATCGAAGGAGACCTCACAGGGAGGGAG
1065




CCAAGGGTAAACCCTAACTTTGTTTCCCCATTTCTCCTATCTCTGCCTAGGGGTCCTCACTG




GCAGAACCAACCAG





BLM
ADXCRAG_U39817_s_at
GGGTCTGCCACATGTAGAAAGATATCTTCCAAAACGAAATCCTCCAGCATCATTGGATCCAG
SEQ ID




TTCAGCCTCACATACTTCTCAAGCGACATCAGGAGCCAATAGCAAATTGGGGATTATGGCTC
NO:




CACCGAAGCCTATAAATAGACCGTTTCTTAAGCCTTCATATGCATTCTCATAACAACCGAAT
1067




CTCAATGTACATAGACCCTCTTTCTTGTTTGTCAGCATCTGACCATCTGTGACTATAA





HMGB1
ADXCRAG_U51677_x_at
ATGATGAATAAGTTGGTTCTAGCGCAGTTTTTTTTTTCTTGTCTATAAAGCATTTAACCCCC
SEQ ID




CTGTACACAACTCACTCCTTTTAAAGAAAAAAATTGAAATGTAAGGCTGTGTAAGATTTGTT
NO:




TTTAAACTGTACAGTGTCTTTTTTTGTATAGTTAACACACTACCGAATGTGTCTTTAGATAG
1068




CCCTGTCCTGGTGGTATTTTCAATAGCCACTAACCTTGCCTG





MAP4K1
ADXCRAD_BG397984_s_at
TTCTGGAAGCATGGAGTGCAGGTGTGGGCTCTAGGCTCGGATCAGCTGCTACAGGAGCTGAG
SEQ ID




AGACCCTACCCTCACTTTCCGTCTGCTTGGCTCCCCCAGGCCTGTAGTGGTGGAGACACGCC
NO:




CAGTGGATGATCCTACTGCTCCCAGCAACCTCTACATCCAGGAATGAGTCCCTAGGGGGGTG
1070




TCAGGAACTAGTCCTTGCACCCCCTCCCCCATAGACACACTAGTGGTCATGGCATGTCCTCA




TCTCCCAATAAACATGACTTTAGCCTCTGCAAAA





GCN1L1
ADXCRAG_U88837_s_at
TGATACTGCCCACCATACAGAAGTCCTTACTGAGGAGTCCAGAGAATGTTATTGAAACTATT
SEQ ID




TCTAGTCTGCTGGCATCAGTGACGCTTGACCTCAGCCAGTATGCCATGGACATCGTGAAAGG
NO:




ACTGGCTGGTCACCTGAAATCCAACAGTCCCCGCCTGATGGATGAAGCTGTGCTGGCACTGC
1077




GGAACCTGGCACGCCAGTGCAGTGACTCTTCGGCCATGGAGTCCCTGACCAAGCACCTATTT




GCTATCCTCGGAGGCTCGGAAGGAAAACTAACTGTTGTAGCCCAGAA





ATP5D
ADXCRAG_X63423_at
GCCCTGGAGTAGGCGAGCCAGCCGCCAAGGTTGACC
SEQ ID





NO:





1080





ATP5D
ADXCRAD_CV025452_s_at
CCACCTCCAAATACTTTGTGAGCAGCGGTTCCATCGCAGTGAACGCCGACTCTTCGGTGCAG
SEQ ID




TTGTTGGCCGAAGAGGCCGTGACGCTGGACATGTTGGACCTGGGGGCAGCCAAGGCAAACTT
NO:




GGAGAAGGCCCAGGCGGAGCTGGTGGGGACAGCTGACGAGGCCACGCGGGCAGAGATCCAGA
1081




TCCGAATCGAGGCCAACGAGGC





ATP5G2
ADXCRAG_X69908_at
TAAGATGTTTCTTGAGTCTCCTGTGTATATTTCTTTTCCACAGTTGGCTGAGTGCCTTCGTG
SEQ ID




AGAGTACAAGGCCCGAAGGGTAGTGATGGTGCTAAACTCAACATGGATTTGGCTGAGCTC
NO:





1083





GCN1L1
ADXCRAG_XM_0457920_at
TAAAGGCTTTGATTTAATCTTGATATAAACAGATTTTTAAAAATCTCCACCCATTAAACATG
SEQ ID




AAGCTTCCTGCATCAGGAA
NO:





1085





GCN1L1
ADXCRAD_BU599568_s_at
TCTTCTCCTGTGCTTGAGCTCTGGTTTGAGAGCTGGCGCTACCAACCTTTTTCCTATATCCC
SEQ ID




GAGTGGGGCACAGACGGTGGATCTCTGCCCAGTGTGGTGTGTCTGGCTTGGCTTTTCAATAT
NO:




TGTGAGGTCTGAATGGATCTGATCCCTGTCAGATGAAAATGATTCACAGCTCTGGCAGTTCC
1086




CAAGTCTGGGGAGGGGTATAGGTTTGAAAGGCTGTTTGAA





CHD7
ADXCRAG_XM_0987621_at
TTTAATAAAAGTGACCCATGATATGCAGAGATGTAA
SEQ ID





NO:





1087





CHD7
ADXCRAD_BU675017_s_at
GGTCTTGTAATGCACTGGTAAAAACAAAATAAATAGATGAATAAATAAAGAGTGAGAGAAGA
SEQ ID




GAGAATCAGGTACCTTTTTTAAATTAAAGGACTTTGTTACTTTAGCCACAAAGCTAAAACAG
NO:




CATTACCTCAGCTCTAAACTAGCCTTGAAGTTTACAGACATGACTTTGTAAATGTATTGTTT
1088




TTCTTTGTTGTGATGTCCTTTTATTT





CHD7
ADXCRAD_BU538327_s_at
AACAGCCATCTTTTCAGCAGTTGCCAACCTGTCCTCCACTGCAGCCTCACCCGGGCTTGCAC
SEQ ID




CACCAGTCTTCACCTCCACACCCTCATCACCAGCCTTGGGCACAGCTCCACCCATCACCCCA
NO:




GAACACCCCGCAGAAAGTGCCTGTGCATCAGCATTCCCCGTCGGAGCCCTTTCTAGAGAAAC
1089




CAGCGCCGGATATGACTCACGTTAGTGGACCGAATGCTCAGCTAGTGAAGAGTGATGATTAC




CTGCCATCAATAGAACAGCAGCCACAAC





TMEM176B
ADXCRAG_XM_377999_s_at
TACAAGCCTCTATGTAAAGCACAGGCTGGTGAGGGCCCCAGGAAGAGCAGCACCGCCCTCGG
SEQ ID




CACAGGCCCCTACTCCAAGTCCTGTGCAGGAGCAGGTCTTGCCCAGCGCAGCAGCTCTGCAC
NO:




CTCTGTGGCACCGCTCTGCCAAGAGGGAAGGTGCAGGCCCTGCAGCCCATCGCCTTGGATCT
1093




GAAGACCAGCCCTGTGGGGCTGCTAAGTCATGAAACTGGCCTCATGGAGATTTCATAA





GLTSCR2
ADXCRIH.292.C1_s_at
TGATCGAGCCTCGAGAGAGAGCCAAGTTCAAACGCAAGTACTAGGTGAAGCTGGGTGGAGAA
SEQ ID




GCGGGCGTTCCGTGAGATCCAGTTGTAGCTGCCATCAGATGCC
NO:





1102





MYC
ADXCRIH.2640.C1_s_at
TGATCAAATGCAACCTCACAACCTTGGCTGAGTCTTGAGACTGAAAGATTTAGCCATAATGT
SEQ ID




AAACTGCCTCAAATTGGACTTTGG
NO:





1105





TOP1
ADXCRIH.2689.C1_x_at
CTTGATTTTAAAGATCGTGTAGATTGGGGTTGGGGAGGGATGAAGGGCGAGTGAATTTAAGG
SEQ ID




ATAATGAAATAATCAGTGACTGAAACCATTTTCCCATCATCCTTTGTTTTGAGCATTCGCTG
NO:




TACCCTTTAAGATATCCATCTTTTTCTTTTTAACCCTAATCTTTCACTTGAAAGATTTTATT
1110




GTATAAAAAGTTTCACAGGTCAATAAAATTAG





PSMB10
ADXCRIH.3674.C1_at
TCGCGGCCCGTAGATAACGCGTGTAGCTCCATCTTGGACGCCACCATCCGTGTGGTCATCTC
SEQ ID




GGCGTCCGCGGCTACTCCAGCCCCACAGCAGTAGATTTTGGGGGCGATGAAGTGGATCTTCT
NO:




CGCAGCTCTTGTCCGCCACGACCGAATCGTTAGTGGCTCGCGTATCGGCGCCCAGAATGACC
1114




CCCGTCTTGGAACACCAAGCCCGCGATGGTGGTCCCGGTCTTGCGTGCGTGAAGGGACCTTG




AGCCCCGGGAGGACGCGTTCCAATGATGCATTTT





CNBP
ADXCRIH.383.C1_s_at
GGAAAGAGCAACTGAAGTCCTAGAAAATAGAAATGT
SEQ ID





NO:





1131





ANP32B
ADXCRIH.2787.C1_s_at
ACATTCCGCCTTCCTTCCATGTAGTCCCTCTTGGTAATCTACCACCAAGCTTGTGGACTTCA
SEQ ID




CTCCAACAAAATTGTAAGCGTTGTTAGGTTTTTGTGTAAGATTCTTGCTGTAGCGTGGATAG
NO:




CTGTGATTGGTGAGTCAACCGTCTGTGGCTACCAGTTACACTGAGATTGTAACAGCATTTTT
1143




ACTTTCT





MRPL16
ADXCRIH.2001.C1_s_at
ACATGCTGGGCATACGGAAAGTACTGAGCCCATATGACTTGACCCACAAGGGGAAATACTGG
SEQ ID




GGCAAGTTCTACATGCCCAAACGTGTGTAGTGAGTGTAGGAGATAACTGTATATAGGCTACT
NO:




GAAAGAAGGATTCTGCATTTCTATTCCCCTCAGCCTACCCACTGAAGTCTTTGGGTAGCTCT
1144




TAAGCCATAACTAAGGAGCAGCATTTGAGTAGATTTCTGAAA





TUFM
ADXCRIH.1094.C1_s_at
TAGAGAAAGGCCAGCGTTTCACCCTGCGAGATGGCAACCGGACTATTGGCACCGGTCTAGTC
SEQ ID




ACCAACACGCTGGCCATGACTGAGGAGGAGAAGAATATCAAATGGGGTTGAGTGTGCAGATC
NO:




TCTGCTCAGCTTCCCTTGCGTTTAAGGCCTGCCCTAGCCAGGGCTCCCTCCTGCTTCCAGTA
1146




CCCTCTCATGGCATAGGCTGCAACCCAGCAGAGGGCAGCTAGATGGACATTTCCCCTGCTCG




GAAGGG





PIM2
ADXCRIH.2055.C1_s_at
AGTGGATCTCTCGACACCAGTACCATGCACTCCCGGCCACTGTCTGGTCACTGGGCATCCTC
SEQ ID




CTCTATGACATGGTGTGTGGGGACATTCCCTTTGAGAGGGACCAGGAGATTCTGGAAGCTGA
NO:




GCTCCACTTCCCAGCCCATGTCTCCCCAGACTGCTGTGCCCTAATCCGCCGGTGCCTGGCCC
1149




CCAAACCTTCTTCCCGACCCTCACTGGAAGAGATCCTGCTGGACCCCTGGATGCAAACACCA




GCCGAGGATGTACCCCT





PFDN5
ADXCRIH.3098.C1_s_at
GATAGATTTTCTAACCAAGCAGATGGAGAAAATCCAACCAGCTCTTCAGGAGAAGCACGCCA
SEQ ID




TGAAACAGGCCGTCATGGAAATGATGAGTCAGAAGATTCAGCAGCTCACAGCCCTGGGGGCA
NO:




GCTCAGGCTACTGCTAAGGCCTGAGAGTTTTTGCAGAAATGGGGCAGAGGGACACCCTTTGG
1158




GCGTGGCTTCCTGGTGATGGGAAGGGTCTTGTGTTTTAATGCCAATAAATGTGCCAGCTGGG




C





RPL3
ADXCRIH.445.CB1_s_at
CCTTGCTGGTGCAGACGAAGCGGCGGGCTCTGGAGAAGATTGACCTTAAGTTCATTGACACC
SEQ ID




ACCTCCAAGTTTGGCCATGGCCGCTTCCAGACCATGGAGGAGAAGAAAGCATTCATGGGACC
NO:




ACTGAAGAAAGACCGAATTGCAAAGGAAGAAGGAGCTTAATGCCAGGAACAGATTTTGCAGT
1162




TGGTGGGGTCTCAATAA





MSH2
ADXCRIH.1841.C1_at
AAATGGCTGGTCGTACATATGGAACAGGTGCTCCATTTGACACGTGAGCAAAGCTGACAACA
SEQ ID




GCATCTAGCTGAGCTAACACATCATTGAGTGTCTGCATTGGTTCTACATAGCCTGAAGAAAT
NO:




ATTGACAATTTCTTTAACAATGGCATCCTGGGCTTCTTCATATTCTGTTTTATTTTTGGTAT
1164




ACTCTTCATTTAAAGAAGTCAATTTGCTGTTGGTAAATTTAACACCATTCTTCTGGATATCT




AC





TPT1
ADXCRAD_NM_017627_s_at
GGGACTGATGTCATCTTGAGCTCTTCATTTATTTTGACTGTGATTTATTTGGAGTGGAGGCA
SEQ ID




TTGTTTTTA
NO:





1167





TPT1
ADXCRIH.18.CB1_x_at
ACTCATCAATTAACTTCTACAGTGGAGACTACTTCTGGGACTGGAATATAAAAAAGAATCAA
SEQ ID




AGGTTCTGATTTTGAGTTGCAATAAAGGGAAAGACCATGCTCATAGCAGTGCCAACATCTGA
NO:




AGTGTGGAGCCTTACCCATTTCATCACCTACAACGGAAGTAGTTAACTGGAAGAGATTACCA
1168




AGAGAATAAAAAGAGACTCATTCAGTGGAACCAACCTCGTGCAGCCCGGG





SLC9A3R1
ADXCRIH.2825.C1_s_at
TTTTGTTAAGAGTGCAGTATTGCAGAGTCTAGAGGAATTTTTGTTTCCTTGATTAACATGAT
SEQ ID




TTTCCTGGTTGTTACATCCAGGGCATGGCAGTGGCCTCAGCCTTAAACTTTTGTTCCTACTC
NO:




CCACCCTCAGCGAACTGGGCAGCACGGGGAGGGTTTGGCTACCCCTGCCCATCCCTGAGCCA
1169




GGTACCACCATTGTAAGGAAACACTTTCAG





NDUFAB1
ADXCRIH.1103.C1_s_at
TTGGGTTTGAAATTCCTGATATAGATGCTGAAAAGTTAATGTGTCCACAAGAAATTGTAGAT
SEQ ID




TACATTGCAGATAAGAAGGATGTATATGAATAAAGTATCAGACCCTTTGGCTTTGCTGAGAG
NO:




AGGACTCAGATGATAGTGACGAATGTCTGGCAGTGAGGACACATTTTGGCATTCTTGCTGAC
1172




TCTGACAGAGTGATTCTGATGGACTTGTATTTAA





AKAP1
ADXCRAD_NM_139275_s_at
TTCTATTTGTGCAAACTCTGTAAATATGTGTTTAAACAAATGTAATATTTTGTACAAGATAC
SEQ ID




ACTGGAGAACAAAGGGAACTCAAGATTCTTCCAGCCACATGTCACCTGTAGGTAGAAGTAAA
NO:




CTCTGCAGTGCAGCTTCTGCTCTTGGCCCCTCTGGCCAGGGCCCCTGTGGCTTCCTGCACAC
1173




TGGACAGGTGACTGTATGGTAGAGACTGTGATCTGGGAACTTTTTGCTGTACAAATCTGT





IL2RG
ADXCRIH.841.C1_at
GGGAATCTCACTGACGAGGCAGAGTCGTTCACTGTAGTCTGGCTGCAGACTCTCAGCCAGTC
SEQ ID




CCTTAGACACACCACTCCAGGCCGAAAAGTTCCCGTGGTATTCAGTAACAAGATCCTCTAAG
NO:




TTCTTCAGGGTGGGAATTCGGGGCATCGTCCGTTCCAGCCAGAAATACACACAGAGAAGGCT
1179




GATAATCAATCCCATGGAGCCAACAGAGATAACCACGGCTTCCAATGCAAACAG





IMPDH2
ADXCRIH.1164.C1_at
CACATTTTGGATTCCTCCATCAGCAATGACCGGAACACCAAAGCGCCGTGCATACTCTGACA
SEQ ID




CCTTGTACACTGCTGTTGCTTGGGGCCGCCCACAGGCCAGCACTTCCTGCGTAATGCAGATG
NO:




GAGCCCACTTCCCATGCCCACCCGCAGGGCATCCACACCTGCATCAATGAGGTTCTTGGCCT
1184




GGGCAGCAGTGACCACATTGCCTCCAATGACTTGGAGATTAGGGTATTTGTCTTTGATGTAC




TTGATCATATTGATCTGGAAGATGGAATTTCCCTGGG





MTHFD2
ADXCRIH.873.C1_s_at
GCTGCAAAAAAGGTGCTGAGGCTTGAAGAGCGAGAAGTGCTGAAGTCTAAAGAGCTTGGGGG
SEQ ID




TAGCCACTAATTAACTACTGTGTCTTCTGTGTCACAAACAGCACTCCAGGCCAGCTCAAGAA
NO:




GCAAAGCAGGCCAATAGAAATGCAATATTTTTAATTTATTCTACTGAAATGGTTTAAATGAT
1189




GCCTTGTATTTATTGAAAGCTTAAATGGGTGGGTGTTTCTGCACATACCTTCTGCAGTACCT




CACCAGGGAGCAT





TMPO
ADXCRIH.3127.C1_at
GAAATTGTGAGAAGCTTCATTTAGTGTTTAAAAATGTGGGGAGATAAATCAGACTTAACATG
SEQ ID




TATGTAAGATCAATTCACTTAAAAGTATGGTCCAAATAGCAAAAATAGGACCAGGTGAAACA
NO:




TGTAGTCATTTTTTAAAAACATGTACTTGGTCTTTTGTGTGTGTCTGTTTTATTCCATTAGA
1197




ATAAATGTGTCCTTGATGTAATGCAAAGCATTTCTTCCTGATTAAATTGTAGATGTAGACTT




TAC





TMPO
ADXCRIH.3127.C1_x_at
TCCCATACTGTTTTCAGCCTTTTGTTTATAATTAGAAATTGTGAGAAGCTTCATTTAGTGTT
SEQ ID




TAAAAATGTGGGGAGATAAATCAGACTTAACATGTATGTAAGATCAATTCACTTAAAAGTAT
NO:




GGTCCAAATAGCAAAAATAGGACCAGGTGAAACATGTAGTCATTTTTTAAAAACATGTACTT
1198




GGTCTTTTGTGTGTGTCTGTTTTATTCCATTAGAATAAATGTGTCCTTGATGTAATGCAAAG




CATTTCTTCCTGATTAA





PTPN2
ADXCRIH.138.C1_at
GCAAAGCAAGACCTGAAGCCCACTCCGGAAACTAAAGTGAGGCTCGCTAACCCTCTAGATTG
SEQ ID




CCTCACAGTTGTTTGTTTACAAAGTAAACTTTACATCCAGGGGATGAAGAGCACCCACCAGC
NO:




AGAAGACTTTGCAGAACCTTTAATTGGATGTGTTAAGTGTTTTTAATGAGTGTATGAAATGT
1199




AGAAAGATGTACAAGAAATAAATTAGGAGAGATTACTTTGTATTGTACTGCCATTCCTACTG




TAT





LBR
ADXCRIH.2185.C1_s_at
TTGTTTTATCAGTGCTAATGTGTGCAAGCAGTTTTTTTATTTTGCTTTTCTCCTGGCATCAG
SEQ ID




AAAGTGGTGGCGTTTTCTGTACTGGATTGCACCAAGGAAGCTTTTGGGGAGGAAGGAAGGAC
NO:




ATTAAATTCTTTCCCTGGTAATGAAAAGAGCCCTTTATCAATACAGTGCTGCAATTTCTGGA
1200




TATCAGCTACACTTTGTTTT





SP110
ADXCRIH.149.C1_s_at
ATCCTCAGTGAAGTGCATTCGGAATGAGGATGGAACTTGGTTAACACCAAATGAATTTGAAG
SEQ ID




TCGAAGGAA
NO:





1202





SP110
ADXCRIH.149.C1_x_at
ATATACGTTGTGAAAGGACGACCCTAGGAGAGCTGCTGAAGAGTGGACCTTTGCTCTGTCCT
SEQ ID




CCAAGAATAAATCTCCAGAGAGAGTTTAAATAGCAAGTGAATTTCTACTACC
NO:





1203





TMEM176B
ADXCRIH.2580.C1_s_at
CCTTCGCCCTCTAGGGAGCAGACCTCCACTGCCATTGTCCTGTGAGCCGCCAAAGACCCCAC
SEQ ID




GGGGTGCCCGCATGTCCCTGTCTAGGGCAGCCCAGGGCCCCCACTCCTGGCTCCTCACACTT
NO:




GCCTCCCCTATGGCCGCTCTCCAGACCCTCCTCCTTTCTTCTCCCCACATCCGCACCTGCTG
1215




TTCCCACTCTGGGGTTCTCAAGTCCATGAACAGATATTGTTGCATTTTCCACAATG





ATHL1
ADXCRIH.1963.C1_s_at
GATGTTCGCAGGAAAAATCTGGAGATTTACGAGGCTGTGACGTCCCCCCAGGGCCCCGCCAT
SEQ ID




GACCTGGAGCATGTTTGCTGTGGGCTGGATGGAGCTGAAGGACGCAGTGCGGGCCCGGGGCC
NO:




TCCTGGACAGGAGCTTTGCCAACATGGCTGAACCCTTCAAGGTGTGGACGGAGAATGCAGAC
1222




GGGTCAGCGCTGTGAACTTCCTGACAGGCATGGGGGGCTTCCTGCAGGCGGTGGTCTTCGGG




TGCACGGGGGTTCAGGGTCACCCGAGCGGGTGTGACCTTTGAC





PAICS
ADXCRIH.2946.C1_at
TTGAATTTACCGTCTTCTCATCCTCTGTACAAAAGCCTCAAGTGAGGGTCAAATTCAACATT
SEQ ID




ATCCTGATCTAGACAGCCCCCATTCTCAATCCACCCTTTTCCAAGTTGATTGCCCAAGGACT
NO:




TCTAACAATAAACTCTCTTTTGCACCACAGACTTCTTTGAAAATATACATGCTGTTGACCCT
1228




CTCTGTAGAAAACCGCACACATAAAACTTACCAACAGATTTCATTGGTTCTTGGGTTCTCCC




GAAGCCTATCCATGGTTTATA





MYB
ADXCRIH.2957.C1_at
ATCAAATGCAAAACTCCCAAATTATAAAACAGTCAGGCTACACTCAAAACAAAACATAGAAC
SEQ ID




ATCAACAACACACATCTCCCAAAAAAGAAGTGCAACGCATGCTTGTATAAACCAACAATAAC
NO:




AAAAAAACCACAATAAAAAATGCAGAGTCTCCCAAACAAGTTTTCAAATGTATTGCAGAAGN
1232




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGTCTGAAATACTAGTGCATAGTCAATTACC




TAACACCAAGTT





REPIN1
ADXCRIH.2978.C1_s_at
CTTTTCTCCATTTCTAGCATATGGACACCTGGCCTCTGCTTGAGCACTTAGGTGACAGGAAC
SEQ ID




TTCCGCACCTCCTGAGGCCCTGGATGATTCTAATTGTTAGAAATTCTAATTGTTAGAAATCC
NO:




TTCCTTATAATGAATGAATTCTGCTTTCCTATAATTTCTACCTATTGGGCCTTGTTCTGTTC
1236




TCTGGAACTAAAC





NCKAP1L
ADXCRIH.2983.C1_at
CGACCTTCATCCACTATTCTTATGATAATGCTGGCGGGCAGAGATGATCAATCTCCTATTAA
SEQ ID




ATCAT
NO:





1237





NCKAP1L
ADXCRIH.2983.C1_s_at
CAGGAGCCAGAGTTGATGAGCAGATCTGTGGAAGAACAATCCAGGGCTGAGAAATCGTAGAG
SEQ ID




CAGTGAGGCAGGCTGGGAGCATGGAGGACAGCTTATGGAAAAAGTTAGGGCGTGGGGCCACA
NO:




TGTGTGAATTTTAC
1238





USH1C
ADXCRIH.2211.C1_s_at
ACCAGGGCCAGATAAGGAACAGCTCGGGCCACTCTTCTGAAGGCCAACGTGGAGGAAAGGGA
SEQ ID




GCAGCCAGCCATTTGGGAGAAGATCTCAAGGATCCAGACTCTCATTCCTTTCCTCTGGCCCA
NO:




GTGAATTTGGTCTCTCCCAGCTCTGGGGGACTCCTTCCTTGAACCCTAATAAGACCCCACTG
1242




GAGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAATTGCTGCCAGGATTGTCAC




TCCA





TMPO
ADXCRIH.994.C1_s_at
ATATCCTGGGATAGTGCATGTTCACCATCTATTTTGTCAGATAATGGGGCCTTTTAAAAAAT
SEQ ID




AATACTTTGCTTTCATGATATATTGTATTTTTGTGGAAAGTTAAGTTTAGCAATATATACTC
NO:




TAAAAGCAAATTTAATTTTTTTTAAGCCATAAAGAAATTATACTATATCCCAGTATCTGTAT
1247




GTCTGTATAAAGCAGTGTATTATC





GCH1
ADXCRIH.1611.C1_s_at
TTCTGAGCACTCAACTCATGTTTGGCATTTTAAAGTAAAAACAAGTGTGACTTCGAGGACCA
SEQ ID




AAGAAATTGTCAGCTATACATTTATCTTTATGAACTCATTTATATTCCTTTTTAATGACTCG
NO:




TTGTTCTAACATTTCCTAGAAGTGTTCTTATAAGGTCTAATGTATCCACAGGCTGTTGTCTT
1252




ATTAGTAAATGCAAAGTAATGACTTTGTCTGTTTTACTCTAGTCTTTAGTACTTCAAATTAC




CTTTTCATATCCATGATCTTGAGTCCATTTGGG





HNRNPA2B1
ADXCRIH.840.C2_s_at
ACACAGTCTGTAAGCTTTCCCCATTGTTCGTAGTAGTTCCTCAAACTTTCTTCTGTGGTTTC
SEQ ID




AAAGCTTAAGCCACCAATAAAGAGCTTACGGAACTGTTCCTTTTCTCTCTCCATCGCGGACT
NO:




CAGTCGCTTCAGCCCGATTTCCCGCAGCCGAGCGAGATGAGAGAGATCTCCGCGGACGAACA
1263




CGAACCGGACTCGTCCTGGCGCTGTAGTGAGAACTGCCGCTGCTCGAGAAACAACTCTGCGA





RPS6
ADXCRIH.344.CB1_x_at
GACCAAAGCACCCAAGATTCAGCGTCTTGTTACTCCACGTGTCCTGCAGCACAAACGGCGGC
SEQ ID




GTATTGCTCTGAAGAAGCAGCGTACCAAGAAAAATAAAGAAGAGGCTGCAGAATATGCTAAA
NO:




CTTTTGGCCAAGAGAATGAAGGAGGCTAAGGAGAAGCGCCAGGAACAAATTGCGAAGAGACG
1266




CAGACTTTCCTCTCTGCGAGCTTCTACTTCTAAGTCTGAATCCAGTC





DENND2D
ADXCRIH.1679.C1_s_at
GGTATTGCTTCAAACTGGTGTCTGAGATTTGGATCCCTGGTATTGATTTCTCAGGACTTTGG
SEQ ID




AGGGCTCTGACACCATGCTCACAGAACTGGGCTCATAGCTCCATTTTTTGCAGAGGTGACAC
NO:




AGGTAGGAAACAGTAGTACATGTGTTGTAGACACTTGGTTAGAAGCTGCTGCAACTGCTCTC
1274




TCCCATCATTATAACATCTTCAACACAGAACACACTTTGTGGTCGAAAGGCTCA





PCBP2
ADXCRIH.132.C4_s_at
GAGATGTTGATACGTGCACCACTCTCCTCGCGCATCTTCTTAACTGATTCTCCTTTCTTTCC
SEQ ID




GATGATACTGCCAACTTCCTTTCCATGCATAAGTAGCCGGATGGTGAGAGTGACATTTAATC
NO:




CACCTTCAATCACACCGGTGTCCATGTCGAGCAGTGTTCTGGGGAGCTGGACTTTGAGTGGT
1286




CAAGTCTTTGGTCACTGGT





HMGB1
ADXCRIH.157.C4_s_at
TTTAGTAGGTACGTCATGACAACTACCATTTTTTTAAGATGTTGAGAATGGGAACAGTTTTT
SEQ ID




TTAGGGTTTATTCTTGACCACAGATCTTAAGAAAAT
NO:





1289





RPLP0
ADXCRIH.6.CB1_s_at
CAAACGAGTCCTGGCCTTGTCTGTGGAGACGGATTACACCTTCCCACTTGCTGAAAAGGT
SEQ ID





NO:





1292





NAP1L1
ADXCRIH.187.C2_s_at
TGAAAACTTCCTTTCTGAGAAGTTAGTGTTAAGGTCTTGGAATGTGAACACATTGTTTGTAG
SEQ ID




TGCTATCCATTCCTCTCCTGAGATTTTAACTTACTACTGGAAATCCTTAACCAATTATAATA
NO:




GCTTTTTTTCTTTATTTTCAAATGATTTCCTTTGCTTTGATTAGACACTATGT
1301





PSMB10
ADXCRIHRC.3674.C1_s_at
TCACCGCCGGGATCTTGGGTGACCTGGGCTCCGGGGGCAATGTGGACGCATGTGTGATCACA
SEQ ID




AAGACTGGCGCCAAGCTGCTGCGGACACTGAGCTCACCCACAGAGCCCGTGAAGAGGTCTGG
NO:




CCGCTACCACTTTGTGCCTG
1307





IL2RG
ADXCRIHRC.841.C1_s_at
ATGCAACCAGCATAGCCCCTACTGGGCCCCCCCATGTTACACCCTAAAGCCTGAAACCTGAA
SEQ ID




CCCCAATCCTCTGACAGAAGAACCCCAGGGTCCTGTAGCCCTAAGTGGTACTAACTTTCCTT
NO:




CATTCAACCCACCTGCGTCTCATACTCACCTCACCCCACTGTGGCTGATTTGGAATTTTGTG
1316




CCCCCATGTAAGCACCCCTTCATTTGGCATTCCCCACTTGAG





TMPO
ADXCRIHRC.3127.C1_at
TGAAATCAAAATTGTGTGCTGGTCTAAATATACATCTTCGGCTTCTTCCTTTTTAGTAAGTA
SEQ ID




TTTTTATTTCAGATGTATTTAAAAATAACTTACATTTTTAGTGTGCTTTATGGTCAATGACT
NO:




GTAAAGTTGAAACTCAAATGAGTCAGTTTAAAATTTTTGTCTCATTTGATTCTATTGAAATT
1320




TTAATCACCTACTACTTTAATCAAGTTATTCATGAGGTAAGTTTCAGCT





MYB
ADXCRIHRC.2957.C1_s_at
GATGTGTGTTGTTGATGTTCTATGTTTTGTTTTGAGTGTAGCCTGACTGTTTTATAATTTGG
SEQ ID




GAGTTTTGCATTTGATCCGCATCCCCTGTGGTTTTTAAGTGTATGGTTTCAGAACTGTTGCA
NO:




TGGATCCTGTGTTTGCAACTGGGGAGACAGAAACTGTGGTTGATAGCCAGTCACTGCCTTAA
1325




GAACATTTGATGCAAGATGGCCAGCACTGAACTTTTGAGATATGACGGTGTACTTACTGCCT




T





REPIN1
RDCR241_B04_at
CCTGTGCACAGTCTGACACTGGGAATGAGTGACCTTTGTGTTCCCTGAGAAGAGAGAGTGCG
SEQ ID




CTCTAGGGAATTTAGAAGGATGTGTCTGGAGCTTGTGAGCAGGCACAGAAGGGCCCTTAGGA
NO:




GCCTAACTGCTTCCTTCCTCCTTCCGCGGAGGAGGCTCCTGTGCAGGAATCTGGGCTCCCCT
1339




GAGCTGTGGAAGAGCTGAACATGGGGCAGCCCCTGGCGAGGTTGGGGCAGGACCGGGCAGGG




GACTGAGATTGCAGTCTCATCTTCCC





RNF44
RDCR179_F10_x_at
CTGGGCGAATCTCCTCCAAGGAAGTCCCAGGAGGATGGGGACCAGGAAGGCTGTGGACCCCC
SEQ ID




ATCTCCAGGGGGCCTTCCCAGCCTGATCCCTGTCCTCCAAGTTCTGGAGGAGGCCGGTGTAG
NO:




GGTCTGGCTGAACTTCCCACCCACTTTCCCTGGTCCCAATCCTTTCTTGTCCTATACCAAGC
1351




TGGGGTTGCTGCCTTGAACGAACTGCGTGTGTTTTCGTCACATCCTATCAGGCAGCCCCTGG




CGTCTGCTGCCTCAGGTATGCTCCAA





LGALS9
RDCR039_D09_at
CATAAGGAGACTAGGCAGCCATGGGTAACACCTCACAAGGAAATGAGCGTGTTATCTGTATA
SEQ ID




GTGGTGTCACTCTGGCTGAATGTCAATTTAGGTGATTACTTAAAGGCCATTCACCTGATAGG
NO:




GCTGGGGGTCCCAGGGGTGAGAGGTGGGGAGGGGATTCTTGCTCACCTTGAAATCTGAGCTC
1354




TGCACCAGGAAGCAGAGGTCAAAGGGCATCTCCTTCTGGAAAGGCATGTGTGTCTTCCTCTC




CCTCGGGCCCCCAGCTTCCGTTCTGCCTCGTGTTG





LRMP
RDCR162_D09_s_at
TCCTGGGCAACAAATCTCAAGTCCTCCATCAGAAAGGCTAATAAGGCTCTCTGGCTCTCTAT
SEQ ID




TGCATTCATTGTACTGTTTGCAGCTTTGATGAGCTTCCTCACAGGCCAATTATTCCAGAAGT
NO:




CTGTGGATGCCGCTCCCACACAGCAAGAGGACTCATGGACGTCTCTAGAACATATCTTGTGT
1359




CATTTACCAGACTCGACACAATGGGCCACCACCAGTGTGACAGCAGACATCCTAATATATGG




ATCTTGAT





GTF3A
RDCR434_D07_at
AGGTTAAAGCAGTTGGGAGTCCATACACAGCCTACCCAACTTCCTGAAACTCTTAGAGAGGA
SEQ ID




AAAGGCATCCTTAGGCATCCTTCCTGTGAAGTTTGCCTATTCCGTGATCACGCTGAGAAGAT
NO:




GGGAACTCTGAAGTTTGCTTCACAAGAAGGTAAAATCCTTAAAGGGAGGCACCTTGCTGTGC
1369




CACTGTTCAGTTTTACTATAACATCAATCTTTTTTTAGTTTTTATTCCCACCTCAAGAGGCT




GAGTTGAATACTATTAGGC





CALML4
RDCR490_C03_at
GGGAGCAGCACGAACTCCTGAAGACTTGGGAGCGTCAGCAGCTTCTGCGGAAGGGGTGGGGC
SEQ ID




TGAGGGTGGAGAGAGGAAGGGAAGGAAGAAAAGGGGAGCCTTCCTGGCCAGGGTAACCGGCA
NO:




CTAAGAGGCCTCACTCCAAGCCCCCGAGGAGCCTGTGGTGGGGCTGGAGACCCGGGCTCAGC
1373




CCCTCCACCACCCTTAAAGTCCTCAGAAGGTGGGAACTGAACTGGGCACAGGCTGGGAAACC




GGCTGTGCGCTGGGCACTTGGAT





CALML4
RDCR490_C03_x_at
GAGCAGCACGAACTCCTGAAGACTTGGGAGCGTCAGCAGCTTCTGCGGAAGGGGTGGGGCTG
SEQ ID




AGGGTGGAGAGAGGAAGGGAAGGAAGAAAAGGGGAGCCTTCCTGGCCAGGGTAACCGGCACT
NO:




AAGAGGCCTCACTCCAAGCCCCCGAGGAGCCTGTGGTGGGGCTGGAGACCCGGGCTCAGCCC
1374




CTCCACCACCCTTAAAGTCCTCAGAAGGTGGGAACTGAACTGGGCACAGGCTGGGAAACCGG




CTGTGCGCTGGGCACTTGGATTTTGCCAGCTGC





RPS6
RDCR236_E11_at
ACATACTTTGTGCATTTTTCACTGATCCAAGAATGTTTTTAGTCATTTCCTTTTCAGTGTGT
SEQ ID




GAACAGCCTAACAATTCACTGGAGTTGAAAAGCTTTGTTAAAACAAATTTGAAATGGCTTAA
NO:




AAACCATTTAGTGGATGGTATCCACTAAAACTAGGTATCCACTAAAACTATGCCTTAAAAGT
1377




TACCTTTTAAAAAAGACATGTTCATCTTCACAAGGTCAATTTTCATGTATTAAATTGTGTAT




AGTGCTTTAAAGAGCTATATTCCTCAAAAATA





GTF3A
ADXCRIHRC.2186.C1_s_at
GGCCTCTCATCTCAGTGGATATATCCCTCCCAAAAGGAAACAAGGGCAAGGCTTATCTTTGT
SEQ ID




GTCAAAACGGAGAGTCACCCAACTGTGTGGAAGACAAGATGCTCTCGACAGTTGCAGTACTT
NO:




ACCCTTGGCTAAGAACT
1382





RPL10A
ADXCRIHRC.799.C2_s_at
AGGTGTTATGTCTGGCTGTAGCTGTTGGTCACGTGAAGATGACAGACGATGAGCTTGTGTAT
SEQ ID




AACATTCACCTGGCTGTCAACTTCTTGGTGTCATTGCTCAAGA
NO:





1384





BLM
ADXCRPD.16944.C1_at
TTAGGGCCTTTGCTCTAGCCAAAGCTTCTTGCAGGAAAGCTCACATCCAGGGAGCTGCCAGC
SEQ ID




TAACTCCCTTCTTCAAGATTTTCCTCAGCTCCCATCTTCTCAGTTAGACTTCCAAGGACCAC
NO:




CCCGTCTAATACTGCATCCTGCACTCTACCCATTCCTCCTGTCTTTTTACTCTGCTGTGCCA
1385




TTCACCACAGCTCTTATCCTTTCATGTATATTTATTGTGTATATTGTTTGTAACTGGCCTCC




CTCTGCTAGAGTGTAAG





SLC19A1
ADXCRPD.7962.C1_s_at
GCCGCGGGCTTCGTGAAGATCCGCTGGGCGCGCTGGTCCAAGCTGCTCATCGCGGGCGTCAC
SEQ ID




GGCCACGCAGGCGGGGNCTGGTCTTCCTTCTGGCGCACACGCGCCACCCGAGCAGCATCTGG
NO:




CTGTGCTATGCGGCCTTCGTGCTGTTCCGCGGCTCCTACCAGTTCCTCGTGCCCATCGCCAC
1389




CTTTCAGATTGCATCTTCTCTGTCTAAAGAGCTCTGTGCCCTGGTCTTCGGGGTCAACACGT




TCTTTGCCACCATCGTCAAGACCATCATCACTTTCATTGTCTCGGACGTGC





PPRC1
ADXCRPD.9220.C1_at
CAGGTATTGAAACAAGTTAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCC
SEQ ID




AGTGTTTGGAACATAAGTCACTATGCAGACTAATAAACATCAACTAGAG
NO:





1398





PPRC1
ADXCRPD.9220.C1_x_at
TCCCTGCTATCCTTTTTCTCCTTTGGAGGTGCNCCAACCTCCTCCACCCCCTTCCCCTACTC
SEQ ID




TAGGGGAGAGAGCTGCTAGTGAGATGACTGTTTTATAAAGAAATGGAAAAAAGTGAAATAAA
NO:




AAATATGTTGAATCAGATTTTTTAAAAGGGGTATTTGTTTTTTTATAACAGGTATTGAAACA
1399




AGTTAACTTGCATTCCTATGTAAGATAGGAGGGGCTGAGGGGATCCCCAGTGTTTGGAACAT




AAGTCACTATGCAGACTAATAAACATCAACTAGAG





ITM2A
ADXCRPD.18289.C1_at
GTAACCTTGGCATCTTTATTTACCAACTTTGCAATAACAGAAAGTCCTTCCGCCTTCGTCGC
SEQ ID




AGAGACCTCTTGCTGGGTTTCAACAAACGTGCCATTGATAAATGCTGGAAGATTAGACACTT
NO:




CCCCAACGAATTTATTGTTGAGACCAAGATCTGTCAAGAGTAAGAGGGCACAGATAGAGTGT
1403




CCTTGGTAATAAGAAGTCAGAGATTTACAATATGACTTTAACATTAAGGTTTATGGGATACT




NNCAGATATTACTCATGCATTTACTCTAATGCTTTATGCTTTA





AQP3
ADXCRPD.10405.C1_at
GGGCCACAGATTAGGTTGGAGCTCTGGATGTACATACATAGTATGAGCAGTGGGACGTGTTT
SEQ ID




CTGTCTTAATGCAGGCATCAAGGGTGGAGTGAAGTCAGGTCATAAGTGTCATGTCCGCTTGG
NO:




GTTTTGTTTTGTTTTTAATGTATGTAGCAGATGTTACAGTCTTAGGGATCCGGGATGGGAGA
1410




CCCCACTTTAGAAAGGGTCGTCACTCCTTTAATCCTCTACTCAACAATGTACTCTTTTA





PAICS
ADXCRPD.2080.C1_s_at
GCTCTGATGTGCTATGCTTAGCTATCTGTCAGAGATTAGTAAATTATAAAACTCATGTGTAC
SEQ ID




TACTTAAGTTTATATCTTATGCTAGTTTATAAGAACAATTAAAAGGACTTAGAAGATTAACT
NO:




TTGGTTTCATGGTCTCTGAAGTCACTGACTGCTATTTCAGCTTGTTTACCCTTACCTAGCAT
1415




TAAGACTCCATCTACTTCTGTGCAGTATATGAAAATTTTTAAACTTTCATTTAGACTGGTGG




ATAGGACTGACCATTACAAATTGT





GMFG
ADXCRPD.1437.C1_at
TGATCTCTGGGCTGGGGACTGAATTCCTGATGTCTGAGTCCTCAAGGTGACTGGGGACTTGG
SEQ ID




AACCCCTAGGACCTGAACAACCAAGACTTTAAATAAATTTTAAAATGGCGCCAGGCCCCCCC
NO:




ACGTAAAAGAAAANAACTTGTTCGGCCGCCCTCGGCCCCTCAAAAAACTTTTCTAAACCCTT
1417




TCGTTTGGGCCCCCGGGGCCCACTTAGGTAAGGGAAAAATGGGGCCTAAACCTGTTTCCCTA




GGAAAATCCCTTGGCCATGAACTAA





USH1C
ADXCRPD.18376.C1_s_at
GTCCATCAAAGTGAGACACATCGGCCTGATCCCCGTGAAAAGCTCTCCTGATGAGCCCCTCA
SEQ ID




CTTGGCAGTATGTGGATCAGTTCGTGTCGGAATCTGGGGGCGTGCGAGGCAGCCTGGGCTCC
NO:




CCTGGAACATCGGGAAACCAAGGAGAAGAAGGTCTTCATCAGCCTGGTAGGCTCCCGAGGCC
1421




TTG





ATP5G2
ADXCRPD.11199.C1_s_at
AAGAATAGACTAGGGCCTCAGTCTTACACTTCTTGACCACACCTGAATCTTAAAGGCATTTG
SEQ ID




AAGTCTACATCCTACGTTAAAAGGTTCTACTTGCCAGCATTTTAGGGCGTTAAACAA
NO:





1439





IL2RG
ADXCRPD.2198.C1_at
AACCACTGTTTGGAGCACTTGGTGCAGTACCGGACTGACTGGGACCACAGCTGGACTGAACA
SEQ ID




ATCAGTGGATTATAGACATAAGTTCTCCTTGCCTAGTGTGGATGGGCAGAAACGCTACACGT
NO:




TTCGTGTTCGGAGCCGCTTTAACCCACTCTGTGGAAATGCTCACCATTGGAAGTGAATGGAG
1440




CCACCCAATCAACTGGGGGGAGCAATACTTNCAAAAGAGAATCCTTTTCCTGGTTGCAT





LCP1
ADXCRPD.1593.C1_at
GGGTGTAATGGGAGCATCCAGCCACTCGGCGGGCAGCATGGAGCTATAAACTAGCCATCCCT
SEQ ID




TTTAGGGGTTCTGC
NO:





1444





LCP1
ADXCRPD.1593.C1_s_at
GAAGTAAGCCTCATCATCAGAGCCTTTCCTCAAAACTGGAGTCCCAAATGTCATCAGGNNNN
SEQ ID




NNNNNNNNNCAGCCACTAAGAACCCCTCTGCTTTTAACTCTAGAATTTGGGCTTGGACCAGA
NO:




TCTAACATCTTGAATACTCTGCCCTCTAGAGCCTTCAGCCTTAATGGAAGGTT
1445





TAPBPL
ADXCRPD.18421.C1_at
TTTCTGCTGCTCCAGATAGAGCCAGGCAGAGCAGCAGGCACCAGCCCTCCTGTGTGCCCATG
SEQ ID




GAGGCTGCTCTCGAGTTCCCTCCTTGCCCACCGCCCGTTCTCCACAGTCCTACGCTGCTTGC
NO:




GAGGCCCGGCGGAAGAAGGGGGCTCTCCAAGCACACACTGGCAGCCTGCAGCCTTTAGGTTT
1446




CTTCCCCTGTTCCCTGCTGCATCCTCGGGATTTCGCGCACCCCATTAATCTATTCTCGGAGT




CGGGTGGGT





MDN1
ADXCRPD.8864.C1_s_at
AAAGCAGTGCTGAATACTTGAAACTGTGTGCTCTGTTCTACTTAATGTTCTGTCAGAATGTT
SEQ ID




CTTTTGTAGGCAGTATGTCATGATGTAATCATCTATCTCCTTGTCTGTTTCCAAGTTACACT
NO:




GTGAAGTCTGCGACCCTTTTGAGGTGGTCATCAAAGACACAGATTCCTTGTTTAACCAAGTG
1455




TCCCAAAGCATGTACCTGAAGTTATATCAT





SP110
ADXCRPD.2201.C1_s_at
AAGCACTTCAGTGACCAATGACAAGTTAACATCCAAAATGAATGCGGAAGAAGACTCAGAAG
SEQ ID




AGATGCCCAGCCTCCTCACTAGCACTGTGCAAGTGGCCAGTGACAACCTGATCCCCCAAATA
NO:




AGAGATAAAGAAGACCCTCAAGAGATGCCCCACTCTCCCTTGGGCTCTATGCCAGAGATAAG
1456




AGAT





CXCR4
ADXCRPD.2235.C1_at
TGGGATCAGCATCGAATTCCTTTCACCTCCTGGAAATCCATCAAGCCAGGTGTACATTTGAA
SEQ ID




AACC
NO:





1458





CXCR4
ADXCRPD.2235.C1_s_at
AGATATATCTGTGACCGCTTCTACCCCAATGACTTGTGGGTGGTTGTGTTCCAGTTTCAGCA
SEQ ID




CATCATGGTTGGCCTTATCCTGCCTGGTATTGTCATCCTGTCCTGCTATTGCATTATCATCT
NO:




CCAAGCTGTCACACTCCAAGGGCCACCAGAA
1459





NFATC3
ADXCRPD.9584.C1_at
AGCCTATGCTGCTCCTGTTCTTTTGCCAAATCTACCCAAGGCCTGAGGTGGAGGAATGCTAC
SEQ ID




TTTCCCCACAAATGGTGGGTCCCACTCCTGGCCCCAGACCTGAAGGCTGCAGAGTTGGAAAC
NO:




CCAAGGTCCAAGGAGAGA
1470





MYB
ADXCRPD.10703.C1_s_at
AAGCTTCCAGAAGAACAGTCATTTGATGGGTTTGCTCAGGCTCCGCCTACAGCTCAACTCCC
SEQ ID




TGCCACTGGCCAGCCCACTGTTAACAACGACTATTCCTATTACCACATTTCTGAAGCACAAA
NO:




ATGTCTCCAGTCATGTTCCATACCCTGTAGCGTTACATGTAAATATAGTCAATGTCCCTCAG
1479




CCA





USP7
ADXCRPD.11382.C1_at
GAAATACTTGCCTAAGTTTCCCTGATGCTTTCTCCCCAAGCTCCACGGCCTTTTTACATTCT
SEQ ID




TCTAACAGGTCCCGGACACACCCATGCTTGTCTGGATATAGTGTTATTTCCTAAGTAATGAA
NO:




AAGATAAAATAAGTGCTTTCAAGAAAGCATAAAAGGTCTGCTACCACAAAGGAAGAGAGGAG
1480




AAAGTTGCATCATTGTTCTCAACTGTCCCCAGCTGGCCCCCATGTTCTTGCTCTCATTCCNC




ACCCCAACTCCCTCATCTGTGAATTCACTC





BLM
ADXCRPD.11385.C1_s_at
GGAGAATACAGCTTTTGGCCTACTTTGGTGAAAATGGATTTAATCCTGATTTTTGTAAGAAA
SEQ ID




CACCCAGATGTTTCTTGTGATAATTGCTGTAAAACAAAGGATTATAAAACAAGAGATGTGAC
NO:




TGACGATGTGAAAAGTATTGTAAGATTTGTTCAAGAACATAGTTCATCACAAGGAATGAGAA
1481




ACATAAAACATGTAGGTCCTTCTGGAAGATTTACTATGAATATGCTGGTCGACATTTTCTTG




GGGAGTAAGAGTGCAAAAATCCAGTCAGGTA





HCLS1
ADXCRPD.1749.C1_at
ATAAAAACCTCCTTGTTCGCTGCAGCCCCGGGGGGTGTAAGGGGGAAATTGGCGGCCCTGGG
SEQ ID




CCATACGGAAAACAAGGCGCCGTGACACTCCAACAGAAGATCGGCACCGTCCCATCCACACG
NO:




GCTGCAAACTTGCGCCAAAATGCATCTAAACCACGAGAACGCCCGGGGGGGATCCACCCCGC
1483




GTGGGCACGCCGCGGGGAGAGAGGGCGAACGCCGAAACCCAGGTGTGGCGAGCAAAGCTACC




CCATAAAACCT





41888
ADXCRPD.2412.C1_at
GCTTACAGCGGCGATACAGCTCATAGTGCCGGGTGTGGGTCTGCTCCCGCAGATCCTCCATG
SEQ ID




TTGACCCGAATCAGCATCTCCCGCAGCTTCACAAAGTCGCAGTGGGCCTCGTTTTCAACCTG
NO:




CACAGTGCCCCAAG GATACTGCCGCGCCCTCATCATCTTGTTGCCTATCTTCAGTTCTTCT
1492




GTGCTGCCAATGACAGCAAACGGCAGGTGGGCGTTCATGGTTCCATTGATCTCTGCCACCGA




CTCATCATCTGTAAGGAAACTGATAGATCTGGACTCCGTT





NAP1L1
ADXCRPD.3079.C1_s_at
TCAAAGATAGAATCCCATTTTTAATGAACTGAAGTAGCAAAATCATCTTTTTCATTCTTTAG
SEQ ID




GAAATAGCTATTGCCAAAGTGAAGGTGTAGATAATACCTAGTCTTGTTACATAAAGGGGATG
NO:




TGGTTTGCAGAAGAATTTTCTTTATAAAATTGAAGTTTTAAGGGACGTCAGTG
1494





CD53
ADXCRPD.1819.C1_at
GGTTGCTATGCGAAAGCAAGACTGTGGGTTCATTCCATTTTCCTNATATCGNGATCATCACC
SEQ ID




ATCTGTGTATGTGTGAATGAAGGTTTTGGGGATGTCCTTTTGCCCTGACCCTGAACTGNCAG
NO:




ATTGACAAACCCAGCAGACCCATAGGGTATTGATCTGCAGNAANTCCTTGGGGTGGAAAGAA
1497




ACTGGTTTCATCTTCG G GAATG CCAAACCATTTTATAG CATG GAG CCCCTACCTGT





MSH2
ADXCRPD.1845.C1_at
GATGTTCCACATCATTACTGGCCCCAATATGGGAGGTGAATCAACATATATTCGACAAACTG
SEQ ID




GGGTGAAAGTACTCCTGGCCCAAATTGGGTGTTTTGTGCCCTGTGGAGTCAGCAAAAGTGTC
NO:




CCATGTGGGACTGCATCTTAACCCCAATAGGGGGCTGGTGACCATTCAATTGGAAAGGGATC
1501




CTCCC





FABP5
ADXCRPD.277.C1_x_at
GTGTGTTGGATTAATTAGGATCATCCCTTTGGTTAATAAATAAATGTGTTTGTGCTAANNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCNNNNNNNNNNNNNNNNNNNNNNNNN
NO:




NNNNAATATGTTCGGGCCGCCTCGGGCCCTTCAAAAAACTTTTTCAAGAACCATTTCGTTTT
1504




GGCCCCCGCGGGCCCCAATAGGGTAAAGTGAAAACTTGGCCCATACCTTGTTTTCCCATAGG




AAAATCCCCTGGGCCATTGAACAAAGG





ARHGAP15
ADXCRPD.9769.C1_at
AAAAACATCTTCAGTGCTCCGGTGACAACGTGGATGTCCTCCCACTGGCTGTCGTCCAAATT
SEQ ID




CAGCTTCTCTTCAGTTTAATGAAGTGACAAATTATTGGCTTGCTCTGGAGGTCAAATGACCA
NO:




CTGTGAAAAATCTGCAGCTTACTAGGGGTGTCCACAGGTCTCCATCCAGTTCTGATAGAAGG
1508




GCTGGTATTCCAGAAACGACTTGGTTGACAATAAATCTTAACTTCTGTATTGTTGCCAGATT




GCCACTAACTCGATATATTCCATCAACATCTAGACCTC





PTPN2
ADXCRPD.12103.C1_s_at
CGGCCCTTGCGCCTTTCTAGCATAAAGTGGTGTGTCAGAGCCACTGTCTCCACAGAAAGCAC
SEQ ID




CACGTTTGTTTCATTTGACTTATTTGAACCCGTTTCTCCTGCCTTTGCCTTTTTAAATAAAA
NO:




ATAGCAAAAATTGATTCAAGTGAATCTATTAGAATTTTCTAAAATGGAGCCCATTTGTCTTT
1509




TCAGTCTTGCAAGTAAAGTCTTTAAAACAATTAAGCCTCCCAATGATTTAACCGTATT





PTPN2
ADXCRPD.2533.C1_at
CAGTATTACACAGTGGGAGGTCCAAATTGGATTAGACTTTGGCATTGAATTCCAAAGTATTG
SEQ ID




GTAAGTCTAGCACATACTATAAAGGCTTTGCTAAATTCTGGTGGGTACATTATTTTTAAAAC
NO:




CTGTCTGTCTGTCGGTATCACACAGAGGTCACTTCTTGAGTAAAATAAGATGACCTTAAGAA
1523




TTCACATAATTCTTGAAGAAGAATATAAGTCACGATGCTTCCACATGAGGCCGCGTCACACC




ACCATCGTTTGGAAATCCAGCACCTCAGCCGT





P2RX5
ADXCRPD.2544.C1_s_at
AGAGTTCCTAGATTACCTCACTGGGAATAGCATTGTGCGTGTCCGGAAAAGGGCTCCATTTG
SEQ ID




GTTCCAGCCCACTCCCCTCTGCAAGTGCCGCAGCTTCCCTCAGAGCATACTCTCCAGTGGAT
NO:




CCAAGTACTCTCTCTCCTAAAGACACCACCTTCCTGCCAGCTGTTTGCCCTTAGGCCAGTAC
1524




ACAGAATTAAAGTGGGGGAGATGGCAGACGCTTTCTGGGACCTGCCCAAGATATGTATTCTC




TGACACTCTTATTTGGTCAT





ALDH5A1
ADXCRPD.1911.C1_at
GGGTGTGGCTATGCTCTAATAACATTTTGTTTATGGACACTGAAATCTGAATTTCATAGAAT
SEQ ID




TTTCAGGTGTCATGAAATATTGTTCTTCTTTTGATTTTCTGCCCAATCATTTGAAAACATAT
NO:




AAACCATTCTTAGCTCACAGGTTGTATAAAAACAGGTGGCAGGCCAGGTTTGATTCGTGGGC
1528




CATAGTTTGCCAACCCCTGATCTAATGGTCCTTTTCTAGTCCATGTTGTAAAATGTATATAT




TTTTAAAATCCCGTTACATATGGCTACTTTA





CYFIP2
ADXCRPD.9810.C1_s_at
CCATGCCGAGCGCAGGAAGGACTTTGTCTCTGAGGCCTACCTCCTGACCCTTGGCAAGTTCA
SEQ ID




TCAACATGTTTGCTGTCCTGGATGAGCTAAAGAACATGAAGTGCAGCGTCAAGAATGACCAC
NO:




TCTGCCTACAAGAGGGCAGCACAGTT
1540





MSH2
ADXCRPD.12253.C1_at
CATTTCACGAATAAAAGTTACTACGTGAAAAATCCCAGTAATGGAATGAAGGTAATATTGAT
SEQ ID




AAGCTATTGTCTGTAATAGTTTATATATTGTTTTATATTAACCCTTTTTCCATAGTGTTAAC
NO:




TGTCAGTGCCCATGGGCTATCAACTTAATAAGATATGTAGTAATATTGTACTTTGAGGACAT
1544




TGTCAAAGATTTTTATTGTGAAAAATGAGAGCTGTAACTGAGGACTGTTTGCAATTGACATA




GGCAATAATAAGTGTTGTACTGGA





IGJ
ADXCRPD.2619.C1_at
GGTACACAAATCTGGTTCTCAATGGTGAGGTGGGATCAGAGATATTCTCCCTGTTGTTCAGA
SEQ ID




GGAACAATAATTCGGATGTTTCTCTCCACAATGTCCTCATTAGGATCTTCGGAAGAACGGAT
NO:




GATCCTGGAAGTAATCCGGGCACACTTACATTTGTTGTCAACAAGAACAATCCTTTCATCTT
1546




CTTGGGCTTTCACATGAACAGCCTTAATAAAAACCGCCAGGACTCCCCAGAAAAGCAAATGG




TTCTTCATCTTGACTTC





UTP3
ADXCRPD.2675.C1_at
AGCTTAGGGAAATTTCACAGTTCATTGTGGAGTGTTAAACTTAGAACATGTGTAACTTTTCA
SEQ ID




CATAAAGAGAATGCATCTTTGACAGTTATCTTATTTGTAAGGCAGCCTATAAAATAGTTCTG
NO:




AAGTATTTTATTTACCTAACTATAATTATTGGGCCAGATACTTGTTAATAAATGGGCTTAAT
1550




GTTAACATGGATTTCATATGTTCTGTGTGGT





RNPS1
ADXCRPD.500.C1_at
ATGCATAGATATACACACCACGCCCCCACCGCGATGTTAACGACACCGCGAGATAATACTAT
SEQ ID




TCCCCCCACACTGCGTCTCTGTTCTGTTTCTNAGCACACCTCTCACCTCTCCTCTTATCTCT
NO:




GTGGCGGTCGAGAACATTGCACTCACCCCACTATTTATCTCTATTCTTTCTCTATTACTGAC
1561




CAACATATCCTCTGTGCGCACCCTCGCGCGGAAACAACAACATCGTGTACACACCACAAGAA




GTAAGCACATGATTGCTAGCCTGGGACACCGCGCCCTCATAATATATA





PIM2
ADXCRPD.4065.C1_at
AATGTAAATAACTCACGTATAGTGGGGAGGGGAGTTCCAAGTGTGCCCTCCTCTCTTACTCC
SEQ ID




TGCCTGGATTATTTAAAAAGCCATGTGTGGAAACCCACTATTTAATAAAAGTAATAGAATCT
NO:




GCAAAGTTGGACGGAGCGAGAATTCGT
1573





PIM2
ADXCRPD.4065.C1_x_at
TCCTGAGCCGGGATTGTCCAATTACTAAAATGTAAATAACTCACGTATAGTGGGGAGGGGAG
SEQ ID




TTCCAAGTGTGCCCTCCTCTCTTACTCCTGCCTGGATTATTTAAAAAGCCATGTGTGGAAAC
NO:




CCACTATTTAATAAAAGTAATAGAATCTGCAAAGTTGGACGGAGCGAGAATTCGT
1574





GCH1
ADXCRPD.4094.C1_at
AAGTCATTACTTTGCATTTACTAATAAGACAACAGCCTGTGGATACATTAGACCTTTATAAG
SEQ ID




AACACTTCTAGGAAATGTTAGAACAACGAGTCATTAAAAAGGAATATAAATGAGTTCATAAA
NO:




GATAAATGTATAG CTGACAATTTCTTTG GTCCTCGAAGTCACACTTGTTTTTACTTTAAA
1577




ATGCCAAACATGAGTTGAGTGCTCAGAATTCTACCTATAAATGTCTAAATATTAAGCAGGCT





TTF1
ADXCRPD.2906.C1_at
AAACCCGCGCTAGGTAAATTCTGCTATCTGGCCGTCAACACGCTGTTTTCACCAGCTCATCT
SEQ ID




AGTCGCGCCTGAATAGTAGCGCCGCTACCCGCGGGGCCCGCGTCTATTTCTTTTATTAGTCG
NO:




CCGCCGCGCGGTGTGCATTATATCTCAATCCTTGCGAGTCGCGTGAATGCGGAGCGAATTTG
1598




TGAGNCACGCGAGTGGGCCGCGCCGCACGGGGACGCCTTTCGCTNCCCATCATTCCCACTTT




ACGGCCGTCCGGCCCAGCCGGTCGCGTATTACTTGCCGGTGGC





LBR
ADXCRPD.2923.Cl_at
TTAAGACAGCACTCCTTTACAGGGAGTCAGGTTTGGTAAATATAAAGGATACATAAAAAATA
SEQ ID




CAGTATAAACTGCATAAGCTTAACAGTAGCAAAAACACTGATGAACTTTTAAAAAGTCAAAA
NO:




ATATATAAAAATATTAGCCTGAAATGGCAAATTTTCAAACACCGATCTGTGTAA
1600





TMPO
ADXCRPD.3658.C1_at
TTGTTCACAGTGTTGGCACATGGTAAGGGCTAAGACACTTGATTAGCATAATATTCAAAATT
SEQ ID




AGAAATTGTACACTATTGTACTCTCTTTCAAAAGGCAAACAGCCTAAAACTGTTTGGAAAAA
NO:




ACAGCTTGTACAGTATATTGTACACTTCCTGTGATAGACTAGTGGACTGATACACCCACTAA
1615




TGCACAGCAGTAATAGTCCACCTCTTTACACANTTATGCATGTTAAGTGACAAAAAAACTCA




CTTTAAAAGGCCAAATGATAAAAACATCAGCCTTGAGGCTCTTCGATATAGA





IGJ
ADXCRPD.4305.C1_at
GGCAATTTCTTACACTAACCTGATTATGAAAAAAAGAAGTCTGTATCATCTGCTTCCAAGTC
SEQ ID




TGTTATGTCCAAATATATTTTAATTATGCATTTATTTTGCTACTTTTATAAATATTAGAGAT
NO:




TTCACCTTAAATTATTTTTGTAACTAGTTCTAGAACATGTTTTCCAATTATTATTTTTCTAA
1619




TGGAGACATATAATTGACCTATGTTTATGCATATATGTTCTCTACACAGTGAAACTTTTTTT




AAAAAGAATAGTAAAGAAAATGCGGAAGCTCTGGCTCTCCAAG





ICAM2
ADXCRPD.4332.C1_at
GAGGCTGCCCCACCGTTCCGGCCATAGCAACCATGAGTGGCATGGCCCACACCACGGTGG
SEQ ID





NO:





1622





ICAM2
ADXCRPD.4332.C1_s_at
TGTCGGTGTTGCTGTCCCTGTTCGTGACATCTGTCCTGCTCTGCTTCATCTTCGGCCAGCAC
SEQ ID




TTGCGCCAGCAGCGGATGGGCACCTACGGGGTGCGAGCGGCTTGGAGGAGGCTGCCCCACCG
NO:




TTCCGGCCATAGCAACCATGAGTGGCATGGCCCACACCACGGTGGTCACTGGAACTCAGTGT
1623




GACTCCTCAGGGTTGAGGTCCAGCCCTGGCTGAAGGACTGTGAC





TMEM177
ADXCRPD.4336.C1_at
TGCCATTGAGTCTGGAGGGCCCTGTTGGAGCCTTTGGACCTATAGCTCAAGGCCAGAAAAAT
SEQ ID




CACTGGCTTTGGAATTAAATAGCTTAGATTGTACTATAACCACTACTTATGAACTCAGGGAC
NO:




TATGAGGGACTATTCAGGGGCTATGAATCTGAGCCTTTGTTTCTTGAACTGTAAAGTGGAGA
1624




TGATGTAAACCGCCTTGCAAGATTGTAGAGTTGGGTAAGGTCATGAACATAAGGGCCTGGCA




CAAAGGGTGCACTGTAAATAAACAGACATCCCTCCTTA





NUP210
ADXCRPD.12713.C1_at
ATCCCTGTTTGTCTGCAGCTTTATATATGAGTTGGGCGACATTAATATTTGTTCTGCTTCTA
SEQ ID




TTTCAGGGTTGAGCAGCTGCAGCTTCTCAAACACCTGGACTTGGATCTCATCCGAGAGTTCT
NO:




CTGGCCAGGCCATACAGCTGCCCCGATGTGGGGTCCACAGCCTTGACCACCACCCTCAGCCC
1628




GGTCCGGCCTTTTACCCGCCGAGCACGTTCATGGCAAAGTTGTATCTGTGACGGGAGTCGGA




TCACGCCTCGTGT





CD53
ADXCRPD.3701.C1_at
TGGACCATTGTCACAACCCTCTGTTTCTCTTTGACTAAGTGCCCTGGCTACAGGAATTACAC
SEQ ID




AGTTCTCTTTCTCCAAAGGGCAAGATCTCATTTCAATTTCTTTATTAGAGGGCCTTATTGAT
NO:




GTGTTCTAAGTCTTTCCAGAAAAAAACTATCCAGTGATTTATATCCTGATTTCAACCAGTCA
1629




CTTAGCTGATAATCACAGTAA





IQGAP2
ADXCRPD.12735.C1_at
CCACGCCTGTGTACATGTGGTTTCATAAAACATCCTTAAGCATGAGCTAGACATTAAACAGT
SEQ ID


2

CTTGGAGATTCTAGTTCAGAATTTACCTCAAACGTGTGAATTATGGAAATTCATGGTTCATC
NO:




ACAGATGGTTGGGATGTTGCCAAGATACATCCTTTAGCACGCCTCTGTTTGCTTTATGTGAA
1631




CATTAATAACTCTGTTCCAGGAG





ALDH5A1
ADXCRPD.14052.C1_at
TTCAGCTGTGATTATTCTGGCAAGGTCATCCTTATTTTGTATCATTAAATTGTACCACTTCC
SEQ ID




GAAGTAATGAACTCCTCTCCTTGGCGGAGACCTCCCTCCAGCGGCAGAAAGCCTCGTAGGCA
NO:




GCGCGCACGGCGGCGCGGGCCTCTCGCACCCCACAAACGCCCACCATGCCCAGAGCGGCGCC
1636




GCTGGCAGGAGTCTTGCACG





ALDH5A1
ADXCRPD.14052.C1_x_at
AGAGAACCACTCTAGGAAAAAGGCGGAATAGAGAATTTCTCCATGTGCCTCCTTCAGTGGCT
SEQ ID




TTCCACTTTCAGCTGTGATTATTCTGGCAAGGTCATCCTTATTTTGTATCATTAAATTGTAC
NO:




CACTTCCGAAGTAATGAACTCCTCTCCTTGGCGGAGACCTCCCTCCAGCGGCAGAAAGCCTC
1637




GTAGGCAGCGCGCACGGCGGCGCGGGCCTCTCGCACCCCACAAACGCCCACCATGCCCAGAG




CGGCGCCGCTGGCAGGAGTCTTGCACG





PTPRCAP
ADXCRPD.5068.C1_at
CCCAACCACAGGCATCAGGCAACCATTTGAAATAAAAC
SEQ ID





NO:





1645





PTPRCAP
ADXCRPD.5068.C1_x_at
ACCACAGGCATCAGGCAACCATTTGAAATAAAACTCCTTCAGCCTG
SEQ ID





NO:





1646





LBR
ADXCRPD.5090.C1_at
AAACATCAATAGCATTCTTCACAGTACATTTATATTAAGACTGTCTTCTGTTTTCAGGATTA
SEQ ID




ACGGGTTGAAAATTTCCCATTAAAATGCAAATTCTCACATCCTTACTTGTATTTTTCCTATG
NO:




TTAACTGTAAGTTAATACAAGTAAACACGGCTATATTAAAAGATCAACTACTCGGCTCCATA
1650




GTCCTGACTCAA





GCN1L1
ADXCRPD.13574.C1_at
AAGCCTTAGGTTGGTAATCCGGCTGAACTCGGCTTGACGGCCTGAGGCCC
SEQ ID





NO:





1664





GCN1L1
ADXCRPD.13574.C1_s_at
GATGCCCTAAATGCCATCACTAAGAAGCTGGATGCTGGCAACCAGTTGGCACTCATTGAAGA
SEQ ID




GCTGCACAAGGAAATCCGGCTCATAGGGAACGAGAGCAAAGGCGAGCATGTGCCAGGATTCT
NO:




GCCTCCCGAAGAAGGGAGTGACCTCCATCCTTCCAGTGTTGCGGGAAGGAGTCCTGACTGGC
1665




AGCCCTGAGCAGAAGGAGGAGGCAGCCAAAGCCTTA





ALDH5A1
ADXCRPD.13575.C1_at
TTATAACTCTGGATTACCGATGCTGAGATGTGTGCAGGAATACTTCCAAATAAATTTTTAAC
SEQ ID




ATTGTAAGCCAGTAGATTCTTTGGCTGGGTGGCAAATTTTGAGTCTTCTTGCATATTTGGCT
NO:




CATGGGTTCATAAATTGAGGCCAGAGACTCATTGTATATCCTTGATCAATTTTCTAATTAAA
1666




GGAAATAGCTTATTGTTTAGTAAAATGGCC





LBR
ADXCRPD.12940.C1_at
GCCAGTTCTTTTACAACGTATGCTTCTTCCTTAGAATCTATTTCTTTTAATCTATGACTTAT
SEQ ID




TCTCTTCTTGGACGAAGGCTATATCTGTGTTGCTATGTAACTGCTTGACTTGTGACAAAACT
NO:




GAATTTATCCTGTGTATTTATATGAGGTGCGTCATTTCTCATCAATATGACTCAGGCATCCC
1673




CATTAAATCTGACTAGATGCTATTTCACAAATGGCTTCAGAATCAGCGGAGTCAATTTAACT




TCCACTTCCCTCCTTGCTTCCTTAATGTCGGCCTGATGGTAGCAAGACTGCG





TMPO
ADXCRPD.12957.C1_at
TAAACATGCAAACTCACTACCAAATTGGCTTATAGTAATATTAGGCCTTAGCAATTCCATTA
SEQ ID




AATTAAGAGCAACTCATTATTGGAGAACACTTTCTAAGTTGAACTGTAATCATACAAACCGC
NO:




ACAGCCAAGCAAGTAACTTAAAGACATTGTTGTTAAAATAGTCCATTTTGGATTACCTATCT
1676




AAA





THUMPD1
ADXCRAD_BP377292_s_at
TGAAAAGTAGCAGCTTCTCTATCCAGGATGATGAGTCAACAGGTTTCACTAATATTTGTCAT
SEQ ID




GCTGTAGCATTTGTAAGATTTGTAAATGATGAAATTCAAAGAAAACTTTTTCTATTGCTAGG
NO:




AGCCTGCCAGAACAAAGGCCAATATATAATGTTGTGACATCATATCTGATAACCAGAGGTCT
1677




GGTATCTACACTCCTGGTGCCCCATCAGTGGTTGTCTCCATAAGTCATTTTGCGT





FBXL14
ADXCRPD.4724.C1_s_at
GGAGGAATAGATGACTTTCTTTCTTTTGGTGGGGGTTGGGACTTGTGGCTTTAAAGAAATCA
SEQ ID




CTTCTGAGTAGGATGTATATTTTCGTTGGATTTTTGTTGTTATTTCTTTAGAACCCTCCACA
NO:




GCAACATGCAAGACCATGGAGTTAAAGAAACCCAGAGACCTTTATCAATTAATTGTACTGTT
1696




TGTGAAT





UTP3
ADXCRPD.6075.C1_at
AAAATACTACGTTCTAGCTGCTTAAACAGTCTGTATTTTCCACATTATGATGGATTCAAAGC
SEQ ID




AAATAAGAGTCACACTTCAAAGTCAGAAGTTGCATTCCTCTTAAAGGATATTTGTACTCGGC
NO:




TGCTACTATAAGACAAAGGTTAACTTGACAGGCTCAATGTCTCTGTTATATATTGTGGAAAA
1703




ATTACCTAAAATAGCTATCATTTATTAAATTTCTATTTTCTGTTAGGTGCTTTACAAATGCC




A





EZH2
ADXCRPD.13819.C1_at
GTGTTTGACACCGAGAATTTGCTTCAGAGGAGCTCGAAGTTTCATCTTTCTTCTCTTCTTCT
SEQ ID




TCTTTATCATTGTTCTCTCCCCCCGTTTCAGTCCCTGCTTCCCTATCACTGTCTGTATCCTT
NO:




TGATTCCAGCACATTAATGGTGGGGGTGCTGGGCCTGCTACTGTTATTGGGAAGCCGTCCTC
1705




TTCTGCGGCCTCCTGGACGTTTTGGTGGGGTCTTTATCCGCTCAGCGGTGAGAGCAGCAGCA




AACTCCTTTGCTCCCTCCAAATGCTGGTAACACTGT





HNRNPA2B1
ADXCRAD_C N402594_s_at
GAAGAAGTGGTCAACCACAGAGTCTTCAAGAAATAAGAAATTCTGTACCATCTGAAAGTAGT
SEQ ID




TCTTGTTGGTGCCTTCATTTAAA
NO:





1709





LBR
ADXCRPD.13860.C1_at
AATGAAGTGTCTTGGCCAATGGCTTCTCTAATTATTGTTCTGAAACTTTGTGGTTATGTAAT
SEQ ID




CTTCCGAGGTGCAAATTCTCAGAAAAATGCATTCCGGAAAAATCCCAGTGATCCAAAGCTTG
NO:




CACATTTAAAAACCATTCATACTTCAACGGGAAAAAATCTTCTAGTTTCTGGATGGTGGGGC
1711




TTTGTTCGCCACCCCAATTACTTGGGTGATCTCATCATGGNCTTGGCGTGGTCCCTCCCATG




TGGTTTTAACCACATTCTGCCTTAT





PCCB
ADXCRPD.6197.C1_at
GAATCTCCAAAGAGAATAGCCGGCCCGAAAAGGAG
SEQ ID





NO:





1720





PCCB
ADXCRAD_B P253154_s_at
GCTGCTCAGGCAGAGTACATCGAGAAGTTTGCCAACCCTTTCCCTGCAGCAGTGCGAGGGTT
SEQ ID




TGTGGATGACATCATCCAACCTTCTTCCACACGTGCCCGAATCTGCTGTGACCTGGATGTCT
NO:




TGGCCAGCAAGAAGGTACAACGTCCTTGGAGAAAACATGCAAATATTCCATTGTAAACAAAT
1721




CAAAGGAAAAGAAACCAAGAACTGAATTACTGTCTGCCCATTCACATCCCATTCCTGCCTTT




TGCAATCATGAAA





IQGAP2
ADXCRPD.14593.C1_at
CCACTTCTAATGCAATACATATCCCGGAGTGTGCT
SEQ ID





NO:





1725





IQGAP2
ADXCRPD.14593.Cl_s_at
GCACTACCAGGATGTTTTATACCATGCTAAATCACAGAAACTCGGAGACTCTGAGAGTGTTT
SEQ ID




CCAAAGTGCTTTGGCTGGATGAGATACAGCAAGCCGTCGATGAGGCCAACGTGGACGAGGAC
NO:




AGAGCAAAACAATGGGTTACTCTGGTGGTTGATGTTAATCAGTGTTTGGAAGGAAAAAAATC
1726




AAGTGATATTTTGTCTGTATTGAAGTCTTCCACTT





TPT1
ADXCRPD.14624.C1_at
CCAGCTGGAGTTTTTGGGACGCTTTTGTGGGGGCACCGCTGAGTCCGGATAGTGGGACCCAA
SEQ ID




GTCGTCCTGCTCGGCCCCTGGGGAATAATCGTGTGGGGCGCAAGGTCTGTGGGAAGGGACTT
NO:




GGAGAGGAGGGAAGATGTCGCGGGAGTCTGCACAGGGTTTCCATGTGTTCCAATTCTTCGTC
1733




CCATAATTCAAAGCTCGTGGCATTCTGTGGCCGACCGCTACCGAGCTAGCTCTTCCCTTTAC




TATTTCGCACTTGGTCTTGGAAAAGAT





41888
ADXCRPD.5611.C1_x_at
GAAAAACCCTTGTGGGCACCAATGAAATAGAGGGGGCTTCGGGAGATTTTNNNNNNNNNAAC
SEQ ID




ATAAAAAAAGAACACGCCCCCCCGCGGGGGGCGAAAACGCCCAAGGGCGGCTTTTTCTCAGT
NO:




AAAACAAAACTCCCCCCAAAACGTGGGAAGTTTTCTCTCTCGGGAGGGCCCTTATTTGACCC
1734




GGGGGCGTTCTCTATCCCCAACCACGTGGGCGGAGGCTCCCCTAAGGAGAGCGCGCGTCCTC




TCGATAAATATTGCGCGACGACGTGTTTCAGCG





CALML4
ADXCRAD_BX431388_s_at
GAAGCAGATATCGAACCCAATGGCAAAGTGAAGTATGATGAATTTATCCACAAGATCACCCT
SEQ ID




TCCTGGACGGGACTATTGAAGGAGGAGAATGGGAGAGCCTCCCCTGGGCCTGAAAACTTGGA
NO:




GCAATTAATTTTTTTTAAAAAGTGTTCTTTTCACTTGGGAGAGATGGCAAACACAGTGGCAA
1753




GACAACATTACCCAACTATAGAAGAGAGGCTAACTAGCAACAATAATAGATGATTTCAGCCA




TGGTATGAGTAGATCTTTAA





ATHL1
ADXCRAD_AJ708476_s_at
AGTGGGATGGCTCTCTTCCCTCAGCCACGCCGCTTGTGAGGACAGAGGTGGGGGAGTGGGAA
SEQ ID




GTGGGAAGTCACCAGAGAACAGGAGAGGGATTTGAGGGCGCGACCCCAGCGCTCTCCACGGA
NO:




CCAGCCAGAGGGACTGGAGCCAGGTGTGCATGGGTTCAAGGCCCTGGCCCTGCCCAGCCTCT
1756




GTCTTGGGAGCTCAGCCCCAGGGTTCGGTCGTCAGCAGTTTCCCAAGAACAAGATGTGATGG




CATCTGCTGCTGAAACCCTGATGAGGACCAGGCCCC





LRMP
ADXCRPD.6445.C1_at
AGTCTGCCTATGATCTTTGAATGAGCTTTTTAAGGAAGAATATTATATATTGTTTGCTAAAG
SEQ ID




CCTATTGAAATAAAG
NO:





1757





BCL11A
ADXCRPD.15478.C1_at
CCATCCCACCACATCATGTAAAGTGTTTCTAGGCTTCTCTATATAATACCCAGAAATGTGAG
SEQ ID




CATACAAAAAGTACAAGGATGTGAAGGTTATCAACCAGAGAGCAAATTGGTCAATGAGGCAA
NO:




ATCATCACATATGTAAAGAAAACAGTCTTCCTGGCATAACTCCAGAGAACACACACACACAT
1758




ATACCCATGCACACACCCACAGCAACAAATGTGTCTGGTCTGGTAAGTTTA





HCLS1
ADXCRPD.6475.C1_s_at
GTCCTCTCTATCCTGGATGAGCTCATGAACATTTCTCTTGTGTTCCTGACTCCTTCCCAATG
SEQ ID




AACACCTCTCTGCCACCCCAAGCTCTGCTCTCCTCCTCTGTGAGCTCTGGGCTTCCCAGTTT




GTTTACC





NO:




CGGGAAAGTACGTCTAGATTGTGTGGTTTGCCTCATTGTGCTATTTGCCCACTTTCCTTCCC
1760




TGAAGAAATATCTGTGAACCTTCTTTCTG





WDR59
ADXCRPD.15558.C1_s_at
CAGTGTTACCCTGTAAGGTGTTAGCCTTAAACCACCGAGCAGCGTTCTCTTGATGCCAGTGC
SEQ ID




AGAGACCAGAGTCAGATGCCCGAGGACAGTGGGTAGGAATTTCATCAACAAATGGACCTATG
NO:




GCATCATGGCTTTAGAAGCTGGTACATTTACTGAGCTGATGGACAGTGGCCTTCTAAAATAT
1764




GACACTTAAATTGTAAATATGCACTGTACTTAAGGATTCTTAAGATGTATTTTTTTGTTATT




TCTCCTCCAGCTGCTATCCCTTGGCTAATAAA





ATP2A3
ADXCRPD.5908.C1_at
ACATATAAAATCATCAGTCTGCACACGCTCTAGGAGGGGCCAAGACATAGGGACAATCCTTG
SEQ ID




GTGCAGGTTTCTGCTACCCCTCGCTAGTTTTTGCCAAAGTAGCAAAAGCTGAGTTAAGAGAA
NO:




AAATTCTGTCCATCAGAGGCCATCTTCCTCTCATCTGATATGACGTGTTCCTCCAGCAGGGA
1765




GGGAGGGAGAGCGGGTGCCCTGGGGAATCAGCCATCCTTAGTGACATCCTTTCGGCTCATGG




GTGTCGTG





CHD7
ADXCRPD.14939.C1_at
TGCTGGTGCATTAGTCCTTGACCACTGTTTGATGGGAATCCTACAGCATTGGGGTATCTTGG
SEQ ID




TACGGACTGATTCATTGGAGTATTATTTGTAAGGCCTAAATTTTGATTCATCCCTGTATTGT
NO:




TAACTAATCCCTGATTTAGGTTACTGTAAGGATATCGAGAATACTGCCCTGAGTTGTTTATA
1766




GTAGGAGAGGGGACTGTCTGGCTCCGAGAACTAAAGTTAAGGGTTTGCGGCCTAACAGCCCC




TTGTTGGGGAGGATTCGGGGAGAATCTGGGACTGTGGGCAACGGATTC





NUP210
ADXCRPD.7334.C1_at
ACTGAAGTCTGTTCACAGTGGCCCATGGTTGGGCAGCAGCCCTGGGTGAGCTCCTGTGTTCT
SEQ ID




CCAGCCTCTCGCTCACCCAGGGCTTGGCTATCCTGGCCTCCAGGTGCTGGTTCCTGAGGCTT
NO:




CCCTTGCGGCAGTGGCGCAGATACAGGGACACTCATGTCCCATTGCTCCTCAGAAGTCCTAG
1781




CAGCAGCCAGACTAG





SKAP1
ADXCRPD.16383.C1_at
CAGAAGTTCCAGACCCGGTGGACCACCTGGTGAGACCCCTGTCTCTTTAAAAGNNNNNNNNN
SEQ ID




NNNNGGAAGACAATTTATTTTAAAAACATCTGAGAATCATTACTGCTTTTATAATATTTAAA
NO:




TTTTCTACATGAATTAAATAGCCGAAGTACATAGTTATCTATCATTCATCTATCCAGTAAAA
1782




TGTTATGTATTTATGATGCACCAGCATTATAACTAACTCTGAGATCAG





MDN1
ADXCRPD.16426.C1_s_at
GAAAGAAGCCGAGAGTCTACCATTCATACAGCTCATCAATTCCTCATGGACACGATCTTCCA
SEQ ID




GCCCTTTTTAAAAGATGTCAATGAGCTAAGACAGGAGCTGGAGAGACAGCTGGAAATGTGGC
NO:




AGCCACGTGAATCTGGAAACCCAGAGGAGGAGAAGGTTGGAGCTGAGATGTGGCAGAGTTAC
1793




CTGATCTTAACAGCGCCTCTTTCAAAACGGTTATGTGAAGAGCTTCGTCTCATATTAGAGC





USP7
ADXCRPD.16454.C1_at
GTCTGTCTGGATAAAAGCGTGGCATCACCATAATCTTCCATGGCAGATTTCGCACAAAACAC
SEQ ID




GGAGGGCTAAGGACCGACTCACTCAGTCTGCTGAAGCGCTCCACAGTGAACTGAAAGGCTGC
NO:




CTCGGAGCGCCAACTGGTGTCATCCTCCATGTCCTCCTCCGCGGTGTTGTGTCCATCACTCA
1794




GGGCCACATTCCCATTGATCACAGGGTTCTGAGTAATTCTTGGTGGCTCATCATGTATCTCC




CG





NUP210
ADXCRPD.15803.C1_at
ACCTTACTCCCACGATCACTTACAACCCCACGATCACATACACCTTCATCTCACCGAAATGG
SEQ ID




AGTGGGTTCTGCACATCATGTGCCCGGATCACACTGAACCCGATGTCACTGCCTGTGGTCAT
NO:




CACGCCCTTGACAGTAACTGTGGCAACCAGGTGGCTTGACGAAGACCAGCTGAAGTTCCCAC
1795




TGCCACCGTGGGCCCTTATTGTGTACTGATAGGCGCCCGTCTTTGGTTGCCACGGAAATGTC




AAGATGCTGGGATACAGGGT





NUP210
ADXCRPD.15803.C1_s_at
CACCTTCATCTCACCGAAATGGAGTGGGTTCTGCACATCATGTGCCCGGATCACACTGAACC
SEQ ID




CGATGTCACTGCCTGTGGTCATCACGCCCTTGACAGTAACTGTGGCAACCAGGTGGCTTGAC
NO:




GAAGACCAGCTGAAGTTCCCACTGCCACCGTG
1796





TFB1M
ADXCRPD.7488.C1_at
GTGATGAAGACCCACAACTCTTTGCATATAATTTCAGAGAAGAACTCAAGCGAAGAAAAAGC
SEQ ID




AAAAATGAAGAAAAAGAAGAGGATGACGCAGAGAATTACAGACTCTAGCTGCTGCCTGGGGG
NO:




CGAGCAGCCTACCAGATGTCGATTTGCACTACGTGGAGCTTCTTATATAGGTACTCTTTTGT
1800




CTTTACAGAATGACGATACAAATGCCAATGACCAGATGTGACTTATTTTCCTTTTACTATAC




AGCTTGGCAG





TAPBPL
ADXCRPD.6849.C1_s_at
TTCAGAGACGGCAAGCACCTACAGGACTTGGGCTGCTTCAGGCTGAACGCTGGGAGACCACT
SEQ ID




TCCTGTGCTGACACACAGAGCTCCCATCTCCATGAAGACCGCACAGCGCGTGTAAGCCAGCC
NO:




CAGCTGACCTAAAGCGACATGAGACTACTAGAAAGAAACGACACC
1803





MYC
ADXCRPD.8111.C1_at
CAGTGTCCGTCTCCGGCTGTCAGAAATGCGGTGAGCCGAAATTTAAATGCCCTCCCGGAGAC
SEQ ID




GGGGACAAGTCAGCGGCTGCGGAGCGATCTGGCTCACACAGGCGATATGCGGTCCCTACTCC
NO:




AAGGAGCTCAGGATGCAAGGGGCTTTCTGCCCACCGCAAAGCAACCCCCAGCCCCCCAAAAC
1806




CCAGAGAGCAATTAACACAATAAAGCAGGAATGTCCGACCGGCCGGGAGTCAGCGTGAATAT




ATTCATAAGGCAGAAATCTCGAAAGGGTAGTCTT





NUP210
ADXCRPD.15917.C1_at
GCCTGACAGGTCACAAGGATCCAGTGTTGCTGATAATTCCGGGAGGAATGGGGGGCAAAGAG
SEQ ID




AGCCAGGCCGATGCTGTCAGTGTCCTCAGCGGCGACGTTCTGGAAGAATTAGGACGGCTCGA
NO:




GGATCCAAGGTCTGGGACCTCCTTCAAACAGCATCTCCTTTGAGGAGCCCAGGGTTACCAAG
1813




GCAACAGAGGAGGGATCCACAGCCTTGAGGGGCAGGTAGGCAGCAATGGTGATCTTGGCACT




CAGGTGGACGTGGCCGTGTCTGTAGCTCACAAGACGCGTGGTA





CXCR4
ADXCRPD.7562.C1_s_at
GTATGTCTCGTGGTAGGACTGTAGAAAAGGGAACTGAACATTCCAGAGCGTGTAGTGAATCA
SEQ ID




CGTAAAGCTAGAAATGATCCCCAGCTGTTTATGCATAGATAATCTCTCCATTCCCGTGGAAC
NO:




GTTTTTCCTGTTCTTAAGACGTGATTTTGCTGTAGAAGATGGCACTTATAACCAAAGCCCAA
1814




AGTGGTATAGAAATGCTGGTTTTTCAGTTTTCAGGAGTGGGTTGATTTCAGCACCTACAGTG




TACAGTCTTGTA





LGALS9
ADXCRPD.6993.C1_at
AAGATGAAGCCCCATGCTCAGTCCCCTCCCATCCCCCACGCAGCTCCACCCCAGTCCCAAGC
SEQ ID




CACCAGCTGTCTGCTCCTGGTGGGAGGTGGCCTCCTCAGCCCCTCCTCTCTGACCTTTAACC
NO:




TCACTCTCACCTTGCACCGTGCACCAACCCTTCACCCCTCCTGGAAAGCAGGCCTGATGGCT
1820




TCCCACTGGCCTCCACCACCTGACCAGAGTGTTCTCTTCAGAGGACTGGCTCCTTTCCCAGT




GTCCTTAAAATAAAGAAATGAAAATGCTTGTTGGCACAAAAA





LGALS9
ADXCRPD.6993.C1_x_at
AAGATGAAGCCCCATGCTCAGTCCCCTCCCATCCCCCACGCAGCTCCACCCCAGTCCCAAGC
SEQ ID




CACCAGCTGTCTGCTCCTGGTGGGAGGTGGCCTCCTCAGCCCCTCCTCTCTGACCTTTAACC
NO:




TCACTCTCACCTTGCACCGTGCACCAACCCTTCACCCCTCCTGGAAAGCAGGCCTGATGGCT
1821




TCCCACTGGCCTCCACCACCTGACCAGAGTGTTCTCTTCAGAGGACTGGCTCCTTTCCCAGT




GTCCTTAAAATAAAGAAATGAAAATGCTTGTTGGCACAAA





PPRC1
ADXCRPD.16668.C1_at
AGGGCTTCACTGCAGAGCTGTCTTCTTGGCTGGGGCTGGTGGGATGACAAGACAAGGGATGT
SEQ ID




CTGCCAGCCCTGTGGGAGTCTCTGGAAGGCTAGGCCACTTCCCAGTTGGGGGCTGTGGACTT
NO:




CTCTCTTCTGTTTCTGCTTGGCGTTGCTGCCTTCGTCGCCGGTACTCAGATAAGCTGAGAGG
1832




CCGAGGTCTGGCTTCATGGGTTGTAGCACTGGTACCACTTTCAATTTTCA





ALDH5A1
ADXCRPD.1124.C1_at
TAAATTTCTTACCACACTCATTCCCAAGTTTTATCCCACAAAGTATAGCATGAAACAATGAC
SEQ ID




AACATACATATTATTCAAGTAAAATGCTATTTAAAATAGCTGCACACAGGTAATTAAAACAC
NO:




CTAGGATCCAGTTTTTAGAGGAAAAAGNCATGTGGCACAATTNCAAGTTCATAAATTGAGTT
1865




AACAGTAAAACAGATTTGCTCACATTTGCTTCTGATCTTTAT





MFNG
ADXCRPD.17460.C1_x_at
TGGCAATTGGCACTGAAGGCACCCAAGCCCCTGGAGCCTTTCTTGCGGTTAGGGCTAACATG
SEQ ID




GACCAGCTTTGGCAGAGGAACTAAGCAATCCAATAAGATGTTCTTGGAAAGTTTTGAGCCAC
NO:




TCCCATCTTCTGGCAAAATGTGGGTTGAAGGCGGATCT
1873





NUP210
ADXCRPD.9121.C1_at
TGCCTTGCATATTACTTGAGCTTAAACTGACAACCTGGATGTAAATAGGAGCCTTTCTA
SEQ ID





NO:





1884





NUP210
ADXCRAD_CX756211_s_at
TTGGAAAAGTCCTCTCTTCCCAGCTCCTGATTCTGGATCTGAGATTCTCAGATCACAGGCCC
SEQ ID




CTGTGCTCCAGGCCGAGGCTGGGCCACCCTCAGGGAGATCCAGAGACTCATGCCCATGGCCA
NO:




TCCATGCGTGGACGCTGTGTGGAGAGTCCAGGATGACGGGATCCCGCACAAGCTCCCTTCAG
1885




TCCTTCAG





EWSR1
ADXCRPD.18189.C1_x_at
AATGGGAACCCCTTGTGAGCATGCTCAGTATCATTGTGGAGAACCAAGAGGGCCTCTTAACT
SEQ ID




GTAACAATGTTCATGGTTGTGATG
NO:





1890





UBE2L6
ADXCRPD.250.C1_at
TGCCCTTAACCCGATTTGGCCATTCCCCTCTCTCCCCCGTACTATACACCCCCGCCCCGCCT
SEQ ID




TCCTTCCCGCCTTTGTGCGCCTGTCCGATCATANTTTCCGCCCATGGTCCACGTTCTCCGCC
NO:




GCGTAACCTATATCCTGGATTCTCTTCCCGCCCCGCGTGTGCTACCCCCTTATTGCCATTTT
1893




CCCGTTACGCGGAGTTCGCCCGAGGCCCGGGGCTTTGTCGCCGCGTACTTTAGGCCCCGCCC




CGCCTAAGTTCCGCCTTCATTATACCGCGCTGTG





REPIN1
ADXCRPD.869.C1_at
ACATCTGCCGCTAACCGTGAAACACCACCACCCGTGGTTCGCCCCAGTTCGCCACCTCCCGC
SEQ ID




CCTTTTGCCTCCACGCGCTGTACCCACGCCGTGTGGCGGAACAAACCTCGCCGACATTGACA
NO:




CAAAGTGCCTCCCTCTTGTTGATCNCTCCCACGCGCCGGACAAACTAGCCTCGCCCCCAGTG
1901




AACATCCAGGCCCCGCAGGGCGGATCATGGACCATATACCTTCTCTGCATCACCGGCCTCCC




TATAGACACACACTCCCGCTCTGCTGAGTGATATACACGCCCGCCAGGG





NAP1L1
ADXCRPD.367.C1_s_at
AGTGAAGTTCTCAGATGCTGGCCAGCCTATGAGTTTTGTCTTAGAATTTCACTTTGAACCCA
SEQ ID




ATGAATATTTTACAAATGAAGTGCTGACAAAGACATACAGGATGAGGTCAGAACCAGATGAT
NO:




TCTGATCCCTTTTCTTTTGATGGACCAGAAATTATGGGTTGTAC
1910





PIM2
ADXCRPD.11037.C1_at
GCTGGGAAGTGGAGCTCAGCTTCCAGAATCTCCTGGTCCCTCTCAAAGGGAATGTCCCCACA
SEQ ID




CACCATGTCATAGAGGAGGATGCCCAGTGACCAGACAGTGGCCGGGAGTGCATGGTACTGGT
NO:




GTCGAGAGATCCACTCTGGGGGGCTGTACACCCTTGTCCCATCAAAGTCAGTGTAGGGTTCA
1912




TCATGAAGCAGGGCACCAGAACCAAAATCAATGAGTTTGGCACAGCCACGGCGTAGGTCTAT




CAGGATGTTCTCAT





TOP1
ADXCRPD.5549.C2_at
AGAAGAGCGCTATCCTGAAGGCATCAAGTGGAAATTCCTAGAACATAAAGGTCCAGTATTTG
SEQ ID




CCCCACCATATGAGCCTCTTCCAGAGAATGTCAAGTTTTATTATGATGGTAAAGTCATGAAG
NO:




CTGAGCCCCAAAGCAGAGGAAGTAGCTACGTTCTTTGCAAAAATGCTCGACCATGAATATAC
1913




TACCAAGGAAATATTTAGGAAAAATTTCTTTACAAGACTGGAGAAAGGAAATGACTAATGAA




GAGAAGAATATTATCACCACCTAAGCAATGTGATTTAACCAGA





USP7
ADXCRPD.949.C1_s_at
CTGCAAGTGAATTTCACTGATGTTGATATTCATTGTGTGTAGTTTTATTTCGGTCCCAGCCC
SEQ ID




CGTTTCCTTTTATTTTGGAGCTAATGCCAGCTGCGTGTCTAGTTTTGAGTGCAGTAAAATAG
NO:




AATCAGCAAATCACTCTTATTTTTCATCCTTTTCCGGTATTTTTTGGGTTGTTTCTGTGGGA
1919




GCAGTGTACACCAACTCTTCCTGTATATTGCCTT





ANP32A
ADXCRPD.232.C2_s_at
AGCTTCATTTTTGTTACCTGATAGAATAGCTTTTCTTATGAGATATATATAATGTGATACTA
SEQ ID




TGTTTGGATATTTTTGGTCTTAAAGCAAGACTCAGTGGTGTATCTTCATTAAAAGCTTCCTT
NO:




TAAAAAAGTTACAGAGTTACTAAAAAAACAAGTACCCAAACAATCAAGTTGGGCCAACCTTG
1921




GAACCTTGTTTTGAATATCTTTCATTGTTTTGTTTGTCGTATTGTAAAAAGAATGTATGGTT




GAAAACTCAGGAA





AQP3
ADXCRPDRC.2086.C1_at
GCCCCAGCCTTAGGTTTGGAGCTCTGGATGACATACATAAGTAGGAGCAGTGGGAACTGTTT
SEQ ID




CTGTCATAATGGAAGGCTGAAAGCGTGGAGTGAACTCAGGTCCTACAGTTCATGGGTGGCTT
NO:




TTGGTTGGTCCTGGCCTTTACGGGAAGGAAGCAAAGCTATACCGCCCTAAGGGA
1926





TAPBPL
ADXCRPDRC.18421.C1_at
TCCAGATGACTGAGACCACGTGTTCAGACAGCAGCGTTGGTTCACTGGCCAACGTGCAGGTC
SEQ ID




TCTGGAGGGGGACCTAGCTTCTCCTTGTGTGATGAACGACTCCCAGGGTCGCCAAGAATGAG
NO:




GCGCTCTGGCACCCGACCGCTGAACTTGCCACTTGAGGCCCCAGGGAGACTGTGCGAACTTG
1934




CAGTGAAGTTCCAGGTGATGACACATGACCAATCACTGAGACTCCTGCTGGGGTCCTCAGTC




TCCTTGGACCTGTGGGTTCTCCATGGACACGG





NFATC3
ADXCRPDRC.9584.C1_at
GGATACTTTTATATGATGGGTGCTTTGAGTGTGAATGCAGCAGGCTCTCTTGTTTCCGAGGT
SEQ ID




GCTGCTTTTGCAGGTGACCTGGTTACTTAGCTAGGATTGGTGATTTGTACTGCTTTATGG
NO:





1939





USP7
ADXCRPDRC.11382.C1_at
AAGTATTTCTTGAGCCCAATTGTGGACGTTCAGTTAGGGGTGGCAGTTAACGCTGACCTCTG
SEQ ID




CAGTTGCGTTGGTGGAAATCACCCAGCTGGGATCCATGCGCGTCATTCCCAGACTCAGTGGG
NO:




GTGTGCCTCCATTGCAAAGACAGTTGCACAGAAGCTCAACACAGACCCATTGTTGCTCCAGT
1940




TTTTCAAGTCTCAGGGGTAACCCTCAAGCCGCTGTGGTGCAGAGGGTTATGCGTGTTTCACA




ATTAAGCCGCGACA





41888
ADXCRPDRC.2412.C1_at
GATGTCTGGCCCGCTGGGTCAAGAAGCCAACAAGTCATGTTGGCTCGGCAGAATGCATCCCT
SEQ ID




GGC
NO:





1943





41888
ADXCRPDRC.2412.C1_x_at
AGGGTCCTGTTTGTGCTTCCTGTAGACACCCTTTTCCTGCGCAACAGAGCTGGGCCTCCCTT
SEQ ID




TCTCTAATTTCCCCCTTAACATGCCTGGGGGGCATACAATCCAACCCGTGCCCTCTCCTCTC
NO:




TTCCTGCCAAGGTTTATAGAAACCTGAGAATCTGAGGGTGATGTCTGGCCCGCTGGGTCAAG
1944




AAGCCAACAAGTCATGTTGGCTCGGCAGAATGCATCCCTGGCATTCCCAGGT





ARHGAP15
ADXCRPDRC.9769.C1_s_at
TACCCTTCTGCGAGCTGAAAATGAAACAGGAAACATGGCGATCCACATGGTCTACCAGAACC
SEQ ID




AGATAGCTGAGCTCATGCTGAGTGAGTACAGTAAGATCTTCGGCTCAGAGGAAGACTGACAG
NO:




ACAAGACAAGCTACTGAATACGTTCACATCTGTCTTGATGCCTAATATTTTTACATTTCTGT
1952




AAACATATTTCTGAAATATTTTTTGCCTTTCAAGCGACAGATGCCTCATTTTGTGAA





ALDH5A1
ADXCRPDRC.1911.C1_at
GAAAGCAATGGTGAGCAATCTGGTTTACTGGTAACTTCAATATGAACTGTGAATGTGCCACA
SEQ ID




TGACTTTTTCCTCTAAAACTGGAATCCTAGGGTTTTAATTTACTGGNGTGCAGCTATTTTAA
NO:




ATAGCATTTACTTGGAGAAAAAAAGGNAGGTTGGGCATTGTTTCATGGCTAAACTTT
1957





ALDH5A1
ADXCRPDRC.1911.C1_x_at
GAGCTGATCTGCATCTGTTTATCCATTTTAGTAGCTTTTAAATATGATTTTATGTGAAGTGC
SEQ ID




CATTTTTCTTATCTACTAAAGAGAGACAGCAGAAATAAAGATCNGAAAGCAATGGTGAGCAA
NO:




TCTGGTTTACTGGTAACTTCAATATGAACTGTGAATGTGCCACATGACTTTTTCCTCTAAAA
1958




CTGGAATCCTAGGGTTTTAATTTACTGGNGTGCAGCTATTTTAAATAGCATTTACTTGGAGA




AAAAAAGGNAGGTTGGGCATTGTTTCATGGCTAAACTTT





IGJ
ADXCRPDRC.2619.C1_at
ACAGAGACCTGCTACACTTATGACAGAAACAAGTGCTACACAGCTGTGGTCCCACTCGTATA
SEQ ID




TGGTGGTGAGACCAAAATGGTGGAAACAGCCTTAACCCCAGATGCCTGCTATCCTGACTAAT
NO:




TTAAGTCATTGCTGACTGCATAGCTCTTTTTCTTGAGAGGCTCTCCATTTTGATTCAGAAAG
1962




TTAGCATATTTGTTACCAATGAATTTNGAACCAGGGCNNNNNNNNNNNNNNGGGGGATGTAA




AACAACTCCCTGCCACCAAAATAATTA





IGJ
ADXCRPDRC.4305.C1_at
ATATTTGGACATAACAGACTTGGAAGCAGATGATACAGACTTCTTTTTTTCATAATCAGGTT
SEQ ID




AGTGTAAGAAATTGCCATTTGAAACAATCCATTTTGTAACTGAACCTTATGAAATATATGTA
NO:




TTTCATGGTACGTATTCTCTAGCACAGTCTGAGCAA
1974





NUP210
ADXCRPDRC.12713.C1_s_at
ATTGTTGCTGTAAAGGTATCCCCTGTTTCCTACCTGAGGGTTTCCATGAGCCCTGTACTGCA
SEQ ID




CACCCAGAACAAGGAGGCCCTGGTGGCCGTGCCTTTGGGAATGACCGTGACCTTCACTGTCC
NO:




ACTTCCACGACAACTCTGGAGATGTCTTCCATGCTCACAGTTCGGTCCTCAACTTTGCCACT
1976




AACAGAGACGACTTTGTGCAGATCGGGAAGGGCCCCACCAACAACACCTGTGTTGTCCGCAC




AGTCAGCGTGGGCCTGACACTGCTCCGTGTGTG





ALDH5A1
ADXCRPDRC.14052.C1_s_at
AAAGCCACTGAAGGAGGCACATGGAGAAATTCTCTATTCCGCCTTTTTCCTAGAGTGGTTCT
SEQ ID




CTGAGGAAGCCCGCCGTGTTTACGGAGACATTATCTACACCCCGGCAAAGGACAGGCGGGCC
NO:




CTGGTCCTCAAGCAGCCCATAGGCGTGGGCTGCAGTCATCACCCCGTGGAATTTCCCCAGTG
1978




CCATGATCACCCGGAAGGTGGGGGCCGCCCTGGCAGCCGGCTGTACTGTCGTGGTGAAG





LBR
ADXCRPDRC.5090.C1_s_at
TTTTTGTAATATATGGTGACTTCAGATTTTTTTGTACAGTATTTTGAATGTGAGATGATTGT
SEQ ID




CAGGACTAACTGTCTTTTTAACAAAACATTTTCAGTATTTTAAATAAAATTTTGTAAAGTAA
NO:




TGTGAATTAAAAATTTTGGAACAATTAGAATTCATTCACTATTGTATAGAAGATGCTGTTAA
1982




AACATAGGAAGGGTATTTTTCTTGATCCAAAGTTTGTGAATTTGGCTTTGCTACCTCAATTG




CAGGTGTTTGTT





ATP2A3
ADXCRPDRC.4511.C1_at
TCCTGAGCTCGGGAGATGTTCAGAGTCACACTGCCGCCCGGTCTGCCACGCAGAGGTCCAAC
SEQ ID




TTGCCACCCGCGTCCCTGGTACCTGAGACCACCGACATCCTCAGGTTCCTGACCGTGGCGCC
NO:




CTTCTACCCAGCC
1988





ATP2A3
ADXCRPDRC.4511.C1_s_at
GTCAGAGAGACGGACACAAGGAGCCGGCAGGAGGGCGGAGCGAGGATGTCCTTTCCCGGGAG
SEQ ID




ACAAGTCGGGAAAGCCTGGCTGGACTGCCTCAGCCCCGCGCGCCTCCTGGACTCAGGGTTCC
NO:




CCGTCCTGAGCTCGGGAGATGTTCAGAGTCACACTGCCGCCCGGTCTGCCACGCAGAGGTCC
1989




AACTTGCCACCCGCGTCCCTGGTACCTGAGACCACCGACATCCTCAGGTTCCT





ATP2A3
ADXCRPDRC.4511.C1_x_at
AGGATGTCCTTTCCCGGGAGACAAGTCGGGAAAGCCTGGCTGGACTGCCTCAGCCCCGCGCG
SEQ ID




CCTCCTGGACTCAGGGTTCCCCGTCCTGAGCTCGGGAGATGTTCAGAGTCACACTGCCGCCC
NO:




GGTCTGCCACGCAGAGGTCCAACTTGCCACCCGCGTCCCTGGTACCTGAGACCACCGACATC
1990




CTCAGGTTCCTGACCGTGGCGCCCTTCTA





LBR
ADXCRPDRC.12940.C1_at
CCATCCGGGCAAAGGACTTGGAGTTTGGAGGAGTACCTGGTGTGTTTCTCATCATGTTTGGC
SEQ ID




CTGCCTGTGTTCCTCTTCCTGTTGCTGTTGATGTGTAAACAGAAAGATCCCAGTCTTCTGAA
NO:




TTTCCCTCCTCCTTTGCCAGCTTTGTATGAGTTATGGGAAACCAGAGTATTTGGGGTCTACC
1996




TCCTGTGGTTTCTGATTCAAGTCCTGTTCTACCTACTGCCAATTTGGAAAGGTTGTAGAGAC




GCCTCTTACTGATGGGAGCAGA





EZH2
ADXCRPDRC.13819.C1_s_at
AAGATGAAACTTCGAGCTCCTCTGAAGCAAATTCTCGGTGTCAAACACCAATAAAGATGAAG
SEQ ID




CCAAATATTGAACCTCCTGAGAATGTGGAGTGGAGTGGTGCTGAAGCCTCAATGTTTAGAGT
NO:




CCTCATTGGCACTTACTATGACAATTTCTGTGCCATTGCTAGGTTAATTGGGACCAAAACAT
2004




GTAGACAGGTGTATGAGTTTAGAGTCAAANGAATCTAGCATCATAGCTCCAGCTCCCGCTGA




GGATGTGGATAC





TPT1
ADXCRPDRC.14624.C1_at
TTATGGGACGAAGAATTGGAACACATGGAAACCCTGTGCAGACTCCCGCGACATCTTCCCTC
SEQ ID




CTCTCCAAGTCCCTTCCCACAGACCTTGCGCCCCACACGATTATTCCCCAGGGGCCGAGCAG
NO:




GACGACTTGGGTCCCACTATCCGGACTCAGCGGTGCCCCCACAAAAGCGTCCCAAAAACTCC
2009




AGCTGGGGCAGCCCTGGGGCCGATGCTGAAAAGTTGTCAGAGGCCCTCGGGCAGTCCCGAGA




TCTACCCCAGGCCAGAGGGCCTGACCCTCCCTAAATGCGACGTTCT





ATP2A3
ADXCRPDRC.5908.C1_at
ACAACGTGTCGTGCGCGCACCGAAGCCTTACGACCCCGACGGGCGGTGGGGACACCTATCAG
SEQ ID




GAAACAAAAAACGGCGGCACCGCTGCTAGGCCCCGCAAGGAGAGAAACAACACGAACAGCGA
NO:




GTGATGCCCCACTAAATGGCTCGCTTTTAATGACGGAACAAGCCGTCTGCGCCCCAGAACCG
2015




CGAGTGCTCACCGGAATAGAATCCGCACCAGCGCTAGGT





CHD7
ADXCRPDRC.14939.C1_s_at
TCCAATGAATCAGTCCGTACCAAGATACCCCAATGCTGTAGGATTCCCATCAAACAGTGGTC
SEQ ID




AAGGACTAATGCACCAGCAGCCCATCCACCCCAGTGGCTCACTTAACCAAATGAACACACAA
NO:




ACTATGCATCCTTCACAGCCTCAGGGAACTTATGCCTCTCCACCTCCCATGTCACCCATGAA
2016




AGCAATGAGTAATCCAGCAGGCACTCCTC





USP7
ADXCRPDRC.16454.C1_at
GGGATTTCCAATATTATGGGCATGGAGTAAATGGC
SEQ ID





NO:





2022





USP7
ADXCRPDRC.16454.C1_s_at
GACTGAGTGAGTCGGTCCTTAGCCCTCCGTGTTTTGTGCGAAATCTGCCATGGAAGATTATG
SEQ ID




GTGATGCCACGCTTTTATCCAGACAGACCACACCAAAAAAGCGTAGGGATTCTTTCTCCAGT
NO:




GCAATGCTGAATCTGATTCCACGTCATGGTCTTGCGAATGCACAAGCAGTGCTGAAGATAAT
2023




AACTTACAGAGATGATGAAAAGTCGTTCAGTCGTCGTATTAGTCATTTGTTCTTCCA





NUP210
ADXCRPDRC.15803.C1_at
GTGGGGTTGTAAGTGATCGTGGGAGTAAGGTCCGAG
SEQ ID





NO:





2024





NUP210
ADXCRPDRC.15803.C1_s_at
AGCATCTTGACATTTCCGTGGCAACCAAAGACGGGCGCCTATCAGTACACAATAAGGGCCCA
SEQ ID




CGGTGGCAGTGGGAACTTCAGCTGGTCTTCGTCAAGCCACCTGGTTGCCACAGTTACTGTCA
NO:




AGGGCGTGATGACCACAGGCAGTGACATCGGGTTCAGTGTGATCCGGGCACATGATGTGCAG
2025




AACCCACTCCATTTCGGTGAGATGA





NUP210
ADXCRPDRC.15917.C1_s_at
TCTGTTGCCTTGGTAACCCTGGGCTCCTCAAAGGAGATGCTGTTTGAAGGAGGTCCCAGACC
SEQ ID




TTGGATCCTCGAGCCGTCCTAATTCTTCCAGAACGTCGCCGCTGAGGACACTGACAGCATCG
NO:




GCCTGGCTCTCTTTGCCCCCCATTCCTCCCGGAATTATCAGCAACACTGGATCCTTGTGACC
2028




TGTCAGGCCTTGGGTGAGCAGGTCATCGCCCTGTCGGT





PPRC1
ADXCRPDRC.16668.C1_at
GAAGAGAGAAGTCCACAGCCCCCAACTGGGAAGTGGCCTAGCCTTCCAGAGACTCCCACAGG
SEQ ID




GCTGGCAGACATCCCTTGTCTTGTCATCCCACCAGCCCCAGCCAAGAAGACAGCTCTGCAGT
NO:




GAAGCCCTGAAACACCCCTTGAGATTTGCCTTGTGCCTATAGGTCCCAGCCCTGCTTCTCCT
2033




AGTCCTGAGCCACCTGTAAGCAAACCTGTGCCTCATCTCCCACTGAGCAGGTGCCATCCCAG




AAGATGCCACTGTTGGCGAGACCTT





ALDH5A1
ADXCRPDRC.1124.C1_s_at
GTGTTTTAATTACCTGTGTGCAGCTATTTTAAATAGCATTTTACTTGAATAATATGTATGTT
SEQ ID




GTCATTGTTTCATGCTATACTTTGTGGGATAAAACTTGGGAATGAGTGTGGTAAGAAATTTA
NO:




TAAAGTTTTGCTTTTAAAACGTGGACATAACTCAT
2038





ALDH5A1
ADXCRPDRC.1124.C1_x_at
TCCTCTAAAAACTGGATCCTAGGTGTTTTAATTACCTGTGTGCAGCTATTTTAAATAGCATT
SEQ ID




TTACTTGAATAATATGTATGTTGTCATTGTTTCATGCTATACTTTGTGGGATAAAACTTGGG
NO:




AATGAGTGTGGTAAGAAATTTATAAAGTTTTGCTTTTAAAACGTGGACATAACTCATTTTTC
2039




TAGTTTTTGACAATTGTGTGTTTTAGTGTCTAGTCTGCAGAGAGCTGTGTGATTAATAAACG




TGGAATTAACAGAATTTCCTCTCCCTGTAA





MFNG
ADXCRPDRC.7895.C1_s_at
AACCCAAGGGCGCTGCTGCAGCTTCTGAGAGCCTTCCCGCTGGCCCGCGACGTCTATGTGGG
SEQ ID




AAGGCCCAGCCTGAACCGGCCCATCCATGCCTCAGAGCCACAGCCCCACAACCGCACGAGGC
NO:




TGGTACAGTTCTGGTTTGCCACTGGGGGTGCTGGCTTCTGCATCAATCGCAAACTGGCTTTG
2043




AAGATGGCTCCGTGGGCCAGTGGCTCCCGTTTCATGGACACATCTGCTCTCAT





PIM2
ADXCRPDRC.11037.C1_s_at
GGTCATTACCAGTCATTAAAGTCCAGTATTACTAAGGTAAGGGATTGAGGATCAGGGGTTAG
SEQ ID




AAGACATAAACCAAGTCTGCCCAGTTCCCTTCCCAATCCTACAAAGGAGCCTTCCTCCCAGA
NO:




ACCTGTGGTCCCTGATTCTGGAGGGGGAACTTCTTGCTTCTCATTTTGCTAAGGAAGTTTAT
2050




TTTGGTGAAGTTGTTCCCATTCTGAGCCCCGGGACTCTTATTCTGATGATGTG





TRIM14
ADXCRPDRC.2569.C2_at
GCAGCAGCAGACTTGTTTAGGGCCTGTTTGAAACTAGCCTAGGAGAGGAAACCTTCAAAGCA
SEQ ID




CGGTAGGCGTGATGGGTCGGGGAAAGCTGGGGCAGGGAGAGGGCCCTAAGAAGCAGGCAGTA
NO:




AGGGGACCAGCCACGCTGATCTAGGTAGATTAGGCGAGACTGGGCAGCTGCGGCGACCTGGA
2053




GGCTGTCACGCCGGTCCT





AKAP1
ADXCRPDRC.3886.C3_at
GTCTACATGATGTTGAGAGCCTTCTATGTGGCAGATCTGGACGCTCTGGGTGTAAGGCAGGG
SEQ ID




TTGAAATGTAGATCTTGGCACCAGATGTTTGCTTCAGAAAACTCACATAGCGCCCCTGCTTG
NO:




CCAATTAGCCGACCGACTAAGTGCTTTGGCACCTCGATCTCCCAGATGATGAGGTCGACCTT
2054




CTTAGGGTTGGAGCCTGCCTGGGCATTTTGGAAGCTCTCAGTCTTCTTGAGACTGCAACAGC




TATCCACGGAATCCATGCTGTTCCTGTCAGAACCCTGT





PDSS1
ADXCRPDRC.11127.C1_at
GCACACCATCACTCTGTAGTACATACTGTCGAGCTCTGTCTACATCTCCAGGCAAACTGAAC
SEQ ID




CGTCGCATGATCATAGCATTCATTTCTGGGAACTGCTGACAGGCAAACAGGACAGGACCAGT
NO:




GGCTAACCCGAGCTTCAGATCAGCTGATGTTGGTTTGCCCATCTGGTCAGAACACGAGGTGA
2058




AGTCCAATACATCATCTATTAGCTGAAAAGCTATTCCTACATTTTTTCCGTACTGATAGGCG




ATCCCA





HNRNPA2B1
ADXCRSS.Hs#S1848110_s_at
TCAAACGTGAATACAAATCCAGAGTAGATCTGCGCTCCTACCTACATTGCTTATGATGTACT
SEQ ID




TAAGTACGTGTCCTAACCATGTGAGTCTAGAAAGACTTTACTGGGGATCCTGGTACCTAAAA
NO:




CAGCTTCACATGGCTTAAAATAGGGGACCAATGTCTTTTCCAATCTAAGTCCCATTTATAAT
2066




AAAGTCCATGTTCCATTTTTAAAGGACAATCCTTTCGGTTTAAAACCAGGCACGATTACCCA




AACAACTCACA





CYFIP2
ADXCRSS.Hs#S2524484_at
GGCTCAGTGCGCACAACTAGCTAGAGGCACTGACTTTGTAAGCAACAACACTATCTTCTTGA
SEQ ID




GGTCTAATAATTGCCTTGGCAAAGGGCAGCCAATGCCAACGAGGAACCCTGTGTACACAAGT
NO:




TTCTCATCCCGAAAGTGGACACTGGGTGCTCAAAAAATGCCTTCTGGTGACAGTAACACCTG
2071




ACCAGTCAAACAAACATGCACGCA





IQGAP2
ADXCRSS.Hs#S1611967_at
GCTTTAGTCCTGAATCTAATCACATGGAAATATATTCTTGATCCATGACTGTATTGTCAACA
SEQ ID




TATCCCCATTTGCATAGTATGATCCACTTGAGAGCTGAGTTGTCGGCAATATTTTTAAAATC
NO:




GCCCTGAATCATGTGTTAATTCACACTCACTAACAGCATATGCTTGCATTAATAGCACCCGT
2080




CTGTTCAACATCATAATCTTCTAATGGTGTCTGTAATATAAAACTTCTCTTCCAAATATAAG




TTTCGACTTAAAGTCAGCTCCTTAGTATATCCCTTACCGATGGAAAGAC





CHD7
ADXCRSS.Hs#S1919211_at
GAATCAACTCTATATAATCAACAAGAGAATTAGGCAAATAACATCTGGTTGCACTGATGGAC
SEQ ID




AAAGGACATAAAGATGTTATTTTCAAATGTCTTCTCCTGAAGAAAAATGAAAATTGTGTAGC
NO:




CAGTCACCATTTTAGGCCACTCATTCTTGTCCAGTCATCTGTAGGATTATGGTTTGAGGGAC
2093




T





SKAP1
ADXCRSS.Hs#S1928672_at
ATATACCCAATGTCAAATCACTTTTTATGTATACACCAAAAAGGCACTCAATATTAGGACCT
SEQ ID




ATCCCATATCCAGGCACACAGTAGGGAACCGTACTCCAAAGTGACTATCTGCTAGGCCAGAA
NO:




AAGACCAAGATAACCTTGTTAGTCTCCTTACCACTTAGAAATATTGTTATGGTTTTAGAATC
2116




TATTTTTACAAAAATGGTTTTCTCTACCATATATAAATCCATGAAAAATATTGATGTTAATA




TTCTTTCATTCCTGAGTTTAGTCAA





IQGAP2
ADXCRSS.Hs#S1928867_at
GTGTATACAAAGCTCTTAGCACAGAGTGAAGCTCAGTGAACAAATGGCTCTTCTTATGAAGA
SEQ ID




GCAGCCCTCAGCGGAGGCATGGCACCTCCTTCAAGAGAACCAAACTTGGAAACCTTGAATTA
NO:




GGAAGTGATTACTCACTTTACAGGGAATGACTACGGTAATGATATATTTGCTTTCTGTTACC
2118




TAAACTTAGCAGCTTACATATTTATCATCTAATGGTTTCTTTAGCTCAGAAATGTGGGCATA




GCTTTATGGGTCCTCTACTT





BCL11A
ADXCRSS.Hs#S2731126_at
TGCAGTAACTGTGCGCCTATTGTAAAGGCAAATGAAGCTCACCTATTCCCTGCTGGGATCAG
SEQ ID




AAGTGACCTCACCACCCCCCATGCCTCAAATCCTTCCCTTGCCAACCTAACTCAATGCCATT
NO:




GCAGAATGACGAATGAGCTCAGAAATAGACCCCAAGTTACTAACCCTGCTAAGAACAGCAAA
2139




AGCCTTTGCTGAAATGTTTTAAAAATGCATAGGGAGTGCAGCTGGCCAGTAAAAAGCAGGGA




GACAAATTCCAATGAACCCAA





TOP1
ADXCRSS.Hs#S2990754_at
AATGTTTTGTGCTTGGATTGAGTTTAGAGACACCAGATAGAATAAGATTGGCAACACTGTTA
SEQ ID




GCCACCTGCTGACCACAGCTAAACAGGCATATGTGCTTCTGCATGGGGAATGCTATGGCGTT
NO:




AACAGAGCCTTCCTTAAAACCTGTAAGTTCGTTAGGCTTCCGGGTACCAGGGTTGTTAGAGT
2140




AGGCCACAGTTTACTTCCTTTTTCATAAGTGCTTTTCTTTCCTGGATCTCAGTATAGGAAGG




AAAATCAGACAGCATTTCTCAATTGTTGACGCGTAAGGGCCA





USP7
ADXCRSS.Hs#S2990382_at
GATAAATCTTCGTGAAGTGGCAGAAAATATGAAAGCCAGCCAATTGGAATCTTGCTTATTCT
SEQ ID




GATCTGTTATCTCAGGGGTTAGATTCGCGTGCTGAAGTGGTCTACGTAACTTCCATAGCGAT
NO:




TGGGAGGTGTTCTCTGGTGGGGTAGCAGTTCTGTGTTATGACATCACACATGGAATTCACGG
2141




GGAGGAAAGCTGGGTATAGGCATTAAGTGCCCAGTAGAGCAGGT





TPT1
ADXCRSS.Hs#S2979085_at
GGGTGCAGCACAAGTTCCTTCATAGGACTTTAAGACTCTTTGGGATCTAGTCCCTGCGTATC
SEQ ID




TCTCCAGTTCTCCTTACCATTCTCCTGTATCTGCCTCTGGCTGCAGCTGTGCCACAGCCAGA
NO:




CTCTGGAAGGAGCCTCTTGCTGTCAATTATCCAACAAGTGTTTACTGGGTACCCACTTCTGC
2143




CAGGCACTGGGTTAGAGGTTGGAGACATAGCAGTAAAGACTTGCTCTAGTGGAAGACAA





CYFIP2
ADXCRSS.Hs#S3733207_at
GCCTATGTTGTAGAATCCCTCGTACCCAGAGTGGGAGAAGATTACACCCGGGGCACTGCAGG
SEQ ID




GAGGGAACCAGGAGAGATGAAGTAGTAAGCTGAGGCATGCCCTTCTGGCCAGGCTGGCGTCT
NO:




CTGGGCATGGCCACATCTGTTCACAGTCTGAGACTTGAGTCCTGGGGTCACACAAGGGCACT
2161




GGGTAGGAGATGTCTATCTTGGGAGGAGGTCTTGGGAAGCAACCACAGATAG





NFATC3
ADXCRSS.Hs#S3740808_s_at
AAAAAGCAATTTCAACATGGAGCCAGTATGGAGAGATTGCAAGATTACCTAGAAAGTTACCA
SEQ ID




AAAGGCTATGCTCTGGAATGTCTTTTTATATTCCAACACTTCAATGATGGAATGGTCTCTTC
NO:




TCATTTTATCTAACAACAGTTTAGTTTTATAAAGAGGTATGAGCTACATTTGGCTTTATTTC
2162




CTATAAATCTATGAACGTCTTCAGGACACATGCTGACTTTCTGAGGCA





CALML4
ADXCRSS.Hs#S2988186_at
ACGTCTTTCCCGCTCACTGTAGCTGCCACCCATTCTTTTTAATCCCCAGAGAGCATACAGAT
SEQ ID




GAGCCCCAGTGGGCCATCTCAGCCACATAGGGGACAGGCCGGGGAGAGGATCTAGAGCTGGC
NO:




CCAGGAAAGGAGGCCCTTTTCATTTTGAGGGAGGCCTCCCATCAGAGAAGGGTCCAGTCCTG
2163




CCCCGACCCTGTCCTTCCCATGATACCCACAATCCCAGGGTGACCTGTCTCCAGGGCAGAAG




TGACAGACGAGGGCTAGGAGACTGGCTGAGGCCTAAGTCCTCTGCAAT





SKAP1
ADXCRSS.Hs#S2988136_at
GAGAGAAGTGGGAAGCACTAGACACTTATCAAAC
SEQ ID





NO:





2165





SKAP1
ADXCRSS.Hs#S2988136_x_at
GAGAAGTGGGAAGCACTAGACACTTATCAAACAACCAGATCTTGTGAGAACCCACTCACTAT
SEQ ID




CATGAGAGCAGCAAGGGGCAAATCTGCTCCCACGATCTAATCA
NO:





2166





SKAP1
ADXCRSS.Hs#S3015915_at
TCTACCTCAGACATTCCCATTCTAAATATGGTGGGCCTGACACTGCAAAACTGCTAAAGAAG
SEQ ID




TTCCACACAAAAATGTGTTTTAGCTTTAATTACTTATTCAGTTTAAACAAAAAAGAATTTTT
NO:




TTAAATTACCAGCTCTTTTGTTTTCAGTTCTCATAAATACATCTGGTTTCCCCCTCTCTCTC
2172




TATCTGATAAAAGTATTCTGAAAGGCAGAGTCCGGAGTGCCGAGGTTAGAGGATCTAGAA





SKAP1
ADXCRSS.Hs#S3015915_x_at
CTAAGAATCCTTCTACCTCAGACATTCCCATTCTAAATATGGTGGGCCTGACACTGCAAAAC
SEQ ID




TGCTAAAGAAGTTCCACACAAAAATGTGTTTTAGCTTTAATTACTTATTCAGTTTAAACAAA
NO:




AAAGAATTTTTTTAAATTACCAGCTCTTTTGTTTTCAGTTCTCATAAATACATCTGGTTTCC
2173




CCCTCTCTCTCTATCTGATAAAAGTATTCTGAAAGGCAGAGTCCGGAGTGCCGAGGTTAGAG




GATCTAGAA





TPT1
ADXCRSS.Hs#S3017795_at
ACTACTCCAGATTTTTCACCTGCAAGTGGTAAGTCAGGCCAACTTCCGTTGGTGACCCGTTA
SEQ ID




TCTCTGCTTGAAAAAAGATAAGGAGATTCTCCACTTTGGCCTCAGCTCTTAGCTAGGTTCTT
NO:




TAGTCCAGCTAGGAGTTACTGAGCCTCCACCAAGAAGGTGAATCATTTGACCTCATTTAGCT
2175




CCTCCTCCTTATTTATCTTTATTAGAGCTTGCAGTGATGGAGAGTAAGTGATTGGGACCTCA




AACTTCTAACACATAATTCTCTCAGGCGGGTTTGGAATGGTACTCTA





BLM
ADXCRSS.Hs#S3004537_at
GCTTACAACAGTCCATTCATCACCACTTCTTGTTCAGCTAGTTACATATCTGTCTTCAGACC
SEQ ID




ATGTTTCTGTTCTTTATCCATGGAGACACAAAAGACTTGACTATGTGACTCCAATAAGTTAG
NO:




AGGTGTGAGGCAGCAAGAATGATTGGGTGGGACATTGACTCTAGAGTCCTACAGACCTGTAA
2178




TATAAACCTGTCTCCTCCTACTCTTTACTATGTGACTATAGCAAATAGTTTAACTTCTCTGG




ACTTCAGTTTTTTCTTCTATAAAATGAGGAGAATGATATCTACCTTGC





PCBP2
ADXCRSS.Hs#S3736726_at
ATCCCTAATAGGCTGGGCTTTGCAGGAAATGGCATGAAATCAGCTCTTCTGAGTGTACAGAA
SEQ ID




GAACCTTTCGAGCATTATTTCTACACCCTTCTCCCCCACTCTTTCCTCTTTGGAGGCTTCCA
NO:




AGTTAGTGATGAATCCCAACAGCTAATGATGCTGGGTTTCCAGTTTATTTCCTTCTGTTAGT
2209




TTAATGTGCAAGTCAGTGAGGTTTTGAATGCTGTGCATTGAATTTGCTTGCTCTCTTCTGTC




TTTTAGCAGGTTT





IMPDH2
ADXCRSS.Hs#S3737705_x_at
GATCTTCACTTTCCGAACTTCATTGGCCTGGAATTCAGGTAGTACAGTATGTGGTGGATGAA
SEQ ID




GCCAACTACCGCCTGTAAGCTACAGGATAGAAAAGAGACTACTACTAAGTGACAAGAAGCAG
NO:




GACTGAATGCCTTTGGGGGAAAGGCGGATGGAGTCCTTGCTCCTTTTCCCCAAACCCCATGG
2216




GGCTCACCGCCATTGCTATGGCCATCCCAGGCTTCTGTTGACTGTGTCCATTGGGAGAAGGA




AAACCAGTGGGGTCTTAAGAAGTGATTTTCTTGGTCAGAGCAG





MYC
ADXCRSS.Hs#S854806_at
GGGAGGAGACTCAGCCGGGCAGCCGAGCACTCTAGCTCTAGGATGTAAACAGAGTAAGAGAG
SEQ ID




CCGCATGAATTAACTACGCGCGCCTACCATTTTCTTTTGCTCCCTCTCAAACCCTCTCCCTT
NO:




TCTCTGCTGCTCCTCCGTAGCAGTACTGTTTGACAAACCGCATCCTTGTCCTGTGAGTATAA
2226




ATCATCGCAGGCGGAACAGCTG





IFITM1
ADXCRIH.37.C1_s_at
GGGTTACTAGTAGCCGCCCATAGCCTGCAACCTTTGCACTCCACTGTGCAATGCTGGCCCTG
SEQ ID




CACGCTGGGGCTGTTGCCCCTGCCCCCTTGGTCCTGCCCCTAGATACAGCAGTTTATACCCA
NO:




CACACCTGTCTACAGTGTCATTCAATA
2227





RPL10A
ADXCRIH.799.C2_at
GTTGAGTTTTTTCAGCGCCTCGATGTCCATGTGGGGGATATCCACGGCCTTAGCCTCGTCAC
SEQ ID




AGTGCTGCTGGTCCCCCAGGACACACACAGAGAACTTAGGGCGGGGAGTGGACTTAAGCCTG
NO:




ACGGTGCCCGAGAAGCGCTTGTCCTTCTGGGGATCATAGTTCTTCAAGCTGATCTGCAACTC
2230




CACCGTCTCCAGGAACTTGCGGCGCTTGCGCTGGTTCCCGTGCAGGACTTCCCGCACCGCCT




CGTACAGGGTGTCGCGAGAGACTTTGCTGCTCATGGCTTCTCA





GTF3A
ADXCRIH.2186.C1_at
CCCAGGGCCAGGCGCGCTGCCACGTGCCCCTGCA
SEQ ID





NO:





2252





GTF3A
ADXCRIH.2186.C1_s_at
TTTTTGATCACAGCCATTGGCTGCACAAACAAACGGCTTTTCTCCTGTGTGCTTGCACAGGT
SEQ ID




GCGCGTCAAGCTTCCAGGCTTTGCTGTAATTGGCGCTGCAGTCAGGGAAGGAGCAGATGAAC
NO:




CTCCTGGGAAGCGCGGGGCGCGGCGGGGTCGGAGCTGAGCTCTCGCCGGCTGCAATGAACGC
2253




GTCGGCGATGGTCAAGGACGACACCGACTCGG





GTF3A
ADXCRIH.2186.C2_at
CAAGAGAAAGCTGTGGAAGACCTATACAACTGTGGTTTATCTCCAAAGCCATATCCCTCTTC
SEQ ID




TTCCATGAGGAAAGGCCGCCC
NO:





2254





GTF3A
ADXCRIH.2186.C2_s_at
TGGCAAAAACATGGACGGAACTTCTGAAACATGTGAGAGAAACCCATAAAGAGGAAATACTA
SEQ ID




TGTGAAGTATGCCGGAAAACATTTTAAACGCAAAGATTACCTTAAGCAACACATGAAAACTC
NO:




ATGCCCCAGAAAGGGATGTATGTCGCTGTCCAA
2255





ATP5G2
ADXCRIH.3160.C2_s_at
TCCCATAGTTCTCCCGCGTCTGGTTGGCCCCGTGTGTTCCTTTTCCTATACCTCCCCAGGCA
SEQ ID




GCCTGGGGAACGTGGTTGGCTCAGGGTTTGACAGAGAAAAGAC
NO:





2262





RAD51C
ADXCRPD.305.C1_at
GTTCCTGCATTAGCCTCAGGGATTTAGAGATACTGTTGTTACTTCTGCATGTTCATTGCAAA
SEQ ID




CAGAAGGTTCCTTGAGCACCCGGAAACGGTCACGAGACCCAGAGGAAGAATTATAACCCAGA
NO:




AACAATCTCAAGTGTACAAATTTATTGATGTTGTGAAATCTATGTGTACAGTGGACTTGTTA
2263




CCTTAAAGTATAAATAAACACATCTATGGCCATGAATG





RAD51C
ADXCRPD.305.C1_s_at
CAGGCCTTGCTTGTTCCTGCATTAGCCTCAGGGATTTAGAGATACTGTTGTTACTTCTGCAT
SEQ ID




GTTCATTGCAAACAGAAGGTTCCTTGAGCACCCGGAAACGGTCACGAGACCCAGAGGAAGA
NO:





2264





RAD51C
ADXCRPD.305.C2_x_at
CTCTTAATTTTAAGTGTGTATGTGCATTAAACAAAAATTAGCTTACTANNNNNNNNNNNNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNACTCCACGAAACCACAATCCCAACCNAATCACA
NO:




AAAACAAATTTTGGGCCCCTTCGGCCCCTCAGAAAACTTTCTAAAACCCTTTCGTTTGGGGG
2265




CGGGGCGCCCCCATAAGGTATAATGGGACCCTGGGCCCTAAGCGTGGNTTCCCTAGGAAAAA




ACCCTGGGCCACCTGAACCAAATGGGCGCTGGG





PRIM1
ADXCRPD.724.C1_at
CCGTGAATTGGATGCCATTTCCACTAATGAAGAGGAAAAAGAGGAGAATGAAGCTGAATCTG
SEQ ID




ATGTCAAACATAGAACCAGAGATTATAAGAAGACCAGTCTAGCACCTTATGTGAAAGTTTTT
NO:




GAACATTTTCTTGAAAATCTGGATAAATCCCGAAAAGGAGAACTTCTTAAGAAGAGTGATTT
2266




ACAAAAAGATTTCTGAAGACAGAGCTCCTCAAACCATTGTGGATATCTTCTGCCTTCAACCA




CAGATCAAATACTTCAAGAGCCATTTAATAAA





PRIM1
ADXCRPD.724.C2_at
GCCATTGCAACTGGCCGTATTAAGTCCTTTGTATCCTCACTGTTCCATACTAGCTCAGCCTA
SEQ ID




TGATGTGGACTTCAGCAAATGTGTAAGCAAATCTTTGTGCATGATGTGTGTTAAATAGAAGC
NO:




ATTAGGCAAAAAAGAATGTAAAAGTAAATGGGCTTTGTTTTGTTTCCTTTGCTGTTCTTCCA
2267




TATATTATC





TRIM14
ADXCRPD.2569.C1_s_at
CATTCCCAAGGGAGCTTGCACGGTACTGACCGAGTGCTGAGACTACTGGTATTCCCAGCTGC
SEQ ID




CATGTGGCAGCAGCAGGAGCTACTAGAATATTCTCAGCACAGGAATGAGGCTTCCTTGGTTT
NO:




CCATGTCTGTAAGGGTTACTGATCACTTACCTTCTTCTCTT
2276





AKAP1
ADXCRPD.3886.C2_at
TCTGCTGGTCGGTTCTGCTATGGGACTGTGTTCTGGGGACAGGGCTTAGGTGGTGATAGCGC
SEQ ID




TGGCAGGAAACCAGAGGCCTCTTGGTCCCCACATGGGAGGACTACTTTTCCTGGCTCTGCCC
NO:




CCTGGGCACCTTTTAAGTTTTCTAGGCGTTAGCTTAGAAAGGATGGTGTAGTTAGGACAGGA
2279




GATTGGGTGTGTCCAGAGTAGACGTTCACCACCTGAGACCTGGGTGGGACTAGAATCATGGG




TTTGGATGGCGCTTGTTCTTTCTTCTGGTTGAGTCAGGCCTTAACA





DAZAP1
ADXCRPD.4725.C1_s_at
GGCTTTGGACGAGGGCAGAACCACAACGTGCAAGGGTTCCACCCCTACCGACGCTAGCCCGC
SEQ ID




GGCGCCGCGAAGTCTTGCACGGCCCAGACCCAGGATTCCAAACTTGTGAACTCGTGACAATC
NO:




ACAAACTTGGCGGCAAAGTGGCGACTCAACCTTNNNNNNNNNNNNNNNNNNNAGGGCGCGAG
2280




GCTTTTGGAGCGGCTGTGGGTGTCGTCTGGACTGAGGTTTTTAAATATTTCTTTCTCTAACC




CATCAGCACAATAAA





DAZAP1
ADXCRPD.4725.C2_s_at
AAATCTACTGAGTGTATTTCTGTTTTTTGTTTAATTCCTTGCTTTTGTCGACTGACCTGCTT
SEQ ID




GGTAGTGTCTGAGGTGAACTGTGGGGGTTGCGCACAGCCAGCCGCGTGGATCCCACGCAGCG
NO:




CTGAACCGAACCGAGTAGGAA
2281





IRF7
ADXCRPD.7919.C1_at
TGGCCAGGTGTCACAGGTGTCCACAGGTGTGGACTGAGGGCTTGTAGCCACCGACGCTGCCT
SEQ ID




CGGTATGGATCTCTTGGCAGAGGGGGCTACAGGTGTGACTGCAGGTGTGGCCGGCGCGCACA
NO:




CATGAAGTCACAGGTGTTGAACCAGTGTCCAGGCCTGGCGGGAAGGCGCAGGCCGGATCACT
2289




GGGTGCCAGAGCCGCCGGGACGGGAAGTTTCGTCTCGCGGGGAAGTCAGGAGGGCCGGCGCT




TTCACTCGTGCCGAATTAAACACCCGG





IRF7
ADXCRPD.7919.C2_at
CTGCCGCGGCCGCCCAGTCTAATAAAAAGAACTCCAGA
SEQ ID





NO:





2290





IRF7
ADXCRPD.7919.C2_s_at
AGAAGAGCCTGGTCCTGGTGAAGCTGGAACCCTGGCTGTGCCGAGTGCACCTAGAGGGCACG
SEQ ID




CAGCGTGAGGGTGTGTCTTCCCTGGATAGCAGCAGCCTCAGCCTCTGCCTGTCCAGCGCCAA
NO:




CAGCCTCTATGACGACATCGAGTGCTTCCTTATGGAGCTGGAGCAGCCCGCCTAGAACCCAG
2291




TCTAATG





FBXL14
ADXCRPD.10538.C2_at
AATCTCATTGGATTACTCCTCCTTACATTACTGCGTTTGGATTTGTAGTCTTAACAAGGCAA
SEQ ID




TAAATGGAAGGGGAAAGAAGGAATCAATTCATGGTAACTAGAATGTAATGAGCACTTGCATT
NO:




AAGTCACAATTTAATTTGTATACTTTCGGAAATTCTTTCCTGGTTGTAAGCCTAAAGGGGCC
2297




TGCCTAG





LGALS9
ADXCRPD.14181.C1_at
GCACAGTCCCTGTTCAGCCTGCCTTCTCCACGGTGCCGTTCTCCCAGCCTGTCTGTTTCCCA
SEQ ID




CCCAGGCCCAGGGGGCGCAGACAAAAACCTCCCGGCGTGTGGCCTGCCAACCCGGCTCCCAT
NO:




TACCCAGACAGTCATCCACACAGTGCAGAGCGCCCTGGACAGATGTTCTCTACTCCCGCAAT
2307




CCAGCTATGATGTACCCACAACCAGACATCCGAAGCGTAACATCAACCACCAG





LGALS9
ADXCRPD.14181.C1_x_at
AGCTGTCCTACATCAGCTTCCAGAACCCCCGCACAGTCCCTGTTCAGCCTGCCTTCTCCACG
SEQ ID




GTGCCGTTCTCCCAGCCTGTCTGTTTCCCACCCAGGCCCAGGGGGCGCAGACAAAAACCTCC
NO:




CGGCGTGTGGCCTGCCAACCCGGCTCCCATTACCCAGACAGTCATCCACACAGTGCAGAGCG
2308




CCCTGGACAGATGTTCTCTACTCCCGCAATCCAGCTATGATGTACCCACAACCAGACATCCG




AAGCGTAACATCAACCACCAG





LGALS9
ADXCRPD.14181.C2_at
AAGTCCATCCTCCTGTCAGGCACTGTCCTGCCCAGTGCTCAGAGGTTCCACATCAACCTGTG
SEQ ID




CTCTGGGAACCACATCGCCTTCCCACTGAACCCCCGTTTTGATGAGAATGCTGTGGTCCGCA
NO:




ACACCCAGATCGACAACTACCTGGGGGTCTGAGGGAGCGAAGTCTGCCCCCAAAAATGCCCC
2309




TTCGTCCGTGGGCCAGAGCTTCTCAGTGTGGATCTTGTGTGAAGCTCAGTGCCTGACAGGAG




GATGGACTTGGATGGGTACAGCCCCCCCAGAATGGTGGTGATAA





CALML4
ADXCRAD_BQ928122_at
CTGGCCTGCAGGAAAGGAGCGCCCAGCTGCGCGCCTGGGCCGCCCGTCGCTCCCAGTGCTGC
SEQ ID




CGCCCTCGCGTTGCCTCCATGGCTGCCCCGCAGGCCCCTCGGCCCTGCCTTTTCCGAGGAAA
NO:




AACGGTTCAGCTCGGTG
2341





CALML4
ADXCRAD_BQ928122_x_at
AGGTCGAGGTGGAAGGGAGCCGTGCGGGCAGCCTCATCAGCGCTCACAGAGCCATGCCTGGC
SEQ ID




CTGCAGGAAAGGAGCGCCCAGCTGCGCGCCTGGGCCGCCCGTCGCTCCCAGTGCTGCCGCCC
NO:




TCGCGTTGCCTCCATGGCTGCCCCGCAGGCCCCTCGGCCCTGCCTTTTCCGAGGAAAAACGG
2342




TTCAGCTCGGTG





ANP32A
ADXCRAD_AL547157_s_at
AAGAAGGTTATAACGATGGAGAGGTAGATGACGAGGAAGATGAAGAAGAGCTTGGTGAAGAA
SEQ ID




GAA
NO:





2357





ANP32A
ADXCRAD_AL547157_x_at
GGAGGATGAAGAAGGTTATAACGATGGAGAGGTAGATGACGAGGAAGATGAAGAAGAGCTTG
SEQ ID




GTGAAGAAGAAAGGGGTCAGAAGCGAAAACGAGAACCTGAAGATGAGGGAGAAGATGATGAC
NO:




TAAGTGGATAACCTATTTTGAA
2358





BCL11B
ADXCRAD_CD701737_s_at
TTGCAGCATATTCTTCTCTTTGGCCCAGAGGTGGGTTAAACTGTAAGGGACAGCTGAGATTG
SEQ ID




AGTGTCAGTATTGCTAAGCGTGGCATTCACAATACTGGCACTATAAAGAACAAAATAAAATA
NO:




ATAATTTATAGGACAGTTTTTCTACTGCCATTCAATTTGATGTGAGTGCCTTGAAAACTGAT
2359




CTTCCTATTTGAGTCTCTTGAGAC





USP7
ADXCRAD_BU956106_at
CGCTCTTTCCCTTCATTGTGGGGCATTGTTCGGGCCCTTC
SEQ ID





NO:





2368





AKAP1
ADXCRAD_BX394525_at
AACTCATTGAATTAACTTGCAGTGGTGTGTTTGATTCTTTTTTAGACTGGCTTCAGCATTGT
SEQ ID




GCAGTTTAA
NO:





2377





NASP
ADXCRAD_BQ187021_at
CTGGGGCTATAATTCTGTCCTGGAAAAAGAACTCTGAAAACCTGGGTCAGGGGAATGATTCC
SEQ ID




TAAGGAAAACGGTCTGCATTTGAGCTCTGGTTTGAAAGTAGCCAAGGGGACTGATGGTGGAC
NO:




ACTCCAGATGTGGTTGGAAGCATATGTGGGGAGGCTGGCTGGCTGAGTTTTGTTATTTTCTG
2384




TATAGAAAGGTTGAGATATATCAACACTTGGGATTGTTACCCATCTGCAGAATTGACTTCTC




AAATAAAGATGCTA





MYC
ADXCRAD_CA454569_at
TAAATATTGGGCCATTAAATGGTAAATAAACTTTTAATAAAACCGTTTTATTAGCAAGTTAC
SEQ ID




ACCAGAAATTTCAATCCCCTAGGTATATATAGTACCCTCAAGTATTTATTA
NO:





2390





HMGB1
ADXCRAD_CN401906_s_at
AACTCATTCATTAGTCATGTTTATCTGCTTAGGAGTTTAGGGAACAATTTGGCAATTTTGTG
SEQ ID




GTTTTCGAGATTATCGTTTTCTTAAAGTGCCAGTATTTTAAAATAGCGTTCTTGTAATTTTA
NO:




CACGCTTTTGTGATGGAGTGCTGTTTTGTTATATAATTTAGACTTGGATTCTTTCCATTTGC
2402




ATTTGTTTATGTAATTTCAGGAGGAATACTGAACATCTGAGTCCTGGATGATACTAATAAA





TRIM14
ADXCRAD_BX389413_at
TGGTCTCACTGGGAGTTCATGGTGCTTCAGTCCCTAGCACCCAGTGATACCCCCACAGGTAG
SEQ ID




CCCTAAGCATCCTGAAACATCATCCGC
NO:





2407





RNF44
ADXCRAD_CX761728_at
TTTCTATTGTTGCTGATTCCGAGGGATATTCCCTATAATGTATGA
SEQ ID





NO:





2410





RNF44
ADXCRAD_CX761728_x_at
AGTTACCTCATTTTTCCCATGTATGTATTTGAGAAAATGCTAATATATAGAGAAAAAAATGG
SEQ ID




TTCTTAAAGCTTAAATGTGTGGTTTTTTCCATTCCATGGGATTCACATTGGTTTGTAGCATT
NO:




TAACATAACTAGTATGTTGTATTATATATATGTGTATACTGATTGAAATTTTTAACAGATTT
2411




GTACTTTTTTTAAAATGAAAGTTGCTAGTTCTGCTTGACCAAGTAGTGGCATCATTATTTTT




TTTTCTATTGTTGCTGATTCCGAGGGATATTCCCTATAATGTATGA





ATP5D
ADXCRAD_AL548640_at
GAAGCCGCGCCTGCCAAGGAGGCCACCAGAGGGCAGTGCAGGCTTCTGCCTGGGCCCCAGGC
SEQ ID




CCTGCCTGTGTTGAAAGCTCTGGGGACTGGGCCAGGGAAGCTCCTCCTCAGCTTTGAGCTGT
NO:




GGCTGCCACCCATGGGGCTCTCCTTCCGCCTCTCAAGATCCCC
2419





PIM2
ADXCRAD_BQ953509_at
AATGTAAATAATCACGTATTGTGGGGGAGGGGGAGTCCAAGTGTGCCCCTCCTCTCTTCTCC
SEQ ID




TGGCTGGATTATTTAAA
NO:





2423





PIM2
ADXCRAD_BQ953509_x_at
GGGAAATAAGGCTTGCTGTTTGTTCTCCTGGGGCGCTCCCTCCAACTTTTGCAGATTCTTGC
SEQ ID




AACCTCCTCCTGAGCCGGGATTGGCCAATTACTAAAATGTAAATAATCACGTATTGTGGGGG
NO:




AGGGGGAGTCCAAGTGTGCCCCTCCTCTCTTCTCCTGGCTGGATTATTTAAAA
2424





LRMP
ADXCRAD_BG257134_at
ATTGAACTTACGGACTCGTTAAGCTTGAAGACAAAACAGGGGGGGGCGCAAAGAACCCAGGA
SEQ ID




GGGCCAGCTACACAACCCGTTCTGGTAAAGGCGCACAAAGGGCGAAAAAAGAAGCGCGGGTA
NO:




ACACAGCAGGAAAAGCGGTATCCTAGGACAACTGGTGGATAGCACCCAAAGAGAGCAACATG
2430




TAGGAAGCCTGCGCACAGGTAGAACAGCAGCAAAAGCAGAACATCAGCGACATAGCAGA





TTF1
ADXCRAD_BF700791_at
ATGGAAACGAGCACGGGAGATCACACCCGCGGGGACGGACGTAAAGTCCAGAGATGCAACCC
SEQ ID




AGCGGAGAAGATGGACAGACATGACGTGGAATGCGGCAAAGCGGAACCAGAGCGACATCTAG
NO:




AGCGGGGAACGGACCAAGGAATCGGGGTCCCAAGACGTTGGGAAAAAGGGGCCCAGTTGTTA
2433




AAGGCCGGTCCACTGGAGCGGCCCGGGAGAAAAAACATCTTCCACTATACCTTTCAGGTTAA




ACCCTGTGCCTTCAAC





RHOH
ADXCRAD_BM919440_at
ATCCCTTGGGGGAACTGGTGATGAATAATTCCATCTTTGGATTAAAAAAGTGAAAATAGTCT
SEQ ID




CCCATAATTTTTGGGACCAATGAAGTTGAGT
NO:





2435





RHOH
ADXCRAD_BM919440_s_at
GGATACAGTTATTGATGAGGCTTGGCCACTGGATGTTTTCACTAACTACACTCTACAAGTGA
SEQ ID




ACTCCTTGCCCAGGCCAGTTAGAAAATCCCT
NO:





2436





LCP2
ADXCRAD_BP391263_s_at
AACAGTAATAGTTATTGGTGTCACATAAAACTGATTTGTTTTTTACAGCCAAACCTCTGTCA
SEQ ID




GTCAGAGGCATTCATTAGTTTTATACATGTAATTTGAAAATCACTAAACCTCGTTTTCTCAG
NO:




CAGCAA
2439





FYB
ADXCRAD_BG759248_at
GTGTCTTCATCAAAAGGGTCCCCAGCTCCCCTGGGAGTCAGGTCCAAAAGCGGCCCTTTAAA
SEQ ID




ACCAGCAAGGGAAGACTCAGAAACATAAAGACCATGCAGGGGAGATTTCAAGTTTGCCCTTT
NO:




CCTGGAGTGGTTTTGAAACCTGCTGCGAGCAGGGGAGGCCCAGGTCTCTCCAAAAATGGTGA
2440




AGAAAAAAAGGAAGATAGGAAGATAGATGCTGCTAAGAACACCTTCCAGAGCAAACATACAT




CAGGAACGAGTCGGCCTCAGGGCACTCCT





FYB
ADXCRAD_BX095265_at
GATAAGCTTGCTAAACTTTCAGAGTGCCCTGAGACACTTCCAGCCATCCCTCCTCCTGCCTT
SEQ ID




CATTGGGGCAGACTTGCATTGCAGTCTGACAGTAATTTTTTTTCTGATTGAGAATTATGTAA
NO:




ATTCAATACAATGTCAGTTTTTAAAAGTCAAAGTTAGATCAAGAGAATATTTCAGAGTTTTG
2441




GTTTACACATCAAGAAACAGACACACATACCTAGGAAAGATTTACACAATAGATAATCATCC




TTAATGGGA





IKZF1
ADXCRAD_BG685498_at
GTTAGTATAGAATTCTCGAAACTTGGGAATTCACAAATCAGGACTGGGGACTGCGAGACCAC
SEQ ID




AAATTTCTGATCGCATTTCTGATGGATGTGTCACACCTTTTCTGTCAAAACTAACATGTCTT
NO:




GGAGGTTAATCGACGTCCCTTGGGTGGACACACACA
2443





IKZF1
ADXCRAD_BG685498_x_at
GTTAGTATAGAATTCTCGAAACTTGGGAATTCACAAATCAGGACTGGGGACTGCGAGACCAC
SEQ ID




AAATTTCTGATCGCATTTCTGATGGATGTGTCACACCTTTTCTGTCAAAACTAACATGTCTT
NO:




GGAGGTTAATCGACGTCCCTTGGGTGGACACACACA
2444





SNRPG
ADXCRAD_AV757070_s_at
GGTGGCAGACATGTCCAAGGAATATTGCGGGGATTTGATCCCTTTATGAACCTTGTGATAGA
SEQ ID




TGAATGTGTGGAGATGGCGACTAGTGGACAACAGAACAATATTGGAATGGTGGTAATACGAG
NO:




GAAATAGTATCATCATGTTAGAAGCCTTGGAACGAGTATAAATAATGGCTGTTCAGCAGAGA
2445




AACCCATGTCCTCTCTCCATAGGGCCTGTTTTACTATGATGTAAAAATTAGGTCATGTACAT




TTTCATATTAGACTTTTTG





SNRPG
ADXCRAD_BX390183_s_at
GAGGTTCCCAATGTTTCGTCCAGAAAAGTACTTTATTTATGCAAGTCAGGTGACTCTTAGGC
SEQ ID




CACAAAACCATTTGATGATAAACAGATTATCATTAGGTGCATATCTTATTGATATTTTGTGA
NO:




AATGTTATGCCTATGTTGCAAAAGTTGA
2452





NFATC3
ADXCRAD_CR741943_s_at
GATCTGATGGGCTCTAACAGTGCTTACTGCAGCCTTGTGTCCACCACCAACTTCTCAGCATG
SEQ ID




TTTCTCTCCTTGGACCTTGGGTTTCCAACTCTGCAGCCTTCAGGTCTGGGGCCAGGAGTGGG
NO:




ACCCACCATTTGTGGGGAAAGTAGCATTCCTCCACCTCAGGCCTTGGGTAGATTTGGCAAAA
2460




GAACAGGAGCAGCATAGGCTGTTTGAGCTTTGG





ATP2A3
ADXCRAD_CB047171_s_at
AGCAGAAACCTGCACCAAGGATTGTCCCTATGTCTTGGCCCCTCCTAGAGCGTGTGCAGACT
SEQ ID




GATGATTTTATATGTAAATCAAGACTCACATCCCTTTCCTAGTCCCCCACATCCAAAGCCCC
NO:




TCAGCCTGCCTTGCAGACCAATGGGCTCCATGTTCTGTAGCCCCCTCCCCTACGCCTCACCC
2462




CTCCTCCCTCTCACAGGTTCTGGGCGGCCAGTGAGAGAAACGCAGTGGGGGAGGCAGGGAGT




CTGGTGCCTGCAGAGATTCTCTGCTT





NAP1L1
ADXCRAD_BP220549_at
AGTTACTGGTACCACAGTGAGGTGAATAAAACGGGATTTTCAGAAGTTAGCCTGAATTTAAC
SEQ ID




TGTATTTTTAAATTTAACCTCCATTAACTAAGCATCTTTTCTTTGTGGTAGGGTCTACCTTC
NO:




TGCTTCCCTGGAAAGGATGAATTTACATCATTCGACAAGCCTATTTTCAAGTTATTTGNTGG
2470




TTGTTTGCTTGTTTTTGTTTTTGCAGCTAAAATAAAAATTTCAAATACAATTTTAGTTCTTA




CAAGATAATGTCTTAATTTTGTACCAATTCAGGTAGAAG





NAP1L1
ADXCRAD_BP220549_x_at
AGTTACTGGTACCACAGTGAGGTGAATAAAACGGGATTTTCAGAAGTTAGCCTGAATTTAAC
SEQ ID




TGTATTTTTAAATTTAACCTCCATTAACTAAGCATCTTTTCTTTGTGGTAGGGTCTACCTTC
NO:




TGCTTCCCTGGAAAGGATGAATTTACATCATTCGACAAGCCTATTTTCAAGTTATTTGNTGG
2471




TTGTTTGCTTGTTTTTGTTTTTGCAGCTAAAATAAAAATTTCAAATACAATTTTAGTTCTTA




CAAGATAATGTCTTAATTTTGTACCAATTCAGGTAGAAG





TOP1
ADXCRAD_BM541278_s_at
TTTTTGCTATAATCATTAGTTTTAGAGGCATTGTTAGTTTAGTGTG
SEQ ID





NO:





2477





TOP1
ADXCRAD_BM541278_x_at
AGCAGAATTTTTAATGTGAAGACATTTTTTGCTATAATCATTAGTTTTAGAGGCATTGTTAG
SEQ ID




TTTAGTGTGGTGGGCAGAGTCCATTTCCCACATCTTTTCCTCCAGGATCCTCCAATTTTTAT
NO:




CATGAATTTCCCTTTTAATCAACCTG
2478





PCBP2
ADXCRAD_AW294074_s_at
GGAAAGTCTAATCCTCAATCTTTTGGGCACAAGTTTTATAAGGGCCAACCAAGCATGGAGTC
SEQ ID




AGGGAAAAATAGGATCGAGGGCCACAAA
NO:





2486





USP7
ADXCRAD_CA439064_at
GAAGGGCCTCGTGACACATCAGGTCACATCTCCAGTCACCTTATTTGTACACAGTTCTCTCC
SEQ ID




TGGAAAACCTTTCATTTCTTAAGAGTAAATGTGACTAGTTAGAGGCTAAAAAAAAAAAAAAA
NO:




AAGAAACAAGAGACCCTGCCCCCGCAAAACGGAATTAGAAGGAAAAGTACATCTCAGTGAAA
2489




CCTTGTTACAAATGCCAAGGTTTCCCAGGCCTGTTTCCAGGGAGAGTAGAATCTTCCTCCAC




TTCCACGTAACTCACTGAATTATA





FYB
ADXCRAD_BX437100_at
GAAAATTAATGCACAAAACCACTTATTATCATTTGTTATGAAATCCCAATTATCTTTACAAA
SEQ ID




GTGTTTAAAGTTTGAACATAGAAAATRATCTCTCTGCTTAATTGTTATCTCAGAAGACTACA
NO:




TTAGTGAGATGTRAGARTTATTAAATATTCCATTTCCGCTTTGGCTACAA
2517





FYB
ADXCRAD_BX437100_x_at
GAAAATTAATGCACAAAACCACTTATTATCATTTGTTATGAAATCCCAATTATCTTTACAAA
SEQ ID




GTGTTTAAAGTTTGAACATAGAAAATRATCTCTCTGCTTAATTGTTATCTCAGAAGACTACA
NO:




TTAGTGAGATGTRAGARTTATTAAATATTCCATTTCCGCTTTGGCTACAAWTTATGAAGAAG
2518




TTGAAGGTACTTCTTTTAGACCACCA





41888
ADXCRAD_BG284913_at
GGAGTGGCTTTTCTGGAAACAACACAAGACAACAGAAAACAGGTGTACACATATCTCTCATT
SEQ ID




CTCTTAAGCCAAGAAGTGTGCTTCCCTAGCTGAAGTGTAGATGGTCGTGTAGGGGTGGGTGG
NO:




AAAATCATGTGGCATACAGGTGTGGGTGTAATAT
2533





41888
ADXCRAD_BG284913_x_at
GGAGTGGCTTTTCTGGAAACAACACAAGACAACAGAAAACAGGTGTACACATATCTCTCATT
SEQ ID




CTCTTAAGCCAAGAAGTGTGCTTCCCTAGCTGAAGTGTAGATGGTCGTGTAGGGGTGGGTGG
NO:




AAAATCATGTGGCATACAGGTGTGGGT
2534





MDN1
ADXCRAD_BE777779_at
TGTTAATCCCTAAAAAAGGCTATGCAGGTAATAATTCTGGAAAACTTATTTAAAACATTTTC
SEQ ID




CAAGGGTTGGTGGGTGTTCAAAAACACACCGGAGAAGAAAGAGCTTTTGAGAACAAGAAAGA
NO:




AACGAAGAAAAAAAAGAGAAAGAAAAAAAAAAGGGGGGGGGGAATAATTCGGGGAAGAAGAG
2538




ACTTTTAAAAGGGACAAGAGGTAAAAAGGGGGGAAAGAGAGGAAACGGGTGTGGACTTGG





ATP2A3
ADXCRAD_BX328303_at
AGGTCCAACTTTGCACCCGCGTTCTTGGTACCTGAGACCACCGACATCCTCAGGTTCCTGAC
SEQ ID




CGTGCGGCCTTCTACCCA
NO:





2544





ATP2A3
ADXCRAD_BX328303_x_at
AGGATGTCCTTTCCCGGGAGACAAGTCGNGAAAGCCTGGCTGGACTGCCTCAGCCCCGCGCG
SEQ ID




CCTNCTGGACTCAGGGTTCCCCGTCCTGAGCTCNGGGAGATGTCAGAGTCACACTGCCGCCC
NO:




GGTCTGCCACGCAGAGGTCCAACTTTGCACCCGCGTTCTTGGTACCTGAGACCACCGACATC
2545




CTCAGGTTCCTGACCGTGCGGCCTTCTA





HNRNPA1
ADXCRAD_CN296684_s_at
GAACTGATAGTTACTGTTGTGACCTGAAGTTCACCATTAAAAGGGATTACCCAAGCAAAATC
SEQ ID




ATGGAATGGTTATAAAAGTGATTGTTGGCACATCCTATGCAATATATCTAAATTGAATAATG
NO:




GTACCAGATAAAATTATAGATGGGAATGAAGCTTGTGTATCCATTATCATGT
2549





CD3D
ADXCRAD_BX457462_s_at
CGTGGCTGGCATCATTGTCACTGATGTCATTGCCACTCTGCTCCTTGCTTTGGGAGTCTTCT
SEQ ID




GCTTTGCTGGACATGAGACTGGAAGGCTGTCTGGGGCTGCCGACACACAAGCTCTGTTGAGG
NO:




AATGACCAGGTCTATCAGCCCCTCCGAGATCGAGATGATGCTCAGTACAGCCACCTTGGAGG
2553




AAACTGGGCTCGGAACAAGTGAACCTGAGACTGGTGGCTTCTAGAAGCAGCCATTACCAACT




GTACCTTCCCTTCTTGCTCAGCCAATAAAT





41888
ADXCRAD_BQ941634_at
ATCACCACCATTCTGCTGTTCAGTGTCTCTTGAGAGAGCCTCTTTGCATGTTTTCCAGAATC
SEQ ID




TGTGTGTGTTTTTCCTTTCTTCTCCTTTGTTCTTTTTGCTCAAAGGTGTGACCAGTCATTGC
NO:




CCCCTCTGGGGCTTTCATTCTCCAGGAGAAACATCCCAGAACCAGCACTGTTTAGCCTGATA
2554




CCTTTCTAATGTCCATGTCAATTTTCAATAA





NAP1L1
ADXCRAD_CX870261_s_at
CAAGGGACGTGGGACAGTTCGTACTGTGACTAAAACAGTTTCCAATGACTCTTTCTTTAACT
SEQ ID




TTTTTGCCCCTCCTGAAGTTCCTGAGAGTGGAGATCTGGATGATGATGCTGAAGCTATCCTT
NO:




GCTGCAGACTTCGAAATTGGTCACTTTTTACGTGAGCGTATAATCCCAAGATCAGTGTTATA
2555




TTTTACTGGAGAAGCTATTGAA





SHMT2
ADXCRAD_BP384660_s_at
AACAAGACTTAGAAGGAGGGCCCAGGCACTTTCTGTTTGAACCCCTGTCATGATCACAGTGT
SEQ ID




CAGAGACGCGTCCTCTTTCTTGGGGAAGTTGAGGAGTGCCCTTCAGAGCCAGTAGCAGGCAG
NO:




GGGTGGGTAGGCACCCTCCTTCCTGTTTTTATCTAATAAAATGCTAACCTGCCCTGAGTTTC
2559




CATTACTGTGGGT





HMGB1
ADXCRAD_BX429991_at
GTATGGTCTAACCTTTACCATAGGACTTTATTCTTTAAACTCCATTACATGTAAGGGCCGTT
SEQ ID




ATATTTTGCAGCCTCCACATTAAGAATACTTGGTATGCTTTCTCCAAAGCGGTGAGCTTATA
NO:




TACAAGACTGGCATATTAAAATTTTCCGCTACACTTACTCCAAGAAAGCTTTGGAATAGCAG
2572




TCTTAT





BLM
ADXCRAD_AV763452_x_at
ACACACACACACTTAGCCAGGCATGGTGGTGCATGCCTGTAATCCCAGCTACTTCAGATTCT
SEQ ID




GAGGCAGGAAGAATCACTTGCCCCAGAGGCAGAGTTTGCA
NO:





2573





GCN1L1
ADXCRAD_BQ890025_at
TCCAGTTTAGCCATGGCTAGGGTCCTGGAACTATAATAAGCAAGGGTCCAGACTGGTGGGGT
SEQ ID




TTCCTCCTTTCTCCTGTGGCTTGGAACCTCTTGGGTTTGAAAAGCTGGGCGCCTACCNAAAC
NO:




CCTTTTTTTCCCTATAATCCCCGGAATTGGGGGGCAACAGAACGGTTGGGGAATCTCCTG
2576





RPS6
ADXCRAD_BQ955249_at
ATCTGAGCATTTAGCCTAAGGCAGTTAACTCCTACAAAGTGTCCATGAAACCAATACATCTG
SEQ ID




AAAAGGCCTATGCTCCAATGCAGATCTGGAATCCATGAGCAGTTTTGGAGTACCGATCAGAT
NO:




TAATGAAGATACTTTAACAACCTGCCACCTAATCTGGTGGTAATAGGTAACGTTACCCCTGA
2578




ATTTGGCGGAATTGGCCAAGGAAAATAAAGATGGCAAGCTTACATCAAATTTTA





HSPD1
ADXCRAD_BM313583_s_at
AACAGCATGATTGGGTTAGGAATTTGCATAGGATGAGTTCAGTGGTGAGACTTTTGAAACTA
SEQ ID




CACACATCTACCTTGTTTTAGTCCTATTTTCAAAATTTTGGCATTGTGAGATTTTATTTACT
NO:




GTGTGAACCTAAAGTTACTGTTTAAGTACATGCCACGCAACTCTGTGTTATTAAGAAGCACT
2588




GTCTCAGAAGCTGTGTGTAAATTTAATATTAAGGCACTAAAGACCAAGCATAGGTACATGCC




TGTA





CYFIP2
ADXCRAD_AV725374_at
GATATTTTGAATTGTATCTTGCGGGTCCCTGTGTTGAAGTGATAAACATTTGCATCTTATTA
SEQ ID




AAACTGCTTTCACACTTGTAGACCCCACAACTTACAACAATTAATTGGCCGTTGTTTTACAA
NO:




CGGCTGACTGGGAAACCCTTGCCGTCCCCAACTTTATTGCTTGT
2591





WDR59
ADXCRAD_AA393120_at
CCCCTAGAAATCTCCTGGAAGAGAGGAAATCAGATCAACTGGGGCTGCCTCAGACCTTGCAG
SEQ ID




CAGGAATTCTCCCTGATCAATGTGCAAATCCGGAATGTCAATGTGGAGATGGATGCGGCAGA
NO:




CAGGAGCTGCACAGTGTCTGTGCACTGCAGCAACCATCGTGTCAAGATGCTGGTGAAGTTCC
2596




CTGCACAGT





USP7
ADXCRAD_CA437914_at
TGTGTACCTTGGAGTGACTTCCTTTCTCAACTTCCACTGCAGTGTGTGTGCCTTCTGCTCTG
SEQ ID




AGAGCTGCCTTGTGACCCGTGTGATAGAAAGCAGGGAGTGAGGGTCCCCGCGGACCTGGCCC
NO:




TTCCCTCCTTCCTCCCCCAGAAAGAGGAGTTAGAGCAGGGGTGCGAGAGCCGTTCGCTGTGG
2597




GTTTGTCTTTGAACAAACATTAAGGTGTCTTGTTTTTGTTCTGGGCTGGGGGTTGGCTGTAG




TCTTAGGTAACTGAAAGTTCCTACTCTCCCTTAAG





HMGB1
ADXCRAD_DN601918_x_at
GATGCTTCAGTCAACTTCTCAGAGTTTTCTAAGAAGTGCTCAGAGAGGTGGAAGACCATGTC
SEQ ID




TGCTAAAGAGAAAGGAAAATTTGAAGATATGGCAAAAGCGGACAAGGCCCGTTATGAAAGAG
NO:




AAATGAAAACCTATATCCCTCCCAAAGGGGAGACAAAAAAGAAGTTCAAGGATCCCAATGCA
2603




CCCAAGAGGCCTCCTTCGGCCTTCTTCCTCTTCTGCTCTGAGTATCGCCCAAAAATCAAAGG




AGAACATCCTGGCCTGTCCATTGGTGATGTTGC





PTMA
ADXCRAD_BG706596_at
GGATGGACGATGACCGATGACGGAAGCTGAGTC
SEQ ID





NO:





2606





PTMA
ADXCRAD_BG706596_x_at
TGGACGATGACCGATGACGGAAGCTGAGTCAGCTACGGGCAAGCGGGCAGCTGAAGATGATG
SEQ ID




AGGATGACGATGTCGATACCAAGAAGCAGAAGACCGACGAGGATGACTAGACAGCAAAAAAG
NO:




GAAAAGTTAAACTAAAAAAAAAAAAGGCCGCCGTGACCTATTCACCCTCCAATTCCCGTCTC
2607




AGAATCTAAACGTGGTCACCTTCGAGTACGAGAGGCCCGCCCGCCCACCGTGGGCAGTTGCC




ACCCGCAGATGACACGCGCTCTCCACCAGCCAAGCCAAACCATGAGAAT





PAICS
ADXCRAD_CX785294_at
GTGATGTCTGGGAACACTGCATATCCAGTTATCAGCTGTCCTCCCCTCACACCAGACTGGGG
SEQ ID




AGTTCAGGATGTGTGGTCTTCTCTTCGACTACCCAGTGGTCTTGGCTGTTCAACCGTACTTT
NO:




CTCCAGAAGGATCAGCTCAATTTGCTGCTCAGATATTTGGGTTAAGCAACCATTTGGTATGG
2609




AGCAAACTGCGAGCAAGCATTTTGAACACATGGATTTCCTTGAAGCAGGCTGACAAGA





AKAP1
ADXCRAD_CN407762_s_at
GCCTTGCCCAGTGGGTAGACAGCTACTACACAAGCCTTTGACCCCCATGCTGCTTCCTGAGA
SEQ ID




GTCTTTTTTTGCACTGTTGAAATTGGGCTTGGCACTCAAGTCAAAGATGAACATCGGAATAA
NO:




CAAACATTGTCCTCTCCAGAAAGTCCTTTCTTTCTCCATACTGTAGTCCTATTGAGAAGACA
2613




TTTCGTCTCTGAGAAAAAAAGGATGGAACTATGGGTTCTCTTCGCAAAGCCAAAGGATAGTG




TTTAACAAGCCAGCT





HMGB1
ADXCRAD_CX757597_at
GAAAAGCGCCCATGTAACACAAACTGCCATTCAACAGGTATTTCCCTTACTACCTAAGGAAT
SEQ ID




TGTACCATTGCTCAGAATTGTAGGATTTACTATGTTGAAACTACAGGAGAGCCGGGCGCATG
NO:




GTCACCCTGTATCCAGCCTTTGGAGGCANGCGGCAATCACAGTCAGAATGAACATCTGCTAC
2620




TGTGAACCGCTCATAAATCAAAATACACTGTGCTGCCTGATCATATCGAGTAGCGAATGTGA




CGAGGATCAGACATGCTGCCACGGA





TTF1
ADXCRAD_BX457598_s_at
AGGCCGGGACTGATATGCAGGAATCCCAGCCTACTGTGGGCTTGGATGATGAAACTCCACAA
SEQ ID




CTACTAGGAMCCTACTCACAAAAAAAAGTCTAAGAAAAAAAAGAAGAAAAAGTCCAATCACC
NO:




AGGAATTTGAGGC
2624





CBFA2T3
ADXCRAD_AW955147_x_at
ATCTGTGTGCGTGGCTATCAGGAGTTCTAGGAACTCAGTGCAATACGGGAGTGACCCAGCTA
SEQ ID




CTTGACCAGCCACGAACAGCCCGCCAGAGGCCCTGAACTGGACGGTACGTTAATGTGAATGT
NO:




TATAGTCTTTGCAAAATCCCAAAGGATTTCATGAGGGTAATAAACAG
2638





NAP1L1
ADXCRAD_BQ884238_at
GACTATGACCCAAAGAAGGATCAAAACCCAGCAGAGTGCAAGCAGCAGTGAAGCAGGATGTA
SEQ ID




TGTGGCCTTGAGGATAACCTGCACTGGTCTACCTTCTGCT
NO:





2641





TOP1
ADXCRAD_CN309141_s_at
GGAAGCTCAGAAAAGCATAAAGACAAACATAAAGACAGAGACAAGGAAAAACGAAAAGAGGA
SEQ ID




AAAGGTTCGAGCCTCTGGGGATGCAAAAATAAAGAAGGAGAAGGAAAATGGCTTCTCTAGTC
NO:




CACCACAAATTAAAGATGAACCTGAAGATGATGGCTATTTTGTTCCTCCTAAAGAGGATATA
2643




AAGCCATTAAAGAGACCTCGAGATGAGGATGATGCTGATTATAAACCTAAGAA





NCKAP1L
ADXCRAD_BM479866_at
AACAGGGAGCCGACTTATAACACTAGGGCCCGGGGTCCCCCCTTTTTACCACACTTCCGACT
SEQ ID




GGCCAAAAACCGGCTTACCTTTCGGAACCCTTGGGGAAGGAGACACCTACTCCTCTCGGGGC
NO:




GCGGAACCTACATTGGTACAAAAT
2648





TMPO
ADXCRAD_BX482009_s_at
AAAAGGGACGCTCCATTCCCGTATGGATAAAAATTTTGCTGTTTGTTGTTGTGGCAGTTTTT
SEQ ID




TTGTTTTTGGTCTATCAAGCTATGGAAACCAACCAAGTAAATCCCTTCTCTAATTTTCTTCA
NO:




TGTTGACCCTAGAAAATCCAACTGAATGGTATCTCTTTGGCACGTTCAACTTGGTCTCCTAT
2649




TTTCAATAACTGTTGAAAAACATTTGTGTACACTTGTTGACTCCAAGAACTAAAAATAATGT




GATTTCGCCTCAATAA





EWSR1
ADXCRAD_CN353264_s_at
GAAAAGTGGGACTAGACACGGTGTCCATATGGAGAGGAAAAATATACATAGAATATTTTTAA
SEQ ID




CAAAATGTATTCATTGTATAAATGGAATCCTTCTGTAACTTTGGTAACTGCATACTTGTTGT
NO:




TTGGTAATGAACCAGAGGAGGTATAATACTCTAGAATTGTGTAACATT
2650





FYB
ADXCRAD_BF510133_at
CAAGAGAAGAGTAATACGTGGTCCTGGGGGATTTTGAAGATGTTAAAGGGAAAAGATGACAG
SEQ ID




AAAGAAAAGTATACGAGAGAAACCTAAAGTCTCTGACTCAGACAATAATGAAGGTTCATCTT
NO:




TCCCTGCTCCT
2653





FYB
ADXCRAD_BF510133_s_at
TCCCTGCTCCTCCTAAACAATTGGACATGGGAGATGAAGTTTACGATGATGTGGATACCTCT
SEQ ID




GATTTCCCTGTTTCATCAGCAGAGATGAGTCAAGGAACTAATTTTGGA
NO:





2654





FYB
ADXCRAD_BF510133_x_at
AGAGAAGAGTAATACGTGGTCCTGGGGGATTTTGAAGATGTTAAAGGGAAAAGATGACAGAA
SEQ ID




AGAAAAGTATACGAGAGAAACCTAAAGTCTCTGACTCAGACAATAATGAAGGTTCATCTTTC
NO:




CCTGCTCCTCCTAAACAATTGGACATGGGAGATGAAGTTTACGATGATGTGGATACCTCTGA
2655




TTTCCCTGTTTCATCAGCAGAGA





41888
ADXCRAD_CR743228_s_at
TCAGGAGCCACAGCCATTTCTTAGAGGGTTTCAAAAGGACAGCCTTTGGCGCCTTTTCCTTC
SEQ ID




TAACCTTTGAGTCCAGCCCTTTCCAGTTTTCATTCACTCGAAGTAACTGCACTCAAGCTGTG
NO:




CTCAAAATCGGCAACGCATTTATTTACACCAAGCCCTTCCCATAAAACACAACTGCTGAAGA
2661




AAATAGCAGACGTTTCCCCTCTCTCTAACTCTGGGTATCCCACAGATGCAAAAGG





SHMT2
ADXCRAD_CX788770_at
ACTGCCAAGCTCCAGGATTTCAAATCCTTCCTGCTTAAGGACTCAGAAACAAGTCAGCGTCT
SEQ ID




GGCC
NO:





2669





SHMT2
ADXCRAD_CX788770_s_at
TCAGCGTCTGGCCAACCTCAGGCAACGGGTGGAGCAGTTTGCCAGGGCCTTCCCCATGCCTG
SEQ ID




GTTTTGATGAGCATTGAAGGCACCTGGGAAATGAGGCCCACAGACTCAAAGTTACTCTCCTT
NO:




CCCCCTACCTGGGCCAGTGAAATAGAAAGCCTTTCTATTTTTTGGTGCGGGAGGGAAGACCT
2670




CTCACTTAGGGCAAGAGCCA





PTMA
ADXCRAD_BM685721_s_at
GAAAAACAATCTTATTCCGAGCATTCCAGTAACTTTTTTGTGTATGTACTTAGCTGTACTAT
SEQ ID




AAGTAGTTGGTTTGTATGAGATGGTTAAAAAGGCCAAAGATAAAAGGTTTCTTTTTTTTTCC
NO:




TTTTTTGTCTATGAAGTTGCTGTTTATTTTTTTTGGCCTGTTTGATGTATGTGTGAAACAAT
2679




GTTGTCCAACAATAAACAGGAATTTTA





GTF3A
ADXCRAD_BM729250_at
ATATGTCTGTTTTTCCACTACCGTATCATTGCTGTTCACATGTAATGTGTTGTTTGTTCACA
SEQ ID




ACAAGCGCCTGGTTACACATTACACTGACGAATGTGCTGATGCTCCAGCCATGGCTTTGATG
NO:




CTTCTGTCATTTTTAACCTCTTCTATTAATATTTACTGCCTGTGCCATTCTTTTCCTTGTTG
2680




GCCATTCACAAGGCTTGGATAATCGTGTGACATTTTGAGAGCCATCAGATGTTACGTTTCTC




AA





BCL11A
ADXCRAD_BU164469_x_at
TATCTTTTACTATGGGAGTCACTATTTATTATTGCTTATGTGCCCTGTTCAAAACAGAGGCA
SEQ ID




CTTAATTTGATCTTTTATTTTTCTTTGCTTTTATTTTTTTTTTTATTTAGATGACCAAAGGT
NO:




CATTACAACCTGCGCTTTTTATTGAATTTGTTTCTGGCCTTTGTTAAGTTCTATTGGAAAAA
2684




CCACTGTCTGTGGTTTTTTTGGCAGTTGTCTGCATTAACCTGTTC





PVRIG
ADXCRAD_BX437785_at
TGTCATCCCCTTACTTTAATTCTTGGGCCTCCAATAAGTGTCCCATAGGTGTCTGGCCAGGC
SEQ ID




CCACCTGCTGCGGATGTGGTCTGTGTGCGTGTGTGGGCACAGGTGTGAGTGTGTGAGTGACA
NO:




GTGACCCCATTTCAGTCATTTCCTGCTGCAACT
2685





PVRIG
ADXCRAD_BX437785_x_at
GCCCAGGGCCATGGAAGGACCCTTAGGAGTTCGATGAGAGAGACCATGAGGCCACTGGGCTT
SEQ ID




TCCCCCTCCCAGGCCTCCTGGGTGTCATCCCCTTACTTTAATTCTTGGGCCTCCAATAAGTG
NO:




TCCCATAGGTGTCTGGCCAGGCCCACCTGCTGCGGATGTGGTCTGTGTGCGTGTGTGGGCAC
2686




AGGTGTGAGTGTGTGAGTGACAGTGACCCCATTTCAGTCATTTCCTGCTGCAACTAAGTGAG




CAACACAGTTTCTCTGATGT





RNPS1
ADXCRAD_CX785467_at
GATCGGAATGCAAATCTAGTTCTGGGTTCACTGCCTTCTCACTT
SEQ ID





NO:





2688





RNPS1
ADXCRAD_CX785467_x_at
GATCGGAATGCAAATCTAGTTCTGGGTTCACTGCCTTCTCACTTGTCCCCTCGCCCCTAGTA
SEQ ID




ACTTTCTGTTCCTCACCA
NO:





2689





PTPN7
ADXCRAD_BG388017_x_at
TGAGCCCTGTGAGAGGCACGACTGTCTATGCCAATGAGGCTCGGTGGGGGGCTCTCAAGTGC
SEQ ID




CTGATCCTGCCCTGGGCTCAGAGCCAGCCCAGAGGGAAGCAACTGCACAGCCCCACAGGCCC
NO:




TCCTTGGGCACTGTCCCCCCAGACCCATCTCAGAGCTCAGAGGGTACAAGCTCCAGAACAGT
2705




AAGCAAGTGGGAAAATAAAGACTTCTTGGATGACTGAAGACAAAAAA





ITGB7
ADXCRAD_BQ642465_at
AAGGCTCTTTCTCCTTGGAGACAATGGGAACTGGAGGGTGAGAGGAAAGGTGGGTCTGTAAG
SEQ ID




ACCTTGGTAGGGGACTAATTCACTGGCGGAGTTCGGCCACCACCCTACTTCATTTTTAAAGG
NO:




GACACCCAAGAGGGGCTGCTTTCCATTGCCTGGAACCCTTGAATTCCATCTGGGGCCTACCC
2713




CCAACCCAAAGAAAAACAAATAAAAGCCCTTAACCCCCCGGGAGAAAAGAAAGNNAGAGGAA




AAAAACCTCCCGAGGGCCATTCTAATTGTTCCGCGGTGGGCG





ATIC
ADXCRAD_BU189824_at
TCTTCCCTTTCCGAGATAACGTAGACAGAGCTAAAAGGAGTGGTGTGGCGTACATTGCGGCT
SEQ ID




CCCTCCGGTTCTGCTGCTGACAAAGTTGTGATTGAGGCCTGCGACGAACTGGGAATCATCCT
NO:




CGCTCATACGAACCTTCGGCTCTTCCACCACTGATTTTACCACACACTGTTTTTTGGCTTGC
2723




TTATGTGTAGGTGAACAGTCACGCCTGAAACTTTGAGGATAACTTT





AKAP1
ADXCRA2D_CN407756_s_at
GGCTCATGCTGCCTGATGGCATCACCGTGGAGGTCATTGTGGTCAACCAGGTCAATGCCGGG
SEQ ID




CACCTGTTCGTGCAGCAGCACACACACCCTACCTTCCACGCGCTGCGCAGCCTCGACCAGCA
NO:




GATGTACCTCTGTTACTCTCAGCCTGGAATCCCCACCTTGCCCACCCCAGTGGAAATAACGG
2724




TCATCTGTGCCGCCC





EWSR1
ADXCRAD_BG910390_s_at
GAGCGCAGAGATCGGCCCTACTAGATGCAGAGACCCCGCAGAGCTGCATTGACTACCAGATT
SEQ ID




TATTTTTTAAACCAGAAAATGTTTTAAATTTATAATTCCATATTTATAATGTTGGGCACAAC
NO:




ATTATGATTATTCCTTGTCTGTACTTTAGTATTTTTCAC
2726





PTMA
ADXCRAD_BP384625_x_at
AGAGACGCCCCTGCTAACGGGAATGCTAATGAGGAAAATGGGGAGCAGGAGGCTGACAATGA
SEQ ID




GGTAGACGAAGAAGAGGAAGAAGGTGGGGAGGAAGAGGAGGAGGAAGAAGAAGGTGATGGTG
NO:




AGGAAGAGGATGGAGATGAAGATGAGGAAGCTGAGTCAGCTACGGGCAAGCGGGCAGCTGAA
2734




GATGATGAGGATGACGATGTCGATACCAAGAAGCAGAAGACCGACGAGGATGACTAGACAGC




AAAAAAGGAA





ANP32A
ADXCRAD_CN349881_s_at
TTGTAAATAGCAACCTAAAGGCGTATTTTGGCACTGGTCTGGGGACATTCCCCATCTCTCAT
SEQ ID




CCCTTTTCCCCCTTCACAGATGGTGGTGGGCTTCGCTCTACAAAGAGGACTCTGATGTTACT
NO:




CTTGAGCTTATGAGCCAGAGAGCTGAAAACCGCAGGCTTGTTGTGTTAAGTTACAAGGAAAA
2736




TGGATTTGGTAATTAAAATTAGAAGAAACACACCTTCAAACTTCAACTTCTTTAAAAGAAAA




AAAAAACTGTCCTATCTTGTTCTGTAAAATATTAGAACGCTTTGT





TRIM14
ADXCRAD_BI222503_at
CACTTAACCCCTCAGCTATGAAAAGGCTTCCAGGAGTTTCCATGACATAACAAAACAACAAT
SEQ ID




ACAAGCGCCTCACCTTAGCATTCAAGGCTTGTCTAGTCTGCCCAACAATTACTTATCCTCAC
NO:




CTAGCTCCTACCAGTCTTCTTAGAGACTCTCCAGTCAGAACATGTGTCGCATAGTTCCACTC
2740




CACACCTCTCTGCTGACAGCACATTCATGCAGACAAGTCTTTCCACTGTCTCAGACTTCCGC




AGGCTTACCTGCGCAGGCAAGTCTAACCAA





EWSR1
ADXCRAD_BG619847_at
ATAATTATGGGCTCACTTCCTACTGGAGATGTTGAAAGTCTAAATCGGTTTGACCATTTTGA
SEQ ID




TTGATGGCACAATCTGGTTTAGAAAACTTTGTTTAGATCAATGACATAACCCTGCTGCCTCT
NO:




GCCTGCCCTTCCCCTCCCTTCTCCCATCCCCTTTTCCCTATCTGGTGTCTGTACTTTGATGA
2747




AGGTGAGCTATAATATTGGTGGTTAATATAATCCAGAAGGCTTAGTTCTGTGTGT





CHD7
ADXCRAD_CN341021_s_at
GGATATAAACACTTTGACAGGAGAAGAAAGGGTGCCTGTTGTCAATAAACGAAATGGGAAGA
SEQ ID




AGATGGGTGGAGCTATGGCGCCTCCAATGAAGGATCTACCCAGGTGGCTGGAAGAAAATCCT
NO:




GAATTTGCAGTTGCTCCAGACTGGACTGATATAGTTAAGCAGTCTGGTTTTGTTCCTGAGTC
2748




GATGTTTGACCGCCTTCTCACTGGGCCTGTAGTGCGGGGAGAGGGAGCGAGCAGAAGAGGAA




GAAGGCCCAAAAGTGAGATCGCCAGAGCAGC





IKZF1
ADXCRAD_BM456472_s_at
GTGTGGTGATTGTTCAGGTCGAATCTGTTGTATCCAGTACAGCTTTAGGTCTTCAGCTGCCC
SEQ ID




TTCTGGCGAGTACATGCACAGGATTGTAAATGAGAAATGCAGTCATATTTCCAGTCTGCCTC
NO:




TATGATGATGTTAAATTATTGCTGTTTAGCTGTGAACAAGGGATGTACCACTGGAGGAATAG
2749




AGTATCCTTTTGTACACATTTT





SP110
ADXCRAD_NM_080424_s_at
GACTTTGGCCAGGTAGGACTTGACTTAGAGGCAGAATTTGAAAAAGATCTCAAAGACGTGCT
SEQ ID




CGGTTTTCATGAAGCCAATGACGGCGGTTTCTGGACTCTTCCTTGACCCTGTTCTGTAAAGA
NO:




CTGAAGCATCCCCACCTCAGGATTCAGCTGATGGGACCCTGGCTTGGACTGTTGATTGCCAG
2760




TGAGTCTGGGATGTAATTGGCTGCCCTCAGGACCCAAACCCAGACACTTCATAGGATTATCA




CACCCTCCATCTTTATT





SH2D1A
ADXCRAD_NM_002351_at
TCATAATAAGTTGCATAGGTTTAATAATTTTTAATTATATGGCTTGAGTTTAAATTGTAATA
SEQ ID




GGCGTAACTAATTTTAACTCTATAATGTGTTCATTCTGGAATAATCCTAAACATATGAATTA
NO:




TGTTTGCATGTTCACTTCCAAGAGC
2763





SH2D1A
ADXCRAD_NM_002351_x_at
TCATAATAAGTTGCATAGGTTTAATAATTTTTAATTATATGGCTTGAGTTTAAATTGTAATA
SEQ ID




GGCGTAACTAATTTTAACTCTATAATGTGTTCATTCTGGAATAATCCTAAACATATGAATTA
NO:




TGTTTGCATGTTCACTTCCAAGAGCCTTTTTTTGAAAAAAAGCTTTTTTTGAATCATCAAGT
2764




CTTTCACATTTAA





CD247
ADXCRAD_NM_198053_at
AGAGGAGGCCGTTGATTCACTTCACGCTTTCAGCGAATGACAAAATCATCTTTGTGAAGGCC
SEQ ID




TCGCAGGAAGACCCAACACATGGGACCTATAACTGCCCAGCGGACAGTGGCAGGACAGGAAA
NO:




AACCCGTCAATGTACTAGGATACTGCTGCGTCATTACAGGGCACAGGCCATGGATGGAAAAC
2773




GCTCTCTGCTCTGCTTTTTTTCTACTGTTTTAATTTATACTGGCATGCTAAAGCCTTCCTAT




TTTGCATAA





MFNG
ADXCRAD_NM_002405_at
ACGGGTCCCAGCCAATTGTGATGATCCTTTTTGCTCATTTCCCAGCCTTTCTTGCTGTTAGG
SEQ ID




GGCTACCATGGGACCAGCTCTGGCCAGAGGGAACTAAGCAAATCCAATAGAGATGTTTCTGG
NO:




GGAAGGTTTTGCAGCCCACTCCCCATCTTCCTGCTATAAATGTGGGTGTGATGGCTGGATCT
2775




GGGGCAGCCACCTTGCTACCATGAAGGAAAGGCCAAGACAATCATCCACAGCTATTCCCTCC




AGCATCTGGTTCTGTACAAAAATTA





CD28
ADXCRAD_NM_006139_at
TATACAGGGAAGTCCGTTTTCACTATTAGTATGAACCAAGAAATGGTTCAAAAACAGTGGTA
SEQ ID




GGAGCAATGCTTTCATAGTTTCAGATATGGTAGTTATGAAGAAAACAATGTCATTTGCTGCT
NO:




ATTATTGTAAGAGTCTTATAATTAATGGTACTCCTATAATTTTTGATTGTGAGCTCACCTAT
2776




TTGGGTTAAGCATGCCAATTTAAAGAGACCAAGTGTATGTACATTATGTTCTACA





41888
ADXCRAD_AF403061_s_at
TAATCCATGGCTGTGTACTGAATAGTATTCCCCGCTACAGCTGGACTGGACTCCATTTAGCC
SEQ ID




TT
NO:





2780





BCL11A
ADXCRAD_BM193618_at
GAAGCTATAGATCTCAAGAGTGCCTGTGTCCTACAAGGAACACATATTTCACAACTGATTCA
SEQ ID




TTTGCCCCTTACTCTGAGCACATGGGATAATAAAAGAAAGTTTTAGATCATCATTATCCAAA
NO:




GGATAACTTTGAATGCCCTTTTTCAGCATGCTTCTGAAAACATTTCATATCTCATTCAATGC
2785




CACATATAAATGGTATTTGCTGGACAGTGTGGAAAACAGAAACATCCGTGCTAAAAGCCAAT




GGTAAACACCAAGTTTAAAAAATGGATTGCAAAGATCGCATGTCC





PAICS
ADXCRAD_AA902652_s_at
TGGACAGCGAACATAAAGCTCTACTAGCTAACAAATAGGTCTTAATGATAAAAACGTGGGCC
SEQ ID




TTCAGAGAACTAAAGGTACCAATGTGTGGCAGTCCAAAATTACGAGGAAAATGAGTTCCCTT
NO:




CATGGGTCACATCAGCAATT
2798





ANP32A
ADXCRAD_T67821_at
TTTAATGAAGATACACCACTGAGTCTTGCTTTAAGACCAAAAATATCCAAACATAGTATCAC
SEQ ID




ATTATATATATCTCATANGAAAAGCTATTCTATCAGGNAACAAAAATGAAGCTTCCCCCTCA
NO:




CCTAGCAGTTCATCTGGGAATGCATCTTGGAAAAGATCCAATGGCCTGTTGGACTCAAAGAA
2799




GCCATCCCCAAAAAAATTGTATAAAAGGGTTTATTGAAATTTATCCAATGACCAACCGG





ANP32A
ADXCRAD_T67821_x_at
TTTAATGAAGATACACCACTGAGTCTTGCTTTAAGACCAAAAATATCCAAACATAGTATCAC
SEQ ID




ATTATATATATCTCATANGAAAAGCTATTCTATCAGGNAACAAAAATGAAGCTTCCCCCTCA
NO:




CCTAGCAGTTCATCTGGGAATGCATCTTGGAAAAGATCCAATGGCCTGTTGGACTCAAAGAA
2800




GCCATCCCCAAAAAAATTGTATAAAAGGGTTTATTGAAATTTATCCAATGACCAACCGG





PCBP2
ADXCRAD_AA504356_at
TGACAGAGTTGGTTTAGGACTAGTGGATGGCATCATGTCAAGTTGTGGATAATGTCACGGGT
SEQ ID





NO:





2808





PCBP2
ADXCRAD_AA504356_s_at
TGTTAGTCCTGGCTAGTCACTCATAACCTATGAATTTAAATTATCTTAGGGCCTCTATTTTT
SEQ ID




TAATCTGTAAAATGAGGGGATCAATGTGTTACAGATTAGTTGATCCTTAAGGTTCCTTCCAA
NO:




ATCTAAGCATGTCACTTCCTACTCCTGATAGTGCTGGTGGGGAGCAGAAAGGATACGGCCAG
2809




GAATAGAAAAAAGGGTAAAGAAACTTGGTTGACAGAGTTGGTTTAGGACTAGTGGATGGCAT




CATGTCAAGTTGTGGATAATGTCACGGGTTGGCTGAGATATAC





USP7
ADXCRAD_AI972599_at
TTGGGAACCAAATGGCTCCAAAAGCCATTTGTCCTCCAAGCGACTACAGGGCAAAGTAGTGA
SEQ ID




GAATCATGCCCATCTCTCTGAAATAAACAATCAATTCAGGGGCTTCTTTCTACAGCCCAAAT
NO:




GTTGGCTAGATGGAACAGAAGTGACTCAATCTGTCAAATACAAAATCAGGAGTCACCCCTTC
2811




CAGTTTCAGTTCATCGTTCAAATGGAATCATATCCTTCCTCTGTTTGGCTTTTCTATGGGAA




CTGCGC





PAICS
ADXCRAD_AU121975_at
TGCTACCACACCCAATTATGAATTTCATCATTAGTTTCTTAGTAGAGTCCACATGTCCTCAG
SEQ ID




TAGTAAGTTCATCAGTGCTAAATATTT
NO:





2824





PAICS
ADXCRAD_AU121975_x_at
TTAAGAGCCAAGTTCTCACTGTCTCCCAGGCTGGAGTGCAGTGGCATGATTATGGCTCCCTG
SEQ ID




CAGCCTTGAACTCCTGGACTCAAGCTGCAGCCTCTCGAGTAGCTGGGTGCATGTGCTACCAC
NO:




ACCCAATTATGAATTTCATCATTAGTTTCTTAGTAGAGTCCACATGTCCTCAGTAGTAAGTT
2825




CATCAGTGCTAAATATTT





CALML4
ADXCRAD_AI348378_at
AGATCTTGAAAGTTTTATGTGTTTAAAATTGAAATTGTCTAAAAAAATGCTCTTTCCACATT
SEQ ID




AATTTAGTTAGGATATATTTTCACTCCATTTCAGACACTTGACTCA
NO:





2835





BLM
ADXCRAD_AA769438_at
TAGAGATACAGGAACAAGAGATTTAATATTATTTGAAATAATATTGAATACTGAATAATATC
SEQ ID




ATTGAATATATAATATTGAATATTATTATTTCGGCCAGGTGTGGTGGCTCACGTCTTTAATC
NO:




TCAGCACTTTGGGAGGCTGAGGGAGGCAGATCACTTGAGCCCAGGAGTTTGAGACTAGCCTG
2843




GGCAACACAGGGAGAGCCCATCTCTCTCTCTCTCTCTTTTTTTTTAAATTCATTACATAAAA




ACAGATTGGGGCAACGGTTTGTTTATTTACTTGCTTTTGACATCATATTTGC





BLM
ADXCRAD_AA769438_x_at
GAGATACAGGAACAAGAGATTTAATATTATTTGAAATAATATTGAATACTGAATAATATCAT
SEQ ID




TGAATATATAATATTGAATATTATTATTTCGGCCAGGTGTGGTGGCTCACGTCTTTAATCTC
NO:




AGCACTTTGGGAGGCTGAGGGAGGCAGATCACTTGAGCCCAGGAGTTTGAGACTAGCCTGGG
2844




CAACACAGGGAGAGCCCATCTCTCTCTCTCTCTCTTTTTTTTTAAATTCATTACATAAAAAC




AGATTGGGGCAACGGTTTGTTTATTTACTTGCTTTTGACATCATATTTGC





USH1C
ADXCRAD_NM_025034_at
ACATGCACACATAGGATTTTACTTGAAAAAAATAATAAAGGAGACAGATATGTCAAATCTTT
SEQ ID




TTCAGGCACTAATAACATGTAAATGTAAAAGAACTAGAATCTTCTCCACATACCACCTCCCA
NO:




TCAGAAATCATGTCCTTGAAAGTGCTGTTGATAAAGAAATAGGGTTGCCTTTCCCCTATTCC
2848




TTAATCTAATTATTCCAGAAACAGCTGTCATTTTGGTTTTCATT





CD53
ADXCRAD_AW293276_at
TTGAACACTCAGTGCTGACCAGAGATTAACATAGGGCATGCAATACTAAAATTGGTTTGCAT
SEQ ID




TTCACTTTCTGCTTCAACGTTCAGTAAATCCATCATAGCCCTACCAAGTGCCAGGGCAGTTG
NO:




CTGGTCAGTGGTTGTCCTAGTCTTTCTCCACAAACCTGAAAAACCCTGGAGATTTCCAAACC
2849




CCTTCAGGAGCAGATAACATGAGGAGACAAGACCTCAGGGATTCAGTCTAGTTGGAAGATAG




TTGTGGCTTCTTCTCAGAGCCTATTCTGGAGGTCCAAAT





HSPD1
ADXCRAD_AW674195_at
TTTTTATTACACAAAGGTTGTCACATAATTGGATACTTCTCTACTTTGTACACAATTATTCT
SEQ ID




CACTCTCCACAGAAAGGCTGCTTAACTTCTCATCTGGTGGTGGCAAGCACTAAAATCCTGAT
NO:




TTTAACAGAATAGTAGT
2850





HSPD1
ADXCRAD_AW674195_x_at
AATGTTTTACACACATGCCAGCCTGCCCTTCAACTGGCTTTCAATTTTCAGTATCTTCTAAT
SEQ ID




CATGGAAATGCTAACACAATTATTAACTTTAAACAAATTTTTATTACACAAAGGTTGTCACA
NO:




TAATTGGATACTTCTCTACTTTGTACACAATTATTCTCACTCTCCACAGAAAGGCTGCTTAA
2851




CTTCTCATCTGGTGGTGGCAAGCACTAAAATCCTGATTTTAACAGAATAGTAGT





ARHGAP15
ADXCRAD_AI510829_at
GATAAATCTCACACACATACTTCCACTCATACCCACCACATGTATTATATTAGCAATATCAT
SEQ ID




ACTCTAGGTCTTCTGGTTTGAGTCAGTATAACATGATAGGCACATTTCTATGGAATTTCATG
NO:




CATTATTTTCTTTTAATGCTTATGAGGGTAAGTACCAAAATATCCATTTTTCATTCACAGAG
2854




TAGAATTATTTTTTGACTTTTTTTGTGATCTTTTGACCAACTCTCACATCCAGAAAATGTGC




CATT





RNPS1
ADXCRAD_NM_006711_at
AATAAACCCAAGATCATCTGAGATGAATATTAATTTTATTCTCATTTTATAGATGAGGAAAT
SEQ ID




GGGAGTTTTAAAGACATTCAATAACTTTGGCCAAGGTCATTCAGCTATTAAATTTTAAGACC
NO:




ATAAACCAATTGGATTCCTGGAGGAATTC
2859





PAICS
ADXCRAD_AB002325_x_at
GTTGCAGTGAGCCTCGATCCTGTCACTGCACTCCA
SEQ ID





NO:





2861





THUMPD1
ADXCRAD_AL134904_at
CAGCTTGTGTAACAACCGATTCTTACCAAATACAAATAAATATAAAAGACAACTTAAAAACA
SEQ ID




AACTGTATAATCAAAATCTTTCCGTAAAATAGCAGCTTTCACAAAGTAAAAACAATTTAGTT
NO:




CCACAGAGTTGTATGCTCTGTAGGCATATGGCCAATTTTCTTCCGAGTCCTT
2878





THUMPD1
ADXCRAD_AL134904_x_at
CAGGTTACAACCGAACACAGGATTTTGTAACTGGGAAAGAACAGCTTGTGTAACAACCGATT
SEQ ID




CTTACCAAATACAAATAAATATAAAAGACAACTTAAAAACAAACTGTATAATCAAAATCTTT
NO:




CCGTAAAATAGCAGCTTTCACAAAGTAAAAACAATTTAGTTCCACAGAGTTGTATGCTCTGT
2879




AGGCATATGGCCAATTTTCTTCCGAGTCCTTTTGTCTTGCACTATCAA





CALML4
ADXCRAD_AW025529_at
ACCGCAGGTCGGACGCCATGACGTAACCTTTCTTCTCCTTGTCCACCATCAACATGGCTAGA
SEQ ID




AGAATTTCTTTCTTTGGGTCTTCTTGTTTTATTTGCATGTGCATAATGGTCAGAAAAGTGGA
NO:




GAAATCCAGCTCTCCATTTCCGTCTATCCCGTGGGTCTGCAGGTGCCGCTGCACCTCCCCTG
2902




GCGTTGGGCTGGCCCCCAGGCACCTCATGGCCACCATGAGGTCGGGGGCTTTATCTTCCCCC




TCTGCTGCTGTCATACAAGGAGAAGCATTTCTTGTCTCATTAATTT
















TABLE 12







Genes and corresponding Almac probesets predicting resistance to oxaliplatin. There can be


multiple Almac IDs/probesets associated with a given gene.











Almac

SEQ ID


Gene
Probe ID
Probe Sequence
NO





ACTB
AFFX-
TGATATCGCCGCGCTCGTCGTCGACAACGGCTCCGGCATGTGCAAGGCCGGCTTCGCGGG
SEQ ID



HSAC07/X00351_5_at
CGACGATGCCCCCCGGGCCGTCTTCCCCTCCATCGTGGGGCGCCCCAGGCACCAGGGCGT
NO:




GATGGTGGGCATGGGTCAGAAGGATTCCTATGTGGGCGACGAGGCCCAGAGCAAGAGAGG
827




CATCCTCACCCTGAAGTACCCCATCGAGCACGGCATCGTCACCAACTGGGACGACATGGA




GAAAATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGGCTCCCGAGGAGCACCCCGT




GCTGCTGACCGAGGCCCCCCTGAACCCCAAGGCCAACCGCGAGAAGATGACCCAGATCAT




GTTTGAGACCTTCAACACCCCAGCCATGTACGTTGCTATCCAGGCTGTGCTATCCCTGTA




CGCCTCTGGCCGTACCACTGGCATCGTGATGGACTCCGGTGACGGGGTCACCCACACTGT




GCCCATCTACGAGGGGTATGCCCTCCCCCATGCCATCCTGCGTCTGGACCTGGCT





ACTB
AFFX-
ACCACGGCCGAGCGGGAAATCGTGCGTGACATTAAGGAGAAGCTGTGCTACGTCGCCCTG
SEQ ID



HSAC07/X00351_M_at
GACTTCGAGCAAGAGATGGCCACGGCTGCTTCCAGCTCCTCCCTGGAGAAGAGCTACGAG
NO:




CTGCCTGACGGCCAGGTCATCACCATTGGCAATGAGCGGTTCCGCTGCCCTGAGGCACTC
828




TTCCAGCCTTCCTTCCTGGGCATGGAGTCCTGTGGCATCCACGAAACTACCTTCAACTCC




ATCATGAAGTGTGACGTGGACATCCGCAAAGACCTGTACGCCAACACAGTGCTGTCTGGC




GGCACCACCATGTACCCTGGCATTGCCGACAGGATGCAGAAGGAGATCACTGCCCTGGCA




CCCAGCACAATGAAGATCAAGATCATTGCTCCTCCTGAGCGCAAGTACTCCGTGTGGATC




GGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAG




TATGACGAGTCCGGCCCCTCCATCGTCCACCGCAAATGCTTCTAGGCGG





ACTB
AFFX-
TCTTGACAAAACCTAACTTGCGCAGAAAACAAGATGAGATTGGCATGGCTTTATTTGTTT
SEQ ID



HSAC07/X00351_3_at
TTTTTGTTTTGTTTTGGTTTTTTTTTTTTTTTTGGCTTGACTCAGGATTTAAAAACTGGA
NO:




ACGGTGAAGGTGACAGCAGTCGGTTGGAGCGAGCATCCCCCAAAGTTCACAATGTGGCCG
829




AGGACTTTGATTGCACATTGTTGTTTTTTTAATAGTCATTCCAAATATGAGATGCATTGT




TACAGGAAGTCCCTTGCCATCCTAAAAGCCACCCCACTTCTCTCTAAGGAGAATGGCCCA




GTCCTCTCCCAAGTCCACACAGGGGAGGTGATAGCATTGCTTTCGTGTAAATTATGTAAT




GCAAAATTTTTTTAATCTTCGCCTTAATACTTTTTTATTTTGTTTTATTTTGAATGATGA




GCCTTCGTGCCCCCCCTTCCCCCTTTTTGTCCCCCAACTTGAGATGTATGAAGGCTTTTG




GTCTCCCTGGGAGTGGGTGGAGGCAGCCAGGGCTTACCTGTACACTGACTTGAGACCA





CRIM1
ADXCRAG_AC007401_at
GGGCAGAAAAGCCATGTCGCCATTTACTTGACACCTTTCAGTGCCACACACACCCTTCTG
SEQ ID




CCCCTCCCCTGCCTAGTCCAGGGCTTCACACTGAGCCTTCCTATGACAATAGGGGCCGAA
NO:




CTGCCACTGGTTTCTGAGGCCTCAGTGTAAAGGGCAAATGCGACACCAATTCCAACAAAC
842




CTGTAAATGTCAATGGCTAAGTAGTAAAAGTTTCTGCAGAGGCCCCAGAGCTGGGATTGA




TTCAGTTCCACCTCAGGTTTTTTCCTGAGTGAGAGGGAGAGACGTAACTTTGGAAT





RRBP1
ADXCRAG_AF006751_s_at
AGAAGAAGTTAACAAGTGACCTGGGGCGCGCCGCCACGAGACTGCAGGAGCTTCTGAAGA
SEQ ID




CGACCCAGGAGCAGCTGGCAAGGGAGAAGGACACGGTGAAGAAGCTGCAGGAACAGCTGG
NO:




AAAAGGCAGAGGACGGCAGCAGCTCAAAGGAGGGCACCTCTGT
843





CDC14B
ADXCRAG_AF023158_s_at
CATTGACGTGGCCTGCGATCTCAGTGACAATGATCTGCTTTCTGGATCTCACTGTTGCCT
SEQ ID




TTGGTTAGGGAACACAGAGTGCTTCTCCCGCAGCCCTACTGGAACACAGCAGAGTCTGTG
NO:




CCATGAAGCAGTTACAGAAACAGAATTGAT
845





SVIL
ADXCRAD_CA396083_s_at
GAAGCTTGAGATCTATCTCACCGACGAAGACTTCGAGTTTGCACTAGACATGACGAGGGA
SEQ ID




TGAATACAACGCCCTGCCCGCCTGGAAGCAGGTGAACCTGAAGAAAGCAAAAGGCCTGTT
NO:




CTGAGTGGGGAGACGCCAGAGGAGCCTCACGGTCACGTCCAACAACACCACTGCACCAGG
846




GAAATGGATAT





CDC14B
ADXCRAG_AF064104_at
GTGTGTCAGATGGAGAGATCCCCTTAACCTAAGAGCCTTAAATAGCCCTGAAAGTACACT
SEQ ID




GGGACGGTTTGCGATGGAATTAAAATTGGAAGTGAATATTTTTAGGTGCTCTTGAAGCTT
NO:




TCTGGGGACTCAAAATTATCAAAAGTCAGGGACAGTCCGGAGGAAGAGCGTCTGCAAAAC
847




TGGGTTCCTAGAAGTATAGACGGACTTAGCTTTTTGTAGAATTTGGTGAGGAGCAGCGCC




TCGTGAGAGCAGAATGGCCTGGCGTGGCCAGTGCTTC





CDC14B
ADXCRAG_AF064105_at
AATTTCTTGGTCTCCGAAAACTCAGCTGTGACTGCTTTCCATTAACAGTTCCAGCTCTAT
SEQ ID




GTGTTTCCTCTAACGCTAAAGGCACAGCCCCCGGGAATCTACTGCTTCCTAAGAGTCTCC
NO:




ATGGAGTCTATTTTACAACCTCCTTTCCCTCCATGCTTCCGCGGAGGAGTCTATACTATC
848




TCTATAT





LOXL2
ADXCRAG_AF117949_s_at
GAAACTTGTCAGAAGGCATAGGAGTTGTGCGAGGGCTGGATGGGAAGTCTAGATTTAAAC
SEQ ID




AGCCACCAGGCAGCTTATCAAAGCAAGAGGGCATCCGTTCACAGGACAGGGGCTCCCAGC
NO:




AATTCCCAGTGGCAGTGGGGGGTGGCTGGCCCAAGCCCCAAGTCACCCAGACACAGGGGA
858




CTTCCCCTTGTGTCAACAGCATGCTAGGGCCCAGCAAACTAGAGGGTAGGTAGGACCACC




TTGGCACCAA





FOXN3
ADXCRAG_AF138861_s_at
GGTTCATTTTAGTTTCAGATAGATGGCTTCACCAAAGAACTCTTGAAAGAATACTGATTA
SEQ ID




GGGAGGGGCAGGGAAGTAGGAGCTTATGGTATATTATAAGGCTGGGAAAAATCTATGATG
NO:




CAAACCCTTTCCACATAGTACT
865





YPEL5
ADXCRAD_CD103546_s_at
GACTTCTGAGTACAGTTAAGTTCCTCCTATTTGCCACTGGGCTGTTGGTTAGAAGCATAG
SEQ ID




GTAACTGATTAAGTAGGTATGATACTGCATTTGAAATAAGTGGACACAAACTATCCTTTC
NO:




TCCACCATGGACTCAATCTGAGAACAACAGCATTCATTTCCATTCATTTCCATACTGGCT
868




TTTGATTATATGCAGATTCCTAGTAGCATGCCTTACCTACAGCACTATGTGCATTTGCTG




TCACAATAAAGTA





CRIM1
ADXCRAG_AF168681_x_at
ACTAATGATAATCCATCTCCCTTCGCTGACTCTCTTTTCGGACTCAGCCCGCCTGCATCC
SEQ ID




AGGTGAAATAAACAGCCGTGTTGCTCACACAAAGCCTGTTTGGTGGTCTCTTCACACGGA
NO:




CGCACATGAAATTTGGTGCCGTGACTCGGATCGGGGGACCTCCCTTGGGAGATCAATCCC
869




CCTGTCCTCCTGCTCTTTGCTCCATGAGAAAGATCCACCTACGACCTCAGGTCCTCAGAC




CGACCAGCCCAAAAAACAT





DKK1
ADXCRAG_AF177394_s_at
GTTATCTTGACTGACAAATATTCTATATTGAACTGAAGTAAATCATTTCAGCTTATAGTT
SEQ ID




CTTAAAAGCATAACCCTTTACCCCATTTAATTCTAGAGTCTAGAACGCAAGGATCTCTTG
NO:




GAATGACAAATGATAGGTACCTAAAATGTAACATGAAAATACTAGCTTATTTTCTGAAAT
870




GTACTATCTTAATGCTTAAATTATATTTCCCTTTAGGCTGTGATAGTTTTTG





MAP7D1
ADXCRPD.6828.C1_s_at
TTGCCTTGATTTGGTGGGGTACAGTGGATGTGAATACTGTAAATAGCTTGTGCTCAGACT
SEQ ID




CCTCTGCGTGGAGAGGGTGGGTGCAGGAGGCAGACCCTCCCCCCAAAGCCCCCTGGGGAG
NO:




ATCTTCCTCTCTCTATTTAACTGTAACTGAGGG
871





CAV2
ADXCRAG_AF260225_at
GAAAATAGCAATGTGCTGCTCTAAGCATTAGAGGTTCCCAAGTCTGCGCTTCAGAATGGG
SEQ ID




ATTATCTGGGAAACCTGGTAGAGAAGACAGTTTGTTTTTCTTTTTAAAAAGTGTTGAGCT
NO:




GTGGTTTAGGGTATTAAATAATAAAAACTCATCTCTATTTTCCATATCCACATATTTATA
874




ATATTTTACTCTTTATGGGCAAAAATTTATTCTTTCAAACCACCCCCTACTATGCCTCAA




CATGTCTATTACATTAAAATTATCTCATATGTAGAGCAAG





SYNJ2
ADXCRAG_AF318616_s_at
CTTGCAGTGCTGGAAATAGATCTCATTTTTAGGTTTTCTCTTCGTTCCAGATACCAAATA
SEQ ID




AATGGGACAGAGAATAAAATTTTTGTTAAAATATGTGCTCATCTCCTAAGTAGCTCTTCA
NO:




GAGTCTGACCGTAAGTAAAAACACACAGAATTGTGTTGACTGGGGGAGGTGAATCACAAA
875




AAAGTTACGAGGAGTTTAAGAGTTAAATATTATTTGATCGTGGCTGTCAAATTTAGTGAA




C





PPAP2B
ADXCRAG_AF480883_at
GCTCGTAACACAACTCTCATCTCAGGCTCTTCTAAAGAGCTTTTGTATTCTAAAGAGGAT
SEQ ID




TTTTCCATCAGAGAGGTAGGAGCTGTAGGAACCCCGAGGGCAGATAAGCAGCCCTCACTC
NO:




TAGATAAGGTATGCTGGGGGAGCTTACTGAGGGAATCCTGTACACAGCCCACATCAAAGG
878




AAGGCTGAGAATGGCCTGTGGCTCC





TXNRD1
ADXCRAG_AJ001050_s_at
CAAGTCCACCAGTCTCTGAAATTAGAACAGTAGGCACGGTATGAGATAATCAGGCCTAAT
SEQ ID




CATGTTGTGATTCTCTTTTCTTAGTGGAGTGGAATGTTCTATCCCCACAAGAAGGATTAT
NO:




ATCTTATAGACTTGTCTTGTTCAGATTCTGTATTTACCCATTTTATTGAAACATATACTA
880




AGTTCCATGTAT





COL6A2
ADXCRAD_CV571242_s_at
GAGTCGGCGCACTCCATGCGCAAGCAGAACGTGGTACCCACCGTGCTGGCCTTGGGCAGC
SEQ ID




GACGTGGACATGGACGTGCTCACCACGCTCAGCCTGGGTGACCGCGCCGCCGTGTTCCAC
NO:




GAGAAGGACTATGACAGCCTGGCGCAACCCGGCTTCTTCGACCGCTTCATCCGCTGGATC
887




TGCTAGCGCCGCCGCCCGGGCCCCGCAGTCGAGGGTCGTGAGCCCACCCCGTCCATGGTG




CTAAGCGGGCCCGGGT





PRSS23
ADXCRAG_AL832007_at
AAAATAGGCAACCAGAAGCCTTCTGTCAGTGGAGTAGCCATTC
SEQ ID





NO:





891





PRSS23
ADXCRAG_AL832007_x_at
AGAAGCCAGCTGAAGCCCACCAAAACCAAGATGGCCATGAGAGTGACCTCTGGTTGTCCT
SEQ ID




CACTGCTACACTCCCACCAGCACCATGACAGTTTACAGATGCCATGGCAATGTCAGGAAG
NO:




TTACCCTATATGGTCTAAAAGGGGAGGCATGAATAATCCACCCCTTGTTTAGCATATAAT
892




CAAGAAATAACCATAAAAATAGGCAACCAGAAGCCTTCTGTCAGTGGAGTAGCCATTCT





WDR1
ADXCRAG_AL832280_at
ATTAGTTCCCCACGGAGAAGGGATGGATAGTCTGTGCTTCGGGGGTCTAAGGAAGGCTTC
SEQ ID




CTGCAGGTGCTGGTACCTCCTTAGGTCTGGGGTGGTTCCTTCTAAGTTTCCTTACCCTGC
NO:




CTGCATCACCTCTGCCTCTTATGACCTCTGTGCAAAGACTGGGAAGGGTCACCCCCAATG
894




GCTGTGAACGAACCTGTTTGTGATTCTAAACAGGGCACGGGACCATCCTACAATAAAAAT




TACCCAGCCTAAAATGCCAGTAGTGCCAGTAGTCCCTGTTTAGAA





CAST
ADXCRAD_BE538471_s_at
AAATATCTTCGAGACTTGGGTGTTTGTTAATAACTAATAACTGGAGTAAGCTACAGGATC
SEQ ID




TAAAGCAGCCCTTTTTACAGTCTAGTTAGGAGAGAGAAAATAATTGCAAATATCCACTTA
NO:




GAGGCAAAGAAC





895





FLNB
ADXCRAG_AL833551_at
GTCAGGGACGTTGCCTGGGCCCAAATGTGTAGTGTGGTCTGGGCAGGCAGACCTTTAGGT
SEQ ID




TTTGCTGCTTAGTCCTGAGGAAGTGGCCACTCTTGTGGCAGGTGTAGTATCTGGGGCGAG
NO:




TGTTGGGGGTAAAAGCCCACCCTACAGAAAGTGGAACAGCCCGGAGCCTGATGTGAAAGG
900




ACCACGGGTGTTGTAAGCTGGGACACGGAAGCCAAACTGGAATCAAACGCCGACTGTAAA




TTGTATCTT





PLAUR
ADXCRAG_AY194849_at
AAATGCAAGCTTCCAGATCACACACTGAACACTAACCTTCTAGTCTTCTCCTAAACTTCA
SEQ ID




AAGGTTGCAACTATTTTGTTGTTCTAAGGAGACATCCCCACATTTCCCAGCATGCTTTGG
NO:




GAAAGGAGACGGATAGAAGATAACCTGATGGCCAGAACTCCCTGCATGCACTGCAGTGAG
903




GAATAAGGACAGGAGTGCACTTCCCCTGATGTGCTGGGGACCGGGGATAAAGGCTGGGCT




CTATTTCCCGGGATGCCTCAGGACTGTCAGAAAAAGAGACAGAACTACCATTTCAATGGC





RYBP
ADXCRAG_AY228125_s_at
TTGTGAAAACTATGAATCAGGGTATGAAATTCAAAACCTCCACCTGCCCATGCTGCTTGC
SEQ ID




ATCCCTGGAGAATCTTCTGTGGACATCGACCTCTTAGTGATGCTGCCAGGATAATTTCTG
NO:




CTTGCCATGGGCATCTGGCCACCAAGGAATTTCGCACCCTGACGATTACTCTTGACACTT
904




TTATGTATTCCATTGTTTTATATGATTTTCCTAACAATC





NFIB
ADXCRAG_BC001283_s_at
CATGATAAGCTAGTTTTATTGGTTTAGTATTCTTGTTGTTTACGCATGGAATCACTATTC
SEQ ID




CTGGTTATCTCACCAACGAAGGCTAGGAGGCGGCGTCAGAGGTGCTGGGTGACAGAGCCA
NO:




TGAGCCAGCCATTTTATAAGCACTCTGATTTCTAAAAGTTAAAAAAAATATATGAAATCT
913




CTGTAGCCTTTAGTTATCAGTACAGATTTATTAAATTTCGGCCCTTAACCCAGCCTTTTC




CAGTGTGTAACCCAGTTTGA





TPM4
ADXCRPD.6315.C1_s_at
ATGGCACCAGCTTTTTCAGCTCTCTTATTTTTTCCTTAAGTAGCATTTATTCCTAAGGTA
SEQ ID




GGCAGGGTATTTCCTAGTAAGCATACTTTCTTAAGACGGAGGCCATTTGGTTCCTGGGAG
NO:




AATAGGCAGCCCCACACTTTGAAGAATACAGACCCCAGTATCTAGTCGTGGATATAATTA
917




AAACGCTGAAGACCATAACCTTTTGGGTCAACTGTTGGTCAAACTATAG





FKBP9
ADXCRAD_CD251162_s_at
GCAGAGGCCAGCTGCCGCAAGACAGCAATGACAGTCCACCTGCCGACCTGATTCCTGCAT
SEQ ID




CATGGAATAACCACATGGCTACCTTCTATCCTCTGTTCCCAAATGGTGGTGGCACTTATC
NO:




CTGAAGTCGTCAATGATTTCCCTTTGAAACTACTTTATTTTACTAATTTAAACTATTTTG
923




TACTGATGTAGCCCTGAGGTAGTTCATGAAAATGCTGTGCACTCATTCCATGGAATAAAT




GTTGGAAAGCTGATCTTTTCTGATATAA





ITGA5
ADXCRAD_W52075_s_at
GGAGGCCCAGTTCACCCTGATTTAGGAGAAGCCAGGAATTTCCCAGGACCCTGAAGGGGC
SEQ ID




CATGATGGCAACAGATCTGGAACCTCAGCCTGGCCAGACACAGGCCCTCCCTGTTCCCCA
NO:




GAGAAAGGGGAGCCCACTGTCCTGGGCCTGCAGAATTTGGGTTCTGCCTGCCAGCTGCAC
926




TGATGCTGCCCCTCATCTCTCTGCCCAACCCTTCCCNCACCTTGGCACCAGACACCCAGG




ACTTATTTAA





MVP
ADXCRAG_BC008932_s_at
GAGATGCAGGTAAAACTGCTCCAGTCCCTGGGCCTGAAATCAACCCTCATCACCGATGGC
SEQ ID




TCCACTCCCATCAACCTCTTCAACACAGCCTTTGGGCTGCTGGGGATGGGGCCCGAGGGT
NO:




CAGCCCCTGGGCAGAAGGGTGGCCAGTGGGCCCAGCCCTGGGGAGGGGATATCCCCCCAG
927




TCTGCTCAGGCCCCTCAAGCTCCTGGAGACAACCACGTGGTGCCTGTACTGCGCTAACTC




CTGATTAATACAATG





RRBP1
ADXCRAG_BC009700_x_at
ACTCAGAATCAAAGCAAAAAGGCTGAAGGAGCCCCAAACCAGGGCAGAAAGGCAGAGGGA
SEQ ID




ACCCCAAACCAGGGCAAAAAGACAGAGGGAACCCCAAACCAAGGGAAAAAGGCAGAGGGA
NO:




ACCCCAAACCAAGGCAAAAAGGCAGAAGGAACCCCAAACCAAGGCAAAAAGGCGGAGGGG
928




GCCCAGAACCAGGGTAAAAAGGTAGATACAACCCCAAACCAGGGGAAAAAGGTGGAGGGG




GCCCCAACCCAGGGCAGAAAGGCCGAGGGGGCTCAGAACCAGGCCAAAA





AMOTL2
ADXCRAG_BC011454_s_at
TCAGCCCCAGGAGCTATTGGTGGGTTTTAGCAGTTTTGTCTTTACCGTTTTTAGTTCTCC
SEQ ID




TTGATTCTTTGTTTTCTTCCTTTATCGTTTTTAGGTTTGGTATGTGTTGTTTTATTTCCA
NO:




TGGTTCCTCAAGTTTCCTTTTTAAACATTTGCATTTGCTGGACAATTGCAATTTTTTTTA
930





RNH1
ADXCRAG_BC011500_s_at
GCCATGCTCTCACCCTGCATATCCTAGGTTTGAAGAGAAACGCTCAGATCCGCTTATTTC
SEQ ID




TGCCAG
NO:





931





ACTN1
ADXCRAG_BC011987_s_at
GGAAAGATTAACTATTTGCACCGAAATGTCTTGTTTTGTTGCGACATAGGAAAATAACCA
SEQ ID




AGCACAAAGTTATATTCCATCCTTTTTACTGATTTTTTTTTCTTCTATCTGTTCCATCTG
NO:




CTGTATTCATTTCTCCAATCTCATGTCCATTTTGGTGTGGGAGTCGGGGTAGGGGGTACT
934




CTTGTCAAAAGGCACATTGGTGCATGTGTGTTTGCTAGCTCACTTGTCCATGAAAATATT




T





CYP1B1
ADXCRAG_BC012049_s_at
TTCAGGAAAATAACTTAGACTCTAGTATTTATGGGTGGATTTATCCTTTTGCCTTCTGGT
SEQ ID




ATACTTCCTTACTTTTAAGGATAAATCATAAAGTCAGTTGCTCAAAAAGAAATCAATAGT
NO:




TGAATTAGTGAGTATAGTGGGGTTCCATGAGTTATCATGAATTTTAAAGTATGCATTATT
935




AAATTGTAAAACTCCAAGGTGATGTTGTACCTC





TMBIM1
ADXCRAG_BC013428_at
GGTCCTAAGAGGAAGGTGACTTCTCTCTGTTTGTCTTAAGTTGCACTGGGGGATTTCTGA
SEQ ID




CTTGAGGCCCATCTCTCCAGCCAGCCACTGCCTTCTTTGTAATATTAAGTGCCTTGAGCT
NO:




GGAATGGGGAAGGGGGACAAGGGTCAGTCTGTCGGGTGGGGGCAGAAATCAAATCAGCCC
937




AAGGATATAGTTAGGATTAATTACTTAATAGAGAAATCCTAACTATATCACACAAAGGGA




TACAACTATAAA





MAPK1
ADXCRAD_CF143752_s_at
TAAGGTGCCATGGAACAGGCTGTTCCCAAATGCTGACTCCAAAGCTCTGGACTTATTGGA
SEQ ID




CAAAATGTTGACATTCAACCCACACAAGAGGATTGAAGTAGAACAGGCTCTGGCCCACCC
NO:




ATATCTGGAGCAGTATTACGACCCGAGTGACGAGCCCATCGCCGAAGCACCATTCAAGTT
943




CGACATGGAAT





PLAUR
ADXCRAG_BC019258_x_at
CAAGTGATCTGTACATCTCAGCTACTCAGGAGGTTGAGTCAGGGGAACCTCTTGAACCC
SEQ ID





NO:





946





ADAM9
ADXCRAG_BC027996_s_at
TGGCTTTTGTTGGTTGTTGGATTGACTGTGATTTAAAATGTTAAAGATGATATAATGCAT
SEQ ID




CTTGTTCTGCTTCTAGGCTGAAAGGTCACTGAGGCAGAGCTGTTTGTACCTTGTATCCCC
NO:




TGGAATTTTGCCTAAACATTTGTGTACTCATAGGGTGGTAGGAGATAGTCCGCAGATGGT
952




CTAAAGAATGCCATGTGATACTGTGAGATGCCAAT





VIM
ADXCRAD_AL046837_s_at
TTTTAAACTTGGCTGTATTGTGTACAACTATTATACCATCTTTTATAAACACAGTTTTTT
SEQ ID




AAGAAATTTCTTTTTGTAAGTTACAACATTCCACTGGATCCTTATATTGCCTGTAGTGGA
NO:




AGAGGGTCTTGTGTGTCTGCCCCTTCTAGTTTTCACTCATGCAGAAGCAACATAACCTTC
953




TGATTTGCACAATAAATNACATATATTTAGCAGGATTTTTATTTGCCGTGATATATAGGA




TAATTTAGTCTTTGGCATGTGGC





TPBG
ADXCRAG_BC037161_s_at
TATTCTCATGTACCTAAGTTGTGGAGAAAATAATTGCATCCTATAAACTGCCTGCAGACG
SEQ ID




TTAGCAGGCTCTTCAAAATAACTCCATGGTGCACAGGAGCACCTGCATCCAAGAGCATGC
NO:




TTACATTTTACTGTTCTGCATATTACAAAAAATAACTTGCAACTTCATAACTTCTTTGAC
958




AAAGTAAATTACTTTTTTGATTGCAGTTTATATGAAAATGTACTGATTTTTTTTTAATAA




ACTGCATCGAGATCCAACCGACTGAATTGTTAA





FNDC3B
ADXCRAG_BC039297_s_at
AACACAGACTACAGGTTCCGCGTATGTGCGTGTCGTCGCTGTTTAGACACCTCTCAGGAG
SEQ ID




CTAAGCGGAGCCTTCAGCCCCTCTGCGGCTTTTGTATTACAACGAAGTGAGGTCATGCTT
NO:




ACAGGGGACATGGGGAGCTTAGATGATCCCAAAATGAAGAGCATGATGCCTACTGATGAA
961




CAGTTTGCAGCCATCATTGTGCTTGGCTTTGCAACTTTGTCCATTTTATTTGCCTTTATA




TTACAGTACTTCTTA





GALNT2
ADXCRAG_BC041120_s_at
AGAGCCCTTCGAGCAAAGCGTGCCGAAGTTAGTTGTCTTCTCTGTGGTGGTCCTTTCTTA
SEQ ID




TGTCCTCATAAAAGCTCAGATGATGGTATCTGTGAGTATGTTTTGCAAATTCAAAATATA
NO:




GTTTGGTAATTTTTTTTTCCAGTTGATTTTTAAAAAGAACTGCTGTACAGAGCTTGT
964





ALCAM
ADXCRAG_BC041127_s_at
TTGGAATAATTATAGTCACTATGACAAAATTACTTTGCCTAATGATAGCATATAGTTAAT
SEQ ID




GTTACTGTGCAAATAACTGTGCAAATGAATGACTTGAGAAGT
NO:





965





MAP1B
ADXCRAG_BC046114_s_at
TTCAGTGACTGAAAAGGAGGTTCCCAGCAAAGAAGAGCCATCTCCAGTGAAAGCCGAGGT
SEQ ID




GGCTGAGAAGCAAGCCACAGATGTCAAACCCAAAGCTGCCAAGGAGAAGACGGTGAAAAA
NO:




GGAAACAAAGGTAAAGCCTGAAGACA
967





AMIGO2
ADXCRAG_BC047595_s_at
GTGTCAATACCAAAATGTCTGAGTAACTTCTTAAATCCCTGTTCTAGCAAACTAATATTG
SEQ ID




GTTCATGTGCTTGTGTATATGTAAATCTTAAATTATGTGAACTATTAAATAGACCCTACT
NO:




GTACTGTGCTTTGGACATTTGAATTAATGTAAATATATGTAATCTGTGACTTGATATTTT
968




GTTTTATTTGGCTATTTAAAAACATAAATCTAAAATGTCTTATGTTATCAGATTATGCTA




TTTTGTATAAAGCACCACTGATAGCA





CDC42BPA
ADXCRAG_BC050335_x_at
GGGAAGATACTGCTTTAGCCTATCACTCCTTATTTTATTTTGTTTGGTTTTATGCCCTCA
SEQ ID




GTGTCTTAGGGAACTTTTTAAGAGATCCTCTGCTACCAAACAATGATGTGGATTCTTTTG
NO:




CACAGAAATATTTAAGGTGGGATGGTAAAAAATGTCACAAAAGACTCCTCACCAATACTT
971




TATGTTGATATCACTTAATATTAACCAGACTTTGCTGTATTGCAATA





MICALL1
ADXCRAG_BK000466_s_at
AGCTGGTGGGTTTTGCCCAAGAAAGGTCACGCGGCACATGCAGGGATTGGAACTCCCAGG
SEQ ID




CCAGGGCTCTAGGTCGCTCCCACCTTTTCATGTTTCTTTCTGTGGCCATGGGTATAGTGG
NO:




AAAGACATAAAGCTAAAGCCAACTTTTAATCCTGAATGCACTGCTTGCCAGGTAAATGCC
977




CTTGGTTGTGGTATCTTGTTGAGACTTAGTTTTCACAGAGGGATAATGAACCGTTGCAGA




GGTTTATTGAGATCATT





LPP
ADXCRAG_BX648297_s_at
GTAGGGTATGACTTGTGAGTCCACAAGGCCAGCAGTATATATGCTGAATGGACTGCTTAG
SEQ ID




CAGTAACACACTGGAAAAATCCAAAAAGAATGGATTTCAAGTTGGCAAAAAATGCATTAG
NO:




AAGTCAGCAGTGTGATGTGGTCAGGAGAACAACCAGAGTGACTGTGGGATGAGGTCTTGG
984




ATAGCTTTGTT





CDH11
ADXCRAG_D21254_s_at
TTGTTACTGCTGATTCTTGTAAATCTTTTTGCTTCTACTTTCATCTTAAACTAATACGTG
SEQ ID




CCAGATATAACTGTCTTGTTTCAGTGAGAGACGCCCTATTTCTATGTC
NO:





986





TRAM2
ADXCRAD_BM789115_s_at
TGGTGCCCTGAGCAACTGATAATGCAAATGTGGACAAAGTGTCTGTTTTCTACTCTAGCC
SEQ ID




TGTTCATATGGACCAAATTTCAACAAGGAACTCAAGGAAAATTTGTACCTGCCGTATTTA
NO:




TGCTTTCATGTAAAAAAGGGTTGGGGGGAGGGGTGTCTTTTTGCTTTTGGTGAACTTTTT
988




TTCAAAATCATTTTTCCACTGTTTCTGTCTGGTTTTAAAACAAATTACAGTTTTGTATGG




ATTTT





VCAN
ADXCRAG_D32039_s_at
GAAAATGCCAAGACCTTTGGAAAGATGAAACCTCGTTATGAAATCAACTCCCTGATTAGA
SEQ ID




TACCACTGCAAAGATGGTTTCATTCAACGTCACCTTCCAACTATCCGGTGCTTAGGAAAT
NO:




GGAAGATGGGCTATACCTAAAATTACCTGCATGAACCCATCTGCATACCAAAGGACTTAT
989




TC





DNAJB1
ADXCRAG_D85429_at
GTGTCTCACAAAAAAGTGTCAAGCTAAGAGTTGCTTTCCCTTCCCACTGAAACAGTTGAA
SEQ ID




GCGCTGAAAACAGGCTAGGGGCAGCCCTGCCAGTCCAGGAGAACTTTCTGCAATGACTAG
NO:




AACGTTCTATATACCGTTTACTTAAACATCTTACAAATTCAATAAAATTAGAATCAGTTC
990




CTCAGTCCTGCCACACTTCAGTTGCTTAGCAGCCACACATGTATGTGGCCAGTGGCAACT




GTTGGACAAGTCAAGT





MAP1B
ADXCRAG_L06237_at
AAGAGCCAAGTTCAAAGAACCCTAGCACAAATTTGCTTTGGGATT
SEQ ID





NO:





991





MAP1B
ADXCRAD_BX643299_s_at
GAAGTTCTGGCAAGATTGAAGTCTGATATTGCAGTAATGATATTTATTAAAAACCCATAA
SEQ ID




CTACCAGGAATAATGATACCTCCCACCCCTTGATTCCCATAACATAAAAGTGCTACTTGA
NO:




GAGTGGGGGAGAATGGCATGGTAGGCTACTTTTCAGGGCCTTGACAAGTACATCACCCAG
992




NGGTATCCTACATACTTCTTTCAAGA





JAK1
ADXCRAG_M64174_s_at
ATGAGCTGCTGACTTACTGTGATTCAGATTCTAGTCCCATGGCTTTGTTCCTGAAAATGA
SEQ ID




TAGGCCCAACCCATGGCCAGATGACAGTCACAAGACTTGTGAATACGTTAAAAGAAGGAA
NO:




AACGCCTGCCGTGCCCACCTAACTGTCCAGATGAGGTTTATCAGCTTATGAGAAAATGCT
996




GGGAATTCCAACCATCCAATCGGACAAGCTTTCAGAACCTTATTGA





AHNAK
ADXCRAG_M80899_s_at
TCTAGCAATGACAGTGGGAATAAGGTTGGCATCCAGCTTCCCGAGGTGGAGCTGTCAGTT
SEQ ID




TCCACAAAGAAAGAGTAGCAGGCCTTTGTATGTGTGTACATATATATATATATAACAAAA
NO:




CATCAGCCTTGGGTGGTGTGTTCCTATATAAACTCCAAAGGGAAACACACCGACTGCCTC
999




AGCAATCATGCAAAGA





KRT14
ADXCRAG_NG_002781_at
ACCAGGTCATATGTGGCGTCTCCTAGGGTACAGAGAGATATTCATTCATTTCCTCACTCA
SEQ ID




TTTTCATGTGTGTCCATTCATTCACCAGATATTGAGTGCCGCTATGTCAGGCACTATGTT
NO:




AGGTTAAGGATTCCTAATGTTTTTGTGATCAGGGATTCCTTGGAGAATATTGAAAGCTAT
1000




AGATCTTTCCTTCTGCCCCTACCTTCAAATAAGCA





COL5A2
ADXCRAD_CK824374_s_at
AATGATGGTGCTAAAATTCTTCCTATAAAATTCCTTAAAAATAAAGATGGTTTAATCACT
SEQ ID




ACCATTGTGAAAACATAACTGTTAGACTTCCCGTTTCTGAAAGAAAGAGCATCGTTCCAA
NO:




TGCTTGTTCACTGTTCCTCTGTCATACTGTATCTGGAATGCTTTGTAATACTTGCATGCT
1002




TCTTAGACCAGAACATGTAGGTCCCCTTGTGTCTC





CD59
ADXCRAD_BP396775_s_at
CCTCGTGGGTTTATTATTACCTCATAGGGACTTTGCCTCCTGACAGCAGTTTATGGGTGT
SEQ ID




TCATTGTGGCACTTGAGTTTTCTTGCATGCTTGTTAGAGAAACCAAGTTTGTCATCAACT
NO:




TCTTATTTAACCCCCTGGCTATAACTTCATGGATTATGTTATAATTAAGCCATCCAGAGT
1004




AAAATCTGTTTAGATTATCTTGGAGTAAGGGGGAAAAAATCTGTAATTTTTTCTCCTCAA




CTAG





PPIC
ADXCRAG_NM_000943_s_at
CCCTTCCTCAAGTGGTGCTATTTTAAAACTAAAAAAAACTTTGAATTGGCTATTTTTTTA
SEQ ID




ATGCAATATTTTTTTTCTGAATTCATTATGATCCCCATATTGGGTAATGCTGAACATTTA
NO:




TCTGAAACAGATGAGGATATTATTATTTTGTATCCAAACAGAAATTCAGATAAAGGGAAA
1006




TTTGACTAGTGTAATCTGAGATATGTCATAGGGATTTCTTTCTGACAAAAGGGTGCTTTG




CTGTTCTT





GRB10
ADXCRAG_NM_001001549_s_at
AAGCTGGCGGTAGATTTGTGATGTCACAGTGCAAACTGCAGTGACTGTAAATTGGCCTGG
SEQ ID




CGTGTATAAACGTTTTCAGGGAATGCAGAAGGTATTAATGAAGAGACAAAACCTTTATTC
NO:




CATGTGCTTTGCTTCATTCTGTACATAGCTCTTTGGCTCGTGAACCTAATTGTAAACTTT
1007




CAGGTATTTTTGTACAAATAAGGGACTGATGTTCTGTTTCTTGTAATT





CAV2
ADXCRAG_NM_001233_s_at
ATAAAACTGTTTGACTTCTCAAGTAACATGACTTCCTTATTTCTGAACAGTACTGGTTAC
SEQ ID




TTTCAAAATGAATTTTTATTGAGATTTTCCATTAACTATTTTTTTCAAAGACTCAAATTT
NO:




TGTACCAAGTAAATCCAGGCTTTATGTACAAACATGTTGTTTGTTTTATTTGGGGCTGGG
1009




GGAGGTATATGATGAGCAGACTTCTCGGAATTCATAATAA





BCL6
ADXCRAG_NM_001706_s_at
TTTTCAGTTTGTATATACCCGTACAACGTGTCCTCACGGTGCCTTTTTTCACGGAAGTTT
SEQ ID




TCAATGATGGGCGAGCGTGCACCATCCCTTTTTGAAGTGTAGGCAGACACAGGGACTTGA
NO:




AGTTGTTACTAACTAAACTCTCTTTGGGAATGTTTGTCTCATCCCATTCTGCGTCATGCT
1011




TGTGTTATAACTACTCCGGAGACAGGGTTTGGCTGTGTCTAAACTGCATTACCGCGTTGT




AAA





LOX
ADXCRAD_CV574618_s_at
TAGAAGGCAAAGCAAAACTCCCAATGGATAAATCAGTGCCTGGTGTTCTGAAGTGGGAAA
SEQ ID




AAATAGACTAACTTCAGTAGGATTTATGTATTTTGAAAAAGAGAACAGAAAACAACAAAA
NO:




GAATTTTTGTTTGGACTGTTTTCAATAACAAAGCACATAACTGGATTTTGAACGCTTAAG
1013




TCATCATTACTTGGGAAATTTTTAATGTTTATTATTTACATCACTTTGTGAATTAACACA




GTGTTTCAATTCTGTAATTACATATTTGACTCTT





LOXL2
ADXCRAG_NM_002318_s_at
CACCCCTTGTTTTTCAAGATACTATTATTATATTTTCACAGACTTTTGAAGCACAAATTT
SEQ ID




ATTGGCATTTAATATTGGACATCTGGGCCCTTGGAAGTACAAATCTAAGGAAAAACCAAC
NO:




CCACTGTGTAAGTGACTCATCTTCCTGTTGTTCCAATTCTGTGGGTTTTTGATTCAACGG
1014




TGCTATAACCAGGGTCCTGG





NT5E
ADXCRAG_NM_002526_at
CTTTGAACCACTTTGCAATTGTAGATTCCCAACAATAAAATTGAAGA
SEQ ID





NO:





1015





NT5E
ADXCRAG_NM_002526_s_at
GCAGCAAAATAATAGCCTCGGTTCTATGCATATATGGATTGCTATAAAAAATGTCAATAA
SEQ ID




GATTGTACAAGGAAAATTAGAGAAAGTCACATTTAGGGTTTATTTTTTACACTTGGCCAG
NO:




TAAAATAGGGTAAATCCTATTAGAAATTTTTTAAAGAACTTTTTTTAAGTTTCCTAAATC
1016




TGTGTGTGTATTGTGAAGTGGTATAAGAAATGACTTTGAACCACT





MAPK1
ADXCRAG_NM_002745_s_at
TTCTGTGCAGAGATGACTGTCCAAGTGCCACATGCCTACGATTGAAATGAAAACTCTATT
SEQ ID




GTTACCTCTGAGTTGTGTTCCACGGAAAATGCTATCCAGCAGATCATTTAGGAAAAATAA
NO:




TTCTATTTTTAGCTTTTCATTTCTCAGCTGTCCTTTTTTCTTGTTTGATTTTTGACAGCA
1017




ATGGAGAATGGGTTATATAAAGACTGCCTGCTAATATGAACAGAAA





PSMD2
ADXCRAD_CF130280_s_at
ACAGGGTTCCAGACGCATACAACCCCAGTGTTGTTGGCCCACGGGGAACGGGCAGAATTG
SEQ ID




GCCACTGAGGAGTTTCTTCCTGTTACCCCCATTCTGGAAGGTTTTGTTATCCTTCGGAAG
NO:




AACCCCAATTATGATCTCTAAGTGACCACCAGGGGCTCTGAACTGTAGCTGATGTTATCA
1018




GCAGGCCATGCATCCTGCTGCCAAGGGTGGACACGGCTGCAGACTTCTGGGGGAATTGTC




GCCTCCTGCTCTTTTGTTACTGAGTGAGA





VEGFA
ADXCRAG_NM_003376_at
ACGAAAGCGCAAGAAATCCCGGTATAAGTCCTGGAGCGTTCCCTGTGGGCCTT
SEQ ID





NO:





1022





VEGFA
ADXCRAD_AF091352_s_at
GCTGCTGCAATGACGAGGGCCTGGAGTGTGTGCCCACTGAGGAGTCCAACATCACCATGC
SEQ ID




AGATTATGCGGATCAAACCTCACCAAGGCCAGCACATAGGAGAGATGAGCTTCCTACAGC
NO:




ACAACAAATGT
1023





PPAP2B
ADXCRAD_CD678016_s_at
TAAACTGTGTCTCGACCTGTGTTATTTACATTAGCTGCTTAAAAAAGCATTGAGTTAATT
SEQ ID




TTTTTAAATATCAACTAAAATATCATAGTTCTGTGGTAGACATTGTTTTATAATGAAATA
NO:




ACTGCAACTAGAGAAAACTGTATAAAAACATTAAATTGTCAGTATTTTTGTAAGGTTCCA
1024




TTTTGTAAAGAGAATAATATTCAAAGACTTTTGTAGCATACAAAGTGAAAACTTGTATCT




GCGAAACTATACTTGTATTAAATGTGCTTTT





EGFR
ADXCRAD_BX378635_s_at
TCCTAATCTGTGTGTGCCCTGTAACCTGACTGGTTAACAGCAGTCCTTTGTAAACAGTGT
SEQ ID




TTTAAACTCTCCTAGTCAATATCCACCCCATCCAATTTATCAAGGAAGAAATGGTTCAGA
NO:




AAATATTTTCAGCCTACAGTTATGTTCAGTCACACACACATACAAAATGTTCCTTTTGCT
1026




TTTAAAGTAATTTTTGACTCCCAGATCAGTCAGAGCCCCTACAGCATTGTTAA





GATA6
ADXCRAG_NM_005257_at
ATGCTGTATGTGACTATAGATATTCATATAAAACAAGTGCACGTGAAGTTTGCAAAATGC
SEQ ID




TTTAAGGCCTTCCTTTCAAAGCATAGTCCTTTTGGAGCCGTTTTGTACCTTTTATACCTT
NO:




GGCTTATTTGAAGTTGACACATGGGGTTAGTTACTACTCTCCATGTGCATTGGG
1027





FOSL1
ADXCRAG_NM_005438_s_at
GTGCCACTTTACCCACCTAGAACACTAACTCACCAGCCCCACTGCCAGCAGCAGCAGGTG
SEQ ID




ATTGGACCAGGCCATTCTGCCGCCCCCTCCTGAACCGCACAGCTCAGGAGGCGCCCTTGG
NO:




CTTCTGTGATGAGCTGATCTGCGGATCTCAGCTTTGAGAAGCCTTCAGCTCCAGGGAATC
1028




CAAGCCTCCACAGCGAGGGCAGCTGCTATTTATTTTCCTAAAGAGAGTATTTTTATACAA




ACCTACCAAAATGGAATAAAAGGCTTGAAGCT





LPP
ADXCRAG_NM_005578_at
AAATAAGTCATGTGTCCCAGCATAAGGCATCAGGTTGTTAGATGCTGGCATCTCTGCAGC
SEQ ID




TCAAAGATGTGGGTTCTTTTTCTTGTCATTAACACATTGTTATTTCTGTAGGACCAACTT
NO:




CTCTGATCAAAATTACTTTTCTGGGTATGTGCTGATTAAGGGGGTGGACTTATCAACACT
1031




ATAATTGTTCCCTATGAAAGATTCCACAGAGATGTTTATGGTGA





BASP1
ADXCRAD_CN355199_s_at
GCGTTTGATTCTGCCCACAGGGCCTGTGCCAAGGCAATCAGATCTTTATGAGAGCAGTAT
SEQ ID




TTTCTGTGTTTTCTTTTTAATTTACAGCCTTTCTTATTTTGATATTTTTTTAATGTTGTG
NO:




GATGAATGCCAGCTTTCAGACAGAGCCCACTTAGCTTGTCCACATGGATCTCAATGCCAA
1034




TCCTCCATTCTTCCTCTCCAGATATTTTTGGGAGTGACAAACATTCTCTCATCCTACTTA




GCCTACCTAGATTTCTCATGACGAGTTAATGCATGTCCGTGGTTGGGTGCACCTGTA





CORO1C
ADXCRAG_NM_014325_s_at
GCAAGGGAAAGTTACCCTGATCTTAGTTTGTAGCTTATGACTTATTTAATGAATGGATGC
SEQ ID




CCAGCCAAGCTCAGAGTAGGCGCCCAAAGCATTGTGGATTATTTTCCTGTTTTGTCTTTT
NO:




TTTTTTTTTTTTTTTAAGCCATGACATCCCAGAAGAGGACAGTGAATTACTCCTAGGTCG
1041




GCTCTTATAGAGTGGCCATAGTGTTCTGTCAAAA





EHD2
ADXCRAD_BX369705_s_at
CTCCTTTTCAGGGATGTCGTGGGCGGGGGAGGGGGTTCTTGGTGCTACAGCCCTCTCCCC
SEQ ID




ACCCCTAAAGGGACGCCGACGCTGTTTGCTGCCTTCACCACATATTAGTGCTTGACCCTG
NO:




GCAGGGGACCCCATGGAAAAGATGGGGAAGAGCAAAATACATGGAGACGACGCACCCTCC
1043




AGGATGCTCGCTGGGATTCCCACGCCCACCACTGTCCCCCACCCCATGGCTGGGAGGGGC




CTCTGAACGGAACAGTGTCCCCACAGAGCGAATAAAGCCAAGGCTTCTTCCCA





HK1
ADXCRAG_NM_033497_s_at
GTGGGCATAGCATTAGCTGCTTCCTCCCCTCCTGGCACCCACTGTGGCCTGGCATCGCAT
SEQ ID




CGTGGTGTGTCAATGCCACAAAATCGTGTGTCCGTGGAACCAGTCCTAGCCGCGTGTGAC
NO:




AGTCTTGCATTCTGTTTGTCTCGTGGGGGGAGGTGGACAGTCCTGCGGAAATGTGTCTTG
1049




TCTTCCATTTGGATAAAAGGAACCAACCAACAAACAATGCCATCACTGGAATTTCCCACC




GCTTTGTGAGCCGTGTCGTATGACCTAGTAAACTTTGTACCA





COL6A2
ADXCRAG_NM_058175_s_at
TGGTGGCCACCGTGTCCCTTGCTGCGGCTGCATCTTCCAGTCTCTCCTCCGTCTTCCAGT
SEQ ID




GGCCGCTCTCTTTATAAGAACCCTGGTCATTGAATTTAAGGCCCACCCCAAGTCCAGAAT
NO:




GACCTCGCAAGACCC
1050





MALT1
ADXCRAG_NM_173844_s_at
ACATTATACTTCATGGTGATAGACTGAAGGCTGAATGTTTTCCCCTTAAGATTGGGAAGA
SEQ ID




AGGACAAGGATGTTCACTCGGCACTACTTCTATTCAGCATTGTACTTGAAGTTCTAGCCA
NO:




CAGCAGTTAGGTTAGGAATTCAAGGTTTGTTCAACA
1053





IL6ST
ADXCRAD_CN265168_s_at
AACAGTTGGCATGGAGGCTGCGACTGATGAAGGCATGCCTAAAAGTTACTTACCACAGAC
SEQ ID




TGTACGGCAAGGCGGCTACATGCCTCAGTGAAGGACTAGTAGTTCCTGCTACAACTTCAG
NO:




CAGTACCTATAAAGTAAAGCTAAAATGATTTTATCTGTGAATTCAGATTTTAAAAAGTCT
1054




TCACTCTCTGAAGATGATCATTTGCCCTTAAGGACAAAAATGAACTGAAGTTTCACATGA




GCTATTTCCATTCCAGAATATCTGGGATTCTACTTTAAGCACTA





PLOD2
ADXCRAD_BF971357_s_at
AACAAAGTTGTTGAGCCTTGCTTCTTCCGTTTTGCCCTTTGTCTCGCTCCTTATTCTTTT
SEQ ID




TATGGGGGGAGGGTTATTTGCTTTTTTATCTTCCTGGCATAATTTCCATTTTATTCTTCT
NO:




GAGTGTCTATGTTAACTTCCCTCTATCCCGCTTATAAAAAAATTCTCCAACAAAAATACT
1056




TGTTGACTTGATGTTTTATCACTTCTCTAAGTAAGGTTGA





EXT1
ADXCRAG_579639_s_at
CGACTTTGAGGAATCCGGCTGAGTGGGGGAGGGGAAGCAAGAAGGGATGGGGGTCAAGCT
SEQ ID




GCTCTCTCTTCCCAGTGCAGATCCACTCATCAGCAGAGCCAGATTGTGCCAACTATCCAA
NO:




AAACTTAGATGAGCAGAATGACAAAAAAAAAAAAGGCCAATGAGAACTCAACTCCTGGCT
1058




CCTGGGACTGCACCAGACTGCTCCAAACTCACCTCACTGGCTTCTGTGTCCCAAGACTAG




GTTG





CYP1B1
ADXCRAD_AV717387_s_at
TTTGTGTGTTTTTAGCTGTGACACAACTGTGTGATTAAAAGGTATACTTTAGTAGACATT
SEQ ID




TATAACTCAAGGATACCTTCTTATTTAATCTTTTCTTATTTTTGTACTTTATCATGAATG
NO:




CTTTTAGTGTGTGCATAATAGCTACAGTGCATAGTTGTAGACAAAGTACATTCTGGGGAA
1060




ACAACATTTATATGTAGCCTTTACTGTTTGATA





VCAN
ADXCRAD_CN312093_s_at
GGAGCCTTAGAGGTCTTTAATCATTGGTTCGGCTGCTTTTATGTAGTTTAGGCTGGAAAT
SEQ ID




GGTTTCACTTGCTCTTTGACTGTCAGCAAGACTGAAGATGGCTTTTCCTGGACAGCTAGA
NO:




AAACACAAAATCTTGTAGGTCATTGCACCTATCTCAGCCATAGGTGCAGTTTGCTTCTAC
1063




ATGATGCTAAAGGCTGCGAATGGGATCCTGATGGAACTAAGGACTCCAATGTCGAACTCT




TCTT





FOXN3
ADXCRAG_U68723_at
TTTTTCTGTCTATCAAAACTATTTGATCCAAGTGAAAAAAAAAAAAAAACTAGAAAGCTA
SEQ ID




CGGAACCTGCAATGCGGCCG
NO:





1072





FOXN3
ADXCRAD_CR735795_s_at
TGGACGTTGGACTGTTCATGCGCATCGGGTGTCAGTGACTCATGGAGAAGAAATGGGGTA
SEQ ID




AATTTTTAGTGATGTTGCTAATCATTGAATTCTGTTCTCTATTAAATTAAGAAAATGTTC
NO:




CAAAAGCCATAAGCCTGAAGATTGGCCCTGTGCACGCACGCACACACACACACACACACA
1073




CACACACACACACACACACGAAGGAGAGAGAGAGAAAACTGATGGGGAAAACAAGCTGTG




TCTTCTTAACTGCCCAAGTGAAAAGCAACCAAGTCCAGGAAATTACAATAGCTGTT





NFIB
ADXCRAG_U85193_at
GGGAATTCATGGATTATTAAGGTCCTTCAGGCCCTTG
SEQ ID





NO:





1076





NR3C1
ADXCRAG_X03348_s_at
AAAGTGTCTTTTTACCTACGCAGTGAAATGTCAGACTGTAAAACCTTGTGTGGAAATGTT
SEQ ID




TAACTTTTATTTTTTCATTTAAATTTGCTGTTCTGGTATTACCAAACCACACATTTGTAC
NO:




CGAATTGGCAGTAAATGTTAGCCATTTACAGCAATGCCAAATATGGAG
1078





COL4A2
ADXCRAG_X05562_at
CAAAGGCGAGGCTGGATTTTTCGGAATACCCGGTCTGAAGGGTCTGGCTGGTGAGCCAGG
SEQ ID




TTTTAAAGGCAGCCGAGGGGACCCTGGGCCCCCAGGACCACCTCCTGTCATCCTGCCAGG
NO:




AATGAAAGACATTAAAGGAGAGAAAGGAGATGAAGGGCCTATGGGGCTGAAAGGATACCT
1079




GGGCGCAAAAGGTATCCAAGGAATGCCAGGCATCCCAGGGCTGTCAGGAATCCCTGGGCT




GCCTGGGAGGCCCGGCCACATCAAAGGAGTCAAGGGAGACATCGGAGTCCCT





ZNF264
ADXCRAD_BP361385_s_at
TCCATTGGGTGGGTTCTTTTGTACACCTTCTGTTTCTTTGCTTATTTTTTAACGCCAAAG
SEQ ID




AAAGACTCTCAGAGAATAGACAACTATATTCCAAAGTCATGGTTCTCTGGTGGTTTGTCT
NO:




TGACATTTGAATAGAAATGTTAAACTATCTGGGGGAATAGAAAGCCCACAGTCTTCTGAG
1091




TTGTGCTACACCAATATTTCTATGAACAGATCTTACAACTGAGAGTGATCTGCAGATTTT




TCAGAGTCATGTTCTCCATGGAAATGTTTGTAAAATTCCCTAGCTCTCTG





MAP1B
ADXCRAD_AV721962_s_at
TCCAGCACTGGAAAGAAGTGGTCTTGAGCCCAGCTGAGAAGCACTTCACACTCCTCTCTC
SEQ ID




TTGTTCTGAATGGTGTTTGTGTCAGTCTGCAGCTGTGTATGGTATTATGTCTTA
NO:





1094





ALCAM
ADXCRAD_CB160126_s_at
ATTACCATCGATTCAGTGCCTGGATAAAGAGGAAAGCTTACTTGTTTAATGGCAGCCACA
SEQ ID




TGCACGAAGATGCTAAGAAGAAAAAGAATTCCAAATCCTCAACTTTTGAGGTTTCGGCTC
NO:




TCCAATTTAACTCTTTGGCAACAGGAAACAGGTTTTGCAAGTTCAAGGTTCACTCCCTAT
1095




ATGTGATTATAGGAATTGTTTGTGGAAATGGATTAACATACCCGTCTATGCCTAAAAGAT




AA





PYGL
ADXCRAG_Y15233_s_at
GTCTTTGCAGACTACGAAGCCTATGTCAAGTGTCAAGATAAAGTGAGTCAGCTGTACATG
SEQ ID




AATCCAAAGGCCTGGAACACAATGGTACTCAAAAACATAGCTGCCTCGGGGAAATTCTCC
NO:




AGTGACCGAACAATTAAAGAATATGCCCAAAACATCTGGAACGTGGAACCTTCAGATCTA
1096




AAGATTTCTCTATCCAATGAATCTAAC





PTPRK
ADXCRAG_Z70660_at
TATTGAGCCAGCAGCTGTTGTACCTGTTACACTTGTGCAGAAAGATTTTAATGTGGGGGG
SEQ ID




TGGGAGACTTTTACATTTGAGAGGTAAAAGTATTTTTTTTATGAAGTTGTGTATCTTAAT
NO:




AAAAAGAACTGAATTAGTTTTTATTACTATATTAAAGCATCAACATTTCATGCCACATAA
1097




AATTATATTTAATAAGAACCAGATTGAAATGAGAACGTATTGGTGTTTGTACAGTGAACA




TGCCACCTTTTTCCATGGTTTCAGGTAGTGCAGCTACCACATGTT





LMNA
ADXCRIH.3276.C1_s_at
CCCAGAACTGCAGCATCATGTAATCTGGGACCTGCCAGGCAGGGGTGGGGGTGGAGGCTT
SEQ ID




CCTGCGTCCTCCTCACCTCATGCCCACCCCCTGCCCTGCACGTCATGGGAGG
NO:





1099





CKAP4
ADXCRIH.293.C1_s_at
CTTGTCCCCTCTTAAAGAGCAGTTGTCACCACCTGAACACCAAGGCATTGTATTTTCATG
SEQ ID




CCCAGTTAACTTATTTACAATATTTAAGTTCTCTGCTTCTGCATTTGGTTGGTTTCCTGA
NO:




AGCGCAGCCCCTGTGAATAACAGGTGGCTTTTCATGGATGTCTCTAGTCAGAG
1103





CD44
ADXCRAD_CN347079_s_at
TCAACAGTCGAAGAAGGTGTGGGCAGAAGAAAAAGCTAGTGATCAACAGTGGCAATGGAG
SEQ ID




CTGTGGAGGACAGAAAGCCAAGTGGACTCAACGGAGAGGCCAGCAAGTCTCAGGAAATGG
NO:




TGCATTTGGTGAACAAGGAGTCGTCAGAAACTCCAGACCAGTTTATGACAGCTGATGAGA
1104




CAAGGAACCTGCAGA





AHNAK
ADXCRIH.2649.C1_s_at
GTGGTCCCAGCCAGTTTGGTGCTGACGGTGAGAGGAAATTAGAATCTGTTTGCAAATTGT
SEQ ID




CCAACCCACCCCCTCAACATGAGGGGCTTCCATTTTCTGTGTTTTGTAAGGGAACTGTTT
NO:




CCTTCATGCCGCCATGTTCCTGATATTAGTTCTGATTTCTTTTTAACAAATGTTATCATG
1106




ATTAAGAAAATTTCCAGCACTTTAATGGCCAATTAACT





RYBP
ADXCRIH.2682.C1_at
ACATCCCTCAGGCATGTATTCTGGAAATGGAATTCCTGTAACTTCCTGTGTCTGCAGTAT
SEQ ID




GCCCTACAATTAGTAGGCAGCGTGTAAAAACACTAGTGTAGATTATAAAGATATACATTA
NO:




AAAGAGGACCAGAAATACTTGGTATTCAGTGGCACAGAAAGCAGGTTAAACAAACAAAAA
1109




GCACAGTGTTACGCTTGCAAGTTTCCATTTGTTTTAATACCACGCAATCTTTCACACTCG




TGCGTGTGCGCGCACACAGAGCTTACCTGACTTGCTCTGCTTGAGTCATGCAG





MARCKS
ADXCRIH.653.C1_s_at
AGTGAATAGTCAAAAATCCTGTTAGCAAACTGTTATATATTGCTAAGTTTGTTCTTTTAA
SEQ ID




CAGCTGGAATTTATTAAGATGCATTATTTTGATTTTATTCACTGCCTAAAACACTTTGGG
NO:




TGGTATTGATGGAGTTGGTGGATTTTCCTCCAAGTGATTAAATGA
1112





RRAS2
ADXCRIH.3655.C1_at
TTCTTTGTCAGTTAAAAGTGAACAGTGAGAATTAAATACTTATCTTTACATATACACAAG
SEQ ID




GTATGCTATGAAAGCATATCTGCTTACAAACATATAAAAATACTTGTTAACTAGTTTGAT
NO:




AAGAAAATAATGTATAAAAGTATATAGCAAAAACATTAATCATCTCTGACCCTGGAAAGA
1113




TCAATTCCATATTTTATAT





TGFBR2
ADXCRIH.688.C1_s_at
AGTCCACGTTCACAAAATGTGAAGGTGTGGAGACACTTACAAAGCTGCCTCACTTCTCAC
SEQ ID




TGTAAACATTAGCTCTTTCCACTGCCTACCTGGACCCCAGTCTAGGAATTAAATCTGCAC
NO:




CTAACCAAGGTCCCTTGTAAGAAATGTCCATTCA
1115





SDC4
ADXCRIH.1351.C1_s_at
GATGGTGGGATATTTGTGTCTGTGTTCTTATAATATATTATTATTCTTCCTTGGTTCTAG
SEQ ID




AAAAATAGATAAATATATTTTTTTCAGGAAATAGTGTGGTGTTTCCAGTTTGATGTTGCT
NO:




GGGTGGTTGAGTGAGTGAATTTTCATGTGGCTGGGTGGGTT
1116





EPHA2
ADXCRIH.2345.C1_s_at
TGGCCCAGCGCCAAGTAAACAGGGTACCTCAAGCCCCATTTCCTCACACTAAGAGGGCAG
SEQ ID




ACTGTGAACTTGACTGGGTGAGACCCAAAGCGGTCCCTGTCCCTCTAGTGCCTTCTTTAG
NO:




ACCCTCGGGCCCCATCCTCATCCCTGACTGGCCAAACCCTTGCTTTCCTGGGCCTTTGCA
1120




AGATGCTTGGTTGTGTTGAGGTTTT





S100A11
ADXCRIH.305.C1_s_at
AACTGGACACCAACAGTGATGGTCAGCTAGATTTCTCAGAATTTCTTAATCTGATTGGTG
SEQ ID




GCCTAGCTATGGCTTGCCATGACTCCTTCCTCAAGGCTGTCCCTTCCCAGAAGCGGACCT
NO:




GAGGACCCCTTGGCCCTGGCCTTCAAACCCACCCCCTTTCCTTCCAGCCTTTCTGTCATC
1121




ATCTCCACAGCCCACCCATCCCCTGAGCACACTAACCACCTCATGCAGG





FLNB
ADXCRIH.1727.C1_s_at
GGGCCCATGGATTAACGCCCTCATCCCAAGGTCCGTCCCATGACATAACACTCCACACCC
SEQ ID




GCCCCAGCCAACTTCATGGGTCACTTTTTCTGGAAAATAATGATCTGTACAGACAGGACA
NO:




GAATGAAACTCCTGCGGCTCTTTGGCCTGAAAGTTGGGAATGGTTGGGGAGAGAAGGCAG
1127




CAGCTTATTGGTGGTCTTTTCACCATTGGCAGAAACAG





CRIM1
ADXCRAD_BG621095_s_at
AAAAAATTGTAGATGCTTGCTTTTTGTTTTTTCAATCATGGCCATATTATGAAAATACTA
SEQ ID




ACAGGATATAGGACAAGGTGTAAATTTTTTTATTATTATTTTAACAGATATGATTTATCC
NO:




TGAGTGCTGTATCTATTACTCTTTTACTTTGGTTCCTGTTGTGCTCTTGTAAAAAGAAAA
1128




ATATAAATTTCCTGAAGAATAAAATAGATATATGGCACTTGGAGTGCATCATAGTTCTAC




AGTTTGTTT





IGFBP3
ADXCRIH.1767.C1_s_at
GATGCTATATGATACAACTGTGGCCATGACTGAGGAAAGGAGCTCACGCCCAGAGACTGG
SEQ ID




GCTGCTCTCCCGGAGGCCAAACCCAAGAAGGTCTGGCAAAGTCAGGCTCAGGGAGACTCT
NO:




GCCCTGCTGCAGACCTCGGTGTGGACACACGCTGCATAGAGCTCTCCTTGAAAACAGAGG
1130




GGTCTCAAGACATTCTGCCTACCTATTAGCNNNNNNNNNNNNNNNNNNNNNNNNGGGGGG




AAAAGTATTTTTGAGAAGTTTGTCTTGCAATGTATTT





PDLIM7
ADXCRIH.3383.C1_s_at
ATGCACCCAGCTGTGCCAAGTGCAAGAAGAAGATTACAGGCGAGATCATGCACGCCCTGA
SEQ ID




AGATGACCTGGCACGTGCACTGCTTTACCTGTGCTGCCTGCAAGACGCCCATCCGGAACA
NO:




GGGCCTTCTACATGGAGGAGGGCGTGCCCTATTGCGAGCGAGACTATGAGAAGATGTTTG
1132




GCACGAAATGCCATGGCTGTGACTTCAAGATCGACGCTGGGGACCGCTTCCTGGAGGCCC




TGGGCTTCAGCTGGCATGACACCTG





WDR1
ADXCRIH.1007.C1_at
CTTTTCTTTTTCAGTGCAGAAATAAAAGTAAATAATAAGCACGGTGATTGGGA
SEQ ID





NO:





1135





WDR1
ADXCRAD_BU073170_s_at
CATTGTCAGATTTTGTGCTTGATTTTAAGAATGGAATTGTGGGTATCTTTCCTTTTTTTT
SEQ ID




TAATGTATCTTAACTGTTGCCTGTCAGTGTTTACAAACTAGTGCGTTGACGGCACCGTGT
NO:




CCAAGTTTTTAGAACCCTTGTTAGCCAGACCGAGGTGTCCTGGTCACCGTTTCACCATCA
1136




TGCTTT





IL8
ADXCRIH.2782.C1_at
CTGTGTTGGCGCAGTGTGGTCCACTCTCAATCACTCTCAGTTCTTTGATAAATTTGGGGT
SEQ ID




GGAAAGGTTTGGAGTATGTCTTTATGCACTGACATCTAAGTTCTTTAGCACTCCTTGGCA
NO:




AAACTGCACCTTCACACAGAGCTGCAGAAATCAGGAAGGCTGCCAAGAGAGCCACGGCCA
1141




GCTTGGAAGTCATGTTTACACACAGTGAGATGGTTCCTTCCGGTGGTTTCTTCCTGGCTC




TTGTCCTAGAAGCTTGTGTGCTCCTCG





VEGFA
ADXCRIH.2785.C1_s_at
GAACACCGACAAACCCAGCCCTGGCGCTGAGCCTCTCTACCCCAGGTCAGACGGACAGAA
SEQ ID




AGACAGATCACAGGTACAGGGATGAGGACACCGGCTCTGACCAGGAGTTTGGGGAGCTTC
NO:




AGGACATTGC
1142





TNFRSF12A
ADXCRIH.3000.C1_at
CAAAATAAATATCTCCTCCCCGCTTTGGGGAGTTGGGGGGGTCTGTATCTTAGGGCCAGC
SEQ ID




CCTCCTAGTGGGCCAGCCCCCTAGTGTTAAAAATAGGTCCCTAACCCCCCAGGGTGACCC
NO:




CCGTGGTGGAATTTCAGGACATCTGAGTGAGTGGGGCCTAGTGTCAAGTCTGCCCCCCAA
1150




GTCAGCCTGGCCCCCAGGGCCTCTAGGAAGGCCTCGTGC





LAPTM4B
ADXCRIH.1454.C1_s_at
TATATTTGATATACTTCTGCCTAACAACATGGAAAAGGGTTTTCTTTTCCCTGCAAGCTA
SEQ ID




CATCCTACTGCTTTGAACTTCCAAGTATGTCTAGTCACCTTTTAAAATGTAAACATTTTC
NO:




AGAAAAATGAGGATTGCCTTCCTTGT
1153





PEA15
ADXCRAD_CX867144_s_at
GTGTTTTCCTTTGCACCGATCCCCACCCCAATTCAATCCCGGAAGGGACTTACTTAGGAA
SEQ ID




ACCCTTCTTTACTAGATATCCTGGCCCCCTGGGCTTGTGAACACCTCCTAGCCACATCAC
NO:




TACAGTACAGTGAGTGACCCCAGCCTCCTGCCTACCCCAAGATGCCCCTCCCCACCCTGA
1154




CCGTGCTAACTGTGTGTACATATATATTCTACATATATGTATATTAAAACTGCACTGCCA




TGTCTGCCCTTT





JAK1
ADXCRIH.1478.C1_s_at
TTTTCAGTTTGCTTGGAGGTAGCTGGGTAATCAAAAATGTTTAGTCATTGATTCAATGTG
SEQ ID




AACGATTACGGTCTTTATGACCAAGAGTCTTAAAATCTTTTTGTTATGCTGTTTAGTATT
NO:




CGTTTGATATTGTTACTTTTCACCTGTTGAGCCCAAATTCAGGATTGGTTCAGTGGCAGC
1156




AATGAAGTTGCCATTTAAATTTGTTCATAGCCTACATCACCAAGGTCTCTGTGTCAAACC




TGTGGCCACTCTATATGCACTTTGTTTA





CNN3
ADXCRIH.2427.C1_s_at
GCATTTGTGATTATATGTGTACTCATTCTCTTACCTAGCGAACAAGATCTTTTCAAAGTG
SEQ ID




GTGTTTCTAAAAGAGCATGTACAAAAGTGGCCTGTGGACATTTAGGCCTGGGTGATGCAT
NO:




TTGCTCTTCCTGTTTGTGCCAATGTATCAATGTAAAGTTGCTCTGTTTTCTTCAACTGTA
1157




TTTATTGCTGCATTTCTCAGCATAAACTTATCCCATTGT





VIM
ADXCRIH.436.C1_at
TATTCTGAATCTCATCCTGCAGGCGGCCAATAGTGTCTTGGTAGTTAGCAGCTTCAACGG
SEQ ID




CAAAGTTCTCTTCCATTTCACGCATCTGGCGTTCCAGGGACTCATTGGTTCCTTTAAGGG
NO:




CATCCACTTCACAGGTGAGGGACTGCACCTGTCTCCGGTACTCAGTGGACTCCTGCTTTG
1159




CCTGGCGCAGGGCGTCATTGTTCCGGTTGGCAGCCTCAGAGAGTCAGCAAACTTGGATTT




CCTCTTCGTGGAGTTTCTTCAAAAGGCAATCTCTTCTTGCAAAGAT





COL4A1
ADXCRIH.2482.C1_s_at
ATAAAGCTTACATAGTTTTCTTCCTTTGAAAGACTGTGCTGTCCTTTAACATAGGTTTTT
SEQ ID




AAAGACTAGGATATTGAATGTGAAACATCCGTTTTCATTGTTCACTTCTAAACCAAAAAT
NO:




TATGTGTTGCCAAAACCAAACCCAGGTTCATGAATATGGTGTCTATTATAGTGAAACATG
1160




TACTTTGAGCTTATTGTTTTTATTCTGTATTAAATATTTTCAGGGTTTTAAACACTAATC




ACAAACTGAATGACTTGACTTCAAAAGCAACAACCTTAAA





NPC2
ADXCRIH.1839.C1_s_at
AGTCTGCTGAGACTCTTGACAGCACCTCCAGCTCTGCTGCTTCAACAACAGTGACTTGCT
SEQ ID




CTCCAATGGTATCCAGTGATTCGTTGAAGAGGAGGTGCTCTGTAGCAGAAACTGAGCTCC
NO:




GGGTGGCTGGTTCTCAGTGGTTGTCTCATGTCTCTTTTTCTGTCTTAGGTGGTTTCATTA
1163




AATGCAGCACTTGGT





OPTN
ADXCRIH.2853.C1_at
GACCAGCTCAGGACCCAGGTGGTGAGGCTACAAGCAGAGAAGGCAGACCTGTTGGGCATC
SEQ ID




GTGTCTGAACTGCAGCTCAAGCTGAACTCCAGCGGCTCCTCAGAAGATTCCTTTGTTGAA
NO:




ATTAGGATGGCTGAAGGAGAAGCAGAAGGGTCAGTAAAAGAAATCAAGCATAGTCCTGGG
1174




GCCCACGAGAACAGTCTCCACTGGCACGGCATTGTCTAAATATAGGAGCAGATCTGCAGA




TGGGGCCCAGAATTACTTCGAACATGAGGAGTTAACTG





PLAUR
ADXCRIH.1121.C1_at
GGTAAGGCTGGTGATCTTCAAGCCAGTCCGATAGCTCAGGGTCCTGTTGGTCTTCTCTGA
SEQ ID




GTGGGTACAGCTTTTCTCCACCAGCTCCAGCTCTTCTCCTTCTTCCCACAAGCGCACGAT
NO:




CGTGGTCCTGCAGAGGTCCTGTCCCAGGGCGCACTCTTCCACACGGCAATCCCCGTTGGT
1175




CTTACACTGCATGCACCGCA





SVIL
ADXCRIH.3823.C1_at
GGCATTGCCTAGCTGGAACAAGAAGGCAGTGCTATCTATAGCAGCTGCGGCTTAAGTGCA
SEQ ID




CATAACAGATACTTTTATTAATTCTGATAACCTCCTGAATGGTGGAAAGAAGTTTCCAAA
NO:




CAGTTCCCTTGAACATTTACAAAATACACAACTCCGGGACAGCAGTATCTTTAACAATGT
1176




CATGTTCTGAAAACTCTGAT





PRSS23
ADXCRIH.833.C1_at
CCAGATTTGCTATTGGATTAAAGGAAACTACCTGGATTGTAGGGAGGGGTGACACAGTGT
SEQ ID




TCCCTCCTGGCAGCAATTAAGGGTCTTCATGTTCTTATTTTAGGAGAGGCCAAATTGTTT
NO:




TTTGTCATTGGCGTGCACACNNNNNNNNNNNNNNNNNNNNNNNNNNAAGGTGTCTTATAA
1177




TCTTTTACCTATTTCTTACAATTGCAAGATGACTGGCTTTACTATTTGAAAACTGGTTTG




TGTATCATATCATATATCATTTTAGCAGTTTGAAGGCATACTTTTGCAT





C190rf10
ADXCRIH.3832.C1_s_at
AGAGAACAGAGGGTCCAGGGCCCTCCTGGCTCCCAACAGCTTCTCAGTTCCCACTTCCTG
SEQ ID




CTGAGCTCTTCTGGACTCATGATCGCAGATCCGGGGCACAAAGAGGGTGGGGAACATGGG
NO:




GGCTATGCTGGGGAAAGCAGCCATGCTCCCCCGACCTCCAGCCGAGCATCCTTCATGAGC
1178




CTGCAGAACTGCTTTCCTATGTTTACCCAGGG





GATA6
ADXCRIH.2898.C1_s_at
AAGTCACGTCCTCCGTGCGACCGGATTCCTGGTGCGCCCTGGCCCTGGCCTGAGCCCACG
SEQ ID




CCGCCAGGAGGCAGGGAGGGCTCCGCCGCGGGCCTCACTCCACTCGTGTCTGCTTTTGTG
NO:




CAGCAGTCCAGACAGTGGCGACTGCGCTGACAGAACGTGATTCTCGTGCCTTTATTTTGA
1180




AAGAGATGTTTTTCCCAAGAGGCTTGCTGAAAGAGTGAGAGAAGATGGAAGGGAAGGGCC




AGTGCAACTGGGCGCTTGGGCCACTCCA





LGALS1
ADXCRIH.2899.C1_at
GAAAGACAGCCTCCCGCTGCTCGGTCCCCCAGGCCCCGCCGTCCTTGCTGTTGCACACGA
SEQ ID




TGGTGTTGGCGTCGCCGTGGGCGTTGAAGCGAGGGTTGAAGTGCAGGCACAGGTTGTTGC
NO:




TGTCTTTGCCCAGGTTCAGCACGAAGCTCTTAGCGTCAGGAGCCACCTCGCCTCGCACTC
1181




GAAGGCACTCTCCAGGTTTGAGATTCAGGTTGCTGGCGACCAGACCACAAGCCATGATT





PTPRK
ADXCRIH.91.C1_at
TATAATGTGCTTTCTCCATATAGACATATTTACACTTGAGTCTTTGGCTTATGTTATTTT
SEQ ID




CTAAAAAGAACTTTAAATGATCCAGCCATCATTGCACATTAAAAGAAAATAAGCCAGTTA
NO:




TATATATTTATATATTCCCATAGAGATCTGCTACACTGGAAACATATAAAAAACGAACTT
1182




TACTATGAATTTGCACAGCTTTTCTTTTCTTCTTCCTTTTAAGATTCATCAGCTTTCATT




TTAGAAAGGGAGCCTCGTGC





SLC39A7
ADXCRIH.2110.C1_at
AGGGTTAGTTGGTATTCTCATGGCCTGATTTTTTTTGTTTCTATTCCTTTTATATCACTG
SEQ ID




TGTTTGAATCGAGGGGGAGGGGTGGTAACCGGAAATAAAGATCTCCGATCTTCCGCC
NO:





1185





SLC39A7
ADXCRAD_BM796805_s_at
ATAGTGTTGGGCACTGTCTGACCATGTTGCATTTGGAAGGCTAAATGGGGCCATGAAGAA
SEQ ID




GGCTGGAAGGGACAGGTGGTGATGGCAGCCTACCTGGTGTCCCCTACCCCACCTGTTCTC
NO:




GGAGAACCAAGTTGCTACACAGGAAGTTCTCCAAGGTCCAGTTTCCTTTCTCCCACCAGT
1186




TGGTGGAGGCTTCAGGGAAGACCAGAGTCCTGNACAGAGAGGGTAACAGGAGGAGTCGGG




GATAAACATCAAACATCAATCGTGTGTCCTGATTTGGGAGTGAT





RRAS
ADXCRIH.3859.C1_at
GAGGCCTCAAAGTAGGCCACGTGGTGGGAGGCGCCGAAGGCAGAGGCTTCTGATCGGGGG
SEQ ID




ACCTGGCGCTGTGACTCCAGATCTGCCTTGTTCCCGACCAACACAACGGGGAAGTCGTCG
NO:




CGGTCCTTGACCCGCAGAATCTGCGTGAAGAGCTTGCCCACCTCGTTGAAACTCTGCCGG
1188




TCATTAATGGCGAACACCAGCAGGAAACCGTGGCCAGCACGCATGTACTGCTCTCTCATG




GCCCCGAACTCTTCCTGGCCCGCGGTGTCCAGGGATGTCCAGC





PLAU
ADXCRIH.107.C1_at
TCACTGGGTGGGGTGAGGACCACTCCTTACACTG
SEQ ID





NO:





1192





PLAU
ADXCRIH.107.C1_s_at
TAAGTGTGAGTAAGAGCTGGTGTCTGATTGTTAAGTCTAAATATTTCCTTAAACTGTGTG
SEQ ID




GACTGTGATGCCACACAGAGTGGTCTTTCTGGAGAGGTTATAGGTCACTCCTGGGGCCTC
NO:




TTGGGTCCCCCACGTGACAGTGCCTGGGAATGTATTATTCTGCAGCATGACCTGTGACCA
1193




GCACTGTCTCAGTTTCACTTTCACATAGATGTCCCTTTCTTGGCCAGTTATCCCTTCCTT




TTAGCCTAGTTCATCCAATCCTCACTGGGTGGG





MXRA7
ADXCRIH.2503.C1_at
ATGGCAACAGCCACACAGTCATTGCCTTCAACACAGAGCCACGTGTCCCCAAACAGCAAT
SEQ ID




AGTCATGCCCTTGTCCAGGCTGGGATCTAATTGATACAATAGGTCGTTGACTCCCTCCTA
NO:




GTAGAGCTATCTAGGTTTGTCTGGAAAGTTTCCGACCCTGGCTTATAGGCACCACACCTC
1205




ATGTACTCCTCATGGCTTGGATCTCTGTATTCAGCCTTTGTTCAGTCC





CYR61
ADXCRIH.1579.C1_at
TACCTAATATCTGAGTGTATGCCATTCGGTATTTTTAGAGGTGCTCCAAAGTCATTAGGA
SEQ ID




ACAACCTAGCTCACGTACTCAATTATTCAAACAGGACTTATTGGGATACAGCAGTGAATT
NO:




AAGCTATTAAAATAAGATAATGATTGCTTTTATACCTTCAGTAGAGAAAAGTCTTTGCAT
1207




ATAAAGTAATGTTTAAAAAACATGTATTGAACACGACATTGTATGAAGCACAA





HSBP1
ADXCRIH.524.C1_at
CCCTTCAATTATAGTTAGTCTTGGTGAAGTAAGATGTTTGTAGACTTTAGAGTTCTTTAA
SEQ ID




TTCTTGGCACAACGTGACTGTTGAGCTAACACCAAATAGTGTGTTGGCAATACTTTTCAA
NO:




ATGGCTGAAAACACCTAAAAATTGTTCATTCCGAAATATCTGTCACTGCTCTGTTGCCAA
1211




ACTCAGAATAGAACTTAGACGTATGTCTGAGTCCCTGAGATCACATGCTAAAGTCGATGA




AAGTAACCACTGCCACTGTCTGTGTCAGAACTTTACAGTACAG





CALU
ADXCRAD_CX788634_s_at
ATGTCATTGAAAGTGCCTTTAACGAAAGAAATGGTCACTGAATGGGAATTCTCTTAAGAA
SEQ ID




ACCCTGAGATTAAAAAAAGACTATTTGGATAACTTATAGGAAAGCCTAGAACCTCCCAGT
NO:




AGAGTGGGGATTTTTTTCTTCTTCCCTTTCTCTTTTGGACAATAGTTAAATTAGCAGTAT
1218




TAGTTATGAGTTTGGTTGCAGTGTTCTTATCTTGTGGGCTGATTTCCAAAACCACATGCT




GCTGAATTTACCAGGGATCCTCATACCTCACAATGCAAACCACTTACTACCAG





CTSA
ADXCRIH.551.C1_at
AAAGTGCCCCTGCAGGCCGGGTTCTGCCGCCAGGACTGCCCCCTTCCCAGAGCCCTGTAC
SEQ ID




ATCCCAGACTGGGCCCAGGGTCTCCCATAGACAGCCTGGGGGCAAGTTAGCACTTTATTC
NO:




CCGCAGCAGTTCCTGAATGGGGTGGCCTGGCCCCTTCTCTGCTTAAAGAATGCCCTTTAT
1219




GATGCACTGATTCCATCCCAGGAACCCAACAGAGCTCAGGACAGCCCACAGGGAGGTGGT




GGACGGACTGTAATTGATAGAT





ALCAM
ADXCRIH.556.C1_s_at
TAAAACAGAATTTGGTAGCACTTACCTCTACAGACACCTGCTAATAAATTATTTTCTGTC
SEQ ID




AAAAGAAAAACACAGCATGTGTGAGAGACAGTTTGGAAAAATCATGGTCAACATTCCCAT
NO:




TTTCATAGATCACAATGTAAATCACTATAATACAAATTGGTGTTAAATCCTTTGGGTTAT
1220




CCACTGCCTTAA





KDELR3
ADXCRIH.3560.C1_at
GTATGTGACCAAAGTCCTTAAGGGAAAGAAGTTAAGTCTTCCAATGCCAATCTGAGGACC
SEQ ID




TTCAGAGACAGTCTACGCCTTAACAAGCACATGAAGGAAACTATTTTGAATGTTCTCTTT
NO:




GGCAACTTATCCATAATTTGGGATCAAATGTTAAAACCAGAAAAGTGTTTAGTGTGGATT
1221




TCAGCAAACCTG





TIMP1
ADXCRIH.2934.C1_s_at
TGCAAACTGCAGAGTGGCACTCATTGCTTGTGGA
SEQ ID





NO:





1226





TAGLN2
ADXCRIH.1215.C1_at
TGGCCTTGCTTCTACAAGTATGCTTCTCCCACAGCTGTGGCTGCAGGAACTTAATTTATA
SEQ ID




GGGAGGAGCCTGTGGCAGCTGCTGCCCCAGCCACAGCTGCACTGACTGTGCTCACCACAC
NO:




ATCTGGGGCAGCCTTCCCTGGCAGGGGCCCTCGTGGCTTCTCATTTTCCATT
1230





TAGLN
ADXCRIH.1215.C1_x_at
TGGCCTTGCTTCTACAAGTATGCTTCTCCCACAGCTGTGGCTGCAGGAACTTAATTTATA
SEQ ID




GGGAGGAGCCTGTGGCAGCTGCTGCCCCAGCCACAGCTGCACTGACTGTGCTCACCACAC
NO:




ATCTGGGGCAGCCTTCCCTGGCAGGGGCCCTCGTGGCTTCTCATTTTCCATTCCCTTCAC
1231




TGTGGCTAAGGGGTGGGGTGAGGGGATGGAGAGGGAGGGCTGCCTACCATGGTC





COL4A2
ADXCRIH.1229.C1_at
ACTGCCCCACGTTGTCCCTGAGATTTAACCCCTCCACTGCTGGGGGTGAGCTGTACTCTT
SEQ ID




CTGACTGCCCCCTCCTGT
NO:





1234





COL4A2
ADXCRAD_BM700172_s_at
GGCCCTGCTTTCTACGCCAATGTTATGCCAGCTCCATGTTCTCCCAAATACCGTTGATGT
SEQ ID




GAATTATTTTAAAGGCAAAACTGTGCTCTTTATTTTAAAAAACACTGATAATCACACTGC
NO:




GGTAGGTCATTCTTTTGCCACATCCCTATAGACCACTGGGTTTGGCAAAACTCAGGCAGA
1235




AGTGGAGACCTTTCTAGACATCATTGTCAGCCTTGCTACTTGAAGGTACACCCCATAGGG




TCGGAGGTGCTGT





COL5A2
ADXCRIH.2984.C1_s_at
AATTCGGCGTTGAAATTGGGCCAGTTTGTTTTGTGTAAAGTAAGCCAAGACACATCGACA
SEQ ID




ATGAGCACCACCATCAATGACCACCGCCATTCACAAGAACTTTGACTGTTTGAAGTTGAT
NO:




CCTGAGACTCTTGAAGTAATGGCTGATCCTGCATCAGCATTGTATATATGGTCTT
1239





PRNP
ADXCRIH.1264.C1_s_at
CATAGGACAGACTTAGGAGTTTTGTTTAGAGCAGTTAACATCTGAAGTGTCTAATGCATT
SEQ ID




AACTTTTGTAAGGTACTGAATACTTAATATGTGGGAAACCCTTTTGCGTGGTCCTTAGGC
NO:




TTACAATGTGCACTGAATCGTTTCATGTAAGAATCCAAAGTGGACACCATTAACAGGTCT
1241




TTGAAATATGCATGTACTTTATATTTTCTATATTTGTAACTTTGCATGTTCTTGTTTTG





TMBIM1
ADXCRIH.1270.C1_at
GGAGAAGACACATCTTCAGCCTAGTCCCTGCCAAGCCCACCAAGAGCAACAGTTAGTCCC
SEQ ID




TAGCTCCTCCGTCCCCACCAAGTACCCACACATCCATAGCCAGAGAGGCCACCTGTCTCC
NO:




AGGACAGAAAGGAAACTGGGCATGTTACTCAAGGGGAAGGAAAGGGGCCTAAAGCCCAGA
1243




CCACAGTCATAGGGCCCAGCCCTCTAGCTTGGAAGGGAGAGCCCAGGATCGGGTGAAAAT




GGGGGCTTGCTCCTTAATTGCGATCCC





ACTN4
ADXCRIH.2218.C1_at
AGAGCAGGAGAGACGGCAGAGATATGTTGCTAGGTGAATATATATTTATATAATAAATCC
SEQ ID




GTAAGTTAATAAAGTAAATAGTAATTCTCTG
NO:





1244





ACTN4
ADXCRIH.2218.C1_s_at
ACCATCAACCACCAGGCAGCCAGGCCATCAGCCCACCTCCACCTCTGGAGGGTCCCCAGA
SEQ ID




GACCCACGCCCGACGCAGACCCGGAGGAGCATCAGCAAGGGGCCCGGGCAGAGAATCGGC
NO:




TATGTCTTCATTATGAGA
1245





CASK
ADXCRIH.3207.C1_s_at
GTATCTCATGACCAAATGATGCAAGACATCTCTAATAACGAGTACTTGGAGTACGGCAGC
SEQ ID




CACGAGGATGCGATGTATGGGACAAAACTGGAGACCATCCGGAAGATCCACGAGCAGGGG
NO:




CTGATTGCAATACTGGACGTGGAGCCTCAGGCACTGAAGGTCCTGAGAACTGCAGAGTTT
1248




GCTCCTTTTGTTGTTTTCATTGCTGCACCAACTATTACTCCAGGTTTAAATGAGGATGAA




TCTCTTCAGCGTCTGCAGAA





KCMF1
ADXCRIH.1604.C1_s_at
GGTGATTGTAATTTCAGGTCTGTCACTCTTGTTACATTGTGTACATTCAAAAGGAAGAGA
SEQ ID




GAAAATATATATGATAATCATTTCCACTTAACTAATTTTTACTTCTAGCAGGTAAATGTA
NO:




GGTAGCAGTGCAGGGGTGATCTCTGCTTCCTGTACCTTGACATGCAAAAGGCTCTCCTAA
1249




TACTCCACATTCAAACTGAAGAGGAAAATTGAAATCTCTAATGAAGCTGCTGTGTGTATT




TATGAATATTAATGAATAAAAACTGCTTGGATGGT





YES1
ADXCRIH.3214.C1_at
GGCAGGAAAGTTGATGGGATTCATTAGGTTTACTGGATGGAGCAGTTCCCTATATAATAC
SEQ ID




CAATGGAATAGTAAGGGATAAAACCTACATGTGTATTCTT
NO:





1250





YES1
ADXCRAD_CX784933_s_at
GCAAGTTGGCAGTGGTTCTGGTACTAAAAATTGTGGTTGTTTTTTCTGTTTACGTAACCT
SEQ ID




GCTTAGTATTGACACTCTCTACCAAGAGGGTCTTCCTAAGAAGAGTGCTGTCATTATTTC
NO:




CTCTTATCAACAACTTGTGACATGAGATTTTT
1251





MAP1LC3B
ADXCRIH.2287.C1_at
AGTGGTGTAATTGTGATTTTCCTGTGATACTCCCAAGAAAACTATAAATAGTGAACCCCA
SEQ ID




TGCAAGTACTGGGAAGCACTAGTCTTTTATCACAGGTTGAACCTGAGGAGGTTTAACTCT
NO:




TGACATTAGTATCTGTAAAAGAGCGTACGGCTCTTTTTGCTATGTTTTCTCCACAACTGA
1255




CATGCACTTGGTGTGGGAGAATTCCGATGGCTGTCTGACCTAAGAGTGATACTACTATTC




AAAATGTGGGTACCTTTTCAGTAATACTGA





SCRN1
ADXCRIH.243.C1_at
ATAATCGAAATTATGGAGGTTCCTTAGTGCTCAATAATATAAGACCTGTTGTTATTAGAA
SEQ ID




CGAGTCTTTCTTATAAACTAACAGAGCAGGTATATGCCTGTTAGATCTTAGCTGTGGGGT
NO:




TCCTTTACTATTGGGTGAATCATTAGGTATAAAAAATAATCATCAACCAGGCCAAATACT
1256




TTGCTTCCTAGCTGATGTCATCCCACATTGGTACAGTGTTATTCATTACTGGGTGGTTCA




ACAGGGAAGCCAGTGGGA





SCRN1
ADXCRIH.243.C1_s_at
GGTTCCTTTACTATTGGGTGAATCATTAGGTATAAAAAATAATCATCAACCAGGCCAAAT
SEQ ID




ACTTTGCTTCCTAGCTGATGTCATCCCACATTGGTACAGTGTTATTCATTACTGGGTGGT
NO:




TCAACAGGGAAGCCAGTGGGACCAGTGTGTCTGTCATGAAAC
1257





SEPT7
ADXCRIH.335.C3_s_at
TTACACTTTATGGTAAGTAGCAGGGGGGGAAATGCATTTATAGATCATTTCTAGGCAAAA
SEQ ID




TTGTGAAGCTAATGACCAACCTGTTTCTACCTATATGCAGTCTCTTTATTTTACTAGAAA
NO:




TGGGAATCATGGCCTCTTGAAGAGAAAAAAGTCACCATTCTGCATTTAGCTGTAT
1260





YWHAZ
ADXCRAD_CV571569_s_at
TTCTGTCTTGTCACCAACCATTCTTACTTGGTGGCCATGTACTTGGAAAAAGGCCGCATG
SEQ ID




ATCTTTCTGGCTCCACTCAGTGTCTAAGGCACCCTGCTTCCTTTGCTTGCATCCCACAGA
NO:




CTATTTCCCTCATCCTATTTACTGCAGCAAATCTCTCCTTAGTTGATGAGACTGTGTTTA
1264




TCTCCCTT





YWHAZ
ADXCRIH.776.C2_x_at
AAATATTTCCTCAGTACTTTGCAGAAAACACCAAACAAAAATGCCATTTTAAAAAAGGTG
SEQ ID




TATTTTTTCTTTTAGAATGTAAGCTCCTCAAGAGCAGGGACAATGTTTTCTGTATGTTCT
NO:




ATTGTGCCTAGTACACTGTAAATGCTCAATAAATATTGATGATGGGAGGCAGTGAGTCTT
1265




GATGATAAGGGTGAGAAACTGAAATCCCAAACACTGTTTTGTTGCTTGTTTTATTATGAC




CTCAGATTAAATTGGGAAATATTGGCCCTTTTGAATAATTGCCTCGTGC





RCN1
ADXCRIH.419.C1_s_at
ATACAATGCATTTCCTCAGTGATCACTGATTAGAATGAGTTGGTGGGATCCTTGGGAAGC
SEQ ID




CAAACGGAGCGGAGTTCTGGATCATGTCCCATCCAGTCCAGTGAATCCACGACCCGCAGA
NO:




CCTGCCCCCCCGCAACAGCTTATACCATGGAATGAGGACAAGGTGATACTCTGAGCTGTG
1269




GACTGAACTGGCAGACACAACCTGTACAGATTGAAATTTCACCTTGTAA





ZFP36L1
ADXCRIH.786.C2_at
TCTCAAGACATTCCACTCACAGATTTGAGGTTCTGGATTCCAGGTCTGGAGTTTTCCCAT
SEQ ID




GTTAATGTAAACAGAACTGGCACACACACATTAAAGATGAATGTAATTATTATTCCTCTT
NO:




GCTGGTCACTACCGTCGCTTTCTATTTCTCTTTCTTTGTGTGAATTTATTTNNNNNNNNN
1270




NNNNNNNCCTTTTGTAACGACTATTTGCAGTTTAAAATC





ZFP36L1
ADXCRIH.786.C2_x_at
GAGAAACCCTTTGACTTCCACGTGCCCATCTCAAGACATTCCACTCACAGATTTGAGGTT
SEQ ID




CTGGATTCCAGGTCTGGAGTTTTCCCATGTTAATGTAAACAGAACTGGCACACACACATT
NO:




AAAGATGAATGTAATTATTATTCCTCTTGCTGGTCACTACCGTCGCTTTCTATTTCTCTT
1271




TCTTTGTGTGAATTTATTTNNNNNNNNNNNNNNNNCCTTTTGTAACGACTATTTGCAGTT





CAV1
ADXCRIH.1095.C2_at
TTTATTCCTCCTGCTCATATTGTGATTCTGCCTTTGGGGACTTTTCTTAAACCTTCAGTT
SEQ ID




ATGANNNNNNNNNCATACACTTATTGGAACTCTGCTTGATTTTTGCCTCTTCCAGTCTTC
NO:




CTGACACTTTAATTACCAACCTGTTACCTACTTTGACTTTTTGCATTTAAAACAGACACT
1272




GGCATGGATATAGTTTTACTTTTAAACTGTGTACATAACTGAAAATGTGCTATACTGCAT




ACTTTTTAA





PRSS23
ADXCRIH.795.C1_at
GGATCAGAATCATGCCTTCCAATAAAGGCCTTTACACATGTTTTATCAATATGATTATCA
SEQ ID




AATCACAGCATATACAGAAAAGACTTGGACTTATTGTATGTTTTTATTTTATGGCTCTCG
NO:




GCCTAAGCACTTCTTTCTAAATGTATCGGAGAAAAAATCAAATGGACTACAAGCACGTGT
1275




TTGCTGTGCTTGCACCTCAGTAAACCTGCATTGTAGCAATTTGTAAGGATATTCAGATGG




AGCACTGTCACTTAACATTCTCTGGG





ANXA2
ADXCRIH.511.C2_s_at
TAGAAAACCAGCTTGCGAATAACAGTCCCCGTGGCCATCCCTGTGAGGGTGACGTTAGC
SEQ ID





NO:





1276





GJA1
ADXCRIH.1842.C1_at
GTGATGGTAATGATATTGTGCAAGTGGATGGAAAAAGAATATACGTATTTGCAAATGCAT
SEQ ID




GGAAAATCTTATTCTGTGGGCCTTGTCTGAATTTTAAACTGATACCAAGAATAAAAAAAT
NO:




ATAGTAGCACAAGTCCATTGACACCTGGAGGGTCAGGCCTAGAAAGCTTACCTTCAAAGT
1277




GCAAATTTTAACAATGGAATGTTTTAGCAGGGACTTAAGCCTCGTGC





SLC20A1
ADXCRIH.3036.C2_s_at
CAGTAGTGGCAGGATCTATTGGCATATTCGGGAGCTTCTTAGAGGGATGAGGTTCTTTGA
SEQ ID




ACACAGTGAAAATTTAAATTAGTAACTTTTTTGCAAGCAGTTTATTGACTGTTATTGCTA
NO:




AGAAGAAGTAAGAAAGAAAAAGCCTGTTGGCAATCTTGGTTATTTCTTTAAGATTTCTGG
1282




CAGTGTGGGATGGATGAATGAAGTGGAATGTGAACTTTGGGCAAGTTAAATGGGACAGCC




TTCCATGTTCATTTGTCTACCTCTTAACTGAATAAAA





JUN
ADXCRIH.716.C2_at
GATGAAAAGCTGATTACTGTTCAATAAACAGCTTCCTGCCTTT
SEQ ID





NO:





1287





JUN
ADXCRIH.716.C2_s_at
CAAACTGCAATAGAGACTGTAGATTGCTTCTGTAGTACTCCTTAAGAACACAAAGCGGGG
SEQ ID




GGAGGGTTGGGGAGGGGCGGCAGGAGGGAGGTTTGTGAGAGCGAGGCTGAGCCTACAGAT
NO:




GAACTCTTTCTGGCCTGCCTTCGTTAACTGTGTATGT
1288





DNAJB1
ADXCRIH.815.C2_s_at
TGGGGCTTACCAGTGGCCCAGGTAATTTTTTGTTTCATGGACTATGGACTCTTTCAAAGG
SEQ ID




GATCTGATCCTTTTGAATTTTGCACAGCCCTAGATACAATCCCTTTTGATAAAAGGGTCT
NO:




TTGCTTCTGATTACAGGAGCACTGTGGAACGTCTGTAAATATGTTTTTATATTTCCATGT
1290




ATAGTTGGTGTACACTCAAAACCTGTCC





S100A10
ADXCRIH.249.C2_at
GGCAGAAATGAGCAGTTCGCTCCTCCCTGATAAGAGTTGTCCCAAAGGGTCGCTTAAGGA
SEQ ID




ATCTGCCCCACAGCTTCCCCCATAGAAGGATTTCATGAGCAGATCAGGACACTTAGCAAA
NO:




TGTAAAAATAAAATCTAACTCTCATTTGACAAGCAGAGAAAGAAAAGTTAAATACCAGAT
1295




AAGCTTTTGATTTTTGTATTGTTTGCATCCCCTTGCCCT





SPTBN1
ADXCRIH.820.C2_at
CTGTACCTCTCAACTTTTGCCCTATCTGTTAAATATATGCTAT
SEQ ID





NO:





1296





SPTBN1
ADXCRIH.820.C2_s_at
GTTACTCTAATGGTTACTTGCTCGTGCGTTGCCACACTGTGTTATAATTTGCTTCATTTC
SEQ ID




CTTGCTATTTGATACATAGTGTGCATTTCTCTGTCACTGTAACTATTGTAATGACAAATT
NO:




TTCATCTTACTGCACAATCAAAATGACATTGATAGGAATGAACTCCAGAGGCTGGGCCTG
1297




AACAGGGAGGTGGTCGCTCAGGCCTGGTGCTCAGTCGTACGACCTGTACCTCTCAA





MARCKS
ADXCRIHRC.653.C1_at
TTTTTGATCCATTATTCCAATTAAGAATGCGTGTCAAAACCTAATTTGTTATTTTTCTAA
SEQ ID




TGAGTTTAAGATTTGGCATTCAGTTGTTACACATGTGGTTCAATGATTTATCATGAACCC
NO:




TAAACTGCACACTGCTCAAAAACAGCAAAACAGATGTGCATTAAATGAAATAATGTTTTT
1305




GATACATATCTTAAATTTCAATCAGTTTAGGGTCCTTTGAAGGAAAAGATATCCAGTTAT




CGGGTGGCAAAGAGCAGAGGAGGTAAACTCCTCGTGCCG





IL8
ADXCRIHRC.2782.C1_s_at
AACAATCCTAGTTTGATACTCCCAGTCTTGTCATTGCCAGCTGTGTTGGTAGTGCTGTGT
SEQ ID




TGAATTACGGAATAATGAGTTAGAACTATTAAAACAGCCAAAACTCCACAGTCAATATTA
NO:




GTAATTTCTTGCTGGTTGAAACTTGTTTATTATGTACAAATAGATTCTTATAATATTATT
1310




TAAATGACTGCATTTTTAAATACAAGGCTTTATATTTTTAACTTTAAGATGTTTTTATGT




GCTCTCCAAATTTTTTTTACTGTTTCTGATTGTATGGAAAT





TNFRSF12A
ADXCRIHRC.3000.C1_s_at

SEQ ID




ACTTGGGGGGCAGACTTGACACTAGGCCCCACTCACTCAGATGTCCTGAAATTCCACCAC
NO:




GGGGGTCACCCTGGGGGGTTAGGGACCTATTTTTAACACTAGGGGGCTGGCCCACTAGGA




GGGCTGGCCCTAAGATACAGACCCCCCCAACTCCCCAAAGCGGGGAGGAGATATTTATTT
1311




TG





VIM
ADXCRAD_CX873552_s_at
AAGCAGGAGTCCACTGAGTACCGGAGACAGGTGCAGTCCCTCACCTGTGAAGTGGATGCC
SEQ ID




CTTAAAGGAACCAATGAGTCCCTGGAACGCCAGATGCGTGAAATGGAAGAGAACTTTGCC
NO:




GTTGAAGCTGCTAACTACCAAGACACTATTGGCCGCCTGCAGGATGAGATTCAGAATATG
1312




AAGGAGGAAATGGCTCGTCACCTTCGTGAATACCAAGACCTGCTCAATGTTAAGATGGCC




CTTGACATTGAGATTGC





SVIL
ADXCRIHRC.3823.C1_at
ACCGGTTGTAAAAACAGTACACATGTCATTTTGTGATATAGGACTCCCAAATAAAAGTAT
SEQ ID




CAGAATAAACACCTCGTGC
NO:





1314





SVIL
ADXCRAD_CN402078_s_at
GTATCTTCATACACGTTTGGAAATGTTTCCTGCAGCATTAGGTATGACTTGTTCTGAGTA
SEQ ID




CTGCTTCCGGTGCTAAAATGAACAAAGAATTTGTACTTAATGGCATGGACTCTGGAGAAT
NO:




CTATGCGAATCAACCTTTCTACCTTAATATCTCCCCAAAAATGTATAGTGCCTTGTTTTT
1315




ATGTACAGTTTATATACAGAAAAGTTTGCTCTGCATTTTTGATGATGGTTTGGAACATTA




TCTACAAT





LGALS1
ADXCRIHRC.2899.C1_at
AACACCATCGTGTGCAACAGCAAGGACGGCGGGGCCTGGGGGACCGAGCAGCGGGAGGCT
SEQ ID




GTCTTTCCCTTCCAGCCTGGAAGTGTTGCAGAGGTGTGCATCACCTTCGACCAGGCCAAC
NO:




CTGACCGTCAAGCTGCCAGATGGATACGAATTCAAGTTCCCCAACCGCCTCAACCTGGAG
1317




GCCATCAACTACATGGCAGCTGACGGTGACTTCAAGATCAAATGTGTGGCCTTTGACTGA




AATCAGCCAGCCCATGGC





PTPRK
ADXCRIHRC.91.C1_s_at
CAATGCCAGATTCCTGTTTTGCGCATTGTCATGGGATTCTTAAGTGAACCTTTCTAAATG
SEQ ID




TGGTCTTGTTCACATGCTCCACGTAGCTGTAACTTCACATCATCAGCTTGCAGTTTGTAA
NO:




TTGACTAAAGCATTCCAGTGTCCTCTTTCTAGATTGCCAGCTCATGACATGGTGCTTATA
1318




AAGA





RRAS
ADXCRIHRC.3859.C1_at
GAGAGAAGCAACCACCACAAGCTCTCGGGACTAGCTGCCTTCGCACCTTGCTGTGTGACC
SEQ ID




TGAGGCCCTCACTGAGCCTCAATTTCCTCATCTGGGTCTCCCAGGACACATCACATACCC
NO:




ACCCTTACTTCCTGGCCTCTTCTGGGCTACTGCCACTGTGTGCCTTCTGCCAACGCCTCC
1319




TGTCCCCACCTAAGCCTGGTGGGGGTGAGGGGCTCCGGGTCACTGCTGTATATAACTCCC




CTCCCCCAGAAAAATAAATGTCACTGCCAACGTCCTCGTG





ACTN4
ADXCRIHRC.2218.C1_at
ATATTCACCTAGCAACATATCTCTGCCGTCTCTCCTGCTCTCATAATGAAGACATAGCCG
SEQ ID




ATTCTCTGCCCGGGCCCCTTGCTGATGCTCCTCCGGGTCTGCGTCGGGCGTGGGTCTCTG
NO:




GGGACCCTCCAGAGGTGGAGGTGGGCTGATGGCCTGGCTGCCTGGTGGTTGATGGTTTTG
1326




CCTCGT





MAP1LC3B
ADXCRIHRC.2287.C1_at
ATGTATATTCTTAACTGGACTGTCTTGTTTAGACTGTATACATCATATCCGACATTATTG
SEQ ID




TAACTACCGTGTGATCAGTAAGATTCCTGTAAGAAATACTGCTTTTTAAGAAAAAAAATA
NO:




ACATGCTGAGGGGTGACCTATATCCCATGTGAGTGGTCACTTTATTTATAGGATC
1327





YWHAZ
ADXCRIHRC.776.C2_at
TACATGAATTTAATACACGTGTTCTTAACAATTATGCTTGGATTGTTCATGAAAATTTCA
SEQ ID




TAAGACATTAAACAAAGCTAGCCATCATCTCAAGTTATTTCCCTGTTAACTATTTTTACA
NO:




GCACATGCATGTTAGGCAAGTATCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
1328




NNNNNNNNNGTTAAATACATGGGTTTTTGTTTTACTGCTGTGCTTGATATACATGAAGTA




ATGCCTCGTGC





YWHAZ
ADXCRIHRC.776.C2_x_at
AAACTTTTATTCCACTTACATGAATTTAATACACGTGTTCTTAACAATTATGCTTGGATT
SEQ ID




GTTCATGAAAATTTCATAAGACATTAAACAAAGCTAGCCATCATCTCAAGTTATTTCCCT
NO:




GTTAACTATTTTTACAGCACATGCATGTTAGGCAAGTATCNNNNNNNNNNNNNNNNNNNN
1329




NNNNNNNNNNNNNNNNNNNNNNNNNGTTAAATACATGGGTTTTTGTTTTACTGCTGTGCT




TGATATACATGAAGTAATGCCTCGTGC





GJA1
ADXCRIHRC.1842.C1_s_at
TGAAGACATCTACCAGTTTCTCCAAATGCCTTTTTTAAAACTCATCACAGAAGATTGGTG
SEQ ID




AAAATGCTGAGTATGACACTTTTCTTCTTGCATGCATGTCAGCTACATAAACAGTTTTGT
NO:




ACAATGAAAATTACTAATTTGTTTGACATTCCATGTTAAACTACGGTCATGTTCAGCTTC
1330




ATTGCATGTAATGTAGACCTAGTCCATCAGATCATGTGTTCTGGAGAGTGTTCTTTATTC





CAST
ADXCRIHRC.622.C3_at
AGAAGGCATATTCAGAGTTCTTTTTAAATAAATGTTGTTTACTTTTATAGGCATCTTTAA
SEQ ID




ACTTCTGGATTTTGGTATGCCATTTAAAAATACTTCCAGATACACATGGAAATTAGTAAT
NO:




ACTGCAGCCGTATCCTTGCAAACACATCTGTCAGTGTCAAAGGTTTCAAGGTTTTTCTTN
1333




NNNNNNNNNNNNNNNNNNNNNNNCACCTATACTGCCCAAATGGGAGGATTAGATACATGG




TTAGAAATCCCTCAGGAAA





PPIC
RDCR013_A07_at
CATTTATGCATATTTCTCTATACTGTCTTTTACATGCACAAGACATTTGAAGTAATATAC
SEQ ID




TGTAAAACTGTACAATTAAAATTATAAATAAAATGTAAGACCATGACATGAAATCCAAAC
NO:




AGTACATGGATGAATTATAAGAAGATTAGCTAATCTGCTAGCAGTTATCTTTTGTAATAC
1337




TA





PPIC
RDCR013_A07_x_at
GCCTGGCCCAATTACTTTCATTTATGCATATTTCTCTATACTGTCTTTTACATGCACAAG
SEQ ID




ACATTTGAAGTAATATACTGTAAAACTGTACAATTAAAATTATAAATAAAATGTAAGACC
NO:




ATGACATGAAATCCAAACAGTACATGGATGAATTATAAGAAGATTAGCTAATCTGCTAGC
1338




AGTTATCTTTTGTAATACT





FNDC3B
RDCR250_A04_at
ATGGATTAACCTCGTTAACAAGAAGAAAAGGCAATTGTGATTTCTAAAGTGGAAAGGCAG
SEQ ID




GTAGGTTGCAAAGACTCCCCTACACTGAAAATACGATTCTTTTCCATTCTCAGCTGTAAT
NO:




TGCTGAAAGCTCAAGTAATAGGCTAAGGTAACATACAAGGCCTAAAACCTTATTCCTTTA
1340




TCATTCAGTACTGAACGTTCCTCTAAGAGACTGCACTTTTTCCCGCCACCTCAAAAACAG




CCCTGAATCAAGCCTGGCCTGCCCACTTCAGCAACACTAGCCCAGCTACAG





MARCKS
RDCR156_A02_at
GAAGTGAAATAATCATGCCTGCCCTGGCTGCTTCTGTGAGTGGAAGATCATAATTGGAGT
SEQ ID




GCATGAAAGACTTTGTAAACTGTTAAGTGCTCTATAAACGTTAGCATTTTACTCAATAAA
NO:




TTTTTATCACACATTCGATGGAATAAGGAAAGAGAATTGAAATAATACAGTTTTTCTTCA
1347




TTGCCTTAGATTATAATTCAGATATAATACAGTTCATTACATTTCATAGTTGTGGCTATT




TCAGTAAAT





MARCKS
RDCR156_A02_x_at
AGTGAAATAATCATGCCTGCCCTGGCTGCTTCTGTGAGTGGAAGATCATAATTGGAGTGC
SEQ ID




ATGAAAGACTTTGTAAACTGTTAAGTGCTCTATAAACGTTAGCATTTTACTCAATAAATT
NO:




TTTATCACACATTCGATGGAATAAGGAAAGAGAATTGAAATAATACAGTTTTTCTTCATT
1348




GCCTTAGATTATAATTCAGATATAATACAGTTCATTACATTTCATAGTTGTGGCTATTTC




AGTAAAT





MAPK1
RDCR077_G03_at
GTATGTTCAAATAAGCTTTCAGACTAATAGCTTTTTTGGTGTCTAAAATGTAAGCAAAAA
SEQ ID




TTCCTGCTGAAACATTCTAGTCCTTTCATTTAGTATAAAGA
NO:





1349





MAPK1
ADXCRPD.11685.C1_s_at
ATTCCCCTTCCTGGTACTGTGGAGTCAGATTGGCATGAAACCACTAACTTCATTCTAGAA
SEQ ID




TCATTGTAGCCATAAGTTGTGTGCTTTTTATTAATCATGCCTAAACATAATGTAACTGGG
NO:




CAGAGAATGGTCCTAACCATAGGTACCTATGAAAAGCGCTAGCTATCATGTGTAGTAGAT
1350




GCATCATTGTGGCTCTTCTTACATTTGTAAAAATGTACAGATTAGGTCATCTTAATTCAT




ATTA





COL5A2
RDCR149_E06_at
AAAGGGCAAGCAATAGATTTTTCATGACTGAATAAACTGTAATAATAAAACATATGTCTC
SEQ ID




AAAGTGTATCACATATGAATTTAGCCTAATTGTTTTCAGTTTCATTCTCAATATTTAGTT
NO:




TACAACATCATTTTCCCCTAAACTGGTTATATTTTGACCTGTATATCTTAAATTTGAGTA
1356




TTTATATGCCTAAATACATGTGTGAGTTTTGTTTGACTTCCAAGTCCAAACTATAG





COL5A2
RDCR149_E06_x_at
TGCCCTTAAAAATGTCAGAGTAGTATTATTGATAAAAAGGGCAAGCAATAGATTTTTCAT
SEQ ID




GACTGAATAAACTGTAATAATAAAACATATGTCTCAAAGTGTATCACATATGAATTTAGC
NO:




CTAATTGTTTTCAGTTTCATTCTCAATATTTAGTTTACAACATCATTTTCCCCTAAACTG
1357




GTTATATTTTGACCTGTATATCTTAAATTTGAGTATTTATATGCCTAAATACATGTGTGA




GTTTTGTTTGACTTCCAAGTCCAAACTATA





CAV2
RDCR300_A12_at
GGTTCGGCATTCATGTGTATTCCATTCNNNNNNNNNCTCTGTACTTTCTTTTCATACATT
SEQ ID




TCTTGTCTCTGCAATGAGGCTGAGCGAGACTGTCCCAAATGTGTTTTTATCCTGAGTCTG
NO:




AGGCAGGCTGAACTTTAATCTGCATGATGTGCTGCAGCTTGCCATCATGTCGGGACAGCA
1364




GATCCAGTCCCTTGAGTAAGCCAGTTGGTCACAGTTTCAGA





SDC4
RDCR312_B10_at
ACCAAAGGCTACCTTGCCTAAAATGTTAGTGGCTGAGGACCCAAGCCTTCTGCCTCTAGC
SEQ ID




ACAGTGCTCTAAACTAGGCCCTGAAGGATGTGTCGGGTCAAGCCACTGGGGAAGCATCCG
NO:




AAGGGATACCACCTAGGCAGTACAGGGAAAAAGAGGAAAGGACCCAGGAGGTTGCTGAGT
1365




CACCGTGTGCCCAGTCACATGCCAGTTTCCTCCCAGGGGCTGCTGAGCTTTCAAGTGCTT




CAGGGTGCTGAGCAGTC





FNDC3B
RDCR337_C02_at
TATTTACCATTTTACTATCCAGAGATGATAATCACTCTGCTAACATGTTTTTGATTATAT
SEQ ID




CCTTCCAGATGGATTTTTCTTTTCTCTACTCTTTCTCTGTCTCTCAGCCTCTGCTTTTAA
NO:




AGTGGTTTAAAATATGTAATTTTCAGTTTTTAATGATTCTGCTAGGGCGAAAAATTGGCA
1366




GCTACATAGGAAAGTTGCTGAAGCGGAGGCAAGGAATCAAAGATTTATCCTTCTCTGATA




TAAAAACTTACCCATTTTTTCAAGTGTAAGGCATATTGCAGCCACTAATA





KCTD12
RDCR348_G10_at
GGGAGGAAGAACTGGTGAAATGAAGTGAGTGCCTTTGAGAATTGAATGAATTTAA
SEQ ID





NO:





1367





KCTD12
RDCR348_G10_s_at
GTAAAACACCATTCAAGTGTCAGAATCATTATTTTCCACCACTTATCATGGTGCTTGACA
SEQ ID




AGTCTTCCCAATAAATACTGAATGAAC
NO:





1368





PTPRK
RDCR460_E08_at
AGAAATATGCCTTGCCTTCAGAGAATTTATAGAAAGTCTATCTGTCAGTGCTAGGGTGCT
SEQ ID




AGGGGCTGGGAGGAGCTGAGAGCAGCTCTAAAGCCAGGAAGCTGGACCTAAAACAGATGG
NO:




CTATTGAGCGAAGTATTTGAAGCTAGATGATGTGTAAGTAATAATATTCTCTGAGCACCT
1370




CTATTATTATTTTTTAGGTTCTCTGCATCAGAATGAGGAAAGAGATTTAATAAGTTGTGA




ATTTTAAATTCATGAGAATGCCAATAGAGACC





ANXA2
RDCR471_F01_at
CTGTGAGAGCATGAAGCTGCAACAAGTCAGTAGGGGAGCAAACAAATATTGATTCAGATC
SEQ ID




ACGCCACAGAAGAGACAAGCTGGAGCAAGTGCTGTGTGTCCCTCCTGCTCAGTTTGATCG
NO:




AGGTCACTGGGCCGAATTCCAGGAATTCTGGGGAATGAGTTGGCCCTGTGACTCAGTCAT
1371




TAATCAAGACCATAAAACCAAGGAGAAGAATATCTGCTTTCAAAAAGGTTCTGATAATAA




AGATGCAGTACGTGGGTGGAGGATGGAGTACAGTGGGAACCCCTCTTCTC





SDC4
RDCR488_B09_s_at
AGTGGCCATTAGCTCCCGTCACCACTGCAACCCAGGGTCCCAGCTGGCTGGGTCCTCTTC
SEQ ID




TGCCCCCAGTGCCCTTCCCCTTGGGCTGTGTTGGAGTGAGCACCTCCTCTGTAGGCACCT
NO:




CTCACACTGTTGTCTGTTACTGATTTT
1372





FNDC3B
RDCR512_D06_at
GAGTATTTGTGAATTAAATCCTTTATGAAAAGGTGTCCCTTGTAAATGATTGGGGCATGT
SEQ ID




TGCCTCTTTTCCTTCATATTTTTAGTTTCTGCTATTCATAAGAAAATAAGAAAAATACTA
NO:




ACTTCCCTTAAGAGTAACTACTTAATGTCCAAAAACCCCTCAGGTTCTGCAACTATGATG
1375




CACTGATTTATGATGTTTATTTATATACCTCTCAGAAAATTTGAAATGACCAAGAGATTT




ACAAATGCAATGTTCAG





FNDC3B
RDCR512_D06_x_at
GAGTATTTGTGAATTAAATCCTTTATGAAAAGGTGTCCCTTGTAAATGATTGGGGCATGT
SEQ ID




TGCCTCTTTTCCTTCATATTTTTAGTTTCTGCTATTCATAAGAAAATAAGAAAAATACTA
NO:




ACTTCCCTTAAGAGTAACTACTTAATGTCCAAAAACCCCTCAGGTTCTGCAACTATGATG
1376




CACTGATTTATGATGTTTATTTATATACCTCTCAGAAAATTTGAAATGACCAAGAGATTT




ACAAATGCAATGTTCAGCCAAAAATGTTTTT





CD44
ADXCRIHRC.1441.C1_s_at
GAAGAAGAAAAGCTCCTGACTAAATCAGGGCTGGGCTTAGACAGAGTTGATCTGTAGAAT
SEQ ID




ATCTTTAAAGGAGAGATGTCAACTTTCTGCACTATTCCCAG
NO:





1379





MYL9
ADXCRIHRC.2136.C2_s_at
CCACACAAATGCAAGCTCACCAAGGTCCCCTCTCAGTCCCCTTCCCTACACCCTGACCGG
SEQ ID




CCACTGCTGCACACCCACCCAGAGCACGCCACCCGCCATGGGAGTGTGCTCAGGAGTCGC
NO:




GGGCAGCGTGGACATCTGTCCCAGAGGGGGCAGAATCTCCAATAGAG
1381





ACTN4
ADXCRIHRC.2359.C2_s_at
AGCAGAGGGCGCCACCACCACCTGACGGCTGGGGACCCACCCAGCCCCTCTCCCCTCTCT
SEQ ID




GCTCCAGACTCACTTGCCATTGCCAGGAGATGGCCCCAACAAGCACCCCGCTTTTGCAGC
NO:




AGAGGAGCTGAGTTGGCAGACCGGGCCCCCCTGAACCGCACCCCATCCCACCAGCCCCGG
1383




CCTTGCTTTGTCTGGCCTCACGTGTCTCAGATTTTCTAAG





FLNA
ADXCRPD.16964.C1_at
TGGGCTGTCACTTTTGCTGGCGTCACCCTGTGACTTATCCACGTACACCTCGAAGGGGCT
SEQ ID




CTTGGCGATGTGCTGGCCAGCAAAGAGCACAGTAACCTTATGAGTCCCCGTCAACTCGGG
NO:




GACGTACCAGACGGAGAAGGTGCGGTTCTTGTCGTTATTGGCGGTCACTTTTGCCTCCTC
1387




CTGGTGTCCGGCCGGGTCCTCCACGTACACCAGCACCTCTCCCTGGCCAGCACCTCTGGT




CTCCACAGTGAACTCTACCCGCTTCTTCACAATGCACGTGATCAAATCCTGTAGAGTC





FHL1
ADXCRPD.16965.C1_at
GGGCCCTATGAACAGACCATTCCTGGGGACCGAATACCTTGCTTTCCACCTGCAAAAAAA
SEQ ID




GTCTCCCTGGGAAATCCTGGCCCAACAAAAGAGCTTTGTTNTTTCCCCCCAGCGAACAAA
NO:




GGGTATTTGTCCCTGAATGTGTGCCAAAAAACACGTGTAAACACTAACAAGGAGGCTCTC
1388




TTGGACCTTCGAAAAAAGGGCAATTGGAAATCTCCGGCCCCTTTTGAGGCCCTTGACTTT




CATGGCCCTCATCCCCAGTCGATAAGGG





WDR1
ADXCRPD.16980.C1_at
GAAGGTGGAGGTCACTCTCCAAAGAAGCATCTCCAACTACTCTTGGGCAAGGCCATCTCT
SEQ ID




CCAGTAGTCTTACGCATGAGGCTAAACCTCTTCTCTTACCTCAAAGATGGCTTCAGTATC
NO:




CCTCCCGTTACCTNCAACAGGGCATNGAAATGTACCAAAAGCAACACACAGGAGGCCACA
1390




GTGGGGCTGAGAGGACCCAGGTACACATGCTGTTTCCTGCCTGGTTTCTCCCCACCTCTG




CCGTGTGTCATCAACGCTCCT





SDC4
ADXCRPD.16987.C1_at
GAAACTCTGCCCCTCCGGAACAGGAGGGTGACCCCAGGTCCTGGACAGGTGTCCAGAGTG
SEQ ID




GTCTGATACCCTTGGCAAACCCCCTGCCCCCTCTCCCTCCAGGCTGCAAACTGTTCAGCA
NO:




TGAGGCTCCAGCAAATCCCAGCAGGAGAGGTGGGGCTGCCCAGCAACTGGTTCTTGTATA
1391




AACATAAACCCATTCGATAATTAGCAAACAGCCCACTTCTAAGATAAACAAATAGGAGAT




TTGGACTCCAAAAGC





AHNAK
ADXCRPD.16988.C1_at
AAATCGGTCGCAGCTAGTGCACTTTGTTCATCATATGTATCTGTGACAGGAACTGAGTCT
SEQ ID




TAAATCTCCCTGTCTGGCACATGGGTGCGTGAGTGATGTGAGGTCACCGTCTAACGCAGC
NO:




GTGTAATTAGGTGCTGGGACCAGTTGTGTCCATCCCTGGCTGGTTCCGTCTGTAATGCAA
1392




AGTATAGTGTAGGGCATATGGAGGCAGCCGGTATACATGCATTGATTGACTGTTGATACT




TTCCGGATGTAA





CAST
ADXCRPD.1324.C1_s_at
GATCAGCTGAACAGCAGCCATCAGAGAAATCAACAGAACCAAAGACTAAACCACAAGACA
SEQ ID




TGATTTCTGCTGGTGGAGAGAGTGTTGCTGGTATCACTGCAATATCTGGCAAGCCGGGTG
NO:




ACAAGAAAAAAGAAACAGAAATCATTAACCCCAGCTGTGCCAGTTGAATCTAAACCGGAT
1395




AAACCATCGGGAAAGTCAGGCATGGATGCTGCTTTGGATGACTTAATAGATACTTTAGGA




GGACCTGA





FOXN3
ADXCRPD.8652.C1_at
TAATCGGATGTCAGGCAGAGAAAACGTCGAGGTCACTCGTCTTCCTGAAGGGCCTTGGAG
SEQ ID




AAACCGCTGCCCCCGTAACACTGACTCAGTCCACTGGAGACACTAATTCCTGAGCTTTCT
NO:




GGCTTCTTACTGGGAGGCATGACTGGACCCATTTACGTGAAGGCTCCTGGCCGGAGCGGG
1405




GCACGGGGGTGCGGGGGCGCCGCTGCCCTTCAGCAGGAGCCGACAAACTTTCGCGGGCG





RAB31
ADXCRPD.8667.C1_s_at
GATTGGATTAAAGACCTGGCACTTCAGTAACTCAGCACGCTTCCACTTCACTCAACTTAA
SEQ ID




GAGAGTTCATTGACAGTGTTAGGATGTGAAGGCTGGGAAACACTTATTTTGCTTCAAGAG
NO:




TTCCACTTGGCTCTCCCAAATAGGTACCTCAAAAACTGTTAGCAAGCGGCATTTGGATGT
1406




CTTGACAGGGGCTTTGCAGGGATTTTTAGGGTTTTTTCCACATTGTCCACATTAATGGTT




GGCATGATTGTGCTTGCAGGCCAAGAAATGATCATACCCCTTGCCAA





EPHA2
ADXCRPD.8668.C1_at
ATTGTATACAGCGTCACCTGCGAACAGTGCTGGCCCGAGTCTGGGGAATGCGGGCCGTGT
SEQ ID




GAGGCCAGTGTGCGCTACTCGGAGCCTCCTCACGGACTGACCCGCACCAGTGTGACAGTG
NO:




AGCGACCTGGAGCCCCACATGAACTACACCTTCACCGTGGAGGCCCGCAATGGCGTCTCA
1407




GGCCTGGTAACCAGCCGCAGCTTCCGTACTGCCAGTGTCAGCATCAACCA





LAMB1
ADXCRPD.11010.C1_at
ACTGGCACTGGCCTCCGTTGGGATCACACACGGAACTTAACGAACCCTGAGGGTCGCATT
SEQ ID




CACAAGCCAGGCCTGTCTGGTGTAACAGGGCAGAAATGCTAAAGATGATATTTCTGCAAA
NO:




CATCTGTCATCGGGGTTTTCACAAACGCTTCTGCTGTTCTCTAGACATCGGTATCTCTGA
1408




AAGGTTTCCCAGGCACTGTTGGTGACCACCCCATCTCCTGAACCTCCCACGGTGAAGATG




TCCAGTGATTTACAGTAT





FHL1
ADXCRPD.11024.C1_s_at
TGTGCTTTCAAATAACTAACACGAACTTCCAGAAAATTAACATTTGAACTTAGCTGTAAT
SEQ ID




TCTAAACTGACCTTTCCCCGTACTAACGTTTGGTTTCCCCGTGTGGCATGTTTTCTGAGC
NO:




GTTCCTACTTTAAAGCATGGAACATGCAGGTGATTTGGGAAGTGTAGAAAGACCTGAGAA
1409




AACGAGCCTGTTTCAGAGGAACATCGTCACAACGAATACTTCTGGAAG





IGFBP3
ADXCRPD.2051.C1_at
GGCTCCCGAGATGAAACCCGACGTGAACACCACACCCGCGCCCGCCGCACCAATGATCTG
SEQ ID




ATAACTCTCTAGACAAAATAGGGGGCTCGGTCGGGAGAGTCTGAGCCGCCAAATCATCTC
NO:




AACACCGCTTGCTGCCTCGGCGCCTCNCTGTCGATGATGACATGCGTACACCTCTCTCCT
1411




CACGACGACAAGGAGCCTTAGGTGGGACGAANACACAACGCGCACGCACCAATCGCGCGA




GCATGCACACGTATAAGACCC





RAB31
ADXCRPD.2065.C1_at
AATGCGCCGGCCTAACAATAGTTATAAAAAATTGGGGGGAGGACAACCTCCCCTTCCCCC
SEQ ID




TCCCGGATCCCCCGCCCGCCTTTTTTTTCCGCACTATTATCCGCCTCTGCCCCGCCGCCT
NO:




CAGAATACCTCTATCCCGCCGCGGAGAAATTNATTCGCGCCCCGTATTTTCTGCCCGCCG
1412




CGAACACGCCCGCCAACCAGTATTCTCGGGAAAATAATATAATGGGACTCAAAAACACCG




CTCCCCGCCCAAATACGAACGTCGCGGTGGTTATTACTTCTCGCCC





ADAMTS1
ADXCRAD_BM930186_s_at
TCCAGCAGCTGGTCCAACAGTCGTATCCTGGTGAATGTCTGTTCAGCTCTTCTGTGAGAA
SEQ ID




TATGATTT
NO:





1413





CKAP4
ADXCRAD_CF130614_s_at
CAAGGAATGCACAGGTTTCGACTACCAGAAAGGGGAGTCCTTGGGTTCTTTCAAAAAATT
SEQ ID




CGTGAGGAGAGCTGTCTACAGTGGAATAGGGGGTCTCCCTGGGGAATGCAGGCCAAGTCC
NO:




TTTTATTTTAACATGATGTCCATGAAGAGGTTTGCCGTCTGGGCAGCCCTGTCGGCAAGG
1414




AGCGTGCATACTGCGTTTGTGTAATTGTTTGCTGTATCTCCCTTCCCTCTGAGCTGTATT




GTTCTTTAATGGCTGTCTTGCC





FOXN3
ADXCRPD.10462.C1_s_at
GTTCTGTTATGTTCATGTAAACCTAAAGAAACAGTGTGGAGGCAGGCGCGATCAGCCGAA
SEQ ID




CTCTAGGGACTTGGTGTTGCTTGGAAGGCATCCATACCTGCATTTTGCATTCTTCGTATG
NO:




TAATCATATTGCCAAAGACAAACTATTTCATCATTTATTGTAAATAACACTTTTCCCCAG
1418




ACCTACCATAAAGTTTCTGTGATGTATTGTCTTCCAGTTGCAAT





MXRA7
ADXCRPD.17734.C1_at
AAAGGCCTCTAACCTGCTGGAAGATAGGGACCAAGTTGAGTATTTTATTTCTTCTGTCTA
SEQ ID




CAGCATCCAGCATAGTTCTAATTAAATACAATTAGGCAAGTACTCAAATAAGTCTTGCCT
NO:




AATTATATTTAAAGTAAGTATCCTGCTTAAGTGAGAGAAATTCTTGGCAGATCTTACCTC
1422




TAGTACTATTGTTTAGTGCCAGGATGGAAGGTGAGTCTCTGAATTAGACTTTTTGCTGAA




AGAACGCTCCCAGCTGGGCATGCT





FOXN3
ADXCRPD.8765.C1_at
TCTTGAAGAAGGTACTGCCCGGCCAGATGGGTGGACCTGATGTGCTTTGATATGCCTGAG
SEQ ID




GACAGGTGGGAGGTGTATTGAACACGTGTGGGTGTGGGTGATAAGGTGTCTTTTTCAAAG
NO:




CCTGAATTAGATTTTGTCTATACTCTGGGTCTATGCACCACAACGACCCTTTCCCAATAC
1423




TCTGACTCCTCTCTTTGTCCACTTTCTTAAAACACTTATTCAATGATAAATTGTGTCTCA




CTGAGTTTTTCCACCCAGTAGGTGCATTTGCAAAAT





PTPRK
ADXCRPD.11104.C1_at
GGCAGTGGATAATCGTCCGGCCTTCCCCTTCCTCGCATTCCTCCTGCCACTTTTCCACCT
SEQ ID




GAAGTATCAGTTTCAAGAATGACCTTTTGGAACCAGGCACTTCTCGATGAGAAGCCCATC
NO:




CTAGGTACTGAAACTGTTGCACCATCAGATAACCTTCCTGTGGTCTTGTTAGATTGCATA
1425




TCCTAAAAATCCGGTTGATCACATCACAGTCCATTGAACAAGACATACATTCCACTTGGA




TGGGGCCATATCGTAGCATCCCTTCCTCTGGCCAGTACTGAGGGCAGCCCTG





ARID5B
ADXCRPD.11117.C1_at
GATATTCACAAATCCCTTCACAAGGCCCACGTGCGAAGTGAATGATCTGGAGGTGCCTGG
SEQ ID




GCATCTGTGTTGGAAGGGAGTCAAGACTCACCAGCCAGTCAGTTTGTGGGCTAGAGTTGT
NO:




CCCACAAAAATCAGGCATGTTCACCTCCCCTCTGGGCCCCTACAGCTGGGACTGATCATA
1427




GCCTCAGATTAGAAGAAATACTGACTTCTAACTCTATAAGCCAGCACTCCTGGGTAAGGA




GTGAAGCTCTGTTGGCCATGCC





KDELR3
ADXCRPD.11126.C1_at
AGAGGAGGGACATTGTTCCAGATTGGGGTTGACTTGCCCATCATGAGTCTTGCCCTCAGG
SEQ ID




CCTTGGAGAACAATCATTTATGTTTTTTATTTCGTCGGTAAGACACCTTAAGGTTTCTTG
NO:




TTGCAGTGAGGCACCATCTTTGTGCAGTTGGCCGAGGTTTTTTATGACCTTACAATGGGT
1428




CTTTAAGGGCGATCTATTGATGA





ELF4
ADXCRPD.11148.C1_at
AGGCCTCCCAGAGAGTAACTTGGAGGTTCCATTTGCTATTGACTGGATTGTGTTTGCTTG
SEQ ID




AGGAGCCTGTGACCACCCGCAGGGACAGGCAGCCTAGGATAAACTGGACCACCCCTGAGT
NO:




AAAGCACTCCACTCAGTCCCTTGGTCCCCACCCCTCAGTTAGAACTGCTAGGCTTTGGGG
1430




GATGGGAGGGTGGCAATTATTCTTAACCTCCCGAAATTCCTGATGACCCGATAACAAGGA




GGTATTTAGACATAGAATGAGGAGCTAATCTTTTTCCTA





VCAN
ADXCRPD.2145.C1_at
AGGAATGACTCTAGCTACAATAATACACAGTATGTTTAAGCAGGTTCCCTTGGTTGTTGC
SEQ ID




ATTAAATGTAATCCACCTTTAGGTATTTTAGAGCACAGAACAACACTGTGTTGATCTAGT
NO:




AGGTTTCTATTTTTCCTTTCTCTTTACAATGCACATAATACTTTCCTGTATTTATATCAT
1431




AACGTGT





VCAN
ADXCRPD.2145.C1_x_at
GGAATGACTCTAGCTACAATAATACACAGTATGTTTAAGCAGGTTCCCTTGGTTGTTGCA
SEQ ID




TTAAATGTAATCCACCTTTAGGTATTTTAGAGCACAGAACAACACTGTGTTGATCTAGTA
NO:




GGTTTCTATTTTTCCTTTCTCTTTACAATGCACATAATACTTTCCTGTATTTATATCATA
1432




ACGTGTATAGTGTAAAATGTGAATGACTTTTTTTGTGAATGAAAATCTAAAATCTTTGTA




ACTTTTTATATCTGCTTTTGT





CETN2
ADXCRPD.2161.C1_at
TAAACCGCCGCTTATTTACGCCACAGCGCGCCGTCACACTGTATCTATATTTTGTATTCC
SEQ ID




CCCCGTCGCGACTCGTATCTTATCATACCCAAAATTANCGCGCCCGCCCCAGCAGCTAGA
NO:




CACAACCACGACATCGTATATATGGGGCGCTATATTAGTGACATNCTAACAGCTCGCGAG
1434




TTCGGTGCGTCGCCGCCGGGAAG





KDELR2
ADXCRPD.1509.C1_at
AGAGCTGTGCTGACTATGTTACATCCTAAAAAAACTATATAAAGCAATGGATAATGTCGT
SEQ ID




TTATGAATTAAGGTGGGAAAATCGGGTTGGAATTGTGTCAATGGACAAAGGCCGGAGGGG
NO:




CGAAATTAAGTCACTACTCTGACACCTCGGATTTGGGAGAAAATATGCCGCTGCAATAGA
1435




TGGTATTGGAGGAAAAGATGTTTGTGAACAATAAGGGATACGGAAAGATAGCGCCAACAT




CAGGAGCAACGTG





LPP
ADXCRPD.11183.C1_at
GAATGACCAACAATTTGGCTTTCCTAGAAAGAGAAGAGAATATCTGAATTCCCTGTAAAC
SEQ ID




TGGTAAATCCTCTACCATCAGTCCTGAATTCTGAGGGGGCCTGATATTTAAGCAACAAAA
NO:




CTTAGAAGGTTCCACCTGTTATTCCTAGCTCTGTCACTAAAAATCGTGTCCAAACAGAGG
1437




TAATACGAATGTGTTACCCGTTCCCGAAATTNNNNNNNNNNNNNNNNNNNNNNNNNNNNN




NNNNNCCCAGAGCACAGAATGGATCCAGTGTAGTAGTGCAGGTGACCA





LEPROT
ADXCRPD.1565.C1_at
TTGCCTGCCAACACAAGGCCGCAGTCCCCATTTGATCACAGCCACACGAGCAAGAATAAC
SEQ ID




AGGAAATCCAAAGGCAGAAACAACAATTCCAGTAGTGAAGAAATATGCCAGTTCCCGACA
NO:




GGCACTACTGGTTGCATCTGAGTCATAGGTGACTCTTTTGGCAATGAAATGGGGGATGGG
1442




GGAGATGGCGTGGAAAATCAGGACGAATAAGGGCCAGTAAACGCCATAATCCTCTAAGGC




ACATCCCAGCATAAGAAAAGTCAGTCCAATAGCCCCACTGAAGGATAATGGCCCGA





CYR61
ADXCRPD.10589.C1_at
GGAACCGCATCTTCACAGTCCTGGTCAGCTGGGGCGTGCAGCATCGGCCGTCCACGCAGG
SEQ ID




AACCGCAGTACTTGGGCCGGTATTTCTTCACACTCAAACATCCAGCGTAAGTAAACCTGA
NO:




CTGGGTTCGGGGGATATCTTGGTACTTGCTGCATTTCTTGCCCTTCTGTAAGAGAAAGGC
1443




GAGAAGGCAAGTTAGGGGTGATATTTCTCTTTCTTCAAAAAGATGTTCACATCCCAACCA




CCTGCCAGGCAACAGTCTACACGTCCCTTAAGGAACTTACTTTCAGGCTGCTGT





CDC14B
ADXCRPD.9445.C1_at
AATATCGAATAGTGCAAATTGTATAATTACAA
SEQ ID





NO:





1447





CDC14B
ADXCRPD.9445.C1_s_at
ACAGCGTATATTTCTAATCATATTTTTTAAAGCCAAGAGAACTGGTTGAATGAATGTTTA
SEQ ID




TTTTCCTGAAGGTATTTTTAAGATAAAGCTTCCTAATGGCGTGTAAACTTTGCATA
NO:





1448





EPAS1
ADXCRPD.17826.C1_at
CAGTGTAGCCAGTGTGCTCGGCGTCTGAACGTCTCAAAGTGGCCACAGCTGACAATGACA
SEQ ID




GCTGACAAGGGAGAAGAAAAGGAGTAGCTCGGAGAGGAGGAAGGAGAAGTCCCGGGATGC
NO:




TGCGCGGTGCCGGCGGAGCAAGGAGACGGAGGTGTTCTATGAGCTGGCCCATGAGCTGCC
1450





EPAS1
ADXCRPD.17826.C1_x_at
CAGTGTAGCCAGTGTGCTCGGCGTCTGAACGTCTCAAAGTGGCCACAGCTGACAATGACA
SEQ ID




GCTGACAAGGGAGAAGAAAAGGAGTAGCTCGGAGAGGAGGAAGGAGAAGTCCCGGGATGC
NO:




TGCGCGGTGCCGGCGGAGCAAGGAGACGGAGGTGTTCTATGAGCTGGCCCATGAGCTGCC
1451




TCTGCCCCACAGTGTGAGCTCCCATCTGGACATAGTG





POFUT2
ADXCRPD.9474.C1_at
TGAGGAGGGACAGACAGCTCTTCCTTTCGGAGCCTGGCTAGTCTAGGACATCACCTTGCT
SEQ ID




GTGTCTTCTCAAGCTTTTAAAATTGACCCTGAACGTGTGACAGGGTCCTATGGTGTTACT
NO:




CAAAGCTGTGCAGGGTAAATGATGACATATTTATTCTTTTTCCATTTGTTCTAGAAACAG
1452




TGCCTTTTTCATCAGTTGCATTTTCCAGGCTGAGAGCTGTATAAAACATTTTGGACTGTG




ACCATGTACCTTCCTTTTTAA





COL6A1
ADXCRPD.17873.C1_at
TGTGAATGCAAGTGCGGCCCATCGACCTCCTGTTCGTGCTGGACAGCTCAGAGAGCATTG
SEQ ID




GCTGCAGAACTTCGAGATTGCCAAGGACTTCGTCGTCAAGGTCATCGACCGGCTGAGCCG
NO:




GCGACGAAGCTGGCTCAAGCTCGAGCCAGGCCAAGTCGTACGCGGGCTGTAGCTGCAGTA
1454




CAGCCACAGCCAAGATGCAGGAGCATGTGAGCCTGCGGCAGCCCCA





YPEL5
ADXCRPD.11244.C1_s_at
GAAAACTGTACTTTGTACCCTCACATACAAAGGGATCAAATTTGACCTGGTGTTATTTTA
SEQ ID




GCCCCAAATTTATGACATTACACAATATTAAAATGTAAATGTTTCTTTACCCAAACTACT
NO:




TCTAGATATTCTAGTATTTGCTTCTGGTGGAATTAAATGACGGTAAAATTGGCTAATTAT
1457




TTGAATGAATGAATGGATGGATGTTTTGCATGCTCACTTTCTAGGTCCTTTGTCTAGAAA




GGA





RBPMS
ADXCRPD.10645.C1_at
GCGAGGTTGAGCTGTCATGAACTCTGGAGATGTGTCAACTGACAACACCAGACTGACTTT
SEQ ID




GGCTTTGACGAAGTCTGAATAGAATTGGTTCCAAATGCCCACTGCCTCCGTCTCCTGTGG
NO:




GGTGTGGCAGGACGTCTCACAGTGAGCACACGCCATTTGGGAGCTCATGGTATGTGGTCG
1462




GTTTG





MALT1
ADXCRPD.2292.C1_at
ATTATTTTAATCATCTTCAGTGCACTCCACTGGCTCAATCGTCCTTCCAAGGATGATTTC
SEQ ID




AAACCTCCTGGCAAACTGGAACGGGAGA
NO:





1463





SLC20A1
ADXCRPD.10696.C1_at
TATTATCATTGAACTTCGGTAAAGCATTAATTGTGGCATCTTTGTCAGATGTTTAGATAA
SEQ ID




GATGGTTGCCGTACGCATAGTCTGCATGTTGTATTTTTAGTCTTTGAAGATATGAAGTCA
NO:




GGTAAGCAACATCCTAACATAGTCTATTTCTTGACATCTCTTACAAACGTAGAGTATAGC
1465




CTATCCTCAGGTGTGTGCTGAAGTTTATATTAGGGCTTTTGGGTACCTTAGAATGTGGGT




ATTGCAGTCTTTATTCAGGATGTTATCAGTCACTGGTACAGTTAGTCTTGTTAT





MDFIC
ADXCRPD.1686.C1_s_at
TTTATGTTCATAGTACTTTTCCTCTTGTCTACTCCAGACAGTTATTCCATAAAGCATTTG
SEQ ID




TATAATTAAAAGGAAAACAGAAAAAGGAAAAGTAGGCAAATGTGAAAATAGTTTCAATAT
NO:




ATCTTATGATTTCTTAATGTAAAATGTTTTGTTGAAGTATATGGCTATCATGACTAAGTG
1466




CTAGAATTTATAGTTACAGGCGGTGTCCTTTTAAATGTGGAAAGGCTTTTAAAATATTTT




AAAACTGGACCTGTATTATCCTGAATACACT





SYNJ2
ADXCRPD.17920.C1_at
TGAGAGCCGAGTGACCGTTCCTGCAAAAGTTTACCCAGGCCAATT
SEQ ID





NO:





1467





SYNJ2
ADXCRPD.17920.C1_s_at
GAATATCCCCTTCTGACTCATAGTCCAAACTTGTGAAGTCAAAGTTTTCCTCCAGCAAAC
SEQ ID




AGGAGTTGGCAGTGGGAGACACGGGGGCCATGCTGTCTCGTTTCCGAATGATCTCCTCTC
NO:




GCAAACCTTTCAGCCAGTCCTTGGTCTTCGGTCTAATCTTCACTGCTCTGCCTTTCACCT
1468




TCATACCGTCCACGTCCAGGACACTGAGAGCCGA





POFUT2
ADXCRPD.17928.C1_s_at
TTCATCAGCCATGGCGGCTGGCAACGCCGAGGACAGAGCGCCAGCTCTAGAGGCGTGGGG
SEQ ID




CCTCATTCTGGGCCTGGGACCCTGCGAGGGACGGTCACATGTCCAGCCCAGCTCCCGGCT
NO:




GGCAGTAGACGGTGACTCCACGGCGACAGAACCTGCATCCACCCGCGCCTGTCGGGTCCG
1469




GGGAGCGGCCCTGGAGGATCACTCCTCAGTAGGTGATCTTCCAGTGGGTGGGTTGCTCAC




ACGCCTTCTCTT





VCAN
ADXCRPD.8962.C1_s_at
GATTCATTTCACACTTCTGCAACTACTCAGGCAACCAGACAAGAAAGCAGCACCACATTT
SEQ ID




GTTTCTGATGGGTCCCTGGAAAAACATCCTGAGGTGCCAAGCGCTAAAGCTGTTACTGCT
NO:




GATGGATTCCCAACAGTTTCAGTGATGCTGCCTCTTCATTACAGAGCAGAACAAAAGCTC
1471




CCCTGATCCAACTAGCACACTCTCAAATACAGTGTCATATGAGAGGTCCACAGACGGTAG




TTTCCAAGACCGTTTCAGGGAATTCGAG





RND3
ADXCRPD.11316.C1_at
TTCCACAAACTATGTCATCAGGCTCATTTTTCAAAACCAATGTGCACAACACCTGGTCAA
SEQ ID




ACTTCTGCGTCAACTACATTCCGTGTCAATAAAATGTTTGCTTTGCCAAGGGAGACTCTG
NO:




AGAAAGTGACCAATATGTAGCAACTGAGAAGTCATTTAAAGGACATCAGA
1472





PLOD2
ADXCRPD.2305.C1_s_at
TGAAGGACTTCCTGTTAAAAATGGAACAAGATACATTGCAGTGTCATTTATAGATCCCTA
SEQ ID




AGTTATTTACTTTTCATTGAATTGAAATTTATTTTGGATGAATGACTGGCATGAACACGT
NO:




CTTTGAAGTTGTGGCTGAGAAGATGAGAGGAATATTTAAATAACATCAACAGAACAACTT
1473




CACTTTGGGCCAAACATTTGAAAAACTTTTTATAAAAAATTGTTTGATATTTCTTAATGT




CTGCTCTGAGCCTTAAAACACAGATT





CORO1C
ADXCRPD.11328.C1_at
CAAGCAATTGCAAAAAACTCTTTTACCACCTGTGACAATATCCCATTTTATCTGCATAAC
SEQ ID




TTTGGCATCTTACGTCACTGTCTTGTACAGTCTATGCCAACAGTTTCAGTTTTTTCTCTC
NO:




CTTTTGGGGCGAGGGGAAATTTCATGTGGTCAAATGGCATTACAAAATTACTGAAAAGTC
1475




ACTTTACTTTCCCTAAAATCTTCCAACAGAGAACATGTCAACTGTCAATAAGCACATACA




C





CNN3
ADXCRPD.2332.C1_at
CATATCAAATGGTTTCTAACAGGTATTGGTTTGCCTAATTTTCAAAACAAACCTCCTTGA
SEQ ID




TCCACGGGGGCCCTTTTGATGAATTACAATGGGGGAACCTCCATTTCCCCTTTACCCGAC
NO:




GGCGGAACACCACAATTCTTTTTTCCCCAAGCGGGGTTGCTCTCTCTTTACCAAGCAATC
1476




CTTTGGTTACCCAATCACCGTGTGCGCCTTGTGTGGTAACACTTTTTCAACGCGCCCTCA




TGCGGAGACGAAATCGCACTCTCTTTGCG





ARID5B
ADXCRPD.2347.C1_s_at
AAATCTTAAAGGCAGACCACGCAAAAAGAAACCATGCCCACAAAGAAGAGATTCATTCAG
SEQ ID




TGGTGTTAAGGATTCCAACAACAATTCCGATGGCAAAGCCGTTGCCAAGGTGAAATGTGA
NO:




GGCCAGGTCAGCCTTGACCAAGCCGAAGAATAACCATAACTGTAAAAAAGTCTCAAATGA
1477




AGAAAAACCAAAGGTTGCCATTGGTGAAGAGTGCAGGGCAGATGAACAAGCCTTCTTGG





PTRF
ADXCRPD.10702.C1_s_at
GACAGAGCAGAATGAGCCCTCACCCTGGCTGGGGGTCCAGCACAGGCTGTATCTGCAGAG
SEQ ID




GGTCCCAGAGGAACGCTGGAGCCAAGAGAAGCCCTGGGAAGGAGGGGTGGGGAACGACAT
NO:




GCATGTGAGGGATGGCACACTGATGTGTTTATGCACCTGCACACAGGAGCGCATGGCCAT
1478




GGCTT





SYNJ2
ADXCRPD.1723.C1_s_at
GAAATCTACAAAATCACTGCCACTGACTTTTACCCTCTTCAGGAAGAGGGCCAAGGAGGA
SEQ ID




GGAACGCCTCATAGCTTTGAAGAAAATCCTCAGCTCGGGGGTGTTCTATTTCTCATGGCC
NO:




AAACGATGGGTCTCGCTTTGACCTGACTGTCCGCACGCAGAAG
1482





CTNNAL1
ADXCRPD.129.C1_at
GACAGACACACTGGGAGTCGTGCTGCGCACCCCCCCTATTATTTTCGCGCACCCAATTTA
SEQ ID




AAGAGGTGGGCCGGCCGCGCCCACCCGTCCATCACCTCGATATGCACACTACCTCCGCCG
NO:




TCGGGGCCCTCGCGGCCCGCCATGCTGTTCGCAAACACTCACCGCCCGGCCGCGGGTCCG
1484




CGATGCTGCGCGTGTGTGAGAAGTATGGTGAGCGCGATATGGCGGCAACACCACTGTCGA




CTTGTCTCG





RABAC1
ADXCRPD.9642.C1_at
AACCCGTGTGAGGTGTCTTCTGGGACCTGCCGGCCTCCCGGGCCAGCTGCCCCACCCCTG
SEQ ID




CCCATGCCTGTCCTGCACGGCTCTGCTGCTCGGGCCCACAGCGCCGTCCCATCACAAGCC
NO:




CGGGGAGGGATCCCGCCTTTGAAAATAAAGCTGTTATGGGTGTCATTCAGGAAAA
1485





RABAC1
ADXCRPD.9642.C1_x_at
GAGGAGCTGCAGATGGAACCCGTGTGAGGTGTCTTCTGGGACCTGCCGGCCTCCCGGGCC
SEQ ID




AGCTGCCCCACCCCTGCCCATGCCTGTCCTGCACGGCTCTGCTGCTCGGGCCCACAGCGC
NO:




CGTCCCATCACAAGCCCGGGGAGGGATCCCGCCTTTGAAAATAAAGCTGTTATGGGTGTC
1486




ATTCAGGAAAA





GALNT2
ADXCRPD.12003.C1_at
CTAGTGCTGTCATGTTGGAGGTGTCTGACCTTTGCACTAAGTTTCCCCACTTACACTAAA
SEQ ID




TGGGGATAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NO:




NNNNNNNNNNNNNNNNNNNNNTAATGCAGAACTACTCACTGCTGCTGGAGTGCGCTGTTA
1487




TATTCTTTATTAGGTCCTCAGACTTTTTCTATGCCTAAGCTTGAGGGTCTCTCTCAGCTG




TGTTTTTC





EPAS1
ADXCRPD.3002.C1_at
ACCTTGTGGGCAGACGACAGGCTGTAGTCCTGGTACTGGGTGGCGTAGCACAGTGGCGGG
SEQ ID




AACCTGCTCTTGCTGTTCTCCCCGGAACTGATGGCAGATGGAGGCTGTGGCACCGGCAGA
NO:




TGTCTCAGGGGATGGCCCAGGCCCCTCATGGGGTATCGGGTGAACTTATCATTGGGTACA
1488




TTTGCGCTCAGTGGCTTGTCCGGCATCAAAGGGCAGCTCCCACGCCTGAGGTTCTTCATC




CGTTTCCACATCAAATGTGAGGTGCTGCCACCAAGTTGGGTCTCCCGCATACGCAA





SVIL
ADXCRPD.12020.C1_s_at
GCTTCTGGGTGGCCAAACCAGTTACCCAATCTGCTGGAGACCCAAAAGAAGATGAACTCT
SEQ ID




ATGAAGCAGCCATAATAGAAACTAACTGCATTTACCGTCTCATGGATGACAAACTTGTTC
NO:




CTGATGACGACTACTGGGGGAAAATTCCGAAGTGCTCCCTTCTGCAACCCAAAGAGGTAC
1489




TGGTGTATGATTTTGGTAGTGAAGTTTACGTATGGCATGGGAAAGAAGTCACATTAGCAC




AACGAAA





FLNA
ADXCRPD.3034.C1_at
AGTACAATGAACAGCACGTCCCAGGCAGCCCCTTCACTGCTCGGGTCACAGGTGACGACT
SEQ ID




CCATGCGTATGTCCCACCTAAAGGTCGGCTCTGCTGCCGACATCCCCATCAACATCTCAG
NO:




AGACGGATCTCAGCCTGCTCGTACGGCCACTGTGGTCCCGCCCTCGGGCCGCGAGGAGCC
1490




CTGTCTGCTGAAGCGGCTGCGCAATGGCCACGTGCGCATTGCATTCGTGCCCAAGGAG





PLAU
ADXCRPD.12085.C1_s_at
AGAATTCACCACCATCGAGAACCAGCCCTGGTTTGCGGCCATCTACAGGAGGCACCGGGG
SEQ ID




GGGCTCTGTCACCTACGTGTGTGGAGGCAGCCTCATCAGCCCTTGCTGGGTGATCAGCGC
NO:




CACACACTGCTTCATTGATTACCCAAAGAAGGAGGACTACATCGTCTACCTGGGTCGCTC
1491




AAGGCTTAACTCCAACACGCAAGGGGAGATGAAGTTTGAGGTGGAAAACCTCATCCTACA




CA





RAB31
ADXCRPD.2471.C1_at
GGTTGTAAAGCCTCATTGTAGACAAGGCCTGAGCATCCACAGAGAAGATACAATGTTTAT
SEQ ID




ATGAATCCTGGTGTGCCCAAGTGTGATCTACTCTCTTCACTGACTACTCTGAGTGCTGAT
NO:




GAGAATATATATATTATCCTCTGACTGGCTTGAATAGCTAAGACAATACAGAAAGGTAAC
1496




AGAGTGGTTTCACACCCTCATGTGCTTCTGAAATAAAACCATGGGCTCATTAGTGGGTAG




CTCACTATCTGTGGCAA





ATP2B4
ADXCRPD.11491.C1_at
TTCATTTTTCTTCCCCTCTGCTAGTTTGGAAGTTATATTATACCAAGTTTTTTAGTATTA
SEQ ID




GCCTAGAAATCTTAACATAAAGACTTCTAATAAGCAATATCTTTAATTTTTTTTNCCTAC
NO:




CCAATACTAGATCATGAGCATTTTCCCACATCATAAAGAATTGGTCACAAGTCAGCCCCA
1498




AACATAGTCCAGTGGAATCCAATGATA





ALCAM
ADXCRPD.1829.C1_at
AATCCTGGGAAAGAAATCGCTGTGCAGTGTTCTCCCAGAAACCAGGCTTCTGCTTGAAAG
SEQ ID




AGCAAAGTTTAAAAGTCTAGTCACAAGTAGCCCATATCTGGTCTACTTCAAAAAGTTTCC
NO:




ATTTATACTACCACCTTAAAAATTTCCTCAAGCATAAAACATGTTTATAAAGTTACAAAT
1499




TTGAATGTAACTAAAGATACATAGACATTTTATTATTACACTTTCATGTACTGCTTGATA




A





ARID5B
ADXCRPD.10890.C1_at
GACACACCAACACAGTGAAATACAGTACTTGAGAATTCATGCACCAGGTCAGAAAGTTGT
SEQ ID




AAAGTTAACATCGAGTTTTAACAAACCCTTCTGTATATGCCCTGATAAACAAGTGAACTT
NO:




AAGAGCTTCTAGCTAGTAAATAAATAAGTCAGTCCTGTGGCAAATATTACAAGTGTTGAA
1503




TCACTTACTAGAAGAATACTTAATTCCGAAACTCGGTTGGGCTGGTTTTATTTTTTTATC




ATGTGGAGTTGCCAAACATTAAACCAGAA





TPM4
ADXCRPD.295.C1_at
GTGTGGGGGCTGACTAAAGTTTACAATTCCAACTAAAAATCACCCTGCTTCTGGCTTATC
SEQ ID




TGAATCCCTTACCCACCCCACCCCACCACCCTACTCCTATTTATTCAGCACCACACTACC
NO:




CAGGAAATACACTAGCAAATTGTGCAATGGAATAAAATCCACACTTTAGATTCTTGCAAC
1505




TGTATCATATGTAATAGTATCACTTTTTCTACATTTTGGCGCAAATAAATTTTTACATAA




ACTACGGGAGGCCAAGGGAGCTCGATATAAAAAACATGT





NFIB
ADXCRPD.9768.C1_s_at
TCCATGTCACAAGGGTAAAGCTTACAGTTTACAAACTGGGAACGCCAGGGTGTAGGATAT
SEQ ID




AAAAACGCACTCTTGAGAAAACAAATGTAATCAGGGTGCTGAAAACTTGCATGGTGCTTT
NO:




CAGACATTAGCCTTGTTCAACAAATTTCTTGTATTGACAGATCCATAGTGTGCATGGGCA
1507




GACACATTTTGCCTCTATGTCTCTTAAAATTTTAATTAAAAATACTCTTTCCAGTAATCC




TAATTTGCACGAAGATATAATGTCCACATTACGTGCCTTGC





EHD2
ADXCRPD.3133.C1_at
TGGTACAAGAGACAATCCCGGCATTGGACATGGAGTTCGGGCTGATCTGTCCTACCTGAA
SEQ ID




CACCGCTTCCGTTCCTGGGCTGTCGTCTTCACCGCCTGGTTTTCCATGGAAAGGAAGCCT
NO:




CCCCAGTGGCCTTTTGAAAAGGCACTGTGGCGTGGTCCGATAAGTCTCTGCAGAGGCACC
1510




AGGGATGCTTTCAGGACACAGCACCCAGAACGGAGGCTCGATGGTTTAAAGTTTGGCTCT




GCATACACCTTAGGGTCGCTGACACAATATCTGGACACGACGTCAGACATGATAT





FOXN3
ADXCRPD.12156.C1_at
CCGAGCTGACGAGTCATAGATGCATAATTGCAAGATATAACCAGTAGGAGAGAGAGAATA
SEQ ID




CACAAGGAGTATAACCACCATCGGCGGTGCTCTCTCAAAAGGA
NO:





1511





FOXN3
ADXCRPD.12156.C1_s_at
AAGGTGCAGCACCATAGACACATCGGTTTCGGCTGTTAAAAGATGGATCGTTTTAAAAAC
SEQ ID




TGTGTTTTCCTTCCTTAATTTTTGGTCAGTGAAGCTAGCACTTGTTTGCTGAACTGTGGA
NO:




AGAACTGCAAGGTCACACACATTATTCATGATAAAGCAACCGAGCTGACGAGTC
1512





P4HA1
ADXCRPD.11500.C1_at
AACCCAGACTACAAGGCAATATAAAACTTTTTTTCAATAGTCTTTTGCACTAATTTTTTT
SEQ ID




GGCATAATTAAAAGTTGTACACATTTTTCAACTGTTTTACCATCTAAGTTACCAAAACAC
NO:




AAAATGGCCAATGTAATTATCCGCCTACCAAAGTCCTGATTTTCAGTACTTCAAAATAAA
1513




ACTCATTTCAAAATGTCAATAAAAACAGCACTACCCATTTAAAAGAGACAGAAATAGTCC




TTTTCCTAGTTAGTCTATGTAAATCTAAGAAACATTTGTCATCAGCTATCAAAA





AHNAK
ADXCRPD.3149.C1_at
GATGGTCAGCCCGTGGGAGCCACTACCCTGCCAGTTGGGCAGCAGCAGCTCCCGGGTTGT
SEQ ID




CTCCTCCTTCTCCATCTTTGCAGGATTCCGCTCAGGAGCGAATGCCTTGCCAGGAGCCCG
NO:




CCCCTCCTTCCTCTCTTCCCCTCAGTCTCTCTCGTCGGGAATCTCGGTCACAACCTGAGG
1515




GCTCAGCCCCAGGGCACGGCCATAGCCGGCGCGAGGCCCAAGGCTGCGGTGCTGCGGCTA




CTGGCGGCGACGAGCCCCGTTCCGGGCGGGTCTGGCAGAGAGG





LAMB1
ADXCRPD.12165.C1_at
TGAAAAGCATACACCCAAGTTTTACTTTTGAAATCCTAAGGTCTTGGTTTTGAAAACCCC
SEQ ID




AGGCGCTAAGGAAATTACATGTTTTAAAATCCTAAAGGTTGGGGAATTAATATTCTAAAC
NO:




TTCAAATTTGTGAATAATCATGACGTTATGGGCAAATACATATAAATAAACATATAACCA
1516




GAACACGTCTTTCCCCTTTATCCAATGGAAATACGATCAAGCATCACTCTTAGCAGAAGA




TACCAGACACTTGTAGGGACACGAAAAGCGATAT





AMOTL2
ADXCRPD.2508.C1_at
TTGGGAACCACTTCGGGTGTTGCGATAACACCCCTCCACCCACGTGGGGCATAACCCTGG
SEQ ID




GGCTACATGCCAACCCCCAGTGGAAACACTTCTCGAACGTTTCCGGGGAGACACATTACA
NO:




TCAGAGAAAGCCCCTACTGTCGCGGTGTGAGG
1517





AMOTL2
ADXCRPD.2508.C1_x_at
CGGAGCTCCCCGAAGTGGCGTTTTGGGAACCACTTCGGGTGTTGCGATAACACCCCTCCA
SEQ ID




CCCACGTGGGGCATAACCCTGGGGCTACATGCCAACCCCCAGTGGAAACACTTCTCGAAC
NO:




GTTTCCGGGGAGACACATTACATCAGAGAAAGCCCCTACTGTCGCGGTGTGAGGGCCCCC
1518




CCCACCGTAAAAATCTTTTTGGTGGGGGCGTGGTGGGACCTCTATAATCA





YES1
ADXCRPD.12191.C1_at
CTGATTATCAGGTTTTGGCTGGGTTTTGTTAACTGCTGAGCTCTTTGAACAAATAAAATA
SEQ ID




TTTGGNCTACAAGTGCTCTGATTATGAGGTGGGTGAACCTGTAGCCTTGCCAGTCACCCT
NO:




CCTTTACCACCTTAACAGGTCCTCACTATTTAAAAATCACTGTTTTGAGTTCCCTGTTAG
1519




GAGACTCAGATTCTCCCAATAAGGCATTGCTAT





TFE3
ADXCRPD.2523.C1_s_at
TTATTGCTCCGCATACTGAGAATCTAGGCCACCCCAACCTCTGTTCCCCACCCAGTTCTT
SEQ ID




CATTTGGAGGAATCACCCCA
NO:





1520





CAPN2
ADXCRPD.2526.C1_at
GGCACGAGAATGTACTCTCCTGGCGGCAGCTTGAAGCGGTTGAGCACCTCCCGGAGGTTG
SEQ ID




ATGAAGGTGTCTGAGCGCTCCCTGGCGCGATTCGTCAGGAAGAAGTTTTTGCTGAGGTGG
NO:




ATGTTGGTCTGCCCACTTAACTCCTCTGGAACCTCATAGATGCCAAAGCCGATGGTGTGC
1521




ATGTCCTCGCCCATCTTCCTCTGCCGCCGTCGGTGCTTCTGAATGAG





ADAM9
ADXCRPD.11545.C1_at
CTCCGCACTGCAACTGCTAAAGTTTCTGGAACACGATGCTCCTGAATTCATGATGCAGCT
SEQ ID




CTTTGCTCCACAGGAACAATCTCTCCCATCATCGTGATTCATTCCAAGATTATGACCCAA
NO:




TTCATGAGCAACAATGGAAGCAAATGTCTCCACAGTGATTTGTCCAAACACATTAATCCC
1522




GCCTGCGTGGCTCCTTGAACACACTGTTCCCACAAATGCCATTCCTGCAGTTCCACCCCG




ACCTTTCTTTAGAACTAGCTGTGTACTGTCA





PTPRK
ADXCRPD.10919.C1_at
CATAATAGTTCCAAGCTAAAAACAACCCAAATGTCTGTCAGCAGTGCAATGTATAAATAA
SEQ ID




ATGGTGGCATATTCATAAAGTGAAATATTGTACTGCAAATAAATGAAAGAACCATTGCTT
NO:




TATACAATAACATGAATGAATTTCGCAAACACAATCTTAAGGGAGAGAAACCAGATGCAA
1525




GAGAGTATGTATATATACATTTATATAAATTATGTAAGTTTCAGAAACAGGCAAAACTAA




TCAATGATATTAGAAATCAGCATATTATTTACTTGAAGAGGATTTGGGCAACTT





CD44
ADXCRPD.11577.C1_s_at
AAACAGCATTGCTTTCTGAAATTAGGGCCCAATTAATAATCAGCAAGAATTTGATCGTTC
SEQ ID




CAGTTCCCACTTGGAGGCCTTTCATCCCTCGGGTGTGCTATGGATGGCTTCTAACAAAAA
NO:




CTACACATATGTATTCCTGATCGCCAACCTTT
1527





SPTBN1
ADXCRPD.1922.C1_at
TCATATAGCATCTTGGTTAGTTTTTCCTTATCTCTATGTACATATCTATCTACTTCTGAC
SEQ ID




TGTAGATGGGTATATAGATAGATGCCAAAGCTTCTTATGGTTCTGGGGGTAGTATGCATC
NO:




ATTTATTGGGGTCTCTGCCTTTAA
1532





SPTBN1
ADXCRPD.1922.C1_s_at
GTCAGGATAACGTCATATAGCATCTTGGTTAGTTTTTCCTTATCTCTATGTACATATCTA
SEQ ID




TCTACTTCTGACTGTAGATGGGTATATAGATAGATGCCAAAGCTTCTTATGGTTCTGGGG
NO:




GTAGTATGCATCATTTATTGGGGTCTCTGCCTTTAAACACATCAAAATTCATTTTAGACA
1533





RAB31
ADXCRPD.1938.C1_s_at
AGCCGCCGGTGCTGTTGACCCAAGGGCCGTGGTCCACGGTACTTGAAGAAGCCAGAGCCC
SEQ ID




ACATCCTGTGCACTGCTGAAGGACCCTACGCTCGGTGGCCTGGCACCTCACTTTGAGAAG
NO:




AGTGAGCACACTGGCTTTGCATCCTGGAAGACCTGCAGGGGGCGGGGCAGGAAATGTACC
1535




TGAAAAGGATTTTAGAAAACCCTGGGAAAACCCACCACACCACCACAAAATGGCCTTTAG




TGTATGAAATGCACATGGA





MAPK1
ADXCRPD.10998.C1_at
GAGATATCCGTAGATGGTTTATAGAAATGCATTTGACTTTGGTAAACTGATGAATTACTG
SEQ ID




GAATAAAAAGATGTCCAACAAACTCTTATTCCAGTAATCCCTCTTTAAATTTTTTAAGGA
NO:




CAAACATATCATCTGAAAATCATGATATTTTGTTTCTTTTCATGACGTAGATATATTTTA
1537




TCTTGTCTTAACTGTGCTGGCCGGACTCTCCATTACAAAGTTGAAGAGCAGTGGTGATAC




AGAGGGCATCCCTGACTTGTTCTGATGTTAAAAGGAAAGCTTTTATTGAGTGATAG





AHNAK
ADXCRPD.9802.C1_at
AACATCAAGGCTCCCAAGATCTCGATGCCTGACGTGGATGTGAACCTGAAGGCCCAAGGT
SEQ ID




GAAGGGTGATGTGGATGTTTCACTACCTAAGGTGGAAGGTGATATGAAAGTGCCAGAGGT
NO:




AGACATTAAAGGTCCTGAAGGGAAGCTCAAAGGTCCCAAGTTTAAGATGCCTGATGTACA
1539




TTTCAAAAGCCCACAAAGGCTAAGGTCCACATCTGGATGTGA





FLNA
ADXCRPD.3227.C1_at
TTCACCCTGTCTGGGTGGAAGTCCTGGGGCGCGTCACGGATGTCAGCCATGAAGGGGCTG
SEQ ID




AGGCGGATGTCTTCGCTGTTGCACAGCACGTGAACGGCATACTCGCCAGCCTCCTGCGGC
NO:




CAGTAGCGCACATCACAGGAGCCGTCGCCCTTGTCGTCACATTCGATCTTAGCCTGCGAT
1542




GGCCCTTCCACCGAGAAGCCCAGCGTGCCCACGTCGTCCCCGATAGCCTCCACCACAAAG




TCTGCTGACTTGCCAACGACG





SPTBN1
ADXCRPD.3234.C1_at
TCCTTGTTTTCTTGGTTAGTGATTCATTTGCATAAACATTAATGATCTCTGCATACTGGT
SEQ ID




TTGGGGTTTTCTCTTTCCTTCTAACTCTAAAGAAAAAATTTTTGCTGCAGAATTATCCTC
NO:




AGAAGAGGCTTCCTGGCCTTCATCTACCCTGCAGTCTGACCAAGTATGATAAATTTTAGC
1543




CGTTTTCAAGGAAACATCTCTCTACCCAGGTCATTGCTGTCACTACAGCTTTCAAGTCAC




CACACTAATT





SEC61A1
ADXCRPD.3290.C1_s_at
CAGCCCACGCTTAGGAATGCTTGGCCTCTGGCAGGCAGGCAGCTGTACCCAAGCTGGTGG
SEQ ID




GCAGGGGGCTGGAAGGCACCAGGCCTCAGGAGGAGCCCCATAGTCCCGCCTGCAGCCTGT
NO:




AACCATCGGCTGGGCCCTGCAAGGCCCACACTCACGCCCTGTGGGTGATGGTCACGGTGG
1547




GTGGGTGGGGGCTGACCCCAGCTTCCAGGGGACTGTCACTGTGGACGCCAAAATGGCATA




ACTGAGATAAGGTGAA





NPC1
ADXCRPD.11658.C1_at
GTTCTTACGGGTCTGAGCCTCTGGATGCTCTCTCAGATTTCTGCTGTGGATGAAGGGACT
SEQ ID




CAGCTGCTCGCTGCAGGTCACCTGACCTCCCTCATGCCGTCACCCATCCACTCTGACGGG
NO:




TGGGTCATATGCAGAAGCTTCTCAGCACCTGGCCAAGTTGTAGCCGATGGTCTGTCCGAA
1548




AATGCTGGTTCACTCTCCACTGGCCAACTGTCTGTCTGCACTGCACTGCCAGTTGCCTCT




TGCCTGCGCCATTGCGCTAACATC





VCAN
ADXCRPD.2656.C1_at
CTTTCCTCACACAATTTGGAATCATATAATATAAGTACTTTGTCCCTGATTAAATAATGT
SEQ ID




GACGGATAGAATGCATCAAGTGTTTATTATGAAAAGAGTGGGAAAAGGATATAGCTTTTT
NO:




AACCAAAAGGTGTTTTGCCCCATTCCTAAGAAAATGGAGCGGATTAATATAGAAAAATAA
1549




GTGTGGGGCATTTTCTTTCCCTGGTTAAGGGGGAAAATGGTATGTGGGTTTGAACATTTT




TCTTCCCCCAATTGC





SVIL
ADXCRPD.9920.C1_at
GTGAGTCAAGAAGGCCCTCCCCTGTCGGCGTTTGATCTCTCCAGCAGCAAACATCGCACA
SEQ ID




TGGATTCTTGCAGAGCTTCTCCTGCGGCTGTTCCGAAGAATCCTGGGGCTTCCAGGACAC
NO:




GGGGGCTGTGGTTTAAGCAATAGTTTTCCCAGCAGCTGTCCCCGTCTGCTCGGAAGTGGG
1551




CTCCCCGAACTCTGCCGCTCTTAGTGAAAACTTCCTTTTCATAACATTCTCCACCTCCAC




CTTCTCTTCAAAGGGCAGCCTGTCCTCAAGTC





CAPN2
ADXCRPD.9976.C1_at
TCGGCTCCGGTGACCGAGTACGCGTGCCCCTTCACCAGCTTCTGAAACGTGAATGGCCTC
SEQ ID




CGAGTCCCCGGCGCTGGTGATGTCGATGGAGCAGCCAAGGAGAGAGCCTTTTTGCAGAGC
NO:




TTTCTGGATGATCTTGAACAGGTTGGGAGGGGGCTTCTTCAACTCATACCACTCAGCAAT
1552




GCTCCGGTGAAGTCTTCGAAGCCCTCAGTGGTGGCACCCCCTGATAGTGCTTCATAGCAT




CCGTTGATCTTGCGTATGCCTTC





COL4A1
ADXCRPD.3378.C1_at
CTAAGACTACTAAGGCCTTTTATGTAATTTCTTTAAATGTGTATTTCTTAAGAATTCAAA
SEQ ID




TTTGTAATAAAACTATTTGTATAAAAATTAAGCTTTTATTAATTTGTTGCTAGTATTGCC
NO:




ACAGACGCATTAAAAGAAACTTACTGCACAAGCTGCTAATAAATTTGTAAGCTTTGCATA
1553




CCTT





COL4A1
ADXCRAD_CN256234_s_at
ACCTTAAAGGCCGTCATTTCATTAGTATTCCTCATTCTGCATCCTGGCTTGAAAAACAGC
SEQ ID




TCTGTTGAATCACAGTATCAGTATTTTCACACGTAAGCACATTCGGGCCATTTCCGTGGT
NO:




TTCTCATGAGCTGTGTTCACAGACCTCAGCAGGGCATCGCATGGACCGCAGGAGGGCAGA
1554




TTCGGACCACTAGGCCTGAAATGACATT





SNAPC1
ADXCRPD.2725.C1_at
GAAAGAATCCATCCTTAAAGTCAAAAACTAATGATGGAGAAGAAAAAATGGAAGGAAATA
SEQ ID




CACAAGAAACGGAGAGATGTGAAAGGGCAGAATCATTAGCGAAAATAAAATCAAAGGCCT
NO:




TTTCAGTTGTCATACAGGCATCCAAATCAAGAAGGCATCATCAAGTCAAACTCGACTCTT
1555




CGGACTCTGATTCTGCATCTGGTCAAGGCAAGTCAAAGCAACTAGGAAAAAAGAGAAGAA




AGAAAGAGTGAAACCAGCAGGAAGGAAGATGTCTCTCTAGAATAATAC





SPTBN1
ADXCRPD.2749.C1_s_at
AGAGAAGCGGTTCAGCCTTTTTGGCAAAAAGAAATGAACTCCTTTCCTTCACCTCCTGCC
SEQ ID




CTTCTCTTACCTTTTCAGTGAAATTCCAGCATGCAAGCTCAGAACCAACACATTACTCTC
NO:




TGTGCCTAATGTTCCTCA
1556





AHNAK
ADXCRPD.11792.C1_at
TCTGGTCCCTCAATGTCAATGTCTGGCCCACTGACATCCACATGTGGCCCTTTAAGGTCC
SEQ ID




CCTTCCAATGTGGGAACATCTACATCCACCTCTCCTTTTGCCTTGGGGCTCTTCAAGTGT
NO:




AGATCGAGGTCTGGCATAGAGATTGTGGGAGCTTTAAAGTGCATATCTGGCATCTGGAAC
1559




TTAGAAGTTTTCCACTTGCCATTTGGGCCTTCCACAGCTACTTCTGGCATGCCAG





CORO1C
ADXCRPD.2786.C1_at
AAGTCTTCCTGTTGTACAGTCATCAAAATGACCAGGTTTGTGCTGCAAAGGAGCCAGCAC
SEQ ID




CATGTGGCTACTGCTTTGATTGTTCTCAGATGAATGTTTATACAAAATAATATCTTATCT
NO:




TCATTTAGTTTATAAACATACACAGTGCTGTCCCTTTCAAATTAAGGANAAAAACCACAC
1560




ACACAAATACTGCAAAGTAGCAAAATACAAAGGAAAACAAAGCTACTTTTGGTTTTGGCA




ACATTAAAAAAGAAAGAAATATAAAAAGCAATGTGGCATTGGTCCCTATTCAT





CALU
ADXCRPD.558.C1_at
GTAAACCAAGTTTTATATTCTGCAATGCGAACAGGTACCTATCTGTTTCTAAATA
SEQ ID





NO:





1563





CALU
ADXCRAD_CN403921_s_at
GATAATTTAATAATGCCACCAACTCTGGCTTAGTTAAGTGAGAGTGTGAACTGTGTGGCA
SEQ ID




AGAGAGCCTCACACCTCACTAGGTGCAGAGAGCCCAGGCCTTATGTTAAAATCATGCACT
NO:




TGAAAAGCAAACCTTAATCTGCAAAGACAGCAGCAAGCATTATACGGTCATCTTGAATGA
1564




TCCCTTTGAAATTTTTTTTTTGTTTGTTTGTTTAAATCAAGCCTGAGGCTGGTGAACAGT




AGCTACACACCCATATTGTGTGTTCTGTGAATGCTAGCTCTCTTGAATTTGGATATT





JAK1
ADXCRPD.4023.C1_at
TGCATTTATTCAGCTGTCCAGTGTTCTCCAAGAAGCAAACTGGATTTTCTTCTCTACTTT
SEQ ID




CCAAAGCTACTTCAGAGAAGCGCACTTCCGTGTGCGCCTGGGCCAGGCAGCGCCCCGTCG
NO:




CTGCGCTGGCTGGGGTCGACCGGCAGGCTCGCTAGGCGGCCAGCCCCGCGGGGCCCCAGC
1568




GTGCGCGCGCCCAGGGCTGAGGAGGGGTCGCGGCGAGGACAGCCGGGACTGGGCGCAGG





MAPK1
ADXCRPD.4057.C1_s_at
GAATCTGAATGTTTATTCATTATATTGTTACAATTTAACATTAACATTTATTTGTGGTAT
SEQ ID




TTGTGATTTGGTTAATCTGTATAAAAATTGTAAGTAGAAAGGTTTATATTTCATCTTAAT
NO:




TCTTTTGATGTTGTAAACGTACTTTTTAAAAGATGGATTATTTGAATGTTTATGGCACCT
1569




GACTTGTNNNNNNNNNNNCTACAAACAAATCCTCTAGAATCATTAAATTGTGTCCCTGTA




TTACCAAA





TSPAN4
ADXCRPD.13071.C1_at
ACCCTGTTTCTGGAAGGCCCTAGCTCAGGTGGCTTCAGGGCCTCCGGACCCCCCCTGGGA
SEQ ID




GGGGTGGCCACGTGCTGGCTGCGGAACCCAGGGCAGGGGTGGGAGGGGCCTCCAGCACTT
NO:




TTTATATTTACGTATTCTCCAAAGCAGTGTTCACACGGGAGCCAGCCTGTGCCCCCAGCC
1570




TCCTGGAAAACAGGTTGGCGCTGGAGGAGCCGGGTCTTGGCATCCTGGAGGTGGCCCCAC




TGGTCCTGGTGCTCCAGGCGGGGCCGTGGACCCCTCACCTACATTCCATAGTGGGCCC





LAMB1
ADXCRPD.12445.C1_at
AAGGCCAAGTGCGTGATCTTTGAGAGGTTTTGGTAGGTAAGAAAGGAGGACTCTATGCAT
SEQ ID




GTGTGATGGCAGTCGGGGGTGGTAATTTGGGAACACTTCATCTACCTTTGTTCCTTTGTT
NO:




TGTACTGTTTTCTTAAACCTGTGGAATGTTTTCCCACTTCCCCTGCGCAAATCCCACCAG
1576




CCAACAGCTTCTTCAGCTACAACTGTAGCATTCCTCTGCAGTCTCTCCTTTGTCGACTTT




CTTTCATAGTGACTGCATCTGACCTATTCTTGCCCTGC





PLAUR
ADXCRPD.3441.C1_s_at
CAGCCCTACAGACTTGCTGTGTGACCTCAGGCCAGTGTGCCGACCTCTCTGGGCCTCAGT
SEQ ID




TTTCCCAGCTATGAAAACAGCTATCTCACAAAGTTGTGTGAAGCAGAAGAGAAAAGCTGG
NO:




AGGAAGGCCGTGGGCCAATGGGAGAGCTCTTGTTATTATTAATATTGTTGCCGCTGTTGT
1578




GTTGTTGTTATTAATTAATATTCATATTATTTATTTTATACTTACATAAAGATTTTGTAC




CAG





IL6ST
ADXCRPD.11859.C1_at
AAATGCTTGGCCTAGAAGATGACATGCATGAAGACCCCCCAATACCACTGCTGTGTCCTT
SEQ ID




CAGTATTAATTTTTTCCTTTTTGAACAGGTCCAATGATTTCAGATCTTCTGGAAAAGGCT
NO:




TATTGTCATTTGCTTCTATTTCCACAACACTTACATCAGTGAAATTGCCATCTGAATACA
1581




TTTGATCTTCCGAATTAAAATTGTGCCTTGGAGGAGTGTGAGGTGACCACTGGGCAATAT




GACTCTTTGAAGGATCTGGAACATTAGGCCAGATGTGTAAACAATTAGGTCTCGCTTAT





CRIM1
ADXCRPD.11873.C1_at
GTCCCTACTGCATAGAAGACACAATTCCAAAGAAGGTGGTGTGCCACTTCAGTGGGAAGG
SEQ ID




CCTATGCCGACGAGGAGCGGTGGGACCCTTGACAGCTGCACCCACTGCTACTGCCTGCAG
NO:




GGCCAGACCCTCTGCTCGACCGTCAGCTGCCCCCCTCTGCCTGTGTTAGCCCATCAACGT
1583




GGAAGGAAGTTGCTGCCCATGCGTCCATGTAAGG





CRIM1
ADXCRPD.11873.C1_s_at
TGCATTGATAGCGTAATTAGCTGTTTCTCTGAGTCCTGCCCTTCTGCATCCTGTGAAAGA
SEQ ID




CCTGTCTTGAGAAAAGGCCAGTGATGTCCCTACTGCATAGAAGACACAATTCCAAAGAAG
NO:




GTGGTGTGCCACTTCAGTGGGAAGGCCTATGCCGACGAGGAGCGGTGGGACCCTTGACAG
1584




CTGCACCCACTGCTACTGCCTGCAGGGCCAGACCCTCTGCTCGACCGTCAGCTGCCCCCC




TCTGCCTGTGTTAGCCCATCAACGTGGAAGGAAGTTGCTGCCCA





P4HA1
ADXCRPD.653.C1_s_at
AGTATTTCACTACATCTCAGTTGGTGGGTGTTAAGCTAGAATGGGCTGTGTGATAGGAAA
SEQ ID




CAAATGCCTTACAGATGTGCCTAGGTGTTCTGTTTACCTAGTGTCTTACTCTGTTTTCTG
NO:




GATCTGAAGACTAGTAATAAACTAGGACACTAACTGGGTTCCATGTGATTGCCCTTTCAT
1585




ATGATCTTCTAAGTTGATTTTTTTCCTCCCAAGTCTTTTTTAAAGAAAGTATACTGTATT




TTACCAACCCCCTCTCTTTTCTTTTAGCTCCTCTGTGGTGAATTAAACGTACTTGAG





AXL
ADXCRAD_NM_021913_s_at
GTTCTAACCCTATACTGTAGTATTCTTTGGGGTGCCCCTCTCCTTCTTAGCTATCATTGC
SEQ ID




TTCCTCCTCCCCAACTGTGGGGGTGTGCCCCCTTCAAGCCTGTGCAATGCATTAGGGATG
NO:




CCTCCTTTCCCGCAGGGGATGGACGATCTCCCACCTTTCGGGCCATGTTGCCCCCGTGAG
1586




CCAATCCCTCACCTTCTGAGTACAGAGTGTGGACTCTGGTGCCTCCAGAGGGGCTCAGGT




CACATAAAACTT





FNDC3B
ADXCRAD_BU665386_s_at
ACTACTTCTAATCTAATCACTAGAGTTATTATATTCTGTTATGTTTGACCAGAATTATAT
SEQ ID




GACAAGAACTGGTGACAGTTTAGTGCCTCTGCCCATTGTCCATGATTTACACTAATTGTG
NO:




AGCAGTCTTCTTA
1587





PPIC
ADXCRPD.13145.C1_at
CATTTTATCTGCTATAAGGAGAATTTTGGTAGGGCTAAAAGTGGAAGCAGTCCTTATCAG
SEQ ID




GAAACCCAAACATTTATAACTTTTGGGAATTTCTCACTCCTGGGACTGGCTTTAGAAAGT
NO:




GATCCAAAATTGTAAGGGGAGATCATCAGTGTTTTGGTCAGCCTGGCAATTTAGTCCACT
1590




TGCTCTGGTGATGGCTGCCCAATTTCTTATTTTTCTTTTGAGAAATCACATCCTTCCCTC




ACCCATCTCTAGTCCTTAGGGTGGGCTGACTCTACAGGATGGGTAC





FLNB
ADXCRPD.13162.C1_s_at
AAGGACGGCACGGTCACTGTTAGATATGCCCCCACTGAGGTCGGGCTCCATGAGATGCAC
SEQ ID




ATCAAATACATGGGCAGCCACATCCCTGAGAGCCCACTCCAGTTCTACGTGAACTACCCC
NO:




AACAGTGGAAGTGTTTCTGCATACGGTCCAGGCCTCGTGTATGGAGTGGCCAACAAAACT
1591




GCCACCTTCACCATCGTCACAGAGGATGCAGGAGAAGGTGGTCTGGACTTGGCTATTGAG




GGCCCCTCAAAA





CCND1
ADXCRPD.3501.C1_s_at
TCTGTCTGAACCACGCGGGGGCCTTGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGC
SEQ ID




ACAAGTCCTGGATGTTGTGTGTATCGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGGGCA
NO:




CAGCGGAGTCTGTCCTGTGACGCGCAAGTCTGAGGGTCTGGGCGGCG
1592





CCND1
ADXCRAD_BM551840_x_at
TGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACAAGTCCTGGATGTTGTGTGTAT
SEQ ID




CGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGNGCACAGCGGAGTCTGTCCTGTGACGCG
NO:




CAAGTCTGAGGGTCTGGGCGGCGGGCGGCTGGGTCTGTGCATTTCTGGTTGCACCGCGGC
1593




GCTTCCCAGCACCAACATGTAACCGGCATG





FTH1
ADXCRPD.13188.C1_at
AAGTGCAGGGTCAGTACTCCAGCGCCCTCTCATCAGACAATGAATTCTGACACTGGCTGT
SEQ ID




AAGTTTTCTGTGCAGTAATACAGATCCTTAAGACATTGCCCCAGGCAATGCCCATAATAT
NO:




CCTAAAGGTTCCTTGAAGTTAAGTTTCAAGGATCAAGTTTCAGTTTTCTATTTTAGAATA
1594




GAAACATTACTCTTGGGTTCAATCCAGTAGCTCATCTGCCCCCCAGTCTCCTTAGGCACT




GATTCCTTCATGCTGTGCTTTGA





PTPRK
ADXCRPD.13194.C1_at
ATCACATGAATATATCTGCCTGACAAAAATTTGGGAAGTCCAGCATCTCTGATTTAAAAA
SEQ ID




GAAGAAACTATTTGTAATTTTAGTCTCTTGTTCTTAATGCAGGATCTGACCATTGGTTAG
NO:




TAATGCAACAGCTGCGATTAGCAATGAAGGAAAACTATTTTCAGAGTCTTCTCATGACCT
1595




AGCCACATTAGCAATCTAAAAATACAAACAGGAAAAGTTTTTAAAAGCTTAACCTTTTAT




AAAGTGACTAAACTGCATAAGCCATCAGCCACAGA





PTPRK
ADXCRPD.13198.C1_at
CACCGGAGGTAGTTGATAGATCGAGAATACACAAGGACACTCACAGTCACACATAGAACC
SEQ ID




TAGAAACAACACTCCCCAAAACAGATGTAGATTCAACAAAATACTATAAAAAGCCATAAA
NO:




GCATATTCAGTATATAATGTTTAAATTGTTCTGACATATATGTTGTTTGTATACCCGCAC
1596




AAATGTTACTGTCATTAAACTAATGATCCTATTTTCTTCTTCTCAAAAAAAGTCCTAGAA




ATCTGTTTGTGATGGCTTGATGAAGTTTAGTCACTTTATAAAAGCCACCTTGG





KDELR3
ADXCRPD.3569.C1_at
TACTTAGGCGAGTACCATTTGCACAATCACTGTTTTACTTATGAGCAGATACAGATATAT
SEQ ID




CCAAACCCTTACCTACTAGGTATCCTGCTAGGGTTTTCAATTCCAATTCTTGTATTAAGT
NO:




TTTTTCCTTTCAGTTTTAGGTGCGAAAGTAATCAGTCAATCCAATATCCCCCATCTTTGT
1599




CTTGAAACAAAAACTGTTTTAAGACGTCTACGTTGAATTATTCAGAGAATTAAGCAATAA




AAGCTCACACCTTAT





VEGFA
ADXCRPD.3590.C1_s_at
GATTCTGATAAAATAGACATTGCTATTCTGTTTTTTATATGTAAAAACAAAACAAGAAAA
SEQ ID




AATAGAGAATTCTACATACTAAATCTCTCTCCTTTTTTAATTTTAATATTTGTTATCATT
NO:




TATTTATTGGTGCTACTGTTTATCCGTAATAATTGTGGGGAAAAGATATTAACATCACGT
1601




CTTTGTCTCTAGTGCAGTTTTTCGAGATATTCCGTAGTACATAT





CORO1C
ADXCRPD.2994.C1_s_at
GAACATTCTGGATAGCAAGCCCACTGCAAACAAGAAGTGCGACCTGATCAGCATCCCCAA
SEQ ID




GAAAACCACAGACACGGCCAGTGTGCAAAATGAAGCCAAGTTGGATGAGATTTTAAAAGA
NO:




GATCAAATCTATAAAAGACACAATCTGCAATCAAGATGAGCCGTATTTCCAAGTTAGAAC
1604




AAGCAGATGGCAAAGATAGCAGCCTGAAGGTCCCACC





KIF2C
ADXCRPD.737.C1_s_at
AGCATCCTGCCTGCGTGGACTGGCTGCTAATGGAGAGCTCCCTGGGGTTGTCCTGGCTCT
SEQ ID




GGGGAGAGAGACGGAGCCTTTAGTACAGCTATCTGCTGGCTCTAAACCTTCTACGCCTTT
NO:




GGGCCGAGCACTGAATGTCTTGTACTTTAA
1607





TGFBR2
ADXCRPD.4225.C1_s_at
AAAGACCAAGGAATAACATTCTGTAGTTCCTAAAAATACTGACTTTTTTCACTACTATAC
SEQ ID




ATAAAGGGAAAGTTTTATTCTTTTATGGAACACTTCAGCTGTAC
NO:





1610





EPAS1
ADXCRPD.4267.C1_s_at
TGCACGGCATTACCCCACACAGGGTGGCAGAACTTGAAGGGTTACTGACGTGTAAATGCT
SEQ ID




GGTATTTGATTTCCTGTGTGTGTTGCCCTGGCATTAAGGGCATTTTACCCTTGCAGTTTT
NO:




ACTAAAACACTGAAAAATATTCCAAGCTTCATATTAACCCTACCTGTCAACGTAACGATT
1611




TCATGAACGTTATTATATTGTCGAATTCCTACTGACAACATTATAACTGTATGGGAGCTT




AACTTTATA





SYNJ2
ADXCRPD.4271.C1_s_at
TTACTGTACCGCCTGTTGTATCTGGGAGCCTCGTACAGAGGCTCGCACAGCAGTGATCAA
SEQ ID




GTGTCATCCCTTACGTGACTGGGGGATGTCTGTCCTAAAAGCTGACTGCTAGGATAGTAA
NO:




GGATCATCTTGCCTGGGCTATGCCACTGTCTTGTTACCAATTAGACATCTGGAATTTCAT
1612




AATTAGTTTTCATTGTCACTGTCAAG





JAK1
ADXCRPD.3619.C1_at
CAGTTGTTGAAGTGTAGCAGCAGCTTTTTGCAGGGAAAGAGGGAGTTGTATTTATTGCTT
SEQ ID




CTCCATGACATGGTTCTTTTCTCATTAGTTCATGGGCAAGTCAAGGGAAAGAGACCTAGG
NO:




TAGCAGCTGAGTCTGTAGCCTACAGATGGCCTGGGCTGGCTTGGCTCAGTCACTTCCCTT
1613




AGTCACTTCCACACATTCCAGAAATT





PHACTR2
ADXCRPD.12664.C1_at
TTATACCAAGATCAAACAAAGCCATGATTTCTGTTTCACTCTGCATTGGGCTAATTGATG
SEQ ID




TTTGGACAGTTCAATTCTGATAACAGCAGCGCACACTCTAATTCTCTCTGGGAAGTGAAG
NO:




GAAACACTGCCCTGTATTTTCCTGACTTCAGGCTTATACTCTGGCAATCTTCCAAAAACT
1614




TCCCATGGCTGCCCATCTTACTTCCAACAATCCCTGAAC





PPP4R1
ADXCRPD.4310.C1_s_at
ATACCTTGAGGGAAGTCTGCGATGATGAAAGAGATTGTATTGCTGTTTTGGAAAGAATTA
SEQ ID




GCAGATTGGCCGATGATTCAGAACCAACTGTGAGAGCGGAGCTGATGGAACAGGTGCCTC
NO:




ACATCGCACTGTTTTGTCAAGAAAACCGGCCTTCAATACCATATGCTTTTTCAAAATTCT
1620




TACTACCTATTGTGGTTAGATACCTTGCAGATCAGAATAATCAGGTGAGGAAAACAAGTC




AGGCAGCTTTGCTGGCTCTGTTGGAGCAGGAGCTCATTGAACGATTTGA





FLNA
ADXCRPD.13338.C1_at
GGTAGGCGTCAATGTCACTTACTGGAGGGGATCCCAGCCCTAAGAGCCCTTTCTCAGTGG
SEQ ID




CAGTATCTCCAAGCCTGGACCTCAGCAAGATCAAGGTGTCTGGCCTGGGAGAGAAGGTGG
NO:




ACGTTGGCAAAGACCAGGAGTTCACAGTCACAATCAAAGGGTGCTGGTGGTACAAGGCAA
1621




AGTGGCATCCAAGTATTGTGGGCCCCTCGGGTGCAGCGGTGCCCTGCAAGGTGGAGCCAG




GCCTGGGGGCTGACAACAGTGTGGTGCGCTTCCTGCCCCGTGAGGAAGGGCCCTATGA





CTSA
ADXCRPD.13357.C1_at
GGGATAGCAAAGATAGATCACTAACAGCGATAGGACCCCAGAGTAGCACAGCAAGCTGGG
SEQ ID




GGCCCTATGAGACTTCCTGTCAGGACAAGGGAAGCTGAAACTCCGAAAGGCGAAGCCCAG
NO:




GGTCCTGTGATTGGTGGGGTCAGAATTTGAACCTGGGTTTGTCCCCACCCATGCTGTCCT
1625




GCTATAGGAGGCCTAGGGGTCTGCATCAGCCACGGAGTCTTAAGGGTGAGAAGAGCTTCA




TTCATGCCAAAAATGGGCCAGCAGAT





ZDHHC7
ADXCRPD.12706.C1_at
TTGGTCCGGAGCCACCTGCGGACAAGCGTTCTGCCTGGGTCTTGGCTCTTGGCGTTTCTT
SEQ ID




TGCAGCTCCATCTCTCCGAGTGCTCCCATCTGATACACGTTTCAAAAGTTCAATTCCAGG
NO:




GTAGCCAAAAGTGTGAAGCTGCCATGGAGAAGGGCTAAAAAACAACCAGGAACCAAGCAA
1626




CCACT





ADAMTS1
ADXCRPD.13363.C1_at
TATGATGCGATCACAACCAGCTTTTACACACTGTCCTTGCACACAGACAGAGGTGGAATC
SEQ ID




TGGGCTACATGGAGTACCATCTACAACCTTGGGCTGCAAAACGAAGAAGTAGCCAATGCC
NO:




TTTGGCTTGGCAGATGAGCTTGCACCTGTCCTTTGGTGAGACGCCAGCGTACTTGGGAAT
1627




CCATTCCACCGCAGGCCCACTCCCAAAGGAAGCTTTTGAAAACTCGTTGTGTGCTTCACA




TT





PMP22
ADXCRPD.5015.C1_s_at
AAATCATAAAGCCTTCATCACTCCCACATTTTTCTTACGGTCGGAGCATCAGAACAAGCG
SEQ ID




TCTAGACTCCTTGGGACCGTGAGTTCCTAGAGCTTGGCTGGGTCTAGGCTGTTCTGTGCC
NO:




TCCAAGGACTGTCTGGCAATGACTTGTATTGGCCACCAACTGTAGATGTATATATGGTGC
1634




CCTTCTGATGCTAAGACTCCAGACCTTTTGT





KCMF1
ADXCRPD.14034.C1_at
ATTGCCAAGTGGAGATAAAGGTGTCCATTTGGGTAGGGTCAGGAAGCTGTGGTATTCATG
SEQ ID




CCTCATGGCCTTTCATTTTCTTAGAGCCGTAGGGGTAAAATCATGCCATTTTTTGCCTCT
NO:




GTGCCTCATAAGTTTGTACTCCTTCCTCCTTTAAAAATCAGCTGTAAGAGCTGGATGTGC
1635




TGTA





SPTBN1
ADXCRPD.13403.C1_at
GGGCAGACAGGAGGGCATCCTTCTTCCTGTCAACCAGTTCTCTGAACTGGCTCCACCTTG
SEQ ID




TGTTGAGTTTGTCCTGCTGGGCTTTGATTTCCTTCTCACTTGGGTGGCCGCTGTGCATCA
NO:




GCTGGCGTGCCATCTGGTTCACCACTGCAACCCGGGAAGCCTGGTTGTTCATTTCTGGTT
1639




CTACGGCTCTCAATCTGTGCTGGATGTACCTCCACGATCCTCCAGCTTCTCTGGGATCTG




CATGTTGTTGAGCCACTGCTCCTTCTCGTCGATCCAGAGCTCACGGCATAGC





PPAP2B
ADXCRPD.13412.C1_s_at
ATGTTCTGGCAGGATTTGCTCAAGGAGCCCTGGTGGCCTGCTGCATAGTTTTCTTCGTGT
SEQ ID




CTGACCTCTTCAAGACTAAGACGACGCTCTCCCTGCCTGCCCCTGCTATCCGGAAGGAAA
NO:




TCCTTTCACCTGTGGACATTATTGACAGGAACAATCACCACAACATGATGTAGGTGCCAC
1641




CCACCTCCTGAGCTGTTTTTGTAAAATGACTGCTGACAGCAAGTTCTTGCTGCTCTCCAA




TCTCATCAGACAGTA





PTPRK
ADXCRPD.14082.C1_at
ACTAATATGTTCAAAGTGCCAGGATTCAGTCCTTTCTGGCTATATAATAGGTAACTGAAA
SEQ ID




TCAATGCAGTGAGTGTCGTTCTCCTTCATTGTAGGCAGCTGAAGTCTGGCTTTTTCTCCA
NO:




GGGTCGTGATCTGAAGAGTCCACTATCATATAGGAACCTTGGGGCATCTCGGGTGGTAGA
1647




TAATGAGGCTCTTGAGCACTAACATGCACCCATTCAAAGTCATCATACAGATCCTGGTGG




TAATCACAGGCCCCTGGAC





MARCKS
ADXCRPD.4423.C1_at
TTCAACAAAGAAACTCAACAGATCCAAGAGGGGAAACAAAGAGCCTCGGGTTGGTGTAAC
SEQ ID




GACGGGGCGAGCAGCAGCAGCAGCGGCGGCCAACAGCGGCAGCCTACAGCACACCGGAGG
NO:




AAGGGGGGTGGGGGTGGTGGAGAGGACAGAACAGAACCGATTAAATACACTCCGGATAAA
1648




AAAATTTTAGTCGAAGAGATCAAAAAGCAGCAGCACAGGAGGGAGGGAAAAAGGGTGGAA




AAGTCGAGCACCAAAAAAGGAGCCCCAGT





MARCKS
ADXCRPD.4423.C1_x_at
CCCATGCTGGCTTCTTCAACAAAGAAACTCAACAGATCCAAGAGGGGAAACAAAGAGCCT
SEQ ID




CGGGTTGGTGTAACGACGGGGCGAGCAGCAGCAGCAGCGGCGGCCAACAGCGGCAGCCTA
NO:




CAGCACACCGGAGGAAGGGGGGTGGGGGTGGTGGAGAGGACAGAACAGAACCGATTAAAT
1649




ACACTCCGGATAAAAAAATTTTAGTCGAAGAGATCAAAAAGCAGCAGCACAGGAGGGAGG




GAAAAAGGGTGGAAAAGTCGAGCACCAAAAAAGGAGCCCCAGT





ARID5B
ADXCRPD.12803.C1_at
GATTCTCTAGTATGTAGGACAGTTTCACAGCCTAGATAAGGTAAGTACAATGCTCAATAT
SEQ ID




TTTCACAGAACCCAATACTTCAAAGCAAAGCATTTGGCTGGGTAAGCAGTGTATAAGCTC
NO:




TTTCAACTATGCCATTTATGAGGAACAAAATCCTTAAGTTGCGGATCTACAAAGGAACGT
1652




TCTTTGCACTATTGTGTGCTTGACTGTTTCTTTTTCATTTGTTCCACTAGAATCAGTTAG




CTTCAATGTGTAACAACACGCGCG





COL5A2
ADXCRPD.12854.C1_at
ATGTGCACGTCTTGCTCACGAGCAGTTCTATTATACATTTAGCTAACAAGTAAACAGCAT
SEQ ID




ATATTACATCATCAACTTGGTGATATAATAAGAAATACTACAGAATTAAAAAACATAATG
NO:




TGGATCAAATCATCCTTGCTTAAATACATCAAGAACTTCCCAACTACTTAA
1654





COL5A2
ADXCRPD.3875.C1_s_at
GGGACCATCCCAAAAGACAAGCCATGCATACAACTTTGGTCATGTATCTCTGCAAAGCAT
SEQ ID




CAAATTAAATGCACGCTTTTGTCA
NO:





1656





FNDC3B
ADXCRPD.14126.C1_at
ACCATGGCAACGAGGTAGTCTGTTCTATTTTTGGAGTATGAAAGTAGTGCCTTCTTAAAT
SEQ ID




CTAATAATAAATGAGAGTTCCAGAAAACCAGTGCTTCAAACAAATTTGATTTA
NO:





1658





TFE3
ADXCRPD.14170.C1_at
CCTTTTGAAGGCACGGCAGAACGAAAGACATCAACAACCTTAATTTGAGCGTCGCAAGGC
SEQ ID




GATTCCAACATTTACCGACAGGAATCAGGGAACTGGGGCCTCCTCATCCTAGTCCAGTGA
NO:




CCGGAGA
1660





ID3
ADXCRPD.4520.C1_s_at
CCCAAGTTCTAAGGTCTTTTCAGAGCGTGGAGGTGTGGAAGGAGTGGCTGCTCTCCAAAC
SEQ ID




TATGCCAAGGCGGCGGCAGAGCTGGTCTTCTGGTCTCCTTGGAGAAAGGTTCTGTTGCCC
NO:




TGATTTATGAACTCTATAATAGAGTATATAGGTTTTGTACCTTTTTTACAGGAAGGTGAC
1661




TTTCTGTAACAATGCGATGTATATTAAACTTT





SGCE
ADXCRPD.12912.C1_at
GTTGGATGTCTGGTGTATGCATGTAATCTCTTTTCCACGCCTTCCCGTCGGCAGCACATG
SEQ ID




ATATAAAGCAAGTATTAGACAAAAGGACCAGTTGCCACTGCCGAGGGCACAGCCAGTGTA
NO:




ATCAGGAACTCCGTGTAATAGTCTCTGCTTTTCAAAGAATCAGAAGGGGGTTAGTATTCT
1663




CCCACCATCAGGTAAAATCCCCTCTCCAGGAATTACTTCTTGATAGTGGACCCTTGCTTG




TTTATCACCAATG





FNDC3B
ADXCRPD.13581.C1_at
CCGGATTAGAAGCAGTCAGCCTGAATGTATACTGTGTGCTTCTTTTGAGATTTTTCACAG
SEQ ID




TACAGGTTAAATCCTCTCCAGTGTATTTTGGGTGGAAAAGGTTATCATTTTCATCCTCCT
NO:




GAATTTCCAAGGTGTAGGTGATCACTTCCTCGGGTGAACAGCCTTCTGGCTTACTCCACT
1667




GCAACGTGACCCATGTGATGCCAGCTCGAACCAGCCTTGGTGCAGAAGGCATCTGAGGGA




TATTTCCTAATGTGTAGCACACCACCTCTTGGCTATAACCACTGGTACCAATGTCGTTTC





KCMF1
ADXCRPD.13587.C1_at
GATGGATATCTTTGTCAGTACATATAATTCTATTTGGTTCTCTTTAATGGTCACATAGTA
SEQ ID




AGACTTATTATATTAGGGTCAGCAAAGTATGGCCTCTAGACCAAATATGG
NO:





1669





LMNA
ADXCRPD.3925.C1_s_at
TTGAGCTGCCTTCCCTAGCTTTAGACCCTGGGTGGGCTCTGTGCAGTCACTGGAGGTTGA
SEQ ID




AGCCAAGTGGGGTGCTGGGAGGAGGGAGAGGGAGGTCACTGGAAAGGGGAGAGCCTGCTG
NO:




GCACCCACCGTGGAGGAGGAAGGCAAGAGGGGGTGGAGGGGTGTGGCAGTGGTTTTGGCA
1671




AACGCTAAAGAGCCCTTGCCTCCCCATTTCCCATCTGCACCCCTTCTCTCCTCCCCAAAT




CAATACACTAGTTGTTTCTACCCCTGGC





MARCKS
ADXCRPD.3926.C1_at
AATCCTCCCGTCTCTCCAAAACCATCTCCCCGTCCCCTGACATTGCGGCGCTCTGANNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NO:




NNNNNNNNNNNGAGAGAGCTTTTTGGCGCGCGCCTTTCCCCTGGCGCTTTTCTCCCCGGG
1672




AGGATTGTTCTCCACTTTTCGCCCGTCATAGCCTAAATCCG





LOXL2
ADXCRPD.4590.C1_at
GGGTTGCTCTGGCTTGTACGCTTTCCGGAATCTCGAGGGTCCGTCAGGGCTGAAGACCTG
SEQ ID




CCCAGGCACACAACTCACCACGGCCGGTAGCCCATTCTCGCAGGTGACATTCTTCATGGG
NO:




GTCCAGTGACACCTGGGGGCCCAGCTTGCAGCTGGAGATGTGGGCCTCTGTGCCGGTGCA
1674




GTCCATGGAGAATGGCCAGTAGCGCTGCTTCCTCCGTGAAGCACACATTTTGTACACTTT





YWHAZ
ADXCRPD.12994.C1_at
AAAATCTCCCTTCCAATGCCAGGAAATCTCCTCTAACATAATGAATTTCCCACCCCACCA
SEQ ID




CTATCCCTTACATTTCTTTAAATTCAAGATCACTTTTCTTCTTAAAAAGTAATCAGAGAA
NO:




TTTATAAACTAAGGGTCCTTAGACCAAACCCCAAAATTATGAACAAGAACTCAATCATTA
1678




AGTATTTGTACATTCACCTCAGTCCTGAAGAATAGCCAACCTGCCACTATACACTCAAAC




CACCGTGCTATGTGCTGAGATTTGGGCTTGCCAACCATCTCCGGGAT





CCND1
ADXCRPD.3980.C1_s_at
GGAGGTGGACCTGGCTTGCACACCCACCGACGTGCGGGACGTGGACATCTGAGGGCGCCA
SEQ ID




GGCAGGCGGGCGCCACCGCCACCCGCAGCGAGGGCGGAGCCGGCCCCAGGTGCTCCCCTG
NO:




ACAGTCCCTCCTCTCCGGAGCATTTTGATACCAGAAGGGAAAGCTTCATTCTCCTTGTTG
1679




TTGGTTGTTTTTTCCTTTGCTCTTTCCCCCTTCCATCTCTGACTTAAGCAAAAGA





SERPINH1
ADXCRPD.5216.C1_x_at
AAACTAGGTGCTGCAGCCCCTGGGACCAGGCACCCCCAGAATGACCTGGCCGCAGTGAGG
SEQ ID




CGGATTGAGAAGGAGCTCCCAGGAGGGGCTTCTGGGCAGACTCTGGTCAAGAAGCATCGT
NO:




GTCTGGCGTTGTGGGGATGAACTTTTTGTTTTGTTTCTTCCTTTTTTAGTTCTTCAAAGA
1680




TAGGGAGGGAAGGGGGAACATGAGCCTTTGTTGCTATCAATCCAAGAACTTATTTGTACA




NNNNNNNNNNCAATAAAACTTTTCCCACCCCCCTCACACCTCTTCTCCCTAGAATA





NT5E
ADXCRPD.5241.C1_at
CACAGAGTTCTTGAAACCCACGATTCTTCTTCAAATCCAGATGTGTGTGAGCCCCACCTC
SEQ ID




ATCAACTCTGAAGGCTGAAGGATCAGCTGGAATTTCTGCTGCAGGGTGTCCCTGATAAGC
NO:




TCAAAAGCATCAGAACGGAGGGAGCTTTCTCCCCTTCTCTCATCTCATTAAAATGAGCTT
1683




TCTTGTTGTGGGGGGTTGGGGAGGGACCTTTAAAACCAAACAATGGTGCCCTCTTATCAT




CTTTTNCTGTCCTCCTTTCTCCAAGTTTCCAGAGGG





PEA15
ADXCRPD.14289.C1_at
AAATCAGCACATTCCTCCTACTTCCCTTTCCTCCACTCCCCCCATATCTTTAAAGTGTGG
SEQ ID




AAGCAGAAAGGACCTGCATTTTCCTACATTGAGGAGCTGACATAGGGGTAAGGTATGGGA
NO:




GAGGTAGGTGGATCCAGGGAAAA
1684





PEA15
ADXCRPD.14289.C1_s_at
AAAAGCCAGAGTTCCATGTTTGTACTCCTTGTGCTGGACTGTTTCCTGAGTACCAGCAGG
SEQ ID




TCCCTTTTTGTCTC
NO:





1685





PEA15
ADXCRPD.14289.C1_x_at
AAATCAGCACATTCCTCCTACTTCCCTTTCCTCCACTCCCCCCATATCTTTAAAGTGTGG
SEQ ID




AAGCAGAAAGGACCTGCATTTTCCTACATTGAGGAGCTGACATAGGGGTAAGGTATGGGA
NO:




GAGGTAGGTGGATCCAGGGAAAAGCAGTGGGGACGGAAGGCAAGAGACCACTCAACCCCC
1686




ACCTGGAAGGGGCAAAGAAAAGCCAGAGTTCCATGTTTGTACTCCTTGTGCTGGACTGTT




TCCTGAGTACCAGCAGGTCCCTTTTTGT





IL6ST
ADXCRPD.13648.C1_at
GATAGACCATCTAAAGCACCAAGTTTCTGGTATAAAATAGATCCATCCCATACTCAAGGC
SEQ ID




TACAGAACTGTACAACTCGTGTGGGAGACATTGCCTCCTTT
NO:





1687





IL6ST
ADXCRPD.13648.C1_x_at
ATATGTGTATAGGATTCGCTGTATGAAGGAAGATGGTAAGGGATACTGGAGTGACTGGAG
SEQ ID




TGAAGAAGCAAGTGGGATCACCTATGAAGATAGACCATCTAAAGCACCAAGTTTCTGGTA
NO:




TAAAATAGATCCATCCCATACTCAAGGCTACAGAACTGTACAACTCGTGTGGGAGACATT
1688




GCCTCCTTTTGAAGCCAAT





GJA1
ADXCRPD.13657.C1_at
TTTTAGAATTCTGGTTATCATCGGGGAAATCAAAAGGCTGTGCATGGGAGTTAGAGATGG
SEQ ID




TGCTTCCCGCCTGCCCCATTCGATTTTGTTCTGCACTGTAATTAGCCCAGTTTTGCTCAC
NO:




TTGCTTGCTTGTTGTAATTGCGGCAAGAAGAATTGTTTCTGTCGCCAGTAACCAGCTTGT
1689




ACCCAGGAGGAGACATAGGCGAGAGGGGAGCGGTTGGTGAGGAGCAGCCATTGAAATAAG




CATATTTTTGAGACCCACAGTCTTTGGCAGGGCTCAGCGCA





CD59
ADXCRPD.5301.C1_s_at
AACCCACTGGTGCAAGTCCTAGATTCCAAAGGCTGAAGAACCTGGAGTCTGATGTCCAAG
SEQ ID




AGCAGGAAGAGTGGAAGAAAGCCAGAAGACTCAGCAAACAAGGTAGACAGTGTCTACCAC
NO:




CACAGTGGCCATACCAAAGAGGCTACCGATTCCTTCCTGCTACCTGGATCCCTGAAGTTG
1692




CCCTGGTCTCTGCACCTTCTAAACCTAGTTCTTAAGAGCTTTCCATTACATGAGCTGTCT




CAAAGCCCTCCAATAAA





LPP
ADXCRPD.5328.C1_s_at
GAGCTATAGTACATGTGTGTTATGAATGAAATATGACAGCATGTTCCATACCCCTGCTTT
SEQ ID




AGCCATCTGTGGGAAACCAGCAAACTGAAAAAGACACCTCTGCAAAATGTGCCTCAAGTC
NO:




CATTTCTTGGGATCGCTCGTTTGGTGCACTCTCGTGGGAGACAATCAGAGAACAACATAT
1693




ACTTGTGCCTTATTTTCA





KCMF1
ADXCRPD.14355.C1_at
GGATAACTGCTCTATATGTGGAGAACATTAGAACAAAGGGACCTGAAGTTATATTTCAGT
SEQ ID




GTCTTAGCGAGGATTTCAGGAACTGCTTGGTATGAAGAGTTGTGTCAGGGTGAGTCTGTT
NO:




GTACTTCCCCAGCTAGAACAAGTCATCTTTCATCATTTTCATATGTTTGGCTTTGTTTCT
1695




GTAGGTCTCTATCCCTTAGTCTTCATACTGTTTTAAATGCTTATTTACTTATCCTTATTC




CCCATTTAGGCTCTAAGCACTAAGTGGGTACTGCAAGTGCTCAAAAATTTTG





CDC42BPA
ADXCRPD.15053.C1_at
TGTACTCCAGCTAGCACAGGCAGACGTGTAAGAGACTTTTGCACTTTATGTACCCATCCT
SEQ ID




GAGGC
NO:





1699





CDC42BPA
ADXCRPD.15053.C1_x_at
TGTACTCCAGCTAGCACAGGCAGACGTGTAAGAGACTTTTGCACTTTATGTACCCATCCT
SEQ ID




GAGGCCTTTTCCCCTCTCTCATCCTTTTGCCATGTCCTGTGGT
NO:





1700





SPTBN1
ADXCRPD.15064.C1_at
GGTATTCCCAGAGCCGGATGACATTGTCCTTCCTCGCTGTGATGCGCTTGATGTCGTGGT
SEQ ID




AATTATCGGCCTCGAGCTAACTGGCCACGGCTACCACAGCCTGCACACGCTCCTCGTATG
NO:




CGGCAATGTCTGTCTCAATGGCCTCGTGCTTTTTTGTGGCGGACTCAACTGCAGGAAGGT
1701




CAAACCCAAAGTTGTCCTGAGACACCAGACGCTGCTTTTCGCTCAGCCAAGTCTCCCTCA




TAGCTGCATTGCGATCAAATCTGCGGGCGAGCTGTTCCAGT





TGFBR2
ADXCRPD.13821.C1_at
TTTGTGTCCCACATTCAAATCCTCTCTAGTAATTTCTGCAAAGGTTGAGAAGGCTGGCAT
SEQ ID




GATGGAGAGAACGGTAACCATGAGGAAAGCTTCTTGGAGTAAAGCACTCCTCTCTCCAAT
NO:




GCAGAGGGTAAAACTATTAACATATAAGCAAAAGAAACTTGGGCTAACTGAGACCCTTAA
1706




AGGAGTTCCCCTTTAGTCCAATAAAAGGCCAACTTCAAATCTTTACACCAGATAAGGTAG




TCAAGATCATATCATATACCCAGAGAATGACTGCTTGTATGGACATTTCCTAC





IL6ST
ADXCRPD.14481.C1_s_at
TGTTTACTAACATATATTGACCAAGTACATCAAGCAGGAGAGATCTTCCTTCATTCTGTT
SEQ ID




ATAGTCCACATCATTCTAATTTTGCTCAGTTGTTATTAAGAGCATATTCCTAAACCATAC
NO:




ACTTTTGTTTCAATAAAGTTTTATTTTGTTGAGATGAATAAAATAACAAAGTTATAAGCT
1707




GCATAAGACAAAAGTTCAATT





FAM50A
ADXCRPD.13832.C1_s_at
AATCCAACATTGACAAGAAGTTCTCTGCGCACTACGACGCGGTGGAGGCAGAGCTCAAGT
SEQ ID




CCAGCACCGTGGGTCTCGTGACCCTGAATGA
NO:





1708





FLNB
ADXCRPD.13858.C1_s_at
ATGCTGTTCGCTTCATCCCTCATGAGAATGGTGTCCACACCATCGATGTCAAGTTCAATG
SEQ ID




GGAGCCACGTGGTTGGAAGCCCCTTCAAAGTGCGCGTTGGGGAGCCTGGACAAGCGGGGA
NO:




ACCCTGCCCTGGTGTCCGCCTATGGCACGGGA
1710





HSBP1
ADXCRPD.4853.C1_at
CAACTACAGAACCTCCTTTGATCAGGCCAGTAGGTTGTGATGCAGGCTGGAGCCCCCGAA
SEQ ID




TGCCCCACACACACTGCAGCATTGACCAGACCATCCGAAACCTGCGTCCCTGGTGATGTT
NO:




CTCAAGCCTCGGAAGTGGCAAATGGAAATGATATGGCCGGTTGCGGTTGTAGGAGAGTTG
1713




TGACTTAGGCAGGAGTCGACCTCCTCAAGTAATGGAACGATTTCAAAGGCAGGCTGCCCT




GACCAAAAATATCTGCCATGAATAAAGGTGCCTGAAATCCTGCTATGAA





TGFBR2
ADXCRPD.13873.C1_s_at
AAACATCAAATATTCCCAGGAAATTGGTTTTATTGGAGAACTCCAGAACCAAGCAGAGAA
SEQ ID




GGAAGGGACCCATGACAGCATTAGCATTTGACAATCACACATGCAGTGGTTCTCTGACTG
NO:




TAAAAC
1714





KCMF1
ADXCRPD.14509.C1_at
AGCATTGACAGCAATACTGCTTGTGGTATCTGAACTTCAATACAACATGTCTGTTATGGA
SEQ ID




CTTGCATTTGAAGCCATCACATTTATAGAGTATCTGACTTCTTCATTACTTCTTTAAATA
NO:




ACTTCCTAAGCATCTGTATCTTGAAAGGCATATTATCACATATTGTTTTCATTTGTCCTT
1717




TACATTTGAGCATTTTAC





CDC14B
ADXCRPD.5520.C1_at
ACTCCTCCGCGGAAGCATGGAGGGAAAGGAGGTTGTAAAATAGACTCCATGGAGACTCTT
SEQ ID




AGGAAGCAGTAGATTCCCGGGGGCTGTGCCTTTAGCGTTAGAGGAAACACATAGAGCTGG
NO:




AACTGTTAATGGAAAGCAGTCACAGCTGAGTTTTCCGAGACCAAGAAATTA
1718





CDC14B
ADXCRPD.5520.C1_x_at
TCGAGAGCAGGCCATTTCCCAAGAAGATGAAGAATGGTGACTGTGTTTTTATTGAAGGAA
SEQ ID




TTTCAAATGAAGAATAATGTTTAAAATGTGTATATAGAGATAGTATAGACTCCTCCGCGG
NO:




AAGCATGGAGGGAAAGGAGGTTGTAAAATAGACTCCATGGAGACTCTTAGGAAGCAGTAG
1719




ATTCCCGGGGGCTGTGCCTTTAGCGTTAGAGGAAACACATAGAGCTGGAACTGTTAATGG




AAAGCAGTCACAGCTGAGTTTTCCGAGACCAAGAAATTA





CCND1
ADXCRPD.13939.C_1_at
TTCACATTGTTTGCTGCTATGTGGAGGATCAGTGTTTTGTGTTACAATGTCATATACTGC
SEQ ID




CATGTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCNNNNNNNNNNNNN
NO:




NNNNNNNNNNNATGTGATCAATTTTGACTTAATGTGATTACTGCTCTATTCCAAAAAGGT
1727




TGCTGTTTCACAATACCTCATGCTTC





CASK
ADXCRPD.4921.C1_at
GGGAATTGCTGGTTTCACCATTTCAGATCTGTGTTGTCTAAGAGTATTAACGTTTTAATT
SEQ ID




AAGCAAAGAAATGATTTTTAATCTGTATGTAATTGTTTTAAAGCACCCATTTTAAGAGAA
NO:




AATACTGTGCAATGAAGAAACCAGTTTAGGCATTTGCTATAAACTGAAATATTCCAAAAG
1729




AATCATCTATAACAGCCCTGTAAATTCCTTTAAAATGATAACTAACAGGACAGTTTGACC




AATTTTTTTTAAATATACTTCCTTTTATGTGTTCAATAATTAAATGCCTTTGGGTCCT





FLNB
ADXCRPD.6237.C1_at
AAATTAGGTCATGGGTCTGGGATCAGATTCTGTGAAGTTACTGAGCTTCAGGACCTGCAT
SEQ ID




GTGTTTGTGTGCATGTATGTGTCCCCTGTGTATGTGTGAATGAGAGAGGGAAGAAAAAGA
NO:




AGAAAGAGAAGCTTTACTTGGATATCTGCCTCTATTATGAAGGACTCTCAAGTAACAGCC
1730




TTTTGATGTAAAGAGCAGCTTCCACTGTCTCTGAAACTGCAGCGAGTTGACAGGTGATGC




GGCTGCATTTAGGAAGCCTGGACCCTCTAC





LPP
ADXCRPD.14604.C1_at
AATACCGAACTAATGGTCCTTGTCTCAATGACCTGCCTATCCTTTGTCCCTTCATGGGAA
SEQ ID




TCTTCTCACAGATCAAGTTACTATGATCTACAAGGCCAGTTCCCATAGCCTCGTTCCACT
NO:




TACACACGATCTTAACCATTTCTGTCCAGTGGGAGTCACCCACTCACCTCCTAAAACCTC
1731




TATGCATGCCCCATACCCCTAGTCATAATACTCTTATACAAATGTTTAACACTTTGCAGT




TGAAGACCCAAT





JAK1
ADXCRPD.6270.C1_at
GGGATGTAACCTGGCTGAGGTGGGAACCTGCACCCGACTTTTGACAACCATCCCTCATGG
SEQ ID




CCGGTCCACCTGCCTTTGAAGAAGACCTTGAACAAGGTGGCAGGGGTGGCCCCACAAGGC
NO:




AAGTTTCAGGAACTTTTTCAAAATCCAAGGGGCAAAAAGGGGCCCCTTAACGTTCCTGGC
1735




CACGGTTTCGGGAACGGCAAACCTTCTCCCACACTTGGGGGAGAGACCTCCCTTGAACGC




CCCCGCTCTAAAGAAGACA





AHNAK
ADXCRPD.15294.C1_at
CGTTAAAGGGAACACGAGTATCTCTGCGACCGGTC
SEQ ID





NO:





1736





AHNAK
ADXCRPD.15294.C1_s_at
AGGTGGTGTCACTGGCTCACCAGAAGCATCAATTTCTGGGTCCAAAGGTGACCTGAAAAG
SEQ ID




TTCAAAGGCCAGCCTGGGCTCTCTGGAAGGAGAGGCATGAGGCCGAAGCCTCTTCACCGA
NO:




AAGGCAAATTCTCCTGATTTAAAAGTAAGAAGCCACGGCACCGCTCAAATTCATTCAGTG
1737




ATGAAAGAGAGTTCTCT





PPP4R1
ADXCRPD.5630.C1_s_at
ACGTATAATGTATGTCTGGTGTTTTTAACTTGATCATGATCAGCTCTGAGGTGCAACTTC
SEQ ID




TTCACATACTGTACATACCTGTGACCACTCTTGGGAGTGCTGCAGTCTTTAATCATGCTG
NO:




TTTAAACTGTTGTGGCACAAGTTCTCTTG
1738





GRB10
ADXCRPD.15300.C1_at
CAGAGGTGTGAAGGCTCGCCATAGAGGAGGGCTTGTTGAGTGTCACTCCTGGAGCCTACG
SEQ ID




GAGTCGCAGGGAGGCCTGGCATGGTCAGGTAGACTTGGTAAGGCCTGACTGCTGGGGAAT
NO:




GTATCCTGCCAATAGATTCCTGGGCCTGGAACAGCTCTTCTTTGGACACATGCCATCCAT
1740




CTTTGGAATAAGACAATCTGGCATTTATGTACCTGGTGGGTTACC





HK1
ADXCRPD.6337.C1_s_at
ATCGTGCACGGCAGTGGAAGCCAGCTTTTTGATCATGTTGCTGAGTGCCTGGGAGATTTC
SEQ ID




ATGGAGAAAAGGAAGATCAAGGACAAGAAGTTACCTGTGGGATTCACGTTTTCTTTTCCT
NO:




TGCCAACAATCCAAAATAGATGAGGCCATCCTGATCACCTGGACAAAGCGATTTAAAGCG
1742




AGCGGAGTGGAAGGAGCAGATGTGGTCAAACTGCTTAACAAAGCCATCAAAAGCGAGGGG




ACTATGATGCCAACAT





FAM50A
ADXCRPD.6370.C1_at
TGGGACAAGTACACGATCCGCTGAGCATCCAGGAGGCTGCGCGGCCCCGGCTCCTCAGCT
SEQ ID




CCCTCAGTGTGCCCCGTGGTGTCACCGGGACTCCAGGCACCCGCTCCCCTGCGACCATGC
NO:




CAGGCACGCTGGGAGGAGGACGGCAGCTGCTCGTGTCCTGCCCCTGCCACATCAGTGACT
1743




GCTTTATTCTTTTCCAATAAAGAAGTGCACGTGTCAGAGCTGGAGCGCCTGCATTGTGAG




AAACCAA





FAM50A
ADXCRPD.6370.C1_x_at
GACAAGTACACGATCCGCTGAGCATCCAGGAGGCTGCGCGGCCCCGGCTCCTCAGCTCCC
SEQ ID




TCAGTGTGCCCCGTGGTGTCACCGGGACTCCAGGCACCCGCTCCCCTGCGACCATGCCAG
NO:




GCACGCTGGGAGGAGGACGGCAGCTGCTCGTGTCCTGCCCCTGCCACATCAGTGACTGCT
1744




TTATTCTTTTCCAATAAAGAAGTGCACGTGTCAGAGCTGGAGCGCCTGCATTGTGAGAAA




CCAA





CD59
ADXCRPD.15392.C1_at
GGGCTATTGAGAGTCAGCACCAGCACTGATCATATATAGGATCAGCCTACTGGGGTTGGC
SEQ ID




CACGTTGTATGTAGCTGCGAATAGCAAGGAGGGGAACAGCAACATCCCTAGGGAAACCGA
NO:




TCACAGAAAGGCAGCTCACTACCCCACAGTAAAAAGAACCTTGAGTTTCCCAGTTCAGTC
1745




CCCTGCTGGGTGCATGCTACCCCCCTCCTCTCCCAGAGGCTCTGGACCTACACAGCTGCT




GAAAAAGAGAAAATGTCCTTACCTACAATGAACCATCACAGGCACCCA





RCN1
ADXCRPD.14742.C1_at
GTTGCAATTGTCTCTCACTGACGTATTTGAAGGATATTTGAGCTGGAAAGCTCAACCAAA
SEQ ID




TGATGCGTTTTTGCTAATATGATGACTTCTCCATAGACTTCTTTAGATTTATATATGTTC
NO:




CTGTGCACTTATCAACCTTCTCATAGTGCCTCCTGGCTTATCATGGCTTTTGAAAGAATA
1746




GAGGATCTTTGTCACTTTGAC





ZDHHC7
ADXCRPD.5764.C1_s_at
AAGAGCTGCGTCACAGCCAGAGGGACAAAGTGTGGGTGATCCTGGAGACGCCAGTTTCCG
SEQ ID




AGATTGTTCTGCATATTCATTTGCACATTGTTGTCTGGGTTGGACATGCGTGTGGGCTTC
NO:




AGTGTGAGGCTTTTAATATGTATATCCTGTTATCAATAAAACAATTATCCAAGTGGTTGA
1747




ATCCTGTGAGACTTGGCAAGTGTGTGCAAATCAAGTATACTTGACTTTTCAACCTCTT





CDC42BPA
ADXCRPD.16014.C1_s_at
AAGAGCCTCTCCCTGGAGAGCACTGACCGCGGGAGCTGGGACCCGTGAGCTGCCTCAGCA
SEQ ID




CTGGGACCTCTCGCTCTCCGCTCCCTGCCACTCGCCTCCTCTCACTTTCATCTCTTCCCT
NO:




CCACCTCGCCTGCTCGGCCTGAAAGCCACCAGGGGCTGGCAGCAGTAGCAGGACAGGGAT
1749




TCAGGAGTTCTGACGACACGACTCTCAGATCCACGCCCCCAGCCTAACAGCAACAACAAA




GACAGACTTTCC





COL4A1
ADXCRPD.7020.C1_at
GGACCTAAAGGTGATCCAGGTATAAGTGGAACCCCAGGTGCTCCAGGACTTCCGGGACCA
SEQ ID




AAAGGATCTGTTGGTGGAATGGGCTTGCCAGGAACACCTGGAGAGAAAGGTGTGCCTGGC
NO:




ATCCCTGGCCCACAAGGTTCACCTGGCTTACCTGGAGACAAAGGTGCAAAAGGAGAGAAA
1750




GGGCAGGCAGGCCCACCTGGCATAGGCATCCCAGGGCTGCGAGGTGAAAAGGGAGATCAA




GGGATAGCGGGTTTCCCAGGAAGCCCTG





KCTD12
ADXCRPD.7032.C1_s_at
AGATGCAGTCAAAGTCTTTTCAGACATGCCCAAACTTTGAGAATTTCTTCAACCATCTAA
SEQ ID




TGCTATAAAGATTTTTGTTCTTCCTGTTCACAACCAGTTGTATAACAGAAATACTAGCTA
NO:




CTGTTTTCCTTCCTGTGTGTGAAGTAATGAATCATTGATTATGTGACTTGTTATGTATTC
1751




AATTA





CCND1
ADXCRPD.16054.C1_at
ACCAAGTAGCTGTGGGTTGAACCTGGACGTGAGCTGGTTGCAGGGCCGTTGGGTAGAAAA
SEQ ID




CCAGCATCTCATAAACAGGTCACTACAAAAATAGGAAGAGTATAAAAATAGAATATATTA
NO:




TGTCACTATTTCGTCTTCTCTTTATAGTAGCGTATCGTAGGAGTGGGACAAGGTGGCCTT
1752




TCCCGACACTGCTACGCTGGTCTGTGCCCGACAAACCTCACCTGATGTTGTACCTGAGTA




CGTTACTAAATCCTCAAGACCTTACACACAGC





ITGA5
ADXCRPD.16092.C1_at
AGGCCACAGGGTTCCCCTCTAAGCTGCAGCTCCGCTCCTCTGGGTTGAACATGGCGGGGA
SEQ ID




AGATGGTGAGGGAGGCACTAGCGGACACGATGGGGCGGCCCCTGTATACCACAGCCTTGT
NO:




CCACACCAAAGGACCCCACAATCAGATCAGGATATCCATTGCCATCCAGGTCTCGGCCTC
1754




CTCGAAGGGCAGAGCCAAAGAAGTCTGGGGTGTGGCTGGCTGCCCACAGGGGCTGCAGAA




CCTGGGAAGGCTTAGAGCCCA





ITGA5
ADXCRPD.16092.C1_x_at
GTTGATGCAGGCCACAGGGTTCCCCTCTAAGCTGCAGCTCCGCTCCTCTGGGTTGAACAT
SEQ ID




GGCGGGGAAGATGGTGAGGGAGGCACTAGCGGACACGATGGGGCGGCCCCTGTATACCAC
NO:




AGCCTTGTCCACACCAAAGGACCCCACAATCAGATCAGGATATCCATTGCCATCCAGGTC
1755




TCGGCCTCCTCGAAGGGCAGAGCCAAAGAAGTCTGGGGTGTGGCTGGCTGCCCACAGGGG




CTGCAGAACCTGGGAAGGCTTAGAGCCCA





PRSS23
ADXCRAD_BM979373_s_at
AAAAGGACTCATGGCATTATTAATATAATTAGTGCTTTACATGTGTTAGTTATACATATT
SEQ ID




AGAAGCATATTTGCCTAGTAAGGCTAGTAGAACCACATTTCCCAAAGTGTGCTCCTTAAA
NO:




CACTCATGCCTTATGATTTTCTACCAAAAGTAAAAAGGGTTGTATTAAGTCAGAGGAAGA
1761




TGCCTCTCCATTTTCCCTCTCTTTATCAGAGGTTCACATGCCTGTCTGCACATTAAAAGC




TCTGGGAAGACCTGTTGTAAAGGGACAAGTTGA





FKBP9
ADXCRPD.16135.C1_at
GGGCCATCATCAGAATTTGCACAGGCTGCTGGGAAGAGCCATGGCTGTCTGCTGGGAACT
SEQ ID




CTGCTGGGGCAAGCAAGCCCTTTGACTCTCCTGCCCATCTCAAGAATATTT
NO:





1762





FKBP9
ADXCRPD.16135.C1_x_at
GGGCCATCATCAGAATTTGCACAGGCTGCTGGGAAGAGCCATGGCTGTCTGCTGGGAACT
SEQ ID




CTGCTGGGGCAAGCAAGCCCTTTGACTCTCCTGCCCATCTCAAGAATATTTCTAA
NO:





1763





CASK
ADXCRPD.14972.C1_at
CTAAAACCACTAGCCAGAGCAGGAGTACATAAACAGCAAAAATAAATCCCGCAGAAAAGG
SEQ ID




AGATTCTGATTTATAGAGTTGACACATAATATTATTTAAGACACTCAGTTTTCAACAAAA
NO:




AATTATGAGGCATGCAAAGAAACAAGAAAATATAGCTCACACTTAGAGGGGAAAAGCAAT
1767




CCCATAGAAACTGTTCCTGAGCAAACCCAGATGTTGGACTTACAAGAAAAAGAGTTACCA




AATGGAAAGTATCAAT





YES1
ADXCRPD.16243.C1_at
GTATCAGTGAGGTAACAGCAACCAGACAAAGTGGGTGATAAAATTTGATGGCATTAGATC
SEQ ID




TACAGCTGGAGGGAACTGTAGGGAAGAGGAATATGTTAGATAACATGCAAAACCCATAAG
NO:




ATTAGCAAAACAGTTTTTCCTAAAGATTAAATTTTATATGCTTTCACTCTCAACATTAGG
1770




ATACTTCAGTACAAGAGTTTAGATAGTAACCCAACTAAAGTAATACTGATCGCTGAATTT




CAAGTGAGCTCAAAGGTCTCCTTCCC





VEGFA
ADXCRAD_BX116668_s_at
CACTGGCAGATGTCCCGGCGAAGAGAAGAGACACATTGTTGGAAGAAGCAGCCCATGACA
SEQ ID




GCTCCCCTTCCTGGGACTCGCCCTCATCCTCTTCCTGCTCCCCTTCCTGGGGTGCAGCCT
NO:




AAAAGGACCTATGTCCTCACACCATTGAAACCACTAGTTCTGTCCCCCCAGGAGACCTGG
1771




TTGTGTGTGTGTGAGTGGTTGACCTTCCTCCA





CD55
ADXCRPD.7256.C1_at
TTCCTTTGTTGCACAAATAGAGTTTGGAAAAAGCCTGTGAAAGGTGTCTTCTTTGACTTA
SEQ ID




ATGTCTTTAAAAGTATCCAGAGATACTACAATATTAACATAAGAAAAGATTATATATTAT
NO:




TTCTGAATCGAGATGTCCATAGTCAAATTTGTAAATCTTATTCTTTTGTAATATTTATTT
1772




ATATTTATTTATGACAGTGAACATTCTGATTTTACAT





FLNA
ADXCRPD.15612.C1_at
GCTACACCATTATGGTCCTCTTTGCTGACCAGGCCACGCCCACCAGCCCCATCCGAGTCA
SEQ ID




AGGTGGAGCCCTCTCATGACGCCAGTAAGGTGAAGGCCGAGGGCCACTGGCACTCAGTCG
NO:




CACTGGTGTCGAGCTTGGCAAGCCCACCCACTTCACAGTAAATGCCAAAGCTGCTGGCAA
1773




AGGCAAGCTGGACGTCCAGTTCTCAGGACTCACCAAGGGGGATGCAGTGCGAGATGTGGA




CATCATCGACCACCATGACAACACCTACACAGTCAAGTACACGCCTGTCCAGT





CRIM1
ADXCRPD.15616.C1_at
ACAGATGTCACAGCCGTGCTTATTCTTCAGCAATCCAAGTGGACAATACTTGTCACAGAT
SEQ ID




TATGGGTCTGCACTTCTTGGGCCTTGGGCGGCACTCACAGATCTCACAGTTTTGGGCATC
NO:




AGTAAGGAAACCGAAGGGACAGTTCAAGGTGCAGCCTTGTTTACGTTCTGAACATAGTTC
1774




CTCGGTGTTTATGCACTCACAGGTCCGACAACCATTGTGATCGCGTTTGAAACCATTAAT




GCAGTCCTTCCCTGTCAGAGTGCAGTTTGATACGGTCCCGAC





SPTBN1
ADXCRPD.15631.C1_at
GAAATCCAGGGTGCACCTAGCCTCGCGATTGACGACATCTTTGAGAAGGAGCCAAAACAT
SEQ ID




CGTCACTGACAGCAGCAGCCTCAGCGCTGAGGCCATCAGACAGAGGCTTGCCGACCTGAA
NO:




GCAGCTGTGGGGTCTCCTCATTGAGGAGACAGAGAAACGCCACAGGCGGCTGGAGGAGGC
1775




GCACAGGGCCCAGCAGTACTACTTTGACGCTGCTGAGGACGAAGCCTGGAT





FLNB
ADXCRPD.15647.C1_at
AGGCTTCTGCGGGTCCCAGGATTCGCAGTCTGGGCACAGACCTGGAGCACAGCTGTCTAC
SEQ ID




CAGGGCTCCCAGGGCTTTGCCGTCTTGCCAGTTCTGGTTAAAGTTGGTGATGGGCAAGTA
NO:




GGGGATCTTGTTCTGAATCCACCCCAGCAGCCTCTGCTTTGGCGTCTGCTTCTTGGCATC
1776




ATCATCCCCTTCATCCTCNCACACGGCATGGAGATGGAGTAGTGGAGATCAGCGCCACAC




AGACCTAGATGAGCTCAGTTCCATCACAATGGCTTGCTATCGATGACACGA





PDLIM7
ADXCRPD.15669.C1_at
ATGGCTTACCTCACTTCAGGGAGGCTGTGAGAAGCACTCAGAATCTGGATGTGCCTTGGG
SEQ ID




GGTGGGCCCCACTGGACTTTCCTGGTGGACCTGGTGTGGGGTGTGAGAGGAGGGTGTGTT
NO:




TGGCTGCAGCAGACAGGAGAATGGAGTTGCCACTCCGCGTGATGGGGATGGCTGTGGGAG
1777




GAGAGGTCCTGGTGGTGAGGGAATCCGGATCTGAGTGCTGTACCCTGGCAAGTCTGAACG




CGCAGTGATCGCTCCACTCACGAGAT





FNDC3B
ADXCRPD.7332.C1_s_at
GAGAAGTGCCCTAATTGAATGTGTTTGAATGTTATCCTTGCACAATTCTTTAAATTGAAA
SEQ ID




GATAAAATGTTTTACCTCACTGTTGGACATACATTCCAAGCTTTTCAACTCTAGGAGAAA
NO:




AAGAAAATCATGTTTTCCTGTATTGTAAATTTTAGACTATTTCATATACATTGTATTAAA
1780




ACTGCCATATCAATTTTAATGTATAGATTTTGCAAATATTATGCTATATGTAATACCTAA




CTGTATCTGTAGTG





COL6A1
ADXCRPD.8056.C1_at
CTCGGGACCTGTGGTACCCAGGAATGAAAGGAGAA
SEQ ID





NO:





1789





COL6A1
ADXCRPD.8056.C1_s_at
ACGTACCGGCGCAACTTCACGGCGGCTGACTGGGGCCAGAGCCGCGACGCAGAGGAGGCC
SEQ ID




ATCAGCCAGACCATCGACACCATCGTGGACATGATCAAAAATAACGTGGAGCAAGTGTGC
NO:




TGCTCCTTCGAATGCCAGCCTGCAAGAGGACCTCCGG
1790





ZDHHC7
ADXCRPD.8057.C1_at
CGGGCCTCGGATCCGATCACATAGGACAGTATGCACCTTAAGATCCTGAAGAAACGGCAC
SEQ ID




AAAATGTTCAAGTGATGTTTAGAAATAACTTGTGAGGGTGCGTCAGGGAAATCATGCAGC
NO:




CATCAGGAGACAGGCTCCGGGACGTCGAGCATCATCCTCTCCTGGCTGAAAATGACAACT
1791




A





IGFBP3
ADXCRPD.17075.C1_at
TGCTCTGCATGCTGTAGCAGTGCACGTCCTCCTTCCCCTTGGTGGTGTAGCCTGGGAGAG
SEQ ID




GCTGCCCATACTTATCCACACACCAGCAGAAGCCCCGCTTCCTGCCTTTGGAAGGGCGAC
NO:




ACTGCTTTTTCTTATAAAATCCCTTCTTGTCACAGTTGGGAATGTGTACACCCCTGGGAC
1792




TCAGCACATTGAGGAACTTCAGGTGATTCAGTGTGTCTTCCATTTCTCTACGGCAGGGAC




CATATTCTGTCTCCCGCTTGGACTCGGAGGAGAAGT





PTPRK
ADXCRPD.6814.C1_s_at
TATAGCATATGATCACTCCAGAGTGATTTTGCAACCCGTAGAGGATGATCCTTCCTCAGA
SEQ ID




TTATATTAATGCCAACTATATTGATGGCTACCAGAGACCAAGTCATTACATTGCAACCCA
NO:




AGGTCCCGTTCATGAAACAGTGTATGATTTCTGGAGGATGATTTGGCAAGAACAATCTGC
1797




TTGCATTGTGATGGTTACAAATTTAGTTGAGGTTGGCCGGGTTAAATGCTATAAATATTG




GCCTGATGATACTGAAGTTTA





NFIB
ADXCRPD.15832.C1_s_at
TTCTATTAATATCCTCTTGCATGCTTTAGAAGCCAAAGGAAACAGCCCCCACANNNNNNN
SEQ ID




NNNCCTAAAGCAATGGTTTCAGTTAAGCCAGGCCCATGGCATCTTTGGAGACAGAAAGCT
NO:




ACCCTTTCCATTCACGGCAACATGACATTCACAATGTGCTTTCCTAAATGGATGGAAAAC
1799




CCCTCAAAAAAGCCCCTCAAATCTGTGTTTCATAAACTGTACTCTTAGCAATAAAGTTTA




TTACAGACCTAAAGTATCTGCATAAACCCGGTTAAT





EGFR
ADXCRPD.15857.C1_s_at
TTTGAAACTCAGTATGCTGCCCCTGTCTTGCTGTCATGAAATCAGCAAGAGAGGATGACA
SEQ ID




CATCAAATAATAAACTCGGATTCCAGCCCACATTGGATTCATCAGCATTTGGACCAATAG
NO:




CCCACAGCTGAGAATGTGGAATACCTAAGGATAGCACCGCTTTTGTTCTCGCAAAAACGT
1801




ATCTCCTAATTTGAGGCTCAGATGAAATGCATCAGGTCCTTTGGG





WNT5A
ADXCRPD.6842.C1_s_at
GTTTGAACCTAGAATATTGAATTAAAATGCTGTCTCAGTATTTTAAAAGCAAAAAAGGAA
SEQ ID




TGGAGGAAAATTGCATCTTAGACCATTTTTATATGCAGTGTACAATTTGCTGGGCTAGAA
NO:




ATGAGATAAAGAT
1802





CDC14B
ADXCRPD.8104.C1_s_at
AAATTGTTCATTTTACTGGCTCTGATCAGAGAAAACAAGCAAATGCTGCCTTCCTTGTTG
SEQ ID




GATGCTACATGGTTATATATTTGGGGAGAACCCCAGAAGAAGCATATAGAATATTAATCT
NO:




TTGGAGAGACATCCTATATTCCTTTCAGAGATGCTGCCTATGGAAGTTGCAATTTCTACA
1804




TTACACTTCTTGACTGTTNTCATGCAGTAAAGAAGGCAATGCAGTATGGCTTCCTTAATT




TCAACTCATTTAACCTTGATGAATATGAACACTATGA





PDLIM7
ADXCRPD.8148.C1_at
GCAAACCGCAGAAGGCCTCCGCCCCCGCCGCGGACCCTCCGCGGTACACCTTTGCACCCA
SEQ ID




GCGTCTCCCTCAACAAGACGGCCCGGCCCTTTGGGGCGCCCCCGCCCGCTGACAGCGCCC
NO:




CGCAGCAGAATGGACAGCCGCTC
1808





PDLIM7
ADXCRPD.8148.C1_s_at
GAGAATGCGGGTAGCCTCACACACATCGAAGCTCAGAACAAGATCCGGGCCTGCGG
SEQ ID





NO:





1809





CYP1B1
ADXCRPD.8150.C1_at
GCAAGACGTCAACAGGAACCCGCAGGCCCGGCCTGGACACCTGCTGCCCTCACTGGAAGC
SEQ ID




TTTAACTCCCACTCGAGTCTCTTGGCGTCGTCAGTGCCAGGAGCGCTTGGATTGGGATGG
NO:




GGACGGAGAAGGGTGCCATCGCTCGCCGAGCCCCGCTGCACCTTGGGGACCTGGCAAAGT
1810




CGAGGTTTCCTCACAGCGTTGAGATTGAGACTGGGGGTCGGTGAGTGGCGTCAATTCCCA




TGCCCTTGCGGCCATCTCACAACTGGAGTCGCAGAAGCGCTCGCT





COL6A1
ADXCRPD.6917.C1_s_at
TGGCTGCACTCAAGACCCTCGAGATTAACGGTGCTAACCCCGTCTGCTCCTCCCTCCCGC
SEQ ID




AGAGACTGGGGCCTGGACTGGACATGAGAGCCCCTTGGTGCCACAGAGGGCTGTGTCTTA
NO:




CTAGAAACAACGCAAACCTCTCCTTCCTCAGAATAGTGATGTGTTCGACGTTTTATCAAA
1815




GGCCCCCTTTCTATGTTCATGTTAGTTTTGCTCCTTCTGTGTTTTTTTCTGAACCATATC




CATGTTGCTGACTTTTCCA





GALNT2
ADXCRPD.7576.C1_s_at
GAGGAGAACTCTTGAAATCTCCATTTTCAATCCCTTCGAAATCACGTATGGTTTCCACAA
SEQ ID




AGCCGAGTCGTGTCACGTGGCAGGTTTACGTCAATAGTCCCTCTCTCTGCTCCTCCATTC
NO:




GCAAGTGTCTTCCTGGGCCAGACTCCCCTCCACCTCATGTACTTGCTATATTGAGGATGA
1816




AGTTTTCTATGGTGGGACACTAAATATAAAGCTATATAGAGAAAGAATGTACGGTCAGTT




CCCTATGGTTT





CCND1
ADXCRPD.15960.C1_at
TGCCCGACAAACCTCCACTGGATGGTTTGTCACTGGATGGTTTGTTGGGGTGGTGGTCAC
SEQ ID




AGGCGCAAAGGACATGCACACGGCCACGCTACGCTACTGTAACCAAG
NO:





1817





VCAN
ADXCRPD.6973.C1_at
TTGAAACTGTGCCACTGACCTTTACTTCCTCCTTCTCTACTGGAGCTTTCGTACCTTCCA
SEQ ID




CTTCTGCTGTTGGTAAAATGGTGGATCTTCTATCAATTTCAATGACAGTACCCACTTCTC
NO:




CCAATCCTTCGTCGATAATGGAGGAAGCTGTACCAGAAAACTTTTGCACAGCACTGGGAA
1818




GCACTGGAACAACAGAGCTGCTGACTGTGACCAGTTGCTCACCTGAGCCCTCAGCTGAGG




ATGTAAACTCTTCCCAGGGGAAGGCTGAAGTGCTGACCATGGTGCTA





CREB3L1
ADXCRPD.15997.C1_at
TCCCAAAGTTAGGTGGCCCGTCGCAGGCAGCCCCTAGTAGTCTGGCCTCCTCGCCCGCAC
SEQ ID




AACCCTTCACCCACAGGCCAGGTGCAATCCCGATGCAGGCTCCTGGCCCGACCCTCTACG
NO:




CGCTCAGGCGGACAGCTAAGGTCTGGCTGAGTCTCCGGCAGGGGCGTTTGGAATGTGACC
1819




GGTCACCCACTCTCGGCCCTGCATTTGCTTGTGCATGCAAGTCCACAGGTGTAGAGGCAC




CCGAACCGTGTGCAT





CASK
ADXCRPD.17222.C1_at
CACAGATCTGCTCCATCCATAAATTCGAAAACCATGTAAAGCATTCCATCTGAGCTATAT
SEQ ID




GTCTCCAATAACTCTACAATGTGTGGATGTTTCAGCATATGACAGATACTGGCTTCCCGC
NO:




TTTAGATCTTCTGTACTTAACCCTGGACTTGATGTGAACTTGGCTACATCAACAATTTTT
1822




ACAGCAAATTGTTGCCCAGTTTCTCTGTTGATACATCGTCGTACAACACTGAAGGGACCC




TTTCCGATCA





MICALL1
ADXCRAD_BP398250_s_at
ATGGTCATCACTGGTCTGTCTGCTCTGTTGTCTGTTCTTTCCCTGACTCCCTCCCACCGA
SEQ ID




AGGCCTGATGGCTACTCACCCCTCTGGGATGGCTATGGGAGAGGAGGAGTGATGGGGACC
NO:




GCCACCTTTTCTGCAGGAAATGTGCCCAGCAGCTCTTGGTCAAAGCACTGTTGCTATAAG
1823




CTATCTCTGGGATGCCTCTAGGCCCCCTTCCCTCTACACACCTCTGGGAAAAGATTACAC




TGTATTAACTCTCGAGGAGTTTCCTCACCAA





SYNJ2
ADXCRPD.8240.C1_at
GCCAATGTGGGACAGAAGAGCAACCCAGGAAATACAAAGCAAGCGCTGTCAAGAGTGAAG
SEQ ID




CCGAAGCCCCCCTCACACTCTCTAGAGGGGAAGCAGCATCGTGCTGTGATGACCAGGAAG
NO:




GGATTACCGAGGGTCCGTTACTAGAACACTGAGATCAAACGGAAGATCCAGATGTGTCTA
1824




CAGATGCCAGTCTTTGGGCTGCTACTGTCCTTACAAACTCATGTC





LPP
ADXCRPD.16626.C1_s_at
CTAGATGATTCCAGTGCCCTTCCATCTATCTCTGGAAACTTTCCTCCTCCACCACCTCTT
SEQ ID




GATGAAGAGGCTTTCAAAGTACAGGGGAATCCCGGAGGCAAGACACTTGAGGAGAGGCGC
NO:




TCCAGCCTGGACGCTGAGATTGACTCCTTGA
1828





MARCKS
ADXCRPD.8271.C1_at
CCGTCCTCGGCCTTGGGCGAAGAAGTCGAGGAGGCGGCCGACGCGGCCTCTCCCTCCGCG
SEQ ID




GCCGTGGGCGAGCCGGGCTCGGCAGCCTCGCCTTCCGCGGGGGCCTCCTTCTCTACCGGG
NO:




CTGGCCCCGGCCTCGGGGGCAGCGGCGGCTGCCGGCTCACCTTTCGCGGCCGCG
1829





MARCKS
ADXCRPD.8271.C1_x_at
CCGCTCAGCTTGAAAGACTTCTTGAAGGAAAAGCGCTTCNNNNNNNNNNNCGGGGTCTCG
SEQ ID




TTGCTGGGCGAGGGCGTGGCCCCGTCCTCGGCCTTGGGCGAAGAAGTCGAGGAGGCGGCC
NO:




GACGCGGCCTCTCCCTCCGCGGCCGTGGGCGAGCCGGGCTCGGCAGCCTCGCCTTCCGCG
1830




GGGGCCTCCTTCTCTACCGGGCTGGCCCCGGCCTCGGGGGCAGCGGCGGCTGCCGGCTCA




CCTTTCGCGGCCGCGAAAGGCGACGCCGCCCCGCTCCCGGCGGACGAGGGCTCCTCCTTG





LPP
ADXCRPD.16635.C1_at
TTAGTTAAGAACATGACCCGAAGAGTGAAAGGTATTTCCTGTTCCAAATAGGAGCCCAGT
SEQ ID




CTGCATTTTCTACTACATGATTTAGTAGAAAGACACATTGCATTTGAACCATATTTCTTC
NO:




TGCTAGCCAATTCCATCTTATCTACAACTTTTTGATAATTATTTTGAGAAATAGATCTAG
1831




ATCACAGCCTTCCAATTCCTAGGCCAGGATACTT





LIF
ADXCRPD.16683.C1_s_at
TCACTGAATCACAGAGCCTTTGCGTGAAACAGCTCTGCCAGGCCGGGAGCTGGGTTTCTC
SEQ ID




TTCCCTTTTTATCTGCTGGTGTGGACCACACCAGGGCCTGGCCGAAGGAAGAGAGAGTTT
NO:




ACCAAGAGAGATGTCTCCGGGCCCTTATTTATTATTTAAACATTTTTTTAAAAAGCACTG
1833




CTAGTTTACTTGTCTCTCCTC





PRSS23
ADXCRPD.10010.C1_at
AGGCTACATATGGATCTTGGTCTCATAAAAAATAAGCACTAAAATTAAGTTGAGTTGAGG
SEQ ID




TTGAGTTTAGAGTTAGTGCTGCTCATGCCACCCTAAGCTTCCAAGTATCATTCAGTCACA
NO:




TCTTGTTTCCTGCTTTGGGGTTATTTAACAGGTCATTCGTGAGTTATTACATAACTGGAA
1834




CAAAAGCAAGATAGAATCAAAAGAATACTTAGAGCTGGAGTGACATCAGAAACTGTATGC




AACCTCCTTATTGTCAGGACGGGAAAAGGCAAGTCTGGGAAGCAATA





TMEM158
ADXCRPD.7689.C1_at
AACAAATACACAGGATTTGGTCATTTTCTGCCATGAATCTAGGGCACGTGGGTGCCGGGA
SEQ ID




AGGAGTCGGGCAGGGGGATGCAATAGAGGGGAAAGGGCCCCATTTCCCTCCTCTCCGTCT
NO:




TCGGAGCTGCGATCCCACCCTCAGTCCAAGGGCTTAAACATCTGCTTTTCGGAACTGGAA
1836




GCGCAGCACAAACCTTG





TMEM158
ADXCRPD.7689.C1_x_at
AACAAATACACAGGATTTGGTCATTTTCTGCCATGAATCTAGGGCACGTGGGTGCCGGGA
SEQ ID




AGGAGTCGGGCAGGGGGATGCAATAGAGGGGAAAGGGCCCCATTTCCCTCCTCTCCGTCT
NO:




TCGGAGCTGCGATCCCACCCTCAGTCCAAGGGCTTAAACATCTGCTTTTCGGAACTGGAA
1837




GCGCAGCACAAACCTTGCTTTTCAAAGGCGCTGGG





FHL1
ADXCRPD.10038.C1_at
TGCAGAAGAGTCAATCTACCTAAGTTTTCATTTTTAAATTGCAGCCGGACAGAAATTCAC
SEQ ID




TTTGCTGCAGGGTTGCTTTTTGCTAAATGCTAATATGATCACTGTGTGCCCTTATTTGAG
NO:




TAATACTGTAAAATGGGAGAAAAGACGGAAGGAGAACTTTAAAGAAGGGAAGGACCACTC
1838




TTCCCCTATTGATGGTATAGGGCAGAAAGTAAGGACACAAAGAACGAGATTCAAATGCCA




TTTTACAGGACAGGAGCCCCTGTCAGTTTACAGCTTGAGACACGCGACGGGTACCGAG





MAP1LC3B
ADXCRPD.1021.C1_at
ACCCTGAGTCTTCTCTTCAGGTTCACAGAACCCGCCGCCTTT
SEQ ID





NO:





1839





MAP1LC3B
ADXCRAD_CX870302_s_at
ATCCAATCACAGATCATGAAACAGTAGTGTTCCCACCTAGGAGTGTTAGGAAGTTGTGTT
SEQ ID




TGTGTTTCAAGCAGAAAAACTGAGCTCCAAGTGAGCACATTCAGCTTTGGAAACTATATT
NO:




ATTTAATGTAGGCTAGCTTGTTTTCAAATTTTAAAAGTTTAAAAATAAAATACTTTGCAT
1840




TCTAAGTTGCCAATAAAATAGACCTTCAAGTTATTTTAATGCTCTTTTCTCACTAATAGG




AACTTGTAATTCCAGCAGTAATTTAAAGGCTTTCAG





MAP1B
ADXCRPD.10066.C1_at
GTTTGGGTCAGTCTCCACCTGGGTATGGTATTATGTTTTATAATCCTGCATCACTTCTAT
SEQ ID




CCTATCCAGTCATATTTAATGTAGAAAATTAGTTTCCAGTGAAAGTAAAATGTAGGGCTT
NO:




TTATGAAATTTGTGGGCAAAATCCCC
1843





OPTN
ADXCRPD.1062.C1_at
GAGAATGATGCTTTCGAAGACGGAGGCAGGCAGTCCTTGATGGAGATGCAGAGTCGTCAT
SEQ ID




GGGGCGAGAACAAGTGACTCTGACCAGCAGGCTTACCTTGTTCAAAGAGGAGCTGAGGAC
NO:




AGGGACTGGCGGCAACAGCGGAATATTCCGATTCATTCCTGCCCCAAGTGTGGAGAGGTT
1844




CTGCCTGACATAGACACGTTACAGATTCACGTGATGGATTGCATCATTTAAGTGTTGATG




TATCACCTCCCCAAAACTGTTGGTA





ATP2B4
ADXCRPD.10094.C1_at
AGCCATCTTTATACTTAGGGAAGAAAAATTGTTGGGTTCTAGACTTTTTTAATATAAATT
SEQ ID




TTGTTGATATGGAATTAGGTAAGTTTAAGTGTCTATGTGCATATGTTTTTATATAAGTTT
NO:




TTTCTATTCAGTTTACTGATCCAACTGGCAGTGGGTAAATATGGCATAAGTTAATAACAC
1845




TTTTCCCCAAAATGGTGCTTTGGATTTGAAAAGGGTCTGATGGGGAGAAGGAGAACGTAT




CATCCTAGCTTCCTCTCTTATAAACCTAGAAAAACGGGTAGTAAACTGTGGATAGTCA





CNN3
ADXCRPD.1098.C1_s_at
AAGAGCAAATGCATCACCCAGGCCTAAATGTCCACAGGCCACTTTTGTACATGCTCTTTT
SEQ ID




AGAAACACCACTCTGAAAAGATCTTGTTCGCTAGGTAAGAGAATGAGTACACATATAATC
NO:




ACAAATGCACACTGATCATGACTTTATTTAAAAATTAGCAAACAATACTGTAGAAACATT
1847




GATATGTAAATTTCTAAAATGCTGCATCTTAAATTTAGTTGGCAAAGACCACATTTAGCA




ATAAGCATGAGTTTAGTCTTCCATGTAGAAACCAGATA





NPC1
ADXCRPD.8331.C1_s_at
GCAATAAATTAACTTTGTACACATTTTTATATAAAAAAACAGCAAGTGATTTCAGAATGT
SEQ ID




TGTAGGCCTCATTAGAGCTTGGTCTCCAAAAATCTGTTTGAAAAAAGCAACATGTTCTTC
NO:




ACAGTGTTCCCCTAGAAAGGAAGAGATTTAATTGCCAGTTAGATGTGGCATGAAATGAGG
1849




GACAAAGAAAGCATCTCGTAGG





FHL1
ADXCRAD_BP325154_s_at
GTGATTCCTAGGACTTTTCCTCAAGAGGAAATCTGGATTTCCACCTACCGCTTACCTGAA
SEQ ID




ATGCAGGATCACCTACTTACTGTATTCTACATTATTATATGACATAGTATAATGAGACAA
NO:




TATCAAAAGTAAACATGTAATGACAATACATACTAACATTCTTGTAGGAGTGGTTAGAGA
1850




AGCTGATGCCTCATTTCTACATTCTGTCATTAGCTATTATCATCTAACGTTTCAGTGTAT




CCTTACAGAAATAAAGCAGCA





ELF4
ADXCRPD.7745.C1_s_at
TAAGAAATGTCAGCCACGGAAACAACTCTATTATCTGGTGACTTTGGGTAATGTGAATCA
SEQ ID




GTGCCTGAGGACCTTTGCTGTGTCCTTGGTACAGAACCATCCACTTGACCTAACTACCTC
NO:




CCCTGGACCGCTCTCGCTCTTCTCTTCTTTGTTAAGCCAACAACTATCACCCTCTCCTAC
1853




TCTTCTTCTCCCTGCCCCCTGGAGGGCACTGTGTTTGGTTGTGCAAATGTATTTACTATG




CGTGTTTCCAGCAG





LAMB1
ADXCRPD.10103.C1_at
GATTTTTCTACTGGTCTCATTGCTGGCCAGTGTCGGTGTAAATTAAATGTGGAAGGAGAA
SEQ ID




CATTGTGATGTTTGCAAAGAAGGCTTCTATGATTTAAGCAGTGAAGATCCATTTGGTTGT
NO:




AAATCTTGTGCTTGCAATCCTCTGGGAACAATTCCTGGAGGAAATCCTTGTGATTCCGAG
1854




ACAGGTCACTGCTACTGCAAGCGTCTGGTGACAGGACAGCATTGTGACCATGTGCCTGCC




AGAGCACCTGGGGCTTAAGCTATGAGTTGGATGGATTCGCCATGTACTCGACC





COL6A2
ADXCRPD.10104.C1_at
TTCGTCATCAAACGTGGTCAAACAGGCTGGGTGCCATCGCTAAGGACCCCAAAGTCCGAG
SEQ ID




ACAGGGACGCGTGTGGGCGTGGTGCAGTACAGCCACGAGGGCACCTTTGAGGGCATCCAG
NO:




CTGGACGGACGAACGTATCGACTCCC
1855





COL6A2
ADXCRPD.10104.C1_s_at
GACCCCGGTCTCACGGAGTGTGACGTCATGACCTACGTGAGGGAGACCTGCGGGTGCTGC
SEQ ID




GACTGTGAGAAGCGCTGTGGCGCCCTGGACGTGGTCTTCGTCATCGACAGCTCCGAGAGC
NO:




ATTGGGTACACCAACTTCACACTGGAGAAGAACTTCGTCATCAAACGTGGTCAAACAGGC
1856




TGGGTGCCATCGCTAAGGACCCCAAAGTCCGAGACAGGGACGCGTGTGGGCGTGGTGCAG




TACAGCCACGAGGGCACCTTTGAG





ADAM9
ADXCRPD.10109.C1_s_at
ATTTTCATAGAAATTAGGCTGGAGAAAGAAGGAAGAAATGGTTTTCTTAAATACCTACAA
SEQ ID




AAAAGTTACTGTGGTATCTATGAGTTATCATCTTAGCTGTGTTAAAAATGAATTTTTACT
NO:




ATGGCAGATATGGTATGGATCGTAAAATTTTAAGC
1857





ADAM9
ADXCRPD.10110.C1_s_at
TTAAGTGTTTAAGTGTTATTCTGAATTTTCTACCTTAGTTATCATTAATGTAGTTCCTCA
SEQ ID




TTGAACATGTGATAATCTAATACCTGTGAAAACTGACTAATCAGCTGCCAATAATATCTA
NO:




ATATTTTTCATCATGCACGNNTTAATAATCATCATACTCTAGAATCTTGTCTGTCACTCA
1858




CTACATGAATAAGCAAATATTGTCTTCAAAAGAATGCACAAGAACCACAATTAAGA





EGFR
ADXCRPD.10120.C1_at
GCTGTGGAGCCCTTAAAGATGCCATTTGGCTTGGCTTCCTTGGGAAAGAAGTCCTGCTGG
SEQ ID




TAGTCAGGGTTGTCCAGGCTAATTTGGTGGCTGCCTTTCTGGGCCCAGTGGCGAGGGCTG
NO:




TCGAATGTGCTGTTGACACAGGTGGGCTGGACAGTGTTGAGATACTCGGGGTTGCCCACT
1860




GCAGTGCTGTGGGGGTCCTGGTAGTGTGGGTCTCTGCTGGGCGCGGGGTTCAGAGGCTGA




TTGTGATAGACAGGATTCTGCACAGAGCCAGCGGCCTT





EPAS1
ADXCRPD.10121.C1_at
CGAGCCAGCCATGGGCCACGGAGTTGAGGAGCCACAGCACCCAGAGCGAGGCTGGGAGCC
SEQ ID




TGCCTGCCTTCACCGTGCCCCAGGCAGCTGCCCCGGGCAGCACCACCCCCAGTGCCACCA
NO:




GCAGCAGCAGCAGCTGCTCCACGCCCAATAGCCCTGAAGACTATTACACATCTTTGGATA
1861




ACGACCTGAAGATTGAAGTGATTGAGAAGCTCTTCGCCATGGACACAGAGGCCAAGGACC




AATGCAGTACCCAGACGGATTTCAATGAGCTGGACTTGGAGACACTGGCGAGCTAG





GATA6
ADXCRPD.7794.C1_at
CCGTACACTCCTCTCTGGTTTTCTTCCTCAAAGGAAATTTATGCATGTAATCCACAAGCC
SEQ ID




GAAGAACCCATGTTTTTCTTTGGAAAAGGCTACGCCCTTTCAGGGTTTCCTTTTCTCGGC
NO:




TGTGTTGCCTTCCCATCAGAAGCTGTCTCTTGCCCTCCCCATTATGGGATGTGCGAAATG
1862




AAGGAAAACAGAGACACTGCTGGGCATTTGTCTCCATGAGTTGATCCAATCAGAAATCTT




TGACTTTTCACACATGTGTCCAAAAATGAGTG





FLNA
ADXCRPD.10169.C1_at
TCAGGCAACCTGACGGAGACCTACGTTCAGGACCGTGGCGATGGCATGTACAAAGTGGAG
SEQ ID




TACACGCCTTACGAGGAGGGACTGCACTCCGTGGACGTGACCTATGACGGCAGTCCCGTG
NO:




CCCAGCAGCCCCTTCCAGGTGCCCGTGACCGAGGGCTGCGACCCCTCCCGGGTGCGTGTC
1867




CACGGGCCAGGCATCCAAAGTGGCACCACCAAC





RND3
ADXCRPD.1153.C1_s_at
CACTCAGTTCTATGTCTTACAAGCACTTTGTCTTGTCTCTGCAAGAAAATTCGATTCCAG
SEQ ID




TCATTTCCCATAAAATACAGACATTTTACCAACATAATATGCTTTGATTGATGCAGCATT
NO:




ATGCTTTGGGCAGTATTACAAAATAGCTGGCGAGTGCTTTCTGTATTT
1868





COL4A2
ADXCRPD.10175.C1_s_at
GCTATCAAGGGCCTGATGGACCCCGGGGACCCAAGGGAGAAGCCGGAGACCCAGGGCCCC
SEQ ID




CTGGACTACCTGCCTACTCCCCTCACCCTTCCCTAGCAAAAGGTGCCAGAGGTGACCCGG
NO:




GATTCCCAGGGGCCCAAGGGGAGCCAGGAAGCCAGGGTGAGCCAGGAGACCCGGGCCTCC
1869




CAGGTCCCCCTGGCCTCTCCATCGGAGATGGAGATCAGAGGAGAGGCCTGCCGGGTGAGA




TGGGACCCAAGGGCTTCATCGGAGACCCCGGCATC





LPP
ADXCRPD.9098.C1_at
GCATCCACAGTGAATGGGATCCCATCCAGGCTGCGGTGGCACATCACCGCAGGGTGAAAC
SEQ ID




AGGTGAGGATGATTAGGCCTTCCCGGTGGCTCGGAGAATCCGCTCCATGATGGGCTTGGA
NO:




ACACACATTGCACTGCTCCAGAGTATTAATGTAGCAGGGCTCGCAGTATGCTTTCTTTTC
1872




CACAGCATAAAATGGCTGCCCTCGGAGCTTGTTGTTGAGATGATGCANGTNAAACAATCC




ACGTGGAAGACCTGATCCATGGCAGTGCATTCTGTACCTTTCCCAACTA





YPEL5
ADXCRPD.17470.C1_at
TGGAAAAAGACAACCCAGCAGTTCTGTCCCATCTCAGAAAAAGTTTCCAATCAACACCAA
SEQ ID




TTATGTGGTGACAAATAACTAGGAATGGTGACATCTTTGGGCCAAGACTGACAAGGAAGA
NO:




ATGGGCTCTGGTGCTACGGTTCATCTCCAACAAGAATATGGCACACCGGCCAGCACAAGC
1874




CATGCTAACACTGAGCCTTTAGCGCTGGGCACAGATTCAGATCTCTTCTCTGAAGCTAGC




AAATCAA





ZFP36L1
ADXCRPD.7802.C1_at
TCCTTGAAACTTCCCCAAGTGTCTGCACAACTTACCTTTTCCCGACTTCTCTTCGACACT
SEQ ID




CGGCTCCCTTCGGCAAACCGGGCAGGCCGAGGACATTAGAAATTTGGGACGCACAGAATG
NO:




TTCAAGCCTAGGATTTTATGTTGCTGTTTTTTTTCCAGCGGNGCGTAGGGTGGGGCGCGG
1875




TGCTGGGGGGACTAGGGAAACTTTTTCCCCAGGAGGACATGGTCTGGCGGGCGCGAGCGC




GGCACAATTTAGTGCGTCGCACGCGTCGACACT





RRBP1
ADXCRPD.7803.C1_s_at
GAGGCGTTTGACGTTCTAGGTTATCCCTCCGCAAGGGGATTCTCTGCCTGGCTTGCTGAT
SEQ ID




GTCATATCTGGTGGGGAGTGGATTTAGATCTGACACTTTTTCTGCTCTTCAGAAGCAGAA
NO:




GCACAAGCCCAGTATCCCAATTCTGGTTTAATCTCAAA
1876





MAP1LC3B
ADXCRPD.17493.C1_at
GAGTCTCATTAGTGTCTGTGTTTACTGAACGCTGCGGACATCTTTTCTATATACAGTAAT
SEQ ID




TCTTCCACCCTGTCACAACAAAGAGAAGTTGAGTGGCAGGAATGGGAAATCTTTACATGC
NO:




TTCTTTGGGAAAGAAAAATGCTTATTTGTACATTGTTCTATTGTGTGAGACCTACATAGG
1877




GTTCTGTGTAAGGCCGAGTCAAGCTGTCATCACTTTCCTTGGTAAGTTTGAGAGCTTTAT




CTAGCGGACACGTTCTGAAGT





CAST
ADXCRPD.7890.C1_s_at
AGTTAAGGTATCTGGTATCTGCATGTAAAATCTTCAGCTGGTGGATGGTGACTTTTGAAG
SEQ ID




AACAAAAGGCTTTGGCAACAGAAAACAATTGTTCTGGGTGATTTCTAGAATGGTTTTTGT
NO:




TGAGTCTCTGAACATCCTAAATATTGGTTTGTTA
1879





CAV1
ADXCRPD.1261.C1_s_at
TCAAGTTCCAAGTTGCTAATACAGCAACAATTTATGAATTGAATTATCTTGGTTGAAAAT
SEQ ID




AAAAAGATCACTTTCTCAGTTTTCATAAGTATTATGTCTCTTCTGAGCTATTTCATCTAN
NO:




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTTTGCA
1881




TGTGGATCAACCATCGCTTTATT





CD59
ADXCRPD.18131.C1_s_at
GGCAAGCTCTTCACTATGACAGTAAAGGCTCTCTGCCTGCTGCCAAAGCCTGTGACTTTC
SEQ ID




TAACCTGGCCTCACGCTGGGTAAGCTTAAGGTAGAGGTGCAGGATTAGCAAGCCCACCTG
NO:




GCTACCAGGCCGACAGCTACATCCTCCAACTGAACCTGATCAACGAAGAGGGATTCATGT
1883




GTCTGTCTCAGTTGGTTCCAAATGAAACCAGGGAGCAGG





CORO1C
ADXCRPD.18147.C1_at
GATATCCAAATAGCTTTATTGGCAAGAATCCACCTCTAGGATGTCCTTCCCGTATTTTGC
SEQ ID




TTCATCCTTGAAACTAACATCCTAGGAGCAACACATGCTGCCTCTTTTTAAAGGGGCCTG
NO:




GAGGCGTGGGGCAGACCCTTGAAGGAAGGAAGGAGTTGGTGAGCTGAGATGGTGAATGAG
1886




TTGACATTGTGGGCTATCTTTCAGAATCCGTTTCTGAATCTATGTAGCTACTTGATTACA




GTTTGGGCTTCTC





VCAN
ADXCRPD.18158.C1_at
ATTTCAACGACTTCAAGTCCTTCCTGCTTACACAGCCGAACTAAGACCACCTCACTGGTG
SEQ ID




GAAGACCAAAGAGGCCATTTGCACCTCAGGCTGCTTTCTGACGCCACAGACCTCCAGCAA
NO:




GCACAAATATTTCAACCTGCACATTAATAGTAGATATTATTCGAGGTCAGCAGA
1887





CDC42BPA
ADXCRPD.8518.C1_s_at
AAAGCAAGGGCTTCAACAGCCTTAACCAAATATTATTCCCCATAGCCAGTGGAAAATGGA
SEQ ID




TGTGACAACCCCAGTGCGCAGGCCAGAGTGAGTGAGCCCAGCACGGCGCTCCGACTGGCT
NO:




TCCTCTCTCAGGTGCTGGATTGTGGGGTTAGTGGCATTTCCAGCTGGATTCCTCCTGTTG
1891




TAGTTGCCATAAGGAAATGAGATGCAGAATCAGAAGGATCTATTTCTACAGAATCATTTC




ACCAGTTAAGCACATGAGTAGAGA





FLNB
ADXCRPD.18190.C1_s_at
TGGACTCAAGCTATTGTTCACCTCAGCCTCCCTTTTGTGATTTCTAATTTATTTTTAGTA
SEQ ID




ATTAACAATGTATTGCTTGTATAAATTTT
NO:





1892





LAMB1
ADXCRPD.478.C1_at
TTTTAATCACATTTTGTATGGAGTTAAATAAAGTACAGTGCTTTTGTA
SEQ ID





NO:





1896





LAMB1
ADXCRAD_CN388541_s_at
ATGCCAGAAGGAAAGCCGAAATGCTACAAAATGAAGCAAAAACTCTTTTAGCTCAAGCAA
SEQ ID




ATAGCAAGCTGCAACTGCTCAAAGATTTAGAAAGAAAATATGAAGACAATCAAAGATACT
NO:




TAGAAGATAAAGCTCAAGAATTAGCAAGACTGGAAGGAGAAGTCCGTTCACTCCTAAAGG
1897




ATATAAGCCAGAAAGTTGCTGTGTATAGCACATGCTTGTAACAGAGGAGAATAAAAAATG




GCTGAGGTGACCAAGGTAAAACA





KDELR2
ADXCRPD.491.C1_s_at
AAGGTCTGGAAGCTCTGTGTAGCCATTCCTTCTGCAGTCATCCTACCCAAGTAAAAGTAA
SEQ ID




CCTTGGCTATGTTACCACCGTTTTGGTCACCCAGGAGGACATCTTAGCAAGGGTGCCTGC
NO:




GAGGGAGTGTGGGACTGGGCCTCATCCTCGCCGGCGTTGGAAACCAAGGCCTTGTATGCC
1898




ACGCCTTATGAAGCACTGTTTCACAGTTACTTTCACTTCCCGAA





SCRN1
ADXCRPD.2301.C1_at
CACGTGCTTCCTTACTAAGGCTGAGAGCTCAACTGAAGACCTTCCCCAATAAATGACAGA
SEQ ID




TGGCTCTTCAGTCAGGAATGCAGTTAGTGGTTTCATGACAGACACACTGGTCCCACCTGG
NO:




CTTCCCTGCTGAACCACCCAGTACTGAATAACACCTGTACCAATGTGGGATGACATCAGC
1899




TAGGAAGCAAAGTAATTTGCCTGGTTGATGATTATTTTTTATACCTAATGATTCACCCAA




TAGTAAAGGAACCCCACAGCTAAGATC





CAPN2
ADXCRPD.6630.C1_s_at
TGCGCTTGATCAACTGAACCAGTATGCCAAAACCAGGCATCCAATTTGTAAACCAATTAT
SEQ ID




GATAAAGGACAAAATAAGCTGTTTGCCACCTCAAAACTTTATGAACTTCACCACCACTAG
NO:




TGTCTGTCCATGGAGTTAGAGGGGACATCACTTAGAAGTTCTTATAGAAAGGACACAAGT
1900




TTGTTTCCTGGCTTTACCTTGGGAAAATGCTAGCAACATTATAGAAATTTTGCCTTGTTG




CCTTATCTTCTTCCAAATGTACTGTTAA





FLNA
ADXCRPD.3150.C3_at
CTCATGGGTCTTGCCCGATGGGCTGGTCACCTGGGCTGTCATATCCTGGATGCTAATTTC
SEQ ID




AGGGATTTTCAGGCTGAGGTCACAATGACTACCAACGTTGGCCACTGAAGGAGCCCGACG
NO:




CCTGCGGGTGATGCTCTCTTTCACCCGGCCCTCGCCTGTCACCTTCACAGAGAAGGGGCT
1902




GCCAGGCACGTGCTGGTCGGCAAACTTGATGTTGATGATGTAGTTGCCTGGCTCTGTGGG




GCAGTAGGTGACCCTGCACGTCC





SEPT7
ADXCRPD.177.C1_s_at
ATAAAGGACCGTTTACCTCTTGCTGTGGTAGGTAGTAATACTATCATTGAAGTTAATGGC
SEQ ID




AAAAGGGTCAGAGGAAGGCAGTATCCTTGGGGTGTTGCTGAAGTTGAAAATGGTGAACAT
NO:




TGTGATTTTACAATCCTAAGAAATATGTTGATAAGAACACACATGCAGGACTTGAAAGAT
1905




GTTACTAATAATGTCCACTATGAGAACT





RAB32
ADXCRPD.4345.C1_at
TTTGTCATTGTTGCCATCATATGGAAGATAATGTTTACATCCTTTTAAACATTTTTATAT
SEQ ID




GACAATTCCTCAGGATTTGGTAAGGCTTCCAAGTTGTAGCTT
NO:





1906





RAB32
ADXCRPD.4345.C1_s_at
ATGTCATGTTAGCTGGGAGTCTTCCCACATGTGGCACTTCAAAAGGCAGCACCACTGGGC
SEQ ID




GCCTGCACTTATTTGAAAATGGAACTTTGGGAGAAGTATCCCTGCTAGTGGCTCTGTAAC
NO:




TTAACAGATGACAATTAGGCTTTT
1907





MARCKS
ADXCRPD.2741.C1_at
GGGTCTCCTCTCTCGGGCGGCTACTACTCCACACCGAGAGGGAGTGTCTTACAAGGCGGC
SEQ ID




CGGCGTGCAAACAAAAAAATAATATAACCGNNNNNNNNNNNTCGGTCGCACCTATATTCG
NO:




AGCAAAGAAAAGCGTGGGTGGTAAAGTATATTCTATAAACACAATTTCCTCGCGCCCACC
1908




ACGGTGGAATACCCACTCCCCATAAAACGGCCGGTGGGAGAAGACTCTCGAACACCGCCC




G





CD55
ADXCRPD.1207.C1_at
TTCTATCTGGGCACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGG
SEQ ID




GCTTGCTGACTTAGCCAAAGAAGAGTTAAGAAGAAAATACACACAAGTATACAGACTGTT
NO:




CCTAGTTTCTTAGACTTATCTGCATATTGGATAAAATAAATGCAATTGTGCTCTTC
1911





LEPRE1
ADXCRAD_CN309928_s_at
AGACGGATGGGTGACTAGACCCATGGAGAGGAACTCTTCTGCACTCTGAGCTGGCCAGCC
SEQ ID




CCTCGGGGCTGCAGAGCAGTGAGCCTACATCTGCCACTCAGCCGAGGGGACCCTGCTCAC
NO:




AGCCTTCTACATGGTGCTACTGCTCTTGGAGTGGACATGACCAGACACCGCACCCCCTGG
1914




ATCTGGCTGAGGGCTCAGGACACAGGCCCAGCCACCCCCAGGGGCCTCCACAGGCCGCTG




CATAACAGCGATACAGTACTTAAGTGTCTGTGTAGACAACCAAAGAATAA





LDLR
ADXCRPD.1293.C1_s_at
CCCTGGTTGCTGTATTTGTTCAGTGACTATTCTCGGGGCCCTGTGTAGGGGGTTATTGCC
SEQ ID




TCTGAAATGCCTCTTCTTTATGTACAAAGATTATTTGCACGAACTGGACTGTGTGCAACG
NO:




CTTTTTGGGAGAATGATGTCCCCGTTGTATGTATGAGTGGCTTCTGGGAGATGGGTGTCA
1916




CTTTTTAAACCACTGTATAGAAGGTTTTTGTAGCCTGAATGTCTTACTGTGATCAAT





PTRF
ADXCRPD.2246.C1_x_at
TCTCCCCAGTCACAGCCTGAAGGGAGGCCCCGAGAGCTTCCTCCTTCCCCCCACCTGCTC
SEQ ID




CTTACCTTCTCTGCCCTGCTTTTTAGAACTGCAGTTCATTGTTTTAAGGGATTGGGGGAG
NO:




GGAGCCTGGGGACACAAACCTTTTATACAATACAAAGCTTTGCNNNNNNNNNNNNNNNNC
1917




TTCCCTTTTCCCNTTTCTCGGTTCTCTTTTCTCTCCTCTGGAATGGGCTGAAGACCCCTC




TGCC





FKBP9
ADXCRPD.3075.C1_s_at
AGAAGTTTGGGCTGATCGCCAGTGATAGTAAACAAAATCTGTGCAGAGGGCCTTAGCATG
SEQ ID




GGATGTGTCCAGTATTGAAAAGGCTGCACTGCCAACCATGATTTGTGAGCCTTCTGGGAA
NO:




ATTTTGTTATTAAAGGAATATATAGTGTCAGACGGAAGTTATAATCATCTTGGAGGAACC
1918




ATAAGAAAAGGTGTCCAGGGTATCTATATAAA





S100A11
ADXCRPD.77.C3_at
TTCTCACAGGAGTATAAGGTACAGGATAGGGATTATTAATATTCCCATTTGCCAGATGCA
SEQ ID




GAAACAGACTAAAAGAGGTGAAGTGACCTGCCTAAGGGCCAGACCTGGGCCTTGAACCAA
NO:




AGGTTTTCCCACTCCTAGTCCAGGGCTCTTTCCATGATATAAGGGGCTATTCAGTTTGGT
1920




AAAGCCAGTGGAACACTTTCTTTCAAGTGTTGCATGCACTTCCCAATAGATAAACT





FOXN3
ADXCRPDRC.8652.C1_s_at
GAGCCTTCACGTAAATGGGTCCAGTCATGCCTCCCAGTAAGAAGCCAGAAAGCTCAGGAA
SEQ ID




TTAGTGTCTCCAGTGGACTGAGTCAGTGTTACGGGGGCAGCGGTTTCTCCAAGGCCCTTC
NO:




AGGAAGACGAGTGACCTCGACGTTTTCTCTGCCTGACATCCGATTATAAGAAGGGGGCCA
1924




TGGAAGATGAAGAGCTGACCAACCTGAACTGGCTGCACGAGAGCAAGAACTTGCTGAAGA




GCTTTG





LAMB1
ADXCRPDRC.11010.C1_at
GCCGATGACTGCGACCCAGTGACTGGGGAGTGCTTGAACTGCCAGGACTACACCATGGGT
SEQ ID




CATAACTGTGAAAGGTGCTTGGCTGGTTACTATGGCGACCCCATCATTGGGTACAGGAGA
NO:




TCACTGCCGCCCTTGCCCTTGCCCAGATGGTCCCGACAGTCGGACGCCAGTTTGCCCCGG
1925




AGCTGCAACCAAGATACCTGTTACTTTACTGCTGCCTGTGTTTGTGATCCTGGATACATT




GGTTCCAGATGTGACGATCTGTGCCTACAGG





FOXN3
ADXCRPDRC.8765.C1_s_at
AAAGGGTCGTTGTGGTGCATAGACCCAGAGTATAGACAAAATCTAATTCAGGCTTTGAAA
SEQ ID




AAGACACCTTATCACCCACACCCACACGTGTTCAATACACCTCCCACCTGTCCTCAGGCA
NO:




TATCAAAGCACATCAGGTCCACCCATCTGG
1928





ARID5B
ADXCRPDRC.11117.C1_at
GATTTTTGTGGGACAACTCTAGCCCACAAACTGACTGGCTGGTGAGTCTTGACTCCCTTC
SEQ ID




CAACACAGATGCCCAGGCACCTCCAGATCATTCACTTCGCACGTGGGCCTTGTGAAGGGA
NO:




TTTGTGAATATCCAGGAAGAACTTAGAGGACCCCATCTGAGTTCGGATGGTCAGGAAACA
1931




ATCTGGGCAAAAAAGAGGCAGGCATTTCAAAGGAAGGGGCAAGGAAGACTGGCAAACAGA




TGGCAAGGC





KDELR3
ADXCRPDRC.11126.C1_at
GACCTTTTCATCAATAGATCGCCCTTAAAGACCCATTGTAAGGTCATAAAAAACCTCGGC
SEQ ID




CAACTGCACAAAGATGGTGCCTCACTGCAACAAGAAACCTTAAGGTGTCTTACCGACGAA
NO:




ATAAAAAACATAAATGATTGTTCTCCAAGGCCTGAGGGCAAGACTCATGATGGGCAAGTC
1932




AACCCCAATCTGGAACAATGTCCCTCCTCTTAG





LEPROT
ADXCRPDRC.1565.C1_s_at
CTGAAGCCCCACTCTGGACCCAGGACATTTTGATGAGATCCAAAGGAGTTGTATGCACAT
SEQ ID




GAAAGTTTGAGAAGCATCATCATAGAGAAGTAAACATCACACCCAACTTCCTTATCTTTC
NO:




CAGTGGCTAAACCACTTAACCTCTCTGGGTGTTACCTGCTCATTTGTTT
1933





MALT1
ADXCRPDRC.2292.C1_at
GGGTGATGCCCTACGTTTACTGAATTTTCCACTTGGATCCTAGATATTGGATCCCAAAAG
SEQ ID




ATGGCAAATTAAAGGGCACACCCTGAAAGAAACCTGGGAAGCTAACTTGGGTATTCCAAA
NO:




GGAATTTTTCCCCAAGGCATTTGCCCTTCTATACCCAAGACTTCAGGTTCCCCTGGCAAA
1935





SYNJ2
ADXCRPDRC.17920.C1_at
TAAGAGAATTCCCGCCAAAGGGCCAAAATTGGCCTGGGTAAACTTTTGCAGGAACGGTCA
SEQ ID




CTCGGCTCTCA
NO:





1936





SYNJ2
ADXCRPDRC.17920.C1_s_at
GTCACTCGGCTCTCAGTGTCCTGGACGTGGACGGTATGAAGGTGAAAGGCAGAGCAGTGA
SEQ ID




AGATTAGACCGAAGACCAAGGACTGGCTGAAAGGTTTGCGAGAGGAGATCATTCGGAAAC
NO:




GAGACAGCATGGCCCCCGTGTCTCCCACTGCCAACTCCTGTTTGCTGGAGGAAAACTTTG
1937




ACTTCACAAGTTTGGACTATGAGTCA





POFUT2
ADXCRPDRC.17928.C1_at
AATGCTGGAAGTGGCCCCAGCATCCTTCCGCCANNNNNNNNNNNNNNNNNNNNNNNNNNN
SEQ ID




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCAGGACAGCTCATTTTATATTATCAAAT
NO:




CCCGTTCTTTTAACACGCGACAGTCGCGCAGTTTAATCTTCCCTCCCCCCCTATGCCTCG
1938




CCCATTGCCCGTTGGCGGTTATACGCAGTATCCTGATAACGTAGTACCCGCGC





EPAS1
ADXCRPDRC.3002.C1_at
TGAACGTGCCCGTGCTTGGGAAGCTGCACGCTCCTGCAAGGAGGGGACCTCTTTCAGAGC
SEQ ID




TCCTGGACCAGGACACTTGAGCCAGGCCTTCTACCTGGCATCA
NO:





1941





EPAS1
ADXCRPDRC.3002.C1_x_at
GAACAGCAAGAGCAGGTTCCCGCCACTGTGCTACGCCACCCAGTACCAGGACTACAGCCT
SEQ ID




GTCGTCTGCCCACAAGGTGTCAGGCATGGCAAGCCGGCTGCTCGGGCCCTCATTTGAGTC
NO:




CTACCTGCTGCCCGAACTGACCAGATATGACTGTGAGGTGAACGTGCCCGTGCTTGGGAA
1942




GCTGCACGCTCCTGCAAGGAGGGGACCTCTTTCAGAGCTCCTGGACCAGGACACTTGAGC




CAGGCCTTCTACCTGGCATCA





ALCAM
ADXCRPDRC.1829.C1_s_at
TTCTAGGTATAGAACTATGTTATTGAAAGGAAAAGGAAAACTGGTGTTTGTTTCTTAGAC
SEQ ID




TCATGAAATAAAAAATTATGAAGGCAATGAAAAATAAATTGAAAATTAAAGTCAGATGAG
NO:




AATAGGAATAATACTTTGCCACTTCTGCATTATTTAGAAACATACGTTATTGTACATTTG
1947




TAAACCATTTACTGTCTGGGCAATAGTGACTCCGTTTAATAAAAGCTTCCGTAGTGCATT




GGTATGGATTAAATGCATAAAATATTCTTAGACTCGATGCTGTATAAAATATTA





ARID5B
ADXCRPDRC.10890.C1_at
TTATACTTTTGTAGACTCTCCTGTGTTGTCCATATTGTATACTTTTGGTGATTCCAGCTA
SEQ ID




TTTAACCTCTATGTCTCTGCTAAGGTGATTATTTGTATATAGCACTCGGCCCTGTGATAT
NO:




TATAGAGTTTCCCGTGGAGA
1948





FOXN3
ADXCRPDRC.12156.C1_at
GTGAACGATCATTTCTGACTTAACCGTGAGATGCTCACGAGTACCCTTCCTGTTGTTTTG
SEQ ID




TTAGCATTGAAATCGAGACTATTTATTTGGAATATATACAACAGTGTTTTTCCACTGTAT
NO:




TTCATTTGCAAAAGTTGAGAACTGCTTTCTCTACCCTTTGCCAAATTAATGAATATCCAA
1953




TATGGGATTTTCAAAGACTCCGATATGGTGAACCTATTAAACCTAGAAATTGTATTCATC




CTTTCATGACTGTGGCCTGAGTTCCCCAG





AHNAK
ADXCRPDRC.3149.C1_s_at
TCCTGGCAAGGCATTCGCTCCTGAGCGGAATCCTGCAAAGATGGAGAAGGAGGAGACAAC
SEQ ID




CCGGGAGCTGCTGCTGCCCAACTGGCAGGGTAGTGGCTCCCACGGGCTGACCATCGCCCA
NO:




GAGGGACGACTGTGTGTTTGTGCAGGAGGTGACGCAGAACTCCCCTGCGGCCCGCACTGG
1954




GGTGGTCAAGGAGGGGGACCAGATTGTGGGTGCCACCATCTACTTTGACAAGCTGCAGTC




GGGTGAGGTGACCCAGCTGCTGAACACCATGG





ADAM9
ADXCRPDRC.11545.C1_at
AAAAGCCAAGTGTGCCCCAAAGATTGTTCCATGGAAGTGACATTCTACACAGGTGACAGA
SEQ ID




TTTGG
NO:





1955





ADAM9
ADXCRPDRC.11545.C1_x_at
GCTCAATGTCAAGTCATCTTTGGCACAAAAGCCAAGTGTGCCCCAAAGATTGTTCCATGG
SEQ ID




AAGTGACATTCTACACAGGTGACAGATTTGGCAATTGTGGTTACTCTGGCCATGAATACA
NO:




AGAAGTGTGCCACTGGGAATAGCTTTGTGTGGAAAGCTTCAGTGTGAGAATGTACAAGAG
1956




ATACCTGTATTTGGCATTGTGCCTGCTATTATTCAACACGCCTAGTCGAGGCACCCAATG




TTGGG





FLNA
ADXCRPDRC.3227.C1_at
AGAAGACAGGTGTGGCCGTCAACAAGCCAGCAGAGTTCACAGTGGATGCCAAGCACGGTG
SEQ ID




GCAAGGCCCCACTTCGGGTCCAAGTCCAGGACAATGAAGGCTGCCCTGTGGAGGCGTTGG
NO:




TCAAGGACAACGGCAATGGCACTTACAGCTGCTCCTACGTGCCCAGGAAGCCGGTGAAGC
1960




ACACAGCCATGGTGTCCTGGGGAGGCGTCAGCATCCCCAACAGCCCCTTCAGGGTGAATG




TGGGAGCTGGCAGACACCCCAACAAGGTCAAAGTAT





SVIL
ADXCRPDRC.9920.C1_at
CATGTCTATAAAGAAAGATGGCACTGTTGAAGAAAAGCGGGGAGGAAGATTGGAGAAACA
SEQ ID




GACTCAGCAGGAGGCAGGAGGGCGGCAGCGCCGCCACAGCCGCACACCCAGAAGCAGGCG
NO:




TCCCTCATCAGAAGCGT
1963





SVIL
ADXCRPDRC.9920.C1_s_at
TGGAAGCCCCAGGATTCTTCGGAACAGCCGCAGGAGAAGCTCTGCAAGAATCCATGTGCG
SEQ ID




ATGTTTGCTGCTGGAGAGATCAAACGCCGACAGGGGAGGGCCTTCTTGACTCACCCAGCA
NO:




A
1964





CAPN2
ADXCRPDRC.9976.C1_at
ACGCGTACTCGGTCACCGGAGCCGAGGAGGTTGAAAGTAACGGAAGCCTACAGAAACTGA
SEQ ID




TCCGCATCCGAAATCCCTGGGGAGAAGTGGAGTGGACAGGGCGGTGGAATGACAACTGCC
NO:




CAAGCTGGAACACTATAGACCCAGAGGAGAGGGAAAGGCTGACCAGACGGCATGAAGATG
1965




GAGAATTCTGGATGTCTTTCAGTGACTTCCTGAGGCACTATTCCCGCCTGGAGATCTGTA




ACCTGCCGAAGACCCAGCTTGAG





CORO1C
ADXCRPDRC.2786.C1_s_at
AATCAAAGCAGTAGCCACATGGTGCTGGCTCCTTTGCAGCACAAACCTGGTCATTTTGAT
SEQ ID




GACTGTACAACAGGAAGACTTGAAAAATCACGTGGATTCATATTACCACCGCTCTCATTT
NO:




CATGGAGTCTTCTGATCAAAAAAGCTCACGTCGTATTTCTTCTTTTCCTTTCTCTTTTCT
1966




AGAAATTGGGTGTTTGTACCAGAATGGAATTTTGCTTCTCGGTTATCCTGTGCTTCAGAT




GAT





IL6ST
ADXCRPDRC.11859.C1_s_at
ACACTTCGAGCACTGTCCAGTATTCTACCGTGGTACACAGTGGCTACAGACACCAAGTTC
SEQ ID




CGTCAGTCCAAGTCTTCTCAAGATCCGAGTCTACCCAGCCCTTGTTAGATTCAGAGGAGT
NO:




GGCCAGAAGATCTACAATTAGTAGATCATGTAGATGGCGGTGATGGTATTTTTCCCAGGC
1971




AACAGTACTTCAAACAGTACTGCAGTCAGCATGAATCCAGTCCAGATATTTCACATTTTG




AAAGGTCAAAGCAAGTTTCATCAGTCAATGAGG





ADAMTS1
ADXCRPDRC.13363.C1_at
AAAGGCATTGGCTACTTCTTCGTTTTGCAGCCCAAGGTTGTAGATGGTACTCCATGTAGC
SEQ ID




CCAGATTCCACCTCTGTCTGTGTGCAAGGACAGTGTGTAAAAGCTGGTTGTGATCGCATC
NO:




ATAGACTCCAAAAAGAAGTTTGATAAATGTGGTGTTTGCGGGGGAAATGGATCTACTTGT
1975




AAAAAAATGATCAGGATCAGTTACTAGTGCGAAACCTGGATATCATGATATCATCACAAT




TCCAACTGGAGCCACCAACATCGAAGTG





SPTBN1
ADXCRPDRC.13403.C1_at
CAGTACATGTTTCTGCGGCAGCGGCTGCAGGCTCTGGACACTGGATGGAACGAGCTCCAC
SEQ ID




AAGATGTGGGAGAACAGACAAAATCTCCTATCCCAGTCACATGCCTACCAGCAGTTCCTC
NO:




AGAGACACGAAGCAAGCCGAAGCCTTTCTTAACAACCAGGTAAGGTTTGTTCCTGCCTTT
1979




GCTTCCTTTCGGTGAAAGCAGCGCTGGCTGCCTTTTGAAATGTTTTGGCTGGGGCAGCTG




GTTTAAACCACACCCTGTATGGAATATATGGATAATTTAGAGACCGCGATG





PTPRK
ADXCRPDRC.14082.C1_s_at
GGATTCACGGGTAGAGATTGGCTTCGGGCTGAGCTAGCAGTGAGCACCTTTTGGCCCAAT
SEQ ID




GAATATCAGGTAATATTTGAAGCTGAAGTCTCAGGAGGGAGAAGTGGTTATATTGCCATT
NO:




GATGACATCCAAGTACTGAGTTATCCTTGTGATAAATCTCCTCATTTCCTCCCGTCTAGG
1980




GGATGTAGAGGTGAATGCAGGGCAAAACGCTACATTTCAGTGCATTGCCACAGGGAGAGA




TG





MARCKS
ADXCRPDRC.4423.C1_s_at
CGTTACACCAACCCGAGGCTCTTTGTTTCCCCTCTTGGATCTGTTGAGTTTCTTTGTTGA
SEQ ID




AGAAGCCAGCATGGGTGCCCAGTTCTCCAAGACCGCAGCGAAGGGAGAAGCCGCCGCGGA
NO:




GAGGCCTGGGGAGGCGGCTGTGGCCTCGTCGCCTTCCAAAGCGAACGGACAGGAGAATGG
1981




CCACGTGAAGGTAAACGGCGAC





ARID5B
ADXCRPDRC.12803.C1_at
ACCACCTGGCAATACAGTCCACTTTCTGGTTTCTTTTATTGTGGGAAGTAAATGGTCAAG
SEQ ID




CTGCTCAGGCAGTGAAAAGATGTGGAGAATGTCCGTTGTCATTCTTGCCACTGTATTCCA
NO:




TTTGCTACCGAGATATAACATTAAGGTGGACACATTTTCTAACTGTATTAATTAAAAGTC
1985




AATGGATACAGAGAGTGGATTTTCTCCCCAAGTCCCATCCCTGCTGAAGACCGCTTGGAT




GACTCCCCAACCCACTGTGCCCCTCCCGCAACACTACCAGTAACAACAACGCG





SGCE
ADXCRPDRC.12912.C1_at
TATTAAGTGTATACCCTATAATCGACATTCTC
SEQ ID





NO:





1991





SGCE
ADXCRPDRC.12912.C1_s_at
TCCACCCTGTGACTGGGGAAATCATTACCTCCTTTACACACTAGACAACTATGATAGCAC
SEQ ID




TAACATGCCATTGATGCAAACGCAGCAGAACTTGCCACATCAGACT
NO:





1992





SGCE
ADXCRPDRC.12912.C1_x_at
GGGAAATCATTACCTCCTTTACACACTAGACAACTATGATAGCACTAACATGCCATTGAT
SEQ ID




GCAAACGCAGCAGAACTTGCCACATCAGACTCAGATTCCCCAACAGCAGACTTACAGGTA
NO:




AATGGTATCCCTGAAGAAAGAAAACTGACTGAAGCAATGAATTTATAATCAGACTCATAT
1993




AGCAGTTACATCACATTTCTTTTCTCTTCCTATAATGCATGAGCTTTTCTGTCATATGTT




ATGCATGTTGCAGTATTAAGTGTATACCCTATAATCGACATTCTC





FNDC3B
ADXCRPDRC.13581.C1_at
TTTATTCAAATCCAATAGCAAGCTCTGTTTTCTAATATAGTAAATGTCTTTATAGTAATA
SEQ ID




GTGAGTAATCATCAATTCTAAAGATAGAATTATTATTACAATAAACAAACTTTAGTCACA
NO:




TATTGGCAGTTT
1994





FNDC3B
ADXCRPDRC.13581.C1_s_at
TGGCTTTAGTGTCAAATGGGATCCCCCTAAGGACAATGGTGGTTCAGAAATCCTCAAGTA
SEQ ID




CTTGCTAGAGATTACTGATGGAAATTCTG
NO:





1995





LOXL2
ADXCRPDRC.4590.C1_s_at
ACCGTCTGCGACGACAAGTGGGACCTGGTGTCGGCCAGTGTGGTCTGCAGAGAGCTGGGC
SEQ ID




TTTGGGAGTGCCAAAGAGGCAGTCACTGGCTCCCGACTGGGGCAAGGGATCGGACCCATC
NO:




CACCTCAACGAGATCCAGTGCACAGGCAATGAGAAGTCCATTATAGACTGCAAGTTCAAT
1997




GCCGAGTCTCAGGGCTGCAACCACGAGGAGGATGCTGGTGTGAGATGCAACACCCCTGCC




AT





GJA1
ADXCRPDRC.13657.C1_at
GCCTATGTCTCCTCCTGGGTACAAGCTGGTTACTGGCGACAGAAACAATTCTTCTTGCCG
SEQ ID




CAATTACAACAAGCAAGCAAGTGAGCAAAACTGGGCTAATTACAGTGCAGAACAAAATCG
NO:




AATGGGGCAGGCGGGAAGCACCATCTCTAACTCCCATGCACAGCCTTTTGATTTCCCCGA
2000




TGATAACCAGAATTCTAAAAAAACTAGCTGCTGGACATGAATTACAGCCACTAGCCACTT




GTGGACCAGCGCCTTTCACAGTTCGTAGGGAT





SPTBN1
ADXCRPDRC.15064.C1_at
CTGCAGTTGAGTCCGCCACAAAAAAGCACGAGGCCATTGAGACAGACATTGCCGCATACG
SEQ ID




AGGAGCGTGTGCAGGCTGTGGTAGCCGTGGCCAGTTAGCTCGAGGCCGATAATTACCACG
NO:




ACATCAAGCGCATCACAGCGAGGAAGGACAATGTCATCCGGCTCTGGGAATACCTACTGG
2002




ACCTGCTCAGGGCCCGGAGACAGCGGCTCGAGATGAACCTGGGGCTGCAGAAGATATTCC




AGGAAATGCTCTCCTTATGTGCTA





LAMB1
ADXCRPDRC.14422.C1_at
GTCAGCCTTGCCAGTGTCACAACAACATTGACACGACAGACCCAGAAGCCTGTGACAAGG
SEQ ID




AGACTGGGAGGTGTCTCAAGTGCCTGTACCACACGGAAGGGGAACACTGTCAGTTCTGCC
NO:




CGGTTTGGATACTATGGTGATGCCCTCCGGCAGGACTGTCGAAAGTGTGTCTGTAATTAC
2003




CTGGGCACCGTGCAAGAGCACTGTAACGGCTCTGACTGCCAGTGCGACAAAGCCCACTGG




TCAGTGCTTGTGTCTTCCTAATGTGATCGGGCAGAAACTGTGACCGCTGTGTATTC





TGFBR2
ADXCRPDRC.13821.C1_s_at
ATGCCAGCCTTCTCAACCTTTGCAGAAATTACTAGAGAGGATTTGA
SEQ ID





NO:





2005





TGFBR2
ADXCRPDRC.13821.C1_x_at
CAGCCTTCTCAACCTTTGCAGAAATTACTAGAGAGGATTTGAATGTGGGACACAAAGGTC
SEQ ID




CCATTTTGCACGTTAGAAAATTTGTGTCCACAAGGACAAGAACAAAGTANTGAGCTTTAA
NO:




AGCTCCATAGGAAACTTGTTAAATCAACAAGAGAAGTGTTAATGCTGCAAGTANTCCTCN
2006




NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCAAGCCAAAATAGGAATATTAAGAN




GAGGGGACTGGGTANGTGAGAATATCAGCTCCGGTTTGGGATGGTG





FAM50A
ADXCRPDRC.6370.C1_at
ACTGCTGCATGGTGTTGCCCTTTCTCATCTTGACTGTCCGCCGGTGCCCAGAGCCATCCC
SEQ ID




AGTAGCTGAAGGTGATCTCGATCTCCTCACTCTTGATCTTCTCCTGCTTGGCTTCCCACT
NO:




CCTGCCGCAGCTCTTCCCGAAGCCGATTCTCCTCCTCCTCACGGTCTCGATCAGGCAAGA
2010




AGCTTGTGTCAACGTCTGGGT





CD59
ADXCRPDRC.15392.C1_at
ATCTTTCCCCTTGCGGTACTAATCTATTGGCGCACAAGGAGGGCGTCACAGTGCT
SEQ ID





NO:





2011





CD59
ADXCRPDRC.15392.C1_s_at
GTAGTGAGCTGCCTTTCTGTGATCGGTTTCCCTAGGGATGTTGCTGTTCCCCTCCTTGCT
SEQ ID




ATTCGCAGCTACATACAACGTGGCCAACCCCAGTAGGCTGATCCTATATATGATCAGTGC
NO:




TGGTGCTGACTCTCAATAGCCCCAC
2012





CCND1
ADXCRPDRC.16054.C1_at
GTAGTGACCTGTTTATGAGATGCTGGTTTTCTACCCAACGGCCCTGCAACCAGCTCACGT
SEQ ID




CCAGGTTCAACCCACAGCTACTTGGTTTGTGTTCTTCTTCATATTCTAAAACCATTCCAT
NO:




TTCCAAGCACTTTCAGTCCAATAGGTGTAGGAAATAGCGCTGTTTTTGTTGTGTGTGCAG
2013




GGAGGGCAGTTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCAAGCAGGA




CTTTGAGGCAAGTG





PPP4R1
ADXCRPDRC.6469.C1_s_at
GAATATCTTTATCAACTTCAGGAGTTTTTGGTGACAGATAATAGTAGAAATTGGCGGTTT
SEQ ID




CGAGCTGAACTGGCTGAACAGCTGATTTTACTTCTAGAGTTATATAGTCCCAGAGATGTT
NO:




TATGACTATTTACGTCCCATTGCTCTGAATCTGTGTGCCGACAAAGTTTCTTCTGTTCGT
2014




TGGATTTCCTACAAGTTGGTCAGCGAGATGGTGAAGAAGCTGCACGCGGCAACACCACCA




ACGTTCGGAGTGGACCTCATC





CRIM1
ADXCRPDRC.15616.C1_s_at
AGTGCAGACCCATAATCTGTGACAAGTATTGTCCACTTGGATTGCTGAAGAATAAGCACG
SEQ ID




GCTGTGACATCTGTCGCTGTAAGAAATGTCCAGAGCTCTCATGCAGTAAGATCTGCCCCT
NO:




TGGGTTTCCAGCAGGACAGTCACGGCTGTCTTATCTGCAAGTGCAGAGAGGCCTCTGCTT
2018




CAGCTGNGCCACCCATCCTGTCGGACACTTGTCTCACCGTGGATGGTCATCATCATAAAA




ATGAGGAGAGCTGGCACGATGNGTGCCGNGAATGCTACTGTCTCAATGGACGGG





FLNB
ADXCRPDRC.15647.C1_at
CGAACTCAACCCGAAGAAAGCCAGGGCCTATGGCAGAGGAATCGAGCCCACTGGAAACAT
SEQ ID




GGTGAAGCAGCCAGCCAAGTTCACTGTGGACACCATCAGCGCCGGGCAAGGAGACGTGAT
NO:




GGTGTTTGTTGAGGACCCAGAAGGGAACAAAGAGGAGGCACGAGTGACCCCTGACAGTGA
2019




CAAGAACAAGACATACTCTGTGGAGTATCTGCCCAAGGTCACCGGGCTACTACAAAGTCA




CAGTCCTCTTGCAGGACAGCACATCTCCGAA





IGFBP3
ADXCRPDRC.17075.C1_at
TTTTCTTGTCGGCTTCCTATCAGAATATTCAGAG
SEQ ID





NO:





2020





IGFBP3
ADXCRPDRC.17075.C1_s_at
TTGAATGGTAAACTTGAGCATCTTTTCACTTTCCAGTAGTCAGCAAAGAGCAGTTTGAAT
SEQ ID




TTTCTTGTCGGCTTCCTATCAGAATATTCAGAGACTCGAGCACAGCACCCAGACTTCATG
NO:




CGCCCGTGGAATGCTCACCACATGTTGGTCGAAGCGGCCGACCACTGACTTTGTGACTTA
2021




GGCGGCTGTGTTGCCTATGTAGA





CASK
ADXCRPDRC.17222.C1_at
TTGAAATCGTAAAGCGAGCTGACGCTGGTTTTGTGTACAGTGAAGCTGTAGCCAGCCATT
SEQ ID




ATATGAGACAGATACTGGAAGCTCTACGCTACTGCCATGATAATAACATAATTCACAGGG
NO:




ATGTGAAGCCCCACTGTGTTCTCCTTGCCTCAAAAGAAAACTCGGCACCTGTTAAACTTG
2029




GAGGCTTTGGGTAGCTATTCATTAGGGGAGTCTGGACTTGTAGCTGGGAGACGTGTTGGA




ACACC





SYNJ2
ADXCRPDRC.8240.C1_at
TCGGCTTCACTCTTGACAGCGCTTGCTTTGTATTTCCTGGGTTGCTCTTCTGTCCCACAT
SEQ ID




TGGCTCATTGCCATCTGTCCCTTGTCCATGCTTCCTTACAAAGTGGACCTTTTTCCTCCG
NO:




CCTCTTCCCTGTTCAGATGCTCCTCGACTTAAAATGGGGTTACATCCCAATAAACCCATC
2030




GTAAGTTGAAAAATAGCGTGTCAAAACTGCATCTCATACACCTAACCTAGCAAACGTCAT




GGTCTCGCTGACCTTGAACACACTCAGAACACATACATTAGCCTACGGCT





MARCKS
ADXCRPDRC.8271.C1_s_at
GAAGGCGAGGCTGCCGAGCCCGGCTCGCCCACGGCCGCGGAGGGAGAGGCCGCGTCGGCC
SEQ ID




GCCTCCTCGACTTCTTCGCCCAAGGCCGAGGACGGGGCCACGCCCTCGCCCAGCAACGAG
NO:




ACCCCGNNNNNNNNNNNGAAGCGCTTTTCCTTCAAGAAGTCTTTCAAGCTGAGCGGCTTC
2032




TCCTTCAAGAAGAACAAGAAGGAGGCTGGAGAAGGCGGTGAGGCTGAGGCGCCC





TMEM158
ADXCRPDRC.7689.C1_s_at
GATTAAATTGCTATTGCTGTAGTAAGAGAAGCTCTTTGTATCTGAACATAGTTGTATTTG
SEQ ID




AAATTTGTGGTTTTTTAATTTATTTAAAATTGGGGGGAGGGCATGGGAAGGATTTAACAC
NO:




CGATATATTGTTACCGCTGAAAATGAACTTTATGAACCTTTTCCAAGTTGATCTATCCAG
2034




TGACGTGGCCTGGTGGGCGTTTCTTCTTGTACT





FHL1
ADXCRPDRC.10038.C1_at
AGTATTACTCAAATAAGGGCACACAGTGATCATATTAGCATTTAGCAAAAAGCAACCCTG
SEQ ID




CAGCAAAGTGAATTTCTGTCCGGCTGCAATTTAAAAATGAAAACTTAGGTAGATTGACTC
NO:




TTCTGCATGTTTCTCATAGAGCAGAAAAGTGCTAATCATTTAGCCACTTAGTGATGTAAG
2035




CAAGAAGCATAGGAGATAAAACCCCCACTGAGATGCCTCTCATGCCTCAGCTGGGACCCA




GCTTGAGACCCGCGA





EGFR
ADXCRAD_CV574329_s_at
GGAAGCCAAGCCAAATGGCATCTTTAAGGGCTCCACAGCTGAAAATGCAGAATACCTAAG
SEQ ID




GGTCGCGCCACAAAGCAGTGAATTTATTGGAGCATGACCACGGAGGATAGTATGAGCCCT
NO:




AAAAATCCAGACTCTTTCGATACCCAGGACCAAGCCACAGCAGGTCCTCCATCCCAACAG
2037




CCATGCCCGCATTAGCTCTTAGACCCACAGACTGGTTTTGCAACGTTTACACCGACTAGC




CAGGAAGTACTTCCACCTCGGGCACATTT





LPP
ADXCRPDRC.9098.C1_s_at
AGGAGACTGTCCGTATTGTGGCTTTGGATCGAGATTTCCATGTTCACTGCTACCGATGCG
SEQ ID




AGGATTGCGGTGGTCTCCTGTCTGAAGGAGATAACCAAGGCTGCTACCCCTTGGATGGGC
NO:




ACATCCTCTGCAAGACCTGCAACTCTGCCCGCATCAGGGTGTTGACCGCCAAGGCGAGCA
2040




CTGACCTTTAGATTCAGTCACCTGTTCAGCCG





YPEL5
ADXCRPDRC.17470.C1_s_at
GAATCTGTGCCCAGCGCTAAAGGCTCAGTGTTAGCATGGCTTGTGCTGGCCGGTGTGCCA
SEQ ID




TATTCTTGTTGGAGATGAACCGTAGCACCAGAGCCCATTCTTCCTTGTCAGTCTTGGCCC
NO:




AAAGATGTCACCATTCCTAGTTATTTGTCACCACATAATTGGTGTTGATTGGAAACTTTT
2041




TCTGAGATGGGACAGAACTGCTGGGTTGTCTTTTTCCATGTAACT





ZFP36L1
ADXCRPDRC.7802.C1_at
GGAAGTTTCAAGGAGACCGCCAGCTCAAGATGGAAACCGCGGCCCGGGCGCTAAGAACGG
SEQ ID




GCTTCAGCTCCCGCTGGCAAAAAGAGAAAGTCGAGCCCGCCTTCCTGCCCAACAAAAAAC
NO:




AACAACATGACAACAAGAACCCCGGAGGGAGTGGAATGAGTGACGTCACAGCCGCGCTCT
2042




GAGGCTGACAAAGGAGGGGGCGCGCCCCTCCCGCTCTGCGCCCGCGCGGCCCCGGAGAGG




GGGCGCCTGAAGCGCCGGGTAGGGAAGTCAGCCGACTTGAAACTTTTCCTCTT





JUN
ADXCRPDRC.3805.C1_s_at
AACTTGTGCGCGCAGCCCAAACTAACCTCACGTGAAGTGACGGACTGTTCTATGACTGCA
SEQ ID




AAGATGGAAACGACCTTCTATGACGATGCCCTCAACGCCTCGTTCCTCCCGTCCGAGAGC
NO:




GGACCTTATGGCTACAGTAACCCCAAGATCCTGAAA
2045





SCRN1
ADXCRAD_CK001870_at
AGATGGAAATGCTATTGGCGGGAATATATAAAAAAAAAGAATCTTCTGTTCTGCATGG
SEQ ID





NO:





2046





SCRN1
ADXCRAD_CK001870_s_at
GAGCAGCAGGTCATGTGCACATGCCGTTGCAGCACAAGCTTATGCTTCCCGTAGCCGTGG
SEQ ID




CTTTTCATTCTGCACAGTCCCAGGTCCCAGCTCCCCTCTTATGGTTTCTGTCATAATGTG
NO:




CTTTATCTGATTGACTCCAAACATCCCGAAATGTCACCTGCAGATTTCTCGTGGGAACCA
2047




ATATGTACATGTT





FLNA
ADXCRPDRC.3150.C3_s_at
GTCTCGTCAGCAACCACAGCCTCCACGAGACATCATCAGTGTTTGTAGACTCTCTGACCA
SEQ ID




AGGCCACCTGTGCCCCACAGCATGGGGCCCCGGGTCCTGGGCCTGCTGACGCCAGCAAGG
NO:




TGGTGGCCAAGGGCCTGGGGCTGAGCAAGGCCTACGTAGGCCAGAAGAGCAGCTTCACAG
2048




TAGACTGCAGCAAAGC





FLNA
ADXCRPDRC.16964.C1_at
AAAAGTGACCGCCAATAACGACAAGAACCGCACCTTCTCCGTCTGGTACGTCCCCGAGTT
SEQ ID




GACGGGGACTCATAAGGTTACTGTGCTCTTTGCTGGCCAGCACATCGCCAAGAGCCCCTT
NO:




CGAGGTGTACGTGGATAAGTCACAGGGTGACGCCAGCAAAAGTGACAGCCCAAGGTCCCG
2051




GCCTGGAGCCCAGTGGCAACATCGCCAACAAGACCACCTACTTTGAGATCTCCACGGCAG




GAGCTGGCAC





SPTBN1
ADXCRPDRC.1211.C4_at
CAGGGCTTGTAACCTTACCCGTCTGTAGAGAACTTCTGGGCGGAGGCATTGACACCTCTC
SEQ ID




ACCCGCTCTGCCTGGATGCCAATGTCTGCTTCAACCAGGGTGTGCTTCTGTAACAGGTCT
NO:




TCCACACCAAGTAAGTGTTTGCCATAGTCTTGAGACAATACTAGCACCTTCATTTCATCC
2052




ATCCAGTCCATAATGTAGAGCATTTCCTGGAATATCTTCTGAAGCCCCAGGTTAATCTGA




ACCGCTGGTTTCCGGGC





SPTBN1
ADXCRPDRC.5087.C2_s_at
GAGAGGATCATTTACATCCGGGAGCAGTGGGCCAACCTAGAGCAGCTCTCGGCCATTCGG
SEQ ID




AAGAAGCGCCTGGAGGAGGCCTCCCTGCTGCACCAGTTCCAGGCAGATGCTGATGACATT
NO:




GATGCCTGGATGCTGGACATCCTCAAGATTGTCTCCAGCAGCGACGTGGGCCACGATGAG
2055




TATTCCACACAGTCTCTGGTCAAGAAACACAAGGACGTGGCGGAAGAGATCGCCAATTAC




AGGCCCACCCTTGACACGCTGCACGAACAAGCCAG





ATP2B4
ADXCRPDRC.5728.C1_s_at
TGGAAGGAGATGAGCTCCCATAACTGAATTGGCCTTTGGTTCATGTTTTCTCCCCATATG
SEQ ID




TATATATGCCATATGTGAATATGCCATATATATGTGCCCACAAATCTATCTACGTTGTTC
NO:




TTTTCAAATTAGCACGCAGATAGGAATTTTGAGTTTCTTCTTCTTTTAGTAACTAGTATA
2056




ACAAGCACTGGTATTTT





LAMB1
ADXCRPDRC.10237.C2_at
CTGTGGTGGTCTGGTTACTGTTGCACACAACGCCTGGCAGAAAGCCATGGACTTGGACCA
SEQ ID




AGATGTCCTGAGTGCCCTGGCTGAAGTGGAACAGCTCTCCAAGATGGTCTCTGAAGCAAA
NO:




ACTGAGGGCAGATGAGGCAAAACAAAGTGCCTGAAAGACATTCTGTTGAAGACAAATGCT
2057




ACCAAAGAAAAAATGGACAAGAGCAATGAGGAGCTGAGAAATCTAATCAAGCAACATCAG




AAACTTTTTTGACCCAGGATGTAGGAACTGGTCTCTGGCCCAGAGA





TGFBR2
ADXCRPDRC.12527.C1_s_at
AGAGCTGCTGCCCATTGAGCTGGACACCCTGGTGGGGAAAGGTCGCTTTGCTGAGGTCTA
SEQ ID




TAAGGCCAAGCTGAAGCAGAACACTTCAGAGCAGTTTGAGACAGTGGCAGTCAAGATCTT
NO:




TCCCTATGAGGAGTATGCCTCTTGGAAGACAGAGAAGGACATCTTCTCAGACATCAATCT
2059




GAAGCATGAGAACATACTCCAGTTCCTGACGGCTGAGGAG





PDLIM7
ADXCRSS.Hs#S5951004_s_at
TGGCAGCACCTGCTTACTTACCACTCATGGTGCAAGATGACACTTCAGCCTCCGCCAAAA
SEQ ID




TGCTCACCTTCCAGCCAGCAGGAAGTCGGAAGGAGAAGAAAGGGGACAGAGCCCCATGGC
NO:




GTCCATCCTTAGAGGATGCTGCCACCTGAACCTCTGCTTT
2060





LPP
ADXCRSS.Hs#S1294625_at
TGAAGGTCTTCAGCAAAAATTTGGACTGTAAACACAGCTTGGCATTATCAGCATTCTGTT
SEQ ID




AAGTTCAAAGAAGAGATAGTTACAACAAATACAGCTTGCTTTATTTCTGAAACAAAACTG
NO:




TGCACATATTTGTGGCCATACTACTAATTAACCTGTAGATTGTTCCTTTCATCTATTCAG
2063




CGTGTTTTTCTGCCCCCTGTTACAACAGTGTTGGGTTACTTTTCCCATATGGACTATATT




TAAACAGTTCCCTTATAGGCATTAGAG





NT5E
ADXCRSS.Hs#S1299958_at
ATTGAACAGAGAATCTACCCCAAAGCTGTGAGCTTAATTACTCTCAAGCTCCGGGGTCAA
SEQ ID




AGAGATCTGGTGTCCATTCTTATCACGTCTCCCTTTTTGCGGGGATGGTGCCTGTTAATT
NO:




TATTCAGCTTCTTCGACGCGGTTTCCCTTTCAATAAGATTGAGATAAAGCATTTTTCGAA
2064




AGATCTAGATTGAGATAAAGCATTCTTTGAAAGATCTAGCAGTAAA





CRIM1
ADXCRSS.Hs#S1805720_s_at
GAAGATGTTTGTCTGAGCATCCCATGAGGTAAGCAGCCCCATGGAAGGACCAGCTGCATC
SEQ ID




CAGCAAAGGGCTCCAGGTCCCTGACGTAGTTGACGGTGATGGCAGAAGTAAATCTTTGTA
NO:




TTCTTGCAGAGACTTTGTTTTTCTGTCATTCCACAGCAGCTCAGCATACTCTAATAAACG
2065




TCCTCCTCTTCCCCTTCGTAGCATTCTGGGACTAATCAGGGTTTCATCTGCTCACATATT




GTAGCGATGGGTTC





CD44
ADXCRSS.Hs#S1228681_at
TGCATTCCATTCCTTGTGTCTTAAAAGCAGACTGCAGTGTAGCTGAAGCAACCTTCTATT
SEQ ID




CATGCCAAAGTGCTTTATTCTGTGACTATACCTTGTATTGAGCTCTAAAACCTCAGAGAG
NO:




CTTTAAACTGGTTTTGCCTTTATAGAAAGGTTAAGTCCATTTGTGCATTACAGCTTTTAT
2068




TCTGTGTGTGTGTGCATACTTAAATTAAAATGGAAATTTATTTGTTAGGTTAGTTTCTCC




CAGAATTGCTCCTGGCAAAGAG





CD55
ADXCRSS.Hs#S2874822_at
GTAAAAAGGAGATAGGTCACATCATCTAAAGAATTAAAACAGACAATTTAATAACAGCAT
SEQ ID




TAAATTAATAGTTTTCTTATTAATGGGAAAAACGGACAGGCATTAGGGCAGCTTAGAAAT
NO:




AACTCAAGTTTGTATAAATTCCACAACTAGT
2073





CD55
ADXCRSS.Hs#S2874822_x_at
TATTTTTCTACAAGACTGACTCATTTAGTGAGTTAAAGAATATTTACATGCTTTAACTTA
SEQ ID




TAATAGGCTTAAGTAATATTCTTAATTTAAGTAGAAAAATTGTAGAGGGTAAAAAGGAGA
NO:




TAGGTCACATCATCTAAAGAATTAAAACAGACAATTTAATAACAGCATTAAATTAATAGT
2074




TTTCTTATTAATGGGAAAAACGGACAGGCATTAGGGCAGCTTAGAAATAACTCAAGTTTG




TATAAATTCCACAACTAGTTTTCTGAACAGT





CD55
ADXCRSS.Hs#S2948409_at
TTGGTGAATATCCTTGTACTGTATATTTTCATATTATTGGAGGTATATCTTCAGAGTTCA
SEQ ID




TTTCTAGATGTGAGACTGGTGGATCAAAGGGTAAATGCGTATGTGTGGGGTTTTTTTTAG
NO:




ATATTGGAAAATTCCCCTATAAAATGGCCGTATCAGTTTGCATTCCCACCAATAATATAT
2075




AAAAACATCTGATTTTCCACAGCCACACCAATAGGAAGTCTGGTCACATGAAAACCACAT




TCTCAACATAACTAGAAGACAAAGCACCTACTTCAAATTGCCTATAAG





RCN1
ADXCRSS.Hs#S1371296_at
AGCTCCACAGCTGGCCTAGGTTTCACAAATTTCCCACTGAACTCCACTGAGGTACCCTAA
SEQ ID




ATGCTAGCCCAGAGCAAACTTCAGGCTGGGAACCCACTTTTGTCATCTCTAGACCAGATG
NO:




GTCCCAAACCAGGACAGCATCCCAGTGGGGAACTTCAAAAACACCTCCAAGCTATCCCCA
2077




GTGTTTAAAAAAGTTTCACCCTTGTAGTCCATTTATCTGGGAGGAGGTCATACAGGCTAA




CTCTAGATTTCTTTCTTTGTTTTGGGCTGGAATTCTAACAGCTTC





LAMB1
ADXCRSS.Hs#S1582622_at
CAGAAACCCTGGGAGCAGCATGGTGGAGTAGAAAAGTATGAGCTGGGCATTAGACGGGCT
SEQ ID




GGGCTTTGAGTTTTGGCTTTGTTGCTTGTGTACTTCAGTTAGGATTTCTTAGTTGCAAGC
NO:




AGCCCAAAACAGCTCTGGCCAGCCTCACCATGCCTTGGCTATGATAAAAGCCATAAAGAG
2078




GAATGGCACCGCTCCTTGATGCTTGTTGGCAGCAAGTACCTGGAATTATGCTCCCACCAA




GACTGCATGCATGG





PHACTR2
ADXCRSS.Hs#S1584468_s_at
AGAAGACCAGCGACAAATTTAGAGAAACCTCGGCAGTATTAGAAAGGAAGATATCCACAC
SEQ ID




GACAAAGTAGAGAGGAGCTGATAAGAAGGCGAGTGCTTAAGGAATTGCCTGATCAAGATG
NO:




GAGATGTAACAGTTAACTTTGAAAATTCAAACGGGCACATGATACCCATCGGAGAGGAAT
2079




CTACCCGAGAGGAAAATGTAGTAAAGTCTGAAGAAGGTAATGGCTCTGTATCTGAAAAAA




CACCACCTCTGG





COL5A2
ADXCRSS.Hs#S11048343_at
GAGGGCACACCTGAGAAGTCATTCCGCTACATGAACTCTGTTATTTTCCTTATCCCTTAT
SEQ ID




TTTTTCCTCCCCTTCACATCCAAATCTTTCAAGTCCGCCATCAAGTCTGATGTGCATCCT
NO:




CTTTGAAACCTTTTTGAACATCATAGACATATTTTTTCTCTTTTCTCTAAAAGGTAGCAC
2083




TTCCTCTTTCTTTAACACATTTAGCACACAATAAATCCTTTTATTTATTGCCCACTGTTT




TCTAAATAACATTTATTGTAAATGTCATTGATTATTTAGTTATATCATATGCTCCTTGA





SEPT7
ADXCRSS.Hs#S1914581_at
GGGCCCAGAGTTTGCTCCCAGGGAATCTAATGAACCACCTGGAATCAAACATTTGGAGAG
SEQ ID




AAGGCCAGTCACTTTTATCGGAACGTCAGATGGTCATGGACCCTCAAGAATGATTGAAGA
NO:




AATTTGTAAGCCCAGTTAAAACATCCACAGTCTTCTTTCCTCAGTGCAAAAGTTGCCCTT
2088




TTTGATATCTCATATTTAGAGTAAAAAAATTTCGTTAATAAGAGATCCTCT





ZDHHC7
ADXCRSS.Hs#S1917518_at
TGTATTATATGATCTGAACCCTGGGGAACATCTATAAAGTGGGGACGTCCCAGAGACCTG
SEQ ID




CGGCCTTTTCCACCTGAGAAGGTGCCTCAGCCGATTCAAATAAGAGGATGTTCCTGTGTT
NO:




CCCTTCCCAAGAGGATCTACCAGGAACTTCAGCGACAGCTGTTCCCAGGACACCCTTTAT
2089




TTTATGCTGGGAGGCATCGTCCTCCGTGGACCACTCATTTGGGGTTAGCTGCCTGTAGAA




CCGATTCCTGGGACAAACCCGTTGTCACGTATCCACAGAATGG





FNDC3B
ADXCRSS.Hs#S1917639_at
ACGATCAACGGTGTGACTGTTGGGTGGTTGAATTGAAACTTAGGAGTGTATGATGTTCAT
SEQ ID




ATGTTCCCACTTGATCTTTCTCAGGAGTGTTTGTACATACAGCCTCCCTGTCTCCCCTTC
NO:




CTCCATCCCTTCCCAGTCATTTCTAGTAACCACTGAACACTGTATGAGGTGGAAAGTCCA
2090




TCATGTAGTAGAGAAAAAGATTCAAGCATCTCACCTAAAGTTGTCTATGAAGTTTTCAAA




AGCAAATATAATGATCTCCTTGTGCCAGTGGACTTCTTTGGTTTAT





ZCCHC14
ADXCRSS.Hs#S1918747_at
AATCGGCTAGCAGGCTTTGTTTCTGCAGGCACCACAAACTCTATTCCAGGAGTCTTCTTG
SEQ ID




GGACACCCTATTATGAACAAGGCATCGCTGCTTCAGAGCCAGGGACCCCATCTCTTACTG
NO:




TCGGCCATGCAACAAAAGATCAGACCAGAAAGGGCTCACCTGGATTGATCACAGAAGACA
2091




TTTAGGCTAAAAAGTTTCAGATTTACCTCCCACTGCAGCTATGACCAGACCCTCATCCCC




TAGGCACCTGGTATCTGCCCAACTGAACTTCAC





PPP4R1
ADXCRSS.Hs#S1919443_at
CCAGGATTCTTAAATGTTACCTTCTCTAACTAATATATATGGCTTGACTATCTAGACTTA
SEQ ID




TACTTAACAGGTATTTACATCTTTGAACACAGAACAGCTGATGGAGAAAGAAGCATTATA
NO:




AATAATATACATAAACTCAGTTGGTACAGATAATCCGTAATTGTTAATGTTGAACTTGTC
2094




TAAATGCTATATGTAATATCTTGCATCAGTAAGATAAAGTAATTATCCTTTCATATCGTT




TTTTCCCACCAAATAAACAATAAAGGACCGAAATATCAAGGG





PPP4R1
ADXCRSS.Hs#S1919443_x_at
GAAGTCCCAGGATTCTTAAATGTTACCTTCTCTAACTAATATATATGGCTTGACTATCTA
SEQ ID




GACTTATACTTAACAGGTATTTACATCTTTGAACACAGAACAGCTGATGGAGAAAGAAGC
NO:




ATTATAAATAATATACATAAACTCAGTTGGTACAGATAATCCGTAATTGTTAATGTTGAA
2095




CTTGTCTAAATGCTATATGTAATATCTTGCATCAGTAAGATAAAGTAATTATCCTTTCAT




ATCGTTTTTTCCCACCAAATA





COL4A2
ADXCRSS.Hs#S2731998_at
TGAAATATACAAGTGAGTTCACCAAACTCATAAAAATGTCCTTAAAATGATAAAATGGAG
SEQ ID




AACTTGGGGGTCCCAACAAAGAGGAATTAAGGCCTGGATCATGATTACCTCTGTTTTCCA
NO:




TGTGACTTTGAAAGCAGCAGGGCTGGAGCCAAGTTGGCCCTGCTCCCTCCTAGGGACAGC
2098




AGGGTTGATGTCCACCTCCATTTCCATTTGCTTCTGTCCAGCCGGCAGGCTTGGCGGCCC




CTCCTGGCTCTGGAGCTTTAATACTTTCTTATTCTATCCGATCAGCG





LPP
ADXCRSS.Hs#S1921588_at
GATTCAGTGGGCAACTGTGGCAATAGTTCTTGGCTAACCTGGTCACTATGGAAGTTCTTT
SEQ ID




CCGTGGAAAAAGATTCTCCATCCTTCAATTTGAGATAAGATTTACTAATTGAGACCTCAT
NO:




TTGTATCTGATTTTAATCTTTGCATCATTTTAGTTTTAATAAACTAACTTTCCAACTTAC
2104




CAGATTTTCGGGTTGACAAAGACCATTATTTAGAGAAACACAGGCAAAGGAAAGTCTAAA




AGCTTTGGCTGGAATTTCAACTGCTTCTGGTCCAGAAT





CREB3L1
ADXCRSS.Hs#S2306153_at
AAGCAACGTTGCACATCAGCTCCACTTGGACATCATGAGTATCACGCTGAGCATGAGCTT
SEQ ID




GCACCAGCCCTGACATTGTGGGACATGTGACTGCCAGGCGCTTGTGTCTCAGCTATGACA
NO:




TCAGAAGCCCCTCTGCAGGGTCAGAACGACAGTTGACATCTGGGTAGCCAATTCCTGGGT
2107




GCTGCCTCATCTAGACACCACAGAGGCCCAGCTCCTTTACCAGCCTCGGCCTTGGCATAG




ACATCA





LPP
ADXCRSS.Hs#S2732094_at
CAAAAATTCCTGCATATACCCACTCAGGAAATATTTTCCCAAATCTTCTCCATCTCAACT
SEQ ID




CTGTGAGGCATTGGAAGAGGTGCTTTTAGGCATAGACTGATGCACTCTATATATGATGTC
NO:




TCGCCCTCCAGGGCAGCACACAGTTTAGTGAGGTAAATGTCTCATGAATATTCCACAAGA
2109




TCCACCTTGATAATGCTCTAACGTTACTCATAGAGGGCTGAATGTGGAAAGATGCTTTCG




TCTGGTGGCAAA





FNDC3B
ADXCRSS.Hs#S1927775_at
AGGACTTTGGTAACAGAACATTCTGTCACCATTAACTTTTGCTTGACATTGGATTATTTC
SEQ ID




TAAATACAGTTTGGCTGTCTTCTGATCGGACATTTTCAGAGGAAATGAAGTTAGGTTAAA
NO:




CAAATACTACGTGAAAGGCTACATTTGATTTTGACAGCCAAGAATGTTTCCTGGGTATGG
2110




AGTTTTATGAAGAATCTCCTATTTGCTCTGGTTAATTTGATATTGCATTGCCCATAGTTA




CAGAGTACAGTCCCCATCTGTACATCACCTACCTATTTC





RYBP
ADXCRSS.Hs#S1924603_at
TCCATAGTATTTTAAGCTCCGTAAGGAACAGGGACCTGGTCTGTCTTTATACCACTGTAC
SEQ ID




ACCAAGAGCGCAAATGGCTGTGTGCTCAATAAAAACTTGTCAAATGACCACAACTACCCA
NO:




GGTAATTTACTTTAAGGTCACCAAGTACACATAAGATCAAGTCACCACCAATAAATCAGT
2113




AAGTCCAATGAAACAGTAAACACAAAATAAATTATTACTCTGTTCCTGGGTAAAATGATC




TTAAATTGTACCAGCTTTCAGCTTGGAAGGTTTGA





PLAUR
ADXCRSS.Hs#S1925412_at
ATGGATGAATGTGTGGACGAATAGATAGATGAAAGAATGGATGGATGGATAAATGGGTAG
SEQ ID




ATGAATGGAATGGGTGGATGGATAGGTAATTGTACTGATGGGAGAAGACTTGTCTTGCTC
NO:




CCATCAGCCCCCTGAGTAGCTGGGGTTATAGGTGCACGCCACCACACCCAGCTAATTTTT
2114




GTAATTTTTTGTAGAGACAGGGTTTCACCATGGTGGCCAGGCTTGCTCTCATACTCCTGA




CCTCAGTGGTCTCCTCCTCAC





PLAUR
ADXCRSS.Hs#S1925412_x_at
ATGGATGAATGTGTGGACGAATAGATAGATGAAAGAATGGATGGATGGATAAATGGGTAG
SEQ ID




ATGAATGGAATGGGTGGATGGATAGGTAATTGTACTGATGGGAGAAGACTTGTCTTGCTC
NO:




CCATCAGCCCCCTGAGTAGCTGGGGTTATAGGTGCACGCCACCACACCCAGCTAATTTTT
2115




GTAATTTTTTGTAGAGACAGGGTTTCACCATGGTGGCCAGGCTTGCTCTCATACTCCTGA




CCTCAGTGGTCTCCT





FLNB
ADXCRSS.Hs#S1926534_at
GTCAGGCTCACATCTGAAACATGTTTAAACAGCTAATGGAGCTGAGCAACTAAAAGCTAA
SEQ ID




ATGAGTTTCTATGCTGGGCTGCCTATGAGACAAGGTCACAATAGTTACCAAGTATAATAA
NO:




CTATTATTAAGAGACCCTGGCAGTCCCAATAAAAGTAGGTCCTAAAAACTTTTAAGAGAC
2117




AGAAAGTGGCTGGAACACCTCCATGCCGTGGTTGACCAAACATATTTCTAGCACAAGGGA




GACTGCAAACCACAATGAGACTCAATGAGACCTTCATTTAATGTGGGACACAG





LPP
ADXCRSS.Hs#S1908923_at
TGCCCTTTTTTGTGCCTGGGCTTCATCCTTGGAATGTTTTACCTCATGGGCCATGAGACG
SEQ ID




GCTGCCTGCTGAAACCCAAACTATAGATATCCCTGTTCCCATTTAGGGGAAAGAGCCTGG
NO:




TTTGCTATATTCTCATAGGCTTGGCTGACTGTATATTTCTGAACCAGTCATTGAAGCCAA
2119




GAGAATGGGATTATGGTAATATGAACCACTATTCTCCTGAAACTGAATTTGGACATAGTC




CCATCCAAACCTCATGGTACTTACACAGTGG





NR3C1
ADXCRSS.Hs#S1907985_at
GGGACTAATGTAGCCTTGCTTCTGAGATGTGGCCCCTAGGTCTCTACTGAATGCCCGGCA
SEQ ID




TATTTAATTAGATCTTTCTTTCCTCTATGGCCTCAAGGGATTTCACCCTAAGTATGCACA
NO:




AATTTTTATTCAGCCGAAGACTGTACAGATTTCTGGAGGCCTTTCTTTGTGTACCTCCTT
2121




CGTTTCCAGTAGTCTGACCCATAAATTGTACAGATTTCTG





LAMB1
ADXCRSS.Hs#S1908684_at
TCTTGGGAAGACTCATAGGCCTTTTCTAGTAGAATCTTACCTAGCATCAGCCCTCATAAA
SEQ ID




TTTGCTGATGTAATTTTAAGTTATACTTTCTAGCTGCTGGAACACGCATGAGCGAGTGTC
NO:




TATCCTATTTCCTCAAAGTTGCTCAACTTGCTTAAGAAATACATAACTGCATATTGGACA
2122




TCAGAAGTGCTTGGTTCTAGCTGGGGGAAAAGGATGGTTAATTCCCCCCTAAAGCATCAT




TGTTTTGCAATCGAGTGAATCGGATGGATTCTCCTTCCCAG





LPP
ADXCRSS.Hs#S1910599_at
GAAGACAACAACAGGTAAACGAGAAAATCCTTGGAAAAGAACACCGTTAATTTACAATAG
SEQ ID




TATATGTCTCTCTCTGGCCAACGTACTTTGTTTCATGACACTACTGGCATCATCCATCCC
NO:




AAATACTTTCGGTCGCTGTGTGTTTCAGACTCTGAAAAACCTTCAAATAACACAATAAAA
2123




CCTGCTCCTCTTTTCCTTTAATCTTACATAAAGGCAGTTCTCTTAAGTCTATAGTCAAAG




C





FNDC3B
ADXCRSS.Hs#S1910605_at
TAAATGAAGACACCTAACGGTTTGAAACCTTCTGGCTCTGAGGAGAGGAAGAGGGTCCCC
SEQ ID




AGATACAGGTTTCAATTCCTTACCATTTAGTCTGGTTCCATTGATCAGGGGTTCAGTTTT
NO:




CTCACCTTAAAATAAGAGGATTAGAACAGATAATTTCTAAAATTATTTTTACCACCCCTT
2124




TTCTCTTTTCTTTCTTTAATTCCTGTGGCGTTCTCTGCAGTTTATATGTCCCTAATTTTA




TG





LDLR
ADXCRSS.Hs#S1911522_at
TTGGCAGAACTTTCTGGCTTTTCCCCCTTCATGTTACGTGGGTCATTGAGGCTTGGCTAG
SEQ ID




CAAGCGTCACTATGTGTTCAGCCTCACGGGGCGGGGATCACAGGATCACGGGGATCACGA
NO:




CCAGCGGGAATCACAGCGGCTTGCCAGTGTGTGTGCCAGGTGGCTAGCCCTCGGTAGGGA
2125




CAGCCTCCCTGACTGTGCGTGACAAACCCGAAGAGGTAGCACCATCCCCACTTTGTAATG




CCTCCTGGTCAA





MAP7D1
ADXCRSS.Hs#S1907164_at
GGCTTAATGTGATTTGCTCCATAACACTGTGCCAATGACATTTCATCAGGGTTGGCAAAA
SEQ ID




TTGTGAAGAAAATATTTGTATTCAGGGTCAATAGTGTGCCGGGTCACAAGAGGAGTTCCA
NO:




AACTTCTTGTTTGCCTCTTGAGAAGTTTTTCTTGTTGAGCTGCTGGAGTAAACACTCATT
2126




ATTATTTTTATTAACTTCTACCTGTGTGGCTTAGTCCAGGAAGCTGCCCAAACACTATTG




AGATGGAGTTGTTTTGCTTCTCTTCAAATGTTTATCTTTT





SPTBN1
ADXCRSS.Hs#S1929015_at
AAGCCAAAGACGATGTAAGTTTCTAAATGTTATTTCTCTCCACTACTTAGGAGTTTGCAA
SEQ ID




GTGTTTGTGTGATGATGGGCTTTATTCAGAAAGTTCTTCATGTAAATGATGATCAGTGAT
NO:




GGTTTCTATCACTGGGCTCCAGTCACCAGCACTAGAAGGTGTTTGGTTCTGTCTCTAGAA
2127




GGCAGTGAATATGATCTCACTGTCCCTTTGCCGTGGCAGGATCCCTTAAAGTCGATGGAA




TCTTTGCCTGT





PPAP2B
ADXCRSS.Hs#S524340_at
TGACTGATAGCTGCCGCTTATGGTTACTTAGTAAAAACTCCTGTTGCTAAATGGCTCAAA
SEQ ID




TGGATGTCTGTGTGTTTATTTTGCCATCTAATACAAAGCATAAATTTTTCTTACTCCAGT
NO:




AGCTCATCAAACCCTTGAATCTTTCATCATAAGCACATTGAGGCAGGAACTATGCCTGTG
2129




CCATCCTCACACCTTTGCAAGTGGCACTCAATAAATGTTTCTCAAGTATTGTTCAGACTC




AGTGAGGGTCACATCCCCAGGAGGAA





LAMB1
ADXCRSS.Hs#S2732721_at
TTTTTCCAGGGCTCTAATCACTACTCTGTTAAATTCCTCAAACTTGTAATGCCCCAAGGC
SEQ ID




TTGATTTTTTCCAGATAATGGCTCTATCGTTGCACATACCCTGATTCTGTCAGGATGTGT
NO:




CATTGGCAAAAGTAGCTTTCTCTGCCAAAGCTTTCTGACCGTTGGCTCCATCTTAGCGTT
2130




GTTAGCAGGAAAGGCCTGCTACCCAGAGTCAGAGTCAATCAGAGAATAGTTCATGTGGTC




CTTAGAACTTTACTCCT





FLNB
ADXCRSS.Hs#S2733261_at
GATGTCAAGACCACTACCTTTAGGCACAGAACATTCTACTAAGATTTCCATTTTTGTGTA
SEQ ID




AGGTTAATTTTAATCCCTAGGATTTCAAAATTCTCTCTTTCAGGATCCTGCTCACCCTAT
NO:




CTTCACTATTGCATACCTGAAACTTCAAATCACCTCTCTCTATAAAAATTTAAGGGTGGA
2131




GACCACAGTCATTGCTTCAAAGGCATCAAAGTAGAACATATCTAGAAGCTAACTGCATTT




CAACCAAAATATTGATGAAAATTTATTACAAACTAGTCTCTCTCCAGA





ARID5B
ADXCRSS.Hs#S4463141_at
CTGTGTTCAGCAGTGGGTTTACATGGGTGAACATGACAGCACCTGCTCTCAGGGAGCTCC
SEQ ID




CACCCCTATCCTCCATTGATGGAGAAAACAGATGAGACTCCAGACCAAGGAGGAGTTGGT
NO:




GGCTCCCAAAGAAACAGTGGAGCCCAGGGGATGAATAATTAAAACGTAAAGCACATCCCA
2134




GAGCTCAGCACTTTGAAGGTGTTTATGTCCCAGCTCTGAAAAAGATGTTCTGTATTTCAT




CTCTGAGTCTGAGATTCTAAAAGCTATGGTTGGTACA





ARID5B
ADXCRSS.Hs#S3010218_at
ATGACTTCAATGACGAATCCTACTGGCATAACATCTATGGTTTCACCAACTCTTAGCAGT
SEQ ID




GATCTTTGGTTCCAGATTCATGTGAAAAGCCAAGAACCGCTTTCCACAATTTGTCTTGTC
NO:




ATGACTCTCCGGCTCCATATTTTAAGAAGCAGTCTACACTAGCCCTTGAATCTAGACTCT
2138




AATTTTTTAAGATACAAAGGAAATCATTAAGCCCCGGAATATTAGTAGAATATACGGCAA




TATGGATCAAGTAATCCAAAGTATTAGCAATGGTGCAAGAGGCTGTCA





FNDC3B
ADXCRSS.Hs#S2978758_at
ATGTGAGAGTGCTTTGCAGTTGGAAAGTGCTGTAGGAACCCTGAATTCATCTGAAACTGT
SEQ ID




AGCTTAGTGTTTAAATGATGTCTGTTATTACTTTTTTGAATAGTCTGGAGTGCTTGTTAA
NO:




AGAAAAAATTATTCTGTGATATTTGTTGAATGAAGCACAGTGAGGAAGACTTTACTCAGG
2142




GCCCTTGTAATAGCTATAGGGACCACTGCAATAGGGTCTTGCAGTGGGGGAGAGAGAATA




GGCTCAATTCTGAATACATCATCATGGGCAAGTGGG





GALNT2
ADXCRSS.Hs#S2734613_at
AATGTGGCATGGGTTCCAAAGCTCTGTGATTTTCCTATACTGAAAGATTTCTCCCAACCA
SEQ ID




TGGAGGAGCCTAACAATTCAGTCTTCAGGGTCTCTAACAGCACTGACACACTGGATGTTA
NO:




ATTACATTGTGATTGGAGCTTCCTTCCCAGACACTCCAGTGTACTACTTTCCTCCTTTAC
2145




AGCCTCTCTTCTAACTGCCAATAAAAGAGTCCTCATGAGCTCAGCTCCAGCACAGATAAG




ACTGACAGAAGGTTCCGAGGTTGGCATTTGCAAAATCGCATGAGCAT





PHACTR2
ADXCRSS.Hs#S2978384_at
ATCTGGGAAGATTCTTAGAACCTATAATATTAAACATTTCTGTAGCAAACATGATTATTT
SEQ ID




GCTCTAAGTGGAATAAGTAAAGATTTTTAATAGCGTCACGTCACTTCAAGTTATGACACT
NO:




AAATGCATTTTGGAGCGAAACTTACAAAAAACAATATTTTTAAAACTTTCTGGATTTTAG
2146




ACTTGTGAGTAAAGATTAGATTTTATATAAATCGCATTGTGAGTTAGGGAGTGCTTAATG




GACTGGCCTTGGAAGCCAGTCAGTATTTATGGCAAGTCAGTGCGTAT





PTPRK
ADXCRSS.Hs#S2979568_at
TGCTGTGTTAGCAACTGACGTACAATAAAGTTGAATTCACCCGAATATCTAAGTCTTAAA
SEQ ID




AGATAAATGCAAGTAGCTGGTAGCTGATTTAGGCACCAGTAACAGAAGTGAACACCTAAA
NO:




AAGTAAATGCTATCACAGGTAGGAACATGTGAGTGACCCTGATTACTTGTCAGTAGGAAA
2148




AGATGTGGAGTGCAGGCATATTCTCTTTCTACTTTGGATCAGCAATCAGATTCACTCACA




GATCATCGATTC





KDELR3
ADXCRSS.Hs#S3732256_at
GGCTTAACCAGCTAGACATTCCTCTAAATACATACGTAACAAAAATTGATGGCAGGAGAT
SEQ ID




TTTATTGGGATCACTGGATACCTACACTCAACAGGCAGAACTTGGCTAATTCCATTTATA
NO:




CCACTACTGAGACAGTGAAGACAAATTAAGAATCAGAACAGGAAGCACATAGCATAGGGA
2149




TACCCGTGTCAGCGACATATTTAATATGCCCCTCAGCTTAAGACTCAATACTGAACAGAC




CAAAAGGCCACCTCAATTGCCGCTCCCGCCACACTTGCTATTGAAACT





SLC20A1
ADXCRSS.Hs#S2981378_at
ATGAGAATATCCAGCAAACCAGTCCTAAATGACTGATTACTGAAGATCAGATATAACTAA
SEQ ID




TGACTTCAGTAGTTGAGGTCAGTATTAATTCCAGCATTTTTAGCATAGACAGGAGAAAGG
NO:




GAAGGAGATGATCATATTATCAGTGGATCCTGTGAAGACTAAAGAGGAAAGGTCTGTAGT
2151




GATTTAGAATCTGAGCAGGTCTCTTTGGTTGAAAAACTATCTAGGTTAACTCAGCGTACA




CTAGCCTGCAGCCTTCTGA





OPTN
ADXCRSS.Hs#S2984022_at
AGAAGAGAGTAACCCGGTATAACTGGGACCAGCTTAAAGGAACTGCTTTCCATAACATTC
SEQ ID




TCCAACTAATTCTACACTAGTGAACAAGCACAGCTGGTCCTGGGTACCCCAGTGCCTAGC
NO:




TCCTCCATGCTTCCTATGGAACGTGTGGAGACTCAGTGAGGCTCTGGAGAGGCCAGCTTA
2153




CAATGTACACACCCACGTTCTCCAAACAGTCACTGTGTAGCTTATAACACAACACAAAAA




TTCTCGGAA





CAPN2
ADXCRSS.Hs#S2984172_at
GAGCCACCACGGGTAGCAAAGTGAACTTCCCCCGAATCACGGTTAAGCCCCCTGGGCCAC
SEQ ID




ATGGAGCTGTCATCTGCAGTTTTTCCCACCTCGGAGGCCTGACCCTGTGCTCTCCATAAT
NO:




CAATGAGTAGATGTGGCCCTTTATGTTCCCTGAGGCTTCCCTGACTGCTCATTAAAAGGA
2154




TCTGCTCAGTCCTAGTGAATTGATTTACTTTGCCACAGTCCTTGAAGGATGCTACAGATC




AAAAGGTGTCCAGGAAAGTGATCTTAAAGATGCTGACACTACTCCCAGTT





EGFR
ADXCRSS.Hs#S2984803_at
CGCATTGCGTGGGCACAGGAATCTCAATAGCTGGCCCCAGAGCAGAAGCAGAGAAGGTGT
SEQ ID




GAAGGCCTGGACTCTTCTGAGCTTGAGGTCAGGGGATCTACTTGCACATTAGAGTTATTT
NO:




AAATGAGGAAAATGCATGCCCTTTTTGAATCGATGTTGTCAAGCCTTTCTTTTCCTAGGA
2155




GAATCTTTCGATTCCCAGCATGGGGAAAGCATGTTTTCAGGTATTAAAATGAGTAAGGTT




GTAACAGTTACCATGAATCCACATGTTGTGCCCCATTCTAAATCAAGTA





RBPMS
ADXCRSS.Hs#S2984882_at
ATCCTTTGATTGGATCTAGCCTCCAGCTCAATATACCTTCCTCAATTGGCCTACAAGAAG
SEQ ID




AAAAAGATCTGAAGCTCAGCATAATGCTGGCTTTAGCCAGAAGAATCCAGCCTTTAAGCC
NO:




ATCTATATGTGTAGCCATGAAGGACCTTCTAATATGCCTTGTGAGCCCTTATGGGGCCAC
2156




CTCACAGCCACAATTTATGCCCACGTGTCAGCCTCACAGACTCAGG





COL4A2
ADXCRSS.Hs#S2984630_at
TTTTCTCTAAACGAAGGCTTTCTGCACAAAAGGTAAAAGAAATCCAACTGTTTGGCCCAT
SEQ ID




TTAAAATCAAGTCACTGAAGTTTCTCTGAGCTCAATCACACTCTTCATCTCTGAGGTTCA
NO:




TCTCTGTTCTTACCACATGATAACGTGAAAAAATAGTTTCTTAAAGAGCTGGCCCCATCA
2159




TCTCCAGAAATGATGTTAGGGAAGGTCCGTGGAAGGCACAGGCCTGCAGTACTGAAGGCA




GAGGCATAACTGCCAACCACAATG





LPP
ADXCRSS.Hs#S2984275_at
GTAGCAGAAGCAGGACTGGAACCCAGAACCCAAGTTGGACCACTAGACTGGTGCCTCTCC
SEQ ID




CTAAGCCCACTCTGCCTCTTCCATGTCTGTGAATGAGCTTACCACTCCTAGCTATGCAAA
NO:




ACTGCATAGAACCATTTCAGCAAGAGGCTCAGGTAGCATTAAAGAAGTTCCCACCTCAAC
2160




GATGTCAATTTTTTGTTACTGTTGTCTTGAGGAAGCATGTTTGCTTTTAAACGCTCCCAA




ATTAAAAGCCATTCTCAGCCTTCCTACAATTGTATG





EPHA2
ADXCRSS.Hs#S3000558_at
TGAGCAGTGTTTCAGCGCCCAGAGAGACACTGTGGAGAAGGTCCACCAGGATGCCTACCT
SEQ ID




GCCTTACACAAGAGCCTAACTTTGGCACACCTGTGGCACACCTGTGGAGAGCTGTTCTGG
NO:




CCCCGGTTGTCTGGCAGGCCTGGGCTACTCCGAGCAGGGTAACTGGGGCACAGAAGCTGC
2169




ACCTCCGGCTATACCCTGGTTTTTCCAGTTCCTGATGCCCGCCCCTCAGGTGGCAGCATG




AGGTGACTCAGGGACAGACGCACTTATCGTGACGCAAGTCCACCCTGTCGAGTG





FNDC3B
ADXCRSS.Hs#S3003052_at
TTTCTTCCTACTCCAGGGATCTCCTCCCTTCCCCAGGGTTGAAGCAATGCACACTGAAGT
SEQ ID




ATTAATAGTAGTGATCAGCACCTTCAAGACAGCAGGACCCTTCTGTTGCCTTCTGGCTGT
NO:




GGTGTGATGTCCTAGGGCCTGTGGTGCATAAGCAGGTGGAATCTAAGCACTGACCCTGGT
2170




CATTCTACATATAAGAGGAAGAGGACTAGGAAAGCTCGACAAATGCTGTTCTCCTCTTCA




TGGCAAAGCCTTGCTCTTTGGAATCCTTATCTGCATTTAAAA





MVP
ADXCRSS.Hs#S3017763_at
GTGAAATAAGCCACTGACCAGTAAACAACTGAGGCTTAAACCAGCATGCCAGCTCAGGTG
SEQ ID




GGGAGCCCCCAGCACTGGTTATATTCCCTAGATTCCTCACTGGATAGGAAAGTTGGGCCT
NO:




CAGGCACTCTTCCCTCCTCTGCAGTCAAACAGTGCAGATGAAGAGCCAGGCTCTGTTCCC
2174




AGTGCTTTATGTGCTAACTTGGTTGATAATGTTATCCATTCTCATTTTGTAGATGAGGAA




ACAGGCACAGGGTGGTCAAGGGACTTGTTCAAATCACTGATCCCATAAGGG





MALT1
ADXCRSS.Hs#S3002450_at
GAATTGTGTTTGTTCATCCGTTAAATACTTACTAAGCTCCTGCTCTCTATGCCAGGAACA
SEQ ID




CACAATTAAATTAATGTTAGACCATCTCTGCCCTTACAGAACTCCTTAGCTTCTTGGAGG
NO:




TAGTACCATATCAGTCAGGAGCAGAAATCCTAGCTGCTTTCTTTCGTATATATCATAACA
2176




TTTAATTGTATTTTATATTATACTATTGGTTACAAATATTTTTTATATATCAGGATATAC




TTCAGACAGCATT





GALNT2
ADXCRSS.Hs#S3741276_at
GGGAGCCAGACAGTAGACATGAAGTCAGTTATGTCGTGTGCAGAAAGGTGCTGTGTGCTG
SEQ ID




TGGAAAAAATAGAGCAGTGTATGGGGATTAGGGATGAGGGCGGAAGGATAGTTGCAGTAT
NO:




TAAAGTGGTGATCACGTAGGCTCATGGGGAAGGCAGGATTGGAGCTGAGACTAAGAGGGA
2179




GCCATTGTGGTTCCCTCTGCTTCAGAGGTAGCCCCTGGTTTCATCTTCGTCCAGCCTCTT




TTTCGGTGATCTCTCTACTC





AHNAK
ADXCRSS.Hs#S3016566_s_at
GGGTAGCATCACTGGCCCCAGTGTGGAAGTTCAGGCCCCTGACATTGATGTTCAGGGGCC
SEQ ID




TGGGAGCAAACTGAATGTGCCCAAGATGAAAGTCCCCAAGTTCTCTGTATCAGGTGCAAA
NO:




GGGAGAGGAAACTGCGATTGATGTGACACTGCCTACAGGTGAAGTGACTGTTCCTGGGGT
2180




CTCTGGGGATGTCAGCCTGCCTGAGATTGCTACTGGTGGGCTGGAAGGAAAGATGAAGGG




TACTAAAGTGAAGACTCCTGAAATGATTATTCAGAAACCTAAAATCTCCATGGG





TGFBR2
ADXCRSS.Hs#S3019327_at
ACCAGTTTGGAGGACTACGTGCACAGATGAAGCCAAACCTCTGGCCCATCATCTATTCCA
SEQ ID




CCCTTCACGTCCCTCATGCCCGGGTTCCACTGGAACCCAGCGGCCTCACACATCCTTTTG
NO:




GCTTACAAATTTCCTAGCTGGTGACCATTCTCCACCACCTCCCCCCAAGTTTTACCATTC
2182




TCTATTGGTGCCCTACAACGGCTCCACCCTTGGAAATAAGGCCGGGTCTAAATGTTACTT




TTTCTAGTGGGCCTTCCTGGATTATCCATCCCACGGTGATTCCTTT





TIMP1
ADXCRSS.Hs#S2992355_at
GAGGGACAGGTGATCACACGGTATTGGACACAGGGAAAGGGAGCAGCCAGAATTTGTAAG
SEQ ID




GGAGCAGTCTCGGGCTTGGGGAAATAGCAAGAGAGATCAGGGACAGCCCTTAGGGTTGGG
NO:




GAGCAGCCACAGGGACACAGAATAGCCAGAGGGAGCAAGAAACAAGCCCACGATTTAGGG
2183




AATGGCCCCGGGAAGGATCTCCCGTTGGAGGTCAGGGTCCAGGCACTCACTGTGCATTCC




TCACAGCCAACAGTGTAGGTCTTGGTGAAGCCC





GALNT2
ADXCRSS.Hs#S2992100_at
TTTGAGGCCCACCAGCTGATTCTGAGAACCTCCTGCACCACCATGGAAAAGGGATTCCCT
SEQ ID




AGCCTTCTACTAACCAAATACCCCAGAAGATACGATTTCAGCTAAAAAAGATAGTGGTTC
NO:




CATTAACCTTAGGAGCCAGGAGGCGAGACCCTGATCCGGGGCGCTCTCTGCCACCTACCG
2184




CCAGAGCCAACCTCCCTGCCTCCCTCGGAACCCCCAACACCCCAGAACCTCATGACCCTT




GCAGAGCCAGCCTGCTGCCTCCTTTGAAGAGAACCATAAGAGAAGCTTCAGG





TPM4
ADXCRSS.Hs#S2991999_at
GTCGGAATGGAGTGCCACAGATGAACCACAAGAGGAAGAAAAAAACACGTGAGCAAACAA
SEQ ID




AGCACAGACTAGGAGAAAGCTGTGTTCCATGTGAACCAGATGAAGAAAACCAAAGATCTA
NO:




TGGAGTTTGATCTCTAAGTGGTTTGAGGTTCTGCAGGGTGGATTAGCCACAATGAAGCTT
2186




CAAAACAGTGGTAACCAGAAGTGACAGAGCTTCCCCCCACTGGTCCCCACCCCTCAGTAA




ATTTCGGGATATCCAATGACG





PPP4R1
ADXCRSS.Hs#S624701_at
CAATGTGTTATGTTTTCAGATGACTTACGTATGTTTTTGTTCATCAGTATTTTAAAAAAT
SEQ ID




AATCACCTGTTTGTGAAAATAATGGTTTTGAAAACAGCATTATGATGAGAGGGAACTTCG
NO:




TAATTTCATGAGAATGTAGATGGTGACTGTTTAAGTGGGAGCTCACATAGGCATTAACAT
2188




CACCCTCCTTTTGCACAGTCCTTTTAAGTCTCCTGTTAAACATCTTTTATTGTGTGTATT




TAAAGGCACACAGATGCTTTTTCCTGTATTCATCTTACAAATTTACCTACATA





SYNJ2
ADXCRSS.Hs#S756942_at
GGGCCATTCAATAGTGTATCTTATAAGATAAAAGGTGAGGTGTCAACATTTGGAATTATT
SEQ ID




TTATTCCTAAATAGCACATGAATTATTTTGTGACTACTTAAAGCAGATTAATAGAGTTGG
NO:




TTTGCCGAGAGGCAGGGATGAGCTGTTCTTGGTCAATATCAACACTGAAGGCAGGGCAAT
2189




ATTTGTACCCCCTCCTGAAACCAAGTCCTTGAGCTCAAACATTCCAGCTTTTTGCTCATT




ACTCATCATCCTAGAACTGGATTTGTAAGAATCATCTCTTTAAGAGTGT





PTPRK
ADXCRSS.Hs#S794492_at
GACCTTATTATTTCTCAGTTTACATACCAATACTCTCCTATACATACACAATATACTAAG
SEQ ID




AGGAATACTGTTGTCTTCGTACCCAAATTACACATAAACAGATAAAAACTGACTTTTGCC
NO:




ATCCCTTTGCAAATGTTGTAGCAAATTCTAATGTTCTCAGGCCACGCTGGTTCATGATCC
2190




GAGAATCTGAGACAGTTATAGTCGAAATGTCATAGGAGGCAGGCGTGGTGGCTTGCCCTG




TAATTCAGCACTTGGGAGGTCCCTTGGACGA





ARID5B
ADXCRSS.Hs#S797577_at
ACTAGATCTGTTTTTCCTGACCTGAACACCATACACCTGTTGAGTTCACTAAGTACTTTG
SEQ ID




GGGTTTCCAAAATGATTGAGGAGGTGCTAATTAAAGAATCAACATTTAACGTTTTCAATG
NO:




ATCCACCACCTATTTGATATTAACCACATCCTTCCACGGGATTGAGTTATAACTAATCCA
2191




GCCTTCAACTGGGGCAGTAAGAAGTGCTGAACCAGCAATACAAAAAGCTAGAGTTCTAAT




CTTGGTTTGGTTGCTAACTTGCTAGGTGACCCTCAGTTTCTACC





FHL1
ADXCRSS.Hs#S3747393_at
TGCAGCTCCCTTTGCCAAGGCATTTCCTATAGAATCCTGCCACCCAAAAGGTACCAAATA
SEQ ID




TGAGTTTCTATTAGCTTTCAACTTCTTTAAACATATGCTAATTTGTTCCTCTCCCCCGAA
NO:




AAAGAGATTTGCACGGGTAAATAGATAGCAATTATTTCATTTGTGCAGGAAATACAAGAA
2193




TTGAGACTACTTTCTAAAACTATCCACAAACATGGTTATTGTGCTAGCAAACTTCCAGCG




TAATTTAGAGAGAAAGAATGAGAGAAAATAAATGAGCAGTTGCCTGGTACTCAC





WDR1
ADXCRSS.Hs#S3747394_at
ACTTGGACCTGAGGATGGCCCCAAACTCCCTTGGCTCCTCTACAAAATCAGGGCACTTTT
SEQ ID




CAGGGAGGACAGCGTCCCACGATGGCCACTTATTTATGTGGTCTGTCCTTTGCAACAGTC
NO:




TCCGCAACAGCCTTCCATTGAATTCTGTCTCATTGGACACCTTTCTGGGGACTGGGGACA
2194




GGGTAGGCCTGGGCCCGCAGGTTCTCAGCTTGCAGCTGACAGGGCACGGACAATGTGCCA




GGCAGGAGCGGAGGCCCTTGCCAACTGATT





PHACTR2
ADXCRSS.Hs#S3747744_at
AGGGTAACCTCTCTCATGATTCATTACCTCCCACCGGCTCTCTCCCATGACATATGGGGA
SEQ ID




TTATGGGAACTACAATTCAAGATAAGATTTGGATGGGAATACAGCCAAACCATATCAAAG
NO:




AGTATATTATGATCCATGCTGATATGAAGGAAAATTATTCTGCCTTGGTATGAGATGGAT
2195




TGTGAAAGAGAAGGACAAGATTTGCTGATTTATTCAAAACATATTTACTGCATGCTTACA




ATATACTGGCCCTCTTCTAATCAA





PHACTR2
ADXCRSS.Hs#S3747744_x_at
AGGGTAACCTCTCTCATGATTCATTACCTCCCACCGGCTCTCTCCCATGACATATGGGGA
SEQ ID




TTATGGGAACTACAATTCAAGATAAGATTTGGATGGGAATACAGCCAAACCATATCAAAG
NO:




AGTATATTATGATCCATGCTGATATGAAGGAAAATTATTCTGCCTTGGTATGAGATGGAT
2196




TGTGAAAGAGAAGGACAAGATTTGCTGATTTATTCAAAACATATTTACTGCATGCTTACA




ATATACTGGCCCTCTTCTAATCAA





LPP
ADXCRSS.Hs#S3748577_at
ATGGCAGTGAGCATTTATTCCGGGCTGAGTTTTACACTACCCATACTGTCTCTAACTCTC
SEQ ID




CCAACACTCCCACAAGGCAGGTGCTATTATCCCCATTTTACTTTTGAGAAAATTAAGGCC
NO:




TAAAGAAGTGAGAAAGCTTGTCCAAACCGCTATAGCTCTTGGGCAAAGGCATTAGTGACC
2197




AATGTGTATTTGACTCCAAAGCCCAGGATGTTAGCCACAGTGCAGGGCTACTATCCTTTT




ATACAATCTGTCAGGCTTCTTCCATCCGTGGCATGTATTCATCTA





ZCCHC14
ADXCRSS.Hs#S3747057_at
GGGTTTACTAGGCTACAATCTCTACTCCTGAACTGGAAAATGTTCACAATAAATAGGTCA
SEQ ID




GGAAAAAAAGGAATGATTTCACTGGTTAATGTGTACTCATAGGCACTGCCCACACAACGG
NO:




TGTGTTTTCCACTTTCAGTACAGTCCCACCTTTCTTTTCCTCTGCTATTTTCTTCAGCCA
2198




GCCACAGGGTTAAGAGCATTAGCTCTGGCTTTGAATCCCAGCTGACCTCAGGAAAATTTC




TTATCTGTGACTCAGTTCTCCCATCTGAGTGAGCTC





LAMB3
ADXCRSS.Hs#S3745344_at
GTGAGTAATGCGGTGGCCCCAAGGTGGTGCTGAAATATCCTTCCTCAACAAAGAAGATAA
SEQ ID




GCAGCAAATGTTTTGAGGGTGGCCACAGGGGTCATTACTGGTGGGAATTCAGGAAAGTCA
NO:




GCAAGGGGAGCTGGCGAGGGTGTTTCCGTCCCTTCTCAAGAGTCCGTGTGGCTGTGTGAA
2202




CAGTGGGACATCAGGGATTTCTCCCCAGGCCTACTTTTCAGGATTCCCTCTACCTA





ACTN1
ADXCRSS.Hs#S3748482_at
GGCACAGAGGAAACCCGCTGAGCCTGCTTCCTTAGTTCTGGCAGATGGGTCAGCCCCCAC
SEQ ID




AGGACTCAGGATTCAATTTAGCCCGGGGTTCTGGCTCCATCTCCCACAGTGCCGGTGCCA
NO:




GTGTGCTCCTAAGTACTGTTTGTGCAAACCTGGCTCTGACTGAGACAAGGAGCCTTAGGA
2203




GTAGTAGGGACAGGAGACACAGCAAACTAGGGCTCAGA





FNDC3B
ADXCRSS.Hs#S3748224_at
GATTGCCTAGGAGGACACTGTCCTCAGTCTTTGGGGCTAGAAGGTTGAAGAGAAGTAAAC
SEQ ID




TTTGACTGAATTATCCTTCTCATAGAGTTTAACAGGCACAGTGGAAATTCCTAGGCCGAT
NO:




TTCACTCTCATATAACACTGTTGGCAGGAGAATGGGTAGCATGGGAGAGTATCAGCGATA
2204




CCAGAATCTGACCAGAAGGACAATGTACAAGAAAAGGTAGGGACTTTCTGAAGGCATTTT




TGGTGGCCGTTGGTGGGGATTAGGTATACAGCACAGATTAGACTG





FLNB
ADXCRSS.Hs#S3748946_at
ATTCTTTGTCAGGAGAGTTTTGTGAATTTCTGTTTAGTGGCAAGTTGTAGAAACCACTTG
SEQ ID




AAACTGCTTAAAGGCAAAAGAGGGAGCCACTTGTCCCAGTAACTGAGACATCCCAGAGCC
NO:




GACTGCCCCCAAGCATTACTTGGTCCCAAGTTTCAAACGGGTCTTCAGGGTTTGATCTCT
2205




CTCCTCATCTCCAGTCTGCTTCATTCATTTTGGCTCTATGTGGTGGCAGAAGGGCTTCTG




GCATCTCTGGACCTTTATGCCTCCCAGGT





COL4A1
ADXCRSS.Hs#S3748447_at
AAGGATTTAAACCAACCTGTGCAATGCGAGTGTGTTCAGATACCTGGAGCCAGCCTTTGG
SEQ ID




AACCTGCTGGATCAAAACCAACGTGTGCTCTGTGGGGCCCCTGAAACACGAATCCTCTGT
NO:




GGGGTTGATTGAGAAAGGATTCACAGGCTTCAAGTCCCAGCAAGATTTATTTGCTAGAAT
2206




TCAAGCAAATCTTTACGAAAGGGAGTTCTCATGGATGAGGCCACTGTTGGGGGCTGGGCC




AGGACTAGATGGAGCCATGGATTCCA





NT5E
ADXCRSS.Hs#S3735513_at
TTCCCTCTGGCAAGGAAAGACTCAGATAAAATTCCCCATGACTTCTAAAGGTGCTCCTGG
SEQ ID




GCATTACTTTTCATTGTTTTTCCTGGGGATGCTGTTTCCTCAGAATGTCGTTGTATTATA
NO:




GTACATTCCTTAAGGGATATGGTTTTCATTTTCCTGAATGTTGCTCCTTTCTCTCATTTT
2207




ACCAGCAACTTGTTACTCCCTTTCACTTTCAGACTCTTTTCTCTCTTTCCCTTCTCCTTC




AGCAACTTCTCTCCCCATTGAAGTTAGAAGT





ZCCHC14
ADXCRSS.Hs#S3734556_at
GCTTTAGCTGCCAAGTTTCTGTTACTTGTATTTTTTAAAAACATGCTACTCCGATAGGTA
SEQ ID




TTTCTGTTACTTCTAAGTCACAGAATGACACTGATAAATCATACATCAAAATAGACTATT
NO:




AAATCTTTAATGTTCAAATACAATTTTTCTAGAAAAGTAAAACGCAGAAGGCTGGAAGGT
2208




GTGACCGGCACTCCACTCTGGCCTTGCTCCTTAACTGCAAAGTCACACCTGCTGACTGGG




CGCTTACCCTACCCCGACACCAGGAGGATGCCAGTCTACGCCTCGAAA





FTH1
ADXCRSS.Hs#S3729871_at
TCCCTTTTCTGGATTCTCAAGCAGTTACTTTCACGGTCAGAACACGCAGCTATTATGATT
SEQ ID




GAAAACTTAAAAGGGCAACAATTTCAGTCTTGCTTCTAGGGCTAGACAGGAACTTGGCAA
NO:




ACATCTGTGGCCTGTTCAGCAAAGGATGTTAATATTTAAGAATCTTGTCTTGGGCTGGGT
2211




GT





FTH1
ADXCRSS.Hs#S3729871_s_at
TCAGATATTTCCCTTTATTCCAGATTTCCTGGACACTTTCACCCAATTATAAACACCCCA
SEQ ID




CTTCAGCCCCAATCACGTGGGAGGAAGTGTAACTTCCCTTTTCTGGATTCTCAAGCAGTT
NO:




ACTTTCACGGTCAGAAC
2212





FTH1
ADXCRSS.Hs#S3729871_x_at
ATTTCCCTTTATTCCAGATTTCCTGGACACTTTCACCCAATTATAAACACCCCACTTCAG
SEQ ID




CCCCAATCACGTGGGAGGAAGTGTAACTTCCCTTTTCTGGATTCTCAAGCAGTTACTTTC
NO:




ACGGTCAGAACACGCAGCTATTATGATTGAAAACTTAAAAGGGCAACAATTTCAGTCTTG
2213




CTTCTAGGGCTAGACAGGAACTTGGCAAACATCTGTGGCCTGTTCAGCAAAGGATGTTAA




TATTTAAGAATCTTGTCTTGGGCTGGGTGT





COL4A2
ADXCRSS.Hs#S3736483_at
CTTCCAGGCTGTTAGGAGTCTCACAGGCTCATCCGAAAACCAATTCATGCTCCTGAGCTT
SEQ ID




CATGGGTTCGCCTGCCAGTGGAGGCCTAGCCTCCATCTCGCTTAGGATGCCTGATGTGGG
NO:




CTGATGGCAGAATCAGGGGAGCGACACCTGCTTCCCACACCACAGAGAAGCCTCTTCGGG
2214




CTGGGGTTGGCAGCAGGGACTAACGACAATGCCATAAACAGATAAACAGTGAATGCACCG




AGTCACAGTTTTAACCCGCATTCT





PHACTR2
ADXCRSS.Hs#S3740773_at
ACACACACAGATCCCAACAAGAATGGACACTGATGGGTGAGGACAGCTGCTCCCTGAGGA
SEQ ID




GATGGCCACTGGGCACTGTTGGCACATCATTCTGGGAAATTTCAGTTTAGAGCTTATTAG
NO:




AAGAGACCCAGACACTAAAGGTCAAAGGCGGGACATGAGGAGCACAGGGAGAGGGATGTC
2215




TATTGGCATTCAGAGATCTGTTATACTGTCAACTAAACCGCTCTCTGAATTTGAGCATTA




TGGTCATACAT





MVP
ADXCRSS.Hs#S4460147_at
TTCACTTTCCATAGTGGGAGTCTCGGGTTTGAAGTAAGGAGATTAAACAAACGGTCCCAC
SEQ ID




CCTCAGTACCACTCATCGATCG
NO:





2218





EGFR
ADXCRSS.Hs#S3896483_at
TCAAGGAAAACTCTACGTCCAAGTAAACTCAAGATATCAGGAAATAAGATTAAAAAGGAG
SEQ ID




TGTGGGGCTGCCACTGACATTTTAAAATCTCCTCTTTGTATTCTCTATTTTCAGAAAACA
NO:




ATTTCAACATCAAGCATGAAGTTTATGATGAATATAGGAAATAGAAAGGATGGTGAGGAT
2220




TGAGGATTTGTCTGTGGGAAATTATTATTGTTCTGATATTTTAAAACAGAAGAGCCAAAC




CAAAACAACTGTTCTTTTGACTAAAAAGGTGATGAGAGATTTTTAGTGTCCCCA





CD44
ADXCRSS.Hs#S3898008_at
GTGAAACCAAAAGAACGCAGGCAAGAAACAGAACAGGAGGGGGAGGGCGACTAAAACATA
SEQ ID




CACTACCAGGGGAAGAAGAAAAAGTGGCCGCAGCCCCAGGAGGAAAATAAAGAAAAGGAA
NO:




CCCACCACCTAGAAGACAGACATAATAAAAAAGAACACGCCGAGCATGCACGCGTCAAAA
2222




ACAAAAGAAGAAGGAGAAAACAAGCACCGCACGAGGTGAAGTCATTTGTGAAGGAAACGC




ACAACACAATATGTGCGGGGAGGAAAAATAAGAGCGATACCACCCTCACG





COL5A2
ADXCRSS.Hs#S821070_at
TCCTTTGGGTCCTGAAGAACCTACAGGACCCCGTTCTCCTTGAGCACCTTTGGGCCAGGT
SEQ ID




AAACCATCAGAGCCTGGAAAACCACGATTGGCAAGAGCACCCTTTCTTCCAATGGCCCTG
NO:




GAAGAACAACTGTTCCTGAGGTCACTCTGGGAACCCTTTTGCCTTCTTTAGCGGGTGGGC
2223




CTATCGGACCTGGATACATGTGGCCTGGTTC





NR3C1
ADXCRSS.Hs#S821188_at
AATGAGCAAGCGTAGTTCACTAAATATAAAGGAGTTTGTTAAAACCAGACAGTAATAGCT
SEQ ID




ATAAAAGGCACAACTTCCCTTTTCTGATATACACTTGTAAACTTTTTTTCAGGTTTCCAT
NO:




GCATAAATCAAAAATGCTATCCTAACTATACAGGGGGGGGATACACCAACAGAAAGTCTA
2224




GAAAATTTCATCCAGCCAACTGTGTAAAAAAGTATGAAGAGAAAGTTCCTCACACAGACT




TTGGGCACTGGTGGTTTAGGTGGCATCCATCTTTGACTGT





TGFBR2
ADXCRSS.Hs#S849165_at
GGGCATTTCTTAATTGCTCCTCAGTTCTAAGTGTCCCTCAGAATGCCTCAGATATTTGCT
SEQ ID




TTGACTCAGCAGAAGAAGGGAAGATCGTGGCCAGAGATAGCCTGAACCCTGCGAGAGGAG
NO:




GTTAGAAAGCAGAAAGCCCTCTGCCAGCCAGGTGGGTACCAATGGTCGTTCCTAGGATGA
2225




GACCTCATGTAACAGAGCCCAGGCAGTCCTGGGGAACTGGACATAGCTGGTGATTGGCAA




CAAGTTGATGGCCTGAGACCTTTGACACT





CAPN2
ADXCRIH.1382.C1_at
GTATCTGGACCTCAAAATTATGGGAACATTTACTTAAACGGATGATCATAGCTGAAAATA
SEQ ID




ATGATACTGTCAATTTGAGATAGCAGACGTTTCACACATCAAGTAAAAGATTTGCATATC
NO:




ATTATACTAAATGCAAATGAGTCGCTTAACCCTTGACCAGGTCAAAGAAAAGCTTT
2233





CAPN2
ADXCRIH.1382.C2_s_at
TGGCTCTGTTTCTCAGTACTTTGAAGTTATAACTAATCTGCCTGAAGACTTCTCATGATG
SEQ ID




GAAAATCAGCCAAGGACTAAGCTTCCATAGAAATACACTTTGT
NO:





2234





CD44
ADXCRIH.1441.C1_at
CATCAAGAACAGACAAGGGTGTGTAGCGGTTTACAAATACAGCCATAAAAAAGTCAAACA
SEQ ID




GGATCTACATGGCATCATCATTCCCCTTGGCCAATCCT
NO:





2235





CD44
ADXCRIH.1441.C1_s_at
AATCGGACACCCTGACTGATGAATAAATGCCACAAAGGACTTGCCAAGTGGGAGAAAATA
SEQ ID




TGAGGTTAGAGGATAAAGCCAGTACTCTCTTGTTTGGTCATAAACTTGCCTATCTGGTGA
NO:




TAAGATTCCAATGATGGGAATCCCTTTAACCTTTTGAGGGACTCCCCAGGCACTTAACTC
2236




ATCCTAAATAGCAACTGCATCAAGAACAGACAAGGGTGTGTAGCGGTTTACAAATACAGC




CATAAAAAAGTCAAACAGGATCTACATGGCATCA





CD44
ADXCRIH.1441.C2_s_at
ATGGTCCATTCACCTTTATGTTATAGATATGTCTTTGTGTAAATCATTTGTTTTGAGTTT
SEQ ID




TCAAAGAATAGCCCATTGTTCATTCTTGTGCTGTACAATGACCACTGTTATTGTTACTTT
NO:




GACTTTTCAGAGCACACCCTTCCTCTGGTTTTTGTATATTTATTGATGGATCAATAATAA
2237




TGAGGAAAGCATGATATGTATATTGCTGAGTTGAAA





IL8
ADXCRIH.1699.C2_at
TAAGAGCTCCACAAGTCTGCTTGTACGTAGTTATGTAGATTTACCTGAATATTTATCAAT
SEQ ID




TCATTTGTTTTCCATTCTTTCTCATGTTATGTCTCAGGCCTTTTATACCAGTTTCTTTCT
NO:




GCCACAAAGACATCCTTAGAATTTAGTTTAGTGATGGTCTGGTGAAGACAAATTTTCTCA
2238




TTGGTTGTCCAAAGGAAGATTAATTCCAAGTTTGTTCTTGAGAGGTATTTTTGCTGGCAT




ATGTTCAATTTGTCATAATATTTGTCAATTGTAAACTGTTGTGCAC





CD63
ADXCRIH.1914.C1_s_at
TAATGTTACTGTGGGCTGTGGGATTAATTTCAACGAGAAGGCGATCCATAAGGAGGGCTG
SEQ ID




TGTGGAGAAGATTGGGGGCTGGCTGAGGAAAAATGTGCTGGTGGTAGCTGCAGCAGCCCT
NO:




TGGAATTGCTTTTGTCGAGGTTTTGGGAATTGTCTTTGCCTGCTGCCTCGTGAAGAGTAT
2239




CAGAAGTGGCTACGAGGTGATGTAGGGGTCTGGTCTCCTCAGCCTCCTCATCTGGGGGAG




TGGAATAGTATCCTCCAGGTTTTTC





FHL2
ADXCRIH.1926.C1_at
TTGTGATAGTTCAGTCCCAGGGAAAGAGAAAACTCGCCCTAGGCCCTAGGTGGGAAGATG
SEQ ID




GTTTGAAATTTTTGTAATCGAGTAAGGCACACCCAAATGTAAAAATCCTTTTGAATGATG
NO:




CCTTTATAAATCTTTCTCTCACTGTCTATTTAAGTGCAATTAACATATGTCACGAACTTG
2240




AAAGTTTTCTAAACTCAATAAGGTAATGACCAGTTGTTATTTACAGCTCTGTAACCTCCC




GTTGCGTCAAGTCTAAACCAAGATTATGTGAC





FHL2
ADXCRIH.1926.C1_s_at
CGCCCTAGGCCCTAGGTGGGAAGATGGTTTGAAATTTTTGTAATCGAGTAAGGCACACCC
SEQ ID




AAATGTAAAAATCCTTTTGAATGATGCCTTTATAAATCTTTCTCTCACTGTCTATTTAAG
NO:




TGCAATTAACATATGTCACGAACTTGAAAGTTTTCTAAACTCAATAAGGTAATGACCAGT
2241




TGTTATTTACAGCTCTGTAACCTCCCGTTGCGTCAAGTCTAAACCAAGATTATGTGACTT




GCAATAAAGTTATTCAGA





FHL2
ADXCRIH.1926.C2_at
CGCTTCACAGCTCGCGATGACTTTGCCTACTGCCTGAACTGCTTCTGTGACTTGTATGCC
SEQ ID




AAGAAGTGTGCTGGGTGCACCAACCCCATCAGCGGACTTGGTGGCACAAAATACATCTCC
NO:




TTTGAGGAACGGCAGTGGGCATAACGACTGCTTTAACTGTAAGAAGTGCTCCCTCTCACT
2242




GGTGGGGCGTGGCTTCCTCACAGAGAGGGACGACATCCTTGTGCCCCGACTGTGGGAAAG




ACATCTGAATCAACACAGAGAAGTTGCTGCTTGTGATCTCCCACACGAATTTTTATGTT





FHL2
ADXCRIH.1926.C2_s_at
TCAGCGGACTTGGTGGCACAAAATACATCTCCTTTGAGGAACGGCAGTGGGCATAACGAC
SEQ ID




TGCTTTAACTGTAAGAAGTGCTCCCTCTCACTGGTGGGGCGTGGCTTCCTCACAGAGAGG
NO:




GACGACATCCTTGTGCCCCGACTGTGGGAAAGACATCTGAA
2243





MYL9
ADXCRIH.2136.C2_at
TAGTCGTCTTTATCCTTGGCGCCATGTTTGAGGATGCGGGTGAACTCCACGTATTTGAAG
SEQ ID




TTGCCTTTCTTATCATGGGTGCCTCCCGGTACATCTCGTCCACTTCCTCATCTGTGAAGC
NO:




GGTCACCCATGGTGGTGAGCAGCTCCCGGAGGTGGTCCTCATGGGATGAAACCTGAGGCT
2251




TTCCTCGTCGAAGCAGGCAAGGGCGTTGCGAATCACATCCTCGGGGGTGCGTGCCGTTCA




GCTTCTTCC





ACTN4
ADXCRIH.2359.C1_s_at
TTGGGGAGACTTGGGGCCAGCGCTTCTGGTCTGGTAAATATGTATGATGTGTTGTGCTTT
SEQ ID




TTTAACCAAGGAGGGGCCAGTGGATTCCCACAGCACAACCGGTCCCTTCCATGCCCTGGG
NO:




ATGCCTCACCACACCCAGGTCTCTTCCTTTGCTCTGAGGTCTCTTCAAGGCCTCCCCAAT
2256




CCAGGCCAAAGCCCCATGTGCCTTGTCCA





ACTN4
ADXCRIH.2359.C2_at
TCAGAGCAAAGGAAGAGACCTGGGTGTGGTGAGGCATCCCAGGGCATGGAAGGGACCGGT
SEQ ID




TGTGCTGTGGGAATCCACTGGCCCCTCCTTGGTTAAAAAAGCACAACACATCATACATAT
NO:




TTACCAGACCCGAAGCGCTGGCCCCAAGTC
2257





ACTN4
ADXCRIH.2359.C2_x_at
AGGCCTTGAAGGGACCTCAGAGCAAAGGAAGAGACCTGGGTGTGGTGAGGCATCCCAGGG
SEQ ID




CATGGAAGGGACCGGTTGTGCTGTGGGAATCCACTGGCCCCTCCTTGGTTAAAAAAGCAC
NO:




AACACATCATACATATTTACCAGACCCGAAGCGCTGG
2258





ID1
ADXCRIH.2765.C1_at
GCACTGGCGAGGAGAGGGCGCTCCTCTCTGCACACCTACTAGTCACCAGAGACTTTAGGG
SEQ ID




GGTGGGATTCCACTCTTGTGTTTCTATTTTTTGAAAAACAGACATTTTAAAAAATGGTCA
NO:




CGTTTGGTGCTTCTCAGATTTCTGAGGAAATTGCTTTGTATTGTATATTACATGATCACC
2261




GACTGAAAATATTGTTTT





RBPMS
ADXCRPD.1301.C1_at
TGAGGCAAAGCCCAACACACCTGTCTTTTGTCCACTTCTCCAGCAAATTAGATTTGTCTC
SEQ ID




TGGGAATGTGTTTGTAACATACCAACCTACTGCAGACCAGCAGAGGGAGCTCCCATGTTG
NO:




AATTTGTTTGTTAGCTATTTTCCCCCCTTTCACAAAAACTATTTCTTGACGACCTTTGAG
2269




AGATTTCAATAA





RBPMS
ADXCRPD.1301.C2_at
AGGCTACTTCTCAGGGCTGGAAGTCCCGTCAGTTCTGCTGAATACTATGTCCCAGGTGTG
SEQ ID




TGATGGCGGCTGCAATCTGTCTTGTGGGTATTAATGCAATCTTCAGTGGTGGCTACTGTT
NO:




CTCTAGCTTGTTCTACAAAACT
2270





NPC2
ADXCRPD.1525.C1_at
AAAAATTCTTGTCCCCGCCGCTATGTGGAACACCCACTCCCCACAACACCTAGTGTACTG
SEQ ID




CTCAACAAACACTTGATTTTCGCCCATGCGGGCAACTCTTANNNNNNNNNNNNNNNNNNN
NO:




NNNGGCGAGATAAATATACTTTCCCGCCGCGGGAGGAAAAACACGCGCCGGNGAAAAAAA
2271




TTAATTTCTTTAATTATTCGCCACCCCATTTATAACACACAAGAGCGGGGGGGACCACAC




CCCCCCGCCGGGTGTTGTGGGCGCACACAAAAGAATATATT





LMNA
ADXCRAD_CD620845_s_at
CACGCCTACCGCAAGCTCTTGGAGGGCGAGGAGGAGAGGCTACGCCTGTCCCCCAGCCCT
SEQ ID




ACCTCGCAGCGCAGCCGTGGCCGTGCTTCCTCTCACTCATCCCAGACACAGGGTGGGGGG
NO:




CAGCGTCACCAAAAAGCGCAAACTGGAGTCCACTGAGAGCCGCAGCAGCTTCTCACAGCA
2272




CGCACGCACTAGCGGGCGCGT





ZCCHC14
ADXCRPD.3467.C1_s_at
CCTTCACAGCTTCTATTGGACATATTTTCTTTTTAGGAATGAAGGAAAATTCTCCCATTT
SEQ ID




TTGAGCCATTCTTTTGTCAATTCTACAAAATTGCATGTAACTTTATAAATATTTTTAAAA
NO:




GATATAGTTTTGTAAATATTTAATATTCCGCTAATTTGATTTTGAATTGTAAATGTCAAG
2278




TATTCTGTTTTTGGGGTTTTTATGTTTTATTATACTTTGTTAAAAAGGACAAATTGTACA




TTTTTAGAATG





SPTBN1
ADXCRPD.5087.C1_at
GGTTTCCATCCACGATGTCATGGGACCCCATGTTCTCAAGATGGACTCTCTGCTCCTTCA
SEQ ID




GGAACTGAAGGGCCTTGTCCACATTCTCTAAGCAGTGGATGCGCATTCGTCCCTTGGTGG
NO:




GTTTAGGCAGCCTCTCTCCAGAGAGGACCTCCAGCAGCTTGATGAGCATCCGTCCATCTC
2283




GAAGGTCAGTGTACAGGTCTGTGATCCGGCAGGACACACGGGCAAGGTGGGAATTGACCC




ACTTGGTGAAGGTCTTCTTCTGCACGGC





ATP2B4
ADXCRPD.5728.C2_at
ATGGGAGCTCATCTCCTTCCATCTCTCCTAATCAAGAGCAAAGGGAACAGCAGGCCTAAC
SEQ ID




AGCAGGGTTGGGAAGGCAAA
NO:





2284





ATP2B4
ADXCRPD.5728.C2_x_at
CAATAGTCAATCTTTGGTTTTTCTTTTTGGTACAAAAATACCAGTGCTTGTTATACTAGT
SEQ ID




TACTAAAAGAAGAAGAAACTCAAAATTCCTATCTGCGTGCTAATTTGAAAAGAACAACGT
NO:




AGATAGATTTGTTGGCACATATATATGGCATATTCACATATGGCATATATACATATGGGG
2285




AGAAAACATGAACCAAAGGCCAATTCAGTTATGGGAGCTCATCTCCTTCCATCTCTCCTA




ATCAAGAGCAAAGGGAACAGCAGGCCTAACAGCAGGGTTGGGAAGGCAAA





MAPK1
ADXCRPD.6501.C1_s_at
CTTTATTCACAATCTTAGGTCTCAAATATTCTGTCAAACCCTAACAAAGAAGCCCCGACA
SEQ ID




TCTCAGGTTGGATTCCCTGGTTCTCTCTAAAGAGGGCCTGCCCTTGTGCCCCAGAGGTGC
NO:




TGCTGGGCACAGCCAAGAGTTGGGAAGGGCCGCCCCACAGTACGCAGTCCTCACCACCCA
2286




GCCCAGGGTGCTCACACTCACCACTCCTGTGGCTGAGGAAGGATAGCTGGCTCATCCTCG




GAAAACAGACCCACATCTCTATTCTTGCCCTGAAATACG





TMBIM1
ADXCRPD.6583.C1_at
CCTCGCCTAATTTTCACCACAAAGATTTTCTTCCACCCCGTTCTCTCCTCTTCCTGTCGG
SEQ ID




TTTTACGGCCTCTCACGGCGTGGCCATGCCGCTCACTATCACGGACACCCATAAGCCCCT
NO:




CACATATATTCTTCCCCCCAAAACACTCACTGAGAGTTTTGTTCCCCCCTATATCAGACC
2287




CCCATATATCGCGGTTCTGCCGCCGCCTTTATTGCACGCTGG





ZYX
ADXCRPD.7105.C1_s_at
TGACCCAGGACCCAACATGGTCTAGGGATGCAGGATCCCCGCCCTGGGGTCTGGTCCTCG
SEQ ID




CCCATCCTGCAGGGATTGCCCACCGTCTTCCAGACACCCCACCTGAGGGGGGCACCAGGT
NO:




TTAGTGCTGCTGCTTTCACTGCTGCACCCGCGCCCTCGGCCGGCCCCCCGAGCAGCCTTT
2288




GTACTCTGCTTGCGGAGGGCTGGG





COL6A2
ADXCRPD.9074.C1_at
ACAGCGCCCGCAAGTTGAGGTCATCGTCCCGAGGGTCGTGGCGCCCGTCCGTGATGACTA
SEQ ID




CCGCAAACACACGTGTCTTCTGGCGCCGGCTCTCCTTGATGAGGCGGTCGTAGGCAAACT
NO:




TGAGGGCTGAGGGTGTCCAGGTGCCACCTGCAATCCACTCGAGGTTCTCGACAGCCTCCA
2292




TTGAAGCTCGACAGGGAGTCGATATGTTCGTCGTCCAGCTGGATGCACTCAAAGGTGCCC




TCGTGCTGTACT





LAMB1
ADXCRPD.10237.C1_at
GAGAATCCAGTTCTTTGGCTGTGCTGTTGCTTTGGGAAGTTGTGTCAGATAATTTCACTT
SEQ ID




CTACTTGAGCCATCATTTCTGTAACATCTTTAATCAGTTTCTCTGCTTCCTCAAAGAGAT
NO:




TCCCTATGTTTTTCAGTGGCTCTGCTGCGGGGCTCTGCGCCAGGATGTCTTTTATCTCGC
2296




TGACTTTCCTCTCCACCGAGTCCACAGTCTCACGGTAAGGCCCGATCACACCACTGATCT




TCAGGCCTTGCTTTCTCCAGGAATCTGTGTGTCCTGTTGGCAGCA





ZDHHC7
ADXCRPD.11267.C1_at
GCCAGTGTTGTTTAGGCAGTGTAACATTTACCGGCTGTGTACAGCAAACAAGCTATTTTT
SEQ ID




TAGAAACCGACGTTTCAGGGAAGAGGGGAGAGAGCCGCGGGGTCCTGCCCGTGGTTACTA
NO:




TGAATGTATTGCTGTTGGAGGACATCTCGATCCAAAGAACAGCCGTTCCTGTGCGGCCCT
2299




TCGTTGCCCTAAAGCTTTCATTTTTTAAAGAAATAAAGAGTGCTTGAGGGCCTTGGAACT





ZDHHC7
ADXCRPD.11267.C2_at
TGGGCTGGCGCCTAGTAGGATTCTTGCTCTGAGCCAATACATTACTGCCACTCGGGGTTA
SEQ ID




TTCACGGACCACGTTATAACCACACTTCCTCTTAGTCCGCACGAATGCCAGTGATTTTTC
NO:




ACCTCCGCATAACTGTAATCCTGTTGATCTTCCTGTGCCTTGAGGGTCTTCTGTTTTTCA
2300




CTTTCACTGCAGTTATGTTTGGCACCCAAATCCACTCCATATGCAACGACGAGACGGTAA




GCTTTGTTCTCGGCTGTGTGGACTTCA





ZDHHC7
ADXCRPD.11267.C3_x_at
GGGAACCGAGTCTGTGCAAAGCCTCCTGCTTGTGAGTGTGGGGTAGGCACATGGGGGAGG
SEQ ID




GTCAGCCTGGCTGGGAGTCCTCAGCAGTTTGCTCCTCTTTGCTGACAAGCGCACTTGCCC
NO:




CTTCCTCCTCTGCGCTCAGACTCTACAGCTACTCAGCAGTCCAGCTTCTGCTCCCACCCC
2301




GCTCCTGCTCCTGCGGAAAAGGCCCCAGAAGCCTGGAGAGCTGGAGGCGGCCAGGAAGTC




AGGGTAGAAGGTGTGTGCAGGGCGTGCTCCTGCCTGGTGACAGAAGTC





TGFBR2
ADXCRPD.12527.C2_at
TGGCAGGAGCCTGATGCCGGTCAACTTGAAATATGACTAGCAACAAGTCAGGATTGCTGG
SEQ ID




TGTTATATTCTCTAAAGCCTGGGGTCTTCATCACATGAGCAGATTCCCAGCCAGTGTTTT
NO:




GACAAGTGCTCCTTTGCAATCGATTGTTTGAACCTATATGTCTGATTTTACATCTACCTT
2306




CTGAGAA





JAK1
ADXCRAD_CN418378_at
TCCACAGATTATCAAGTCCTTCTCCTGCAACAAATGCCCAAGTCATTTTTTAAAAATTTC
SEQ ID




TAATGAAAGAAGTTTGTGTTCTG
NO:





2311





JAK1
ADXCRAD_AL555086_s_at
ACAACAAGACCATTTGTGACAGCAGCGTGTCCACGCATGACCTGAAGGTGAAATACTTGG
SEQ ID




CTACCTTGGAAACTTTGACAAAACATTACGGTGCTGAAATATTTGAGACTTCCATGTTAC
NO:




TGATTTCATCAGAAAATGAGATGAATTGGTTTCATTCGAATGACGGTGGAAACGTTCTCT
2312




ACTACGAATGATGGTGACTGGGAATCTTGGAATCCAGTGGAGGCATAAACCAAATGTTGT




T





NT5E
ADXCRAD_BX404438_s_at
TTGTGGGAATCGTTGGATACACTTCCAAAGAAACCCCTTTTCTCTCAAATCCAGGGACAA
SEQ ID




ATTTAKTGTTTGAAGATGAAATCACTGCATTACAACCTGAAGTAGATAAGTTAAAAACTC
NO:




TAAATGTGAACAAAATTATTGCACTGGGACATTCGGGTTTTGAAATGGATAAACTCATCG
2316




CTCAGAAAGTGAGGGGTGTGGACGTCGTGGTGGGAGGACACTCCAACACATTTCTTT





ULK2
ADXCRAD_BP319713_at
GAGCTTTTCCATTTGGTGCTCCAATGTCTCCTGCTGGACCCATCTGCCTAGTGGAAGGCA
SEQ ID




GCAAAATTTCAAGAAACAGGTGAGGTTGAGCAGCTTGGTGCAACCCCATGGG
NO:





2317





ULK2
ADXCRAD_BP319713_x_at
AGAGAAGACTGTCGGCGCTCTGCCATAGCACCGCAACCGTGTGAGCAGCAGGCTCATCCC
SEQ ID




GTGGACCGGTGGTGGGAACGTGAGGAAGAGGGGAAGGAAGGAAGAGCTTTTCCATTTGGT
NO:




GCTCCAATGTCTCCTGCTGGACCCATCTGCCTAGTGGAAGGCAGCAAAATTTCAAGAAAC
2318




AGGTGAGGTTGAGCAGCTTGGTGCAACCCCATGGGGCCCTGGAGTTGGAGCTCAACAGCA




ATGGATTTCAGA





RBPMS
ADXCRAD_CD172092_at
AGCTTTCCAGAAAACCTCCTTCTGACTTAAAACTCTTTTAGGTTGGACAGAAATTCCTGT
SEQ ID




CCTTGATAAAGAACCACCTAGAAGCAGCCCCCAGCGAGGGGTTCTTGAAAAGTCA
NO:





2325





RBPMS
ADXCRAD_CD172092_x_at
AGGTTTCATTTGTCTTTCTGCATGTGTAATTCAGCCTTTAAATTTTAAATTTTTAAAAAT
SEQ ID




TATTANGCTGGACAGGCAGAGTTTTCGTTTGCCTGTTTTGCTCANTGTTTGTTTACAAGG
NO:




CTGGGTGAAATAAACAGCTTTCCAGAAAACCTCCTTCTGACTTAAAACTCTTTTAGGTTG
2326




GACAGAAATTCCTGTCCTTGATAAAGAACCACCTAGAAGCAGCCCC





CD44
ADXCRAD_CV026388_at
AATGCCTTTGATGGACCAATTACCATAACTATTGTTAACCGTGATGGCACCCGCTATGTC
SEQ ID




CAGAAAGGAGAATACAGAACGAATCCTGAAGACATCT
NO:





2327





CD44
ADXCRAD_CV026388_x_at
GTATGACACATATTGCTTCAATGCTTCAGCTCCACCTGAAGAAGATTGTACATCAGTCAC
SEQ ID




AGACCTGCCCAATGCCTTTGATGGACCAATTACCATAACTATTGTTAACCGTGATGGCAC
NO:




CCGCTATGTCCAGAAAGGAGAATACAGAACGAATCCTGAAGACATCTACCCCAGC
2328





PTRF
ADXCRAD_AL545542_at
GCTCCTTCCCTAGGAGCATGGGTGGCACGTGCC
SEQ ID





NO:





2330





PTRF
ADXCRAD_AL545542_x_at
AGGGTGCCGGCCCTGCCACCAAGTTGAGAGCTGGAGGGGAGGTGGGGAGAGAACATCACA
SEQ ID




GAGCAGCCAGCCCTGGTTCACTCCTGGSAGTTTCTTCTCAAGCTCCTTCCCTAGGAGCAT
NO:




GGGTGGCACGTGCCTGTTGGTCTCAGC
2331





MAPK1
ADXCRAD_BQ889971_x_at
AAAAGTAGCCGGCCGTGGCGGTGTGCGCCTGTGG
SEQ ID





NO:





2332





SEPT7
ADXCRAD_BF855173_at
AAGGTACTTAGAGCTCTTACTTTCTAAGTACAGAACACCCTAGACAATTCAAGGCATCTT
SEQ ID




AATCTCCATCAAGAACAAAAAAAAAAATAATTTTGGTCATGCGGTTAAATCCATCATTAG
NO:




GGATAAAACGGGTGCAAATGGGTCAAAGGGATCCAACAAACACGGATGTCCAAGCGGGCA
2333




TATGGGCAACTATTACGTTAACGGGGGGTCAATAGAGAGTTAAAAAGATCTTCCCTTTCT




TCTGGTTCTTTTCCAGGGTTCTGGAAGAGTTCTGGT





PDLIM7
ADXCRD_BU927740_at
AGGCAGGAAAAATCGCTTTGATCCTGAAAAGGTGG
SEQ ID





NO:





2334





WDR1
ADXCRAD_CV811638_s_at
GGGACTAGAGTTTAACTGCAGCGGAACATGTCATTTCTCTATTTCTGTGACGCGCCCCCA
SEQ ID




TGCCCCCACCCCACCACAAGAGGCAGGAGGGCCCAGTCATGACCCTCGTCTCTGCAGGGT
NO:




GTCTGTACACGTTCTTCTGAAAGCTTTAGACAGTAACAGTTTGCACATGAAAAATAAAGC
2335




GAGCACCTAAACAATGTGGTGGAGCATAACTAAAACCCACAGCCC





YWHAZ
ADXCRAD_BM461687_s_at
TGAATGGACTTTTCAACTACTTTCTCTACAGCTTTTCATGTAAATTAGTCTTGGTTCTGA
SEQ ID




AACTTCTCTAAAGGAAATTGTACATTTTTTGAAATTTATTCCTTATTCCCCTCTGGNCAG
NO:




CTAATGGGCTCTTACCAAGTTTAAACACAAAATTTATCATAACAAAAATACTACTAATAT
2336




AACTACTGGTTCCATGTCCCATGATCCCCTCTCT





SPTBN1
ADXCRAD_BI823572_s_at
TTAAGACTGATTCTGGAGGTCCATCAGTTCTCAAGAGACGCCAGTGTGGCCGAGGCCTGG
SEQ ID




CTGCTTGGACAGGAGCCGTACCTATCCAGCCGAGAGATAGGCCAGAGCGTGGACGAGGTG
NO:




GAGAAGCTCATCAAGCGCCACGAGGCATTTGAAAAGTCTGCAGCAACCTGGGATGAGAGG
2238




TTCTCTGCCCTGGAAAGGCTGACTACATTGGAGTTACTGGAAGTGCGCAGACAGCAA





CALU
ADXCRAD_BP380290_s_at
GAATGCTGATGGTTTCATTGATCTAGAAGAGTATATTGGTGACATGTACAGCCATGATGG
SEQ ID




GAATACTGATGAGCCAGAATGGGTAAAGACAGAGCGAGAGCAGTTTGTTGAGTTTCGGGA
NO:




TAAGAACCGTGATGGGAAGATGGACAAGGAAGAGACCAAAGACTGGATCCTTCCCTCAGA
2344




CTATGATCATGCAGAGGCAGAAGCCAGGCACCTGGTCTATGAATCAGACCAAAACAAGGA




TGGCAAGCTTACCAAGGAGGAGATCGTTGACAAGTATGACTTAT





FLNA
ADXCRAD_CN332899_at
TGACCTCTCGGCTTTCACTTGGGCAGAGGGAGCCATTTGGTGGCGCTGCTTGTCTTCTTT
SEQ ID




GGTTCTGGGAGGGGTGAAGGATGGGGGTCCTGTACACAACCACCCA
NO:





2347





FLNA
ADXCRAD_CN332899_x_at
TGACCTCTCGGCTTTCACTTGGGCAGAGGGAGCCATTTGGTGGCGCTGCTTGTCTTCTTT
SEQ ID




GGTTCTGGGAGGGGTGAAGGATGGGGGTCCTGTACACAACCAC
NO:





2348





EPAS1
ADXCRAD_BQ228942_at
TTTCACTCTCCTCCGTCTGGTTTTGGCACTAGGTATTTCTAACGCCCGCGACACTAATTT
SEQ ID




ACAAAATGGGAATTTACCTGGCGAAAACTTGCCCACGGCTCACCCAAGCAAGGGGCCTTT
NO:




TTTTCTGGAGATGGCTCCCTTTAATTATCCCCAATTTTTTAAAGGGACCCCACTTGGTTT
2349




AAGCCTGGTTTCTAAAAAGGTGCCTTAAAATTTGTGGAGGGATTTTTTTTTCCCCCCCAC




CCCTCCAAAGGGCTCTCCAGCAGTTCAAATTAGCCCGGCGGG





CD59
ADXCRAD_CX784253_s_at
GAGCTAACGTACTACTGCTGCAAGAAGGACCTGTGTAACTTTAACGAACAGCTTGAAAAT
SEQ ID




GGTGGGACATCCTTATCAGAGAAAACAGTTCTTCTGCTGGTGACTCCATTTCTGGCAGCA
NO:




GCCTGGAGCCTTCATCCCTAAGTCAACACCAGGAGAGCTTCTCCCAAACTCCCCGTTCCT
2353




GCGTAGTCCGCTTTCTCTTGCTGCCACATTCTAAAGGCTT





CD59
ADXCRAD_CN431378_s_at
GATAGCAGGGCATGAAAACTTAGAGAGGTACAAGTGGCTGAAAATCGAGTTTTTCCTCTG
SEQ ID




TCTTTAAATTTTATATGGCTTTGTTATCTTCCACTGGAAAAGTGTAATAGCATACATC
NO:





2354





CD59
ADXCRAD_BP343697_s_at
TGCTAACTCCTAGCTGACTCAGCATAGATTGTATAAAATACCTTTGTAACGGCTCTTAGC
SEQ ID




ACACTCACAGATGTTTGAGGCTTTCAGAAGCTCTTCTAAAAAATGATACACACCTTTCAC
NO:




AAGGGCAAACTTTTTCCTTTTCCCTGTGTATTCTAGTGAATGAATCTCAAGATTCAGTAG
2355




ACCTAATGACATTTGTATTTTATGATCTTGGCTGTATTTAATGGCATAGGCTGACTTTTG




CAGATGGAGGAATTTCTTGATTAA





CKAP4
ADXCRAD_CX752475_at
AGCAGATTACCTCAGAATCCTGTCTGGTGGCAGAATTCAGTAAAAAAAAAAAGTGGGTGG
SEQ ID




GGGACCTTTCTTTCAGTGCTTAAGAAATATTTACTTTTTTGTCTGCGAATTTTGAATACC
NO:




CATGCTCATTGACGTTAGCCAACGCCCTTATAGAGAGACTGGCTCTGAGATCCGTAGGCC
2356




CAGGCGCTCTCACTTGACAGATACCGGTAGG





RRBP1
ADXCRAD_CB159041_at
TAAACACTATCCTGGGCGCAGCCCCGGGCCACCGCCGAGTGACGCCAAAGCCCTGGTTGA
SEQ ID




CTCTGACAGCCCCGTGGGTGTGTGGGAGGCCGGGCGCTCTGGGGTCTGTCTGTCAGT
NO:





2360





RRBP1
ADXCRAD_CB159041_s_at
AAAGCCCTGGTTGACTCTGACAGCCCCGTGGGTGTGTGGGAGGCCGGGCGCTCTGGGGTC
SEQ ID




TGTCTGTCAGTGCAATCGTTTAGTGTTTTTTCAGTGGGGCGGGGCGGGAAGCGGGTGGGA
NO:




CCGGGCAGCCAGTTCTCAAAGGCTGTGGGGCCGACTGGAGGCCACAGCCCCTCACCCCTA
2361




GACGTTGCCAACCAGAACTGACGTG





RRBP1
ADXCRAD_BQ778389_at
TGGTGGTGAGTTTTCGCCATCTCCTTGCGCTGGTTGGCTAGGGCTTCTTCATATGACGTT
SEQ ID




TCCTTCATGGAGAAAGTCGACACCAGGAAGATGCCAATGGCAGAAACAACCATGAATCCT
NO:




CCAAAGACCACAACCCCCAAGGTTTGAGTGTCGTAAATATCCATCCTGGCTTGCTTTC
2362





RRBP1
ADXCRAD_BQ931525_at
CCATGAGAGAACAAGTCTCCTTAGAGCCACAAGAAGTAGACCCTTCCCAGAGCCCCCAGT
SEQ ID




TTTGTAAAATGAAACCCTGTGCTCCCCATTTT
NO:





2363





RRBP1
ADXCRAD_BQ931525_x_at
CCATGAGAGAACAAGTCTCCTTAGAGCCACAAGAAGTAGACCCTTCCCAGAGCCCCCAGT
SEQ ID




TTTGTAAAATGAAACCCTGTGCTCCCCATTTTGGATAAACCACTAATCCCG
NO:





2364





ATP1B1
ADXCRAD_BP311263_s_at
GAAGTTAAGAGCTGATCACAAGCACAAATCTTTCCCACTAGCCATTTAATAAGTTAAAAA
SEQ ID




AAGATACAAAAACAAAAACCTACTAGTCTTGAACAAACTGTCATACGTATGGGACCTACA
NO:




CTTAATCTATATGCTTTACACTAGCTTTCTGCATTTAATAGGTTAG
2367





FHL1
ADXCRAD_CX872156_s_at
CACTTACCAGGATCAGCCCTGGCATGCCGATTGCTTTGTGTGTGTTACCTGCTCTAAGAA
SEQ ID




GCTGGCTGGGCAGCGTTTCACCGCTGTGGAGGACCAGTATTACTGCGTGGATTGCTACAA
NO:




GAACTTTGTGGCCAAGAAGTGTGCTGGATGCAAGAACCCCATCACTGGG
2369





PPP4R1
ADXCRAD_BG291984_at
CCCACAGTACCGAGAAACACAAGAGGCACAACACACAAGACCAAGAACACAAAGGAGGGC
SEQ ID




GGGCGCCACAAAGTAGACACCAAGCAGGAGGCGACAAGAACACAGGACCACAGAGTGTAC
NO:




AAAAAAGAGGCCCTACATAGCGACAGAAATACACGAGAGCAGACGGGCCCGAGATCACAC
2370




GCAGACGGCGAAAAGCAGAGTGGGGCCTGAGAAGACACATCCCGCGGGAGATCACAGACC




A





MARCKS
ADXCRAD_CD110028_at
CAACGGCAGCGTCCCGGCCCGCCGAACAAAGAGGAAGCCCGCGGGCCGCCGGGAAGCGGG
SEQ ID




GGGCGGCCTTCACCCCTCCCTCGGGCCCGAAAAAAGGGTGAAGTCGGGTCCCGCCGAACC
NO:




GCCATGCCCTCCCTAAAGG
2374





MARCKS
ADXCRAD_AV732105_at
GAATGTACTTTGCTTTACAAAATGCTATAACTCTGCTTAGGNGTCTATTTTCTTGAGCCA
SEQ ID




CTAAAGCGAAAATAATGT
NO:





2375





MARCKS
ADXCRAD_AV732105_s_at
ATTTTAAACTCAACCAAGCTGTGATAAGTGGAATGGTTACTGTTTATACTGTGGTATGTT
SEQ ID




TTTGATTACAGCAGATAATGCTTTCTTTTCCAGTCGTCTTTGAGAATAAAGGAAAAAAAA
NO:




TCTTCAGATGCAATGGTTNTGTGTAGCATCTTGGCTATCATGTTTTGGAAATACTGGAGA
2376




AGCTTTGACCAATT





RYBP
ADXCRAD_BM931122_at
CTAAAGTGTCAGTTGGTGGTTTTGTGAACTGGTCAAAAATTCACAGGTCTTAAATGTTTT
SEQ ID




GGGGGAAATTTATATTGGACACTGCTCTTTGTCTAGCAAATAAAAGATGTTAATATATTC
NO:




CTGTTACTGGCATGTGCACGACTATGTTATTAGAAGCCACTTTATCATTTTCCTGCTTTA
2378




AATAGAAATGTCTATTTATGAATTCTGCTTGTAGTTTTTTCAC





NR3C1
ADXCRAD_CA392568_at
GTGCCTTTTATAGCTATTACTGTCTGGTTTTAACAATTTCCTTTATATTTAGTGAACTAC
SEQ ID




GCTTGCTCATTTTTTCTTACATAATTTTTTATTCAAGTTATTGTACAGCTGTTTAAGATG
NO:




GGCAGCTAGTTCGTAGCTTTCCCAAATAAACTCTAAACATTAATCAATCATCTGTGTGAA
2379




AATGGGTTGGTGCTTCTAACCTGATGGCACTTAGCTATCAGAAGACCACAAAAATTGACT




CAAATCTCCAGTATTCTTG





NR3C1
ADXCRAD_BQ433598_at
GGTTACTTTCACATACAGCCCTCCCCCAGCAGTTGAATGACAACAGAAGCTTCAGAAGTT
SEQ ID




TGGCAATAGTTTGCATAGAGGTACCAGCAATATGTAAATAGTGCAGAATCTCATAGGTTG
NO:




CCAATAATACACTAATTCCTTTCTATCCTACAACAAGAGTTTATTTCCAAATAAAATGAG
2380




GACATGTTTTTGTTTTCTTTGAATGGGCTTTTGAATGTTATTTGTTATTTTCAGAATTTT




GGAGAAATTATTTAATAAAAAAACAATCATTTGGCTTTTTGAATGCTC





LDLR
ADXCRAD_CX873479_at
GAGGCAGAGCCTGAGTCACCGGTCACCCTTAATATTTATTAAGTGCCTGAGACACCCGGT
SEQ ID




TACCTTGGCCGTGAGGACACGTGGCCTGCACCCAGGTGTGGCTGTCAGGACACCAGCCTG
NO:




GTGCCCGTCCTCCCGACCCCTACCCACTTCCATTCCCGTGGTCTCCTTGCACTTTCTCAG
2385




TTCAGAGTTGTACACTGTGTACATTTGGCATTTGTGTTATTATTTTGCACTGTTTTCTGT




CGTGTGTGTTGGGGATGGGATCCCAGGCCAGGGAAAGCCCGTGTCAATGAATGCCG





CYP1B1
ADXCRAD_BQ939150_at
CCGCGCAGCCGCCAAAGTCTCGAGGGCCACGTGCTGAGCGAAGCGCGCGAANCTGGTGGC
SEQ ID




CCTTCTGGGGGCCCGCANCGCGGACGGGGCCTTCCTCCGACCCAGGGCGCTGAACCGTCC
NO:




TGGCCGTGGCCAACCTCTTGAATGGCCGTGGGGTTTCGGCTGGCGCTAACNCCCCAACAA
2391




ACCCCAAGTCCCGGGGAGTCGCTCCCCCACACAACAAAAAG





CYP1B1
ADXCRAD_BX104039_s_at
AAAGCTGTGTTTATATGGAAGAAAGTAAGGTGCTTGGAGTTTACCTGGCTTATTTAATAT
SEQ ID




GCTTATAACCTAGTTAAAGAAAGGAAAAGAAAACAAAAAACGAATGAAAATAACTGAATT
NO:




TGGAGGCTGGAGTAATCAGATTACTGCTTTAATCAGAAACCCTCATTGTGTTTCTACCGG
2392




AGAGAGAATGTATT





CRIM1
ADXCRAD_CD101810_at
AAATAGAATTGACCTCCAGCCCGGATTAGGCATAAATTTTG
SEQ ID





NO:





2396





CRIM1
ADXCRAD_CD101810_x_at
GGTGTTCTACCTGTTTGCATCAAAGGAAAAAAAGATTTTTTTTCCAAGGGCCAATTTTTT
SEQ ID




TATCTTTTCCCAAAAAAAATTTGTTAATGGAACATTTACAAAAATAGAATTGACCTCCAG
NO:




CCCGGATTAGGCATAAATTTTGGTTGGGA
2397





ACTB
ADXCRAD_CD514490_x_at
CACCCCACTTCTCTCTAAGGAGAATGGCCCAGTCCTCTCCCAAGTCCACACAGGGGAGGT
SEQ ID




GATAGCATTGCTTTCGTGTAAATTATGTAATGCAAAATTTTTTTAATCTTCGCCTTAATA
NO:




CTTTTTTATTTTGTTTTATTTTGAATGATGAGCCTTCGTGCCCCCCCTTCCCCCTTTTTT
2399




GTCCCCCAACTTGAGATGTATGAAGGCTTTTGGTCTCCCTGGGAGTGGGTGGAGGCAGCC




AGGGCTTACCTGTACACTGACTTGAGACCAGTTGAATAAAAGTGCACACCTT





LPP
ADXCRAD_BM456598_at
TTGTCTTGGAAGTATCTCATAGGTCTTTAAATGAGTAAAACATTTTTATGCCAGAAGGTG
SEQ ID




ATATAATGGATGTTAGTGTTTTTTATTGGATTTTACAGGAGTTTTAGTCAGATAATGAGG
NO:




ACAGAGACCTCCACTTGAATTCTTTACCACCATTTCAGCAATATTTTTTTAATGGCCTTT
2400




CACTTGGATTTTGGCTTAAATAAGGGCCCCGAACAAGATCCAAAACTTTGTGTCCTCAGG




GAAGGGCCATTAATA





LPP
ADXCRAD_BM456598_x_at
TTGTCTTGGAAGTATCTCATAGGTCTTTAAATGAGTAAAACATTTTTATGCCAGAAGGTG
SEQ ID




ATATAATGGATGTTAGTGTTTTTTATTGGATTTTACAGGAGTTTTAGTCAGATAATGAGG
NO:




ACAGAGACCTCCACTTGAATTCTTTACCACCATTTCAGCAATATTTTTTTAATGGCCTTT
2401




CACTTGGATTTTGGCTTAAATAAGGGCCCCGAACAAGATCCAAAACTTTGTGTCCTCAGG




GAAGGGCCATTAATA





LOXL2
ADXCRAD_CF619371_at
CCATGGTGGGTCTGCCCGCCAGCTGGGCCTTGGGAATTCGCCCACCAAACGCCTTTCAAG
SEQ ID




AAAACCTTGGTTATTGGGCCCCGGAAGATGTTCAACAGCCCAACAA
NO:





2405





BCL6
ADXCRAD_BM454297_at
GCGCCCCTTTTTTTATGTGACGAGCAAAACCCTCCTTTCTCCCTG
SEQ ID





NO:





2406





FNDC3B
ADXCRAD_CK126145_at
TTTCATAGTGTCACCTAATCTGCGTAAAGCCGCCGCTTCCTTTATGAGGGTAATGCTTCA
SEQ ID




GCAACTGATAAATACTTGATGGTTGGACAACCCACTAAAGCATGAAAATGTTTTTGGAAT
NO:




TGGAGCATGCTTATGACCTAAACGCAAAAATTAACACATGCTCTTTTTTCGT
2409





CAV2
ADXCRAD_BM804910_at
TAAAAACAAAACCGTGCGCATTGTGGGCCCCCCTTT
SEQ ID





NO:





2412





ELF4
ADXCRAD_AW970249_at
CCAGTTTATTAATGCCAGTTTCCCGATGGTTGGAAAGGAACCATTTTG
SEQ ID





NO:





2415





EPHA2
ADXCRAD_BU174123_at
GACAGAGGGTGTCAAACATTCGTGAGCTGGGGACTCAGGGACCGGTGCTGCAGGAGTGTC
SEQ ID




CTGCCCATGCCCCAGTCGGCCCCATCTCTCATCCTTTTGGATAAGTTTCTATTCTGTCAG
NO:




TGTTAAAGATTTGTTTTGTTGGACATTTTTTTCGAATCTTAATTTATTATTTTTTTTATA
2416




TTTATTGTTAGAAAATGACTTATTTCTGCTCTGGAATAAAGTTGCAGATGATTCAAA





CDC42BPA
ADXCRAD_BM048315_at
CTTTATAAGAGATCCTCTGTACCAAAACAATGA
SEQ ID





NO:





2417





CDC42BPA
ADXCRAD_BM048315_s_at
ATGAAAACAAAATGACTTGTCTTTTTATTTGATAGTGTAATATCATTCATTTTATAAATT
SEQ ID




TTTTAGGGTTTTTCTCGTTGTAATATTGTACAGTTTTGCATGGCCTGGTGTGATCATTTT
NO:




TTGGTTAGAATATAATGCTGACAAATGTGGATGGAGGGGAAGATACTGTTTAGCCTATCA
2418




CTCCTTATTTTATTTTGTTTGGTTTTATGCCCTCAGTG





PHACTR2
ADXCRAD_BX119839_s_at
AAGTCAGATGTAATGTGACCCTAGAAAACTGTAGCAAGCTTCAGAAATAAATCTTTTGAT
SEQ ID




CTTTCCCTATCTTGATTAGATCCAAAGTCAAAGCAACCATACTTCACCTAGAGAAGACAG
NO:




TATTGGCAATCATGACACCTGTAATAAAAACTTGAATCCAAAGTCAAAACTTAAGCAAGA
2420




TACAAATGTGCTGCCTGCAGTTAGTCCTGCATGGGAATAAGGACTAGTTAT





ULK2
ADXCRAD_CK818454_s_at
AGTTGGTGACCTAAAGGCTTGTTAGTGATGTGGAGTTCCTACATGCAGTGAGTGGAAAAT
SEQ ID




GAAGTTCGTTTTCTCTTAGGAAAATGGGCAGCTGTCTTCTGCCTAATGTGTATTTTTCAT
NO:




GTTAATTCTGACAGTTCACCAAATAGCTAGTCATGGAGAATGCAGGCAGTTAACTTAATA
2421




TCCCTCCAGGAATGGTTCTACGTTGTGTATTATTTGGTTTCTTTTACTTACCTGCTTGAA




TACT





AURKA
ADXCRAD_BM790362_at
GCCCTGACCCCGATCAGTTAAGGAGCTGTGCAATAACCTTCCTAGTACCTGAGTGAGTGT
SEQ ID




GTAACTTATTGGGTTGGCGAAGCCTGGTAAAGCTGTTGGAATGAGTATGTGATTCTTTTT
NO:




AAGTATGAAAATAAAGATATATGTACAGACTTGTATTTTTTCTCTGGTGGCATTCCTTTA
2422




GGAATGCTGTGTGTCTGTCCGGCACCCCGGTAGGCCTGATTGGGTTTCTAGTCCTCCTTA




ACCACTTATCTCCCATATGAGAGTGTG





F3
ADXCRAD_BU941055_at
GGAATTGTTACTGGTGTACTTATTCTATCTTCCATTTTATTATTTATGTACAATTTTGGT
SEQ ID




GTTTGTATTA
NO:





2425





F3
ADXCRAD_BU941055_x_at
GGAATTGTTACTGGTGTACTTATTCTATCTTCCATTTTATTATTTATGTACAATTTTGGT
SEQ ID




GTTTGTATTAGCTC
NO:





2426





LDOC1
ADXCRAD_CN356531_s_at
GCCGTTCAGCCTGGTTAGTTTTCTACCTACTCCGAGTGTCCTCCCCTGCCCCACCAGATT
SEQ ID




GCTGCAGGGGCGCGGTGTGCCTGGCAGCCAAATTGTTGACACTTCTTTTTTCCTATGCAC
NO:




TGGTTTTACACAGCTGTCATTTTTCTTTCAAAATTGCAGCAGTCCCACAGATGTGTGCAT
2427




TTGGACAAATAGTACTTAAAAACAAAACAAACAAGCACTCAGCCCAGCTCCTCAATACTA




CCTGGAAAAAGCATTGGCA





CD44
ADXCRAD_BP233968_at
TGAATGGGTCCATTTTGCCCTTCCATAGCCTAATCCCTGGGCATTGCTTTCCACTGAGGT
SEQ ID




TGGGGGTTGGGGTGTACTAGTTACACATCTTCAACAGACCCCCTCTAGAAATTTTTCAGA
NO:




TGCTTCTGGGAGACACCCAAAGGGTGAAGCTATTTATCTGTAGTAAACTATTTATCTGTG
2428




TTTTTGAAATATTAAACCCTGGATCAGTCCTTTGATCAGTATAAT





PPIC
ADXCRAD_AL540607_s_at
GAAAAGTCATTGATGGGATGACAGTGGTGCACTCCATAGAGCTCCAAGCAACTGATGGGC
SEQ ID




ATGACCGTCCACTCACC
NO:





2429





IL6ST
ADXCRAD_AV662263_s_at
CTGATGTAAGTGTTGTGGAAATAGAAGCAAATGACAAAAAGCCTTTTCCAGAAGATCTGA
SEQ ID




AATCATTGGACCTGTTCAAAAAGGAAAAAATTAATACTGAAGGACACAGCAGTGGTATTG
NO:




GGGGGTCTTCATGCATGTCATCTTCTAGGCCAAGCATTTCTAGCAGTG
2434





SPTBN1
ADXCRAD_CX872934_at
ACTAGAATTATCTCAAACGTACAATATAATGTATTTCAGCAAAAAAAAAAAAAATTGAAA
SEQ ID




TTACAGATTATTTAAAACAGTATCAGTTTTCTATTCCTTCTTGTATACCGACATTCTTAA
NO:




CCGTCATAGCAGTTGATGCAAAAAAGCCGCATGTCGTGTGTTAGTAAGTGATGCCAGATA
2437




CAAATGGTTTGGTCTGTAGAGTTAATGTGGAGCTGCACTGTGGCTGCAGCAAGATCATAA




TATGCGATCTGTTTAATAAAGGTTAGCC





FOXN3
ADXCRAD_BP254636_s_at
CATCTTGTGGCTCCCCAGTGGTCAGCGGAGACCCCAAGGAGGATCACAACTACAGCAGTG
SEQ ID




CCAAGTCCTCCAACGCCCGGAGCACCTCGCCCACCAGCGACTCCATCTCCTCCTCCTCCT
NO:




CCTCAGCCGACGACCACTATGAGTTTGCCACCAAGGGGAGCCAGGAGGGCAGCGAGGGCA
2438




GCGAGGGGAGCTTTCGGAGCCACGAGAGCCCCAGCGACACGGAAGAGGACGACA





MXRA7
ADXCRAD_BX099460_at
TGATCACCCCACTGGCAGGACAATTCACAGTTCTTGAGCAAACTGAGTTAGGGAGGGTAT
SEQ ID




GCTAACGACAGAACCTATGCAAGTTCTTAGAAATATTTTTTGTTTGCTGAAATAAAGCTC
NO:




AATCAACACACTACCTTAAAAAAAAGTGGGAGCAGTGGCATTTCCATGCCTCATGCTCAC
2442




CATCATGAGGTTAACTTCCCGCCGTCGCCTCTTGCCTGCCAGGGGTTTTTCGGGAGCCCC




TCTCTGTTCCACTCTGATTCCTTTTGNTTCTTTGCTGACCATTCACTCTCTG





NT5E
ADXCRAD_BM704188_at
GGAGAAAGCTCCCTCCGTTCTGATGCTTTTGAGCTTATCAGGGACACCCTGCAGCAGAAA
SEQ ID




TTCCAGCTGATCCTTCAGCCTTCAGAGTTGATGAGGTGGGGCTCACACACATCTGGATTT
NO:




GAAGAAGAATCGTGGGTTTCAAGAACTCTGTGGTCTCTTAAGCATTGGTATTCCACAGCT
2446




ACACTTCCCTGATACTTTGCACTCAGTAATGACAA





PHACTR2
ADXCRAD_CA944993_s_at
GTGGGTATAAATATCTACAAGTATACACACATATGTACTTGTATTCCACTATTGTAACCT
SEQ ID




GAAAGAAAGACTATGTATTCCCTTTTTTAATTCCGTACTGGTATTTGTGTTATTTAAAAA
NO:




GCAAAATTCTGCTCTATTTAGTTGTATAATATTAGAGGATACTTTGCTGTGCACAATTCC
2451




A





CRIM1
ADXCRAD_AI651806_s_at
ACATTTTCTTTTCACGTTAAGCATACTGGGTATCTGTGTCTTTCACAACAAGCATTTTTA
SEQ ID




AAAGAAAACTCAATGCACAAATGGGTTAATTAGTATAAAAGTGCTAAGGGCTGTTTGAAA
NO:




AGTTACCACTATAGTATACAGTCAGTTATATTTGAGGCATACTACAACAAACTTCCAGCT
2454




TATTGTGGACAATATTCCAGTAGTTGTTTCAAACCATTGTTTGAAAAAAAAAAAAAAAAA




ATCCAGGAGCTGATTAGTGATGCAG





CDH11
ADXCRAD_BG435621_at
ACAAACTAGTGGTGGGGGCACAGCAGAGCCCACGAAAAGAAGTTTTGT
SEQ ID





NO:





2458





CD44
ADXCRAD_BM840380_s_at
GAGATCACTTCCAGCCTAATGTGCATTTGGCTGGAATATGGTTGTCTCAGAATAACATCA
SEQ ID




TGCACTCGGGCTTTTATACTTCTGCCTTTAGGGGACTGTGGCAGCATGGCATGGGTCAAG
NO:




AAGTACTTCTCCTTCATCTTCCTTTGATGTCGGTAACTCATCCTTTCTGCACTGCGGGAG
2459




TTGTTAATGCTTTTGTGTCCTCCAGTTCACATGCTGATTGCTAAGAAGAAAATGAGCATG




AGTGAACCCAAAGCTGCTGAAACATTCTGCGTTTATGCAACTTCCTTG





P4HA1
ADXCRAD_CD013931_at
ATGACAGATGATTTTGTTCAGGAATTTTGCTGTTTTTCTTAGTGCTAATACCTTGCCTCT
SEQ ID




TATTCCTGCTACAGCAGGGTGGTAATATTGGCATTCTGATTAAATACTGTGCCTTAGGAG
NO:




ACTGGAAGTTTAAAAATGTACAAGTCCTTTCAGTGATGAGGGAATTGATTTTTTTTAAAA
2463




GTCTTTTTCTTAGAAAGCCAAAATGTTTGTTTTTTTAAGATTCTGAAATGTGTTGTGACA




ACAATGACCTATTTATGATCTTAA





PRSS23
ADXCRAD_BU164591_at
AAAAAACTGGGCTGTTCAATCTCCTTTCCATTTTTAAAAACCTATTTTGAAAAAAGCTAA
SEQ ID




AAAAAAACTATTATGGCCTCCCTTTAGGGGGGGTTTATTTTTAATCCCCCGCTTTTTTTA
NO:




TTCACTTTTTAAAAATTAAAAAGTTAAAAAAAAAAATGGAAGCACCCCTGGCTAAAAAAT
2464





ZNF264
ADXCRAD_BM504879_s_at
GTGTGTGTACATATGGACCACTTCAAGCTACACACACACACACACACACATATACACGTG
SEQ ID




TATGAATATATATATATGGCTATAAGTGGTGCGACTTGCAGGTACTCCCTTTGTTCACCT
NO:




TTGTAAAGATGTTATTGCCAGTTCAGTGTGTATTTCTATAGTATATATGTAAACAATTTG
2465




TCATCCTTTTGTTGCTGCTTTTGAAACTAGTTCATGGCTTCAGTGG





MALT1
ADXCRAD_BU164882_s_at
ATTTTAGTAGAAGTAATGTGCCAGTAGAGACAACTGATGAAATACCATTTAGTTTCTCTG
SEQ ID




ACAGGCTCAGAATTTCTGAAAAATGACCTCCTTGTTTTTGAAAGTTAGCATAATTTTAGA
NO:




TGCCTGTGAAATAGTACTGCACTTACATAAAGTGAGACATTGTGAAAAGGCAAATTTGTA
2466




TATGTAGAGAAAGAATAGTAGTAACTGTTTCATAGCAAACTTCAGGACTTTGAGATGTTG




AAATTAC





FLNB
ADXCRAD_BP358943_s_at
TGCTATAGCGCCATTCCCAAGGCATCCTCGGACGCCAGCAAGGTGACCTCTAAGGGGGCA
SEQ ID




GGGCTCTCAAAGGCCTTTGTGGGCCAGAAGAGTTCCTTCCTGGTGGACTGCAGCAAAGCT
NO:




GGCTCCAACATGCTGCTGATCGGGGTCCATGGGCCCACCACCCCCTGCGAGGAGGTCTCC
2468




ATGAAGCATGTAGGCAACCAGCAATACAACGTCACATACGTCGTCAAGGAGAGGGGCGAT




TATGTGCTGGCTGTGAAGTGGGGGGAGGAACACATCCCTGGCAGCCCT





ACTN1
ADXCRAD_CX871590_s_at
TCTCCTGCCTGGGTTCGGTTTCAGCTCCCAGCCTCCACCCGGGTGAGCTGGGGCCCACGT
SEQ ID




GGCATCGATCCTCCCTGCCCGCGAAGTGACAGTTTACAAAATT
NO:





2469





PTRF
ADXCRAD_BU186765_at
TTCCATTGAACCCAAAGGTCCGCAACACCTGCCTCCCAGGCCTGGGGCGGAAAAAATTGA
SEQ ID




AACACCTCCTCTCCACCTTGAATGGGAGCCTTCAAGGG
NO:





2474





PTRF
ADXCRAD_BU186765_x_at
TCTACTAAGCCGAAACCCATCTCTACTAAAATTACCAAAATTTNCCTGGGCATGATTGCG
SEQ ID




CATGCCTGTAAATCCAGCTACTTTTGGAGGCTTGAGGGGGGCAGCAATTGCTTGAACCTG
NO:




GGGAAGGGGGCAGGTTTCCATTGAACCCAAAGGTCCGCAACACCTGCCTCCCAGGCCTGG
2475




GGCGGAAAAAATTGAAACACCTCCTCTCCACCTTGAATGGGAGCCTTCAAG





FOXN3
ADXCRAD_BM995629_s_at
CCGTGTAGGTCTATTGGCCAGCCAAGGTCAGACGACCCTAAGCATCAATAGTAAACCTCT
SEQ ID




TGGTCTTCTGATTGCTTTATCACTTTTTTTTTTTTTCTGTAAAACAAAACAAAACTCAGA
NO:




AATGTTACAGAATCAGAGTATTAAAAAATGTACAAGTGTATATGCTTCCCAGACACACAT
2480




GGATACATTTTTCCTCCACATTTTCACCATGGCAGTATTAAGTAGTGAGTGTGAATGACA




CAGCATGAAACTGGTTACTGAATCAGCTATGAGCTCAGATGGCCTCAAC





TUBB6
ADXCRAD_BP390113_at
AACAGCAGAGAATTGCGGGTTCTACCCAGTCAGAAGATCACACCATGGAGACTTTCTACT
SEQ ID




AGAGGACTTGAAAGAGAACTGAGGGGCCACAAAATAAACTTCACCTTCCATTAAGTGTTC
NO:




AAGCATGTCTGCAAATTAGGAGGGAGTTAGAAACAGTCTTTTTCATCCTTTGTGATGAAG
2491




CCTGAAATTGTGCCGTGTTGCCTTATATGAATATGCAGTATGGGACTTTGAAATAATGAT




TCATAATAAAATACTAAACGTGTGTCTTCAA





NFIB
ADXCRAD_BX442437_at
TACAACAAAGTGACATCACTACACTTGTTTTGCTGCATTTATTATCATTTTAAATCTTTA
SEQ ID




CCATTTTTATGACAAAATATTTTGTACTCCAGACGAAGAAAAATGTGTGACATCATGGAT
NO:




TTTTTAGACAGTTATACCTTTATCTCMCATTTATAAAGCATATCATGGCTGTGTATAGTT
2492




GC





NFIB
ADXCRAD_BU902064_at
ATGTTGGTTTAACTGCACCCTCCTGNAGGTAGATTTATTTATTAAAAATACTGGTTGCAT
SEQ ID




CAAGACCCATAGGGTGTACAAAAGGTCTATAAAATCTGCATTATAGAGAAAAAGAGGCAN
NO:




GCAAATCCATGTCCCAAGGTAAAAGCTACAGTTTACAACTGGGAACCCCAGGGTGAAGAT
2493




ATAAAACCCCCTCTTGAAAACAAATTGAAACAGGGGCTGAAAACTTGCGTGGGGCTTCAA




AATTACCCTGGTCAAAATTTCCTGATTG





GRB10
ADXCRAD_BG258819_at
AAGATCAGCGGAAACGTTGAAAATAACTGGAATGATCATCTGGGGTGGGCCGCTACGAAC
SEQ ID




AGAACCGCAAACAGGATGGCATGAATCTTGCCCTGGATATCTGACATTACACGGACTGTC
NO:




ACTAACGATGACACC
2496





FHL1
ADXCRAD_BP361024_at
GACTGTGTCAAGAGTGAGCCACCCAGTCTCTAAAGCTAGGAAGCCCCCAGTGTGCCACGG
SEQ ID




GAAACGCTTGCCTCTCACCCTGTTTCCCAGCGCCAACCTCCGGGGCAGGCATCCGGGTGG
NO:




AGAGAGGACTTGTCCCTCGTGGGTGGTGGTTCTTTATAGAA
2502





ACTB
ADXCRAD_BM476291_at
CCCAAGTCACACAGGGGAAGGTGATAGCATTGGCTTTCGGGGAAATTATGTAATGCAAAA
SEQ ID




ATTTTTTTAAATCTTCGGCCTAAATACCTTTTTTAATTTGGGTTTTATTTTGAATGGAGG
NO:




AAGCCTTTCCTGC
2504





ACTB
ADXCRAD_BM476291_x_at
CCCCACTCTCTCTAAAGAGAATGGCCCAGTCCTCTCCCAAGTCACACAGGGGAAGGTGAT
SEQ ID




AGCATTGGCTTTCGGGGAAATTATGTAATGCAAAAATTTTTTTAAATCTTCGGCCTAAAT
NO:




ACCTTTTTTAATTTGGGTTTTATTTTGAATGGAGGAAGCCTTTCCTGCCCCCCCCTTTCC
2505




CCCTTTTTTTGTCCCCCCAACTTGAGAAGGATTGAAAAGCTTTTTGGC





WDR1
ADXCRAD_BE740367_at
ATACCGGCTGGCCACGGGAAGCGATGATAACTGCGCGGCATTCTTTGAGGGACCCCCATT
SEQ ID




CAAGTTCAAGTTCACAGTTGGCGACCACAGCCGCTTGTCAACTGTGTGCGATTCTCTCCT
NO:




GATGGGAACAGATTTGCCACAGCCAGTGCTGACGGCCAGATATACATCTATGACGGGAAG
2506




ACTGGGGAGAAGGTGTGCGCGCTGGGCGGAAGCAAGGCCCACGACGGTGGGATTTACGCA




ATTAGTTGGAGTCCCGACAGCACCCATTTGCTTT





GRB10
ADXCRAD_BI833263_at
GGGCGCGGCGCCAAAAAGCAGACCCCGAAGAGAGAGCCGCATAGGCACAAGAGGCCACAG
SEQ ID




CCAGATACCAACGGACAACAAGCTGGGCAAACAAATGGCGACACGACCGACGGAAAAAAC
NO:




CACGAGGAGACACAGCCAACCCAGACGACAAACCCGAGACACGCCGCCCACAAGACAGGG
2507




AACCACAAGCACCCCGACCGGGAGGCACACTCAAAGGACGCCGCACCCACCCACACAGGC




AGGAGAGCGCCGACCGCGGCAACAAGAGCACCCAGA





IL6ST
ADXCRAD_AU280467_s_at
GATAACAGTTACTCCAGTATATGCTGATGGACCAGGAAGCCCTGAATCCATAAAGGCATA
SEQ ID




CCTTAAACAAGCTCCACCTTCCAAAGGACCTACTGTTCGGACAAAAAAAGTAGGGAAAAA
NO:




CGAAGCTGTCTTAGAGTGGGACCAACTTCCTGTTGATGTTCAGAATGGATTTATCAGAAA
2508




TTATACTATATTTTATAGAACCATCATTGGAAATGAAACTGCTGTGAATGTGGATTCTTC




CCACACAGAATATACATTGTCCTCTTTGACTAGTG





CASK
ADXCRAD_AW959845_s_at
CTACATTCCGTTCATGGGGCACACCCAGGGGAATAAGAATAAAATGCTATTATGACTAAG
SEQ ID




TTGTAAACCTATGCACATCCCTTGCATTTTGGGCAACTTTAT
NO:





2509





NFIB
ADXCRAD_BP382229_s_at
GAAGTCCAAGCCACAATGATCCTGCCAAGAATCCTCCAGGTTACCTTGAGGGTAGTTTTG
SEQ ID




TAAAATCTGGAGTCTTCAATGTATCAGAACTTGTAAGAGTATCCAGAACGCCCATAACCC
NO:




AAGGAACTGGAGTCAACTTCCCAATTGGAGAAAT
2510





VEGFA
ADXCRAD_AI557291_at
ATCCAGAAACCTGAAATGAAGGAAGAGGAGACTCTGCGCAGAGCACTTTGGGTCCGGAGG
SEQ ID




CGAGACTCCGGCGGAA
NO:





2511





VEGFA
ADXCRAD_AI557291_s_at
ATTCCCGGGCGGGTGACCCAGCACGGTCCCTCTTGGAATTGGATTCGCCATTTTATTTTT
SEQ ID




CTTGCTGCTAAATCACCGAGCCCGGAAGATTAGAGAGTTTTATTTCTGGGATTCCTGTAG
NO:




ACACACCCACC
2512





LAMB1
ADXCRAD_CN388523_s_at
GAAACCTTGTTCAACGCGTCCCAGCGCATCAGCGAGTTAGAGAGGAATGTGGAAGAACTT
SEQ ID




AAGCGGAAAGCTGCCCAAAACTCCGGGGAGGCAGAATATATTGAAAAAGTAGTATATACT
NO:




GTGAAGCAAAGTGCAGAAGATGTTAAGAAGACTTTAGATGGTGAACTTGATGAAAAGTAT
2513




AAAAAAGTAGAAAATTTAATTGCCAAAAAAACTGAAGAGTCAGCTGATGCCAGAAGGAA





PLAU
ADXCRAD_CX787154_at
AGAGACTGGGAAGATAGGCTCTGCACAGATGGATTTGCCTGTGCCACCCACCAGGGTGAA
SEQ ID




CGACAATAGCTTTACCCTCAGGCATAGGCC
NO:





2514





PLAU
ADXCRAD_CX787154_s_at
GCCAGGCGTCTACACGAGAGTCTCACACTTCTTACCCTGGATCCGCAGTCACACCAAGGA
SEQ ID




AGAGAATGGCCTGGCCCTCTGAGGGTCCCCAGGGAGGAAACGGGCACCACCCGCTTTCTT
NO:




GCTGGTTGTCATTTTTGCAGTAGAGTCATCTCCATCAGCTGTAAGAAGAGACTGGGAA
2515





MDFIC
ADXCRAD_BE878413_at
GGACACCATAGCAGACAAGATAAAGAGGCAAGAAATTGTCCACGATCAAAAAGAGACTAT
SEQ ID




ATACGACAGTGAGAAAGAGGGTAGCCTATAAGATAGCAAACGGAGGGTGACAACAATCTA
NO:




TTAATGAACAATATTTAACAGAGGGAGCACAAATAGCAGGATAAAACAACGGGTGAGAAT
2516




AAAAAAGTGGAGTAGAAAAAGAGATTAGTAGTACGAGAGAAAATAGGGGTGGAAAACCCA




CAGTAATAGAACAA





ZFP36L1
ADXCRAD_BU073871_s_at
AATATATTATTCTTCAACGACATTTTTTGTAACTTTACACTTTTTTGGTTATTTTATTTT
SEQ ID




AAAAAAATGAAAAATTAATTTAAAAAAATGCAAAAAACTGTTGGATTATTTATTTTAGAA
NO:




ATTCCCCCCTTTGTGTTGGACTGCAAATTGAGTTTCTTTCTCTTTAGGCCTTTCACAACT
2519




AGGACTGAGAATGTATGTAAAAGTTCTGTGACAGTACAGAAGGAAAACAACTTTTTATGT




ATAGCTTCTA





LMNA
ADXCRAD_BI770050_at
AGAGAAGTTATTTTCGTACAGGTGGTTTTATACCTGAAGGGAATAAACGACAATGCAAAA
SEQ ID




ATAAACAGATCCGAGCCTCTATCTCAGTACATGTTGTCAGGCCGATAATGTCCGACCTCG
NO:




CGTTTCGTTTTGCCCGTGTTTCCCGTGAAGCGTCGGAATTCGGCCTTGAAAACCAATAAG
2520




GGAATTCCTTTAGAAGCCAGGGCTGAAAGGGGTAGCGTAAGTAAAGAGGTCAACCTGCGA




GGTATCATGACCTTGTAGGTTGGCCCGC





COL6A1
ADXCRAD_CX781062_at
GGGCTCAGCCCTGAGTTGGCATCACCTGCGCAGGGCCCTCTGGGGCTCAGCCCTGAGCTA
SEQ ID




GTGTCACCTGC
NO:





2521





CDC14B
ADXCRAD_BM842156_at
ACGCCCGGGAACACACACTGTGCTGGGGAGGAAGTGGGCCTAGGAGGGCCTGCAGGTCCA
SEQ ID




GGCAGCTGTAGAGCTGCTAGAAGCTGGGGTGTTGCTCTCCCCGCTTTCTCATAGACACAG
NO:




AGGTACTGTCTGCCTGTTGTCACACAGTTCATATGCTCGCTTGAGATGGAATCTGAACCT
2522




TGGTCCCAGGATCTGTGCTTTTTCCCACTTTGCCACACTGTCTAAGGTGGCTTTGAACTG




GAACCCAAGTGCAAATAAAGGTTGGTATTCGCTCCT





ATP2B4
ADXCRAD_CN299966_at
ACAAATGGTGATATCAAAGCAACGTATACCCCAGTCCAGTGTGTGTTGCCATAATTTGCA
SEQ ID




ATTCAGCTTAACAGTGCACCCAATCTATATTTGCATTTTG
NO:





2523





IGFBP3
ADXCRAD_CD512795_at
AGCTCTTTAAAGGGCAAAAGCTTATTTCCACTNCTCATCCTTTTGTCCTCCTTTAGCACA
SEQ ID




ATGGTAAAAAAGAATAAGTAATATCCGAACCAGGGAAGGGAGGGAATGGGCTTTGTCTGG
NO:




GGGAAGCCCAATCCAGGGACAA
2524





IGFBP3
ADXCRAD_CD512795_s_at
GACAGGGAGAGTCAGCCTCCACATTCAGAGGCATCACAAGTAATGGCACAATTCTTCGGA
SEQ ID




TGACTGCAGAAAATAGTGTTTTGTAGTTCAACAACTCAAGACGAAGCTTATTTCTGAGGA
NO:




TAA
2525





KCTD12
ADXCRAD_BQ881289_at
TTTGTTTAATACATGTGGACCATGAACAGTATTCATTCTCCTTTTTCAATGATATGCTGT
SEQ ID




AGAAAATATTCCTTGAAGATGTGAGATTTAAAAATTTTTCCCTTTCAATGTTGGTTTAAT
NO:




TGAATTTCCTAACTTGGGTTTTTTTGATTGATAGCCCAGTGATAAATCCTAATACTAGAC
2526




AAAATTTGTCTTCTCTTTTTCAACCAGAGCCCAAATATAATGGCCTGGAATAAAGGGGAA




CCTTACTGCCTTCTCTTTGA





KCTD12
ADXCRAD_BQ881289_x_at
CATGTGGACCATGAACAGTATTCATTCTCCTTTTTCAATGATATGCTGTAGAAAATATTC
SEQ ID




CTTGAAGATGTGAGATTTAAAAATTTTTCCCTTTCAATGTTGGTTTAATTGAATTTCCTA
NO:




ACTTGGGTTTTTTTGATTGATAGCCCAGTGATAAATCCTAATACTAGACAAAATTTGTCT
2527




TCTCTTTTTCAACCAGAGCCCAAATATAATGGCCTGGAATAAAGGGGAACCTTACTGCCT




TCTCTTTGAGGAAA





MAPK1
ADXCRAD_CX757452_at
TTCAGTGTTGCTTTCCTCTTGATCAGCGTGTCTGAATGACAGTCAGGTTCAGGTGTGCTG
SEQ ID




ACACAGAATGCTCACAGGCTCACTTGCCG
NO:





2531





RRAS2
ADXCRAD_CX788826_at
GTTTGCCAAGCTGAAGCTACAGGTTGTGAAATAATTTTTAACTTTTGGAATCATACTGCC
SEQ ID




TACTGTTACTCTAAATAGAAATATAGGGTTTTTTTTAATGTGAATTTTTGCCTATCTTTA
NO:




AACATTTCAATGTCAGCCTTTGTTAACCTTAAATACACTGAATTGAATCTACAAAAGTGA
2536




ACCATCTCAGACCTTTACTGATACTACAACTTTTGTTTTCTGATGGCCAAAATACCAAAT




GCCTGTTGTATTTATGGATTAAA





ARID5B
ADXCRAD_BG285011_at
CTCTATGCTCTGTAAGGTGATTATTTGTATATAGCAACATGGCCCAGTGATATTATATAG
SEQ ID




TTTCCCAATGGAGAGGTTATTGAGTAACCTTTGCATTAGTTTAAACACTACCAGAAGAAT
NO:




GCTGAGCCAACTATAAACACTCAATTTTGTATGTTTTCCAAATTGGTACTTATTACTGCT
2537




TTTGATACTGTATTACGTGCCAATAGTTTCCCAATCACATAGCAGGCAAGAGATATTTTG




TACTTTCTGATCCACTGTAATATTTA





NFIB
ADXCRAD_CA430617_at
GCCTGTTCAATTTCACAGTCTCTGTTGAGTTCAGTTGTAAATATGTTTCAAATGACATTT
SEQ ID




TCTTGGGAAAAAAAATCTCTACAACATTGTAGAATGTGAGGGGTAACTACATCCCAGGCA
NO:




TAGGTTTCTCAAAGCTGCAGTAGATTATGTCTTCATCAAGCTGTTAATTTGTGCTTATAT
2542




CATATAGAACTTTTAGCATCCTG





NFIB
ADXCRAD_BQ068224_s_at
TATGGCTTTTTATGCATCCTTCATCGAGGGCATTGAAGTTGCATGGACTGATAAAAGTTG
SEQ ID




ATGCNAAACAAGAAAGAAACAAACAAAAAAAAAAAAACCAGCAAAATGTTTACCCAAAAA
NO:




CTCAAACAAATGAGCAGTGCCTGTT
2543





CREB3L1
ADXCRAD_BM850478_at
CCCACTGTACAGAGACCAAGAACAGAAATTGTTTGTAAATAATGAACCTTATTTTTTATT
SEQ ID




ATTGCCAATCCCCTAAGATATTGTATTTTACAAATCTCCCTCTTCCCTTCGCCCCTCCCT
NO:




TGTTTTATATTTTATGAAGTTAGTGCGGGCTTTGCTGCTCCCTGGCCCAGGAAAGAGGGA
2546




CTCCCTGACCCTCACCTGGCACCCCCCTGCTGCTGCCCAAGCCGCTGGGCCTTTTTAATT




GCCAAACTGCTCTCTTCATCAGCTCAGCACATGCTTTAAGAAA





TUBB3
ADXCRAD_CX870071_at
GAAGGTGGCCGTGTGTGACATCCCGCCCCGCGGCCTCAAGATGTCCTCCACCTTCATCGG
SEQ ID




GAACAGCA
NO:





2550





TUBB3
ADXCRAD_CX870071_x_at
GTGGATCCCCAACAACGTGAAGGTGGCCGTGTGTGACATCCCGCCCCGCGGCCTCAAGAT
SEQ ID




GTCCTCCACCTTCATCGGGAACAGCACGGCCATCCAGGAGCTGTTCAAGCGCATCTCCGA
NO:




GCAGTTCACGGCCATGTTCCGGCGCAAGGCCTTCCTGCACTGGTACACGGGCGAGGGCAT
2551




GGACGAGATGGAGTTCACCGAGGCCGAGAGCAACATGAACGACCTGGTGTCCGAGTACCA




GCAGTACCAGGACGCCACGGCCGAGGAAGAGGGCGAGATGTACGAAGACGA





CREB3L1
ADXCRAD_BU528167_at
GATTCAACTGCCCACGGATTCAAGCCAAACCCTCTGGAAGCGGAACCCAGTTCCTCCAAG
SEQ ID




TGACACCCGGAGGAACTGGTGCCAGATGCCTCCGACGCCCCCCCATAGACCATGGGCAGG
NO:




GACAGCGAACGGGTTCCCAGAAGTCCCCCGCTTTCTTTGCCCCCCCTACGGGCCCTGTTC
2552




AAGGGCCATGG





PDLIM7
ADXCRAD_CN278331_at
TCTGCCCACGTGCTCAACGTGCAGTCGTAGCCCGGCCCTCTCCAGCCGGCTGCCCTCTCT
SEQ ID




GCCTCCCTCTTTCTGTTCCTCCTGCCCAGGGCACCCCCTTAGTGCCTCCAGCTTCTGCCT
NO:




ACCTCACCCCCCCTTTCGTGCCCCTGGCCTGAGCCTCCTGCTGGCCTGGCCCTGGCCGCC
2560




CACCTGGGTTCATCTGACACTGCCTTCCCTCTTTGCCCTGTGGTACTGCTGTCTGCCAGG




TCTGTGCTGCCTTGGGCATGGAATAAACATTCTCA





PDLIM7
ADXCRAD_CN278331_x_at
TCTGCCCACGTGCTCAACGTGCAGTCGTAGCCCGGCCCTCTCCAGCCGGCTGCCCTCTCT
SEQ ID




GCCTCCCTCTTTCTGTTCCTCCTGCCCAGGGCACCCCCTTAGTGCCTCCAGCTTCTGCCT
NO:




ACCTCACCCCCCCTTTCGTGCCCCTGGCCTGAGCCTCCTGCTGGCCTGGCCCTGGCCGCC
2561




CACCTGGGTTCATCTGACACTGCCTTCCCTCTTTGCCCTGTGGTACTGCTGTCTGCCAGG




TCTGTGCTGCCTTGGGCATGGAATAAACATTCT





PDLIM7
ADXCRAD_CD366841_at
GATGCGGAAGGAACGCGACTGGCCTGTCCCCGGCCGCGGCCGCCAGTCCTCTGTGTTCTC
SEQ ID




CATCAGCCGCTGCTTGCTGGCATCTGGGACCAGCGGTCGGAGCGGCTGTCCATTCTGCTG
NO:




CGGGGCGCTGT
2562





PDLIM7
ADXCRAD_CD366841_s_at
CTGTGTTCTCCATCAGCCGCTGCTTGCTGGCATCTGGGACCAGCGGTCGGAGCGGCTGTC
SEQ ID




CATTCTGCTGCGGGGCGCTGTCAGCGGGCGGGGGCGCCCCANAGGGCCGGGCCGTCTTGT
NO:




TGAGGGAGACGCTGGGTGCACAGGTGTACCGCGGAGGGTCCGCGGCGGNGGCGGAGGCCT
2563




TCTGCGGTTTGCTCTGAACCGGCTGGGCCCTGCTGAG





PDLIM7
ADXCRAD_CD366841_x_at
GGAAGGAACGCGACTGGCCTGTCCCCGGCCGCGGCCGCCAGTCCTCTGTGTTCTCCATCA
SEQ ID




GCCGCTGCTTGCTGGCATCTGGGACCAGCGGTCGGAGCGGCTGTCCATTCTGCTGCGGGG
NO:




CGCTGTCAGCGGGCGGGGGCGCCCCANAGGGCCGGGCCGTCTTGTTGAGGGAGACGCTGG
2564




GTGCACAGGTGTACCGCGGAGGGTCCGCGGCGGNGGCGGAGGCCTTCTGCGGTTTGCTCT




GAACCGGCTGGGCCCT





LMNA
ADXCRAD_AV703605_at
TCTACCGCGGGTTTATACTGGATGAAAAACTCATGCCAACACCAAAAAGCAAACTCCAGG
SEQ ID




GGGTTCCCCGTACCCAATAGGGCCCATGGTGAGTCGGCCCACAATTAACTTGCCCTTCTA
NO:




TTACAACCGTCTAGTCTTGCGAAAACCCCTGCGGTTACCCACCCTAAATGGCCTTGCAGA
2565




ACTTCCCCCTTTTGCCCGATTGCCGTAACATCCAAACAGGCCCCTACCGATCTGCCCTTC




CAACAAATGGGCAACCCTTAATGGGCGAAT





CDC42BPA
ADXCRAD_BU508210_at
GAAATTTTGAATAACCTATATACACAAATAAAAACACGGGCAGGCCGCCTCTTAGAAGAA
SEQ ID




TTCCCTCCAAGGGGGCCCAAACTTTACGCGGTACCCCACCTTTTCTTTGGTAAAAAGAGG
NO:




GGCCCCCTATTAGAGGAGCCGGCATTTTTAACGTTAAGGGACTGGGGCCGGACTATTTTA
2567




TAAAGTCTGTGGTAACTGGGAAAAAACTGCCCAACCTTGGGAAACCTTTCGTGAAAGGAA




AACTTTTACTTTTGGGGGGTGAGCGCAATAATATGTGGCCACACACTTCCTTCC





MAP1B
ADXCRAD_BG164365_at
TTGGGCCCCATTTCAGAAAATCTCAGACTCTAAACCACCAGTGATTGCCCTAGCATGCTC
SEQ ID




CAGAATTGTCCCGCACTTAGTCACTCTGGTTCGATTACTGTTGCGAAACCAGTCCCCCAT
NO:




TATGACAATACCCAGCGGGGTCTTTGGTAACATGGCCGAGATGAATCAAAACGGGCCCTT
2568




CGGGCACGTTAAACCTGCTACTAAACAGGATGGGTAAAACACTCCAGGCAAACACCAGCG




AAAGATT





IL8
ADXCRAD_BG340548_at
ACTCTGGACATCAGCAGCACGCGGGGCTTCCCATTCAGTCCTGAGAGGGGGGGAAGTACG
SEQ ID




GCAGCCACCTCTCACAGGTGGCTGGTGCTTCCAAGGAGGTCATGCCGGGCACACGCCAAC
NO:




CCGTGGTGTGCGCAGTCACGCCCCGAGGACAAGAAAAAACGGCCTTCCACTGTTGGCTGA
2570




GCTGC





S100A10
ADXCRAD_BG675291_at
TGACTTTCAATTCCTGGCCGTTGGTCTGTTGTTCTCAAGAATTCCAAAAGACCCTCTTTG
SEQ ID




GTGGTGGGACCAACACATATGTAAGGCACCGTGCAACCAGGTTTAATCGAAGTGACCAAG
NO:




TGAGGGCATCACGAAAGCTTTCTTCACCCCCATAATGGGAGGGCAGCACACAATAGCTGT
2579




CAGACACCTATTGGTGACGTCACCCTGCTACGGACGGGCAAAAAATTCGCACACAATCGA




AGAACCCACCTCCTGATAGAAGTTTCCCAGACGCTCGTTAGAATCGTGCCCA





RAB31
ADXCRAD_AL552789_s_at
GACCGACTGGGTATCTAGCTTACTGTTTTAACATCATTGTTGAAACCAGACCCTGTAGTC
SEQ ID




CAGTGGTGCTGCCCTGTTGTGCAAACTGCTCCTTTTTCTCGTGTTTTTGTAAAGAGCTTC
NO:




CATCTGGGCTGGACCCAGTTCTTGCACATACAAGACACCGCTGCAGTCAGCTAGGACCTT
2580




TCCGCCATGTATTCTATTCTGTAGTAAAGCATTTCCATCAACAATGCCTAATTGTATCTG




TTATTTTTGGTTTAACACACACTGATTCATACT





GALNT2
ADXCRAD_CO405530_at
GCAACTGAGTGACTCTCACCTACCACCGACTGGGGAGTGGTAAAAGCACTTGACGGATGC
SEQ ID




CTGGCAACTTAAGACCTGCTGGAAGAGGGGCACAATGCCCCCGGAGCGAGAAAACCCTGA
NO:




ATCTCATTTCATCCCTTCAATCCGTATGTTTCACAACCCCAACTTTCACTGGCAGTTACT
2581




TAAAGTCCTCTCCTGCTCTCTTCCAAGTGTTCTAGGCAAACCCTC





MVP
ADXCRAD_BP354622_s_at
CTTGTGAGCCCTGGGCTTAGGAGTCACCATGGCAACTGAAGAGTTCATCATCCGCATCCC
SEQ ID




CCCATACCACTATATCCATGTGCTGGACCAGAACAGCAACGTGTCCCGTGTGGGAGGTCG
NO:




GGCCAAAGACCTACATCCGGCAGGACA
2583





PTPLA
ADXCRAD_CD299090_at
ATCTCTGCAAAACAAGTGCTTTTTCCAGAATAACCAAGATTTACTGAGTCCAAGTTTTTA
SEQ ID




ATAACAAGAAATAAACAACCTTTGTGAAAATAATCATGGGATTGGTATGGGTTTT
NO:





2585





PTPLA
ADXCRAD_CD299090_s_at
ATTATTTTCTTCTTATAACCATGGCATCATATATACCTTTGTTTCCACAACTCTATTTTC
SEQ ID




ATATGTTACGTCAAAGAAGAAAG
NO:





2586





LRP12
ADXCRAD_BP368157_s_at
GATTGTTTTCATCCTGATACTGTAGTTCACTGTAGAAATGTGGCTGCTGAAACTCATTTG
SEQ ID




ATTGTCATTTTTATCTATCCTATGTTAAATGGTTTGTTTTTACAAAATAATACCTTATTT
NO:




TAATTGAAACGTTTATGCTTTTGCCAACACATCTTGTAACTTAATAT
2589





MAPK1
ADXCRAD_AA467802_s_at
CTCTCTCTGCAGGAGTGCTAATCACTGTGGCTTCTGTTAAGAATTCCCAACTTGATCTCT
SEQ ID




CTCCTGATGCTGCTGGAAGGATGGAACCGTCATCTCCTCCATCTGAATCACTGACAGGCA
NO:




TTCTTAGATTTTTAAATCAGGATGCTGAAAACTATCTTTGTCCCTTACCTCCACCTTCTT
2590




TTTGTACCTCCCAGACCCAGGCCCACCTCTCACGTTTATAAGGTCTAGGTCAAGAATACA




AATGGAGCCCTACATACCATTA





CD55
ADXCRAD_AA632649_at
CATCAGAAAGATTCCCAGGCTGGCTACTTCGGGATGACCCTTGCATTTTTTATTGAAATC
SEQ ID




ATTTCTGAATCTTTTTTCCCCACTAGCTTTTAAGACATAGGAACTATATCTTGTTCAGCT
NO:




TTGCACTTCCAATTATAAAAAAATGCCTGGCGTGTGTTAGGCACTCAGAAAATGTTTGAA
2593




CTGAACCAATGGTGTGTGTGTCTCTGCACACTCTAAGTTAGTGTAAATCAGAACAGCTTG




TTGTTGCTGCTTGTTTTGATCAAG





COL5A2
ADXCRAD_CN415190_s_at
TACAACAGTTTAGGTTTAAGATGACCAATGACAATGACCACCTTTGCAGAAAGTAAACTG
SEQ ID




ATTGAATAAATAAATCTCCGTTTTCTTCAATTTATTTCAGTGTAATGAAAAAGTTGCTTA
NO:




GTATTTATGAGGAAATTCTTCTTCCTGGCAGGTAGCTTAAAGAGTGGGGTATATAGAGCC
2594




ACAACACATGTTTATTTTGCTTGGCTGCAGTTGAAAAAATAGAAATTAGTGCCCTTTTTG




TGACCTCTCATTCCAAGATTGTC





NFIB
ADXCRAD_AW975114_at
CTGAGGGTTGGCATGAATGCTTTTCTTTTTCACGTGTAACATTAGGTTCAGACATATATG
SEQ ID




TGTGCAGTGCATTGCTGTAATGTGTGCACATGGTAAGAACACATATGTCTCAATACCATG
NO:




CTGTATCGCTCAATAGCCTGACAGATGTATATGGGTGAATTCATTCATTGCCCTCTCTGG
2598




TGATTAGTAGCACTTTGAAAATGATGTCGTAATTTGGCAAACT





KCMF1
ADXCRAD_CN402369_at
AAGACTGTTGACCACTTGAATTTCTTTGGTGTTAGTGGATTAACCTAACCATTACTCTGA
SEQ ID




GA
NO:





2601





KCMF1
ADXCRAD_CN402369_x_at
GGTCTTTCAAACACATCTGCACATAAGTCACACATTTCAATAAAGCATTTTCAAGACTGT
SEQ ID




TGACCACTTGAATTTCTTTGGTGTTAGTGGATTAACCTAACCATTACTCTGAGATTTTAT
NO:




ATCTCTAATCCAGTATTTTTTTTCTTTTTATGCTAAACATGGGAGATCCTGGTTTTGTGT
2602




GAATGCATTATTTTGGATGTGAGAAATAAATGCCAATTATATGTACTTTCCCTTTTCTGC




ACAA





ADAMTS1
ADXCRAD_CN354195_at
CTGCCAGTTGCAAATTTGATAGGATAGTTAGTGAGGATTATTAACCTCTGAGCAGTGATA
SEQ ID




TAGCATAATAAAGCCCCGGGCATTATTATTATTATTTCTTTTGTTACATCTATTACAAGT
NO:




TTAGAAAAAACAAAGCAATTGTCAAAAAAAGTTAGAACTATTACAACCCCTGTTTCCTGG
2604




TACTTATCAAATACTTAGTATCATGGGGGGTTGGGAAATGAAAAGTAGGAGAAAAGTGAG




ATTTTACTAAGACCTGGTTTA





ADAMTS1
ADXCRAD_CN354195_x_at
CTGCCAGTTGCAAATTTGATAGGATAGTTAGTGAGGATTATTAACCTCTGAGCAGTGATA
SEQ ID




TAGCATAATAAAGCCCCGGGCATTATTATTATTATTTCTTTTGTTACATCTATTACAAGT
NO:




TTAGAAAAAACAAAGCAATTGTCAAAAAAAGTTAGAACTATTACAACCCCTGTTTCCTGG
2605




TACTTATCAAATACTTAGTATCATGGGGGGTTGGGAAATGAAAAGTAGGAGAAAAGTGAG




ATTTTACTAAGACCTGGTTTA





PEA15
ADXCRAD_CN347927_at
TGAACTGTCCTTCCATTTGGGATATGTTACATTAGAGTGAGAGAGAGAATAAGGAGCCTT
SEQ ID




TCTTATGGAAGAAATGGGAGAAGAGAGACAGGGTTCTTTTCAGCAGAGTCTAGTAGTTTC
NO:




TCTGTAAGGCAAAATAATCTAAAAAGACTAACCTGCCCACCCACTCCTTATATTGCTGTG
2608




AGATTGCCCCTATCTTGTGCTCTTCTGTCTGCAGTGTGCACGGCCTTGTTCTAACCC





RRBP1
ADXCRAD_CN262594_s_at
CACAGTGAAGCATCTCGAAGAGATTGTAGAGAAGCTAAAAGGAGAACTTGAAAGTTCGGA
SEQ ID




CCAGGTGAGGGAGCACACGTTGCATTTGGAGGCAGAGCTGGAAAAGCACATGGCGGCCGC
NO:





2610





MARCKS
ADXCRAD_CD103045_at
TGAGGGAGGTTTACAGCACTACAGGTCTTGAGTTAAGAAGGAAAGAGGAAAAAGAAAAAA
SEQ ID




CCCCCATACCCCGATTTAAAAAAAAAAAAAACCGATCCTTAGTCTTTAGAAGTTCCATTT
NO:




AAACCCATAGGGAACCTTTTCCCCTTAATCCTCATGGTTAAGCCTGTACCCAGTTCCAG
2612





OPTN
ADXCRAD_BQ719953_at
TTTGGCTTCATTTAAGCTGTATACTTAGTCATATATCTTTCATTAGTTCTATGGATATGA
SEQ ID




GCAGATCCCTTTACTGGAGCCCAGTATGTGCTGTGTGAGTTAGAAGTCATTCTTGCTGAG
NO:




AAGGTGAATAGGTAGGGATTTGCCTTGTTTTGTAAGTCTACAATTTGCCAAGAGTAAATA
2614




ACACTGGACCAGCTGT





LPP
ADXCRAD_CX867590_at
TCTTGATGGGCCTTTTGTCCCAGGACTTCCACATTT
SEQ ID





NO:





2618





YES1
ADXCRAD_BQ439982_at
TTCTCATTGAATGCACCTATTAATCGTTTTAGTTGCTATTCATATTCTCATTCGTTTTTT
SEQ ID




AAAAATGATATATTCCTGATTTATTCTTCCATTGAGAAAAAATGTTCAGTTACTTGTAAC
NO:




TACTGAGCAGAATTAATCAATCCCTTTATAA
2619





PHACTR2
ADXCRAD_CA390198_s_at
ATCCTTTAGTGCCTCAGAAGATGAAGGCCACAGGGAATACCAAGCCAATGACTCTGACTC
SEQ ID




GGACGGGCCTATCTTGTACACCGATGATGAGGACGAAGACGAAGATGAGGATGGCAGTGG
NO:




AGAAAGTGCTTTGGCAAGTAAAATACGCCGGAGGGATACTCTTGCTATCAAACTTGGCAA
2622




CAGACCATCTAAGAAAGAACTAGAGGACAAAAACATCTTGCAGCGTACATCTGAAGAAGA




GAGGCAGGAAATCCGACAACAAATTGGA





MARCKS
ADXCRAD_BM557039_at
AAAATAGCTTTTGAGGATTAACGCAAAAATAAAATAACTCCTTGTACCAGGTCCAGAAAT
SEQ ID




TGGCCTATTAAAACCTGAATTTGGGCAGTATTTTATAATGGGCCATTTGGCTTGTGGGTT
NO:




ACAAAA
2623





ATP2B4
ADXCRAD_BQ223439_s_at
CCCCATTCAGGTCATGGTAGAATCTACTCCTTGGTAGTCACTTGTCATTTTTANAGAAAT
SEQ ID




GATGACAATCCTCTTGGCATCACCCCACCCCACATTCTCCCCGATGGTCCTCTCCTGAAT
NO:




TCTGGATTTTGTCCTACAAGTCTGTGCCATTTATAA
2627





RRAS2
ADXCRAD_CX783318_s_at
AACGGCCAGGAAAAGCCCTCATCTTCTCTTTCTCTCCTCAGTTTACATCTTGTTGGTACC
SEQ ID




TTTCTAGCCTTAGACAAATGATCACCATGTTAGCCTTAGACCAAGAAGCTGGCTAGTCCT
NO:




TTCTGTGAAGCTAATACAATGGTCATTTCCAGACAAATTTAAAGGAAACACTAAGGCTGC
2639




TTCAAAGATTATCTGATTCCTTTAAAATATATGTCTATATACACAGACATGCTCTTTTTT




TAAGTGCTTACATTTTAATAGAGATGAATCAGTTTTGGAATCTAAGCTGTTTGCC





CCND1
ADXCRAD_BQ436873_at
AAAAATAGTATTTGCATAACCCTGAACGGTGGGGGAAGAGGGGTGTGCTACANATGATAG
SEQ ID




AGGGATTTTATACCCCAATTATCAACTCCGTTTTTATATTAATG
NO:





2640





PTRF
ADXCRAD_BI869786_at
GGTGTATCCCGGTATTTGGTGTACAAACAGTTGGTCCCATTATTGAAGTCGCACTTTTAT
SEQ ID




ATACACACATAGTACGATGTCAACCGTTGTTTTACACACCGCTGGAGATCGGGCAAAACA
NO:




CGCGAACAGACACGGGGCGAAACCTCGGGCAGAAGCGCACCCCAACATCACAGAGGGGGC
2642




TGAACACCAAGGCGCAAAACTCAACCATAAAGCGAGATTAAAGACAGACGAGGGCACAAA




GTAAAACCTGTACACGCGCCAACACGGGACACAA





WNT5A
ADXCRAD_BU627790_at
AGTGGGCTGAATATTCCTTAGGGACTCAATTAATAAGTACTGTCATTTCTAATAGGCATG
SEQ ID




GGTTTCCATTCTGCAGAATGAACTAAGAAAAGAGAAACATTGCTGATGCTTCTGAGTTTT
NO:




GAATATCTC
2645





WNT5A
ADXCRAD_BU627790_x_at
GATATGAAAGCCAACCTGCCTAAGGGGGGTATGAAAGATGTGTATCTTTCCAAACTTTTA
SEQ ID




AAACAACGTAAGTCTGAGATAAGAACATATTTGATGGCACTGTTTGGAAAGAGGTGTCCT
NO:




TATTAAAAAAAAAAAAAAAAAAAAAGCTATCTATGTAGTGGGCTGAATATTCCTTAGGGA
2646




CTCAATTAATAAGTACTGTCATTTCTAATAGGCATGGGTTTCCATTCTGCAGAATGAACT




AAGAAAAGAGAAACATTGCTGATGCTTCTGAGTTTTGAATAT





KIF2C
ADXCRAD_CV804054_at
GCAGCCTGAAAAGCAGGCTAGCAGACAAATAAACAGCAAGAAAACGGCCCCATTGACGAC
SEQ ID




TGGCAATAAAAAT
NO:





2651





KIF2C
ADXCRAD_CV804054_s_at
CTGGAGACCTTTGTGAACAAAGCGGAATCTGCTCTGGCCCAGCAAGCCAAGCATTTCTCA
SEQ ID




GCCCTGCGAGATGTCATCAAGGC
NO:





2652





COL4A2
ADXCRAD_BM546367_at
CCTGGAAGGCCACAAGCTTAACCACTTTCGCACAAACCCCATGTTAACCACTGGCNACTT
SEQ ID




TTCCAATGGCCACAGAACCAACTCACCATTGGTTCA
NO:





2656





COL4A2
ADXCRAD_BM546367_x_at
TGGAAGGCCACAAGCTTAACCACTTTCGCACAAACCCCATGTTAACCACTGGCNACTTTT
SEQ ID




CCAATGGCCACAGAACCAACTCACCATTGGTTCA
NO:





2657





IL6ST
ADXCRAD_BQ887381_at
AGGGATTTTTACCACATGAAAGTCATTCCAGTGGACCCTAACCTCCTTATTGGTGGAAGG
SEQ ID




TTAGTG
NO:





2658





IL6ST
ADXCRAD_BQ887381_s_at
TTTTACTATGGATCAGTCGGCACTCGGGAACAGCAGCAAGGAAAAAAAGCAAATTTCATT
SEQ ID




CACATGTTC
NO:





2659





IL6ST
ADXCRAD_BQ887381_x_at
TTTTACTATGGATCAGTCGGCACTCGGGAACAGCAGCAAGGAAAAAAAGCAAATTTCATT
SEQ ID




CACATGTTCTGGGTTCATACCTCTTCTCTACCTAATTGGTCATTTTAAATTTCCAGCCTT
NO:




ATTCCCTGGATAAGGGATTTTTACCACATGAAAGTCATTCCAGTGGACCCTAACCTCCTT
2660




ATTGGTGGAAGGTTAGTG





RRAS2
ADXCRAD_BU929840_at
GTATTCCCTGCTAGATATTGATTGTTATTTCAAGTATTAAGTGTAAGCTTTTAATGGATA
SEQ ID




ATTAGTATAACTGTGGATGGCATCTGATTTTGTTTTTAATTCTGTGGATTGTGTTTAAGC
NO:




AATTCAATAGTATGTTCCTGATTTTGAGATGCTAAGTGGTATTGCACAGTTGTCACTTTA
2662




TCAAGTGTGTACAACAGTCCCATGAAGTTTATAGAGCATACCCTTGTATAGCTTCAGGTG




CTAGA





PRNP
ADXCRAD_CX762421_at
ATAACATTGGTTATCTGGACTATTTTGGACTAGTGCACAGGTGAGCTAAACAATCTAGAC
SEQ ID




ATCTGAATACTTGCTGGATCTCTGCTCTCACACTAAGTCATACTATGCTACTATAAATCA
NO:




ACTATAAGAATCATTAGAACGAACTCGCAG
2673





PRNP
ADXCRAD_CX762421_s_at
CTCTTTGTCCCGGATAGGCTAATCAATACCCTTGGCACTGATGGGCACTGGAAAACATAG
SEQ ID




AGTAGACCTGAGATGCTGGTCAAGCCCCCTTTGATTGAGTTCATCATGAGCCGTTGCTAA
NO:




TGCCAGGCCAGTAAAAGTATAACA
2674





SPTBN1
ADXCRAD_AW028717_at
CTTGCCTTAAAGCAGCATACTTATTTTTTGTTTATTTATTGTGAGCTTTNTACTTTATTA
SEQ ID




AGATTNTACAGCGAAACCCTTACATGAGTAATTGAAATG
NO:





2675





SPTBN1
ADXCRAD_AW028717_s_at
TGAAGTTCACTACCATTTGTCAAGAATCACCCTTTCCAAATCCTCTGGGTTTTGACTTTT
SEQ ID




TGGCTTCCACTTCACCCAAAATGTTAAAATTTTTACTTAATTCATAGCCTTCCTTGGTTT
NO:




CATATTTGTTTGCATTTAATTCATGTTTGAGTCTCTTAACTGATGGATGCCCACTTGCCT
2676




TAAAGCAG





SYNJ2
ADXCRAD_BF875753_at
TCATAGGGAGAAGAGCGCTGCTTGTGGCAGGGTGGCGTGTGGCTGTCATTAAAGTGCGTT
SEQ ID




CCTTTAATGAGCGCTCAGGGCTCCCAGGGGCCTGCTGCTATGCCATGGGGTGGGGCTGCC
NO:




AGCAGGGCAGGGGGTTGATCCCATCACATCTCCCCAGACACATCCTCAGGAAACCACCTC
2677




AAAACCACCTAAGAACAAAGGAAGTTATCACACTGGGGACAGGGACACGGGTCAGAGTTC




AGCTACGCTGGAATGGAA





SYNJ2
ADXCRAD_BF875753_x_at
TTTCCTCACCACACTTCATAGGGAGAAGAGCGCTGCTTGTGGCAGGGTGGCGTGTGGCTG
SEQ ID




TCATTAAAGTGCGTTCCTTTAATGAGCGCTCAGGGCTCCCAGGGGCCTGCTGCTATGCCA
NO:




TGGGGTGGGGCTGCCAGCAGGGCAGGGGGTTGATCCCATCACATCTCCCCAGACACATCC
2678




TCAGGAAACCACCTCAAAACCACCTAAGAACAAAGGAAGTTATCACACTGGGGACAGGGA




CACGGGTCAGAGTTCAGCTACGCTGGAATGGAA





MAP7D1
ADXCRAD_BU178034_x_at
GTAAATAGCTTGTGCTCAGACTCCTCTGCGTGGAGAAGGTGGGTGCANGAGGCAGACCCT
SEQ ID




CCCCCCAAAGCCCCCTGGGGAGATCTTCCTCTCTCTATTTAACTGTAACTGAGGGGGGAT
NO:




CCCCAGGTCTGGGGGATGGGGGACAACCTTGGGGCCACAGGATACTGGGTTTGCTTCAGG
2681




GGGTACCCATGGCCCCCCTGCCCTCGGCCTGGGAATCAGTGGNTACTGGCATCTGAATTA




AAATGTTCTTCCCCGA





LRP12
ADXCRAD_BP262656_s_at
AAACGAAACGAGTGATGATGAGGCTTTGTTACTTTGTTAGGTACGAATCACATAAGGGAG
SEQ ID




ATTGTATACAAGTTGGAGCAATATCCATTTATT
NO:





2687





PHACTR2
ADXCRAD_AV721683_at
TATTAGAAAAGTTGAATCGCATGACTACATTTATACAGGGGAAATTCAAGCATTTGTGTG
SEQ ID




TGAATTAAATGCTTCGTTAATAGGATAAGCAGGTGATTCATTTGGAACTTATGGGATGCA
NO:




GCATAACCAGGTGAAATCTAATGGTGATTTATTTCCAAAGACCACCAGGTTTGTTCAAGT
2690




GCATTGCTAGTCTGTGTTTGTGTTTAACCCATGCAACAATCCTCATGACAGTAACAAGGA




TTATGACCAAT





CORO1C
ADXCRAD_BU181829_at
GGTATTTGCCCTGGGGGGATCCTGATACCCTGGGCTG
SEQ ID





NO:





2692





PHACTR2
ADXCRAD_CN369598_at
AAAAGGTCCAGTTTTACAGCCTGCAATTAATTCAGGGCTGCGTTGGCATTAAAAAAGAAA
SEQ ID




ATATATATATATATATATATATATATATATATATATATGTATATTATATATACAGTAGCT
NO:




TACACTTAAAAGAGGAAAAATTTGCATTAACATTGCATATTCTGATATGTACCATATTAA
2693




CACATAACAGGCATTTTATTTATGCTTCATAGAATCAGACAGACACAACTTTCAAAA





JUN
ADXCRAD_NM_002228_s_at
CAGCCCACTGAGAAGTCAAACATTTCAAAGTTTGGATTGTATCAAGTGGCATGTGCTGTG
SEQ ID




ACCATTTATAATGTTAGTAGAAATTTTACAATAGGTGCTTATTCTCAAAGCAGGAATTGG
NO:




TGGCAGATTTTACAAAAGATGTATCCTTCCAATTTGGAATCTTCTCTTTGACAATTCCTA
2694




GATAAAAAGATGGCCTTTGCTTATGAATATTTATAACAGCATTCTTGTCACAATAAATGT





LOXL2
ADXCRAD_BI825165_at
GGAATAACAAGAAAGATCTATGAACAGAACACAAACAAACACAGCAAGCTAACAAAA
SEQ ID





NO:





2695





CASK
ADXCRAD_CX786970_at
TGGTCCCTAGAGACTACCTAGTTGTAGTGTGACCTACATTTATAATTATTGTCATGTCCG
SEQ ID




AATAGATAGGAGGAGAAAAACAATTACACACTAATTTAAAGAGACAGTATCTTTTTTAAT
NO:




CAGTTCTCCTAAACTTTAATAAAATGTATCTTTAAATGTATGTATTATTCAATCCTTTGG
2696




AATGTTATATTTTTGGAAATCATAGCTTTTTA





MGAT1
ADXCRAD_BP302925_at
AAAATCAGTGCCCTCCCTGTTGCTCTAGGAGGCTCCTGCTGGCTTGGTAGAAGACAGAAT
SEQ ID




TCGATCTGCCTGTCCCTTTTTCCCCTGGGGTTTGACACACAGGCTCCTCTCAGCATGAGG
NO:




TGGAGCAGTGACCAGGTGGAGCAGTGACCAGGACGCCTCTGGCCCAGTGCTGCCCAGCCT
2697




CCCCGCCCGCTCCCAGGCGCCCCATGTCCTCACAGGCCAGGACGCCATGGCAGGATGGAG




AGGACTTGGTGGATTTTT





MGAT1
ADXCRAD_BP302925_x_at
AAAATCAGTGCCCTCCCTGTTGCTCTAGGAGGCTCCTGCTGGCTTGGTAGAAGACAGAAT
SEQ ID




TCGATCTGCCTGTCCCTTTTTCCCCTGGGGTTTGACACACAGGCTCCTCTCAGCATGAGG
NO:




TGGAGCAGTGACCAGGTGGAGCAGTGACCAGGACGCCTCTGGCCCAGTGCTGCCCAGCCT
2698




CCCCGCCCGCTCCCAGGCGCCCCATGTCCTCACAGGCCAGGACGCCATGGCAGGATGGAG




AGGACTTGGTGGATTTTTGTTTCTTGCCTGACCTCAGTTTCATGAAAGAA





AMOTL2
ADXCRAD_BU580920_at
GTGTCTGTATGTTTAAGTTATCGTAAATATTTAAAATGTAAACATGGCTGTTTTGTTATG
SEQ ID




CCACCCTGTACCAGGATTG
NO:





2699





AMOTL2
ADXCRAD_BU580920_x_at
TTAAAGTATTTTTTGTGCTGTGAACATTTTCTGCCAAAGACCATGATGTGTGTCTGTATG
SEQ ID




TTTAAGTTATCGTAAATATTTAAAATGTAAACATGGCTGTTTTGTTATGCCACCCTGTAC
NO:




CAGGATTGCTG
2700





HK1
ADXCRAD_BG675101_at
AAAAATAGAGGCTCACCCCAGTCTCGTCGGCAACAGGGGGGCCCCCAAAGAGGAGGGCAT
SEQ ID




ATATAGACGCCACGCGAGCGGCGGCTATAAACCACACGCTGCAGGGGGAAACACGCCGCA
NO:




CCTAGCGCCCTGGGGAAGACGCCCATACATGAGGGCGGGGCCACACGTGGGACACACACT
2702




CACCGAAAATTAGCGCCGGGGGAACAACAATGCGGGGTAGCGGGCAACACAGCGGAGGGC




GCGGGAAGAAATGCCACGGGCATATGAGCCATAACCG





PYGL
ADXCRAD_BQ933107_at
TTGGTTTTGTAAGCTAACAAATCTATAATAATTTGAGTATCCCCGGGGAATG
SEQ ID





NO:





2703





PDLIM7
ADXCRAD_CN298673_at
ATCAACCTGGAAGGAAAGACCTTCTACTCCAAGAAGGACAGGCCTCTCTGCAAGAGCCAT
SEQ ID




GCCTTCTCTCATGTGTGAGCCCCTTCTGCCCACAGCTGCCGCGGTGGCCCCTAGCCTGAG
NO:




GGGCCTGGAGTCGTGGCCCTGCATTTCTGGGTAGGGCTGGCAATGGTTGCCTTA
2706





CDH11
ADXCRAD_CX866982_s_at
GGGTCCCTGAGCTCCCTAGAGTCGGCCACCACAGATTCAGACTTGGACTATGATTATCTA
SEQ ID




CAGAACTGGGGACCTCGTTTTAAGAAACTAGCAGATTTGTATGGTTCCAAAGACACTTTT
NO:




GATGACGATTCTTAACAATAACGATACAAATTTGGCCTTAAGAACTGTGTCTGGCGTTCT
2709




CAAGAATCTAGAA





TUBB3
ADXCRAD_CN295380_at
GGGCCCCAAGTGAAGCTGCTCGCAGCTGGAGTGAGAGGCAGGTGGCGGCCGGGGCCGAAG
SEQ ID




CCAGCAGTGTCTAAACCCCCGGAGCCATCTTGCTGCCGACACCCTGCTTTCCCCTCGCCC
NO:




TAGGGCTCCCTTGCCGCCCTCCTGCAGTATTTATGGCCTCGTCCTCCCCACCTAGGCCAC
2710




GTGTGAGCTGCTCCTGTCTCTGTCTTATTGCAGCTCCAGGCCTGACGTTTTACGGTTTTG




TTTTTTACTGGTTTGTGTTTATATTTTCGGGGATACTTAATAAATCTATTGCTGTCAGA





NT5E
ADXCRAD_BG611920_at
TAAAAATTGGACAGATTAGCCCAAAAAAAGACACAATCACAACAAACAAAACAAAAACTA
SEQ ID




TTGTTGGCGGCACTGTGCGCCCCAAAGAAACTCTGTAAAACACCTAGCGGTTAGGCACAG
NO:




CGGCCCCATAGGAAAGCGAACATGTGCAAACATGTCCCCAGAAAAACCCGGAACAAAAAA
2714




ACGGCGCGGAAACGCACCCAAAAAACACGCCCGGGGAACCGCGGTTTTGGACAAACCAGA




GACATCACAACAAAA





LIF
ADXCRAD_BU175373_at
GCACATGGGCCTTGGGGTGACAAATTCCCTCCTTTGGATGAATGTACCCCTGGGGGGGAT
SEQ ID




GGTTTCATACTGGAAGGATTAATTTTTTATTTCATTCCCATGGGCCATAATTCTAAAAAT
NO:





2715





LIF
ADXCRAD_BU175373_x_at
TTTCCACTGAAAAGCACATGGGCCTTGGGGTGACAAATTCCCTCCTTTGGATGAATGTAC
SEQ ID




CCCTGGGGGGGATGGTTTCATACTGGAAGGATTAATTTTTTATTTCATTCCCATGGGCCA
NO:




TAATTCTAAAAAT
2716





JUN
ADXCRAD_AJ712294_s_at
AGGAAGCGCATGAGGAACCGCATCGCTGCCTCCAAGTGCCGAAAAAGGAAGCTGGAGAGA
SEQ ID




ATCGCCCGGCTGGAGGAAAAAGTGAAAACCTTGAAAGCTCAGAACTCGGAGCTGGCGTCC
NO:




ACGGCCAACATGCTCAGGGAACAGGTGGCACAGCTTAAACAGAAAGTCATGAACCACGTT
2719




AACAGTGGGTGCCAACTCATGCTAACGCAGCAGTTGCAAACATTTTGA





TGFBR2
ADXCRAD_BI334991_at
TGTACTCATGTTTTACCAACTCCGGAATGTGAATGCTATAATACTCTTTTTATATCACAA
SEQ ID




AGGTCCTCAAGCACTTTATTTCTATTCTAATGCATTGGTGTGTCCTTTTACCATTAACTC
NO:




ACAACTGTTTCCTCCAGACTGGATTACAGCAAATACTCCTGGGTCAAAACAAA
2720





LAMB3
ADXCRAD_CB122452_s_at
TACTATGCCACCTGCAAGTGATGCTACAGCTTCCAGCCCGTTGCCCCACTCATCTGCCGC
SEQ ID




CTTTGCTTTTGGTTGGGGGCAGATTGGGTTGGAATGCTTTCCATCTCCAGGAGACTTTCA
NO:




TGTAGCCTAAAGTACAGCCTGGACCACCCCTGGTGTGTAGCTAGTAAGATTACCCTGAGC
2721




TGCAGCTGAGCCTGAGCCAATGGGACAGTTACACTTGACAGACAAAGATGGTGGAGATTG




GCATGCCATTGAAACTAAGAGCTCTCAAGTCAAGGAA





YWHAZ
ADXCRAD_CX870884_at
TCTATTATGAGATTCTGAACTCCCCAGAGAAAGCCTGCTCTCTTGCAAAGACAGCTTTTG
SEQ ID




ATGAAGCCATTGCTGAACTTGATACATTAAGTGAAGAGTCATACAAAGACAGCACGCTAA
NO:




TAATGCAATTACTGAGAGACAACTTGACATTGTGGACATCGGATACCCAAGGAGACGAAG
2722




CTGAAGCAGGAGAAGGAGGGGAAAATTAACCGGCCTTCCAACTTTTGTCTGCCTCATTCT




AAAATTTACACAGTAGACCATTTGTCATCCATGCTGTCCCACAAATAGTTTT





GATA6
ADXCRAD_BX384651_s_at
AAATTGCCTTTCTCTATTTGTTAAGAATTTTTATACAAGAACACCAATATACCCCCTTTA
SEQ ID




TTTTACTGTGGAATATGTGCTGGAAAAATTGCAACAACACTTTACTACCTAACGGATAGC
NO:




ATTTGTAAATACTCTAGGTATCTGTAAACACTCTGATGAAGTCTGTATAGTGTGACTAAC
2725




CCACAGGCAGGTTGGTTTACATTAATTTTTTTTTTTGAATGGGATGTCCTATGGAAACCT




ATTTCACCAGAGTTT





NFIB
ADXCRAD_BQ672667_at
AGTTCAGGCCTCTGGGATCAACCCCAGACTGGGCCAGAATGTTAGTGAAGGTTTTATTGT
SEQ ID




GCCCGGTTGGAGGATAACGTTCTTTGGGTACTTTTTGTGGGTTGCAAATGAACTCAATTG
NO:




CCACAAGTTTTAAACTGGTGTAAATCAAGCTTGACTTAATGTGATTGTTACTGTTATATC
2727




CAGCCTATACTGCTAGCAGCTGCTCATACTGCAGTCAATTACTGGAAGCGGATATATTTC




CTATGCAAAA





ZFP36L1
ADXCRAD_CX782083_at
TCCCGGAGCCTCTGCCCATGGCGGGGTGGAGACCCGGAACCAGCAGCCCCCTCCACTGGC
SEQ ID




GACACAACTGCACCTTCCCTCATTTCAGTCTCCCGCACACTTATTCCTCCTCCCCTCTTC
NO:




CCGGTGGCACCTCTCCACCT
2731





ZFP36L1
ADXCRAD_CX782083_s_at
TTCTTCCCGATCTGAACCCCTGTTGACTAATCTTGCCTGGGTTTGTGTAGGTCTGCAGGA
SEQ ID




AGGA
NO:





2732





COL4A1
ADXCRAD_CX761316_s_at
AGCCGCTGCCAAGTCTGTATGAGAAGAACATAATGAAGCCTGACTCAGCTAATGTCACAA
SEQ ID




CATGGTGCTACTTCTTCTTCTTTTTGTTAACAGCAACGAACCCTAGAAATATATCCTGTG
NO:




TACCTCACTGTCCAATATGAAAACCGTAAAGTGCCTTATAGGAATTTGCGTAACTAACAC
2733




ACCCTGCTTCATTGACCTCTACTTGCTGAAGGAGAAAAAGACAGCGATAAGCTTTTCATA




GTGGCATACCAAATGGCACTTTTGA





LDLR
ADXCRAD_BX113541_x_at
AACTCAGCTGGACTTTTCTTGCTTTAATAACAGCTTTATTGAGATACAATTCACATATCA
SEQ ID




CGAAATTCTTTTTAAAAATTTTACAGTTCAGGCCGGGCGCGGTGGCTCATGCCTGTAATC
NO:




CCAACACTTTGGGAGGCTGAGGCTGGCGGGTCACCTGANGTCAGGAGTTCGAGACCAGCT
2735




TGGCCAGCATGGCAAAATCCCGTCTCCACTA





ACTN1
ADXCRAD_BM714793_at
AAGAGAATTTATGTGGCTTCTCATTTTTAAATCCCCTCAGAGGTGTGACTAGTCTCTTTA
SEQ ID




TCAGCACACACTTAAAAAATTTTTAATATTGTCTATTAAAAATAGGACAAACTTGGAGAG
NO:




TATGGACAACTTTGATATTGCTTGGCACAGATGGTATTAAAAAA
2737





RYBP
ADXCRAD_BU151619_at
AAGGTTATCAACCACACATCCAGTCCTGACATGGAGCTTTTCAGTGTTTGGAGACATTTC
SEQ ID




TCAATCCCCTGCTGTGGTAGGAACTCCAGTGGTGAACGGCTTGCGCGCCTGCAGCCAGAG
NO:




TTGCAGGGAAAGCTCGTACTTACTGCGAGCAGCATGTAATCTTTTTTCTTCCTGGACATA
2738




AAGATAGCTTGAGTAAACTGTTCTATTTCATTCTCTTCACTCTTTTTACTGTCTTGCAAA




AA





TRAM2
ADXCRAD_BM700086_s_at
AGGCTGTGTCATTGGCAGGGCTTCACATGCAGGAGGCCTCTCTCAGGTGAGTCCAGGTTA
SEQ ID




AACTGTTGAGTTGTGGCTTCAACAGATATGTATGGCATGCTGGGATGTGCCAGGTGCCTG
NO:




CGTTGTGCCAGTTGCTGGAGAGGTAGTGTGAGCAGAGCAGCTGAAATCTTGCCATCAAGC
2739




AACCCTCATTCTCATGCCTGTAGGTTTCCATTGCTCTGTCCCAGGACACTTGCGTGCCAG




AGACGCCACAACTTCATGTCCCTGTCTCTTGCAA





CDC14B
ADXCRAD_AW021718_at
AGACTTTTATCTAACCTGCACTCATGTACAGATTATTAAAAGTTTTAAAATGTAACTGAT
SEQ ID




CAGTATTGATCAATCATTGTCTTGATT
NO:





2742





SEC61A1
ADXCRAD_BQ711397_at
TCCTGGCACTGGCAAAAAGAACTGTGAAAGTGAAATTTTATTCAGCCGACTGCCCAAAAA
SEQ ID




GTGGGAAATGGGAATAGGATTGTCCCCCAGTGTCCATGGTAACTTTTGTTTTAACCTTTG
NO:




CACCTTCTCAGTGGCTGTATGGCGGCTGCAACCGGCCTCACCTGTTTTCCCCCCAAAGGG
2746




GATTTCTCCACCTCTTGGTTGGAAACACCAA





CRIM1
ADXCRAD_C16716_s_at
CTTCTAGCCGTCAAACTCTGATCGACTTACACTTAAGACTGTGTCTTTGGTAGCCTACCC
SEQ ID




TATTCCACTTTTATTACAAAGGCAGCTCTTAAGACATAAATCCATCTCTTCAGGCTCGAA
NO:




CTGCAAAACACACGTCGAGAGGTGACAATGTTGGGACTGTCAAAAAGAACTTAAAGAGTG
2751




GGATAACCAGCCGGGC





CASK
ADXCRAD_BP254716_at
TCCTCAGGAGCAGTCTCACAGGTGCTGGACAGCCTGGAAGAGATTCATGCGCTTACAGAC
SEQ ID




TGCAGTGAAAAGGACCTGGATTTTCTACACAGTGTTTTCCAGGATCAGCATCTTCACACA
NO:




CTACTAGATCTGTATGACAAAATTAACACAAAGTCTTCACCACAAATCAGGAATCCTCCA
2753




AGCGATGCAGTACAGAGAGCCAAAGAGGTATTGGAAGAAATTTCATGTTACCCTGAGAAT





ADAM9
ADXCRAD_NM_001005845_at
TTTGTGTCTCCTAGTAGCTTCCTACTCAACTATTTATAATCTCATTAATTAAAAAGTTAT
SEQ ID




AATTTTAGATAAAAATTCTAGTCAAATTTTTACAGATATTATCTCACTAATTTTCAGACT
NO:




TTTGCCAAAGTGTGCACAATGGCTTTTTGTTAATAAAGAACAGATTAGTTTTGAAGAAGG
2758




CA





ADAM9
ADXCRAD_NM_001005845_x_at
TACTTGAAATTCTCTTTTGTGTCTCCTAGTAGCTTCCTACTCAACTATTTATAATCTCAT
SEQ ID




TAATTAAAAAGTTATAATTTTAGATAAAAATTCTAGTCAAATTTTTACAGATATTATCTC
NO:




ACTAATTTTCAGACTTTTGCCAAAGTGTGCACAATGGCTTTTTGTTAATAAAGAACAGAT
2759




TAGTTTTGAAGAAGGCAAAAATTTCAGTTTTCTGAAGACAGCATGTTAT





PHACTR2
ADXCRAD_NM_014721_at
TAACCACAAGACCTCTCTATAATGGTAAATGTAAGACATCACCATTTTATCACTCAAAGT
SEQ ID




ATGTTATTGAAAGTTTCTATTTGGTTGATAAAAGGAACAATTTTTTCCCACTTTTGATGC
NO:




CTGTGATGCAATTTTTTATTGCCTACAATGAGATACACTTAGTACAAAAAATGAAAATCT
2761




GGTATTTCAAAATTGCATTTCTTGTATAATAGGTCAGATTTATTAACTACTCATACTTTT




TCTTTACACTAATCGATACATTTA





PHACTR2
ADXCRAD_NM_014721_x_at
TAACCACAAGACCTCTCTATAATGGTAAATGTAAGACATCACCATTTTATCACTCAAAGT
SEQ ID




ATGTTATTGAAAGTTTCTATTTGGTTGATAAAAGGAACAATTTTTTCCCACTTTTGATGC
NO:




CTGTGATGCAATTTTTTATTGCCTACAATGAGATACACTTAGTACAAAAAATGAAAATCT
2762




GGTATTTCAAAATTGCATTTCTTGTATAATAGGTCAGATTTATTAACTACTCATACTTTT




TCTTTACACTAATCG





EGFR
ADXCRAD_NM_201283_at
ATCACAGGTTTGAGCTGAATTATCACATGAATATAAATGGGAAATCAGTGTTTTAGAGAG
SEQ ID




AGAACTTTTCGACATATTTCCTG
NO:





2765





EGFR
ADXCRAD_NM_201283_s_at
AATGCTACGAATATTAAACACTTCAAAAACTGCACCTCCATCAGTGGCGATCTCCACATC
SEQ ID




CTGCCGGTGGCATTTAGGGGTGACTCCTTCACACATACTCCTCCTCTGGATCCACAGGAA
NO:




CTGGATATTCTGAAAACCGTAAAGGAAATCACAG
2766





ULK2
ADXCRAD_NM_014683_at
AAGTGATTGGCCTAAAGTCAGGAACTAGGCAAGTGGTCAAGCCATGCTTTGTGACTTTCA
SEQ ID




AGTTAATTCTTCTTGTTCTTGTATATTAAAGGTCTTGGGGTAGATGGTGTGTGTGAAACA
NO:




GTGAAGTCTCAACAGCAGAAAAGAACAAAATGTAAATTCATGAATAATGGTTCTGGTTAT
2771




ACTTCCATTATCAAGGCTAATTAAGAGATTTTGCCTTGAGTATAGCAATAATAAACAAAT




GCTTTATGTTTCCCT





NT5E
ADXCRAD_BC015940_at
TTCTTTACACAGGTAATTGTTTCAAAAGGATTGCATGGGCCAGGATGTCCAGATAAGCAC
SEQ ID




TGTGTCTCTTTTGCCTTTGTAACTGTTATTACTCTTTTTACTGCTATTTAATATGTAATG
NO:




TATATTATATGATCTATAATATATATGTAATATACATTAAATGGGAACATGTGCAAATCT
2778




TACAAAA





LPP
ADXCRAD_AL833171_at
TTGGCCTATTCTGGACTGCAAATAGCATTGCCAAGCACTTCCCTTAAATAACTTCTCTTT
SEQ ID




TTTGCAGGACTATCCTCTCAGCCCTGCCAAAACCCCATCACCTACTCTTTCTTTACTACT
NO:




TTGCCTATTTAATGCTGGAATTTTTATTTAAACTGTAGCTGATTTACTGAAGGTAATTAA
2784




GTGCTTTCATGCTGTAGATCTCCTGCTAGACTACAGGCTGTACTTGGGAGTGAGAGTGAA




CCAAATGTAA





CRIM1
ADXCRAD_BC016339_s_at
AAGAATCTTCACTTGGGTGCAGCCTGTTATCTCTGTAATCTACCTGGAGGTGACCCATAT
SEQ ID




CTAGGAGAAAAAAAATTATAAGCATTTATTACCTAAACCAGAATTGTTAAGGATTATTTT
NO:




AATGACATTGCAAATAGAGATCAGCAACTTGGTTTTATTGCTTCCCAGTTTTTTGAGGCT
2786




AAAAATGTGATTAAAATCTAATGTTGATCCAAAGAGCTCTTAGTAGAGAGCAGAGCGCTT




A





ZNF264
ADXCRAD_AL832061_x_at
AGGCATGATGGCAGGCACCTCTAATCCCAGCTACTCAGGAAGCTGAGGCATGAGAATCGC
SEQ ID




TTGAACCCAGGAGGTGGAGGTTGCAGTGAGCTGACAGCGTGCCACTCTACTCCAGCCTTG
NO:




GTGATAGAGTGAGACTCCA
2787





LDLR
ADXCRAD_BC021296_s_at
GTCCCTGCTGTTTAGATGTCGTGTTGTAGGAGCCTGTTGCTCAGCCTCCCGAGTAGCTGG
SEQ ID




GATTACAGGTGCCTGCCACCACACCCAGCTAACGTCTCTACTAAAAATACAAAAAATTAG
NO:




CCGGGCGTGGTGGCGGGCACCTGTAGTCCCAGCTACTCGGGAGGCCGAGGCAGGAGAATG
2788




GTGTGAACCCGGGAGGCGGAGCTTGCCGTCAGCCAAGATAGCGCCACTGCATTCCCGCAG




CGAAAGAGCGAGAC





MDFIC
ADXCRAD_BC040713_at
TTCAGCAGATCCAGGACTGCCGCAGCTCTCTGAACAAGCGTGCACTTACTCCATTTCATC
SEQ ID




TT
NO:





2789





MDFIC
ADXCRAD_BC040713_s_at
CTGTTTCTTGTTGGCTCCTCTACCACCCGGTTGATAATTCAGGTTTCTGTGACCAGTAGC
SEQ ID




TTTGGAATGGCTTATGCTTGTTTTCA
NO:





2790





MDFIC
ADXCRAD_BC040713_x_at
ACAGCCCAGGGTCTCTTCAGCAGATCCAGGACTGCCGCAGCTCTCTGAACAAGCGTGCAC
SEQ ID




TTACTCCATTTCATCTTTCTGTTTCTTGTTGGCTCCTCTACCACCCGGTTGATAATTCAG
NO:




GTTTCTGTGACCAGTAGCTTTGGAATGGCTTATGCTTGTTTTCAAT
2791





PLAUR
ADXCRAD_AF087989_at
TTAGCTGGGCATCAGGCATCGTGCACAATCCTGTACTCCCGGCTACTTGTGAGGCCGAGG
SEQ ID




TAGGAGGATTGTTTGAGCCTGGGAGGTCAAGGCTGCAGTAAGCTATGATTGCACCACTGC
NO:




ATCCTGGTTGACAGAGCAAGATTCTGTAAGTAAGTAAATAAAATAAATAAATAAATAAAT
2792




AAATATAGCAAGCTGGTTTGGAGTGAGGAATATTAA





PLAUR
ADXCRAD_AF087989_x_at
TTAGCTGGGCATCAGGCATCGTGCACAATCCTGTACTCCCGGCTACTTGTGAGGCCGAGG
SEQ ID




TAGGAGGATTGTTTGAGCCTGGGAGGTCAAGGCTGCAGTAAGCTATGATTGCACCACTGC
NO:




ATCCTGGTTGACAGAGCAAGATTCTGTAAGTAAGTAAATAAAATAAATAAATAAATAAAT
2793




AAATATAGCAAGCTGGTTTGGAGTGAGGAATAT





CAST
ADXCRAD_AK026822_at
TGGCCCACACATCAAAGTCCTCGAGTTTAGGACTGAAGAAAAGTCTGCTTTTGTAGAAAA
SEQ ID




TGTGTATGCTTCATGTTCTCTTTTACCAGACAATGAGAATAACTCATACTGATTCCTCAT
NO:




TTTTCCTTGACTTCCAGGAATGTCTGTGATAAATTCAGGGGACAATTGCGAGAATTATCC
2794




TCAGCCATAAGTCCCTCACATGGTTATCACCTGTCCATTATGTATCTTTTTGTCCTTCAT




TTTAACATTTCTTTTATACATGGATCTTA





ZNF264
ADXCRAD_AL833343_x_at
TTGAAGTGAACTGAGATCTCGCCACTGCACTCCAGCCTGGGTAACAGAGCTACTCTGTCT
SEQ ID




CAACAACAACAACA
NO:





2796





WNT5A
ADXCRAD_NM_003392_s_at
CAGATTGTTCCTTTTTAGTGACTCATGTTTATGAAGAGAGTTGAGTTTAACAATCCTAGC
SEQ ID




TTTTAAAAGAAACTATTTAATGTAAAATATTCTACATGTCATTCAGATATTATGTATATC
NO:




TTCTAGCCTTTATTCTGTACTTTTAATGTACATATTTCTGTCTTGCGTGATTTGTATATT
2804




TCACTGGTT





SEPT7
ADXCRAD_AI831470_at
ATTAAGTTTATCCTTTTCTCCATCTTTTCTTTCTTGCCACCTAATGAAGGAAATGTCTCC
SEQ ID




AAGGTCTTTTTGACTAATAGAAACTAAATGTATAACTCGACATCTAGAAGGGTTTCAAGA
NO:




TAGTAGATATGTCTGCTGGGATGTTTTGTCATTACCCTGCCCAATGTTGCGACGCTAGGA
2805




GTTTCCTTGACACTACATTATAAATAAGGCCCAACCTGTTAGCAAAAATATCACATTCCC




TAATTTTCTCTCCTTTAACTGTGTGTAATTTATCCAGGCATGTCTTTAGTTCAG





BCL6
ADXCRAD_AW264036_at
AGGATCGCTGCCTGCGCTGCGCTGGCCGCCGGGGATTCACCCGGGGAGGCGGGGCCGCTG
SEQ ID




GGGAAGGCTCGCGGGGAATACAGCACACTTTCCCCTAAATCCCTCGTCCGCGCCGAGTGC
NO:




AGGGCTCTCAGAGTTCACCTAGTCCCACCTCTCACCCACAACAGTTTATAAATGGGGAAG
2806




GTCAGACAAGTTAGTAGCAGAGCTGGGTCTAGAACCCAGGAGTTCGAATACAATCCGAGG




CTCATATCGAGACTTTAAGTTGTCCGATTCCGAAGTTTATTTGCT





AURKA
ADXCRAD_NM_003158_at
GTTAAGGCACACCTGCTGAGTAAAACAAATATTTCTTGTGTAGCGTTCTTAGGAATCTGG
SEQ ID




TGTCTGTCCGGCCCCGGTAGGCCTGTTGGGTTTCTAGTCCTCCTTACCATCATCTCCATA
NO:




TGAGAGTGTGAAAATAGGAACACGTGCTCTACCTCCATTTAGGGATTTGCTTGGGATACA
2810




GAAGAGGCCATGTGTCTCAGAGCTGTTAAGGGCTTATTTTTTTAAAACATTGGAGTCATA




GCATGTGTGTAAACTT





EGFR
ADXCRAD_AA678124_at
AGCTGGACGCCTCTCTGACAATTGTGGCTCTGGTGGTGAACCCCTCGGTGTCTCTTCTGC
SEQ ID




ACCTCTCAAGGCTGCAAAGTGCCAAATACTCTTTTCCAACCAGCTCCCGAATTCCCCCCT
NO:




CCATCTGGGACTGCATGTCCTGCTTAGCGATTTCAAGCAATGATTTCACCTTTTCATAGA
2813




CAAGGACATTGTCTCATCAGGGCTTGACCATCACTCTGATTTCCAATGCTGACAGCCAAG




TGGAGGTTT





NR3C1
ADXCRAD_AI934556_at
GATGAATGTGCGCTTTGGAAATGTTTAAATAGATATGAAATGATTAAATAAAATCACAGT
SEQ ID




CTTGTGCAACATCCATAGCTTACAGTTATTTGGCAACTATGAAACCACAGTTACTAATGG
NO:




AATTAAGACTTTNTAAAAAATTGCAAATGTACTTATTTGTATATGAAAGAGGTATTCAGC
2815




TATTAACTCAGTATTTAATAAACATTGATATGTAATTTTTACTTGAAATGGCCTAAGGTT




TATAATACCAACTAGTTCATAGAGCTTTTTT





ACTN1
ADXCRAD_M95178_at
GACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAAATTGCGCTGAAT
SEQ ID




CGTATGCTTTTTCC
NO:





2816





ACTN1
ADXCRAD_M95178_x_at
GTGCGCCGTGCCCACAGATGTGAAATGAATGTAATCTAATAGAAGCCTAATCAGCCCACC
SEQ ID




ATGTTCTCCACTGAAAAATCCTCTTTCTTTGGGGTTTTTCTTTCTTTCTTTTTTGATTTT
NO:




GCACTGGACGGTGACGTCAGCCTGTACAGGCTCCCAGGGGTGGCGTCAAATGCTATTGAA
2817




ATTGCGCTGAATCGTATGCTTTTTCCTTTTGA





EGFR
ADXCRAD_AU147861_at
AAGGACCCTGAAAAATGACTTCTCATTTCCTGCCTGCAGAAAAGAGAAATATTAGGATAG
SEQ ID




TGTTGTGTGCAAAAAAATGCAAGCTTGCAATGAGAGATGCAGAGTGTGAGGGAGAGAGGC
NO:




ACGAAGGGGGTGGAGAAAAAAGACAGAGAATTTGAGGTTGACTCACGGCTTTGAAGGGAA
2818




AACAGGAAGANGAAGAAAGTCTGTCTNCCATGGGTCGGCAACCCACACTTTACACATTTT





EGFR
ADXCRAD_AU147861_x_at
ATGACTTCCTGAAGGACCCTGAAAAATGACTTCTCATTTCCTGCCTGCAGAAAAGAGAAA
SEQ ID




TATTAGGATAGTGTTGTGTGCAAAAAAATGCAAGCTTGCAATGAGAGATGCAGAGTGTGA
NO:




GGGAGAGAGGCACGAAGGGGGTGGAGAAAAAAGACAGAGAATTTGAGGTTGACTCACGGC
2819




TTTGAAGGGAAAACAGGAAGANGAAGAAAGTCTGTCTNCCATGGGTCGGCAACCCACACT




TTACACATTTTTTCCATGGG





AHNAK
ADXCRAD_AA523289_at
GGCATTTTCACCTTGGGCATCTTCAGGTGCCAGTCTGGGCCATGAACATCCACATCTGGG
SEQ ID




GCATCAATGTCCACTTTGGGGCCCTTGATGTCAACTTCAGGGNGCTTTAGATCACCTTCC
NO:




ATCTTAGGCAGAGAAACATCCACATCTCCTTTCACCTTAGGGCCTTTCAGATGCAAATCA
2821




AAGTCAGGCATGGAGATCTTGGGGGGCTTTGATGTTCATCTCTGGCATCTGTATTTAGGG




CCTTCAGTTCGCATCTGGACTTCATATTCA





RRBP1
ADXCRAD_BE646396_at
GAGCAGAGCACATACCTGGTCCGAACTTACAAGTCTCCTTATAGCTTCTCTACAATCTC
SEQ ID





NO:





2822





RRBP1
ADXCRAD_BE646396_s_at
GCAGGTCTGCACAGGGCCCGTGGCTGGGTCTCAGGGTCCTCTGAGGTAGTCAATGTCTCT
SEQ ID




CATTAAGGAAAAACAGGATGGACAAGATCCCTTGGCTTGAGAGAGAATGCCTCTCTTAAG
NO:




GCACACGGTCCATGAGGAAGAAATCAGTGAAGTGTCCTCTGCATTAACGTCACTTTCAAA
2823




GAAGCTCCCNGGACATGAGAAAGAGTTCTCTGAGCAGAGCACATA





CAPN2
ADXCRAD_AK023851_s_at
AGAATGGCAGTTGTCAGTCCTGTCCGTGTAACAGAGGAGTGAAGTGGTGAGGAGGGCAGG
SEQ ID




TCTAAGGCACTGGCAGCTCTTTTCCATGGATTTTGAACTCTGGAGGAAGGCAGCAACTAA
NO:




ATAACTGTCTCATTCTGCTATTATGCATTGTATTAGCAAAGTGAAAATATAGTCTATCTG
2826




GTTACAAATAACACTAACTTGCTTAAAACTTTACATATCCTAGGAAATATCTCTACCCCT




AGATTGCAATGTAGAGTCAACCCCATCT





COL5A2
ADXCRAD_AU144167_at
ATTCATGTATATGAGACCTGCTCTACTTCAAAGCTGTAATCTTCTTAGTTGATAAACAAT
SEQ ID




ATTCTTAAACAAATGCCTTGTAAGGATTCTTAGTAAATGCAGCAGGGCAATTGCTATAGA
NO:




CCAGTGCATCCTCAGGAGGCCTGGTTCCGGCCATTGCTAACAGGTTTATAAATGGTTTAT
2827




TAAAAAGAGGATAGGTCTCTCACAATGAAATTCGCTAA





COL5A2
ADXCRAD_AU144167_x_at
ATTCATGTATATGAGACCTGCTCTACTTCAAAGCTGTAATCTTCTTAGTTGATAAACAAT
SEQ ID




ATTCTTAAACAAATGCCTTGTAAGGATTCTTAGTAAATGCAGCAGGGCAATTGCTATAGA
NO:




CCAGTGCATCCTCAGGAGGCCTGGTTCCGGCCATTGCTAACAGGTTTATAAATGGTTTAT
2828




TAAAAAGAGGATAGGTCTCTCACAATGAAATTCGCTAA





LDLR
ADXCRAD_S70123_at
GAGGATGAGGTCCACATTTGCCACAACCAGGACGGCTACAGCTACCCCTCGAGACAGATG
SEQ ID




GTCAGTCTGGAGGATGACGTGGCGTGAACATCTGCCTGGAGTCCCGCCCCTGCCCAGAAC
NO:




CCTTCCTGAGACCTCGCCGGCCTTGTTTTATTCAAAGACAGAGAAGACCAAAGCATTGCC
2832




TGCCAGAGCTTTGTTTTATATATTTATTCATCTGGGAGGCAGAACAGGCTTCGGACAGTG




CCCA





PTRF
ADXCRAD_AI282511_s_at
CTTACTTGGGCAGAAATGTATTACTTATTGTGCCTATTTTCTTT
SEQ ID





NO:





2833





GALNT2
ADXCRAD_AA604126_at
TAGGCTATGGGCTACCCAGATCTGCTGCAAGTGTTACATAGAACATTTCGTGTAAAGCAC
SEQ ID




ACGGCCCGGTGCCTGGCTCGTAGGAGGCACTCAGTAAACGGCGGTGATATTACAGACACA
NO:




AAACACGAGGCTGATGTCTCCCTCAC
2836





GALNT2
ADXCRAD_AA604126_s_at
TGGGCAGACTTGTCAGGTGGTCTAATGTGAACAAAGCCACAGCCACGGGGAAGAACAACG
SEQ ID




TGCTTCAGAACCAGATCCAAACCTCAGCCCACCTCTGCCAGGTGCTGGCTTTCAGGCAAG
NO:




ACTCTCTCTGAAGCTCGATTTGCCCTTTGGTAGGCTATGGGCTACCCAGATCTGCTGCAA
2837




GTGTTACATAGAACATTTCGTGTAAAGCACACGGCCCGGTGCCTGGCTCGTAGGAGGCAC




TCAGTAAA





WDR1
ADXCRAD_AW770902_at
TTCCCAGTCTTTGCACAGAGGTCATAAGAGGCAGAGGTGATGCAGGCAGGGTAAGGAAAC
SEQ ID




TTATAAGGAACCACCCCAGACCTAAGGAGGTACCAGCACCTGCAGGAAGCCTTCCTTAGA
NO:




CCCCCGAAGCACAGACTATCCATCCCTTCTCCGTGGGGAACTAATGTCTCTCAAACACAG
2839




TGTACATATGGTTCACTGGAATCCCCTTCTTGGAGCTCTCTCCTTCTGGAATATTAGTTT




CTACATGGCCACCATTATAGTCTTTCACTCTACAG





ALCAM
ADXCRAD_BE502785_at
TACTCGCTTTAGAAAAGTGTCCTGAGCAGTGCACTATTCATCTTTCTAATAACATGAAAG
SEQ ID




TGAAATAGAAAAAAAAAAAAATACATGGGCCACTGGCAAATGCAGGATGCAGACTATTTG
NO:




GGATGTTTTATGGAAACAGGCATGACTGCAAACACTTGGTTTGCACTTGGTTTGATTCAT
2840




ACAACGATCGAGAAGTGTGGATGGTTTCTGGAAAGTGCCTTCTAAGCTGAAA





FNDC3B
ADXCRAD_N32832_at
GGGCATCTGATACAGGACGTTCTAACCCACAGGGCACTCGCACATGGGTAGGATGTGACT
SEQ ID




TCTATGTACTGCTCTGCTCTCACAGAGGCCACTCAACAGTGTAACACCAAAGTACATACA
NO:




TGGCATTCAAAAAGGAAAAGCAAATTATGCTTTCCAAGCGGCAGTGTGTTTTACCTTATC
2846




AAAATCATCTGAGCAGTCAAGATGACCAAGCAGTCCATTT





LPP
ADXCRAD_AI079544_at
GACCTAAAACTGTCTCCAGGACACAAGGCTATTCCAAGCAACATTAAGAGAGAGCTCTGT
SEQ ID




AGGAAAAGAGGGTCTTGTCAACACAATTCTCAGAATAA
NO:





2852





LPP
ADXCRAD_AI079544_s_at
GGACTCACAAGTCATACCCTACTAAACACCCATCAGATGGACTTGTCTACTTTATTGAGA
SEQ ID




AACAACAGAAGATAGACCTGCAAGTCCAGCTGTTCATCTACCTCCACCCCACAGCCCAAG
NO:




CCACATTCCCACCCTTTGTGGATGAAGCTCAGGGATGCAGATCCCATTCCAAGATCC
2853





SEPT7
ADXCRAD_N39126_at
CAACAGAAAGATGGACTAAATATAAAGGGGGGAATTCCTGGACCTCCTTTGGGTGGCTAG
SEQ ID




ACTGGTANGTCATAGGCTAAGCCGGAAGGGTGG
NO:





2855





SEPT7
ADXCRAD_N39126_s_at
AAACAAGTACAATATCCTGGCATAAAACTATCTTTCAGACAAAATCCACCTGCTGTGTAT
SEQ ID




TAAAAAATGTAATACTTGAAAACTTCCTGCCTTGGGAGAGACTAAACCCGATTCATAATA
NO:




CAAA
2856





PDLIM7
ADXCRAD_AI825846_at
GCAGGCCCGGATCTTGTTCTGAGCTTCGATGTGTGTGAGGCTACCCGCATTCTCGCCATC
SEQ ID




GATGCTCAGCACCCAGTCACCCACGGACACTCCGGCCTGCGCCGCTTTGCCCCCAGGAGT
NO:




GAGCCGGGAAATGGAGAGGGGCACATTGAAGTCCTTGCCCCCTTGCAGCCGGAAGCCCCA
2857




AGGTGCTGGCCCCTCCAGCACTACTTTGAAGGAATCCATGA





SERPINH1
ADXCRAD_NM_004353_at
GAGCCTTTGTTGCTAATCAAATCCGGGACTTGTTTGTACG
SEQ ID





NO:





2858





WDR1
ADXCRAD_AF274954_at
GTAAGTTTAAAGCACCTGATTGGGAGTGTTTTGCGTGTTCGGAATCACTTGTAATGTTGG
SEQ ID




CTGAGACAATCCTTCCTTGCACTTTGAAACACTTTGAGCCTTTAAGAGATAGCCTGAGAA
NO:





2862





NFIB
ADXCRAD_U70862_at
AAATGCATCAAGATATAGGTGTCCTTGCATTACCAACAATCCATAGTAAAACAATCATTT
SEQ ID




TACAAAGCCGCATACCAAAAGTAGACTAAAGTTTGAGCTGTCACAGATGGTAGGTCATTT
NO:




CCAAACTTGGCCTGGTGGGAGGAAAAATGGCCTGCAGATAGCCAGGTGACAGACTGTTAC
2863




CTGAGGTTTGTTATATAAATGTGGGACTTAATAAACTGCTATGAGCT





PTPRK
ADXCRAD_AU145587_at
TGCTGGGCTGTTCTCTACCGAATACCATAAAACTGAATATTGTTCACCACTATGGTCGAT
SEQ ID




CTTTCTAACTTTAAAGAGTACACAACTGAACTCAATTACTCCAAAGATATGTGAAAACAC
NO:




AGAAAAATGACCCCTGTTAAAAGAGTAAACCTAGCTTTTGNTTTACTTTCCTTTTATATA
2864




AAAAAAGATGTACAGGGTTCTCTTCT





CDC14B
ADXCRAD_AK024886_at
GAACATTTGGGTTTTCAATCAGAAGGTTTGTGACAGCAAAGTCATTGGAATAAATCTTTC
SEQ ID




TTCTTGTGGAGATGAAATATGTGGCTAGTCTTCGTGAGGCAGTCACCAATTAATCAACTT
NO:




CAGAAAAATAGAACCAAGCAGAATACTGAGGAGGGGTGCGTTACAGGAAATAAAAATGCT
2865




ATCAGAGGGCAACCCGCTCTGGTC





CDC14B
ADXCRAD_AK024886_x_at
TAGACAGTCCCTGTTGATGAACATTTGGGTTTTCAATCAGAAGGTTTGTGACAGCAAAGT
SEQ ID




CATTGGAATAAATCTTTCTTCTTGATGGAGATGAAATATGTGGCTAGTCTTCGTGAGGCA
NO:




GTCACCAATTAATCAACTTCAGAAAAATAGAACCAAGCAGAATACTGAGGAGGGGTGCGT
2866




TACAGGAAATAAAAATGCTATCAGAGGGCAACCCGCTCTGGTC





ARID5B
ADXCRAD_AI289774_at
GTATAATAATTCTGTCTGCCTTGTCCAGCAGTAATTGCCAGGACTCAATGGGTTGATACA
SEQ ID




AATGAAGTAGCATGTCAGAATTAGCTATCATGATCATTGTTATTTCTTCTCTAAATTGGT
NO:




GTTTTCCAAACCGTGGCATGCAGAGATGATTTTAGATGGTTCACAGGTAGACTTTTAA
2871





CRIM1
ADXCRAD_AA642418_s_at
GACTTATACTCATGAGGTCTACCTACAGTCCATTCCCATTTAGGGGAAGAGAAAGGAGAG
SEQ ID




GAAATGGCCAAGAAGTCCATAAGAAGTGGACAGTGCTTTAACTTTTTCAAGTTTTGCTAA
NO:




CATATTTTATGTAAGTTATTCAATACCCCCATATTAAAGAGCAGCAGCTATTAAACACCA
2873




ACATTTATTAGCTGCTGGAAAGTAATAAATAACTTCAGCTAGTCCCCTTCAGTTTCCATA




AAATTATAAAACCAACCATTTGACGTGAAAAAGCAGTTT





FNDC3B
ADXCRAD_AA703239_at
TGACAAAGCCACTCCAATTTTGCTGGCCAAAAGGAAAAGTGTCCCGGGCACAAGGGCTGA
SEQ ID




GTTAATGGAGAGCAAGTGGTAATTATCTGCTCTATTAGATCCCTCTTCCTCCAGCCCAAT
NO:




TTCATGGGAGGCTTGGTTTATAAAACACTGGCTGTCTGACTAAACCTCAACAACAGATTA
2874




ACCATAAATGCATTCCTGGAATTTACGTTCTTCCCGCCTCAGTGTTGTGTAAAATTATCA




GGGAACACAGACCCACAGGGTCAGGA





VCAN
ADXCRAD_BF590263_at
ACATACTGTGTATTATTGTAGCTAGAGTCATTCCTTCTAAGCCAAAGGAGGTTTTATAAA
SEQ ID




AAAGAATCAATATTGGGCCAATCCCTTTGTGCCCTTTTTCTCTTTTTCTATGTGCATTTT
NO:




ATTTTTTGTCTACTCTTCTTCAAGTTGCTCTAAACTGAAATTAGGGAAGGAGTCTCACTT
2877




TCCATTACAGGTTTTTCTTTAAACATTAAATTAAGTGGATAAGGATTCAAAGTCATC





SYNJ2
ADXCRAD_AK026758_at
GGCACCTCTGGAGAGTTAGGACCCAGGCCTGCTCTCAGCACAATGAGAGGAAAACTAACC
SEQ ID




CTGAACTCCCTGCCACCCCCCACCCCTGGCCCCTGGAATGTGTTAGAGTGTAGAT
NO:





2884





SYNJ2
ADXCRAD_AK026758_x_at
GGCACCTCTGGAGAGTTAGGACCCAGGCCTGCTCTCAGCACAATGAGAGGAAAACTAACC
SEQ ID




CTGAACTCCCTGCCACCCCCCACCCCTGGCCCCTGGAATGTGTTAGAGTGTAGATTTGGA
NO:




AAAGAAACCTGCGCCAGGCATGGTGCC
2885





CDC42BPA
ADXCRAD_AK027000_at
AGGAGACTCCTAGAGTGGTCCCAATGGAAACCAATGAGGGCTTGGGATGCAGCAGGGGCA
SEQ ID




GAAGGAGAGAAGATGGTAGATTCTCCAGATATATTTTCAGAGTTAAAAGCAGTAAGACTT
NO:




GATGATGAATTAGTCATGGAAAAGTAAGGGAGAGAGTTAAAGATGACTCCCAGACTTCCT
2886




GCTAGGGCCTTAGTATGATACCATTTACTCCCATTTACCACCGTTTAAGAAGGGGCTGAG




GCAGGACATTCCACGCATGTCCAAAGGTCCCGAGGTAGCAA





NFIB
ADXCRAD_T90642_s_at
CTTTGACCCTGCACAATGACCTTTGCATCAGCCAAACTCATTGCCATGACAACTCTTTGT
SEQ ID




ACTGTGTCCGTGCCACAGATCTGTTGGTCACAT
NO:





2887





EGFR
ADXCRAD_AU156822_x_at
CCATGGCAATCTGTCTTGCTGCTGTGCAGTCCTTCCCTGGGTGGCTGCAGGGGCAAACAC
SEQ ID




AGGGTTTGTNGGTCCTGGGTCTTATAAAAATCAGGTACAAATTGACACNTNTATTTAAAA
NO:




GGANAAATTGCCAAATGANACAAAATGTTTTCCTTATGCAAATTTCAT
2890





BCL6
ADXCRAD_AI733564_at
GGGCGCGGAGTGGAGATTGGCTCTCTGAGGTGGTCAGGGGCCCTGTGACAGCTTGGGACT
SEQ ID




TTCAGCACCTGGTTTGGGGTCATTTATCTGCTCAACTGTCAGACCCCCCACCCCCAAACC
NO:




CCAGCCACCAACACAACCATCGTAGAAGGGAACACAACACAGAGGGTCTTTTTTCA
2891





KCMF1
ADXCRAD_R53065_at
TCGTCAGTGTGATATTTTCCAAGGTAAGTCTGAATCGTGAGTGGTCAGCACACATGGTGG
SEQ ID




GCTGCTATCCGATAGGACAATTCAACAGACACTGCTAATTAGCATACTATATATTTAAAA
NO:




ATGGACTTTTATGGGGAAACTAGTGTCTTGTTAATTGTCATGAAAGGTTCTCGTGGGCAA
2892




AATTAAATGGATTCAAGGCTGGCCAGAATAGCTTTCATGACTAGGGGGTAAGAATCCATG




AACTTTCCTTCAGTCCCTAGCGACAGTGGCTGAGG





MAPK1
ADXCRAD_AA088464_at
AATAAAAACCTCAGCTGAAAAGCTAATAACTCCAGAATGCAGGTTGAAAGCAAGCTTAAA
SEQ ID




GGTCATCTAGGCTGGGGTCAGTAGCTCACGCCTGCAATCCCAACACCCTGGGAGGCCCAG
NO:




GTGAGAGGACCGCTCGAGCCCNGGAGGTAAAGGCCGCAGCGAGCTATGACCGCGCCACTG
2893




CACACCAGCCTGTGCCACAAAGTAGA





MAPK1
ADXCRAD_AA088446_x_at
AATAAAAACCTCAGCTGAAAAGCTAATAACTCCAGAATGCAGGTTGAAAGCAAGCTTAAA
SEQ ID




GGTCATCTAGGCTGGGGTCAGTAGCTCACGCCTGCAATCCCAACACCCTGGGAGGCCCAG
NO:




GTGAGAGGACCGCTCGAGCCCNGGAGGTAAAGGCCGCAGCGAGCTATGACCGCGCCACTG
2894




CACACCAGCCTGTGCCACAAAGTAGA





MICALL1
ADXCRAD_W46406_at
ACAGAGCAGACAGACCAGTGATGACCATGGGCGGGACGAAGCCTCTTCCCTGGACCGGGG
SEQ ID




TGGCAGAGGAAAGCCTAAGTGAGGGGTCAGACTATAAACGTTAAGGAACCCGAGATNAGC
NO:




ACCTGCTTCAAGTGCACCCTTCCTACCTNACAACCAGGGACCAGAACTGCAANCTTTGGG
2898




GACAGCACTTGGGAGCAGCTAACAGAGCACTCACCTGCCCCAAGANGGCCGTCGCAGCCC




TGGTCCTGGCAAGGGAAGCT





EHD2
ADXCRAD_AI417917_at
GAGCAGATCACCTGAATTGCGAGTCGAGACCAGCT
SEQ ID





NO:





2899





EHD2
ADXCRAD_AI417917_s_at
TGGCCCAGCAATCCTTAAGTCCAGATTACCAGCTGTGGGGAGGCTTCCAGGGGGCCAGGA
SEQ ID




GCAGGCTTGGCAGTTCCAGCCACAGACACGTGGGTGAGGACGGAAATATCTCCAAGGGGG
NO:




CACAGTAT
2900





EHD2
ADXCRAD_AI417917_x_at
GGCCCAGCAATCCTTAAGTCCAGATTACCAGCTGTGGGGAGGCTTCCAGGGGGCCAGGAG
SEQ ID




CAGGCTTGGCAGTTCCAGCCACAGACACGTGGGTGAGGACGGAAATATCTCCAAGGGGGC
NO:




ACAGTATCAGAGGAGCAGGATGGAAGGGCTTTTCTGCCTGCTACGGATCCTTTTAAAGAA
2901




ATGGTGTGAAGCCGGCCGGNGCTCATGCCTGAATCCCATCACTTTGGAGGCCGAGCGAGC




AGATCACCTGAATTGCGAGTCGAGACCAGCTGCCAAC










Sequencing


Expression levels of biomarkers may be determined using sequencing technologies, such as next generation sequencing platforms (e.g., RNA-Seq), as described in Mortazavi et al., Nat. Methods 5: 621-628, 2008, hereby incorporated by reference. Sequencing methods for expression profiling offer broader dynamic range than microarray and offer the possibility of quantifying sequences for which pre-designed probes are not available (e.g., novel transcripts, novel splice variants, or low-abundance transcripts). RNA-Seq is a robust technology for monitoring expression by direct sequencing the RNA molecules in a sample. In certain embodiments, this methodology includes fragmentation of RNA to an average length of, e.g., 200 nucleotides, conversion to cDNA by random priming, and synthesis of double-stranded cDNA (e.g., using the Just cDNA DoubleStranded cDNA Synthesis Kit from Agilent Technology). Then, the cDNA is converted into a molecular library for sequencing by addition of sequence adapters for each library (e.g., from Illumina®/Solexa), and the resulting 50-100 nucleotide reads are mapped onto the genome.


Exemplary sequencing platforms suitable for use according to the invention include, but are not limited to, 454 pyrosequencing, Illumina sequencing by synthesis, SOLiD sequencing, Ion Torrent sequencing, and PacBio RS sequencing.


Other Systems


Expression levels of biomarkers may, alternatively, be determined using any other methods known in the art. For example, biomarker expression may be assayed using a NanoString nCounter system. In this system, a capture probe and reporter probe are hybridized to a target nucleic acid (e.g., a biomarker of the invention). The capture probe is used to immobilize the probe/target complex for isolation and data collection, and the reporter probe carries a combination of fluorescent moieties representing a “color code,” which can be identified and tabulated to count the number of such target molecules present in the original solution. In some embodiments, biomarker expression is assayed using a protein array to measure the expression of one or more polypeptide gene products (e.g., proteins, protein fragments, protein complexes, or peptides) of the biomarker genes. The protein array can include protein binding moieties (e.g., antibodies, antibody fragments, scFvs, or other protein binding agents) capable of detectably binding to such polypeptide gene products, such as those described herein.


Methods of Treatment


The diagnostic methods of the present invention permit the assessment of whether a given subject is likely to be sensitive or resistant to treatment with a target drug, and can therefore be used to direct the subject's treatment. Exemplary target drugs include chemotherapeutic agents, such as 5-FU, capecitabine, tegafur, irinotecan, oxaliplatin, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, estramustine, etoposide, azaguanine, aclarubicin, mitoxantrone, mitomycin, paclitaxel, taxotere, dexamethasone, ara-c, methylprednisolone, methotrexate, methyl-gag, belinostat, carboplatin, idarubicin, melphalan, IL4-PR38, valproic acid, all-trans retinoic acid (ATRA), cytoxan, topotecan, suberoylanilide hydroxamic acid (SAHA, vorinostat), leukeran, fludarabine, vinblastine, dacarbazine, hydroxyurea, tegafur, daunorubicin, mechlorethamine, streptozocin, carmustine, mercaptopurine, dactinomycin, tretinoin, ifosfamide, tamoxifen, floxuridine, thioguanine, PSC 833, herceptin, bevacizumab, celecoxib, iressa, anastrozole, letrozole, rituximab, radiation, and histone deacetylase (HDAC) inhibitors, as well as prodrugs, derivatives, metabolites, enantiomers, and analogs thereof. A subject found to be sensitive to a target drug according to the methods of the invention may be preferentially selected for treatment with the target drug or drug combinations including the target drug. Thus, the present invention further features methods of treatment that leverage the improved understanding of the subject's drug responsiveness profile to improve outcomes. For example, a subject can be identified as sensitive to a target drug by determining the expression level of one or more biomarkers of sensitivity and/or resistance in a biological sample obtained from the subject, and subsequently administered the target drug (e.g., alone or as part of a combination therapy). Alternatively, a subject can be, e.g., identified as resistant to a target drug by determining the expression level of one or more biomarkers of sensitivity and/or resistance in a biological sample obtained from the subject, and subsequently administered a drug other than the target drug or a combination therapy predicted to have a greater effect than administration of the target drug alone. In some embodiments, the level of expression of one or more biomarkers of sensitivity to a target drug are assayed in a sample from a subject. In other embodiments, the level of expression of one or more biomarkers of resistance to a target drug are assayed in a sample from a subject. In still other embodiments, the level of expression of one or more biomarkers of sensitivity and the level of expression of one or more biomarkers of resistance to a target drug are assayed in a sample from a subject.


Administration and Dosage of Target Drugs


Routes of administration, frequency of administration, and/or dosage of target drugs (e.g., 5-FU, irinotecan, or oxaliplatin) will vary from individual to individual, and may be readily established using standard techniques. Once a patient has been determined to be responsive to one or more target drugs, according to the methods described herein, the target drug(s) of the invention can be administered to the patient by the usual means known in the art, for example, by injection, intravenously, orally, subcutaneously, intraperitoneally, intramuscularly, by infusion, by infiltration, by irrigation, intra-articularly, by inhalation, topically, rectally, vaginally, cutaneously, nasally, transdermally, or by ocular administration and the like. In certain embodiments, the target drug is administered intravenously. In particular embodiments, 5-FU, irinotecan, and/or oxaliplatin are administered by intravenous injection. For administration by injection, infiltration, or infusion, a target drug may be suspended or dissolved, as known in the art, in a vehicle suitable for injection, infiltration, or infusion. Such vehicles include, e.g., isotonic saline, buffered or unbuffered, and the like. Depending on the intended use, they also may contain other ingredients, including other active ingredients, such as isotonicity agents, sodium chloride, pH modifiers, colorants, preservatives, antibodies, enzymes, antibiotics, antifungals, antivirals, other anti-infective agents, and/or diagnostic aids such as radio-opaque dyes, radiolabeled agents, and the like, as known in the art. Compositions including a target drug may include a simple solution or suspension of the target drug or a pharmaceutically acceptable salt of the target drug, in distilled water or saline. Alternatively, a target drug may be delivered by other means, such as intranasally, by inhalation, or in the form of liposomes, nanocapsules, vesicles, and the like. Compositions for intranasal administration usually take the form of drops, sprays containing liquid forms (solutions, suspensions, emulsions, liposomes, etc.) of the active compounds. Administration by inhalation generally involves formation of vapors, mists, dry powders or aerosols, and again may include solutions, suspensions, emulsions and the like containing the active therapeutic agents.


Administration of a target drug of the invention to a subject can be performed according to, e.g., courses of therapy standard in the art. A target drug can be administered at a frequency of, for example, at least once hourly, once daily, twice daily, once weekly, once every two weeks, once every three weeks, once every four weeks, once monthly, once every two months, once every three months, once every six months, or once every year. The administration can be repeated at such a frequency for a certain period of time, followed by a period without treatment. In certain embodiments, a target drug is administered once daily for up to four days. In particular embodiments, the administration is repeated every 30 days or every month. Such repeated administrations can occur over a course of therapy lasting a specified length of time (e.g., at least 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months, 8 months, 10 months, 12 months, 18 months, 24 months, 36 months, 48 months, or 60 months). In certain embodiments, administration of a target drug is repeated for at least 12 months or 60 months.


A subject may be monitored or assessed according to the methods of the invention before, during, or after treatment. For example, a subject may be assessed for target drug responsiveness between administrations of the target drug. Multiple assessments can be performed over the course of therapy, and the results combined to determine change in responsiveness of the subject to the target drug over time. Each of the assessments can involve determining the expression level of the same biomarkers of responsiveness, or can involve determining the expression level of different biomarkers (e.g., selecting one or more distinct biomarkers per assessment, or varying only a subset of the biomarkers tested between individual assessments).


A suitable dose or therapeutic amount of a given target drug is generally an amount of a compound that, when administered as described above, is capable of treating a disease (e.g., by killing or slowing the growth of cancers or cancer cells). In general, an appropriate dosage and treatment regimen provides the active compound(s) in an amount sufficient to provide therapeutic and/or prophylactic benefit. In certain embodiments, a dose includes about 0.1-5000 mg of the active ingredient (e.g., a target drug), for example, about 0.1 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 10 mg, 12 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg, 80 mg, 85 mg, 90 mg, 100 mg, 125 mg, 130 mg, 150 mg, 175 mg, 180 mg, 200 mg, 250 mg, 300 mg, 350 mg, 370 mg, 400 mg, 450 mg, 500 mg, 600 mg, 700 mg, 800 mg, 900 mg, 1000 mg, 1500 mg, 2000 mg, 2500 mg, 3000 mg, 4000 mg, or 5000 mg of the active ingredient. In particular embodiments, the dosage is 800 mg per day. Dosage may vary from subject to subject. For example, a drug may be administered in a particular amount per amount of a subject's body weight, e.g., milligram per kilogram of the subject's body weight (mg/kg), or a drug may be administered in a particular amount per amount of a subject's body surface area, e.g., milligrams per square meter of the subject's body surface area (mg/m2). Body surface area can be estimated, for example, based on a subject's height and weight.


Therapeutic and/or prophylactic effect (e.g., benefit) can be monitored by establishing an improved clinical outcome (e.g., more frequent remissions, complete or partial, longer disease-free survival, decreased morbidity, or an improvement in one or more standard tests or assays known in the art for the assessment of the disease, condition, or disorder status) in treated patients as compared to non-treated patients.


A therapeutic amount of a target drug described herein refers to an amount effective to yield the desired therapeutic response, such as, for example, an amount effective to delay the growth of a cancer or to cause a cancer to shrink or not metastasize. If what is administered is not the target drug but an enantiomer, prodrug, salt, or metabolite of the target drug, then the term “therapeutically effective amount” means an amount of such material that produces in the patient the same blood concentration of the active component of the target drug in question that is produced by the administration of a therapeutically effective amount of the target drug itself.


Target drugs, such as those described herein, may be used alone or in combination with one or more additional therapeutic agents suitable for treatment of a particular indication. For example, a target drug of the invention may be co-administered to a subject who has, or is at risk for developing, cancer with conventional anti-cancer therapeutic regimens such as surgery, irradiation, chemotherapy and/or bone marrow transplantation (autologous, syngeneic, allogeneic, or unrelated) or in combination with conventional therapeutic regimens to treat age-related cataracts, spinal injuries, wounds or congenital defects. Such combination therapies are described in further detail below.


Subjects that can be treated with a target drug as described herein, and/or the pharmaceutically acceptable salts, prodrugs, enantiomers, and metabolites of such compounds, according to the methods of the invention include, for example, patients that have been diagnosed as having any of the diseases or disorders described herein. As used herein, a “patient” or a “subject” refers to any animal (e.g., a mammal), preferably a human. The sensitivity and/or resistance of a subject to treatment with a target drug can be determined using the devices and methods of the invention, e.g., by measuring the expression level of one or more biomarkers of sensitivity and/or resistance to the target drug (e.g., 5-FU, irinotecan, or oxaliplatin). A subject may be suffering from, in remission from, or susceptible to developing a cancer (e.g., a colon cancer). Accordingly, pharmaceutical compositions including a target drug may be used to prevent the development or progression of a cancer or other disorder, or delay its appearance or reappearance, or to treat a patient afflicted with a cancer. A cancer or other disorder treatable by the methods of the invention may be diagnosed using the diagnostic methods described herein and/or by criteria generally accepted in the art. In the case of cancer, target drugs may be administered either prior to or following surgical removal of primary or other tumors and/or treatment such as administration of radiotherapy or conventional chemotherapeutic drugs, or bone marrow transplantation (autologous, allogeneic, or syngeneic).


5-Fluorouracil


5-fluorouracil (5-FU) is an antineoplastic suicide inhibitor commonly used as a chemotherapeutic agent in the treatment of cancer (e.g., colon cancer, rectal cancer, anal cancer, breast cancer, esophageal cancer, stomach cancer, pancreatic cancer, and skin cancer). 5-FU can be administered to a subject in, e.g., its active form, or administered in the form of a prodrug, such as capecitabine or tegafur. The effective dosage and maximally-tolerated dosage of 5-FU can vary dramatically from subject to subject. As such, there is a need for methods, such as those described herein, for assessing a subject's responsiveness (e.g., sensitivity or resistance) to 5-FU treatment.


5-FU is generally administered to subjects intravenously. 5-FU packaged for intravenous administration is commonly available in 50 mL or 100 mL packages containing 50 mg/mL of 5-FU dissolved in saline solution (water, pH adjusted to 8.6 to 9.4 with sodium hydroxide). The daily dosage of 5-FU delivered to a subject generally depends on the subject's weight, e.g., 12 mg 5-FU daily per kilogram subject weight (mg/kg), but is not to exceed 800 mg per day. A standard dosage regimen for 5-FU includes, e.g., intravenous administration of 12 mg/kg once daily for four successive days, followed by 6 mg/kg on the 6th, 8th, 10th, and 12th days unless toxicity occurs. Subjects identified as “poor risk” may be, e.g., administered only 6 mg/kg daily for 3 days, followed by 3 mg/kg on the 5th, 7th, and 9th days unless toxicity occurs. A maintenance dosage of 10-15 mg/kg per week can be administered as a single dose when toxic signs from an initial dosage regimen have subsided. A course of treatment can be repeated, e.g., every 30 days after the last day of the previous round of treatment. Such repetition can occur up to, e.g., 9 to 45 times over periods of about 12 to 60 months.


5-FU can also be administered orally (e.g., in the form of the produg capecitabine, which is enzymatically converted to 5-FU upon ingestion) for the treatment of, e.g., colon cancer, rectal cancer, breast cancer, gastric cancer, or esophageal cancer. In some embodiments, capecitabine is orally administered in the form of tablets. In certain embodiments, each tablet contains 150 mg capecitabine or 500 mg capecitabine. In particular embodiments, tablets are administered twice daily, once in the morning and once in the evening (e.g., after a meal), for a course of 14 days, followed by no treatment for 7 days. This cycle of 14 days and 7 days can be, e.g., repeated every 3 weeks. The total daily dosage of capecitabine administered to a subject can be, e.g., 2500 mg/m2. Another 5-FU prodrug, tegafur, is used to treat, for example, stomach cancer, breast cancer, gall bladder cancer, lung cancer, colon cancer, rectal cancer, cancer of the head and neck, liver cancer, or pancreatic cancer. In certain embodiments, tegafur is administered alongside one or more additional therapeutic agents (e.g., gimeracil, oteracil, and/or uracil). The combination of tegafur and uracil can be, for example, orally administered at a daily dosage of 300-400 mg/mg2 in cycles of, e.g., 5 days of treatment followed by 2 days off treatment, or at a daily dosage of 300-600 mg/mg2 in cycles of, e.g., 28 days of treatment followed by one week off treatment. In certain embodiments, tegafur and uracil can be administered on a long term basis (e.g., for about 6 months up to about 11 years).


5-FU treatment can be combined with other cancer treatments. For example, 5-FU can be administered in combination with leucovorin, irinotecan, and/or oxaliplatin. In certain embodiments, leucovorin is administered intravenously at 200 mg/m2 over a minimum of 3 minutes, followed by intravenous administration of 5-FU at 370 mg/m2; or leucovorin is administered intravenously at 20 mg/m2 followed by intravenous administration of 5-FU at 425 mg/m2. Such treatments can be performed daily for, e.g., a five day course of treatment. A course of treatment may be repeated at, e.g., four week intervals for two courses, followed by repetition at, e.g., 4-5 week intervals. 5-FU and leucovorin are generally administered separately to avoid precipitation. In some embodiments, 5-FU can be administered in combination with irinotecan, e.g., in a FOLFIRI regimen, as described in detail below. In alternate embodiments, 5-FU can be administered in combination with oxaliplatin, e.g., in a FOLFOX regimen, such as the FOLFOX4 regiment described in detail below.


Irinotecan


Irinotecan, a topoisomerase I inhibitor, is a chemotherapeutic agent commonly used in the treatment of cancers (e.g., colon cancer, rectal cancer, pancreatic cancer, ovarian cancer, glioblastoma, or lung caner). In the body, irinotecan is converted into its metabolite, SN-38, which has significantly greater potency as a topoisomerase inhibitor than irinotecan. Irinotecan monotherapy can include, for example, 125 mg/m2 intravenous infusion over 90 minutes on each of days 1, 8, 15, 22, followed by 2 weeks off treatment. Alternatively, irinotecan monotherapy can include, e.g., 350 mg/m2 intravenous infusion over 30-90 minutes, administered once every three weeks. Irinotecan is often administered in combination with other chemotherapeutic agents (e.g., 5-FU and/or leucovorin). In certain embodiments, irinotecan is administered in combination with 5-FU and leucovorin, e.g., in a FOLFIRI regimen. An exemplary FOLFIRI cycle includes, in order, (i) intravenous co-administration of irinotecan (180 mg/m2 over 90 minutes) with leucovorin (400 mg/m2 (or 2×250 mg/m2) over 120 minutes, (ii) intravenous administration of 5-FU (400-500 mg/m2 bolus), and (iii) intravenous administration of 5-FU (2400-3000 mg/m2 intravenous infusion over 46 hours). Such a cycle can be repeated, e.g., every two weeks. An alternate FOLFIRI regimen can include, for example, a 180 mg/m2 intravenous infusion of irinotecan over 30-90 minutes, followed by infusion with leucovorin and 5-fluorouracil, on each of days 1, 15, and 29, with the subsequent cycle beginning on day 43. A FOLFIRI cycle can also include, e.g., 125 mg/m2 intravenous infusion of irinotecan over 90 minutes, followed by bolus doses of leucovorin and 5-fluorouracil, on each of days 1, 8, 15, and 22. Dosages can vary from cycle to cycle or from subject to subject, as required.


Oxaliplatin


Oxaliplatin is a platinum-based antineoplastic agent commonly used to treat cancers (e.g., colon cancer and rectal cancer). Oxaliplatin can be administered as a monotherapy, e.g., by intravenous administration of 130 mg/m2 over two hours, once every three weeks. More commonly, however, oxaliplatin is given in combination with, e.g., 5-FU and/or leucovorin. For example, the FOLFOX4 regimen is a two-day regimen recommended for, e.g., stage III colon cancer. On day 1 of FOLFOX4, simultaneous administration of 85 mg/m2 of oxaliplatin and 200 mg/m2 of leucovorin by intravenous infusion over two hours, followed by 400 mg/m2 5-FU delivered as an intravenous bolus over 2-4 minutes, followed by 600 mg/m2 of 5-FU as a 22-hour, continuous intravenous infusion. On day 2 of FOLFOX4, 200 mg/m2 of leucovorin is administered by intravenous infusion over two hours, followed by a 400 mg/m2 5-FU bolus given intravenously over 2-4 minutes, followed by 600 mg/m2 of 5-FU as a 22-hour, continuous intravenous infusion. Such two-day cycles can be repeated about 12 times, once every two weeks. Dosages can vary from cycle to cycle or from subject to subject, as required.


Combination Therapies


Once a patient is assessed to be responsive to one or more target drugs, according to the methods of the invention, one or more of the target drug(s) (e.g., 5-FU, irinotecan, or oxaliplatin, or an analog thereof) can be administered in combination with one or more additional therapies, including but not limited to therapeutic agents (e.g., compounds, pharmaceuticals, or compositions), treatments, therapies, medical procedures, and combinations thereof. Such therapies can also be administered in lieu of treatment with the target drug (e.g., 5-FU, irinotecan, or oxaliplatin, or analog thereof), if the subject is, for example, identified as resistant to the target drug according to the methods of the invention. Methods, devices, and kits of the present invention can be used to determine the responsiveness of a subject to such combination therapies. In such combination therapies, target drugs of the invention may be formulated with or administered concurrently with, prior to, or subsequent to, one or more other desired therapies. The particular combination of therapies to employ in a combination regimen will take into account compatibility of the desired therapeutics and/or procedures and the desired therapeutic effect to be achieved. It will also be appreciated that the therapies employed may achieve a desired effect for a condition, disease, or disorder, or they may achieve different effects (e.g., control of any adverse effects).


In general, for use in treatment, the target drugs described herein may be used alone, as mixtures of two or more agents, or in combination with other agents, compounds, and/or pharmaceuticals. Examples of other agents that can be combined with the compounds described herein include agents that are known to be used for the treatment of cancer (e.g., colon cancer). Other potential agents to combine with the compounds described herein can include agents for the treatment of different yet associated or related symptoms or indications. Depending on the mode of administration, the agents may be formulated into suitable compositions to permit facile delivery. Each component of a combination therapy may be formulated in a variety of ways that are known in the art. For example, the first and second agents of the combination therapy may be formulated together or separately. The target drug of the present invention and additional agent may be suitably administered to the patient at one time or over a series of treatments.


The combination therapy may provide “synergy” and prove “synergistic,” i.e., the effect achieved when the active ingredients used together is greater than the sum of the effects that results from using the ingredients separately. A synergistic effect may be attained when the active ingredients are: (1) co-formulated and administered or delivered simultaneously in a combined, unit dosage formulation; (2) delivered by alternation or in parallel as separate formulations; or (3) by some other regimen. When delivered in alternation therapy, a synergistic effect may be attained when the compounds, agents, and/or treatments are administered or delivered sequentially, e.g., by different injections in separate syringes. Suitable dosages for any of the above co-administered agents are those presently used and may be lowered due to the combined action (synergy) of a compound of the present invention and other co-administered agents or treatments.


Each component of a combination therapy, as described herein, may be formulated in a variety of ways that are known in the art. For example, the first and second agents of the combination therapy may be formulated together or separately. The individually or separately formulated agents can be packaged together as a kit. Non-limiting examples include, but are not limited to, kits that contain, e.g., a liquid in a container (e.g., a bag or a vial), two pills, a pill and a powder, a suppository, two topical creams, etc. The kit can include optional components that aid in the administration of the unit dose to patients, such as vials for reconstituting powder forms, syringes for injection, customized IV delivery systems, inhalers, etc. Additionally, the unit dose kit can contain instructions for preparation and administration of the compositions. The kit may be manufactured as a single use unit dose for one patient, multiple uses for a particular patient (at a constant dose or in which the individual compounds may vary in potency as therapy progresses); or the kit may contain multiple doses suitable for administration to multiple patients (“bulk packaging”). The kit components may be assembled in cartons, blister packs, bottles, tubes, and the like. Two or more components may be mixed together in a liquid, tablet, capsule, or other vehicle, or may be partitioned.


Exemplary therapies that can be combined with target drugs of the present invention can include, for example, drugs (e.g., chemotherapeutic agents) and/or non-pharmacological therapies (e.g., surgery or radiation therapy). Chemotherapeutic agents suitable for, e.g., combination with target drugs of the present invention (in particular, 5-FU, irinotecan, and/or oxaliplatin) may include, for example, one or more of the following: 5-FU, capecitabine, tegafur, irinotecan, oxaliplatin, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, estramustine, etoposide, azaguanine, aclarubicin, mitoxantrone, mitomycin, paclitaxel, taxotere, dexamethasone, ara-c, methylprednisolone, methotrexate, methyl-gag, belinostat, carboplatin, idarubicin, melphalan, IL4-PR38, valproic acid, all-trans retinoic acid (ATRA), cytoxan, topotecan, suberoylanilide hydroxamic acid (SAHA, vorinostat), leukeran, fludarabine, vinblastine, dacarbazine, hydroxyurea, tegafur, daunorubicin, mechlorethamine, streptozocin, carmustine, mercaptopurine, dactinomycin, tretinoin, ifosfamide, tamoxifen, floxuridine, thioguanine, PSC 833, herceptin, bevacizumab, celecoxib, iressa, anastrozole, letrozole, rituximab, radiation, and histone deacetylase (HDAC) inhibitors.


Methods for Identifying Biomarkers of Drug Sensitivity or Resistance


The invention features methods for identifying biomarkers of sensitivity or resistance to a drug of interest (e.g., 5-FU, irinotecan, or oxaliplatin). Such methods can involve, for example, an algorithm based on growth inhibition values (GI50) of cell lines (e.g., NCI60 cell lines) subjected to treatment with a drug (e.g., 5-FU, irinotecan, oxaliplatin, or a metabolite thereof), followed by measurement of gene expression (e.g., using an Affymetrix HG-U133A array).


In certain embodiments, the gene expression measurements of NCI60 cancer cell lines are obtained from a publically available database (e.g., the National Cancer Institute and the Massachusetts Institute of Technology). Each dataset is normalized so that sample expression measured by different chips could be compared. The preferred method of normalization is the logit transformation, which is performed for each gene yon each chip:

log it(y)=log [(y−background)/(saturation−y)],

where background is calculated as the minimum intensity measured on the chip minus 0.1% of the signal intensity range: min−0.001*(max−min), and saturation is calculated as the maximum intensity measured on the chip plus 0.1% of the signal intensity range: max+0.001*(max−min). The resulting logit transformed data is then z-transformed to mean zero and standard deviation 1.


Next, gene expression is correlated to cancer cell growth inhibition. Growth inhibition data (GI50) of the NCI60 cell lines in the presence of any one of thousands of tested compounds is obtained from the NCI. The correlation between the logit-transformed expression level of each gene in each cell line and the logarithm of GI50 (the concentration of a given compound that results in a 50% inhibition of growth) can be calculated, e.g., using the Pearson correlation coefficient or the Spearman Rank-Order correlation coefficient. Instead of using GI50s, any other measure of patient sensitivity to a given compound may be correlated to a subject's gene expression levels. Since a plurality of measurements may be available for a single gene, the most accurate determination of correlation coefficient can be, e.g., the median of the correlation coefficients calculated for all probes measuring expression of the same gene.


The median correlation coefficient of gene expression measured on a probe to growth inhibition or patient sensitivity is calculated for all genes, and genes that have a median correlation above, e.g., 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 0.95, or 0.99 can be used as biomarker genes. Preferably, the correlation coefficient of a biomarker gene will exceed 0.3. This can be repeated for multiple drug compounds to be tested. The result is a list of marker genes that correlates to sensitivity for each drug tested. Such methods are further described in PCT Publication No. WO 2011/135459, which is incorporated herein in its entirety.


Devices and Kits


The present invention features devices and kits for determining the expression level of one or more biomarkers of sensitivity and/or resistance to a target drug. Devices of the invention can include, for example, microarrays, protein arrays, or chips containing one or more probes suitable for hybridization to one or more biomarkers of interest. Kits of the invention can include, for example, reagents for microarray analysis of gene expression, reagents for sequencing (e.g., Sanger sequencing or next generation sequencing), and/or reagents for PCR-based techniques, as well as instructions for their use. Exemplary next generation sequencing platforms suitable for use with the present invention include the MiSeq and HiSeq platforms (Illumina), the SOLiD platform (Applied Biosystems), Roche 454 pyrosequencing, Ion Torrent/Ion Proton (Life Technologies), PacBio RS, Oxford Nanopore, and other NGS platforms known in the art.


A device or kit of the invention may include pre-designed probes and/or primers targeting the one or more biomarkers of interest such as those described herein (see, e.g., Tables 1-6). Such probes can be, e.g., oligonucleotide probes identical to or sharing at least 85%, 90%, 95%, or 99% identity to the one or more biomarkers or to a nucleic acid complementary to the one or more biomarkers (e.g., the probe includes at least about 5, 10, 15, or 20 contiguous nucleic acid residues that are complementary to the one or more biomarkers). The probes can be complementary to, e.g., at least 5, 8, 12, 20, 30, 40, 60, 80, 100, 150, or 200 consecutive nucleotides (or nucleotide analogs) of the one or more of the biomarkers. The probes may be, e.g., 5-20, 25, 5-50, 50-100, or over 100 nucleotides long, and may be deoxyribonucleic acids (DNA) or ribonucleic acids (RNA). Consecutive nucleotides within the probes (e.g., 5-20, 25, 5-50, 50-100, or over 100 consecutive nucleotides) may also appear as consecutive nucleotides in one or more of the biomarkers described herein beginning at or near, e.g., the first, tenth, twentieth, thirtieth, fortieth, fiftieth, sixtieth, seventieth, eightieth, ninetieth, hundredth, hundred-fiftieth, two-hundredth, five-hundredth, or one-thousandth nucleotide of one or more of the biomarkers listed in one or more of Tables 1-6 (e.g., NT5E). In certain embodiments, devices of the present invention can include microarrays having one or more oligonucleotide probes, as described in detail below.


Probes that may be employed on devices (e.g., microarrays) of the invention include oligonucleotide probes having sequences complementary to or identical to (or sharing at least 85%, 90%, 95%, or 99% identity to) any of the target biomarker sequences described herein (e.g., NT5E). Additionally, probes employed on devices (e.g., microarrays) of the invention may also include proteins, peptides, or antibodies that selectively bind any of the oligonucleotide probe sequences or their complementary sequences. Exemplary biomarkers of drug sensitivity and resistance are listed in Tables 1-6 alongside exemplary Affymetrix probes useful for detecting the associated biomarkers.


Any of the devices or kits described herein can be adapted to include a solid support. Exemplary solid supports include a glass or a polymer surface, including one or more of a well, a plate, a wellplate, a tube, an array, a bead, a disc, a microarray, a protein array, or a microplate. In particular, the solid support can be adapted to allow for automation of any one of the methods described herein (e.g., PCR, microarray, next generation sequencing, or NanoString). Alternatively, microfluidics or microdroplets could be used (e.g., for polony-based sequencing or 454 pyrosequencing).


Devices


Devices of the present invention can be useful, e.g., for detecting the level of expression of at least one biomarker of responsiveness (e.g., sensitivity or resistance) to a target drug (e.g., 5-FU, irinotecan, or oxaliplatin). In some embodiments, the device includes at least one single-stranded nucleic acid (e.g., a probe) having at least 85% sequence identity (e.g., 85%, 90%, 95%, 97%, 98%, 99%, or 100% sequence identity) to a nucleic acid sequence that is complementary or identical to at least 5 consecutive nucleotides of one or more biomarkers, in which the at least one single-stranded nucleic acid is sufficient for the detection of the level of expression of the one or more biomarkers. The device may detect the expression level of a given biomarker by specific hybridization between the single-stranded nucleic acid and the biomarker (e.g., an mRNA, genomic DNA, or non-coding RNA), a nucleic acid encoding the biomarker (e.g., an mRNA), or a complementary nucleic acid thereof. In certain embodiments, the device includes a microarray. In alternate embodiments, the device includes reagents and materials for next generation sequence (e.g., sequencing by synthesis). In further embodiments, the device includes NanoString reagents and at least one nCounter cartridge. In additional embodiments, the device includes a protein array, which contains one or more protein binding moieties (e.g., proteins, antibodies, nucleic acids, aptamers, affibodies, lipids, phospholipids, small molecules, labeled variants of any of the above, and any other moieties useful for protein detection as well known in the art) capable of detectably binding to the polypeptide gene product(s) of one or more biomarkers of sensitivity and/or resistance (e.g., those shown in Tables 1-6) to treatment with a target drug (e.g., 5-FU, irinotecan, or oxaliplatin). In some embodiments, the target drug is 5-FU and the biomarker is selected from the biomarkers of Table 1 or 2. In alternate embodiments, the target drug is irinotecan and the biomarker is selected from the biomarkers of Table 3 or 4. In other embodiments, the target drug is oxaliplatin and the biomarker is selected from the biomarkers of Table 5 or 6.


Kits


Kits of the present invention can be used for diagnosing the responsiveness of a subject to a treatment for cancer (e.g., 5-FU, irinotecan, or oxaliplatin, or an analog thereof) and/or for treating the subject for cancer. Kits of the invention can include reagents and/or materials for, e.g., collecting and/or purifying nucleic acids from biological samples (such as those obtained from a subject to be treated with a target drug of the invention), reagents for amplifying such nucleic acids to produce an amplified sample, and/or at least one device of the invention as described herein. Reagents for amplifying nucleic acids may include, e.g., PCR reagents, including but not limited to DNA polymerase, RNA polymerase, PCR buffer, magnesium chloride solutions, nucleic acid primers (e.g., primers designed to target particular biomarkers of responsiveness to a target drug of interest), and/or any other PCR reagents as are well known in the art. In some embodiments, a kit of the invention includes one or more probes capable of detecting one or more biomarkers of responsiveness to a target drug of interest. Such probes can, for example, include nucleic acids capable of hybridizing to the biomarker based on nucleic acid sequence complementarity. In certain embodiments, a probe has at least 85% sequence identity (e.g., 85%, 90%, 95%, 97%, 98%, 99%, or 100% sequence identity) to a nucleic acid sequence that is complementary or identical to at least 5 (e.g., at least 15) consecutive nucleotides of one or more biomarkers. The probes can be attached a solid surface, such as a microarray. In certain embodiments, the kit includes NanoString capture probes, NanoString reporter probes, and/or one or more nCounter cartridges. In certain embodiments, the kit includes reagents for next generation sequencing, including but not limited to poly(T) oligonucleotides, dye terminators, sequencing adapters, adapter ligation reagents, reverse transcriptase, primers (e.g., random primers), DNA-cleaving enzymes, polymerases, and/or any combination thereof. In alternate embodiments, the kit includes a protein array and/or reagents for detection of the polypeptide gene products of one or more biomarkers of responsiveness, such as those described herein.


The invention further includes kits for administering one or more target drugs, including but not limited to 5-FU, irinotecan, and oxaliplatin, as well as analogs thereof, such as prodrugs, derivatives, metabolites, enantiomers, and combinations thereof. For example, 5-FU prodrugs that can be included in kits of the invention include capecitabine and tegafur. Such kits may contain a composition or formulation of the target drug in question, or an enantiomer, prodrug, metabolite, or pharmaceutically acceptable salt thereof, together with the customary items for administering the therapeutic ingredient as are known in the art. In certain embodiments, a kit for administering a target drug may further include any of the reagents, materials, kits, or devices described above.


The following examples are intended to illustrate, rather than limit, the invention.


EXAMPLES
Example 1
Predicting Drug Responsiveness to 5-FU in Various Cancer Patient Populations

An mRNA-based predictor of responsiveness to 5-FU developed according to the methods of the invention was applied to 3522 patients having a variety of cancers, from each of whom we have a pre-treatment measurement of gene expression with an Affymetrix array of either type U133A or U133Plus2. When the patients were grouped by indication (e.g., a particular cancer exhibited by the patient), it was possible to compare the indications and identify particular cancer types predicted to be more sensitive to 5-FU (FIG. 1). In an analysis of 27 different cancer indications, it was predicted that chronic myelogenous leukemia—chronic phase, acute lymphoblastic leukemia, colon cancer, hepatocellular carcinoma, and multiple myeloma were most sensitive to 5-FU. In a similar analysis of 62 cancer drugs approved by the FDA, the indication for which 5-FU treatment was approved by the FDA was (in 13 cases) predicted by our drug response predictor as “most sensitive” to 5-FU treatment (out of the 28 indications examined in our preclinical analysis). In 33 cases, the indication approved was among the top five predictions. This indicates that our pre-clinical prediction of indication sensitivity can successfully predict the indication that is later approved by the FDA. Also, in prior analyses of drugs tested in such studies, we have found that a difference in predicted sensitivity translated to a difference in clinical response rate. Table 13 ranks all 27 indications according to their predicted mean sensitivity to 5-FU.









TABLE 13







27 indications ordered by rank of their mean predicted sensitivity to 5-fluorouracil. The


reference cites the publication of the trial from which the samples were obtained.










Rank
Abbrev.
Full name
Reference













1
CMLCP
Chronic myelogenous leukemia - cronic
Bruennert




phase


2
ALL
Acute lympho-blastic leukemia
Ross (2003); Holleman


3
Colon
Colon Cancer
Smith; Khambata-Ford


4
HCC
Hepatocellular Carcinoma
Liao


5
MM
Multiple Myeloma
Agnelli


6
AML
Acute myelogenous leukemia
Metzeler; Lubbert; Ross





(2004)


7
DLBCL
Diffuse Large B cell lymphoma
Hummel; Lenz


8
eso
Esophageal cancer
Kimchi


9
MDS
Myelodysplastic syndrome
Mills


10
CLL
Chronic lymphocytic leukemia
Ouilette


11
ERpos
ERpos breast cancer
Hess


12
PTCL
Peripheral T-cell lymphoma
Piccaluga


13
Breast
Breast cancer
Hess; Zhang


14
ovary
Ovarian Cancer
Bild; Denkert


15
Bladder
Bladder Cancer
Dyrksjot


16
RCC
Renal Cell Carcinoma
Lenburg


17
Hodgkin
Hodgkin's lymphoma
VanLoo; Steidl; Chetaille


18
Cervix
Cervical cancer
Scotto


19
pancreas
Pancreatic cancer
Gautier


20
NSCLC
Non small cell lung cancer
Bild


21
Prosta
Prostate cancer
Wanf


22
CTCL
Cutaneous T-Cell lymphoma
Shin


23
Melan
Melanoma
Xu


24
SCCHN
Squamous Cell Carcinoma of the Head
Slebos




and Neck


25
glioma
Glioma
Freije


26
GIST
Gastrointestinal Stromal Tumor
Yamaguchi; Ostrowski; Astolfi


27
Sarcom
Sarcoma
Barretina










Subgroup Analysis in Non-Small Cell Lung Cancer (NSCLC)


The predicted sensitivity to 5-FU was compared among different subgroups of NSCLC. A dataset of 226 primary adenocarcinomas with corresponding mutation statuses was obtained from Japan (see PMID: 22080568). FIG. 2 shows the predicted sensitivity to 5-FU for each sample, according to mutation status. A Wilcoxon rank test was run to compare the three mutation subgroups to wild type: EGFR P-value: 0.27, KRAS P-value: 0.032, ALK fusion P-value: 0.091.


Subgroup Analysis in Breast Cancer


The predicted sensitivity to 5-FU was compared among different subgroups of breast cancer. A dataset of 243 breast cancer specimens was obtained (Hess, 2006). FIG. 3 shows the predicted sensitivity to 5-FU for each specimen, according to ER, HER2, and PR status. A Wilcoxon rank test was run to compare the three receptor subtypes to their wild type counterpart: ERpos versus ERneg P-value: 0.11, PRpos versus PRneg P-value: 0.8, HER2pos versus HER2neg P-value: 0.24, triple negative versus not triple negative P-value: 0.048.


Drug Combinations


The strategy behind drug combination therapy is to exploit multiple targets in, e.g., anticancer treatment and thereby increase response. As drug similarity is revealed according to the present invention, it can be used for selecting drugs for combination therapy by selecting drugs that show little similarity. Here, the predictor of response to 5-FU was compared to other drug response predictors in order to identify candidates for combination treatment. If a patient predicted to be responsive to 5-FU was likewise predicted to be responsive to a given combination drug candidate, then that drug would be considered as a poor candidate, as in such a case, a trial comparing the drug with or without combination with 5-FU would be predicted to provide little difference between the two arms. Conversely, it is predicted that a trial comparing a good combination candidate (e.g., a drug having different predictors of responsiveness from 5-FU) with or without 5-FU will give greater response rate in the 5-FU arm, because patients that fail therapy with the good combination candidate are likely to respond to 5-FU.


The analysis has to be performed on specific patients with a specific disease. It is not certain that the pattern would be the same if another disease is chosen. We decided to use 243 breast cancer specimens from a published cohort (Hess, 2006). If other indications are to be considered, it is possible to repeat the analysis in a different indication and see if the results change. Candidate drugs were selected according to the following criteria: (1) FDA approved, (2) NCI60 growth inhibition data available, with more than 2 sensitive cell lines, (3) in vitro correlation between prediction and cell line test set greater than 0.15. A total of 52 anticancer drugs met these criteria, and response predictors were thus developed for these drugs using the same procedure as was used for the 5-FU predictor. The Pearson correlation between the predicted sensitivity to the drug and to 5-FU was calculated using the 243 breast cancer patients. The most promising candidate drugs would have a negative CC, meaning that their predicted sensitivity in breast cancer is negatively correlated with sensitivity to 5-FU. The 95% confidence interval was calculated based on the 243 patients.









TABLE 14







Candidate combination drugs sorted according to Pearson correlation to


5-FU in breast cancer.












Pearson



Rank
Drug
CC
95% C.I.













1
Afinitor (everolimus)
−0.74
−0.79 −0.674


2
Temsirolimus (Torisel)
−0.63
−0.703 −0.552


3
Bleomycin
−0.55
−0.628 −0.45


4
Lomustine
−0.46
−0.555 −0.356


5
Depsipeptide (ISTODAX)
−0.42
−0.516 −0.307


6
Carboplatin
−0.35
−0.457 −0.236


7
Bortezomib
−0.32
−0.431 −0.205


8
Erlotinib (tarceva)
−0.32
−0.426 −0.199


9
Gemcitabine (Gemzar)
−0.32
−0.424 −0.197


10
Gemcitabine (Gemzar)
−0.32
−0.424 −0.197


11
Mitoxantrone
−0.31
−0.423 −0.196


12
Cisplatin
−0.2
−0.317 −0.0748


13
Busulfan
−0.16
−0.277 −0.0317


14
Epirubicin (epiadriamycin)
−0.16
−0.276 −0.0301


15
Arsenic trioxide (Trisenox)
−0.15
−0.27 −0.0238


16
bendamustine (Treanda)
−0.14
−0.261 −0.0141


17
Irinotecan
−0.14
−0.257 −0.0104


18
Vincristine
−0.12
−0.241 0.00706


19
Fulvestrant
−0.098
−0.222 0.0277


20
Teniposide
−0.096
−0.219 0.0306


21
Adriamycin
−0.091
−0.215 0.0349


22
5-Aza-2′-deoxycytidine (decitabine)
−0.037
−0.163 0.0888


23
Estramustine
−0.0074
−0.133 0.119


24
Leukeran (Chlorambucil)
0.0033
−0.123 0.129


25
Melphalan
0.006
−0.12 0.132


26
Hydroxyurea
0.014
−0.112 0.14


27
Ixabepilone (Ixempra)
0.018
−0.108 0.143


28
Procarbazine (Matulane)
0.032
−0.094 0.157


29
Sorafenib (Nexavar)
0.033
−0.093 0.158


30
Thiotepa (Thioplex)
0.045
−0.0813 0.17


31
Vinblastine (velban)
0.045
−0.0812 0.17


32
Daunorubicin
0.048
−0.0781 0.173


33
Vinorelbine (Navelbine)
0.049
−0.0776 0.174


34
Dacarbazine
0.053
−0.0738 0.177


35
Valrubicin (Valstar)
0.064
−0.0626 0.188


36
Carmustine
0.083
−0.0432 0.207


37
Exemestane
0.11
−0.0172 0.232


38
Tamoxifen
0.15
 0.022 0.268


39
Eribulin
0.18
 0.0519 0.296


40
Fludarabine
0.18
 0.0541 0.298


41
Iressa
0.2
 0.0815 0.323


42
Ara-C (Cytarabine hydrochloride)
0.25
 0.13 0.366


43
Mechlorethamine
0.26
 0.134 0.37


44
Idarubicin
0.29
 0.173 0.404


45
Gleevec (Imatinib)
0.36
 0.247 0.466


46
Lapatinib (Tykerb)
0.38
 0.269 0.484


47
Taxotere (docetaxel)
0.41
 0.303 0.512


48
Asparaginase (Elspar)
0.44
 0.332 0.536


49
Thioguanine
0.45
 0.348 0.548


50
Clofarabine (Clolar)
0.48
 0.372 0.567


51
Nilotinib (Tasigna)
0.48
 0.374 0.569


52
Mercaptopurine
0.5
 0.398 0.588


53
Vorinostat (SAHA)
0.66
 0.576 0.721


54
Paclitaxel (Taxol)
0.69
 0.616 0.749


55
Oxaliplatin
0.72
 0.654 0.776


56
Pralatrexate (Folotyn)
0.72
 0.658 0.779


57
Methotrexate
0.85
 0.811 0.882


58
5-Fluorouracil (5-FU)
0.99
 0.992 0.995





95% C.I. = 95% confidence interval.


CC = correlation coefficient.






The drugs Afinitor (everolimus), Temsirolimus (Torisel), Bleomycin, and Lomustine were predicted to be good candidates for combination therapy with 5-FU in breast cancer. FIG. 4 shows the predicted sensitivity of 243 breast cancer patients to 5-FU and to Afinitor (everolimus). For the drugs Vectibix and Bevacizumab, NCI60 in vitro data was absent. For the drugs Cetuximab and Xeloda, NCI60 data was of poor quality or inconclusive. The drugs Pemetrexed, Temozolomide, Mitomycin, Topotecan, Streptozocin, Herceptin, Anastrozole and Letrozole failed in our internal quality criteria.


Example 2
Predicting Survival in Colon Cancer Patients Treated with 5-FU

A clinical dataset of 232 pre-treatment fresh frozen colorectal cancer surgical biopsies was downloaded from Gene Expression Omnibus under accession number GSE17538. The biopsies were analyzed using the Affymetrix HG-U133-Plus_2 array type. The expression of NT5E was determined by reading the intensity of Affymetrix probeset 203939_at, which is predicted to be more highly expressed in 5-FU-resistant patients. Patients were predicted sensitive to 5-FU if the expression of NT5E was below the population median. Patients were predicted resistant if expression of NT5E was above the population median. As shown in FIG. 5, there was a statistically significant difference in survival between the predicted-sensitive group and the predicted-resistant group after months of adjuvant chemotherapy with 5-FU, with the predicted-sensitive group showing a significantly higher rate of survival than the predicted-resistant group (p=0.006).


If using more genes from Tables 1 and 2 than NT5E to predict sensitivity, the prediction can be performed as follows:

Prediction=mean(genes from Table 1)−mean(genes from Table 2)


Example 3
Predicting FOLFIRI Treatment Response in Colon Cancer Patients

A dataset of 40 formalin-fixed paraffin embedded (FFPE) colorectal cancer patient biopsies analyzed on the Almac Colorectal Cancer DSATM array type was downloaded from ArrayExpress under accession number E-MEXP-3549. The advantage of the Almac array compared to the HG-U133_Plus_2 array used in Example 2 is that the Almac array can use FFPE samples instead of fresh frozen samples. Fresh frozen samples are not routinely stored in surgical or pathological practice, but storing FFPE samples is standard procedure, and has been done for more than 100 years. Thus, the Almac array is logistically easier to incorporate into existing clinical practice than the HG-U133_Plus_2 array. All patients were treated with 5-FU and irinotecan (FOLFIRI).


The NT5E gene for 5-FU resistance was mapped to corresponding Almac probesets ADXCRAG_NM_002526_at (SEQ ID NO: 1015), ADXCRAG_NM_002526_s_at (SEQ ID NO: 1016), ADXCRPD.5241.C1_at (SEQ ID NO: 1683), ADXCRSS.Hs # S1299958_at (SEQ ID NO: 2064), ADXCRSS.Hs #53735513_at (SEQ ID NO: 2207), ADXCRAD_BX404438_s_at (SEQ ID NO: 2316), ADXCRAD_BM704188_at (SEQ ID NO: 2446), ADXCRAD_BG611920_at (SEQ ID NO: 2714), ADXCRAD_BC015940_at (SEQ ID NO: 2778) by using the file A-AFFY-101.adf.txt associated with the Almac array.


The PRF1 gene for irinotecan sensitivity was mapped to corresponding Almac probesets ADXCRAD_BQ654088_at (SEQ ID NO: 2314), ADXCRAD_BQ654088_x_at (SEQ ID NO: 2315), ADXCRAD_A1445650_at (SEQ ID NO: 2881).



FIG. 6 shows the predicted sensitivity to FOLFIRI based on the expression of the Almac probesets, based on the following algorithm:

Prediction=mean(PRF1 Almac probesets)−mean(NT5E Almac probesets)

normalized to a scale of 0 to 100 in the patients, when grouped according to clinical response to adjuvant chemotherapy with 5-FU and irinotecan. The population median was used as a cutoff between sensitive and resistant patients. The correlation between clinical response (CR=4,PR=2,SD=2,PD=1) and predicted sensitivity was evaluated with a Pearson correlation and gave a one-sided p-value of 0.004 and a correlation coefficient (CC) of 0.40.


If using more genes from Tables 1, 2, 3 and 4 to predict sensitivity, the genes can be mapped to the matching Almac probesets by lookup in file A-AFFY-101.adf.txt associated with the Almac array and available from ArrayExpress at http://www.ebi.ac.uk/arrayexpress/files/A-AFFY-101/A-AFFY-101.adf.txt. The prediction is then performed as follows:

Prediction=mean(probesets matching Table 1/3)−mean(probesets matching Table 2/4)


Example 4
Predicting FOLFOX Treatment Response in Colon Cancer Patients

A clinical dataset of 17 pre-treatment fresh frozen colorectal cancer surgical biopsies was downloaded from Gene Expression Omnibus under accession number GSE19860. The biopsies have been analyzed using the Affymetrix HG-U133-Plus_2 array type. All patients were treated adjuvantly with mFOLFOX6 (5-FU and oxaliplatin). The expression of NT5E was determined by reading the intensity of Affymetrix probeset 203939_at that is predicted higher expressed in 5-FU resistant patients. The expression of MRPL16 was determined by reading the intensity of Affymetrix probeset 217980_s_at that is predicted to be higher expressed in oxaliplatin sensitive patients.



FIG. 7 shows the predicted sensitivity to FOLFOX based on the following algorithm:

Prediction=217980_s_at−203939_s_at

normalized to a scale of 0 to 100 in the patients when grouped according to clinical response to adjuvant chemotherapy with FOLFOX. The population median was used as a cutoff between sensitive and resistant patients. A t-test of difference in predicted sensitivity between responders and non-responders gave a statistically significant one-sided p-value of 0.015.


Example 5
Predicting 5-FU Treatment Responsiveness and Adjusting Subsequent Treatment

The diagnostic methods of the present invention can be used to predict the responsiveness of a subject (e.g., a subject suffering from or susceptible to colon cancer or breast cancer) to treatment with 5-FU or a prodrug for 5-FU, such as capecitabine or tegafur. A biological sample (e.g., a tumor biopsy) may be obtained from the subject through methods well known in the art. The sample may be frozen and/or prepared, e.g., by formalin fixation and paraffin embedding. mRNA can be isolated from the sample and a gene expression profile determined, e.g., using a microarray platform such as the Almac Colorectal Cancer DSATM array or the Affymetrix HG-U133-Plus_2 array. Alternatively, specific biomarkers of resistance and/or sensitivity to 5-FU can be measured, e.g., by microarray, sequencing, or PCR-based techniques, such as those described herein. For example, the expression levels of the 5-FU resistance biomarkers NT5E, CNN3, ACTN1, FLNA, and/or ATP2B4 can be determined. The expression levels of the 5-FU sensitivity biomarkers APRT, GSR, TUFM, MRPS2, and/or MTHFD2 can also be determined. An elevated level of one or more of the biomarkers of resistance and/or sensitivity can indicate the responsiveness of the subject to treatment with 5-FU. For example, an elevated level of one or more 5-FU resistance biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is resistant to 5-FU treatment. Alternatively, for example, an elevated level of one or more 5-FU sensitivity biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is sensitive to 5-FU treatment. Furthermore, the relative expression levels of 5-FU resistance and sensitivity biomarkers can indicate the responsiveness of the subject to 5-FU treatment.


If a subject is predicted to be sensitive to 5-FU treatment, then subsequent treatment of the subject can be altered, e.g., to include 5-FU and/or a prodrug thereof (e.g., capecitabine or tegafur), or to decrease dosage, frequency of administration, and/or length of treatment with 5-FU and/or a prodrug thereof (e.g., capecitabine or tegafur). Conversely, if a subject is predicted to be resistant to 5-FU treatment, then subsequent treatment of the subject can be altered, e.g., to omit 5-FU and/or a prodrug thereof (e.g., capecitabine or tegafur), or to increase dosage, frequency of administration, and/or length of treatment with 5-FU and/or a prodrug thereof (e.g., capecitabine or tegafur). Furthermore, a subject predicted to be resistant to 5-FU can be administered drugs other than 5-FU, such as irinotecan, oxaliplatin, and/or another chemotherapeutic agent as described herein.


Example 6
Predicting Irinotecan Treatment Responsiveness and Adjusting Subsequent Treatment

The diagnostic methods of the present invention can be used to predict the responsiveness of a subject (e.g., a subject suffering from or susceptible to colon cancer or breast cancer) to treatment with irinotecan. A biological sample (e.g., a tumor biopsy) may be obtained from the subject through methods well known in the art. The sample may be frozen and/or prepared, e.g., by formalin fixation and paraffin embedding. mRNA can be isolated from the sample and a gene expression profile determined, e.g., using a microarray platform such as the Almac Colorectal Cancer DSATM array or the Affymetrix HG-U133-Plus_2 array. Alternatively, specific biomarkers of resistance and/or sensitivity to irinotecan can be measured, e.g., by microarray, sequencing, or PCR-based techniques, such as those described herein. For example, the expression levels of the irinotecan sensitivity biomarkers PRF1, GZMB, PTPRC, PTPRC, and/or PTPRCAP can be determined. The expression levels of the irinotecan resistance biomarkers CCND1, LGALS3, INPP4B, TMEM97, and/or TCF7L2 can also be determined. An elevated level of one or more of the biomarkers of resistance and/or sensitivity can indicate the responsiveness of the subject to treatment with irinotecan. For example, an elevated level of one or more irinotecan resistance biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is resistant to irinotecan treatment. Alternatively, for example, an elevated level of one or more irinotecan sensitivity biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is sensitive to irinotecan treatment. Furthermore, the relative expression levels of irinotecan resistance and sensitivity biomarkers can indicate the responsiveness of the subject to irinotecan treatment.


If a subject is predicted to be sensitive to irinotecan treatment, then subsequent treatment of the subject can be altered, e.g., to include irinotecan or to decrease dosage, frequency of administration, and/or length of treatment with irinotecan. Conversely, if a subject is predicted to be resistant to irinotecan treatment, then subsequent treatment of the subject can be altered, e.g., to omit irinotecan or to increase dosage, frequency of administration, and/or length of treatment with irinotecan. Furthermore, a subject predicted to be resistant to irinotecan can be administered drugs other than irinotecan, such as 5-FU, capecitabine, tegafur, oxaliplatin, and/or another chemotherapeutic agent as described herein.


Example 7
Predicting Oxaliplatin Treatment Responsiveness and Adjusting Subsequent Treatment

The diagnostic methods of the present invention can be used to predict the responsiveness of a subject (e.g., a subject suffering from or susceptible to colon cancer or breast cancer) to treatment with oxaliplatin. A biological sample (e.g., a tumor biopsy) may be obtained from the subject through methods well known in the art. The sample may be frozen and/or prepared, e.g., by formalin fixation and paraffin embedding. mRNA can be isolated from the sample and a gene expression profile determined, e.g., using a microarray platform such as the Almac Colorectal Cancer DSATM array or the Affymetrix HG-U133-Plus_2 array. Alternatively, specific biomarkers of resistance and/or sensitivity to oxaliplatin can be measured, e.g., by microarray, sequencing, or PCR-based techniques, such as those described herein. For example, the expression levels of the oxaliplatin sensitivity biomarkers MRPL16, ANP32A, SRSF2, PDSS1, and/or PRIM1 can be determined. The expression levels of the oxaliplatin resistance biomarkers LPP, RHOC, CAPN2, FLNA, and/or WDR1 can also be determined. An elevated level of one or more of the biomarkers of resistance and/or sensitivity can indicate the responsiveness of the subject to treatment with oxaliplatin. For example, an elevated level of one or more oxaliplatin resistance biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is resistant to oxaliplatin treatment. Alternatively, for example, an elevated level of one or more oxaliplatin sensitivity biomarkers in the subject, relative to a control (e.g., the population median) can indicate that the subject is sensitive to oxaliplatin treatment. Furthermore, the relative expression levels of oxaliplatin resistance and sensitivity biomarkers can indicate the responsiveness of the subject to oxaliplatin treatment.


If a subject is predicted to be sensitive to oxaliplatin treatment, then subsequent treatment of the subject can be altered, e.g., to include oxaliplatin or to decrease dosage, frequency of administration, and/or length of treatment with oxaliplatin. Conversely, if a subject is predicted to be resistant to oxaliplatin treatment, then subsequent treatment of the subject can be altered, e.g., to omit oxaliplatin or to increase dosage, frequency of administration, and/or length of treatment with oxaliplatin. Furthermore, a subject predicted to be resistant to oxaliplatin can be administered drugs other than oxaliplatin, such as 5-FU, capecitabine, tegafur, irinotecan, and/or another chemotherapeutic agent as described herein.


OTHER EMBODIMENTS

All publications, patents, and patent applications mentioned in the above specification are hereby incorporated by reference to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety. Various modifications and variations of the described methods, pharmaceutical compositions, and kits of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific embodiments, it will be understood that it is capable of further modifications and that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention that are obvious to those skilled in the art are intended to be within the scope of the invention. This application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure come within known customary practice within the art to which the invention pertains and may be applied to the essential features herein before set forth.

Claims
  • 1. A method of treating cancer in a subject in need thereof comprising administering 5-FU to said subject, wherein the subject has been determined to be responsive to 5-FU according to a method comprising: (a) contacting a tumor sample from the subject comprising a plurality of nucleic acid molecules with a device comprising: (i) single-stranded nucleic acid molecules capable of specifically hybridizing with the nucleotides of biomarkers of resistance to 5-FU, wherein the biomarkers of resistance are NTSE, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158;(ii) single-stranded nucleic acid molecules capable of specifically hybridizing with the nucleotides of biomarkers of sensitivity to 5-FU wherein the biomarkers of sensitivity comprise APRT, GSR, TUFM, MRPS2, MTHFD2, WDR59, ANP32B, PMM2, STOML2, and NDUFAB1;(b) detecting a level of expression of the biomarkers of resistance and the biomarkers of sensitivity by performing microarray analysis or quantitative reverse transcriptase polymerase chain reaction (qRT-PCR); and(c) calculating a difference score for the subject by subtracting the mean expression levels of the plurality of biomarkers of resistance from the mean expression levels of the plurality of biomarkers of sensitivity, wherein the difference score is above a cutoff value.
  • 2. The method of claim 1, further comprising administering one or more additional therapies to said subject, wherein said one or more additional therapies is administered: (a) concurrently with said administration of 5-FU; or(b) separately from said administration of 5-FU; or(c) prior to said administration of 5-FU; or(d) after said administration of 5-FU.
  • 3. The method of claim 2, wherein said one or more additional therapies is administered within 1 week of said administration of 5-FU.
  • 4. The method of claim 2, wherein said one or more additional therapies comprises one or more additional therapeutic agents, surgery, or radiation therapy.
  • 5. The method of claim 4, wherein said one or more additional therapies comprises one or more additional therapeutic agents, wherein said 5-FU is administered alone or in admixture with said one or more additional therapeutic agents.
  • 6. The method of claim 5 wherein said one or more additional therapeutic agents is selected from: (a) the group consisting of: irinotecan, oxaliplatin, cetuximab, leucovorin, SN-38, everolimus, temsirolimus, bleomycin, lomustine, depsipeptide, carboplatin, bortezomib, erlotinib, gemcitabine, mitoxantrone, cisplatin, busulfan, epirubicin, arsenic trioxide, bendamustine, vincristine, fulvestrant, teniposide, adriamycin, decitabine, and estramustine; or(b) everolimus, temsirolimus, bleomycin, or lomustine; or(c) leucovorin and at least one of irinotecan or oxaliplatin.
  • 7. The method of claim 1, wherein said 5-FU is administered to said subject intravenously, orally, intraperitoneally, intramuscularly, topically, rectally, cutaneously, subcutaneously, nasally, intracerebroventricularly, intraparenchymally, intrathecally, intracranially, ocularly, via inhalation, or through the skin.
  • 8. The method of claim 7, wherein said 5-FU is administered to said subject: (a) once daily; and/or(b) once daily, for up to four years; and/or(c) once weekly, once every other week, or once every three weeks; and/or(d) in six week cycles; and/or(c) repeated 30 days after the completion of the previous administration; and/or(d) repeated for at least 12 to 60 months.
  • 9. The method of claim 1, wherein said 5-FU is administered to the subject once daily at a dose of up to 800 mg.
  • 10. The method of claim 1, further comprising determining the expression level of one or more additional biomarkers, wherein said one or more additional biomarkers is selected from the group consisting of: carcinoembryonic antigen (CEA), BRAF, KRAS, Fas-ligand, p53, Ki-67, thymidylate-synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, microsatellite instability (MIS), and 18q allelic loss of heterozygosity (LOH18q).
  • 11. A method of treating cancer in a subject in need thereof comprising administering 5-FU to the subject with a difference score above a cutoff value, wherein the difference score is the difference between a mean of a level of expression of biomarkers of sensitivity and a mean of a level of expression of biomarkers of resistance determined in a tumor sample from the subject, wherein the biomarkers of sensitivity are APRT, GSR, TUFM, MRPS2, MTHFD2, WDR59, ANP32B, PMM2, STOML2, and NDUFAB1 and the biomarkers of resistance are NT5E, CNN3, ACTN1, FLNA, ATP2B4, CYR61, LGALS1, RHOC, RAB32, and TMEM158.
  • 12. The method of claim 11, wherein the cutoff value is a 50th percentile of the difference score in a reference population with the same diagnosis as the subject, or greater.
  • 13. The method of claim 12, wherein the cutoff value is a 60th percentile of the difference score in a reference population with the same diagnosis as the subject, or greater.
  • 14. The method of claim 13, wherein the cutoff value is a 70th percentile of the difference score in a reference population with the same diagnosis as the subject, or greater.
  • 15. The method of claim 14, wherein the cutoff value is an 80th percentile of the difference score in a reference population with the same diagnosis as the subject, or greater.
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2015/002055 9/25/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2016/046640 3/31/2016 WO A
US Referenced Citations (35)
Number Name Date Kind
6911306 Vertino Jun 2005 B1
7239986 Golub et al. Jul 2007 B2
7709616 Bentwich et al. May 2010 B2
8445198 Knudsen May 2013 B2
9598734 Knudsen Mar 2017 B2
9725769 Knudsen Aug 2017 B1
20010051344 Shalon et al. Dec 2001 A1
20020164663 Fuqua et al. Nov 2002 A1
20030073083 Tamayo et al. Apr 2003 A1
20040018525 Wirtz et al. Jan 2004 A1
20040072722 Kornblith et al. Apr 2004 A1
20050176669 Al-Murrani Aug 2005 A1
20050260586 Demuth et al. Nov 2005 A1
20050260646 Baker et al. Nov 2005 A1
20060105360 Croce et al. May 2006 A1
20060121511 Lee et al. Jun 2006 A1
20070172844 Lancaster Jul 2007 A1
20080227663 Tisone Sep 2008 A1
20080306006 Croce et al. Dec 2008 A1
20090023149 Knudsen Jan 2009 A1
20090221435 Baskerville et al. Sep 2009 A1
20090239223 Gehrmann et al. Sep 2009 A1
20100240043 Rotter et al. Sep 2010 A1
20110123990 Baker et al. May 2011 A1
20120046186 Pelham et al. Feb 2012 A1
20120214703 Croce et al. Aug 2012 A1
20120302626 Dave et al. Nov 2012 A1
20130053275 Knudsen Feb 2013 A1
20130059015 Lancaster et al. Mar 2013 A1
20140294730 Slack-Davis et al. Oct 2014 A1
20150353928 Weiner Dec 2015 A1
20160199399 Knudsen Jul 2016 A1
20170283884 Knudsen Oct 2017 A1
20180087113 Knudsen Mar 2018 A1
20180202004 Knudsen Jul 2018 A1
Foreign Referenced Citations (35)
Number Date Country
2428112 Nov 2003 CA
102002490 Apr 2011 CN
1550731 Jul 2005 EP
2081950 Jul 2009 EP
2001-17171 Jan 2001 JP
2002-531066 Sep 2002 JP
2004-43446 Feb 2004 JP
2005-530784 Oct 2005 JP
2528247 Sep 2014 RU
WO-0031930 Jun 2000 WO
WO-0035473 Jun 2000 WO
WO-03082078 Oct 2003 WO
WO-2005005601 Jan 2005 WO
WO-2005014856 Feb 2005 WO
WO-2005047534 May 2005 WO
WO-2005066371 Jul 2005 WO
WO-2005087948 Sep 2005 WO
WO-2005094863 Oct 2005 WO
WO-2005100606 Oct 2005 WO
WO-2007072225 Jun 2007 WO
WO-2008073177 Jun 2008 WO
WO-2008073629 Jun 2008 WO
WO-2008112283 Sep 2008 WO
WO-2008138578 Nov 2008 WO
WO-2009036332 Mar 2009 WO
WO-2009080437 Jul 2009 WO
WO-2011032563 Mar 2011 WO
WO-2011098578 Aug 2011 WO
WO-2011135459 Nov 2011 WO
WO-2012024543 Feb 2012 WO
WO-2012106718 Aug 2012 WO
WO-2012109233 Aug 2012 WO
WO-2012163541 Dec 2012 WO
WO-2013130465 Sep 2013 WO
WO-2014195032 Dec 2014 WO
Non-Patent Literature Citations (68)
Entry
NIH DailyMed for Fluorouracil (Sandoz Inc). Available via URL: <dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1911e06a-2f16-4b99-adfa-4b914d559e1e&type=display>, May 2010.
Buhl et al., “A genetic response profile to predict efficacy of adjuvant 5-fu in colon cancer,” Annals of Oncology 25(Supplement 4):iv167-iv209 (2014) (1 page).
Invitation to Pay Additional Fees for International Application No. PCT/IB2015/002055, dated Mar. 29, 2016 (12 pages).
Mizutani et al., “Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma,” J Urol. 171(2 Pt 1):605-10 (2004).
Okumura et al., “Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer,” Oncol Rep. 15(4):875-82 (2006).
Ooyama et al., “Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs,” Cancer Sci. 97(6):510-22 (2006).
International Search Report for International Patent Application No. PCT/IB2015/002055, dated Jun. 10, 2016 (10 pages).
International Preliminary Report on Patentability and Written Opinion for International Patent Application No. PCT/IB2015/002055, dated Mar. 28, 2017 (14 pages).
Abba et al., “Gene expression signature of estrogen receptor alpha status in breast cancer,” BMC Genomics. 6:37 (2005) (13 pages).
Affymetrix Expression Probeset Details for HG-U133_PLUS_2:209083_AT, <https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133_PLUS_2:209083_AT>, retrieved Nov. 27, 2018 (4 pages).
Agrawal et al., “Long-term effect of fulvestrant on hormone receptors and proliferation marker in breast cancer,” EJC Supplements. 8(3):111 (2010).
Arienti et al., “Activity of lipoplatin in tumor and in normal cells in vitro,” Anti-Cancer Drugs. 19(10):983-990 (2008) (8 pages).
Baker, “The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer,” J Natl Cancer Inst. 95(7):511-5 (2003).
Bild et al., “Oncogenic pathway signatures in human cancers as a guide to targeted therapies,” Nature. 439(7074):353-7 (2006).
Castelli et al., “In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes,” Hum Immunol. 70(12):1020-5 (2009).
Chow et al., “Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors,” Proteomics Clin Appl. 3(6):654-62 (2009).
Dahlén et al., “Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12),” Am J Pathol. 164(5):1645-53 (2004).
Di Lisio, “MicroRNA expression in B-cell lymphomas,” Doctoral Thesis, Facultad de Ciencias, Departamento de Biologia Molecular, Universidad Autónoma de Madrid (2012) (223 pages).
Elstrom et al., “Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies,” Clin Lymphoma Myeloma Leuk. 10(3):192-6 (2010).
Etter et al., “The combination of chemotherapy and intraperitoneal MegaFas Ligand improves treatment of ovarian carcinoma,” Gynecol Oncol. 107(1):14-21 (2007).
Fournier et al., “Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer,” Cancer Res. 66(14):7095-7102 (2006).
Friis-Hansen et al., “Mir-449 inhibits growth of gastric cancer cells partly by inhibiting the expression of met and amphiregulin,” Gastroenterology. 136(5):A-165 (2009) (1 page).
Fumagalli et al., “Oral vinorelbine and capecitabine plus bevacizumab in recurrent inflammatory breast cancer: gene profiling and response to treatment,” Thirty-Third Annual CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 8-12, San Antonio, TX. Cancer Res. 70(24 Suppl.): Abstract P6-12-06 (2010) (2 pages).
Gallardo et al., “miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer,” Carcinogenesis. 30(11):1903-9 (2009).
Genbank Accession No. AY889152.1. Retrieved on Mar. 5, 2013 (2 pages).
GenBank Accession No. HC040507.1: Sequence 486 from Patent EP2112235 (1 page).
Gerspach et al., “Therapeutic targeting of CD95 and the TRAIL death receptors,” Recent Pat Anticancer Drug Discov. 6(3):294-310 (2011).
Grimm et al., “Drugs interfering with apoptosis in breast cancer,” Curr Pharm Des. 17(3):272-83 (2011).
Juncker-Jensen et al., “Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator,” Growth Horm IGF Res. 16(4):224-39 (2006).
Knudsen et al., “Development and validation of a gene expression score that predicts response to fulvestrant in breast cancer patients,” PLoS One. 9(2):e87415 (2014) (12 pages).
Koeppel et al., “Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells,” Clin Cancer Res. 10(16):5604-13 (2004) (11 pages).
Kornmann et al., “Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil,” Clinical Cancer Res. 9(11):4116-24 (2003).
Kuter et al., “Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study,” Breast Cancer Res Treat. 133(1):237-46 (2012).
Lee et al., “Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development,” Oncologist. 10(2):104-11 (2005) (9 pages).
Li et al., “Intronic microRNA: discovery and biological implications,” DNA Cell Biol. 26(4):195-207 (2007).
Li et al., “Selection of optimal oligonucleotide probes for microarrays using multiple criteria, global alignment and parameter estimation,” Nucleic Acids Res. 33(19):6114-23 (2005).
Liang et al., “Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells,” Mol Cancer Ther. 3(11):1385-96 (2004) (13 pages).
Liang et al., “Characterization of microRNA expression profiles in normal human tissues,” BMC Genomics. 8(166):1-20 (2007).
Liu et al., “Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter,” Biochem J. 383(Pt 2):249-57 (2004).
López et al., Chapter 11: MicroRNAs in Lymphoma, MicroRNAs in Cancer Translational Research. W.C.S. Cho (ed.), 239-67 (2011).
McCune et al., “Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet,” Cancer Res. 70(2):685-96 (2010).
Medinger et al., “Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents,” Cancer Genomics Proteomics.13(4):275-9 (2016).
Michels, “The promises and challenges of epigenetic epidemiology,” Exp Gerontol. 45(4):297-301 (2010).
Nair et al., “A simple practice guide for dose conversion between animals and human,” J Basic Clin Pharm. 7(2):27-31 (2016).
Narita et al., “Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy,” Blood Cancer J. 5:e373 (2015) (8 pages).
NCode™ Multi-Species miRNA Microarray Probe Set, Version 2.0 (Cat. # MIRMPS2-01 ), retrieved from <http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/epigenetics-noncoding-rna-research/miRNA-Profiling-/miRNA-Probe-Set-Files.html> (2009) (21 pages).
Nielsen et al., “Design of oligonucleotides for microarrays and perspectives for design of multi-transcriptome arrays,” Nucleic Acids Res. 31(13):3491-6 (2003).
Nikas et al., “Prognosis of treatment response (pathological complete response) in breast cancer,” Biomark Insights. 7:59-70 (2012).
Ocio et al., “The Activation of Fas Receptor by APO010, a Recombinant Form of Fas Ligand, Induces In Vitro and In Vivo Antimyeloma Activity,” Blood. 110(11):1515 (2007) (4 pages) (Abstract Only).
Paul et al., “Impact of miRNA deregulation on mRNA expression profiles in response to environmental toxicant, nonylphenol,” Mol Cell Toxicol. 7:259-69 (2011).
Pradervand et al., “Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs,” Biotechniques. 48(3):219-222 (2010).
Reid et al., “Circulating microRNAs: Association with disease and potential use as biomarkers,” Crit Rev Oncol Hematol. 80(2):193-208 (2011).
Rouillard et al., “OligoArray 2.0: design of oligonucleotide probes for DNA microarrays using a thermodynamic approach,” Nucleic Acids Res. 31(12):3057-62 (2003).
Senzer et al., “Irofulven demonstrates clinical activity against metastatic hormone-refractory prostate cancer in a phase 2 single-agent trial,” Am J Clin Oncol. 28(1):36-42 (2005).
Sezaki et al., “Over-expression of the dominant-negative isoform of Ikaros confers resistance to dexamethasone-induced and anti-IgM-induced apoptosis,” Br J Haematol. 121(1):165-9 (2003) (Abstract only).
Slonim, “From patterns to pathways: gene expression data analysis comes of age,” Nat Genet. 32 Suppl:502-8 (2002).
Suresh et al., “Resistance/response molecular signature for oral tongue squamous cell carcinoma,” Dis Markers. 32(1):51-64 (2012).
The Japanese Journal of Urology, 94(2):159 (APP-105) (2003).
Van't Veer et al., “Gene expression profiling predicts clinical outcome of breast cancer,” Nature. 415(6871):530-6 (2002).
Vangsted et al., “APO010 sensitivity in relapsed multiple myeloma patients,” Annals of Oncol. 27(Supplement 6): vi15-vi42 (2016) (2 pages) (Abstract only).
Verbrugge et al., “Combining radiotherapy with APO010 in cancer treatment,” Clin Cancer Res. 15(6):2031-8 (2009) (9 pages).
Wang et al., “Independent Validation of a Model Using Cell Line Chemosensitivity to Predict Response to Therapy,” J Natl Cancer Inst. 105(17): 1284-91 (2013).
Woynarowska et al., “Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven,” Invest New Drugs. 19(4):283-91 (2001).
Xu et al., “[Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia],” Zhonghua Xue Ye Xue Za Zhi. 32(3):178-81 (Abstract only) (2011).
Yang et al., “The role of microRNA in human lung squamous cell carcinoma,” Cancer Genet Cytogenet. 200(2):127-33 (2010).
Yin, “Screening of laryngeal carcinoma multidrug resistance-associated genes and study on reversion by Chinese herbs,” China Doctoral Dissertations Full-text Database, Division of Medical and Hygiene Technology. 8:E072-85 (2010) (3 pages) (Abstract only).
Zhang et al., “MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity,” Biochem Biophys Res Commun. 395(2):275-280 (2010).
Communication pursuant to Article 164(2)(b) and Article 94(3) EPC for European Application No. 15820250.7, dated Jun. 6, 2019 (17 pages).
Related Publications (1)
Number Date Country
20170283884 A1 Oct 2017 US
Provisional Applications (1)
Number Date Country
62056295 Sep 2014 US